interactions:
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=0&limit=100
  response:
    content: '{"offset": 0, "next": 100, "data": [{"paperId": "01063e45d9fc9635d29d8d78aa24ed8de351f36a",
      "externalIds": {"PubMedCentral": "10470746", "DOI": "10.1128/mbio.01007-23",
      "CorpusId": 261369988, "PubMed": "37345956"}, "corpusId": 261369988, "publicationVenue":
      {"id": "ed29e34d-f5a1-46d1-aa25-10e20a98f063", "name": "mBio", "type": "journal",
      "alternate_names": ["Mbio"], "issn": "2150-7511", "url": "https://mbio.asm.org/"},
      "url": "https://www.semanticscholar.org/paper/01063e45d9fc9635d29d8d78aa24ed8de351f36a",
      "title": "SARS-CoV-2 hijacks p38\u03b2/MAPK11 to promote virus replication",
      "abstract": "ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
      the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, drastically
      modifies infected cells to optimize virus replication. One such modification
      is the activation of the host p38 mitogen-activated protein kinase (MAPK) pathway,
      which plays a major role in inflammatory cytokine production, a hallmark of
      severe COVID-19. We previously demonstrated that inhibition of p38/MAPK activity
      in SARS-CoV-2-infected cells reduced both cytokine production and viral replication.
      Here, we combined quantitative genetic screening, genomics, proteomics, and
      phosphoproteomics to better understand mechanisms underlying the dependence
      of SARS-CoV-2 on the p38 pathway. We found that p38\u03b2 is a critical host
      factor for SARS-CoV-2 replication in multiple relevant cell lines and that it
      functions at a step after viral mRNA expression. We identified putative host
      and viral p38\u03b2 substrates in the context of SARS-CoV-2 infection and found
      that most host substrates have intrinsic antiviral activities. Taken together,
      this study reveals a unique proviral function for p38\u03b2 and supports exploring
      p38\u03b2 inhibitor development as a strategy toward creating a new class of
      COVID-19 therapies. IMPORTANCE SARS-CoV-2 is the causative agent of the COVID-19
      pandemic that has claimed millions of lives since its emergence in 2019. SARS-CoV-2
      infection of human cells requires the activity of several cellular pathways
      for successful replication. One such pathway, the p38 MAPK pathway, is required
      for virus replication and disease pathogenesis. Here, we applied systems biology
      approaches to understand how MAPK pathways benefit SARS-CoV-2 replication to
      inform the development of novel COVID-19 drug therapies. SARS-CoV-2 is the causative
      agent of the COVID-19 pandemic that has claimed millions of lives since its
      emergence in 2019. SARS-CoV-2 infection of human cells requires the activity
      of several cellular pathways for successful replication. One such pathway, the
      p38 MAPK pathway, is required for virus replication and disease pathogenesis.
      Here, we applied systems biology approaches to understand how MAPK pathways
      benefit SARS-CoV-2 replication to inform the development of novel COVID-19 drug
      therapies.", "venue": "mBio", "year": 2023, "referenceCount": 56, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-06-22", "journal": {"volume": "14", "name": "mBio"},
      "citationStyles": {"bibtex": "@Article{Higgins2023SARSCoV2HP,\n author = {Christina
      A. Higgins and Benjamin E. Nilsson-Payant and Boris Bonaventure and A. Kurland
      and C. Ye and Tomer M. Yaron and Jared L. Johnson and Prithy Adhikary and Ilona
      Golynker and M. Panis and O. Danziger and Brad R. Rosenberg and L. Cantley and
      L. Mart\u00ednez-Sobrido and B. tenOever and Jeffrey R. Johnson},\n booktitle
      = {mBio},\n journal = {mBio},\n title = {SARS-CoV-2 hijacks p38\u03b2/MAPK11
      to promote virus replication},\n volume = {14},\n year = {2023}\n}\n"}, "authors":
      [{"authorId": "21581175", "name": "Christina A. Higgins"}, {"authorId": "1422205499",
      "name": "Benjamin E. Nilsson-Payant"}, {"authorId": "52034318", "name": "Boris
      Bonaventure"}, {"authorId": "2091925403", "name": "A. Kurland"}, {"authorId":
      "1820803613", "name": "C. Ye"}, {"authorId": "5247030", "name": "Tomer M. Yaron"},
      {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId": "2124144278",
      "name": "Prithy Adhikary"}, {"authorId": "1420415021", "name": "Ilona Golynker"},
      {"authorId": "3579494", "name": "M. Panis"}, {"authorId": "8777036", "name":
      "O. Danziger"}, {"authorId": "39166273", "name": "Brad R. Rosenberg"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "1390112686", "name": "L. Mart\u00ednez-Sobrido"},
      {"authorId": "5462120", "name": "B. tenOever"}, {"authorId": "2185012922", "name":
      "Jeffrey R. Johnson"}]}, {"paperId": "03df05f4f245084b72a3099c105801f4d63d6e1d",
      "externalIds": {"DOI": "10.1016/j.cell.2023.07.014", "CorpusId": 260891325,
      "PubMed": "37582357"}, "corpusId": 260891325, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/03df05f4f245084b72a3099c105801f4d63d6e1d",
      "title": "Pan-cancer proteogenomics connects oncogenic drivers to functional
      states", "abstract": null, "venue": "Cell", "year": 2023, "referenceCount":
      184, "citationCount": 6, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0092867423007808/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-08-01", "journal": {"volume": "186", "pages": "3921-3944.e25",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Li2023PancancerPC,\n
      author = {Yize Li and E. Porta-Pardo and Collin J Tokheim and Matthew H. Bailey
      and Tomer M. Yaron and Vasileios Stathias and Y. Geffen and Kathleen J. Imbach
      and Song Cao and Shankara K. Anand and Y. Akiyama and Wenke Liu and Matthew
      A. Wyczalkowski and Yizhe Song and E. Storrs and M. Wendl and Wubing Zhang and
      Mustafa Sibai and Victoria Ruiz-Serra and Wen-Wei Liang and Nadezhda V. Terekhanova
      and F. M. Rodrigues and K. Clauser and David I Heiman and Qing Zhang and F.
      Aguet and A. Calinawan and S. Dhanasekaran and Chet Birger and S. Satpathy and
      D. Zhou and Liang-Bo Wang and Jessika Baral and Jared L. Johnson and Emily M
      Huntsman and Pietro Pugliese and A. Colaprico and A. Iavarone and M. Chheda
      and C. Ricketts and D. Feny\u00f6 and S. Payne and Henry Rodriguez and Ana I.
      Robles and Michael A. Gillette and Chandan Kumar-Sinha and A. Lazar and L. Cantley
      and G. Getz and Li Ding and E. An and M. Anurag and Jasmin H. Bavarva and M.
      Birrer and A. Calinawan and M. Ceccarelli and Daniel W. Chan and A. Chinnaiyan
      and Han-Byoul Cho and S. Chowdhury and M. Cieslik and F. Leprevost and Corbin
      Day and M. Domagalski and Yongchao Dou and B. Druker and Nathan Edwards and
      M. Ellis and M. Selvan and S. Foltz and Alicia Francis and Tania J. Gonzalez
      Robles and Sara J. C. Gosline and Z. G\u00fcm\u00fc\u015f and Tara Hiltke and
      R. Hong and G. Hostetter and Yingwei Hu and Chen Huang and Emily M Huntsman
      and Eric J. Jaehnig and Scott D. Jewel and Jiayi Ji and Wen Jiang and L. Katsnelson
      and K. Ketchum and Iga Ko\u0142odziejczak and Jonathan T. Lei and Yuxing Liao
      and Caleb M Lindgren and T. Liu and Weiping Ma and Wilson H. McKerrow and A.
      Nesvizhskii and Chelsea J. Newton and R. Oldroyd and G. Omenn and A. Paulovich
      and F. Petralia and B. Reva and K. Rodland and Kelly V. Ruggles and Dmitry Rykunov
      and Sara R. Savage and E. Schadt and M. Schnaubelt and Tobias Schraink and Zhiao
      Shi and Richard D. Smith and Xiaoyu Song and Jimin Tan and Ratna R. Thangudu
      and N. Tignor and Joshua M Wang and Pei Wang and Ying Wang and Bo Wen and M.
      Wiznerowicz and Xinpei Yi and Bing Zhang and Hui Zhang and Xu Zhang and Zhen
      Zhang},\n booktitle = {Cell},\n journal = {Cell},\n pages = {3921-3944.e25},\n
      title = {Pan-cancer proteogenomics connects oncogenic drivers to functional
      states},\n volume = {186},\n year = {2023}\n}\n"}, "authors": [{"authorId":
      "2110456727", "name": "Yize Li"}, {"authorId": "1399201106", "name": "E. Porta-Pardo"},
      {"authorId": "50364002", "name": "Collin J Tokheim"}, {"authorId": "32799542",
      "name": "Matthew H. Bailey"}, {"authorId": "5247030", "name": "Tomer M. Yaron"},
      {"authorId": "4187414", "name": "Vasileios Stathias"}, {"authorId": "16307269",
      "name": "Y. Geffen"}, {"authorId": "2266354894", "name": "Kathleen J. Imbach"},
      {"authorId": "145733601", "name": "Song Cao"}, {"authorId": "48361643", "name":
      "Shankara K. Anand"}, {"authorId": "153604992", "name": "Y. Akiyama"}, {"authorId":
      "2143702454", "name": "Wenke Liu"}, {"authorId": "4953858", "name": "Matthew
      A. Wyczalkowski"}, {"authorId": "2115712860", "name": "Yizhe Song"}, {"authorId":
      "1742409571", "name": "E. Storrs"}, {"authorId": "1707033", "name": "M. Wendl"},
      {"authorId": "1508582925", "name": "Wubing Zhang"}, {"authorId": "1492035459",
      "name": "Mustafa Sibai"}, {"authorId": "1416123698", "name": "Victoria Ruiz-Serra"},
      {"authorId": "50676162", "name": "Wen-Wei Liang"}, {"authorId": "3650868", "name":
      "Nadezhda V. Terekhanova"}, {"authorId": "31600403", "name": "F. M. Rodrigues"},
      {"authorId": "2027516", "name": "K. Clauser"}, {"authorId": "37329835", "name":
      "David I Heiman"}, {"authorId": "2112725056", "name": "Qing Zhang"}, {"authorId":
      "48975912", "name": "F. Aguet"}, {"authorId": "1580783790", "name": "A. Calinawan"},
      {"authorId": "3113892", "name": "S. Dhanasekaran"}, {"authorId": "69878839",
      "name": "Chet Birger"}, {"authorId": "34794500", "name": "S. Satpathy"}, {"authorId":
      "38178101", "name": "D. Zhou"}, {"authorId": "2144691004", "name": "Liang-Bo
      Wang"}, {"authorId": "2049093242", "name": "Jessika Baral"}, {"authorId": "145916288",
      "name": "Jared L. Johnson"}, {"authorId": "2137359212", "name": "Emily M Huntsman"},
      {"authorId": "1791880674", "name": "Pietro Pugliese"}, {"authorId": "2550756",
      "name": "A. Colaprico"}, {"authorId": "2078840019", "name": "A. Iavarone"},
      {"authorId": "7661076", "name": "M. Chheda"}, {"authorId": "6155292", "name":
      "C. Ricketts"}, {"authorId": "3297236", "name": "D. Feny\u00f6"}, {"authorId":
      "145540232", "name": "S. Payne"}, {"authorId": "2054449618", "name": "Henry
      Rodriguez"}, {"authorId": "2129211402", "name": "Ana I. Robles"}, {"authorId":
      "39595909", "name": "Michael A. Gillette"}, {"authorId": "1396440493", "name":
      "Chandan Kumar-Sinha"}, {"authorId": "2063985933", "name": "A. Lazar"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2110594", "name": "G. Getz"},
      {"authorId": "2153731784", "name": "Li Ding"}, {"authorId": "5605144", "name":
      "E. An"}, {"authorId": "48304712", "name": "M. Anurag"}, {"authorId": "2127569",
      "name": "Jasmin H. Bavarva"}, {"authorId": "2167106", "name": "M. Birrer"},
      {"authorId": "1580783790", "name": "A. Calinawan"}, {"authorId": "2149683606",
      "name": "M. Ceccarelli"}, {"authorId": "2111734912", "name": "Daniel W. Chan"},
      {"authorId": "2186786", "name": "A. Chinnaiyan"}, {"authorId": "153429785",
      "name": "Han-Byoul Cho"}, {"authorId": "46216123", "name": "S. Chowdhury"},
      {"authorId": "50748126", "name": "M. Cieslik"}, {"authorId": "2687528", "name":
      "F. Leprevost"}, {"authorId": "2229239473", "name": "Corbin Day"}, {"authorId":
      "5670306", "name": "M. Domagalski"}, {"authorId": "40429872", "name": "Yongchao
      Dou"}, {"authorId": "144082761", "name": "B. Druker"}, {"authorId": "2207234317",
      "name": "Nathan Edwards"}, {"authorId": "2059004868", "name": "M. Ellis"}, {"authorId":
      "4506880", "name": "M. Selvan"}, {"authorId": "36381769", "name": "S. Foltz"},
      {"authorId": "2064227355", "name": "Alicia Francis"}, {"authorId": "2189321519",
      "name": "Tania J. Gonzalez Robles"}, {"authorId": "2003009", "name": "Sara J.
      C. Gosline"}, {"authorId": "1894070", "name": "Z. G\u00fcm\u00fc\u015f"}, {"authorId":
      "7547869", "name": "Tara Hiltke"}, {"authorId": "95014017", "name": "R. Hong"},
      {"authorId": "48397691", "name": "G. Hostetter"}, {"authorId": "7741582", "name":
      "Yingwei Hu"}, {"authorId": "1608909090", "name": "Chen Huang"}, {"authorId":
      "2137359212", "name": "Emily M Huntsman"}, {"authorId": "6199236", "name": "Eric
      J. Jaehnig"}, {"authorId": "2231548289", "name": "Scott D. Jewel"}, {"authorId":
      "9665187", "name": "Jiayi Ji"}, {"authorId": "2116486417", "name": "Wen Jiang"},
      {"authorId": "1491302748", "name": "L. Katsnelson"}, {"authorId": "3965003",
      "name": "K. Ketchum"}, {"authorId": "1435547387", "name": "Iga Ko\u0142odziejczak"},
      {"authorId": "6070264", "name": "Jonathan T. Lei"}, {"authorId": "12354549",
      "name": "Yuxing Liao"}, {"authorId": "2027009424", "name": "Caleb M Lindgren"},
      {"authorId": "46999370", "name": "T. Liu"}, {"authorId": "50143276", "name":
      "Weiping Ma"}, {"authorId": "1391880623", "name": "Wilson H. McKerrow"}, {"authorId":
      "3314036", "name": "A. Nesvizhskii"}, {"authorId": "2106778949", "name": "Chelsea
      J. Newton"}, {"authorId": "80857745", "name": "R. Oldroyd"}, {"authorId": "2716422",
      "name": "G. Omenn"}, {"authorId": "2029001", "name": "A. Paulovich"}, {"authorId":
      "2185134", "name": "F. Petralia"}, {"authorId": "78881029", "name": "B. Reva"},
      {"authorId": "2653902", "name": "K. Rodland"}, {"authorId": "6107793", "name":
      "Kelly V. Ruggles"}, {"authorId": "47615781", "name": "Dmitry Rykunov"}, {"authorId":
      "5129394", "name": "Sara R. Savage"}, {"authorId": "1732072", "name": "E. Schadt"},
      {"authorId": "28477636", "name": "M. Schnaubelt"}, {"authorId": "89978968",
      "name": "Tobias Schraink"}, {"authorId": "46451092", "name": "Zhiao Shi"}, {"authorId":
      "2115707021", "name": "Richard D. Smith"}, {"authorId": "2118945184", "name":
      "Xiaoyu Song"}, {"authorId": "1716703212", "name": "Jimin Tan"}, {"authorId":
      "2671601", "name": "Ratna R. Thangudu"}, {"authorId": "2797149", "name": "N.
      Tignor"}, {"authorId": "2110240066", "name": "Joshua M Wang"}, {"authorId":
      "2118951483", "name": "Pei Wang"}, {"authorId": "2155515911", "name": "Ying
      Wang"}, {"authorId": "48781796", "name": "Bo Wen"}, {"authorId": "5281963",
      "name": "M. Wiznerowicz"}, {"authorId": "51101724", "name": "Xinpei Yi"}, {"authorId":
      "2117925498", "name": "Bing Zhang"}, {"authorId": "2178835774", "name": "Hui
      Zhang"}, {"authorId": "2115463448", "name": "Xu Zhang"}, {"authorId": "2116701366",
      "name": "Zhen Zhang"}]}, {"paperId": "08d38971193f866694eb9bdbc4ca6e2f37857d8d",
      "externalIds": {"PubMedCentral": "10011881", "DOI": "10.1158/1078-0432.CCR-22-2270",
      "CorpusId": 255463401, "PubMed": "36595567"}, "corpusId": 255463401, "publicationVenue":
      {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0", "name": "Clinical Cancer Research",
      "type": "journal", "alternate_names": ["Clin Cancer Res"], "issn": "1078-0432",
      "url": "https://clincancerres.aacrjournals.org/", "alternate_urls": ["http://clincancerres.aacrjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/08d38971193f866694eb9bdbc4ca6e2f37857d8d",
      "title": "Genetic Heterogeneity and Tissue-specific Patterns of Tumors with
      Multiple PIK3CA Mutations", "abstract": "Abstract Purpose: To comprehensively
      characterize tissue-specific and molecular subclasses of multiple PIK3CA (multi-PIK3CA)
      mutations and assess their impact on potential therapeutic outcomes. Experimental
      Design: We profiled a pan-cancer cohort comprised of 352,392 samples across
      66 tumor types using a targeted hybrid capture-based next-generation sequencing
      panel covering at least 324 cancer-related genes. Molecularly defined subgroups,
      allelic configuration, clonality, and mutational signatures were identified
      and tested for association with PI3K inhibitor therapeutic response. Results:
      Multi-PIK3CA mutations are found in 11% of all PIK3CA-mutant tumors, including
      9% of low tumor mutational burden (TMB) PIK3CA-mutant tumors, and are enriched
      in breast and gynecologic cancers. Multi-PIK3CA mutations are frequently clonal
      and in cis on the same allele and occur at characteristic positions across tumor
      types. These mutations tend to be mutually exclusive of mutations in other driver
      genes, and of genes in the PI3K pathway. Among PIK3CA-mutant tumors with a high
      TMB, 18% are multi-PIK3CA mutant and often harbor an apolipoprotein B mRNA-editing
      enzyme, catalytic polypeptide (APOBEC) mutational signature. Despite large differences
      in specific allele combinations comprising multi-PIK3CA mutant tumors, especially
      across cancer types, patients with different classes of multi-PIK3CA mutant
      estrogen receptor\u2013positive, HER2-negative breast cancers respond similarly
      to PI3K inhibition. Conclusions: Our pan-tumor study provides biological insights
      into the genetic heterogeneity and tissue specificities of multi-PIK3CA mutations,
      with potential clinical utility to guide PI3K inhibition strategies.", "venue":
      "Clinical Cancer Research", "year": 2023, "referenceCount": 0, "citationCount":
      2, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-22-2270/3265595/ccr-22-2270.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-01-03", "journal": {"volume": "29", "pages": "1125
      - 1136", "name": "Clinical Cancer Research"}, "citationStyles": {"bibtex": "@Article{Sivakumar2023GeneticHA,\n
      author = {S. Sivakumar and D. Jin and Ruchita Rathod and J. Ross and L. Cantley
      and Maurizio Scaltriti and Jessica W. Chen and K. Hutchinson and T. Wilson and
      E. Sokol and N. Vasan},\n booktitle = {Clinical Cancer Research},\n journal
      = {Clinical Cancer Research},\n pages = {1125 - 1136},\n title = {Genetic Heterogeneity
      and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations},\n volume
      = {29},\n year = {2023}\n}\n"}, "authors": [{"authorId": "40088390", "name":
      "S. Sivakumar"}, {"authorId": "3287834", "name": "D. Jin"}, {"authorId": "2199403555",
      "name": "Ruchita Rathod"}, {"authorId": "2150933707", "name": "J. Ross"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2158234116", "name": "Maurizio
      Scaltriti"}, {"authorId": "2115896184", "name": "Jessica W. Chen"}, {"authorId":
      "2807476", "name": "K. Hutchinson"}, {"authorId": "2017652", "name": "T. Wilson"},
      {"authorId": "48156320", "name": "E. Sokol"}, {"authorId": "35123724", "name":
      "N. Vasan"}]}, {"paperId": "31b70de325b76347e3025102a850f3ac513660fd", "externalIds":
      {"PubMedCentral": "9876800", "DOI": "10.1038/s41586-022-05575-3", "CorpusId":
      255748612, "PubMed": "36631611"}, "corpusId": 255748612, "publicationVenue":
      {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/31b70de325b76347e3025102a850f3ac513660fd",
      "title": "An atlas of substrate specificities for the human serine/threonine
      kinome", "abstract": null, "venue": "Nature", "year": 2023, "referenceCount":
      94, "citationCount": 88, "influentialCitationCount": 8, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.nature.com/articles/s41586-022-05575-3.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2023-01-11", "journal":
      {"volume": "613", "pages": "759 - 766", "name": "Nature"}, "citationStyles":
      {"bibtex": "@Article{Johnson2023AnAO,\n author = {Jared L. Johnson and Tomer
      M. Yaron and Emily M Huntsman and A. Kerelsky and Junho Song and Amit Regev
      and Ting Lin and Katarina M Liberatore and Daniel M. Cizin and B. M. Cohen and
      N. Vasan and Yilun Ma and K. Krismer and Jaylissa Torres Robles and Bert van
      de Kooij and Anne E. van Vlimmeren and Nicole Andr\u00e9e-Busch and N. K\u00e4ufer
      and M. Dorovkov and A. Ryazanov and Y. Takagi and Edward R. Kastenhuber and
      M. Goncalves and B. Hopkins and O. Elemento and D. Taatjes and A. Maucuer and
      A. Yamashita and A. Degterev and Mohamed Uduman and Jingyi Lu and S. Landry
      and Bin Zhang and Ian Cossentino and R. Linding and J. Blenis and P. Hornbeck
      and B. Turk and M. Yaffe and L. Cantley},\n booktitle = {Nature},\n journal
      = {Nature},\n pages = {759 - 766},\n title = {An atlas of substrate specificities
      for the human serine/threonine kinome},\n volume = {613},\n year = {2023}\n}\n"},
      "authors": [{"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId":
      "5247030", "name": "Tomer M. Yaron"}, {"authorId": "2137359212", "name": "Emily
      M Huntsman"}, {"authorId": "14658204", "name": "A. Kerelsky"}, {"authorId":
      "2115753391", "name": "Junho Song"}, {"authorId": "2166242001", "name": "Amit
      Regev"}, {"authorId": "2115348830", "name": "Ting Lin"}, {"authorId": "51910553",
      "name": "Katarina M Liberatore"}, {"authorId": "2152463969", "name": "Daniel
      M. Cizin"}, {"authorId": "2055611292", "name": "B. M. Cohen"}, {"authorId":
      "35123724", "name": "N. Vasan"}, {"authorId": "50032234", "name": "Yilun Ma"},
      {"authorId": "49181291", "name": "K. Krismer"}, {"authorId": "2124145062", "name":
      "Jaylissa Torres Robles"}, {"authorId": "49094504", "name": "Bert van de Kooij"},
      {"authorId": "1601471755", "name": "Anne E. van Vlimmeren"}, {"authorId": "1447106051",
      "name": "Nicole Andr\u00e9e-Busch"}, {"authorId": "2007005", "name": "N. K\u00e4ufer"},
      {"authorId": "6547314", "name": "M. Dorovkov"}, {"authorId": "4097704", "name":
      "A. Ryazanov"}, {"authorId": "49710109", "name": "Y. Takagi"}, {"authorId":
      "4306515", "name": "Edward R. Kastenhuber"}, {"authorId": "145524334", "name":
      "M. Goncalves"}, {"authorId": "48821307", "name": "B. Hopkins"}, {"authorId":
      "150097652", "name": "O. Elemento"}, {"authorId": "34762957", "name": "D. Taatjes"},
      {"authorId": "4165148", "name": "A. Maucuer"}, {"authorId": "144561115", "name":
      "A. Yamashita"}, {"authorId": "145919811", "name": "A. Degterev"}, {"authorId":
      "1942601", "name": "Mohamed Uduman"}, {"authorId": "2200206589", "name": "Jingyi
      Lu"}, {"authorId": "47507246", "name": "S. Landry"}, {"authorId": "2119454508",
      "name": "Bin Zhang"}, {"authorId": "2200155031", "name": "Ian Cossentino"},
      {"authorId": "1892258", "name": "R. Linding"}, {"authorId": "4037343", "name":
      "J. Blenis"}, {"authorId": "46627576", "name": "P. Hornbeck"}, {"authorId":
      "25581223", "name": "B. Turk"}, {"authorId": "88402408", "name": "M. Yaffe"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "3deab2bd5a8cc17023524f0ced603cd65991cadd",
      "externalIds": {"DOI": "10.1093/neuonc/noad117", "CorpusId": 259315394, "PubMed":
      "37399061"}, "corpusId": 259315394, "publicationVenue": {"id": "885e4962-6eb4-4c11-90b7-03fad705f9bd",
      "name": "Neuro-Oncology", "type": "journal", "alternate_names": ["Neuro-oncology"],
      "issn": "1522-8517", "url": "https://academic.oup.com/neuro-oncology/issue",
      "alternate_urls": ["http://www.oxfordjournals.org/", "http://neuro-oncology.dukejournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/3deab2bd5a8cc17023524f0ced603cd65991cadd",
      "title": "Insulin feedback is a targetable resistance mechanism of PI3K inhibition
      in glioblastoma.", "abstract": "BACKGROUND\nInsulin feedback is a critical mechanism
      responsible for poor clinical efficacy of PI3K inhibition in cancer, and hyperglycemia
      is an independent factor associated with poor prognosis in glioblastoma. We
      investigated combination anti-hyperglycemic therapy in a mouse model of glioblastoma
      and evaluated the association of glycemic control in clinical trial data from
      patients with glioblastoma.\n\n\nMETHODS\nThe effect of the anti-hyperglycemic
      regimens metformin and the ketogenic diet were evaluated in combination with
      PI3K inhibition in patient-derived glioblastoma cells and an orthotopic glioblastoma
      mouse model. Insulin feedback and the immune microenvironment were retrospectively
      evaluated in blood and tumor tissue from a Phase 2 clinical trial of buparlisib
      in patients with recurrent glioblastoma.\n\n\nRESULTS\nWe found that PI3K inhibition
      induces hyperglycemia and hyperinsulinemia in mice and that combining metformin
      with PI3K inhibition improves treatment efficacy in an orthotopic glioblastoma
      xenograft model. Through examination of clinical trial data, we found that hyperglycemia
      was an independent factor associated with poor progression-free survival in
      patients with glioblastoma. We also found that PI3K inhibition increased insulin
      receptor activation and T cell and microglia abundance in tumor tissue from
      these patients.\n\n\nCONCLUSION\nReducing insulin feedback improves the efficacy
      of PI3K inhibition in glioblastoma in mice, and hyperglycemia worsens progression-free
      survival in patients with glioblastoma treated with PI3K inhibition. These findings
      indicate that hyperglycemia is a critical resistance mechanism associated with
      PI3K inhibition in glioblastoma and that anti-hyperglycemic therapy may enhance
      PI3K inhibitor efficacy in glioblastoma patients.", "venue": "Neuro-Oncology",
      "year": 2023, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noad117/50788616/noad117.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-07-03", "journal": {"name": "Neuro-oncology"}, "citationStyles":
      {"bibtex": "@Article{Noch2023InsulinFI,\n author = {E. Noch and Laura N Palma
      and I. Yim and Nayah Bullen and Yuqing Qiu and H. Ravichandran and Junbum Kim
      and Andr\u00e9 F. Rendeiro and M. Davis and O. Elemento and D. Pisapia and Kevin
      Zhai and H. C. Lekaye and J. Koutcher and P. Wen and K. Ligon and L. Cantley},\n
      booktitle = {Neuro-Oncology},\n journal = {Neuro-oncology},\n title = {Insulin
      feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma.},\n
      year = {2023}\n}\n"}, "authors": [{"authorId": "3913142", "name": "E. Noch"},
      {"authorId": "2221003431", "name": "Laura N Palma"}, {"authorId": "1716222698",
      "name": "I. Yim"}, {"authorId": "2221003216", "name": "Nayah Bullen"}, {"authorId":
      "2114967379", "name": "Yuqing Qiu"}, {"authorId": "2699031", "name": "H. Ravichandran"},
      {"authorId": "22786641", "name": "Junbum Kim"}, {"authorId": "2125979971", "name":
      "Andr\u00e9 F. Rendeiro"}, {"authorId": "50983934", "name": "M. Davis"}, {"authorId":
      "150097652", "name": "O. Elemento"}, {"authorId": "5528689", "name": "D. Pisapia"},
      {"authorId": "35374276", "name": "Kevin Zhai"}, {"authorId": "6057803", "name":
      "H. C. Lekaye"}, {"authorId": "3603231", "name": "J. Koutcher"}, {"authorId":
      "145426034", "name": "P. Wen"}, {"authorId": "5627829", "name": "K. Ligon"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "4b2372d2b2dbcc75577235a212eb00d2136f0fc3",
      "externalIds": {"DOI": "10.1158/2159-8290.CD-23-0171", "CorpusId": 257912643,
      "PubMed": "37009701"}, "corpusId": 257912643, "publicationVenue": {"id": "de16002a-77c3-4d03-9348-5a1813238e0b",
      "name": "Cancer Discovery", "type": "journal", "alternate_names": ["Cancer Discov"],
      "issn": "2159-8274", "url": "https://cancerdiscovery.aacrjournals.org/"}, "url":
      "https://www.semanticscholar.org/paper/4b2372d2b2dbcc75577235a212eb00d2136f0fc3",
      "title": "The Hallmarks of a Cancer Discovery.", "abstract": null, "venue":
      "Cancer Discovery", "year": 2023, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cancerdiscovery/article-pdf/13/4/797/3319086/797.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-04-03", "journal": {"volume": "13 4", "pages": "\n          797-798\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Diaz2023TheHO,\n
      author = {Luis A. Diaz and L. Cantley},\n booktitle = {Cancer Discovery},\n
      journal = {Cancer discovery},\n pages = {\n          797-798\n        },\n title
      = {The Hallmarks of a Cancer Discovery.},\n volume = {13 4},\n year = {2023}\n}\n"},
      "authors": [{"authorId": "2189433262", "name": "Luis A. Diaz"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "5f1bfd0eae5a69a69b237c08d7db31a1e5f311fa",
      "externalIds": {"DOI": "10.1158/1557-3125.ras23-b034", "CorpusId": 258460189},
      "corpusId": 258460189, "publicationVenue": {"id": "e89b8f81-f9cd-4d2a-ab62-905167b1b2df",
      "name": "Molecular Cancer Research", "type": "journal", "alternate_names": ["Mol
      Cancer Res"], "issn": "1541-7786", "url": "https://mcr.aacrjournals.org/", "alternate_urls":
      ["http://mcr.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/5f1bfd0eae5a69a69b237c08d7db31a1e5f311fa",
      "title": "Abstract B034: Determination of KRAS- and ERK-regulated phosphoproteomes
      in KRAS-mutant cancers", "abstract": "\n Direct inhibitors of mutationally activated
      KRAS are currently under intense preclinical and clinical development, with
      one KRASG12C mutant-selective inhibitor approved. However, treatment-associated
      resistance to KRASG12C inhibitors has been reported, with ~60% of relapsed patients
      acquiring mutations in signaling components both upstream and downstream, and
      at the level of RAS itself, that led to reactivation of RAF-MEK-ERK and PI3K-AKT
      effector pathways. Unexpectedly, we found that ectopic expression of constitutively
      activated MEK1, ERK1 or ERK2, but not AKT1, drove near-complete resistance to
      direct inhibitors of KRASG12C or KRASG12D in KRAS-mutant pancreatic ductal adenocarcinoma
      (PDAC). Despite comprehensive studies, how ERK supports KRAS-dependent cancer
      growth remains poorly understood. Therefore, we focused on delineating the ERK-dependent
      phosphoproteome. We treated a panel of six KRAS-mutant PDAC cell lines acutely
      (1 h) and long-term (24 h) with the highly selective ERK1/2 inhibitor SCH772984.
      Our proteomics analyses identified 5,117 phosphosites on 2,252 proteins significantly
      dysregulated by ERK inhibition. We first compared our PDAC ERK phosphoproteome
      with a recent compendium of published direct/indirect ERK substrates identified
      in non-PDAC cells and found, surprisingly, only 12% overlap. Thus, our dataset
      substaintially extends the complexity of ERK-regulated phosphoproteins, in part,
      reflecting a pancreatic cancer selective profile. To elucidate the kinase network
      that drives our PDAC ERK-dependent phosphoproteome, we utilized our newly described
      global atlas of kinase-substrate specificities and reported kinase-substrate
      interaction datasets. This revealed a highly dynamic kinome dominated by ERK
      at 1 h, then dominated by ERK-regulation of CDK1-6 cell cycle components and
      RHO GTPase signaling. Next, we established the subcellular distribution of the
      PDAC ERK phosphoproteome, then evaluated data from DepMap, and found enrichment
      of nuclear ERK substrates that displayed strong dependencies in PDAC. We also
      determined the KRASG12C-regulated phosphoproteome in pancreatic, lung, and colorectal
      cancer cells using the KRASG12C selective inhibitor MRTX1257. We used our global
      atlas of kinase-motif specificities and ERK-regulated phosphoproteome to determine
      KRAS-regulated signaling pathways in KRASG12C mutant cancers. We found a high
      correlation between KRAS- and ERK-regulated phosphorylations, primarily driven
      by CDK substrates. However, we also noted key differences, principally in DNA
      damage response pathways not identified in our ERK-regulated phosphoproteome.
      Finally, we performed a high-throughput drug sensitivity and resistance screen
      of (DSRT) comprised of >500 clinically actionable drugs in combination with
      a KRASG12C inhibitor, and found ERK inhibitors as top hits. In summary, our
      studies establish a comprehensive profile of KRAS-ERK signaling output that
      may define new therapeutic targets for targeting KRAS- and ERK-dependent cancer
      growth.\n Citation Format: Jennifer E. Klomp, Jeff A. Klomp, Nathaniel J. Diehl,
      Cole A. Edwards, Kristina Drizyte-Miller, Priya S. Hibshman, Runying Yang, Alexis
      J. Morales, Khalilah E. Taylor, Mariaelena Pierobon, Emanuel F. Petricoin III,
      Johnson L. Jared, Emily M. Huntsman, Tomer M. Yaron, Markus V\u00e4h\u00e4-Koskela,
      Laura E. Herring, Alex W. Prevatte, Natalie K. Barker, Lee M. Graves, Wennerberg
      Krister, Lewis C. Cantley, James G. Christensen, Adrienne D. Cox, Channing J.
      Der, Clint A. Stalnecker. Determination of KRAS- and ERK-regulated phosphoproteomes
      in KRAS-mutant cancers [abstract]. In: Proceedings of the AACR Special Conference:
      Targeting RAS; 2023 Mar 5-8; Philadelphia, PA. Philadelphia (PA): AACR; Mol
      Cancer Res 2023;21(5_Suppl):Abstract nr B034.", "venue": "Molecular Cancer Research",
      "year": 2023, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2023-05-01", "journal": {"name": "Molecular Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Klomp2023AbstractBD,\n author = {Jennifer E. Klomp and
      J. Klomp and Nathaniel J. Diehl and Cole A. Edwards and Kristina Drizyte-Miller
      and Priya S. Hibshman and Run-Wei Yang and Alexis J. Morales and Khalilah E
      Taylor and M. Pierobon and E. Petricoin and John Jared and Emily M Huntsman
      and Tomer M. Yaron and M. V\u00e4h\u00e4-Koskela and Laura E. Herring and Alex
      W. Prevatte and Natalie K. Barker and L. Graves and Wennerberg Krister and L.
      Cantley and J. Christensen and A. Cox and C. Der and Clint A. Stalnecker},\n
      booktitle = {Molecular Cancer Research},\n journal = {Molecular Cancer Research},\n
      title = {Abstract B034: Determination of KRAS- and ERK-regulated phosphoproteomes
      in KRAS-mutant cancers},\n year = {2023}\n}\n"}, "authors": [{"authorId": "49504555",
      "name": "Jennifer E. Klomp"}, {"authorId": "49504598", "name": "J. Klomp"},
      {"authorId": "2216156226", "name": "Nathaniel J. Diehl"}, {"authorId": "2213671027",
      "name": "Cole A. Edwards"}, {"authorId": "1442026406", "name": "Kristina Drizyte-Miller"},
      {"authorId": "1823323733", "name": "Priya S. Hibshman"}, {"authorId": "4630965",
      "name": "Run-Wei Yang"}, {"authorId": "2215954569", "name": "Alexis J. Morales"},
      {"authorId": "2215956076", "name": "Khalilah E Taylor"}, {"authorId": "50259934",
      "name": "M. Pierobon"}, {"authorId": "46319892", "name": "E. Petricoin"}, {"authorId":
      "71093663", "name": "John Jared"}, {"authorId": "2137359212", "name": "Emily
      M Huntsman"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "1397981788", "name": "M. V\u00e4h\u00e4-Koskela"}, {"authorId": "10001931",
      "name": "Laura E. Herring"}, {"authorId": "40962829", "name": "Alex W. Prevatte"},
      {"authorId": "2181246320", "name": "Natalie K. Barker"}, {"authorId": "3647882",
      "name": "L. Graves"}, {"authorId": "66591502", "name": "Wennerberg Krister"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144222599", "name":
      "J. Christensen"}, {"authorId": "5310343", "name": "A. Cox"}, {"authorId": "4764611",
      "name": "C. Der"}, {"authorId": "15534610", "name": "Clint A. Stalnecker"}]},
      {"paperId": "6d702533f857774b5cb478800321a740bef44602", "externalIds": {"DOI":
      "10.1126/scitranslmed.ade1857", "CorpusId": 257079476, "PubMed": "36812344"},
      "corpusId": 257079476, "publicationVenue": {"id": "1cd4baea-5ccc-4522-9dbf-0566f39d3b37",
      "name": "Science Translational Medicine", "type": "journal", "alternate_names":
      ["Sci Transl Med"], "issn": "1946-6234", "url": "https://stm.sciencemag.org/",
      "alternate_urls": ["https://stm.sciencemag.org/site/misc/about.xhtml"]}, "url":
      "https://www.semanticscholar.org/paper/6d702533f857774b5cb478800321a740bef44602",
      "title": "Obesity promotes breast epithelium DNA damage in women carrying a
      germline mutation in BRCA1 or BRCA2", "abstract": "Obesity, defined as a body
      mass index (BMI) \u2265 30, is an established risk factor for breast cancer
      among women in the general population after menopause. Whether elevated BMI
      is a risk factor for women with a germline mutation in BRCA1 or BRCA2 is less
      clear because of inconsistent findings from epidemiological studies and a lack
      of mechanistic studies in this population. Here, we show that DNA damage in
      normal breast epithelia of women carrying a BRCA mutation is positively correlated
      with BMI and with biomarkers of metabolic dysfunction. In addition, RNA sequencing
      showed obesity-associated alterations to the breast adipose microenvironment
      of BRCA mutation carriers, including activation of estrogen biosynthesis, which
      affected neighboring breast epithelial cells. In breast tissue explants cultured
      from women carrying a BRCA mutation, we found that blockade of estrogen biosynthesis
      or estrogen receptor activity decreased DNA damage. Additional obesity-associated
      factors, including leptin and insulin, increased DNA damage in human BRCA heterozygous
      epithelial cells, and inhibiting the signaling of these factors with a leptin-neutralizing
      antibody or PI3K inhibitor, respectively, decreased DNA damage. Furthermore,
      we show that increased adiposity was associated with mammary gland DNA damage
      and increased penetrance of mammary tumors in Brca1+/\u2212 mice. Overall, our
      results provide mechanistic evidence in support of a link between elevated BMI
      and breast cancer development in BRCA mutation carriers. This suggests that
      maintaining a lower body weight or pharmacologically targeting estrogen or metabolic
      dysfunction may reduce the risk of breast cancer in this population. Description
      Elevated body mass index is positively associated with DNA damage in breast
      epithelium of BRCA mutation carriers. Reducing risk for BRCA carriers Individuals
      with an inherited mutation in the DNA repair genes Breast Cancer gene 1 or 2
      (BRCA1 or BRCA2) have a higher risk of developing breast and ovarian cancer,
      however, the effect of BMI on this risk is unclear. Here, Bhardwaj et al. evaluated
      the impact of a BRCA mutation in breast tissue of carriers with high and low
      BMI. They saw increased DNA damage in individuals with higher BMI and identified
      a direct causal link between obesity-associated factors and increased DNA damage.
      Thus, suggesting that maintaining a lower BMI may reduce the risk of breast
      cancer in this already at-risk population. \u2014DH", "venue": "Science Translational
      Medicine", "year": 2023, "referenceCount": 84, "citationCount": 7, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2023-02-22", "journal":
      {"volume": "15", "name": "Science Translational Medicine"}, "citationStyles":
      {"bibtex": "@Article{Bhardwaj2023ObesityPB,\n author = {Priya Bhardwaj and N.
      Iyengar and Heba Zahid and Katharine M. Carter and Dong Jun Byun and Man-Ho
      Choi and Qi Sun and O. Savenkov and Charalambia Louka and Catherine Liu and
      Phoebe Piloco and Monica Acosta and R. Bareja and O. Elemento and M. Foronda
      and L. Dow and Sofya Oshchepkova and D. Giri and M. Pollak and X. Zhou and B.
      Hopkins and Ashley M. Laughney and M. Frey and L. Ellenson and M. Morrow and
      J. Spector and L. Cantley and K. Brown},\n booktitle = {Science Translational
      Medicine},\n journal = {Science Translational Medicine},\n title = {Obesity
      promotes breast epithelium DNA damage in women carrying a germline mutation
      in BRCA1 or BRCA2},\n volume = {15},\n year = {2023}\n}\n"}, "authors": [{"authorId":
      "38811957", "name": "Priya Bhardwaj"}, {"authorId": "4018492", "name": "N. Iyengar"},
      {"authorId": "34651211", "name": "Heba Zahid"}, {"authorId": "1961806917", "name":
      "Katharine M. Carter"}, {"authorId": "1884946007", "name": "Dong Jun Byun"},
      {"authorId": "8860004", "name": "Man-Ho Choi"}, {"authorId": "2149098057", "name":
      "Qi Sun"}, {"authorId": "13774442", "name": "O. Savenkov"}, {"authorId": "2180407428",
      "name": "Charalambia Louka"}, {"authorId": "2116905534", "name": "Catherine
      Liu"}, {"authorId": "2126991989", "name": "Phoebe Piloco"}, {"authorId": "2180408384",
      "name": "Monica Acosta"}, {"authorId": "9753461", "name": "R. Bareja"}, {"authorId":
      "150097652", "name": "O. Elemento"}, {"authorId": "3813868", "name": "M. Foronda"},
      {"authorId": "3918769", "name": "L. Dow"}, {"authorId": "80751685", "name":
      "Sofya Oshchepkova"}, {"authorId": "4227896", "name": "D. Giri"}, {"authorId":
      "78091495", "name": "M. Pollak"}, {"authorId": "2109614954", "name": "X. Zhou"},
      {"authorId": "48821307", "name": "B. Hopkins"}, {"authorId": "3009053", "name":
      "Ashley M. Laughney"}, {"authorId": "4396333", "name": "M. Frey"}, {"authorId":
      "6288829", "name": "L. Ellenson"}, {"authorId": "144607636", "name": "M. Morrow"},
      {"authorId": "4963563", "name": "J. Spector"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2246730", "name": "K. Brown"}]}, {"paperId": "8c190b732141c5cde1f75be59e9311eb89e79703",
      "externalIds": {"DOI": "10.1038/s41589-023-01273-x", "CorpusId": 257153891,
      "PubMed": "36823351"}, "corpusId": 257153891, "publicationVenue": {"id": "7758f686-2a47-473d-835c-6784e70a0aac",
      "name": "Nature Chemical Biology", "type": "journal", "alternate_names": ["Nat
      Chem Biology"], "issn": "1552-4450", "url": "https://www.nature.com/nchembio/",
      "alternate_urls": ["http://www.nature.com/nchembio/index.html"]}, "url": "https://www.semanticscholar.org/paper/8c190b732141c5cde1f75be59e9311eb89e79703",
      "title": "Depletion of creatine phosphagen energetics with a covalent creatine
      kinase inhibitor", "abstract": null, "venue": "Nature Chemical Biology", "year":
      2023, "referenceCount": 44, "citationCount": 5, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2023-02-23", "journal":
      {"volume": "19", "pages": "815-824", "name": "Nature Chemical Biology"}, "citationStyles":
      {"bibtex": "@Article{Darabedian2023DepletionOC,\n author = {Narek Darabedian
      and Wenzhi Ji and Mengyang Fan and Shan Lin and H. Seo and E. Vinogradova and
      Tomer M. Yaron and E. Mills and Haopeng Xiao and Kristine Senkane and Emily
      M Huntsman and Jared L. Johnson and Jianwei Che and L. Cantley and B. Cravatt
      and S. Dhe-Paganon and K. Stegmaier and Tinghu Zhang and N. Gray and Edward
      T. Chouchani},\n booktitle = {Nature Chemical Biology},\n journal = {Nature
      Chemical Biology},\n pages = {815-824},\n title = {Depletion of creatine phosphagen
      energetics with a covalent creatine kinase inhibitor},\n volume = {19},\n year
      = {2023}\n}\n"}, "authors": [{"authorId": "144357557", "name": "Narek Darabedian"},
      {"authorId": "50119404", "name": "Wenzhi Ji"}, {"authorId": "2054876541", "name":
      "Mengyang Fan"}, {"authorId": "2115275087", "name": "Shan Lin"}, {"authorId":
      "91486080", "name": "H. Seo"}, {"authorId": "48066407", "name": "E. Vinogradova"},
      {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId": "27144415",
      "name": "E. Mills"}, {"authorId": "11757760", "name": "Haopeng Xiao"}, {"authorId":
      "147252736", "name": "Kristine Senkane"}, {"authorId": "2137359212", "name":
      "Emily M Huntsman"}, {"authorId": "145916288", "name": "Jared L. Johnson"},
      {"authorId": "1768974", "name": "Jianwei Che"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "4029107", "name": "B. Cravatt"}, {"authorId": "1400570681",
      "name": "S. Dhe-Paganon"}, {"authorId": "6521164", "name": "K. Stegmaier"},
      {"authorId": "2262535", "name": "Tinghu Zhang"}, {"authorId": "2126648439",
      "name": "N. Gray"}, {"authorId": "6624082", "name": "Edward T. Chouchani"}]},
      {"paperId": "994f457ac4fc4da1efb741475d2fbcc85c5ba6d9", "externalIds": {"DOI":
      "10.1016/j.cell.2023.07.013", "CorpusId": 260891333, "PubMed": "37582358"},
      "corpusId": 260891333, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/994f457ac4fc4da1efb741475d2fbcc85c5ba6d9",
      "title": "Pan-cancer analysis of post-translational modifications reveals shared
      patterns of protein regulation", "abstract": null, "venue": "Cell", "year":
      2023, "referenceCount": 193, "citationCount": 5, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S009286742300781X/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-08-01", "journal": {"volume": "186", "pages": "3945-3967.e26",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Geffen2023PancancerAO,\n
      author = {Y. Geffen and Shankara K. Anand and Y. Akiyama and Tomer M. Yaron
      and Yizhe Song and Jared L. Johnson and Akshay Govindan and \u00d6zg\u00fcn
      Babur and Yize Li and Emily M Huntsman and Liang-Bo Wang and Chet Birger and
      David I Heiman and Qing Zhang and Mendy Miller and Y. Maruvka and N. Haradhvala
      and A. Calinawan and Saveliy Belkin and A. Kerelsky and K. Clauser and Karsten
      Krug and S. Satpathy and S. Payne and D. Mani and Michael A. Gillette and S.
      Dhanasekaran and M. Thiagarajan and M. Mesri and H. Rodriguez and Ana I. Robles
      and Steve Carr and A. Lazar and F. Aguet and L. Cantley and Li Ding and G. Getz
      and E. An and M. Anurag and Jasmin H. Bavarva and M. Birrer and Song Cao and
      M. Ceccarelli and Daniel W. Chan and A. Chinnaiyan and Hanbyul Cho and S. Chowdhury
      and M. Cieslik and A. Colaprico and D. Zhou and F. Leprevost and Corbin Day
      and M. Domagalski and Yongchao Dou and B. Druker and Nathan Edwards and M. Ellis
      and M. Selvan and D. Fenyo and S. Foltz and Alicia Francis and Tania J. Gonzalez
      Robles and Sara J. C. Gosline and Z. G\u00fcm\u00fc\u015f and Tara Hiltke and
      R. Hong and G. Hostetter and Yingwei Hu and Chen Huang and A. Iavarone and Eric
      J. Jaehnig and Scott D. Jewel and Jiayi Ji and Wen Jiang and L. Katsnelson and
      K. Ketchum and Iga Ko\u0142odziejczak and Chandan Kumar-Sinha and Jonathan T.
      Lei and Wen-Wei Liang and Yuxing Liao and Caleb M Lindgren and T. Liu and Wenke
      Liu and Weiping Ma and F. M. Rodrigues and Wilson H. McKerrow and A. Nesvizhskii
      and Chelsea J. Newton and R. Oldroyd and G. Omenn and A. Paulovich and F. Petralia
      and Pietro Pugliese and B. Reva and K. Rodland and Kelly V. Ruggles and Dmitry
      Rykunov and Sara R. Savage and E. Schadt and M. Schnaubelt and Tobias Schraink
      and Zhiao Shi and Richard D. Smith and Xiaoyu Song and Vasileios Stathias and
      E. Storrs and Jimin Tan and Nadezhda V. Terekhanova and Ratna R. Thangudu and
      N. Tignor and Joshua M Wang and Pei Wang and Ying Wang and Bo Wen and M. Wiznerowicz
      and Yige Wu and Matthew A. Wyczalkowski and L. Yao and Xinpei Yi and Bing Zhang
      and Hui Zhang and Xu Zhang and Zhen Zhang},\n booktitle = {Cell},\n journal
      = {Cell},\n pages = {3945-3967.e26},\n title = {Pan-cancer analysis of post-translational
      modifications reveals shared patterns of protein regulation},\n volume = {186},\n
      year = {2023}\n}\n"}, "authors": [{"authorId": "16307269", "name": "Y. Geffen"},
      {"authorId": "48361643", "name": "Shankara K. Anand"}, {"authorId": "153604992",
      "name": "Y. Akiyama"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "2115712860", "name": "Yizhe Song"}, {"authorId": "145916288", "name": "Jared
      L. Johnson"}, {"authorId": "2054692286", "name": "Akshay Govindan"}, {"authorId":
      "8017947", "name": "\u00d6zg\u00fcn Babur"}, {"authorId": "2110456727", "name":
      "Yize Li"}, {"authorId": "2137359212", "name": "Emily M Huntsman"}, {"authorId":
      "2144691004", "name": "Liang-Bo Wang"}, {"authorId": "69878839", "name": "Chet
      Birger"}, {"authorId": "37329835", "name": "David I Heiman"}, {"authorId": "2145802967",
      "name": "Qing Zhang"}, {"authorId": "3004576", "name": "Mendy Miller"}, {"authorId":
      "123051505", "name": "Y. Maruvka"}, {"authorId": "4047392", "name": "N. Haradhvala"},
      {"authorId": "1580783790", "name": "A. Calinawan"}, {"authorId": "1410760672",
      "name": "Saveliy Belkin"}, {"authorId": "14658204", "name": "A. Kerelsky"},
      {"authorId": "2027516", "name": "K. Clauser"}, {"authorId": "40329575", "name":
      "Karsten Krug"}, {"authorId": "34794500", "name": "S. Satpathy"}, {"authorId":
      "145540232", "name": "S. Payne"}, {"authorId": "2073717971", "name": "D. Mani"},
      {"authorId": "39595909", "name": "Michael A. Gillette"}, {"authorId": "3113892",
      "name": "S. Dhanasekaran"}, {"authorId": "2789936", "name": "M. Thiagarajan"},
      {"authorId": "51411580", "name": "M. Mesri"}, {"authorId": "144906863", "name":
      "H. Rodriguez"}, {"authorId": "2129211402", "name": "Ana I. Robles"}, {"authorId":
      "2072711707", "name": "Steve Carr"}, {"authorId": "2063985933", "name": "A.
      Lazar"}, {"authorId": "48975912", "name": "F. Aguet"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2153731784", "name": "Li Ding"}, {"authorId":
      "2110594", "name": "G. Getz"}, {"authorId": "5605144", "name": "E. An"}, {"authorId":
      "48304712", "name": "M. Anurag"}, {"authorId": "2127569", "name": "Jasmin H.
      Bavarva"}, {"authorId": "48380975", "name": "M. Birrer"}, {"authorId": "145733601",
      "name": "Song Cao"}, {"authorId": "2149683606", "name": "M. Ceccarelli"}, {"authorId":
      "2111734912", "name": "Daniel W. Chan"}, {"authorId": "2186786", "name": "A.
      Chinnaiyan"}, {"authorId": "12888294", "name": "Hanbyul Cho"}, {"authorId":
      "46216123", "name": "S. Chowdhury"}, {"authorId": "50748126", "name": "M. Cieslik"},
      {"authorId": "2550756", "name": "A. Colaprico"}, {"authorId": "38178101", "name":
      "D. Zhou"}, {"authorId": "2687528", "name": "F. Leprevost"}, {"authorId": "2229239473",
      "name": "Corbin Day"}, {"authorId": "5670306", "name": "M. Domagalski"}, {"authorId":
      "40429872", "name": "Yongchao Dou"}, {"authorId": "144082761", "name": "B. Druker"},
      {"authorId": "2207234317", "name": "Nathan Edwards"}, {"authorId": "2059004868",
      "name": "M. Ellis"}, {"authorId": "4506880", "name": "M. Selvan"}, {"authorId":
      "1743195", "name": "D. Fenyo"}, {"authorId": "36381769", "name": "S. Foltz"},
      {"authorId": "2064227355", "name": "Alicia Francis"}, {"authorId": "2189321519",
      "name": "Tania J. Gonzalez Robles"}, {"authorId": "2003009", "name": "Sara J.
      C. Gosline"}, {"authorId": "1894070", "name": "Z. G\u00fcm\u00fc\u015f"}, {"authorId":
      "7547869", "name": "Tara Hiltke"}, {"authorId": "95014017", "name": "R. Hong"},
      {"authorId": "48397691", "name": "G. Hostetter"}, {"authorId": "7741582", "name":
      "Yingwei Hu"}, {"authorId": "2150607455", "name": "Chen Huang"}, {"authorId":
      "2700430", "name": "A. Iavarone"}, {"authorId": "6199236", "name": "Eric J.
      Jaehnig"}, {"authorId": "2231548289", "name": "Scott D. Jewel"}, {"authorId":
      "9665187", "name": "Jiayi Ji"}, {"authorId": "2116486417", "name": "Wen Jiang"},
      {"authorId": "1491302748", "name": "L. Katsnelson"}, {"authorId": "3965003",
      "name": "K. Ketchum"}, {"authorId": "1435547387", "name": "Iga Ko\u0142odziejczak"},
      {"authorId": "1396440493", "name": "Chandan Kumar-Sinha"}, {"authorId": "6070264",
      "name": "Jonathan T. Lei"}, {"authorId": "50676162", "name": "Wen-Wei Liang"},
      {"authorId": "12354549", "name": "Yuxing Liao"}, {"authorId": "2027009424",
      "name": "Caleb M Lindgren"}, {"authorId": "46999370", "name": "T. Liu"}, {"authorId":
      "2143702454", "name": "Wenke Liu"}, {"authorId": "50143276", "name": "Weiping
      Ma"}, {"authorId": "31600403", "name": "F. M. Rodrigues"}, {"authorId": "1391880623",
      "name": "Wilson H. McKerrow"}, {"authorId": "3314036", "name": "A. Nesvizhskii"},
      {"authorId": "2106778949", "name": "Chelsea J. Newton"}, {"authorId": "80857745",
      "name": "R. Oldroyd"}, {"authorId": "2716422", "name": "G. Omenn"}, {"authorId":
      "2029001", "name": "A. Paulovich"}, {"authorId": "2185134", "name": "F. Petralia"},
      {"authorId": "1791880674", "name": "Pietro Pugliese"}, {"authorId": "78881029",
      "name": "B. Reva"}, {"authorId": "2653902", "name": "K. Rodland"}, {"authorId":
      "6107793", "name": "Kelly V. Ruggles"}, {"authorId": "47615781", "name": "Dmitry
      Rykunov"}, {"authorId": "5129394", "name": "Sara R. Savage"}, {"authorId": "1732072",
      "name": "E. Schadt"}, {"authorId": "28477636", "name": "M. Schnaubelt"}, {"authorId":
      "89978968", "name": "Tobias Schraink"}, {"authorId": "46451092", "name": "Zhiao
      Shi"}, {"authorId": "2115707021", "name": "Richard D. Smith"}, {"authorId":
      "2192523520", "name": "Xiaoyu Song"}, {"authorId": "4187414", "name": "Vasileios
      Stathias"}, {"authorId": "1742409571", "name": "E. Storrs"}, {"authorId": "12076800",
      "name": "Jimin Tan"}, {"authorId": "3650868", "name": "Nadezhda V. Terekhanova"},
      {"authorId": "2671601", "name": "Ratna R. Thangudu"}, {"authorId": "2797149",
      "name": "N. Tignor"}, {"authorId": "2110240066", "name": "Joshua M Wang"}, {"authorId":
      "6753134", "name": "Pei Wang"}, {"authorId": "2155517439", "name": "Ying Wang"},
      {"authorId": "48781796", "name": "Bo Wen"}, {"authorId": "5281963", "name":
      "M. Wiznerowicz"}, {"authorId": "2896178", "name": "Yige Wu"}, {"authorId":
      "4953858", "name": "Matthew A. Wyczalkowski"}, {"authorId": "145095579", "name":
      "L. Yao"}, {"authorId": "51101724", "name": "Xinpei Yi"}, {"authorId": "2117925498",
      "name": "Bing Zhang"}, {"authorId": "2135711575", "name": "Hui Zhang"}, {"authorId":
      "2115463374", "name": "Xu Zhang"}, {"authorId": "2116701366", "name": "Zhen
      Zhang"}]}, {"paperId": "9df866b5c57a92ff7bb47ef1c9007ed5c3e9e48d", "externalIds":
      {"PubMedCentral": "9891700", "DOI": "10.1126/sciadv.ade8641", "CorpusId": 256501216,
      "PubMed": "36724278"}, "corpusId": 256501216, "publicationVenue": {"id": "cb30f0c9-2980-4b7d-bbcb-68fc5472b97c",
      "name": "Science Advances", "type": "journal", "alternate_names": ["Sci Adv"],
      "issn": "2375-2548", "url": "http://www.scienceadvances.org/", "alternate_urls":
      ["https://advances.sciencemag.org/"]}, "url": "https://www.semanticscholar.org/paper/9df866b5c57a92ff7bb47ef1c9007ed5c3e9e48d",
      "title": "PI5P4K\u03b1 supports prostate cancer metabolism and exposes a survival
      vulnerability during androgen receptor inhibition", "abstract": "Phosphatidylinositol
      (PI)regulating enzymes are frequently altered in cancer and have become a focus
      for drug development. Here, we explore the phosphatidylinositol-5-phosphate
      4-kinases (PI5P4K), a family of lipid kinases that regulate pools of intracellular
      PI, and demonstrate that the PI5P4K\u03b1 isoform influences androgen receptor
      (AR) signaling, which supports prostate cancer (PCa) cell survival. The regulation
      of PI becomes increasingly important in the setting of metabolic stress adaptation
      of PCa during androgen deprivation (AD), as we show that AD influences PI abundance
      and enhances intracellular pools of PI-4,5-P2. We suggest that this PI5P4K\u03b1-AR
      relationship is mitigated through mTORC1 dysregulation and show that PI5P4K\u03b1
      colocalizes to the lysosome, the intracellular site of mTORC1 complex activation.
      Notably, this relationship becomes prominent in mouse prostate tissue following
      surgical castration. Finally, multiple PCa cell models demonstrate marked survival
      vulnerability following stable PI5P4K\u03b1 inhibition. These results nominate
      PI5P4K\u03b1 as a target to disrupt PCa metabolic adaptation to castrate resistance.",
      "venue": "Science Advances", "year": 2023, "referenceCount": 85, "citationCount":
      4, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.science.org/doi/pdf/10.1126/sciadv.ade8641?download=true", "status":
      null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-02-01", "journal": {"volume": "9", "name": "Science
      Advances"}, "citationStyles": {"bibtex": "@Article{Triscott2023PI5P4K\u03b1SP,\n
      author = {J. Triscott and Matthias Reist and Lukas K\u00fcng and Francielle
      C Moselle and Marika Lehner and J. Gallon and Archna Ravi and Gurpreet K. Arora
      and S. de Brot and Mark Lundquist and H. Gallart-Ayala and J. Ivanisevic and
      S. Piscuoglio and L. Cantley and B. Emerling and M. Rubin},\n booktitle = {Science
      Advances},\n journal = {Science Advances},\n title = {PI5P4K\u03b1 supports
      prostate cancer metabolism and exposes a survival vulnerability during androgen
      receptor inhibition},\n volume = {9},\n year = {2023}\n}\n"}, "authors": [{"authorId":
      "10334665", "name": "J. Triscott"}, {"authorId": "2092057827", "name": "Matthias
      Reist"}, {"authorId": "2204160949", "name": "Lukas K\u00fcng"}, {"authorId":
      "2204154254", "name": "Francielle C Moselle"}, {"authorId": "1490724622", "name":
      "Marika Lehner"}, {"authorId": "50143922", "name": "J. Gallon"}, {"authorId":
      "14099966", "name": "Archna Ravi"}, {"authorId": "34304607", "name": "Gurpreet
      K. Arora"}, {"authorId": "2147020998", "name": "S. de Brot"}, {"authorId": "49142390",
      "name": "Mark Lundquist"}, {"authorId": "1390123615", "name": "H. Gallart-Ayala"},
      {"authorId": "2117173", "name": "J. Ivanisevic"}, {"authorId": "6115888", "name":
      "S. Piscuoglio"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "5542751", "name": "B. Emerling"}, {"authorId": "144014266", "name": "M. Rubin"}]},
      {"paperId": "9e1fa172ce064998f6a5a5a1225ae491753d739d", "externalIds": {"PubMedCentral":
      "10068449", "DOI": "10.1158/2159-8290.CD-22-0805", "CorpusId": 256388134, "PubMed":
      "36715544"}, "corpusId": 256388134, "publicationVenue": {"id": "de16002a-77c3-4d03-9348-5a1813238e0b",
      "name": "Cancer Discovery", "type": "journal", "alternate_names": ["Cancer Discov"],
      "issn": "2159-8274", "url": "https://cancerdiscovery.aacrjournals.org/"}, "url":
      "https://www.semanticscholar.org/paper/9e1fa172ce064998f6a5a5a1225ae491753d739d",
      "title": "LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability
      between Human and Mouse Lung Adenocarcinoma", "abstract": "Differences in the
      effects of LKB1 loss in human versus murine lung adenocarcinoma are attributed
      to differential TPI1 regulation that leads to divergent metabolic liabilities
      and has implications for therapeutic targeting in cancer.", "venue": "Cancer
      Discovery", "year": 2023, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-22-0805/3283571/cd-22-0805.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-01-30", "journal": {"volume": "13", "pages": "1002
      - 1025", "name": "Cancer Discovery"}, "citationStyles": {"bibtex": "@Article{Stein2023LKB1DependentRO,\n
      author = {Benjamin D. Stein and J. Ferrarone and Eric E. Gardner and J. W. Chang
      and David Wu and Pablo E. Hollstein and R. Liang and Min Yuan and Qiuying Chen
      and John S. Coukos and Miriam Sindelar and B. Ngo and S. Gross and R. Shaw and
      Chen Zhang and J. Asara and R. Moellering and H. Varmus and L. Cantley},\n booktitle
      = {Cancer Discovery},\n journal = {Cancer Discovery},\n pages = {1002 - 1025},\n
      title = {LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability
      between Human and Mouse Lung Adenocarcinoma},\n volume = {13},\n year = {2023}\n}\n"},
      "authors": [{"authorId": "40353456", "name": "Benjamin D. Stein"}, {"authorId":
      "12021693", "name": "J. Ferrarone"}, {"authorId": "123766050", "name": "Eric
      E. Gardner"}, {"authorId": "2169334013", "name": "J. W. Chang"}, {"authorId":
      "144790190", "name": "David Wu"}, {"authorId": "6028952", "name": "Pablo E.
      Hollstein"}, {"authorId": "46875693", "name": "R. Liang"}, {"authorId": "49059923",
      "name": "Min Yuan"}, {"authorId": "2109625387", "name": "Qiuying Chen"}, {"authorId":
      "14394779", "name": "John S. Coukos"}, {"authorId": "32040251", "name": "Miriam
      Sindelar"}, {"authorId": "5891999", "name": "B. Ngo"}, {"authorId": "5769141",
      "name": "S. Gross"}, {"authorId": "4426388", "name": "R. Shaw"}, {"authorId":
      "2200060905", "name": "Chen Zhang"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "4021080", "name": "R. Moellering"}, {"authorId": "2681217", "name":
      "H. Varmus"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "a14ce1e6d63b64da4e59c9c6dfb3e04e4412ded8",
      "externalIds": {"DOI": "10.1016/j.ccell.2023.06.009", "CorpusId": 260908311,
      "PubMed": "37582339"}, "corpusId": 260908311, "publicationVenue": {"id": "11e469cb-37ad-487e-b0ab-d26e82037c22",
      "name": "Cancer Cell", "type": "journal", "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/a14ce1e6d63b64da4e59c9c6dfb3e04e4412ded8",
      "title": "Proteogenomic data and resources for pan-cancer analysis.", "abstract":
      null, "venue": "Cancer Cell", "year": 2023, "referenceCount": 89, "citationCount":
      10, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1535610823002192/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Computer Science", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "2023-08-01",
      "journal": {"volume": "41 8", "pages": "\n          1397-1406\n        ", "name":
      "Cancer cell"}, "citationStyles": {"bibtex": "@Article{Li2023ProteogenomicDA,\n
      author = {Yize Li and Yongchao Dou and Felipe da Veiga Leprevost and Y. Geffen
      and A. Calinawan and F. Aguet and Y. Akiyama and Shankara K. Anand and Chet
      Birger and Song Cao and Rekha Chaudhary and Padmini Chilappagari and M. Cieslik
      and A. Colaprico and D. Zhou and Corbin Day and M. Domagalski and Myvizhi Esai
      Selvan and D. Feny\u00f6 and S. Foltz and Alicia Francis and Tania J. Gonz\u00e1lez-Robles
      and Z. G\u00fcm\u00fc\u015f and David I Heiman and M. Holck and R. Hong and
      Yingwei Hu and Eric J. Jaehnig and Jiayi Ji and Wen Jiang and L. Katsnelson
      and K. Ketchum and R. Klein and Jonathan T. Lei and Wen-Wei Liang and Yuxing
      Liao and Caleb M Lindgren and Weiping Ma and Lei Ma and M. MacCoss and Fernanda
      Martins Rodrigues and Wilson H. McKerrow and N. Nguyen and R. Oldroyd and Alexander
      R Pilozzi and Pietro Pugliese and B. Reva and P. Rudnick and Kelly V. Ruggles
      and Dmitry Rykunov and Sara R. Savage and M. Schnaubelt and Tobias Schraink
      and Zhiao Shi and Deepak Singhal and Xiaoyu Song and E. Storrs and Nadezhda
      V. Terekhanova and Ratna R. Thangudu and M. Thiagarajan and Liang-Bo Wang and
      Joshua M Wang and Ying Wang and Bo Wen and Yige Wu and Matthew A. Wyczalkowski
      and Yi Xin and L. Yao and Xinpei Yi and Hui Zhang and Qing Zhang and Maya Zuhl
      and G. Getz and Li Ding and A. Nesvizhskii and Pei Wang and Ana I. Robles and
      Bing Zhang and S. Payne and A. Lazar and A. Paulovich and A. Iavarone and A.
      Chinnaiyan and B. Druker and Chandan Kumar-Sinha and Chelsea J. Newton and Chen
      Huang and D. Mani and Richard D. Smith and Emily M Huntsman and E. Schadt and
      E. An and F. Petralia and G. Hostetter and G. Omenn and Han-Byoul Cho and Henry
      Rodriguez and Iga Ko\u0142odziejczak and Jared L. Johnson and Jasmin H. Bavarva
      and Jimin Tan and K. Rodland and K. Clauser and Karsten Krug and L. Cantley
      and M. Wiznerowicz and M. Ellis and M. Anurag and M. Mesri and Michael A. Gillette
      and M. Birrer and M. Ceccarelli and S. Dhanasekaran and Nathan Edwards and N.
      Tignor and \u00d6zg\u00fcn Babur and Sara J. C. Gosline and S. Jewell and S.
      Satpathy and S. Chowdhury and S. Sch\u00fcrer and Steve Carr and T. Liu and
      Tara Hiltke and Tomer M. Yaron and Vasileios Stathias and Wenke Liu and Xu Zhang
      and Yizhe Song and Zhen Zhang},\n booktitle = {Cancer Cell},\n journal = {Cancer
      cell},\n pages = {\n          1397-1406\n        },\n title = {Proteogenomic
      data and resources for pan-cancer analysis.},\n volume = {41 8},\n year = {2023}\n}\n"},
      "authors": [{"authorId": "2110456727", "name": "Yize Li"}, {"authorId": "40429872",
      "name": "Yongchao Dou"}, {"authorId": "38104431", "name": "Felipe da Veiga Leprevost"},
      {"authorId": "16307269", "name": "Y. Geffen"}, {"authorId": "1580783790", "name":
      "A. Calinawan"}, {"authorId": "48975912", "name": "F. Aguet"}, {"authorId":
      "153604992", "name": "Y. Akiyama"}, {"authorId": "48361643", "name": "Shankara
      K. Anand"}, {"authorId": "69878839", "name": "Chet Birger"}, {"authorId": "145733601",
      "name": "Song Cao"}, {"authorId": "2229245149", "name": "Rekha Chaudhary"},
      {"authorId": "2231593342", "name": "Padmini Chilappagari"}, {"authorId": "50748126",
      "name": "M. Cieslik"}, {"authorId": "2550756", "name": "A. Colaprico"}, {"authorId":
      "38178101", "name": "D. Zhou"}, {"authorId": "2229239473", "name": "Corbin Day"},
      {"authorId": "5670306", "name": "M. Domagalski"}, {"authorId": "13250027", "name":
      "Myvizhi Esai Selvan"}, {"authorId": "3297236", "name": "D. Feny\u00f6"}, {"authorId":
      "36381769", "name": "S. Foltz"}, {"authorId": "2064227355", "name": "Alicia
      Francis"}, {"authorId": "2220994874", "name": "Tania J. Gonz\u00e1lez-Robles"},
      {"authorId": "1894070", "name": "Z. G\u00fcm\u00fc\u015f"}, {"authorId": "37329835",
      "name": "David I Heiman"}, {"authorId": "2005294613", "name": "M. Holck"}, {"authorId":
      "95014017", "name": "R. Hong"}, {"authorId": "7741582", "name": "Yingwei Hu"},
      {"authorId": "6199236", "name": "Eric J. Jaehnig"}, {"authorId": "9665187",
      "name": "Jiayi Ji"}, {"authorId": "2116486417", "name": "Wen Jiang"}, {"authorId":
      "1491302748", "name": "L. Katsnelson"}, {"authorId": "3965003", "name": "K.
      Ketchum"}, {"authorId": "145234908", "name": "R. Klein"}, {"authorId": "6070264",
      "name": "Jonathan T. Lei"}, {"authorId": "50676162", "name": "Wen-Wei Liang"},
      {"authorId": "12354549", "name": "Yuxing Liao"}, {"authorId": "2027009424",
      "name": "Caleb M Lindgren"}, {"authorId": "50143276", "name": "Weiping Ma"},
      {"authorId": "2109705414", "name": "Lei Ma"}, {"authorId": "2167765", "name":
      "M. MacCoss"}, {"authorId": "1403802824", "name": "Fernanda Martins Rodrigues"},
      {"authorId": "1391880623", "name": "Wilson H. McKerrow"}, {"authorId": "2072556029",
      "name": "N. Nguyen"}, {"authorId": "80857745", "name": "R. Oldroyd"}, {"authorId":
      "1456336840", "name": "Alexander R Pilozzi"}, {"authorId": "1791880674", "name":
      "Pietro Pugliese"}, {"authorId": "78881029", "name": "B. Reva"}, {"authorId":
      "4167115", "name": "P. Rudnick"}, {"authorId": "6107793", "name": "Kelly V.
      Ruggles"}, {"authorId": "47615781", "name": "Dmitry Rykunov"}, {"authorId":
      "5129394", "name": "Sara R. Savage"}, {"authorId": "28477636", "name": "M. Schnaubelt"},
      {"authorId": "89978968", "name": "Tobias Schraink"}, {"authorId": "46451092",
      "name": "Zhiao Shi"}, {"authorId": "2064659924", "name": "Deepak Singhal"},
      {"authorId": "2118944336", "name": "Xiaoyu Song"}, {"authorId": "1742409571",
      "name": "E. Storrs"}, {"authorId": "3650868", "name": "Nadezhda V. Terekhanova"},
      {"authorId": "2671601", "name": "Ratna R. Thangudu"}, {"authorId": "2789936",
      "name": "M. Thiagarajan"}, {"authorId": "2144691004", "name": "Liang-Bo Wang"},
      {"authorId": "2110240066", "name": "Joshua M Wang"}, {"authorId": "2155515911",
      "name": "Ying Wang"}, {"authorId": "48781796", "name": "Bo Wen"}, {"authorId":
      "2896178", "name": "Yige Wu"}, {"authorId": "4953858", "name": "Matthew A. Wyczalkowski"},
      {"authorId": "2114688441", "name": "Yi Xin"}, {"authorId": "145095579", "name":
      "L. Yao"}, {"authorId": "51101724", "name": "Xinpei Yi"}, {"authorId": "2135711575",
      "name": "Hui Zhang"}, {"authorId": "2112725056", "name": "Qing Zhang"}, {"authorId":
      "51932024", "name": "Maya Zuhl"}, {"authorId": "2110594", "name": "G. Getz"},
      {"authorId": "2153731784", "name": "Li Ding"}, {"authorId": "3314036", "name":
      "A. Nesvizhskii"}, {"authorId": "6753134", "name": "Pei Wang"}, {"authorId":
      "2129211402", "name": "Ana I. Robles"}, {"authorId": "2117925498", "name": "Bing
      Zhang"}, {"authorId": "145540232", "name": "S. Payne"}, {"authorId": "2063985933",
      "name": "A. Lazar"}, {"authorId": "2029001", "name": "A. Paulovich"}, {"authorId":
      "2078840019", "name": "A. Iavarone"}, {"authorId": "2186786", "name": "A. Chinnaiyan"},
      {"authorId": "144082761", "name": "B. Druker"}, {"authorId": "1396440493", "name":
      "Chandan Kumar-Sinha"}, {"authorId": "2106778949", "name": "Chelsea J. Newton"},
      {"authorId": "1608909090", "name": "Chen Huang"}, {"authorId": "2073717971",
      "name": "D. Mani"}, {"authorId": "2115707021", "name": "Richard D. Smith"},
      {"authorId": "2137359212", "name": "Emily M Huntsman"}, {"authorId": "1732072",
      "name": "E. Schadt"}, {"authorId": "5605144", "name": "E. An"}, {"authorId":
      "2185134", "name": "F. Petralia"}, {"authorId": "48397691", "name": "G. Hostetter"},
      {"authorId": "2716422", "name": "G. Omenn"}, {"authorId": "153429785", "name":
      "Han-Byoul Cho"}, {"authorId": "2054449618", "name": "Henry Rodriguez"}, {"authorId":
      "1435547387", "name": "Iga Ko\u0142odziejczak"}, {"authorId": "145916288", "name":
      "Jared L. Johnson"}, {"authorId": "2127569", "name": "Jasmin H. Bavarva"}, {"authorId":
      "12076800", "name": "Jimin Tan"}, {"authorId": "2653902", "name": "K. Rodland"},
      {"authorId": "2027516", "name": "K. Clauser"}, {"authorId": "40329575", "name":
      "Karsten Krug"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "5281963", "name": "M. Wiznerowicz"}, {"authorId": "2059004868", "name": "M.
      Ellis"}, {"authorId": "48304712", "name": "M. Anurag"}, {"authorId": "51411580",
      "name": "M. Mesri"}, {"authorId": "39595909", "name": "Michael A. Gillette"},
      {"authorId": "2167106", "name": "M. Birrer"}, {"authorId": "2149683606", "name":
      "M. Ceccarelli"}, {"authorId": "3113892", "name": "S. Dhanasekaran"}, {"authorId":
      "2207234317", "name": "Nathan Edwards"}, {"authorId": "2797149", "name": "N.
      Tignor"}, {"authorId": "8017947", "name": "\u00d6zg\u00fcn Babur"}, {"authorId":
      "2003009", "name": "Sara J. C. Gosline"}, {"authorId": "4317180", "name": "S.
      Jewell"}, {"authorId": "34794500", "name": "S. Satpathy"}, {"authorId": "46216123",
      "name": "S. Chowdhury"}, {"authorId": "2734482", "name": "S. Sch\u00fcrer"},
      {"authorId": "2072711707", "name": "Steve Carr"}, {"authorId": "46999370", "name":
      "T. Liu"}, {"authorId": "7547869", "name": "Tara Hiltke"}, {"authorId": "5247030",
      "name": "Tomer M. Yaron"}, {"authorId": "4187414", "name": "Vasileios Stathias"},
      {"authorId": "2143702454", "name": "Wenke Liu"}, {"authorId": "2115463448",
      "name": "Xu Zhang"}, {"authorId": "10782371", "name": "Yizhe Song"}, {"authorId":
      "2116701366", "name": "Zhen Zhang"}]}, {"paperId": "a76bb671101e536b0aead09cf315bf7f10a57c21",
      "externalIds": {"DOI": "10.1101/2022.03.09.483647", "CorpusId": 255776016},
      "corpusId": 255776016, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/a76bb671101e536b0aead09cf315bf7f10a57c21",
      "title": "NAK associated protein 1/NAP1 is required for mitosis and cytokinesis
      by activating TBK1", "abstract": "Subcellular location and activation of Tank
      Binding Kinase 1 (TBK1) govern precise progression through mitosis. Either loss
      of activated TBK1 or its sequestration from the centrosomes causes error in
      mitosis and growth defects. Yet, what regulates its recruitment and activation
      on the centrosomes is unknown. We identified that NAK Associated Protein 1 (NAP1)
      is essential for mitosis which binds to TBK1 on the centrosomes to activate
      it. Loss of NAP1 causes several mitotic and cytokinetic defects due to inactivation
      of TBK1. Our quantitative phosphoproteomics identified numerous TBK1 substrates
      that are not only confined to the centrosomes but also are associated with microtubules.
      Substrate motifs analysis indicates that TBK1 acts upstream of other essential
      cell cycle kinases like Aurora and PAK kinases. We also identified NAP1 as a
      TBK1 substrate at S318 promoting its degradation by ubiquitin proteasomal system
      acting as a negative regulatory step. These data uncover an important distinct
      function for the NAP1-TBK1 complex during cell division.", "venue": "bioRxiv",
      "year": 2023, "referenceCount": 102, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2023-01-11", "journal": {"name":
      "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Paul2023NAKAP,\n author =
      {Swagatika Paul and Shireen A. Sarraf and Ki Hong Nam and Leila Zavar and S.
      Biswas and Lauren E Fritsch and Nicole DeFoor and Tomer M. Yaron and Jared L.
      Johnson and Emily M Huntsman and L. Cantley and A. Ordureau and Alicia M. Pickrell},\n
      booktitle = {bioRxiv},\n journal = {bioRxiv},\n title = {NAK associated protein
      1/NAP1 is required for mitosis and cytokinesis by activating TBK1},\n year =
      {2023}\n}\n"}, "authors": [{"authorId": "1387837394", "name": "Swagatika Paul"},
      {"authorId": "2817135", "name": "Shireen A. Sarraf"}, {"authorId": "2179009294",
      "name": "Ki Hong Nam"}, {"authorId": "2158669194", "name": "Leila Zavar"}, {"authorId":
      "1491128989", "name": "S. Biswas"}, {"authorId": "1401161913", "name": "Lauren
      E Fritsch"}, {"authorId": "2042247002", "name": "Nicole DeFoor"}, {"authorId":
      "5247030", "name": "Tomer M. Yaron"}, {"authorId": "145916288", "name": "Jared
      L. Johnson"}, {"authorId": "2137359212", "name": "Emily M Huntsman"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4096885", "name": "A. Ordureau"},
      {"authorId": "6458611", "name": "Alicia M. Pickrell"}]}, {"paperId": "aeca67a03e1dd79bfb44c88c92422739e2cf315c",
      "externalIds": {"DOI": "10.1101/2023.06.27.546774", "CorpusId": 259298113, "PubMed":
      "37425798"}, "corpusId": 259298113, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/aeca67a03e1dd79bfb44c88c92422739e2cf315c",
      "title": "Lysine vitcylation is a novel vitamin C-derived protein modification
      that enhances STAT1-mediated immune response", "abstract": "Vitamin C (vitC)
      is a vital nutrient for health and also used as a therapeutic agent in diseases
      such as cancer. However, the mechanisms underlying vitC\u2019s effects remain
      elusive. Here we report that vitC directly modifies lysine without enzymes to
      form vitcyl-lysine, termed \u201cvitcylation\u201d, in a dose-, pH-, and sequence-dependent
      manner across diverse proteins in cells. We further discover that vitC vitcylates
      K298 site of STAT1, which impairs its interaction with the phosphatase PTPN2,
      preventing STAT1 Y701 dephosphorylation and leading to increased STAT1-mediated
      IFN pathway activation in tumor cells. As a result, these cells have increased
      MHC/HLA class-I expression and activate immune cells in co-cultures. Tumors
      collected from vitC-treated tumor-bearing mice have enhanced vitcylation, STAT1
      phosphorylation and antigen presentation. The identification of vitcylation
      as a novel PTM and the characterization of its effect in tumor cells opens a
      new avenue for understanding vitC in cellular processes, disease mechanisms,
      and therapeutics.", "venue": "bioRxiv", "year": 2023, "referenceCount": 96,
      "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf":
      null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2023-06-27",
      "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{He2023LysineVI,\n
      author = {Xiadi He and Yun Wei and Jiang Wu and Qiwei Wang and J. Bergholz and
      Hao Gu and Junjie Zou and Sheng Lin and Weihua Wang and Shaozhen Xie and Tao
      Jiang and James F. Lee and J. Asara and Ke Zhang and L. Cantley and Jean J.
      Zhao},\n booktitle = {bioRxiv},\n journal = {bioRxiv},\n title = {Lysine vitcylation
      is a novel vitamin C-derived protein modification that enhances STAT1-mediated
      immune response},\n year = {2023}\n}\n"}, "authors": [{"authorId": "2167613711",
      "name": "Xiadi He"}, {"authorId": "2158296377", "name": "Yun Wei"}, {"authorId":
      "2145109009", "name": "Jiang Wu"}, {"authorId": "2109274049", "name": "Qiwei
      Wang"}, {"authorId": "4137145", "name": "J. Bergholz"}, {"authorId": "2214814958",
      "name": "Hao Gu"}, {"authorId": "50136763", "name": "Junjie Zou"}, {"authorId":
      "2203049090", "name": "Sheng Lin"}, {"authorId": "2167471709", "name": "Weihua
      Wang"}, {"authorId": "35124627", "name": "Shaozhen Xie"}, {"authorId": "2087012821",
      "name": "Tao Jiang"}, {"authorId": "2108529052", "name": "James F. Lee"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "2119058001", "name": "Ke Zhang"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "50985038", "name":
      "Jean J. Zhao"}]}, {"paperId": "bf2595d18e4db5616d470c09c3de98da357deabf", "externalIds":
      {"DOI": "10.1158/1538-7445.am2023-3514", "CorpusId": 257989371}, "corpusId":
      257989371, "publicationVenue": {"id": "b0bd78b2-6591-460e-af71-196409b62e2c",
      "name": "Cancer Research", "type": "journal", "alternate_names": ["Cancer Res"],
      "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/", "alternate_urls":
      ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/bf2595d18e4db5616d470c09c3de98da357deabf",
      "title": "Abstract 3514: A genetic-metabolic circuit of liver-specific metastatic
      organotropism", "abstract": "\n Liver metastasis (LM) occurs frequently in patients
      with melanoma and is associated with a poor prognosis and reduced therapy response.
      To identify drivers of metastatic niches, we used a syngeneic mouse melanoma
      model which recapitulates genomic, metastatic and therapy response patterns
      seen in patients, and performed a large-scale in vivo CRISPR-Cas9 knockout screen,
      which identified perturbations that strongly promoted liver but not lung metastasis.
      The \u201ctop hit\u201d in this screen associated with LM was loss Pip4k2c.
      Mechanistically, loss of Pip4k2c sensitized both mouse and human melanoma to
      insulin-mediated PI3K/AKT pathway activation. Interestingly, this observation
      was dependent on the allosteric but not kinase domain activity. Treatment with
      different PI3K inhibitors abrogated the pathway in vitro, but was partly bypassed
      in the presence of insulin. As expected, loss of Pip4k2c was associated with
      significant increase in LM but not lung-metastatic burden in both syngeneic
      and patient-derived xenograft models, and this phenotype was rescued by reconstitution
      of full-length, but not allosteric domain deficient Pip4k2c constructs. We reasoned
      that Pip4k2cKO cells preferentially colonized the liver by co-opting the insulin-rich
      milieu in this organ. To test this, we generated Pip4k2c-/-/InsrshIR-KD and
      showed that Insr was required but not sufficient to enhance LM burden. Surprisingly,
      treatment with PI3K inhibition in vivo resulted in increased and not decreased
      LM burden as we had expected. PET-CT imaging of animals treated with PI3K revealed
      increased glucose uptake in LM in the presence of PI3K inhibition. We therefore
      reasoned that paradoxical activation due to host-mediated increase in glucose
      and insulin in response to PI3K inhibitor, may results in increased homing and
      metastasis to the liver. In further in vivo experiments, we showed that breaking
      this loop with either SGLT2 inhibitor or ketogenic diet circumvented host responses
      and resulted in reduced LM burden, while having no effect on lung metastasis
      burden. To further substantiate these findings, we performed single cell RNA-seq
      of concurrent liver and lung metastasis bearing mice which revealed strong tumor-intrinsic
      enrichment of central carbon metabolism. Lastly, analysis of 243 human liver
      vs extra-hepatic metastases across 75 cancers and addition of newly generated
      RNA-seq data of additional melanoma LM, revealed concordant pathways enrichment
      of glycolysis and oxidative phosphorylation LM. Together, we identify an axis
      of liver-metastatic organotropism that can be abrogated with a combination of
      PI3K inhibition and SGLT2-inhibition or concurrent ketogenic diet.\n Citation
      Format: Meri Rogava, Tyler Joseph Aprati, Wei-Yu Chen, Johannes Melms, Clemens
      Hug, Amit Dipak Amin, Bryan Ngo, Michae l Lee, Patricia Ho, Yiping Wang, Stephen
      Tang, Ethan Earlie, Sean Chen, Thomas T\u00fcting, Martin R\u00f6cken, Thomas
      K. Eigentler, Samuel F. Bakhoum, Andrei Molotkov, Akiva Mintz, Dirk Schadendorf,
      Lewis C. Cantley, Peter K. Sorger, Ashley Laughney, David Liu, Benjamin Izar.
      A genetic-metabolic circuit of liver-specific metastatic organotropism [abstract].
      In: Proceedings of the American Association for Cancer Research Annual Meeting
      2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia
      (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3514.", "venue": "Cancer
      Research", "year": 2023, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2023-04-04", "journal": {"name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Rogava2023Abstract3A,\n author = {Meri Rogava and T. Aprati and Weiyuan
      Chen and Johannes C. Melms and C. Hug and A. D. Amin and B. Ngo and Michael
      Lee and P. Ho and Yiping Wang and Stephen Tang and Ethan M. Earlie and Sean
      W Chen and T. T\u00fcting and M. R\u00f6cken and T. Eigentler and S. Bakhoum
      and A. Molotkov and A. Mintz and D. Schadendorf and L. Cantley and P. Sorger
      and Ashley M. Laughney and David Liu and B. Izar},\n booktitle = {Cancer Research},\n
      journal = {Cancer Research},\n title = {Abstract 3514: A genetic-metabolic circuit
      of liver-specific metastatic organotropism},\n year = {2023}\n}\n"}, "authors":
      [{"authorId": "5255438", "name": "Meri Rogava"}, {"authorId": "2196162263",
      "name": "T. Aprati"}, {"authorId": "2155026970", "name": "Weiyuan Chen"}, {"authorId":
      "51047419", "name": "Johannes C. Melms"}, {"authorId": "8667141", "name": "C.
      Hug"}, {"authorId": "35444784", "name": "A. D. Amin"}, {"authorId": "5891999",
      "name": "B. Ngo"}, {"authorId": "2170968780", "name": "Michael Lee"}, {"authorId":
      "122989121", "name": "P. Ho"}, {"authorId": "2130357530", "name": "Yiping Wang"},
      {"authorId": "2005623534", "name": "Stephen Tang"}, {"authorId": "2126900564",
      "name": "Ethan M. Earlie"}, {"authorId": "2133441787", "name": "Sean W Chen"},
      {"authorId": "4693025", "name": "T. T\u00fcting"}, {"authorId": "49365056",
      "name": "M. R\u00f6cken"}, {"authorId": "3513959", "name": "T. Eigentler"},
      {"authorId": "3543494", "name": "S. Bakhoum"}, {"authorId": "2071317850", "name":
      "A. Molotkov"}, {"authorId": "3572270", "name": "A. Mintz"}, {"authorId": "144267265",
      "name": "D. Schadendorf"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2940596", "name": "P. Sorger"}, {"authorId": "3009053", "name": "Ashley M.
      Laughney"}, {"authorId": "123084101", "name": "David Liu"}, {"authorId": "6923907",
      "name": "B. Izar"}]}, {"paperId": "cacfe1ff7ff0813a41e498089a0ea0d01c96fbe7",
      "externalIds": {"DOI": "10.1002/anie.202302364", "CorpusId": 257438232, "PubMed":
      "36898968"}, "corpusId": 257438232, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/cacfe1ff7ff0813a41e498089a0ea0d01c96fbe7",
      "title": "Targeting the Dark Lipid Kinase PIP4K2C with a\u00a0Potent and Selective
      Binder and Degrader.", "abstract": "Phosphatidylinositol 5-phosphate 4-kinase,
      type II, gamma (PIP4K2C) remains a poorly understood lipid kinase with minimal
      enzymatic activity but potential scaffolding roles in immune modulation and
      autophagy-dependent catabolism. Achieving potent and selective agents for PIP4K2C
      while sparing other lipid and non-lipid kinases has been challenging. Here,
      we report the discovery of the highly potent PIP4K2C binder TMX-4102, which
      shows exclusive binding selectivity for PIP4K2C. Furthermore, we elaborated
      this molecule into TMX-4153, a bivalent degrader capable of rapidly and selectively
      degrading endogenous PIP4K2C. Collectively, our work demonstrates that PIP4K2C
      is a tractable and a degradable target, and that TMX-4102 and TMX-4153 are useful
      leads to further interrogate the biological roles and therapeutic potential
      of PIP4K2C.", "venue": "Angewandte Chemie", "year": 2023, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Chemistry", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-03-10", "journal": {"pages": "\n          e202302364\n        ",
      "name": "Angewandte Chemie"}, "citationStyles": {"bibtex": "@Article{Teng2023TargetingTD,\n
      author = {Mingxing Teng and Jie Jiang and Eric S. Wang and Qixiang Geng and
      Sean T. Toenjes and K. Donovan and Nada Mageed and Hong Yue and Rados\u0142aw
      P. Nowak and Jinhua Wang and Theresa D. Manz and E. Fischer and L. Cantley and
      N. Gray},\n booktitle = {Angewandte Chemie},\n journal = {Angewandte Chemie},\n
      pages = {\n          e202302364\n        },\n title = {Targeting the Dark Lipid
      Kinase PIP4K2C with a\u00a0Potent and Selective Binder and Degrader.},\n year
      = {2023}\n}\n"}, "authors": [{"authorId": "32195044", "name": "Mingxing Teng"},
      {"authorId": "143916454", "name": "Jie Jiang"}, {"authorId": "2253321434", "name":
      "Eric S. Wang"}, {"authorId": "40756081", "name": "Qixiang Geng"}, {"authorId":
      "13540104", "name": "Sean T. Toenjes"}, {"authorId": "10775141", "name": "K.
      Donovan"}, {"authorId": "2173889756", "name": "Nada Mageed"}, {"authorId": "2057124884",
      "name": "Hong Yue"}, {"authorId": "2162227936", "name": "Rados\u0142aw P. Nowak"},
      {"authorId": "2110285824", "name": "Jinhua Wang"}, {"authorId": "16018077",
      "name": "Theresa D. Manz"}, {"authorId": "145053102", "name": "E. Fischer"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2126648439", "name":
      "N. Gray"}]}, {"paperId": "e5ca6223d07a07a3314be0d724709f5a0422d914", "externalIds":
      {"PubMedCentral": "10518635", "DOI": "10.1016/j.xcrm.2023.101173", "CorpusId":
      260919022, "PubMed": "37582371"}, "corpusId": 260919022, "publicationVenue":
      {"id": "dfdbcdaf-006b-4347-8298-d580abc9b5d3", "name": "Cell Reports Medicine",
      "type": "journal", "alternate_names": ["Cell Rep Med"], "issn": "2666-3791",
      "url": "https://www.cell.com/cell-reports-medicine", "alternate_urls": ["https://www.sciencedirect.com/journal/cell-reports-medicine/issues",
      "https://www.sciencedirect.com/journal/cell-reports-medicine"]}, "url": "https://www.semanticscholar.org/paper/e5ca6223d07a07a3314be0d724709f5a0422d914",
      "title": "Deep learning integrates histopathology and proteogenomics at a pan-cancer
      level", "abstract": null, "venue": "Cell Reports Medicine", "year": 2023, "referenceCount":
      42, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S2666379123003269/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Computer Science",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2023-08-01", "journal": {"volume": "4", "name": "Cell Reports Medicine"}, "citationStyles":
      {"bibtex": "@Article{Wang2023DeepLI,\n author = {Joshua M Wang and R. Hong and
      Elizabeth G. Demicco and Jimin Tan and R. Lazcano and A. Moreira and Yize Li
      and A. Calinawan and N. Razavian and Tobias Schraink and Michael A. Gillette
      and G. Omenn and E. An and Henry Rodriguez and A. Tsirigos and Kelly V. Ruggles
      and Li Ding and Ana I. Robles and D. Mani and K. Rodland and A. Lazar and Wenke
      Liu and D. Feny\u00f6 and F. Aguet and Y. Akiyama and Shankara K. Anand and
      M. Anurag and \u00d6zg\u00fcn Babur and Jasmin H. Bavarva and Chet Birger and
      M. Birrer and L. Cantley and Song Cao and Steve Carr and M. Ceccarelli and Daniel
      W. Chan and A. Chinnaiyan and Han-Byoul Cho and S. Chowdhury and M. Cieslik
      and K. Clauser and A. Colaprico and D. Zhou and Felipe da Veiga Leprevost and
      Corbin Day and S. Dhanasekaran and M. Domagalski and Yongchao Dou and B. Druker
      and Nathan Edwards and M. Ellis and M. Selvan and S. Foltz and Alicia Francis
      and Y. Geffen and G. Getz and Tania J. Gonz\u00e1lez Robles and Sara J. C. Gosline
      and Z. G\u00fcm\u00fc\u015f and David I Heiman and Tara Hiltke and G. Hostetter
      and Yingwei Hu and Chen Huang and Emily M Huntsman and A. Iavarone and Eric
      J. Jaehnig and S. Jewell and Jiayi Ji and Wen Jiang and Jared L. Johnson and
      L. Katsnelson and K. Ketchum and Iga Ko\u0142odziejczak and Karsten Krug and
      Chandan Kumar-Sinha and Jonathan T. Lei and Wen-Wei Liang and Yuxing Liao and
      Caleb M Lindgren and T. Liu and Weiping Ma and F. M. Rodrigues and Wilson H.
      McKerrow and A. Nesvizhskii and Chelsea J. Newton and R. Oldroyd and A. Paulovich
      and S. Payne and F. Petralia and Pietro Pugliese and B. Reva and Dmitry Rykunov
      and S. Satpathy and Sara R. Savage and E. Schadt and M. Schnaubelt and S. Sch\u00fcrer
      and Zhiao Shi and Richard D. Smith and Xiaoyu Song and Yizhe Song and Vasileios
      Stathias and E. Storrs and Nadezhda V. Terekhanova and Ratna R. Thangudu and
      M. Thiagarajan and N. Tignor and Liang-Bo Wang and Peisen Wang and Ying Wang
      and Bo Wen and M. Wiznerowicz and Yige Wu and Matthew A. Wyczalkowski and L.
      Yao and Tomer M. Yaron and Xinpei Yi and Bing Zhang and Hui Zhang and Qing Zhang
      and Xu Zhang and Zhen Zhang},\n booktitle = {Cell Reports Medicine},\n journal
      = {Cell Reports Medicine},\n title = {Deep learning integrates histopathology
      and proteogenomics at a pan-cancer level},\n volume = {4},\n year = {2023}\n}\n"},
      "authors": [{"authorId": "2110240066", "name": "Joshua M Wang"}, {"authorId":
      "95014017", "name": "R. Hong"}, {"authorId": "11416327", "name": "Elizabeth
      G. Demicco"}, {"authorId": "1716703212", "name": "Jimin Tan"}, {"authorId":
      "1491969449", "name": "R. Lazcano"}, {"authorId": "144849915", "name": "A. Moreira"},
      {"authorId": "2110456727", "name": "Yize Li"}, {"authorId": "1580783790", "name":
      "A. Calinawan"}, {"authorId": "2678645", "name": "N. Razavian"}, {"authorId":
      "89978968", "name": "Tobias Schraink"}, {"authorId": "39595909", "name": "Michael
      A. Gillette"}, {"authorId": "2716422", "name": "G. Omenn"}, {"authorId": "5605144",
      "name": "E. An"}, {"authorId": "2054449618", "name": "Henry Rodriguez"}, {"authorId":
      "2669575", "name": "A. Tsirigos"}, {"authorId": "6107793", "name": "Kelly V.
      Ruggles"}, {"authorId": "2153731784", "name": "Li Ding"}, {"authorId": "2129211402",
      "name": "Ana I. Robles"}, {"authorId": "2073717971", "name": "D. Mani"}, {"authorId":
      "2653902", "name": "K. Rodland"}, {"authorId": "2063985933", "name": "A. Lazar"},
      {"authorId": "2143702454", "name": "Wenke Liu"}, {"authorId": "3297236", "name":
      "D. Feny\u00f6"}, {"authorId": "48975912", "name": "F. Aguet"}, {"authorId":
      "153604992", "name": "Y. Akiyama"}, {"authorId": "48361643", "name": "Shankara
      K. Anand"}, {"authorId": "48304712", "name": "M. Anurag"}, {"authorId": "8017947",
      "name": "\u00d6zg\u00fcn Babur"}, {"authorId": "2127569", "name": "Jasmin H.
      Bavarva"}, {"authorId": "69878839", "name": "Chet Birger"}, {"authorId": "2167106",
      "name": "M. Birrer"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "145733601", "name": "Song Cao"}, {"authorId": "2072711707", "name": "Steve
      Carr"}, {"authorId": "2149683606", "name": "M. Ceccarelli"}, {"authorId": "2111734912",
      "name": "Daniel W. Chan"}, {"authorId": "2186786", "name": "A. Chinnaiyan"},
      {"authorId": "153429785", "name": "Han-Byoul Cho"}, {"authorId": "46216123",
      "name": "S. Chowdhury"}, {"authorId": "50748126", "name": "M. Cieslik"}, {"authorId":
      "2027516", "name": "K. Clauser"}, {"authorId": "2550756", "name": "A. Colaprico"},
      {"authorId": "38178101", "name": "D. Zhou"}, {"authorId": "38104431", "name":
      "Felipe da Veiga Leprevost"}, {"authorId": "2229239473", "name": "Corbin Day"},
      {"authorId": "3113892", "name": "S. Dhanasekaran"}, {"authorId": "5670306",
      "name": "M. Domagalski"}, {"authorId": "40429872", "name": "Yongchao Dou"},
      {"authorId": "144082761", "name": "B. Druker"}, {"authorId": "2207234317", "name":
      "Nathan Edwards"}, {"authorId": "2059004868", "name": "M. Ellis"}, {"authorId":
      "4506880", "name": "M. Selvan"}, {"authorId": "36381769", "name": "S. Foltz"},
      {"authorId": "2064227355", "name": "Alicia Francis"}, {"authorId": "16307269",
      "name": "Y. Geffen"}, {"authorId": "2110594", "name": "G. Getz"}, {"authorId":
      "2126561999", "name": "Tania J. Gonz\u00e1lez Robles"}, {"authorId": "2003009",
      "name": "Sara J. C. Gosline"}, {"authorId": "1894070", "name": "Z. G\u00fcm\u00fc\u015f"},
      {"authorId": "37329835", "name": "David I Heiman"}, {"authorId": "7547869",
      "name": "Tara Hiltke"}, {"authorId": "48397691", "name": "G. Hostetter"}, {"authorId":
      "7741582", "name": "Yingwei Hu"}, {"authorId": "1608909090", "name": "Chen Huang"},
      {"authorId": "2137359212", "name": "Emily M Huntsman"}, {"authorId": "2078840019",
      "name": "A. Iavarone"}, {"authorId": "6199236", "name": "Eric J. Jaehnig"},
      {"authorId": "4317180", "name": "S. Jewell"}, {"authorId": "9665187", "name":
      "Jiayi Ji"}, {"authorId": "2116486417", "name": "Wen Jiang"}, {"authorId": "145916288",
      "name": "Jared L. Johnson"}, {"authorId": "1491302748", "name": "L. Katsnelson"},
      {"authorId": "3965003", "name": "K. Ketchum"}, {"authorId": "1435547387", "name":
      "Iga Ko\u0142odziejczak"}, {"authorId": "40329575", "name": "Karsten Krug"},
      {"authorId": "1396440493", "name": "Chandan Kumar-Sinha"}, {"authorId": "6070264",
      "name": "Jonathan T. Lei"}, {"authorId": "50676162", "name": "Wen-Wei Liang"},
      {"authorId": "12354549", "name": "Yuxing Liao"}, {"authorId": "2027009424",
      "name": "Caleb M Lindgren"}, {"authorId": "46999370", "name": "T. Liu"}, {"authorId":
      "50143276", "name": "Weiping Ma"}, {"authorId": "31600403", "name": "F. M. Rodrigues"},
      {"authorId": "1391880623", "name": "Wilson H. McKerrow"}, {"authorId": "3314036",
      "name": "A. Nesvizhskii"}, {"authorId": "2106778949", "name": "Chelsea J. Newton"},
      {"authorId": "80857745", "name": "R. Oldroyd"}, {"authorId": "2029001", "name":
      "A. Paulovich"}, {"authorId": "145540232", "name": "S. Payne"}, {"authorId":
      "2185134", "name": "F. Petralia"}, {"authorId": "1791880674", "name": "Pietro
      Pugliese"}, {"authorId": "78881029", "name": "B. Reva"}, {"authorId": "47615781",
      "name": "Dmitry Rykunov"}, {"authorId": "34794500", "name": "S. Satpathy"},
      {"authorId": "5129394", "name": "Sara R. Savage"}, {"authorId": "1732072", "name":
      "E. Schadt"}, {"authorId": "28477636", "name": "M. Schnaubelt"}, {"authorId":
      "2734482", "name": "S. Sch\u00fcrer"}, {"authorId": "46451092", "name": "Zhiao
      Shi"}, {"authorId": "2115707021", "name": "Richard D. Smith"}, {"authorId":
      "2179188345", "name": "Xiaoyu Song"}, {"authorId": "10782371", "name": "Yizhe
      Song"}, {"authorId": "4187414", "name": "Vasileios Stathias"}, {"authorId":
      "1742409571", "name": "E. Storrs"}, {"authorId": "3650868", "name": "Nadezhda
      V. Terekhanova"}, {"authorId": "2671601", "name": "Ratna R. Thangudu"}, {"authorId":
      "2789936", "name": "M. Thiagarajan"}, {"authorId": "2797149", "name": "N. Tignor"},
      {"authorId": "2144691004", "name": "Liang-Bo Wang"}, {"authorId": "2118951705",
      "name": "Peisen Wang"}, {"authorId": "2155517439", "name": "Ying Wang"}, {"authorId":
      "48781796", "name": "Bo Wen"}, {"authorId": "5281963", "name": "M. Wiznerowicz"},
      {"authorId": "2896178", "name": "Yige Wu"}, {"authorId": "4953858", "name":
      "Matthew A. Wyczalkowski"}, {"authorId": "145095579", "name": "L. Yao"}, {"authorId":
      "5247030", "name": "Tomer M. Yaron"}, {"authorId": "51101724", "name": "Xinpei
      Yi"}, {"authorId": "2117925498", "name": "Bing Zhang"}, {"authorId": "2178835774",
      "name": "Hui Zhang"}, {"authorId": "2112725056", "name": "Qing Zhang"}, {"authorId":
      "2115463374", "name": "Xu Zhang"}, {"authorId": "2116701366", "name": "Zhen
      Zhang"}]}, {"paperId": "e7144e1fd1a9ad52909a4401185aea48e193bce8", "externalIds":
      {"DOI": "10.1016/j.ccell.2023.07.013", "CorpusId": 260920938, "PubMed": "37582362"},
      "corpusId": 260920938, "publicationVenue": {"id": "11e469cb-37ad-487e-b0ab-d26e82037c22",
      "name": "Cancer Cell", "type": "journal", "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/e7144e1fd1a9ad52909a4401185aea48e193bce8",
      "title": "Integrative multi-omic cancer profiling reveals DNA methylation patterns
      associated with therapeutic vulnerability and cell-of-origin.", "abstract":
      null, "venue": "Cancer Cell", "year": 2023, "referenceCount": 127, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2023-08-01", "journal": {"name": "Cancer cell"}, "citationStyles":
      {"bibtex": "@Article{Liang2023IntegrativeMC,\n author = {Wen-Wei Liang and Rita
      Jui-Hsien Lu and R. Jayasinghe and S. Foltz and E. Porta-Pardo and Y. Geffen
      and M. Wendl and R. Lazcano and Iga Ko\u0142odziejczak and Yizhe Song and Akshay
      Govindan and Elizabeth G. Demicco and Xia Li and Yize Li and Sunantha Sethuraman
      and S. Payne and D. Feny\u00f6 and Henry Rodriguez and M. Wiznerowicz and Hui
      Shen and D. Mani and K. Rodland and A. Lazar and Ana I. Robles and Li Ding and
      F. Aguet and Y. Akiyama and E. An and Shankara K. Anand and M. Anurag and O.
      Babur and Jasmin H. Bavarva and Chet Birger and M. Birrer and A. Calinawan and
      L. Cantley and Song Cao and Steve Carr and M. Ceccarelli and Daniel W. Chan
      and A. Chinnaiyan and Han-Byoul Cho and S. Chowdhury and M. Cieslik and K. Clauser
      and A. Colaprico and D. Zhou and Felipe da Veiga Leprevost and Corbin Day and
      M. Dhanasekaran and M. Domagalski and Yongchao Dou and B. Druker and Nathan
      Edwards and M. Ellis and M. Selvan and Alicia Francis and G. Getz and Michael
      A. Gillette and Tania J. Gonzalez Robles and Sara J. C. Gosline and Z. G\u00fcm\u00fc\u015f
      and David I Heiman and Tara Hiltke and R. Hong and G. Hostetter and Yingwei
      Hu and Chen Huang and Emily M Huntsman and A. Iavarone and Eric J. Jaehnig and
      S. Jewel and Jiayi Ji and Wen Jiang and Jared Lee Johnson and L. Katsnelson
      and K. Ketchum and Karsten Krug and Chandan Kumar-Sinha and Jonathan T. Lei
      and Yuxing Liao and Caleb M Lindgren and T. Liu and Wenke Liu and Weiping Ma
      and F. M. Rodrigues and Wilson H. McKerrow and M. Mesri and A. Nesvizhskii and
      Chelsea J. Newton and R. Oldroyd and G. Omenn and A. Paulovich and F. Petralia
      and Pietro Pugliese and B. Reva and Kelly V. Ruggles and Dmitry Rykunov and
      S. Satpathy and Sara R. Savage and Eric Schadt and M. Schnaubelt and Tobias
      Schraink and Zhiao Shi and Dick Smith and Xiaoyu Song and Vasileios Stathias
      and E. Storrs and Jimin Tan and Nadezhda V. Terekhanova and Ratna R. Thangudu
      and M. Thiagarajan and N. Tignor and Joshua M Wang and Liang-Bo Wang and Pei
      Wang and Ying Wang and Bo Wen and Yige Wu and L. Yao and Tomer M. Yaron and
      Xinpei Yi and Bing Zhang and Hui Zhang and Qing Zhang and Xu Zhang and Zhen
      Zhang},\n booktitle = {Cancer Cell},\n journal = {Cancer cell},\n title = {Integrative
      multi-omic cancer profiling reveals DNA methylation patterns associated with
      therapeutic vulnerability and cell-of-origin.},\n year = {2023}\n}\n"}, "authors":
      [{"authorId": "50676162", "name": "Wen-Wei Liang"}, {"authorId": "147931409",
      "name": "Rita Jui-Hsien Lu"}, {"authorId": "39011183", "name": "R. Jayasinghe"},
      {"authorId": "36381769", "name": "S. Foltz"}, {"authorId": "1399201106", "name":
      "E. Porta-Pardo"}, {"authorId": "16307269", "name": "Y. Geffen"}, {"authorId":
      "1707033", "name": "M. Wendl"}, {"authorId": "1491969449", "name": "R. Lazcano"},
      {"authorId": "1435547387", "name": "Iga Ko\u0142odziejczak"}, {"authorId": "2115712860",
      "name": "Yizhe Song"}, {"authorId": "2054692286", "name": "Akshay Govindan"},
      {"authorId": "11416327", "name": "Elizabeth G. Demicco"}, {"authorId": "48569910",
      "name": "Xia Li"}, {"authorId": "2110456727", "name": "Yize Li"}, {"authorId":
      "35451984", "name": "Sunantha Sethuraman"}, {"authorId": "145540232", "name":
      "S. Payne"}, {"authorId": "3297236", "name": "D. Feny\u00f6"}, {"authorId":
      "2054449618", "name": "Henry Rodriguez"}, {"authorId": "5281963", "name": "M.
      Wiznerowicz"}, {"authorId": "1410672339", "name": "Hui Shen"}, {"authorId":
      "2073717971", "name": "D. Mani"}, {"authorId": "2653902", "name": "K. Rodland"},
      {"authorId": "2063985933", "name": "A. Lazar"}, {"authorId": "2129211402", "name":
      "Ana I. Robles"}, {"authorId": "2153731784", "name": "Li Ding"}, {"authorId":
      "48975912", "name": "F. Aguet"}, {"authorId": "153604992", "name": "Y. Akiyama"},
      {"authorId": "5605144", "name": "E. An"}, {"authorId": "48361643", "name": "Shankara
      K. Anand"}, {"authorId": "48304712", "name": "M. Anurag"}, {"authorId": "2039003",
      "name": "O. Babur"}, {"authorId": "2127569", "name": "Jasmin H. Bavarva"}, {"authorId":
      "69878839", "name": "Chet Birger"}, {"authorId": "2069059637", "name": "M. Birrer"},
      {"authorId": "1580783790", "name": "A. Calinawan"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "145733601", "name": "Song Cao"}, {"authorId":
      "2172352294", "name": "Steve Carr"}, {"authorId": "2149683606", "name": "M.
      Ceccarelli"}, {"authorId": "2111734912", "name": "Daniel W. Chan"}, {"authorId":
      "2186786", "name": "A. Chinnaiyan"}, {"authorId": "153429785", "name": "Han-Byoul
      Cho"}, {"authorId": "46216123", "name": "S. Chowdhury"}, {"authorId": "50748126",
      "name": "M. Cieslik"}, {"authorId": "2097664941", "name": "K. Clauser"}, {"authorId":
      "2550756", "name": "A. Colaprico"}, {"authorId": "38178101", "name": "D. Zhou"},
      {"authorId": "38104431", "name": "Felipe da Veiga Leprevost"}, {"authorId":
      "2229239473", "name": "Corbin Day"}, {"authorId": "87164750", "name": "M. Dhanasekaran"},
      {"authorId": "5670306", "name": "M. Domagalski"}, {"authorId": "40429872", "name":
      "Yongchao Dou"}, {"authorId": "144082761", "name": "B. Druker"}, {"authorId":
      "2207234317", "name": "Nathan Edwards"}, {"authorId": "2059004868", "name":
      "M. Ellis"}, {"authorId": "4506880", "name": "M. Selvan"}, {"authorId": "2064227355",
      "name": "Alicia Francis"}, {"authorId": "153395395", "name": "G. Getz"}, {"authorId":
      "39595909", "name": "Michael A. Gillette"}, {"authorId": "2189321519", "name":
      "Tania J. Gonzalez Robles"}, {"authorId": "2003009", "name": "Sara J. C. Gosline"},
      {"authorId": "1894070", "name": "Z. G\u00fcm\u00fc\u015f"}, {"authorId": "37329835",
      "name": "David I Heiman"}, {"authorId": "7547869", "name": "Tara Hiltke"}, {"authorId":
      "95014017", "name": "R. Hong"}, {"authorId": "48397691", "name": "G. Hostetter"},
      {"authorId": "7741582", "name": "Yingwei Hu"}, {"authorId": "1608909090", "name":
      "Chen Huang"}, {"authorId": "2137359212", "name": "Emily M Huntsman"}, {"authorId":
      "2700430", "name": "A. Iavarone"}, {"authorId": "6199236", "name": "Eric J.
      Jaehnig"}, {"authorId": "69956754", "name": "S. Jewel"}, {"authorId": "9665187",
      "name": "Jiayi Ji"}, {"authorId": "2116486417", "name": "Wen Jiang"}, {"authorId":
      "2231657108", "name": "Jared Lee Johnson"}, {"authorId": "1491302748", "name":
      "L. Katsnelson"}, {"authorId": "3965003", "name": "K. Ketchum"}, {"authorId":
      "40329575", "name": "Karsten Krug"}, {"authorId": "1396440493", "name": "Chandan
      Kumar-Sinha"}, {"authorId": "6070264", "name": "Jonathan T. Lei"}, {"authorId":
      "12354549", "name": "Yuxing Liao"}, {"authorId": "2027009424", "name": "Caleb
      M Lindgren"}, {"authorId": "46999370", "name": "T. Liu"}, {"authorId": "2143702454",
      "name": "Wenke Liu"}, {"authorId": "50143276", "name": "Weiping Ma"}, {"authorId":
      "31600403", "name": "F. M. Rodrigues"}, {"authorId": "1391880623", "name": "Wilson
      H. McKerrow"}, {"authorId": "51411580", "name": "M. Mesri"}, {"authorId": "3314036",
      "name": "A. Nesvizhskii"}, {"authorId": "2106778949", "name": "Chelsea J. Newton"},
      {"authorId": "80857745", "name": "R. Oldroyd"}, {"authorId": "2716422", "name":
      "G. Omenn"}, {"authorId": "2029001", "name": "A. Paulovich"}, {"authorId": "2185134",
      "name": "F. Petralia"}, {"authorId": "1791880674", "name": "Pietro Pugliese"},
      {"authorId": "78881029", "name": "B. Reva"}, {"authorId": "6107793", "name":
      "Kelly V. Ruggles"}, {"authorId": "47615781", "name": "Dmitry Rykunov"}, {"authorId":
      "34794500", "name": "S. Satpathy"}, {"authorId": "5129394", "name": "Sara R.
      Savage"}, {"authorId": "2083205303", "name": "Eric Schadt"}, {"authorId": "28477636",
      "name": "M. Schnaubelt"}, {"authorId": "89978968", "name": "Tobias Schraink"},
      {"authorId": "46451092", "name": "Zhiao Shi"}, {"authorId": "1664672611", "name":
      "Dick Smith"}, {"authorId": "2118944336", "name": "Xiaoyu Song"}, {"authorId":
      "4187414", "name": "Vasileios Stathias"}, {"authorId": "1742409571", "name":
      "E. Storrs"}, {"authorId": "12076800", "name": "Jimin Tan"}, {"authorId": "3650868",
      "name": "Nadezhda V. Terekhanova"}, {"authorId": "2671601", "name": "Ratna R.
      Thangudu"}, {"authorId": "2789936", "name": "M. Thiagarajan"}, {"authorId":
      "2797149", "name": "N. Tignor"}, {"authorId": "2110240066", "name": "Joshua
      M Wang"}, {"authorId": "2144691004", "name": "Liang-Bo Wang"}, {"authorId":
      "6753134", "name": "Pei Wang"}, {"authorId": "2155516588", "name": "Ying Wang"},
      {"authorId": "48781796", "name": "Bo Wen"}, {"authorId": "2896178", "name":
      "Yige Wu"}, {"authorId": "145095579", "name": "L. Yao"}, {"authorId": "5247030",
      "name": "Tomer M. Yaron"}, {"authorId": "51101724", "name": "Xinpei Yi"}, {"authorId":
      "2117925498", "name": "Bing Zhang"}, {"authorId": "48212888", "name": "Hui Zhang"},
      {"authorId": "2112725056", "name": "Qing Zhang"}, {"authorId": "2115463374",
      "name": "Xu Zhang"}, {"authorId": "2116701366", "name": "Zhen Zhang"}]}, {"paperId":
      "f0f53983175ebf15a4d246b31b264b59d2b7d72e", "externalIds": {"DOI": "10.1101/2023.06.21.545980",
      "CorpusId": 259246175}, "corpusId": 259246175, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/f0f53983175ebf15a4d246b31b264b59d2b7d72e",
      "title": "Lineage-specific intolerance to oncogenic drivers restricts histological
      transformation", "abstract": "Lung adenocarcinoma (LUAD) and small cell lung
      cancer (SCLC) are thought to originate from different epithelial cell types
      in the lung. Intriguingly, LUAD can histologically transform into SCLC following
      treatment with targeted therapies. Here we designed models to follow the conversion
      of LUAD to SCLC and found the barrier to histological transformation converges
      on tolerance to Myc, which we implicate as a lineage-specific driver of the
      pulmonary neuroendocrine cell. Histological transformations are frequently accompanied
      by activation of the Akt pathway. Manipulating this pathway permitted tolerance
      to Myc as an oncogenic driver, producing rare, stem-like cells, transcriptionally
      resembling the pulmonary basal lineage. These findings suggest histological
      transformation may require the plasticity inherent to the basal stem cell, enabling
      tolerance to previously incompatible oncogenic driver programs. One-Sentence
      Summary By modeling histological transformation of lung cancer, we uncover neuroendocrine-specific
      tolerance to Myc as an oncogenic driver.", "venue": "bioRxiv", "year": 2023,
      "referenceCount": 99, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2023/06/22/2023.06.21.545980.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2023-06-22", "journal": {"name": "bioRxiv"}, "citationStyles":
      {"bibtex": "@Article{Gardner2023LineagespecificIT,\n author = {Eric E. Gardner
      and Ethan M. Earlie and Kate Li and Jerin Thomas and M. Hubisz and Benjamin
      D. Stein and Chen Zhang and L. Cantley and Ashley M. Laughney and H. Varmus},\n
      booktitle = {bioRxiv},\n journal = {bioRxiv},\n title = {Lineage-specific intolerance
      to oncogenic drivers restricts histological transformation},\n year = {2023}\n}\n"},
      "authors": [{"authorId": "123766050", "name": "Eric E. Gardner"}, {"authorId":
      "2126900564", "name": "Ethan M. Earlie"}, {"authorId": "2220791862", "name":
      "Kate Li"}, {"authorId": "2204029821", "name": "Jerin Thomas"}, {"authorId":
      "2313345", "name": "M. Hubisz"}, {"authorId": "40353456", "name": "Benjamin
      D. Stein"}, {"authorId": "2111574700", "name": "Chen Zhang"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "3009053", "name": "Ashley M. Laughney"},
      {"authorId": "2681217", "name": "H. Varmus"}]}, {"paperId": "f9bfd1af33bafb55395d1299a92d3fbe7a8eb9ce",
      "externalIds": {"DOI": "10.1101/2023.05.04.539294", "CorpusId": 258559305, "PubMed":
      "37205525"}, "corpusId": 258559305, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/f9bfd1af33bafb55395d1299a92d3fbe7a8eb9ce",
      "title": "Submitochondrial Protein Translocation Upon Stress Inhibits Thermogenic
      Energy Expenditure", "abstract": "Mitochondria-rich brown adipocytes dissipate
      cellular fuel as heat by thermogenic energy expenditure (TEE). Prolonged nutrient
      excess or cold exposure impair TEE and contribute to the pathogenesis of obesity,
      but the mechanisms remain incompletely understood. Here we report that stress-induced
      proton leak into the matrix interface of mitochondrial innermembrane (IM) mobilizes
      a group of proteins from IM into matrix, which in turn alter mitochondrial bioenergetics.
      We further determine a smaller subset that correlates with obesity in human
      subcutaneous adipose tissue. We go on to show that the top factor on this short
      list, acyl-CoA thioesterase 9 (ACOT9), migrates from the IM into the matrix
      upon stress where it enzymatically deactivates and prevents the utilization
      of acetyl-CoA in TEE. The loss of ACOT9 protects mice against the complications
      of obesity by maintaining unobstructed TEE. Overall, our results introduce aberrant
      protein translocation as a strategy to identify pathogenic factors. One-Sentence
      Summary Thermogenic stress impairs mitochondrial energy utilization by forcing
      translocation of IM-bound proteins into the matrix.", "venue": "bioRxiv", "year":
      2023, "referenceCount": 1, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2023/05/04/2023.05.04.539294.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Environmental Science",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2023-05-04",
      "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Haczeyni2023SubmitochondrialPT,\n
      author = {F. Haczeyni and S. Steensels and Benjamin D. Stein and James M. Jordan
      and Le Li and Vincent Dartigue and Selenay S. Sarklioglu and Jixuan Qiao and
      X. Zhou and A. Dannenberg and N. Iyengar and Haiyuan Yu and L. Cantley and Baran
      A. Ersoy},\n booktitle = {bioRxiv},\n journal = {bioRxiv},\n title = {Submitochondrial
      Protein Translocation Upon Stress Inhibits Thermogenic Energy Expenditure},\n
      year = {2023}\n}\n"}, "authors": [{"authorId": "16187759", "name": "F. Haczeyni"},
      {"authorId": "2425551", "name": "S. Steensels"}, {"authorId": "40353456", "name":
      "Benjamin D. Stein"}, {"authorId": "2216572230", "name": "James M. Jordan"},
      {"authorId": "2151534978", "name": "Le Li"}, {"authorId": "2216573171", "name":
      "Vincent Dartigue"}, {"authorId": "2216571898", "name": "Selenay S. Sarklioglu"},
      {"authorId": "1739961930", "name": "Jixuan Qiao"}, {"authorId": "2109614954",
      "name": "X. Zhou"}, {"authorId": "3860528", "name": "A. Dannenberg"}, {"authorId":
      "4018492", "name": "N. Iyengar"}, {"authorId": "145339878", "name": "Haiyuan
      Yu"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "32202204",
      "name": "Baran A. Ersoy"}]}, {"paperId": "1e1722c24354818457609a4a04df2345237045b3",
      "externalIds": {"DOI": "10.1158/1541-7786.MCR-22-0804", "CorpusId": 253267506,
      "PubMed": "36325685"}, "corpusId": 253267506, "publicationVenue": {"id": "e89b8f81-f9cd-4d2a-ab62-905167b1b2df",
      "name": "Molecular Cancer Research", "type": "journal", "alternate_names": ["Mol
      Cancer Res"], "issn": "1541-7786", "url": "https://mcr.aacrjournals.org/", "alternate_urls":
      ["http://mcr.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/1e1722c24354818457609a4a04df2345237045b3",
      "title": "The AACR Journals: Advancing Progress Toward the AACR''s 115-Year
      Mission.", "abstract": null, "venue": "Molecular Cancer Research", "year": 2022,
      "referenceCount": 1, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2022-11-03", "journal": {"volume": "20 11", "pages": "\n          1591-1597\n        ",
      "name": "Molecular cancer research : MCR"}, "citationStyles": {"bibtex": "@Article{Anderson2022TheAJ,\n
      author = {K. Anderson and L. Cantley and Riccardo Dalla-Favera and C. V. Dang
      and Luis A. Diaz and R. Dubois and K. Flaherty and Philip D. Greenberg and M.
      Loda and E. Mardis and E. Platz and Michael N. Pollak and R. Schreiber and L.
      Siu and B. Teicher},\n booktitle = {Molecular Cancer Research},\n journal =
      {Molecular cancer research : MCR},\n pages = {\n          1591-1597\n        },\n
      title = {The AACR Journals: Advancing Progress Toward the AACR''s 115-Year Mission.},\n
      volume = {20 11},\n year = {2022}\n}\n"}, "authors": [{"authorId": "2178880764",
      "name": "K. Anderson"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2149691856", "name": "Riccardo Dalla-Favera"}, {"authorId": "2059177512", "name":
      "C. V. Dang"}, {"authorId": "2189433262", "name": "Luis A. Diaz"}, {"authorId":
      "4135978", "name": "R. Dubois"}, {"authorId": "145213930", "name": "K. Flaherty"},
      {"authorId": "2069169888", "name": "Philip D. Greenberg"}, {"authorId": "6213932",
      "name": "M. Loda"}, {"authorId": "3286001", "name": "E. Mardis"}, {"authorId":
      "4008854", "name": "E. Platz"}, {"authorId": "2059212154", "name": "Michael
      N. Pollak"}, {"authorId": "39884192", "name": "R. Schreiber"}, {"authorId":
      "2469902", "name": "L. Siu"}, {"authorId": "5866492", "name": "B. Teicher"}]},
      {"paperId": "24f56eedec56a97712d17808ebdd4a50f6107475", "externalIds": {"DOI":
      "10.1038/s41571-022-00611-7", "CorpusId": 246946213, "PubMed": "35181748"},
      "corpusId": 246946213, "publicationVenue": {"id": "e665d258-d079-4464-9b33-2291ffb17a14",
      "name": "Nature Reviews Clinical Oncology", "type": "journal", "alternate_names":
      ["Nat Rev Clin Oncol"], "issn": "1759-4774", "url": "http://www.nature.com/nrclinonc/",
      "alternate_urls": ["http://www.nature.com/nrclinonc", "http://www.nature.com/nrclinonc/index.html"]},
      "url": "https://www.semanticscholar.org/paper/24f56eedec56a97712d17808ebdd4a50f6107475",
      "title": "Author Correction: Radiotherapy as a tool to elicit clinically actionable
      signalling pathways in cancer", "abstract": null, "venue": "Nature Reviews Clinical
      Oncology", "year": 2022, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/s41571-022-00611-7.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review"], "publicationDate": "2022-02-18", "journal":
      {"volume": "19", "pages": "281", "name": "Nature Reviews Clinical Oncology"},
      "citationStyles": {"bibtex": "@Article{Petroni2022AuthorCR,\n author = {G. Petroni
      and L. Cantley and L. Santambrogio and S. Formenti and L. Galluzzi},\n booktitle
      = {Nature Reviews Clinical Oncology},\n journal = {Nature Reviews Clinical Oncology},\n
      pages = {281},\n title = {Author Correction: Radiotherapy as a tool to elicit
      clinically actionable signalling pathways in cancer},\n volume = {19},\n year
      = {2022}\n}\n"}, "authors": [{"authorId": "21711615", "name": "G. Petroni"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4204823", "name":
      "L. Santambrogio"}, {"authorId": "145423973", "name": "S. Formenti"}, {"authorId":
      "3974364", "name": "L. Galluzzi"}]}, {"paperId": "2a616128b7d77e2a246ed3f0b9f7f6a45c08211a",
      "externalIds": {"PubMedCentral": "9436778", "DOI": "10.1038/s41430-022-01179-2",
      "CorpusId": 251108431, "PubMed": "35896818"}, "corpusId": 251108431, "publicationVenue":
      {"id": "68d9e7c1-01cc-4bd0-a6c7-8c976e44b931", "name": "European Journal of
      Clinical Nutrition", "type": "journal", "alternate_names": ["Eur J Clin Nutr"],
      "issn": "0954-3007", "url": "https://www.nature.com/ejcn/", "alternate_urls":
      ["http://www.naturesj.com/ejcn/index.html", "http://www.nature.com/ejcn/index.html"]},
      "url": "https://www.semanticscholar.org/paper/2a616128b7d77e2a246ed3f0b9f7f6a45c08211a",
      "title": "Competing paradigms of obesity pathogenesis: energy balance versus
      carbohydrate-insulin models", "abstract": null, "venue": "European Journal of
      Clinical Nutrition", "year": 2022, "referenceCount": 244, "citationCount": 31,
      "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.nature.com/articles/s41430-022-01179-2.pdf", "status": null}, "fieldsOfStudy":
      ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": "2022-07-28", "journal": {"volume": "76",
      "pages": "1209 - 1221", "name": "European Journal of Clinical Nutrition"}, "citationStyles":
      {"bibtex": "@Article{Ludwig2022CompetingPO,\n author = {D. S. Ludwig and C.
      Apovian and L. Aronne and A. Astrup and L. Cantley and C. Ebbeling and S. Heymsfield
      and James D. Johnson and J. King and R. Krauss and Gary Taubes and J. Volek
      and E. Westman and W. Willett and W. Yancy and M. Friedman},\n booktitle = {European
      Journal of Clinical Nutrition},\n journal = {European Journal of Clinical Nutrition},\n
      pages = {1209 - 1221},\n title = {Competing paradigms of obesity pathogenesis:
      energy balance versus carbohydrate-insulin models},\n volume = {76},\n year
      = {2022}\n}\n"}, "authors": [{"authorId": "2137680835", "name": "D. S. Ludwig"},
      {"authorId": "6767830", "name": "C. Apovian"}, {"authorId": "4471209", "name":
      "L. Aronne"}, {"authorId": "47518061", "name": "A. Astrup"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4056154", "name": "C. Ebbeling"}, {"authorId":
      "1703514", "name": "S. Heymsfield"}, {"authorId": "143913880", "name": "James
      D. Johnson"}, {"authorId": "1756443", "name": "J. King"}, {"authorId": "2106276088",
      "name": "R. Krauss"}, {"authorId": "2240718990", "name": "Gary Taubes"}, {"authorId":
      "2054653160", "name": "J. Volek"}, {"authorId": "47270053", "name": "E. Westman"},
      {"authorId": "2132591752", "name": "W. Willett"}, {"authorId": "41183477", "name":
      "W. Yancy"}, {"authorId": "143673144", "name": "M. Friedman"}]}, {"paperId":
      "34562411fc5cc3303c13197c5c70b9e309a6651f", "externalIds": {"DOI": "10.1158/1078-0432.CCR-22-3167",
      "CorpusId": 253245912, "PubMed": "36317374"}, "corpusId": 253245912, "publicationVenue":
      {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0", "name": "Clinical Cancer Research",
      "type": "journal", "alternate_names": ["Clin Cancer Res"], "issn": "1078-0432",
      "url": "https://clincancerres.aacrjournals.org/", "alternate_urls": ["http://clincancerres.aacrjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/34562411fc5cc3303c13197c5c70b9e309a6651f",
      "title": "The AACR Journals: Advancing Progress Toward the AACR''s 115-Year
      Mission.", "abstract": null, "venue": "Clinical Cancer Research", "year": 2022,
      "referenceCount": 1, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://aacrjournals.org/clincancerres/article-pdf/28/21/4593/3220466/4593.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-11-01", "journal":
      {"volume": "28 21", "pages": "\n          4593-4599\n        ", "name": "Clinical
      cancer research : an official journal of the American Association for Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Anderson2022TheAJ,\n author
      = {K. Anderson and L. Cantley and R. Dalla-Favera and C. V. Dang and Luis A.
      Diaz and R. Dubois and K. Flaherty and Philip D. Greenberg and M. Loda and E.
      Mardis and E. Platz and Michael N. Pollak and R. Schreiber and L. Siu and B.
      Teicher},\n booktitle = {Clinical Cancer Research},\n journal = {Clinical cancer
      research : an official journal of the American Association for Cancer Research},\n
      pages = {\n          4593-4599\n        },\n title = {The AACR Journals: Advancing
      Progress Toward the AACR''s 115-Year Mission.},\n volume = {28 21},\n year =
      {2022}\n}\n"}, "authors": [{"authorId": "2178880764", "name": "K. Anderson"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1396265158", "name":
      "R. Dalla-Favera"}, {"authorId": "2059177512", "name": "C. V. Dang"}, {"authorId":
      "2189433262", "name": "Luis A. Diaz"}, {"authorId": "4135978", "name": "R. Dubois"},
      {"authorId": "145213930", "name": "K. Flaherty"}, {"authorId": "2069169888",
      "name": "Philip D. Greenberg"}, {"authorId": "6213932", "name": "M. Loda"},
      {"authorId": "3286001", "name": "E. Mardis"}, {"authorId": "4008854", "name":
      "E. Platz"}, {"authorId": "2059212154", "name": "Michael N. Pollak"}, {"authorId":
      "39884192", "name": "R. Schreiber"}, {"authorId": "2469902", "name": "L. Siu"},
      {"authorId": "5866492", "name": "B. Teicher"}]}, {"paperId": "48155eae59bfbb67b6621bea1351bba745b50d3d",
      "externalIds": {"DOI": "10.1038/s41422-022-00723-w", "CorpusId": 252181567,
      "PubMed": "36085369"}, "corpusId": 252181567, "publicationVenue": {"id": "45c77f4e-d4c0-4df3-99dd-119b0d2adb78",
      "name": "Cell Research", "type": "journal", "alternate_names": ["Cell Res"],
      "issn": "1001-0602", "url": "http://www.cell-research.com/", "alternate_urls":
      ["http://www.cell-research.com/index.asp", "http://www.nature.com/cr/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/48155eae59bfbb67b6621bea1351bba745b50d3d",
      "title": "Live cold to grow old? Thermogenesis to fight cancer", "abstract":
      null, "venue": "Cell Research", "year": 2022, "referenceCount": 11, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.nature.com/articles/s41422-022-00723-w.pdf", "status": null}, "fieldsOfStudy":
      ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Environmental
      Science", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-09-09", "journal":
      {"volume": "32", "pages": "1042 - 1043", "name": "Cell Research"}, "citationStyles":
      {"bibtex": "@Article{Langer2022LiveCT,\n author = {H. Langer and L. Cantley
      and M. Goncalves},\n booktitle = {Cell Research},\n journal = {Cell Research},\n
      pages = {1042 - 1043},\n title = {Live cold to grow old? Thermogenesis to fight
      cancer},\n volume = {32},\n year = {2022}\n}\n"}, "authors": [{"authorId": "38751542",
      "name": "H. Langer"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "145524334", "name": "M. Goncalves"}]}, {"paperId": "49596b7d8df1ad22a4e0c723dde9fff5baa8fd11",
      "externalIds": {"PubMedCentral": "9352595", "DOI": "10.1038/s41586-022-04984-8",
      "CorpusId": 251133354, "PubMed": "35896750"}, "corpusId": 251133354, "publicationVenue":
      {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/49596b7d8df1ad22a4e0c723dde9fff5baa8fd11",
      "title": "PI3K drives the de novo synthesis of coenzyme A from vitamin B5",
      "abstract": null, "venue": "Nature", "year": 2022, "referenceCount": 77, "citationCount":
      27, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.nature.com/articles/s41586-022-04984-8.pdf", "status": null}, "fieldsOfStudy":
      ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2022-07-27", "journal": {"volume": "608", "pages": "192 - 198", "name": "Nature"},
      "citationStyles": {"bibtex": "@Article{Dibble2022PI3KDT,\n author = {Christian
      C. Dibble and S. Barritt and Grace E. Perry and Evan C. Lien and Renee C. Geck
      and Sarah E DuBois-Coyne and David Bartee and Thomas T. Zengeya and Emily B.
      Cohen and Min Yuan and B. Hopkins and J. Meier and J. Clohessy and J. Asara
      and L. Cantley and A. Toker},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {192 - 198},\n title = {PI3K drives the de novo synthesis of coenzyme
      A from vitamin B5},\n volume = {608},\n year = {2022}\n}\n"}, "authors": [{"authorId":
      "7449887", "name": "Christian C. Dibble"}, {"authorId": "2096849703", "name":
      "S. Barritt"}, {"authorId": "2179440798", "name": "Grace E. Perry"}, {"authorId":
      "4729701", "name": "Evan C. Lien"}, {"authorId": "13850298", "name": "Renee
      C. Geck"}, {"authorId": "2179439798", "name": "Sarah E DuBois-Coyne"}, {"authorId":
      "8023165", "name": "David Bartee"}, {"authorId": "13474796", "name": "Thomas
      T. Zengeya"}, {"authorId": "49273595", "name": "Emily B. Cohen"}, {"authorId":
      "49059923", "name": "Min Yuan"}, {"authorId": "48821307", "name": "B. Hopkins"},
      {"authorId": "6033148", "name": "J. Meier"}, {"authorId": "4102988", "name":
      "J. Clohessy"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "145751285", "name": "A. Toker"}]}, {"paperId":
      "4e01cd4e5ee73cda411ec541b60c46df1bfd912f", "externalIds": {"DOI": "10.1101/2022.07.19.500601",
      "CorpusId": 250945722}, "corpusId": 250945722, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/4e01cd4e5ee73cda411ec541b60c46df1bfd912f",
      "title": "Epinephrine inhibits PI3K alpha via the Hippo kinases", "abstract":
      "The phosphoinositide 3-kinase, p110\u03b1, is an essential mediator of insulin
      signaling and glucose homeostasis. We systematically interrogated the human
      serine, threonine, and tyrosine kinome to search for novel regulators of p110\u03b1
      and found that the Hippo kinases phosphorylate and completely inhibit its activity.
      This inhibitory state corresponds to a conformational change of a membrane binding
      domain on p110\u03b1, which impairs its ability to engage membranes. In human
      primary hepatocytes, cancer cell lines, and rodent tissues, activation of the
      Hippo kinases, MST1/2, using forskolin or epinephrine is associated with phosphorylation
      and inhibition of p110\u03b1, impairment of downstream insulin signaling, and
      suppression of glycolysis and glycogen synthesis. These changes are abrogated
      when MST1/2 are genetically deleted or inhibited with small molecules. Our study
      reveals a novel inhibitory pathway of PI3K signaling and a previously unappreciated
      link between epinephrine and insulin signaling.", "venue": "bioRxiv", "year":
      2022, "referenceCount": 7, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2022-07-20", "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Lin2022EpinephrineIP,\n
      author = {Ting-Yu Lin and Shakti Ramsamooj and Katarina M Liberatore and L.
      Lantier and N. Vasan and Kannan R. Karukurichi and Seo-Kyoung Hwang and E. Kesicki
      and Edward R. Kastenhuber and Thorsten Wiederhold and Tomer M. Yaron and Mengmeng
      Zhu and Yilun Ma and M. Paddock and Guoan Zhang and B. Hopkins and O. McGuinness
      and R. Schwartz and L. Cantley and Jared L. Johnson and M. Goncalves},\n booktitle
      = {bioRxiv},\n journal = {bioRxiv},\n title = {Epinephrine inhibits PI3K alpha
      via the Hippo kinases},\n year = {2022}\n}\n"}, "authors": [{"authorId": "144181325",
      "name": "Ting-Yu Lin"}, {"authorId": "2058412873", "name": "Shakti Ramsamooj"},
      {"authorId": "51910553", "name": "Katarina M Liberatore"}, {"authorId": "4238131",
      "name": "L. Lantier"}, {"authorId": "35123724", "name": "N. Vasan"}, {"authorId":
      "3662293", "name": "Kannan R. Karukurichi"}, {"authorId": "4151944", "name":
      "Seo-Kyoung Hwang"}, {"authorId": "4354461", "name": "E. Kesicki"}, {"authorId":
      "4306515", "name": "Edward R. Kastenhuber"}, {"authorId": "47847765", "name":
      "Thorsten Wiederhold"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "2178292087", "name": "Mengmeng Zhu"}, {"authorId": "50032234", "name": "Yilun
      Ma"}, {"authorId": "4422893", "name": "M. Paddock"}, {"authorId": "49288368",
      "name": "Guoan Zhang"}, {"authorId": "48821307", "name": "B. Hopkins"}, {"authorId":
      "3532500", "name": "O. McGuinness"}, {"authorId": "46462360", "name": "R. Schwartz"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "145916288", "name":
      "Jared L. Johnson"}, {"authorId": "145524334", "name": "M. Goncalves"}]}, {"paperId":
      "563beccd56c46533238cdcc1b97e45cc50b5e5c2", "externalIds": {"DOI": "10.1158/1078-0432.CCR-21-3045",
      "CorpusId": 246776268, "PubMed": "35149538"}, "corpusId": 246776268, "publicationVenue":
      {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0", "name": "Clinical Cancer Research",
      "type": "journal", "alternate_names": ["Clin Cancer Res"], "issn": "1078-0432",
      "url": "https://clincancerres.aacrjournals.org/", "alternate_urls": ["http://clincancerres.aacrjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/563beccd56c46533238cdcc1b97e45cc50b5e5c2",
      "title": "Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients
      with Advanced Triple-Negative Breast Cancer.", "abstract": "PURPOSE\nWe had
      previously reported on the safety and the recommended phase 2 dose (RP2D) of
      olaparib in combination with the PI3K\u03b1-specific inhibitor alpelisib in
      patients with high-grade serous ovarian cancer as studied in a phase 1b trial
      (NCT01623349). Here we report on the breast cancer cohort from that study.\n\n\nEXPERIMENTAL
      DESIGN\nEligible patients had recurrent triple-negative breast cancer (TNBC),
      or recurrent breast cancer of any subtype with a germline BRCA mutation and
      were enrolled to a dose escalation or expansion cohort. After definition of
      the RP2D, secondary end points included safety and objective response rate (ORR).
      Exploratory analyses were performed using circulating free DNA (cfDNA).\n\n\nRESULTS\n17
      patients with TNBC were enrolled with a median of 3 prior lines of chemotherapy.
      The most common treatment-related grade 3-4 adverse events were hyperglycemia
      (18%) and rash (12%). The ORR was 18% (23% for patients treated at the RP2D)
      and 59% had disease control. The median duration of response was 7.4 months.
      Analysis of cfDNA tumor fractions (TFx) revealed that patients with TFx<15%
      after completion of the first cycle had a longer progression-free survival compared
      to those with TFx>15% (6.0 months vs 0.9 months, p=0.0001).\n\n\nCONCLUSIONS\nAlpelisib
      in combination with olaparib is tolerable in patients with pre-treated TNBC,
      with evidence of activity in non-BRCA carriers. CfDNA provided important prognostic
      information. Results highlight potential synergistic use of a PI3Ki to sensitize
      HR-proficient (BRCA wild-type) TNBC to PARPi and suggest the potential to expand
      the use of PARPi beyond BRCA-mutant tumors.", "venue": "Clinical Cancer Research",
      "year": 2022, "referenceCount": 0, "citationCount": 16, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/clincancerres/article-pdf/28/8/1493/3185604/1493.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-02-11", "journal":
      {"name": "Clinical cancer research : an official journal of the American Association
      for Cancer Research"}, "citationStyles": {"bibtex": "@Article{Batalini2022Phase1C,\n
      author = {Felipe Batalini and N. Xiong and N. Tayob and Madeline Polak and J.
      Eismann and L. Cantley and G. Shapiro and V. Adalsteinsson and E. Winer and
      P. Konstantinopoulos and A. D\u2019Andrea and E. Swisher and U. Matulonis and
      G. Wulf and E. Mayer},\n booktitle = {Clinical Cancer Research},\n journal =
      {Clinical cancer research : an official journal of the American Association
      for Cancer Research},\n title = {Phase 1b Clinical Trial with Alpelisib plus
      Olaparib for Patients with Advanced Triple-Negative Breast Cancer.},\n year
      = {2022}\n}\n"}, "authors": [{"authorId": "6936023", "name": "Felipe Batalini"},
      {"authorId": "1867565334", "name": "N. Xiong"}, {"authorId": "4518265", "name":
      "N. Tayob"}, {"authorId": "51160410", "name": "Madeline Polak"}, {"authorId":
      "27883005", "name": "J. Eismann"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2014583", "name": "G. Shapiro"}, {"authorId": "4298787", "name":
      "V. Adalsteinsson"}, {"authorId": "2369378", "name": "E. Winer"}, {"authorId":
      "49610180", "name": "P. Konstantinopoulos"}, {"authorId": "1396108662", "name":
      "A. D\u2019Andrea"}, {"authorId": "3733822", "name": "E. Swisher"}, {"authorId":
      "6927295", "name": "U. Matulonis"}, {"authorId": "31554501", "name": "G. Wulf"},
      {"authorId": "3349811", "name": "E. Mayer"}]}, {"paperId": "5a41a6716e9d75f4c08cd32a4f9c4afc43c96642",
      "externalIds": {"DOI": "10.1158/0008-5472.CAN-22-2453", "CorpusId": 253258327,
      "PubMed": "36321264"}, "corpusId": 253258327, "publicationVenue": {"id": "b0bd78b2-6591-460e-af71-196409b62e2c",
      "name": "Cancer Research", "type": "journal", "alternate_names": ["Cancer Res"],
      "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/", "alternate_urls":
      ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/5a41a6716e9d75f4c08cd32a4f9c4afc43c96642",
      "title": "The AACR Journals: Advancing Progress Toward the AACR''s 115-Year
      Mission.", "abstract": null, "venue": "Cancer Research", "year": 2022, "referenceCount":
      1, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://aacrjournals.org/cancerres/article-pdf/82/21/3861/3220451/3861.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-11-02", "journal":
      {"volume": "82 21", "pages": "\n          3861-3867\n        ", "name": "Cancer
      research"}, "citationStyles": {"bibtex": "@Article{Anderson2022TheAJ,\n author
      = {K. Anderson and L. Cantley and R. Dalla-Favera and C. V. Dang and Luis A.
      Diaz and R. Dubois and K. Flaherty and Philip D. Greenberg and M. Loda and E.
      Mardis and E. Platz and Michael N. Pollak and R. Schreiber and L. Siu and B.
      Teicher},\n booktitle = {Cancer Research},\n journal = {Cancer research},\n
      pages = {\n          3861-3867\n        },\n title = {The AACR Journals: Advancing
      Progress Toward the AACR''s 115-Year Mission.},\n volume = {82 21},\n year =
      {2022}\n}\n"}, "authors": [{"authorId": "2178880764", "name": "K. Anderson"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1396265158", "name":
      "R. Dalla-Favera"}, {"authorId": "2059177512", "name": "C. V. Dang"}, {"authorId":
      "2189433262", "name": "Luis A. Diaz"}, {"authorId": "4135978", "name": "R. Dubois"},
      {"authorId": "145213930", "name": "K. Flaherty"}, {"authorId": "2069169888",
      "name": "Philip D. Greenberg"}, {"authorId": "6213932", "name": "M. Loda"},
      {"authorId": "3286001", "name": "E. Mardis"}, {"authorId": "4008854", "name":
      "E. Platz"}, {"authorId": "2059212154", "name": "Michael N. Pollak"}, {"authorId":
      "39884192", "name": "R. Schreiber"}, {"authorId": "2469902", "name": "L. Siu"},
      {"authorId": "5866492", "name": "B. Teicher"}]}, {"paperId": "696a7d9d25ef420b7724adbca60a3fa8dd82917e",
      "externalIds": {"PubMedCentral": "9360437", "DOI": "10.1038/s41467-022-32135-0",
      "CorpusId": 251444738, "PubMed": "35941104"}, "corpusId": 251444738, "publicationVenue":
      {"id": "43b3f0f9-489a-4566-8164-02fafde3cd98", "name": "Nature Communications",
      "type": "journal", "alternate_names": ["Nat Commun"], "issn": "2041-1723", "url":
      "https://www.nature.com/ncomms/", "alternate_urls": ["http://www.nature.com/ncomms/about/index.html",
      "http://www.nature.com/ncomms/index.html"]}, "url": "https://www.semanticscholar.org/paper/696a7d9d25ef420b7724adbca60a3fa8dd82917e",
      "title": "Blocking ActRIIB and restoring appetite reverses cachexia and improves
      survival in mice with lung cancer", "abstract": null, "venue": "Nature Communications",
      "year": 2022, "referenceCount": 107, "citationCount": 18, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/s41467-022-32135-0.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2022-08-08", "journal": {"volume": "13", "name": "Nature
      Communications"}, "citationStyles": {"bibtex": "@Article{Queiroz2022BlockingAA,\n
      author = {Andr\u00c9 L Queiroz and E. Dantas and Shakti Ramsamooj and Anirudh
      Murthy and Mujmmail Ahmed and Elizabeth R. M. Zunica and R. Liang and Jessica
      Murphy and Corey D. Holman and Curtis J. Bare and G. Ghahramani and Zhidan Wu
      and D. Cohen and J. Kirwan and L. Cantley and C. Axelrod and M. Goncalves},\n
      booktitle = {Nature Communications},\n journal = {Nature Communications},\n
      title = {Blocking ActRIIB and restoring appetite reverses cachexia and improves
      survival in mice with lung cancer},\n volume = {13},\n year = {2022}\n}\n"},
      "authors": [{"authorId": "7706581", "name": "Andr\u00c9 L Queiroz"}, {"authorId":
      "144901772", "name": "E. Dantas"}, {"authorId": "2058412873", "name": "Shakti
      Ramsamooj"}, {"authorId": "2087916646", "name": "Anirudh Murthy"}, {"authorId":
      "2181973235", "name": "Mujmmail Ahmed"}, {"authorId": "25057716", "name": "Elizabeth
      R. M. Zunica"}, {"authorId": "46875693", "name": "R. Liang"}, {"authorId": "2180811849",
      "name": "Jessica Murphy"}, {"authorId": "46415060", "name": "Corey D. Holman"},
      {"authorId": "34685572", "name": "Curtis J. Bare"}, {"authorId": "2126874550",
      "name": "G. Ghahramani"}, {"authorId": "2385505", "name": "Zhidan Wu"}, {"authorId":
      "2233766036", "name": "D. Cohen"}, {"authorId": "4881087", "name": "J. Kirwan"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "51224707", "name":
      "C. Axelrod"}, {"authorId": "145524334", "name": "M. Goncalves"}]}, {"paperId":
      "750d2117770a3746fd79bda769aa32436401815a", "externalIds": {"DOI": "10.1093/ajcn/nqab385",
      "CorpusId": 246700740, "PubMed": "35139162"}, "corpusId": 246700740, "publicationVenue":
      {"id": "52460d26-e705-465a-b49c-92bb07e81ee0", "name": "American Journal of
      Clinical Nutrition", "type": "journal", "alternate_names": ["The American Journal
      of Clinical Nutrition", "Am J Clin Nutr"], "issn": "0002-9165", "url": "http://www.ajcn.org/"},
      "url": "https://www.semanticscholar.org/paper/750d2117770a3746fd79bda769aa32436401815a",
      "title": "Reply to A Drewnowski et al, O Devinsky, D A Booth and E L Gibson,
      and D J Millward.", "abstract": null, "venue": "American Journal of Clinical
      Nutrition", "year": 2022, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://academic.oup.com/ajcn/article-pdf/115/2/595/43337594/nqab385.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-02-09", "journal":
      {"volume": "115 2", "pages": "\n          595-597\n        ", "name": "The American
      journal of clinical nutrition"}, "citationStyles": {"bibtex": "@Article{Ludwig2022ReplyTA,\n
      author = {D. S. Ludwig and L. Aronne and A. Astrup and R. de Cabo and L. Cantley
      and M. Friedman and S. Heymsfield and James D Johnson and Janet C. King and
      R. Krauss and D. Lieberman and G. Taubes and J. Volek and E. Westman and W.
      Willett and W. Yancy and C. Ebbeling},\n booktitle = {American Journal of Clinical
      Nutrition},\n journal = {The American journal of clinical nutrition},\n pages
      = {\n          595-597\n        },\n title = {Reply to A Drewnowski et al, O
      Devinsky, D A Booth and E L Gibson, and D J Millward.},\n volume = {115 2},\n
      year = {2022}\n}\n"}, "authors": [{"authorId": "2137680835", "name": "D. S.
      Ludwig"}, {"authorId": "4471209", "name": "L. Aronne"}, {"authorId": "47518061",
      "name": "A. Astrup"}, {"authorId": "144285023", "name": "R. de Cabo"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "143673144", "name": "M. Friedman"},
      {"authorId": "1703514", "name": "S. Heymsfield"}, {"authorId": "2154426574",
      "name": "James D Johnson"}, {"authorId": "2116964873", "name": "Janet C. King"},
      {"authorId": "2106276088", "name": "R. Krauss"}, {"authorId": "32514132", "name":
      "D. Lieberman"}, {"authorId": "5951734", "name": "G. Taubes"}, {"authorId":
      "2054653160", "name": "J. Volek"}, {"authorId": "47270053", "name": "E. Westman"},
      {"authorId": "2132591752", "name": "W. Willett"}, {"authorId": "41183477", "name":
      "W. Yancy"}, {"authorId": "4056154", "name": "C. Ebbeling"}]}, {"paperId": "761964f2f25dfe76d67d9da0f80025e487710d94",
      "externalIds": {"DOI": "10.1016/j.cub.2022.01.027", "CorpusId": 246638820, "PubMed":
      "35134350"}, "corpusId": 246638820, "publicationVenue": {"id": "9469269e-53d7-4955-b1a5-17a75bee7634",
      "name": "Current Biology", "type": "journal", "alternate_names": ["Curr Biology"],
      "issn": "0960-9822", "url": "http://www.current-biology.com/", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/09609822"]}, "url": "https://www.semanticscholar.org/paper/761964f2f25dfe76d67d9da0f80025e487710d94",
      "title": "Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control
      mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb",
      "abstract": null, "venue": "Current Biology", "year": 2022, "referenceCount":
      0, "citationCount": 5, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0960982222000380/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2022-02-01", "journal": {"volume": "32", "pages": "733-734",
      "name": "Current Biology"}, "citationStyles": {"bibtex": "@Article{Tee2022TuberousSC,\n
      author = {Andrew R. Tee and B. Manning and Philippe P Roux and L. Cantley and
      J. Blenis},\n booktitle = {Current Biology},\n journal = {Current Biology},\n
      pages = {733-734},\n title = {Tuberous Sclerosis Complex Gene Products, Tuberin
      and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein
      Complex toward Rheb},\n volume = {32},\n year = {2022}\n}\n"}, "authors": [{"authorId":
      "2273106160", "name": "Andrew R. Tee"}, {"authorId": "2339651", "name": "B.
      Manning"}, {"authorId": "1718769", "name": "Philippe P Roux"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4037343", "name": "J. Blenis"}]},
      {"paperId": "8152ae775c54f372297d18357ffe24efbe244c3f", "externalIds": {"DOI":
      "10.1038/s41568-022-00485-y", "CorpusId": 249065532, "PubMed": "35614234"},
      "corpusId": 249065532, "publicationVenue": {"id": "db36cc4c-07df-41a8-9169-9ace7e520923",
      "name": "Nature Reviews. Cancer", "type": "journal", "alternate_names": ["Nature
      Reviews Cancer", "Nat Rev Cancer"], "issn": "1474-175X", "url": "https://www.nature.com/nrc/",
      "alternate_urls": ["http://www.nature.com/nrc/index.html"]}, "url": "https://www.semanticscholar.org/paper/8152ae775c54f372297d18357ffe24efbe244c3f",
      "title": "Developing dietary interventions as therapy for cancer", "abstract":
      null, "venue": "Nature Reviews. Cancer", "year": 2022, "referenceCount": 241,
      "citationCount": 37, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "2022-05-25",
      "journal": {"volume": "22", "pages": "452 - 466", "name": "Nature Reviews Cancer"},
      "citationStyles": {"bibtex": "@Article{Taylor2022DevelopingDI,\n author = {Samuel
      R. Taylor and John N. Falcone and L. Cantley and M. Goncalves},\n booktitle
      = {Nature Reviews. Cancer},\n journal = {Nature Reviews Cancer},\n pages = {452
      - 466},\n title = {Developing dietary interventions as therapy for cancer},\n
      volume = {22},\n year = {2022}\n}\n"}, "authors": [{"authorId": "2110994237",
      "name": "Samuel R. Taylor"}, {"authorId": "2103152900", "name": "John N. Falcone"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "145524334", "name":
      "M. Goncalves"}]}, {"paperId": "83a97a9787e65494bc50105484adfda6ae10e7e2", "externalIds":
      {"PubMedCentral": "9050834", "DOI": "10.1038/s42255-022-00553-5", "CorpusId":
      247855394, "PubMed": "35361954"}, "corpusId": 247855394, "publicationVenue":
      {"id": "f8dd1b61-789d-48ec-b550-a6245826a9aa", "name": "Nature Metabolism",
      "alternate_names": ["Nat Metab"], "issn": "2522-5812", "url": "https://www.nature.com/natmetab/"},
      "url": "https://www.semanticscholar.org/paper/83a97a9787e65494bc50105484adfda6ae10e7e2",
      "title": "Altered propionate metabolism contributes to tumor progression and
      aggressiveness", "abstract": null, "venue": "Nature Metabolism", "year": 2022,
      "referenceCount": 26, "citationCount": 19, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://lirias.kuleuven.be/bitstream/20.500.12942/693146/2/Altered%20propionate%20metabolism%20contributes%20to%20tumor%20progression%20and%20aggressiveness.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2022-03-18", "journal": {"volume": "4", "pages": "435 -
      443", "name": "Nature metabolism"}, "citationStyles": {"bibtex": "@Article{Gomes2022AlteredPM,\n
      author = {Ana P. Gomes and Didem Ilter and V. Low and S. Dr\u00e1pela and Tanya
      Schild and Edouard Mullarky and Julie Han and Ilaria Elia and D. Broekaert and
      Adam Rosenzweig and Michal J. Nagiec and Joana B. Nunes and Bethany E. Schaffer
      and A. Mutvei and J. Asara and L. Cantley and S. Fendt and J. Blenis},\n booktitle
      = {Nature Metabolism},\n journal = {Nature metabolism},\n pages = {435 - 443},\n
      title = {Altered propionate metabolism contributes to tumor progression and
      aggressiveness},\n volume = {4},\n year = {2022}\n}\n"}, "authors": [{"authorId":
      "2087116099", "name": "Ana P. Gomes"}, {"authorId": "3324022", "name": "Didem
      Ilter"}, {"authorId": "121128193", "name": "V. Low"}, {"authorId": "13926786",
      "name": "S. Dr\u00e1pela"}, {"authorId": "50356549", "name": "Tanya Schild"},
      {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId": "1886508939",
      "name": "Julie Han"}, {"authorId": "2382021", "name": "Ilaria Elia"}, {"authorId":
      "11236293", "name": "D. Broekaert"}, {"authorId": "1887417083", "name": "Adam
      Rosenzweig"}, {"authorId": "37644389", "name": "Michal J. Nagiec"}, {"authorId":
      "49872748", "name": "Joana B. Nunes"}, {"authorId": "31358846", "name": "Bethany
      E. Schaffer"}, {"authorId": "5135907", "name": "A. Mutvei"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "46775302", "name": "S. Fendt"}, {"authorId": "4037343", "name": "J. Blenis"}]},
      {"paperId": "83b7dc1d3c010b7473aecf1b33c1a2596ddd5b0b", "externalIds": {"DOI":
      "10.1158/1940-6207.CAPR-22-0369", "CorpusId": 253246166, "PubMed": "36317369"},
      "corpusId": 253246166, "publicationVenue": {"id": "30248bd8-0140-4a2a-b2f7-d817cf173fdd",
      "name": "Cancer Prevention Research", "type": "journal", "alternate_names":
      ["Cancer Prev Res"], "issn": "1940-6215", "url": "https://cancerpreventionresearch.aacrjournals.org/"},
      "url": "https://www.semanticscholar.org/paper/83b7dc1d3c010b7473aecf1b33c1a2596ddd5b0b",
      "title": "The AACR Journals: Advancing Progress Toward the AACR''s 115-Year
      Mission.", "abstract": null, "venue": "Cancer Prevention Research", "year":
      2022, "referenceCount": 1, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cancerpreventionresearch/article-pdf/15/11/705/3220045/705.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-11-01", "journal":
      {"volume": "15 11", "pages": "\n          705-712\n        ", "name": "Cancer
      prevention research"}, "citationStyles": {"bibtex": "@Article{Anderson2022TheAJ,\n
      author = {K. Anderson and L. Cantley and R. Dalla-Favera and C. V. Dang and
      Luis A. Diaz and R. Dubois and K. Flaherty and Philip D. Greenberg and M. Loda
      and E. Mardis and E. Platz and Michael N. Pollak and R. Schreiber and L. Siu
      and B. Teicher},\n booktitle = {Cancer Prevention Research},\n journal = {Cancer
      prevention research},\n pages = {\n          705-712\n        },\n title = {The
      AACR Journals: Advancing Progress Toward the AACR''s 115-Year Mission.},\n volume
      = {15 11},\n year = {2022}\n}\n"}, "authors": [{"authorId": "2178880764", "name":
      "K. Anderson"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "1396265158", "name": "R. Dalla-Favera"}, {"authorId": "2059177512", "name":
      "C. V. Dang"}, {"authorId": "2189433262", "name": "Luis A. Diaz"}, {"authorId":
      "4135978", "name": "R. Dubois"}, {"authorId": "145213930", "name": "K. Flaherty"},
      {"authorId": "2069169888", "name": "Philip D. Greenberg"}, {"authorId": "6213932",
      "name": "M. Loda"}, {"authorId": "3286001", "name": "E. Mardis"}, {"authorId":
      "4008854", "name": "E. Platz"}, {"authorId": "2059212154", "name": "Michael
      N. Pollak"}, {"authorId": "39884192", "name": "R. Schreiber"}, {"authorId":
      "2469902", "name": "L. Siu"}, {"authorId": "5866492", "name": "B. Teicher"}]},
      {"paperId": "99d2a19bc372400eb229907e964c25cfaabdc71b", "externalIds": {"DOI":
      "10.1158/1055-9965.EPI-22-0852", "CorpusId": 253258253, "PubMed": "36321301"},
      "corpusId": 253258253, "publicationVenue": {"id": "9888b440-2c06-477b-9a8a-d051b0287fbc",
      "name": "Cancer Epidemiology, Biomarkers and Prevention", "type": "journal",
      "alternate_names": ["Cancer Epidemiology, Biomarkers & Prevention", "Cancer
      Epidemiology Biomarkers  Prev", "Cancer Epidemiology Biomarkers Prev"], "issn":
      "1055-9965", "url": "https://cebp.aacrjournals.org/", "alternate_urls": ["http://cebp.aacrjournals.org//"]},
      "url": "https://www.semanticscholar.org/paper/99d2a19bc372400eb229907e964c25cfaabdc71b",
      "title": "The AACR Journals: Advancing Progress Toward the AACR''s 115-Year
      Mission.", "abstract": null, "venue": "Cancer Epidemiology, Biomarkers and Prevention",
      "year": 2022, "referenceCount": 1, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cebp/article-pdf/31/11/1995/3220436/1995.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-11-02", "journal":
      {"volume": "31 11", "pages": "\n          1995-2001\n        ", "name": "Cancer
      epidemiology, biomarkers & prevention : a publication of the American Association
      for Cancer Research, cosponsored by the American Society of Preventive Oncology"},
      "citationStyles": {"bibtex": "@Article{Anderson2022TheAJ,\n author = {K. Anderson
      and L. Cantley and Riccardo Dalla-Favera and C. V. Dang and Luis A. Diaz and
      R. Dubois and K. Flaherty and Philip D. Greenberg and M. Loda and E. Mardis
      and E. Platz and Michael N. Pollak and R. Schreiber and L. Siu and B. Teicher},\n
      booktitle = {Cancer Epidemiology, Biomarkers and Prevention},\n journal = {Cancer
      epidemiology, biomarkers & prevention : a publication of the American Association
      for Cancer Research, cosponsored by the American Society of Preventive Oncology},\n
      pages = {\n          1995-2001\n        },\n title = {The AACR Journals: Advancing
      Progress Toward the AACR''s 115-Year Mission.},\n volume = {31 11},\n year =
      {2022}\n}\n"}, "authors": [{"authorId": "2178880764", "name": "K. Anderson"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2149691856", "name":
      "Riccardo Dalla-Favera"}, {"authorId": "2059177512", "name": "C. V. Dang"},
      {"authorId": "2189433262", "name": "Luis A. Diaz"}, {"authorId": "4135978",
      "name": "R. Dubois"}, {"authorId": "145213930", "name": "K. Flaherty"}, {"authorId":
      "2069169888", "name": "Philip D. Greenberg"}, {"authorId": "6213932", "name":
      "M. Loda"}, {"authorId": "3286001", "name": "E. Mardis"}, {"authorId": "4008854",
      "name": "E. Platz"}, {"authorId": "2059212154", "name": "Michael N. Pollak"},
      {"authorId": "39884192", "name": "R. Schreiber"}, {"authorId": "2469902", "name":
      "L. Siu"}, {"authorId": "5866492", "name": "B. Teicher"}]}, {"paperId": "a6c37d54638b52049bd75c1db63b57c625563b33",
      "externalIds": {"DOI": "10.1200/jco.2022.40.16_suppl.tps1113", "CorpusId": 249450778},
      "corpusId": 249450778, "publicationVenue": {"id": "a5913268-3957-484f-b41f-347b0ba23338",
      "name": "Journal of Clinical Oncology", "type": "journal", "alternate_names":
      ["J Clin Oncol"], "issn": "0732-183X", "url": "https://ascopubs.org/loi/jco",
      "alternate_urls": ["http://www.jco.org/", "http://jco.ascopubs.org/"]}, "url":
      "https://www.semanticscholar.org/paper/a6c37d54638b52049bd75c1db63b57c625563b33",
      "title": "Targeting insulin feedback to enhance alpelisib (TIFA): A phase II
      randomized trial in metastatic, PIK3CA-mutant, hormone receptor\u2013positive
      breast cancer.", "abstract": "TPS1113 Background: Breast cancer is the most
      common malignancy among women in the U.S. and is a leading cause of cancer-related
      death. Among women with hormone receptor (HR)-positive, human epidermal growth
      factor receptor 2 (HER2)-negative breast cancer, 45% harbor activating mutations
      in the PIK3CA gene , which induces hyperactivation of phosphatidylinositol 3-kinase
      (PI3K) and drives cell growth and survival. The SOLAR-1 trial found that the
      combination of alpelisib, a PI3K inhibitor, and fulvestrant, an endocrine therapy,
      significantly improved progression-free survival compared to fulvestrant alone,
      leading to Food and Drug Administration approval in PIK3CA-mutated metastatic
      breast cancer. While PI3K inhibition induces apoptosis of cancer cells, inhibition
      of this pathway in the liver and skeletal muscle impairs physiologic insulin
      signaling leading to hyperglycemia. This affects > 60% of patients, results
      in grade 3-4 hyperglycemia in 36% of patients, and is a major cause of interrupted/reduced
      dosing or discontinuation. In preclinical models, application of a very low
      carbohydrate (ketogenic) diet or a sodium-glucose cotransporter 2 inhibitor
      (SGLT2i), a commonly used diabetes medication, minimized hyperglycemia and improved
      the anti-tumor efficacy of PI3K inhibition. These interventions are safe and
      feasible in cancer patients but have not been studied for the prevention of
      PI3K inhibitor-associated hyperglycemia. Methods: We are conducting a multicenter
      phase II clinical trial (NCT05090358) in patients receiving standard-of-care
      alpelisib plus fulvestrant to test the efficacy of three interventions (n =
      106): 1) ketogenic diet, 2) low-carbohydrate diet, or 3) canagliflozin (a SGLT2i)
      in preventing alpelisib-associated hyperglycemia. The goal of this study is
      to mitigate a major toxicity of PI3K inhibitors and maximize their clinical
      efficacy. Eligible patients must be postmenopausal and have histologically confirmed
      HR-positive, HER2-negative metastatic breast cancer, \u22651 activating PIK3CA
      mutations, measurable disease per RECIST v1.1 or at least one predominantly
      lytic bone lesion, recurrence or progression during or after endocrine-based
      therapy, ECOG performance status of 0-1, hemoglobin A1c < 8%, and fasting blood
      glucose < = 140mg/dL. Prior CDK4/6 inhibitor use is allowed. The primary endpoint
      is the grade 3-4 hyperglycemia-free rate at 12 weeks. Secondary endpoints include
      the 6- and 12-month overall response rate, 6- and 12-month progression-free
      survival, alpelisib adherence, changes in systemic hormones and metabolites
      related to glucose homeostasis, changes in body composition, and quality of
      life. The first patient was enrolled on October 15, 2021. Participating sites
      include Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center,
      and the Ohio State University Wexner Medical Center. Clinical trial information:
      NCT05090358.", "venue": "Journal of Clinical Oncology", "year": 2022, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2022-06-01", "journal": {"name": "Journal of Clinical Oncology"}, "citationStyles":
      {"bibtex": "@Article{Shen2022TargetingIF,\n author = {S. Shen and Erica Salehi
      and A. Farooki and J. Flory and Dominiq Williams and A. Carpio and Cassandra
      Chang and M. Lacouture and E. Andreopoulou and S. Sardesai and K. Jhaveri and
      L. Cantley and M. Goncalves and N. Iyengar},\n booktitle = {Journal of Clinical
      Oncology},\n journal = {Journal of Clinical Oncology},\n title = {Targeting
      insulin feedback to enhance alpelisib (TIFA): A phase II randomized trial in
      metastatic, PIK3CA-mutant, hormone receptor\u2013positive breast cancer.},\n
      year = {2022}\n}\n"}, "authors": [{"authorId": "1988901845", "name": "S. Shen"},
      {"authorId": "83272213", "name": "Erica Salehi"}, {"authorId": "4116933", "name":
      "A. Farooki"}, {"authorId": "5472574", "name": "J. Flory"}, {"authorId": "2217827768",
      "name": "Dominiq Williams"}, {"authorId": "2158283600", "name": "A. Carpio"},
      {"authorId": "2157872668", "name": "Cassandra Chang"}, {"authorId": "2397510",
      "name": "M. Lacouture"}, {"authorId": "5685899", "name": "E. Andreopoulou"},
      {"authorId": "14626356", "name": "S. Sardesai"}, {"authorId": "47352468", "name":
      "K. Jhaveri"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "145524334",
      "name": "M. Goncalves"}, {"authorId": "4018492", "name": "N. Iyengar"}]}, {"paperId":
      "a878a8e06a3770e4c23a9304e5daa6150bb9fd91", "externalIds": {"DOI": "10.1158/1535-7163.MCT-22-0655",
      "CorpusId": 253266395, "PubMed": "36325690"}, "corpusId": 253266395, "publicationVenue":
      {"id": "05590b5e-de5a-404d-bec3-bfe1e9d96382", "name": "Molecular Cancer Therapeutics",
      "type": "journal", "alternate_names": ["Mol Cancer Ther"], "issn": "1535-7163",
      "url": "https://mct.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/a878a8e06a3770e4c23a9304e5daa6150bb9fd91",
      "title": "The AACR Journals: Advancing Progress Toward the AACR''s 115-Year
      Mission.", "abstract": null, "venue": "Molecular Cancer Therapeutics", "year":
      2022, "referenceCount": 1, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2022-11-03", "journal": {"volume": "21 11", "pages": "\n          1625-1631\n        ",
      "name": "Molecular cancer therapeutics"}, "citationStyles": {"bibtex": "@Article{Anderson2022TheAJ,\n
      author = {K. Anderson and L. Cantley and Riccardo Dalla-Favera and C. V. Dang
      and Luis A. Diaz and R. Dubois and K. Flaherty and Philip D. Greenberg and M.
      Loda and E. Mardis and E. Platz and Michael N. Pollak and R. Schreiber and L.
      Siu and B. Teicher},\n booktitle = {Molecular Cancer Therapeutics},\n journal
      = {Molecular cancer therapeutics},\n pages = {\n          1625-1631\n        },\n
      title = {The AACR Journals: Advancing Progress Toward the AACR''s 115-Year Mission.},\n
      volume = {21 11},\n year = {2022}\n}\n"}, "authors": [{"authorId": "2178880764",
      "name": "K. Anderson"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2149691856", "name": "Riccardo Dalla-Favera"}, {"authorId": "2059177512", "name":
      "C. V. Dang"}, {"authorId": "2189433262", "name": "Luis A. Diaz"}, {"authorId":
      "4135978", "name": "R. Dubois"}, {"authorId": "145213930", "name": "K. Flaherty"},
      {"authorId": "2069169888", "name": "Philip D. Greenberg"}, {"authorId": "6213932",
      "name": "M. Loda"}, {"authorId": "3286001", "name": "E. Mardis"}, {"authorId":
      "4008854", "name": "E. Platz"}, {"authorId": "2059212154", "name": "Michael
      N. Pollak"}, {"authorId": "39884192", "name": "R. Schreiber"}, {"authorId":
      "2469902", "name": "L. Siu"}, {"authorId": "5866492", "name": "B. Teicher"}]},
      {"paperId": "aee4ba305609bb8995909db6e6bec4c81fdf1048", "externalIds": {"DOI":
      "10.1158/1538-7445.am2022-162", "CorpusId": 249726980}, "corpusId": 249726980,
      "publicationVenue": {"id": "b0bd78b2-6591-460e-af71-196409b62e2c", "name": "Cancer
      Research", "type": "journal", "alternate_names": ["Cancer Res"], "issn": "0008-5472",
      "url": "https://cancerres.aacrjournals.org/", "alternate_urls": ["http://cancerres.aacrjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/aee4ba305609bb8995909db6e6bec4c81fdf1048",
      "title": "Abstract 162: Identification of novel targets of Serine/arginine-rich
      protein-specific kinase 2", "abstract": "\n Altered metabolism is one of the
      hallmarks of cancer cells, supporting aberrant proliferation and survival in
      nutrient scarce and stressful environments. The reprogrammed metabolism supports
      the acquisition of malignant traits, increasing cellular fitness and providing
      a selective advantage in tumorigenesis. Multiple signaling cascades converge
      to regulate cancer cell metabolism to maintain a delicate balance between anabolic
      and catabolic processes, with the overall goal to fuel ATP production, biosynthesis
      of macromolecules and maintaining redox balance. Specifically, 70% of human
      cancers have hyperactivated mechanistic target of rapamycin (mTOR) signaling,
      the master regulator of cellular metabolism. As an important signaling node,
      mTOR complex 1(mTORC1) integrates upstream stimuli such as growth factors, amino
      acids and oxygen levels to regulate a myriad of anabolic processes including
      protein and nucleotide synthesis, RNA biogenesis and lipid metabolism, thereby
      promoting cell growth. The highly proliferative state of cancer cells, coupled
      with a change in energy demands, forces these cells to rewire their cellular
      metabolism to increase production of cellular building blocks like proteins,
      lipids and nucleotides. De novo lipogenesis provides lipids which act as an
      integral component of the plasma membrane as well as functioning as signaling
      molecules. In addition to promoting various anabolic processes, our lab has
      demonstrated that mTORC1-activated serine/arginine-rich protein-specific kinase
      2 (SRPK2) phosphorylates splicing factors that stabilize lipogenic transcripts,
      protecting them from nonsense-mediated decay and thereby increasing de novo
      lipogenesis. This is in contrast to another serine/arginine-rich protein-specific
      kinase 1 (SRPK1), which is not regulated by mTORC1. Inhibition of the mTORC1-SRPK2
      signaling axis blunts de novo lipogenesis and impedes tumor growth in several
      tumor xenograft models. SRPK2 overexpression is also observed in lung and colon
      cancers, suggesting SRPK2 may promote the growth of some human tumors. Despite
      the emerging role for SRPK2 in tumor growth, very few substrates of this kinase
      are known. We conducted a phospho-proteomics screen to identify novel substrates
      of SRPK1 and SRPK2. While some of the targets we identified are regulated in
      an mTORC1-dependent manner, many appear to be regulated independent of mTORC1,
      such as PTP1B, EGLN1 and EI24. We hypothesize that these mTORC1-independent
      targets could be SRPK1-dependent revealing potential distinct branches of SRPK
      signaling. Future studies will focus on not only validating a subset of these
      novel targets and their role in tumor growth, but also on exploring mTORC1-dependent
      and independent SRPK signaling.\n Citation Format: Kripa Shobana Ganesh, Bethany
      Schaffer, Gina Lee, Jared Johnson, Tomer M. Yaron, Noah Dephoure, Lewis C. Cantley,
      John Blenis. Identification of novel targets of Serine/arginine-rich protein-specific
      kinase 2 [abstract]. In: Proceedings of the American Association for Cancer
      Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer
      Res 2022;82(12_Suppl):Abstract nr 162.", "venue": "Cancer Research", "year":
      2022, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2022-06-15",
      "journal": {"name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Ganesh2022Abstract1I,\n
      author = {Kripa Ganesh and Bethany E. Schaffer and G. Lee and Jared L. Johnson
      and Tomer M. Yaron and Noah E. Dephoure and L. Cantley and J. Blenis},\n booktitle
      = {Cancer Research},\n journal = {Cancer Research},\n title = {Abstract 162:
      Identification of novel targets of Serine/arginine-rich protein-specific kinase
      2},\n year = {2022}\n}\n"}, "authors": [{"authorId": "144066592", "name": "Kripa
      Ganesh"}, {"authorId": "31358846", "name": "Bethany E. Schaffer"}, {"authorId":
      "2157397749", "name": "G. Lee"}, {"authorId": "145916288", "name": "Jared L.
      Johnson"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId": "4622316",
      "name": "Noah E. Dephoure"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "4037343", "name": "J. Blenis"}]}, {"paperId": "afbfc30d640d578663e0b6ba55294d0862dca11a",
      "externalIds": {"DOI": "10.1158/1538-7445.am2022-981", "CorpusId": 249721835},
      "corpusId": 249721835, "publicationVenue": {"id": "b0bd78b2-6591-460e-af71-196409b62e2c",
      "name": "Cancer Research", "type": "journal", "alternate_names": ["Cancer Res"],
      "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/", "alternate_urls":
      ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/afbfc30d640d578663e0b6ba55294d0862dca11a",
      "title": "Abstract 981: A genetic-metabolic axis of metastatic liver organotropism",
      "abstract": "\n Genomic and adaptive determinants of organ-specific metastasis
      are poorly understood. A model of sequential acquisition of divergent somatic
      mutations is insufficient to explain metastasis. Liver metastasis (LM) occurs
      frequently and is associated with a poor prognosis and reduced therapy response
      in several cancers, including in patients with melanoma and lung cancer. To
      identify drivers of metastatic niches, we used a syngeneic mouse melanoma model
      which recapitulates genomic, metastatic and therapy response patterns seen in
      patients. We performed a large-scale in vivo CRISPR-Cas9 knockout screen and
      identified perturbations that promote LM, but not primary tumor growth or metastasis
      to other organs (e.g. lung). The \u201ctop hit\u201d in this screen associated
      with LM was loss Pip4k2c. We generated Pip4k2cKO cells and show that in otherwise
      isogenic melanoma cell lines, loss of Pip4k2c led to increased baseline and
      insulin-induced activation of the PI3K/AKT pathway, and increased invasive capacity.
      Rescuing Pip4k2cKO with full-length (Pip4k2cRec) or allosteric domain deficient
      (Pip4k2cAD) Pip4k2c ORFs, we show that hyperactivation of the PI3K/AKT pathway
      in is mediated by loss of the allosteric domain function, and not loss of the
      kinase domain of Pip4k2c. Treatment with different PI3K inhibitors effectively
      abrogated the pathway, but was partly bypassed in the presence of insulin in
      Pip4k2cKO and Pip4k2cAD, but not parental or Pip4k2cRec cells. Upon tail vein
      injection, Pip4k2cKO cells produced a significantly increased LM burden compared
      to parental cells, and this effect was rescued in Pip4k2cRec but not Pip4k2cAD,
      further affirming that loss of allosteric domain was required for this phenotype.
      We reasoned that Pip4k2cKO cells preferentially colonized the liver by co-opting
      the insulin-rich milieu in this organ. To test this, we used shRNA targeted
      against the insulin receptor (Insr) generated Pip4k2cKO/InsrshIR and showed
      that Insr was required but not sufficient to enhance LM burden. Given the promising
      in vitro activity of PI3K inhibitors, we next tested whether these could abrogate
      LM in vivo. Surprisingly, we found a substantial increase in LM burden in mice
      with Pip4k2cKO-bearing LM treated with PI3K inhibition compared to vehicle treated
      animals. We show that this paradoxical observation was due to host-mediated
      increased in glucose and insulin in response to PI3K inhibitor, which promoted
      a forward loop of increased liver metastasis. Breaking this loop with either
      ketogenic diet or treatment with a SGLT2 inhibitor in turn rescued increased
      these host responses and resulted in reduced LM burden in combination with PI3K
      inhibition. In summary, we identify a novel mechanism of metastatic liver organotropism
      and pharmacological and dietary combinations to reduced liver metastatic burden.
      Given the expanding use of PI3K inhibitors, our findings may have important
      clinical implications.\n Citation Format: Meri Rogava, Johannes C. Melms, Stephanie
      Davis, Clemens Hug, Bryan Ngo, Michael J. Lee, Patricia Ho, Amit Dipak Amin,
      Yiping Wang, Sean Chen, William Ge, David Liu, Thomas T\u00fcting, Martin R\u00f6cken,
      Thomas K. Eigentler, Samuel F. Bakhoum, Andrei Molotkov, Akiva Mintz, Lewis
      C. Cantley, Peter K. Sorger, Benjamin Izar. A genetic-metabolic axis of metastatic
      liver organotropism [abstract]. In: Proceedings of the American Association
      for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR;
      Cancer Res 2022;82(12_Suppl):Abstract nr 981.", "venue": "Cancer Research",
      "year": 2022, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2022-06-15",
      "journal": {"name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Rogava2022Abstract9A,\n
      author = {Meri Rogava and Johannes C. Melms and Stephanie H. Davis and C. Hug
      and B. Ngo and Michael J. Lee and P. Ho and A. D. Amin and Yiping Wang and Sean
      W Chen and William Ge and David Liu and T. T\u00fcting and M. R\u00f6cken and
      T. Eigentler and S. Bakhoum and A. Molotkov and A. Mintz and L. Cantley and
      P. Sorger and B. Izar},\n booktitle = {Cancer Research},\n journal = {Cancer
      Research},\n title = {Abstract 981: A genetic-metabolic axis of metastatic liver
      organotropism},\n year = {2022}\n}\n"}, "authors": [{"authorId": "5255438",
      "name": "Meri Rogava"}, {"authorId": "51047419", "name": "Johannes C. Melms"},
      {"authorId": "145134818", "name": "Stephanie H. Davis"}, {"authorId": "8667141",
      "name": "C. Hug"}, {"authorId": "5891999", "name": "B. Ngo"}, {"authorId": "2115303865",
      "name": "Michael J. Lee"}, {"authorId": "122989121", "name": "P. Ho"}, {"authorId":
      "35444784", "name": "A. D. Amin"}, {"authorId": "2130357530", "name": "Yiping
      Wang"}, {"authorId": "2133441787", "name": "Sean W Chen"}, {"authorId": "48583937",
      "name": "William Ge"}, {"authorId": "2145010756", "name": "David Liu"}, {"authorId":
      "4693025", "name": "T. T\u00fcting"}, {"authorId": "49365056", "name": "M. R\u00f6cken"},
      {"authorId": "3513959", "name": "T. Eigentler"}, {"authorId": "3543494", "name":
      "S. Bakhoum"}, {"authorId": "2071317850", "name": "A. Molotkov"}, {"authorId":
      "3572270", "name": "A. Mintz"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2066157320", "name": "P. Sorger"}, {"authorId": "6923907", "name":
      "B. Izar"}]}, {"paperId": "b1e64c48c765a33732688665333c7c6df7082546", "externalIds":
      {"PubMedCentral": "9584945", "DOI": "10.1038/s41467-022-33862-0", "CorpusId":
      253041901, "PubMed": "36266345"}, "corpusId": 253041901, "publicationVenue":
      {"id": "43b3f0f9-489a-4566-8164-02fafde3cd98", "name": "Nature Communications",
      "type": "journal", "alternate_names": ["Nat Commun"], "issn": "2041-1723", "url":
      "https://www.nature.com/ncomms/", "alternate_urls": ["http://www.nature.com/ncomms/about/index.html",
      "http://www.nature.com/ncomms/index.html"]}, "url": "https://www.semanticscholar.org/paper/b1e64c48c765a33732688665333c7c6df7082546",
      "title": "Tumor-produced and aging-associated oncometabolite methylmalonic acid
      promotes cancer-associated fibroblast activation to drive metastatic progression",
      "abstract": null, "venue": "Nature Communications", "year": 2022, "referenceCount":
      55, "citationCount": 4, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.nature.com/articles/s41467-022-33862-0.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2022-10-20", "journal": {"volume": "13", "name": "Nature
      Communications"}, "citationStyles": {"bibtex": "@Article{Li2022TumorproducedAA,\n
      author = {Zhongchi Li and V. Low and V. Luga and Janet Y. Sun and Ethan M. Earlie
      and Bobak Parang and Kripa Shobana Ganesh and Sungyun Cho and J. Endress and
      Tanya Schild and Mengying Hu and D. Lyden and Wen-Bing Jin and Chunjun Guo and
      Noah E. Dephoure and L. Cantley and Ashley M. Laughney and J. Blenis},\n booktitle
      = {Nature Communications},\n journal = {Nature Communications},\n title = {Tumor-produced
      and aging-associated oncometabolite methylmalonic acid promotes cancer-associated
      fibroblast activation to drive metastatic progression},\n volume = {13},\n year
      = {2022}\n}\n"}, "authors": [{"authorId": "13676191", "name": "Zhongchi Li"},
      {"authorId": "121128193", "name": "V. Low"}, {"authorId": "6052155", "name":
      "V. Luga"}, {"authorId": "2110677133", "name": "Janet Y. Sun"}, {"authorId":
      "2126900564", "name": "Ethan M. Earlie"}, {"authorId": "6375303", "name": "Bobak
      Parang"}, {"authorId": "2188427564", "name": "Kripa Shobana Ganesh"}, {"authorId":
      "4051887", "name": "Sungyun Cho"}, {"authorId": "83689245", "name": "J. Endress"},
      {"authorId": "50356549", "name": "Tanya Schild"}, {"authorId": "47603369", "name":
      "Mengying Hu"}, {"authorId": "49293831", "name": "D. Lyden"}, {"authorId": "31949254",
      "name": "Wen-Bing Jin"}, {"authorId": "2170974216", "name": "Chunjun Guo"},
      {"authorId": "4622316", "name": "Noah E. Dephoure"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "3009053", "name": "Ashley M. Laughney"},
      {"authorId": "4037343", "name": "J. Blenis"}]}, {"paperId": "b99f18c6c7336aa896d2766c4a2e46b39b0c6e4f",
      "externalIds": {"PubMedCentral": "9011027", "DOI": "10.1016/j.gore.2022.100974",
      "CorpusId": 247882578, "PubMed": "35434236"}, "corpusId": 247882578, "publicationVenue":
      {"id": "753bdea8-6488-43c7-89cf-6a9f5897123c", "name": "Gynecologic Oncology
      Reports", "type": "journal", "alternate_names": ["Gynecologic oncology reports",
      "Gynecol oncol rep", "Gynecol Oncol Rep"], "issn": "2352-5789", "url": "https://www.journals.elsevier.com/gynecologic-oncology-reports/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/23525789"]},
      "url": "https://www.semanticscholar.org/paper/b99f18c6c7336aa896d2766c4a2e46b39b0c6e4f",
      "title": "A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma",
      "abstract": null, "venue": "Gynecologic Oncology Reports", "year": 2022, "referenceCount":
      15, "citationCount": 8, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["CaseReport"], "publicationDate": "2022-03-01", "journal":
      {"volume": "40", "name": "Gynecologic Oncology Reports"}, "citationStyles":
      {"bibtex": "@Article{Stover2022API,\n author = {E. Stover and N. Xiong and A.
      Myers and N. Tayob and Victoria Engvold and Madeline Polak and R. Broaddus and
      V. Makker and R. Drapkin and Joyce F. Liu and N. Horowitz and F. Meric-Bernstam
      and C. Aghajanian and R. Coleman and G. Mills and L. Cantley and U. Matulonis
      and S. Westin and P. Konstantinopoulos},\n booktitle = {Gynecologic Oncology
      Reports},\n journal = {Gynecologic Oncology Reports},\n title = {A phase II
      study of MK-2206, an AKT inhibitor, in uterine serous carcinoma},\n volume =
      {40},\n year = {2022}\n}\n"}, "authors": [{"authorId": "40406162", "name": "E.
      Stover"}, {"authorId": "1867565334", "name": "N. Xiong"}, {"authorId": "6324437",
      "name": "A. Myers"}, {"authorId": "4518265", "name": "N. Tayob"}, {"authorId":
      "2161108934", "name": "Victoria Engvold"}, {"authorId": "51160410", "name":
      "Madeline Polak"}, {"authorId": "6416382", "name": "R. Broaddus"}, {"authorId":
      "3553012", "name": "V. Makker"}, {"authorId": "5340828", "name": "R. Drapkin"},
      {"authorId": "2108419806", "name": "Joyce F. Liu"}, {"authorId": "8523393",
      "name": "N. Horowitz"}, {"authorId": "1397965147", "name": "F. Meric-Bernstam"},
      {"authorId": "6128162", "name": "C. Aghajanian"}, {"authorId": "3124983", "name":
      "R. Coleman"}, {"authorId": "2084778769", "name": "G. Mills"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "6927295", "name": "U. Matulonis"},
      {"authorId": "2974900", "name": "S. Westin"}, {"authorId": "49610180", "name":
      "P. Konstantinopoulos"}]}, {"paperId": "ba279253ef001c2ba482811998fd701f81ec6463",
      "externalIds": {"PubMedCentral": "9216717", "DOI": "10.1101/2022.06.16.496428",
      "CorpusId": 249854522, "PubMed": "35734085"}, "corpusId": 249854522, "publicationVenue":
      {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0", "name": "bioRxiv", "type": "journal",
      "url": "http://biorxiv.org/"}, "url": "https://www.semanticscholar.org/paper/ba279253ef001c2ba482811998fd701f81ec6463",
      "title": "Evolution of host protease interactions among SARS-CoV-2 variants
      of concern and related coronaviruses", "abstract": "Previously, we showed that
      coagulation factors directly cleave SARS-CoV-2 spike and promote viral entry
      (Kastenhuber et al., 2022). Here, we show that substitutions in the S1/S2 cleavage
      site observed in SARS-CoV-2 variants of concern (VOCs) exhibit divergent interactions
      with host proteases, including factor Xa and furin. Nafamostat remains effective
      to block coagulation factor-mediated cleavage of variant spike sequences. Furthermore,
      host protease usage has likely been a selection pressure throughout coronavirus
      evolution, and we observe convergence of distantly related coronaviruses to
      attain common host protease interactions, including coagulation factors. Interpretation
      of genomic surveillance of emerging SARS-CoV-2 variants and future zoonotic
      spillover is supported by functional characterization of recurrent emerging
      features.", "venue": "bioRxiv", "year": 2022, "referenceCount": 60, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.biorxiv.org/content/biorxiv/early/2022/06/16/2022.06.16.496428.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2022-06-16", "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Kastenhuber2022EvolutionOH,\n
      author = {Edward R. Kastenhuber and Jared L. Johnson and Tomer M. Yaron and
      Marisa Mercadante and L. Cantley},\n booktitle = {bioRxiv},\n journal = {bioRxiv},\n
      title = {Evolution of host protease interactions among SARS-CoV-2 variants of
      concern and related coronaviruses},\n year = {2022}\n}\n"}, "authors": [{"authorId":
      "4306515", "name": "Edward R. Kastenhuber"}, {"authorId": "145916288", "name":
      "Jared L. Johnson"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "2042047500", "name": "Marisa Mercadante"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "bc99b74ec0dfa86f06cd4d74b88bc9fd5e30d493", "externalIds":
      {"DOI": "10.1158/2326-6066.CIR-22-0782", "CorpusId": 253258361, "PubMed": "36321298"},
      "corpusId": 253258361, "publicationVenue": {"id": "65d10e90-2076-49fd-b6f4-070cf4edad5b",
      "name": "Cancer immunology research", "type": "journal", "alternate_names":
      ["Cancer immunol res"], "issn": "2326-6066", "url": "https://cancerimmunolres.aacrjournals.org/"},
      "url": "https://www.semanticscholar.org/paper/bc99b74ec0dfa86f06cd4d74b88bc9fd5e30d493",
      "title": "The AACR Journals: Advancing Progress Toward the AACR''s 115-Year
      Mission.", "abstract": null, "venue": "Cancer immunology research", "year":
      2022, "referenceCount": 1, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cancerimmunolres/article-pdf/10/11/1282/3220481/1282.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-11-02", "journal":
      {"volume": "10 11", "pages": "\n          1282-1288\n        ", "name": "Cancer
      immunology research"}, "citationStyles": {"bibtex": "@Article{Anderson2022TheAJ,\n
      author = {K. Anderson and L. Cantley and R. Dalla-Favera and C. V. Dang and
      Luis A. Diaz and R. Dubois and K. Flaherty and Philip D. Greenberg and M. Loda
      and E. Mardis and E. Platz and Michael N. Pollak and R. Schreiber and L. Siu
      and B. Teicher},\n booktitle = {Cancer immunology research},\n journal = {Cancer
      immunology research},\n pages = {\n          1282-1288\n        },\n title =
      {The AACR Journals: Advancing Progress Toward the AACR''s 115-Year Mission.},\n
      volume = {10 11},\n year = {2022}\n}\n"}, "authors": [{"authorId": "2178880764",
      "name": "K. Anderson"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "1396265158", "name": "R. Dalla-Favera"}, {"authorId": "2059177512", "name":
      "C. V. Dang"}, {"authorId": "2189433262", "name": "Luis A. Diaz"}, {"authorId":
      "4135978", "name": "R. Dubois"}, {"authorId": "145213930", "name": "K. Flaherty"},
      {"authorId": "2069169888", "name": "Philip D. Greenberg"}, {"authorId": "6213932",
      "name": "M. Loda"}, {"authorId": "3286001", "name": "E. Mardis"}, {"authorId":
      "4008854", "name": "E. Platz"}, {"authorId": "2059212154", "name": "Michael
      N. Pollak"}, {"authorId": "39884192", "name": "R. Schreiber"}, {"authorId":
      "2469902", "name": "L. Siu"}, {"authorId": "5866492", "name": "B. Teicher"}]},
      {"paperId": "be8a3bca32a5d86b9c556d6ab7dd6f330e13fb17", "externalIds": {"PubMedCentral":
      "9352307", "DOI": "10.1021/acs.biochem.2c00123", "CorpusId": 250453623, "PubMed":
      "35819845"}, "corpusId": 250453623, "publicationVenue": {"id": "ae7a3201-e479-4666-8a93-3d35d6bf7cd1",
      "name": "Biochemistry", "type": "journal", "issn": "0006-2960", "alternate_issns":
      ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw", "alternate_urls":
      ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/be8a3bca32a5d86b9c556d6ab7dd6f330e13fb17",
      "title": "Discovery and Characterization of a Novel Allosteric Small-Molecule
      Inhibitor of NADP+-Dependent Malic Enzyme 1", "abstract": "NADP+-dependent malic
      enzyme 1 (ME1) decarboxylates malate to form pyruvate and NADPH in the cytoplasm,
      where it mediates diverse biological functions related to the generation of
      lipids and other cellular building blocks. As such, ME1 has been implicated
      in the progression of cancers and has received attention as a promising drug
      target. Here we report the identification of a novel small-molecule inhibitor
      of ME1, designated AS1134900. AS1134900 is highly selective for ME1 compared
      with ME2 and uncompetitively inhibits ME1 activity in the presence of its substrates
      NADP+ and malate. In addition, X-ray crystal structure analysis of the enzyme\u2013inhibitor
      complex revealed that AS1134900 binds outside the ME1 active site in a novel
      allosteric site. Structural comparison of the ME1 quaternary complex with AS1134900,
      NADPH, and Mn2+, alongside known crystal structures of malic enzymes, indicated
      the determined crystal ME1\u2013inhibitor complex is in the open form conformation.
      These results provide insights and a starting point for further discovery of
      drugs that inhibit ME1 activity in cancer cells.", "venue": "Biochemistry",
      "year": 2022, "referenceCount": 15, "citationCount": 2, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-07-12", "journal":
      {"volume": "61", "pages": "1548 - 1553", "name": "Biochemistry"}, "citationStyles":
      {"bibtex": "@Article{Yoshida2022DiscoveryAC,\n author = {Tomohiro Yoshida and
      Tetsuhiro Kawabe and L. Cantley and C. Lyssiotis},\n booktitle = {Biochemistry},\n
      journal = {Biochemistry},\n pages = {1548 - 1553},\n title = {Discovery and
      Characterization of a Novel Allosteric Small-Molecule Inhibitor of NADP+-Dependent
      Malic Enzyme 1},\n volume = {61},\n year = {2022}\n}\n"}, "authors": [{"authorId":
      "46875269", "name": "Tomohiro Yoshida"}, {"authorId": "1517006580", "name":
      "Tetsuhiro Kawabe"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}]}, {"paperId": "c544cb4ed7f8964954833e3931db9365ba39577d",
      "externalIds": {"DOI": "10.1101/2022.07.29.502090", "CorpusId": 251323122},
      "corpusId": 251323122, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/c544cb4ed7f8964954833e3931db9365ba39577d",
      "title": "Obesity promotes breast epithelium DNA damage in BRCA mutation carriers",
      "abstract": "Obesity is an established risk factor for breast cancer among women
      in the general population after menopause. Whether elevated bodyweight is a
      risk factor for women with a germline mutation in BRCA1 or BRCA2 is less clear
      due to inconsistent findings from epidemiological studies and lack of mechanistic
      studies in this population. Here, we show that DNA damage in normal breast epithelium
      of BRCA mutation carriers is positively correlated with body mass index and
      with biomarkers of metabolic dysfunction. Additionally, RNA-sequencing reveals
      significant obesity-associated alterations to the breast adipose microenvironment
      of BRCA mutation carriers, including activation of estrogen biosynthesis, which
      impacts neighboring breast epithelial cells. We found that blockade of estrogen
      biosynthesis or estrogen receptor activity decreases DNA damage, whereas treatment
      with leptin or insulin increases DNA damage in BRCA heterozygous epithelial
      cells. Furthermore, we show that increased adiposity is associated with mammary
      gland DNA damage and increased penetrance of mammary tumors in Brca1+/- mice.
      Overall, our results provide mechanistic evidence in support of a link between
      bodyweight and breast cancer development in BRCA mutation carriers and suggests
      that maintaining a healthy bodyweight or pharmacologically targeting estrogen
      or metabolic dysfunction may reduce the risk of breast cancer in this population.
      One Sentence Summary Elevated bodyweight is positively associated with DNA damage
      in breast epithelium of BRCA mutation carriers", "venue": "bioRxiv", "year":
      2022, "referenceCount": 101, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Environmental Science", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2022-08-02", "journal": {"name": "bioRxiv"}, "citationStyles":
      {"bibtex": "@Article{Bhardwaj2022ObesityPB,\n author = {Priya Bhardwaj and N.
      Iyengar and Heba Zahid and Katharine M. Carter and Dong Jun Byun and Man-Ho
      Choi and Qi Sun and O. Savenkov and Charalambia Louka and Catherine Liu and
      Phoebe Piloco and Monica Acosta and R. Bareja and O. Elemento and M. Foronda
      and L. Dow and Sofya Oshchepkova and D. Giri and M. Pollak and X. Zhou and B.
      Hopkins and Ashley M. Laughney and M. Frey and L. Ellenson and M. Morrow and
      J. Spector and L. Cantley and K. Brown},\n booktitle = {bioRxiv},\n journal
      = {bioRxiv},\n title = {Obesity promotes breast epithelium DNA damage in BRCA
      mutation carriers},\n year = {2022}\n}\n"}, "authors": [{"authorId": "38811957",
      "name": "Priya Bhardwaj"}, {"authorId": "4018492", "name": "N. Iyengar"}, {"authorId":
      "34651211", "name": "Heba Zahid"}, {"authorId": "1961806917", "name": "Katharine
      M. Carter"}, {"authorId": "1884946007", "name": "Dong Jun Byun"}, {"authorId":
      "8860004", "name": "Man-Ho Choi"}, {"authorId": "2149098057", "name": "Qi Sun"},
      {"authorId": "13774442", "name": "O. Savenkov"}, {"authorId": "2180407428",
      "name": "Charalambia Louka"}, {"authorId": "2116905534", "name": "Catherine
      Liu"}, {"authorId": "2126991989", "name": "Phoebe Piloco"}, {"authorId": "2180408384",
      "name": "Monica Acosta"}, {"authorId": "9753461", "name": "R. Bareja"}, {"authorId":
      "150097652", "name": "O. Elemento"}, {"authorId": "3813868", "name": "M. Foronda"},
      {"authorId": "3918769", "name": "L. Dow"}, {"authorId": "80751685", "name":
      "Sofya Oshchepkova"}, {"authorId": "4227896", "name": "D. Giri"}, {"authorId":
      "78091495", "name": "M. Pollak"}, {"authorId": "2109614954", "name": "X. Zhou"},
      {"authorId": "48821307", "name": "B. Hopkins"}, {"authorId": "3009053", "name":
      "Ashley M. Laughney"}, {"authorId": "4396333", "name": "M. Frey"}, {"authorId":
      "6288829", "name": "L. Ellenson"}, {"authorId": "144607636", "name": "M. Morrow"},
      {"authorId": "4963563", "name": "J. Spector"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2246730", "name": "K. Brown"}]}, {"paperId": "c920f5a95411852de842ce3dcdfc6e2b612f467b",
      "externalIds": {"DOI": "10.1101/2022.05.22.492882", "CorpusId": 249047830},
      "corpusId": 249047830, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/c920f5a95411852de842ce3dcdfc6e2b612f467b",
      "title": "A global atlas of substrate specificities for the human serine/threonine
      kinome", "abstract": "Protein phosphorylation is one of the most widespread
      post-translational modifications in biology. With the advent of mass spectrometry-based
      phosphoproteomics, more than 200,000 sites of serine and threonine phosphorylation
      have been reported, of which several thousand have been associated with human
      diseases and biological processes. For the vast majority of phosphorylation
      events, it is not yet known which of the more than 300 protein Ser/Thr kinases
      encoded in the human genome is responsible. Here, we utilize synthetic peptide
      libraries to profile the substrate sequence specificity of nearly every functional
      human Ser/Thr kinase. Viewed in its entirety, the substrate specificity of the
      kinome was substantially more diverse than expected and was driven extensively
      by negative selectivity. Our kinome-wide dataset was used to computationally
      annotate and identify the most likely protein kinases for every reported phosphorylation
      site in the human Ser/Thr phosphoproteome. For the small minority of phosphosites
      where the protein kinases involved have been previously identified, our predictions
      were in excellent agreement. When this approach was applied to examine the signaling
      response of tissues and cell lines to hormones, growth factors, targeted inhibitors,
      and environmental or genetic perturbations, it revealed unexpected insights
      into pathway complexity and compensation. Overall, these studies reveal the
      full extent of substrate specificity of the human Ser/Thr kinome, illuminate
      cellular signaling responses, and provide a rich resource to link unannotated
      phosphorylation events to biological pathways.", "venue": "bioRxiv", "year":
      2022, "referenceCount": 31, "citationCount": 10, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2022/05/23/2022.05.22.492882.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2022-05-23", "journal": {"name": "bioRxiv"}, "citationStyles":
      {"bibtex": "@Article{Johnson2022AGA,\n author = {Jared L. Johnson and Tomer
      M. Yaron and Emily M Huntsman and A. Kerelsky and J. Song and Amit Regev and
      Ting-Yu Lin and Katarina M Liberatore and Daniel M. Cizin and B. M. Cohen and
      N. Vasan and Yilun Ma and K. Krismer and Jaylissa Torres Robles and Bert van
      de Kooij and Anne E. van Vlimmeren and Nicole Andr\u00e9e-Busch and N. K\u00e4ufer
      and M. Dorovkov and A. Ryazanov and Y. Takagi and Edward R. Kastenhuber and
      M. Goncalves and O. Elemento and D. Taatjes and A. Maucuer and A. Yamashita
      and A. Degterev and R. Linding and J. Blenis and P. Hornbeck and B. Turk and
      M. Yaffe and L. Cantley},\n booktitle = {bioRxiv},\n journal = {bioRxiv},\n
      title = {A global atlas of substrate specificities for the human serine/threonine
      kinome},\n year = {2022}\n}\n"}, "authors": [{"authorId": "145916288", "name":
      "Jared L. Johnson"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "2137359212", "name": "Emily M Huntsman"}, {"authorId": "14658204", "name":
      "A. Kerelsky"}, {"authorId": "2144577350", "name": "J. Song"}, {"authorId":
      "2166242001", "name": "Amit Regev"}, {"authorId": "144181325", "name": "Ting-Yu
      Lin"}, {"authorId": "51910553", "name": "Katarina M Liberatore"}, {"authorId":
      "2152463969", "name": "Daniel M. Cizin"}, {"authorId": "2055611292", "name":
      "B. M. Cohen"}, {"authorId": "35123724", "name": "N. Vasan"}, {"authorId": "50032234",
      "name": "Yilun Ma"}, {"authorId": "49181291", "name": "K. Krismer"}, {"authorId":
      "2124145062", "name": "Jaylissa Torres Robles"}, {"authorId": "49094504", "name":
      "Bert van de Kooij"}, {"authorId": "1601471755", "name": "Anne E. van Vlimmeren"},
      {"authorId": "1447106051", "name": "Nicole Andr\u00e9e-Busch"}, {"authorId":
      "88029761", "name": "N. K\u00e4ufer"}, {"authorId": "6547314", "name": "M. Dorovkov"},
      {"authorId": "4097704", "name": "A. Ryazanov"}, {"authorId": "49710109", "name":
      "Y. Takagi"}, {"authorId": "4306515", "name": "Edward R. Kastenhuber"}, {"authorId":
      "145524334", "name": "M. Goncalves"}, {"authorId": "150097652", "name": "O.
      Elemento"}, {"authorId": "34762957", "name": "D. Taatjes"}, {"authorId": "4165148",
      "name": "A. Maucuer"}, {"authorId": "144561115", "name": "A. Yamashita"}, {"authorId":
      "145919811", "name": "A. Degterev"}, {"authorId": "1892258", "name": "R. Linding"},
      {"authorId": "4037343", "name": "J. Blenis"}, {"authorId": "46627576", "name":
      "P. Hornbeck"}, {"authorId": "25581223", "name": "B. Turk"}, {"authorId": "88402408",
      "name": "M. Yaffe"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "dee8b56119d506d203ff44191db06dfe36380e91", "externalIds": {"DOI": "10.1158/1538-7445.am2022-794",
      "CorpusId": 249729792}, "corpusId": 249729792, "publicationVenue": {"id": "b0bd78b2-6591-460e-af71-196409b62e2c",
      "name": "Cancer Research", "type": "journal", "alternate_names": ["Cancer Res"],
      "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/", "alternate_urls":
      ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/dee8b56119d506d203ff44191db06dfe36380e91",
      "title": "Abstract 794: Pan-cancer proteogenomic analysis reveals functional
      mechanisms underlying DNA repair deficiencies", "abstract": "\n Emerging classifiers
      that leverage recent advances in the characterization of mutational signatures
      have identified a broader range of cancer patients with DNA repair deficiencies,
      many of whom do not harbor mutations or epigenetic silencing of canonical DNA
      repair genes. Investigating the various mechanisms underlying dysfunctional
      DNA damage response (DDR) and heterogeneity across patients will be crucial
      to understand disparate responses to therapy, including to PARP1 inhibitors
      and to immunotherapy. In this study, we integrate genomic, transcriptomic, proteomic,
      and post-translational modification (PTM) data across 11 cancer types to elucidate
      the diverse functional mechanisms of DNA repair deficiencies and their therapeutic
      implications through an in-depth proteogenomic analysis. We first characterized
      the landscape of mutational signatures in 1110 patients by applying SignatureAnalyzer,
      a tool that uses a Bayesian non-negative matrix factorization method to discover
      patterns of somatic mutations. Our analysis identified 144 homologous recombination-deficient
      (HRD) and 60 mismatch repair-deficient (MMRD) patients. Multi-omic (mRNA, protein,
      PTMs) signature based hierarchical clustering revealed two distinct clusters
      of HRD patients defined by either (i) acute or (ii) chronic hypoxic states.
      The acute hypoxia cluster exhibited typical HRD phenotypes, including a preference
      for non-homologous end joining (NHEJ) and enrichment in PARP1 activity, as well
      as phosphorylation patterns driven by DNA-PKcs, ATM, and ATR. In contrast, tumors
      under chronic hypoxia exhibited a halting of replication and silencing of DDR,
      suggesting that patients with these tumors may respond poorly to common HRD
      treatments that exploit alternative error-prone repair and PARP1 activation.
      Notably, these tumors were enriched in signatures representative of highly active
      kinases involved in cellular stress responses, potentially providing additional
      avenues for therapy. Additional analysis of both HRD and MMRD tumors revealed
      groups of highly immunogenic DNA repair-deficient tumors that may respond well
      to some types of immunotherapy given their increased mutagenesis. Moreover,
      differences in inflammation-related kinase activities offer further insight
      into the interaction between faulty DDR and the innate immune response (e.g.,
      alterations in the cGAS-STING DNA sensing pathway). Overall, our multi-omic
      signature analysis provides insights into the mechanisms underlying DDR and
      its crosstalk with other cancer-related pathways that remain unexplained by
      evaluating genomic and transcriptomic data alone. Our characterization of the
      heterogeneity within the population of patients with DNA repair deficiency shows
      promise for improved prediction of treatment response, as well as identifying
      additional potential therapeutic targets.\n Citation Format: Yo Akiyama, Yifat
      Geffen, Shankara Anand, Tomer Yaron, Jared L. Johnson, Emily Huntsman, David
      Heiman, Chet Birger, Karl Clauser, \u00d6zg\u00fcn Babur, Mendy Miller, Karsten
      Krug, D R Mani, Lewis C. Cantley, Steven A. Carr, PanCancer Oncogenic Drivers
      and Pathways Group, Clinical Proteomic Tumor Analysis Consortium (CPTAC), Francois
      Aguet, Li Ding, Gad Getz. Pan-cancer proteogenomic analysis reveals functional
      mechanisms underlying DNA repair deficiencies [abstract]. In: Proceedings of
      the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13.
      Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 794.", "venue":
      "Cancer Research", "year": 2022, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2022-06-15",
      "journal": {"name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Akiyama2022Abstract7P,\n
      author = {Yoshie Akiyama and Y. Geffen and Shankara K. Anand and Tomer M. Yaron
      and Jared L. Johnson and Emily M Huntsman and David I Heiman and Chet Birger
      and K. Clauser and \u00d6zg\u00fcn Babur and Mendy Miller and Karsten Krug and
      D. Mani and L. Cantley and Steve Carr and F. Aguet and L. Ding and G. Getz},\n
      booktitle = {Cancer Research},\n journal = {Cancer Research},\n title = {Abstract
      794: Pan-cancer proteogenomic analysis reveals functional mechanisms underlying
      DNA repair deficiencies},\n year = {2022}\n}\n"}, "authors": [{"authorId": "116703773",
      "name": "Yoshie Akiyama"}, {"authorId": "16307269", "name": "Y. Geffen"}, {"authorId":
      "48361643", "name": "Shankara K. Anand"}, {"authorId": "5247030", "name": "Tomer
      M. Yaron"}, {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId":
      "2137359212", "name": "Emily M Huntsman"}, {"authorId": "37329835", "name":
      "David I Heiman"}, {"authorId": "69878839", "name": "Chet Birger"}, {"authorId":
      "2097664941", "name": "K. Clauser"}, {"authorId": "8017947", "name": "\u00d6zg\u00fcn
      Babur"}, {"authorId": "3004576", "name": "Mendy Miller"}, {"authorId": "40329575",
      "name": "Karsten Krug"}, {"authorId": "2073717971", "name": "D. Mani"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2072711707", "name": "Steve
      Carr"}, {"authorId": "48975912", "name": "F. Aguet"}, {"authorId": "49594724",
      "name": "L. Ding"}, {"authorId": "2110594", "name": "G. Getz"}]}, {"paperId":
      "e29d68e46df33890982df05a67f3ad1231cfe6fe", "externalIds": {"DOI": "10.1038/s41571-022-00633-1",
      "CorpusId": 248423779, "PubMed": "35484287"}, "corpusId": 248423779, "publicationVenue":
      {"id": "e665d258-d079-4464-9b33-2291ffb17a14", "name": "Nature Reviews Clinical
      Oncology", "type": "journal", "alternate_names": ["Nat Rev Clin Oncol"], "issn":
      "1759-4774", "url": "http://www.nature.com/nrclinonc/", "alternate_urls": ["http://www.nature.com/nrclinonc",
      "http://www.nature.com/nrclinonc/index.html"]}, "url": "https://www.semanticscholar.org/paper/e29d68e46df33890982df05a67f3ad1231cfe6fe",
      "title": "At a crossroads: how to translate the roles of PI3K in oncogenic and
      metabolic signalling into improvements in cancer therapy", "abstract": null,
      "venue": "Nature Reviews Clinical Oncology", "year": 2022, "referenceCount":
      178, "citationCount": 39, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": "2022-04-28", "journal": {"volume": "19",
      "pages": "471 - 485", "name": "Nature Reviews Clinical Oncology"}, "citationStyles":
      {"bibtex": "@Article{Vasan2022AtAC,\n author = {N. Vasan and L. Cantley},\n
      booktitle = {Nature Reviews Clinical Oncology},\n journal = {Nature Reviews
      Clinical Oncology},\n pages = {471 - 485},\n title = {At a crossroads: how to
      translate the roles of PI3K in oncogenic and metabolic signalling into improvements
      in cancer therapy},\n volume = {19},\n year = {2022}\n}\n"}, "authors": [{"authorId":
      "35123724", "name": "N. Vasan"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "ece822a63264bf7d46c6cef759b899324b76559d", "externalIds": {"DOI":
      "10.1158/2643-3230.BCD-22-0165", "CorpusId": 253257644, "PubMed": "36321294"},
      "corpusId": 253257644, "publicationVenue": {"id": "6b2d326f-e39b-464b-8359-1ef475cd7495",
      "name": "Blood Cancer Discovery", "type": "journal", "alternate_names": ["Blood
      Cancer Discov"], "issn": "2643-3230", "url": "https://bloodcancerdiscov.aacrjournals.org/"},
      "url": "https://www.semanticscholar.org/paper/ece822a63264bf7d46c6cef759b899324b76559d",
      "title": "The AACR Journals: Advancing Progress Toward the AACR''s 115-Year
      Mission.", "abstract": null, "venue": "Blood Cancer Discovery", "year": 2022,
      "referenceCount": 1, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://aacrjournals.org/bloodcancerdiscov/article-pdf/3/6/469/3221028/469.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-11-02", "journal":
      {"volume": "3 6", "pages": "\n          469-475\n        ", "name": "Blood cancer
      discovery"}, "citationStyles": {"bibtex": "@Article{Anderson2022TheAJ,\n author
      = {K. Anderson and L. Cantley and R. Dalla-Favera and C. V. Dang and Luis A.
      Diaz and R. Dubois and K. Flaherty and Philip D. Greenberg and M. Loda and E.
      Mardis and E. Platz and Michael N. Pollak and R. Schreiber and L. Siu and B.
      Teicher},\n booktitle = {Blood Cancer Discovery},\n journal = {Blood cancer
      discovery},\n pages = {\n          469-475\n        },\n title = {The AACR Journals:
      Advancing Progress Toward the AACR''s 115-Year Mission.},\n volume = {3 6},\n
      year = {2022}\n}\n"}, "authors": [{"authorId": "2178880764", "name": "K. Anderson"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1396265158", "name":
      "R. Dalla-Favera"}, {"authorId": "2059177512", "name": "C. V. Dang"}, {"authorId":
      "2189433262", "name": "Luis A. Diaz"}, {"authorId": "4135978", "name": "R. Dubois"},
      {"authorId": "145213930", "name": "K. Flaherty"}, {"authorId": "2069169888",
      "name": "Philip D. Greenberg"}, {"authorId": "6213932", "name": "M. Loda"},
      {"authorId": "3286001", "name": "E. Mardis"}, {"authorId": "4008854", "name":
      "E. Platz"}, {"authorId": "2059212154", "name": "Michael N. Pollak"}, {"authorId":
      "39884192", "name": "R. Schreiber"}, {"authorId": "2469902", "name": "L. Siu"},
      {"authorId": "5866492", "name": "B. Teicher"}]}, {"paperId": "f729e5d864f78dea013afec3f59a96429d888034",
      "externalIds": {"PubMedCentral": "9830954", "DOI": "10.1126/scisignal.abm0808",
      "CorpusId": 253119647, "PubMed": "36282911"}, "corpusId": 253119647, "publicationVenue":
      {"id": "c0efe552-8a0a-41a7-8ce2-340fb0dbfe6f", "name": "Science Signaling",
      "type": "journal", "alternate_names": ["Sci Signal"], "issn": "1945-0877", "url":
      "https://www.sciencemag.org/", "alternate_urls": ["https://stke.sciencemag.org/about/",
      "https://stke.sciencemag.org/"]}, "url": "https://www.semanticscholar.org/paper/f729e5d864f78dea013afec3f59a96429d888034",
      "title": "Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation
      and viral replication", "abstract": "Multiple coronaviruses have emerged independently
      in the past 20 years that cause lethal human diseases. Although vaccine development
      targeting these viruses has been accelerated substantially, there remain patients
      requiring treatment who cannot be vaccinated or who experience breakthrough
      infections. Understanding the common host factors necessary for the life cycles
      of coronaviruses may reveal conserved therapeutic targets. Here, we used the
      known substrate specificities of mammalian protein kinases to deconvolute the
      sequence of phosphorylation events mediated by three host protein kinase families
      (SRPK, GSK-3, and CK1) that coordinately phosphorylate a cluster of serine and
      threonine residues in the viral N protein, which is required for viral replication.
      We also showed that loss or inhibition of SRPK1/2, which we propose initiates
      the N protein phosphorylation cascade, compromised the viral replication cycle.
      Because these phosphorylation sites are highly conserved across coronaviruses,
      inhibitors of these protein kinases not only may have therapeutic potential
      against COVID-19 but also may be broadly useful against coronavirus-mediated
      diseases. Description Inhibiting host kinases that phosphorylate the SARS-CoV-2
      nucleocapsid protein blocks viral replication. Targeting the host instead of
      the virus Although vaccines have been very effective in responding to the COVID-19
      pandemic caused by the virus SARS-CoV-2, there is a continuing need to develop
      new therapeutics. Through phosphoproteomic analysis of SARS-CoV-2\u2013infected
      cells, Yaron et al. identified multiple phosphorylation sites in a conserved
      region of the viral nucleocapsid (N) protein, which is critical for viral replication.
      Biochemical analyses identified the host kinases that sequentially phosphorylated
      distinct motifs in the N protein, and knockdown or inhibition of members of
      the priming kinase family SPRK reduced N protein phosphorylation. An FDA-approved
      drug that can inhibit kinases of the SRPK family reduced N protein phosphorylation
      and blocked viral replication in vitro, suggesting that the approach of targeting
      host proteins required by the virus might have therapeutic potential in the
      treatment of coronavirus-mediated infections.", "venue": "Science Signaling",
      "year": 2022, "referenceCount": 95, "citationCount": 20, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2022-10-25", "journal":
      {"volume": "15", "pages": "eabm0808 - eabm0808", "name": "Science signaling"},
      "citationStyles": {"bibtex": "@Article{Yaron2022HostPK,\n author = {Tomer M.
      Yaron and B. Heaton and T. Levy and Jared L. Johnson and Tristan X. Jordan and
      B. M. Cohen and A. Kerelsky and Ting-Yu Lin and Katarina M Liberatore and Danielle
      K Bulaon and Samantha J. Van Nest and Nikos Koundouros and Edward R. Kastenhuber
      and Marisa Mercadante and Kripa Shobana-Ganesh and Long He and R. Schwartz and
      Shuibing Chen and H. Weinstein and O. Elemento and E. Piskounova and Benjamin
      E. Nilsson-Payant and Gina Lee and Joseph D. Trimarco and Kaitlyn N Burke and
      C. Hamele and Ryan R. Chaparian and Alfred T. Harding and A. Tata and Xinyu
      Zhu and P. R. Tata and Clare M. Smith and A. Possemato and Sasha L Tkachev and
      P. Hornbeck and S. Beausoleil and Shankara K. Anand and F. Aguet and G. Getz
      and A. Davidson and K. Heesom and M. Kavanagh-Williamson and D. Matthews and
      B. tenOever and L. Cantley and J. Blenis and Nicholas S. Heaton},\n booktitle
      = {Science Signaling},\n journal = {Science signaling},\n pages = {eabm0808
      - eabm0808},\n title = {Host protein kinases required for SARS-CoV-2 nucleocapsid
      phosphorylation and viral replication},\n volume = {15},\n year = {2022}\n}\n"},
      "authors": [{"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "38692984", "name": "B. Heaton"}, {"authorId": "32603328", "name": "T. Levy"},
      {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId": "145658521",
      "name": "Tristan X. Jordan"}, {"authorId": "2055611292", "name": "B. M. Cohen"},
      {"authorId": "14658204", "name": "A. Kerelsky"}, {"authorId": "144181325", "name":
      "Ting-Yu Lin"}, {"authorId": "51910553", "name": "Katarina M Liberatore"}, {"authorId":
      "1931600430", "name": "Danielle K Bulaon"}, {"authorId": "30572053", "name":
      "Samantha J. Van Nest"}, {"authorId": "13532971", "name": "Nikos Koundouros"},
      {"authorId": "4306515", "name": "Edward R. Kastenhuber"}, {"authorId": "2042047500",
      "name": "Marisa Mercadante"}, {"authorId": "2042286049", "name": "Kripa Shobana-Ganesh"},
      {"authorId": "2112463843", "name": "Long He"}, {"authorId": "46462360", "name":
      "R. Schwartz"}, {"authorId": "47336157", "name": "Shuibing Chen"}, {"authorId":
      "50028113", "name": "H. Weinstein"}, {"authorId": "150097652", "name": "O. Elemento"},
      {"authorId": "6016224", "name": "E. Piskounova"}, {"authorId": "1422205499",
      "name": "Benjamin E. Nilsson-Payant"}, {"authorId": "2123198", "name": "Gina
      Lee"}, {"authorId": "66419419", "name": "Joseph D. Trimarco"}, {"authorId":
      "2042240908", "name": "Kaitlyn N Burke"}, {"authorId": "30094094", "name": "C.
      Hamele"}, {"authorId": "6181769", "name": "Ryan R. Chaparian"}, {"authorId":
      "16048806", "name": "Alfred T. Harding"}, {"authorId": "47203895", "name": "A.
      Tata"}, {"authorId": "8361947", "name": "Xinyu Zhu"}, {"authorId": "38101990",
      "name": "P. R. Tata"}, {"authorId": "2110209555", "name": "Clare M. Smith"},
      {"authorId": "6536164", "name": "A. Possemato"}, {"authorId": "2188844191",
      "name": "Sasha L Tkachev"}, {"authorId": "46627576", "name": "P. Hornbeck"},
      {"authorId": "4424720", "name": "S. Beausoleil"}, {"authorId": "48361643", "name":
      "Shankara K. Anand"}, {"authorId": "48975912", "name": "F. Aguet"}, {"authorId":
      "153395395", "name": "G. Getz"}, {"authorId": "35178796", "name": "A. Davidson"},
      {"authorId": "4107601", "name": "K. Heesom"}, {"authorId": "2042810306", "name":
      "M. Kavanagh-Williamson"}, {"authorId": "2055674540", "name": "D. Matthews"},
      {"authorId": "5462120", "name": "B. tenOever"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "4037343", "name": "J. Blenis"}, {"authorId": "35057532",
      "name": "Nicholas S. Heaton"}]}, {"paperId": "fbef25965511124276964eec90a8db33a29cb3ae",
      "externalIds": {"DOI": "10.1016/j.ejmech.2022.115027", "CorpusId": 255117733,
      "PubMed": "36584631"}, "corpusId": 255117733, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/fbef25965511124276964eec90a8db33a29cb3ae",
      "title": "Development of potent and selective degraders of PI5P4K\u03b3.", "abstract":
      null, "venue": "European journal of medicinal chemistry", "year": 2022, "referenceCount":
      36, "citationCount": 3, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2022-12-01", "journal": {"volume": "247", "pages": "\n          115027\n        ",
      "name": "European journal of medicinal chemistry"}, "citationStyles": {"bibtex":
      "@Article{Ji2022DevelopmentOP,\n author = {Wenzhi Ji and Eric S. Wang and Theresa
      D. Manz and Jie Jiang and K. Donovan and Xianmixinuer Abulaiti and E. Fischer
      and L. Cantley and Tinghu Zhang and N. Gray},\n booktitle = {European journal
      of medicinal chemistry},\n journal = {European journal of medicinal chemistry},\n
      pages = {\n          115027\n        },\n title = {Development of potent and
      selective degraders of PI5P4K\u03b3.},\n volume = {247},\n year = {2022}\n}\n"},
      "authors": [{"authorId": "50119404", "name": "Wenzhi Ji"}, {"authorId": "2253321434",
      "name": "Eric S. Wang"}, {"authorId": "16018077", "name": "Theresa D. Manz"},
      {"authorId": "143916454", "name": "Jie Jiang"}, {"authorId": "10775141", "name":
      "K. Donovan"}, {"authorId": "26575358", "name": "Xianmixinuer Abulaiti"}, {"authorId":
      "145053102", "name": "E. Fischer"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2262535", "name": "Tinghu Zhang"}, {"authorId": "3977406", "name":
      "N. Gray"}]}, {"paperId": "09187a09993357927084c39a4dddf9d0fa8c4bca", "externalIds":
      {"DOI": "10.1158/2159-8290.CD-21-0082", "CorpusId": 232018498, "PubMed": "33619209"},
      "corpusId": 232018498, "publicationVenue": {"id": "de16002a-77c3-4d03-9348-5a1813238e0b",
      "name": "Cancer Discovery", "type": "journal", "alternate_names": ["Cancer Discov"],
      "issn": "2159-8274", "url": "https://cancerdiscovery.aacrjournals.org/"}, "url":
      "https://www.semanticscholar.org/paper/09187a09993357927084c39a4dddf9d0fa8c4bca",
      "title": "A Decade of Cancer Discovery.", "abstract": "As Cancer Discovery turns
      10, we reflect on the journal''s success and look ahead to the future.", "venue":
      "Cancer Discovery", "year": 2021, "referenceCount": 11, "citationCount": 0,
      "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://aacrjournals.org/cancerdiscovery/article-pdf/11/4/795/3099338/795.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Editorial"], "publicationDate": "2021-02-22", "journal":
      {"name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Diaz2021ADO,\n
      author = {L. Diaz and L. Cantley},\n booktitle = {Cancer Discovery},\n journal
      = {Cancer discovery},\n title = {A Decade of Cancer Discovery.},\n year = {2021}\n}\n"},
      "authors": [{"authorId": "1381145942", "name": "L. Diaz"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "0c4716ad7841684510816323fa58220445cefcca",
      "externalIds": {"PubMedCentral": "7992237", "DOI": "10.1093/noajnl/vdab024.074",
      "CorpusId": 232479878}, "corpusId": 232479878, "publicationVenue": {"id": "4390a6c7-bd1a-4ccc-b9e6-e988368f95cb",
      "name": "Neuro-Oncology Advances", "type": "journal", "alternate_names": ["Neuro-oncology
      Adv"], "issn": "2632-2498"}, "url": "https://www.semanticscholar.org/paper/0c4716ad7841684510816323fa58220445cefcca",
      "title": "FSMP-10. CYSTEINE INDUCES CYTOTOXICITY IN GLIOBLASTOMA THROUGH MITOCHONDRIAL
      HYDROGEN PEROXIDE PRODUCTION", "abstract": "Abstract Glioblastoma (GBM) is a
      poorly treatable disease with high mortality. Tumor metabolism in GBM is a critical
      mechanism responsible for growth because of upregulation of glucose, amino acid,
      and fatty acid utilization. However, little is known about the specific metabolic
      alterations in GBM that are targetable with FDA-approved compounds. To investigate
      metabolic signatures unique to GBM, we interrogated the TCGA and a cancer metabolite
      database for alterations in glucose and amino acid signatures in GBM relative
      to other human cancers and relative to low-grade glioma. From these analyses,
      we found that GBM exhibits the highest levels of cysteine and methionine pathway
      gene expression of 32 human cancers and that GBM exhibits high levels of cysteine
      metabolites compared to low-grade gliomas. To study the role of cysteine in
      GBM pathogenesis, we treated patient-derived GBM cells with FDA-approved cyst(e)ine-promoting
      compounds in vitro, including N-acetylcysteine (NAC) and the cephalosporin antibiotic,
      Ceftriaxone (CTX), which induces cystine import through system Xc transporter
      upregulation. Cysteine-promoting compounds, including NAC and CTX, inhibit growth
      of GBM cells, which is exacerbated by glucose deprivation. This growth inhibition
      is associated with reduced mitochondrial metabolism, manifest by reduction in
      ATP, NADPH/NADP+ ratio, mitochondrial membrane potential, and oxygen consumption
      rate. Mechanistic experiments revealed that cysteine compounds induce a rapid
      increase in the rate of H2O2 production in isolated GBM mitochondria, an effect
      blocked by the H2O2 scavenger, catalase. Such findings are consistent with reductive
      stress, a ROS-producing process whereby excess mitochondrial reducing equivalents
      prevent electron transfer to oxidized electron acceptors, inducing O2 reduction
      to H2O2. We show that cysteine-promoting compounds reduce cell growth and induce
      rapid mitochondrial toxicity in GBM, which may be due to reductive stress. This
      pathway is targetable with FDA-approved cysteine-promoting compounds and could
      synergize with glucose-lowering treatments, including the ketogenic diet, for
      GBM.", "venue": "Neuro-Oncology Advances", "year": 2021, "referenceCount": 0,
      "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf":
      null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2021-03-01", "journal": {"volume": "3", "pages": "i18 - i18", "name": "Neuro-oncology
      Advances"}, "citationStyles": {"bibtex": "@Article{Noch2021FSMP10CI,\n author
      = {E. Noch and L. Palma and I. Yim and Bhavneet Binder and E. Benedetti and
      J. Krumsiek and O. Elemento and L. Cantley},\n booktitle = {Neuro-Oncology Advances},\n
      journal = {Neuro-oncology Advances},\n pages = {i18 - i18},\n title = {FSMP-10.
      CYSTEINE INDUCES CYTOTOXICITY IN GLIOBLASTOMA THROUGH MITOCHONDRIAL HYDROGEN
      PEROXIDE PRODUCTION},\n volume = {3},\n year = {2021}\n}\n"}, "authors": [{"authorId":
      "3913142", "name": "E. Noch"}, {"authorId": "2065330100", "name": "L. Palma"},
      {"authorId": "1716222698", "name": "I. Yim"}, {"authorId": "1454461390", "name":
      "Bhavneet Binder"}, {"authorId": "123664542", "name": "E. Benedetti"}, {"authorId":
      "2067285", "name": "J. Krumsiek"}, {"authorId": "150097652", "name": "O. Elemento"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "1098b27466f2336f0023f9cfcd4f106f63d6917f",
      "externalIds": {"MAG": "3151637556", "DOI": "10.1038/s43018-021-00183-y", "CorpusId":
      233532015, "PubMed": "34179825"}, "corpusId": 233532015, "publicationVenue":
      {"id": "f511c64e-b292-49b6-a819-65678fadeebb", "name": "Nature Cancer", "type":
      "journal", "alternate_names": ["Nat Cancer"], "issn": "2662-1347", "url": "https://www.nature.com/natcancer/"},
      "url": "https://www.semanticscholar.org/paper/1098b27466f2336f0023f9cfcd4f106f63d6917f",
      "title": "Fatty acid synthesis is required for breast cancer brain metastasis",
      "abstract": null, "venue": "Nature Cancer", "year": 2021, "referenceCount":
      88, "citationCount": 116, "influentialCitationCount": 6, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc8223728?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2021-04-01", "journal": {"volume": "2", "pages": "414 -
      428", "name": "Nature Cancer"}, "citationStyles": {"bibtex": "@Article{Ferraro2021FattyAS,\n
      author = {G. Ferraro and A. Ali and Alba Luengo and D. Kodack and A. Deik and
      Keene L. Abbott and Divya Bezwada and L. Blanc and Brendan Prideaux and Xin
      Jin and Jessica M Posada and Jiang Chen and Christopher R Chin and Zohreh Amoozgar
      and Raphael Ferreira and Ivy X. Chen and K. Naxerova and C. Ng and Anna M. Westermark
      and M. Duquette and S. Roberge and N. Lindeman and C. Lyssiotis and J. Nielsen
      and D. Housman and D. Duda and E. Brachtel and T. Golub and L. Cantley and J.
      Asara and S. Davidson and D. Fukumura and V. Dartois and C. Clish and R. Jain
      and M. V. Vander Heiden},\n booktitle = {Nature Cancer},\n journal = {Nature
      Cancer},\n pages = {414 - 428},\n title = {Fatty acid synthesis is required
      for breast cancer brain metastasis},\n volume = {2},\n year = {2021}\n}\n"},
      "authors": [{"authorId": "35545769", "name": "G. Ferraro"}, {"authorId": "2157679423",
      "name": "A. Ali"}, {"authorId": "114311983", "name": "Alba Luengo"}, {"authorId":
      "10029385", "name": "D. Kodack"}, {"authorId": "2922270", "name": "A. Deik"},
      {"authorId": "39862913", "name": "Keene L. Abbott"}, {"authorId": "11045592",
      "name": "Divya Bezwada"}, {"authorId": "29960670", "name": "L. Blanc"}, {"authorId":
      "4151707", "name": "Brendan Prideaux"}, {"authorId": "2149169420", "name": "Xin
      Jin"}, {"authorId": "40351159", "name": "Jessica M Posada"}, {"authorId": "2144207912",
      "name": "Jiang Chen"}, {"authorId": "2056653349", "name": "Christopher R Chin"},
      {"authorId": "10042929", "name": "Zohreh Amoozgar"}, {"authorId": "2067628106",
      "name": "Raphael Ferreira"}, {"authorId": "19188310", "name": "Ivy X. Chen"},
      {"authorId": "5110430", "name": "K. Naxerova"}, {"authorId": "49689673", "name":
      "C. Ng"}, {"authorId": "115500939", "name": "Anna M. Westermark"}, {"authorId":
      "40602288", "name": "M. Duquette"}, {"authorId": "5239105", "name": "S. Roberge"},
      {"authorId": "3734755", "name": "N. Lindeman"}, {"authorId": "4901222", "name":
      "C. Lyssiotis"}, {"authorId": "145414907", "name": "J. Nielsen"}, {"authorId":
      "10127476", "name": "D. Housman"}, {"authorId": "2250708594", "name": "D. Duda"},
      {"authorId": "6207661", "name": "E. Brachtel"}, {"authorId": "2900051", "name":
      "T. Golub"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "34711277", "name": "S. Davidson"}, {"authorId":
      "3057625", "name": "D. Fukumura"}, {"authorId": "3361348", "name": "V. Dartois"},
      {"authorId": "3633091", "name": "C. Clish"}, {"authorId": "32514332", "name":
      "R. Jain"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"}]}, {"paperId":
      "114f9ead1ca1165e2bd5a6254af4e39b23ceae89", "externalIds": {"PubMedCentral":
      "9256808", "DOI": "10.1101/2021.05.09.443334", "CorpusId": 234474789, "PubMed":
      "35584006"}, "corpusId": 234474789, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/114f9ead1ca1165e2bd5a6254af4e39b23ceae89",
      "title": "Pyruvate Kinase M1 Suppresses Development and Progression of Prostate
      Adenocarcinoma", "abstract": "Most cancers, including prostate cancers, express
      the M2 splice isoform of pyruvate kinase (Pkm2). This isoform can promote anabolic
      metabolism to support cell proliferation; however, Pkm2 expression is dispensable
      for many cancers in vivo. Pyruvate kinase M1 (Pkm1) isoform expression is restricted
      to relatively few tissues and has been reported to promote growth of select
      tumors, but the role of PKM1 in cancer has been less studied. Pkm1 is expressed
      in normal prostate tissue; thus, to test how differential pyruvate kinase isoform
      expression affects cancer initiation and progression we generated mice harboring
      a conditional allele of Pkm1 and crossed this allele, as well as a Pkm2 conditional
      allele, to a Pten loss-driven prostate cancer model. We found that Pkm1 loss
      leads to Pkm2 expression and accelerates prostate cancer, while deletion of
      Pkm2 leads to increased Pkm1 expression and suppresses cancer. Consistent with
      these data, a small molecule pyruvate kinase activator that mimics a PKM1-like
      state suppresses progression of established prostate tumors. PKM2 expression
      is retained in most human prostate cancers, arguing that pharmacological PKM2
      activation may be beneficial for some prostate cancer patients.", "venue": "bioRxiv",
      "year": 2021, "referenceCount": 67, "citationCount": 12, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2021-05-10", "journal": {"volume": "82",
      "pages": "2403 - 2416", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Davidson2021PyruvateKM,\n author = {S. Davidson and Julia Heyman and
      James P. O\u2019Brien and Amy C. Liu and D. R. Schmidt and William J. Israelsen
      and T. Dayton and Raghav Sehgal and R. Bronson and Elizaveta Freinkman and H.
      Mak and S. Malstrom and G. Bellinger and A. Carracedo and P. Pandolfi and K.
      Courtney and J. Frangioni and Abhishek K. Jha and R. DePinho and J. Horner and
      Craig J. Thomas and L. Cantley and M. Loda and M. V. Vander Heiden},\n booktitle
      = {bioRxiv},\n journal = {Cancer Research},\n pages = {2403 - 2416},\n title
      = {Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma},\n
      volume = {82},\n year = {2021}\n}\n"}, "authors": [{"authorId": "34711277",
      "name": "S. Davidson"}, {"authorId": "2073832290", "name": "Julia Heyman"},
      {"authorId": "2066826610", "name": "James P. O\u2019Brien"}, {"authorId": "86899047",
      "name": "Amy C. Liu"}, {"authorId": "49718538", "name": "D. R. Schmidt"}, {"authorId":
      "5553029", "name": "William J. Israelsen"}, {"authorId": "40576003", "name":
      "T. Dayton"}, {"authorId": "40880369", "name": "Raghav Sehgal"}, {"authorId":
      "40803408", "name": "R. Bronson"}, {"authorId": "5169232", "name": "Elizaveta
      Freinkman"}, {"authorId": "10185930", "name": "H. Mak"}, {"authorId": "3870192",
      "name": "S. Malstrom"}, {"authorId": "5679020", "name": "G. Bellinger"}, {"authorId":
      "6988610", "name": "A. Carracedo"}, {"authorId": "4499580", "name": "P. Pandolfi"},
      {"authorId": "13782167", "name": "K. Courtney"}, {"authorId": "1788876", "name":
      "J. Frangioni"}, {"authorId": "38884428", "name": "Abhishek K. Jha"}, {"authorId":
      "5593407", "name": "R. DePinho"}, {"authorId": "40006904", "name": "J. Horner"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "6213932", "name": "M. Loda"}, {"authorId":
      "3804233", "name": "M. V. Vander Heiden"}]}, {"paperId": "144acb59f597d5db52f93f00bbb00922f545fc88",
      "externalIds": {"DOI": "10.1038/s41571-021-00579-w", "CorpusId": 244492478,
      "PubMed": "34819622"}, "corpusId": 244492478, "publicationVenue": {"id": "e665d258-d079-4464-9b33-2291ffb17a14",
      "name": "Nature Reviews Clinical Oncology", "type": "journal", "alternate_names":
      ["Nat Rev Clin Oncol"], "issn": "1759-4774", "url": "http://www.nature.com/nrclinonc/",
      "alternate_urls": ["http://www.nature.com/nrclinonc", "http://www.nature.com/nrclinonc/index.html"]},
      "url": "https://www.semanticscholar.org/paper/144acb59f597d5db52f93f00bbb00922f545fc88",
      "title": "Radiotherapy as a tool to elicit clinically actionable signalling
      pathways in cancer", "abstract": null, "venue": "Nature Reviews Clinical Oncology",
      "year": 2021, "referenceCount": 367, "citationCount": 49, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2021-11-24", "journal": {"volume": "19", "pages": "114-131",
      "name": "Nature Reviews Clinical Oncology"}, "citationStyles": {"bibtex": "@Article{Petroni2021RadiotherapyAA,\n
      author = {G. Petroni and L. Cantley and L. Santambrogio and S. Formenti and
      L. Galluzzi},\n booktitle = {Nature Reviews Clinical Oncology},\n journal =
      {Nature Reviews Clinical Oncology},\n pages = {114-131},\n title = {Radiotherapy
      as a tool to elicit clinically actionable signalling pathways in cancer},\n
      volume = {19},\n year = {2021}\n}\n"}, "authors": [{"authorId": "21711615",
      "name": "G. Petroni"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4204823", "name": "L. Santambrogio"}, {"authorId": "145423973", "name": "S.
      Formenti"}, {"authorId": "3974364", "name": "L. Galluzzi"}]}, {"paperId": "1f67258bd5c8945f8d3fa34d66df3b6bc8046367",
      "externalIds": {"DOI": "10.1101/2021.08.20.457146", "CorpusId": 237271121},
      "corpusId": 237271121, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/1f67258bd5c8945f8d3fa34d66df3b6bc8046367",
      "title": "SARS-CoV-2 hijacks p38\u03b2/MAPK11 to promote virus replication",
      "abstract": "SARS-CoV-2, the causative agent of the COVID-19 pandemic, drastically
      modifies infected cells in an effort to optimize virus replication. Included
      is the activation of the host p38 mitogen-activated protein kinase (MAPK) pathway,
      which plays a major role in inflammation and is a central driver of COVID-19
      clinical presentations. Inhibition of p38/MAPK activity in SARS-CoV-2-infected
      cells reduces both cytokine production and viral replication. Here, we combined
      genetic screening with quantitative phosphoproteomics to better understand interactions
      between the p38/MAPK pathway and SARS-CoV-2. We found that several components
      of the p38/MAPK pathway impacted SARS-CoV-2 replication and that p38\u03b2 is
      a critical host factor for virus replication, and it prevents activation of
      the type-I interferon pathway. Quantitative phosphoproteomics uncovered several
      SARS-CoV-2 nucleocapsid phosphorylation sites near the N-terminus that were
      sensitive to p38 inhibition. Similar to p38\u03b2 depletion, mutation of these
      nucleocapsid residues was associated with reduced virus replication and increased
      activation of type-I interferon signaling. Taken together, this study reveals
      a unique proviral function for p38\u03b2 that is not shared with p38\u03b1 and
      supports exploring p38\u03b2 inhibitor development as a strategy towards developing
      a new class of COVID-19 therapies. Importance SARS-CoV-2 is the causative agent
      of the COVID-19 pandemic that has claimed millions of lives since its emergence
      in 2019. SARS-CoV-2 infection of human cells requires the activity of several
      cellular pathways for successful replication. One such pathway, the p38 mitogen-activated
      protein kinase (MAPK) pathway, is required for virus replication and disease
      pathogenesis. Here, we applied systems biology approaches to understand how
      MAPK pathways benefit SARS-CoV-2 replication to inform the development of novel
      COVID-19 drug therapies.", "venue": "bioRxiv", "year": 2021, "referenceCount":
      57, "citationCount": 4, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2022/09/14/2021.08.20.457146.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2021-08-20", "journal": {"name": "bioRxiv"}, "citationStyles":
      {"bibtex": "@Article{Higgins2021SARSCoV2HP,\n author = {Christina A. Higgins
      and Benjamin E. Nilsson-Payant and A. Kurland and C. Ye and Tomer M. Yaron and
      Jared L. Johnson and Boris Bonaventure and Prithy Adhikary and Ilona Golynker
      and M. Panis and O. Danziger and Brad R. Rosenberg and L. Cantley and L. Mart\u00ednez-Sobrido
      and B. tenOever and Jeffrey R. Johnson},\n booktitle = {bioRxiv},\n journal
      = {bioRxiv},\n title = {SARS-CoV-2 hijacks p38\u03b2/MAPK11 to promote virus
      replication},\n year = {2021}\n}\n"}, "authors": [{"authorId": "21581175", "name":
      "Christina A. Higgins"}, {"authorId": "1422205499", "name": "Benjamin E. Nilsson-Payant"},
      {"authorId": "2091925403", "name": "A. Kurland"}, {"authorId": "1820803613",
      "name": "C. Ye"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "145916288", "name": "Jared L. Johnson"}, {"authorId": "52034318", "name": "Boris
      Bonaventure"}, {"authorId": "2124144278", "name": "Prithy Adhikary"}, {"authorId":
      "1420415021", "name": "Ilona Golynker"}, {"authorId": "3579494", "name": "M.
      Panis"}, {"authorId": "8777036", "name": "O. Danziger"}, {"authorId": "39166273",
      "name": "Brad R. Rosenberg"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "1390112686", "name": "L. Mart\u00ednez-Sobrido"}, {"authorId":
      "5462120", "name": "B. tenOever"}, {"authorId": "2185012922", "name": "Jeffrey
      R. Johnson"}]}, {"paperId": "2db9debd53e753e13f5a11a2dde09035d7d460c6", "externalIds":
      {"MAG": "3182483332", "DOI": "10.1158/1538-7445.AM2021-16", "CorpusId": 237760821},
      "corpusId": 237760821, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/2db9debd53e753e13f5a11a2dde09035d7d460c6",
      "title": "Abstract 16: Patterns and regulation of post translational modifications
      in cancer", "abstract": null, "venue": "Cancer Chemistry", "year": 2021, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2021-07-01", "journal": {"name": "Cancer Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Geffen2021Abstract1P,\n author = {Y. Geffen and Shankara
      K. Anand and Yoshihisa Akiyama and Tommer M. Yaron and A. Kerelsky and Jared
      L. Johnson and Karsten Krug and David I Heiman and S. Satpathy and K. Clauser
      and Michael A. Gillette and D. Mani and Chet Birger and Steve Carr and L. Cantley
      and F. Aguet and G. Getz},\n booktitle = {Cancer Chemistry},\n journal = {Cancer
      Chemistry},\n title = {Abstract 16: Patterns and regulation of post translational
      modifications in cancer},\n year = {2021}\n}\n"}, "authors": [{"authorId": "16307269",
      "name": "Y. Geffen"}, {"authorId": "48361643", "name": "Shankara K. Anand"},
      {"authorId": "122529265", "name": "Yoshihisa Akiyama"}, {"authorId": "2128934859",
      "name": "Tommer M. Yaron"}, {"authorId": "14658204", "name": "A. Kerelsky"},
      {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId": "40329575",
      "name": "Karsten Krug"}, {"authorId": "37329835", "name": "David I Heiman"},
      {"authorId": "34794500", "name": "S. Satpathy"}, {"authorId": "2097664941",
      "name": "K. Clauser"}, {"authorId": "39595909", "name": "Michael A. Gillette"},
      {"authorId": "2073717971", "name": "D. Mani"}, {"authorId": "69878839", "name":
      "Chet Birger"}, {"authorId": "2072711707", "name": "Steve Carr"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "48975912", "name": "F. Aguet"},
      {"authorId": "2110594", "name": "G. Getz"}]}, {"paperId": "414c0a65ce84112ee418944c0e8f7022b745146c",
      "externalIds": {"PubMedCentral": "9753996", "DOI": "10.1182/blood-2021-153378",
      "CorpusId": 244535280, "PubMed": "36282572"}, "corpusId": 244535280, "publicationVenue":
      {"id": "8c9a9e1b-acf2-4274-8d73-6ea0ecd11fd1", "name": "Journal of Clinical
      Investigation", "type": "journal", "alternate_names": ["J Clin Investig"], "issn":
      "0021-9738", "url": "https://www.jci.org/", "alternate_urls": ["http://www.jci.org/",
      "https://www.jci.org/archive", "http://www.jci.org/impact"]}, "url": "https://www.semanticscholar.org/paper/414c0a65ce84112ee418944c0e8f7022b745146c",
      "title": "A FOXO1-dependent transcription network is a targetable vulnerability
      of mantle cell lymphomas", "abstract": "Targeting lineage-defined transcriptional
      dependencies has emerged as an effective therapeutic strategy in cancer treatment.
      Through screening for molecular vulnerabilities of mantle cell lymphoma (MCL),
      we identified a set of transcription factors (TFs) including FOXO1, EBF1, PAX5,
      and IRF4 that are essential for MCL propagation. Integrated chromatin immunoprecipitation
      and sequencing (ChIP-Seq) with transcriptional network reconstruction analysis
      revealed FOXO1 as a master regulator that acts upstream in the regulatory TF
      hierarchy. FOXO1 is both necessary and sufficient to drive MCL lineage commitment
      through supporting the lineage-specific transcription programs. We further show
      that FOXO1, but not its close paralog FOXO3, can reprogram myeloid leukemia
      cells and induce B-lineage gene expression. Finally, we demonstrate that cpd10,
      a small molecule identified from an enriched FOXO1 inhibitor library, induces
      a robust cytotoxic response in MCL cells in vitro and suppresses MCL progression
      in vivo. Our findings establish FOXO1 inhibition as a therapeutic strategy targeting
      lineage-driven transcriptional addiction in MCL.", "venue": "Journal of Clinical
      Investigation", "year": 2021, "referenceCount": 79, "citationCount": 2, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2021-11-05", "journal":
      {"volume": "132", "name": "The Journal of Clinical Investigation"}, "citationStyles":
      {"bibtex": "@Article{Jang2021AFT,\n author = {Ja-Young Jang and I. Hwang and
      H. Pan and Jun Yao and L. Alinari and E. Imada and Claudio Zanettini and M.
      Kluk and Yizhe Wang and Yun-Kyoung Lee and H. Lin and Xiangao Huang and M. Di
      Liberto and Zhengming Chen and K. Ballman and L. Cantley and L. Marchionni and
      G. Inghirami and O. Elemento and R. Baiocchi and S. Chen\u2010Kiang and S. Belvedere
      and Hongwu Zheng and J. Paik},\n booktitle = {Journal of Clinical Investigation},\n
      journal = {The Journal of Clinical Investigation},\n title = {A FOXO1-dependent
      transcription network is a targetable vulnerability of mantle cell lymphomas},\n
      volume = {132},\n year = {2021}\n}\n"}, "authors": [{"authorId": "6134501",
      "name": "Ja-Young Jang"}, {"authorId": "40169754", "name": "I. Hwang"}, {"authorId":
      "47837375", "name": "H. Pan"}, {"authorId": "144027014", "name": "Jun Yao"},
      {"authorId": "6401197", "name": "L. Alinari"}, {"authorId": "7461456", "name":
      "E. Imada"}, {"authorId": "2081531809", "name": "Claudio Zanettini"}, {"authorId":
      "5833490", "name": "M. Kluk"}, {"authorId": "47905638", "name": "Yizhe Wang"},
      {"authorId": "7856471", "name": "Yun-Kyoung Lee"}, {"authorId": "2216706143",
      "name": "H. Lin"}, {"authorId": "22172195", "name": "Xiangao Huang"}, {"authorId":
      "5174216", "name": "M. Di Liberto"}, {"authorId": "49864822", "name": "Zhengming
      Chen"}, {"authorId": "8914112", "name": "K. Ballman"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2479350", "name": "L. Marchionni"}, {"authorId":
      "2536360", "name": "G. Inghirami"}, {"authorId": "150097652", "name": "O. Elemento"},
      {"authorId": "5097073", "name": "R. Baiocchi"}, {"authorId": "1398158850", "name":
      "S. Chen\u2010Kiang"}, {"authorId": "48738953", "name": "S. Belvedere"}, {"authorId":
      "145735876", "name": "Hongwu Zheng"}, {"authorId": "2136475667", "name": "J.
      Paik"}]}, {"paperId": "60e82aca861a616ba7a8e5d85edb14daca9197f6", "externalIds":
      {"DOI": "10.1038/s41586-021-03827-2", "CorpusId": 237214802, "PubMed": "34408323"},
      "corpusId": 237214802, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/60e82aca861a616ba7a8e5d85edb14daca9197f6",
      "title": "Dietary fructose improves intestinal cell survival and nutrient absorption",
      "abstract": null, "venue": "Nature", "year": 2021, "referenceCount": 48, "citationCount":
      105, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2021-08-18", "journal": {"volume": "597", "pages": "263
      - 267", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Taylor2021DietaryFI,\n
      author = {Samuel R. Taylor and Shakti Ramsamooj and R. Liang and Alyna Katti
      and Rita Pozovskiy and N. Vasan and Seo-Kyoung Hwang and Navid Nahiyaan and
      N. Francoeur and Emma M Schatoff and Jared L. Johnson and Manish A. Shah and
      A. Dannenberg and R. Sebra and L. Dow and L. Cantley and K. Rhee and M. Goncalves},\n
      booktitle = {Nature},\n journal = {Nature},\n pages = {263 - 267},\n title =
      {Dietary fructose improves intestinal cell survival and nutrient absorption},\n
      volume = {597},\n year = {2021}\n}\n"}, "authors": [{"authorId": "2110994237",
      "name": "Samuel R. Taylor"}, {"authorId": "2058412873", "name": "Shakti Ramsamooj"},
      {"authorId": "46875693", "name": "R. Liang"}, {"authorId": "51042358", "name":
      "Alyna Katti"}, {"authorId": "2123702437", "name": "Rita Pozovskiy"}, {"authorId":
      "35123724", "name": "N. Vasan"}, {"authorId": "4151944", "name": "Seo-Kyoung
      Hwang"}, {"authorId": "2046170895", "name": "Navid Nahiyaan"}, {"authorId":
      "4546655", "name": "N. Francoeur"}, {"authorId": "4598930", "name": "Emma M
      Schatoff"}, {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId":
      "143609289", "name": "Manish A. Shah"}, {"authorId": "3860528", "name": "A.
      Dannenberg"}, {"authorId": "46517710", "name": "R. Sebra"}, {"authorId": "3918769",
      "name": "L. Dow"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4097554", "name": "K. Rhee"}, {"authorId": "145524334", "name": "M. Goncalves"}]},
      {"paperId": "62785cd4170382ba0da22cb4e4a7da687abf5d88", "externalIds": {"DOI":
      "10.1016/j.molcel.2021.06.029", "CorpusId": 236000856, "PubMed": "34270944"},
      "corpusId": 236000856, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/62785cd4170382ba0da22cb4e4a7da687abf5d88",
      "title": "Editorial Note to: Glucose Addiction of TSC Null Cells Is Caused by
      Failed mTORC1-Dependent Balancing of Metabolic Demand with Supply.", "abstract":
      null, "venue": "Molecules and Cells", "year": 2021, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1097276521005396/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2021-07-15", "journal": {"volume": "81 14", "pages": "\n          3031\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Choo2021EditorialNT,\n
      author = {A. Y. Choo and Sang Gyun Kim and M. V. Vander Heiden and S. J. Mahoney
      and Hieu S. Vu and Sang-Oh Yoon and L. Cantley and J. Blenis},\n booktitle =
      {Molecules and Cells},\n journal = {Molecular cell},\n pages = {\n          3031\n        },\n
      title = {Editorial Note to: Glucose Addiction of TSC Null Cells Is Caused by
      Failed mTORC1-Dependent Balancing of Metabolic Demand with Supply.},\n volume
      = {81 14},\n year = {2021}\n}\n"}, "authors": [{"authorId": "32210637", "name":
      "A. Y. Choo"}, {"authorId": "46876889", "name": "Sang Gyun Kim"}, {"authorId":
      "3804233", "name": "M. V. Vander Heiden"}, {"authorId": "48247811", "name":
      "S. J. Mahoney"}, {"authorId": "46470616", "name": "Hieu S. Vu"}, {"authorId":
      "6168327", "name": "Sang-Oh Yoon"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "4037343", "name": "J. Blenis"}]}, {"paperId": "7bffa46e6a5270ccd086d48bb16202a5a66c8190",
      "externalIds": {"DOI": "10.1101/2021.03.31.437960", "CorpusId": 233037086, "PubMed":
      "33821268"}, "corpusId": 233037086, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/7bffa46e6a5270ccd086d48bb16202a5a66c8190",
      "title": "Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral
      entry", "abstract": "Coagulopathy is recognized as a significant aspect of morbidity
      in COVID-19 patients. The clotting cascade is propagated by a series of proteases,
      including factor Xa and thrombin. Other host proteases, including TMPRSS2, are
      recognized to be important for cleavage activation of SARS-CoV-2 spike to promote
      viral entry. Using biochemical and cell-based assays, we demonstrate that factor
      Xa and thrombin can also directly cleave SARS-CoV-2 spike, enhancing viral entry.
      A drug-repurposing screen identified a subset of protease inhibitors that promiscuously
      inhibited spike cleavage by both transmembrane serine proteases as well as coagulation
      factors. The mechanism of the protease inhibitors nafamostat and camostat extend
      beyond inhibition of TMPRSS2 to coagulation-induced spike cleavage. Anticoagulation
      is critical in the management of COVID-19, and early intervention could provide
      collateral benefit by suppressing SARS-CoV-2 viral entry. We propose a model
      of positive feedback whereby infection-induced hypercoagulation exacerbates
      SARS-CoV-2 infectivity.", "venue": "bioRxiv", "year": 2021, "referenceCount":
      108, "citationCount": 28, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2021/07/30/2021.03.31.437960.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2021-04-01", "journal": {"name":
      "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Kastenhuber2021CoagulationFD,\n
      author = {Edward R. Kastenhuber and Javier A. Jaimes and Jared L. Johnson and
      Marisa Mercadante and F. Muecksch and Y. Weisblum and Y. Bram and R. Schwartz
      and G. Whittaker and L. Cantley},\n booktitle = {bioRxiv},\n journal = {bioRxiv},\n
      title = {Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral
      entry},\n year = {2021}\n}\n"}, "authors": [{"authorId": "4306515", "name":
      "Edward R. Kastenhuber"}, {"authorId": "31952434", "name": "Javier A. Jaimes"},
      {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId": "2042047500",
      "name": "Marisa Mercadante"}, {"authorId": "3520712", "name": "F. Muecksch"},
      {"authorId": "1705035052", "name": "Y. Weisblum"}, {"authorId": "4785493", "name":
      "Y. Bram"}, {"authorId": "46462360", "name": "R. Schwartz"}, {"authorId": "2779993",
      "name": "G. Whittaker"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "7e8343ac14d336624675b4ee61a42e32a80c9512", "externalIds": {"MAG": "3155082499",
      "DOI": "10.1158/1557-3265.RADSCI21-PO-051", "CorpusId": 234875594}, "corpusId":
      234875594, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/7e8343ac14d336624675b4ee61a42e32a80c9512",
      "title": "Abstract PO-051: Radiation therapy enhances the presentation of phosphopeptides
      by MHC-I on cancer cells", "abstract": null, "venue": "", "year": 2021, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2021-04-15", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Nest2021AbstractPR,\n
      author = {S. V. Nest and Tomer M. Yaron and M. Klatt and Noah E. Dephoure and
      G. Getz and L. Santambrogio and O. Elemento and D. Scheinberg and S. Demaria
      and L. Cantley},\n title = {Abstract PO-051: Radiation therapy enhances the
      presentation of phosphopeptides by MHC-I on cancer cells},\n year = {2021}\n}\n"},
      "authors": [{"authorId": "94355326", "name": "S. V. Nest"}, {"authorId": "5247030",
      "name": "Tomer M. Yaron"}, {"authorId": "49124983", "name": "M. Klatt"}, {"authorId":
      "4622316", "name": "Noah E. Dephoure"}, {"authorId": "2110594", "name": "G.
      Getz"}, {"authorId": "4204823", "name": "L. Santambrogio"}, {"authorId": "150097652",
      "name": "O. Elemento"}, {"authorId": "4864508", "name": "D. Scheinberg"}, {"authorId":
      "46869413", "name": "S. Demaria"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "86d0fa809c754c11fe1bd8b629af606f6aa936d7", "externalIds": {"DOI":
      "10.1101/2021.10.01.462764", "CorpusId": 238359345}, "corpusId": 238359345,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/86d0fa809c754c11fe1bd8b629af606f6aa936d7",
      "title": "Non-conserved metabolic regulation by LKB1 distinguishes human and
      mouse lung adenocarcinoma", "abstract": "KRAS is the most frequently mutated
      oncogene in human lung adenocarcinomas (hLUAD) and activating mutations in KRAS
      frequently co-occur with loss-of-function mutations in the tumor suppressor
      genes, TP53 or STK11/LKB1. However, mutation of all three genes is rarely observed
      in hLUAD, even though engineered mutations of all three genes produces a highly
      aggressive lung adenocarcinoma in mice (mLUAD). Here we provide an explanation
      of this difference between hLUAD and mLUAD by uncovering an evolutionary divergence
      in regulation of the glycolytic enzyme triosephosphate isomerase (TPI1). Using
      KRAS/TP53 mutant hLUAD cell lines, we show that TPI1 enzymatic activity can
      be altered via phosphorylation at Ser21 by the Salt Inducible Kinases (SIKs)
      in an LKB1-dependent manner; this allows modulation of glycolytic flux between
      completion of glycolysis and production of glycerol lipids. This metabolic flexibility
      appears to be critical in rapidly growing cells with KRAS and TP53 mutations,
      explaining why loss of LKB1 creates a metabolic liability in these tumors. In
      mice, the amino acid at position 21 of TPI1 is a Cys residue which can be oxidized
      to alter TPI1 activity, allowing regulation of glycolytic flux balance without
      a need for SIK kinases or LKB1. Our findings reveal an unexpected role for TPI1
      in metabolic reprogramming and suggest that LKB1 and SIK family kinases are
      potential targets for treating KRAS/TP53 mutant hLUAD. Our data also provide
      a cautionary example of the limits of genetically engineered murine models as
      tools to study human diseases such as cancers.", "venue": "", "year": 2021,
      "referenceCount": 35, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2021-10-02", "journal": {"name": "bioRxiv"}, "citationStyles":
      {"bibtex": "@Article{Stein2021NonconservedMR,\n author = {Benjamin D. Stein
      and J. Ferrarone and Eric E. Gardner and Jae-Won Chang and David Wu and Qiuying
      Chen and Pablo E. Hollstein and Min Yuan and R. Liang and John S. Coukos and
      Miriam Sindelar and B. Ngo and S. Gross and R. Shaw and J. Asara and R. Moellering
      and H. Varmus and L. Cantley},\n journal = {bioRxiv},\n title = {Non-conserved
      metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinoma},\n
      year = {2021}\n}\n"}, "authors": [{"authorId": "40353456", "name": "Benjamin
      D. Stein"}, {"authorId": "12021693", "name": "J. Ferrarone"}, {"authorId": "123766050",
      "name": "Eric E. Gardner"}, {"authorId": "77500164", "name": "Jae-Won Chang"},
      {"authorId": "144790190", "name": "David Wu"}, {"authorId": "2109625387", "name":
      "Qiuying Chen"}, {"authorId": "6028952", "name": "Pablo E. Hollstein"}, {"authorId":
      "49059923", "name": "Min Yuan"}, {"authorId": "46875693", "name": "R. Liang"},
      {"authorId": "14394779", "name": "John S. Coukos"}, {"authorId": "32040251",
      "name": "Miriam Sindelar"}, {"authorId": "5891999", "name": "B. Ngo"}, {"authorId":
      "5769141", "name": "S. Gross"}, {"authorId": "4426388", "name": "R. Shaw"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "4021080", "name":
      "R. Moellering"}, {"authorId": "2681217", "name": "H. Varmus"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "acdbe092660029211124b68ef0f51ddf09e07f44",
      "externalIds": {"DOI": "10.1016/j.cell.2021.03.059", "CorpusId": 233247370,
      "PubMed": "33861966"}, "corpusId": 233247370, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/acdbe092660029211124b68ef0f51ddf09e07f44",
      "title": "The mTORC1 pathway stimulates glutamine metabolism and cell proliferation
      by repressing SIRT4", "abstract": null, "venue": "Cell", "year": 2021, "referenceCount":
      55, "citationCount": 9, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0092867421004323/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2021-04-15", "journal": {"volume": "184", "name": "Cell"},
      "citationStyles": {"bibtex": "@Article{Csibi2021TheMP,\n author = {A. Csibi
      and S. Fendt and Chenggang Li and G. Poulogiannis and A. Y. Choo and Douglas
      J. Chapski and S. Jeong and J. Dempsey and A. Parkhitko and Tasha A Morrison
      and E. Henske and M. Haigis and L. Cantley and G. Stephanopoulos and Jane J.
      Yu and J. Blenis},\n booktitle = {Cell},\n journal = {Cell},\n title = {The
      mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing
      SIRT4},\n volume = {184},\n year = {2021}\n}\n"}, "authors": [{"authorId": "6688912",
      "name": "A. Csibi"}, {"authorId": "46775302", "name": "S. Fendt"}, {"authorId":
      "49672566", "name": "Chenggang Li"}, {"authorId": "4612853", "name": "G. Poulogiannis"},
      {"authorId": "32210637", "name": "A. Y. Choo"}, {"authorId": "2267037785", "name":
      "Douglas J. Chapski"}, {"authorId": "2112433", "name": "S. Jeong"}, {"authorId":
      "3765048", "name": "J. Dempsey"}, {"authorId": "3744617", "name": "A. Parkhitko"},
      {"authorId": "4644464", "name": "Tasha A Morrison"}, {"authorId": "4397360",
      "name": "E. Henske"}, {"authorId": "6212141", "name": "M. Haigis"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "1813278", "name": "G. Stephanopoulos"},
      {"authorId": "79481462", "name": "Jane J. Yu"}, {"authorId": "4037343", "name":
      "J. Blenis"}]}, {"paperId": "bfa491656ae73a07a4dc55193de476493f7c1ec6", "externalIds":
      {"DOI": "10.1186/s40170-021-00246-9", "CorpusId": 256367455}, "corpusId": 256367455,
      "publicationVenue": {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f", "name": "Cancer
      & Metabolism", "type": "journal", "alternate_names": ["Cancer Metab", "Cancer
      and Metabolism", "Cancer  Metab"], "issn": "2049-3002", "url": "http://www.cancerandmetabolism.com/"},
      "url": "https://www.semanticscholar.org/paper/bfa491656ae73a07a4dc55193de476493f7c1ec6",
      "title": "GLUT5 (SLC2A5) enables fructose-mediated proliferation independent
      of ketohexokinase", "abstract": null, "venue": "Cancer & Metabolism", "year":
      2021, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/s40170-021-00246-9",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2021-03-24", "journal": {"volume":
      "9", "name": "Cancer & Metabolism"}, "citationStyles": {"bibtex": "@Article{Liang2021GLUT5E,\n
      author = {R. Liang and Samuel R. Taylor and Navid Nahiyaan and Junho Song and
      Charles J Murphy and E. Dantas and Shuyuan Cheng and Ting-Wei Hsu and Shakti
      Ramsamooj and Rahul Grover and Seo-Kyoung Hwang and B. Ngo and L. Cantley and
      K. Rhee and M. Goncalves},\n booktitle = {Cancer & Metabolism},\n journal =
      {Cancer & Metabolism},\n title = {GLUT5 (SLC2A5) enables fructose-mediated proliferation
      independent of ketohexokinase},\n volume = {9},\n year = {2021}\n}\n"}, "authors":
      [{"authorId": "46875693", "name": "R. Liang"}, {"authorId": "2110994237", "name":
      "Samuel R. Taylor"}, {"authorId": "2046170895", "name": "Navid Nahiyaan"}, {"authorId":
      "2115753391", "name": "Junho Song"}, {"authorId": "47107919", "name": "Charles
      J Murphy"}, {"authorId": "144901772", "name": "E. Dantas"}, {"authorId": "40857819",
      "name": "Shuyuan Cheng"}, {"authorId": "2057635408", "name": "Ting-Wei Hsu"},
      {"authorId": "2058412873", "name": "Shakti Ramsamooj"}, {"authorId": "2062963678",
      "name": "Rahul Grover"}, {"authorId": "4151944", "name": "Seo-Kyoung Hwang"},
      {"authorId": "5891999", "name": "B. Ngo"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "4097554", "name": "K. Rhee"}, {"authorId": "145524334",
      "name": "M. Goncalves"}]}, {"paperId": "cee741f6b1a98a9a65a96bb7b7a314c8eee3380c",
      "externalIds": {"DOI": "10.1038/s43018-021-00283-9", "CorpusId": 242158007,
      "PubMed": "35122065"}, "corpusId": 242158007, "publicationVenue": {"id": "f511c64e-b292-49b6-a819-65678fadeebb",
      "name": "Nature Cancer", "type": "journal", "alternate_names": ["Nat Cancer"],
      "issn": "2662-1347", "url": "https://www.nature.com/natcancer/"}, "url": "https://www.semanticscholar.org/paper/cee741f6b1a98a9a65a96bb7b7a314c8eee3380c",
      "title": "Author Correction: Fatty acid synthesis is required for breast cancer
      brain metastasis", "abstract": null, "venue": "Nature Cancer", "year": 2021,
      "referenceCount": 0, "citationCount": 2, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://www.nature.com/articles/s43018-021-00283-9.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2021-10-08", "journal": {"volume": "2", "pages": "1243 -
      1243", "name": "Nature Cancer"}, "citationStyles": {"bibtex": "@Article{Ferraro2021AuthorCF,\n
      author = {G. Ferraro and A. Ali and Alba Luengo and D. Kodack and A. Deik and
      Keene L. Abbott and Divya Bezwada and L. Blanc and Brendan Prideaux and Xin
      Jin and Jessica M Posada and Jiang Chen and Christopher R Chin and Zohreh Amoozgar
      and Raphael Ferreira and Ivy X. Chen and K. Naxerova and Christopher Ng and
      Anna M. Westermark and M. Duquette and S. Roberge and N. Lindeman and C. Lyssiotis
      and J. Nielsen and D. Housman and D. Duda and E. Brachtel and T. Golub and L.
      Cantley and J. Asara and S. Davidson and D. Fukumura and V. Dartois and C. Clish
      and R. Jain and M. V. Vander Heiden},\n booktitle = {Nature Cancer},\n journal
      = {Nature Cancer},\n pages = {1243 - 1243},\n title = {Author Correction: Fatty
      acid synthesis is required for breast cancer brain metastasis},\n volume = {2},\n
      year = {2021}\n}\n"}, "authors": [{"authorId": "35545769", "name": "G. Ferraro"},
      {"authorId": "2157679423", "name": "A. Ali"}, {"authorId": "114311983", "name":
      "Alba Luengo"}, {"authorId": "10029385", "name": "D. Kodack"}, {"authorId":
      "2922270", "name": "A. Deik"}, {"authorId": "39862913", "name": "Keene L. Abbott"},
      {"authorId": "11045592", "name": "Divya Bezwada"}, {"authorId": "29960670",
      "name": "L. Blanc"}, {"authorId": "4151707", "name": "Brendan Prideaux"}, {"authorId":
      "2149169420", "name": "Xin Jin"}, {"authorId": "40351159", "name": "Jessica
      M Posada"}, {"authorId": "2144207912", "name": "Jiang Chen"}, {"authorId": "2056653349",
      "name": "Christopher R Chin"}, {"authorId": "10042929", "name": "Zohreh Amoozgar"},
      {"authorId": "2067628106", "name": "Raphael Ferreira"}, {"authorId": "19188310",
      "name": "Ivy X. Chen"}, {"authorId": "5110430", "name": "K. Naxerova"}, {"authorId":
      "6294709", "name": "Christopher Ng"}, {"authorId": "115500939", "name": "Anna
      M. Westermark"}, {"authorId": "40602288", "name": "M. Duquette"}, {"authorId":
      "5239105", "name": "S. Roberge"}, {"authorId": "3734755", "name": "N. Lindeman"},
      {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "2117720586",
      "name": "J. Nielsen"}, {"authorId": "1456579956", "name": "D. Housman"}, {"authorId":
      "2250708594", "name": "D. Duda"}, {"authorId": "6207661", "name": "E. Brachtel"},
      {"authorId": "2900051", "name": "T. Golub"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "34711277",
      "name": "S. Davidson"}, {"authorId": "3057625", "name": "D. Fukumura"}, {"authorId":
      "3361348", "name": "V. Dartois"}, {"authorId": "3633091", "name": "C. Clish"},
      {"authorId": "32514332", "name": "R. Jain"}, {"authorId": "3804233", "name":
      "M. V. Vander Heiden"}]}, {"paperId": "d13943fd02bf2527bc4f234053ab1670e43eaeb7",
      "externalIds": {"DOI": "10.1101/2021.05.01.441686", "CorpusId": 233745373},
      "corpusId": 233745373, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/d13943fd02bf2527bc4f234053ab1670e43eaeb7",
      "title": "Diverse Hotspot Thermal Profiling Methods Detect Phosphorylation-Dependent
      Changes in Protein Stability", "abstract": "Hotspot thermal profiling (HTP)
      methods utilize modified-peptide level information in order to interrogate proteoform-specific
      stability inside of live cells. The first demonstration of HTP involved the
      integration of phosphopeptide enrichment into a TMT-based, single-LC separation
      thermal profiling workflow1. Here we present a new \u2018label-fractionate-enrich\u2019
      (LFE)-HTP method that involves high-pH reverse phase fractionation of TMT-labeled
      peptides prior to phosphopeptide enrichment, followed by peptide detection and
      quantitation using multi-notch LC-MS3. We find that LFE-HTP, while more resource
      intensive, improves the depth and precision of (phospho)proteoform coverage
      relative to the initial published HTP workflow. The fraction of detected phosphorylation
      sites that are significantly perturbed in this new dataset are consistent with
      those seen in our previous study, as well as those published by others, when
      compared head-to-head with the same analysis pipelines. Likewise, many \u2018hotspot\u2019
      phosphorylation sites identified in our paper are consistently reproduced by
      LFE-HTP as well as other modified HTP methods. The LFE-HTP dataset contains
      many novel \u2018hotspot\u2019 phosphorylation sites that regulate the stability
      of diverse proteins, including phosphosites in the central glycolytic enzyme
      Aldolase A that are associated with monomer-to-oligomer formation, enzymatic
      activity and metabolic regulation in cancer cells. Our comparative analyses
      confirm that several variants of the HTP method can track modified proteoforms
      in live cells to detect and prioritize PTM-dependent changes in protein stability
      that may be associated with function.", "venue": "bioRxiv", "year": 2021, "referenceCount":
      20, "citationCount": 2, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2021/05/01/2021.05.01.441686.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Chemistry", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2021-05-01", "journal": {"name": "bioRxiv"}, "citationStyles":
      {"bibtex": "@Article{Stein2021DiverseHT,\n author = {Benjamin D. Stein and Jun
      X. Huang and David Wu and L. Cantley and R. Moellering},\n booktitle = {bioRxiv},\n
      journal = {bioRxiv},\n title = {Diverse Hotspot Thermal Profiling Methods Detect
      Phosphorylation-Dependent Changes in Protein Stability},\n year = {2021}\n}\n"},
      "authors": [{"authorId": "40353456", "name": "Benjamin D. Stein"}, {"authorId":
      "50535527", "name": "Jun X. Huang"}, {"authorId": "144790190", "name": "David
      Wu"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4021080",
      "name": "R. Moellering"}]}, {"paperId": "d3a39e2f4b31947b77f8cf560ca620b32695db4d",
      "externalIds": {"DOI": "10.1101/2021.09.10.459864", "CorpusId": 237495049},
      "corpusId": 237495049, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/d3a39e2f4b31947b77f8cf560ca620b32695db4d",
      "title": "Cysteine induces mitochondrial reductive stress in glioblastoma through
      hydrogen peroxide production", "abstract": "Glucose and amino acid metabolism
      are critical for glioblastoma (GBM) growth, but little is known about the specific
      metabolic alterations in GBM that are targetable with FDA-approved compounds.
      To investigate tumor metabolism signatures unique to GBM, we interrogated The
      Cancer Genome Atlas for alterations in glucose and amino acid signatures in
      GBM relative to other human cancers and found that GBM exhibits the highest
      levels of cysteine and methionine pathway gene expression of 32 human cancers.
      Treatment of patient-derived GBM cells with the FDA-approved cysteine compound
      N-acetylcysteine (NAC) reduce GBM cell growth and mitochondrial oxygen consumption,
      which was worsened by glucose starvation. Mechanistic experiments revealed that
      cysteine compounds induce rapid mitochondrial H2O2 production and reductive
      stress in GBM cells, an effect blocked by oxidized glutathione, thioredoxin,
      and redox enzyme overexpression. These findings indicate that GBM is uniquely
      susceptible to NAC-driven reductive stress and could synergize with glucose-lowering
      treatments for GBM.", "venue": "", "year": 2021, "referenceCount": 80, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.biorxiv.org/content/biorxiv/early/2021/09/11/2021.09.10.459864.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2021-09-11",
      "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Noch2021CysteineIM,\n
      author = {E. Noch and L. Palma and I. Yim and D. Barnett and Alexander Walsh
      and B. Bhinder and E. Benedetti and J. Krumsiek and Justin Gurvitch and Sumaiyah
      Khwaja and O. Elemento and L. Cantley},\n journal = {bioRxiv},\n title = {Cysteine
      induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide
      production},\n year = {2021}\n}\n"}, "authors": [{"authorId": "3913142", "name":
      "E. Noch"}, {"authorId": "2065330100", "name": "L. Palma"}, {"authorId": "1716222698",
      "name": "I. Yim"}, {"authorId": "27860524", "name": "D. Barnett"}, {"authorId":
      "2126518026", "name": "Alexander Walsh"}, {"authorId": "4139100", "name": "B.
      Bhinder"}, {"authorId": "123664542", "name": "E. Benedetti"}, {"authorId": "2067285",
      "name": "J. Krumsiek"}, {"authorId": "2038115111", "name": "Justin Gurvitch"},
      {"authorId": "2126534129", "name": "Sumaiyah Khwaja"}, {"authorId": "150097652",
      "name": "O. Elemento"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "da5860f1c54a497f76c8767c7f98f9392ae3d9f3", "externalIds": {"MAG": "3170169430",
      "DOI": "10.21203/RS.3.RS-563743/V1", "CorpusId": 236423781}, "corpusId": 236423781,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/da5860f1c54a497f76c8767c7f98f9392ae3d9f3",
      "title": "Blocking ActRIIB signaling and restoring appetite reverses cachexia
      and improves survival in mice with lung cancer", "abstract": "\n The cancer
      anorexia-cachexia syndrome (CACS) is a common, debilitating condition with limited
      therapeutic options. The defining feature of CACS is weight loss, which suggests
      a state of negative energy balance. It is unclear whether this net reduction
      in energy is due solely to anorexia or if a combination of anorexia and increased
      energy expenditure (EE) occurs. To address this question, we induced lung cancer
      in mice and measured changes in food intake, EE, and body composition. Mice
      with CACS developed reductions in food intake, spontaneous activity, and EE.
      There was severe atrophy and markers of metabolic dysfunction in the adipose
      and skeletal muscle tissues as compared to mice without CACS and pair-fed wild-type
      mice. We used anamorelin fumarate (Ana), a ghrelin receptor agonist, alone or
      in combination ActRIIB-Fc, a ligand trap for TGF-\u03b2/activin family members,
      to reverse anorexia and skeletal muscle atrophy, respectively. Ana effectively
      increased food intake and the combination of drugs increased lean mass, restored
      spontaneous activity, and improved overall survival. These beneficial effects
      were limited to female mice. Our findings suggest that multimodal, gender-specific,
      therapies are needed to reverse CACS.", "venue": "", "year": 2021, "referenceCount":
      81, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2021-05-28", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Queiroz2021BlockingAS,\n author = {Andr\u00c9 L Queiroz
      and Shakti Ramsamooj and E. Dantas and Elizabeth R. M. Zunica and R. Liang and
      Anirudh Murthy and Charles J Murphy and Corey D. Holman and Curtis J. Bare and
      G. Ghahramani and Zhidan Wu and D. Cohen and J. Kirwan and L. Cantley and C.
      Axelrod and M. Goncalves},\n title = {Blocking ActRIIB signaling and restoring
      appetite reverses cachexia and improves survival in mice with lung cancer},\n
      year = {2021}\n}\n"}, "authors": [{"authorId": "7706581", "name": "Andr\u00c9
      L Queiroz"}, {"authorId": "2058412873", "name": "Shakti Ramsamooj"}, {"authorId":
      "144901772", "name": "E. Dantas"}, {"authorId": "25057716", "name": "Elizabeth
      R. M. Zunica"}, {"authorId": "46875693", "name": "R. Liang"}, {"authorId": "2087916646",
      "name": "Anirudh Murthy"}, {"authorId": "47107919", "name": "Charles J Murphy"},
      {"authorId": "46415060", "name": "Corey D. Holman"}, {"authorId": "34685572",
      "name": "Curtis J. Bare"}, {"authorId": "2126874550", "name": "G. Ghahramani"},
      {"authorId": "2385505", "name": "Zhidan Wu"}, {"authorId": "2233766036", "name":
      "D. Cohen"}, {"authorId": "4881087", "name": "J. Kirwan"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "51224707", "name": "C. Axelrod"}, {"authorId":
      "145524334", "name": "M. Goncalves"}]}, {"paperId": "dc97e05941eefbae4ee9540f9ee086354e6bffd2",
      "externalIds": {"PubMedCentral": "8634575", "DOI": "10.1093/ajcn/nqab270", "CorpusId":
      237493808, "PubMed": "34515299"}, "corpusId": 237493808, "publicationVenue":
      {"id": "52460d26-e705-465a-b49c-92bb07e81ee0", "name": "American Journal of
      Clinical Nutrition", "type": "journal", "alternate_names": ["The American Journal
      of Clinical Nutrition", "Am J Clin Nutr"], "issn": "0002-9165", "url": "http://www.ajcn.org/"},
      "url": "https://www.semanticscholar.org/paper/dc97e05941eefbae4ee9540f9ee086354e6bffd2",
      "title": "The carbohydrate-insulin model: a physiological perspective on the
      obesity pandemic", "abstract": "ABSTRACT According to a commonly held view,
      the obesity pandemic is caused by overconsumption of modern, highly palatable,
      energy-dense processed foods, exacerbated by a sedentary lifestyle. However,
      obesity rates remain at historic highs, despite a persistent focus on eating
      less and moving more, as guided by the energy balance model (EBM). This public
      health failure may arise from a fundamental limitation of the EBM itself. Conceptualizing
      obesity as a disorder of energy balance restates a principle of physics without
      considering the biological mechanisms that promote weight gain. An alternative
      paradigm, the carbohydrate-insulin model (CIM), proposes a reversal of causal
      direction. According to the CIM, increasing fat deposition in the body\u2014resulting
      from the hormonal responses to a high-glycemic-load diet\u2014drives positive
      energy balance. The CIM provides a conceptual framework with testable hypotheses
      for how various modifiable factors influence energy balance and fat storage.
      Rigorous research is needed to compare the validity of these 2 models, which
      have substantially different implications for obesity management, and to generate
      new models that best encompass the evidence.", "venue": "American Journal of
      Clinical Nutrition", "year": 2021, "referenceCount": 172, "citationCount": 102,
      "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://academic.oup.com/ajcn/article-pdf/114/6/1873/41395094/nqab270.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Philosophy", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2021-09-13", "journal": {"volume": "114", "pages": "1873
      - 1885", "name": "The American Journal of Clinical Nutrition"}, "citationStyles":
      {"bibtex": "@Article{Ludwig2021TheCM,\n author = {D. Ludwig and L. Aronne and
      A. Astrup and R. de Cabo and L. Cantley and M. Friedman and S. Heymsfield and
      James D. Johnson and J. King and R. Krauss and D. Lieberman and G. Taubes and
      J. Volek and E. Westman and W. Willett and W. Yancy and C. Ebbeling},\n booktitle
      = {American Journal of Clinical Nutrition},\n journal = {The American Journal
      of Clinical Nutrition},\n pages = {1873 - 1885},\n title = {The carbohydrate-insulin
      model: a physiological perspective on the obesity pandemic},\n volume = {114},\n
      year = {2021}\n}\n"}, "authors": [{"authorId": "5357296", "name": "D. Ludwig"},
      {"authorId": "4471209", "name": "L. Aronne"}, {"authorId": "47518061", "name":
      "A. Astrup"}, {"authorId": "144285023", "name": "R. de Cabo"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "143673144", "name": "M. Friedman"},
      {"authorId": "1703514", "name": "S. Heymsfield"}, {"authorId": "143913880",
      "name": "James D. Johnson"}, {"authorId": "1756443", "name": "J. King"}, {"authorId":
      "8678177", "name": "R. Krauss"}, {"authorId": "32514132", "name": "D. Lieberman"},
      {"authorId": "5951734", "name": "G. Taubes"}, {"authorId": "2054653160", "name":
      "J. Volek"}, {"authorId": "47270053", "name": "E. Westman"}, {"authorId": "5042577",
      "name": "W. Willett"}, {"authorId": "41183477", "name": "W. Yancy"}, {"authorId":
      "4056154", "name": "C. Ebbeling"}]}, {"paperId": "e1a2d7472834d9dd1ad5be1c3c1799ecae47a531",
      "externalIds": {"PubMedCentral": "7992201", "DOI": "10.1093/noajnl/vdab024.044",
      "CorpusId": 232479877}, "corpusId": 232479877, "publicationVenue": {"id": "4390a6c7-bd1a-4ccc-b9e6-e988368f95cb",
      "name": "Neuro-Oncology Advances", "type": "journal", "alternate_names": ["Neuro-oncology
      Adv"], "issn": "2632-2498"}, "url": "https://www.semanticscholar.org/paper/e1a2d7472834d9dd1ad5be1c3c1799ecae47a531",
      "title": "DDRE-22. TARGETING SERINE SYNTHESIS IN BRAIN METASTASIS", "abstract":
      "Abstract The brain environment is low in amino acids, including serine and
      glycine, both of which are important for tumor growth as they are precursors
      of proteins and nucleotide bases. How tumor cells overcome these conditions
      to proliferate and survive in the brain is incompletely understood. Here, we
      show that 3-phosphoglycerate dehydrogenase (PHGDH), which catalyzes the first
      and rate-limiting step of glucose-derived serine synthesis, enables brain metastasis
      in multiple human types and in preclinical models. Genetic suppression and small
      molecule inhibition of PHGDH attenuated brain metastasis, but not extra cranial
      tumors, and improved the overall survival of mice bearing brain metastasis.
      These results demonstrate that the tumor nutrient microenvironment determines
      tumor cell sensitivity to loss of serine synthesis pathway activity and raise
      the possibility that serine synthesis inhibitors may be useful in the treatment
      of brain metastases.", "venue": "Neuro-Oncology Advances", "year": 2021, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2021-03-01", "journal": {"volume":
      "3", "pages": "i11 - i11", "name": "Neuro-oncology Advances"}, "citationStyles":
      {"bibtex": "@Article{Ngo2021DDRE22TS,\n author = {B. Ngo and Eugenie Kim and
      Victoria Osorio-Vasquez and S. Doll and Sophia Bustraan and R. Liang and Alba
      Luengo and S. Davidson and A. Ali and G. Ferraro and Grant M Fischer and Ariana
      Plasger and Vinagolu K. Rajasekhar and Edward R. Kastenhuber and Roozbeh Eskandari
      and Sarah Bacha and Roshan K. Sriram and S. Bakhoum and M. Snuderl and P. Cotzia
      and J. Healey and D. Sabatini and Drew R. Jones and Jean J. Zhao and Min Yu
      and R. Jain and K. Keshari and M. Davies and M. V. Heiden and E. Hernando and
      M. Mann and L. Cantley and M. Pacold},\n booktitle = {Neuro-Oncology Advances},\n
      journal = {Neuro-oncology Advances},\n pages = {i11 - i11},\n title = {DDRE-22.
      TARGETING SERINE SYNTHESIS IN BRAIN METASTASIS},\n volume = {3},\n year = {2021}\n}\n"},
      "authors": [{"authorId": "5891999", "name": "B. Ngo"}, {"authorId": "115819822",
      "name": "Eugenie Kim"}, {"authorId": "1600811114", "name": "Victoria Osorio-Vasquez"},
      {"authorId": "50535810", "name": "S. Doll"}, {"authorId": "1600820777", "name":
      "Sophia Bustraan"}, {"authorId": "46875693", "name": "R. Liang"}, {"authorId":
      "114311983", "name": "Alba Luengo"}, {"authorId": "34711277", "name": "S. Davidson"},
      {"authorId": "2157679423", "name": "A. Ali"}, {"authorId": "35545769", "name":
      "G. Ferraro"}, {"authorId": "26984663", "name": "Grant M Fischer"}, {"authorId":
      "1600820946", "name": "Ariana Plasger"}, {"authorId": "5734623", "name": "Vinagolu
      K. Rajasekhar"}, {"authorId": "4306515", "name": "Edward R. Kastenhuber"}, {"authorId":
      "6108327", "name": "Roozbeh Eskandari"}, {"authorId": "145170581", "name": "Sarah
      Bacha"}, {"authorId": "49408849", "name": "Roshan K. Sriram"}, {"authorId":
      "3543494", "name": "S. Bakhoum"}, {"authorId": "3579975", "name": "M. Snuderl"},
      {"authorId": "10371243", "name": "P. Cotzia"}, {"authorId": "1846047", "name":
      "J. Healey"}, {"authorId": "1843680", "name": "D. Sabatini"}, {"authorId": "151477189",
      "name": "Drew R. Jones"}, {"authorId": "50985038", "name": "Jean J. Zhao"},
      {"authorId": "145684949", "name": "Min Yu"}, {"authorId": "32514332", "name":
      "R. Jain"}, {"authorId": "5460116", "name": "K. Keshari"}, {"authorId": "2117692562",
      "name": "M. Davies"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId":
      "4586359", "name": "E. Hernando"}, {"authorId": "144979479", "name": "M. Mann"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5141475", "name":
      "M. Pacold"}]}, {"paperId": "e52695c4890f10ad7fd85d5b8a6e83f458534f13", "externalIds":
      {"PubMedCentral": "7992317", "DOI": "10.1093/noajnl/vdab024.029", "CorpusId":
      232480272}, "corpusId": 232480272, "publicationVenue": {"id": "4390a6c7-bd1a-4ccc-b9e6-e988368f95cb",
      "name": "Neuro-Oncology Advances", "type": "journal", "alternate_names": ["Neuro-oncology
      Adv"], "issn": "2632-2498"}, "url": "https://www.semanticscholar.org/paper/e52695c4890f10ad7fd85d5b8a6e83f458534f13",
      "title": "DDRE-07. FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN
      METASTASIS", "abstract": "Abstract Brain metastases are refractory to therapies
      that otherwise control systemic disease in patients with human epidermal growth
      factor receptor 2 (HER2+) breast cancer, and the unique brain microenvironment
      contributes to this therapy resistance. Nutrient availability can vary across
      tissues, therefore metabolic adaptations required for breast cancer growth in
      the brain microenvironment may also introduce liabilities that can be exploited
      for therapy. Here, we assessed how metabolism differs between breast tumors
      growing in the brain versus extracranial sites and found that fatty acid synthesis
      is elevated in breast tumors growing in the brain. We determine that this phenotype
      is an adaptation to decreased lipid availability in the brain relative to other
      tissues, which results in a site-specific dependency on fatty acid synthesis
      for breast tumors growing at this site. Genetic or pharmacological inhibition
      of fatty acid synthase (FASN) reduces HER2+ breast tumor growth in the brain,
      demonstrating that differences in nutrient availability across metastatic sites
      can result in targetable metabolic dependencies.", "venue": "Neuro-Oncology
      Advances", "year": 2021, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2021-03-01",
      "journal": {"volume": "3", "pages": "i7 - i8", "name": "Neuro-oncology Advances"},
      "citationStyles": {"bibtex": "@Article{Ferraro2021DDRE07FA,\n author = {G. Ferraro
      and A. Ali and Alba Luengo and D. Kodack and A. Deik and Keene L. Abbott and
      Divya Bezwada and L. Blanc and Brendan Prideaux and Xin Jin and Jessica M. Possada
      and Jiang Chen and Christopher R Chin and Zohreh Amoozgar and Raphael Ferreira
      and Ivy X. Chen and K. Naxerova and Christopher Ng and Anna M. Westermark and
      M. Duquette and S. Roberge and C. Lyssiotis and D. Duda and T. Golub and L.
      Cantley and J. Asara and S. Davidson and D. Fukumura and V. Dartois and C. Clish
      and M. V. Heiden and R. Jain},\n booktitle = {Neuro-Oncology Advances},\n journal
      = {Neuro-oncology Advances},\n pages = {i7 - i8},\n title = {DDRE-07. FATTY
      ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS},\n volume = {3},\n
      year = {2021}\n}\n"}, "authors": [{"authorId": "35545769", "name": "G. Ferraro"},
      {"authorId": "2157679423", "name": "A. Ali"}, {"authorId": "114311983", "name":
      "Alba Luengo"}, {"authorId": "10029385", "name": "D. Kodack"}, {"authorId":
      "2922270", "name": "A. Deik"}, {"authorId": "39862913", "name": "Keene L. Abbott"},
      {"authorId": "11045592", "name": "Divya Bezwada"}, {"authorId": "29960670",
      "name": "L. Blanc"}, {"authorId": "4151707", "name": "Brendan Prideaux"}, {"authorId":
      "2149169420", "name": "Xin Jin"}, {"authorId": "89996372", "name": "Jessica
      M. Possada"}, {"authorId": "2144207912", "name": "Jiang Chen"}, {"authorId":
      "2056653349", "name": "Christopher R Chin"}, {"authorId": "10042929", "name":
      "Zohreh Amoozgar"}, {"authorId": "2067628106", "name": "Raphael Ferreira"},
      {"authorId": "19188310", "name": "Ivy X. Chen"}, {"authorId": "5110430", "name":
      "K. Naxerova"}, {"authorId": "2064839498", "name": "Christopher Ng"}, {"authorId":
      "115500939", "name": "Anna M. Westermark"}, {"authorId": "40602288", "name":
      "M. Duquette"}, {"authorId": "5239105", "name": "S. Roberge"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "2250708594", "name": "D. Duda"},
      {"authorId": "2900051", "name": "T. Golub"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "34711277",
      "name": "S. Davidson"}, {"authorId": "3057625", "name": "D. Fukumura"}, {"authorId":
      "3361348", "name": "V. Dartois"}, {"authorId": "3633091", "name": "C. Clish"},
      {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "32514332", "name":
      "R. Jain"}]}, {"paperId": "0154ddc39a5bcb8056991c828561841786d04caf", "externalIds":
      {"PubMedCentral": "7607628", "MAG": "3097171810", "DOI": "10.1186/s13058-020-01354-y",
      "CorpusId": 226229418, "PubMed": "33138866"}, "corpusId": 226229418, "publicationVenue":
      {"id": "1290af6c-c79c-4253-8957-8db4a6069766", "name": "Breast Cancer Research",
      "type": "journal", "alternate_names": ["Breast Cancer Res"], "issn": "1465-5411",
      "url": "http://breast-cancer-research.com/"}, "url": "https://www.semanticscholar.org/paper/0154ddc39a5bcb8056991c828561841786d04caf",
      "title": "Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor,
      in patients with metastatic triple-negative breast cancer", "abstract": null,
      "venue": "Breast Cancer Research", "year": 2020, "referenceCount": 49, "citationCount":
      45, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-020-01354-y",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2020-11-02", "journal":
      {"volume": "22", "name": "Breast Cancer Research : BCR"}, "citationStyles":
      {"bibtex": "@Article{Garrido-Castro2020Phase2S,\n author = {A. Garrido-Castro
      and C. Saura and R. Barroso-Sousa and Hao Guo and E. Ciruelos and B. Bermejo
      and J. Gavil\u00e1 and V. Serra and A. Prat and L. Par\u00e9 and P. C\u00e9liz
      and P. Villagrasa and Yisheng Li and J. Savoie and Zhan Xu and C. Arteaga and
      I. Krop and D. Solit and G. Mills and L. Cantley and E. Winer and N. Lin and
      J. Rod\u00f3n},\n booktitle = {Breast Cancer Research},\n journal = {Breast
      Cancer Research : BCR},\n title = {Phase 2 study of buparlisib (BKM120), a pan-class
      I PI3K inhibitor, in patients with metastatic triple-negative breast cancer},\n
      volume = {22},\n year = {2020}\n}\n"}, "authors": [{"authorId": "1401041241",
      "name": "A. Garrido-Castro"}, {"authorId": "143772689", "name": "C. Saura"},
      {"authorId": "1393643694", "name": "R. Barroso-Sousa"}, {"authorId": "143887802",
      "name": "Hao Guo"}, {"authorId": "4316212", "name": "E. Ciruelos"}, {"authorId":
      "144441047", "name": "B. Bermejo"}, {"authorId": "1901703", "name": "J. Gavil\u00e1"},
      {"authorId": "49229190", "name": "V. Serra"}, {"authorId": "145594197", "name":
      "A. Prat"}, {"authorId": "3372070", "name": "L. Par\u00e9"}, {"authorId": "145716996",
      "name": "P. C\u00e9liz"}, {"authorId": "152815847", "name": "P. Villagrasa"},
      {"authorId": "2111151410", "name": "Yisheng Li"}, {"authorId": "37392807", "name":
      "J. Savoie"}, {"authorId": "47047818", "name": "Zhan Xu"}, {"authorId": "2057460",
      "name": "C. Arteaga"}, {"authorId": "2101923", "name": "I. Krop"}, {"authorId":
      "2344124", "name": "D. Solit"}, {"authorId": "2241330", "name": "G. Mills"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2369378", "name":
      "E. Winer"}, {"authorId": "35141217", "name": "N. Lin"}, {"authorId": "143607446",
      "name": "J. Rod\u00f3n"}]}, {"paperId": "0a0032872553b2783d774418c075815e3605b2fb",
      "externalIds": {"DOI": "10.1016/j.cmet.2020.12.005", "CorpusId": 229692208,
      "PubMed": "33357456"}, "corpusId": 229692208, "publicationVenue": {"id": "ad36b49e-5c03-4c48-be8d-321a0d17c2f6",
      "name": "Cell Metabolism", "type": "journal", "alternate_names": ["Cell Metab"],
      "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/15504131", "http://www.cellmetabolism.org/"]},
      "url": "https://www.semanticscholar.org/paper/0a0032872553b2783d774418c075815e3605b2fb",
      "title": "High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid
      Leukemic Cells.", "abstract": null, "venue": "Cell Metabolism", "year": 2020,
      "referenceCount": 58, "citationCount": 29, "influentialCitationCount": 1, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.cell.com/article/S1550413120306604/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-12-17", "journal": {"name": "Cell metabolism"}, "citationStyles":
      {"bibtex": "@Article{Jeong2020HighFD,\n author = {Sangmoo Jeong and A. Savino
      and Rachel Chirayil and Ersilia Barin and Yuanming Cheng and Sun-Mi Park and
      Alexandria Schurer and Edouard Mullarky and L. Cantley and M. Kharas and K.
      Keshari},\n booktitle = {Cell Metabolism},\n journal = {Cell metabolism},\n
      title = {High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid
      Leukemic Cells.},\n year = {2020}\n}\n"}, "authors": [{"authorId": "3583062",
      "name": "Sangmoo Jeong"}, {"authorId": "9567228", "name": "A. Savino"}, {"authorId":
      "6734378", "name": "Rachel Chirayil"}, {"authorId": "1744766868", "name": "Ersilia
      Barin"}, {"authorId": "50860020", "name": "Yuanming Cheng"}, {"authorId": "120425242",
      "name": "Sun-Mi Park"}, {"authorId": "153666453", "name": "Alexandria Schurer"},
      {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "152500082", "name": "M. Kharas"}, {"authorId":
      "5460116", "name": "K. Keshari"}]}, {"paperId": "1e64ffd0b17e1d16151e185cdd76ac1a571db2d6",
      "externalIds": {"MAG": "3021120315", "DOI": "10.1101/2020.05.05.079095", "CorpusId":
      218571941, "PubMed": "32511403"}, "corpusId": 218571941, "publicationVenue":
      {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0", "name": "bioRxiv", "type": "journal",
      "url": "http://biorxiv.org/"}, "url": "https://www.semanticscholar.org/paper/1e64ffd0b17e1d16151e185cdd76ac1a571db2d6",
      "title": "Identification of Candidate COVID-19 Therapeutics using hPSC-derived
      Lung Organoids", "abstract": "The SARS-CoV-2 virus has caused already over 3.5
      million COVID-19 cases and 250,000 deaths globally. There is an urgent need
      to create novel models to study SARS-CoV-2 using human disease-relevant cells
      to understand key features of virus biology and facilitate drug screening. As
      primary SARS-CoV-2 infection is respiratory-based, we developed a lung organoid
      model using human pluripotent stem cells (hPSCs) that could be adapted for drug
      screens. The lung organoids, particularly aveolar type II cells, express ACE2
      and are permissive to SARS-CoV-2 infection. Transcriptomic analysis following
      SARS-CoV-2 infection revealed a robust induction of chemokines and cytokines
      with little type I/III interferon signaling, similar to that observed amongst
      human COVID-19 pulmonary infections. We performed a high throughput screen using
      hPSC-derived lung organoids and identified FDA-approved drug candidates, including
      imatinib and mycophenolic acid, as inhibitors of SARS-CoV-2 entry. Pre- or post-treatment
      with these drugs at physiologically relevant levels decreased SARS-CoV-2 infection
      of hPSC-derived lung organoids. Together, these data demonstrate that hPSC-derived
      lung cells infected by SARS-CoV-2 can model human COVID-19 disease and provide
      a valuable resource to screen for FDA-approved drugs that might be repurposed
      and should be considered for COVID-19 clinical trials.", "venue": "bioRxiv",
      "year": 2020, "referenceCount": 38, "citationCount": 101, "influentialCitationCount":
      5, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2020/05/05/2020.05.05.079095.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2020-05-05", "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Han2020IdentificationOC,\n
      author = {Yuling Han and Liuliu Yang and Xiaohua Duan and Fuyu Duan and Benjamin
      E. Nilsson-Payant and Tomer M. Yaron and Pengfei Wang and Xuming Tang and Tuo
      Zhang and Zeping Zhao and Y. Bram and D. Redmond and S. Houghton and Duc-Huy
      T. Nguyen and Dong-Li Xu and Xing Wang and S. Uhl and Yaoxing Huang and Jared
      L. Johnson and J. Xiang and Hui Wang and F. C. Pan and L. Cantley and B. tenOever
      and D. Ho and T. Evans and R. Schwartz and H. Chen and Shuibing Chen},\n booktitle
      = {bioRxiv},\n journal = {bioRxiv},\n title = {Identification of Candidate COVID-19
      Therapeutics using hPSC-derived Lung Organoids},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "1678087048", "name": "Yuling Han"}, {"authorId": "1733349662",
      "name": "Liuliu Yang"}, {"authorId": "8121194", "name": "Xiaohua Duan"}, {"authorId":
      "8751560", "name": "Fuyu Duan"}, {"authorId": "1422205499", "name": "Benjamin
      E. Nilsson-Payant"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "152702655", "name": "Pengfei Wang"}, {"authorId": "1687775322", "name": "Xuming
      Tang"}, {"authorId": "40543563", "name": "Tuo Zhang"}, {"authorId": "2186108428",
      "name": "Zeping Zhao"}, {"authorId": "4785493", "name": "Y. Bram"}, {"authorId":
      "1682800", "name": "D. Redmond"}, {"authorId": "145731038", "name": "S. Houghton"},
      {"authorId": "50652368", "name": "Duc-Huy T. Nguyen"}, {"authorId": "48207902",
      "name": "Dong-Li Xu"}, {"authorId": "2144803226", "name": "Xing Wang"}, {"authorId":
      "88725738", "name": "S. Uhl"}, {"authorId": "2108678622", "name": "Yaoxing Huang"},
      {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId": "2236077469",
      "name": "J. Xiang"}, {"authorId": "2113635227", "name": "Hui Wang"}, {"authorId":
      "34160280", "name": "F. C. Pan"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5462120", "name": "B. tenOever"}, {"authorId": "144705651", "name":
      "D. Ho"}, {"authorId": "144263094", "name": "T. Evans"}, {"authorId": "46462360",
      "name": "R. Schwartz"}, {"authorId": "2145302790", "name": "H. Chen"}, {"authorId":
      "47336157", "name": "Shuibing Chen"}]}, {"paperId": "2808e4458bedf8bbe953c5bbce8ae90ac0ce9e79",
      "externalIds": {"MAG": "3005914208", "DOI": "10.1158/1538-7445.SABCS19-GS6-06",
      "CorpusId": 213426689}, "corpusId": 213426689, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/2808e4458bedf8bbe953c5bbce8ae90ac0ce9e79",
      "title": "Abstract GS6-06: A neoadjuvant trial with letrozole identifiesPRR11in
      the 17q23 amplicon as a mechanism of resistance to endocrine therapy in ER-positive
      breast cancer", "abstract": "Although the 17q23 amplicon has been associated
      with luminal B breast cancer (BC) and high risk of recurrence, a specific gene
      or genes in this region that would be causal to endocrine resistance have not
      yet been uncovered. We performed whole transcriptome analysis on RNA extracted
      from 58 estrogen receptor (ER)+ BCs treated with neoadjuvant letrozole for median
      7.2 months. PRR11 (Proline rich 11), located in 17q23, was upregulated in non-responding
      tumors as defined by relapse after a median follow up of 5 years and/or a preoperative
      endocrine prognostic index (PEPI) \u22654. Differential gene expression analysis
      between tumors expressing low vs high PRR11 mRNA showed that BC signatures associated
      with proliferation, IGF-1 and PI3K signaling were enriched in tumors with high
      PRR11 expression. Rate of PRR11 amplification is 15.2% in the Metastatic Breast
      Cancer project, but 9.5% and 9.4% in METABRIC and The Cancer Genome Atlas (TCGA),
      respectively. Gene Set Enrichment Analysis revealed an enrichment of hallmark
      gene sets associated with proliferation in PRR11-amplified ER+ BCs in METABRIC
      and TCGA. Integrated analysis of gene expression with on-treatment Ki67 levels
      from three independent studies with operable ER+ BCs treated with neoadjuvant
      aromatase inhibitor (ACOSOG-Z1031, NCT00651976, Llombart-Cussac et al.) showed
      that PRR11 was the only gene in 17q23 with a significant correlation with a
      high Ki67 levels across all studies. PRR11 knockdown inhibited E2-independent
      growth of HCC1428 LTED (long-term estrogen deprived) and MCF7 LTED cells in
      culture and MCF7 xenografts. PRR11 siRNA also inhibited growth of fulvestrant-resistant
      and tamoxifen-resistant MCF7 cells. Conversely, PRR11 transduction induced MDA-MB-134VI
      cell growth under estrogen-depleted conditions. Using a PCR array with 84-cell
      cycle genes, we identified SKP2, CDKN1A, CCNB2, CCNA2, CKS2 and CCNB1 as genes
      downregulated by PRR11 knockdown. Except for SKP2 and CDKN1A, expression of
      all those genes was elevated in PRR11-amplifiedER+ BCs in TCGA and METABRIC.
      Suggesting a link to activation of PI3K signaling, we found the proline-rich
      motif of PRR11 associates with the SH3 domain of the p85 regulatory subunit
      of PI3K. We hypothesized that this association suppresses p85 homodimer formation,
      thus facilitating binding of PI3K\u03b1 (p110\u03b1)-p85 dimers to IRS1, retention
      of p110\u03b1 at the plasma membrane and, hence, activation of PI3K/AKT. To
      test this, we co-transfected HEK293T cells with HA-p85 and FLAG-p85. Forced
      expression of PRR11 reduced HA-p85 and FLAG-p85 homodimers as shown by HA and
      FLAG pulldowns followed by FLAG and HA immunoblots, respectively. PRR11 overexpression
      enhanced insulin-stimulated association of IRS1 to p110\u03b1 and activation
      of AKT. PRR11 knockdown reduced insulin/IGF-1/2-stimulated p-AKT. In METABRIC
      and TCGA, PRR11 amplification and PIK3CA mutations are exclusive of each other,
      suggesting these alterations would be functionally linked with the same pathway.
      Connectivity map analysis with the list of genes significantly overexpressed
      in ER+/PRR11-amplified BCs predicted PI3K inhibitors as perturbations that suppress
      such gene list. In the MGH/Sanger dataset, PRR11-amplified BC cell lines displayed
      significantly higher sensitivity to the pan-PI3K inhibitor pictilisib compared
      to cell lines without PRR11 amplification. Finally, inhibition of PI3K\u03b1
      by siRNA or alpelisib abrogated E2-independent growth and insulin-stimulated
      growth of PRR11-transduced MDA-MB-134VI and MCF10A cells, respectively, suggesting
      p110\u03b1 is required for the growth promoting effects of PRR11. These data
      suggest that 1) PRR11 is a mediator of resistance to antiestrogens via amplification
      of PI3K/AKT signaling, and 2) PI3K\u03b1 is a potential therapeutic target in
      ER+ BCs harboring PRR11 amplification. Citation Format: Kyung-min Lee, Angel
      Guerrero-Zotano, Ariella Hanker, Alberto Servetto, Dhivya Sudhan, Luigi Formisano,
      Valerie Jansen, Paula Gonzalez-Ericsson, Melinda Sanders, Thomas Stricker, Lewis
      Cantley, Carlos Arteaga. A neoadjuvant trial with letrozole identifies PRR11
      in the 17q23 amplicon as a mechanism of resistance to endocrine therapy in ER-positive
      breast cancer [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer
      Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer
      Res 2020;80(4 Suppl):Abstract nr GS6-06.", "venue": "", "year": 2020, "referenceCount":
      0, "citationCount": 2, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2020-02-15", "journal": {"volume":
      "80", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Lee2020AbstractGA,\n
      author = {Kyung-min Lee and A. Guerrero-Zotano and A. Hanker and A. Servetto
      and D. Sudhan and L. Formisano and V. Jansen and Paula I. Gonzalez-Ericsson
      and M. Sanders and T. Stricker and L. Cantley and C. Arteaga},\n journal = {Cancer
      Research},\n title = {Abstract GS6-06: A neoadjuvant trial with letrozole identifiesPRR11in
      the 17q23 amplicon as a mechanism of resistance to endocrine therapy in ER-positive
      breast cancer},\n volume = {80},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "46542827", "name": "Kyung-min Lee"}, {"authorId": "1403641116", "name": "A.
      Guerrero-Zotano"}, {"authorId": "5872582", "name": "A. Hanker"}, {"authorId":
      "5294693", "name": "A. Servetto"}, {"authorId": "6577378", "name": "D. Sudhan"},
      {"authorId": "40940752", "name": "L. Formisano"}, {"authorId": "144653026",
      "name": "V. Jansen"}, {"authorId": "1400994437", "name": "Paula I. Gonzalez-Ericsson"},
      {"authorId": "46945931", "name": "M. Sanders"}, {"authorId": "47705275", "name":
      "T. Stricker"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2057460", "name": "C. Arteaga"}]}, {"paperId": "37e5c491fe8335b24dae149954c4ad5fc5e41b52",
      "externalIds": {"MAG": "3089217892", "DOI": "10.1016/j.annonc.2020.08.1346",
      "CorpusId": 225275236}, "corpusId": 225275236, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/37e5c491fe8335b24dae149954c4ad5fc5e41b52",
      "title": "1954P A pan-cancer analysis of double PIK3CA mutations", "abstract":
      null, "venue": "", "year": 2020, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.annalsofoncology.org/article/S0923753420413420/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2020-09-01", "journal": {"volume": "31", "name": "Annals
      of Oncology"}, "citationStyles": {"bibtex": "@Article{Vasan20201954PAP,\n author
      = {N. Vasan and S. Sivakumar and D. Jin and J. Ross and L. Cantley and M. Scaltriti
      and E. Sokol},\n journal = {Annals of Oncology},\n title = {1954P A pan-cancer
      analysis of double PIK3CA mutations},\n volume = {31},\n year = {2020}\n}\n"},
      "authors": [{"authorId": "35123724", "name": "N. Vasan"}, {"authorId": "40088390",
      "name": "S. Sivakumar"}, {"authorId": "3287834", "name": "D. Jin"}, {"authorId":
      "2205951354", "name": "J. Ross"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "8336319", "name": "M. Scaltriti"}, {"authorId": "48156320", "name":
      "E. Sokol"}]}, {"paperId": "3b7575f733f5972bc3dfd07d5f3ba8f3cf1b38ee", "externalIds":
      {"MAG": "3010473282", "DOI": "10.1016/j.chembiol.2020.02.003", "CorpusId": 212417732,
      "PubMed": "32130941"}, "corpusId": 212417732, "publicationVenue": {"id": "66a2a80a-90f1-4c5a-8798-1be97c318574",
      "name": "Cell Chemical Biology", "alternate_names": ["Cell Chem Biology"], "issn":
      "2451-9456", "alternate_issns": ["2451-9448"], "url": "https://www.sciencedirect.com/journal/cell-chemical-biology",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/24519456",
      "http://www.sciencedirect.com/science/journal/24519456/23/"]}, "url": "https://www.semanticscholar.org/paper/3b7575f733f5972bc3dfd07d5f3ba8f3cf1b38ee",
      "title": "Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent
      Inhibitors.", "abstract": null, "venue": "Cell Chemical Biology", "year": 2020,
      "referenceCount": 59, "citationCount": 29, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.cell.com/article/S2451945620300672/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-03-03", "journal": {"name": "Cell chemical biology"},
      "citationStyles": {"bibtex": "@Article{Sivakumaren2020TargetingTP,\n author
      = {S. Sivakumaren and Hyeseok Shim and Tinghu Zhang and F. Ferguson and Mark
      Lundquist and Christopher M Browne and H. Seo and M. Paddock and Theresa D.
      Manz and Theresa D. Manz and Baishan Jiang and Mingfeng Hao and P. Krishnan
      and Diana G. Wang and T. Yang and Nicholas Kwiatkowski and Nicholas Kwiatkowski
      and S. Ficarro and S. Ficarro and J. Cunningham and J. Marto and S. Dhe-Paganon
      and L. Cantley and N. Gray},\n booktitle = {Cell Chemical Biology},\n journal
      = {Cell chemical biology},\n title = {Targeting the PI5P4K Lipid Kinase Family
      in Cancer Using Covalent Inhibitors.},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "6443517", "name": "S. Sivakumaren"}, {"authorId": "13574443", "name": "Hyeseok
      Shim"}, {"authorId": "2262535", "name": "Tinghu Zhang"}, {"authorId": "11404167",
      "name": "F. Ferguson"}, {"authorId": "49142390", "name": "Mark Lundquist"},
      {"authorId": "39374687", "name": "Christopher M Browne"}, {"authorId": "91486080",
      "name": "H. Seo"}, {"authorId": "4422893", "name": "M. Paddock"}, {"authorId":
      "16018077", "name": "Theresa D. Manz"}, {"authorId": "16018077", "name": "Theresa
      D. Manz"}, {"authorId": "7864101", "name": "Baishan Jiang"}, {"authorId": "11796890",
      "name": "Mingfeng Hao"}, {"authorId": "50822194", "name": "P. Krishnan"}, {"authorId":
      "152325571", "name": "Diana G. Wang"}, {"authorId": "2219789781", "name": "T.
      Yang"}, {"authorId": "6254222", "name": "Nicholas Kwiatkowski"}, {"authorId":
      "6254222", "name": "Nicholas Kwiatkowski"}, {"authorId": "2297254", "name":
      "S. Ficarro"}, {"authorId": "2297254", "name": "S. Ficarro"}, {"authorId": "36406440",
      "name": "J. Cunningham"}, {"authorId": "2605597", "name": "J. Marto"}, {"authorId":
      "1400570681", "name": "S. Dhe-Paganon"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "3977406", "name": "N. Gray"}]}, {"paperId": "3fd887bbf1178f1ced49551888df37abe245b09b",
      "externalIds": {"MAG": "3113241844", "DOI": "10.1101/2020.08.14.251207", "CorpusId":
      229549364}, "corpusId": 229549364, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/3fd887bbf1178f1ced49551888df37abe245b09b",
      "title": "The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid
      phosphorylation and inhibits viral infection in vitro", "abstract": "While vaccines
      are vital for preventing COVID-19 infections, it is critical to develop new
      therapies to treat patients who become infected. Pharmacological targeting of
      a host factor required for viral replication can suppress viral spread with
      a low probability of viral mutation leading to resistance. In particular, host
      kinases are highly druggable targets and a number of conserved coronavirus proteins,
      notably the nucleoprotein (N), require phosphorylation for full functionality.
      In order to understand how targeting kinases could be used to compromise viral
      replication, we used a combination of phosphoproteomics and bioinformatics as
      well as genetic and pharmacological kinase inhibition to define the enzymes
      important for SARS-CoV-2 N protein phosphorylation and viral replication. From
      these data, we propose a model whereby SRPK1/2 initiates phosphorylation of
      the N protein, which primes for further phosphorylation by GSK-3\u03b1/\u03b2
      and CK1 to achieve extensive phosphorylation of the N protein SR-rich domain.
      Importantly, we were able to leverage our data to identify an FDA-approved kinase
      inhibitor, Alectinib, that suppresses N phosphorylation by SRPK1/2 and limits
      SARS-CoV-2 replication. Together, these data suggest that repurposing or developing
      novel host-kinase directed therapies may be an efficacious strategy to prevent
      or treat COVID-19 and other coronavirus-mediated diseases.", "venue": "", "year":
      2020, "referenceCount": 106, "citationCount": 32, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2020/12/16/2020.08.14.251207.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2020-08-14", "journal": {"volume":
      "", "name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Yaron2020TheFD,\n
      author = {Tomer M. Yaron and B. Heaton and T. Levy and Jared L. Johnson and
      Tristan X. Jordan and B. M. Cohen and A. Kerelsky and Ting-Yu Lin and Katarina
      M Liberatore and Danielle K Bulaon and Edward R. Kastenhuber and Marisa Mercadante
      and Kripa Shobana-Ganesh and Long He and R. Schwartz and Shuibing Chen and H.
      Weinstein and O. Elemento and E. Piskounova and Benjamin E. Nilsson-Payant and
      Gina Lee and Joseph D. Trimarco and Kaitlyn N Burke and C. Hamele and Ryan R.
      Chaparian and Alfred T. Harding and A. Tata and Xinyu Zhu and P. R. Tata and
      Clare M. Smith and A. Possemato and S. Tkachev and P. Hornbeck and S. Beausoleil
      and Shankara K. Anand and F. Aguet and G. Getz and A. Davidson and K. Heesom
      and M. Kavanagh-Williamson and D. Matthews and B. tenOever and L. Cantley and
      J. Blenis and Nicholas S. Heaton},\n journal = {bioRxiv},\n title = {The FDA-approved
      drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits
      viral infection in vitro},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "5247030", "name": "Tomer M. Yaron"}, {"authorId": "38692984", "name": "B. Heaton"},
      {"authorId": "32603328", "name": "T. Levy"}, {"authorId": "145916288", "name":
      "Jared L. Johnson"}, {"authorId": "145658521", "name": "Tristan X. Jordan"},
      {"authorId": "2055611292", "name": "B. M. Cohen"}, {"authorId": "14658204",
      "name": "A. Kerelsky"}, {"authorId": "144181325", "name": "Ting-Yu Lin"}, {"authorId":
      "51910553", "name": "Katarina M Liberatore"}, {"authorId": "1931600430", "name":
      "Danielle K Bulaon"}, {"authorId": "4306515", "name": "Edward R. Kastenhuber"},
      {"authorId": "2042047500", "name": "Marisa Mercadante"}, {"authorId": "2042286049",
      "name": "Kripa Shobana-Ganesh"}, {"authorId": "2109324253", "name": "Long He"},
      {"authorId": "46462360", "name": "R. Schwartz"}, {"authorId": "47336157", "name":
      "Shuibing Chen"}, {"authorId": "50028113", "name": "H. Weinstein"}, {"authorId":
      "1513334045", "name": "O. Elemento"}, {"authorId": "6016224", "name": "E. Piskounova"},
      {"authorId": "1422205499", "name": "Benjamin E. Nilsson-Payant"}, {"authorId":
      "2123198", "name": "Gina Lee"}, {"authorId": "66419419", "name": "Joseph D.
      Trimarco"}, {"authorId": "2042240908", "name": "Kaitlyn N Burke"}, {"authorId":
      "30094094", "name": "C. Hamele"}, {"authorId": "6181769", "name": "Ryan R. Chaparian"},
      {"authorId": "16048806", "name": "Alfred T. Harding"}, {"authorId": "47203895",
      "name": "A. Tata"}, {"authorId": "8361947", "name": "Xinyu Zhu"}, {"authorId":
      "38101990", "name": "P. R. Tata"}, {"authorId": "2110209555", "name": "Clare
      M. Smith"}, {"authorId": "6536164", "name": "A. Possemato"}, {"authorId": "48769916",
      "name": "S. Tkachev"}, {"authorId": "46627576", "name": "P. Hornbeck"}, {"authorId":
      "4424720", "name": "S. Beausoleil"}, {"authorId": "48361643", "name": "Shankara
      K. Anand"}, {"authorId": "48975912", "name": "F. Aguet"}, {"authorId": "2110594",
      "name": "G. Getz"}, {"authorId": "35178796", "name": "A. Davidson"}, {"authorId":
      "4107601", "name": "K. Heesom"}, {"authorId": "2042810306", "name": "M. Kavanagh-Williamson"},
      {"authorId": "145133405", "name": "D. Matthews"}, {"authorId": "5462120", "name":
      "B. tenOever"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4037343", "name": "J. Blenis"}, {"authorId": "35057532", "name": "Nicholas
      S. Heaton"}]}, {"paperId": "401cc9b7849e2c20c2f7dbe227945550f7f704e9", "externalIds":
      {"DOI": "10.1038/s41586-020-2901-9", "CorpusId": 256822086}, "corpusId": 256822086,
      "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature",
      "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls":
      ["http://www.nature.com/nature/", "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/401cc9b7849e2c20c2f7dbe227945550f7f704e9",
      "title": "Identification of SARS-CoV-2 inhibitors using lung and colonic organoids",
      "abstract": null, "venue": "Nature", "year": 2020, "referenceCount": 29, "citationCount":
      27, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.nature.com/articles/s41586-020-2901-9.pdf", "status": null}, "fieldsOfStudy":
      null, "s2FieldsOfStudy": [{"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Environmental
      Science", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2020-10-28", "journal": {"volume": "589", "pages": "270 - 275", "name": "Nature"},
      "citationStyles": {"bibtex": "@Article{Han2020IdentificationOS,\n author = {Yuling
      Han and Xiaohua Duan and Liuliu Yang and Benjamin E. Nilsson-Payant and Pengfei
      Wang and Fuyu Duan and Xuming Tang and Tomer M. Yaron and Tuo Zhang and S. Uhl
      and Y. Bram and Chanel Richardson and Jiajun Zhu and Zeping Zhao and D. Redmond
      and S. Houghton and Duc-Huy T. Nguyen and Dong-Li Xu and Xing Wang and J. Jessurun
      and A. Borczuk and Yaoxing Huang and Jared L. Johnson and Yuru Liu and J. Xiang
      and Hui Wang and L. Cantley and B. tenOever and D. Ho and F. C. Pan and T. Evans
      and H. Chen and R. Schwartz and Shuibing Chen},\n booktitle = {Nature},\n journal
      = {Nature},\n pages = {270 - 275},\n title = {Identification of SARS-CoV-2 inhibitors
      using lung and colonic organoids},\n volume = {589},\n year = {2020}\n}\n"},
      "authors": [{"authorId": "1678087048", "name": "Yuling Han"}, {"authorId": "8121194",
      "name": "Xiaohua Duan"}, {"authorId": "1733349662", "name": "Liuliu Yang"},
      {"authorId": "1422205499", "name": "Benjamin E. Nilsson-Payant"}, {"authorId":
      "152702655", "name": "Pengfei Wang"}, {"authorId": "8751560", "name": "Fuyu
      Duan"}, {"authorId": "1687775322", "name": "Xuming Tang"}, {"authorId": "5247030",
      "name": "Tomer M. Yaron"}, {"authorId": "40543563", "name": "Tuo Zhang"}, {"authorId":
      "88725738", "name": "S. Uhl"}, {"authorId": "4785493", "name": "Y. Bram"}, {"authorId":
      "2006900424", "name": "Chanel Richardson"}, {"authorId": "2144872721", "name":
      "Jiajun Zhu"}, {"authorId": "2186108428", "name": "Zeping Zhao"}, {"authorId":
      "2067971033", "name": "D. Redmond"}, {"authorId": "145731038", "name": "S. Houghton"},
      {"authorId": "50652368", "name": "Duc-Huy T. Nguyen"}, {"authorId": "48207902",
      "name": "Dong-Li Xu"}, {"authorId": "2144803226", "name": "Xing Wang"}, {"authorId":
      "3503076", "name": "J. Jessurun"}, {"authorId": "3177215", "name": "A. Borczuk"},
      {"authorId": "2108678622", "name": "Yaoxing Huang"}, {"authorId": "145916288",
      "name": "Jared L. Johnson"}, {"authorId": "47909573", "name": "Yuru Liu"}, {"authorId":
      "2236077469", "name": "J. Xiang"}, {"authorId": "2113635227", "name": "Hui Wang"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5462120", "name":
      "B. tenOever"}, {"authorId": "2105307558", "name": "D. Ho"}, {"authorId": "34160280",
      "name": "F. C. Pan"}, {"authorId": "144263094", "name": "T. Evans"}, {"authorId":
      "2145302790", "name": "H. Chen"}, {"authorId": "2168670973", "name": "R. Schwartz"},
      {"authorId": "47336157", "name": "Shuibing Chen"}]}, {"paperId": "44afbde776b7519a22a73725a55c07ffc36e418b",
      "externalIds": {"MAG": "3013488946", "DOI": "10.1158/1538-7445.sabcs19-p3-03-01",
      "CorpusId": 216169805}, "corpusId": 216169805, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/44afbde776b7519a22a73725a55c07ffc36e418b",
      "title": "Abstract P3-03-01: DoublePIK3CAmutations incisdrive oncogene addiction
      and enhance sensitivity to PI3K alpha inhibitors in breast cancer", "abstract":
      "Activating mutations in PIK3CA, the gene coding for the catalytic subunit (p110\u03b1)
      of phosphoinositide-3-kinase (PI3K), are the most frequent oncogenic alterations
      in estrogen receptor-positive (ER+) breast cancer and are also prevalent in
      other tumor types. PI3K\u03b1 inhibitors including alpelisib have recently been
      shown to be clinically active in ER+ PIK3CA mutant breast cancer. To characterize
      determinants of sensitivity to these agents, we undertook a comprehensive analysis
      of PIK3CA mutant cancer genomes and observed the presence of double PIK3CA mutations
      in 12-15% of breast cancer and other tumor types. These double PIK3CA mutations
      are clonal, located in cis on the same allele, and are composed of a single
      hotspot mutation combined with a recurrent second-site mutation. Double PIK3CA
      mutations in cis result in increased PI3K activity and downstream signaling
      together with enhanced cell proliferation and tumor growth compared to single
      hotspot mutations. The biochemical mechanisms underlying this increased oncogenicity
      include increased disruption of p110\u03b1 binding to the inhibitory subunit
      p85\u03b1, which relieves its catalytic inhibition, and increased membrane lipid
      binding. Finally, these double PIK3CA mutations predict for increased sensitivity
      to PI3K\u03b1 inhibitors compared to single hotspot mutations (e.g. E545K or
      H1047R) in experimental models and in patients with ER+ PIK3CA mutant metastatic
      breast cancer from the SANDPIPER randomized phase III clinical trial. These
      findings implicate double PIK3CA mutations in cis as a novel mechanism of oncogene
      addiction relative to single hotspot mutations, providing a rationale to develop
      PI3K\u03b1 inhibitors for the therapy of double PIK3CA mutant cancers. Citation
      Format: Neil Vasan, Pedram Razavi, Jared L Johnson, Hong Shao, Timothy Wilson,
      Frauke Schimmoller, Hardik Shah, Alesia Antoine, Erik Ladewig, Alexander Gorelick,
      Ting-Yu Lin, Eneda Toska, Guotai Xu, Abiha Kazmi, Matthew T Chang, Barry S.
      Taylor, Maura N. Dickler, Komal Jhaveri, Sarat Chandarlapaty, Raul Rabadan,
      Ed Reznik, Melissa L Smith, Robert Sebra, Lori Friedman, Lewis C Cantley, Maurizio
      Scaltriti, Jose Baselga. Double PIK3CA mutations in cis drive oncogene addiction
      and enhance sensitivity to PI3K alpha inhibitors in breast cancer [abstract].
      In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14;
      San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract
      nr P3-03-01.", "venue": "", "year": 2020, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2020-02-15", "journal": {"volume": "80", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Vasan2020AbstractPD,\n author = {N. Vasan and P. Razavi
      and Jared L. Johnson and H. Shao and T. Wilson and F. Schimmoller and H. Shah
      and Alesia Antoine and Erik Ladewig and A. Gorelick and Ting-Yu Lin and Eneda
      Toska and Guotai Xu and Abiha Kazmi and Matthew T. Chang and B. Taylor and M.
      Dickler and K. Jhaveri and S. Chandarlapaty and R. Rabad\u00e1n and E. Reznik
      and M. Smith and R. Sebra and L. Friedman and L. Cantley and M. Scaltriti and
      J. Baselga},\n journal = {Cancer Research},\n title = {Abstract P3-03-01: DoublePIK3CAmutations
      incisdrive oncogene addiction and enhance sensitivity to PI3K alpha inhibitors
      in breast cancer},\n volume = {80},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "35123724", "name": "N. Vasan"}, {"authorId": "3224289", "name": "P. Razavi"},
      {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId": "2959236",
      "name": "H. Shao"}, {"authorId": "2017652", "name": "T. Wilson"}, {"authorId":
      "5323777", "name": "F. Schimmoller"}, {"authorId": "49820132", "name": "H. Shah"},
      {"authorId": "49335811", "name": "Alesia Antoine"}, {"authorId": "3139198",
      "name": "Erik Ladewig"}, {"authorId": "48892954", "name": "A. Gorelick"}, {"authorId":
      "144181325", "name": "Ting-Yu Lin"}, {"authorId": "4733908", "name": "Eneda
      Toska"}, {"authorId": "51290929", "name": "Guotai Xu"}, {"authorId": "150907238",
      "name": "Abiha Kazmi"}, {"authorId": "2141904248", "name": "Matthew T. Chang"},
      {"authorId": "36898514", "name": "B. Taylor"}, {"authorId": "4713308", "name":
      "M. Dickler"}, {"authorId": "47352468", "name": "K. Jhaveri"}, {"authorId":
      "6037809", "name": "S. Chandarlapaty"}, {"authorId": "40620158", "name": "R.
      Rabad\u00e1n"}, {"authorId": "145632788", "name": "E. Reznik"}, {"authorId":
      "2116670076", "name": "M. Smith"}, {"authorId": "46517710", "name": "R. Sebra"},
      {"authorId": "48530297", "name": "L. Friedman"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "8336319", "name": "M. Scaltriti"}, {"authorId":
      "144806171", "name": "J. Baselga"}]}, {"paperId": "6fbfc199c9508fc0a7f113a6b5477ac4ff463476",
      "externalIds": {"MAG": "3009258273", "DOI": "10.1038/s41574-020-0329-9", "CorpusId":
      211836188, "PubMed": "32127696"}, "corpusId": 211836188, "publicationVenue":
      {"id": "72983286-4c30-4ba6-b32a-33fb49586d6e", "name": "Nature Reviews Endocrinology",
      "type": "journal", "alternate_names": ["Nat Rev Endocrinol"], "issn": "1759-5029",
      "url": "http://www.nature.com/nrendo/", "alternate_urls": ["http://www.nature.com/nrendo/index.html"]},
      "url": "https://www.semanticscholar.org/paper/6fbfc199c9508fc0a7f113a6b5477ac4ff463476",
      "title": "Insulin\u2013PI3K signalling: an evolutionarily insulated metabolic
      driver of cancer", "abstract": null, "venue": "Nature Reviews Endocrinology",
      "year": 2020, "referenceCount": 84, "citationCount": 130, "influentialCitationCount":
      6, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "2020-03-03",
      "journal": {"volume": "16", "pages": "276-283", "name": "Nature Reviews Endocrinology"},
      "citationStyles": {"bibtex": "@Article{Hopkins2020InsulinPI3KSA,\n author =
      {B. Hopkins and M. Goncalves and L. Cantley},\n booktitle = {Nature Reviews
      Endocrinology},\n journal = {Nature Reviews Endocrinology},\n pages = {276-283},\n
      title = {Insulin\u2013PI3K signalling: an evolutionarily insulated metabolic
      driver of cancer},\n volume = {16},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "48821307", "name": "B. Hopkins"}, {"authorId": "145524334", "name": "M. Goncalves"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "7bc2772d879dea17c95f1a78285eabedf6c65c76",
      "externalIds": {"MAG": "3016653743", "DOI": "10.1021/acs.jmedchem.0c00227",
      "CorpusId": 215802532, "PubMed": "32298120"}, "corpusId": 215802532, "publicationVenue":
      {"id": "4cce60a8-2106-4240-bece-fb6488df6bd1", "name": "Journal of Medicinal
      Chemistry", "type": "journal", "alternate_names": ["J Med Chem"], "issn": "0022-2623",
      "url": "https://pubs.acs.org/journal/jmcmar", "alternate_urls": ["http://pubs.acs.org/journal/jmcmar",
      "http://pubs.acs.org/journals/jmcmar/index.html"]}, "url": "https://www.semanticscholar.org/paper/7bc2772d879dea17c95f1a78285eabedf6c65c76",
      "title": "Discovery and Structure-Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one
      Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase
      Inhibitors.", "abstract": "Due to their role in many important signaling pathways,
      phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are attractive targets
      for the development of experimental therapeutics for cancer, metabolic and immunological
      disorders. Recent efforts to develop small molecule inhibitors for these lipid
      kinases resulted in compounds with low- to sub-micromolar potencies. Here, we
      report the identification of CVM-05-002 using a high-throughput screen of PI5P4K\u03b1
      against our in-house kinase inhibitor library. CVM-05-002 is a potent and selective
      inhibitor of PI5P4Ks and a 1.7 \u00c5 X-ray structure reveals its binding interactions
      in the ATP-binding pocket. Further investigation of the structure-activity relationship
      led to the development of compound 13, replacing the rhodanine-like moiety present
      in CVM-05-002 with an indole, a potent pan-PI5P4K inhibitor with excellent kinome-wide
      selectivity. Finally, we employed isothermal cellular thermal shift assays (CETSAs)
      to demonstrate effective cellular target engagement of PI5P4K\u03b1 and -\u03b2
      by the inhibitors in HEK 293T cells.", "venue": "Journal of Medicinal Chemistry",
      "year": 2020, "referenceCount": 45, "citationCount": 17, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2020-04-16", "journal": {"name": "Journal
      of medicinal chemistry"}, "citationStyles": {"bibtex": "@Article{Manz2020DiscoveryAS,\n
      author = {Theresa D. Manz and S. Sivakumaren and F. Ferguson and Tinghu Zhang
      and Adam Yasgar and H. Seo and S. Ficarro and Joseph D. Card and Hyeseok Shim
      and Chandrasekhar V. Miduturu and A. Simeonov and M. Shen and J. Marto and S.
      Dhe-Paganon and M. Hall and L. Cantley and N. Gray},\n booktitle = {Journal
      of Medicinal Chemistry},\n journal = {Journal of medicinal chemistry},\n title
      = {Discovery and Structure-Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one
      Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase
      Inhibitors.},\n year = {2020}\n}\n"}, "authors": [{"authorId": "16018077", "name":
      "Theresa D. Manz"}, {"authorId": "6443517", "name": "S. Sivakumaren"}, {"authorId":
      "11404167", "name": "F. Ferguson"}, {"authorId": "2262535", "name": "Tinghu
      Zhang"}, {"authorId": "6707118", "name": "Adam Yasgar"}, {"authorId": "91486080",
      "name": "H. Seo"}, {"authorId": "2297254", "name": "S. Ficarro"}, {"authorId":
      "5223652", "name": "Joseph D. Card"}, {"authorId": "13574443", "name": "Hyeseok
      Shim"}, {"authorId": "5861054", "name": "Chandrasekhar V. Miduturu"}, {"authorId":
      "145183304", "name": "A. Simeonov"}, {"authorId": "145829790", "name": "M. Shen"},
      {"authorId": "2605597", "name": "J. Marto"}, {"authorId": "1400570681", "name":
      "S. Dhe-Paganon"}, {"authorId": "143999402", "name": "M. Hall"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "3977406", "name": "N. Gray"}]},
      {"paperId": "7c7cd2df56ea3c778bae9b69142bf284398a036d", "externalIds": {"MAG":
      "3097576427", "PubMedCentral": "7599336", "DOI": "10.1038/s41467-020-19291-x",
      "CorpusId": 226219046, "PubMed": "33127913"}, "corpusId": 226219046, "publicationVenue":
      {"id": "43b3f0f9-489a-4566-8164-02fafde3cd98", "name": "Nature Communications",
      "type": "journal", "alternate_names": ["Nat Commun"], "issn": "2041-1723", "url":
      "https://www.nature.com/ncomms/", "alternate_urls": ["http://www.nature.com/ncomms/about/index.html",
      "http://www.nature.com/ncomms/index.html"]}, "url": "https://www.semanticscholar.org/paper/7c7cd2df56ea3c778bae9b69142bf284398a036d",
      "title": "Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and
      promotes antiestrogen resistance in breast cancer", "abstract": null, "venue":
      "Nature Communications", "year": 2020, "referenceCount": 65, "citationCount":
      27, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.nature.com/articles/s41467-020-19291-x.pdf", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2020-10-30", "journal":
      {"volume": "11", "name": "Nature Communications"}, "citationStyles": {"bibtex":
      "@Article{Lee2020ProlineR1,\n author = {Kyung-min Lee and A. Guerrero-Zotano
      and A. Servetto and D. Sudhan and Chang-Ching Lin and L. Formisano and V. Jansen
      and Paula I. Gonzalez-Ericsson and M. Sanders and T. Stricker and G. Raj and
      K. Dean and R. Fiolka and L. Cantley and A. Hanker and C. Arteaga},\n booktitle
      = {Nature Communications},\n journal = {Nature Communications},\n title = {Proline
      rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen
      resistance in breast cancer},\n volume = {11},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "46542827", "name": "Kyung-min Lee"}, {"authorId": "1403641116",
      "name": "A. Guerrero-Zotano"}, {"authorId": "5294693", "name": "A. Servetto"},
      {"authorId": "6577378", "name": "D. Sudhan"}, {"authorId": "123260589", "name":
      "Chang-Ching Lin"}, {"authorId": "40940752", "name": "L. Formisano"}, {"authorId":
      "144653026", "name": "V. Jansen"}, {"authorId": "1400994437", "name": "Paula
      I. Gonzalez-Ericsson"}, {"authorId": "46945931", "name": "M. Sanders"}, {"authorId":
      "47705275", "name": "T. Stricker"}, {"authorId": "2445482", "name": "G. Raj"},
      {"authorId": "2084800", "name": "K. Dean"}, {"authorId": "50572665", "name":
      "R. Fiolka"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5872582",
      "name": "A. Hanker"}, {"authorId": "2057460", "name": "C. Arteaga"}]}, {"paperId":
      "873b1457f2251650f556603b81cf77bd0d3e1274", "externalIds": {"MAG": "3093156639",
      "PubMedCentral": "7608751", "DOI": "10.1101/gad.341545.120", "CorpusId": 222835739,
      "PubMed": "33060135"}, "corpusId": 222835739, "publicationVenue": {"id": "94df828d-8411-48df-8aec-f13101ebb8f4",
      "name": "Genes & Development", "type": "journal", "alternate_names": ["Gene  Dev"],
      "issn": "0890-9369", "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=101",
      "alternate_urls": ["http://www.genesdev.org/", "http://genesdev.cshlp.org/"]},
      "url": "https://www.semanticscholar.org/paper/873b1457f2251650f556603b81cf77bd0d3e1274",
      "title": "Selective inhibition of CDK7 reveals high-confidence targets and new
      models for TFIIH function in transcription", "abstract": "In this study, Rimel
      et al. set out to investigate the roles of CDK7 in transcription. Using SILAC-based
      phosphoproteomics with transcriptomics and biochemical assays, the authors identified
      high-confidence CDK7 substrates, a surprisingly widespread requirement for CDK7
      activity in splicing, and unexpected aspects of CDK7 kinase regulation that
      involve its association with TFIIH.", "venue": "Genes & Development", "year":
      2020, "referenceCount": 82, "citationCount": 45, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "http://genesdev.cshlp.org/content/34/21-22/1452.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-10-15", "journal": {"volume": "34", "pages": "1452
      - 1473", "name": "Genes & Development"}, "citationStyles": {"bibtex": "@Article{Rimel2020SelectiveIO,\n
      author = {Jenna K. Rimel and Zachary C. Poss and Benjamin Erickson and Zachary
      L. Maas and Christopher C. Ebmeier and Jared L. Johnson and T. Decker and Tomer
      M. Yaron and M. Bradley and Kristin B. Hamman and Shanhu Hu and G. Malojcic
      and J. Marineau and P. White and M. Brault and L. Tao and Patrick DeRoy and
      Christian Clavette and Shraddha Nayak and Leah J. Damon and I. H. Kaltheuner
      and Heeyoun Bunch and L. Cantley and M. Geyer and J. Iwasa and R. Dowell and
      D. Bentley and W. Old and D. Taatjes},\n booktitle = {Genes & Development},\n
      journal = {Genes & Development},\n pages = {1452 - 1473},\n title = {Selective
      inhibition of CDK7 reveals high-confidence targets and new models for TFIIH
      function in transcription},\n volume = {34},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "46200980", "name": "Jenna K. Rimel"}, {"authorId": "6748388",
      "name": "Zachary C. Poss"}, {"authorId": "47130731", "name": "Benjamin Erickson"},
      {"authorId": "1581339333", "name": "Zachary L. Maas"}, {"authorId": "5254479",
      "name": "Christopher C. Ebmeier"}, {"authorId": "145916288", "name": "Jared
      L. Johnson"}, {"authorId": "144829833", "name": "T. Decker"}, {"authorId": "5247030",
      "name": "Tomer M. Yaron"}, {"authorId": "49651964", "name": "M. Bradley"}, {"authorId":
      "47246659", "name": "Kristin B. Hamman"}, {"authorId": "10193089", "name": "Shanhu
      Hu"}, {"authorId": "3743925", "name": "G. Malojcic"}, {"authorId": "4705135",
      "name": "J. Marineau"}, {"authorId": "32075599", "name": "P. White"}, {"authorId":
      "92643932", "name": "M. Brault"}, {"authorId": "15250512", "name": "L. Tao"},
      {"authorId": "11578215", "name": "Patrick DeRoy"}, {"authorId": "13409612",
      "name": "Christian Clavette"}, {"authorId": "1381646273", "name": "Shraddha
      Nayak"}, {"authorId": "5924419", "name": "Leah J. Damon"}, {"authorId": "1739105914",
      "name": "I. H. Kaltheuner"}, {"authorId": "4215426", "name": "Heeyoun Bunch"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1882871", "name":
      "M. Geyer"}, {"authorId": "33181582", "name": "J. Iwasa"}, {"authorId": "31600919",
      "name": "R. Dowell"}, {"authorId": "39787128", "name": "D. Bentley"}, {"authorId":
      "48892914", "name": "W. Old"}, {"authorId": "34762957", "name": "D. Taatjes"}]},
      {"paperId": "8912d86e4aaec13eef3fbaf0af7b2ae2b8882298", "externalIds": {"MAG":
      "3023156490", "DOI": "10.1074/jbc.RA119.012425", "CorpusId": 217546560, "PubMed":
      "32350110"}, "corpusId": 217546560, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/8912d86e4aaec13eef3fbaf0af7b2ae2b8882298",
      "title": "Phosphorylation-dependent substrate selectivity of protein kinase
      B (AKT1)", "abstract": "Protein kinase B (AKT1) is a central node in a signaling
      pathway that regulates cell survival. The diverse pathways regulated by AKT1
      are communicated in the cell via the phosphorylation of perhaps more than 100
      cellular substrates. AKT1 is itself activated by phosphorylation at Thr-308
      and Ser-473. Despite the fact that these phosphorylation sites are biomarkers
      for cancers and tumor biology, their individual roles in shaping AKT1 substrate
      selectivity are unknown. We recently developed a method to produce AKT1 with
      programmed phosphorylation at either or both of its key regulatory sites. Here,
      we used both defined and randomized peptide libraries to map the substrate selectivity
      of site-specific, singly and doubly phosphorylated AKT1 variants. To globally
      quantitate AKT1 substrate preferences, we synthesized three AKT1 substrate peptide
      libraries: one based on 84 \u201cknown\u201d substrates and two independent
      and larger oriented peptide array libraries (OPALs) of \u223c1011 peptides each.
      We found that each phospho-form of AKT1 has common and distinct substrate requirements.
      Compared with pAKT1T308, the addition of Ser-473 phosphorylation increased AKT1
      activities on some, but not all of its substrates. This is the first report
      that Ser-473 phosphorylation can positively or negatively regulate kinase activity
      in a substrate-dependent fashion. Bioinformatics analysis indicated that the
      OPAL-activity data effectively discriminate known AKT1 substrates from closely
      related kinase substrates. Our results also enabled predictions of novel AKT1
      substrates that suggest new and expanded roles for AKT1 signaling in regulating
      cellular processes.", "venue": "Journal of Biological Chemistry", "year": 2020,
      "referenceCount": 63, "citationCount": 29, "influentialCitationCount": 1, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925817494026/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-04-29", "journal": {"volume": "295", "pages": "8120
      - 8134", "name": "The Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Balasuriya2020PhosphorylationdependentSS,\n author = {Nileeka Balasuriya
      and Norman E. Davey and Jared L. Johnson and Huadong Liu and K. Biggar and L.
      Cantley and S. Li and P. O''Donoghue},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {8120
      - 8134},\n title = {Phosphorylation-dependent substrate selectivity of protein
      kinase B (AKT1)},\n volume = {295},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "51073035", "name": "Nileeka Balasuriya"}, {"authorId": "2084912", "name": "Norman
      E. Davey"}, {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId":
      "46935668", "name": "Huadong Liu"}, {"authorId": "1772313", "name": "K. Biggar"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1854738", "name":
      "S. Li"}, {"authorId": "1398307288", "name": "P. O''Donoghue"}]}, {"paperId":
      "90be5bf5e637e5434b8daebf4a40f52dad76fa47", "externalIds": {"DOI": "10.1038/s41586-020-2630-0",
      "CorpusId": 256820079}, "corpusId": 256820079, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/90be5bf5e637e5434b8daebf4a40f52dad76fa47",
      "title": "Age-induced accumulation of methylmalonic acid promotes tumour progression",
      "abstract": null, "venue": "Nature", "year": 2020, "referenceCount": 43, "citationCount":
      3, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://lirias.kuleuven.be/bitstream/123456789/661819/2/2020.06.04.135087v1.full.pdf",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Environmental Science", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2020-08-19", "journal": {"volume": "585", "pages": "283
      - 287", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Gomes2020AgeinducedAO,\n
      author = {Ana P. Gomes and Didem Ilter and V. Low and J. Endress and J. Fern\u00e1ndez-Garc\u00eda
      and Adam Rosenzweig and Tanya Schild and D. Broekaert and Adnan Ahmed and M.
      Planque and Ilaria Elia and Julie Han and Charles G. Kinzig and Edouard Mullarky
      and A. Mutvei and J. Asara and R. de Cabo and L. Cantley and Noah E. Dephoure
      and S. Fendt and J. Blenis},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {283 - 287},\n title = {Age-induced accumulation of methylmalonic acid
      promotes tumour progression},\n volume = {585},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "2087116099", "name": "Ana P. Gomes"}, {"authorId": "3324022",
      "name": "Didem Ilter"}, {"authorId": "121128193", "name": "V. Low"}, {"authorId":
      "83689245", "name": "J. Endress"}, {"authorId": "52621189", "name": "J. Fern\u00e1ndez-Garc\u00eda"},
      {"authorId": "1887417083", "name": "Adam Rosenzweig"}, {"authorId": "50356549",
      "name": "Tanya Schild"}, {"authorId": "11236293", "name": "D. Broekaert"}, {"authorId":
      "1887422976", "name": "Adnan Ahmed"}, {"authorId": "8444258", "name": "M. Planque"},
      {"authorId": "2382021", "name": "Ilaria Elia"}, {"authorId": "1886508939", "name":
      "Julie Han"}, {"authorId": "1887752916", "name": "Charles G. Kinzig"}, {"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "5135907", "name": "A.
      Mutvei"}, {"authorId": "1394348007", "name": "J. Asara"}, {"authorId": "144285023",
      "name": "R. de Cabo"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4622316", "name": "Noah E. Dephoure"}, {"authorId": "46775302", "name": "S.
      Fendt"}, {"authorId": "4037343", "name": "J. Blenis"}]}, {"paperId": "abd557840e492110cdff0885d3c40e5c4d27945a",
      "externalIds": {"MAG": "3035766511", "DOI": "10.1158/2159-8290.CD-19-1228",
      "CorpusId": 219988633, "PubMed": "32571778"}, "corpusId": 219988633, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/abd557840e492110cdff0885d3c40e5c4d27945a",
      "title": "Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity
      to PHGDH Inhibition.", "abstract": "A hallmark of metastasis is the adaptation
      of tumor cells to new environments. Metabolic constraints imposed by the serine
      and glycine-limited brain environment restrict metastatic tumor growth. How
      brain metastases overcome these growth-prohibitive conditions is poorly understood.
      Here, we demonstrate that 3-phosphoglycerate dehydrogenase (PHGDH), which catalyzes
      the rate-limiting step of glucose-derived serine synthesis, is a major determinant
      of brain metastasis in multiple human cancer types and preclinical models. Enhanced
      serine synthesis proved important for nucleotide production and cell proliferation
      in highly aggressive brain metastatic cells. In vivo, genetic suppression and
      pharmacological inhibition of PHGDH attenuated brain metastasis, but not extracranial
      tumor growth, and improved overall survival in mice. These results reveal that
      extracellular amino acid availability determines serine synthesis pathway dependence,
      and suggests that PHGDH inhibitors may be useful in the treatment of brain metastasis.",
      "venue": "Cancer Discovery", "year": 2020, "referenceCount": 94, "citationCount":
      118, "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://cancerdiscovery.aacrjournals.org/content/candisc/10/9/1352.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Environmental Science", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2020-06-22", "journal": {"name": "Cancer discovery"}, "citationStyles": {"bibtex":
      "@Article{Ngo2020LimitedES,\n author = {B. Ngo and Eugenie Kim and Victoria
      Osorio-Vasquez and S. Doll and Sophia Bustraan and R. Liang and Alba Luengo
      and S. Davidson and A. Ali and G. Ferraro and Grant M Fischer and Roozbeh Eskandari
      and Diane Kang and Jing Ni and Ariana Plasger and Vinagolu K. Rajasekhar and
      Edward R. Kastenhuber and Sarah Bacha and Roshan K. Sriram and Benjamin D. Stein
      and S. Bakhoum and M. Snuderl and P. Cotzia and J. Healey and N. Mainolfi and
      Vipin Suri and Adam J. Friedman and M. Manfredi and D. Sabatini and Drew R.
      Jones and Min Yu and Jean J. Zhao and R. Jain and K. Keshari and M. Davies and
      M. V. Vander Heiden and E. Hernando and M. Mann and L. Cantley and M. Pacold},\n
      booktitle = {Cancer Discovery},\n journal = {Cancer discovery},\n title = {Limited
      Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH
      Inhibition.},\n year = {2020}\n}\n"}, "authors": [{"authorId": "5891999", "name":
      "B. Ngo"}, {"authorId": "115819822", "name": "Eugenie Kim"}, {"authorId": "1600811114",
      "name": "Victoria Osorio-Vasquez"}, {"authorId": "50535810", "name": "S. Doll"},
      {"authorId": "1600820777", "name": "Sophia Bustraan"}, {"authorId": "46875693",
      "name": "R. Liang"}, {"authorId": "114311983", "name": "Alba Luengo"}, {"authorId":
      "34711277", "name": "S. Davidson"}, {"authorId": "2157679423", "name": "A. Ali"},
      {"authorId": "35545769", "name": "G. Ferraro"}, {"authorId": "26984663", "name":
      "Grant M Fischer"}, {"authorId": "6108327", "name": "Roozbeh Eskandari"}, {"authorId":
      "8118329", "name": "Diane Kang"}, {"authorId": "1776165", "name": "Jing Ni"},
      {"authorId": "1600820946", "name": "Ariana Plasger"}, {"authorId": "5734623",
      "name": "Vinagolu K. Rajasekhar"}, {"authorId": "4306515", "name": "Edward R.
      Kastenhuber"}, {"authorId": "145170581", "name": "Sarah Bacha"}, {"authorId":
      "49408849", "name": "Roshan K. Sriram"}, {"authorId": "40353456", "name": "Benjamin
      D. Stein"}, {"authorId": "3543494", "name": "S. Bakhoum"}, {"authorId": "3579975",
      "name": "M. Snuderl"}, {"authorId": "10371243", "name": "P. Cotzia"}, {"authorId":
      "1846047", "name": "J. Healey"}, {"authorId": "10006170", "name": "N. Mainolfi"},
      {"authorId": "2272920", "name": "Vipin Suri"}, {"authorId": "2054407866", "name":
      "Adam J. Friedman"}, {"authorId": "47769189", "name": "M. Manfredi"}, {"authorId":
      "1843680", "name": "D. Sabatini"}, {"authorId": "151477189", "name": "Drew R.
      Jones"}, {"authorId": "145684949", "name": "Min Yu"}, {"authorId": "50985038",
      "name": "Jean J. Zhao"}, {"authorId": "32514332", "name": "R. Jain"}, {"authorId":
      "5460116", "name": "K. Keshari"}, {"authorId": "2172770398", "name": "M. Davies"},
      {"authorId": "3804233", "name": "M. V. Vander Heiden"}, {"authorId": "4586359",
      "name": "E. Hernando"}, {"authorId": "144979479", "name": "M. Mann"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5141475", "name": "M. Pacold"}]},
      {"paperId": "b047faadd4ccc0e48f819dcea00523bd9e3c22dd", "externalIds": {"MAG":
      "2985842281", "DOI": "10.1021/acsmedchemlett.9b00402", "CorpusId": 209581796,
      "PubMed": "32184968"}, "corpusId": 209581796, "publicationVenue": {"id": "513ddb82-8e57-474b-852a-bae692e8ebfa",
      "name": "ACS Medicinal Chemistry Letters", "type": "journal", "alternate_names":
      ["AC Med Chem Lett"], "issn": "1948-5875", "url": "https://pubs.acs.org/journal/amclct",
      "alternate_urls": ["https://pubs.acs.org/loi/amclct", "http://pubs.acs.org/journal/amclct"]},
      "url": "https://www.semanticscholar.org/paper/b047faadd4ccc0e48f819dcea00523bd9e3c22dd",
      "title": "Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol
      5-Phosphate 4-Kinase Inhibitors.", "abstract": "Phosphatidylinositol 5-phosphate
      4-kinases (PI5P4Ks) are important molecular players in a variety of diseases,
      such as cancer. Currently available PI5P4K inhibitors are reversible small molecules,
      which may lack selectivity and sufficient cellular on-target activity. In this
      study, we present a new class of covalent pan-PI5P4K inhibitors with potent
      biochemical and cellular activity. Our designs are based on THZ-P1-2, a covalent
      PI5P4K inhibitor previously developed in our lab. Here, we report further structure-guided
      optimization and structure-activity relationship (SAR) study of this scaffold,
      resulting in compound 30, which retained biochemical and cellular potency, while
      demonstrating a significantly improved selectivity profile. Furthermore, we
      confirm that the inhibitors show efficient binding affinity in the context of
      HEK 293T cells using isothermal CETSA methods. Taken together, compound 30 represents
      a highly selective pan-PI5P4K covalent lead molecule.", "venue": "ACS Medicinal
      Chemistry Letters", "year": 2020, "referenceCount": 34, "citationCount": 13,
      "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Chemistry", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2020-03-12", "journal": {"volume": "11 3", "pages": "\n          346-352\n        ",
      "name": "ACS medicinal chemistry letters"}, "citationStyles": {"bibtex": "@Article{Manz2020StructureActivityRS,\n
      author = {Theresa D. Manz and S. Sivakumaren and Adam Yasgar and M. Hall and
      Mindy I. Davis and H. Seo and Joseph D. Card and S. Ficarro and Hyeseok Shim
      and J. Marto and S. Dhe-Paganon and A. Sasaki and M. Boxer and A. Simeonov and
      L. Cantley and M. Shen and Tinghu Zhang and F. Ferguson and N. Gray},\n booktitle
      = {ACS Medicinal Chemistry Letters},\n journal = {ACS medicinal chemistry letters},\n
      pages = {\n          346-352\n        },\n title = {Structure-Activity Relationship
      Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors.},\n
      volume = {11 3},\n year = {2020}\n}\n"}, "authors": [{"authorId": "16018077",
      "name": "Theresa D. Manz"}, {"authorId": "6443517", "name": "S. Sivakumaren"},
      {"authorId": "6707118", "name": "Adam Yasgar"}, {"authorId": "143999402", "name":
      "M. Hall"}, {"authorId": "29195749", "name": "Mindy I. Davis"}, {"authorId":
      "91486080", "name": "H. Seo"}, {"authorId": "5223652", "name": "Joseph D. Card"},
      {"authorId": "2297254", "name": "S. Ficarro"}, {"authorId": "13574443", "name":
      "Hyeseok Shim"}, {"authorId": "2605597", "name": "J. Marto"}, {"authorId": "1400570681",
      "name": "S. Dhe-Paganon"}, {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId":
      "3275486", "name": "M. Boxer"}, {"authorId": "145183304", "name": "A. Simeonov"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "145829790", "name":
      "M. Shen"}, {"authorId": "2262535", "name": "Tinghu Zhang"}, {"authorId": "11404167",
      "name": "F. Ferguson"}, {"authorId": "3977406", "name": "N. Gray"}]}, {"paperId":
      "b079b2292a25c9f6e73634ccd1746f2187694e00", "externalIds": {"MAG": "3004455455",
      "PubMedCentral": "7021536", "DOI": "10.1016/j.gore.2020.100546", "CorpusId":
      211213044, "PubMed": "32083163"}, "corpusId": 211213044, "publicationVenue":
      {"id": "753bdea8-6488-43c7-89cf-6a9f5897123c", "name": "Gynecologic Oncology
      Reports", "type": "journal", "alternate_names": ["Gynecologic oncology reports",
      "Gynecol oncol rep", "Gynecol Oncol Rep"], "issn": "2352-5789", "url": "https://www.journals.elsevier.com/gynecologic-oncology-reports/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/23525789"]},
      "url": "https://www.semanticscholar.org/paper/b079b2292a25c9f6e73634ccd1746f2187694e00",
      "title": "Results of an abbreviated phase II study of AKT inhibitor MK-2206
      in the treatment of recurrent platinum-resistant high grade serous ovarian,
      fallopian tube, or primary peritoneal carcinoma (NCT 01283035)", "abstract":
      null, "venue": "Gynecologic Oncology Reports", "year": 2020, "referenceCount":
      17, "citationCount": 8, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["CaseReport"], "publicationDate": "2020-02-03", "journal":
      {"volume": "32", "name": "Gynecologic Oncology Reports"}, "citationStyles":
      {"bibtex": "@Article{Lee2020ResultsOA,\n author = {Elizabeth K. Lee and Z. Tan-Wasielewski
      and C. Aghajanian and R. Coleman and J. Curtis and M. Hirsch and U. Matulonis
      and L. Cantley and G. Mills and L. Doyle and Joyce F. Liu},\n booktitle = {Gynecologic
      Oncology Reports},\n journal = {Gynecologic Oncology Reports},\n title = {Results
      of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of
      recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary
      peritoneal carcinoma (NCT 01283035)},\n volume = {32},\n year = {2020}\n}\n"},
      "authors": [{"authorId": "50288013", "name": "Elizabeth K. Lee"}, {"authorId":
      "1418847559", "name": "Z. Tan-Wasielewski"}, {"authorId": "6128162", "name":
      "C. Aghajanian"}, {"authorId": "3124983", "name": "R. Coleman"}, {"authorId":
      "49142258", "name": "J. Curtis"}, {"authorId": "2319517", "name": "M. Hirsch"},
      {"authorId": "6927295", "name": "U. Matulonis"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2241330", "name": "G. Mills"}, {"authorId": "39667616",
      "name": "L. Doyle"}, {"authorId": "2108419806", "name": "Joyce F. Liu"}]}, {"paperId":
      "b3b924c016dde2d1b35e319ac00f9f4098297de0", "externalIds": {"MAG": "3091931150",
      "DOI": "10.1158/1557-3125.PI3K-MTOR18-IA12", "CorpusId": 225165638}, "corpusId":
      225165638, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/b3b924c016dde2d1b35e319ac00f9f4098297de0",
      "title": "Abstract IA12: Coordination of mRNA processing, translation, and metabolism
      by mTORC1", "abstract": "The mTOR complex 1 (mTORC1)\u2013S6 protein kinase
      (S6K1) signaling pathway has evolved to sense and respond to changes in growth
      factor and hormone-dependent signaling, cellular energy status, nutrient availability,
      and surrounding oxygen concentrations. A major mechanism through which mTOR
      regulates downstream processes is via the coordinated regulation of gene expression,
      mRNA biogenesis, protein synthesis, and protein degradation. I will discuss
      our studies linking mTORC1/S6K1 to mRNA processing, metabolism, and cancer progression.
      Citation Format: John Blenis, Gina Lee, Sungyun Cho, Yuxiang Zheng, Cholsoon
      Jang, Lew Cantley, Joshua Rabinowitz, Noah Dephoure. Coordination of mRNA processing,
      translation, and metabolism by mTORC1 [abstract]. In: Proceedings of the AACR
      Special Conference on Targeting PI3K/mTOR Signaling; 2018 Nov 30-Dec 8; Boston,
      MA. Philadelphia (PA): AACR; Mol Cancer Res 2020;18(10_Suppl):Abstract nr IA12.",
      "venue": "", "year": 2020, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2020-10-01", "journal": {"volume":
      "18", "name": "Molecular Cancer Research"}, "citationStyles": {"bibtex": "@Article{Blenis2020AbstractIC,\n
      author = {J. Blenis and Gina Lee and Sungyun Cho and Yuxiang Zheng and Cholsoon
      Jang and L. Cantley and J. Rabinowitz and Noah E. Dephoure},\n journal = {Molecular
      Cancer Research},\n title = {Abstract IA12: Coordination of mRNA processing,
      translation, and metabolism by mTORC1},\n volume = {18},\n year = {2020}\n}\n"},
      "authors": [{"authorId": "4037343", "name": "J. Blenis"}, {"authorId": "2123198",
      "name": "Gina Lee"}, {"authorId": "4051887", "name": "Sungyun Cho"}, {"authorId":
      "1723564", "name": "Yuxiang Zheng"}, {"authorId": "2131834", "name": "Cholsoon
      Jang"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "35264286",
      "name": "J. Rabinowitz"}, {"authorId": "4622316", "name": "Noah E. Dephoure"}]},
      {"paperId": "b6d957b5c6136940be6ca4a261c0bb0bdee47514", "externalIds": {"PubMedCentral":
      "7056863", "MAG": "3007653203", "DOI": "10.3389/fchem.2020.00147", "CorpusId":
      211518735, "PubMed": "32175313"}, "corpusId": 211518735, "publicationVenue":
      {"id": "7f0649e7-1c25-49d4-a210-6177946c6d4a", "name": "Frontiers in Chemistry",
      "type": "journal", "alternate_names": ["Front Chem"], "issn": "2296-2646", "url":
      "http://www.frontiersin.org/Chemistry", "alternate_urls": ["http://www.frontiersin.org/Chemistry/archive",
      "http://journal.frontiersin.org/journal/chemistry", "https://www.frontiersin.org/journals/chemistry"]},
      "url": "https://www.semanticscholar.org/paper/b6d957b5c6136940be6ca4a261c0bb0bdee47514",
      "title": "Development of a CDK10/CycM in vitro Kinase Screening Assay and Identification
      of First Small-Molecule Inhibitors", "abstract": "Cyclin-dependent kinases (CDKs)
      constitute a family of 20 serine/threonine protein kinases that play pivotal
      roles in the regulation of numerous important molecular and cellular processes.
      CDKs have long been considered promising therapeutic targets in a variety of
      pathologies, and the recent therapeutic success of CDK4/6 inhibitors in breast
      cancers has renewed interest in their therapeutic potential. Small-molecule
      inhibitors have been identified for every human CDK, except for CDK10. The only
      recent discovery of an activating cyclin (CycM) for CDK10 enabled us to identify
      its first phosphorylation substrates and gain insights into its biological functions.
      Yet, our knowledge of this kinase remains incomplete, despite it being the only
      member of its family that causes severe human developmental syndromes, when
      mutated either on the cyclin or the CDK moiety. CDK10 small-molecule inhibitors
      would be useful in exploring the functions of this kinase and gauging its potential
      as a therapeutic target for some cancers. Here, we report the identification
      of an optimized peptide phosphorylation substrate of CDK10/CycM and the development
      of the first homogeneous, miniaturized CDK10/CycM in vitro kinase assay. We
      reveal the ability of known CDK inhibitors, among which clinically tested SNS-032,
      riviciclib, flavopiridol, dinaciclib, AZD4573 and AT7519, to potently inhibit
      CDK10/CycM. We also show that NVP-2, a strong, remarkably selective CDK9 inhibitor
      is an equally potent CDK10/CycM inhibitor. Finally, we validate this kinase
      assay for applications in high-throughput screening campaigns to discover new,
      original CDK10 inhibitors.", "venue": "Frontiers in Chemistry", "year": 2020,
      "referenceCount": 46, "citationCount": 11, "influentialCitationCount": 1, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://www.frontiersin.org/articles/10.3389/fchem.2020.00147/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-02-27", "journal": {"volume": "8", "name": "Frontiers
      in Chemistry"}, "citationStyles": {"bibtex": "@Article{Robert2020DevelopmentOA,\n
      author = {Thomas Robert and Jared L. Johnson and Roxane Guichaoua and Tomer
      M. Yaron and S. Bach and L. Cantley and P. Colas},\n booktitle = {Frontiers
      in Chemistry},\n journal = {Frontiers in Chemistry},\n title = {Development
      of a CDK10/CycM in vitro Kinase Screening Assay and Identification of First
      Small-Molecule Inhibitors},\n volume = {8},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "144017436", "name": "Thomas Robert"}, {"authorId": "145916288",
      "name": "Jared L. Johnson"}, {"authorId": "1508394280", "name": "Roxane Guichaoua"},
      {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId": "39747539",
      "name": "S. Bach"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "8339673", "name": "P. Colas"}]}, {"paperId": "b704acbdf74290834c727ecd80dd2c86e1227c86",
      "externalIds": {"MAG": "3083160159", "DOI": "10.1158/1538-7445.am2020-ng16",
      "CorpusId": 225366119}, "corpusId": 225366119, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/b704acbdf74290834c727ecd80dd2c86e1227c86",
      "title": "Abstract NG16: DoublePIK3CAmutations incisincrease oncogenicity and
      sensitivity to PI3K\u03b1 inhibitors", "abstract": "PIK3CA is the most frequently
      mutated oncogene across all human cancers, and codes for p110\u03b1, the catalytic
      subunit of the PI3K complex. PI3K catalyzes the phosphorylation of the lipid
      PIP2 to PIP3, which initiates a downstream signaling cascade involving the activation
      of AKT and mTOR. Hotspot E545K and H1047R mutations constitutively activate
      PI3K and are oncogenic in multiple cancer histologies including breast cancer,
      where PIK3CA mutations are present in 40% of tumors and are a target for cancer
      therapy. Recently, the PI3K\u03b1 inhibitor alpelisib has demonstrated improved
      PFS in patients with ER+ PIK3CA mutant metastatic breast cancer on a phase 3
      randomized clinical trial, resulting in its FDA approval. In early clinical
      trials, we observed a population of patients with displayed prolonged clinical
      benefit to alpelisib, with double PIK3CA mutant tumors. This prompted us to
      undertake a comprehensive analysis of the prevalence of multiple PIK3CA mutations
      and to investigate their potential biological relevance and correlation with
      sensitivity to PI3K\u03b1 inhibitors.We analyzed multiple independent primary
      and metastatic tumor cohorts and found that 10-15% of all PIK3CA mutant tumors
      across all cancer histologies contain multiple PIK3CA mutations, the vast majority
      of which carry exactly two mutations. Double mutations occur at specific amino
      acid positions by codon enrichment analysis, where the most frequent combinations
      in breast cancer are comprised of a canonical \u201cmajor mutant\u201d hotspot
      (involving either E542, E545, or H1047) combined with a second \u201cminor mutant\u201d
      site (involving either E453, E726, or M1043). Double PIK3CA mutations are enriched
      in ER+/HER2- breast cancers and occur at similar frequencies in therapy-naive
      primary tumors and metastatic tumors. To study the allelic configuration of
      double mutations, we leveraged single molecule real time sequencing (SMRT-seq)
      on fresh breast tumor samples from patients known to carry two PIK3CA mutations
      in their tumors by NGS. Six tumors representative of the most frequent double
      mutants in breast cancer were obtained from patients, and were analyzed by SMRT-seq.
      All contained double mutations in cis. We overexpressed double cis mutants and
      constituent single mutants in nontransformed and ER+ breast cancer cells. Double
      PIK3CA mutations in cis increased downstream PI3K pathway signaling and cell/tumor
      proliferation in vitro and in vivo, when compared to single mutations. In contrast,
      mutations in trans do not increase cell signaling or growth proliferation more
      than single mutations.The prevailing model of PI3K activation occurs through
      the engagement of the p85\u03b1 regulatory subunit with phosphotyrosines on
      RTK signaling complexes, which relieves catalytic inhibition. Single oncogenic
      mutations recapitulate these events by weakening the interactions between p110\u03b1
      and p85\u03b1 (\u201cdisrupters\u201d), or by promoting binding to membrane
      (\u201cbinders\u201d). We purified recombinant full length PI3K\u03b1 complexes
      containing single and double cis p110\u03b1 mutations to dissect the biochemical
      mechanisms by which these double PIK3CA mutations in cis modulate kinase activity.
      We demonstrate that cis mutants have increased kinase activity compared to single
      mutants and that this activation is due to both increased p85\u03b1 disruption
      and increased lipid binding, compared to single mutants.We tested whether cis
      mutant cells exhibit differential sensitivity to PI3K\u03b1 inhibitors. While
      in the absence of treatment, cis mutant signaling is increased compared to single
      mutants, treatment with the PI3K\u03b1 inhibitors alpelisib or GDC-0077 results
      in a similar PI3K pathway inhibition in nontransformed and ER+ breast cancer
      cells. With respect to cell viability, E545K and H1047R major hotspot mutants
      are more sensitive to alpelisib and GDC-0077 compared to minor mutants and WT.
      In turn, all cis mutants are synergistically more sensitive to alpelisib and
      GDC-0077 compared to single major and minor hotspots.We analyzed response data
      from SANDPIPER, a randomized phase 3 clinical trial that tested the efficacy
      of the ER degrader fulvestrant with or without the PI3K\u03b1/\u03b3/\u03b4
      inhibitor taselisib in metastatic ER+ PIK3CA mutant breast cancer. We used ctDNA
      to detect the presence of PIK3CA mutations. PIK3CA mutant patients on the taselisib
      arm had an objective response rate (ORR) of 20.3% vs 9.7% compared to the placebo
      arm, which was statistically significant, confirming that PIK3CA mutation predicts
      response to PI3K\u03b1 inhibition. We then compared responses of patients with
      single vs multiple mutations. Single mutant patients on the taselisib arm had
      an ORR of 18.1% vs 10.0% compared to the placebo arm, which was not statistically
      significant. On the contrary, multiple mutant patients on the taselisib arm
      achieved an ORR of 30.2% vs 8.7% compared to the placebo arm, which was statistically
      significant. These findings confirm that breast cancer patients with multiple
      mutant tumors achieve higher clinical benefit to PI3K\u03b1 inhibition compared
      to single mutant tumors.In this work, we have identified double mutations in
      cis as a novel, and relatively frequent, genomic alteration in PIK3CA, which
      translates into a clinically meaningful number of patients who may derive additional
      benefit from targeted therapy. Our results implicate a model of oncogene addiction
      to double mutant PIK3CA in breast cancer, with graded levels of activation and
      inhibition for single vs double mutants. PI3K\u03b1 inhibitors are now a standard
      of care in PIK3CA mutant ER+ metastatic breast cancer and are being explored
      in other PIK3CA mutant tumor histologies. Our findings provide a rationale for
      testing whether patients with multiple PIK3CA mutant tumors are exquisitely
      sensitive to PI3K\u03b1 inhibitors. Citation Format: Neil Vasan, Pedram Razavi,
      Jared L. Johnson, Hong Shao, Hardik Shah, Alesia Antoine, Erik Ladewig, Alexander
      Gorelick, Ting-Yu Lin, Eneda Toska, Guotai Xu, Abiha Kazmi, Matthew T. Chang,
      Barry S. Taylor, Maura N. Dickler, Komal Jhaveri, Sarat Chandarlapaty, Raul
      Rabadan, Ed Reznik, Melissa L. Smith, Robert Sebra, Frauke Schimmoller, Timothy
      R. Wilson, Lori S. Friedman, Lewis C. Cantley, Maurizio Scaltriti, Jose Baselga.
      Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3K\u03b1
      inhibitors [abstract]. In: Proceedings of the Annual Meeting of the American
      Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia
      (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr NG16.", "venue": "", "year":
      2020, "referenceCount": 0, "citationCount": 1, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2020-08-15", "journal": {"volume":
      "80", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Vasan2020AbstractND,\n
      author = {N. Vasan and P. Razavi and Jared L. Johnson and H. Shao and H. Shah
      and Alesia Antoine and Erik Ladewig and A. Gorelick and Ting-Yu Lin and Eneda
      Toska and Guotai Xu and Abiha Kazmi and Matthew T. Chang and B. Taylor and M.
      Dickler and K. Jhaveri and S. Chandarlapaty and R. Rabad\u00e1n and E. Reznik
      and M. Smith and R. Sebra and F. Schimmoller and T. Wilson and L. Friedman and
      L. Cantley and M. Scaltriti and J. Baselga},\n journal = {Cancer Research},\n
      title = {Abstract NG16: DoublePIK3CAmutations incisincrease oncogenicity and
      sensitivity to PI3K\u03b1 inhibitors},\n volume = {80},\n year = {2020}\n}\n"},
      "authors": [{"authorId": "35123724", "name": "N. Vasan"}, {"authorId": "3224289",
      "name": "P. Razavi"}, {"authorId": "145916288", "name": "Jared L. Johnson"},
      {"authorId": "2959236", "name": "H. Shao"}, {"authorId": "49820132", "name":
      "H. Shah"}, {"authorId": "49335811", "name": "Alesia Antoine"}, {"authorId":
      "3139198", "name": "Erik Ladewig"}, {"authorId": "48892954", "name": "A. Gorelick"},
      {"authorId": "144181325", "name": "Ting-Yu Lin"}, {"authorId": "4733908", "name":
      "Eneda Toska"}, {"authorId": "51290929", "name": "Guotai Xu"}, {"authorId":
      "150907238", "name": "Abiha Kazmi"}, {"authorId": "2141904248", "name": "Matthew
      T. Chang"}, {"authorId": "36898514", "name": "B. Taylor"}, {"authorId": "4713308",
      "name": "M. Dickler"}, {"authorId": "47352468", "name": "K. Jhaveri"}, {"authorId":
      "6037809", "name": "S. Chandarlapaty"}, {"authorId": "40620158", "name": "R.
      Rabad\u00e1n"}, {"authorId": "145632788", "name": "E. Reznik"}, {"authorId":
      "2116670076", "name": "M. Smith"}, {"authorId": "46517710", "name": "R. Sebra"},
      {"authorId": "5323777", "name": "F. Schimmoller"}, {"authorId": "2017652", "name":
      "T. Wilson"}, {"authorId": "48530297", "name": "L. Friedman"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "8336319", "name": "M. Scaltriti"},
      {"authorId": "144806171", "name": "J. Baselga"}]}, {"paperId": "bfbd98ef8086d158453befcad0667e00ccd437f8",
      "externalIds": {"PubMedCentral": "7785256", "DOI": "10.1038/s41586-020-2630-0",
      "CorpusId": 231960831}, "corpusId": 231960831, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/bfbd98ef8086d158453befcad0667e00ccd437f8",
      "title": "Age-induced methylmalonic acid accumulation promotes tumor progression",
      "abstract": null, "venue": "Nature", "year": 2020, "referenceCount": 0, "citationCount":
      22, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://lirias.kuleuven.be/bitstream/123456789/661819/2/2020.06.04.135087v1.full.pdf",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Environmental Science", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2020-07-14", "journal": {"volume": "585", "pages":
      "283 - 287", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Gomes2020AgeinducedMA,\n
      author = {Ana P. Gomes and Didem Ilter and V. Low and J. Endress and J. Fern\u00e1ndez-Garc\u00eda
      and Adam Rosenzweig and Tanya Schild and D. Broekaert and Adnan Ahmed and M.
      Planque and Ilaria Elia and Julie Han and Charles G. Kinzig and Edouard Mullarky
      and A. Mutvei and J. Asara and R. de Cabo and L. Cantley and Noah E. Dephoure
      and S. Fendt and J. Blenis},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {283 - 287},\n title = {Age-induced methylmalonic acid accumulation
      promotes tumor progression},\n volume = {585},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "2087116099", "name": "Ana P. Gomes"}, {"authorId": "3324022",
      "name": "Didem Ilter"}, {"authorId": "121128193", "name": "V. Low"}, {"authorId":
      "83689245", "name": "J. Endress"}, {"authorId": "52621189", "name": "J. Fern\u00e1ndez-Garc\u00eda"},
      {"authorId": "1887417083", "name": "Adam Rosenzweig"}, {"authorId": "50356549",
      "name": "Tanya Schild"}, {"authorId": "11236293", "name": "D. Broekaert"}, {"authorId":
      "1887422976", "name": "Adnan Ahmed"}, {"authorId": "8444258", "name": "M. Planque"},
      {"authorId": "2382021", "name": "Ilaria Elia"}, {"authorId": "1886508939", "name":
      "Julie Han"}, {"authorId": "1887752916", "name": "Charles G. Kinzig"}, {"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "5135907", "name": "A.
      Mutvei"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "144285023",
      "name": "R. de Cabo"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4622316", "name": "Noah E. Dephoure"}, {"authorId": "46775302", "name": "S.
      Fendt"}, {"authorId": "4037343", "name": "J. Blenis"}]}, {"paperId": "c04af48f79107d1167907e6b60205310f868f6b8",
      "externalIds": {"MAG": "3034026561", "DOI": "10.1158/2159-8290.CD-19-1262",
      "CorpusId": 219552322, "PubMed": "32513774"}, "corpusId": 219552322, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/c04af48f79107d1167907e6b60205310f868f6b8",
      "title": "The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes
      Triple Negative Breast Cancer.", "abstract": "Inactivation of the tumor suppressor
      lipid phosphatase INPP4B is common in triple negative breast cancer (TNBC).
      We generated a genetically-engineered TNBC mouse model deficient in INPP4B.
      We found a dose-dependent increase in tumor incidence in INPP4B homozygous and
      heterozygous knockout mice compared to wild-type, supporting a role for INPP4B
      as a tumor suppressor in TNBC. Tumors derived from INPP4B knockout mice are
      enriched for AKT and MEK gene signatures. Consequently, mice with INPP4B deficiency
      are more sensitive to PI3K or MEK inhibitors, compared to wild-type mice. Mechanistically,
      we found that INPP4B deficiency increases PI(3,4)P2 levels in endocytic vesicles
      but not at the plasma membrane. Moreover, INPP4B loss delays degradation of
      EGFR and MET, while promoting recycling of RTKs, thus enhancing the duration
      and amplitude of signaling output upon growth factor stimulation. Therefore,
      INPP4B inactivation in TNBC promotes tumorigenesis by modulating RTK recycling
      and signaling duration.", "venue": "Cancer Discovery", "year": 2020, "referenceCount":
      89, "citationCount": 30, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://aacrjournals.org/cancerdiscovery/article-pdf/10/8/1226/1814650/1226.pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-06-08", "journal": {"name": "Cancer discovery"}, "citationStyles":
      {"bibtex": "@Article{Liu2020TheIT,\n author = {Hui Liu and M. Paddock and Haibin
      Wang and Charles J Murphy and Renee C. Geck and Adrija Navarro and G. Wulf and
      O. Elemento and V. Haucke and L. Cantley and A. Toker},\n booktitle = {Cancer
      Discovery},\n journal = {Cancer discovery},\n title = {The INPP4B Tumor Suppressor
      Modulates EGFR Trafficking and Promotes Triple Negative Breast Cancer.},\n year
      = {2020}\n}\n"}, "authors": [{"authorId": "2146671919", "name": "Hui Liu"},
      {"authorId": "4422893", "name": "M. Paddock"}, {"authorId": "2113220569", "name":
      "Haibin Wang"}, {"authorId": "47107919", "name": "Charles J Murphy"}, {"authorId":
      "13850298", "name": "Renee C. Geck"}, {"authorId": "40810332", "name": "Adrija
      Navarro"}, {"authorId": "31554501", "name": "G. Wulf"}, {"authorId": "150097652",
      "name": "O. Elemento"}, {"authorId": "3838808", "name": "V. Haucke"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "145751285", "name": "A. Toker"}]},
      {"paperId": "c9cf4243792a54c5210c260c0750c1e8e4e073b0", "externalIds": {"PubMedCentral":
      "7992954", "DOI": "10.1186/s40170-021-00246-9", "CorpusId": 232353166, "PubMed":
      "33762003"}, "corpusId": 232353166, "publicationVenue": {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f",
      "name": "Cancer & Metabolism", "type": "journal", "alternate_names": ["Cancer
      Metab", "Cancer and Metabolism", "Cancer  Metab"], "issn": "2049-3002", "url":
      "http://www.cancerandmetabolism.com/"}, "url": "https://www.semanticscholar.org/paper/c9cf4243792a54c5210c260c0750c1e8e4e073b0",
      "title": "GLUT5 (SLC2A5) enables fructose-mediated proliferation independent
      of ketohexokinase", "abstract": null, "venue": "Cancer & Metabolism", "year":
      2020, "referenceCount": 73, "citationCount": 11, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/s40170-021-00246-9",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-07-16", "journal": {"volume": "9", "name": "Cancer
      & Metabolism"}, "citationStyles": {"bibtex": "@Article{Liang2020GLUT5E,\n author
      = {R. Liang and Samuel R. Taylor and Navid Nahiyaan and J. Song and Charles
      J Murphy and E. Dantas and Shuyuan Cheng and Ting-Wei Hsu and Shakti Ramsamooj
      and Rahul Grover and Seo-Kyoung Hwang and B. Ngo and L. Cantley and K. Rhee
      and M. Goncalves},\n booktitle = {Cancer & Metabolism},\n journal = {Cancer
      & Metabolism},\n title = {GLUT5 (SLC2A5) enables fructose-mediated proliferation
      independent of ketohexokinase},\n volume = {9},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "46875693", "name": "R. Liang"}, {"authorId": "2110994237", "name":
      "Samuel R. Taylor"}, {"authorId": "2046170895", "name": "Navid Nahiyaan"}, {"authorId":
      "2144577350", "name": "J. Song"}, {"authorId": "47107919", "name": "Charles
      J Murphy"}, {"authorId": "144901772", "name": "E. Dantas"}, {"authorId": "40857819",
      "name": "Shuyuan Cheng"}, {"authorId": "2057635408", "name": "Ting-Wei Hsu"},
      {"authorId": "2058412873", "name": "Shakti Ramsamooj"}, {"authorId": "2062963678",
      "name": "Rahul Grover"}, {"authorId": "4151944", "name": "Seo-Kyoung Hwang"},
      {"authorId": "5891999", "name": "B. Ngo"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "4097554", "name": "K. Rhee"}, {"authorId": "145524334",
      "name": "M. Goncalves"}]}, {"paperId": "cb54ae094afe53c4b8ef7acf71cfe64c9068aab5",
      "externalIds": {"MAG": "3091952721", "DOI": "10.1158/1557-3125.PI3K-MTOR18-B24",
      "CorpusId": 225157186}, "corpusId": 225157186, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/cb54ae094afe53c4b8ef7acf71cfe64c9068aab5",
      "title": "Abstract B24: Phase II trial of AKT inhibitor MK-2206 in patients
      with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or
      PTEN loss/PTEN mutation", "abstract": "Background: The PI3K/AKT pathway is activated
      through PIK3CA or AKT1 mutations and PTEN loss in breast cancer. We conducted
      a phase II trial with an allosteric AKT Inhibitor MK-2206 in patients with advanced
      breast cancer who had tumors with PIK3CA/AKT1 mutations and/or PTEN loss/mutation.
      Methods: The primary endpoint was objective response rate (ORR). Secondary endpoints
      were 6-month progression-free survival (6m PFS), predictive and pharmacodynamic
      markers, safety and tolerability. Patients had pretreatment and on-treatment
      biopsies as well as collection of peripheral blood mononuclear cells (PBMC)
      and platelet-rich plasma (PRP). Next-generation sequencing, immunohistochemistry
      and reverse phase protein arrays (RPPA) were performed. Results: Twenty-seven
      patients received MK-2206. Eighteen patients were enrolled into the PIK3CA/AKT1
      mutation arm (cohort A): 13 had PIK3CA mutations, four had AKT1 mutations and
      one had a PIK3CA mutation as well as PTEN loss. ORR and 6m PFS were both 5.6%
      (1/18), with one patient with HR+ breast cancer and a PIK3CA E542K mutation
      experiencing a partial response (on treatment for 36 weeks). Nine patients were
      enrolled on the PTEN loss/mutation arm (cohort B). ORR was 0% and 6m PFS was
      11% (1/9), observed in a patient with triple-negative breast cancer and PTEN
      loss. The study was stopped early due to futility. The most common adverse events
      were fatigue (48%) and rash (44%). On pretreatment biopsy, PIK3CA and AKT1 mutation
      status was concordant with archival tissue testing. However, two patients with
      PTEN loss based on archival testing had PTEN expression on the pretreatment
      biopsy. MK-2206 treatment was associated with a significant decline in pAKT
      S473 and pAKT T308 and PI3K activation score in PBMC and PRPs, but not in tumor
      biopsies. By IHC, there was no significant decrease in median pAKT S473 or Ki-67
      staining, but a drop was observed in both responders. Conclusions: MK-2206 monotherapy
      had limited clinical activity in advanced breast cancer patients selected for
      PIK3CA/AKT1 or PTEN mutations or PTEN loss. This may, in part, be due to inadequate
      target inhibition at tolerable doses in heavily pretreated patients with pathway
      activation, as well as tumor heterogeneity and evolution in markers such as
      PTEN conferring challenges in patient selection. Citation Format: Yan Xing,
      Nancy U. Lin, Mathew Mauer, Huiqin Chen, Armeen Mahvash, Aysegul Sahin, Argun
      Akcakanat, Yisheng Li, Vandana Abraham, Jennifer Litton, Mariana Chavez-McGregor,
      Vicente Valero, Sarina A. Piha-Paul, David Hong, Kim-Anh Do, Emily Tarco, Dianna
      Riall, Karina Agda Eterovic, Lewis Cantley, Gordon B. Mills, L. Austin Doyle,
      Eric Winer, Gabriel Hortobagyi, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam.
      Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer
      who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
      [abstract]. In: Proceedings of the AACR Special Conference on Targeting PI3K/mTOR
      Signaling; 2018 Nov 30-Dec 8; Boston, MA. Philadelphia (PA): AACR; Mol Cancer
      Res 2020;18(10_Suppl):Abstract nr B24.", "venue": "Poster Presentations - Proffered
      Abstracts", "year": 2020, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2020-10-01", "journal": {"name": "Poster Presentations - Proffered Abstracts"},
      "citationStyles": {"bibtex": "@Article{Xing2020AbstractBP,\n author = {Y. Xing
      and N. Lin and M. Mauer and Huiqin Chen and A. Mahvash and A. Sahin and A. Akcakanat
      and Yisheng Li and Vandana Abraham and J. Litton and Mariana Chavez-McGregor
      and V. Valero and S. Piha-Paul and D. Hong and K. Do and E. Tarco and Dianna
      Riall and K. Eterovic and L. Cantley and G. Mills and L. Doyle and E. Winer
      and G. Hortobagyi and A. Gonz\u00e1lez-Angulo and F. Meric-Bernstam},\n booktitle
      = {Poster Presentations - Proffered Abstracts},\n journal = {Poster Presentations
      - Proffered Abstracts},\n title = {Abstract B24: Phase II trial of AKT inhibitor
      MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA
      or AKT mutations, and/or PTEN loss/PTEN mutation},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "145712222", "name": "Y. Xing"}, {"authorId": "35141217", "name":
      "N. Lin"}, {"authorId": "82475977", "name": "M. Mauer"}, {"authorId": "49177752",
      "name": "Huiqin Chen"}, {"authorId": "5314564", "name": "A. Mahvash"}, {"authorId":
      "2676017", "name": "A. Sahin"}, {"authorId": "6046757", "name": "A. Akcakanat"},
      {"authorId": "2111151410", "name": "Yisheng Li"}, {"authorId": "2235798996",
      "name": "Vandana Abraham"}, {"authorId": "3219926", "name": "J. Litton"}, {"authorId":
      "1404073708", "name": "Mariana Chavez-McGregor"}, {"authorId": "116205756",
      "name": "V. Valero"}, {"authorId": "1422512895", "name": "S. Piha-Paul"}, {"authorId":
      "2788997", "name": "D. Hong"}, {"authorId": "145302986", "name": "K. Do"}, {"authorId":
      "5285731", "name": "E. Tarco"}, {"authorId": "1417281255", "name": "Dianna Riall"},
      {"authorId": "6648425", "name": "K. Eterovic"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2241330", "name": "G. Mills"}, {"authorId": "39667616",
      "name": "L. Doyle"}, {"authorId": "2369378", "name": "E. Winer"}, {"authorId":
      "4172107", "name": "G. Hortobagyi"}, {"authorId": "1398194828", "name": "A.
      Gonz\u00e1lez-Angulo"}, {"authorId": "1397965147", "name": "F. Meric-Bernstam"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '391297'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:35 GMT
      Via:
      - 1.1 7d4cada96f0b733f4f539a3bab2e2d16.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - hINMi7W6uOdBAhkBjgKx0yLjP07pZTO70l2aremKxew5HRwhMY7vjw==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0xMG5vPHcEGPQ=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '391297'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:35 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - f938c522-9e0c-402c-8f22-9cded5837fec
    http_version: HTTP/1.1
    status_code: 200
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=100&limit=100
  response:
    content: '{"offset": 100, "next": 200, "data": [{"paperId": "d0a142a766ddb29f861369a80dacf1f778cbe2e0",
      "externalIds": {"MAG": "3010345862", "DOI": "10.1101/2020.03.03.974980", "CorpusId":
      214723130}, "corpusId": 214723130, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/d0a142a766ddb29f861369a80dacf1f778cbe2e0",
      "title": "Limited Environmental Serine Confers Sensitivity to PHGDH Inhibition
      in Brain Metastasis", "abstract": "A hallmark of metastasis is the adaptation
      of tumor cells to new environments. Although it is well established that the
      metabolic milieu of the brain is severely deprived of nutrients, particularly
      the amino acids serine and its catabolite glycine, how brain metastases rewire
      their metabolism to survive in the nutrient-limited environment of the brain
      is poorly understood. Here we demonstrate that cell-intrinsic de novo serine
      synthesis is a major determinant of brain metastasis. Whole proteome comparison
      of triple-negative breast cancer (TNBC) cells that differ in their capacity
      to colonize the brain reveals that 3-phosphoglycerate dehydrogenase (PHGDH),
      which catalyzes the rate-limiting step of glucose-derived serine synthesis,
      is the most significantly upregulated protein in cells that efficiently metastasize
      to the brain. Genetic silencing or pharmacological inhibition of PHGDH attenuated
      brain metastasis and improved overall survival in mice, whereas expression of
      catalytically active PHGDH in a non-brain trophic cell line promoted brain metastasis.
      Collectively, these findings indicate that nutrient availability determines
      serine synthesis pathway dependence in brain metastasis, and suggest that PHGDH
      inhibitors may be useful in the treatment of patients with cancers that have
      spread to the brain. Statement of Significance Our study highlights how limited
      serine and glycine availability within the brain microenvironment potentiates
      tumor cell sensitivity to serine synthesis inhibition. This finding underscores
      the importance of studying cancer metabolism in physiologically-relevant contexts,
      and provides a rationale for using PHGDH inhibitors to treat brain metastasis.",
      "venue": "bioRxiv", "year": 2020, "referenceCount": 80, "citationCount": 2,
      "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.biorxiv.org/content/biorxiv/early/2020/03/04/2020.03.03.974980.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Environmental
      Science", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2020-03-04", "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Ngo2020LimitedES,\n
      author = {B. Ngo and Eugenie Kim and Victoria Osorio-Vasquez and S. Doll and
      Sophia Bustraan and Alba Luengo and S. Davidson and A. Ali and G. Ferraro and
      Diane Kang and Jing Ni and R. Liang and Ariana Plasger and Edward R. Kastenhuber
      and Roozbeh Eskandari and Sarah Bacha and Roshan K. Siriam and S. Bakhoum and
      Edouard Mullarky and M. Snuderl and P. Cotzia and N. Mainolfi and Vipin Suri
      and Adam J. Friedman and M. Manfredi and D. Sabatini and Drew R. Jones and Min
      Yu and Jean J. Zhao and R. Jain and M. V. Vander Heiden and E. Hernando and
      M. Mann and L. Cantley and M. Pacold},\n booktitle = {bioRxiv},\n journal =
      {bioRxiv},\n title = {Limited Environmental Serine Confers Sensitivity to PHGDH
      Inhibition in Brain Metastasis},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "5891999", "name": "B. Ngo"}, {"authorId": "115819822", "name": "Eugenie Kim"},
      {"authorId": "1600811114", "name": "Victoria Osorio-Vasquez"}, {"authorId":
      "50535810", "name": "S. Doll"}, {"authorId": "1600820777", "name": "Sophia Bustraan"},
      {"authorId": "114311983", "name": "Alba Luengo"}, {"authorId": "34711277", "name":
      "S. Davidson"}, {"authorId": "2157679423", "name": "A. Ali"}, {"authorId": "4469681",
      "name": "G. Ferraro"}, {"authorId": "8118329", "name": "Diane Kang"}, {"authorId":
      "1776165", "name": "Jing Ni"}, {"authorId": "46875693", "name": "R. Liang"},
      {"authorId": "1600820946", "name": "Ariana Plasger"}, {"authorId": "4306515",
      "name": "Edward R. Kastenhuber"}, {"authorId": "6108327", "name": "Roozbeh Eskandari"},
      {"authorId": "145170581", "name": "Sarah Bacha"}, {"authorId": "1600821371",
      "name": "Roshan K. Siriam"}, {"authorId": "3543494", "name": "S. Bakhoum"},
      {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId": "3579975",
      "name": "M. Snuderl"}, {"authorId": "10371243", "name": "P. Cotzia"}, {"authorId":
      "10006170", "name": "N. Mainolfi"}, {"authorId": "2272920", "name": "Vipin Suri"},
      {"authorId": "2054407866", "name": "Adam J. Friedman"}, {"authorId": "47769189",
      "name": "M. Manfredi"}, {"authorId": "1843680", "name": "D. Sabatini"}, {"authorId":
      "151477189", "name": "Drew R. Jones"}, {"authorId": "145684949", "name": "Min
      Yu"}, {"authorId": "50985038", "name": "Jean J. Zhao"}, {"authorId": "32514332",
      "name": "R. Jain"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"},
      {"authorId": "4586359", "name": "E. Hernando"}, {"authorId": "144979479", "name":
      "M. Mann"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5141475",
      "name": "M. Pacold"}]}, {"paperId": "d4c0f402152727c1273dc8fe0f3b54faa932a711",
      "externalIds": {"MAG": "3071340143", "DOI": "10.1038/s41586-020-2630-0", "CorpusId":
      221179251, "PubMed": "32814897"}, "corpusId": 221179251, "publicationVenue":
      {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/d4c0f402152727c1273dc8fe0f3b54faa932a711",
      "title": "Age-induced accumulation of methylmalonic acid promotes tumour progression",
      "abstract": null, "venue": "Nature", "year": 2020, "referenceCount": 50, "citationCount":
      76, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://lirias.kuleuven.be/bitstream/123456789/661819/2/2020.06.04.135087v1.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Environmental Science", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-08-19", "journal": {"volume": "", "pages": "1-5", "name":
      "Nature"}, "citationStyles": {"bibtex": "@Article{Gomes2020AgeinducedAO,\n author
      = {Ana P. Gomes and Didem Ilter and V. Low and J. Endress and J. Fern\u00e1ndez-Garc\u00eda
      and Adam Rosenzweig and Tanya Schild and D. Broekaert and Adnan Ahmed and M.
      Planque and Ilaria Elia and Julie Han and Charles G. Kinzig and Edouard Mullarky
      and A. Mutvei and J. Asara and R. de Cabo and L. Cantley and Noah E. Dephoure
      and S. Fendt and J. Blenis},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {1-5},\n title = {Age-induced accumulation of methylmalonic acid promotes
      tumour progression},\n year = {2020}\n}\n"}, "authors": [{"authorId": "2087116099",
      "name": "Ana P. Gomes"}, {"authorId": "3324022", "name": "Didem Ilter"}, {"authorId":
      "121128193", "name": "V. Low"}, {"authorId": "83689245", "name": "J. Endress"},
      {"authorId": "52621189", "name": "J. Fern\u00e1ndez-Garc\u00eda"}, {"authorId":
      "1887417083", "name": "Adam Rosenzweig"}, {"authorId": "50356549", "name": "Tanya
      Schild"}, {"authorId": "11236293", "name": "D. Broekaert"}, {"authorId": "1887422976",
      "name": "Adnan Ahmed"}, {"authorId": "8444258", "name": "M. Planque"}, {"authorId":
      "2382021", "name": "Ilaria Elia"}, {"authorId": "1886508939", "name": "Julie
      Han"}, {"authorId": "1887752916", "name": "Charles G. Kinzig"}, {"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "5135907", "name": "A.
      Mutvei"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "144285023",
      "name": "R. de Cabo"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4622316", "name": "Noah E. Dephoure"}, {"authorId": "46775302", "name": "S.
      Fendt"}, {"authorId": "4037343", "name": "J. Blenis"}]}, {"paperId": "d6d13b639d29baf68684cbf7356a59d04c53deef",
      "externalIds": {"DOI": "10.1186/s13058-020-01354-y", "CorpusId": 255980355},
      "corpusId": 255980355, "publicationVenue": {"id": "1290af6c-c79c-4253-8957-8db4a6069766",
      "name": "Breast Cancer Research", "type": "journal", "alternate_names": ["Breast
      Cancer Res"], "issn": "1465-5411", "url": "http://breast-cancer-research.com/"},
      "url": "https://www.semanticscholar.org/paper/d6d13b639d29baf68684cbf7356a59d04c53deef",
      "title": "Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor,
      in patients with metastatic triple-negative breast cancer", "abstract": null,
      "venue": "Breast Cancer Research", "year": 2020, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-020-01354-y",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2020-11-02",
      "journal": {"volume": "22", "name": "Breast Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Garrido-Castro2020Phase2S,\n author = {A. Garrido-Castro
      and C. Saura and R. Barroso-Sousa and Hao Guo and E. Ciruelos and B. Bermejo
      and J. Gavil\u00e1 and V. Serra and A. Prat and L. Par\u00e9 and P. C\u00e9liz
      and P. Villagrasa and Yisheng Li and J. Savoie and Zhan-ping Xu and Carlos L.
      Arteaga and I. Krop and D. Solit and G. Mills and L. Cantley and Eric P. Winer
      and N. Lin and J. Rod\u00f3n},\n booktitle = {Breast Cancer Research},\n journal
      = {Breast Cancer Research},\n title = {Phase 2 study of buparlisib (BKM120),
      a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast
      cancer},\n volume = {22},\n year = {2020}\n}\n"}, "authors": [{"authorId": "1401041241",
      "name": "A. Garrido-Castro"}, {"authorId": "143772689", "name": "C. Saura"},
      {"authorId": "1393643694", "name": "R. Barroso-Sousa"}, {"authorId": "143887802",
      "name": "Hao Guo"}, {"authorId": "4316212", "name": "E. Ciruelos"}, {"authorId":
      "144441047", "name": "B. Bermejo"}, {"authorId": "1901703", "name": "J. Gavil\u00e1"},
      {"authorId": "49229190", "name": "V. Serra"}, {"authorId": "145594197", "name":
      "A. Prat"}, {"authorId": "3372070", "name": "L. Par\u00e9"}, {"authorId": "145716996",
      "name": "P. C\u00e9liz"}, {"authorId": "152815847", "name": "P. Villagrasa"},
      {"authorId": "2111151410", "name": "Yisheng Li"}, {"authorId": "37392807", "name":
      "J. Savoie"}, {"authorId": "2155024736", "name": "Zhan-ping Xu"}, {"authorId":
      "48121794", "name": "Carlos L. Arteaga"}, {"authorId": "2101923", "name": "I.
      Krop"}, {"authorId": "2344124", "name": "D. Solit"}, {"authorId": "2084778769",
      "name": "G. Mills"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2165631687", "name": "Eric P. Winer"}, {"authorId": "35141217", "name": "N.
      Lin"}, {"authorId": "143607446", "name": "J. Rod\u00f3n"}]}, {"paperId": "d8422cb2ed7c2612f66b0691fde34717a02c9d7b",
      "externalIds": {"MAG": "3043008369", "DOI": "10.1038/s42255-020-0225-6", "CorpusId":
      220699548, "PubMed": "32694797"}, "corpusId": 220699548, "publicationVenue":
      {"id": "f8dd1b61-789d-48ec-b550-a6245826a9aa", "name": "Nature Metabolism",
      "alternate_names": ["Nat Metab"], "issn": "2522-5812", "url": "https://www.nature.com/natmetab/"},
      "url": "https://www.semanticscholar.org/paper/d8422cb2ed7c2612f66b0691fde34717a02c9d7b",
      "title": "A \u2018fast\u2019er way to treat breast cancer", "abstract": null,
      "venue": "Nature Metabolism", "year": 2020, "referenceCount": 13, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2020-07-01", "journal":
      {"volume": "2", "pages": "559 - 560", "name": "Nature Metabolism"}, "citationStyles":
      {"bibtex": "@Article{Goncalves2020AW,\n author = {M. Goncalves and L. Cantley},\n
      booktitle = {Nature Metabolism},\n journal = {Nature Metabolism},\n pages =
      {559 - 560},\n title = {A \u2018fast\u2019er way to treat breast cancer},\n
      volume = {2},\n year = {2020}\n}\n"}, "authors": [{"authorId": "145524334",
      "name": "M. Goncalves"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "dcc3c19495bc55b355780ff79017973d9fccc468", "externalIds": {"MAG": "3092576713",
      "DOI": "10.1158/1557-3125.PI3K-MTOR18-A21", "CorpusId": 225150070}, "corpusId":
      225150070, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/dcc3c19495bc55b355780ff79017973d9fccc468",
      "title": "Abstract A21: Compound PIK3CA mutations support a mutational dose-response
      model for oncogene activation and response to PI3K inhibitor targeted therapy
      in breast cancer", "abstract": "PIK3CA mutations represent the most frequent
      oncogenic driver lesion found across all human cancers. Given that single PIK3CA
      mutations are a predictive biomarker for response to PI3K inhibition, and that
      these clinical benefits are small, we hypothesized that additional genomic factors
      may cooperate with single PIK3CA mutations in oncogenesis and response to PI3K
      inhibitors. We analyzed several large pan-cancer datasets and have discovered
      a phenomenon of dual PIK3CA mutations in 15% of all PIK3CA-mutant cancers, including
      breast cancer. Dual PIK3CA mutations are clonal, are found in both primary untreated
      and metastatic tumors, and are enriched at conserved amino acid positions. We
      have proved that the majority of dual PIK3CA mutations\u2014including the most
      frequent dual PIK3CA mutant combinations in breast cancer\u2014are in cis compound
      mutations (i.e., on the same allele, resulting in a protein molecule with two
      mutations) in patient samples and cell lines, as shown through multiple sequencing
      techniques including long-range single-molecule real-time sequencing (SMRT-seq).
      Compound PIK3CA mutations increase PI3K pathway signaling and growth proliferation
      in nontransformed cells and cancer cells in vitro and in vivo. Biochemical experiments
      using recombinant PI3K complexes reveal a mechanism where compound mutants increase
      PI3K complex thermal instability, resulting in increased kinase activity and
      liposome binding as compared to single mutants. Compound PIK3CA mutations render
      cells more sensitive to the PI3K\u03b1 inhibitors BYL719 and GDC-0077 than single
      PIK3CA mutations. These data translate to the clinic, where patients with dual
      PIK3CA-mutant metastatic breast cancer exhibit more durable responses to PI3K
      inhibition versus patients with single PIK3CA-mutant breast tumors. Our data
      support a novel mutational dose-response model for oncogene activation, where
      compound mutations amplify PI3K signaling and growth to a greater degree than
      single mutants, resulting in increased sensitivity to PI3K\u03b1 inhibitor targeted
      therapy. These findings also have therapeutic relevance, where compound PIK3CA
      mutations may be a superior predictive biomarker for response to PI3K\u03b1
      inhibitors than single PIK3CA mutations, across PIK3CA-mutant cancers. Citation
      Format: Neil Vasan, Jared Johnson, Hong Shao, Pedram Razavi, Alexander Gorelick,
      Erik Ladewig, Alesia Antoine, Hardik Shah, Eneda Toska, Guotai Xu, Abiha Kazmi,
      Barry Taylor, Komal Jhaveri, Maura Dickler, Elisa de Stanchina, Eduard Reznik,
      Raul Rabadan, Melissa Smith, Robert Sebra, Lewis Cantley, Maurizio Scaltriti,
      Jose Baselga. Compound PIK3CA mutations support a mutational dose-response model
      for oncogene activation and response to PI3K inhibitor targeted therapy in breast
      cancer [abstract]. In: Proceedings of the AACR Special Conference on Targeting
      PI3K/mTOR Signaling; 2018 Nov 30-Dec 8; Boston, MA. Philadelphia (PA): AACR;
      Mol Cancer Res 2020;18(10_Suppl):Abstract nr A21.", "venue": "", "year": 2020,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2020-10-01", "journal": {"volume": "18", "name": "Molecular
      Cancer Research"}, "citationStyles": {"bibtex": "@Article{Vasan2020AbstractAC,\n
      author = {N. Vasan and Jared L. Johnson and H. Shao and P. Razavi and A. Gorelick
      and Erik Ladewig and Alesia Antoine and H. Shah and Eneda Toska and Guotai Xu
      and Abiha Kazmi and B. Taylor and K. Jhaveri and M. Dickler and E. Stanchina
      and E. Reznik and R. Rabad\u00e1n and M. Smith and R. Sebra and L. Cantley and
      M. Scaltriti and J. Baselga},\n journal = {Molecular Cancer Research},\n title
      = {Abstract A21: Compound PIK3CA mutations support a mutational dose-response
      model for oncogene activation and response to PI3K inhibitor targeted therapy
      in breast cancer},\n volume = {18},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "35123724", "name": "N. Vasan"}, {"authorId": "145916288", "name": "Jared L.
      Johnson"}, {"authorId": "2959236", "name": "H. Shao"}, {"authorId": "3224289",
      "name": "P. Razavi"}, {"authorId": "48892954", "name": "A. Gorelick"}, {"authorId":
      "3139198", "name": "Erik Ladewig"}, {"authorId": "49335811", "name": "Alesia
      Antoine"}, {"authorId": "49820132", "name": "H. Shah"}, {"authorId": "4733908",
      "name": "Eneda Toska"}, {"authorId": "51290929", "name": "Guotai Xu"}, {"authorId":
      "150907238", "name": "Abiha Kazmi"}, {"authorId": "36898514", "name": "B. Taylor"},
      {"authorId": "47352468", "name": "K. Jhaveri"}, {"authorId": "4713308", "name":
      "M. Dickler"}, {"authorId": "74760251", "name": "E. Stanchina"}, {"authorId":
      "145632788", "name": "E. Reznik"}, {"authorId": "40620158", "name": "R. Rabad\u00e1n"},
      {"authorId": "2116670076", "name": "M. Smith"}, {"authorId": "46517710", "name":
      "R. Sebra"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "8336319",
      "name": "M. Scaltriti"}, {"authorId": "144806171", "name": "J. Baselga"}]},
      {"paperId": "e852673197a1eec76b5db1dc058115533b8e0a4e", "externalIds": {"MAG":
      "3111004311", "DOI": "10.1093/neuonc/noaa215.926", "CorpusId": 230659238}, "corpusId":
      230659238, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/e852673197a1eec76b5db1dc058115533b8e0a4e",
      "title": "TAMI-38. CYSTEINE-PROMOTING COMPOUNDS INDUCE MITOCHONDRIAL TOXICITY
      IN GLIOBLASTOMA THROUGH ALTERED PYRUVATE AND SERINE METABOLISM", "abstract":
      "\n Glioblastoma (GBM) remains a poorly treatable disease with high mortality.
      Tumor metabolism in GBM is a critical mechanism responsible for accelerated
      growth because of upregulation of glucose, amino acid, and fatty acid utilization.
      However, little is known about the metabolic alterations that are specific to
      GBM and that are targetable with FDA-approved compounds. To investigate tumor
      metabolism signatures unique to GBM, we interrogated the TCGA and a cancer metabolite
      database for alterations in glucose and amino acid signatures in GBM relative
      to other human cancers and relative to low-grade glioma. From these analyses,
      we found that GBM exhibits the highest levels of cysteine and methionine pathway
      gene expression of 32 human cancers and that GBM exhibits high levels of cysteine-related
      metabolites compared to low-grade gliomas. To study the role of cysteine in
      GBM pathogenesis, we treated patient-derived GBM cells with a variety of FDA-approved
      cyst(e)ine-promoting compounds in vitro, including N-acetylcysteine (NAC) and
      the cephalosporin antibiotic, Ceftriaxone (CTX), which induces cystine import
      through System Xc transporter upregulation. Cysteine-promoting compounds, including
      NAC and CTX, inhibit growth of GBM cells, which is exacerbated by glucose deprivation.
      This growth inhibition is associated with reduced mitochondrial metabolism,
      manifest by reduction in ATP, NADPH/NADP+ ratio, mitochondrial membrane potential,
      and oxygen consumption rate. Metabolic tracing experiments with 13C6-glucose
      demonstrate that L-serine is rapidly depleted in GBM cells upon treatment with
      NAC and CTX, and exogenous serine rescues NAC- and CTX-mediated cell growth
      inhibition. In addition, these compounds reduce GBM mitochondrial pyruvate transport.
      We show that cysteine-promoting compounds reduce cell growth and induce mitochondrial
      toxicity in GBM, which may be due to rapid serine depletion and reduced mitochondrial
      pyruvate transport. This metabolic phenotype is exacerbated by glucose deprivation.
      This pathway is targetable with FDA-approved cysteine-promoting compounds and
      could synergize with glucose-lowering treatments, including the ketogenic diet,
      for GBM.", "venue": "", "year": 2020, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://academic.oup.com/neuro-oncology/article-pdf/22/Supplement_2/ii221/34691304/noaa215.926.pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2020-11-09",
      "journal": {"volume": "22", "name": "Neuro-oncology"}, "citationStyles": {"bibtex":
      "@Article{Noch2020TAMI38CC,\n author = {E. Noch and L. Palma and I. Yim and
      Bhavneet Binder and E. Benedetti and J. Krumsiek and O. Elemento and L. Cantley},\n
      journal = {Neuro-oncology},\n title = {TAMI-38. CYSTEINE-PROMOTING COMPOUNDS
      INDUCE MITOCHONDRIAL TOXICITY IN GLIOBLASTOMA THROUGH ALTERED PYRUVATE AND SERINE
      METABOLISM},\n volume = {22},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "3913142", "name": "E. Noch"}, {"authorId": "2065330100", "name": "L. Palma"},
      {"authorId": "1716222698", "name": "I. Yim"}, {"authorId": "1454461390", "name":
      "Bhavneet Binder"}, {"authorId": "123664542", "name": "E. Benedetti"}, {"authorId":
      "2067285", "name": "J. Krumsiek"}, {"authorId": "150097652", "name": "O. Elemento"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "ec7a1d7d9e7122eefe417eb432c1b7876505964a",
      "externalIds": {"MAG": "3083301001", "DOI": "10.1158/1538-7445.am2020-5712",
      "CorpusId": 225364009}, "corpusId": 225364009, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/ec7a1d7d9e7122eefe417eb432c1b7876505964a",
      "title": "Abstract 5712: Nutrient scarcity confers breast cancer brain metastasis
      sensitivity to serine synthesis pathway inhibition", "abstract": null, "venue":
      "", "year": 2020, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2020-08-15", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Ngo2020Abstract5N,\n
      author = {B. Ngo and Eugenie Kim and S. Doll and Sophia Bustraan and Alba Luengo
      and S. Davidson and A. Ali and G. Ferraro and Diane Kang and Jing Ni and R.
      Liang and Ariana Plasger and Edward R. Kastenhuber and Roozbeh Eskandari and
      Sarah Bacha and Roshan K. Sriram and Benjamin D. Stein and S. Bakhoum and Edouard
      Mullarky and M. Snuderl and N. Mainolfi and Vipin Suri and Adam J. Friedman
      and M. Manfredi and D. Sabatini and Drew R. Jones and Min Yu and Jean J. Zhao
      and R. Jain and M. V. Heiden and M. Mann and L. Cantley and M. Pacold},\n title
      = {Abstract 5712: Nutrient scarcity confers breast cancer brain metastasis sensitivity
      to serine synthesis pathway inhibition},\n year = {2020}\n}\n"}, "authors":
      [{"authorId": "5891999", "name": "B. Ngo"}, {"authorId": "115819822", "name":
      "Eugenie Kim"}, {"authorId": "50535810", "name": "S. Doll"}, {"authorId": "1600820777",
      "name": "Sophia Bustraan"}, {"authorId": "114311983", "name": "Alba Luengo"},
      {"authorId": "34711277", "name": "S. Davidson"}, {"authorId": "2157679423",
      "name": "A. Ali"}, {"authorId": "4469681", "name": "G. Ferraro"}, {"authorId":
      "8118329", "name": "Diane Kang"}, {"authorId": "1776165", "name": "Jing Ni"},
      {"authorId": "46875693", "name": "R. Liang"}, {"authorId": "1600820946", "name":
      "Ariana Plasger"}, {"authorId": "4306515", "name": "Edward R. Kastenhuber"},
      {"authorId": "6108327", "name": "Roozbeh Eskandari"}, {"authorId": "145170581",
      "name": "Sarah Bacha"}, {"authorId": "49408849", "name": "Roshan K. Sriram"},
      {"authorId": "40353456", "name": "Benjamin D. Stein"}, {"authorId": "3543494",
      "name": "S. Bakhoum"}, {"authorId": "6424987", "name": "Edouard Mullarky"},
      {"authorId": "3579975", "name": "M. Snuderl"}, {"authorId": "10006170", "name":
      "N. Mainolfi"}, {"authorId": "2272920", "name": "Vipin Suri"}, {"authorId":
      "2054407866", "name": "Adam J. Friedman"}, {"authorId": "47769189", "name":
      "M. Manfredi"}, {"authorId": "1843680", "name": "D. Sabatini"}, {"authorId":
      "151477189", "name": "Drew R. Jones"}, {"authorId": "145684949", "name": "Min
      Yu"}, {"authorId": "50985038", "name": "Jean J. Zhao"}, {"authorId": "32514332",
      "name": "R. Jain"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId":
      "144979479", "name": "M. Mann"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5141475", "name": "M. Pacold"}]}, {"paperId": "f64eef571470a633f345880527574314bfd4d63a",
      "externalIds": {"PubMedCentral": "8034380", "MAG": "3096177766", "DOI": "10.1038/s41586-020-2901-9",
      "CorpusId": 226060032, "PubMed": "33116299"}, "corpusId": 226060032, "publicationVenue":
      {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/f64eef571470a633f345880527574314bfd4d63a",
      "title": "Identification of SARS-CoV-2 Inhibitors using Lung and Colonic Organoids",
      "abstract": null, "venue": "Nature", "year": 2020, "referenceCount": 34, "citationCount":
      361, "influentialCitationCount": 18, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://www.nature.com/articles/s41586-020-2901-9.pdf", "status": null},
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Environmental Science",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2020-10-28", "journal": {"volume": "589", "pages": "270 - 275", "name": "Nature"},
      "citationStyles": {"bibtex": "@Article{Han2020IdentificationOS,\n author = {Yuling
      Han and Xiaohua Duan and Liuliu Yang and Benjamin E. Nilsson-Payant and Pengfei
      Wang and Fuyu Duan and Xuming Tang and Tomer M. Yaron and Tuo Zhang and S. Uhl
      and Y. Bram and Chanel Richardson and Jiajun Zhu and Zeping Zhao and D. Redmond
      and S. Houghton and Duc-Huy T. Nguyen and Dong-Li Xu and Xing Wang and J. Jessurun
      and A. Borczuk and Yaoxing Huang and Jared L. Johnson and Yuru Liu and J. Xiang
      and Hui Wang and L. Cantley and B. tenOever and D. Ho and F. C. Pan and T. Evans
      and H. Chen and R. Schwartz and Shuibing Chen},\n booktitle = {Nature},\n journal
      = {Nature},\n pages = {270 - 275},\n title = {Identification of SARS-CoV-2 Inhibitors
      using Lung and Colonic Organoids},\n volume = {589},\n year = {2020}\n}\n"},
      "authors": [{"authorId": "1678087048", "name": "Yuling Han"}, {"authorId": "8121194",
      "name": "Xiaohua Duan"}, {"authorId": "1733349662", "name": "Liuliu Yang"},
      {"authorId": "1422205499", "name": "Benjamin E. Nilsson-Payant"}, {"authorId":
      "152702655", "name": "Pengfei Wang"}, {"authorId": "8751560", "name": "Fuyu
      Duan"}, {"authorId": "1687775322", "name": "Xuming Tang"}, {"authorId": "5247030",
      "name": "Tomer M. Yaron"}, {"authorId": "40543563", "name": "Tuo Zhang"}, {"authorId":
      "88725738", "name": "S. Uhl"}, {"authorId": "4785493", "name": "Y. Bram"}, {"authorId":
      "2006900424", "name": "Chanel Richardson"}, {"authorId": "2144872721", "name":
      "Jiajun Zhu"}, {"authorId": "2186108428", "name": "Zeping Zhao"}, {"authorId":
      "1682800", "name": "D. Redmond"}, {"authorId": "145731038", "name": "S. Houghton"},
      {"authorId": "50652368", "name": "Duc-Huy T. Nguyen"}, {"authorId": "48207902",
      "name": "Dong-Li Xu"}, {"authorId": "2144803226", "name": "Xing Wang"}, {"authorId":
      "3503076", "name": "J. Jessurun"}, {"authorId": "3177215", "name": "A. Borczuk"},
      {"authorId": "2108678622", "name": "Yaoxing Huang"}, {"authorId": "145916288",
      "name": "Jared L. Johnson"}, {"authorId": "47909573", "name": "Yuru Liu"}, {"authorId":
      "2236077469", "name": "J. Xiang"}, {"authorId": "2113635227", "name": "Hui Wang"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5462120", "name":
      "B. tenOever"}, {"authorId": "144705651", "name": "D. Ho"}, {"authorId": "34160280",
      "name": "F. C. Pan"}, {"authorId": "144263094", "name": "T. Evans"}, {"authorId":
      "2145302790", "name": "H. Chen"}, {"authorId": "46462360", "name": "R. Schwartz"},
      {"authorId": "47336157", "name": "Shuibing Chen"}]}, {"paperId": "f7c7cf82bd09f7f4efa7cf9fd3f4318fcae32717",
      "externalIds": {"MAG": "3027751799", "DOI": "10.1002/cne.24956", "CorpusId":
      213031990, "PubMed": "32449185"}, "corpusId": 213031990, "publicationVenue":
      {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0", "name": "bioRxiv", "type": "journal",
      "url": "http://biorxiv.org/"}, "url": "https://www.semanticscholar.org/paper/f7c7cf82bd09f7f4efa7cf9fd3f4318fcae32717",
      "title": "Distribution and localization of phosphatidylinositol 5-phosphate,
      4-kinase alpha and beta in the brain", "abstract": "Phosphatidylinositol-4,5-bisphosphate
      (PI-4,5-P2) is critical for synaptic vesicle docking and fusion and generation
      of the second messengers, diacylglycerol and inositol-1,4,5-trisphosphate. PI-4,5-P2
      can be generated by two families of kinases: type 1 phosphatidylinositol-4-phosphate
      5-kinases, encoded by PIP5K1A, PIP5K1B and PIP5K1C, and type 2 phosphatidylinositol-5-phosphate
      4-kinases, encoded by PIP4K2A, PIP4K2B, and PIP4K2C. While the roles of the
      type 1 enzymes in brain function have been extensively studied, the roles of
      the type 2 enzymes are poorly understood. Using selective antibodies validated
      by genetic deletion of pip4k2a or pip4k2b in mouse brain, we characterized the
      location of the enzymes, PI5P4K\u03b1 and PI5P4K\u00df, encoded by these genes.
      In mice, we demonstrate that PI5P4K\u03b1 is expressed in adulthood, whereas
      PI5P4K\u00df is expressed early in development. PI5P4K\u03b1 localizes to white
      matter tracts, especially the corpus callosum, and at a low level in neurons,
      while PI5P4K\u00df is expressed in neuronal populations, especially hippocampus
      and cortex. Dual labeling studies demonstrate that PI5P4K\u03b1 co-localizes
      with the oligodendrocyte marker, Olig2, whereas PI5P4K\u00df co-localizes with
      the neuronal marker, NeuN. Immunohistochemical subcellular distribution studies
      demonstrate that PI5P4K\u03b1 and PI5P4K\u00df are expressed in the early endosome
      system. Ultrastructural analysis demonstrates that both kinases are contained
      in axon terminals and dendritic spines adjacent to the synaptic membrane, which
      support a potential role in synaptic transmission. Immunohistochemical analysis
      of macaque and human brain tissue demonstrate a conserved pattern for PI5P4K\u03b1
      and PI5P4K\u00df. These results highlight the diverse cell-autonomous expression
      of PI5P4K\u03b1 and PI5P4K\u00df and support further exploration into their
      role in synaptic function in the brain.", "venue": "bioRxiv", "year": 2020,
      "referenceCount": 53, "citationCount": 3, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Biology", "Medicine"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2020-01-30", "journal": {"name": "bioRxiv"}, "citationStyles":
      {"bibtex": "@Article{Noch2020DistributionAL,\n author = {E. Noch and Isaiah
      Yim and T. Milner and L. Cantley},\n booktitle = {bioRxiv},\n journal = {bioRxiv},\n
      title = {Distribution and localization of phosphatidylinositol 5-phosphate,
      4-kinase alpha and beta in the brain},\n year = {2020}\n}\n"}, "authors": [{"authorId":
      "3913142", "name": "E. Noch"}, {"authorId": "121514578", "name": "Isaiah Yim"},
      {"authorId": "1732734", "name": "T. Milner"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "fddab39eee67d11d7abb392232baafd01fa191f1", "externalIds":
      {"MAG": "3033691847", "DOI": "10.1101/2020.06.04.135087", "CorpusId": 219603961},
      "corpusId": 219603961, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/fddab39eee67d11d7abb392232baafd01fa191f1",
      "title": "Age-induced methylmalonic acid accumulation promotes tumor progression
      and aggressiveness", "abstract": "From age 65 onwards, the risk of cancer incidence
      and associated mortality is substantially higher1-3. Nonetheless, our understanding
      of the complex relationship between age and cancer is still in its infancy4.
      For decades, the link has largely been attributed to increased exposure time
      to mutagens in older individuals. However, this view does not account for the
      well-established role of diet, exercise and small molecules that target the
      pace of metabolic aging5-8. Here, we show that metabolic alterations that occur
      with age can render a systemic environment favorable to progression and aggressiveness
      of tumors. Specifically, we show that methylmalonic acid (MMA), a by-product
      of propionate metabolism, is significantly up-regulated in the serum of older
      people, and functions as a mediator of tumor progression. We traced this to
      the induction of SOX4 and a consequent transcriptional reprogramming that can
      endow cancer cells with aggressive properties. Thus, accumulation of MMA represents
      a novel link between aging and cancer progression, implicating MMA as a novel
      therapeutic target for advanced carcinomas.", "venue": "bioRxiv", "year": 2020,
      "referenceCount": 46, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2020/06/05/2020.06.04.135087.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2020-06-05", "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Gomes2020AgeinducedMA,\n
      author = {Ana P. Gomes and Didem Ilter and V. Low and J. Endress and J. Fern\u00e1ndez-Garc\u00eda
      and Adam Rosenzweig and Tanya Schild and D. Broekaert and Adnan Ahmed and M.
      Planque and Ilaria Elia and Julie Han and Charles G. Kinzig and Edouard Mullarky
      and A. Mutvei and J. Asara and R. de Cabo and L. Cantley and Noah E. Dephoure
      and S. Fendt and J. Blenis},\n booktitle = {bioRxiv},\n journal = {bioRxiv},\n
      title = {Age-induced methylmalonic acid accumulation promotes tumor progression
      and aggressiveness},\n year = {2020}\n}\n"}, "authors": [{"authorId": "2087116099",
      "name": "Ana P. Gomes"}, {"authorId": "3324022", "name": "Didem Ilter"}, {"authorId":
      "121128193", "name": "V. Low"}, {"authorId": "83689245", "name": "J. Endress"},
      {"authorId": "52621189", "name": "J. Fern\u00e1ndez-Garc\u00eda"}, {"authorId":
      "1887417083", "name": "Adam Rosenzweig"}, {"authorId": "50356549", "name": "Tanya
      Schild"}, {"authorId": "11236293", "name": "D. Broekaert"}, {"authorId": "1887422976",
      "name": "Adnan Ahmed"}, {"authorId": "8444258", "name": "M. Planque"}, {"authorId":
      "2382021", "name": "Ilaria Elia"}, {"authorId": "1886508939", "name": "Julie
      Han"}, {"authorId": "1887752916", "name": "Charles G. Kinzig"}, {"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "5135907", "name": "A.
      Mutvei"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "144285023",
      "name": "R. de Cabo"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4622316", "name": "Noah E. Dephoure"}, {"authorId": "46775302", "name": "S.
      Fendt"}, {"authorId": "4037343", "name": "J. Blenis"}]}, {"paperId": "01c94cb91a94a7683b2ce5dd444f33fb1357b7c3",
      "externalIds": {"MAG": "2946677666", "DOI": "10.1093/ANNONC/MDZ095", "CorpusId":
      181760896, "PubMed": "32084703"}, "corpusId": 181760896, "publicationVenue":
      {"id": "9777e708-5066-48fd-ab6a-57496cbca033", "name": "Annals of Oncology",
      "type": "journal", "alternate_names": ["Ann Oncol"], "issn": "0923-7534", "url":
      "https://academic.oup.com/annonc/issue", "alternate_urls": ["http://annonc.oxfordjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/01c94cb91a94a7683b2ce5dd444f33fb1357b7c3",
      "title": "Double PIK3CA mutations in cis enhance PI3K\u03b1 oncogene activation
      and sensitivity to PI3K\u03b1 inhibitors in breast cancer.", "abstract": null,
      "venue": "Annals of Oncology", "year": 2019, "referenceCount": 0, "citationCount":
      6, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.annalsofoncology.org/article/S092375341930273X/pdf", "status": null},
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-05-01", "journal":
      {"volume": "30 Suppl 3", "pages": "\n          iii1\n        ", "name": "Annals
      of oncology : official journal of the European Society for Medical Oncology"},
      "citationStyles": {"bibtex": "@Article{Vasan2019DoublePM,\n author = {N. Vasan
      and P. Razavi and J. Johnson and H. Shao and E. Reznik and M. Smith and R. Sebra
      and L. Cantley and M. Scaltriti and J. Baselga},\n booktitle = {Annals of Oncology},\n
      journal = {Annals of oncology : official journal of the European Society for
      Medical Oncology},\n pages = {\n          iii1\n        },\n title = {Double
      PIK3CA mutations in cis enhance PI3K\u03b1 oncogene activation and sensitivity
      to PI3K\u03b1 inhibitors in breast cancer.},\n volume = {30 Suppl 3},\n year
      = {2019}\n}\n"}, "authors": [{"authorId": "35123724", "name": "N. Vasan"}, {"authorId":
      "3224289", "name": "P. Razavi"}, {"authorId": "2157356093", "name": "J. Johnson"},
      {"authorId": "2959236", "name": "H. Shao"}, {"authorId": "145632788", "name":
      "E. Reznik"}, {"authorId": "2149040221", "name": "M. Smith"}, {"authorId": "46517710",
      "name": "R. Sebra"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "1657637983", "name": "M. Scaltriti"}, {"authorId": "66042490", "name": "J.
      Baselga"}]}, {"paperId": "043a453e94a480bbf361e1eb4ffbedf8db30523e", "externalIds":
      {"MAG": "2944155389", "PubMedCentral": "6551940", "DOI": "10.1210/JS.2019-SAT-LB057",
      "CorpusId": 165053647}, "corpusId": 165053647, "publicationVenue": {"id": "ccbeb193-d73e-4c27-9e78-65553fb9c08a",
      "name": "Journal of the Endocrine Society", "type": "journal", "alternate_names":
      ["J Endocr Soc"], "issn": "2472-1972", "url": "http://www.endocrine.org/endocrine-press/journals/open-access-journal"},
      "url": "https://www.semanticscholar.org/paper/043a453e94a480bbf361e1eb4ffbedf8db30523e",
      "title": "SAT-LB057 High-Fructose Corn Syrup Enhances Intestinal Tumor Growth
      in Mice", "abstract": "Abstract An increasing number of studies have suggested
      a potential link between sugar consumption and cancer. However, a direct relationship
      between the two remains controversial. Here, we treated APC-mutant mice daily
      with a modest amount of high-fructose corn syrup (HFCS) via oral gavage to mimic
      sugar-sweetened beverage (SSB) consumption and evaluated the effects of SSBs
      on intestinal tumorigenesis. We observed a dramatic increase in tumor size and
      tumor grade in HFCS-treated mice despite no signs of obesity or metabolic syndrome.
      A bolus of HFCS spikes the level of fructose and glucose in the intestinal lumen
      and serum, respectively, allowing tumors to take up both sugars efficiently.
      Ketohexokinase (KHK) in tumors rapidly converts fructose to fructose-1-phosphate
      (F1P), lowering cytosolic ATP in the process. Consequently, this leads to the
      activation of glycolysis as ATP depletion relieves the allosteric inhibition
      of phosphofructokinase (PFK), the most critical regulatory enzyme in glycolysis.
      This accelerated glycolysis contributes to the increased de novo lipogenesis
      pathway that enhances tumor growth in HFCS-treated mice. Importantly, the deletion
      of KHK or fatty acid synthase (FASN) in APC-mutant mice abolishes the HFCS-induced
      metabolic changes and tumor growth. Overall, our results provide a mechanistic
      rationale for restricting SSB consumption to decrease the rate of growth of
      early stage colorectal cancers. Unless otherwise noted, all abstracts presented
      at ENDO are embargoed until the date and time of presentation. For oral presentations,
      the abstracts are embargoed until the session begins. Abstracts presented at
      a news conference are embargoed until the date and time of the news conference.
      The Endocrine Society reserves the right to lift the embargo on specific abstracts
      that are selected for promotion prior to or during ENDO.", "venue": "Journal
      of the Endocrine Society", "year": 2019, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2019-04-15", "journal": {"volume":
      "3", "name": "Journal of the Endocrine Society"}, "citationStyles": {"bibtex":
      "@Article{Goncalves2019SATLB057HC,\n author = {M. Goncalves and Changyuan Lu
      and T. Hartman and Seo-Kyoung Hwang and C. Pauli and Samuel R. Taylor and S.
      Gross and K. Rhee and L. Cantley and Jihye Yun},\n booktitle = {Journal of the
      Endocrine Society},\n journal = {Journal of the Endocrine Society},\n title
      = {SAT-LB057 High-Fructose Corn Syrup Enhances Intestinal Tumor Growth in Mice},\n
      volume = {3},\n year = {2019}\n}\n"}, "authors": [{"authorId": "145524334",
      "name": "M. Goncalves"}, {"authorId": "7434113", "name": "Changyuan Lu"}, {"authorId":
      "32250589", "name": "T. Hartman"}, {"authorId": "4151944", "name": "Seo-Kyoung
      Hwang"}, {"authorId": "34187590", "name": "C. Pauli"}, {"authorId": "2110994237",
      "name": "Samuel R. Taylor"}, {"authorId": "5769141", "name": "S. Gross"}, {"authorId":
      "4097554", "name": "K. Rhee"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "40164091", "name": "Jihye Yun"}]}, {"paperId": "0807ee160b498717eac4489e1c0444eb23a4faa9",
      "externalIds": {"MAG": "2920641325", "DOI": "10.1146/ANNUREV-CANCERBIO-030518-055855",
      "CorpusId": 86678376}, "corpusId": 86678376, "publicationVenue": {"id": "4c63af56-3e48-4bc9-a971-0d19a9b932e5",
      "name": "Annual Review of Cancer Biology", "alternate_names": ["Annu Rev Cancer
      Biology"], "issn": "2472-3428", "url": "https://www.annualreviews.org/journal/cancerbio"},
      "url": "https://www.semanticscholar.org/paper/0807ee160b498717eac4489e1c0444eb23a4faa9",
      "title": "Dietary Fat and Sugar in Promoting Cancer Development and Progression",
      "abstract": "The uncontrolled cellular growth that characterizes tumor formation
      requires a constant delivery of nutrients. Since the 1970s, researchers have
      wondered if the supply of nutrients from the diet could impact tumor development.
      Numerous studies have assessed the impact of dietary components, specifically
      sugar and fat, to increased cancer risk. For the most part, data from these
      trials have been inconclusive; however, this does not indicate that dietary
      factors do not contribute to cancer progression. Rather, the dietary contribution
      may be dependent on tumor, patient, and context, making it difficult to detect
      in the setting of large trials. In this review, we combine data from prospective
      cohort trials with mechanistic studies in mice to argue that fat and sugar can
      play a role in tumorigenesis and disease progression. We find that certain tumors
      may respond directly to dietary sugar (colorectal and endometrial cancers) and
      fat (prostate cancer) or indirectly to the obese state (breast cancer).", "venue":
      "Annual Review of Cancer Biology", "year": 2019, "referenceCount": 143, "citationCount":
      25, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.annualreviews.org/doi/pdf/10.1146/annurev-cancerbio-030518-055855",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review"], "publicationDate": "2019-03-04", "journal":
      {"name": "Annual Review of Cancer Biology"}, "citationStyles": {"bibtex": "@Article{Goncalves2019DietaryFA,\n
      author = {M. Goncalves and B. Hopkins and L. Cantley},\n booktitle = {Annual
      Review of Cancer Biology},\n journal = {Annual Review of Cancer Biology},\n
      title = {Dietary Fat and Sugar in Promoting Cancer Development and Progression},\n
      year = {2019}\n}\n"}, "authors": [{"authorId": "145524334", "name": "M. Goncalves"},
      {"authorId": "48821307", "name": "B. Hopkins"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "095e393ccfe2e8379e167f3d9268c75626acc2d6", "externalIds":
      {"MAG": "2936445722", "DOI": "10.1021/acs.jproteome.8b00969", "CorpusId": 106408394,
      "PubMed": "30964683"}, "corpusId": 106408394, "publicationVenue": {"id": "c7bbca07-9604-48a6-85d8-512fa663722e",
      "name": "Journal of Proteome Research", "type": "journal", "alternate_names":
      ["J Proteome Res"], "issn": "1535-3893", "url": "https://pubs.acs.org/journal/jprobs",
      "alternate_urls": ["http://pubs.acs.org/journals/jprobs/", "http://pubs.acs.org/journals/jprobs/index.html",
      "http://pubs.acs.org/journal/jprobs"]}, "url": "https://www.semanticscholar.org/paper/095e393ccfe2e8379e167f3d9268c75626acc2d6",
      "title": "Mapping Post-Translational Modifications of de Novo Purine Biosynthetic
      Enzymes: Implications for Pathway Regulation.", "abstract": "Purines represent
      a class of essential metabolites produced by the cell to maintain cellular homeostasis
      and facilitate cell proliferation. In times of high purine demand, the de novo
      purine biosynthetic pathway is activated; however, the mechanisms that facilitate
      this process are largely unknown. One plausible mechanism is through intracellular
      signaling, which results in enzymes within the pathway becoming post-translationally
      modified to enhance their individual enzyme activities and the overall pathway
      metabolic flux. Here, we employ a proteomic strategy to investigate the extent
      to which de novo purine biosynthetic pathway enzymes are post-translationally
      modified in 293T cells. We identified 7 post-translational modifications on
      135 residues across the 6 human pathway enzymes. We further asked whether there
      were differences in the post-translational modification state of each pathway
      enzyme isolated from cells cultured in the presence or absence of purines. Of
      the 174 assigned modifications, 67% of them were only detected in one experimental
      growth condition in which a significant number of serine and threonine phosphorylations
      were noted. A survey of the most-probable kinases responsible for these phosphorylation
      events uncovered a likely AKT phosphorylation site at residue Thr397 of PPAT,
      which was only detected in cells under purine-supplemented growth conditions.
      These data suggest that this modification might alter enzyme activity or modulate
      its interaction(s) with downstream pathway enzymes. Together, these findings
      propose a role for post-translational modifications in pathway regulation and
      activation to meet intracellular purine demand.", "venue": "Journal of Proteome
      Research", "year": 2019, "referenceCount": 49, "citationCount": 10, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc6499638?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Review"], "publicationDate": "2019-04-09", "journal": {"volume": "18 5", "pages":
      "\n          2078-2087\n        ", "name": "Journal of proteome research"},
      "citationStyles": {"bibtex": "@Article{Liu2019MappingPM,\n author = {Chunlian
      Liu and G. Knudsen and Anthony M. Pedley and Jingxuan He and Jared L. Johnson
      and Tomer M. Yaron and L. Cantley and S. Benkovic},\n booktitle = {Journal of
      Proteome Research},\n journal = {Journal of proteome research},\n pages = {\n          2078-2087\n        },\n
      title = {Mapping Post-Translational Modifications of de Novo Purine Biosynthetic
      Enzymes: Implications for Pathway Regulation.},\n volume = {18 5},\n year =
      {2019}\n}\n"}, "authors": [{"authorId": "2927467", "name": "Chunlian Liu"},
      {"authorId": "2667612", "name": "G. Knudsen"}, {"authorId": "5480995", "name":
      "Anthony M. Pedley"}, {"authorId": "2000159002", "name": "Jingxuan He"}, {"authorId":
      "145916288", "name": "Jared L. Johnson"}, {"authorId": "5247030", "name": "Tomer
      M. Yaron"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6523855",
      "name": "S. Benkovic"}]}, {"paperId": "14fed95b45bd5925f1e4d5374cfab78bb7b8e067",
      "externalIds": {"PubMedCentral": "6941320", "MAG": "2964136203", "DOI": "10.1186/s40170-019-0202-2",
      "CorpusId": 199629307, "PubMed": "31908776"}, "corpusId": 199629307, "publicationVenue":
      {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f", "name": "Cancer & Metabolism",
      "type": "journal", "alternate_names": ["Cancer Metab", "Cancer and Metabolism",
      "Cancer  Metab"], "issn": "2049-3002", "url": "http://www.cancerandmetabolism.com/"},
      "url": "https://www.semanticscholar.org/paper/14fed95b45bd5925f1e4d5374cfab78bb7b8e067",
      "title": "Tissue of origin dictates GOT1 dependence and confers synthetic lethality
      to radiotherapy", "abstract": null, "venue": "Cancer & Metabolism", "year":
      2019, "referenceCount": 68, "citationCount": 23, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/s40170-019-0202-2",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-07-25", "journal":
      {"volume": "8", "name": "Cancer & Metabolism"}, "citationStyles": {"bibtex":
      "@Article{Nelson2019TissueOO,\n author = {Barbara S Nelson and Lin Lin and Daniel
      M. Kremer and C. Sousa and Cecilia Cotta-Ramusino and Amy L. Myers and Johanna
      Ramos and Tina Gao and I. Kovalenko and K. Wilder-Romans and Joseph Dresser
      and Mary A Davis and Ho-Joon Lee and Z. Nwosu and Scott Campit and Oksana Mashadova
      and Brandon Nicolay and Zachary P. Tolstyka and Christopher J. Halbrook and
      Sriram Chandrasekaran and J. Asara and H. Crawford and L. Cantley and Alec C.
      Kimmelman and D. Wahl and C. Lyssiotis},\n booktitle = {Cancer & Metabolism},\n
      journal = {Cancer & Metabolism},\n title = {Tissue of origin dictates GOT1 dependence
      and confers synthetic lethality to radiotherapy},\n volume = {8},\n year = {2019}\n}\n"},
      "authors": [{"authorId": "2053022852", "name": "Barbara S Nelson"}, {"authorId":
      "49478108", "name": "Lin Lin"}, {"authorId": "40237579", "name": "Daniel M.
      Kremer"}, {"authorId": "48247953", "name": "C. Sousa"}, {"authorId": "1397966521",
      "name": "Cecilia Cotta-Ramusino"}, {"authorId": "35171451", "name": "Amy L.
      Myers"}, {"authorId": "2069856065", "name": "Johanna Ramos"}, {"authorId": "1491340265",
      "name": "Tina Gao"}, {"authorId": "2058928795", "name": "I. Kovalenko"}, {"authorId":
      "1401906161", "name": "K. Wilder-Romans"}, {"authorId": "39740614", "name":
      "Joseph Dresser"}, {"authorId": "29884234", "name": "Mary A Davis"}, {"authorId":
      "49923389", "name": "Ho-Joon Lee"}, {"authorId": "152709401", "name": "Z. Nwosu"},
      {"authorId": "11184021", "name": "Scott Campit"}, {"authorId": "13470228", "name":
      "Oksana Mashadova"}, {"authorId": "4374034", "name": "Brandon Nicolay"}, {"authorId":
      "4171577", "name": "Zachary P. Tolstyka"}, {"authorId": "7745600", "name": "Christopher
      J. Halbrook"}, {"authorId": "39821422", "name": "Sriram Chandrasekaran"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "36509270", "name": "H. Crawford"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4668673", "name":
      "Alec C. Kimmelman"}, {"authorId": "35426517", "name": "D. Wahl"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}]}, {"paperId": "26a34f290fed39e7c904bb4c4f71fb2c86fdcbb9",
      "externalIds": {"MAG": "2934863159", "DOI": "10.1016/j.chembiol.2019.02.015",
      "CorpusId": 89619879, "PubMed": "30930164"}, "corpusId": 89619879, "publicationVenue":
      {"id": "66a2a80a-90f1-4c5a-8798-1be97c318574", "name": "Cell Chemical Biology",
      "alternate_names": ["Cell Chem Biology"], "issn": "2451-9456", "alternate_issns":
      ["2451-9448"], "url": "https://www.sciencedirect.com/journal/cell-chemical-biology",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/24519456",
      "http://www.sciencedirect.com/science/journal/24519456/23/"]}, "url": "https://www.semanticscholar.org/paper/26a34f290fed39e7c904bb4c4f71fb2c86fdcbb9",
      "title": "Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity.",
      "abstract": null, "venue": "Cell Chemical Biology", "year": 2019, "referenceCount":
      51, "citationCount": 19, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S2451945619300704/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2019-06-01", "journal": {"volume": "26 6", "pages": "\n          804-817.e12\n        ",
      "name": "Cell chemical biology"}, "citationStyles": {"bibtex": "@Article{Ferguson2019DiscoveryOC,\n
      author = {F. Ferguson and Zainab M. Doctor and S. Ficarro and Christopher M
      Browne and J. Marto and Jared L. Johnson and Tomer M. Yaron and L. Cantley and
      N. Kim and Taebo Sim and Matthew J. Berberich and M. Kalocsay and P. Sorger
      and N. Gray},\n booktitle = {Cell Chemical Biology},\n journal = {Cell chemical
      biology},\n pages = {\n          804-817.e12\n        },\n title = {Discovery
      of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity.},\n volume =
      {26 6},\n year = {2019}\n}\n"}, "authors": [{"authorId": "11404167", "name":
      "F. Ferguson"}, {"authorId": "47040242", "name": "Zainab M. Doctor"}, {"authorId":
      "2297254", "name": "S. Ficarro"}, {"authorId": "39374687", "name": "Christopher
      M Browne"}, {"authorId": "2605597", "name": "J. Marto"}, {"authorId": "145916288",
      "name": "Jared L. Johnson"}, {"authorId": "5247030", "name": "Tomer M. Yaron"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "7473112", "name":
      "N. Kim"}, {"authorId": "35668012", "name": "Taebo Sim"}, {"authorId": "90357718",
      "name": "Matthew J. Berberich"}, {"authorId": "10019624", "name": "M. Kalocsay"},
      {"authorId": "2940596", "name": "P. Sorger"}, {"authorId": "3977406", "name":
      "N. Gray"}]}, {"paperId": "327f1fd849443381b07c6d3544e90153fa7812c6", "externalIds":
      {"MAG": "2955592227", "DOI": "10.1158/1538-7445.SABCS18-2062", "CorpusId": 198353844},
      "corpusId": 198353844, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/327f1fd849443381b07c6d3544e90153fa7812c6",
      "title": "Abstract 2062: Evaluating the effect of tumor necrosis on glycolytic
      flux and cell survival in glioblastoma", "abstract": null, "venue": "Molecular
      and Cellular Biology / Genetics", "year": 2019, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2019-07-01", "journal": {"name": "Molecular and Cellular Biology / Genetics"},
      "citationStyles": {"bibtex": "@Article{Noch2019Abstract2E,\n author = {E. Noch
      and Isaiah Yim and L. Cantley},\n booktitle = {Molecular and Cellular Biology
      / Genetics},\n journal = {Molecular and Cellular Biology / Genetics},\n title
      = {Abstract 2062: Evaluating the effect of tumor necrosis on glycolytic flux
      and cell survival in glioblastoma},\n year = {2019}\n}\n"}, "authors": [{"authorId":
      "3913142", "name": "E. Noch"}, {"authorId": "121514578", "name": "Isaiah Yim"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "3c1320342cfeb3aa51c22b8938467f991bea7331",
      "externalIds": {"MAG": "2952013696", "DOI": "10.1016/j.ccell.2019.05.002", "CorpusId":
      206529595, "PubMed": "31185214"}, "corpusId": 206529595, "publicationVenue":
      {"id": "11e469cb-37ad-487e-b0ab-d26e82037c22", "name": "Cancer Cell", "type":
      "journal", "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/3c1320342cfeb3aa51c22b8938467f991bea7331",
      "title": "Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis.",
      "abstract": null, "venue": "Cancer Cell", "year": 2019, "referenceCount": 94,
      "citationCount": 65, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S1535610819302405/pdf", "status": null},
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-06-01", "journal":
      {"volume": "35 6", "pages": "\n          916-931.e9\n        ", "name": "Cancer
      cell"}, "citationStyles": {"bibtex": "@Article{Li2019NononcogeneAT,\n author
      = {Meng Li and Ying-Ling Chiang and C. Lyssiotis and Matt Teater and J. Hong
      and Hao Shen and Ling Wang and Jing Hu and Hui Jing and Zhengming Chen and N.
      Jain and C. Duy and S. Mistry and L. Cerchietti and J. Cross and L. Cantley
      and Michael R. Green and Hening Lin and A. Melnick},\n booktitle = {Cancer Cell},\n
      journal = {Cancer cell},\n pages = {\n          916-931.e9\n        },\n title
      = {Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis.},\n
      volume = {35 6},\n year = {2019}\n}\n"}, "authors": [{"authorId": "50651874",
      "name": "Meng Li"}, {"authorId": "50462482", "name": "Ying-Ling Chiang"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "79496189", "name": "Matt Teater"},
      {"authorId": "47728412", "name": "J. Hong"}, {"authorId": "2110770666", "name":
      "Hao Shen"}, {"authorId": "2151978477", "name": "Ling Wang"}, {"authorId": "2118517499",
      "name": "Jing Hu"}, {"authorId": "145782282", "name": "Hui Jing"}, {"authorId":
      "1410160150", "name": "Zhengming Chen"}, {"authorId": "50399566", "name": "N.
      Jain"}, {"authorId": "145546240", "name": "C. Duy"}, {"authorId": "36529561",
      "name": "S. Mistry"}, {"authorId": "6791438", "name": "L. Cerchietti"}, {"authorId":
      "4001772", "name": "J. Cross"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2272638745", "name": "Michael R. Green"}, {"authorId": "35643033",
      "name": "Hening Lin"}, {"authorId": "145150236", "name": "A. Melnick"}]}, {"paperId":
      "3cebf7ca2285f3b768c94019b39170d3d3c42917", "externalIds": {"MAG": "2953450966",
      "DOI": "10.1158/1538-7445.AM2019-3917", "CorpusId": 219269535}, "corpusId":
      219269535, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/3cebf7ca2285f3b768c94019b39170d3d3c42917",
      "title": "Abstract 3917: DoublePIK3CAmutations incisenhance oncogene activation
      and sensitivity to PI3K alpha inhibitors in breast cancer", "abstract": "Activating
      mutations in PIK3CA, the gene coding for the catalytic subunit (p110\u03b1)
      of phosphoinositide 3-kinase (PI3K), are the most frequent oncogenic alterations
      in all cancers, including estrogen receptor-positive (ER+) breast cancer. There
      are many distinct oncogenic PIK3CA mutations including major hotspot mutations
      (e.g. E542K, E545K, H1047R) which are predictive of response to PI3K\u03b1 inhibitors.
      While responses to PI3K\u03b1 inhibitors can be variable, some patients with
      single hotspot mutant tumors derive a deep and prolonged clinical benefit. In
      a comprehensive analysis of the genomic data available in breast cancer, we
      observed double PIK3CA mutations and investigated their potential biological
      relevance and potential correlation with sensitivity to PI3K\u03b1 inhibitors.
      We detected double PIK3CA mutations in 10-15% of all PIK3CA-mutant cancers including
      breast cancer. Double PIK3CA mutations in breast cancer are defined by a pattern
      of co-expression of a major hotspot mutation associated with a recurrent second-site
      PIK3CA mutation (\u2018minor mutation\u2019). We have found that these double
      PIK3CA mutations are compound, that is in cis on the same allele, using single
      molecule real time sequencing (SMRT-seq) of fresh breast tumor samples. Double
      compound PIK3CA mutations result in increased PI3K activity and downstream signaling
      compared to single hotspot mutants in nontransformed cells and in ER+ breast
      cancer cells. Double compound mutations also increase cell proliferation and
      xenograft growth compared to single hotspot mutants. Biochemical experiments
      using recombinant PI3K compound mutant protein complexes reveal a combination
      mechanism of action, with simultaneous PI3K destabilization and increased membrane
      binding compared to single hotspot mutants, leading to increased kinase activity.
      Importantly, these compound mutations predict for increased sensitivity to PI3K\u03b1
      inhibitors compared to single hotspot mutants in both preclinical models and
      also in patients with breast cancer. Together, our data support that double
      compound PIK3CA mutations enhance the oncogenicity of single hotspot PIK3CA
      mutations and this increased dependency results in increased sensitivity to
      PI3K\u03b1 inhibitors compared to single hotspot mutations. We propose that
      double compound activating mutations are an additional mechanism of oncogenic
      transformation in addition to other known mechanisms such as gene amplification,
      point mutation, or gene translocation. We speculate that double compound mutant
      PIK3CA may function as a clinical biomarker of increased sensitivity to PI3K-directed
      targeted therapies and may improve the therapeutic window of PI3K inhibitors
      in ER+ breast cancer and other PIK3CA-mutant tumor histologies. Citation Format:
      Neil Vasan, Pedram Razavi, Jared Johnson, Hong Shao, Hardik Shah, Alesia Antoine,
      Erik Ladewig, Alexander Gorelick, Eneda Toska, Guotai Xu, Abiha Kazmi, Matthew
      T. Chang, Barry S. Taylor, Maura N. Dickler, Komal Jhaveri, Raul Rabadan, Ed
      Reznik, Melissa L. Smith, Robert Sebra, Lewis C. Cantley, Maurizio Scaltriti,
      Jose Baselga. Double PIK3CA mutations in cis enhance oncogene activation and
      sensitivity to PI3K alpha inhibitors in breast cancer [abstract]. In: Proceedings
      of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar
      29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract
      nr 3917.", "venue": "Experimental and Molecular Therapeutics", "year": 2019,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2019-07-01", "journal": {"name": "Experimental and
      Molecular Therapeutics"}, "citationStyles": {"bibtex": "@Article{Vasan2019Abstract3D,\n
      author = {N. Vasan and P. Razavi and Jared L. Johnson and H. Shao and H. Shah
      and Alesia Antoine and Erik Ladewig and A. Gorelick and Eneda Toska and Guotai
      Xu and Abiha Kazmi and Matthew T. Chang and B. Taylor and M. Dickler and K.
      Jhaveri and R. Rabad\u00e1n and E. Reznik and M. Smith and R. Sebra and L. Cantley
      and M. Scaltriti and J. Baselga},\n booktitle = {Experimental and Molecular
      Therapeutics},\n journal = {Experimental and Molecular Therapeutics},\n title
      = {Abstract 3917: DoublePIK3CAmutations incisenhance oncogene activation and
      sensitivity to PI3K alpha inhibitors in breast cancer},\n year = {2019}\n}\n"},
      "authors": [{"authorId": "35123724", "name": "N. Vasan"}, {"authorId": "3224289",
      "name": "P. Razavi"}, {"authorId": "145916288", "name": "Jared L. Johnson"},
      {"authorId": "2959236", "name": "H. Shao"}, {"authorId": "49820132", "name":
      "H. Shah"}, {"authorId": "49335811", "name": "Alesia Antoine"}, {"authorId":
      "3139198", "name": "Erik Ladewig"}, {"authorId": "48892954", "name": "A. Gorelick"},
      {"authorId": "4733908", "name": "Eneda Toska"}, {"authorId": "51290929", "name":
      "Guotai Xu"}, {"authorId": "150907238", "name": "Abiha Kazmi"}, {"authorId":
      "2141904248", "name": "Matthew T. Chang"}, {"authorId": "36898514", "name":
      "B. Taylor"}, {"authorId": "4713308", "name": "M. Dickler"}, {"authorId": "47352468",
      "name": "K. Jhaveri"}, {"authorId": "40620158", "name": "R. Rabad\u00e1n"},
      {"authorId": "145632788", "name": "E. Reznik"}, {"authorId": "2116670076", "name":
      "M. Smith"}, {"authorId": "46517710", "name": "R. Sebra"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "8336319", "name": "M. Scaltriti"}, {"authorId":
      "144806171", "name": "J. Baselga"}]}, {"paperId": "4267d68ed03ff01b3144bb4a2c133a8196745624",
      "externalIds": {"MAG": "2982032674", "DOI": "10.1101/819961", "CorpusId": 208589901},
      "corpusId": 208589901, "publicationVenue": {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0",
      "name": "bioRxiv", "type": "journal", "url": "http://biorxiv.org/"}, "url":
      "https://www.semanticscholar.org/paper/4267d68ed03ff01b3144bb4a2c133a8196745624",
      "title": "Targeting the PI5P4K lipid kinase family in cancer using novel covalent
      inhibitors", "abstract": "The PI5P4Ks have been demonstrated to be important
      for cancer cell proliferation and other diseases. However, the therapeutic potential
      of targeting these kinases is understudied due to a lack of potent, specific
      small molecules available. Here we present the discovery and characterization
      of a novel pan-PI5P4K inhibitor, THZ-P1-2, that covalently targets cysteines
      on a disordered loop in PI5P4K\u03b1/\u03b2/\u03b3. THZ-P1-2 demonstrates cellular
      on-target engagement with limited off-targets across the kinome. AML/ALL cell
      lines were sensitive to THZ-P1-2, consistent with PI5P4K\u2019s reported role
      in leukemogenesis. THZ-P1-2 causes autophagosome clearance defects and upregulation
      in TFEB nuclear localization and target genes, disrupting autophagy in a covalent-dependent
      manner and phenocopying the effects of PI5P4K genetic deletion. Our studies
      demonstrate that PI5P4Ks are tractable targets, with THZ-P1-2 as a useful tool
      to further interrogate the therapeutic potential of PI5P4K inhibition and inform
      drug discovery campaigns for these lipid kinases in cancer metabolism and other
      autophagy-dependent disorders.", "venue": "bioRxiv", "year": 2019, "referenceCount":
      59, "citationCount": 2, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.biorxiv.org/content/biorxiv/early/2019/10/25/819961.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2019-10-25", "journal": {"name": "bioRxiv"}, "citationStyles": {"bibtex": "@Article{Sivakumaren2019TargetingTP,\n
      author = {S. Sivakumaren and Hyeseok Shim and Tinghu Zhang and F. Ferguson and
      Mark Lundquist and Christopher M Browne and H. Seo and M. Paddock and Theresa
      D. Manz and Theresa D. Manz and Baishan Jiang and Mingfeng Hao and P. Krishnan
      and Diana G. Wang and T. Yang and Nicholas Kwiatkowski and Nicholas Kwiatkowski
      and S. Ficarro and J. Cunningham and J. Marto and J. Marto and S. Dhe-Paganon
      and L. Cantley and N. Gray},\n booktitle = {bioRxiv},\n journal = {bioRxiv},\n
      title = {Targeting the PI5P4K lipid kinase family in cancer using novel covalent
      inhibitors},\n year = {2019}\n}\n"}, "authors": [{"authorId": "6443517", "name":
      "S. Sivakumaren"}, {"authorId": "13574443", "name": "Hyeseok Shim"}, {"authorId":
      "2262535", "name": "Tinghu Zhang"}, {"authorId": "11404167", "name": "F. Ferguson"},
      {"authorId": "49142390", "name": "Mark Lundquist"}, {"authorId": "39374687",
      "name": "Christopher M Browne"}, {"authorId": "91486080", "name": "H. Seo"},
      {"authorId": "4422893", "name": "M. Paddock"}, {"authorId": "16018077", "name":
      "Theresa D. Manz"}, {"authorId": "16018077", "name": "Theresa D. Manz"}, {"authorId":
      "7864101", "name": "Baishan Jiang"}, {"authorId": "11796890", "name": "Mingfeng
      Hao"}, {"authorId": "50822194", "name": "P. Krishnan"}, {"authorId": "152325571",
      "name": "Diana G. Wang"}, {"authorId": "2219789781", "name": "T. Yang"}, {"authorId":
      "6254222", "name": "Nicholas Kwiatkowski"}, {"authorId": "6254222", "name":
      "Nicholas Kwiatkowski"}, {"authorId": "2297254", "name": "S. Ficarro"}, {"authorId":
      "36406440", "name": "J. Cunningham"}, {"authorId": "2605597", "name": "J. Marto"},
      {"authorId": "2605597", "name": "J. Marto"}, {"authorId": "1400570681", "name":
      "S. Dhe-Paganon"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3977406", "name": "N. Gray"}]}, {"paperId": "545b1417bcc9098925a34151cd069f2114481cce",
      "externalIds": {"MAG": "2913208997", "DOI": "10.1194/jlr.S092130", "CorpusId":
      73416527, "PubMed": "30718284"}, "corpusId": 73416527, "publicationVenue": {"id":
      "1bf7bea6-6d70-4600-bae6-dbe7ac74bc80", "name": "Journal of Lipid Research",
      "type": "journal", "alternate_names": ["J Lipid Res"], "issn": "0022-2275",
      "url": "https://www.jlr.org/", "alternate_urls": ["http://www.jlr.org/", "http://www.jlr.org/contents-by-date.0.shtml"]},
      "url": "https://www.semanticscholar.org/paper/545b1417bcc9098925a34151cd069f2114481cce",
      "title": "Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing
      efficacy and overcoming resistance", "abstract": "The discovery of the phosphatidylinositol-3-kinase
      (PI3K) pathway was a major advance in understanding growth factor signaling.
      The high frequency of PI3K pathway mutations in many cancers has encouraged
      a new field targeting cancer driver mutations. Although there have been many
      successes, targeting PI3K itself has proven challenging, in part because of
      its multiple isoforms with distinct roles. Despite promising preclinical results,
      development of PI3K inhibitors as pharmacologic anticancer agents has been limited
      by modest single-agent efficacy and significant adverse effects. If we could
      overcome these limitations, PI3K inhibitors would be a powerful cancer-fighting
      tool. Data from phase III clinical trials yields insight into some of the problems
      with PI3K inhibitors. Recent advances have shed light on the mechanisms of tumor
      resistance to PI3K inhibitors via feedback pathways that cause elevated insulin
      levels that then activate the same PI3K pathways that are the targets of inhibition.
      Improving our understanding of the complex regulatory feedback pathways that
      activate in response to PI3K inhibition will reveal ways to increase the efficacy
      of PI3K inhibitors and reduce adverse effects, increasing the usefulness of
      this class as a treatment option for multiple cancer types. Graphical Abstract",
      "venue": "Journal of Lipid Research", "year": 2019, "referenceCount": 36, "citationCount":
      13, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.jlr.org/content/60/4/747.full.pdf", "status": null}, "fieldsOfStudy":
      ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2019-02-04", "journal": {"volume": "60", "pages": "747 -
      752", "name": "Journal of Lipid Research"}, "citationStyles": {"bibtex": "@Article{Paddock2019TreatingCW,\n
      author = {M. Paddock and S. Field and L. Cantley},\n booktitle = {Journal of
      Lipid Research},\n journal = {Journal of Lipid Research},\n pages = {747 - 752},\n
      title = {Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing
      efficacy and overcoming resistance},\n volume = {60},\n year = {2019}\n}\n"},
      "authors": [{"authorId": "4422893", "name": "M. Paddock"}, {"authorId": "123039768",
      "name": "S. Field"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "5e7ef7cefc2799b7b0bc9155b7273d9d59798e3f", "externalIds": {"CorpusId": 198974721},
      "corpusId": 198974721, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/5e7ef7cefc2799b7b0bc9155b7273d9d59798e3f",
      "title": "Vulnerabilities of PTEN \u2013 TP 53-Defi cient Prostate Cancers to
      Compound PARP \u2013 PI 3 K Inhibition", "abstract": "Prostate cancer is the
      most prevalent cancer in males, and treatment options are limited for advanced
      forms of the disease. Loss of the PTEN and TP53 tumor suppressor genes is commonly
      observed in prostate cancer, whereas their compound loss is often observed in
      advanced prostate cancer. Here, we show that PARP inhibition triggers a p53-dependent
      cellular senescence in a PTEN -defi cient setting in the prostate. Surprisingly,
      we also fi nd that PARPinduced cellular senescence is morphed into an apoptotic
      response upon compound loss of PTEN and p53. We further show that superactivation
      of the prosurvival PI3K\u2013AKT signaling pathway limits the effi cacy of a
      PARP single-agent treatment, and that PARP and PI3K inhibitors effectively synergize
      to suppress tumorigenesis in human prostate cancer cell lines and in a Pten
      / Trp53 \u2013defi cient mouse model of advanced prostate cancer. Our fi ndings,
      therefore, identify a combinatorial treatment with PARP and PI3K inhibitors
      as an effective option for PTEN -defi cient prostate cancer. SIGNIFICANCE: The
      paucity of therapeutic options in advanced prostate cancer displays an urgent
      need for the preclinical assessment of novel therapeutic strategies. We identifi
      ed differential therapeutic vulnerabilities that emerge upon the loss of both
      PTEN and p53, and observed that combined inhibition of PARP and PI3K provides
      increased effi cacy in hormone-insensitive advanced prostate cancer. Cancer
      Discov; 4(8); 896\u2013904. \u00a92014 AACR. Authors\u2019 Affi liations: 1
      Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of
      Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical
      School; 2 Department of Medicine; Divisions of 3 Hematology/Oncology and 4 Signal
      Transduction, Department of Medicine; 5 Preclinical Murine Pharmacogenetics
      Facility, Beth Israel Deaconess Medical Center; 6 Department of Pathology, Brigham
      and Women\u2019s Hospital; 7 Department of Systems Biology, Harvard Medical
      School; 8 Center for Molecular Oncologic Pathology; 9 Department of Medical
      Oncology, Dana-Farber Cancer Institute, Boston; 10 Broad Institute of Harvard
      and Massachusetts Institute of Technology, Cambridge, Massachusetts; and 11
      On leave of absence: Servicio de Hematolog\u00eda y Oncolog\u00eda M\u00e9dica,
      Hospital Universitario Morales Meseguer, Murcia, Spain Note: Supplementary data
      for this article are available at Cancer Discovery Online (http://cancerdiscovery.aacrjournals.org/).
      E. Gonz\u00e1lez-Billalabeitia and N. Seitzer contributed equally to this work.
      Corresponding Author: Pier Paolo Pandolfi , Cancer Genetics Program, Beth Israel
      Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical
      Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215. Phone:
      617-735-2121/2141; Fax: 617-735-2120; E-mail: ppandolf@bidmc.harvard.edu doi:
      10.1158/2159-8290.CD-13-0230 \u00a92014 American Association for Cancer Research.
      INTRODUCTION There is an urgent need for the development of novel successful
      strategies for advanced prostate cancer to improve patient outcomes ( 1, 2 ).
      The loss of at least one allele of phosphatase and tensin homolog deleted on
      chromosome 10 ( PTEN ) is observed in more than 40% of prostate cancers ( 3,
      4 ). As a lipid phosphatase, PTEN suppresses the activation of the PI3K\u2013AKT
      signaling cascade that is a central proto-oncogenic signaling on June 11, 2019.
      \u00a9 2014 American Association for Cancer Research. cancerdiscovery.aacrjournals.org
      Downloaded from Published OnlineFirst May 27, 2014; DOI: 10.1158/2159-8290.CD-13-0230",
      "venue": "", "year": 2019, "referenceCount": 23, "citationCount": 4, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Gonzalez-Billalabeitia2019VulnerabilitiesOP,\n
      author = {E. Gonzalez-Billalabeitia and N. Seitzer and S. Song and M. Song and
      Akash Patnaik and Xue-Song Liu and M. Epping and A. Papa and R. Hobbs and Ming
      Chen and A. Lunardi and Christopher Ng and Kaitlyn A. Webster and S. Signoretti
      and M. Loda and J. Asara and C. Nardella and J. Clohessy and L. Cantley and
      P. Pandolfi},\n title = {Vulnerabilities of PTEN \u2013 TP 53-Defi cient Prostate
      Cancers to Compound PARP \u2013 PI 3 K Inhibition},\n year = {2019}\n}\n"},
      "authors": [{"authorId": "1398122926", "name": "E. Gonzalez-Billalabeitia"},
      {"authorId": "3793357", "name": "N. Seitzer"}, {"authorId": "9673009", "name":
      "S. Song"}, {"authorId": "2967391", "name": "M. Song"}, {"authorId": "40501341",
      "name": "Akash Patnaik"}, {"authorId": "8015447", "name": "Xue-Song Liu"}, {"authorId":
      "4276612", "name": "M. Epping"}, {"authorId": "5380009", "name": "A. Papa"},
      {"authorId": "4584039", "name": "R. Hobbs"}, {"authorId": "48622732", "name":
      "Ming Chen"}, {"authorId": "5729169", "name": "A. Lunardi"}, {"authorId": "6294709",
      "name": "Christopher Ng"}, {"authorId": "4817196", "name": "Kaitlyn A. Webster"},
      {"authorId": "7505152", "name": "S. Signoretti"}, {"authorId": "6213932", "name":
      "M. Loda"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "3547827",
      "name": "C. Nardella"}, {"authorId": "4102988", "name": "J. Clohessy"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4499580", "name": "P. Pandolfi"}]},
      {"paperId": "61f48f0d697a528e61079ac6c6009f4ca553fb47", "externalIds": {"MAG":
      "2975233555", "DOI": "10.1016/j.ccell.2019.08.006", "CorpusId": 203608586, "PubMed":
      "31564638"}, "corpusId": 203608586, "publicationVenue": {"id": "11e469cb-37ad-487e-b0ab-d26e82037c22",
      "name": "Cancer Cell", "type": "journal", "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/61f48f0d697a528e61079ac6c6009f4ca553fb47",
      "title": "Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential
      for Acquisition of Aggressive Traits and Metastatic Colonization.", "abstract":
      null, "venue": "Cancer Cell", "year": 2019, "referenceCount": 88, "citationCount":
      52, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1535610819303745/pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-10-01", "journal":
      {"name": "Cancer cell"}, "citationStyles": {"bibtex": "@Article{Gomes2019DynamicIO,\n
      author = {Ana P. Gomes and Didem Ilter and V. Low and Adam Rosenzweig and Zih-Jie
      Shen and Tanya Schild and Mart\u00edn A. Rivas and E. E. Er and Dylan R McNally
      and A. Mutvei and Julie Han and Yi-Hung Ou and Paola Cavaliere and Edouard Mullarky
      and Michal J. Nagiec and Sejeong Shin and Sang-Oh Yoon and Noah E. Dephoure
      and J. Massagu\u00e9 and A. Melnick and L. Cantley and J. Tyler and J. Blenis},\n
      booktitle = {Cancer Cell},\n journal = {Cancer cell},\n title = {Dynamic Incorporation
      of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive
      Traits and Metastatic Colonization.},\n year = {2019}\n}\n"}, "authors": [{"authorId":
      "2087116099", "name": "Ana P. Gomes"}, {"authorId": "3324022", "name": "Didem
      Ilter"}, {"authorId": "121128193", "name": "V. Low"}, {"authorId": "1887417083",
      "name": "Adam Rosenzweig"}, {"authorId": "50530764", "name": "Zih-Jie Shen"},
      {"authorId": "50356549", "name": "Tanya Schild"}, {"authorId": "143749460",
      "name": "Mart\u00edn A. Rivas"}, {"authorId": "48004390", "name": "E. E. Er"},
      {"authorId": "1381392860", "name": "Dylan R McNally"}, {"authorId": "5135907",
      "name": "A. Mutvei"}, {"authorId": "1886508939", "name": "Julie Han"}, {"authorId":
      "50051932", "name": "Yi-Hung Ou"}, {"authorId": "47026720", "name": "Paola Cavaliere"},
      {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId": "37644389",
      "name": "Michal J. Nagiec"}, {"authorId": "3592587", "name": "Sejeong Shin"},
      {"authorId": "6168327", "name": "Sang-Oh Yoon"}, {"authorId": "4622316", "name":
      "Noah E. Dephoure"}, {"authorId": "32314188", "name": "J. Massagu\u00e9"}, {"authorId":
      "145150236", "name": "A. Melnick"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "143917917", "name": "J. Tyler"}, {"authorId": "4037343", "name":
      "J. Blenis"}]}, {"paperId": "631e702c51d2c9b1a00a14fd00aa833d1df16ae2", "externalIds":
      {"MAG": "2994107797", "DOI": "10.1016/j.celrep.2019.10.117", "CorpusId": 208646787,
      "PubMed": "31801093"}, "corpusId": 208646787, "publicationVenue": {"id": "a3fb5dc1-0d6e-4cd0-a720-8cb68cbf6486",
      "name": "Cell Reports", "type": "journal", "alternate_names": ["Cell Rep"],
      "issn": "2211-1247", "url": "https://www.cell.com/cell-reports/home", "alternate_urls":
      ["http://cellreports.cell.com/"]}, "url": "https://www.semanticscholar.org/paper/631e702c51d2c9b1a00a14fd00aa833d1df16ae2",
      "title": "Quantitative In\u00a0Vivo Proteomics of Metformin Response in Liver
      Reveals AMPK-Dependent and -Independent Signaling Networks.", "abstract": null,
      "venue": "Cell Reports", "year": 2019, "referenceCount": 111, "citationCount":
      28, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S2211124719314500/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine", "Chemistry"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "external"}, {"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-12-01", "journal":
      {"volume": "29 10", "pages": "\n          3331-3348.e7\n        ", "name": "Cell
      reports"}, "citationStyles": {"bibtex": "@Article{Stein2019QuantitativeIV,\n
      author = {Benjamin D. Stein and Diego Calzolari and Kristina Hellberg and Ying
      S. Hu and Lin He and C. Hung and E. Q. Toyama and Debbie S. Ross and Bj\u00f6rn
      F. Lillemeier and L. Cantley and J. Yates and R. Shaw},\n booktitle = {Cell
      Reports},\n journal = {Cell reports},\n pages = {\n          3331-3348.e7\n        },\n
      title = {Quantitative In\u00a0Vivo Proteomics of Metformin Response in Liver
      Reveals AMPK-Dependent and -Independent Signaling Networks.},\n volume = {29
      10},\n year = {2019}\n}\n"}, "authors": [{"authorId": "40353456", "name": "Benjamin
      D. Stein"}, {"authorId": "3095517", "name": "Diego Calzolari"}, {"authorId":
      "47088230", "name": "Kristina Hellberg"}, {"authorId": "49994864", "name": "Ying
      S. Hu"}, {"authorId": "2112501583", "name": "Lin He"}, {"authorId": "11153400",
      "name": "C. Hung"}, {"authorId": "7252928", "name": "E. Q. Toyama"}, {"authorId":
      "4088273", "name": "Debbie S. Ross"}, {"authorId": "3960161", "name": "Bj\u00f6rn
      F. Lillemeier"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "143613691", "name": "J. Yates"}, {"authorId": "4426388", "name": "R. Shaw"}]},
      {"paperId": "638dda37bbc4ca0c75e635a75dd696c6d678d76a", "externalIds": {"MAG":
      "2989982593", "DOI": "10.1016/j.bbrc.2019.11.130", "CorpusId": 208536464, "PubMed":
      "31787239"}, "corpusId": 208536464, "publicationVenue": {"id": "1a9c698b-7fe4-4444-b391-208b4b2326e2",
      "name": "Biochemical and Biophysical Research Communications - BBRC", "type":
      "journal", "alternate_names": ["Biochem Biophys Res Commun", "Biochemical and
      Biophysical Research Communications", "Biochem Biophys Res Commun  BBRC"], "issn":
      "0006-291X", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description",
      "alternate_urls": ["http://www.idealibrary.com/links/toc/bbrc", "https://www.journals.elsevier.com/biochemical-and-biophysical-research-communications/",
      "http://www.sciencedirect.com/science/journal/0006291X"]}, "url": "https://www.semanticscholar.org/paper/638dda37bbc4ca0c75e635a75dd696c6d678d76a",
      "title": "A covalent small molecule inhibitor of glutamate-oxaloacetate transaminase
      1 impairs pancreatic cancer growth.", "abstract": null, "venue": "Biochemical
      and Biophysical Research Communications - BBRC", "year": 2019, "referenceCount":
      21, "citationCount": 30, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2019-11-28", "journal": {"name": "Biochemical and biophysical
      research communications"}, "citationStyles": {"bibtex": "@Article{Yoshida2019ACS,\n
      author = {Tomohiro Yoshida and S. Yamasaki and O. Kaneko and Naofumi Taoka and
      Y. Tomimoto and I. Namatame and Toshiko Yahata and S. Kuromitsu and L. Cantley
      and C. Lyssiotis},\n booktitle = {Biochemical and Biophysical Research Communications
      - BBRC},\n journal = {Biochemical and biophysical research communications},\n
      title = {A covalent small molecule inhibitor of glutamate-oxaloacetate transaminase
      1 impairs pancreatic cancer growth.},\n year = {2019}\n}\n"}, "authors": [{"authorId":
      "1439474141", "name": "Tomohiro Yoshida"}, {"authorId": "2054062334", "name":
      "S. Yamasaki"}, {"authorId": "2061019033", "name": "O. Kaneko"}, {"authorId":
      "47819651", "name": "Naofumi Taoka"}, {"authorId": "48259254", "name": "Y. Tomimoto"},
      {"authorId": "10280879", "name": "I. Namatame"}, {"authorId": "1439712317",
      "name": "Toshiko Yahata"}, {"authorId": "9541523", "name": "S. Kuromitsu"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4901222", "name":
      "C. Lyssiotis"}]}, {"paperId": "6d532f6d1aa7ee773657e1e0b83c3950dc2a4c73", "externalIds":
      {"MAG": "2982786587", "DOI": "10.1126/science.aaw9032", "CorpusId": 207943491,
      "PubMed": "31699932"}, "corpusId": 207943491, "publicationVenue": {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad",
      "name": "Science", "type": "journal", "issn": "0193-4511", "alternate_issns":
      ["0036-8075"], "url": "https://www.jstor.org/journal/science", "alternate_urls":
      ["https://www.sciencemag.org/", "http://www.sciencemag.org/", "http://www.jstor.org/journals/00368075.html",
      "http://www.sciencemag.org/archive/"]}, "url": "https://www.semanticscholar.org/paper/6d532f6d1aa7ee773657e1e0b83c3950dc2a4c73",
      "title": "Double PIK3CA mutations in cis increase oncogenicity and sensitivity
      to PI3K\u03b1 inhibitors", "abstract": "Seeing double can be a good thing Many
      human breast cancers harbor activating mutations in PIK3CA, the gene coding
      for the catalytic subunit of phosphoinositide 3-kinase (PI3K). Clinical trials
      are underway to evaluate the efficacy of PI3K inhibitors in cancer patients.
      Vasan et al. found unexpectedly that a subset of breast cancers harbor not one\u2014but
      two\u2014PIK3CA mutations, and the mutations occur on the same allele (see the
      Perspective by Toker). In model systems, the double mutations hyperactivate
      PI3K signaling and enhance tumor growth. Preliminary analysis of clinical trial
      data suggests that breast cancers with double mutations are more responsive
      to PI3K inhibitors than those with a single mutation. PIK3CA mutational status
      could help identify the breast cancer patients most likely to benefit from these
      drugs. Science, this issue p. 714; see also p. 685 Activating mutations in PIK3CA
      are frequent in human breast cancer, and phosphoinositide 3-kinase alpha (PI3K\u03b1)
      inhibitors have been approved for therapy. To characterize determinants of sensitivity
      to these agents, we analyzed PIK3CA-mutant cancer genomes and observed the presence
      of multiple PIK3CA mutations in 12 to 15% of breast cancers and other tumor
      types, most of which (95%) are double mutations. Double PIK3CA mutations are
      in cis on the same allele and result in increased PI3K activity, enhanced downstream
      signaling, increased cell proliferation, and tumor growth. The biochemical mechanisms
      of dual mutations include increased disruption of p110\u03b1 binding to the
      inhibitory subunit p85\u03b1, which relieves its catalytic inhibition, and increased
      p110\u03b1 membrane lipid binding. Double PIK3CA mutations predict increased
      sensitivity to PI3K\u03b1 inhibitors compared with single-hotspot mutations.
      Some breast cancers harbor not one\u2014but two\u2014PIK3CA mutations, and this
      enhances their response to certain drugs.", "venue": "Science", "year": 2019,
      "referenceCount": 74, "citationCount": 154, "influentialCitationCount": 10,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc7173400?pdf=render",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2019-11-07", "journal": {"volume": "366", "pages": "714
      - 723", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Vasan2019DoublePM,\n
      author = {N. Vasan and P. Razavi and Jared L. Johnson and H. Shao and H. Shah
      and Alesia Antoine and Erik Ladewig and A. Gorelick and Ting-Yu Lin and Eneda
      Toska and Guotai Xu and Abiha Kazmi and Matthew T. Chang and B. Taylor and M.
      Dickler and K. Jhaveri and S. Chandarlapaty and R. Rabad\u00e1n and E. Reznik
      and M. Smith and R. Sebra and F. Schimmoller and T. Wilson and L. Friedman and
      L. Cantley and M. Scaltriti and J. Baselga},\n booktitle = {Science},\n journal
      = {Science},\n pages = {714 - 723},\n title = {Double PIK3CA mutations in cis
      increase oncogenicity and sensitivity to PI3K\u03b1 inhibitors},\n volume =
      {366},\n year = {2019}\n}\n"}, "authors": [{"authorId": "35123724", "name":
      "N. Vasan"}, {"authorId": "3224289", "name": "P. Razavi"}, {"authorId": "145916288",
      "name": "Jared L. Johnson"}, {"authorId": "2959236", "name": "H. Shao"}, {"authorId":
      "49820132", "name": "H. Shah"}, {"authorId": "49335811", "name": "Alesia Antoine"},
      {"authorId": "3139198", "name": "Erik Ladewig"}, {"authorId": "48892954", "name":
      "A. Gorelick"}, {"authorId": "144181325", "name": "Ting-Yu Lin"}, {"authorId":
      "4733908", "name": "Eneda Toska"}, {"authorId": "51290929", "name": "Guotai
      Xu"}, {"authorId": "150907238", "name": "Abiha Kazmi"}, {"authorId": "2141904248",
      "name": "Matthew T. Chang"}, {"authorId": "36898514", "name": "B. Taylor"},
      {"authorId": "4713308", "name": "M. Dickler"}, {"authorId": "47352468", "name":
      "K. Jhaveri"}, {"authorId": "6037809", "name": "S. Chandarlapaty"}, {"authorId":
      "40620158", "name": "R. Rabad\u00e1n"}, {"authorId": "145632788", "name": "E.
      Reznik"}, {"authorId": "2116670076", "name": "M. Smith"}, {"authorId": "46517710",
      "name": "R. Sebra"}, {"authorId": "5323777", "name": "F. Schimmoller"}, {"authorId":
      "2017652", "name": "T. Wilson"}, {"authorId": "48530297", "name": "L. Friedman"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "8336319", "name":
      "M. Scaltriti"}, {"authorId": "144806171", "name": "J. Baselga"}]}, {"paperId":
      "71ee96dbf928c1ff5bb600f55ea8afb2feb77e6c", "externalIds": {"MAG": "2908494180",
      "PubMedCentral": "6356657", "DOI": "10.3390/cancers11010037", "CorpusId": 58619743,
      "PubMed": "30609754"}, "corpusId": 58619743, "publicationVenue": {"id": "d30776c0-e524-4f14-a524-871d0586862c",
      "name": "Cancers", "type": "journal", "issn": "2072-6694", "url": "http://www.e-helvetica.nb.admin.ch/directAccess?callnumber=bel-154879",
      "alternate_urls": ["http://nbn-resolving.de/urn/resolver.pl?urn=urn:nbn:ch:bel-154879",
      "https://www.mdpi.com/journal/cancers"]}, "url": "https://www.semanticscholar.org/paper/71ee96dbf928c1ff5bb600f55ea8afb2feb77e6c",
      "title": "Rac-Mediated Macropinocytosis of Extracellular Protein Promotes Glucose
      Independence in Non-Small Cell Lung Cancer", "abstract": "Cancer cells can adapt
      to nutrient poor conditions by rewiring their metabolism and using alternate
      fuel sources. Identifying these adaptive metabolic pathways may provide novel
      targets for cancer therapy. Here, we identify a subset of non-small cell lung
      cancer (NSCLC) cell lines that survive in the absence of glucose by internalizing
      and metabolizing extracellular protein via macropinocytosis. Macropinocytosis
      is increased in these glucose independent cells, and is regulated by phosphoinositide
      3-kinase (PI3K) activation of Rac-Pak signaling. Furthermore, inhibition of
      Rac-dependent macropinocytosis blocks glucose-independent proliferation. We
      find that degradation of internalized protein produces amino acids, including
      alanine, which generates TCA cycle and glycolytic intermediates in the absence
      of glucose. In this process, the conversion of alanine to pyruvate by alanine
      transaminase 2 (ALT2) is critical for survival during glucose starvation. Collectively,
      Rac driven macropinocytosis of extracellular protein is an adaptive metabolic
      pathway used by a subset of lung cancers to survive states of glucose deprivation,
      and may serve as a potential drug target for cancer therapy.", "venue": "Cancers",
      "year": 2019, "referenceCount": 64, "citationCount": 37, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.mdpi.com/2072-6694/11/1/37/pdf?version=1546497470",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2019-01-01", "journal": {"volume": "11", "name": "Cancers"},
      "citationStyles": {"bibtex": "@Article{Hodakoski2019RacMediatedMO,\n author
      = {Cindy Hodakoski and B. Hopkins and Guoan Zhang and Taojunfeng Su and Zhe
      Cheng and R. Morris and K. Rhee and M. Goncalves and L. Cantley},\n booktitle
      = {Cancers},\n journal = {Cancers},\n title = {Rac-Mediated Macropinocytosis
      of Extracellular Protein Promotes Glucose Independence in Non-Small Cell Lung
      Cancer},\n volume = {11},\n year = {2019}\n}\n"}, "authors": [{"authorId": "7331238",
      "name": "Cindy Hodakoski"}, {"authorId": "48821307", "name": "B. Hopkins"},
      {"authorId": "49288368", "name": "Guoan Zhang"}, {"authorId": "41096321", "name":
      "Taojunfeng Su"}, {"authorId": "2113278909", "name": "Zhe Cheng"}, {"authorId":
      "29869805", "name": "R. Morris"}, {"authorId": "4097554", "name": "K. Rhee"},
      {"authorId": "145524334", "name": "M. Goncalves"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "7c8465ae4bb9c9628afd90cabf5555d91e7d43aa", "externalIds":
      {"MAG": "2921937041", "DOI": "10.1158/1538-7445.SABCS18-TS2-1", "CorpusId":
      87124605}, "corpusId": 87124605, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/7c8465ae4bb9c9628afd90cabf5555d91e7d43aa",
      "title": "Abstract TS2-1: The complexity of targeting PI3K for cancer therapy",
      "abstract": "Phosphoinositide 3-Kinase (PI3K) is activated by insulin and other
      growth factors to mediate cell growth. The PI3K enzyme encoded by the PIK3CA
      gene is one of the most frequently mutated oncogenes in human cancer. This same
      enzyme mediates insulin responses in liver, muscle, fat and other tissues. The
      most common mutations in this gene enhance the ability of PI3K to be activated
      by insulin. Since breast cancers typically express relatively high levels of
      the insulin receptor, high serum insulin levels are likely to enhance activation
      of PI3K in breast cancers. PI3K inhibitors that target PIK3CA have the expected
      physiological effect of raising serum glucose and insulin levels and the elevated
      insulin is likely to compromise the effectiveness of therapy. Data will be presented
      showing that in mouse models of human breast cancers and other cancers, dietary
      interventions and pharmaceutical interventions that limit elevation of serum
      insulin during PI3K therapy improve responses to PI3K inhibitors. Citation Format:
      Cantley L. The complexity of targeting PI3K for cancer therapy [abstract]. In:
      Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San
      Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr
      TS2-1.", "venue": "Invited Speaker Abstracts", "year": 2019, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2019-02-15", "journal": {"name":
      "Invited Speaker Abstracts"}, "citationStyles": {"bibtex": "@Article{Cantley2019AbstractTT,\n
      author = {L. Cantley},\n booktitle = {Invited Speaker Abstracts},\n journal
      = {Invited Speaker Abstracts},\n title = {Abstract TS2-1: The complexity of
      targeting PI3K for cancer therapy},\n year = {2019}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "8133bedd80d6d8bfd87f5a07f4fd578cca72603c",
      "externalIds": {"MAG": "2985502989", "DOI": "10.1002/ijc.32783", "CorpusId":
      207939132, "PubMed": "31714586"}, "corpusId": 207939132, "publicationVenue":
      {"id": "a71ca720-16ee-4930-9112-7e88084f2312", "name": "International Journal
      of Cancer", "type": "journal", "alternate_names": ["Int J Cancer"], "issn":
      "0020-7136", "url": "http://www.interscience.wiley.com/jpages/0020-7136/", "alternate_urls":
      ["https://onlinelibrary.wiley.com/journal/10970215", "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215"]},
      "url": "https://www.semanticscholar.org/paper/8133bedd80d6d8bfd87f5a07f4fd578cca72603c",
      "title": "Phase II, 2\u2010stage, 2\u2010arm, PIK3CA mutation stratified trial
      of MK\u20102206 in recurrent endometrial cancer", "abstract": "Endometrial cancers
      have high rates of phosphoinositide 3\u2010kinase (PI3K) pathway alterations.
      MK\u20102206 is an allosteric inhibitor of AKT, an effector kinase of PI3K signals.
      We hypothesized patients with tumors harboring PIK3CA mutations would be more
      likely to benefit from MK\u20102206 than those without PIK3CA mutation. A Phase
      II study was performed in patients with recurrent endometrial cancer; all histologies
      except carcinosarcoma were eligible. Up to two prior chemotherapy lines were
      permitted, excluding prior treatment with PI3K pathway inhibitors. The first
      18 patients were treated with MK\u20102206 200\u2009mg weekly. Due to unacceptable
      toxicity, dose was reduced to 135\u2009mg. Co\u2010primary endpoints were objective
      response rate (ORR) and progression\u2010free survival at 6 months (6moPFS).
      Thirty\u2010seven patients were enrolled (one ineligible). By somatic PIK3CA
      mutation analysis, nine patients were mutant (MT) [one with partial response
      (PR)/6moPFS, two with 6moPFS]. Twenty\u2010seven patients were wild\u2010type
      (WT) (one PR and four 6moPFS). Most common toxicities were rash (44%), fatigue
      (41%), nausea (42%) and hyperglycemia (31%). Grade 3 and 4 toxicities occurred
      in 25 and 17% of patients, respectively. Exploratory analysis found serous histology
      had greater 6moPFS as compared to all other histologies (5/8 vs. 2/28, p =\u20090.003).
      PTEN expression was associated with median time to progression (p =\u20090.04).
      No other significant associations with PI3K pathway alterations were identified.
      There is limited single agent activity of MK\u20102206 in PIK3CA MT and PIK3CA
      WT endometrial cancer populations. Activity was detected in patients with serous
      histology and due to their poor outcomes warrants further study (NCT01307631).",
      "venue": "International Journal of Cancer", "year": 2019, "referenceCount":
      32, "citationCount": 28, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-11-12", "journal":
      {"volume": "147", "name": "International Journal of Cancer"}, "citationStyles":
      {"bibtex": "@Article{Myers2019PhaseI2,\n author = {A. Myers and P. Konstantinopoulos
      and W. Barry and W. Luo and R. Broaddus and V. Makker and R. Drapkin and Joyce
      F. Liu and A. Doyle and N. Horowitz and F. Meric-Bernstam and M. Birrer and
      C. Aghajanian and R. Coleman and G. Mills and L. Cantley and U. Matulonis and
      S. Westin},\n booktitle = {International Journal of Cancer},\n journal = {International
      Journal of Cancer},\n title = {Phase II, 2\u2010stage, 2\u2010arm, PIK3CA mutation
      stratified trial of MK\u20102206 in recurrent endometrial cancer},\n volume
      = {147},\n year = {2019}\n}\n"}, "authors": [{"authorId": "6324437", "name":
      "A. Myers"}, {"authorId": "49610180", "name": "P. Konstantinopoulos"}, {"authorId":
      "143997654", "name": "W. Barry"}, {"authorId": "4146119", "name": "W. Luo"},
      {"authorId": "6416382", "name": "R. Broaddus"}, {"authorId": "3553012", "name":
      "V. Makker"}, {"authorId": "5340828", "name": "R. Drapkin"}, {"authorId": "2108419806",
      "name": "Joyce F. Liu"}, {"authorId": "2523814", "name": "A. Doyle"}, {"authorId":
      "8523393", "name": "N. Horowitz"}, {"authorId": "1397965147", "name": "F. Meric-Bernstam"},
      {"authorId": "2167106", "name": "M. Birrer"}, {"authorId": "6128162", "name":
      "C. Aghajanian"}, {"authorId": "3124983", "name": "R. Coleman"}, {"authorId":
      "2241330", "name": "G. Mills"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "6927295", "name": "U. Matulonis"}, {"authorId": "2974900", "name":
      "S. Westin"}]}, {"paperId": "9929df74a7789e0bf73699a7ceb5cd2b0bf0b1a1", "externalIds":
      {"PubMedCentral": "6414673", "MAG": "2921326512", "DOI": "10.1038/s41598-019-40950-7",
      "CorpusId": 75138869, "PubMed": "30862944"}, "corpusId": 75138869, "publicationVenue":
      {"id": "f99f77b7-b1b6-44d3-984a-f288e9884b9b", "name": "Scientific Reports",
      "type": "journal", "alternate_names": ["Sci Rep"], "issn": "2045-2322", "url":
      "http://www.nature.com/srep/", "alternate_urls": ["http://www.nature.com/srep/index.html"]},
      "url": "https://www.semanticscholar.org/paper/9929df74a7789e0bf73699a7ceb5cd2b0bf0b1a1",
      "title": "Regulation of folate and methionine metabolism by multisite phosphorylation
      of human methylenetetrahydrofolate reductase", "abstract": null, "venue": "Scientific
      Reports", "year": 2019, "referenceCount": 28, "citationCount": 22, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/s41598-019-40950-7.pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-03-12", "journal":
      {"volume": "9", "name": "Scientific Reports"}, "citationStyles": {"bibtex":
      "@Article{Zheng2019RegulationOF,\n author = {Yuxiang Zheng and Shivan Ramsamooj
      and Qian Li and Jared L. Johnson and Tomer M. Yaron and Klaus Sharra and L.
      Cantley},\n booktitle = {Scientific Reports},\n journal = {Scientific Reports},\n
      title = {Regulation of folate and methionine metabolism by multisite phosphorylation
      of human methylenetetrahydrofolate reductase},\n volume = {9},\n year = {2019}\n}\n"},
      "authors": [{"authorId": "1723564", "name": "Yuxiang Zheng"}, {"authorId": "14390729",
      "name": "Shivan Ramsamooj"}, {"authorId": "2146274806", "name": "Qian Li"},
      {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId": "5247030",
      "name": "Tomer M. Yaron"}, {"authorId": "82239758", "name": "Klaus Sharra"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "c11be0f675f6355e027f1bfb270824da7a5312f3",
      "externalIds": {"DOI": "10.1158/1078-0432.CCR-18-4269", "CorpusId": 73496753,
      "PubMed": "30770491"}, "corpusId": 73496753, "publicationVenue": {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0",
      "name": "Clinical Cancer Research", "type": "journal", "alternate_names": ["Clin
      Cancer Res"], "issn": "1078-0432", "url": "https://clincancerres.aacrjournals.org/",
      "alternate_urls": ["http://clincancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/c11be0f675f6355e027f1bfb270824da7a5312f3",
      "title": "Correction: PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide
      3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive
      to PI3K\u03b1 Inhibitors", "abstract": null, "venue": "Clinical Cancer Research",
      "year": 2019, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-02-15", "journal":
      {"volume": "25", "pages": "1432 - 1432", "name": "Clinical Cancer Research"},
      "citationStyles": {"bibtex": "@Article{Croessmann2019CorrectionPC,\n author
      = {Sarah Croessmann and J. Sheehan and Kyung-min Lee and Gregory Sliwoski and
      Ji\u00e9 He and R. Nagy and David A Riddle and I. Mayer and J. Balko and R.
      Lanman and V. Miller and L. Cantley and J. Meiler and C. Arteaga},\n booktitle
      = {Clinical Cancer Research},\n journal = {Clinical Cancer Research},\n pages
      = {1432 - 1432},\n title = {Correction: PIK3CA C2 Domain Deletions Hyperactivate
      Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely
      Sensitive to PI3K\u03b1 Inhibitors},\n volume = {25},\n year = {2019}\n}\n"},
      "authors": [{"authorId": "5404128", "name": "Sarah Croessmann"}, {"authorId":
      "6251014", "name": "J. Sheehan"}, {"authorId": "46542827", "name": "Kyung-min
      Lee"}, {"authorId": "3381467", "name": "Gregory Sliwoski"}, {"authorId": "50774890",
      "name": "Ji\u00e9 He"}, {"authorId": "39540895", "name": "R. Nagy"}, {"authorId":
      "82059310", "name": "David A Riddle"}, {"authorId": "2346140", "name": "I. Mayer"},
      {"authorId": "66935619", "name": "J. Balko"}, {"authorId": "3484938", "name":
      "R. Lanman"}, {"authorId": "2134288", "name": "V. Miller"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "1754226", "name": "J. Meiler"}, {"authorId":
      "2057460", "name": "C. Arteaga"}]}, {"paperId": "d5e9bb8cfc867603a88d4765516a87d199a8c102",
      "externalIds": {"MAG": "2955973158", "PubMedCentral": "6612080", "DOI": "10.1186/s13058-019-1154-8",
      "CorpusId": 195804282, "PubMed": "31277699"}, "corpusId": 195804282, "publicationVenue":
      {"id": "1290af6c-c79c-4253-8957-8db4a6069766", "name": "Breast Cancer Research",
      "type": "journal", "alternate_names": ["Breast Cancer Res"], "issn": "1465-5411",
      "url": "http://breast-cancer-research.com/"}, "url": "https://www.semanticscholar.org/paper/d5e9bb8cfc867603a88d4765516a87d199a8c102",
      "title": "Phase II trial of AKT inhibitor MK-2206 in patients with advanced
      breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN
      mutation", "abstract": null, "venue": "Breast Cancer Research", "year": 2019,
      "referenceCount": 32, "citationCount": 132, "influentialCitationCount": 2, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-019-1154-8",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-07-05", "journal":
      {"volume": "21", "name": "Breast Cancer Research : BCR"}, "citationStyles":
      {"bibtex": "@Article{Xing2019PhaseIT,\n author = {Y. Xing and N. Lin and M.
      Maurer and M. Maurer and Huiqin Chen and A. Mahvash and A. Sahin and A. Akcakanat
      and Yisheng Li and V. Abramson and J. Litton and M. Ch\u00e1vez-MacGregor and
      V. Valero and S. Piha-Paul and D. Hong and K. Do and E. Tarco and Dianna Riall
      and A. K. Eterovic and G. Wulf and L. Cantley and G. Mills and L. Doyle and
      E. Winer and G. Hortobagyi and A. Gonz\u00e1lez-Angulo and F. Meric-Bernstam},\n
      booktitle = {Breast Cancer Research},\n journal = {Breast Cancer Research :
      BCR},\n title = {Phase II trial of AKT inhibitor MK-2206 in patients with advanced
      breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN
      mutation},\n volume = {21},\n year = {2019}\n}\n"}, "authors": [{"authorId":
      "145712222", "name": "Y. Xing"}, {"authorId": "144650470", "name": "N. Lin"},
      {"authorId": "144226560", "name": "M. Maurer"}, {"authorId": "144226560", "name":
      "M. Maurer"}, {"authorId": "49177752", "name": "Huiqin Chen"}, {"authorId":
      "5314564", "name": "A. Mahvash"}, {"authorId": "2676017", "name": "A. Sahin"},
      {"authorId": "6046757", "name": "A. Akcakanat"}, {"authorId": "2111151410",
      "name": "Yisheng Li"}, {"authorId": "2186029", "name": "V. Abramson"}, {"authorId":
      "3219926", "name": "J. Litton"}, {"authorId": "1390005035", "name": "M. Ch\u00e1vez-MacGregor"},
      {"authorId": "116205756", "name": "V. Valero"}, {"authorId": "1422512895", "name":
      "S. Piha-Paul"}, {"authorId": "2788997", "name": "D. Hong"}, {"authorId": "145302986",
      "name": "K. Do"}, {"authorId": "5285731", "name": "E. Tarco"}, {"authorId":
      "1417281255", "name": "Dianna Riall"}, {"authorId": "2927324", "name": "A. K.
      Eterovic"}, {"authorId": "31554501", "name": "G. Wulf"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2241330", "name": "G. Mills"}, {"authorId":
      "39667616", "name": "L. Doyle"}, {"authorId": "2369378", "name": "E. Winer"},
      {"authorId": "4172107", "name": "G. Hortobagyi"}, {"authorId": "1398194828",
      "name": "A. Gonz\u00e1lez-Angulo"}, {"authorId": "1397965147", "name": "F. Meric-Bernstam"}]},
      {"paperId": "e0f844bdbb33fad4a3485cecb85af76b7ab22f36", "externalIds": {"MAG":
      "2938641131", "DOI": "10.1038/s41568-019-0135-7", "CorpusId": 106409019, "PubMed":
      "30967651"}, "corpusId": 106409019, "publicationVenue": {"id": "db36cc4c-07df-41a8-9169-9ace7e520923",
      "name": "Nature Reviews. Cancer", "type": "journal", "alternate_names": ["Nature
      Reviews Cancer", "Nat Rev Cancer"], "issn": "1474-175X", "url": "https://www.nature.com/nrc/",
      "alternate_urls": ["http://www.nature.com/nrc/index.html"]}, "url": "https://www.semanticscholar.org/paper/e0f844bdbb33fad4a3485cecb85af76b7ab22f36",
      "title": "Targeting cancer vulnerabilities with high-dose vitamin C", "abstract":
      null, "venue": "Nature Reviews. Cancer", "year": 2019, "referenceCount": 148,
      "citationCount": 220, "influentialCitationCount": 11, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc6526932?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": "2019-04-09", "journal": {"volume": "19",
      "pages": "271 - 282", "name": "Nature Reviews Cancer"}, "citationStyles": {"bibtex":
      "@Article{Ngo2019TargetingCV,\n author = {B. Ngo and Justin Van Riper and L.
      Cantley and Jihye Yun},\n booktitle = {Nature Reviews. Cancer},\n journal =
      {Nature Reviews Cancer},\n pages = {271 - 282},\n title = {Targeting cancer
      vulnerabilities with high-dose vitamin C},\n volume = {19},\n year = {2019}\n}\n"},
      "authors": [{"authorId": "5891999", "name": "B. Ngo"}, {"authorId": "88611660",
      "name": "Justin Van Riper"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "40164091", "name": "Jihye Yun"}]}, {"paperId": "e47452e6e2f9ba30da769cbdcb44fb917ec6796a",
      "externalIds": {"MAG": "2921991537", "DOI": "10.1016/S1470-2045(18)30905-7",
      "CorpusId": 81983081, "PubMed": "30880072"}, "corpusId": 81983081, "publicationVenue":
      {"id": "4bb62465-2dd3-4eca-923f-4649b9dea666", "name": "The Lancet Oncology",
      "type": "journal", "alternate_names": ["Lancet Oncol", "Lancet Oncology"], "issn":
      "1470-2045", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/621215/description#description",
      "alternate_urls": ["https://www.sciencedirect.com/journal/the-lancet-oncology/",
      "http://www.sciencedirect.com/science/journal/14702045", "http://www.thelancet.com/journals/lanonc",
      "http://oncology.thelancet.com/journal"]}, "url": "https://www.semanticscholar.org/paper/e47452e6e2f9ba30da769cbdcb44fb917ec6796a",
      "title": "Olaparib and \u03b1-specific PI3K inhibitor alpelisib for patients
      with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b
      trial.", "abstract": null, "venue": "The Lancet Oncology", "year": 2019, "referenceCount":
      33, "citationCount": 157, "influentialCitationCount": 3, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc7025391?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2019-04-01", "journal":
      {"volume": "20 4", "pages": "\n          570-580\n        ", "name": "The Lancet.
      Oncology"}, "citationStyles": {"bibtex": "@Article{Konstantinopoulos2019OlaparibA\u0391,\n
      author = {P. Konstantinopoulos and W. Barry and M. Birrer and S. Westin and
      K. Cadoo and G. Shapiro and E. Mayer and R. O\u2019Cearbhaill and R. Coleman
      and B. Kochupurakkal and C. Whalen and J. Curtis and Sarah Farooq and W. Luo
      and J. Eismann and M. Buss and C. Aghajanian and G. Mills and Sangeetha Palakurthi
      and P. Kirschmeier and Joyce F. Liu and L. Cantley and S. Kaufmann and E. Swisher
      and A. D\u2019Andrea and E. Winer and G. Wulf and U. Matulonis},\n booktitle
      = {The Lancet Oncology},\n journal = {The Lancet. Oncology},\n pages = {\n          570-580\n        },\n
      title = {Olaparib and \u03b1-specific PI3K inhibitor alpelisib for patients
      with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b
      trial.},\n volume = {20 4},\n year = {2019}\n}\n"}, "authors": [{"authorId":
      "49610180", "name": "P. Konstantinopoulos"}, {"authorId": "143997654", "name":
      "W. Barry"}, {"authorId": "2167106", "name": "M. Birrer"}, {"authorId": "2974900",
      "name": "S. Westin"}, {"authorId": "5372086", "name": "K. Cadoo"}, {"authorId":
      "2014583", "name": "G. Shapiro"}, {"authorId": "3349811", "name": "E. Mayer"},
      {"authorId": "1388881568", "name": "R. O\u2019Cearbhaill"}, {"authorId": "3124983",
      "name": "R. Coleman"}, {"authorId": "4604359", "name": "B. Kochupurakkal"},
      {"authorId": "122974814", "name": "C. Whalen"}, {"authorId": "49142258", "name":
      "J. Curtis"}, {"authorId": "7862178", "name": "Sarah Farooq"}, {"authorId":
      "4146119", "name": "W. Luo"}, {"authorId": "27883005", "name": "J. Eismann"},
      {"authorId": "31331831", "name": "M. Buss"}, {"authorId": "6128162", "name":
      "C. Aghajanian"}, {"authorId": "2241330", "name": "G. Mills"}, {"authorId":
      "32453098", "name": "Sangeetha Palakurthi"}, {"authorId": "3588774", "name":
      "P. Kirschmeier"}, {"authorId": "2108419806", "name": "Joyce F. Liu"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "144100151", "name": "S. Kaufmann"},
      {"authorId": "3733822", "name": "E. Swisher"}, {"authorId": "1396108662", "name":
      "A. D\u2019Andrea"}, {"authorId": "2369378", "name": "E. Winer"}, {"authorId":
      "31554501", "name": "G. Wulf"}, {"authorId": "6927295", "name": "U. Matulonis"}]},
      {"paperId": "ef116c6a59f19a7884162d1c58b34d27fc9929f2", "externalIds": {"MAG":
      "2971718133", "DOI": "10.1093/neuonc/noz126.209", "CorpusId": 202802898}, "corpusId":
      202802898, "publicationVenue": {"id": "885e4962-6eb4-4c11-90b7-03fad705f9bd",
      "name": "Neuro-Oncology", "type": "journal", "alternate_names": ["Neuro-oncology"],
      "issn": "1522-8517", "url": "https://academic.oup.com/neuro-oncology/issue",
      "alternate_urls": ["http://www.oxfordjournals.org/", "http://neuro-oncology.dukejournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/ef116c6a59f19a7884162d1c58b34d27fc9929f2",
      "title": "P11.63 PI3K inhibition in conjunction with the ketogenic diet reduces
      growth and neuroinflammation in pediatric high-grade glioma", "abstract": "\n
      Background: Pediatric high-grade glioma remains a poorly treatable disease with
      high mortality.Therapeutic advances have lagged behind that of adult glioblastoma,
      due to small patient numbers, inappropriate generalization from adult tumor
      types, and unique biology. The use of targeted therapy has recently gained interest
      in this disease, but efficacy is limited by therapeutic resistance, often as
      a result of tumor heterogeneity. In the case of phosphatidylinositol 3-kinase
      (PI3K) inhibition, clinically relevant PI3K inhibitors represent a strong class
      of drugs for pediatric high-grade glioma, but their use is associated with insulin
      feedback that reactivates the PI3K pathway and drives therapeutic resistance.
      Here, we target insulin feedback that is the primary mechanism of PI3K inhibitor-related
      therapeutic resistance in pediatric high-grade glioma using the ketogenic diet.\n
      Materials and Methods: Patient-derived pediatric high-grade glioma stem cells
      were treated with vehicle or the pan-PI3K inhibitor, BKM-120, with glucose deprivation
      or phenformin to decrease glucose utilization. NSG mice containing patient-derived
      pediatric high-grade glioma xenografts were treated with vehicle or BKM-120
      on a regular or ketogenic diet to determine whether reducing insulin feedback
      increases BKM-120 efficacy. To determine the effect of glioma cells on neuro-inflammation,
      we measured pro-inflammatory cytokines in glioma cells treated with BKM-120
      and phenformin in comparison to vehicle-treated cells. We then applied conditioned
      medium from glioma cells treated with BKM-120 and phenformin to cortical neuronal
      cultures to measure oxidative stress and neuro-inflammation. Results: Pediatric
      high-grade glioma cells exhibited increased toxicity when exposed to BKM-120
      with glucose deprivation or phenformin. Furthermore, mice with intracranial
      high-grade glioma xenografts survived longer when treated with BKM-120 on the
      ketogenic diet than with BKM-120 or the ketogenic diet alone. Phenformin reduced
      the production of pro-inflammatory cytokines by BKM-120-treated glioma cells.
      Cortical neurons treated with conditioned medium from BKM-120- and phenformin-treated
      glioma cells exhibited less oxidative stress than those treated with BKM-120
      alone. Our results demonstrate that strategies to lower glucose utilization
      and insulin feedback increase efficacy of BKM-120 and decrease neuro-inflammation.\n
      Conclusions: We show that strategies to lower glucose utilization and insulin
      feedback increase efficacy of BKM-120. Furthermore, reducing insulin feedback
      decreases the production of pro-inflammatory cytokines in tumor cells and reduces
      oxidative stress in neurons treated with conditioned medium from BKM-120-treated
      glioma cells. By using the ketogenic diet to reduce glucose levels, this strategy
      may enhance efficacy of PI3K inhibitors in this patient population.", "venue":
      "Neuro-Oncology", "year": 2019, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2019-09-06", "journal": {"name":
      "Neuro-Oncology"}, "citationStyles": {"bibtex": "@Article{Noch2019P1163PI,\n
      author = {E. Noch and I. Yim and L. Cantley},\n booktitle = {Neuro-Oncology},\n
      journal = {Neuro-Oncology},\n title = {P11.63 PI3K inhibition in conjunction
      with the ketogenic diet reduces growth and neuroinflammation in pediatric high-grade
      glioma},\n year = {2019}\n}\n"}, "authors": [{"authorId": "3913142", "name":
      "E. Noch"}, {"authorId": "1716222698", "name": "I. Yim"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "f03f57a566a0058b551e4bb9f2aa20f2bf9ea965",
      "externalIds": {"MAG": "2955344115", "DOI": "10.1016/j.bmcl.2019.07.011", "CorpusId":
      198133583, "PubMed": "31327531"}, "corpusId": 198133583, "publicationVenue":
      {"id": "56cde9e1-007e-4232-b5ea-ac20f55c39e8", "name": "Bioorganic & Medicinal
      Chemistry Letters", "type": "journal", "alternate_names": ["Bioorganic  Med
      Chem Lett"], "issn": "0960-894X", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/0960894X",
      "https://www.journals.elsevier.com/bioorganic-and-medicinal-chemistry"]}, "url":
      "https://www.semanticscholar.org/paper/f03f57a566a0058b551e4bb9f2aa20f2bf9ea965",
      "title": "Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides
      abrogates de novo serine synthesis in cancer cells.", "abstract": null, "venue":
      "Bioorganic & Medicinal Chemistry Letters", "year": 2019, "referenceCount":
      26, "citationCount": 37, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2019-09-01", "journal": {"name": "Bioorganic & medicinal
      chemistry letters"}, "citationStyles": {"bibtex": "@Article{Mullarky2019InhibitionO3,\n
      author = {Edouard Mullarky and Jiayi Xu and A. Robin and D. Huggins and A. Jennings
      and N. Noguchi and A. Olland and D. Lakshminarasimhan and Michael Miller and
      D. Tomita and M. Michino and Taojunfeng Su and Guoan Zhang and A. Stamford and
      P. Meinke and S. Kargman and L. Cantley},\n booktitle = {Bioorganic & Medicinal
      Chemistry Letters},\n journal = {Bioorganic & medicinal chemistry letters},\n
      title = {Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides
      abrogates de novo serine synthesis in cancer cells.},\n year = {2019}\n}\n"},
      "authors": [{"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId":
      "49394520", "name": "Jiayi Xu"}, {"authorId": "13966444", "name": "A. Robin"},
      {"authorId": "1969533", "name": "D. Huggins"}, {"authorId": "47923264", "name":
      "A. Jennings"}, {"authorId": "15227811", "name": "N. Noguchi"}, {"authorId":
      "13348478", "name": "A. Olland"}, {"authorId": "46409661", "name": "D. Lakshminarasimhan"},
      {"authorId": "2111174044", "name": "Michael Miller"}, {"authorId": "46586540",
      "name": "D. Tomita"}, {"authorId": "4944172", "name": "M. Michino"}, {"authorId":
      "41096321", "name": "Taojunfeng Su"}, {"authorId": "49288368", "name": "Guoan
      Zhang"}, {"authorId": "6453464", "name": "A. Stamford"}, {"authorId": "3284914",
      "name": "P. Meinke"}, {"authorId": "4524238", "name": "S. Kargman"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "ff97d958779a9e6edbd5c4bb0a984aa2cf61705f",
      "externalIds": {"MAG": "2897987907", "DOI": "10.1016/j.jaci.2018.10.005", "CorpusId":
      53020063, "PubMed": "30336224"}, "corpusId": 53020063, "publicationVenue": {"id":
      "db8b4563-d667-494e-b2e2-bc65c4faba39", "name": "Journal of Allergy and Clinical
      Immunology", "type": "journal", "alternate_names": ["The Journal of Allergy
      and Clinical Immunology", "J Allergy Clin Immunol"], "issn": "0091-6749", "url":
      "http://www.sciencedirect.com/science/journal/00916749", "alternate_urls": ["http://www.jacionline.org/",
      "https://www.jacionline.org/"]}, "url": "https://www.semanticscholar.org/paper/ff97d958779a9e6edbd5c4bb0a984aa2cf61705f",
      "title": "Human primary immunodeficiency caused by expression of a kinase-dead
      p110\u03b4 mutant.", "abstract": null, "venue": "Journal of Allergy and Clinical
      Immunology", "year": 2019, "referenceCount": 10, "citationCount": 23, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jacionline.org/article/S0091674918314404/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2019-02-01", "journal": {"volume": "143
      2", "pages": "\n          797-799.e2\n        ", "name": "The Journal of allergy
      and clinical immunology"}, "citationStyles": {"bibtex": "@Article{Cohen2019HumanPI,\n
      author = {S. Cohen and Wayne Bainter and Jared L. Johnson and Ting-Yu Lin and
      Jenny C. Y. Wong and Jacqueline G. Wallace and Jennifer Jones and S. Qureshi
      and F. Mir and F. Qamar and L. Cantley and R. Geha and J. Chou},\n booktitle
      = {Journal of Allergy and Clinical Immunology},\n journal = {The Journal of
      allergy and clinical immunology},\n pages = {\n          797-799.e2\n        },\n
      title = {Human primary immunodeficiency caused by expression of a kinase-dead
      p110\u03b4 mutant.},\n volume = {143 2},\n year = {2019}\n}\n"}, "authors":
      [{"authorId": "2116349094", "name": "S. Cohen"}, {"authorId": "4303471", "name":
      "Wayne Bainter"}, {"authorId": "145916288", "name": "Jared L. Johnson"}, {"authorId":
      "144181325", "name": "Ting-Yu Lin"}, {"authorId": "40497062", "name": "Jenny
      C. Y. Wong"}, {"authorId": "144318077", "name": "Jacqueline G. Wallace"}, {"authorId":
      "39780100", "name": "Jennifer Jones"}, {"authorId": "3523481", "name": "S. Qureshi"},
      {"authorId": "144229106", "name": "F. Mir"}, {"authorId": "5522123", "name":
      "F. Qamar"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "47142358",
      "name": "R. Geha"}, {"authorId": "144585371", "name": "J. Chou"}]}, {"paperId":
      "0c7f4d6945cbe59eb8bd1aff8be1376daadc137f", "externalIds": {"MAG": "2902258211",
      "DOI": "10.1016/j.cell.2018.09.041", "CorpusId": 54114483, "PubMed": "30500537"},
      "corpusId": 54114483, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/0c7f4d6945cbe59eb8bd1aff8be1376daadc137f",
      "title": "Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity
      in Cancer Cells", "abstract": null, "venue": "Cell", "year": 2018, "referenceCount":
      74, "citationCount": 71, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0092867418312534/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2018-11-01", "journal": {"volume": "175", "pages": "1546-1560.e17",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Zheng2018MitochondrialOP,\n
      author = {Yuxiang Zheng and Ting-Yu Lin and Gina Lee and M. Paddock and Jessica
      Momb and Zhe Cheng and Qian Li and D. Fei and Benjamin D. Stein and Shivan Ramsamooj
      and Guoan Zhang and J. Blenis and L. Cantley},\n booktitle = {Cell},\n journal
      = {Cell},\n pages = {1546-1560.e17},\n title = {Mitochondrial One-Carbon Pathway
      Supports Cytosolic Folate Integrity in Cancer Cells},\n volume = {175},\n year
      = {2018}\n}\n"}, "authors": [{"authorId": "1723564", "name": "Yuxiang Zheng"},
      {"authorId": "144181325", "name": "Ting-Yu Lin"}, {"authorId": "2123198", "name":
      "Gina Lee"}, {"authorId": "4422893", "name": "M. Paddock"}, {"authorId": "5546246",
      "name": "Jessica Momb"}, {"authorId": "46504255", "name": "Zhe Cheng"}, {"authorId":
      "2146274806", "name": "Qian Li"}, {"authorId": "6841228", "name": "D. Fei"},
      {"authorId": "40353456", "name": "Benjamin D. Stein"}, {"authorId": "14390729",
      "name": "Shivan Ramsamooj"}, {"authorId": "49288368", "name": "Guoan Zhang"},
      {"authorId": "4037343", "name": "J. Blenis"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "0d9ae101ee3cb4a46076eeda1298750a7b0aeb0c", "externalIds":
      {"MAG": "2901352207", "DOI": "10.1182/BLOOD-2018-99-118355", "CorpusId": 186627443},
      "corpusId": 186627443, "publicationVenue": {"id": "9b6db04a-2990-4cf9-a14c-01d47636ee53",
      "name": "Blood", "type": "journal", "issn": "0006-4971", "url": "http://www.bloodjournal.org/"},
      "url": "https://www.semanticscholar.org/paper/0d9ae101ee3cb4a46076eeda1298750a7b0aeb0c",
      "title": "Development of Inhibitors of PIP4K2 As a Treatment for Patients with
      Hematologic Malignancies", "abstract": "\n Phosphoinositide signaling is central
      to many cellular processes including the cell survival pathway known as autophagy.
      While there is evidence that autophagy can suppress tumorigenesis under certain
      circumstances, there is increasingly abundant evidence that autophagy promotes
      tumorigenesis and tumor cell survival in solid tumors and hematologic malignancies.\n
      Autophagy is a complex process that has evolved to promote survival of cells
      under a variety of stress or nutrient starvation conditions. There are a multitude
      of molecules and structures involved in initiating, promoting, and resolving
      the autophagy process. It is known that PI5P is an important component for the
      resolution of autophagy. PIP4K2\u03b1,\u03b2,\u03b3 are a family of lipid kinases
      that convert PI5P to PI(4,5)P2. These enzymes have recently been shown to be
      critical for the fusion of autophagosomes with lysosomes. This known activity,
      coupled with the observation that PIP4K2 activity is essential for the survival
      and leukemia initiating potential of human and mouse acute myeloid leukemia
      (AML) cells, suggest that the PIP4K2 family of enzymes may be a promising target
      for a new class of therapeutics for the treatment of hematologic malignancies.\n
      We have investigated the role of PIP4K2 enzymes in supporting the survival of
      cancer cells by developing potent and selective inhibitors of PIP4K2 enzymatic
      activity. A screen of human cancer cell lines show that potent and selective
      inhibitors of PIP4K2 are effective at inhibiting growth of a variety of hematologic
      cancers including leukemia- and lymphoma-derived lines. In vivo studies demonstrate
      that these inhibitors induce rapid regression of an AML tumor (MOLM-16) in a
      mouse xenograft model. These studies show a dose-dependent control of tumor
      growth with sustained regression of tumor volume with QD oral dosing of a prototype
      molecule. Body weights of the mice were stable over the course of the study
      suggesting that the molecule is well tolerated in this dosing protocol.\n A
      preliminary toxicity study in rats has not revealed any identifiable toxicity
      at doses up to 100 mg/Kg given QD/PO for 14 days. Additional in vitro safety
      studies suggest minimal safety concerns due to off-target activity.\n Exploration
      of the structure activity relationship of PIP4K2 inhibitors, using fragment
      and structure-based drug discovery, has led to highly potent and selective molecules
      with exceptional drug-like properties. A clinical development candidate has
      been selected and that candidate is currently in the late stages of preclinical
      studies preceding anticipated clinical entry in early 2019.\n \n \n McElligott:
      Petra Pharma: Employment, Equity Ownership. Kesicki:Petra Pharma: Employment,
      Equity Ownership. Karukarichi:Petra Pharma: Employment, Equity Ownership. Shim:Petra
      Pharma: Employment, Equity Ownership. Wang:Petra Pharma: Employment, Equity
      Ownership. Yu:Petra Pharma: Employment, Equity Ownership. Zolfaghari:Petra Pharma:
      Employment, Equity Ownership. Linstrom:Sprint Bioscience: Employment, Equity
      Ownership. Persson:Sprint Bioscience: Employment, Equity Ownership. Hoglund:Sprint
      Bioscience: Employment, Equity Ownership. Ericsson:Sprint Bioscience: Employment,
      Equity Ownership. Tr\u00e9saugues:Sprint Bioscience: Employment, Equity Ownership.
      Livendahl:Sprint Bioscience: Employment, Equity Ownership. Santangelo:Sprint
      Bioscience: Employment, Equity Ownership. Viklund:Sprint Bioscience: Employment,
      Equity Ownership. Pettersson:Sprint Bioscience: Employment, Equity Ownership.
      W\u00e4hling:Sprint Bioscience: Employment, Equity Ownership. Forsblom:Sprint
      Bioscience: Employment, Equity Ownership. Karlsson:Sprint Bioscience: Employment,
      Equity Ownership. Ginman:Sprint Bioscience: Employment, Equity Ownership. Braga:Sprint
      Bioscience: Employment, Equity Ownership. Henley:Sprint Bioscience: Employment,
      Equity Ownership. Talagas:Sprint Bioscience: Employment, Equity Ownership. Rahm:Sprint
      Bioscience: Employment, Equity Ownership. Johansson:Sprint Bioscience: Employment,
      Equity Ownership. Martinsson:Sprint Bioscience: Employment, Equity Ownership.
      Andersson:Sprint Bioscience: Employment, Equity Ownership. Cantley:Petra Pharma:
      Equity Ownership.\n", "venue": "Blood", "year": 2018, "referenceCount": 0, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2018-11-29", "journal": {"name":
      "Blood"}, "citationStyles": {"bibtex": "@Article{McElligott2018DevelopmentOI,\n
      author = {D. McElligott and E. Kesicki and Kannan Karukarichi and Hyeseok Shim
      and Rui Wang and A. Yu and Parisa Zolfaghari and J. Linstrom and Persson Lars
      Boukharta and A. H\u00f6glund and U. Ericsson and L. Tr\u00e9saugues and Livendahl
      Madeleine and E. Santangelo and J. Viklund and M. Pettersson and H. W\u00e4hling
      and Rickard Forsblom and F. Karlsson and T. Ginman and Tiago Braga and A. Henley
      and A. Talagas and F. Rahm and T. Johansson and J. Martinsson and M. Andersson
      and L. Cantley},\n booktitle = {Blood},\n journal = {Blood},\n title = {Development
      of Inhibitors of PIP4K2 As a Treatment for Patients with Hematologic Malignancies},\n
      year = {2018}\n}\n"}, "authors": [{"authorId": "8046282", "name": "D. McElligott"},
      {"authorId": "4354461", "name": "E. Kesicki"}, {"authorId": "1435233809", "name":
      "Kannan Karukarichi"}, {"authorId": "13574443", "name": "Hyeseok Shim"}, {"authorId":
      "2151036825", "name": "Rui Wang"}, {"authorId": "145955019", "name": "A. Yu"},
      {"authorId": "1435230665", "name": "Parisa Zolfaghari"}, {"authorId": "150151571",
      "name": "J. Linstrom"}, {"authorId": "2196197544", "name": "Persson Lars Boukharta"},
      {"authorId": "35742521", "name": "A. H\u00f6glund"}, {"authorId": "87585264",
      "name": "U. Ericsson"}, {"authorId": "50076917", "name": "L. Tr\u00e9saugues"},
      {"authorId": "2196193854", "name": "Livendahl Madeleine"}, {"authorId": "2083195145",
      "name": "E. Santangelo"}, {"authorId": "2409612", "name": "J. Viklund"}, {"authorId":
      "117559764", "name": "M. Pettersson"}, {"authorId": "13984371", "name": "H.
      W\u00e4hling"}, {"authorId": "15701764", "name": "Rickard Forsblom"}, {"authorId":
      "35383870", "name": "F. Karlsson"}, {"authorId": "48235855", "name": "T. Ginman"},
      {"authorId": "89679374", "name": "Tiago Braga"}, {"authorId": "33023819", "name":
      "A. Henley"}, {"authorId": "50405647", "name": "A. Talagas"}, {"authorId": "7782461",
      "name": "F. Rahm"}, {"authorId": "2022372", "name": "T. Johansson"}, {"authorId":
      "38766462", "name": "J. Martinsson"}, {"authorId": "144725033", "name": "M.
      Andersson"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "191c5d5e815a92a5073304ffd393c1582dd58b98",
      "externalIds": {"PubMedCentral": "6363433", "MAG": "2905656919", "DOI": "10.1084/jem.20181965",
      "CorpusId": 58300215, "PubMed": "30587505"}, "corpusId": 58300215, "publicationVenue":
      {"id": "7d071626-1aa2-4dad-a259-bcccedccf44d", "name": "Journal of Experimental
      Medicine", "type": "journal", "alternate_names": ["J Exp Med"], "issn": "0022-1007",
      "url": "http://www.jem.org/"}, "url": "https://www.semanticscholar.org/paper/191c5d5e815a92a5073304ffd393c1582dd58b98",
      "title": "Toward a better understanding of folate metabolism in health and disease",
      "abstract": "In this review, Zheng and Cantley provide a historical perspective
      of the folate metabolism field, delve into folate chemistry that is often overlooked,
      and point out various missing links and underdeveloped areas in folate metabolism
      for future exploration.", "venue": "Journal of Experimental Medicine", "year":
      2018, "referenceCount": 172, "citationCount": 83, "influentialCitationCount":
      5, "isOpenAccess": true, "openAccessPdf": {"url": "https://rupress.org/jem/article-pdf/216/2/253/1171573/jem_20181965.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2018-12-26", "journal": {"volume": "216", "pages": "253
      - 266", "name": "The Journal of Experimental Medicine"}, "citationStyles": {"bibtex":
      "@Article{Zheng2018TowardAB,\n author = {Yuxiang Zheng and L. Cantley},\n booktitle
      = {Journal of Experimental Medicine},\n journal = {The Journal of Experimental
      Medicine},\n pages = {253 - 266},\n title = {Toward a better understanding of
      folate metabolism in health and disease},\n volume = {216},\n year = {2018}\n}\n"},
      "authors": [{"authorId": "1723564", "name": "Yuxiang Zheng"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "1a6e6951ee4fd64c0644dbf144822f22ca9efea9",
      "externalIds": {"MAG": "2898094763", "DOI": "10.2210/PDB6DND/PDB", "CorpusId":
      239839561}, "corpusId": 239839561, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/1a6e6951ee4fd64c0644dbf144822f22ca9efea9",
      "title": "Crystal structure of wild-type (WT) human Glutamate oxaloacetate transaminase
      1 (GOT1)", "abstract": "Pancreatic cancer cells are characterized by deregulated
      metabolic programs that facilitate growth and resistance to oxidative stress.
      Among these programs, pancreatic cancers preferentially utiliz...", "venue":
      "", "year": 2018, "referenceCount": 27, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2018-10-26", "journal": {"volume": "57", "pages": "6604-6614",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Holt2018CrystalSO,\n
      author = {M. Holt and Z. Assar and R. B. Zavareh and Lin Lin and J. Anglin and
      Oksana Mashadova and D. Haldar and Edouard Mullarky and Daniel M. Kremer and
      L. Cantley and Alec C. Kimmelman and A. Stein and L. Lairson and C. Lyssiotis},\n
      journal = {Biochemistry},\n pages = {6604-6614},\n title = {Crystal structure
      of wild-type (WT) human Glutamate oxaloacetate transaminase 1 (GOT1)},\n volume
      = {57},\n year = {2018}\n}\n"}, "authors": [{"authorId": "29607220", "name":
      "M. Holt"}, {"authorId": "13087299", "name": "Z. Assar"}, {"authorId": "3992718",
      "name": "R. B. Zavareh"}, {"authorId": "2043282808", "name": "Lin Lin"}, {"authorId":
      "35906509", "name": "J. Anglin"}, {"authorId": "13470228", "name": "Oksana Mashadova"},
      {"authorId": "2077262439", "name": "D. Haldar"}, {"authorId": "6424987", "name":
      "Edouard Mullarky"}, {"authorId": "40237579", "name": "Daniel M. Kremer"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4668673", "name": "Alec C. Kimmelman"},
      {"authorId": "49052322", "name": "A. Stein"}, {"authorId": "6627833", "name":
      "L. Lairson"}, {"authorId": "4901222", "name": "C. Lyssiotis"}]}, {"paperId":
      "1aaecc5d195a5efca7681b44e778c29269beeca7", "externalIds": {"MAG": "2937255160",
      "CorpusId": 145953224}, "corpusId": 145953224, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/1aaecc5d195a5efca7681b44e778c29269beeca7",
      "title": "Targeting PI3K Remains Complex in Cancer Therapy", "abstract": "Dr.
      Lewis Cantley discusses targeting the PI3K pathway in breast cancer and the
      importance of managing ambient insulin levels during therapy.", "venue": "",
      "year": 2018, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2018-12-13", "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex":
      "@Inproceedings{Cantley2018TargetingPR,\n author = {L. Cantley},\n title = {Targeting
      PI3K Remains Complex in Cancer Therapy},\n year = {2018}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "2b4ba645fb0855858a2ad6b08edfe2beebe88a2e",
      "externalIds": {"PubMedCentral": "6155007", "MAG": "2889819841", "DOI": "10.1038/s41467-018-06377-w",
      "CorpusId": 52313304, "PubMed": "30242288"}, "corpusId": 52313304, "publicationVenue":
      {"id": "43b3f0f9-489a-4566-8164-02fafde3cd98", "name": "Nature Communications",
      "type": "journal", "alternate_names": ["Nat Commun"], "issn": "2041-1723", "url":
      "https://www.nature.com/ncomms/", "alternate_urls": ["http://www.nature.com/ncomms/about/index.html",
      "http://www.nature.com/ncomms/index.html"]}, "url": "https://www.semanticscholar.org/paper/2b4ba645fb0855858a2ad6b08edfe2beebe88a2e",
      "title": "The chromatin remodeler RSF1 controls centromeric histone modifications
      to coordinate chromosome segregation", "abstract": null, "venue": "Nature Communications",
      "year": 2018, "referenceCount": 47, "citationCount": 20, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/s41467-018-06377-w.pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2018-09-21", "journal": {"volume": "9",
      "name": "Nature Communications"}, "citationStyles": {"bibtex": "@Article{Lee2018TheCR,\n
      author = {Ho-Soo Lee and Zhonghui Lin and Sunyoung Chae and Young-Suk Yoo and
      Byung-Gyu Kim and Youngsoo Lee and Jared L. Johnson and You-Sun Kim and L. Cantley
      and Chang-Woo Lee and Hongtao Yu and Hyeseong Cho},\n booktitle = {Nature Communications},\n
      journal = {Nature Communications},\n title = {The chromatin remodeler RSF1 controls
      centromeric histone modifications to coordinate chromosome segregation},\n volume
      = {9},\n year = {2018}\n}\n"}, "authors": [{"authorId": "6385088", "name": "Ho-Soo
      Lee"}, {"authorId": "49290502", "name": "Zhonghui Lin"}, {"authorId": "36702959",
      "name": "Sunyoung Chae"}, {"authorId": "48078019", "name": "Young-Suk Yoo"},
      {"authorId": "2151899561", "name": "Byung-Gyu Kim"}, {"authorId": "2145430145",
      "name": "Youngsoo Lee"}, {"authorId": "145916288", "name": "Jared L. Johnson"},
      {"authorId": "49171188", "name": "You-Sun Kim"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2145053608", "name": "Chang-Woo Lee"}, {"authorId":
      "2243681565", "name": "Hongtao Yu"}, {"authorId": "6353303", "name": "Hyeseong
      Cho"}]}, {"paperId": "3005e38ea353047f213aeb34d1a8988a57fd2896", "externalIds":
      {"MAG": "2810727645", "DOI": "10.1016/j.cmet.2018.06.017", "CorpusId": 49652244,
      "PubMed": "29972796"}, "corpusId": 49652244, "publicationVenue": {"id": "ad36b49e-5c03-4c48-be8d-321a0d17c2f6",
      "name": "Cell Metabolism", "type": "journal", "alternate_names": ["Cell Metab"],
      "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/15504131", "http://www.cellmetabolism.org/"]},
      "url": "https://www.semanticscholar.org/paper/3005e38ea353047f213aeb34d1a8988a57fd2896",
      "title": "A Glycolysis Outsider Steps into the Cancer Spotlight.", "abstract":
      null, "venue": "Cell Metabolism", "year": 2018, "referenceCount": 11, "citationCount":
      18, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1550413118303991/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine", "Chemistry"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "external"}, {"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["LettersAndComments", "JournalArticle"], "publicationDate":
      "2018-07-01", "journal": {"volume": "28 1", "pages": "\n          3-4\n        ",
      "name": "Cell metabolism"}, "citationStyles": {"bibtex": "@Article{Goncalves2018AGO,\n
      author = {M. Goncalves and L. Cantley},\n booktitle = {Cell Metabolism},\n journal
      = {Cell metabolism},\n pages = {\n          3-4\n        },\n title = {A Glycolysis
      Outsider Steps into the Cancer Spotlight.},\n volume = {28 1},\n year = {2018}\n}\n"},
      "authors": [{"authorId": "145524334", "name": "M. Goncalves"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "31036b47894196e04618a6c46f77ba2929481ba5",
      "externalIds": {"MAG": "2941524734", "CorpusId": 149987512}, "corpusId": 149987512,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/31036b47894196e04618a6c46f77ba2929481ba5",
      "title": "Targeting chromosomal instability and downstream cytosolic dna signaling
      for cancer treatment", "abstract": "As described herein, chromosomal missegregations,
      chromosomal micronuclei, cytosolic DNA, and combinations thereof are indicative
      of metastatic cancer. Methods and compositions are described herein that are
      useful for detection and treatment of patients with chromosomal instabilities
      such as chromosomal missegregations, chromosomal micronuclei, cytosolic DNA,
      and combinations thereof. For example, some of the methods and compositions
      include use of kinesin-13 proteins such as Kif2b, MCAK/Kif2c, or KIF13A. The
      methods and compositions can also include inhibitors of STING, ENPP1, cGAS,
      NF-kB transcription factor p52, NF-kB transcription factor RelB, or any combination
      thereof. Methods are also described for identifying compounds that are effective
      for treatment of cancer, including metastatic cancer.", "venue": "", "year":
      2018, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Inproceedings{Cantley2018TargetingCI,\n author = {L. Cantley and
      B. Ngo and S. Bakhoum},\n title = {Targeting chromosomal instability and downstream
      cytosolic dna signaling for cancer treatment},\n year = {2018}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5891999", "name":
      "B. Ngo"}, {"authorId": "3543494", "name": "S. Bakhoum"}]}, {"paperId": "3952921a53f246c6cc92ac59dd5a28559a659539",
      "externalIds": {"MAG": "2884111611", "PubMedCentral": "6619495", "DOI": "10.1101/370544",
      "CorpusId": 92194916, "PubMed": "31091439"}, "corpusId": 92194916, "publicationVenue":
      {"id": "027ffd21-ebb0-4af8-baf5-911124292fd0", "name": "bioRxiv", "type": "journal",
      "url": "http://biorxiv.org/"}, "url": "https://www.semanticscholar.org/paper/3952921a53f246c6cc92ac59dd5a28559a659539",
      "title": "PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent
      Mechanism", "abstract": "Insulin stimulates conversion of phosphatidylinositol-4,5-bisphosphate
      (PI(4,5)P2) to phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3), which
      mediates downstream cellular responses. PI(4,5)P2 is produced by phosphatidylinositol-4-phosphate
      5-kinases (PIP5Ks) and byphosphatidylinositol-5-phosphate 4-kinases (PIP4Ks).
      Here we show that deletion of the three genes that encode PIP4Ks (PIP4K2A, PIP4K2B
      and PIP4K2C) in vitro results in a paradoxical increase in PI(4,5)P2 and a subsequent
      increase in insulin-stimulated production of PI(3,4,5)P3. Surprisingly, reintroduction
      of either wild-type or kinase-dead forms of the PIP4Ks restored cellular PI(4,5)P2
      levels and insulin stimulation of the PI3K pathway. These effects are explained
      by an increase in PIP5K activity upon deletion of PIP4Ks, which we demonstrate
      can suppress PIP5K activity in vitro through a direct binding interaction. Collectively,
      our work reveals an important non-catalytic function of PIP4Ks in suppressing
      PIP5K-mediated PI(4,5)P2 synthesis and insulin-dependent conversion to PI(3,4,5)P3
      by PI3K enzymes and suggests that pharmacological depletion of PIP4K enzymes
      using emerging degrader technologies could represent a novel strategy for stimulating
      insulin signaling.", "venue": "bioRxiv", "year": 2018, "referenceCount": 51,
      "citationCount": 27, "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S2211124719305431/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2018-07-20", "journal": {"volume": "27",
      "pages": "1991 - 2001.e5", "name": "Cell reports"}, "citationStyles": {"bibtex":
      "@Article{Wang2018PIP4KsSI,\n author = {Diana G. Wang and M. Paddock and Mark
      Lundquist and Janet Y. Sun and Oksana Mashadova and Solomon C. Amadiume and
      Timothy W. Bumpus and Cindy Hodakoski and B. Hopkins and Matthew Fine and Amanda
      Hill and T. Yang and Jeremy M. Baskin and L. Dow and L. Cantley},\n booktitle
      = {bioRxiv},\n journal = {Cell reports},\n pages = {1991 - 2001.e5},\n title
      = {PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism},\n
      volume = {27},\n year = {2018}\n}\n"}, "authors": [{"authorId": "152325571",
      "name": "Diana G. Wang"}, {"authorId": "4422893", "name": "M. Paddock"}, {"authorId":
      "49142390", "name": "Mark Lundquist"}, {"authorId": "2110677133", "name": "Janet
      Y. Sun"}, {"authorId": "13470228", "name": "Oksana Mashadova"}, {"authorId":
      "51160946", "name": "Solomon C. Amadiume"}, {"authorId": "15205001", "name":
      "Timothy W. Bumpus"}, {"authorId": "7331238", "name": "Cindy Hodakoski"}, {"authorId":
      "48821307", "name": "B. Hopkins"}, {"authorId": "48771941", "name": "Matthew
      Fine"}, {"authorId": "2072855104", "name": "Amanda Hill"}, {"authorId": "2219789781",
      "name": "T. Yang"}, {"authorId": "4863571", "name": "Jeremy M. Baskin"}, {"authorId":
      "3918769", "name": "L. Dow"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "3f961b8fb88af90c6b47bd077f4fe027ee0d57d2", "externalIds": {"MAG":
      "2782608603", "DOI": "10.1073/pnas.1714703115", "CorpusId": 3445571, "PubMed":
      "29311302"}, "corpusId": 3445571, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/3f961b8fb88af90c6b47bd077f4fe027ee0d57d2",
      "title": "Fenofibrate prevents skeletal muscle loss in mice with lung cancer",
      "abstract": "Significance The cancer anorexia cachexia syndrome (CACS) is a
      condition characterized by skeletal muscle degradation with no effective treatment.
      CACS is particularly prevalent in patients with nonsmall cell lung cancer, where
      it reduces quality of life and increases mortality. Using an inducible lung
      cancer model, we characterize the changes in intermediary metabolism that occur
      during CACS in mice. We identify a unique serum metabolite profile consisting
      of low ketones and increased glucocorticoid levels. Hypoketonemia is associated
      with reduced expression of hepatic peroxisome proliferator-activated receptor-\u03b1
      (PPAR\u03b1) targets that regulate fatty acid oxidation and ketogenesis. Replacing
      ketone production using the PPAR\u03b1 agonist, fenofibrate, reduced glucocorticoid
      levels, prevented skeletal muscle wasting, and minimized weight loss. These
      exciting results provide important preclinical data toward a therapeutic strategy.
      The cancer anorexia cachexia syndrome is a systemic metabolic disorder characterized
      by the catabolism of stored nutrients in skeletal muscle and adipose tissue
      that is particularly prevalent in nonsmall cell lung cancer (NSCLC). Loss of
      skeletal muscle results in functional impairments and increased mortality. The
      aim of the present study was to characterize the changes in systemic metabolism
      in a genetically engineered mouse model of NSCLC. We show that a portion of
      these animals develop loss of skeletal muscle, loss of adipose tissue, and increased
      inflammatory markers mirroring the human cachexia syndrome. Using noncachexic
      and fasted animals as controls, we report a unique cachexia metabolite phenotype
      that includes the loss of peroxisome proliferator-activated receptor-\u03b1
      (PPAR\u03b1) -dependent ketone production by the liver. In this setting, glucocorticoid
      levels rise and correlate with skeletal muscle degradation and hepatic markers
      of gluconeogenesis. Restoring ketone production using the PPAR\u03b1 agonist,
      fenofibrate, prevents the loss of skeletal muscle mass and body weight. These
      results demonstrate how targeting hepatic metabolism can prevent muscle wasting
      in lung cancer, and provide evidence for a therapeutic strategy.", "venue":
      "Proceedings of the National Academy of Sciences of the United States of America",
      "year": 2018, "referenceCount": 79, "citationCount": 77, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/115/4/E743.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2018-01-08", "journal": {"volume": "115", "pages": "E743
      - E752", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Goncalves2018FenofibratePS,\n author = {M. Goncalves and
      Seo-Kyoung Hwang and C. Pauli and Charles J Murphy and Zhe Cheng and B. Hopkins
      and David Wu and Ryan Loughran and B. Emerling and Guoan Zhang and D. Fearon
      and L. Cantley},\n booktitle = {Proceedings of the National Academy of Sciences
      of the United States of America},\n journal = {Proceedings of the National Academy
      of Sciences},\n pages = {E743 - E752},\n title = {Fenofibrate prevents skeletal
      muscle loss in mice with lung cancer},\n volume = {115},\n year = {2018}\n}\n"},
      "authors": [{"authorId": "145524334", "name": "M. Goncalves"}, {"authorId":
      "4151944", "name": "Seo-Kyoung Hwang"}, {"authorId": "34187590", "name": "C.
      Pauli"}, {"authorId": "47107919", "name": "Charles J Murphy"}, {"authorId":
      "2113278909", "name": "Zhe Cheng"}, {"authorId": "48821307", "name": "B. Hopkins"},
      {"authorId": "144790190", "name": "David Wu"}, {"authorId": "31875049", "name":
      "Ryan Loughran"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId":
      "49288368", "name": "Guoan Zhang"}, {"authorId": "6971231", "name": "D. Fearon"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "478792c14d32ff2adcc0b2b87975df4fed1038ae",
      "externalIds": {"MAG": "2891405227", "DOI": "10.1016/j.cell.2018.08.027", "CorpusId":
      52173591, "PubMed": "30193109"}, "corpusId": 52173591, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/478792c14d32ff2adcc0b2b87975df4fed1038ae",
      "title": "The Multifaceted Role of Chromosomal Instability in Cancer and Its
      Microenvironment", "abstract": null, "venue": "Cell", "year": 2018, "referenceCount":
      113, "citationCount": 354, "influentialCitationCount": 9, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0092867418310432/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Environmental Science",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2018-09-01", "journal": {"volume": "174", "pages": "1347-1360",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Bakhoum2018TheMR,\n
      author = {S. Bakhoum and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n
      pages = {1347-1360},\n title = {The Multifaceted Role of Chromosomal Instability
      in Cancer and Its Microenvironment},\n volume = {174},\n year = {2018}\n}\n"},
      "authors": [{"authorId": "3543494", "name": "S. Bakhoum"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "5061739e99921c101b56545115e033eb80c25d7d",
      "externalIds": {"MAG": "2902716259", "DOI": "10.1021/jacs.8b07911", "CorpusId":
      54526289, "PubMed": "30518210"}, "corpusId": 54526289, "publicationVenue": {"id":
      "4193a393-c091-455e-858d-3d2c151b52b8", "name": "Journal of the American Chemical
      Society", "type": "journal", "alternate_names": ["J Am Chem Soc"], "issn": "0002-7863",
      "url": "https://pubs.acs.org/journal/jacsat", "alternate_urls": ["http://pubs.acs.org/journals/jacsat/index.html",
      "http://pubs.acs.org/journals/jacsat/"]}, "url": "https://www.semanticscholar.org/paper/5061739e99921c101b56545115e033eb80c25d7d",
      "title": "A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor
      Target-Site Identification.", "abstract": "Despite recent clinical successes
      for irreversible drugs, potential toxicities mediated by unpredictable modification
      of off-target cysteines represents a major hurdle for expansion of covalent
      drug programs. Understanding the proteome-wide binding profile of covalent inhibitors
      can significantly accelerate their development; however, current mass spectrometry
      strategies typically do not provide a direct, amino acid level readout of covalent
      activity for complex, selective inhibitors. Here we report the development of
      CITe-Id, a novel chemoproteomic approach that employs covalent pharmacologic
      inhibitors as enrichment reagents in combination with an optimized proteomic
      platform to directly quantify dose-dependent binding at cysteine-thiols across
      the proteome. CITe-Id analysis of our irreversible CDK inhibitor THZ1 identified
      dose-dependent covalent modification of several unexpected kinases, including
      a previously unannotated cysteine (C840) on the understudied kinase PKN3. These
      data streamlined our development of JZ128 as a new selective covalent inhibitor
      of PKN3. Using JZ128 as a probe compound, we identified novel potential PKN3
      substrates, thus offering an initial molecular view of PKN3 cellular activity.
      CITe-Id provides a powerful complement to current chemoproteomic platforms to
      characterize the selectivity of covalent inhibitors, identify new, pharmacologically
      addressable cysteine-thiols, and inform structure-based drug design programs.",
      "venue": "Journal of the American Chemical Society", "year": 2018, "referenceCount":
      56, "citationCount": 57, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc6487859?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2018-12-06", "journal": {"volume": "141 1", "pages": "\n          191-203\n        ",
      "name": "Journal of the American Chemical Society"}, "citationStyles": {"bibtex":
      "@Article{Browne2018ACS,\n author = {Christopher M Browne and Baishan Jiang
      and S. Ficarro and Zainab M. Doctor and Jared L. Johnson and Joseph D. Card
      and S. Sivakumaren and William M. Alexander and Tomer M. Yaron and Charles J
      Murphy and Nicholas Kwiatkowski and Tinghu Zhang and L. Cantley and N. Gray
      and J. Marto},\n booktitle = {Journal of the American Chemical Society},\n journal
      = {Journal of the American Chemical Society},\n pages = {\n          191-203\n        },\n
      title = {A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor
      Target-Site Identification.},\n volume = {141 1},\n year = {2018}\n}\n"}, "authors":
      [{"authorId": "39374687", "name": "Christopher M Browne"}, {"authorId": "7864101",
      "name": "Baishan Jiang"}, {"authorId": "2297254", "name": "S. Ficarro"}, {"authorId":
      "47040242", "name": "Zainab M. Doctor"}, {"authorId": "145916288", "name": "Jared
      L. Johnson"}, {"authorId": "5223652", "name": "Joseph D. Card"}, {"authorId":
      "6443517", "name": "S. Sivakumaren"}, {"authorId": "33579905", "name": "William
      M. Alexander"}, {"authorId": "5247030", "name": "Tomer M. Yaron"}, {"authorId":
      "47107919", "name": "Charles J Murphy"}, {"authorId": "6254222", "name": "Nicholas
      Kwiatkowski"}, {"authorId": "2262535", "name": "Tinghu Zhang"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "3977406", "name": "N. Gray"},
      {"authorId": "2605597", "name": "J. Marto"}]}, {"paperId": "51794dcdf7ffb5f828868ea533ea9842aa5e9a95",
      "externalIds": {"DOI": "10.1038/s41586-018-0506-3", "CorpusId": 256769916},
      "corpusId": 256769916, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/51794dcdf7ffb5f828868ea533ea9842aa5e9a95",
      "title": "Publisher Correction: Suppression of insulin feedback enhances the
      efficacy of PI3K inhibitors", "abstract": null, "venue": "Nature", "year": 2018,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://www.nature.com/articles/s41586-018-0506-3.pdf",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2018-08-29",
      "journal": {"volume": "563", "pages": "E24 - E24", "name": "Nature"}, "citationStyles":
      {"bibtex": "@Article{Hopkins2018PublisherCS,\n author = {B. Hopkins and C. Pauli
      and X. Du and Diana G. Wang and Xia Li and David Wu and Solomon C. Amadiume
      and M. Goncalves and Cindy Hodakoski and Mark Lundquist and R. Bareja and Yan
      Ma and Emily M. Harris and A. Sboner and H. Beltran and M. Rubin and Siddhartha
      Mukherjee and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n pages
      = {E24 - E24},\n title = {Publisher Correction: Suppression of insulin feedback
      enhances the efficacy of PI3K inhibitors},\n volume = {563},\n year = {2018}\n}\n"},
      "authors": [{"authorId": "48821307", "name": "B. Hopkins"}, {"authorId": "34187590",
      "name": "C. Pauli"}, {"authorId": "2107496989", "name": "X. Du"}, {"authorId":
      "152325571", "name": "Diana G. Wang"}, {"authorId": "48569910", "name": "Xia
      Li"}, {"authorId": "144790190", "name": "David Wu"}, {"authorId": "51160946",
      "name": "Solomon C. Amadiume"}, {"authorId": "145524334", "name": "M. Goncalves"},
      {"authorId": "7331238", "name": "Cindy Hodakoski"}, {"authorId": "49142390",
      "name": "Mark Lundquist"}, {"authorId": "9753461", "name": "R. Bareja"}, {"authorId":
      "2004581377", "name": "Yan Ma"}, {"authorId": "2205370098", "name": "Emily M.
      Harris"}, {"authorId": "2315866", "name": "A. Sboner"}, {"authorId": "145305292",
      "name": "H. Beltran"}, {"authorId": "144014266", "name": "M. Rubin"}, {"authorId":
      "2205219038", "name": "Siddhartha Mukherjee"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "5344ba08b4815e226aa32938e6b5a244477ef018", "externalIds":
      {"MAG": "2889104327", "DOI": "10.1038/s41586-018-0506-3", "CorpusId": 52127240,
      "PubMed": "30158705"}, "corpusId": 52127240, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/5344ba08b4815e226aa32938e6b5a244477ef018",
      "title": "Publisher Correction: Suppression of insulin feedback enhances the
      efficacy of PI3K inhibitors", "abstract": null, "venue": "Nature", "year": 2018,
      "referenceCount": 0, "citationCount": 5, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://www.nature.com/articles/s41586-018-0506-3.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2018-08-29", "journal":
      {"volume": "563", "pages": "E24", "name": "Nature"}, "citationStyles": {"bibtex":
      "@Article{Hopkins2018PublisherCS,\n author = {B. Hopkins and C. Pauli and Xing
      Du and Diana G. Wang and Xia Li and David Wu and Solomon C. Amadiume and M.
      Goncalves and Cindy Hodakoski and Mark Lundquist and R. Bareja and Yan Ma and
      E. Harris and A. Sboner and H. Beltran and M. Rubin and S. Mukherjee and L.
      Cantley},\n booktitle = {Nature},\n journal = {Nature},\n pages = {E24},\n title
      = {Publisher Correction: Suppression of insulin feedback enhances the efficacy
      of PI3K inhibitors},\n volume = {563},\n year = {2018}\n}\n"}, "authors": [{"authorId":
      "48821307", "name": "B. Hopkins"}, {"authorId": "34187590", "name": "C. Pauli"},
      {"authorId": "145323219", "name": "Xing Du"}, {"authorId": "152325571", "name":
      "Diana G. Wang"}, {"authorId": "48569910", "name": "Xia Li"}, {"authorId": "144790190",
      "name": "David Wu"}, {"authorId": "51160946", "name": "Solomon C. Amadiume"},
      {"authorId": "145524334", "name": "M. Goncalves"}, {"authorId": "7331238", "name":
      "Cindy Hodakoski"}, {"authorId": "49142390", "name": "Mark Lundquist"}, {"authorId":
      "9753461", "name": "R. Bareja"}, {"authorId": "2004581377", "name": "Yan Ma"},
      {"authorId": "152768171", "name": "E. Harris"}, {"authorId": "2315866", "name":
      "A. Sboner"}, {"authorId": "145305292", "name": "H. Beltran"}, {"authorId":
      "144014266", "name": "M. Rubin"}, {"authorId": "49581145", "name": "S. Mukherjee"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "693a82eab3e42b59143a343b3018fa3cc3d52fce",
      "externalIds": {"MAG": "2885614395", "DOI": "10.1158/1538-7445.AM2018-NG03",
      "CorpusId": 81750744}, "corpusId": 81750744, "publicationVenue": {"id": "ad2cb22c-bcde-4ec4-a7a8-503aba675402",
      "name": "Tumor Biology", "type": "journal", "issn": "1010-4283", "url": "https://www.karger.com/tbi",
      "alternate_urls": ["https://journals.sagepub.com/home/tub", "http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=224124",
      "http://www.springer.com/biomed/cancer/journal/13277", "http://link.springer.com/journal/13277",
      "https://uk.sagepub.com/en-gb/eur/tumor-biology/journal202707"]}, "url": "https://www.semanticscholar.org/paper/693a82eab3e42b59143a343b3018fa3cc3d52fce",
      "title": "Abstract NG03: Chromosomal instability promotes metastasis through
      a cytosolic DNA response", "abstract": "Chromosomal instability (CIN) is a hallmark
      of cancer and it results from ongoing errors in chromosome segregation during
      mitosis. While CIN is a major driver of tumor evolution, its role in metastasis
      has not been established. Here we show that CIN promotes metastasis by sustaining
      a tumor-cell autonomous response to cytosolic DNA. Errors in chromosome segregation
      create a preponderance of micronuclei whose rupture spills genomic DNA into
      the cytosol. This leads to the activation of the cGAS-STING cytosolic DNA-sensing
      pathway and downstream noncanonical NF-\u03baB signaling. Genetic suppression
      of CIN significantly delays metastasis even in highly aneuploid tumor models,
      whereas inducing continuous chromosome segregation errors promotes cellular
      invasion and metastasis in a STING-dependent manner. Using single-cell RNA sequencing,
      we uncover a CIN-induced transcriptional switch from a proliferative and metabolically
      active state to a mesenchymal phenotype associated with inflammatory pathways,
      offering an opportunity to target chromosome segregation errors for therapeutic
      benefit. Our work reveals an unexpected link between CIN, cytosolic DNA sensing
      pathways, and metastasis. The use of an isogenic system has enabled us to dissect
      the role of CIN from that of aneuploidy. Importantly, while we do not discount
      the role of CIN in generating karyotypic heterogeneity that can serve as the
      substrate for natural selection, our work demonstrates that continuous chromosome
      missegregation is also required to replenish cytosolic DNA pools leading to
      chronic upregulation of inflammatory pathways. In non-transformed settings,
      cytosolic DNA sensing is incompatible with viability. Unlike normal cells, chromosomally
      unstable cells are awash with cytosolic DNA and have adapted to coexist with
      a chronically active cGAS-STING pathway by suppressing downstream type I interferon
      signaling and instead upregulating the alternative NF-\u03baB pathway. Persistent
      STING activation mediates carcinogen-induced tumor formation and we now show
      that tumor cells co-opt this otherwise lethal program to spread to distant organs.
      The evolutionary benefit of the noncanonical pathway might justify the scarcity
      of inactivating mutations in cGAS and STING among human cancers. The emergence,
      and subsequent tolerance, of CIN represents an important bottleneck during tumor
      evolution. Our single-cell analysis revealed that CIN induces a transcriptional
      switch whereby cells shift from a proliferative and highly metabolic state,
      ideally suited for primary tumor growth, to a chromosomally unstable and mesenchymal
      state associated with upregulation of inflammatory pathways. These two largely
      mutually exclusive states likely account for the reversibility in chromosome
      missegregation rates seen in primary tumors and metastases, and provide an explanation
      for the negative effect of aneuploidy during early tumorigenesis. Interestingly,
      this mutual exclusivity was recently observed in a pan-cancer genomic analysis
      of metastatic tumors, and it leads us to suggest that CIN underlies the subset
      of metastases that are characterized by EMT and inflammation. By providing a
      mechanistic link between CIN and metastasis, our work opens new avenues to target
      chromosomally unstable tumors for therapeutic benefit. Citation Format: Samuel
      F. Bakhoum, Bryon Ngo, Ashley L. Bakhoum, Julie-Ann Cavallo, Charles J. Murphy,
      Peter Ly, Pragya Shah, Roshan K. Sriram, Thomas B.k. Watkins, Neil K. Taunk,
      Mercedes Duran, Chantal Pauli, Christine Shaw, Kalyani Chadalavada, Vinagolu
      K. Rajasekhar, Giulio Genovese, Subramanian Venkatesan, Nicolai J. Birkbak,
      Nicholas McGranahan, Mark Lundquist, Quincy LaPlant, John H. Healey, Olivier
      Elemento, Christine H. Chung, Nancy Y. Lee, Marcin Imielinski, Gouri Nanjangud,
      Dana Pe9er, Don W. Cleveland, Simon N. Powell, Jan Lammerding, Charles Swanton,
      Lewis C. Cantley. Chromosomal instability promotes metastasis through a cytosolic
      DNA response [abstract]. In: Proceedings of the American Association for Cancer
      Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA):
      AACR; Cancer Res 2018;78(13 Suppl):Abstract nr NG03.", "venue": "Tumor Biology",
      "year": 2018, "referenceCount": 0, "citationCount": 2, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://pdfs.semanticscholar.org/693a/82eab3e42b59143a343b3018fa3cc3d52fce.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2018-07-01", "journal": {"name": "Tumor Biology"}, "citationStyles":
      {"bibtex": "@Article{Bakhoum2018AbstractNC,\n author = {S. Bakhoum and Bryon
      Ngo and A. Bakhoum and J. Cavallo and Charles J Murphy and P. Ly and Pragya
      Shah and Roshan K. Sriram and T. Watkins and N. Taunk and Mercedes A. Duran
      and C. Pauli and Christine J. Shaw and Kalyani Chadalavada and Vinagolu K. Rajasekhar
      and G. Genovese and Subramanian Venkatesan and N. Birkbak and N. Mcgranahan
      and Mark Lundquist and Q. Laplant and J. Healey and O. Elemento and C. Chung
      and N. Y. Lee and M. Imieli\u0144ski and G. Nanjangud and D. Pe\u2019er and
      D. Cleveland and S. Powell and J. Lammerding and C. Swanton and L. Cantley},\n
      booktitle = {Tumor Biology},\n journal = {Tumor Biology},\n title = {Abstract
      NG03: Chromosomal instability promotes metastasis through a cytosolic DNA response},\n
      year = {2018}\n}\n"}, "authors": [{"authorId": "3543494", "name": "S. Bakhoum"},
      {"authorId": "87292656", "name": "Bryon Ngo"}, {"authorId": "87660245", "name":
      "A. Bakhoum"}, {"authorId": "115814912", "name": "J. Cavallo"}, {"authorId":
      "47107919", "name": "Charles J Murphy"}, {"authorId": "50497340", "name": "P.
      Ly"}, {"authorId": "30382930", "name": "Pragya Shah"}, {"authorId": "49408849",
      "name": "Roshan K. Sriram"}, {"authorId": "3103142", "name": "T. Watkins"},
      {"authorId": "3794250", "name": "N. Taunk"}, {"authorId": "2143838550", "name":
      "Mercedes A. Duran"}, {"authorId": "34187590", "name": "C. Pauli"}, {"authorId":
      "145674442", "name": "Christine J. Shaw"}, {"authorId": "8584328", "name": "Kalyani
      Chadalavada"}, {"authorId": "5734623", "name": "Vinagolu K. Rajasekhar"}, {"authorId":
      "2070205", "name": "G. Genovese"}, {"authorId": "26710439", "name": "Subramanian
      Venkatesan"}, {"authorId": "2004080", "name": "N. Birkbak"}, {"authorId": "5530694",
      "name": "N. Mcgranahan"}, {"authorId": "49142390", "name": "Mark Lundquist"},
      {"authorId": "87374663", "name": "Q. Laplant"}, {"authorId": "1846047", "name":
      "J. Healey"}, {"authorId": "150097652", "name": "O. Elemento"}, {"authorId":
      "1950427", "name": "C. Chung"}, {"authorId": "47683514", "name": "N. Y. Lee"},
      {"authorId": "46369140", "name": "M. Imieli\u0144ski"}, {"authorId": "46745715",
      "name": "G. Nanjangud"}, {"authorId": "1397424343", "name": "D. Pe\u2019er"},
      {"authorId": "144383862", "name": "D. Cleveland"}, {"authorId": "1695518", "name":
      "S. Powell"}, {"authorId": "5859625", "name": "J. Lammerding"}, {"authorId":
      "145867033", "name": "C. Swanton"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "775caf90e63ef52adf26303ee23ab41f2c7c4783", "externalIds": {"DOI":
      "10.1038/s41586-018-0343-4", "CorpusId": 256769147}, "corpusId": 256769147,
      "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature",
      "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls":
      ["http://www.nature.com/nature/", "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/775caf90e63ef52adf26303ee23ab41f2c7c4783",
      "title": "Suppression of insulin feedback enhances the efficacy of PI3K inhibitors",
      "abstract": null, "venue": "Nature", "year": 2018, "referenceCount": 0, "citationCount":
      16, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://boris.unibe.ch/125521/1/nihms-978143.pdf", "status": null}, "fieldsOfStudy":
      null, "s2FieldsOfStudy": [{"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2018-07-04", "journal": {"volume":
      "560", "pages": "499 - 503", "name": "Nature"}, "citationStyles": {"bibtex":
      "@Article{Hopkins2018SuppressionOI,\n author = {B. Hopkins and C. Pauli and
      X. Du and Diana G. Wang and Xia Li and David Wu and Solomon C. Amadiume and
      M. Goncalves and Cindy Hodakoski and Mark Lundquist and R. Bareja and Yan Ma
      and Emily M. Harris and A. Sboner and H. Beltran and M. Rubin and S. Mukherjee
      and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n pages = {499
      - 503},\n title = {Suppression of insulin feedback enhances the efficacy of
      PI3K inhibitors},\n volume = {560},\n year = {2018}\n}\n"}, "authors": [{"authorId":
      "48821307", "name": "B. Hopkins"}, {"authorId": "34187590", "name": "C. Pauli"},
      {"authorId": "2107496989", "name": "X. Du"}, {"authorId": "152325571", "name":
      "Diana G. Wang"}, {"authorId": "48569910", "name": "Xia Li"}, {"authorId": "144790190",
      "name": "David Wu"}, {"authorId": "51160946", "name": "Solomon C. Amadiume"},
      {"authorId": "145524334", "name": "M. Goncalves"}, {"authorId": "7331238", "name":
      "Cindy Hodakoski"}, {"authorId": "49142390", "name": "Mark Lundquist"}, {"authorId":
      "9753461", "name": "R. Bareja"}, {"authorId": "2004581377", "name": "Yan Ma"},
      {"authorId": "2205370098", "name": "Emily M. Harris"}, {"authorId": "2315866",
      "name": "A. Sboner"}, {"authorId": "145305292", "name": "H. Beltran"}, {"authorId":
      "144014266", "name": "M. Rubin"}, {"authorId": "49581145", "name": "S. Mukherjee"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "778cb68cfff551c518564d380d191257f3910f73",
      "externalIds": {"MAG": "2803910055", "DOI": "10.1126/scitranslmed.aaq1011",
      "CorpusId": 44147416, "PubMed": "29794058"}, "corpusId": 44147416, "publicationVenue":
      {"id": "1cd4baea-5ccc-4522-9dbf-0566f39d3b37", "name": "Science Translational
      Medicine", "type": "journal", "alternate_names": ["Sci Transl Med"], "issn":
      "1946-6234", "url": "https://stm.sciencemag.org/", "alternate_urls": ["https://stm.sciencemag.org/site/misc/about.xhtml"]},
      "url": "https://www.semanticscholar.org/paper/778cb68cfff551c518564d380d191257f3910f73",
      "title": "Cancer metabolism gets physical", "abstract": "The physical microenvironment
      regulates cancer cell metabolism, and engineered culture systems need to reflect
      physical properties of tumors. Patient-derived culture models enable assessment
      of drug sensitivity and can connect personalized genomics with therapeutic options.
      However, their clinical translation is constrained by limited fidelity. We outline
      how the physical microenvironment regulates cell metabolism and describe how
      engineered culture systems could enhance the predictive power for precision
      medicine.", "venue": "Science Translational Medicine", "year": 2018, "referenceCount":
      56, "citationCount": 32, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc5990021?pdf=render",
      "status": null}, "fieldsOfStudy": ["Computer Science", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Computer Science", "source": "external"}, {"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Engineering", "source": "s2-fos-model"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"], "publicationDate":
      "2018-05-23", "journal": {"volume": "10", "name": "Science Translational Medicine"},
      "citationStyles": {"bibtex": "@Article{DelNero2018CancerMG,\n author = {P. DelNero
      and B. Hopkins and L. Cantley and C. Fischbach},\n booktitle = {Science Translational
      Medicine},\n journal = {Science Translational Medicine},\n title = {Cancer metabolism
      gets physical},\n volume = {10},\n year = {2018}\n}\n"}, "authors": [{"authorId":
      "15213426", "name": "P. DelNero"}, {"authorId": "48821307", "name": "B. Hopkins"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "143879299", "name":
      "C. Fischbach"}]}, {"paperId": "813c657c78657d78edcc87b829f1b631e9d17295", "externalIds":
      {"MAG": "2786113733", "DOI": "10.1158/1535-7163.TARG-17-KN01", "CorpusId": 90306898},
      "corpusId": 90306898, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/813c657c78657d78edcc87b829f1b631e9d17295",
      "title": "Abstract KN01: Keynote Lecture: PI 3-kinase links obesity, insulin
      resistance, and cancer", "abstract": "Phosphoinositide 3-kinase (PI3K) is activated
      by insulin and other growth factors to mediate cell growth. The PI3K enzyme
      encoded by the PIK3CA gene is one of the most frequently mutated oncogenes in
      human cancer. This same enzyme mediates insulin responses in liver, muscle,
      fat, and other tissues. The most common mutations in this gene enhance the ability
      of PI3K to bind to the insulin receptor substrates, IRS1 and IRS2, and thereby
      enhance the ability of PI3K to be activated by insulin and IGF1. This observation
      raises the possibility that elevated levels of serum insulin could enhance the
      growth of tumors that express the insulin receptor, especially when the tumor
      expresses a mutant form of PIK3CA. Consistent with this idea, retrospective
      studies have shown that cancers that correlate with obesity and insulin resistance
      (conditions where serum insulin levels are high), such as endometrial, breast,
      and colorectal cancers, frequently have activating mutations in PIK3CA. These
      observations suggest a model in which tumors with mutations in PIK3CA are highly
      sensitized to insulin-dependent growth and that the elevated serum insulin levels
      in individuals with insulin resistance in liver, muscle, and fat promote anabolic
      metabolism in the tumor. This condition would allow the tumor to take up glucose
      more readily than muscle or fat in insulin-resistant individuals. We have generated
      mouse models to interrogate the role of PI3Ks in metabolic control and in the
      generation of cancers. These studies indicate that inhibitors of PI3Ks could
      be effective in treating cancers in specific mutational backgrounds. More than
      20 PI3K inhibitors that target the gene product of PIK3CA have entered clinical
      trials for treating solid cancers. Although these inhibitors look promising,
      a variety of toxicities have created challenges. Some of the toxicities, such
      as hyperglycemia, are on target since inhibition of the PIK3CA gene product
      is expected to cause insulin resistance. Importantly, the acute insulin resistance
      that occurs in response to PI3K inhibitors not only raises serum glucose levels,
      but also induces insulin release from the pancreas, which raises insulin levels.
      As discussed above, the increased serum insulin has the potential to activate
      PI3K in the tumor, and it is possible that very high insulin levels could reactivate
      PI3K in the tumor despite the presence of a PI3K inhibitor. We have interrogated
      this possibility in a wide variety of mouse models of cancer and find that the
      high serum insulin levels that appear following an oral dose of a variety of
      PI3K inhibitors in both human and mouse are sufficient to activate the PI3K-mTOR
      signaling pathway. We have utilized multiple therapeutic interventions in attempts
      to prevent this rebound of insulin-dependent PI3K reactivation in tumors, including
      metformin, a sodium-glucose co-transporter inhibitor, and a ketogenic diet.
      We found that the ketogenic diet is more effective than other therapies at lowering
      serum insulin levels during PI3K treatment. Importantly, combining a ketogenic
      diet with a PI3K inhibitor causes a dramatic shrinkage of tumors compared to
      either therapy alone. Citation Format: Lewis C. Cantley. Keynote Lecture: PI
      3-kinase links obesity, insulin resistance, and cancer [abstract]. In: Proceedings
      of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer
      Therapeutics; 2017 Oct 26-30; Philadelphia, PA. Philadelphia (PA): AACR; Mol
      Cancer Ther 2018;17(1 Suppl):Abstract nr KN01.", "venue": "", "year": 2018,
      "referenceCount": 0, "citationCount": 2, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": null, "publicationDate": null, "journal":
      {"volume": "17", "name": "Molecular Cancer Therapeutics"}, "citationStyles":
      {"bibtex": "@Article{Cantley2018AbstractKK,\n author = {L. Cantley},\n journal
      = {Molecular Cancer Therapeutics},\n title = {Abstract KN01: Keynote Lecture:
      PI 3-kinase links obesity, insulin resistance, and cancer},\n volume = {17},\n
      year = {2018}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "872ac792ca74ee81f00310b0e48a4c6c883d3886", "externalIds": {"DOI":
      "10.1096/fasebj.2018.32.1_supplement.250.4", "CorpusId": 249766482}, "corpusId":
      249766482, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/872ac792ca74ee81f00310b0e48a4c6c883d3886",
      "title": "Obesity, Insulin Resistance and Cancer: The PI3K connection", "abstract":
      "Retrospective studies have revealed that cancer rates in certain organ sites
      increase with obesity and some studies have suggested that the subset of obese
      individuals who develop insulin resistance are more likely to develop cancers
      than those who are obese but remain insulin sensitive. The risk of developing
      uterine and breast cancers are particularly high in women who are obese and
      insulin resistant and these two cancers have the highest rates of activating
      mutations in PIK3CA, the gene that encodes phosphoinositide 3\u2010kinase 1
      alpha (PI3K1alpha). PI3K1alpha mediates insulin dependent cell growth and the
      activating mutations in PIK3CA allow this enzyme to be more readily activated
      by insulin in tumors that express the insulin receptor. Normal endometrial and
      breast epithelial cells express the insulin receptor and tumors in these tissues
      often have elevated expression of the insulin receptor. These observations raise
      the possibility that the elevated serum insulin in patients who are insulin
      resistant may be contributing to the development of tumors, especially tumors
      in tissues with PI3K pathway mutations. Many PI3K inhibitors have entered clinical
      trials and some have been approved. However, since the inhibitors that target
      PI3K1alpha cause insulin resistance in liver, muscle and fat, they cause hyperglycemia
      and hyperinsulinemia. Our studies indicate that the elevated insulin in the
      serum can ultimately re\u2010activate PI3K1alpha in the tumor, compromising
      the effect of these drugs. Strategies for making PI3K inhibitors more effective
      by preventing this feedback reactivation of PI3K1alpha in tumors will be discussed.",
      "venue": "", "year": 2018, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2018-04-01",
      "journal": {"volume": "32", "name": "The FASEB Journal"}, "citationStyles":
      {"bibtex": "@Article{Cantley2018ObesityIR,\n author = {L. Cantley},\n journal
      = {The FASEB Journal},\n title = {Obesity, Insulin Resistance and Cancer: The
      PI3K connection},\n volume = {32},\n year = {2018}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "8a1cfa349d0e577c45073a809a9cee520d8a41cd",
      "externalIds": {"MAG": "2803030323", "DOI": "10.1016/j.bmcl.2018.04.061", "CorpusId":
      19186067, "PubMed": "29731362"}, "corpusId": 19186067, "publicationVenue": {"id":
      "56cde9e1-007e-4232-b5ea-ac20f55c39e8", "name": "Bioorganic & Medicinal Chemistry
      Letters", "type": "journal", "alternate_names": ["Bioorganic  Med Chem Lett"],
      "issn": "0960-894X", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/0960894X",
      "https://www.journals.elsevier.com/bioorganic-and-medicinal-chemistry"]}, "url":
      "https://www.semanticscholar.org/paper/8a1cfa349d0e577c45073a809a9cee520d8a41cd",
      "title": "Discovery and optimization of aspartate aminotransferase 1 inhibitors
      to target redox balance in pancreatic ductal adenocarcinoma.", "abstract": null,
      "venue": "Bioorganic & Medicinal Chemistry Letters", "year": 2018, "referenceCount":
      12, "citationCount": 27, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc6119644?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2018-09-01", "journal": {"volume": "28 16", "pages": "\n          2675-2678\n        ",
      "name": "Bioorganic & medicinal chemistry letters"}, "citationStyles": {"bibtex":
      "@Article{Anglin2018DiscoveryAO,\n author = {J. Anglin and R. B. Zavareh and
      Philipp N. Sander and Daniel Haldar and Edouard Mullarky and L. Cantley and
      Alec C. Kimmelman and C. Lyssiotis and L. Lairson},\n booktitle = {Bioorganic
      & Medicinal Chemistry Letters},\n journal = {Bioorganic & medicinal chemistry
      letters},\n pages = {\n          2675-2678\n        },\n title = {Discovery
      and optimization of aspartate aminotransferase 1 inhibitors to target redox
      balance in pancreatic ductal adenocarcinoma.},\n volume = {28 16},\n year =
      {2018}\n}\n"}, "authors": [{"authorId": "35906509", "name": "J. Anglin"}, {"authorId":
      "3992718", "name": "R. B. Zavareh"}, {"authorId": "46492334", "name": "Philipp
      N. Sander"}, {"authorId": "41048742", "name": "Daniel Haldar"}, {"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "4668673", "name": "Alec C. Kimmelman"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "6627833", "name": "L. Lairson"}]},
      {"paperId": "912caffb1fd0169c3f0926c8527a1f7ef5e8cfc6", "externalIds": {"MAG":
      "2756713090", "DOI": "10.1007/978-3-319-61401-4_2", "CorpusId": 91000193}, "corpusId":
      91000193, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/912caffb1fd0169c3f0926c8527a1f7ef5e8cfc6",
      "title": "A topical report on the design principles of metabolism", "abstract":
      null, "venue": "", "year": 2018, "referenceCount": 71, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": {"volume": "",
      "pages": "29-44", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Halbrook2018ATR,\n
      author = {Christopher J. Halbrook and H. Lee and L. Cantley and C. Lyssiotis},\n
      pages = {29-44},\n title = {A topical report on the design principles of metabolism},\n
      year = {2018}\n}\n"}, "authors": [{"authorId": "7745600", "name": "Christopher
      J. Halbrook"}, {"authorId": "2149418230", "name": "H. Lee"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4901222", "name": "C. Lyssiotis"}]}, {"paperId":
      "9ece277d9de89d08fd9a3c1322ca7545f9f7ce1b", "externalIds": {"MAG": "2801628465",
      "DOI": "10.1016/j.molcel.2018.03.037", "CorpusId": 19263628, "PubMed": "29727621"},
      "corpusId": 19263628, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/9ece277d9de89d08fd9a3c1322ca7545f9f7ce1b",
      "title": "Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid
      Metabolism By Facilitating Autophagy.", "abstract": null, "venue": "Molecules
      and Cells", "year": 2018, "referenceCount": 69, "citationCount": 59, "influentialCitationCount":
      6, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276518302685/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2018-05-03", "journal": {"volume": "70 3", "pages": "\n          531-544.e9\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Lundquist2018Phosphatidylinositol5Phosphate4R,\n
      author = {Mark Lundquist and M. Goncalves and Ryan Loughran and Elite Possik
      and Tarika Vijayaraghavan and A. Yang and C. Pauli and Archna Ravi and A. Verma
      and Zhiwei Yang and Jared L. Johnson and Jenny C. Y. Wong and Yilun Ma and K.
      Hwang and D. Weinkove and N. Divecha and J. Asara and O. Elemento and M. Rubin
      and Alec C. Kimmelman and A. Pause and L. Cantley and B. Emerling},\n booktitle
      = {Molecules and Cells},\n journal = {Molecular cell},\n pages = {\n          531-544.e9\n        },\n
      title = {Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid
      Metabolism By Facilitating Autophagy.},\n volume = {70 3},\n year = {2018}\n}\n"},
      "authors": [{"authorId": "49142390", "name": "Mark Lundquist"}, {"authorId":
      "145524334", "name": "M. Goncalves"}, {"authorId": "31875049", "name": "Ryan
      Loughran"}, {"authorId": "5353550", "name": "Elite Possik"}, {"authorId": "48618491",
      "name": "Tarika Vijayaraghavan"}, {"authorId": "46889299", "name": "A. Yang"},
      {"authorId": "34187590", "name": "C. Pauli"}, {"authorId": "14099966", "name":
      "Archna Ravi"}, {"authorId": "40253432", "name": "A. Verma"}, {"authorId": "50109290",
      "name": "Zhiwei Yang"}, {"authorId": "145916288", "name": "Jared L. Johnson"},
      {"authorId": "40497062", "name": "Jenny C. Y. Wong"}, {"authorId": "50032234",
      "name": "Yilun Ma"}, {"authorId": "41029821", "name": "K. Hwang"}, {"authorId":
      "5011109", "name": "D. Weinkove"}, {"authorId": "9277588", "name": "N. Divecha"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "150097652", "name":
      "O. Elemento"}, {"authorId": "144014266", "name": "M. Rubin"}, {"authorId":
      "4668673", "name": "Alec C. Kimmelman"}, {"authorId": "4976869", "name": "A.
      Pause"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5542751",
      "name": "B. Emerling"}]}, {"paperId": "b2ddfd54cd0c141201bf6f6b6f0aa1feb2edb737",
      "externalIds": {"MAG": "2891117613", "DOI": "10.1158/1538-7445.PRCA2017-A078",
      "CorpusId": 81331182}, "corpusId": 81331182, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/b2ddfd54cd0c141201bf6f6b6f0aa1feb2edb737",
      "title": "Abstract A078: Towards understanding noncanonical phosphatidylinositol
      kinases in the maintenance of prostate metabolism", "abstract": "An estimated
      1 in 7 men will develop prostate cancer (PCa) with many progressing to advanced
      castrate-resistant disease. Unlike other tissue types, normal prostate cell
      growth and development is heavily dependent on the androgen receptor (AR) signaling
      pathway. While the introduction of novel AR antagonists for clinical treatment
      has improved outcomes, most castration-resistant prostate cancer (CRPC) patients
      ultimately develop resistance to these therapies. A need exists to better understand
      the mechanisms that control the transition of prostate cells from a hormone-dependent
      to castrate-resistant state. Androgens strongly influence the metabolic state
      of PCa cells to favor sustained cellular growth. We hypothesize there are effectors
      working in conjunction with AR to coordinate alterations to androgen-dependent
      metabolism that are linchpins in the orchestration of the transition to CRPC.
      Leading candidates are members of phosphoinositol (PI) pathways, which have
      a high frequency of alteration in PCa (i.e phosphoinositide 3-kinase (PI3K)).
      Herein we explore a family of poorly understood lipid kinases called the type
      II phosphatidylinositol-5-phosphate 4-kinases (PI5P4Ks) and predict them to
      be critical regulators of cancer cell survival. PI5P4Ks are druggable targets
      that act by phosphorylating the lipid phosphatidylinositol-5-phosphate (PI 5-P)
      at the 4 position of the inositol ring to generate phosphatidylinositol-4,5-bisphosphate
      (PI-4,5-P2; PIP2). We implicate the three PI5P4K isoforms (PI5P4K\u03b1, PI5P4K\u03b2,
      and PI5P4K\u03b3) encoded by the genes PIP4K2A, B, and C, to be important regulators
      of cancer metabolism that play a role in the maintenance of prostate biology
      and oncogenesis. Analysis of transcript data revealed expression of PIP4K2A,
      B, and C in primary PCa patient samples, which was correlated with an AR activation
      gene signature and hotspot tumor suppressor deletion. As well, isoform expression
      was assessed for differential expression in relation to an integrated neuroendocrine
      prostate cancer mRNA score (TCGA; n=333). PI5P4K\u03b1 and PI5P4K\u03b2 protein
      was detected in primary and advanced prostate cancer using optimized antibodies
      of patient tissue TMAs (n= 72). Using in vitro LNCaP cell models, siRNA knockdown
      systems were tested to evaluate the molecular consequence of targeting PIP4K2A
      and PIP4K2B in androgen-dependent systems. Stable knockdown using fluorescently
      labeled lentiviral shRNA constructs significantly reduced proliferation of shPIP4K2
      treated cells. As well, we have produced a prostate-specific PI5P4K knockout
      mouse model by expressing probasin-driven Cre in a homozygous 129/SvEv Pip4k2aflx/flx
      murine strain. Finally, implementation of a discovery-based metabolomic platform
      (Metabolon HD4) was used to profile the overall shift in metabolite species
      that results from downregulating the expression of PIP4K2A in androgen-dependent
      cell models. In summary, we have developed novel insights into the role of a
      family of noncanonical PI kinases in prostate biology. There are a growing number
      of PI3K/AKT inhibitors being tested in combination with androgen deprivation
      therapy in clinical trials, but there is still almost nothing known about the
      potential crosstalk of the greater PI kinase network. These data convincingly
      implicate a fundamental role for PI5P4Ks in PCa androgen signaling and metabolism,
      as well as lay the foundation of phenotypic understanding of what PI5P4K is
      responsible for in the prostate. Citation Format: Joanna Triscott, Matteo Benelli,
      Verena Sailer, Davide Prandi, Brooke Emerling, Francesca Demichelis, Lewis Cantley,
      Mark A. Rubin. Towards understanding noncanonical phosphatidylinositol kinases
      in the maintenance of prostate metabolism [abstract]. In: Proceedings of the
      AACR Special Conference: Prostate Cancer: Advances in Basic, Translational,
      and Clinical Research; 2017 Dec 2-5; Orlando, Florida. Philadelphia (PA): AACR;
      Cancer Res 2018;78(16 Suppl):Abstract nr A078.", "venue": "Poster Presentations
      - Proffered Abstracts", "year": 2018, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2018-08-14", "journal": {"name": "Poster Presentations - Proffered Abstracts"},
      "citationStyles": {"bibtex": "@Article{Triscott2018AbstractAT,\n author = {J.
      Triscott and M. Benelli and V. Sailer and D. Prandi and B. Emerling and F. Demichelis
      and L. Cantley and M. Rubin},\n booktitle = {Poster Presentations - Proffered
      Abstracts},\n journal = {Poster Presentations - Proffered Abstracts},\n title
      = {Abstract A078: Towards understanding noncanonical phosphatidylinositol kinases
      in the maintenance of prostate metabolism},\n year = {2018}\n}\n"}, "authors":
      [{"authorId": "10334665", "name": "J. Triscott"}, {"authorId": "1962148", "name":
      "M. Benelli"}, {"authorId": "2009967", "name": "V. Sailer"}, {"authorId": "35102567",
      "name": "D. Prandi"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId":
      "2382122", "name": "F. Demichelis"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "144014266", "name": "M. Rubin"}]}, {"paperId": "ba63ab40844892ae7a060e1279a1a9f6a902ceb3",
      "externalIds": {"MAG": "2801092231", "DOI": "10.1016/j.jid.2018.03.1249", "CorpusId":
      90438620}, "corpusId": 90438620, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/ba63ab40844892ae7a060e1279a1a9f6a902ceb3",
      "title": "1234 Vitamin C as a potential treatment for melanoma", "abstract":
      null, "venue": "", "year": 2018, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2018-05-01", "journal": {"volume": "138", "name": "Journal of Investigative
      Dermatology"}, "citationStyles": {"bibtex": "@Article{Gade20181234VC,\n author
      = {A. Gade and J. Yun and L. Cantley and J. Zippin},\n journal = {Journal of
      Investigative Dermatology},\n title = {1234 Vitamin C as a potential treatment
      for melanoma},\n volume = {138},\n year = {2018}\n}\n"}, "authors": [{"authorId":
      "2056440104", "name": "A. Gade"}, {"authorId": "15358355", "name": "J. Yun"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6765019", "name":
      "J. Zippin"}]}, {"paperId": "bc4614b74721a6d0e76c3cdda35cc375db1bb824", "externalIds":
      {"DOI": "10.1021/acs.biochem.8b00914", "CorpusId": 53099461, "PubMed": "30365304"},
      "corpusId": 53099461, "publicationVenue": {"id": "ae7a3201-e479-4666-8a93-3d35d6bf7cd1",
      "name": "Biochemistry", "type": "journal", "issn": "0006-2960", "alternate_issns":
      ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw", "alternate_urls":
      ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/bc4614b74721a6d0e76c3cdda35cc375db1bb824",
      "title": "Biochemical Characterization and Structure-Based Mutational Analysis
      Provide Insight into the Binding and Mechanism of Action of Novel Aspartate
      Aminotransferase Inhibitors.", "abstract": "Pancreatic cancer cells are characterized
      by deregulated metabolic programs that facilitate growth and resistance to oxidative
      stress. Among these programs, pancreatic cancers preferentially utilize a metabolic
      pathway through the enzyme aspartate aminotransferase 1 [also known as glutamate
      oxaloacetate transaminase 1 (GOT1)] to support cellular redox homeostasis. As
      such, small molecule inhibitors that target GOT1 could serve as starting points
      for the development of new therapies for pancreatic cancer. We ran a high-throughput
      screen for inhibitors of GOT1 and identified a small molecule, iGOT1-01, with
      in vitro GOT1 inhibitor activity. Application in pancreatic cancer cells revealed
      metabolic and growth inhibitory activity reflecting a promiscuous inhibitory
      profile. We then performed an in silico docking analysis to study inhibitor-GOT1
      interactions with iGOT1-01 analogues that possess improved solubility and potency
      properties. These results suggested that the GOT1 inhibitor competed for binding
      to the pyridoxal 5-phosphate (PLP) cofactor site of GOT1. To analyze how the
      GOT1 inhibitor bound to GOT1, a series of GOT1 mutant enzymes that abolished
      PLP binding were generated. Application of the mutants in X-ray crystallography
      and thermal shift assays again suggested but were unable to formally conclude
      that the GOT1 inhibitor bound to the PLP site. Mutational studies revealed the
      relationship between PLP binding and the thermal stability of GOT1 while highlighting
      the essential nature of several residues for GOT1 catalytic activity. Insight
      into the mode of action of GOT1 inhibitors may provide leads to the development
      of drugs that target redox balance in pancreatic cancer.", "venue": "Biochemistry",
      "year": 2018, "referenceCount": 31, "citationCount": 25, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2018-10-26", "journal":
      {"volume": "57 47", "pages": "\n          6604-6614\n        ", "name": "Biochemistry"},
      "citationStyles": {"bibtex": "@Article{Holt2018BiochemicalCA,\n author = {M.
      Holt and Z. Assar and Reza B. Beheshti Zavareh and Lin Lin and J. Anglin and
      Oksana Mashadova and Daniel Haldar and Edouard Mullarky and Daniel M. Kremer
      and L. Cantley and Alec C. Kimmelman and A. Stein and L. Lairson and C. Lyssiotis},\n
      booktitle = {Biochemistry},\n journal = {Biochemistry},\n pages = {\n          6604-6614\n        },\n
      title = {Biochemical Characterization and Structure-Based Mutational Analysis
      Provide Insight into the Binding and Mechanism of Action of Novel Aspartate
      Aminotransferase Inhibitors.},\n volume = {57 47},\n year = {2018}\n}\n"}, "authors":
      [{"authorId": "29607220", "name": "M. Holt"}, {"authorId": "13087299", "name":
      "Z. Assar"}, {"authorId": "8280749", "name": "Reza B. Beheshti Zavareh"}, {"authorId":
      "49478108", "name": "Lin Lin"}, {"authorId": "35906509", "name": "J. Anglin"},
      {"authorId": "13470228", "name": "Oksana Mashadova"}, {"authorId": "41048742",
      "name": "Daniel Haldar"}, {"authorId": "6424987", "name": "Edouard Mullarky"},
      {"authorId": "40237579", "name": "Daniel M. Kremer"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4668673", "name": "Alec C. Kimmelman"},
      {"authorId": "49052322", "name": "A. Stein"}, {"authorId": "6627833", "name":
      "L. Lairson"}, {"authorId": "4901222", "name": "C. Lyssiotis"}]}, {"paperId":
      "be78a2ba227820f0071d1137650094e75e410cde", "externalIds": {"MAG": "2901442091",
      "DOI": "10.1056/NEJMra1704560", "CorpusId": 53752906, "PubMed": "30462943"},
      "corpusId": 53752906, "publicationVenue": {"id": "dc31f077-7737-4e33-baa3-bceeff44ec27",
      "name": "New England Journal of Medicine", "type": "journal", "alternate_names":
      ["n engl J Med", "The New England Journal of Medicine", "N Engl J Med"], "issn":
      "0028-4793", "url": "https://www.nejm.org/", "alternate_urls": ["http://www.nejm.org/content/index.asp",
      "http://www.nejm.org/"]}, "url": "https://www.semanticscholar.org/paper/be78a2ba227820f0071d1137650094e75e410cde",
      "title": "Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer.", "abstract":
      "The Central Role of PI3K in Cell Signaling Phosphatidylinositol 3-kinase (PI3K)
      is involved in multiple cell processes, including insulin signaling, cell growth,
      immunity, and brain development. It...", "venue": "New England Journal of Medicine",
      "year": 2018, "referenceCount": 0, "citationCount": 182, "influentialCitationCount":
      5, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2018-11-21", "journal": {"volume": "379 21", "pages": "\n          2052-2062\n        ",
      "name": "The New England journal of medicine"}, "citationStyles": {"bibtex":
      "@Article{Goncalves2018Phosphatidylinositol3G,\n author = {M. Goncalves and
      B. Hopkins and L. Cantley},\n booktitle = {New England Journal of Medicine},\n
      journal = {The New England journal of medicine},\n pages = {\n          2052-2062\n        },\n
      title = {Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer.},\n volume
      = {379 21},\n year = {2018}\n}\n"}, "authors": [{"authorId": "145524334", "name":
      "M. Goncalves"}, {"authorId": "48821307", "name": "B. Hopkins"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "f0a8725403e4e749649595311be501372d99227d",
      "externalIds": {"PubMedCentral": "6197057", "MAG": "2809999132", "DOI": "10.1038/s41586-018-0343-4",
      "CorpusId": 51724283, "PubMed": "30051890"}, "corpusId": 51724283, "publicationVenue":
      {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/f0a8725403e4e749649595311be501372d99227d",
      "title": "Suppression of insulin feedback enhances the efficacy of PI3K inhibitors",
      "abstract": null, "venue": "Nature", "year": 2018, "referenceCount": 30, "citationCount":
      406, "influentialCitationCount": 14, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://boris.unibe.ch/125521/1/nihms-978143.pdf", "status": null},
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2018-06-27", "journal":
      {"volume": "560", "pages": "499 - 503", "name": "Nature"}, "citationStyles":
      {"bibtex": "@Article{Hopkins2018SuppressionOI,\n author = {B. Hopkins and C.
      Pauli and Xing Du and Diana G. Wang and Xiang Li and David Wu and Solomon C.
      Amadiume and M. Goncalves and Cindy Hodakoski and Mark Lundquist and R. Bareja
      and Yan Ma and E. Harris and A. Sboner and H. Beltran and M. Rubin and S. Mukherjee
      and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n pages = {499
      - 503},\n title = {Suppression of insulin feedback enhances the efficacy of
      PI3K inhibitors},\n volume = {560},\n year = {2018}\n}\n"}, "authors": [{"authorId":
      "48821307", "name": "B. Hopkins"}, {"authorId": "34187590", "name": "C. Pauli"},
      {"authorId": "145323219", "name": "Xing Du"}, {"authorId": "152325571", "name":
      "Diana G. Wang"}, {"authorId": "2144438826", "name": "Xiang Li"}, {"authorId":
      "144790190", "name": "David Wu"}, {"authorId": "51160946", "name": "Solomon
      C. Amadiume"}, {"authorId": "145524334", "name": "M. Goncalves"}, {"authorId":
      "7331238", "name": "Cindy Hodakoski"}, {"authorId": "49142390", "name": "Mark
      Lundquist"}, {"authorId": "9753461", "name": "R. Bareja"}, {"authorId": "2004581377",
      "name": "Yan Ma"}, {"authorId": "152768171", "name": "E. Harris"}, {"authorId":
      "2315866", "name": "A. Sboner"}, {"authorId": "145305292", "name": "H. Beltran"},
      {"authorId": "144014266", "name": "M. Rubin"}, {"authorId": "49581145", "name":
      "S. Mukherjee"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "face3d1e834aac0eb61f8df3f4929d9b0b64df8a", "externalIds": {"MAG": "2896543401",
      "DOI": "10.1038/s41418-018-0213-5", "CorpusId": 53086490, "PubMed": "30323273"},
      "corpusId": 53086490, "publicationVenue": {"id": "47f0445e-46e2-4685-8244-ddf7c2d587e2",
      "name": "Cell Death and Differentiation", "type": "journal", "alternate_names":
      ["Cell Death Differ", "Cell Death  Differ", "Cell Death & Differentiation"],
      "issn": "1350-9047", "url": "http://www.nature.com/cdd/", "alternate_urls":
      ["http://www.nature.com/cdd/index.html"]}, "url": "https://www.semanticscholar.org/paper/face3d1e834aac0eb61f8df3f4929d9b0b64df8a",
      "title": "Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment
      Interaction in carcinogenesis: novel opportunities for precision medicine",
      "abstract": null, "venue": "Cell Death and Differentiation", "year": 2018, "referenceCount":
      218, "citationCount": 27, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.nature.com/articles/s41418-018-0213-5.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Environmental
      Science", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2018-10-15", "journal": {"volume": "25", "pages": "1885
      - 1904", "name": "Cell Death & Differentiation"}, "citationStyles": {"bibtex":
      "@Article{Carbone2018ConsensusRO,\n author = {M. Carbone and I. Amelio and E.
      Affar and J. Brugarolas and L. Cannon-Albright and L. Cantley and W. Cavenee
      and Zhijian J. Chen and C. Croce and Alan D\u2019 Andrea and D. Gandara and
      C. Giorgi and Wei Jia and Q. Lan and T. Mak and J. Manley and K. Mikoshiba and
      J. Onuchic and H. Pass and P. Pinton and C. Prives and N. Rothman and S. Sebti
      and J. Turkson and Xifeng Wu and Haining Yang and Herbert Yu and G. Melino},\n
      booktitle = {Cell Death and Differentiation},\n journal = {Cell Death & Differentiation},\n
      pages = {1885 - 1904},\n title = {Consensus report of the 8 and 9th Weinman
      Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities
      for precision medicine},\n volume = {25},\n year = {2018}\n}\n"}, "authors":
      [{"authorId": "145800854", "name": "M. Carbone"}, {"authorId": "143937138",
      "name": "I. Amelio"}, {"authorId": "3916548", "name": "E. Affar"}, {"authorId":
      "4185744", "name": "J. Brugarolas"}, {"authorId": "1389506384", "name": "L.
      Cannon-Albright"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4140577", "name": "W. Cavenee"}, {"authorId": "1410159779", "name": "Zhijian
      J. Chen"}, {"authorId": "144749275", "name": "C. Croce"}, {"authorId": "1411854449",
      "name": "Alan D\u2019 Andrea"}, {"authorId": "153754649", "name": "D. Gandara"},
      {"authorId": "3571606", "name": "C. Giorgi"}, {"authorId": "145229527", "name":
      "Wei Jia"}, {"authorId": "2359692", "name": "Q. Lan"}, {"authorId": "48696675",
      "name": "T. Mak"}, {"authorId": "1879130", "name": "J. Manley"}, {"authorId":
      "34162721", "name": "K. Mikoshiba"}, {"authorId": "2110238", "name": "J. Onuchic"},
      {"authorId": "2922584", "name": "H. Pass"}, {"authorId": "3936492", "name":
      "P. Pinton"}, {"authorId": "2145921", "name": "C. Prives"}, {"authorId": "144639248",
      "name": "N. Rothman"}, {"authorId": "32381915", "name": "S. Sebti"}, {"authorId":
      "6200449", "name": "J. Turkson"}, {"authorId": "50171708", "name": "Xifeng Wu"},
      {"authorId": "40013732", "name": "Haining Yang"}, {"authorId": "2621257", "name":
      "Herbert Yu"}, {"authorId": "6693964", "name": "G. Melino"}]}, {"paperId": "157b5265d7221c692eb32edbd516701a8808ed39",
      "externalIds": {"MAG": "2601380465", "DOI": "10.1158/2159-8290.CD-16-1154",
      "CorpusId": 13729378, "PubMed": "28331002"}, "corpusId": 13729378, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/157b5265d7221c692eb32edbd516701a8808ed39",
      "title": "Personalized In Vitro and In Vivo Cancer Models to Guide Precision
      Medicine.", "abstract": "Precision medicine is an approach that takes into account
      the influence of individuals'' genes, environment, and lifestyle exposures to
      tailor interventions. Here, we describe the development of a robust precision
      cancer care platform that integrates whole-exome sequencing with a living biobank
      that enables high-throughput drug screens on patient-derived tumor organoids.
      To date, 56 tumor-derived organoid cultures and 19 patient-derived xenograft
      (PDX) models have been established from the 769 patients enrolled in an Institutional
      Review Board-approved clinical trial. Because genomics alone was insufficient
      to identify therapeutic options for the majority of patients with advanced disease,
      we used high-throughput drug screening to discover effective treatment strategies.
      Analysis of tumor-derived cells from four cases, two uterine malignancies and
      two colon cancers, identified effective drugs and drug combinations that were
      subsequently validated using 3-D cultures and PDX models. This platform thereby
      promotes the discovery of novel therapeutic approaches that can be assessed
      in clinical trials and provides personalized therapeutic options for individual
      patients where standard clinical options have been exhausted.Significance: Integration
      of genomic data with drug screening from personalized in vitro and in vivo cancer
      models guides precision cancer care and fuels next-generation research. Cancer
      Discov; 7(5); 462-77. \u00a92017 AACR.See related commentary by Picco and Garnett,
      p. 456This article is highlighted in the In This Issue feature, p. 443.", "venue":
      "Cancer Discovery", "year": 2017, "referenceCount": 46, "citationCount": 651,
      "influentialCitationCount": 25, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://cancerdiscovery.aacrjournals.org/content/candisc/7/5/462.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Review"], "publicationDate": "2017-05-01", "journal": {"volume": "7 5", "pages":
      "\n          462-477\n        ", "name": "Cancer discovery"}, "citationStyles":
      {"bibtex": "@Article{Pauli2017PersonalizedIV,\n author = {C. Pauli and B. Hopkins
      and D. Prandi and Reid Shaw and T. Fedrizzi and A. Sboner and V. Sailer and
      Michael A. Augello and L. Puca and R. Rosati and Terra J. McNary and Yelena
      Churakova and Cynthia Cheung and J. Triscott and D. Pisapia and R. Rao and J.
      Mosquera and B. Robinson and B. Faltas and Brooke E Emerling and V. Gadi and
      Brady Bernard and O. Elemento and H. Beltran and F. Demichelis and C. Kemp and
      C. Grandori and L. Cantley and M. Rubin},\n booktitle = {Cancer Discovery},\n
      journal = {Cancer discovery},\n pages = {\n          462-477\n        },\n title
      = {Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.},\n
      volume = {7 5},\n year = {2017}\n}\n"}, "authors": [{"authorId": "34187590",
      "name": "C. Pauli"}, {"authorId": "48821307", "name": "B. Hopkins"}, {"authorId":
      "35102567", "name": "D. Prandi"}, {"authorId": "33091056", "name": "Reid Shaw"},
      {"authorId": "5541341", "name": "T. Fedrizzi"}, {"authorId": "2315866", "name":
      "A. Sboner"}, {"authorId": "2009967", "name": "V. Sailer"}, {"authorId": "5658635",
      "name": "Michael A. Augello"}, {"authorId": "6063687", "name": "L. Puca"}, {"authorId":
      "50826946", "name": "R. Rosati"}, {"authorId": "14792558", "name": "Terra J.
      McNary"}, {"authorId": "13154644", "name": "Yelena Churakova"}, {"authorId":
      "48541155", "name": "Cynthia Cheung"}, {"authorId": "10334665", "name": "J.
      Triscott"}, {"authorId": "5528689", "name": "D. Pisapia"}, {"authorId": "40067278",
      "name": "R. Rao"}, {"authorId": "4906489", "name": "J. Mosquera"}, {"authorId":
      "3239948", "name": "B. Robinson"}, {"authorId": "4328624", "name": "B. Faltas"},
      {"authorId": "14805624", "name": "Brooke E Emerling"}, {"authorId": "3380008",
      "name": "V. Gadi"}, {"authorId": "10715010", "name": "Brady Bernard"}, {"authorId":
      "150097652", "name": "O. Elemento"}, {"authorId": "145305292", "name": "H. Beltran"},
      {"authorId": "2382122", "name": "F. Demichelis"}, {"authorId": "3829374", "name":
      "C. Kemp"}, {"authorId": "6623101", "name": "C. Grandori"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "144014266", "name": "M. Rubin"}]}, {"paperId":
      "25ad6cec8f59910b53c4ee9e463a8a0dd78c1548", "externalIds": {"MAG": "2607099952",
      "DOI": "10.1016/j.molcel.2017.04.001", "CorpusId": 453177, "PubMed": "28431227"},
      "corpusId": 453177, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/25ad6cec8f59910b53c4ee9e463a8a0dd78c1548",
      "title": "Membrane Lipids Speak to Histones.", "abstract": null, "venue": "Molecules
      and Cells", "year": 2017, "referenceCount": 8, "citationCount": 3, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276517302319/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-04-20", "journal": {"volume": "66 2", "pages": "\n          163-164\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Zheng2017MembraneLS,\n
      author = {Yuxiang Zheng and L. Cantley},\n booktitle = {Molecules and Cells},\n
      journal = {Molecular cell},\n pages = {\n          163-164\n        },\n title
      = {Membrane Lipids Speak to Histones.},\n volume = {66 2},\n year = {2017}\n}\n"},
      "authors": [{"authorId": "1723564", "name": "Yuxiang Zheng"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "2808229a6148ee77a4949d86c9fde07eae00dc01",
      "externalIds": {"MAG": "2783642736", "DOI": "10.1016/j.ccell.2017.08.008", "CorpusId":
      2812197, "PubMed": "28898700"}, "corpusId": 2812197, "publicationVenue": {"id":
      "11e469cb-37ad-487e-b0ab-d26e82037c22", "name": "Cancer Cell", "type": "journal",
      "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/2808229a6148ee77a4949d86c9fde07eae00dc01",
      "title": "MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism
      to Impart Gemcitabine Resistance to Pancreatic Cancer.", "abstract": null, "venue":
      "Cancer Cell", "year": 2017, "referenceCount": 0, "citationCount": 150, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1535610817303525/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-09-11", "journal": {"volume": "32 3", "pages": "\n          392\n        ",
      "name": "Cancer cell"}, "citationStyles": {"bibtex": "@Article{Shukla2017MUC1AH,\n
      author = {S. Shukla and V. Purohit and Kamiya Mehla and V. Gunda and Nina V.
      Chaika and E. Vernucci and Ryan J. King and J. Abrego and G. Goode and Aneesha
      Dasgupta and Alysha L. Illies and T. Gebregiworgis and B. Dai and Jithesh J.
      Augustine and Divya Murthy and Kuldeep S Attri and Oksana Mashadova and P. Grandgenett
      and R. Powers and Quan P. Ly and A. Lazenby and J. Grem and F. Yu and J. Mat\u00e9s
      and J. Asara and Jung-whan Kim and J. Hankins and C. Weekes and M. Hollingsworth
      and N. Serkova and A. Sasson and J. Fleming and J. Oliveto and C. Lyssiotis
      and L. Cantley and L. Berim and P. Singh},\n booktitle = {Cancer Cell},\n journal
      = {Cancer cell},\n pages = {\n          392\n        },\n title = {MUC1 and
      HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart
      Gemcitabine Resistance to Pancreatic Cancer.},\n volume = {32 3},\n year = {2017}\n}\n"},
      "authors": [{"authorId": "5313024", "name": "S. Shukla"}, {"authorId": "40401242",
      "name": "V. Purohit"}, {"authorId": "6262895", "name": "Kamiya Mehla"}, {"authorId":
      "3474931", "name": "V. Gunda"}, {"authorId": "12164048", "name": "Nina V. Chaika"},
      {"authorId": "4197522", "name": "E. Vernucci"}, {"authorId": "14809253", "name":
      "Ryan J. King"}, {"authorId": "6519716", "name": "J. Abrego"}, {"authorId":
      "40498919", "name": "G. Goode"}, {"authorId": "4198255", "name": "Aneesha Dasgupta"},
      {"authorId": "19371882", "name": "Alysha L. Illies"}, {"authorId": "50019590",
      "name": "T. Gebregiworgis"}, {"authorId": "39746276", "name": "B. Dai"}, {"authorId":
      "47024265", "name": "Jithesh J. Augustine"}, {"authorId": "48665899", "name":
      "Divya Murthy"}, {"authorId": "12496228", "name": "Kuldeep S Attri"}, {"authorId":
      "13470228", "name": "Oksana Mashadova"}, {"authorId": "6621353", "name": "P.
      Grandgenett"}, {"authorId": "145461840", "name": "R. Powers"}, {"authorId":
      "14222342", "name": "Quan P. Ly"}, {"authorId": "3652387", "name": "A. Lazenby"},
      {"authorId": "4068345", "name": "J. Grem"}, {"authorId": "145120646", "name":
      "F. Yu"}, {"authorId": "35070687", "name": "J. Mat\u00e9s"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "2110045806", "name": "Jung-whan Kim"}, {"authorId":
      "5866146", "name": "J. Hankins"}, {"authorId": "143872276", "name": "C. Weekes"},
      {"authorId": "38154576", "name": "M. Hollingsworth"}, {"authorId": "6361174",
      "name": "N. Serkova"}, {"authorId": "3803395", "name": "A. Sasson"}, {"authorId":
      "144926646", "name": "J. Fleming"}, {"authorId": "4425897", "name": "J. Oliveto"},
      {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "11588674", "name": "L. Berim"}, {"authorId": "144633198",
      "name": "P. Singh"}]}, {"paperId": "2d85aa1a4f5eaacceb79defa1340ed836d43aec6",
      "externalIds": {"MAG": "2770225202", "DOI": "10.1016/j.cell.2017.10.037", "CorpusId":
      4783970, "PubMed": "29153836"}, "corpusId": 4783970, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/2d85aa1a4f5eaacceb79defa1340ed836d43aec6",
      "title": "Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2
      Signaling", "abstract": null, "venue": "Cell", "year": 2017, "referenceCount":
      81, "citationCount": 148, "influentialCitationCount": 8, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0092867417312631/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2017-12-14", "journal": {"volume": "171",
      "pages": "1545-1558.e18", "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Lee2017PosttranscriptionalRO,\n
      author = {Gina Lee and Yuxiang Zheng and Sungyun Cho and Cholsoon Jang and Christina
      England and J. Dempsey and Yonghao Yu and Xiaolei Liu and Long He and Paola
      Cavaliere and Andre Chavez and E. Zhang and Meltem I\u015f\u0131k and A. Couvillon
      and Noah E. Dephoure and T. Blackwell and Jane J. Yu and Josh Rabinowitz and
      L. Cantley and J. Blenis},\n booktitle = {Cell},\n journal = {Cell},\n pages
      = {1545-1558.e18},\n title = {Post-transcriptional Regulation of De Novo Lipogenesis
      by mTORC1-S6K1-SRPK2 Signaling},\n volume = {171},\n year = {2017}\n}\n"}, "authors":
      [{"authorId": "2123198", "name": "Gina Lee"}, {"authorId": "1723564", "name":
      "Yuxiang Zheng"}, {"authorId": "4051887", "name": "Sungyun Cho"}, {"authorId":
      "2131834", "name": "Cholsoon Jang"}, {"authorId": "2106923211", "name": "Christina
      England"}, {"authorId": "3765048", "name": "J. Dempsey"}, {"authorId": "40508577",
      "name": "Yonghao Yu"}, {"authorId": "2118355735", "name": "Xiaolei Liu"}, {"authorId":
      "2109324253", "name": "Long He"}, {"authorId": "47026720", "name": "Paola Cavaliere"},
      {"authorId": "2056845844", "name": "Andre Chavez"}, {"authorId": "3081571",
      "name": "E. Zhang"}, {"authorId": "4662983", "name": "Meltem I\u015f\u0131k"},
      {"authorId": "4328102", "name": "A. Couvillon"}, {"authorId": "4622316", "name":
      "Noah E. Dephoure"}, {"authorId": "34098301", "name": "T. Blackwell"}, {"authorId":
      "79481462", "name": "Jane J. Yu"}, {"authorId": "47520316", "name": "Josh Rabinowitz"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4037343", "name":
      "J. Blenis"}]}, {"paperId": "3b57dcc28a01c5a66fdf7910ccfc6bc02b5b93bb", "externalIds":
      {"PubMedCentral": "5785464", "MAG": "2783667606", "DOI": "10.1038/nature25432",
      "CorpusId": 205263499, "PubMed": "29342134"}, "corpusId": 205263499, "publicationVenue":
      {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/3b57dcc28a01c5a66fdf7910ccfc6bc02b5b93bb",
      "title": "Chromosomal instability drives metastasis through a cytosolic DNA
      response", "abstract": null, "venue": "Nature", "year": 2017, "referenceCount":
      61, "citationCount": 884, "influentialCitationCount": 33, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc5785464?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-12-07", "journal": {"volume": "553", "pages": "467
      - 472", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Bakhoum2017ChromosomalID,\n
      author = {S. Bakhoum and B. Ngo and Ashley M. Laughney and J. Cavallo and Charles
      J Murphy and P. Ly and Pragya Shah and Roshan K. Sriram and T. Watkins and N.
      Taunk and Mercedes A. Duran and C. Pauli and Christine J. Shaw and Kalyani Chadalavada
      and Vinagolu K. Rajasekhar and G. Genovese and Subramanian Venkatesan and N.
      Birkbak and N. Mcgranahan and Mark Lundquist and Q. LaPlant and J. Healey and
      O. Elemento and C. Chung and N. Y. Lee and Marcin Imielenski and G. Nanjangud
      and D. Pe\u2019er and D. Cleveland and S. Powell and J. Lammerding and C. Swanton
      and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n pages = {467
      - 472},\n title = {Chromosomal instability drives metastasis through a cytosolic
      DNA response},\n volume = {553},\n year = {2017}\n}\n"}, "authors": [{"authorId":
      "3543494", "name": "S. Bakhoum"}, {"authorId": "5891999", "name": "B. Ngo"},
      {"authorId": "3009053", "name": "Ashley M. Laughney"}, {"authorId": "115814912",
      "name": "J. Cavallo"}, {"authorId": "47107919", "name": "Charles J Murphy"},
      {"authorId": "50497340", "name": "P. Ly"}, {"authorId": "30382930", "name":
      "Pragya Shah"}, {"authorId": "49408849", "name": "Roshan K. Sriram"}, {"authorId":
      "3103142", "name": "T. Watkins"}, {"authorId": "3794250", "name": "N. Taunk"},
      {"authorId": "2143838550", "name": "Mercedes A. Duran"}, {"authorId": "34187590",
      "name": "C. Pauli"}, {"authorId": "145674442", "name": "Christine J. Shaw"},
      {"authorId": "8584328", "name": "Kalyani Chadalavada"}, {"authorId": "5734623",
      "name": "Vinagolu K. Rajasekhar"}, {"authorId": "2070205", "name": "G. Genovese"},
      {"authorId": "26710439", "name": "Subramanian Venkatesan"}, {"authorId": "2004080",
      "name": "N. Birkbak"}, {"authorId": "5530694", "name": "N. Mcgranahan"}, {"authorId":
      "49142390", "name": "Mark Lundquist"}, {"authorId": "152223669", "name": "Q.
      LaPlant"}, {"authorId": "1846047", "name": "J. Healey"}, {"authorId": "150097652",
      "name": "O. Elemento"}, {"authorId": "1950427", "name": "C. Chung"}, {"authorId":
      "47683514", "name": "N. Y. Lee"}, {"authorId": "1398463689", "name": "Marcin
      Imielenski"}, {"authorId": "46745715", "name": "G. Nanjangud"}, {"authorId":
      "1397424343", "name": "D. Pe\u2019er"}, {"authorId": "144383862", "name": "D.
      Cleveland"}, {"authorId": "1695518", "name": "S. Powell"}, {"authorId": "5859625",
      "name": "J. Lammerding"}, {"authorId": "145867033", "name": "C. Swanton"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "3c8e19a081a82488e4ec5b759ce993347260df37",
      "externalIds": {"MAG": "2623691994", "DOI": "10.1016/j.celrep.2017.05.041",
      "CorpusId": 3815293, "PubMed": "28591573"}, "corpusId": 3815293, "publicationVenue":
      {"id": "a3fb5dc1-0d6e-4cd0-a720-8cb68cbf6486", "name": "Cell Reports", "type":
      "journal", "alternate_names": ["Cell Rep"], "issn": "2211-1247", "url": "https://www.cell.com/cell-reports/home",
      "alternate_urls": ["http://cellreports.cell.com/"]}, "url": "https://www.semanticscholar.org/paper/3c8e19a081a82488e4ec5b759ce993347260df37",
      "title": "Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in
      Response to Insulin.", "abstract": null, "venue": "Cell Reports", "year": 2017,
      "referenceCount": 36, "citationCount": 158, "influentialCitationCount": 10,
      "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S2211124717306836/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-06-06", "journal": {"volume": "19 10", "pages": "\n          2005-2013\n        ",
      "name": "Cell reports"}, "citationStyles": {"bibtex": "@Article{Waldhart2017PhosphorylationOT,\n
      author = {Althea N. Waldhart and Holly Dykstra and Anderson Peck and E. Boguslawski
      and Z. Madaj and Jennifer Wen and Kelsey Veldkamp and Matthew T Hollowell and
      B. Zheng and L. Cantley and T. McGraw and Ning Wu},\n booktitle = {Cell Reports},\n
      journal = {Cell reports},\n pages = {\n          2005-2013\n        },\n title
      = {Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response
      to Insulin.},\n volume = {19 10},\n year = {2017}\n}\n"}, "authors": [{"authorId":
      "11625666", "name": "Althea N. Waldhart"}, {"authorId": "50650966", "name":
      "Holly Dykstra"}, {"authorId": "46737415", "name": "Anderson Peck"}, {"authorId":
      "6560405", "name": "E. Boguslawski"}, {"authorId": "3814949", "name": "Z. Madaj"},
      {"authorId": "50976006", "name": "Jennifer Wen"}, {"authorId": "13507448", "name":
      "Kelsey Veldkamp"}, {"authorId": "14878058", "name": "Matthew T Hollowell"},
      {"authorId": "143918840", "name": "B. Zheng"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "32665208", "name": "T. McGraw"}, {"authorId": "2068343858",
      "name": "Ning Wu"}]}, {"paperId": "3fd230a1b41aba7ee5f6ee1e693d8a2668734694",
      "externalIds": {"MAG": "2954480559", "DOI": "10.1158/2159-8290.CD-17-0679",
      "CorpusId": 4958523, "PubMed": "29203461"}, "corpusId": 4958523, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/3fd230a1b41aba7ee5f6ee1e693d8a2668734694",
      "title": "Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in
      Mouse Models of Triple-Negative Breast Cancer.", "abstract": "Triple-negative
      breast cancers (TNBC) are genetically characterized by aberrations in TP53 and
      a low rate of activating point mutations in common oncogenes, rendering it challenging
      in applying targeted therapies. We performed whole-exome sequencing (WES) and
      RNA sequencing (RNA-seq) to identify somatic genetic alterations in mouse models
      of TNBCs driven by loss of Trp53 alone or in combination with Brca1 Amplifications
      or translocations that resulted in elevated oncoprotein expression or oncoprotein-containing
      fusions, respectively, as well as frameshift mutations of tumor suppressors
      were identified in approximately 50% of the tumors evaluated. Although the spectrum
      of sporadic genetic alterations was diverse, the majority had in common the
      ability to activate the MAPK/PI3K pathways. Importantly, we demonstrated that
      approved or experimental drugs efficiently induce tumor regression specifically
      in tumors harboring somatic aberrations of the drug target. Our study suggests
      that the combination of WES and RNA-seq on human TNBC will lead to the identification
      of actionable therapeutic targets for precision medicine-guided TNBC treatment.Significance:
      Using combined WES and RNA-seq analyses, we identified sporadic oncogenic events
      in TNBC mouse models that share the capacity to activate the MAPK and/or PI3K
      pathways. Our data support a treatment tailored to the genetics of individual
      tumors that parallels the approaches being investigated in the ongoing NCI-MATCH,
      My Pathway Trial, and ESMART clinical trials. Cancer Discov; 8(3); 354-69. \u00a92017
      AACR.See related commentary by Natrajan et al., p. 272See related article by
      Matissek et al., p. 336This article is highlighted in the In This Issue feature,
      p. 253.", "venue": "Cancer Discovery", "year": 2017, "referenceCount": 81, "citationCount":
      56, "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://cancerdiscovery.aacrjournals.org/content/candisc/8/3/354.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-12-01", "journal": {"volume": "8 3", "pages": "\n          354-369\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Liu2017IdentifyingAT,\n
      author = {Hui Liu and Charles J Murphy and F. Karreth and K. B. Emdal and F.
      White and O. Elemento and A. Toker and G. Wulf and L. Cantley},\n booktitle
      = {Cancer Discovery},\n journal = {Cancer discovery},\n pages = {\n          354-369\n        },\n
      title = {Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in
      Mouse Models of Triple-Negative Breast Cancer.},\n volume = {8 3},\n year =
      {2017}\n}\n"}, "authors": [{"authorId": "2146671919", "name": "Hui Liu"}, {"authorId":
      "47107919", "name": "Charles J Murphy"}, {"authorId": "3566950", "name": "F.
      Karreth"}, {"authorId": "12967774", "name": "K. B. Emdal"}, {"authorId": "8863412",
      "name": "F. White"}, {"authorId": "150097652", "name": "O. Elemento"}, {"authorId":
      "145751285", "name": "A. Toker"}, {"authorId": "31554501", "name": "G. Wulf"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "40a5f22ea2b26ac49112b1ba1689495e4411e559",
      "externalIds": {"MAG": "2741687836", "DOI": "10.1158/1538-7445.AM2017-CT008",
      "CorpusId": 79983572}, "corpusId": 79983572, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/40a5f22ea2b26ac49112b1ba1689495e4411e559",
      "title": "Abstract CT008: Phase I study of the alpha specific PI3-Kinase inhibitor
      BYL719 and the poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib in recurrent
      ovarian and breast cancer: Analysis of the dose escalation and ovarian cancer
      expansion cohort", "abstract": "Background:In vivo synergy with concurrent PI3-Kinase
      inhibition and PARP inhibition has been observed in BRCA-deficient and BRCA-proficient
      preclinical models of triple negative breast cancer (TNBC) and ovarian cancer
      (OC). A phase I trial of the oral pan-class I PI3-Kinase inhibitor BKM120 and
      the PARP inhibitor olaparib demonstrated anti-cancer activity in TNBC and OC,
      both in patients with and without germline BRCA1 and BRCA2 (BRCA) mutations.
      However, CNS toxicity (depression) and liver function test abnormalities limited
      dose escalation of BKM120 prompting evaluation of the alpha specific PI3-Kinase
      inhibitor BYL719 (which has no CNS toxicity) in combination with olaparib. Methods:
      Olaparib was administered twice daily (tablet formulation) and BYL719 daily
      on a 28-day cycle, both orally. A 3 + 3 dose-escalation design was employed
      with primary objectives of defining the maximum tolerated dose (MTD) and recommended
      phase 2 dose of the combination of BYL719 and olaparib, and secondary objectives
      of defining toxicity, activity, and pharmacokinetic profiles of both agents.
      Eligibility included recurrent TNBC or high grade serous (HGS) OC, or any histology
      OC or breast cancer (BC) with presence of a known germline BRCA mutation, performance
      status of 0-1 and measurable/evaluable cancer. Patients with platinum sensitive
      or resistant or refractory OC were eligible and prior PARP inhibitor use was
      allowed. Dose-expansion cohorts at the MTD were enrolled for both BC and OC.
      Results: 46 patients (16 BC and 30 OC) have been enrolled in the study; 28 patients
      participated in the dose escalation portion of the study (4 BC and 24 OC). Two
      patients with OC did not receive study drugs because of ineligibility. MTD was
      defined as BYL719 200mg once daily and olaparib 200mg twice daily. Dose limiting
      toxicities included hyperglycemia, rash and fever with decreased neutrophil
      count. Four patients (3 OC and 1 BC) discontinued protocol therapy because of
      toxicity (2 for hyperglycemia, 1 for nausea and 1 for allergic reaction). Most
      common toxicities included nausea, hyperglycemia, fatigue, diarrhea and vomiting.
      At the MTD, 6 patients with OC and 12 patients with BC were enrolled into a
      dose expansion cohort. The OC expansion cohort has completed enrollment, while
      the BC cohort is still enrolling. Among patients with OC who received study
      drugs (28 patients, 26 (93%) with platinum resistant disease), objective response
      rate (ORR) by RECIST 1.1 was 36% (10/28 patients, all partial responses (PRs)).
      Median duration of response was 167 days (range 16-398 days); 5 of 10 patients
      with PR remain on treatment. ORR was 33% for patients with germline BRCA mutations
      and 31% for patients without germline BRCA mutations. Among patients without
      germline BRCA mutations with platinum resistant OC, ORR was 29%. Conclusions:
      Combined BYL719 and olaparib is feasible, and similar clinical benefit was observed
      in patients with and without germline BRCA mutations. The activity of this combination
      in OC patients without germline BRCA mutations and with platinum resistant disease
      was higher than expected from olaparib monotherapy and warrants further investigation.
      This work was funded in part by the Stand Up To Cancer Ovarian Dream Team. Clinical
      trial: NCT01623349. Citation Format: Panagiotis A. Konstantinopoulos, William
      T. Barry, Michael Birrer, Shannon N. Westin, Sarah Farooq, Karen Cadoo, Christin
      Whalen, Weixiu Luo, Hui Liu, Carol Aghajanian, David B. Solit, Gordon B. Mills,
      Barry S. Taylor, Helen Won, Michael F. Berger, Sangeetha Palakurthi, Joyce F.
      Liu, Lew Cantley, Scott H. Kaufmann, Elizabeth M. Swisher, Alan D. D9Andrea,
      Eric Winer, Gerburg M. Wulf, Ursula A. Matulonis. Phase I study of the alpha
      specific PI3-Kinase inhibitor BYL719 and the poly (ADP-Ribose) polymerase (PARP)
      inhibitor olaparib in recurrent ovarian and breast cancer: Analysis of the dose
      escalation and ovarian cancer expansion cohort [abstract]. In: Proceedings of
      the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5;
      Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract
      nr CT008. doi:10.1158/1538-7445.AM2017-CT008", "venue": "", "year": 2017, "referenceCount":
      0, "citationCount": 4, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2017-07-01", "journal": {"volume":
      "77", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Konstantinopoulos2017AbstractCP,\n
      author = {P. Konstantinopoulos and W. Barry and M. Birrer and S. Westin and
      Sarah Farooq and K. Cadoo and C. Whalen and W. Luo and Hui Liu and C. Aghajanian
      and D. Solit and G. Mills and B. Taylor and H. Won and M. Berger and Sangeetha
      Palakurthi and Joyce F. Liu and L. Cantley and S. Kaufmann and E. Swisher and
      A. D\u2019Andrea and E. Winer and G. Wulf and U. Matulonis},\n journal = {Cancer
      Research},\n title = {Abstract CT008: Phase I study of the alpha specific PI3-Kinase
      inhibitor BYL719 and the poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib
      in recurrent ovarian and breast cancer: Analysis of the dose escalation and
      ovarian cancer expansion cohort},\n volume = {77},\n year = {2017}\n}\n"}, "authors":
      [{"authorId": "49610180", "name": "P. Konstantinopoulos"}, {"authorId": "143997654",
      "name": "W. Barry"}, {"authorId": "2167106", "name": "M. Birrer"}, {"authorId":
      "2974900", "name": "S. Westin"}, {"authorId": "7862178", "name": "Sarah Farooq"},
      {"authorId": "5372086", "name": "K. Cadoo"}, {"authorId": "122974814", "name":
      "C. Whalen"}, {"authorId": "4146119", "name": "W. Luo"}, {"authorId": "2146671919",
      "name": "Hui Liu"}, {"authorId": "6128162", "name": "C. Aghajanian"}, {"authorId":
      "2344124", "name": "D. Solit"}, {"authorId": "2241330", "name": "G. Mills"},
      {"authorId": "36898514", "name": "B. Taylor"}, {"authorId": "3738649", "name":
      "H. Won"}, {"authorId": "33727638", "name": "M. Berger"}, {"authorId": "32453098",
      "name": "Sangeetha Palakurthi"}, {"authorId": "2108419806", "name": "Joyce F.
      Liu"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144100151",
      "name": "S. Kaufmann"}, {"authorId": "3733822", "name": "E. Swisher"}, {"authorId":
      "1396108662", "name": "A. D\u2019Andrea"}, {"authorId": "2369378", "name": "E.
      Winer"}, {"authorId": "31554501", "name": "G. Wulf"}, {"authorId": "6927295",
      "name": "U. Matulonis"}]}, {"paperId": "4d84a4d0ca3b007f4812a6e1f5acaf220c6dc124",
      "externalIds": {"DOI": "10.1074/jbc.A117.305602", "CorpusId": 46526155, "PubMed":
      "28363934"}, "corpusId": 46526155, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/4d84a4d0ca3b007f4812a6e1f5acaf220c6dc124",
      "title": "Positive and negative roles of p85\u03b1 and p85\u03b2 regulatory
      subunits of phosphoinositide 3-kinase in insulin signaling.", "abstract": "Kohjiro
      Ueki, David A. Fruman, Claudine M. Yballe, Mathias Fasshauer, Johannes Klein,
      Tomoichiro Asano, Lewis C. Cantley, and C. Ronald Kahn This article has been
      withdrawn by the authors. In many of the experiments reported in this study,
      cells from mice of four genotypes were used (wild-type, p85 / , p85 / , and
      p85 / ), but data from only three of the genotypes (wild-type, p85 / , and p85
      / ) were included in the final paper. As a result, there was splicing of the
      figures of several autoradiograms, which led to several duplicated or mislabeled
      lanes in the Western blots in Figs. 2B, 3C, and 5B. Although the experimental
      data generated in the lab from the same time period support the original conclusions
      of the study, and the studies by this lab and others have confirmed and extended
      the conclusions of the manuscript, in the interest of maintaining accuracy in
      the published scientific literature and because the initial figures were not
      up to the standards of JBC, the authors wish to withdraw this article. The authors
      apologize for these errors. THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 292, NO.
      13, p. 5608, March 31, 2017 \u00a9 2017 by The American Society for Biochemistry
      and Molecular Biology, Inc. Published in the U.S.A.", "venue": "Journal of Biological
      Chemistry", "year": 2017, "referenceCount": 0, "citationCount": 21, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925820413663/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-03-31", "journal": {"volume": "292", "pages": "5608
      - 5608", "name": "The Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Ueki2017PositiveAN,\n author = {K. Ueki and D. Fruman and C. Yballe
      and M. Fasshauer and J. Klein and T. Asano and L. Cantley and Ronald Kahn},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {5608 - 5608},\n title = {Positive and negative roles
      of p85\u03b1 and p85\u03b2 regulatory subunits of phosphoinositide 3-kinase
      in insulin signaling.},\n volume = {292},\n year = {2017}\n}\n"}, "authors":
      [{"authorId": "5177377", "name": "K. Ueki"}, {"authorId": "6241317", "name":
      "D. Fruman"}, {"authorId": "7777071", "name": "C. Yballe"}, {"authorId": "48775825",
      "name": "M. Fasshauer"}, {"authorId": "50073811", "name": "J. Klein"}, {"authorId":
      "1928077", "name": "T. Asano"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2250868285", "name": "Ronald Kahn"}]}, {"paperId": "6cdec1f39d4ecf62772ae400714aa84662b585f5",
      "externalIds": {"MAG": "2735063286", "DOI": "10.1016/j.ccell.2017.06.004", "CorpusId":
      3692828, "PubMed": "28697344"}, "corpusId": 3692828, "publicationVenue": {"id":
      "11e469cb-37ad-487e-b0ab-d26e82037c22", "name": "Cancer Cell", "type": "journal",
      "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/6cdec1f39d4ecf62772ae400714aa84662b585f5",
      "title": "MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism
      to Impart Gemcitabine Resistance to Pancreatic Cancer.", "abstract": null, "venue":
      "Cancer Cell", "year": 2017, "referenceCount": 51, "citationCount": 250, "influentialCitationCount":
      6, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1535610817302544/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-07-10", "journal": {"volume": "32 1", "pages": "\n          71-87.e7\n        ",
      "name": "Cancer cell"}, "citationStyles": {"bibtex": "@Article{Shukla2017MUC1AH,\n
      author = {S. Shukla and V. Purohit and Kamiya Mehla and V. Gunda and Nina V.
      Chaika and E. Vernucci and Ryan J. King and J. Abrego and G. Goode and Aneesha
      Dasgupta and Alysha L. Illies and T. Gebregiworgis and B. Dai and Jithesh J.
      Augustine and Divya Murthy and Kuldeep S Attri and Oksana Mashadova and P. Grandgenett
      and R. Powers and Quan P. Ly and A. Lazenby and J. Grem and F. Yu and J. Mat\u00e9s
      and J. Asara and Jung-whan Kim and J. Hankins and C. Weekes and M. Hollingsworth
      and N. Serkova and A. Sasson and J. Fleming and J. Oliveto and C. Lyssiotis
      and L. Cantley and L. Berim and P. Singh},\n booktitle = {Cancer Cell},\n journal
      = {Cancer cell},\n pages = {\n          71-87.e7\n        },\n title = {MUC1
      and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart
      Gemcitabine Resistance to Pancreatic Cancer.},\n volume = {32 1},\n year = {2017}\n}\n"},
      "authors": [{"authorId": "5313024", "name": "S. Shukla"}, {"authorId": "40401242",
      "name": "V. Purohit"}, {"authorId": "6262895", "name": "Kamiya Mehla"}, {"authorId":
      "3474931", "name": "V. Gunda"}, {"authorId": "12164048", "name": "Nina V. Chaika"},
      {"authorId": "4197522", "name": "E. Vernucci"}, {"authorId": "14809253", "name":
      "Ryan J. King"}, {"authorId": "6519716", "name": "J. Abrego"}, {"authorId":
      "40498919", "name": "G. Goode"}, {"authorId": "4198255", "name": "Aneesha Dasgupta"},
      {"authorId": "19371882", "name": "Alysha L. Illies"}, {"authorId": "50019590",
      "name": "T. Gebregiworgis"}, {"authorId": "39746276", "name": "B. Dai"}, {"authorId":
      "47024265", "name": "Jithesh J. Augustine"}, {"authorId": "48665899", "name":
      "Divya Murthy"}, {"authorId": "12496228", "name": "Kuldeep S Attri"}, {"authorId":
      "13470228", "name": "Oksana Mashadova"}, {"authorId": "6621353", "name": "P.
      Grandgenett"}, {"authorId": "145461840", "name": "R. Powers"}, {"authorId":
      "14222342", "name": "Quan P. Ly"}, {"authorId": "3652387", "name": "A. Lazenby"},
      {"authorId": "4068345", "name": "J. Grem"}, {"authorId": "145120646", "name":
      "F. Yu"}, {"authorId": "35070687", "name": "J. Mat\u00e9s"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "2110045806", "name": "Jung-whan Kim"}, {"authorId":
      "5866146", "name": "J. Hankins"}, {"authorId": "143872276", "name": "C. Weekes"},
      {"authorId": "38154576", "name": "M. Hollingsworth"}, {"authorId": "6361174",
      "name": "N. Serkova"}, {"authorId": "3803395", "name": "A. Sasson"}, {"authorId":
      "144926646", "name": "J. Fleming"}, {"authorId": "4425897", "name": "J. Oliveto"},
      {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "11588674", "name": "L. Berim"}, {"authorId": "144633198",
      "name": "P. Singh"}]}, {"paperId": "76b4925dfbd2860f7c6ec27ad7baade4273ffb8d",
      "externalIds": {"MAG": "2737327904", "DOI": "10.1016/j.celrep.2017.06.074",
      "CorpusId": 4633189, "PubMed": "28723573"}, "corpusId": 4633189, "publicationVenue":
      {"id": "a3fb5dc1-0d6e-4cd0-a720-8cb68cbf6486", "name": "Cell Reports", "type":
      "journal", "alternate_names": ["Cell Rep"], "issn": "2211-1247", "url": "https://www.cell.com/cell-reports/home",
      "alternate_urls": ["http://cellreports.cell.com/"]}, "url": "https://www.semanticscholar.org/paper/76b4925dfbd2860f7c6ec27ad7baade4273ffb8d",
      "title": "Proteomic and Metabolomic Characterization of a Mammalian Cellular
      Transition from Quiescence to Proliferation.", "abstract": null, "venue": "Cell
      Reports", "year": 2017, "referenceCount": 68, "citationCount": 31, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S2211124717309051/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-07-18", "journal": {"volume": "20 3", "pages": "\n          721-736\n        ",
      "name": "Cell reports"}, "citationStyles": {"bibtex": "@Article{Lee2017ProteomicAM,\n
      author = {Ho-Joon Lee and Mark P. Jedrychowski and A. Vinayagam and Ning Wu
      and Ng Shyh\u2010Chang and Yanhui Hu and Chua Min-Wen and Jodene K Moore and
      J. Asara and C. Lyssiotis and N. Perrimon and S. Gygi and L. Cantley and M.
      Kirschner},\n booktitle = {Cell Reports},\n journal = {Cell reports},\n pages
      = {\n          721-736\n        },\n title = {Proteomic and Metabolomic Characterization
      of a Mammalian Cellular Transition from Quiescence to Proliferation.},\n volume
      = {20 3},\n year = {2017}\n}\n"}, "authors": [{"authorId": "49923389", "name":
      "Ho-Joon Lee"}, {"authorId": "6432355", "name": "Mark P. Jedrychowski"}, {"authorId":
      "34371262", "name": "A. Vinayagam"}, {"authorId": "2068343858", "name": "Ning
      Wu"}, {"authorId": "1397529716", "name": "Ng Shyh\u2010Chang"}, {"authorId":
      "2228212", "name": "Yanhui Hu"}, {"authorId": "1436554412", "name": "Chua Min-Wen"},
      {"authorId": "88429432", "name": "Jodene K Moore"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId":
      "2001255", "name": "N. Perrimon"}, {"authorId": "2665934", "name": "S. Gygi"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "40294231", "name":
      "M. Kirschner"}]}, {"paperId": "7bdd02d199d9c3bd5f649d2fe639d9efa6ba99bd", "externalIds":
      {"MAG": "2780640138", "DOI": "10.1158/1078-0432.CCR-17-2141", "CorpusId": 3494231,
      "PubMed": "29284706"}, "corpusId": 3494231, "publicationVenue": {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0",
      "name": "Clinical Cancer Research", "type": "journal", "alternate_names": ["Clin
      Cancer Res"], "issn": "1078-0432", "url": "https://clincancerres.aacrjournals.org/",
      "alternate_urls": ["http://clincancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/7bdd02d199d9c3bd5f649d2fe639d9efa6ba99bd",
      "title": "PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase
      (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K\u03b1
      Inhibitors", "abstract": "Purpose: We describe herein a novel P447_L455 deletion
      in the C2 domain of PIK3CA in a patient with an ER+ breast cancer with an excellent
      response to the PI3K\u03b1 inhibitor alpelisib. Although PIK3CA deletions are
      relatively rare, a significant portion of deletions cluster within amino acids
      446\u2013460 of the C2 domain, suggesting these residues are critical for p110\u03b1
      function. Experimental Design: A computational structural model of PIK3CAdelP447-L455
      in complex with the p85 regulatory subunit and MCF10A cells expressing PIK3CAdelP447-L455
      and PIK3CAH450_P458del were used to understand the phenotype of C2 domain deletions.
      Results: Computational modeling revealed specific favorable inter-residue contacts
      that would be lost as a result of the deletion, predicting a significant decrease
      in binding energy. Coimmunoprecipitation experiments showed reduced binding
      of the C2 deletion mutants with p85 compared with wild-type p110\u03b1. The
      MCF10A cells expressing PIK3CA C2 deletions exhibited growth factor\u2013independent
      growth, an invasive phenotype, and higher phosphorylation of AKT, ERK, and S6
      compared with parental MCF10A cells. All these changes were ablated by alpelisib
      treatment. Conclusions: C2 domain deletions in PIK3CA generate PI3K dependence
      and should be considered biomarkers of sensitivity to PI3K inhibitors. Clin
      Cancer Res; 24(6); 1426\u201335. \u00a92017 AACR.", "venue": "Clinical Cancer
      Research", "year": 2017, "referenceCount": 37, "citationCount": 22, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://clincancerres.aacrjournals.org/content/clincanres/24/6/1426.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2017-12-28", "journal": {"volume": "24",
      "pages": "1426 - 1435", "name": "Clinical Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Croessmann2017PIK3CACD,\n author = {Sarah Croessmann and
      J. Sheehan and Kyung-min Lee and Gregory Sliwoski and Ji\u00e9 He and R. Nagy
      and David A Riddle and I. Mayer and J. Balko and R. Lanman and V. Miller and
      L. Cantley and J. Meiler and C. Arteaga},\n booktitle = {Clinical Cancer Research},\n
      journal = {Clinical Cancer Research},\n pages = {1426 - 1435},\n title = {PIK3CA
      C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate
      Oncogene Dependence, and Are Exquisitely Sensitive to PI3K\u03b1 Inhibitors},\n
      volume = {24},\n year = {2017}\n}\n"}, "authors": [{"authorId": "5404128", "name":
      "Sarah Croessmann"}, {"authorId": "6251014", "name": "J. Sheehan"}, {"authorId":
      "46542827", "name": "Kyung-min Lee"}, {"authorId": "3381467", "name": "Gregory
      Sliwoski"}, {"authorId": "50774890", "name": "Ji\u00e9 He"}, {"authorId": "39540895",
      "name": "R. Nagy"}, {"authorId": "82059310", "name": "David A Riddle"}, {"authorId":
      "2346140", "name": "I. Mayer"}, {"authorId": "66935619", "name": "J. Balko"},
      {"authorId": "3484938", "name": "R. Lanman"}, {"authorId": "2134288", "name":
      "V. Miller"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1754226",
      "name": "J. Meiler"}, {"authorId": "2057460", "name": "C. Arteaga"}]}, {"paperId":
      "861c629752fa0f201872ce88465b1beb643228fe", "externalIds": {"MAG": "2739659697",
      "DOI": "10.1158/1538-7445.am2017-1772", "CorpusId": 57106791}, "corpusId": 57106791,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/861c629752fa0f201872ce88465b1beb643228fe",
      "title": "Abstract 1772:PIK3CAC2 domain deletions hyperactivate PI3K, generate
      oncogene dependence and are exquisitely sensitive to PI3K\u03b1 inhibitors",
      "abstract": null, "venue": "", "year": 2017, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2017-07-01", "journal": {"volume": "77", "pages": "1772-1772", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Croessmann2017Abstract1D,\n
      author = {Sarah Croessmann and J. Sheehan and Gregory Sliwoski and Nalin Leelatian
      and Ji\u00e9 He and R. Nagy and J. Balko and I. Mayer and R. Lanman and V. Miller
      and L. Cantley and J. Irish and J. Meiler and C. Arteaga},\n journal = {Cancer
      Research},\n pages = {1772-1772},\n title = {Abstract 1772:PIK3CAC2 domain deletions
      hyperactivate PI3K, generate oncogene dependence and are exquisitely sensitive
      to PI3K\u03b1 inhibitors},\n volume = {77},\n year = {2017}\n}\n"}, "authors":
      [{"authorId": "5404128", "name": "Sarah Croessmann"}, {"authorId": "6251014",
      "name": "J. Sheehan"}, {"authorId": "3381467", "name": "Gregory Sliwoski"},
      {"authorId": "8805251", "name": "Nalin Leelatian"}, {"authorId": "50774890",
      "name": "Ji\u00e9 He"}, {"authorId": "39540895", "name": "R. Nagy"}, {"authorId":
      "66935619", "name": "J. Balko"}, {"authorId": "2346140", "name": "I. Mayer"},
      {"authorId": "3484938", "name": "R. Lanman"}, {"authorId": "2134288", "name":
      "V. Miller"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "46512580",
      "name": "J. Irish"}, {"authorId": "1754226", "name": "J. Meiler"}, {"authorId":
      "2057460", "name": "C. Arteaga"}]}, {"paperId": "8d23d27e574721b07c07c4ae65412b3bb3f3eb89",
      "externalIds": {"MAG": "2744377419", "DOI": "10.1016/j.cell.2017.07.029", "CorpusId":
      5283960, "PubMed": "28802037"}, "corpusId": 5283960, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/8d23d27e574721b07c07c4ae65412b3bb3f3eb89",
      "title": "The PI3K Pathway in Human Disease", "abstract": null, "venue": "Cell",
      "year": 2017, "referenceCount": 294, "citationCount": 1520, "influentialCitationCount":
      72, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867417308656/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2017-08-10", "journal": {"volume": "170", "pages": "605-635",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Fruman2017ThePP,\n author
      = {D. Fruman and Honyin Chiu and B. Hopkins and S. Bagrodia and L. Cantley and
      R. Abraham},\n booktitle = {Cell},\n journal = {Cell},\n pages = {605-635},\n
      title = {The PI3K Pathway in Human Disease},\n volume = {170},\n year = {2017}\n}\n"},
      "authors": [{"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "16259488",
      "name": "Honyin Chiu"}, {"authorId": "48821307", "name": "B. Hopkins"}, {"authorId":
      "4229053", "name": "S. Bagrodia"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "3148968", "name": "R. Abraham"}]}, {"paperId": "8d37a19158675e90cbdb34494270226c8eac3e46",
      "externalIds": {"MAG": "2595206365", "PubMedCentral": "5426642", "DOI": "10.1016/j.molcel.2017.02.019",
      "CorpusId": 3918156, "PubMed": "28306514"}, "corpusId": 3918156, "publicationVenue":
      {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11", "name": "Molecules and Cells",
      "type": "journal", "alternate_names": ["Molecular Cell", "Mol Cell"], "issn":
      "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"], "url": "https://link.springer.com/journal/10059",
      "alternate_urls": ["http://www.molcells.org/about/sub06.html", "http://www.molecule.org/",
      "http://www.sciencedirect.com/science/journal/10972765", "http://www.cell.com/molecular-cell/"]},
      "url": "https://www.semanticscholar.org/paper/8d37a19158675e90cbdb34494270226c8eac3e46",
      "title": "PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation
      via PTEN S-Nitrosylation", "abstract": null, "venue": "Molecules and Cells",
      "year": 2017, "referenceCount": 66, "citationCount": 101, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S109727651730134X/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Environmental Science", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2017-03-16", "journal": {"volume": "65", "pages": "999 - 1013.e7", "name":
      "Molecular Cell"}, "citationStyles": {"bibtex": "@Article{Gupta2017PARK2DC,\n
      author = {Amit Gupta and S. Anjomani-Virmouni and Nikos Koundouros and M. Dimitriadi
      and R. Choo-Wing and A. Valle and Yuxiang Zheng and Y. Chiu and S. Agnihotri
      and G. Zadeh and J. Asara and D. Anastasiou and M. Arends and L. Cantley and
      G. Poulogiannis},\n booktitle = {Molecules and Cells},\n journal = {Molecular
      Cell},\n pages = {999 - 1013.e7},\n title = {PARK2 Depletion Connects Energy
      and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation},\n volume
      = {65},\n year = {2017}\n}\n"}, "authors": [{"authorId": "2143746859", "name":
      "Amit Gupta"}, {"authorId": "1422350224", "name": "S. Anjomani-Virmouni"}, {"authorId":
      "13532971", "name": "Nikos Koundouros"}, {"authorId": "49235150", "name": "M.
      Dimitriadi"}, {"authorId": "1401641678", "name": "R. Choo-Wing"}, {"authorId":
      "115137674", "name": "A. Valle"}, {"authorId": "1723564", "name": "Yuxiang Zheng"},
      {"authorId": "47591147", "name": "Y. Chiu"}, {"authorId": "144901810", "name":
      "S. Agnihotri"}, {"authorId": "98462145", "name": "G. Zadeh"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "46996935", "name": "D. Anastasiou"},
      {"authorId": "118353344", "name": "M. Arends"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "4612853", "name": "G. Poulogiannis"}]}, {"paperId":
      "8e98f4dac7ecd14346a16290b4b4e96a56a894ea", "externalIds": {"MAG": "3024001711",
      "DOI": "10.1182/BLOOD.V130.SUPPL_1.643.643", "CorpusId": 220333008}, "corpusId":
      220333008, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/8e98f4dac7ecd14346a16290b4b4e96a56a894ea",
      "title": "SIRT3 Is a Novel Metabolic Driver of and Therapeutic Target for Chemotherapy
      Resistant Dlbcls", "abstract": "Understanding the molecular basis of therapy-resistant
      DLBCL is a critical unmet need. We explored whether the family of Sirtuin proteins
      might contribute to such effects. Analysis of four independent clinically annotated
      patient cohorts revealed that higher SIRT3 expression was linked to inferior
      outcome (p=4.7e-5). This was not the case for any other of the sirtuins. SIRT3
      mRNA and protein expression were also much higher in DLBCL patients as compared
      to normal germinal center (GC) B-cells. Among the seven sirtuins, only SIRT3
      depletion universally suppressed proliferation, induced cell cycle arrest, suppressed
      colony formation, and induced apoptosis in a large panel of DLBCL cell lines
      regardless of cell of origin, OxPhos status, or somatic mutation profiles. Constitutive
      Sirt3-/- mice manifested completely normal GC formation after T-cell dependent
      antigen immunization. However SIRT3 depleted human DLBCL cells manifested inferior
      engraftment and tumor formation in mice (p=0.023 for hairpin#1, p=0.045 for
      hairpin#2). Sirt3 inducible knockdown caused strong regression of established
      DLBCL xenografts. We examined whether SIRT3 was important in lymphoma initiation
      by crossing VavP-Bcl2 mice with Sirt3-/- animals. As compared to VavP-Bcl2 controls,
      the VavP-Bcl2/Sirt3-/- mice manifested significantly longer overall survival
      (P=0.0035), and greatly reduced tumor burden and systemic lymphoma infiltration
      of organs. SIRT3 is exclusively localized to mitochondria and hence its actions
      are likely metabolic. We therefore performed metabolomic profiling in SIRT 3
      depleted DLBCL cell lines. This analysis revealed profound suppression of the
      TCA (tricarboxylic acid) cycle, with reduced TCA metabolites such as citrate,
      alpha-ketoglutarate, succinate, fumarate, malate, etc. SIRT3 depletion caused
      significant reduction in acetyl-CoA pools as measured by solid phase extraction
      and LC-MS, indicating that SIRT3 is required to maintain the production of key
      metabolic intermediates from the TCA cycle. To define the nature of the TCA
      defect we performed metabolic tracing studies using 13C-labeled glutamine and
      glucose. The results revealed that SIRT3 drives the TCA cycle through glutaminolysis.
      We showed that SIRT3 mediates this effect by directly deacetylating and hence
      hyper-activating the enzymatic activity of mitochondrial glutamine dehydrogenase
      (GDH). Indeed GDH overexpression could fully rescue the collapse of the TCA,
      cell proliferation arrest and apoptosis induced by SIRT3 depletion. SIRT3 knockdown
      was also rescued by feeding cells DMKG (which mimics alpha-ketoglutarate) and
      hence bypasses the need for SIRT3 mediated glutaminolysis. Because SIRT3 depletion
      caused metabolic collapse, DLBCL cells manifested potent induction of autophagy,
      as shown by ratios of LC3II/LC3I in DLBCL cells and using a mCherry-EGFP-LC3
      reporter to measure autophagic flux. This autophagy effect was rescued by feeding
      cells with DMKG or by overexpressing GDH, which uncouple the TCA cycle from
      SIRT3 dependency. Notably the ratio of LC3II/LCI and perturbed autophagy flux
      was also Increased in lymphoma cells from VavP-Bcl2;sirt3-/- vs. VavP-Bcl2;sirt3+/+
      mice. These data nominate SIRT3 as a putative therapeutic target. Therefore
      we designed a nanomolar-potency SIRT3 selective small molecule inhibitor including
      a mitochondrial-targeting motif that concentrates drug in the mitochondrial
      matrix. This compound (called YC8-02), phenocopied all the effects of SIRT3
      depletion including proliferation arrest, apoptosis, TCA collapse by metabolomics
      study, hyperacetylation of mitochondrial proteins, suppression of GDH activity,
      and induction of autophagy. Yet YC8-02 had no effect on normal B-cells. Moreover,
      YC8-02 treatment of chemotherapy resistant DLBCL cell lines restored their sensitivity
      to clinically relevant doxorubicin concentrations. In summary, SIRT3 is a novel
      metabolic oncoprotein widely required for DLBCL cells to satisfy their metabolic
      needs by enhancing the activity of the TCA cycle through glutaminolysis. SIRT3
      is a crucial new therapeutic vulnerability especially impactful for the most
      resistant DLBCLs regardless of their somatic mutations. YC8-02 and its newer
      derivatives are a promising and entirely new mechanism-based approach to help
      these patients. Disclosures Cerchietti: Leukemia and Lymphoma Society: Research
      Funding; Lymphoma Research Foundation: Research Funding; Weill Cornell Medicine
      - New York Presbyterian Hospital: Employment; Celgene: Research Funding.", "venue":
      "", "year": 2017, "referenceCount": 0, "citationCount": 3, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2017-12-07", "journal": {"volume": "130", "pages": "643-643", "name": "Blood"},
      "citationStyles": {"bibtex": "@Article{Li2017SIRT3IA,\n author = {M. Li and
      Ying-Ling Chiang and C. Lyssiotis and Matt Teater and Hao Shen and Ling Wang
      and J. Hong and Hui Jin and C. Duy and S. Mistry and L. Cerchietti and J. Cross
      and L. Cantley and Hening Lin and A. Melnick},\n journal = {Blood},\n pages
      = {643-643},\n title = {SIRT3 Is a Novel Metabolic Driver of and Therapeutic
      Target for Chemotherapy Resistant Dlbcls},\n volume = {130},\n year = {2017}\n}\n"},
      "authors": [{"authorId": "88436340", "name": "M. Li"}, {"authorId": "50462482",
      "name": "Ying-Ling Chiang"}, {"authorId": "4901222", "name": "C. Lyssiotis"},
      {"authorId": "79496189", "name": "Matt Teater"}, {"authorId": "2110770666",
      "name": "Hao Shen"}, {"authorId": "2151978477", "name": "Ling Wang"}, {"authorId":
      "47728412", "name": "J. Hong"}, {"authorId": "2109930096", "name": "Hui Jin"},
      {"authorId": "145546240", "name": "C. Duy"}, {"authorId": "36529561", "name":
      "S. Mistry"}, {"authorId": "6791438", "name": "L. Cerchietti"}, {"authorId":
      "4001772", "name": "J. Cross"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "35643033", "name": "Hening Lin"}, {"authorId": "145150236", "name":
      "A. Melnick"}]}, {"paperId": "9c85b5c1b1da70b90109fde12ebef63d0e2728f0", "externalIds":
      {"MAG": "2590621600", "DOI": "10.1158/2159-8290.CD-16-0612", "CorpusId": 4528396,
      "PubMed": "28255082"}, "corpusId": 4528396, "publicationVenue": {"id": "de16002a-77c3-4d03-9348-5a1813238e0b",
      "name": "Cancer Discovery", "type": "journal", "alternate_names": ["Cancer Discov"],
      "issn": "2159-8274", "url": "https://cancerdiscovery.aacrjournals.org/"}, "url":
      "https://www.semanticscholar.org/paper/9c85b5c1b1da70b90109fde12ebef63d0e2728f0",
      "title": "PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity
      to Dihydroorotate Dehydrogenase Inhibition.", "abstract": "Metabolic changes
      induced by oncogenic drivers of cancer contribute to tumor growth and are attractive
      targets for cancer treatment. Here, we found that increased growth of PTEN-mutant
      cells was dependent on glutamine flux through the de novo pyrimidine synthesis
      pathway, which created sensitivity to the inhibition of dihydroorotate dehydrogenase,
      a rate-limiting enzyme for pyrimidine ring synthesis. S-phase PTEN-mutant cells
      showed increased numbers of replication forks, and inhibitors of dihydroorotate
      dehydrogenase led to chromosome breaks and cell death due to inadequate ATR
      activation and DNA damage at replication forks. Our findings indicate that enhanced
      glutamine flux generates vulnerability to dihydroorotate dehydrogenase inhibition,
      which then causes synthetic lethality in PTEN-deficient cells due to inherent
      defects in ATR activation. Inhibition of dihydroorotate dehydrogenase could
      thus be a promising therapy for patients with PTEN-mutant cancers.Significance:
      We have found a prospective targeted therapy for PTEN-deficient tumors, with
      efficacy in vitro and in vivo in tumors derived from different tissues. This
      is based upon the changes in glutamine metabolism, DNA replication, and DNA
      damage response which are consequences of inactivation of PTENCancer Discov;
      7(4); 380-90. \u00a92017 AACR.See related article by Brown et al., p. 391This
      article is highlighted in the In This Issue feature, p. 339.", "venue": "Cancer
      Discovery", "year": 2017, "referenceCount": 35, "citationCount": 83, "influentialCitationCount":
      5, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerdiscovery.aacrjournals.org/content/candisc/7/4/380.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-03-02", "journal": {"volume": "7 4", "pages": "\n          380-390\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Mathur2017PTENRG,\n
      author = {Deepti Mathur and E. Stratikopoulos and Sait Ozturk and Nicole Steinbach
      and Sarah Pegno and Sarah M. Schoenfeld and R. Yong and V. Murty and J. Asara
      and L. Cantley and R. Parsons},\n booktitle = {Cancer Discovery},\n journal
      = {Cancer discovery},\n pages = {\n          380-390\n        },\n title = {PTEN
      Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate
      Dehydrogenase Inhibition.},\n volume = {7 4},\n year = {2017}\n}\n"}, "authors":
      [{"authorId": "1683686", "name": "Deepti Mathur"}, {"authorId": "50738000",
      "name": "E. Stratikopoulos"}, {"authorId": "6487574", "name": "Sait Ozturk"},
      {"authorId": "5694306", "name": "Nicole Steinbach"}, {"authorId": "7475438",
      "name": "Sarah Pegno"}, {"authorId": "15429457", "name": "Sarah M. Schoenfeld"},
      {"authorId": "5170353", "name": "R. Yong"}, {"authorId": "145900083", "name":
      "V. Murty"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "47689907", "name": "R. Parsons"}]}, {"paperId":
      "a613e2e4da7aeb2c4e004760afddf8f7bd42d3cd", "externalIds": {"MAG": "2757659639",
      "DOI": "10.1016/j.ijrobp.2017.06.500", "CorpusId": 79825464}, "corpusId": 79825464,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/a613e2e4da7aeb2c4e004760afddf8f7bd42d3cd",
      "title": "Radiation-Induced Activation of Innate Immune Pathways from Errors
      in Mitosis", "abstract": null, "venue": "", "year": 2017, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.redjournal.org/article/S0360301617315523/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Environmental
      Science", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2017-10-01", "journal": {"volume": "99", "name": "International Journal of
      Radiation Oncology Biology Physics"}, "citationStyles": {"bibtex": "@Article{Bakhoum2017RadiationInducedAO,\n
      author = {S. Bakhoum and B. Ngo and A. Bakhoum and J. Cavallo-Fleming and Charles
      J Murphy and S. Powell and L. Cantley},\n journal = {International Journal of
      Radiation Oncology Biology Physics},\n title = {Radiation-Induced Activation
      of Innate Immune Pathways from Errors in Mitosis},\n volume = {99},\n year =
      {2017}\n}\n"}, "authors": [{"authorId": "3543494", "name": "S. Bakhoum"}, {"authorId":
      "5891999", "name": "B. Ngo"}, {"authorId": "87660245", "name": "A. Bakhoum"},
      {"authorId": "1435148670", "name": "J. Cavallo-Fleming"}, {"authorId": "47107919",
      "name": "Charles J Murphy"}, {"authorId": "1695518", "name": "S. Powell"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "d133cf7168dcd88b5ada3463782d53748df28203",
      "externalIds": {"MAG": "2582770688", "DOI": "10.1016/j.jid.2017.01.013", "CorpusId":
      11650426, "PubMed": "28143781"}, "corpusId": 11650426, "publicationVenue": {"id":
      "6c1b0ec7-15b8-4f2e-8113-82a5eb121bde", "name": "Journal of Investigative Dermatology",
      "type": "journal", "alternate_names": ["J Investig Dermatol"], "issn": "0022-202X",
      "url": "http://www.blackwell-synergy.com/issuelist.asp?journal=jid", "alternate_urls":
      ["https://www.jidonline.org/", "http://www.nature.com/jid/index.html"]}, "url":
      "https://www.semanticscholar.org/paper/d133cf7168dcd88b5ada3463782d53748df28203",
      "title": "Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma.",
      "abstract": null, "venue": "Journal of Investigative Dermatology", "year": 2017,
      "referenceCount": 32, "citationCount": 25, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.jidonline.org/article/S0022202X17300520/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2017-05-01", "journal": {"volume": "137
      5", "pages": "\n          1135-1143\n        ", "name": "The Journal of investigative
      dermatology"}, "citationStyles": {"bibtex": "@Article{Trousil2017PhenforminET,\n
      author = {S. Trousil and Shuang Chen and C. Mu and F. Shaw and Z. Yao and Y.
      Ran and T. Shakuntala and T. Merghoub and D. Manstein and N. Rosen and L. Cantley
      and J. Zippin and B. Zheng},\n booktitle = {Journal of Investigative Dermatology},\n
      journal = {The Journal of investigative dermatology},\n pages = {\n          1135-1143\n        },\n
      title = {Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma.},\n
      volume = {137 5},\n year = {2017}\n}\n"}, "authors": [{"authorId": "48333180",
      "name": "S. Trousil"}, {"authorId": "2143502863", "name": "Shuang Chen"}, {"authorId":
      "2144316440", "name": "C. Mu"}, {"authorId": "49749587", "name": "F. Shaw"},
      {"authorId": "47845677", "name": "Z. Yao"}, {"authorId": "52133687", "name":
      "Y. Ran"}, {"authorId": "94373231", "name": "T. Shakuntala"}, {"authorId": "6949756",
      "name": "T. Merghoub"}, {"authorId": "5938253", "name": "D. Manstein"}, {"authorId":
      "144020146", "name": "N. Rosen"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "6765019", "name": "J. Zippin"}, {"authorId": "143918840", "name":
      "B. Zheng"}]}, {"paperId": "d3a1522a6d4bdeb4ece083296badc729f718e163", "externalIds":
      {"MAG": "2579698820", "DOI": "10.1021/acs.jmedchem.6b01166", "CorpusId": 206619415,
      "PubMed": "28085281"}, "corpusId": 206619415, "publicationVenue": {"id": "4cce60a8-2106-4240-bece-fb6488df6bd1",
      "name": "Journal of Medicinal Chemistry", "type": "journal", "alternate_names":
      ["J Med Chem"], "issn": "0022-2623", "url": "https://pubs.acs.org/journal/jmcmar",
      "alternate_urls": ["http://pubs.acs.org/journal/jmcmar", "http://pubs.acs.org/journals/jmcmar/index.html"]},
      "url": "https://www.semanticscholar.org/paper/d3a1522a6d4bdeb4ece083296badc729f718e163",
      "title": "\u03b1-Ketothioamide Derivatives: A Promising Tool to Interrogate
      Phosphoglycerate Dehydrogenase (PHGDH).", "abstract": "Given the putative role
      of PHGDH in cancer, development of inhibitors is required to explore its function.
      In this context, we established and validated a straightforward enzymatic assay
      suitable for high-throughput screening and we identified inhibitors with similar
      chemical scaffolds. Through a convergent pharmacophore approach, we synthesized
      \u03b1-ketothioamides that exhibit interesting in vitro PHGDH inhibition and
      encouraging cellular results. These novel probes may be used to understand the
      emerging biology of this metabolic target.", "venue": "Journal of Medicinal
      Chemistry", "year": 2017, "referenceCount": 18, "citationCount": 40, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc5603230?pdf=render",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-01-27", "journal": {"volume": "60 4", "pages": "\n          1591-1597\n        ",
      "name": "Journal of medicinal chemistry"}, "citationStyles": {"bibtex": "@Article{Ravez2017\u03b1KetothioamideDA,\n
      author = {S\u00e9verine Ravez and C. Corbet and Quentin Spillier and A. Dutu
      and A. Robin and Edouard Mullarky and L. Cantley and O. F\u00e9ron and R. Fr\u00e9d\u00e9rick},\n
      booktitle = {Journal of Medicinal Chemistry},\n journal = {Journal of medicinal
      chemistry},\n pages = {\n          1591-1597\n        },\n title = {\u03b1-Ketothioamide
      Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase
      (PHGDH).},\n volume = {60 4},\n year = {2017}\n}\n"}, "authors": [{"authorId":
      "47476313", "name": "S\u00e9verine Ravez"}, {"authorId": "5469111", "name":
      "C. Corbet"}, {"authorId": "12674173", "name": "Quentin Spillier"}, {"authorId":
      "6205578", "name": "A. Dutu"}, {"authorId": "13966444", "name": "A. Robin"},
      {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2110687", "name": "O. F\u00e9ron"}, {"authorId":
      "3317215", "name": "R. Fr\u00e9d\u00e9rick"}]}, {"paperId": "d6d4fb1f4d953d83293c42671ea2f95071b964a9",
      "externalIds": {"PubMedCentral": "5486569", "MAG": "2591971327", "DOI": "10.1007/s00432-017-2358-x",
      "CorpusId": 25394724, "PubMed": "28247034"}, "corpusId": 25394724, "publicationVenue":
      {"id": "6451604f-a8c1-487f-992d-af7cfbbeabed", "name": "Journal of Cancer Research
      and Clinical Oncology", "type": "journal", "alternate_names": ["J Cancer Res
      Clin Oncol"], "issn": "0171-5216", "url": "https://www.springer.com/medicine/oncology/journal/432",
      "alternate_urls": ["https://link.springer.com/journal/432"]}, "url": "https://www.semanticscholar.org/paper/d6d4fb1f4d953d83293c42671ea2f95071b964a9",
      "title": "Genomic characteristics of trastuzumab-resistant Her2-positive metastatic
      breast cancer", "abstract": null, "venue": "Journal of Cancer Research and Clinical
      Oncology", "year": 2017, "referenceCount": 33, "citationCount": 21, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc5486569?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2017-02-28", "journal":
      {"volume": "143", "pages": "1255 - 1262", "name": "Journal of Cancer Research
      and Clinical Oncology"}, "citationStyles": {"bibtex": "@Article{Taveira2017GenomicCO,\n
      author = {Mateus de Oliveira Taveira and S. Nabavi and Yuker Wang and P. Tonellato
      and F. Esteva and L. Cantley and G. Wulf},\n booktitle = {Journal of Cancer
      Research and Clinical Oncology},\n journal = {Journal of Cancer Research and
      Clinical Oncology},\n pages = {1255 - 1262},\n title = {Genomic characteristics
      of trastuzumab-resistant Her2-positive metastatic breast cancer},\n volume =
      {143},\n year = {2017}\n}\n"}, "authors": [{"authorId": "6096769", "name": "Mateus
      de Oliveira Taveira"}, {"authorId": "145834073", "name": "S. Nabavi"}, {"authorId":
      "47906736", "name": "Yuker Wang"}, {"authorId": "1815350", "name": "P. Tonellato"},
      {"authorId": "46312487", "name": "F. Esteva"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "31554501", "name": "G. Wulf"}]}, {"paperId": "e59bdf9a74d240d4578adcd471571d30d56e476c",
      "externalIds": {"MAG": "2666241239", "DOI": "10.1073/pnas.1704706114", "CorpusId":
      19050387, "PubMed": "28630349"}, "corpusId": 19050387, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/e59bdf9a74d240d4578adcd471571d30d56e476c",
      "title": "PI3K-p110\u03b1 mediates the oncogenic activity induced by loss of
      the novel tumor suppressor PI3K-p85\u03b1", "abstract": "Significance Phosphatidylinositol
      3-kinase (PI3K) pathway hyperactivation is a common event in cancer, and understanding
      alterations in this pathway is critical. Recently, the p85 regulatory subunit
      of PI3K has come into focus as a novel pathway component targeted in cancers.
      We find that decreased p85\u03b1 contributes to transformation of in vitro and
      in vivo models of breast cancer. We provide evidence that partial loss of p85\u03b1
      increases the binding of p110\u03b1\u2013p85 signaling complexes to activated
      receptors, thereby augmenting PI3K pathway output. Our findings indicate that
      p85\u03b1 loss may be transforming in any context where PI3K is activated. Additionally,
      they implicate a role for monomeric free p85 as a negative regulator of PI3K
      signaling. Mutation or loss of the p85 regulatory subunit of phosphatidylinositol
      3-kinase (PI3K) is emerging as a transforming factor in cancer, but the mechanism
      of transformation has been controversial. Here we find that hemizygous deletion
      of the PIK3R1 gene encoding p85\u03b1 is a frequent event in breast cancer,
      with PIK3R1 expression significantly reduced in breast tumors. PIK3R1 knockdown
      transforms human mammary epithelial cells, and genetic ablation of Pik3r1 accelerates
      a mouse model of HER2/neu-driven breast cancer. We demonstrate that partial
      loss of p85\u03b1 increases the amount of p110\u03b1\u2013p85 heterodimers bound
      to active receptors, augmenting PI3K signaling and oncogenic transformation.
      Pan-PI3K and p110\u03b1-selective pharmacological inhibition effectively blocks
      transformation driven by partial p85\u03b1 loss both in vitro and in vivo. Together,
      our data suggest that p85\u03b1 plays a tumor-suppressive role in transformation,
      and suggest that p110\u03b1-selective therapeutics may be effective in the treatment
      of breast cancer patients with PIK3R1 loss.", "venue": "Proceedings of the National
      Academy of Sciences of the United States of America", "year": 2017, "referenceCount":
      40, "citationCount": 62, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/114/27/7095.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-06-19", "journal": {"volume": "114", "pages": "7095
      - 7100", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Thorpe2017PI3Kp110\u03b1MT,\n author = {Lauren M Thorpe
      and J. Spangle and Carolynn E. Ohlson and Hailing Cheng and T. Roberts and L.
      Cantley and Jean J. Zhao},\n booktitle = {Proceedings of the National Academy
      of Sciences of the United States of America},\n journal = {Proceedings of the
      National Academy of Sciences},\n pages = {7095 - 7100},\n title = {PI3K-p110\u03b1
      mediates the oncogenic activity induced by loss of the novel tumor suppressor
      PI3K-p85\u03b1},\n volume = {114},\n year = {2017}\n}\n"}, "authors": [{"authorId":
      "6190753", "name": "Lauren M Thorpe"}, {"authorId": "5217296", "name": "J. Spangle"},
      {"authorId": "38628965", "name": "Carolynn E. Ohlson"}, {"authorId": "7915457",
      "name": "Hailing Cheng"}, {"authorId": "6665338", "name": "T. Roberts"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "50985038", "name": "Jean J.
      Zhao"}]}, {"paperId": "e6d3b06f311b70842adcfde49999f3c00bd1f0ca", "externalIds":
      {"CorpusId": 35243054}, "corpusId": 35243054, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/e6d3b06f311b70842adcfde49999f3c00bd1f0ca",
      "title": "PIK 3 CA C 2 domain deletions hyperactivate phosphoinositide 3-kinase
      ( PI 3 K ) , generate oncogene dependence and are exquisitely sensitive to PI
      3 K\u03b1 inhibitors", "abstract": "Purpose: We describe herein a novel P447_L455
      deletion in the C2 domain of PIK3CA in a patient with an ER+ breast cancer with
      an excellent response to the PI3K\u03b1 inhibitor alpelisib. Although PIK3CA
      deletions are relatively rare, a significant portion of deletions cluster within
      amino acids 446-460 of the C2 domain, suggesting these residues are critical
      for p110\u03b1 function. Design: A computational structural model of PIK3CA
      in complex with the p85 regulatory subunit and MCF10A cells expressing PIK3CA
      and PIK3CA were used to understand the phenotype of C2 domain deletions. Results:
      Computational modeling revealed specific favorable inter-residue contacts that
      would be lost as a result of the deletion, predicting a significant decrease
      in binding energy. Co-immunoprecipitation experiments showed reduced binding
      of the C2 Research. on December 30, 2017. \u00a9 2017 American Association for
      Cancer clincancerres.aacrjournals.org Downloaded from Author manuscripts have
      been peer reviewed and accepted for publication but have not yet been edited.
      Author Manuscript Published OnlineFirst on December 28, 2017; DOI: 10.1158/1078-0432.CCR-17-2141",
      "venue": "", "year": 2017, "referenceCount": 27, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review"],
      "publicationDate": null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Croessmann2017PIK3C,\n
      author = {Sarah Croessmann and J. Sheehan and Kyung-min Lee and Gregory Sliwoski
      and Ji\u00e9 He and R. Nagy and David A Riddle and I. Mayer and J. Balko and
      R. Lanman and V. Miller and L. Cantley and J. Meiler and C. Arteaga},\n title
      = {PIK 3 CA C 2 domain deletions hyperactivate phosphoinositide 3-kinase ( PI
      3 K ) , generate oncogene dependence and are exquisitely sensitive to PI 3 K\u03b1
      inhibitors},\n year = {2017}\n}\n"}, "authors": [{"authorId": "5404128", "name":
      "Sarah Croessmann"}, {"authorId": "6251014", "name": "J. Sheehan"}, {"authorId":
      "46542827", "name": "Kyung-min Lee"}, {"authorId": "3381467", "name": "Gregory
      Sliwoski"}, {"authorId": "50774890", "name": "Ji\u00e9 He"}, {"authorId": "39540895",
      "name": "R. Nagy"}, {"authorId": "82059310", "name": "David A Riddle"}, {"authorId":
      "2346140", "name": "I. Mayer"}, {"authorId": "66935619", "name": "J. Balko"},
      {"authorId": "3484938", "name": "R. Lanman"}, {"authorId": "2134288", "name":
      "V. Miller"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1754226",
      "name": "J. Meiler"}, {"authorId": "2057460", "name": "C. Arteaga"}]}, {"paperId":
      "ed2f419136e0df8b9ba01ce6784e40a7b561824e", "externalIds": {"MAG": "2592811353",
      "DOI": "10.1158/2159-8290.CD-16-0778", "CorpusId": 4500636, "PubMed": "28274958"},
      "corpusId": 4500636, "publicationVenue": {"id": "de16002a-77c3-4d03-9348-5a1813238e0b",
      "name": "Cancer Discovery", "type": "journal", "alternate_names": ["Cancer Discov"],
      "issn": "2159-8274", "url": "https://cancerdiscovery.aacrjournals.org/"}, "url":
      "https://www.semanticscholar.org/paper/ed2f419136e0df8b9ba01ce6784e40a7b561824e",
      "title": "Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating
      Antitumor Innate Immunity.", "abstract": "Several kinase inhibitors that target
      aberrant signaling pathways in tumor cells have been deployed in cancer therapy.
      However, their impact on the tumor immune microenvironment remains poorly understood.
      The tyrosine kinase inhibitor cabozantinib showed striking responses in cancer
      clinical trial patients across several malignancies. Here, we show that cabozantinib
      rapidly eradicates invasive, poorly differentiated PTEN/p53-deficient murine
      prostate cancer. This was associated with enhanced release of neutrophil chemotactic
      factors from tumor cells, including CXCL12 and HMGB1, resulting in robust infiltration
      of neutrophils into the tumor. Critically, cabozantinib-induced tumor clearance
      in mice was abolished by antibody-mediated granulocyte depletion or HMGB1 neutralization
      or blockade of neutrophil chemotaxis with the CXCR4 inhibitor plerixafor. Collectively,
      these data demonstrate that cabozantinib triggers a neutrophil-mediated anticancer
      innate immune response, resulting in tumor clearance.Significance: This study
      is the first to demonstrate that a tyrosine kinase inhibitor can activate neutrophil-mediated
      antitumor innate immunity, resulting in invasive cancer clearance. Cancer Discov;
      7(7); 750-65. \u00a92017 AACR.This article is highlighted in the In This Issue
      feature, p. 653.", "venue": "Cancer Discovery", "year": 2017, "referenceCount":
      54, "citationCount": 98, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://cancerdiscovery.aacrjournals.org/content/candisc/7/7/750.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2017-03-08", "journal": {"volume": "7 7", "pages": "\n          750-765\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Patnaik2017CabozantinibEA,\n
      author = {Akash Patnaik and K. Swanson and E. Csizmadia and Aniruddh Solanki
      and Natalie Landon-Brace and M. Gehring and Katja Helenius and Brian M Olson
      and A. Pyzer and Lily C. Wang and O. Elemento and Jesse S. Novak and T. Thornley
      and J. Asara and L. Montaser and J. Timmons and T. Morgan and Yugang Wang and
      E. Levantini and J. Clohessy and K. Kelly and P. Pandolfi and J. Rosenblatt
      and D. Avigan and Huihui Ye and J. Karp and S. Signoretti and S. Balk and L.
      Cantley},\n booktitle = {Cancer Discovery},\n journal = {Cancer discovery},\n
      pages = {\n          750-765\n        },\n title = {Cabozantinib Eradicates
      Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.},\n
      volume = {7 7},\n year = {2017}\n}\n"}, "authors": [{"authorId": "40501341",
      "name": "Akash Patnaik"}, {"authorId": "6784962", "name": "K. Swanson"}, {"authorId":
      "4793517", "name": "E. Csizmadia"}, {"authorId": "39787428", "name": "Aniruddh
      Solanki"}, {"authorId": "1417572171", "name": "Natalie Landon-Brace"}, {"authorId":
      "33820964", "name": "M. Gehring"}, {"authorId": "49804844", "name": "Katja Helenius"},
      {"authorId": "21582882", "name": "Brian M Olson"}, {"authorId": "15061933",
      "name": "A. Pyzer"}, {"authorId": "2117931332", "name": "Lily C. Wang"}, {"authorId":
      "150097652", "name": "O. Elemento"}, {"authorId": "50577147", "name": "Jesse
      S. Novak"}, {"authorId": "4374091", "name": "T. Thornley"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "49666064", "name": "L. Montaser"}, {"authorId":
      "6571591", "name": "J. Timmons"}, {"authorId": "74997355", "name": "T. Morgan"},
      {"authorId": "49416325", "name": "Yugang Wang"}, {"authorId": "3768843", "name":
      "E. Levantini"}, {"authorId": "4102988", "name": "J. Clohessy"}, {"authorId":
      "145953924", "name": "K. Kelly"}, {"authorId": "4499580", "name": "P. Pandolfi"},
      {"authorId": "31499217", "name": "J. Rosenblatt"}, {"authorId": "145881219",
      "name": "D. Avigan"}, {"authorId": "3073381", "name": "Huihui Ye"}, {"authorId":
      "5747025", "name": "J. Karp"}, {"authorId": "7505152", "name": "S. Signoretti"},
      {"authorId": "6189162", "name": "S. Balk"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "01f49fa909cb1c8fa044e948388d6d9796580776", "externalIds":
      {"MAG": "2442812297", "DOI": "10.1073/pnas.1600934113", "CorpusId": 11852213,
      "PubMed": "27313209"}, "corpusId": 11852213, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/01f49fa909cb1c8fa044e948388d6d9796580776",
      "title": "Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase,
      results in hyperactivation of the immune system", "abstract": "Significance
      The mammalian target of rapamycin complex 1 (mTORC1) signaling pathway is an
      important facet of the immune system, including that it regulates T-cell differentiation
      and activation. Here, we report that type 2 phosphatidylinositol-5-phosphate
      4-kinase gamma (protein, PI5P4K\u03b3; gene, PIP4K2C) plays a role in the regulation
      of the immune system by manipulating mTORC1 signaling. These results suggest
      that the SNP at the PIP4K2C locus (rs1678542) in human patients with autoimmunity
      might cause a decrease in PI5P4K\u03b3 expression and thereby an increase in
      mTORC1 signaling. In addition, these results imply that inhibition of mTORC1
      would be beneficial to these patients. These studies also suggest that agents
      that inhibit PIP4K2C function could be useful to enhance cancer immunotherapy.
      Type 2 phosphatidylinositol-5-phosphate 4-kinase (PI5P4K) converts phosphatidylinositol-5-phosphate
      to phosphatidylinositol-4,5-bisphosphate. Mammals have three enzymes PI5P4K\u03b1,
      PI5P4K\u03b2, and PI5P4K\u03b3, and these enzymes have been implicated in metabolic
      control, growth control, and a variety of stress responses. Here, we show that
      mice with germline deletion of type 2 phosphatidylinositol-5-phosphate 4-kinase
      gamma (Pip4k2c), the gene encoding PI5P4K\u03b3, appear normal in regard to
      growth and viability but have increased inflammation and T-cell activation as
      they age. Immune cell infiltrates increased in Pip4k2c\u2212/\u2212 mouse tissues.
      Also, there was an increase in proinflammatory cytokines, including IFN\u03b3,
      interleukin 12, and interleukin 2 in plasma of Pip4k2c\u2212/\u2212 mice. Pip4k2c\u2212/\u2212
      mice had an increase in T-helper-cell populations and a decrease in regulatory
      T-cell populations with increased proliferation of T cells. Interestingly, mammalian
      target of rapamycin complex 1 (mTORC1) signaling was hyperactivated in several
      tissues from Pip4k2c\u2212/\u2212 mice and treating Pip4k2c\u2212/\u2212 mice
      with rapamycin reduced the inflammatory phenotype, resulting in a decrease in
      mTORC1 signaling in tissues and a decrease in proinflammatory cytokines in plasma.
      These results indicate that PI5P4K\u03b3 plays a role in the regulation of the
      immune system via mTORC1 signaling.", "venue": "Proceedings of the National
      Academy of Sciences of the United States of America", "year": 2016, "referenceCount":
      21, "citationCount": 49, "influentialCitationCount": 4, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/113/27/7596.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-06-16", "journal": {"volume": "113", "pages": "7596
      - 7601", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Shim2016DeletionOT,\n author = {Hyeseok Shim and Chuan
      Wu and Shivan Ramsamooj and Kaitlyn Bosch and Zuojia Chen and B. Emerling and
      Jihye Yun and Hui Liu and R. Choo-Wing and Zhiwei Yang and G. Wulf and V. Kuchroo
      and L. Cantley},\n booktitle = {Proceedings of the National Academy of Sciences
      of the United States of America},\n journal = {Proceedings of the National Academy
      of Sciences},\n pages = {7596 - 7601},\n title = {Deletion of the gene Pip4k2c,
      a novel phosphatidylinositol kinase, results in hyperactivation of the immune
      system},\n volume = {113},\n year = {2016}\n}\n"}, "authors": [{"authorId":
      "13574443", "name": "Hyeseok Shim"}, {"authorId": "46740724", "name": "Chuan
      Wu"}, {"authorId": "14390729", "name": "Shivan Ramsamooj"}, {"authorId": "7881810",
      "name": "Kaitlyn Bosch"}, {"authorId": "153267992", "name": "Zuojia Chen"},
      {"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "40164091", "name":
      "Jihye Yun"}, {"authorId": "2146671919", "name": "Hui Liu"}, {"authorId": "1401641678",
      "name": "R. Choo-Wing"}, {"authorId": "50109290", "name": "Zhiwei Yang"}, {"authorId":
      "31554501", "name": "G. Wulf"}, {"authorId": "4401436", "name": "V. Kuchroo"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "084308ce6f84792f8eba06150a4c460882b899a0",
      "externalIds": {"MAG": "2584068329", "DOI": "10.1038/cdd.2016.114", "CorpusId":
      24656160, "PubMed": "28141794"}, "corpusId": 24656160, "publicationVenue": {"id":
      "47f0445e-46e2-4685-8244-ddf7c2d587e2", "name": "Cell Death and Differentiation",
      "type": "journal", "alternate_names": ["Cell Death Differ", "Cell Death  Differ",
      "Cell Death & Differentiation"], "issn": "1350-9047", "url": "http://www.nature.com/cdd/",
      "alternate_urls": ["http://www.nature.com/cdd/index.html"]}, "url": "https://www.semanticscholar.org/paper/084308ce6f84792f8eba06150a4c460882b899a0",
      "title": "Death-associated protein kinase 1 phosphorylates NDRG2 and induces
      neuronal cell death", "abstract": null, "venue": "Cell Death and Differentiation",
      "year": 2016, "referenceCount": 57, "citationCount": 42, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/cdd2016114.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-11-04", "journal": {"volume": "24", "pages": "238-250",
      "name": "Cell Death and Differentiation"}, "citationStyles": {"bibtex": "@Article{You2016DeathassociatedPK,\n
      author = {M. You and B. Kim and Chun-Hau Chen and M. Begley and L. Cantley and
      T. Lee},\n booktitle = {Cell Death and Differentiation},\n journal = {Cell Death
      and Differentiation},\n pages = {238-250},\n title = {Death-associated protein
      kinase 1 phosphorylates NDRG2 and induces neuronal cell death},\n volume = {24},\n
      year = {2016}\n}\n"}, "authors": [{"authorId": "49529179", "name": "M. You"},
      {"authorId": "145266603", "name": "B. Kim"}, {"authorId": "120897015", "name":
      "Chun-Hau Chen"}, {"authorId": "69874482", "name": "M. Begley"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "145569223", "name": "T. Lee"}]},
      {"paperId": "0b0f7ff147e42ca79bbaa7763d1759dd5eaee1da", "externalIds": {"MAG":
      "2319881581", "DOI": "10.1038/ng0329-473a", "CorpusId": 8524302, "PubMed": "27023779"},
      "corpusId": 8524302, "publicationVenue": {"id": "bb27e645-e57c-42c3-bcbc-c7b443c58209",
      "name": "Nature Genetics", "type": "journal", "alternate_names": ["Nat Genet"],
      "issn": "1061-4036", "url": "http://www.nature.com/ng/", "alternate_urls": ["http://www.nature.com/ng/index.html"]},
      "url": "https://www.semanticscholar.org/paper/0b0f7ff147e42ca79bbaa7763d1759dd5eaee1da",
      "title": "Erratum: NRF2 regulates serine biosynthesis in non\u2013small cell
      lung cancer", "abstract": null, "venue": "Nature Genetics", "year": 2016, "referenceCount":
      1, "citationCount": 8, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.nature.com/articles/ng0329-473a.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-03-29", "journal": {"volume": "48", "pages": "473-473", "name": "Nature
      Genetics"}, "citationStyles": {"bibtex": "@Article{DeNicola2016ErratumNR,\n
      author = {G. DeNicola and Pei-Hsuan Chen and Edouard Mullarky and J. Sudderth
      and Zeping Hu and David Wu and Hao Tang and Yang Xie and J. Asara and K. Huffman
      and I. Wistuba and J. Minna and R. Deberardinis and L. Cantley},\n booktitle
      = {Nature Genetics},\n journal = {Nature Genetics},\n pages = {473-473},\n title
      = {Erratum: NRF2 regulates serine biosynthesis in non\u2013small cell lung cancer},\n
      volume = {48},\n year = {2016}\n}\n"}, "authors": [{"authorId": "4772111", "name":
      "G. DeNicola"}, {"authorId": "4047142", "name": "Pei-Hsuan Chen"}, {"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "5467431", "name": "J.
      Sudderth"}, {"authorId": "3616375", "name": "Zeping Hu"}, {"authorId": "144790190",
      "name": "David Wu"}, {"authorId": "2112388600", "name": "Hao Tang"}, {"authorId":
      "145668114", "name": "Yang Xie"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "5305256", "name": "K. Huffman"}, {"authorId": "46528860", "name":
      "I. Wistuba"}, {"authorId": "2996220", "name": "J. Minna"}, {"authorId": "5834413",
      "name": "R. Deberardinis"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "24021285521e5d21fe2a2fb7f58254186ad1d7e9", "externalIds": {"MAG":
      "2494704798", "DOI": "10.1158/1538-7445.AM2016-1625", "CorpusId": 78226268},
      "corpusId": 78226268, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/24021285521e5d21fe2a2fb7f58254186ad1d7e9",
      "title": "Abstract 1625: CUB domain-containing protein 1 (CDCP1) promotes metastatic
      phenotype in pancreatic ductal adenocarcinoma", "abstract": null, "venue": "",
      "year": 2016, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2016-07-15", "journal": {"volume":
      "76", "pages": "1625-1625", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Kim2016Abstract1C,\n author = {Sunnie S Kim and B. Emerling and B.
      Hopkins and Ryan Loughran and S. Naranjos and L. Cantley},\n journal = {Cancer
      Research},\n pages = {1625-1625},\n title = {Abstract 1625: CUB domain-containing
      protein 1 (CDCP1) promotes metastatic phenotype in pancreatic ductal adenocarcinoma},\n
      volume = {76},\n year = {2016}\n}\n"}, "authors": [{"authorId": "2109648661",
      "name": "Sunnie S Kim"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId":
      "48821307", "name": "B. Hopkins"}, {"authorId": "31875049", "name": "Ryan Loughran"},
      {"authorId": "82902019", "name": "S. Naranjos"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "27ef47762fd0715155c952a9bb89b018ecff9acd", "externalIds":
      {"MAG": "2474366905", "DOI": "10.1073/pnas.1522223113", "CorpusId": 20555480,
      "PubMed": "27402769"}, "corpusId": 20555480, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/27ef47762fd0715155c952a9bb89b018ecff9acd",
      "title": "Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside
      depletion", "abstract": "Significance Mutations in the PI3K pathway are highly
      prevalent in cancers, and isoform-specific and pan-PI3K inhibitors have entered
      clinical trials in both solid and hematologic malignancies. The PI3K \u03b4-specific
      inhibitor idelalisib (in combination with rituximab) was recently approved for
      the treatment of chronic lymphocytic leukemia. However, identifying tumor types
      and biological mechanisms that predict for response to PI3K inhibitors as single
      agents or in combination has been a challenge. Our data indicate that PI3K inhibitors
      induce DNA damage in tumors that have defects in DNA damage-repair pathways
      and that they do so by impairing the production of Rib phosphate and amino acids
      needed for deoxynucleotide synthesis. We previously reported that combining
      a phosphoinositide 3-kinase (PI3K) inhibitor with a poly-ADP Rib polymerase
      (PARP)-inhibitor enhanced DNA damage and cell death in breast cancers that have
      genetic aberrations in BRCA1 and TP53. Here, we show that enhanced DNA damage
      induced by PI3K inhibitors in this mutational background is a consequence of
      impaired production of nucleotides needed for DNA synthesis and DNA repair.
      Inhibition of PI3K causes a reduction in all four nucleotide triphosphates,
      whereas inhibition of the protein kinase AKT is less effective than inhibition
      of PI3K in suppressing nucleotide synthesis and inducing DNA damage. Carbon
      flux studies reveal that PI3K inhibition disproportionately affects the nonoxidative
      pentose phosphate pathway that delivers Rib-5-phosphate required for base ribosylation.
      In vivo in a mouse model of BRCA1-linked triple-negative breast cancer (K14-Cre
      BRCA1f/fp53f/f), the PI3K inhibitor BKM120 led to a precipitous drop in DNA
      synthesis within 8 h of drug treatment, whereas DNA synthesis in normal tissues
      was less affected. In this mouse model, combined PI3K and PARP inhibition was
      superior to either agent alone to induce durable remissions of established tumors.",
      "venue": "Proceedings of the National Academy of Sciences of the United States
      of America", "year": 2016, "referenceCount": 41, "citationCount": 71, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/113/30/E4338.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-07-08", "journal": {"volume": "113", "pages": "E4338
      - E4347", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Juvekar2016Phosphoinositide3I,\n author = {Ashish Juvekar
      and Hai Hu and S. Yadegarynia and C. Lyssiotis and Soumya Ullas and Evan C.
      Lien and G. Bellinger and J. Son and R. Hok and P. Seth and M. B. Daly and Baek
      Kim and R. Scully and J. Asara and L. Cantley and G. Wulf},\n booktitle = {Proceedings
      of the National Academy of Sciences of the United States of America},\n journal
      = {Proceedings of the National Academy of Sciences},\n pages = {E4338 - E4347},\n
      title = {Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside
      depletion},\n volume = {113},\n year = {2016}\n}\n"}, "authors": [{"authorId":
      "49149990", "name": "Ashish Juvekar"}, {"authorId": "113164867", "name": "Hai
      Hu"}, {"authorId": "3893473", "name": "S. Yadegarynia"}, {"authorId": "4901222",
      "name": "C. Lyssiotis"}, {"authorId": "50136879", "name": "Soumya Ullas"}, {"authorId":
      "4729701", "name": "Evan C. Lien"}, {"authorId": "5679020", "name": "G. Bellinger"},
      {"authorId": "38313825", "name": "J. Son"}, {"authorId": "11228582", "name":
      "R. Hok"}, {"authorId": "143667851", "name": "P. Seth"}, {"authorId": "49947506",
      "name": "M. B. Daly"}, {"authorId": "2144570709", "name": "Baek Kim"}, {"authorId":
      "143905392", "name": "R. Scully"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "31554501", "name":
      "G. Wulf"}]}, {"paperId": "2f2ee38e6b78d20cf997cbcb0a7e724d6d755937", "externalIds":
      {"MAG": "2562883911", "DOI": "10.5772/65141", "CorpusId": 4690688}, "corpusId":
      4690688, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/2f2ee38e6b78d20cf997cbcb0a7e724d6d755937",
      "title": "NRF2 Rewires Cellular Metabolism to Support the Antioxidant Response",
      "abstract": "The transcription factor (nuclear factor-erythroid 2 p45-related
      factor 2, NRF2) is a master regulator of the cellular response to oxidative
      insults. While antioxidant response enzymes are well-characterized transcriptional
      targets of NRF2, it is recently becoming clear that NRF2 also supports cellular
      detoxification through metabolic rewiring to support the antioxidant systems.
      In this chapter, we discuss the regulation of NRF2 and how NRF2 activation promotes
      the antioxidant defense of cells. Further-more, we discuss how reactive oxygen
      species influence cellular metabolism and how this affects antioxidant function.
      We also discuss how NRF2 reprograms cellular metabolism to support the antioxidant
      response and how this functions to funnel metabolic intermediates into antioxidant
      pathways. This chapter concludes by exploring how these factors may contribute
      to both normal physiology and disease. transports cystine into the cell which
      is reduced to cysteine via TXNRD, and glutamate is generated by glutaminase
      1 (GLS1) and GLS2 using glutamine as a substrate. Furthermore, xenobiotics undergo
      oxidation, reduction, or hydrolysis by cytochrome P450 enzymes and are subsequently
      conjugated with glucuronic acid, catalyzed by UDP-glucuronosyltransferase (UGT),
      and exported out of the cells by multidrug resistance-associated proteins (MRP).
      Some of the xenobiotics such as quinones can undergo redox cycling which results
      in ROS production, which is counteracted by the NADPH-required reduction reactions
      catalyzed by aldo-keto reductase (AKR) and NAD(P)H: quinone oxidoreductase 1
      (NQO1). The role of NRF2 in mediating the antioxidant response is through (1)
      regulation of NADPH-generating enzymes (G6PD, PGD, IDH1, and ME1); (2) upregulation
      of the enzymes required for GSH production, regeneration, and utilization, such
      as GLS1/GLS2 and GCLM/GCLC; (3) regulation of XCT to increase the intracellular
      cysteine pool in support of GSH synthesis; and (4) upregulation of UDP-glucuronosyltransferase
      (UGT) to promote glucuronidation pathway. \u03b1-KG dehydrogenase complex. Succinyl-CoA
      is then trans-formed to succinate by the succinyl-CoA synthetase. is oxidized
      to fumarate the succinate dehydrogenase (SDH) complex and hydrated to malate
      by fumarate hydratase (FH). Oxidation of malate, catalyzed by malate dehydrogenase,
      finally regenerates oxaloacetate, and the cycle continues.", "venue": "", "year":
      2016, "referenceCount": 131, "citationCount": 30, "influentialCitationCount":
      5, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.intechopen.com/citation-pdf-url/52298",
      "status": null}, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Environmental Science", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-12-21", "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex":
      "@Inproceedings{Lin2016NRF2RC,\n author = {Ting-Yu Lin and L. Cantley and G.
      DeNicola},\n title = {NRF2 Rewires Cellular Metabolism to Support the Antioxidant
      Response},\n year = {2016}\n}\n"}, "authors": [{"authorId": "144181325", "name":
      "Ting-Yu Lin"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4772111", "name": "G. DeNicola"}]}, {"paperId": "34b188d2d5ab1d0e50b32245654c9c091735ca27",
      "externalIds": {"MAG": "2509166389", "DOI": "10.1073/pnas.1606862113", "CorpusId":
      27171538, "PubMed": "27528663"}, "corpusId": 27171538, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/34b188d2d5ab1d0e50b32245654c9c091735ca27",
      "title": "Mitotic MELK-eIF4B signaling controls protein synthesis and tumor
      cell survival", "abstract": "Significance The work identifies the eukaryotic
      translation initiation factor 4B (eIF4B) as a substrate of maternal and embryonic
      leucine zipper kinase (MELK), a mitotic kinase known to be essential for aggressive
      types of malignancy. The MELK\u2013eIF4B axis thus represents a previously unidentified
      signaling pathway that regulates protein synthesis during mitosis and, consequently,
      the survival of cancer cells. The protein kinase maternal and embryonic leucine
      zipper kinase (MELK) is critical for mitotic progression of cancer cells; however,
      its mechanisms of action remain largely unknown. By combined approaches of immunoprecipitation/mass
      spectrometry and peptide library profiling, we identified the eukaryotic translation
      initiation factor 4B (eIF4B) as a MELK-interacting protein during mitosis and
      a bona fide substrate of MELK. MELK phosphorylates eIF4B at Ser406, a modification
      found to be most robust in the mitotic phase of the cell cycle. We further show
      that the MELK\u2013eIF4B signaling axis regulates protein synthesis during mitosis.
      Specifically, synthesis of myeloid cell leukemia 1 (MCL1), an antiapoptotic
      protein known to play a role in cancer cell survival during cell division, depends
      on the function of MELK-elF4B. Inactivation of MELK or eIF4B results in reduced
      protein synthesis of MCL1, which, in turn, induces apoptotic cell death of cancer
      cells. Our study thus defines a MELK\u2013eIF4B signaling axis that regulates
      protein synthesis during mitosis, and consequently influences cancer cell survival.",
      "venue": "Proceedings of the National Academy of Sciences of the United States
      of America", "year": 2016, "referenceCount": 35, "citationCount": 57, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/113/35/9810.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-08-15", "journal": {"volume": "113", "pages": "9810
      - 9815", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Wang2016MitoticMS,\n author = {Yubao Wang and M. Begley
      and Qing Li and Hai-Tsang Huang and Ana Lako and M. Eck and N. Gray and T. Mitchison
      and L. Cantley and Jean J. Zhao},\n booktitle = {Proceedings of the National
      Academy of Sciences of the United States of America},\n journal = {Proceedings
      of the National Academy of Sciences},\n pages = {9810 - 9815},\n title = {Mitotic
      MELK-eIF4B signaling controls protein synthesis and tumor cell survival},\n
      volume = {113},\n year = {2016}\n}\n"}, "authors": [{"authorId": "2145192690",
      "name": "Yubao Wang"}, {"authorId": "69874482", "name": "M. Begley"}, {"authorId":
      "2117896212", "name": "Qing Li"}, {"authorId": "1901277", "name": "Hai-Tsang
      Huang"}, {"authorId": "3931691", "name": "Ana Lako"}, {"authorId": "2026802",
      "name": "M. Eck"}, {"authorId": "3977406", "name": "N. Gray"}, {"authorId":
      "4294579", "name": "T. Mitchison"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "50985038", "name": "Jean J. Zhao"}]}, {"paperId": "467a4bb63f210a0b4aa31be9ac37889dbddb370c",
      "externalIds": {"MAG": "2511352587", "CorpusId": 89555904}, "corpusId": 89555904,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/467a4bb63f210a0b4aa31be9ac37889dbddb370c",
      "title": "Increased insulin sensitivity i subunit of phosphoinositide", "abstract":
      "On the basis of ex vivo studies using insulin-responsive cells, d( activation
      of a Class IA phosphoinositide 3-kinase (P13K) seems to pi be required for a
      wide variety of cellular responses downstream of st insulin. The Class IA P13K
      enzymes are heterodimers of catalytic and ai regulatory subunits. In mammals,
      insulin-responsive tissues ex- o0 press both the p85a and p8513 isoforms of
      the regulatory subunit. ul Surprisingly, recent studies have revealed that disruption
      of the p; p85a gene in the mouse (p85a-/- mice) results in hypoglycemia bi with
      decreased plasma insulin, and the p85a''+- mice exhibit significantly increased
      insulin sensitivity. These results suggest re either that p85a negatively regulates
      insulin signaling, or that ac p85P, which mediates the major fraction of Class
      IA P13K signaling pi in the absence of p85a, is more efficient than p85a in
      mediating Ir insulin responses. To address this question, we have generated
      vi mice in which the p8513 gene is deleted (p8581-''- mice). As with the b''
      p85a-/- mice, the p8513-/- mice showed hypoinsulinemia, hypo- a( glycemia, and
      improved insulin sensitivity. At the molecular level, e2 P13K activity associated
      with phosphotyrosine complexes was P1 preserved despite a 20-30% reduction in
      the total protein level of e) the regulatory subunits. Moreover, insulin-induced
      activation of PI AKT was significantly up-regulated in muscle from the p85p3--
      cl mice. In addition, insulin-dependent tyrosine phosphorylation of P'' insulin
      receptor substrate-2 was enhanced in the p85,18-- mice, a 1phenotype not observed
      in the p85a-''- mice. These results indi- th cate that in addition to their
      roles in recruiting the catalytic subunit Vi of P13K to the insulin receptor
      substrate proteins, both p85a and o0 p8513 play negative roles in insulin signaling.
      (2 ot Insulin activates Class IA phosphoinositide 3-kinase (PI3K) to (", "venue":
      "", "year": 2016, "referenceCount": 6, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Ueki2016IncreasedIS,\n
      author = {K. Ueki and Claudine M. Yballett and S. Brachmann and L. Cantley and
      D. Vicent and J. Watt and C. Kahn},\n title = {Increased insulin sensitivity
      i subunit of phosphoinositide},\n year = {2016}\n}\n"}, "authors": [{"authorId":
      "5177377", "name": "K. Ueki"}, {"authorId": "88813773", "name": "Claudine M.
      Yballett"}, {"authorId": "3710358", "name": "S. Brachmann"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "9928532", "name": "D. Vicent"}, {"authorId":
      "40474206", "name": "J. Watt"}, {"authorId": "144391716", "name": "C. Kahn"}]},
      {"paperId": "469a6c1e14f7a29729a558c5ea715d1c3b1d65f9", "externalIds": {"MAG":
      "2400332577", "DOI": "10.1158/1538-7445.SABCS15-P3-07-41", "CorpusId": 76803133},
      "corpusId": 76803133, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/469a6c1e14f7a29729a558c5ea715d1c3b1d65f9",
      "title": "Abstract P3-07-41: Genomic alterations indicative of a luminal A subtype
      associate with clinical benefit to buparlisib and letrozole in endocrine-resistant
      ER+/HER2\u2013 metastatic breast cancer", "abstract": "Background: Activation
      of the phosphoinositide-3-kinase (PI3K) pathway has been associated with resistance
      to endocrine therapy in estrogen receptor-positive (ER+) breast cancer. Recently,
      we reported a Stand Up 2 Cancer (SU2C) Phase Ib trial of buparlisib, an oral,
      reversible, pan-PI3K inhibitor in combination with the aromatase inhibitor letrozole
      in patients with metastatic ER+/HER2\u2013 breast cancer (n=51) who had previously
      progressed on endocrine therapy. In this study, 31% of patients demonstrated
      clinical benefit (CR, PR and SD \u22656 months; Mayer et al. JCO 2014). Clinical
      activity was observed in patients with PIK3CA-wild type (PIK3CA-WT) and PIK3CA-mutant
      (PIK3CA-MUT) tumors. We performed targeted next-generation sequencing (tNGS)
      to identify somatic alterations associated with clinical benefit to the combination
      therapy. Methods: tNGS was performed using Memorial Sloan Kettering-Integrated
      Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) in DNA extracted
      from tumors of 33 study patients (22 samples from archived primary/untreated
      and 11 from metastatic biopsies). Detected alterations were tested for association
      with clinical benefit (Fisher9s exact test) and progression-free survival (PFS;
      log-rank test). For PFS analysis, patients were censored if they discontinued
      buparlisib for toxicity. Results: The most commonly detected alterations occurred
      in PIK3CA (36%), TP53 (30%), MAP3K1 (27%), GATA3 (24%), CCND1 (24%), CDH1 (21%)
      and PTEN (21%). Additional alterations of note included FGFR1 amplification
      (15%), MYC amplification (12%), ESR1 mutations (6%) and ERBB2 mutations (6%).
      Probable inactivating mutations occurring in MAP3K1 (MAP3K1-MUT) were significantly
      associated with improved clinical benefit, regardless of other mutations (6/9
      patients, 67%, P=0.044). PIK3CA-MUT tumors trended toward greater clinical benefit
      (7/12, 58%, P=0.067). Patients with coexisting PIK3CA-MUT and MAP3K1-MUT tumors
      derived the largest clinical benefit (5/7, 70% P=0.07) compared to patients
      with only PIK3CA-MUT (2/5; 40%, P=1.0) or only MAP3K1-MUT tumors (1/2; 50%,
      P=1.0). Only 2/19 (11%) patients with PIK3CA-WT/MAP3K1-WT cancers benefitted
      from treatment. Both MAP3K1 and PIK3CA alterations were each also associated
      with increased PFS (p=0.03 and p=0.009, respectively). Three of 5 (60%) patients
      with tumors with FGFR1 amplification achieved clinical benefit (including a
      MAP3K1-MUT tumor and a PIK3CA-MUT/MAP3K1-MUT tumor), suggesting that FGFR1 may
      preferentially signal via PI3K and/or FGFR1 amplifications are not associated
      with resistance to the combination of aromatase inhibitors and PI3K inhibitors.
      Conclusions: Both MAP3K1 and PIK3CA are mutated at higher frequencies in luminal
      A breast cancer, suggesting that this alteration pattern (MAP3K1-MUT + PIK3CA-MUT)
      is a surrogate for low grade ER+ breast cancers with PI3K dependence. It is
      also possible that MAP3K1 mutations may predispose tumor cells to sensitivity
      to PI3K inhibition, but this speculation requires further investigation. Finally,
      patients with ER+/FGFR1-amplified cancers appeared to derive clinical benefit
      from combined therapy with letrozole and buparlisib. Citation Format: Balko
      JM, Hicks M, Berger MF, Solit DB, Bouvier N, Sanders ME, Estrada MV, Won H,
      Cantley LC, Mayer IA, Arteaga CL. Genomic alterations indicative of a luminal
      A subtype associate with clinical benefit to buparlisib and letrozole in endocrine-resistant
      ER+/HER2\u2013 metastatic breast cancer. [abstract]. In: Proceedings of the
      Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec
      8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract
      nr P3-07-41.", "venue": "", "year": 2016, "referenceCount": 0, "citationCount":
      2, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2016-02-15", "journal": {"volume":
      "76", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Balko2016AbstractPG,\n
      author = {J. Balko and Mellissa J. Hicks and M. Berger and D. Solit and N. Bouvier
      and M. Sanders and M. V. Estrada and H. Won and L. Cantley and I. Mayer and
      C. Arteaga},\n journal = {Cancer Research},\n title = {Abstract P3-07-41: Genomic
      alterations indicative of a luminal A subtype associate with clinical benefit
      to buparlisib and letrozole in endocrine-resistant ER+/HER2\u2013 metastatic
      breast cancer},\n volume = {76},\n year = {2016}\n}\n"}, "authors": [{"authorId":
      "66935619", "name": "J. Balko"}, {"authorId": "47040859", "name": "Mellissa
      J. Hicks"}, {"authorId": "33727638", "name": "M. Berger"}, {"authorId": "2344124",
      "name": "D. Solit"}, {"authorId": "5285964", "name": "N. Bouvier"}, {"authorId":
      "46945931", "name": "M. Sanders"}, {"authorId": "144820856", "name": "M. V.
      Estrada"}, {"authorId": "3738649", "name": "H. Won"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2346140", "name": "I. Mayer"}, {"authorId":
      "145739236", "name": "C. Arteaga"}]}, {"paperId": "50d95d9b96f4262d141d66a88f52f7d39ed5180b",
      "externalIds": {"MAG": "2501520748", "DOI": "10.1158/1538-7445.AM2016-3858",
      "CorpusId": 79095496}, "corpusId": 79095496, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/50d95d9b96f4262d141d66a88f52f7d39ed5180b",
      "title": "Abstract 3858: Feasibility and efficacy of a precision treatment approach
      for triple-negative breast cancer in mouse models", "abstract": "15-20% of human
      breast tumors are triple negative breast cancer (TNBC), an aggressive and deadly
      subtype of breast cancer that currently lack targeted therapies, leaving chemotherapy
      as the only systemic treatment option. There is a pressing need for a better
      understanding of disease mechanisms of TNBC, and for the development of new
      treatment options. While activating mutations of PIK3CA are frequently found
      in ER-positive and Her2-amplified breast cancer, inactivation of lipid phosphatases
      is more frequent in TNBC. Analysis of large human genomics data in TCGA reveals
      that heterozygous-loss of INPP4B, a lipid phosphates in the PI3K signaling pathway,
      is enriched in TNBC subtype, and strongly correlates with loss of ER expression.
      Guided by human genomics information, we have crossed INPP4B phosphatase deletion
      mice into TNBC mouse model to determine whether INPP4B-loss cooperates with
      loss-of-function of p53 and/or Brca1 to promote tumorigenesis in vivo. Our results
      show dose-dependent increase in tumor development frequency in K14cre; Brca1flox/flox;
      p53flox/flox mice carrying INPP4B Phosphatase KO allele, HET allele compared
      to INPP4B WT allele. Importantly, these tumors resemble human TNBC in their
      pathology, histological patterns and gene expression patterns, providing a valuable
      platform to test their responsiveness to various therapeutic drugs, including
      PI3K-inhibitors. Our goal is to generate data that form the basis for a phase
      I/II clinical study that lead to substantially improved treatment strategies
      for basal-like breast cancer. Toward this goal, we have banked the endogenous
      tumors in a way allowing transplantation in nude mice, and have performed randomized
      drug treatment studies. We found that tumors that are heterozygous or deletion
      for INPP4B are more sensitive to PI3K-inhibition, suggesting these tumors are
      more dependent on Pi3K activation to thrive. Although tumors show partial response
      early on, they inevitably relapsed, begging for an understanding of innate and
      selected drug-resistant mechanisms. To this end, we have completed large-scale
      RNAseq and whole exome sequencing (WES), and have performed in-depth analyses
      on the mouse genomics data to identify genetic alternations including chromosomal
      number variations (CNVs), mutations and gene fusions. Focusing on gene-fusions,
      we found that by targeting these fusions, we can achieve better treatment outcomes
      and in some cases, even complete tumor remission. Significantly TCGA data analyses
      revealed the presence of similar fusions in human TNBC patients and we are in
      the process of investigating whether human cells carrying these fusions respond
      equally well compared to their mouse counterparts. Our approach of precision-medicine
      guided treatment optimization has lead to substantially improved treatment outcomes.
      Citation Format: Hui Liu, Charles Murphy, Florian Karreth, Kangkang Yang, Gerburg
      Wulf, Lewis C. Cantley. Feasibility and efficacy of a precision treatment approach
      for triple-negative breast cancer in mouse models. [abstract]. In: Proceedings
      of the 107th Annual Meeting of the American Association for Cancer Research;
      2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14
      Suppl):Abstract nr 3858.", "venue": "", "year": 2016, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-07-15", "journal": {"volume": "76", "pages": "3858-3858", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Liu2016Abstract3F,\n author
      = {Hui Liu and Charles J Murphy and F. Karreth and Kangkang Yang and G. Wulf
      and L. Cantley},\n journal = {Cancer Research},\n pages = {3858-3858},\n title
      = {Abstract 3858: Feasibility and efficacy of a precision treatment approach
      for triple-negative breast cancer in mouse models},\n volume = {76},\n year
      = {2016}\n}\n"}, "authors": [{"authorId": "2146671919", "name": "Hui Liu"},
      {"authorId": "47107919", "name": "Charles J Murphy"}, {"authorId": "3566950",
      "name": "F. Karreth"}, {"authorId": "2374780", "name": "Kangkang Yang"}, {"authorId":
      "31554501", "name": "G. Wulf"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "657d88ef0ce8d9dd63f346ce70b958d84ca2c5cb", "externalIds": {"MAG":
      "2333628861", "PubMedCentral": "4972100", "DOI": "10.1080/23723556.2016.1164280",
      "CorpusId": 15560079, "PubMed": "27652319"}, "corpusId": 15560079, "publicationVenue":
      {"id": "6150a680-d5fa-46f4-bfc0-c598ebcad821", "name": "Molecular & Cellular
      Oncology", "type": "journal", "alternate_names": ["Mol  Cell Oncol", "Molecular
      and Cellular Oncology", "Mol Cell Oncol"], "issn": "2372-3556", "url": "http://www.tandfonline.com/loi/kmco20",
      "alternate_urls": ["https://www.tandfonline.com/toc/kmco20/current"]}, "url":
      "https://www.semanticscholar.org/paper/657d88ef0ce8d9dd63f346ce70b958d84ca2c5cb",
      "title": "A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenase",
      "abstract": "ABSTRACT Serine metabolism is likely to play a critical role in
      cancer cell growth. A recent study reports the identification of a novel small-molecule
      inhibitor of serine synthesis that targets 3-phosphoglycerate dehydrogenase
      (PHGDH), the first enzyme of the serine synthesis pathway, and selectively abrogates
      the proliferation of PHGDH overexpressing breast cancer cells.", "venue": "Molecular
      & Cellular Oncology", "year": 2016, "referenceCount": 11, "citationCount": 22,
      "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.tandfonline.com/doi/pdf/10.1080/23723556.2016.1164280?needAccess=true",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-03-30", "journal": {"volume": "3", "name": "Molecular
      & Cellular Oncology"}, "citationStyles": {"bibtex": "@Article{Mullarky2016ANS,\n
      author = {Edouard Mullarky and L. Lairson and L. Cantley and C. Lyssiotis},\n
      booktitle = {Molecular & Cellular Oncology},\n journal = {Molecular & Cellular
      Oncology},\n title = {A novel small-molecule inhibitor of 3-phosphoglycerate
      dehydrogenase},\n volume = {3},\n year = {2016}\n}\n"}, "authors": [{"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "6627833", "name": "L.
      Lairson"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4901222",
      "name": "C. Lyssiotis"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '345903'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:37 GMT
      Via:
      - 1.1 97709c0fcba512e9c9f6cf6f0e63e36a.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - CayIGrqmWNopFQprsEcaj1PxieNO-Mnv0NS9KEt7pFMtqoaH_2DnYQ==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0xhF7UPHcEhcQ=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '345903'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:37 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - 99f06739-db37-4d6c-8a5b-e4dc2c6d1b4c
    http_version: HTTP/1.1
    status_code: 200
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=200&limit=100
  response:
    content: '{"offset": 200, "next": 300, "data": [{"paperId": "6ed33b6c25c025e1722a8a0a60aa31ed92fa9311",
      "externalIds": {"MAG": "2516006356", "DOI": "10.1038/nature19084", "CorpusId":
      4460906, "PubMed": "27509858"}, "corpusId": 4460906, "publicationVenue": {"id":
      "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/6ed33b6c25c025e1722a8a0a60aa31ed92fa9311",
      "title": "Pancreatic stellate cells support tumour metabolism through autophagic
      alanine secretion", "abstract": null, "venue": "Nature", "year": 2016, "referenceCount":
      29, "citationCount": 786, "influentialCitationCount": 27, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc5228623?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-08-10", "journal": {"volume": "536", "pages": "479-483",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Sousa2016PancreaticSC,\n
      author = {C. Sousa and Douglas E. Biancur and Xiaoxu Wang and Christopher J.
      Halbrook and M. Sherman and Li Zhang and Daniel M. Kremer and R. Hwang and Agnes
      K. Witkiewicz and H. Ying and J. Asara and Ronald M. Evans and L. Cantley and
      C. Lyssiotis and Alec C. Kimmelman},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {479-483},\n title = {Pancreatic stellate cells support tumour metabolism
      through autophagic alanine secretion},\n volume = {536},\n year = {2016}\n}\n"},
      "authors": [{"authorId": "48247953", "name": "C. Sousa"}, {"authorId": "4430860",
      "name": "Douglas E. Biancur"}, {"authorId": "48631933", "name": "Xiaoxu Wang"},
      {"authorId": "7745600", "name": "Christopher J. Halbrook"}, {"authorId": "5238907",
      "name": "M. Sherman"}, {"authorId": "2152827103", "name": "Li Zhang"}, {"authorId":
      "40237579", "name": "Daniel M. Kremer"}, {"authorId": "4159648", "name": "R.
      Hwang"}, {"authorId": "4862030", "name": "Agnes K. Witkiewicz"}, {"authorId":
      "33312849", "name": "H. Ying"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "2115604337", "name": "Ronald M. Evans"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId":
      "4668673", "name": "Alec C. Kimmelman"}]}, {"paperId": "7a29bb5a459e594b29b5cd4f41a4feff54620a7a",
      "externalIds": {"DOI": "10.1073/pnas.1607478113", "CorpusId": 205280513, "PubMed":
      "27330087"}, "corpusId": 205280513, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/7a29bb5a459e594b29b5cd4f41a4feff54620a7a",
      "title": "Correction for Taniguchi et al., Phosphoinositide 3-kinase regulatory
      subunit p85\u03b1 suppresses insulin action via positive regulation of PTEN",
      "abstract": "MEDICAL SCIENCES Correction for \u201cPhosphoinositide 3-kinase
      regulatory subunit p85\u03b1 suppresses insulin action via positive regulation
      of PTEN,\u201d by Cullen M. Taniguchi, Thien T. Tran, Tatsuya Kondo, Ji Luo,
      Kohjiro Ueki, Lewis C. Cantley, and C. Ronald Kahn, which appeared in issue
      32, August 8, 2006, of Proc Natl Acad Sci USA (103:12093\u201312097; first published
      July 31, 2006; 10.1073/pnas.0604628103). The authors wish to note the following:
      \u201cDue to an error during preparation of the manuscript, the original Fig.
      4A in this manuscript showing examples of PIP3 staining contained two panels
      (the lox/lox sample at 0 min and the KO at 15 min) from animals that were not
      a part of this study. A corrected version of Fig. 4A is now shown below containing
      the correct representative examples of the staining in each genotype at each
      time point. We have also repeated the quantitative analysis of the staining
      intensity, derived from the recovered images, and include a new version of Fig.
      4B as well. This is not significantly different from the original Fig. 4B and
      supports the original conclusion that p85 is involved in the regulation of PTEN
      and PIP3 turnover. We apologize for any confusion that this mistake may have
      caused.\u201d The corrected Fig. 4 and its legend appear below.", "venue": "Proceedings
      of the National Academy of Sciences of the United States of America", "year":
      2016, "referenceCount": 0, "citationCount": 2, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/113/25/E3588.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2016-06-02", "journal":
      {"volume": "113", "pages": "E3588 - E3588", "name": "Proceedings of the National
      Academy of Sciences"}, "citationStyles": {"bibtex": "@Article{Taniguchi2016CorrectionFT,\n
      author = {C. Taniguchi and T. Tran and K. Ueki and L. Cantley and C. Kahn},\n
      booktitle = {Proceedings of the National Academy of Sciences of the United States
      of America},\n journal = {Proceedings of the National Academy of Sciences},\n
      pages = {E3588 - E3588},\n title = {Correction for Taniguchi et al., Phosphoinositide
      3-kinase regulatory subunit p85\u03b1 suppresses insulin action via positive
      regulation of PTEN},\n volume = {113},\n year = {2016}\n}\n"}, "authors": [{"authorId":
      "48311527", "name": "C. Taniguchi"}, {"authorId": "3500862", "name": "T. Tran"},
      {"authorId": "5177377", "name": "K. Ueki"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "144391716", "name": "C. Kahn"}]}, {"paperId": "7b6fabe7f724e42a9460e5aadea8024161cb9858",
      "externalIds": {"MAG": "2565103342", "DOI": "10.1158/1538-7445.PANCA16-B04",
      "CorpusId": 56670047}, "corpusId": 56670047, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/7b6fabe7f724e42a9460e5aadea8024161cb9858",
      "title": "Abstract B04: NRF2 regulates serine biosynthesis in pancreatic ductal
      adenocarcinoma", "abstract": "Tumors have high energetic and anabolic needs
      for rapid growth and proliferation, and the serine biosynthetic pathway has
      recently been identified as an important source of metabolic intermediates for
      these processes. We recently demonstrated that a substantial fraction of NSCLC
      cell lines displayed significant serine/glycine biosynthetic activity due to
      KEAP1 and NRF2 mutations (DeNicola et al. Nature Genetics 2015). We demonstrated
      that NRF2 regulates glucose flux to serine by controlling transcription of serine
      biosynthetic genes through the transcription factor ATF4. Importantly, elevated
      expression of these genes conferred poor prognosis in human NSCLC. Thus, a substantial
      fraction of human NSCLC activates an NRF2-dependent transcriptional network
      that regulates serine and glycine metabolism and is linked to clinical aggressiveness.
      Pancreatic ductal adenocarcinoma (PDAC) also demonstrates high NRF2 activity
      due to mutations in KRAS and high MAPK signaling (DeNicola et al. Nature 2011).
      We demonstrate that serine biosynthesis enzyme expression is elevated in a mouse
      model of PDAC and that NRF2 regulates PHGDH expression in human PDAC cell lines.
      Furthermore, PDAC cell lines are resistant to serine starvation. PHGDH knockdown
      impairs the growth of tumor organoid orthotopic transplants, and the role of
      PHGDH in tumor maintenance is currently being investigated. These results suggest
      that the serine biosynthesis pathway is regulated by NRF2 in multiple cancers
      and may be an important therapeutic target. Citation Format: Gina M. DeNicola,
      Pei-Hsuan Chen, Edouard Mullarky, Christine Chio, John M. Asara, John D. Minna,
      David A. Tuveson, Ralph J. DeBerardinis, Lewis C. Cantley.{Authors}. NRF2 regulates
      serine biosynthesis in pancreatic ductal adenocarcinoma. [abstract]. In: Proceedings
      of the AACR Special Conference on Pancreatic Cancer: Advances in Science and
      Clinical Care; 2016 May 12-15; Orlando, FL. Philadelphia (PA): AACR; Cancer
      Res 2016;76(24 Suppl):Abstract nr B04.", "venue": "", "year": 2016, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2016-12-15", "journal": {"volume": "76", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{DeNicola2016AbstractBN,\n
      author = {G. DeNicola and Pei-Hsuan Chen and Edouard Mullarky and C. Chio and
      J. Asara and J. Minna and D. Tuveson and R. Deberardinis and L. Cantley},\n
      journal = {Cancer Research},\n title = {Abstract B04: NRF2 regulates serine
      biosynthesis in pancreatic ductal adenocarcinoma},\n volume = {76},\n year =
      {2016}\n}\n"}, "authors": [{"authorId": "4772111", "name": "G. DeNicola"}, {"authorId":
      "4047142", "name": "Pei-Hsuan Chen"}, {"authorId": "6424987", "name": "Edouard
      Mullarky"}, {"authorId": "39609817", "name": "C. Chio"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "2996220", "name": "J. Minna"}, {"authorId":
      "4530161", "name": "D. Tuveson"}, {"authorId": "5834413", "name": "R. Deberardinis"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "7be9cb2a8d17c8ce037d95fca0be7c3f08ff0e6e",
      "externalIds": {"MAG": "2343358448", "DOI": "10.1158/1078-0432.CCR-16-0134",
      "CorpusId": 21431138, "PubMed": "27126994"}, "corpusId": 21431138, "publicationVenue":
      {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0", "name": "Clinical Cancer Research",
      "type": "journal", "alternate_names": ["Clin Cancer Res"], "issn": "1078-0432",
      "url": "https://clincancerres.aacrjournals.org/", "alternate_urls": ["http://clincancerres.aacrjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/7be9cb2a8d17c8ce037d95fca0be7c3f08ff0e6e",
      "title": "A Phase Ib Study of Alpelisib (BYL719), a PI3K\u03b1-Specific Inhibitor,
      with Letrozole in ER+/HER2\u2212 Metastatic Breast Cancer", "abstract": "Purpose:
      Alpelisib, a selective oral inhibitor of the class I PI3K catalytic subunit
      p110\u03b1, has shown synergistic antitumor activity with endocrine therapy
      against ER+/PIK3CA-mutated breast cancer cells. This phase Ib study evaluated
      alpelisib plus letrozole''s safety, tolerability, and preliminary activity in
      patients with metastatic ER+ breast cancer refractory to endocrine therapy.
      Experimental Design: Twenty-six patients received letrozole and alpelisib daily.
      Outcomes were assessed by standard solid-tumor phase I methods. Tumor blocks
      were collected for DNA extraction and next-generation sequencing. Results: Alpelisib''s
      maximum-tolerated dose (MTD) in combination with letrozole was 300 mg/d. Common
      drug-related adverse events included hyperglycemia, nausea, fatigue, diarrhea,
      and rash with dose-limiting toxicity occurring at 350 mg/d of alpelisib. The
      clinical benefit rate (lack of progression \u22656 months) was 35% (44% in patients
      with PIK3CA-mutated and 20% in PIK3CA wild-type tumors; 95% CI, 17%\u201356%),
      including five objective responses. Of eight patients remaining on treatment
      \u226512 months, six had tumors with a PIK3CA mutation. Among evaluable tumors,
      those with FGFR1/2 amplification and KRAS and TP53 mutations did not derive
      clinical benefit. Overexpression of FGFR1 in ER+/PIK3CA mutant breast cancer
      cells attenuated the response to alpelisib in vitro. Conclusions: The combination
      of letrozole and alpelisib was safe, with reversible toxicities. Clinical activity
      was observed independently of PIK3CA mutation status, although clinical benefit
      was seen in a higher proportion of patients with PIK3CA-mutated tumors. Phase
      II and III trials of alpelisib and endocrine therapy in patients with ER+ breast
      cancer are ongoing. Clin Cancer Res; 23(1); 26\u201334. \u00a92016 AACR.", "venue":
      "Clinical Cancer Research", "year": 2016, "referenceCount": 35, "citationCount":
      222, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://clincancerres.aacrjournals.org/content/clincanres/23/1/26.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Study", "JournalArticle", "ClinicalTrial"], "publicationDate":
      "2016-04-28", "journal": {"volume": "23", "pages": "26 - 34", "name": "Clinical
      Cancer Research"}, "citationStyles": {"bibtex": "@Article{Mayer2016API,\n author
      = {I. Mayer and V. Abramson and L. Formisano and J. Balko and M. V. Estrada
      and M. Sanders and D. Juric and D. Solit and M. Berger and H. Won and Yisheng
      Li and L. Cantley and E. Winer and C. Arteaga},\n booktitle = {Clinical Cancer
      Research},\n journal = {Clinical Cancer Research},\n pages = {26 - 34},\n title
      = {A Phase Ib Study of Alpelisib (BYL719), a PI3K\u03b1-Specific Inhibitor,
      with Letrozole in ER+/HER2\u2212 Metastatic Breast Cancer},\n volume = {23},\n
      year = {2016}\n}\n"}, "authors": [{"authorId": "2346140", "name": "I. Mayer"},
      {"authorId": "2186029", "name": "V. Abramson"}, {"authorId": "40940752", "name":
      "L. Formisano"}, {"authorId": "66935619", "name": "J. Balko"}, {"authorId":
      "144820856", "name": "M. V. Estrada"}, {"authorId": "46945931", "name": "M.
      Sanders"}, {"authorId": "3342243", "name": "D. Juric"}, {"authorId": "2344124",
      "name": "D. Solit"}, {"authorId": "33727638", "name": "M. Berger"}, {"authorId":
      "3738649", "name": "H. Won"}, {"authorId": "2111151410", "name": "Yisheng Li"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2369378", "name":
      "E. Winer"}, {"authorId": "2057460", "name": "C. Arteaga"}]}, {"paperId": "838ca9a063f858f482d3edd34ea7dcb800137f71",
      "externalIds": {"MAG": "2507391242", "CorpusId": 100002922}, "corpusId": 100002922,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/838ca9a063f858f482d3edd34ea7dcb800137f71",
      "title": "(acidification of coated vesicles/endocytosis/receptors)", "abstract":
      "Clathrin-coated vesicles isolated from calf brain contain an ATP-dependent
      proton pump. Proton movement was monitored by measuring (''4C)methylamine distribution.
      Addition of Mg2+ and ATP to coated vesicles equilibrated with (''4C)methyl-
      amine resulted in the generation of a 4- to 5-fold concentration gra- dient,
      corresponding to a ApH of 0.6-0.7 units between the medi- um and the acidic
      inside of the coated vesicles. ATP-dependent (''4C)methylamine uptake was abolished
      by the proton ionophore carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP)
      and partially inhibited by the carboxyl reagent N,N''-dicyclohex- ylcarbodiimide
      but was unaffected by the Na+,K+-ATPase inhib- itors strophanthidin (100 /M)
      and vanadate (10 j/M) and the mi- tochondrial ATPase inhibitors oligomycin (10
      j/g/ml) and aurovertin (1 /g/ml). GTP, but not the nonhydrolyzable analog 5''-adenylyl
      imidodiphosphate, could support (''4C)methylamine uptake. Dis- sipation of the
      membrane potential with K+ and valinomycin re- sulted in stimulation of (14C)methylamine
      uptake, whereas both FCCP and valinomycin stimulated the strophanthidin-resistant
      ATPase activity. These results are consistent with the existence of an electrogenic,
      ATP-dependent proton pump in clathrin-coated vesicles. This proton pump may
      play a role in the acidification events that are essential in receptor-mediated
      endocytosis.", "venue": "", "year": 2016, "referenceCount": 1, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Forgac2016acidificationOC,\n
      author = {M. Forgac and L. Cantley and Bertram Wiede and Daniel BRANTONt},\n
      title = {(acidification of coated vesicles/endocytosis/receptors)},\n year =
      {2016}\n}\n"}, "authors": [{"authorId": "145289081", "name": "M. Forgac"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "93116398", "name": "Bertram
      Wiede"}, {"authorId": "94066139", "name": "Daniel BRANTONt"}]}, {"paperId":
      "890c350be55c16a5bfacd41c10305e60840a3b96", "externalIds": {"MAG": "2254906934",
      "DOI": "10.1016/j.cell.2015.12.042", "CorpusId": 1991479, "PubMed": "26824656"},
      "corpusId": 1991479, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/890c350be55c16a5bfacd41c10305e60840a3b96",
      "title": "Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization
      of Aldolase from the Actin Cytoskeleton", "abstract": null, "venue": "Cell",
      "year": 2016, "referenceCount": 38, "citationCount": 279, "influentialCitationCount":
      7, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867415017067/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-01-28", "journal": {"volume": "164", "pages": "433-446",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Hu2016Phosphoinositide3R,\n
      author = {Hai Hu and Ashish Juvekar and C. Lyssiotis and Evan C. Lien and J.
      Albeck and Doogie Oh and G. Varma and Y. P. Hung and Soumya Ullas and Josh Lauring
      and Pankaj Seth and Mark Lundquist and D. Tolan and Aaron K. Grant and Daniel
      J. Needleman and J. Asara and L. Cantley and G. Wulf},\n booktitle = {Cell},\n
      journal = {Cell},\n pages = {433-446},\n title = {Phosphoinositide 3-Kinase
      Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton},\n
      volume = {164},\n year = {2016}\n}\n"}, "authors": [{"authorId": "113164867",
      "name": "Hai Hu"}, {"authorId": "49149990", "name": "Ashish Juvekar"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "2253681206", "name": "Evan
      C. Lien"}, {"authorId": "2791479", "name": "J. Albeck"}, {"authorId": "2253639615",
      "name": "Doogie Oh"}, {"authorId": "144092031", "name": "G. Varma"}, {"authorId":
      "2228070708", "name": "Y. P. Hung"}, {"authorId": "50136879", "name": "Soumya
      Ullas"}, {"authorId": "2254085581", "name": "Josh Lauring"}, {"authorId": "2254082817",
      "name": "Pankaj Seth"}, {"authorId": "49142390", "name": "Mark Lundquist"},
      {"authorId": "6482179", "name": "D. Tolan"}, {"authorId": "2253676795", "name":
      "Aaron K. Grant"}, {"authorId": "2254082125", "name": "Daniel J. Needleman"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "31554501", "name": "G. Wulf"}]}, {"paperId": "8a56b6744f943c407c2a6fce4d2324c13cf14651",
      "externalIds": {"MAG": "2611308394", "DOI": "10.1182/BLOOD.V128.22.610.610",
      "CorpusId": 56688751}, "corpusId": 56688751, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/8a56b6744f943c407c2a6fce4d2324c13cf14651",
      "title": "PIK3IP1 Inhibition of PI3K in G1 Arrest Induced By CDK4 Inhibition
      Reprograms MCL for Ibrutinib Therapy", "abstract": "Inhibition of CDK4/6 has
      emerged as a promising therapy for diverse human cancers. Mantle cell lymphoma
      (MCL), in which aberrant cyclin D1 expression and CDK4 activity underlie unrestrained
      proliferation of tumor cells, remains incurable. Targeting Bruton tyrosine kinase
      (BTK) with ibrutinibin recurrent MCLhas unprecedented single agent activity,
      with a completion remission (CR) rate of 21%. However, progression on ibrutinib
      is virtually universal in MCL and is associated with aggressive proliferation
      of tumor cells and a dismal clinical outcome. By longitudinal integrated RNA-
      and exome-seq analysis, we previously discovered a mutation in the ibrutinib
      binding site (BTKC481S) in MCL that was specific to relapse from a durable response,
      but absent in both primary resistance and resistance following a transient response.
      Irrespective of mechanism, ibrutinib resistance was associated with enhanced
      PI3K activation as determined by Western blotting of MCL cells isolated from
      serial biopsies. Induction of prolonged early G1 arrest (pG1) by selective inhibition
      of CDK4 with palbociclib sensitized to PI3K inhibition independent of this BTK
      mutation and to ibrutinib when the wild type BTK was retained. In both cases,
      synergistic killing appears to occur via cooperative inactivation of PI3K. Collectively,
      our data suggest that dual inhibition of CDK4 and BTK or PI3K restrain the expansion
      of resistant clones or even eliminate them to deepen or prolong the clinical
      response to targeting BTK. To test this hypothesis, we initiated a phase I clinical
      trial of palbociclib plus ibrutinib in recurrent MCL patients in August of 2014.
      All 5 dose levels included ibrutinib daily and palbociclib administered on days
      1-21 of each 28-day cycle (Figure 1). Based on an intent-to-treat analysis of
      18 patients, 12 (67%) patients have responded to treatment including 8 (44%)
      complete responses (CR). The median time to CR was 3 cycles and no responding
      patients have progressed on study. The therapy was well tolerated (see ASH abstract
      by Martin et al for clinical information). RNA- and exome-seq were performed
      to assess the genomic alternations and gene expression on purified MCL cells
      from samples before therapy, on progression and on treatment from PR patients.
      Initial analysis did not detect non-synonymous mutation in CDK4, CCND1, or genes
      in the BCR or PI3K signaling pathway. Hemizygous deletion of Rb, p53, ATM and
      the INK4A/B locus and amplification of PIK3CA and PIK3CB occurred in 30-50 %
      of patients before therapy. These copy number variations were predominantly
      associated with primary resistance (4 subjects) but did not preclude CR or PR.
      By contrast, expression of PIK3IP1, a putative PI3K inhibitor, was markedly
      reduced on progression in all primary resistant patients, but not in the PR
      patient. Function studies demonstrated that PIK3IP1 was required for pG1 sensitization
      to BTK and PI3K inhibition in MCL cells in vitro. Moreover, PIK3IP1 was induced
      in pG1 together PI3K inhibition in MCL cells in patients responding to palbociclib
      alone in a separate clinical trial (Martin, DiLiberto et al, unpublished), suggesting
      that PIK3IP1 mediates pG1 reprogramming. In summary, the high CR rate and durability
      support our hypothesis that induction of prolonged early G1 arrest by CDK4 inhibition
      reprograms MCL cells for deepened and durable targeting of BTK in MCL. Our data
      further suggest inhibition of PI3K by PIK3IP1 as a potential mechanism to overcome
      ibrutinib resistance. A phase II multi-center clinical trial is planned to further
      elucidate the genes and mechanisms that discriminate sensitivity from resistance
      to dual targeting of CDK4 and BTK. Disclosures Blum:Pharmacyclics: Research
      Funding. Ruan:Pharmacyclics: Research Funding, Speakers Bureau. Martin:Janssen:
      Consultancy, Honoraria, Other: travel, accommodations, expenses; Celgene: Consultancy,
      Honoraria; Gilead: Consultancy, Other: travel, accommodations, expenses; Novartis:
      Consultancy; Acerta: Consultancy; Teva: Research Funding.", "venue": "", "year":
      2016, "referenceCount": 0, "citationCount": 3, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-12-02", "journal": {"volume": "128", "pages": "610-610", "name": "Blood"},
      "citationStyles": {"bibtex": "@Article{Liberto2016PIK3IP1IO,\n author = {M.
      Liberto and Xiangao Huang and O. Elemento and K. Eng and K. Blum and N. Bartlett
      and Steven I. Park and J. Ruan and K. Maddocks and G. Inghirami and L. Cantley
      and J. Leonard and P. Martin and S. Chen\u2010Kiang},\n journal = {Blood},\n
      pages = {610-610},\n title = {PIK3IP1 Inhibition of PI3K in G1 Arrest Induced
      By CDK4 Inhibition Reprograms MCL for Ibrutinib Therapy},\n volume = {128},\n
      year = {2016}\n}\n"}, "authors": [{"authorId": "52430482", "name": "M. Liberto"},
      {"authorId": "22172195", "name": "Xiangao Huang"}, {"authorId": "150097652",
      "name": "O. Elemento"}, {"authorId": "30850515", "name": "K. Eng"}, {"authorId":
      "5026467", "name": "K. Blum"}, {"authorId": "3111840", "name": "N. Bartlett"},
      {"authorId": "2115196348", "name": "Steven I. Park"}, {"authorId": "2588907",
      "name": "J. Ruan"}, {"authorId": "3536873", "name": "K. Maddocks"}, {"authorId":
      "2536360", "name": "G. Inghirami"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "144240302", "name": "J. Leonard"}, {"authorId": "144085617", "name":
      "P. Martin"}, {"authorId": "1398158850", "name": "S. Chen\u2010Kiang"}]}, {"paperId":
      "969e6a5ed722e4d7bb92eab0f0c453c4ae926ff2", "externalIds": {"MAG": "2266570683",
      "DOI": "10.1073/pnas.1521548113", "CorpusId": 52852929, "PubMed": "26831078"},
      "corpusId": 52852929, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/969e6a5ed722e4d7bb92eab0f0c453c4ae926ff2",
      "title": "Identification of a small molecule inhibitor of 3-phosphoglycerate
      dehydrogenase to target serine biosynthesis in cancers", "abstract": "Significance
      Serine supports a number of anabolic processes, including protein, lipid, and
      nucleic acid synthesis. Cells can either import serine or synthesize it de novo.
      Recently, overexpression of 3-phosphoglycerate dehydrogenase (PHGDH), the gene
      encoding the first committed step of serine synthesis, via focal amplification
      and other mechanisms, has been identified in human cancers. Cancer cell lines
      that overexpress PHGDH are uniquely sensitive to PHGDH knockdown whereas lines
      that express little PHGDH are insensitive, suggesting that PHGDH may be a clinically
      interesting target. Here, we report the discovery of a specific small molecule
      inhibitor of PHGDH, which enables preclinical evaluation of PHGDH as a target
      in cancer and provides a tool to study the biology of de novo serine synthesis.
      Cancer cells reprogram their metabolism to promote growth and proliferation.
      The genetic evidence pointing to the importance of the amino acid serine in
      tumorigenesis is striking. The gene encoding the enzyme 3-phosphoglycerate dehydrogenase
      (PHGDH), which catalyzes the first committed step of serine biosynthesis, is
      overexpressed in tumors and cancer cell lines via focal amplification and nuclear
      factor erythroid-2-related factor 2 (NRF2)-mediated up-regulation. PHGDH-overexpressing
      cells are exquisitely sensitive to genetic ablation of the pathway. Here, we
      report the discovery of a selective small molecule inhibitor of PHGDH, CBR-5884,
      identified by screening a library of 800,000 drug-like compounds. CBR-5884 inhibited
      de novo serine synthesis in cancer cells and was selectively toxic to cancer
      cell lines with high serine biosynthetic activity. Biochemical characterization
      of the inhibitor revealed that it was a noncompetitive inhibitor that showed
      a time-dependent onset of inhibition and disrupted the oligomerization state
      of PHGDH. The identification of a small molecule inhibitor of PHGDH not only
      enables thorough preclinical evaluation of PHGDH as a target in cancers, but
      also provides a tool with which to study serine metabolism.", "venue": "Proceedings
      of the National Academy of Sciences of the United States of America", "year":
      2016, "referenceCount": 42, "citationCount": 226, "influentialCitationCount":
      10, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/113/7/1778.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-02-01", "journal": {"volume": "113", "pages": "1778
      - 1783", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Mullarky2016IdentificationOA,\n author = {Edouard Mullarky
      and Edouard Mullarky and N. Lucki and R. B. Zavareh and J. Anglin and Ana P.
      Gomes and Brandon Nicolay and Jenny C. Y. Wong and S. Christen and Hidenori
      Takahashi and P. Singh and J. Blenis and J. Warren and S. Fendt and J. Asara
      and G. DeNicola and C. Lyssiotis and L. Lairson and L. Cantley},\n booktitle
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences},\n pages = {1778
      - 1783},\n title = {Identification of a small molecule inhibitor of 3-phosphoglycerate
      dehydrogenase to target serine biosynthesis in cancers},\n volume = {113},\n
      year = {2016}\n}\n"}, "authors": [{"authorId": "6424987", "name": "Edouard Mullarky"},
      {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId": "6490745",
      "name": "N. Lucki"}, {"authorId": "3992718", "name": "R. B. Zavareh"}, {"authorId":
      "35906509", "name": "J. Anglin"}, {"authorId": "2087116099", "name": "Ana P.
      Gomes"}, {"authorId": "4374034", "name": "Brandon Nicolay"}, {"authorId": "40497062",
      "name": "Jenny C. Y. Wong"}, {"authorId": "32173727", "name": "S. Christen"},
      {"authorId": "2115843581", "name": "Hidenori Takahashi"}, {"authorId": "2109204398",
      "name": "P. Singh"}, {"authorId": "4037343", "name": "J. Blenis"}, {"authorId":
      "32988325", "name": "J. Warren"}, {"authorId": "46775302", "name": "S. Fendt"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "4772111", "name":
      "G. DeNicola"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId":
      "6627833", "name": "L. Lairson"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "97af5ddd9f193e5472d9c9278e2b8fca04e056d9", "externalIds": {"PubMedCentral":
      "4738311", "MAG": "2342741787", "DOI": "10.1038/srep20471", "CorpusId": 17554242,
      "PubMed": "26839216"}, "corpusId": 17554242, "publicationVenue": {"id": "f99f77b7-b1b6-44d3-984a-f288e9884b9b",
      "name": "Scientific Reports", "type": "journal", "alternate_names": ["Sci Rep"],
      "issn": "2045-2322", "url": "http://www.nature.com/srep/", "alternate_urls":
      ["http://www.nature.com/srep/index.html"]}, "url": "https://www.semanticscholar.org/paper/97af5ddd9f193e5472d9c9278e2b8fca04e056d9",
      "title": "A Cross-Species Study of PI3K Protein-Protein Interactions Reveals
      the Direct Interaction of P85 and SHP2", "abstract": null, "venue": "Scientific
      Reports", "year": 2016, "referenceCount": 67, "citationCount": 35, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/srep20471.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-02-03", "journal": {"volume": "6", "name": "Scientific
      Reports"}, "citationStyles": {"bibtex": "@Article{Breitkopf2016ACS,\n author
      = {S. Breitkopf and Xuemei Yang and M. Begley and Meghana Kulkarni and Y. Chiu
      and Alexa B. Turke and Jessica Lauriol and Min Yuan and J. Qi and J. Engelman
      and Pengyu Hong and M. Kontaridis and L. Cantley and N. Perrimon and J. Asara},\n
      booktitle = {Scientific Reports},\n journal = {Scientific Reports},\n title
      = {A Cross-Species Study of PI3K Protein-Protein Interactions Reveals the Direct
      Interaction of P85 and SHP2},\n volume = {6},\n year = {2016}\n}\n"}, "authors":
      [{"authorId": "3739417", "name": "S. Breitkopf"}, {"authorId": "48520140", "name":
      "Xuemei Yang"}, {"authorId": "69874482", "name": "M. Begley"}, {"authorId":
      "33373476", "name": "Meghana Kulkarni"}, {"authorId": "47591147", "name": "Y.
      Chiu"}, {"authorId": "4039016", "name": "Alexa B. Turke"}, {"authorId": "4978543",
      "name": "Jessica Lauriol"}, {"authorId": "49059923", "name": "Min Yuan"}, {"authorId":
      "46315599", "name": "J. Qi"}, {"authorId": "6828387", "name": "J. Engelman"},
      {"authorId": "145595134", "name": "Pengyu Hong"}, {"authorId": "5806645", "name":
      "M. Kontaridis"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2001255", "name": "N. Perrimon"}, {"authorId": "3028470", "name": "J. Asara"}]},
      {"paperId": "9829e1fd2a50eeb9a2f15370acc12317449759e8", "externalIds": {"MAG":
      "2588573341", "DOI": "10.1016/J.CMET.2016.01.016", "CorpusId": 90115792}, "corpusId":
      90115792, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/9829e1fd2a50eeb9a2f15370acc12317449759e8",
      "title": "Erratum: Divergent regulation of hepatic glucose and lipid metabolism
      by phosphoinositide 3-kinase via Akt and PKC\u03bb/\u03b6 (Cell Metabolism (2006)
      3 (343-353))", "abstract": null, "venue": "", "year": 2016, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S1550413116300092/pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2016-02-09", "journal": {"volume":
      "23", "name": "Cell Metabolism"}, "citationStyles": {"bibtex": "@Article{Taniguchi2016ErratumDR,\n
      author = {C. Taniguchi and Tatsuya Kondo and M. Sajan and Ji Luo and R. Bronson
      and T. Asano and Robert V Farese and L. Cantley and C. Kahn},\n journal = {Cell
      Metabolism},\n title = {Erratum: Divergent regulation of hepatic glucose and
      lipid metabolism by phosphoinositide 3-kinase via Akt and PKC\u03bb/\u03b6 (Cell
      Metabolism (2006) 3 (343-353))},\n volume = {23},\n year = {2016}\n}\n"}, "authors":
      [{"authorId": "48311527", "name": "C. Taniguchi"}, {"authorId": "16114256",
      "name": "Tatsuya Kondo"}, {"authorId": "3511388", "name": "M. Sajan"}, {"authorId":
      "145954100", "name": "Ji Luo"}, {"authorId": "40803408", "name": "R. Bronson"},
      {"authorId": "1928077", "name": "T. Asano"}, {"authorId": "5937884", "name":
      "Robert V Farese"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "144391716", "name": "C. Kahn"}]}, {"paperId": "9a376d60eea4b39dae4c68e5997adb4a9158dc76",
      "externalIds": {"MAG": "2915338336", "DOI": "10.1158/1538-7445.AM2016-4165",
      "CorpusId": 86701488}, "corpusId": 86701488, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/9a376d60eea4b39dae4c68e5997adb4a9158dc76",
      "title": "Abstract 4165: Myc vs. Akt therapy in RapidCap, a GEM model for metastatic
      prostate cancer", "abstract": "We describe our efforts to determine the effect
      of MYC and PI3K inhibition in a genetically engineered mouse model of naive
      and castration-resistant metastatic prostate cancer. Metastasis is a major driver
      of mortality and morbidity in prostate cancer, the most common cancer type in
      men and the second leading cause of cancer-related deaths in the western world.
      To recapitulate the metastatic process in genetically engineered mice, we have
      developed the RapidCaP system, which uses prostate-directed viral infection
      to trigger focal loss of Pten and Trp53. Using luminescence and fluorescence,
      the RapidCaP system allows us to track disease progression in real-time and
      isolate metastases in distant tissues. This system provides a powerful platform
      for the identification and validation of candidate driver genes and for the
      efficient testing of novel therapeutics. Using this system, we have recently
      identified Myc as a critical, spontaneously activated driver in Pten-negative
      metastatic prostate cancer. Preliminary trials indicate that the Myc-suppressing
      Brd4 inhibitor JQ1 is ineffective towards primary disease, but induces metastatic
      regression. This specificity correlates with a switch from AKT-driven primary
      disease to MYC-driven metastatic disease. Our current efforts seek to determine
      how, when and why targeting of Myc using JQ1 and the PI 3-Kinase pathway using
      NVP-BKM120 can be best used to treat naive and castration-resistant metastatic
      prostate cancer. In addition, we are examining changes to the transcriptome
      and epigenetic alterations that characterize Pten-negative metastatic prostate
      cancer, with the goal of understanding the mechanisms of progression toward
      a metastatic state and establishing new therapeutic targets. Citation Format:
      Carlos E. Stahlhut, Alexandra J. Ambrico, Kaitlin E. Watrud, Hyejin Cho, Lily
      Wang, Jun Qi, Lewis C. Cantley, James Bradner, Lloyd Trotman. Myc vs. Akt therapy
      in RapidCap, a GEM model for metastatic prostate cancer. [abstract]. In: Proceedings
      of the 107th Annual Meeting of the American Association for Cancer Research;
      2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14
      Suppl):Abstract nr 4165.", "venue": "", "year": 2016, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-07-15", "journal": {"volume": "76", "pages": "4165-4165", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Stahlhut2016Abstract4M,\n
      author = {Carlos Stahlhut and A. Ambrico and Kaitlin Watrud and Hyejin Cho and
      Lily C. Wang and J. Qi and L. Cantley and J. Bradner and L. Trotman},\n journal
      = {Cancer Research},\n pages = {4165-4165},\n title = {Abstract 4165: Myc vs.
      Akt therapy in RapidCap, a GEM model for metastatic prostate cancer},\n volume
      = {76},\n year = {2016}\n}\n"}, "authors": [{"authorId": "47270173", "name":
      "Carlos Stahlhut"}, {"authorId": "15976560", "name": "A. Ambrico"}, {"authorId":
      "10426666", "name": "Kaitlin Watrud"}, {"authorId": "4485082", "name": "Hyejin
      Cho"}, {"authorId": "2117931332", "name": "Lily C. Wang"}, {"authorId": "145752082",
      "name": "J. Qi"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3685746", "name": "J. Bradner"}, {"authorId": "4603490", "name": "L. Trotman"}]},
      {"paperId": "9be2e2f64408fd8d4c823d3bb145309598b43d16", "externalIds": {"CorpusId":
      163162060}, "corpusId": 163162060, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/9be2e2f64408fd8d4c823d3bb145309598b43d16",
      "title": "The primary pathway from PI 3 K to mTORC 1 : switching on Rheb", "abstract":
      "The class I phosphoinositide 3-kinase (PI3K) mechanistic target of rapamycin
      complex 1 (mTORC1) signaling network directs cellular metabolism and growth.
      Activation of mTORC1, which is composed of mTOR, Raptor, mLST8, PRAS40, and
      DEPTOR, depends on the Rag and Rheb GTPases, and requires signals from amino
      acids, glucose, oxygen, energy (ATP), and growth factors (including cytokines
      and hormones such as insulin). Here we discuss the signal transduction mechanisms
      through which growth factor-responsive PI3K signaling activates mTORC1. We focus
      on how PI3K-dependent activation of Akt and spatial regulation of the TSC complex
      (composed of TSC1, TSC2, and TBC1D7) switches on Rheb at the lysosome, where
      mTORC1 is activated. Integration of PI3Kand amino acid-dependent signals upstream
      of mTORC1 at the lysosome is detailed in a working model. A coherent understanding
      of the PI3KmTORC1 network is imperative as its dysregulation has been implicated
      in diverse pathologies including cancer, diabetes, autism, and aging.", "venue":
      "", "year": 2016, "referenceCount": 154, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Dibble2016ThePP,\n
      author = {Christian C. Dibble and L. Cantley},\n title = {The primary pathway
      from PI 3 K to mTORC 1 : switching on Rheb},\n year = {2016}\n}\n"}, "authors":
      [{"authorId": "7449887", "name": "Christian C. Dibble"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "a4a62f41776983c72d52b9f028c833e040cffed9",
      "externalIds": {"MAG": "2497980300", "DOI": "10.1007/978-3-319-34211-5_1", "CorpusId":
      89590127}, "corpusId": 89590127, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/a4a62f41776983c72d52b9f028c833e040cffed9",
      "title": "PI3K-Akt-mTOR Signaling in Cancer and Cancer Therapeutics", "abstract":
      null, "venue": "", "year": 2016, "referenceCount": 124, "citationCount": 1,
      "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "pages": "1-25", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Chopra2016PI3KAktmTORSI,\n author = {S. Chopra and
      L. Cantley},\n pages = {1-25},\n title = {PI3K-Akt-mTOR Signaling in Cancer
      and Cancer Therapeutics},\n year = {2016}\n}\n"}, "authors": [{"authorId": "49926666",
      "name": "S. Chopra"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "a6e601eee09639ec90db79cceaf5922f7dc45f5f", "externalIds": {"MAG": "2486295304",
      "DOI": "10.1158/1538-7445.AM2016-4979", "CorpusId": 78956513}, "corpusId": 78956513,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/a6e601eee09639ec90db79cceaf5922f7dc45f5f",
      "title": "Abstract 4979: Cabozantinib eradicates advanced murine prostate cancer
      by activating neutrophil-mediated anti-tumor innate immunity", "abstract": "Several
      kinase inhibitors targeting aberrant signaling pathways in tumor cells have
      been deployed in cancer therapy. However, their impact on the tumor immune microenvironment
      remains poorly understood. The tyrosine kinase inhibitor cabozantinib showed
      striking responses in cancer clinical trial patients across several malignancies.
      Here we show that cabozantinib rapidly eradicates invasive, poorly-differentiated
      PTEN/p53 deficient murine prostate cancer. This was associated with enhanced
      release of neutrophil chemotactic factors from tumor cells, including CXCL12
      and HMGB1, resulting in robust infiltration of neutrophils into the tumor. Critically,
      cabozantinib-induced tumor clearance in mice was abolished by antibody-mediated
      granulocyte depletion or HMGB1 neutralization or blockade of neutrophil chemotaxis
      with the CXCR4 inhibitor, plerixafor. Collectively, these data demonstrate that
      cabozantinib triggers a neutrophil-mediated anti-tumor innate immune response,
      resulting in rapid tumor clearance. Citation Format: Akash Patnaik, Kenneth
      D. Swanson, Eva Csizmadia, Marina P. Gehring, Katja Helenius, Athalia R. Pyzer,
      Lily C. Wang, Jesse Novak, Olivier Elemento, Thomas B. Thornley, John M. Asara,
      John G. Clohessy, Kathy Kelly, Pier Paolo Pandolfi, Jacalyn M. Rosenblatt, David
      E. Avigan, Huihui Ye, Sabina Signoretti, Steven P. Balk, Lewis C. Cantley. Cabozantinib
      eradicates advanced murine prostate cancer by activating neutrophil-mediated
      anti-tumor innate immunity. [abstract]. In: Proceedings of the 107th Annual
      Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New
      Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract
      nr 4979.", "venue": "", "year": 2016, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-07-15", "journal": {"volume": "76", "pages": "4979-4979", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Patnaik2016Abstract4C,\n
      author = {Akash Patnaik and K. Swanson and E. Csizmadia and M. Gehring and Katja
      Helenius and A. Pyzer and Lily C. Wang and Jesse S. Novak and O. Elemento and
      T. Thornley and J. Asara and J. Clohessy and K. Kelly and P. Pandolfi and J.
      Rosenblatt and D. Avigan and Huihui Ye and S. Signoretti and S. Balk and L.
      Cantley},\n journal = {Cancer Research},\n pages = {4979-4979},\n title = {Abstract
      4979: Cabozantinib eradicates advanced murine prostate cancer by activating
      neutrophil-mediated anti-tumor innate immunity},\n volume = {76},\n year = {2016}\n}\n"},
      "authors": [{"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId":
      "6784962", "name": "K. Swanson"}, {"authorId": "4793517", "name": "E. Csizmadia"},
      {"authorId": "33820964", "name": "M. Gehring"}, {"authorId": "49804844", "name":
      "Katja Helenius"}, {"authorId": "15061933", "name": "A. Pyzer"}, {"authorId":
      "2117931332", "name": "Lily C. Wang"}, {"authorId": "50577147", "name": "Jesse
      S. Novak"}, {"authorId": "150097652", "name": "O. Elemento"}, {"authorId": "4374091",
      "name": "T. Thornley"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId":
      "4102988", "name": "J. Clohessy"}, {"authorId": "145953924", "name": "K. Kelly"},
      {"authorId": "4499580", "name": "P. Pandolfi"}, {"authorId": "31499217", "name":
      "J. Rosenblatt"}, {"authorId": "145881219", "name": "D. Avigan"}, {"authorId":
      "3073381", "name": "Huihui Ye"}, {"authorId": "7505152", "name": "S. Signoretti"},
      {"authorId": "6189162", "name": "S. Balk"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "a9db948b3a66f190fd042cbe86a1c227b791aff2", "externalIds":
      {"DOI": "10.1038/nature19851", "CorpusId": 4447244, "PubMed": "27706144"}, "corpusId":
      4447244, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/a9db948b3a66f190fd042cbe86a1c227b791aff2",
      "title": "Erratum: Pancreatic stellate cells support tumour metabolism through
      autophagic alanine secretion", "abstract": null, "venue": "Nature", "year":
      2016, "referenceCount": 0, "citationCount": 18, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/nature19851.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-10-05", "journal": {"volume": "540", "pages": "150-150",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Sousa2016ErratumPS,\n
      author = {C. Sousa and Douglas E. Biancur and Xiaoxu Wang and Christopher J.
      Halbrook and M. Sherman and Li Zhang and Daniel M. Kremer and R. Hwang and Agnes
      K. Witkiewicz and H. Ying and J. Asara and Ronald M. Evans and L. Cantley and
      C. Lyssiotis and Alec C. Kimmelman},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {150-150},\n title = {Erratum: Pancreatic stellate cells support tumour
      metabolism through autophagic alanine secretion},\n volume = {540},\n year =
      {2016}\n}\n"}, "authors": [{"authorId": "48247953", "name": "C. Sousa"}, {"authorId":
      "4430860", "name": "Douglas E. Biancur"}, {"authorId": "48631933", "name": "Xiaoxu
      Wang"}, {"authorId": "7745600", "name": "Christopher J. Halbrook"}, {"authorId":
      "5238907", "name": "M. Sherman"}, {"authorId": "2152827103", "name": "Li Zhang"},
      {"authorId": "40237579", "name": "Daniel M. Kremer"}, {"authorId": "4159648",
      "name": "R. Hwang"}, {"authorId": "4862030", "name": "Agnes K. Witkiewicz"},
      {"authorId": "33312849", "name": "H. Ying"}, {"authorId": "3028470", "name":
      "J. Asara"}, {"authorId": "2115604337", "name": "Ronald M. Evans"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4901222", "name": "C. Lyssiotis"},
      {"authorId": "4668673", "name": "Alec C. Kimmelman"}]}, {"paperId": "b0fccaf2d7aafafc516312a14ac1d6e64a3b04f1",
      "externalIds": {"CorpusId": 189807495}, "corpusId": 189807495, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/b0fccaf2d7aafafc516312a14ac1d6e64a3b04f1",
      "title": "NRF 2 regulates serine biosynthesis in non-small cell lung cancer",
      "abstract": null, "venue": "", "year": 2016, "referenceCount": 30, "citationCount":
      43, "influentialCitationCount": 2, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": null, "citationStyles": {"bibtex":
      "@Inproceedings{DeNicola2016NRF2R,\n author = {G. DeNicola and Pei-Hsuan Chen
      and Edouard Mullarky and J. Sudderth and Zeping and Hu and David Wu and Hao
      Tang and Yang Xie and J. Asara and K. Huffman and I. Ignacio and Wistuba and
      J. Minna and R. Deberardinis and L. Cantley},\n title = {NRF 2 regulates serine
      biosynthesis in non-small cell lung cancer},\n year = {2016}\n}\n"}, "authors":
      [{"authorId": "4772111", "name": "G. DeNicola"}, {"authorId": "4047142", "name":
      "Pei-Hsuan Chen"}, {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId":
      "5467431", "name": "J. Sudderth"}, {"authorId": "2102981938", "name": "Zeping"},
      {"authorId": "2054591351", "name": "Hu"}, {"authorId": "144790190", "name":
      "David Wu"}, {"authorId": "2112388600", "name": "Hao Tang"}, {"authorId": "145668114",
      "name": "Yang Xie"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId":
      "5305256", "name": "K. Huffman"}, {"authorId": "145606732", "name": "I. Ignacio"},
      {"authorId": "89777075", "name": "Wistuba"}, {"authorId": "2996220", "name":
      "J. Minna"}, {"authorId": "5834413", "name": "R. Deberardinis"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "c5e715daaab960c84c9f4e7aa642ee35c424a167",
      "externalIds": {"MAG": "2401609195", "DOI": "10.1158/1557-3265.OVCA15-IA08",
      "CorpusId": 88527865}, "corpusId": 88527865, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/c5e715daaab960c84c9f4e7aa642ee35c424a167",
      "title": "Abstract IA08: PI3K- and PARP-inhibitors for the treatment of women
      cancers.", "abstract": "Amplification of PIK3CA is highly prevalent in ovarian
      cancer and isoform-specific and pan-PI3K inhibitors have entered clinical trials.
      However, identifying tumor subtypes and biological mechanisms that predict for
      response to PI3K inhibitors as single agents or in combination has been a challenge.
      We previously reported that combining a phophoinositide 3-kinase (PI3K) inhibitor
      with a poly ADP ribose polymerase (PARP)-inhibitor enhanced DNA damage and cell
      death in breast cancers that have genetic aberrations in BRCA1 and TP53. We
      now show that the enhanced DNA damage induced by PI3K inhibitors in this mutational
      background is a consequence of impaired production of deoxynucleotides needed
      for DNA synthesis and DNA repair. Inhibition of PI3K causes a reduction in all
      four deoxynucleotide triphosphates (dATP, dTTP, dGTP and dCTP), while inhibition
      of AKT is less effective than inhibition of PI3K in suppressing nucleotide synthesis
      and inducing DNA damage. Carbon flux studies reveal that PI3K-inhibition disproportionately
      affects the non-oxidative pentose phosphate pathway (non-ox PPP) that delivers
      ribose-5-posphate required for base ribosylation. In vivo in a mouse model of
      BRCA1-linked triple-negative breast cancer combined PI3K- and PARP-inhibition
      was superior to either agent alone to induce durable remissions of established
      tumors. Our data indicate that PI3K inhibitors induce DNA damage in tumors that
      have defects in DNA damage repair pathways and that they do so by impairing
      the production of Ribose-5-phosphate and amino acids needed for deoxynucleotide
      synthesis. An ongoing phase I/II study (NCT01623349, PI: Matulonis) examines
      the safety and toxicity of a PI3K/Parp-inhibitor combination in ovarian and
      breast cancer. Citation Format: Gerburg M. Wulf, Ashish Juvekar, Lewis C. Cantley,
      Ursula A. Matulonis. PI3K- and PARP-inhibitors for the treatment of women cancers.
      [abstract]. In: Proceedings of the AACR Special Conference on Advances in Ovarian
      Cancer Research: Exploiting Vulnerabilities; Oct 17-20, 2015; Orlando, FL. Philadelphia
      (PA): AACR; Clin Cancer Res 2016;22(2 Suppl):Abstract nr IA08.", "venue": "",
      "year": 2016, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-01-15", "journal": {"volume": "22", "name": "Clinical Cancer Research"},
      "citationStyles": {"bibtex": "@Article{Wulf2016AbstractIP,\n author = {G. Wulf
      and Ashish Juvekar and L. Cantley and U. Matulonis},\n journal = {Clinical Cancer
      Research},\n title = {Abstract IA08: PI3K- and PARP-inhibitors for the treatment
      of women cancers.},\n volume = {22},\n year = {2016}\n}\n"}, "authors": [{"authorId":
      "31554501", "name": "G. Wulf"}, {"authorId": "49149990", "name": "Ashish Juvekar"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6927295", "name":
      "U. Matulonis"}]}, {"paperId": "c7e48adeb3fc5c49fc8318d1fb6edcd9a23fda14", "externalIds":
      {"MAG": "2511108195", "DOI": "10.1093/med/9780199934522.003.0075", "CorpusId":
      88923713}, "corpusId": 88923713, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/c7e48adeb3fc5c49fc8318d1fb6edcd9a23fda14",
      "title": "The PI3K-LKB1 Pathway", "abstract": null, "venue": "", "year": 2016,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2016-06-01", "journal": {"volume": "", "pages": "572-576",
      "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Shaw2016ThePP,\n author
      = {R. Shaw and L. Cantley},\n pages = {572-576},\n title = {The PI3K-LKB1 Pathway},\n
      year = {2016}\n}\n"}, "authors": [{"authorId": "4426388", "name": "R. Shaw"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "dc2f356dffee630c6dbf07ac2f5affc5f985a9e2",
      "externalIds": {"MAG": "2552631557", "DOI": "10.1200/JCO.2016.67.9712", "CorpusId":
      45723038, "PubMed": "27903152"}, "corpusId": 45723038, "publicationVenue": {"id":
      "a5913268-3957-484f-b41f-347b0ba23338", "name": "Journal of Clinical Oncology",
      "type": "journal", "alternate_names": ["J Clin Oncol"], "issn": "0732-183X",
      "url": "https://ascopubs.org/loi/jco", "alternate_urls": ["http://www.jco.org/",
      "http://jco.ascopubs.org/"]}, "url": "https://www.semanticscholar.org/paper/dc2f356dffee630c6dbf07ac2f5affc5f985a9e2",
      "title": "Obesity and Cancer Mechanisms: Cancer Metabolism.", "abstract": "Obesity
      is a risk factor for cancer development and is associated with poor prognosis
      in multiple tumor types. The positive energy balance linked with obesity induces
      a variety of systemic changes including altered levels of insulin, insulin-like
      growth factor-1, leptin, adiponectin, steroid hormones, and cytokines. Each
      of these factors alters the nutritional milieu and has the potential to create
      an environment that favors tumor initiation and progression. Although the complete
      ramifications of obesity as it relates to cancer are still unclear, there is
      convincing evidence that reducing the magnitude of the systemic hormonal and
      inflammatory changes has significant clinical benefits. This review will examine
      the changes that occur in the obese state and review the biologic mechanisms
      that connect these changes to increased cancer risk. Understanding the metabolic
      changes that occur in obese individuals may also help to elucidate more effective
      treatment options for these patients when they develop cancer. Moving forward,
      targeted clinical trials examining the effects of behavioral modifications such
      as reduced carbohydrate intake, caloric restriction, structured exercise, and/or
      pharmacologic interventions such as the use of metformin, in obese populations
      may help to reduce their cancer risk.", "venue": "Journal of Clinical Oncology",
      "year": 2016, "referenceCount": 131, "citationCount": 209, "influentialCitationCount":
      6, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc5562429?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": "2016-11-07", "journal": {"volume": "34
      35", "pages": "\n          4277-4283\n        ", "name": "Journal of clinical
      oncology : official journal of the American Society of Clinical Oncology"},
      "citationStyles": {"bibtex": "@Article{Hopkins2016ObesityAC,\n author = {B.
      Hopkins and M. Goncalves and L. Cantley},\n booktitle = {Journal of Clinical
      Oncology},\n journal = {Journal of clinical oncology : official journal of the
      American Society of Clinical Oncology},\n pages = {\n          4277-4283\n        },\n
      title = {Obesity and Cancer Mechanisms: Cancer Metabolism.},\n volume = {34
      35},\n year = {2016}\n}\n"}, "authors": [{"authorId": "48821307", "name": "B.
      Hopkins"}, {"authorId": "145524334", "name": "M. Goncalves"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "e5066c55949b636d20c4f4abbb898d493f716d19",
      "externalIds": {"MAG": "2479261316", "DOI": "10.1158/1538-7445.AM2016-159",
      "CorpusId": 78317911}, "corpusId": 78317911, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/e5066c55949b636d20c4f4abbb898d493f716d19",
      "title": "Abstract 159: Analysis of resistance to the combination of a PI3K-
      and Parp-inhibitor using a genomic sequencing approach", "abstract": "The objective
      of this study is to investigate the genomic and transcriptonal changes that
      are associated with resistance to treatment with the combination of a PI3K-inhibitor
      (NVP-BKM120) and a PARP-inhibitor (Olaparib). Previous studies have shown that
      the combination of a PI3K-inhibitor and a PARP-inhibitor synergistically reduced
      the growth of BRCA-related xenograft tumors derived from patients with TNBC.
      However, in clinical practice, primary and secondary resistance to this combination
      is observed. We hypothesize that acquired resistance is the result of a genomic
      evolution resulting from the selection pressure exerted by the drug treatment.
      We used a genetically engineered mouse model, K14-Cre BRCA1f/fp53f/f, where
      primary tumors had been propagated in Cre-negative littermates and treated to
      point of resistance with NVP-BKM120 or NVP-BKM120 plus Olaparib. For each of
      the three tumors, we analyzed exome sequencing and RNA-seq using Illumina technology
      at the stage of sensitivity (C), resistance to PI3K-inhibition (B) and resistance
      to the combination (BO); i.e. for each individual tumor a parental clone and
      its drug-resistant subclones, obtained in vivo, were analyzed. We used the Mutect
      software tool to call somatic mutations, VarScan2 to call somatic copy number
      variations, Cuffdiff for differential expression analysis, and TophatFusion.
      Data were integrated to identify genes for functional analyses using MetaCore
      and MSigDB software tools. We found that tumors resistant to the combination
      drug treatment in general had fewer gross genomic alterations (CNVs) than parental
      tumors, indicative of evolution of a less variable subclone. However, these
      tumors also displayed a higher number of non-synonymous mutations than their
      parental clone. Pathway analysis showed that somatically mutated genes in PI3K-inhibitor
      resistant tumors were highly enriched for antigen processing and presentation,
      while those of tumors resistant to the combination treatment were enriched for
      histone modification pathways. Notably, the tumors resistant to PI3K-inhibitor
      alone were enriched for Insulin-processing pathways. Genomic losses in PI3K-inhibitor
      treated tumors enriched for the estrogen receptor pathway (ESR) in breast cancer
      and DNA damage pathways. In conclusion, our experimental design of analyzing
      isogenic tumors resistant to PI3K- or combined PI3K- and Parp-inhibitors enabled
      us to identify genomic alterations and pathways that explain the evolution to
      drug resistance. Citation Format: Sheida Nabavi, Ashish Juvekar, Nicholas Wang,
      Lewis C. Cantley, Gerburg M. Wulf. Analysis of resistance to the combination
      of a PI3K- and Parp-inhibitor using a genomic sequencing approach. [abstract].
      In: Proceedings of the 107th Annual Meeting of the American Association for
      Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer
      Res 2016;76(14 Suppl):Abstract nr 159.", "venue": "", "year": 2016, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2016-07-15", "journal": {"volume":
      "76", "pages": "159-159", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Nabavi2016Abstract1A,\n author = {S. Nabavi and Ashish Juvekar and
      Nicholas J. Wang and L. Cantley and G. Wulf},\n journal = {Cancer Research},\n
      pages = {159-159},\n title = {Abstract 159: Analysis of resistance to the combination
      of a PI3K- and Parp-inhibitor using a genomic sequencing approach},\n volume
      = {76},\n year = {2016}\n}\n"}, "authors": [{"authorId": "145834073", "name":
      "S. Nabavi"}, {"authorId": "49149990", "name": "Ashish Juvekar"}, {"authorId":
      "1722194", "name": "Nicholas J. Wang"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "31554501", "name": "G. Wulf"}]}, {"paperId": "e8882437b636bac43abf4a413d3e46053351e732",
      "externalIds": {"MAG": "2555512044", "DOI": "10.1158/1557-3125.CELLCYCLE16-IA08",
      "CorpusId": 88842212}, "corpusId": 88842212, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/e8882437b636bac43abf4a413d3e46053351e732",
      "title": "Abstract IA08: Reprogramming human cancer cells in CDK4/6 inhibitor
      therapy", "abstract": "CDK4 and CDK6 drive cell cycle progression through early
      G1 and are frequently deregulated in human cancer. Selective inhibition of CDK4/6
      with palbociclib (PD 0332991) has demonstrated exciting clinical efficacy in
      diverse human cancers. However, the mechanism that discriminates sensitivity
      from resistance to targeting CDK4/6 remains obscure. Mantle cell lymphoma (MCL)
      is an incurable non-Hodgkin9s lymphoma where deregulated CDK4 activity and cyclin
      D1 expression underlies unrestrained proliferation and disease progression.
      In a phase I clinical trial in recurrent MCL, we demonstrated that palbociclib
      alone produced a durable clinical response with a favorable toxicity profile.
      To investigate the mechanism for targeting CDK4/6, we have now shown in primary
      cancer cells that 1) inhibition of CDK4/6 leads to early G1 arrest that requires
      Rb, the CDK4/6 substrate; 2) prolonged early G1 arrest (pG1) sensitizes Rb-proficient
      cancer cells to killing by diverse clinically-relevant agents; and 3) pG1 sensitization
      stems from continuous expression of genes scheduled for early G1 only. This
      leads to an imbalance in genes expression, which is exacerbated in synchronous
      progression to S phase (pG1-S) after palbociclib withdrawal, due to incomplete
      restoration of cell cycle-coupled gene expression. In a hypothesis-driven phase
      Ib clinical trial, targeting CDK4 with palbociclib in sequential combination
      with the proteasome inhibitor bortezoimb was well tolerated (n=16). It exhibited
      a durable palbociclib dose-dependent clinical activity, including one complete
      remission for over 3 years with only one progression at the optimal dose combination
      (n=6). Longitudinal integrative whole transcriptome and whole exome sequencing
      of tumor cells isolated from serial lymph node biopsies demonstrated that palbociclib
      initially induced pG1 in MCL cells of all patients, regardless of copy number
      variation or mutation (ATM, p53). Cell cycle control by palbociclib is thus
      initially intact in MCL, but is insufficient to predict the clinical response.
      As predicted, only genes programmed for early G1 were expressed pG1, concurrent
      PI3K inactivation in primary MCL cells. However, This study represents the first
      investigation of genes that discriminate sensitivity from resistance in targeting
      CDK4/CDK6 in human cancer, through integrative longitudinal analysis of whole
      exome and whole transcriptome sequencing in concert with protein expression
      analysis and functional studies. Selective inhibition of CDK4 induces pG1 in
      all MCL patients, which apparently reprograms MCL for clinical response to bortezomib
      through PI3K inactivation and suppression of genes for redox homeostasis. Citation
      Format: Selina Chen-Kiang, Maurizio Di Liberto, Priyanka Vijay, David Chiron,
      Xiangao Huang, Scott Ely, Olivier Elemento, Christopher Mason, Lewis Cantley,
      John P. Leonard, Peter Martin. Reprogramming human cancer cells in CDK4/6 inhibitor
      therapy. [abstract]. In: Proceedings of the AACR Precision Medicine Series:
      Cancer Cell Cycle - Tumor Progression and Therapeutic Response; Feb 28-Mar 2,
      2016; Orlando, FL. Philadelphia (PA): AACR; Mol Cancer Res 2016;14(11_Suppl):Abstract
      nr IA08.", "venue": "", "year": 2016, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-11-01", "journal": {"volume": "14", "name": "Molecular Cancer Research"},
      "citationStyles": {"bibtex": "@Article{Chen\u2010Kiang2016AbstractIR,\n author
      = {S. Chen\u2010Kiang and M. Liberto and P. Vijay and D. Chiron and Xiangao
      Huang and S. Ely and O. Elemento and C. Mason and L. Cantley and J. Leonard
      and P. Martin},\n journal = {Molecular Cancer Research},\n title = {Abstract
      IA08: Reprogramming human cancer cells in CDK4/6 inhibitor therapy},\n volume
      = {14},\n year = {2016}\n}\n"}, "authors": [{"authorId": "1398158850", "name":
      "S. Chen\u2010Kiang"}, {"authorId": "52430482", "name": "M. Liberto"}, {"authorId":
      "145792938", "name": "P. Vijay"}, {"authorId": "46863981", "name": "D. Chiron"},
      {"authorId": "22172195", "name": "Xiangao Huang"}, {"authorId": "121580871",
      "name": "S. Ely"}, {"authorId": "150097652", "name": "O. Elemento"}, {"authorId":
      "2959056", "name": "C. Mason"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "144240302", "name": "J. Leonard"}, {"authorId": "144085617", "name":
      "P. Martin"}]}, {"paperId": "ece465807c23d42d275ffcce19ef06dd0b300f50", "externalIds":
      {"MAG": "2395508446", "DOI": "10.1080/2162402X.2016.1145332", "CorpusId": 34426042,
      "PubMed": "27471611"}, "corpusId": 34426042, "publicationVenue": {"id": "1a084c30-2271-476c-b82a-439820433fe9",
      "name": "Oncoimmunology", "type": "journal", "alternate_names": ["OncoImmunology"],
      "issn": "2162-4011", "url": "http://www.landesbioscience.com/journals/oncoimmunology/",
      "alternate_urls": ["https://www.tandfonline.com/KONI", "http://www.tandfonline.com/toc/koni20/current"]},
      "url": "https://www.semanticscholar.org/paper/ece465807c23d42d275ffcce19ef06dd0b300f50",
      "title": "Prioritization schema for immunotherapy clinical trials in glioblastoma",
      "abstract": "ABSTRACT Background: Emerging immunotherapeutic strategies for
      the treatment of glioblastoma (GBM) such as dendritic cell (DC) vaccines, heat
      shock proteins, peptide vaccines, and adoptive T-cell therapeutics, to name
      a few, have transitioned from the bench to clinical trials. With upcoming strategies
      and developing therapeutics, it is challenging to critically evaluate the practical,
      clinical potential of individual approaches and to advise patients on the most
      promising clinical trials. Methods: The authors propose a system to prioritize
      such therapies in an organized and data-driven fashion. This schema is based
      on four categories of factors: antigenic target robustness, immune-activation
      and -effector responses, preclinical vetting, and early evidence of clinical
      response. Each of these categories is subdivided to focus on the most salient
      elements for developing a successful immunotherapeutic approach for GBM, and
      a numerical score is generated. Results: The Score Card reveals therapeutics
      that have the most robust data to support their use, provides a reference prioritization
      score, and can be applied in a reiterative fashion with emerging data. Conclusions:
      The authors hope that this schema will give physicians an evidence-based and
      rational framework to make the best referral decisions to better guide and serve
      this patient population.", "venue": "Oncoimmunology", "year": 2016, "referenceCount":
      231, "citationCount": 31, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "2016-02-18",
      "journal": {"volume": "5", "name": "OncoImmunology"}, "citationStyles": {"bibtex":
      "@Article{Hodges2016PrioritizationSF,\n author = {T. Hodges and S. Ferguson
      and H. Caruso and G. Kohanbash and Shouhao Zhou and T. Cloughesy and M. Berger
      and G. Poste and M. Khasraw and Sujuan Ba and T. Jiang and T. Mikkelson and
      W. Yung and J. D. de Groot and H. Fine and L. Cantley and I. Mellinghoff and
      D. Mitchell and H. Okada and A. Heimberger},\n booktitle = {Oncoimmunology},\n
      journal = {OncoImmunology},\n title = {Prioritization schema for immunotherapy
      clinical trials in glioblastoma},\n volume = {5},\n year = {2016}\n}\n"}, "authors":
      [{"authorId": "6116001", "name": "T. Hodges"}, {"authorId": "5126443", "name":
      "S. Ferguson"}, {"authorId": "7188898", "name": "H. Caruso"}, {"authorId": "4868530",
      "name": "G. Kohanbash"}, {"authorId": "7523168", "name": "Shouhao Zhou"}, {"authorId":
      "2718826", "name": "T. Cloughesy"}, {"authorId": "82318840", "name": "M. Berger"},
      {"authorId": "4715187", "name": "G. Poste"}, {"authorId": "113753345", "name":
      "M. Khasraw"}, {"authorId": "36807854", "name": "Sujuan Ba"}, {"authorId": "145909831",
      "name": "T. Jiang"}, {"authorId": "39284888", "name": "T. Mikkelson"}, {"authorId":
      "143913370", "name": "W. Yung"}, {"authorId": "143802155", "name": "J. D. de
      Groot"}, {"authorId": "3328992", "name": "H. Fine"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2569035", "name": "I. Mellinghoff"}, {"authorId":
      "40173718", "name": "D. Mitchell"}, {"authorId": "2090005", "name": "H. Okada"},
      {"authorId": "6820582", "name": "A. Heimberger"}]}, {"paperId": "ef05508cb2615e2807411ec18bb18fbcefda2455",
      "externalIds": {"MAG": "2478359261", "DOI": "10.1158/1538-7445.AM2016-SY12-01",
      "CorpusId": 89071141}, "corpusId": 89071141, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/ef05508cb2615e2807411ec18bb18fbcefda2455",
      "title": "Abstract SY12-01: PI 3-kinase and cancer metabolism", "abstract":
      "In general cancer cells produce higher levels of reactive oxygen species (ROS)
      than normal cells due to increased rates of metabolism and defective mitochondria.
      In order to survive under conditions of high ROS, cancer cells typically turn
      on pathways for generating NADPH and glutathione to bring ROS levels back to
      homeostasis. Activating mutations in PIK3CA or loss of PTEN or activating mutations
      in KRAS can stimulate glucose uptake and metabolism and pathways for generating
      NADPH and glutathione to suppress ROS. A detailed understanding of the biochemical
      mechanisms by which cancer cells suppress excess ROS may suggest new therapies
      for inducing synthetic lethality in tumors that evolve in specific mutational
      backgrounds. Our research using human cancer cell lines and genetically engineered
      mouse models suggests new approaches for killing cancer cells by targeting metabolic
      pathways for ROS suppression that allow cancer cells to survive. Citation Format:
      Lewis C. Cantley. PI 3-kinase and cancer metabolism. [abstract]. In: Proceedings
      of the 107th Annual Meeting of the American Association for Cancer Research;
      2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14
      Suppl):Abstract nr SY12-01.", "venue": "", "year": 2016, "referenceCount": 0,
      "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-07-15", "journal": {"volume": "76", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Cantley2016AbstractSP,\n author = {L. Cantley},\n journal
      = {Cancer Research},\n title = {Abstract SY12-01: PI 3-kinase and cancer metabolism},\n
      volume = {76},\n year = {2016}\n}\n"}, "authors": [{"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "f33f4df3c7f3c86bcd232dfeeec11c91364e1029", "externalIds":
      {"MAG": "2735956876", "PubMedCentral": "5047696", "DOI": "10.1242/dmm.026856",
      "CorpusId": 2906468, "PubMed": "27491070"}, "corpusId": 2906468, "publicationVenue":
      {"id": "dbfaf49f-d95c-406a-96d9-3a357140a3a6", "name": "Disease Models & Mechanisms",
      "type": "journal", "alternate_names": ["Dis Model  Mech"], "issn": "1754-8403",
      "url": "https://dmm.biologists.org/", "alternate_urls": ["http://dmm.biologists.org/"]},
      "url": "https://www.semanticscholar.org/paper/f33f4df3c7f3c86bcd232dfeeec11c91364e1029",
      "title": "Seeking out the sweet spot in cancer therapeutics: an interview with
      Lewis Cantley", "abstract": "Lewis C. Cantley, Director of the Sandra and Edward
      Meyer Cancer Center at Weill Cornell Medicine, is a world leader in cancer and
      metabolic disease research. His seminal discoveries have shed light on the regulation
      of ion pumps and other transport proteins, insulin-mediated regulation of glucose
      metabolism and the role of signal transduction networks in cell transformation.
      At Tufts University in the 1980s, Lewis and his collaborators unveiled and characterized
      the phosphoinositide 3-kinase (PI3K) signaling pathway; a discovery that revolutionized
      the field of lipid signaling. In this interview, he documents his journey from
      serendipitous discovery of the pathway to determining its diverse physiological
      functions and role in cancer \u2013 an incredible odyssey that has laid the
      groundwork for clinical trials based on PI3K inhibitors. He also discusses the
      impact his early life had in spurring a thirst to understand biological processes
      at the molecular level, highlights how his multiple collaborations have helped
      in translating his basic discoveries to the clinic and explains why eating a
      high-sugar diet can be harmful. Ongoing studies in the Cantley lab are aimed
      at determining the mechanistic underpinnings of pancreatic, colorectal, ovarian
      and breast cancers, particularly the role of cellular metabolic pathways. The
      group has recently shown, amongst other breakthroughs, that vitamin C could
      provide a promising therapy for certain hard-to-treat cancers. Summary: We spoke
      to Lewis Cantley about his career path and the story behind some of his key
      breakthroughs, including discovery of the phosphoinositide 3-kinase signaling
      pathway and insights into the role of dysregulated metabolism in cancer.", "venue":
      "Disease Models & Mechanisms", "year": 2016, "referenceCount": 0, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://dmm.biologists.org/content/dmm/9/9/911.full.pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2016-09-01", "journal": {"volume": "9", "pages": "911 - 916", "name": "Disease
      Models & Mechanisms"}, "citationStyles": {"bibtex": "@Article{Cantley2016SeekingOT,\n
      author = {L. Cantley},\n booktitle = {Disease Models & Mechanisms},\n journal
      = {Disease Models & Mechanisms},\n pages = {911 - 916},\n title = {Seeking out
      the sweet spot in cancer therapeutics: an interview with Lewis Cantley},\n volume
      = {9},\n year = {2016}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L.
      Cantley"}]}, {"paperId": "f39539f0f785bcfcbd8d51facfc870e941ec380a", "externalIds":
      {"MAG": "2336310263", "PubMedCentral": "4848114", "DOI": "10.1038/ncb3341",
      "CorpusId": 36807122, "PubMed": "27088857"}, "corpusId": 36807122, "publicationVenue":
      {"id": "7d182b83-7d8d-43fb-9fd6-ae67fbafab20", "name": "Nature Cell Biology",
      "type": "journal", "alternate_names": ["Nat Cell Biology"], "issn": "1465-7392",
      "url": "http://www.nature.com/naturecellbiology", "alternate_urls": ["https://www.nature.com/ncb/"]},
      "url": "https://www.semanticscholar.org/paper/f39539f0f785bcfcbd8d51facfc870e941ec380a",
      "title": "Glutathione biosynthesis is a metabolic vulnerability in PI3K/Akt-driven
      breast cancer", "abstract": null, "venue": "Nature Cell Biology", "year": 2016,
      "referenceCount": 42, "citationCount": 187, "influentialCitationCount": 7, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc4848114?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2016-03-16", "journal": {"volume": "18", "pages": "572 -
      578", "name": "Nature cell biology"}, "citationStyles": {"bibtex": "@Article{Lien2016GlutathioneBI,\n
      author = {Evan C. Lien and C. Lyssiotis and Ashish Juvekar and Hai Hu and J.
      Asara and L. Cantley and A. Toker},\n booktitle = {Nature Cell Biology},\n journal
      = {Nature cell biology},\n pages = {572 - 578},\n title = {Glutathione biosynthesis
      is a metabolic vulnerability in PI3K/Akt-driven breast cancer},\n volume = {18},\n
      year = {2016}\n}\n"}, "authors": [{"authorId": "4729701", "name": "Evan C. Lien"},
      {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "49149990", "name":
      "Ashish Juvekar"}, {"authorId": "113164867", "name": "Hai Hu"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "145751285", "name": "A. Toker"}]}, {"paperId": "fa4c3f72ef670ee72a3beb5a8f2d1f4c96be3ba3",
      "externalIds": {"MAG": "2508551534", "DOI": "10.1007/978-3-319-42118-6_3", "CorpusId":
      26123083, "PubMed": "27557534"}, "corpusId": 26123083, "publicationVenue": null,
      "url": "https://www.semanticscholar.org/paper/fa4c3f72ef670ee72a3beb5a8f2d1f4c96be3ba3",
      "title": "Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.",
      "abstract": null, "venue": "Recent results in cancer research. Fortschritte
      der Krebsforschung. Progres dans les recherches sur le cancer", "year": 2016,
      "referenceCount": 200, "citationCount": 155, "influentialCitationCount": 2,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": null, "journal": {"volume": "207", "pages":
      "\n          39-72\n        ", "name": "Recent results in cancer research. Fortschritte
      der Krebsforschung. Progres dans les recherches sur le cancer"}, "citationStyles":
      {"bibtex": "@Article{Lien2016MetabolicRB,\n author = {Evan C. Lien and C. Lyssiotis
      and L. Cantley},\n booktitle = {Recent results in cancer research. Fortschritte
      der Krebsforschung. Progres dans les recherches sur le cancer},\n journal =
      {Recent results in cancer research. Fortschritte der Krebsforschung. Progres
      dans les recherches sur le cancer},\n pages = {\n          39-72\n        },\n
      title = {Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.},\n
      volume = {207},\n year = {2016}\n}\n"}, "authors": [{"authorId": "4729701",
      "name": "Evan C. Lien"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "049e6e417aa01258cc8a28cb244e3f7be7b023fd",
      "externalIds": {"MAG": "2978051430", "DOI": "10.2210/pdb3x07/pdb", "CorpusId":
      210517195}, "corpusId": 210517195, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/049e6e417aa01258cc8a28cb244e3f7be7b023fd",
      "title": "Crystal structure of PIP4KIIBETA N203A complex with AMP", "abstract":
      null, "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-10-14",
      "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Takeuchi2015CrystalSO,\n
      author = {K. Takeuchi and Y. Lo and Kazutaka Sumita and M. Senda and Jumpei
      Terakawa and A. Dimitoris and J. Locasale and Mika Sasaki and H. Yoshino and
      Y. Zhang and E. Kahoud and T. Takano and T. Yokota and B. Emerling and J. Asara
      and T. Ishida and I. Shimada and T. Daikoku and L. Cantley and T. Senda and
      A. Sasaki},\n title = {Crystal structure of PIP4KIIBETA N203A complex with AMP},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "2775065", "name": "K. Takeuchi"},
      {"authorId": "121709354", "name": "Y. Lo"}, {"authorId": "49715313", "name":
      "Kazutaka Sumita"}, {"authorId": "5638813", "name": "M. Senda"}, {"authorId":
      "49515406", "name": "Jumpei Terakawa"}, {"authorId": "1485705386", "name": "A.
      Dimitoris"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "152671464",
      "name": "Mika Sasaki"}, {"authorId": "6824343", "name": "H. Yoshino"}, {"authorId":
      "49891201", "name": "Y. Zhang"}, {"authorId": "4049626", "name": "E. Kahoud"},
      {"authorId": "91895026", "name": "T. Takano"}, {"authorId": "10207871", "name":
      "T. Yokota"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "1394348007",
      "name": "J. Asara"}, {"authorId": "47983250", "name": "T. Ishida"}, {"authorId":
      "144714771", "name": "I. Shimada"}, {"authorId": "145457715", "name": "T. Daikoku"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "50162552", "name":
      "T. Senda"}, {"authorId": "47742211", "name": "A. Sasaki"}]}, {"paperId": "0561d0105e31d38dc212b0f70664a702c4a47cc7",
      "externalIds": {"MAG": "1960369368", "DOI": "10.1016/j.molonc.2015.04.014",
      "CorpusId": 5236294, "PubMed": "26045339"}, "corpusId": 5236294, "publicationVenue":
      {"id": "0f2158b1-4721-44a4-89ab-6cfc91eaca11", "name": "Molecular Oncology",
      "type": "journal", "alternate_names": ["Mol Oncol"], "issn": "1574-7891", "url":
      "http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/",
      "alternate_urls": ["http://www.moloncol.org/home"]}, "url": "https://www.semanticscholar.org/paper/0561d0105e31d38dc212b0f70664a702c4a47cc7",
      "title": "PTEN loss is a context\u2010dependent outcome determinant in obese
      and non\u2010obese endometrioid endometrial cancer patients", "abstract": null,
      "venue": "Molecular Oncology", "year": 2015, "referenceCount": 55, "citationCount":
      46, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2015.04.014",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2015-10-01", "journal": {"volume": "9", "name": "Molecular
      Oncology"}, "citationStyles": {"bibtex": "@Article{Westin2015PTENLI,\n author
      = {S. Westin and Z. Ju and R. Broaddus and C. Krakstad and Jane Li and N. Pal
      and K. Lu and R. L. Coleman and B. Hennessy and S. Klempner and H. M. Werner
      and H. Salvesen and L. Cantley and G. Mills and A. Myers},\n booktitle = {Molecular
      Oncology},\n journal = {Molecular Oncology},\n title = {PTEN loss is a context\u2010dependent
      outcome determinant in obese and non\u2010obese endometrioid endometrial cancer
      patients},\n volume = {9},\n year = {2015}\n}\n"}, "authors": [{"authorId":
      "2974900", "name": "S. Westin"}, {"authorId": "152983291", "name": "Z. Ju"},
      {"authorId": "6416382", "name": "R. Broaddus"}, {"authorId": "6534390", "name":
      "C. Krakstad"}, {"authorId": "2108996618", "name": "Jane Li"}, {"authorId":
      "35508831", "name": "N. Pal"}, {"authorId": "2246960153", "name": "K. Lu"},
      {"authorId": "2205803672", "name": "R. L. Coleman"}, {"authorId": "2030236",
      "name": "B. Hennessy"}, {"authorId": "4677205", "name": "S. Klempner"}, {"authorId":
      "144323272", "name": "H. M. Werner"}, {"authorId": "144568679", "name": "H.
      Salvesen"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2241330",
      "name": "G. Mills"}, {"authorId": "6324437", "name": "A. Myers"}]}, {"paperId":
      "06cdb74dc5e901b4aee2620b2ee8b98e05317b50", "externalIds": {"MAG": "2588625478",
      "DOI": "10.1016/J.IJROBP.2015.07.120", "CorpusId": 79027350}, "corpusId": 79027350,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/06cdb74dc5e901b4aee2620b2ee8b98e05317b50",
      "title": "Inhibition of Phosphatidylinositol-5-Phosphate 4-Kinases (PI5P4K\u03b1
      and \u03b2) Inhibits Proliferation and Radiosensitizes Triple Negative Breast
      Cancer Cells Harboring p53 Mutations", "abstract": null, "venue": "", "year":
      2015, "referenceCount": 0, "citationCount": 1, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2015-11-01", "journal": {"volume": "93", "name": "International Journal of
      Radiation Oncology Biology Physics"}, "citationStyles": {"bibtex": "@Article{Yang2015InhibitionOP,\n
      author = {T. Yang and Diana G. Wang and C. Pauli and Ryan Loughran and H. Kim
      and Tinghu Zhang and D. Annamalai and B. Emerling and S. Powell and N. Gray
      and L. Cantley},\n journal = {International Journal of Radiation Oncology Biology
      Physics},\n title = {Inhibition of Phosphatidylinositol-5-Phosphate 4-Kinases
      (PI5P4K\u03b1 and \u03b2) Inhibits Proliferation and Radiosensitizes Triple
      Negative Breast Cancer Cells Harboring p53 Mutations},\n volume = {93},\n year
      = {2015}\n}\n"}, "authors": [{"authorId": "2219789781", "name": "T. Yang"},
      {"authorId": "152325571", "name": "Diana G. Wang"}, {"authorId": "34187590",
      "name": "C. Pauli"}, {"authorId": "31875049", "name": "Ryan Loughran"}, {"authorId":
      "2155396453", "name": "H. Kim"}, {"authorId": "2262535", "name": "Tinghu Zhang"},
      {"authorId": "48181912", "name": "D. Annamalai"}, {"authorId": "5542751", "name":
      "B. Emerling"}, {"authorId": "1695518", "name": "S. Powell"}, {"authorId": "3977406",
      "name": "N. Gray"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "0a2b2a67b0b346a52c9f13535b03da8d9f50ee24", "externalIds": {"MAG": "2174352319",
      "DOI": "10.1038/nsmb.3117", "CorpusId": 987663, "PubMed": "26551075"}, "corpusId":
      987663, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/0a2b2a67b0b346a52c9f13535b03da8d9f50ee24",
      "title": "EGF-receptor specificity for phosphotyrosine-primed substrates provides
      signal integration with Src", "abstract": null, "venue": "Nature Structural
      &Molecular Biology", "year": 2015, "referenceCount": 56, "citationCount": 34,
      "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc4824005?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2015-11-09", "journal": {"volume": "22", "pages": "983-990", "name": "Nature
      Structural &Molecular Biology"}, "citationStyles": {"bibtex": "@Article{Begley2015EGFreceptorSF,\n
      author = {M. Begley and C. Yun and C. Gewinner and J. Asara and Jared L. Johnson
      and A. Coyle and M. Eck and I. Apostolou and L. Cantley},\n booktitle = {Nature
      Structural &Molecular Biology},\n journal = {Nature Structural &Molecular Biology},\n
      pages = {983-990},\n title = {EGF-receptor specificity for phosphotyrosine-primed
      substrates provides signal integration with Src},\n volume = {22},\n year =
      {2015}\n}\n"}, "authors": [{"authorId": "69874482", "name": "M. Begley"}, {"authorId":
      "3555673", "name": "C. Yun"}, {"authorId": "7739224", "name": "C. Gewinner"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "145916288", "name":
      "Jared L. Johnson"}, {"authorId": "2116662", "name": "A. Coyle"}, {"authorId":
      "153402662", "name": "M. Eck"}, {"authorId": "6817362", "name": "I. Apostolou"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "0b3a0ac2298c34306198ab8958851fde41bff1e8",
      "externalIds": {"MAG": "2114861961", "DOI": "10.1158/0008-5472.CAN-14-2268",
      "CorpusId": 1680774, "PubMed": "25511375"}, "corpusId": 1680774, "publicationVenue":
      {"id": "b0bd78b2-6591-460e-af71-196409b62e2c", "name": "Cancer Research", "type":
      "journal", "alternate_names": ["Cancer Res"], "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/",
      "alternate_urls": ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/0b3a0ac2298c34306198ab8958851fde41bff1e8",
      "title": "Gain of glucose-independent growth upon metastasis of breast cancer
      cells to the brain.", "abstract": "Breast cancer brain metastasis is resistant
      to therapy and a particularly poor prognostic feature in patient survival. Altered
      metabolism is a common feature of cancer cells, but little is known as to what
      metabolic changes benefit breast cancer brain metastases. We found that brain
      metastatic breast cancer cells evolved the ability to survive and proliferate
      independent of glucose due to enhanced gluconeogenesis and oxidations of glutamine
      and branched chain amino acids, which together sustain the nonoxidative pentose
      pathway for purine synthesis. Silencing expression of fructose-1,6-bisphosphatases
      (FBP) in brain metastatic cells reduced their viability and improved the survival
      of metastasis-bearing immunocompetent hosts. Clinically, we showed that brain
      metastases from human breast cancer patients expressed higher levels of FBP
      and glycogen than the corresponding primary tumors. Together, our findings identify
      a critical metabolic condition required to sustain brain metastasis and suggest
      that targeting gluconeogenesis may help eradicate this deadly feature in advanced
      breast cancer patients.", "venue": "Cancer Research", "year": 2015, "referenceCount":
      57, "citationCount": 123, "influentialCitationCount": 3, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://cancerres.aacrjournals.org/content/canres/75/3/554.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2015-02-01", "journal": {"volume": "75 3", "pages": "\n          554-65\n        ",
      "name": "Cancer research"}, "citationStyles": {"bibtex": "@Article{Chen2015GainOG,\n
      author = {Jinyu Chen and Ho\u2010Jeong Lee and Xuefeng Wu and L. Huo and Sun-jin
      Kim and Lei Xu and Yan Wang and Junqin He and L. Bollu and G. Gao and Fei Su
      and James Briggs and Xiaojing Liu and T. Melman and J. Asara and I. Fidler and
      L. Cantley and J. Locasale and Weihua Zhang},\n booktitle = {Cancer Research},\n
      journal = {Cancer research},\n pages = {\n          554-65\n        },\n title
      = {Gain of glucose-independent growth upon metastasis of breast cancer cells
      to the brain.},\n volume = {75 3},\n year = {2015}\n}\n"}, "authors": [{"authorId":
      "2136211075", "name": "Jinyu Chen"}, {"authorId": "2110018995", "name": "Ho\u2010Jeong
      Lee"}, {"authorId": "74585917", "name": "Xuefeng Wu"}, {"authorId": "48605888",
      "name": "L. Huo"}, {"authorId": "46876643", "name": "Sun-jin Kim"}, {"authorId":
      "2116558193", "name": "Lei Xu"}, {"authorId": "47906499", "name": "Yan Wang"},
      {"authorId": "2326587", "name": "Junqin He"}, {"authorId": "4549367", "name":
      "L. Bollu"}, {"authorId": "48807811", "name": "G. Gao"}, {"authorId": "2058372978",
      "name": "Fei Su"}, {"authorId": "2061233933", "name": "James Briggs"}, {"authorId":
      "2110961349", "name": "Xiaojing Liu"}, {"authorId": "1853856", "name": "T. Melman"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "4191038", "name":
      "I. Fidler"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2268976",
      "name": "J. Locasale"}, {"authorId": "2252255758", "name": "Weihua Zhang"}]},
      {"paperId": "176594e5304d63cccd19e57db36f70d54a118f1b", "externalIds": {"MAG":
      "2978599975", "DOI": "10.2210/pdb3x01/pdb", "CorpusId": 210527426}, "corpusId":
      210527426, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/176594e5304d63cccd19e57db36f70d54a118f1b",
      "title": "Crystal structure of PIP4KIIBETA complex with AMP", "abstract": null,
      "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-10-14",
      "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Takeuchi2015CrystalSO,\n
      author = {K. Takeuchi and Y. Lo and Kazutaka Sumita and M. Senda and Jumpei
      Terakawa and A. Dimitoris and J. Locasale and Mika Sasaki and H. Yoshino and
      Y. Zhang and E. Kahoud and T. Takano and T. Yokota and B. Emerling and J. Asara
      and T. Ishida and I. Shimada and T. Daikoku and L. Cantley and T. Senda and
      A. Sasaki},\n title = {Crystal structure of PIP4KIIBETA complex with AMP},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "2775065", "name": "K. Takeuchi"},
      {"authorId": "121709354", "name": "Y. Lo"}, {"authorId": "49715313", "name":
      "Kazutaka Sumita"}, {"authorId": "5638813", "name": "M. Senda"}, {"authorId":
      "49515406", "name": "Jumpei Terakawa"}, {"authorId": "1485705386", "name": "A.
      Dimitoris"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "152671464",
      "name": "Mika Sasaki"}, {"authorId": "6824343", "name": "H. Yoshino"}, {"authorId":
      "49891201", "name": "Y. Zhang"}, {"authorId": "4049626", "name": "E. Kahoud"},
      {"authorId": "91895026", "name": "T. Takano"}, {"authorId": "10207871", "name":
      "T. Yokota"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "1394348007",
      "name": "J. Asara"}, {"authorId": "47983250", "name": "T. Ishida"}, {"authorId":
      "144714771", "name": "I. Shimada"}, {"authorId": "145457715", "name": "T. Daikoku"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "50162552", "name":
      "T. Senda"}, {"authorId": "47742211", "name": "A. Sasaki"}]}, {"paperId": "1de1e1380a6831478b0df4c641fe32e8c6bdb51e",
      "externalIds": {"MAG": "2196075541", "DOI": "10.1158/2159-8290.CD-15-0068",
      "CorpusId": 1553760, "PubMed": "26446169"}, "corpusId": 1553760, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/1de1e1380a6831478b0df4c641fe32e8c6bdb51e",
      "title": "A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals
      Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and
      Metabolic Characteristics.", "abstract": "UNLABELLED\nSeeking to assess the
      representative and instructive value of an engineered mouse model of pancreatic
      neuroendocrine tumors (PanNET) for its cognate human cancer, we profiled and
      compared mRNA and miRNA transcriptomes of tumors from both. Mouse PanNET tumors
      could be classified into two distinctive subtypes, well-differentiated islet/insulinoma
      tumors (IT) and poorly differentiated tumors associated with liver metastases,
      dubbed metastasis-like primary (MLP). Human PanNETs were independently classified
      into these same two subtypes, along with a third, specific gene mutation-enriched
      subtype. The MLP subtypes in human and mouse were similar to liver metastases
      in terms of miRNA and mRNA transcriptome profiles and signature genes. The human/mouse
      MLP subtypes also similarly expressed genes known to regulate early pancreas
      development, whereas the IT subtypes expressed genes characteristic of mature
      islet cells, suggesting different tumorigenesis pathways. In addition, these
      subtypes exhibit distinct metabolic profiles marked by differential pyruvate
      metabolism, substantiating the significance of their separate identities.\n\n\nSIGNIFICANCE\nThis
      study involves a comprehensive cross-species integrated analysis of multi-omics
      profiles and histology to stratify PanNETs into subtypes with distinctive characteristics.
      We provide support for the RIP1-TAG2 mouse model as representative of its cognate
      human cancer with prospects to better understand PanNET heterogeneity and consider
      future applications of personalized cancer therapy.", "venue": "Cancer Discovery",
      "year": 2015, "referenceCount": 69, "citationCount": 137, "influentialCitationCount":
      9, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerdiscovery.aacrjournals.org/content/candisc/5/12/1296.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2015-10-07", "journal": {"volume": "5 12", "pages": "\n          1296-313\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Sadanandam2015ACA,\n
      author = {A. Sadanandam and S. Wullschleger and C. Lyssiotis and C. Gr\u00f6tzinger
      and S. Barbi and S. Bersani and Jan L K\u00f6rner and Ismael Wafy and A. Mafficini
      and R. Lawlor and M. Simbolo and J. Asara and H. Bl\u00e4ker and L. Cantley
      and B. Wiedenmann and A. Scarpa and D. Hanahan},\n booktitle = {Cancer Discovery},\n
      journal = {Cancer discovery},\n pages = {\n          1296-313\n        },\n
      title = {A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals
      Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and
      Metabolic Characteristics.},\n volume = {5 12},\n year = {2015}\n}\n"}, "authors":
      [{"authorId": "49973308", "name": "A. Sadanandam"}, {"authorId": "38356613",
      "name": "S. Wullschleger"}, {"authorId": "4901222", "name": "C. Lyssiotis"},
      {"authorId": "2555682", "name": "C. Gr\u00f6tzinger"}, {"authorId": "6877885",
      "name": "S. Barbi"}, {"authorId": "29823932", "name": "S. Bersani"}, {"authorId":
      "3892565", "name": "Jan L K\u00f6rner"}, {"authorId": "116518204", "name": "Ismael
      Wafy"}, {"authorId": "4782975", "name": "A. Mafficini"}, {"authorId": "3330807",
      "name": "R. Lawlor"}, {"authorId": "6643411", "name": "M. Simbolo"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "3883634", "name": "H. Bl\u00e4ker"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4406446", "name":
      "B. Wiedenmann"}, {"authorId": "143784645", "name": "A. Scarpa"}, {"authorId":
      "6883889", "name": "D. Hanahan"}]}, {"paperId": "21a7c524a9e0a6f7953b14cac628c2439deeced0",
      "externalIds": {"PubMedCentral": "4601138", "MAG": "2114439592", "DOI": "10.1186/s40170-015-0137-1",
      "CorpusId": 1204277, "PubMed": "26462257"}, "corpusId": 1204277, "publicationVenue":
      {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f", "name": "Cancer & Metabolism",
      "type": "journal", "alternate_names": ["Cancer Metab", "Cancer and Metabolism",
      "Cancer  Metab"], "issn": "2049-3002", "url": "http://www.cancerandmetabolism.com/"},
      "url": "https://www.semanticscholar.org/paper/21a7c524a9e0a6f7953b14cac628c2439deeced0",
      "title": "Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven
      metabolic catastrophe induced by \u00df-lapachone", "abstract": null, "venue":
      "Cancer & Metabolism", "year": 2015, "referenceCount": 47, "citationCount":
      98, "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/s40170-015-0137-1",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2015-10-12", "journal":
      {"volume": "3", "name": "Cancer & Metabolism"}, "citationStyles": {"bibtex":
      "@Article{Chakrabarti2015TargetingGM,\n author = {G. Chakrabarti and Zachary
      R. Moore and Xiuquan Luo and Mariya Ilcheva and Aktar Ali and Mahesh S. Padanad
      and Yunyun Zhou and Yang Xie and S. Burma and P. Scaglioni and L. Cantley and
      R. Deberardinis and Alec C. Kimmelman and C. Lyssiotis and D. Boothman},\n booktitle
      = {Cancer & Metabolism},\n journal = {Cancer & Metabolism},\n title = {Targeting
      glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe
      induced by \u00df-lapachone},\n volume = {3},\n year = {2015}\n}\n"}, "authors":
      [{"authorId": "35784792", "name": "G. Chakrabarti"}, {"authorId": "145442892",
      "name": "Zachary R. Moore"}, {"authorId": "5617652", "name": "Xiuquan Luo"},
      {"authorId": "4735589", "name": "Mariya Ilcheva"}, {"authorId": "13336581",
      "name": "Aktar Ali"}, {"authorId": "47393233", "name": "Mahesh S. Padanad"},
      {"authorId": "2118116344", "name": "Yunyun Zhou"}, {"authorId": "145668114",
      "name": "Yang Xie"}, {"authorId": "4579757", "name": "S. Burma"}, {"authorId":
      "3619786", "name": "P. Scaglioni"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5834413", "name": "R. Deberardinis"}, {"authorId": "4668673",
      "name": "Alec C. Kimmelman"}, {"authorId": "4901222", "name": "C. Lyssiotis"},
      {"authorId": "6434802", "name": "D. Boothman"}]}, {"paperId": "23f6c5b2c9a747442b09880328e14ab800474b30",
      "externalIds": {"MAG": "2582692617", "DOI": "10.1158/1078-0432.CCR-15-1846",
      "CorpusId": 207652755, "PubMed": "26429991"}, "corpusId": 207652755, "publicationVenue":
      {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0", "name": "Clinical Cancer Research",
      "type": "journal", "alternate_names": ["Clin Cancer Res"], "issn": "1078-0432",
      "url": "https://clincancerres.aacrjournals.org/", "alternate_urls": ["http://clincancerres.aacrjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/23f6c5b2c9a747442b09880328e14ab800474b30",
      "title": "AACR Cancer Progress Report 2015", "abstract": "*These authors contributed
      to the devlopment and review of this manuscript but are unable to endorse the
      request for NIH funding.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOn
      Sept. 20, 2011, the American Association for Cancer Research (AACR) released
      its inaugural AACR Cancer Progress Report to commemorate the", "venue": "Clinical
      Cancer Research", "year": 2015, "referenceCount": 186, "citationCount": 32,
      "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://clincancerres.aacrjournals.org/content/clincanres/21/19_Supplement/S1.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["Review"], "publicationDate": "2015-10-01", "journal": {"volume": "21", "pages":
      "S1 - S128", "name": "Clinical Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Baselga2015AACRCP,\n author = {J. Baselga and N. Bhardwaj and L. Cantley
      and R. DeMatteo and R. Dubois and M. Foti and S. Gapstur and W. Hahn and L.
      Helman and R. Jensen and E. Paskett and T. Lawrence and S. Lutzker and E. Szabo},\n
      booktitle = {Clinical Cancer Research},\n journal = {Clinical Cancer Research},\n
      pages = {S1 - S128},\n title = {AACR Cancer Progress Report 2015},\n volume
      = {21},\n year = {2015}\n}\n"}, "authors": [{"authorId": "144806171", "name":
      "J. Baselga"}, {"authorId": "144952828", "name": "N. Bhardwaj"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "3572324", "name": "R. DeMatteo"},
      {"authorId": "4135978", "name": "R. Dubois"}, {"authorId": "48762531", "name":
      "M. Foti"}, {"authorId": "4380527", "name": "S. Gapstur"}, {"authorId": "1890553",
      "name": "W. Hahn"}, {"authorId": "4169821", "name": "L. Helman"}, {"authorId":
      "92266338", "name": "R. Jensen"}, {"authorId": "143751246", "name": "E. Paskett"},
      {"authorId": "2984849", "name": "T. Lawrence"}, {"authorId": "3656125", "name":
      "S. Lutzker"}, {"authorId": "143616557", "name": "E. Szabo"}]}, {"paperId":
      "2800b1f76a9c65e8df8c9f703869e9547c3c64a9", "externalIds": {"MAG": "2173466127",
      "PubMedCentral": "4721512", "DOI": "10.1038/ng.3421", "CorpusId": 13931286,
      "PubMed": "26482881"}, "corpusId": 13931286, "publicationVenue": {"id": "bb27e645-e57c-42c3-bcbc-c7b443c58209",
      "name": "Nature Genetics", "type": "journal", "alternate_names": ["Nat Genet"],
      "issn": "1061-4036", "url": "http://www.nature.com/ng/", "alternate_urls": ["http://www.nature.com/ng/index.html"]},
      "url": "https://www.semanticscholar.org/paper/2800b1f76a9c65e8df8c9f703869e9547c3c64a9",
      "title": "NRF2 regulates serine biosynthesis in non-small cell lung cancer",
      "abstract": null, "venue": "Nature Genetics", "year": 2015, "referenceCount":
      32, "citationCount": 537, "influentialCitationCount": 26, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc4721512?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2015-10-15", "journal": {"volume": "47", "pages": "1475
      - 1481", "name": "Nature genetics"}, "citationStyles": {"bibtex": "@Article{DeNicola2015NRF2RS,\n
      author = {G. DeNicola and Pei-Hsuan Chen and Edouard Mullarky and J. Sudderth
      and Zeping Hu and David Wu and Hao Tang and Yang Xie and J. Asara and K. Huffman
      and I. Wistuba and J. Minna and R. Deberardinis and L. Cantley},\n booktitle
      = {Nature Genetics},\n journal = {Nature genetics},\n pages = {1475 - 1481},\n
      title = {NRF2 regulates serine biosynthesis in non-small cell lung cancer},\n
      volume = {47},\n year = {2015}\n}\n"}, "authors": [{"authorId": "4772111", "name":
      "G. DeNicola"}, {"authorId": "4047142", "name": "Pei-Hsuan Chen"}, {"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "5467431", "name": "J.
      Sudderth"}, {"authorId": "3616375", "name": "Zeping Hu"}, {"authorId": "144790190",
      "name": "David Wu"}, {"authorId": "2112388600", "name": "Hao Tang"}, {"authorId":
      "145668114", "name": "Yang Xie"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "5305256", "name": "K. Huffman"}, {"authorId": "46528860", "name":
      "I. Wistuba"}, {"authorId": "2996220", "name": "J. Minna"}, {"authorId": "5834413",
      "name": "R. Deberardinis"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "2baef32a40ae7886157de933d7494df92f6f2a5b", "externalIds": {"MAG":
      "2977458141", "DOI": "10.2210/pdb3wzz/pdb", "CorpusId": 210514480}, "corpusId":
      210514480, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/2baef32a40ae7886157de933d7494df92f6f2a5b",
      "title": "Crystal structure of PIP4KIIBETA", "abstract": null, "venue": "",
      "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-10-14",
      "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Takeuchi2015CrystalSO,\n
      author = {K. Takeuchi and Y. Lo and Kazutaka Sumita and M. Senda and Jumpei
      Terakawa and A. Dimitoris and J. Locasale and Mika Sasaki and H. Yoshino and
      Y. Zhang and E. Kahoud and T. Takano and T. Yokota and B. Emerling and J. Asara
      and T. Ishida and I. Shimada and T. Daikoku and L. Cantley and T. Senda and
      A. Sasaki},\n title = {Crystal structure of PIP4KIIBETA},\n year = {2015}\n}\n"},
      "authors": [{"authorId": "2775065", "name": "K. Takeuchi"}, {"authorId": "121709354",
      "name": "Y. Lo"}, {"authorId": "49715313", "name": "Kazutaka Sumita"}, {"authorId":
      "5638813", "name": "M. Senda"}, {"authorId": "49515406", "name": "Jumpei Terakawa"},
      {"authorId": "1485705386", "name": "A. Dimitoris"}, {"authorId": "2268976",
      "name": "J. Locasale"}, {"authorId": "152671464", "name": "Mika Sasaki"}, {"authorId":
      "6824343", "name": "H. Yoshino"}, {"authorId": "49891201", "name": "Y. Zhang"},
      {"authorId": "4049626", "name": "E. Kahoud"}, {"authorId": "91895026", "name":
      "T. Takano"}, {"authorId": "10207871", "name": "T. Yokota"}, {"authorId": "5542751",
      "name": "B. Emerling"}, {"authorId": "1394348007", "name": "J. Asara"}, {"authorId":
      "47983250", "name": "T. Ishida"}, {"authorId": "144714771", "name": "I. Shimada"},
      {"authorId": "145457715", "name": "T. Daikoku"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "50162552", "name": "T. Senda"}, {"authorId": "47742211",
      "name": "A. Sasaki"}]}, {"paperId": "2f24eea2a2d8a409f3bc14c93aa5f0346681ec0c",
      "externalIds": {"MAG": "2407334388", "DOI": "10.1158/1535-7163.TARG-15-C112",
      "CorpusId": 88593949}, "corpusId": 88593949, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/2f24eea2a2d8a409f3bc14c93aa5f0346681ec0c",
      "title": "Abstract C112: Cabozantinib eradicates advanced murine prostate cancer
      by activating anti-tumor innate immunity", "abstract": "Several kinase inhibitors
      targeting aberrant signaling pathways in tumor cells have been deployed in cancer
      therapy. However, their impact on the tumor immune microenvironment remains
      poorly understood. The tyrosine kinase inhibitor cabozantinib showed striking
      responses in early phase clinical trials, particularly in cancer patients with
      bone metastases. Here we show that cabozantinib rapidly eradicates invasive,
      poorly-differentiated PTEN/p53 deficient murine prostate cancer. This was associated
      with increased neutrophil chemotactic factor expression, including CXCL12 and
      HMGB1 production by tumor cells, and robust infiltration of neutrophils into
      the tumor. Critically, cabozantinib-induced tumor clearance in mice was abolished
      by antibody-mediated granulocyte depletion or HMGB1 neutralization or blockade
      of neutrophil chemotaxis with the CXCR4 inhibitor, plerixafor. Collectively,
      these results demonstrate that cabozantinib triggers neutrophil-mediated anti-tumor
      innate immune response that results in tumor clearance. (Manuscript submitted
      to Science) Citation Format: Akash Patnaik, Kenneth Swanson, Sabina Signoretti,
      Huihui Ye, Eva Csizmadia, Jesse Novak, Marina Gehring, Katja Helenius, Athalia
      Pyzer, Laleh Montaser, Lily Wang, Olivier Elemento, Elena Levantini, John Clohessy,
      John Asara, Kathleen Kelly, Pier Paolo Pandolfi, Jacalyn Rosenblatt, David Avigan,
      Steven Balk, Lewis Cantley. Cabozantinib eradicates advanced murine prostate
      cancer by activating anti-tumor innate immunity. [abstract]. In: Proceedings
      of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer
      Therapeutics; 2015 Nov 5-9; Boston, MA. Philadelphia (PA): AACR; Mol Cancer
      Ther 2015;14(12 Suppl 2):Abstract nr C112.", "venue": "", "year": 2015, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2015-12-01", "journal": {"volume": "14", "name": "Molecular
      Cancer Therapeutics"}, "citationStyles": {"bibtex": "@Article{Patnaik2015AbstractCC,\n
      author = {Akash Patnaik and K. Swanson and S. Signoretti and Huihui Ye and E.
      Csizmadia and Jesse S. Novak and M. Gehring and Katja Helenius and A. Pyzer
      and L. Montaser and Lily C. Wang and O. Elemento and E. Levantini and J. Clohessy
      and J. Asara and K. Kelly and P. Pandolfi and J. Rosenblatt and D. Avigan and
      S. Balk and L. Cantley},\n journal = {Molecular Cancer Therapeutics},\n title
      = {Abstract C112: Cabozantinib eradicates advanced murine prostate cancer by
      activating anti-tumor innate immunity},\n volume = {14},\n year = {2015}\n}\n"},
      "authors": [{"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId":
      "6784962", "name": "K. Swanson"}, {"authorId": "7505152", "name": "S. Signoretti"},
      {"authorId": "3073381", "name": "Huihui Ye"}, {"authorId": "4793517", "name":
      "E. Csizmadia"}, {"authorId": "50577147", "name": "Jesse S. Novak"}, {"authorId":
      "33820964", "name": "M. Gehring"}, {"authorId": "49804844", "name": "Katja Helenius"},
      {"authorId": "15061933", "name": "A. Pyzer"}, {"authorId": "49666064", "name":
      "L. Montaser"}, {"authorId": "2117931332", "name": "Lily C. Wang"}, {"authorId":
      "150097652", "name": "O. Elemento"}, {"authorId": "3768843", "name": "E. Levantini"},
      {"authorId": "4102988", "name": "J. Clohessy"}, {"authorId": "3028470", "name":
      "J. Asara"}, {"authorId": "145953924", "name": "K. Kelly"}, {"authorId": "4499580",
      "name": "P. Pandolfi"}, {"authorId": "31499217", "name": "J. Rosenblatt"}, {"authorId":
      "145881219", "name": "D. Avigan"}, {"authorId": "6189162", "name": "S. Balk"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "35c37182a716d5858bfcc80cbc29ee1d4e2c0181",
      "externalIds": {"MAG": "2977581094", "DOI": "10.2210/pdb3x03/pdb", "CorpusId":
      210511560}, "corpusId": 210511560, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/35c37182a716d5858bfcc80cbc29ee1d4e2c0181",
      "title": "Crystal structure of PIP4KIIBETA complex with AMPPNP", "abstract":
      null, "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-10-14",
      "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Takeuchi2015CrystalSO,\n
      author = {K. Takeuchi and Y. Lo and Kazutaka Sumita and M. Senda and Jumpei
      Terakawa and A. Dimitoris and J. Locasale and Mika Sasaki and H. Yoshino and
      Y. Zhang and E. Kahoud and T. Takano and T. Yokota and B. Emerling and J. Asara
      and T. Ishida and I. Shimada and T. Daikoku and L. Cantley and T. Senda and
      A. Sasaki},\n title = {Crystal structure of PIP4KIIBETA complex with AMPPNP},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "2775065", "name": "K. Takeuchi"},
      {"authorId": "121709354", "name": "Y. Lo"}, {"authorId": "49715313", "name":
      "Kazutaka Sumita"}, {"authorId": "5638813", "name": "M. Senda"}, {"authorId":
      "49515406", "name": "Jumpei Terakawa"}, {"authorId": "1485705386", "name": "A.
      Dimitoris"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "152671464",
      "name": "Mika Sasaki"}, {"authorId": "6824343", "name": "H. Yoshino"}, {"authorId":
      "49891201", "name": "Y. Zhang"}, {"authorId": "4049626", "name": "E. Kahoud"},
      {"authorId": "91895026", "name": "T. Takano"}, {"authorId": "10207871", "name":
      "T. Yokota"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "1394348007",
      "name": "J. Asara"}, {"authorId": "47983250", "name": "T. Ishida"}, {"authorId":
      "144714771", "name": "I. Shimada"}, {"authorId": "145457715", "name": "T. Daikoku"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "50162552", "name":
      "T. Senda"}, {"authorId": "47742211", "name": "A. Sasaki"}]}, {"paperId": "389bf670061ce9a4739177ef80c62e6ff12bccd9",
      "externalIds": {"MAG": "1661254177", "DOI": "10.1158/1538-7445.AM2015-CT324",
      "CorpusId": 70619331}, "corpusId": 70619331, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/389bf670061ce9a4739177ef80c62e6ff12bccd9",
      "title": "Abstract CT324: Phase I of oral BKM120 or BYL719 and olaparib for
      high-grade serous ovarian cancer or triple-negative breast cancer: Final results
      of the BKM120 plus olaparib cohort", "abstract": "Background: Similarities exist
      between high grade serous ovarian cancer (HGSC) and triple negative breast cancer
      (TNBC); both often have gBRCA mutations, are sensitive to platinum agents, and
      have high copy number alterations per the TCGA. Preclinical data for both BKM120/olaparib
      and BYL719/olaparib combinations showed synergistic efficacy. These data served
      as the rationale for this study in pts with either recurrent HGSC or TNBC. The
      phase I study of BKM120 and olaparib has been completed, and the phase I study
      of BYL719 and olaparib is currently in dose escalation (NCT01623349). Methods:
      This study has a 3 + 3 design, escalating dose levels (DL) if 0/3 or 1/6 pts
      have a dose limiting toxicity (DLT) during the first cycle (1st 28 days). Objectives
      were to determine the MTD and RP2D of daily oral olaparib (tablet formulation)
      and BKM120, assess toxicities, activity of this combination, and PK profiles
      of both drugs. Planned translational endpts include PI3kinase pathway effects,
      BRCA1 immunostaining/methylation, IL-8/circulating DNA levels, and somatic mutations
      in BRCA1/2 using FFPE tissue. Eligibility included: recurrent TNBC or HGSC or
      any histology of ovarian cancer (OvCa) or breast cancer (BrCa) with presence
      of a gBRCAmut, PS 0-1, and measurable/evaluable cancer. Prior PARP inhibitor
      use was allowed. Results: 46 pts to date have received study drugs as part of
      the ph1 dose escalation of BKM120/olaparib (12 pts w/BrCa and 34 pts w/OvCa).
      35 have known gBRCAm. Dosing started at DL1 (BKM120 60 mg and olaparib 100 mg
      BID); 2 DLTs were observed (1 gr 3 LFTs and 1 gr 3 hyperglycemia). A lower dose
      (-1) was pursued followed by re-escalation; MTD is BKM120 50 mg and olaparib
      300 mg BID. Toxicities that defined DLTs included CNS toxicities (gr 3 depression)
      and grade 3 LFTs, early in cycle 2 (DL6). At the MTD of BKM120/olaparib, 11
      pts with OvCa and 12 pts w BrCa were enrolled into a dose expansion cohort (DEC).
      Evidence of clinical benefit by RECIST 1.1 was observed on all DL9s and in the
      DEC\u2019s, in pts with a gBRCApos as well as gBRCAwt. AEs seen were compatible
      with AE profile of BKM120 and olaparib. Conclusions: Combined BKM120 and olaparib
      is feasible, and evidence of clinical benefit was seen at all DL9s both in gBRCApos
      and gBRCAwt pts. Toxicities that defined DLTs included CNS toxicities and LFT
      abnormalities. Clinical trial information: NCT01623349. Citation Format: Ursula
      A. Matulonis, Gerburg Wulf, William Barry, Michael Birrer, Shannon Westin, Tatum
      Spagnoletti, Katherine Bell-McGuinn, Elizabeth Obermayer, Christin Whalen, Carol
      Aghajanian, David Solit, Gordon Mills, Lewis Cantley, Eric Winer. Phase I of
      oral BKM120 or BYL719 and olaparib for high-grade serous ovarian cancer or triple-negative
      breast cancer: Final results of the BKM120 plus olaparib cohort. [abstract].
      In: Proceedings of the 106th Annual Meeting of the American Association for
      Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR;
      Cancer Res 2015;75(15 Suppl):Abstract nr CT324. doi:10.1158/1538-7445.AM2015-CT324",
      "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 21, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2015-08-01", "journal": {"volume": "75", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Matulonis2015AbstractCP,\n author = {U. Matulonis and G.
      Wulf and William H. Barry and M. Birrer and S. Westin and T. Spagnoletti and
      K. Bell-McGuinn and Elizabeth Obermayer and C. Whalen and C. Aghajanian and
      D. Solit and G. Mills and L. Cantley and E. Winer},\n journal = {Cancer Research},\n
      title = {Abstract CT324: Phase I of oral BKM120 or BYL719 and olaparib for high-grade
      serous ovarian cancer or triple-negative breast cancer: Final results of the
      BKM120 plus olaparib cohort},\n volume = {75},\n year = {2015}\n}\n"}, "authors":
      [{"authorId": "6927295", "name": "U. Matulonis"}, {"authorId": "31554501", "name":
      "G. Wulf"}, {"authorId": "2774170", "name": "William H. Barry"}, {"authorId":
      "2167106", "name": "M. Birrer"}, {"authorId": "2974900", "name": "S. Westin"},
      {"authorId": "15372310", "name": "T. Spagnoletti"}, {"authorId": "1397923721",
      "name": "K. Bell-McGuinn"}, {"authorId": "12793341", "name": "Elizabeth Obermayer"},
      {"authorId": "122974814", "name": "C. Whalen"}, {"authorId": "6128162", "name":
      "C. Aghajanian"}, {"authorId": "2344124", "name": "D. Solit"}, {"authorId":
      "2241330", "name": "G. Mills"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2369378", "name": "E. Winer"}]}, {"paperId": "42c3e1bc8eddec3d0c1e7d8794521bbbb6faf89e",
      "externalIds": {"MAG": "2144542772", "DOI": "10.1126/science.aaa5004", "CorpusId":
      206634814, "PubMed": "26541605"}, "corpusId": 206634814, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/42c3e1bc8eddec3d0c1e7d8794521bbbb6faf89e",
      "title": "Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer
      cells by targeting GAPDH", "abstract": "Getting all stressed out by vitamin
      C Few experimental cancer therapies have incited as much debate as vitamin C.
      Yet the mechanistic effect of vitamin C on cancer cells is still poorly understood.
      Yun et al. studied human colorectal cancer cells with KRAS or BRAF mutations
      and found that they \u201chandle\u201d vitamin C in a different way than other
      cells, ultimately to their detriment (see the Perspective by Reczek and Chandel).
      Because a certain receptor is up-regulated in the mutant cells, they take up
      the oxidized form of vitamin C (dehydroascorbate). This leads to oxidative stress,
      inactivation of a glycolytic enzyme required by the mutant cells for growth,
      and finally cell death. Whether the selective toxicity of vitamin C to these
      mutant cells can be exploited therapeutically remains unclear. Science, this
      issue p. 1391; see also p. 1317 Cancer cells with certain mutations take up
      the oxidized form of vitamin C, which fatally disrupts their metabolism. [Also
      see Perspective by Reczek and Chandel] More than half of human colorectal cancers
      (CRCs) carry either KRAS or BRAF mutations and are often refractory to approved
      targeted therapies. We found that cultured human CRC cells harboring KRAS or
      BRAF mutations are selectively killed when exposed to high levels of vitamin
      C. This effect is due to increased uptake of the oxidized form of vitamin C,
      dehydroascorbate (DHA), via the GLUT1 glucose transporter. Increased DHA uptake
      causes oxidative stress as intracellular DHA is reduced to vitamin C, depleting
      glutathione. Thus, reactive oxygen species accumulate and inactivate glyceraldehyde
      3-phosphate dehydrogenase (GAPDH). Inhibition of GAPDH in highly glycolytic
      KRAS or BRAF mutant cells leads to an energetic crisis and cell death not seen
      in KRAS and BRAF wild-type cells. High-dose vitamin C impairs tumor growth in
      Apc/KrasG12D mutant mice. These results provide a mechanistic rationale for
      exploring the therapeutic use of vitamin C for CRCs with KRAS or BRAF mutations.",
      "venue": "Science", "year": 2015, "referenceCount": 46, "citationCount": 683,
      "influentialCitationCount": 40, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://science.sciencemag.org/content/sci/350/6266/1391.full.pdf", "status":
      null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2015-12-11", "journal": {"volume": "350", "pages": "1391 - 1396", "name": "Science"},
      "citationStyles": {"bibtex": "@Article{Yun2015VitaminCS,\n author = {Jihye Yun
      and Edouard Mullarky and Changyuan Lu and Kaitlyn Bosch and A. Kavalier and
      Keith D. Rivera and J. Roper and I. I. C. Chio and Eugenia G. Giannopoulou and
      C. Rago and A. Muley and J. Asara and J. Paik and O. Elemento and Zhengming
      Chen and D. Pappin and L. Dow and N. Papadopoulos and S. Gross and L. Cantley},\n
      booktitle = {Science},\n journal = {Science},\n pages = {1391 - 1396},\n title
      = {Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells
      by targeting GAPDH},\n volume = {350},\n year = {2015}\n}\n"}, "authors": [{"authorId":
      "40164091", "name": "Jihye Yun"}, {"authorId": "6424987", "name": "Edouard Mullarky"},
      {"authorId": "7434113", "name": "Changyuan Lu"}, {"authorId": "7881810", "name":
      "Kaitlyn Bosch"}, {"authorId": "8391227", "name": "A. Kavalier"}, {"authorId":
      "6991355", "name": "Keith D. Rivera"}, {"authorId": "145864068", "name": "J.
      Roper"}, {"authorId": "4865028", "name": "I. I. C. Chio"}, {"authorId": "1786519",
      "name": "Eugenia G. Giannopoulou"}, {"authorId": "1907762", "name": "C. Rago"},
      {"authorId": "145927271", "name": "A. Muley"}, {"authorId": "3028470", "name":
      "J. Asara"}, {"authorId": "5056578", "name": "J. Paik"}, {"authorId": "150097652",
      "name": "O. Elemento"}, {"authorId": "49864822", "name": "Zhengming Chen"},
      {"authorId": "2249559", "name": "D. Pappin"}, {"authorId": "3918769", "name":
      "L. Dow"}, {"authorId": "144798543", "name": "N. Papadopoulos"}, {"authorId":
      "5769141", "name": "S. Gross"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "4456c9cd5f347c9a5e3a19518fb0ffe051bd8c8c", "externalIds": {"MAG":
      "2566492858", "DOI": "10.1158/1538-7445.AM2015-5497", "CorpusId": 78941665},
      "corpusId": 78941665, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/4456c9cd5f347c9a5e3a19518fb0ffe051bd8c8c",
      "title": "Abstract 5497: Cabozantinib eradicatesde novocastrate-resistant PTEN/p53
      deficient murine prostate cancer via activation of neutrophil-mediated anti-tumor
      innate immunity", "abstract": "The majority of kinase inhibitors in cancer clinical
      trials have been evaluated in the context of cell autonomous induction of apoptosis.
      However, apoptosis can result in protumorigenic immunosuppression, which limits
      the durability of an anti-tumor response. Recent clinical trial data shows striking
      clinical and radiographic responses with kinase inhibitor cabozantinib (XL-184)
      in metastatic solid tumors, particularly in the context of bone metastases.
      However, the mechanism responsible for this robust antitumor response remain
      unknown. Here we show that cabozantinib eradicates poorly differentiated invasive
      cancer that develop in the context of prostate-specific PTEN and p53 loss, respectively,
      within 48 hours of cabozantinib treatment. This rapid tumor clearance was temporally
      associated with infiltration of mature polymorphonuclear leukocytes into the
      tumor bed. These anti-tumor effects of cabozantinib appear to be MET-independent,
      since the MET inhibitor PF-04217903 did not phenocopy the effects of cabozantinib
      in the prostate-specific PTEN/p53 deficient mouse model in vivo. Unexpectedly,
      in vitro treatment of PTEN/p53 deficient cell lines derived from murine tumors
      showed insignificant apoptosis, but robust extracellular release of HMGB1, a
      neutrophil chemoattractant, and marker of immunogenic cell death. To elucidate
      the relevance of an immunogenic anti-tumor mechanism in vivo, we performed RNA-seq
      profiling and quantitative RT-PCR analysis, which showed an acute increase in
      anti-tumor inflammatory cytokine gene expression signature and neutrophil activation/chemotaxis
      markers following acute cabozantinib treatment. Critically, blockade of neutrophil
      chemotaxis/trafficking with dexamethasone or depletion with anti-Ly6G antibody,
      reversed the effects of cabozantinib towards eradication of advanced PTEN/p53
      deficient tumors. Finally, cytokine array profiling of supernatant from bone
      marrow metastases from castrate-resistant prostate cancer patients showed increased
      neutrophil markers and decreased IL-6 levels within the bone microenvironment
      following 6 weeks of cabozantinib treatment., thus polarizing the neutrophils
      into\u201d N1\u201d effector cells. Collectively, these results shed light on
      a novel anti-tumor immunogenic mechanism for cabozantinib within the tumor microenvironment
      of PTEN/p53 deficient tumors, which unleashes a profound innate anti-tumor immune
      response. These findings suggest the possibility of combination therapies of
      cabozantinib with T-cell checkpoint blockade or vaccine-based approaches, to
      augment immunologic responses in advanced cancers. Citation Format: Akash Patnaik,
      Kenneth Swanson, Katja Helenius, Thornley Thomas, Athalia Pyzer, Vilmosne Csizmadia,
      Sabina Signoretti, Todd Morgan, Yugang Wang, Olivier Elemento, Lily Wang, Elena
      Levantini, John Clohessy, John Asara, David Smith, Jacalyn Rosenblatt, David
      Avigan, Steven Balk, Lewis Cantley. Cabozantinib eradicates de novo castrate-resistant
      PTEN/p53 deficient murine prostate cancer via activation of neutrophil-mediated
      anti-tumor innate immunity. [abstract]. In: Proceedings of the 106th Annual
      Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia,
      PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5497.
      doi:10.1158/1538-7445.AM2015-5497", "venue": "", "year": 2015, "referenceCount":
      0, "citationCount": 2, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2015-08-01", "journal": {"volume": "75", "pages": "5497-5497",
      "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Patnaik2015Abstract5C,\n
      author = {Akash Patnaik and K. Swanson and Katja Helenius and T. Thomas and
      A. Pyzer and V. Csizmadia and S. Signoretti and T. Morgan and Yugang Wang and
      O. Elemento and Lily C. Wang and E. Levantini and J. Clohessy and J. Asara and
      David J. Smith and J. Rosenblatt and D. Avigan and S. Balk and L. Cantley},\n
      journal = {Cancer Research},\n pages = {5497-5497},\n title = {Abstract 5497:
      Cabozantinib eradicatesde novocastrate-resistant PTEN/p53 deficient murine prostate
      cancer via activation of neutrophil-mediated anti-tumor innate immunity},\n
      volume = {75},\n year = {2015}\n}\n"}, "authors": [{"authorId": "40501341",
      "name": "Akash Patnaik"}, {"authorId": "6784962", "name": "K. Swanson"}, {"authorId":
      "49804844", "name": "Katja Helenius"}, {"authorId": "82258692", "name": "T.
      Thomas"}, {"authorId": "15061933", "name": "A. Pyzer"}, {"authorId": "5460409",
      "name": "V. Csizmadia"}, {"authorId": "7505152", "name": "S. Signoretti"}, {"authorId":
      "74997355", "name": "T. Morgan"}, {"authorId": "49416325", "name": "Yugang Wang"},
      {"authorId": "150097652", "name": "O. Elemento"}, {"authorId": "2117931332",
      "name": "Lily C. Wang"}, {"authorId": "3768843", "name": "E. Levantini"}, {"authorId":
      "4102988", "name": "J. Clohessy"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "2153150772", "name": "David J. Smith"}, {"authorId": "31499217",
      "name": "J. Rosenblatt"}, {"authorId": "145881219", "name": "D. Avigan"}, {"authorId":
      "6189162", "name": "S. Balk"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "52dd7ea48b3427ae01ab83d0fa0ffad76c87c8ef", "externalIds": {"MAG":
      "2978599022", "DOI": "10.2210/pdb3x0b/pdb", "CorpusId": 210524079}, "corpusId":
      210524079, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/52dd7ea48b3427ae01ab83d0fa0ffad76c87c8ef",
      "title": "Crystal structure of PIP4KIIBETA I368A complex with AMP", "abstract":
      null, "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-10-14",
      "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Takeuchi2015CrystalSO,\n
      author = {K. Takeuchi and Y. Lo and Kazutaka Sumita and M. Senda and Jumpei
      Terakawa and A. Dimitoris and J. Locasale and Mika Sasaki and H. Yoshino and
      Y. Zhang and E. Kahoud and T. Takano and T. Yokota and B. Emerling and J. Asara
      and T. Ishida and I. Shimada and T. Daikoku and L. Cantley and T. Senda and
      A. Sasaki},\n title = {Crystal structure of PIP4KIIBETA I368A complex with AMP},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "2775065", "name": "K. Takeuchi"},
      {"authorId": "121709354", "name": "Y. Lo"}, {"authorId": "49715313", "name":
      "Kazutaka Sumita"}, {"authorId": "5638813", "name": "M. Senda"}, {"authorId":
      "49515406", "name": "Jumpei Terakawa"}, {"authorId": "1485705386", "name": "A.
      Dimitoris"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "152671464",
      "name": "Mika Sasaki"}, {"authorId": "6824343", "name": "H. Yoshino"}, {"authorId":
      "49891201", "name": "Y. Zhang"}, {"authorId": "4049626", "name": "E. Kahoud"},
      {"authorId": "91895026", "name": "T. Takano"}, {"authorId": "10207871", "name":
      "T. Yokota"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "1394348007",
      "name": "J. Asara"}, {"authorId": "47983250", "name": "T. Ishida"}, {"authorId":
      "144714771", "name": "I. Shimada"}, {"authorId": "145457715", "name": "T. Daikoku"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "50162552", "name":
      "T. Senda"}, {"authorId": "47742211", "name": "A. Sasaki"}]}, {"paperId": "57b3c45c5546a74e4591be8bc4df1079671b360f",
      "externalIds": {"MAG": "1804602290", "DOI": "10.1016/j.tcb.2015.06.002", "CorpusId":
      12240195, "PubMed": "26159692"}, "corpusId": 12240195, "publicationVenue": {"id":
      "81cf38b2-9175-4415-aea1-d852b2702de3", "name": "Trends in Cell Biology", "type":
      "journal", "alternate_names": ["Trends Cell Biology"], "issn": "0962-8924",
      "url": "https://www.cell.com/trends/cell-biology/home", "alternate_urls": ["http://www.sciencedirect.com/science/journal/09628924"]},
      "url": "https://www.semanticscholar.org/paper/57b3c45c5546a74e4591be8bc4df1079671b360f",
      "title": "Regulation of mTORC1 by PI3K signaling.", "abstract": null, "venue":
      "Trends in Cell Biology", "year": 2015, "referenceCount": 154, "citationCount":
      581, "influentialCitationCount": 28, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc4734635?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "2015-09-01",
      "journal": {"volume": "25 9", "pages": "\n          545-55\n        ", "name":
      "Trends in cell biology"}, "citationStyles": {"bibtex": "@Article{Dibble2015RegulationOM,\n
      author = {Christian C. Dibble and L. Cantley},\n booktitle = {Trends in Cell
      Biology},\n journal = {Trends in cell biology},\n pages = {\n          545-55\n        },\n
      title = {Regulation of mTORC1 by PI3K signaling.},\n volume = {25 9},\n year
      = {2015}\n}\n"}, "authors": [{"authorId": "7449887", "name": "Christian C. Dibble"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "6777312c8818dd4002437859cf38362a1b281a36",
      "externalIds": {"MAG": "2258601828", "DOI": "10.1158/1538-8514.PI3K14-IA21",
      "CorpusId": 87431236}, "corpusId": 87431236, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/6777312c8818dd4002437859cf38362a1b281a36",
      "title": "Abstract IA21: Combination treatments that include PI3K-inhibitors
      for the treatment of triple-negative breast cancer", "abstract": "Alterations
      in the PI3K pathway are highly prevalent in triple-negative breast and high
      grade ovarian cancer, including BRCA1- and BRCA2-related disease. On the cellular
      level, loss of BRCA1 increases genomic instability and reliance on single strand
      break repair, hence creating an opportunity to treat BRCA-related TNBC or OC
      with PARP-inhibitors. In addition, loss of BRCA1 and/or p53 lead to relaxation
      of negative feed-back loops in mitogenic signaling, resulting in highly proliferative
      malignancies. For these reasons PARP-inhibitor Olaparib and PI3K-inhibitor NVP-BKM120
      were tested in combination and found to be synergistic in mouse models of BRCA1-related
      BC. Surprisingly, PI3K-inhibition enhanced a DNA damage phenotype, caused by
      a profound decrease in DNA synthesis that could be observed after treatment
      with NVP-BKM120 in vivo and in vitro. The decrease in DNA synthesis was due
      to reduced Nucleoside synthesis resulting from a block in glycolysis that led
      to a drop in flux through the non-oxidative pentose phosphate pathway. In a
      preclinical mouse model (K14-Cre BRCA1f/fp53f/f), the combination of NVP-BKM120
      and Olaparib could induce complete remissions, while PI3K-inhibitor alone marginally
      slowed disease progression and PARP-inhibitor alone stabilized the disease.
      This concept was translated into a clinical trial: BKM120/Olaparib for Triple
      Negative Breast Cancer or High Grade Serous Ovarian Cancer (NCT01623349; PI:
      Ursula Matulonis). Dose escalation for this study and accrual to an extension
      cohort at the MTD (NVP-BKM120 50 mg once a day in combination with Olaparib
      300 mg twice a day) have been completed and a second dose escalation arm with
      NVP-BYL719 and Olaparib is ongoing. Citation Format: Gerburg M. Wulf, Ashish
      Juvekar, Costas M. Lyssiotis, Hai Hu, Kim Baek, Sina Yadegarynia, Ralph Scully,
      Eric Winer, John Asara, Lewis C. Cantley, Ursula Matulonis. Combination treatments
      that include PI3K-inhibitors for the treatment of triple-negative breast cancer.
      [abstract]. In: Proceedings of the AACR Special Conference: Targeting the PI3K-mTOR
      Network in Cancer; Sep 14-17, 2014; Philadelphia, PA. Philadelphia (PA): AACR;
      Mol Cancer Ther 2015;14(7 Suppl):Abstract nr IA21.", "venue": "", "year": 2015,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-07-01",
      "journal": {"volume": "14", "name": "Molecular Cancer Therapeutics"}, "citationStyles":
      {"bibtex": "@Article{Wulf2015AbstractIC,\n author = {G. Wulf and Ashish Juvekar
      and Costas Lyssiotis and Hai Hu and K. Baek and S. Yadegarynia and R. Scully
      and E. Winer and J. Asara and L. Cantley and U. Matulonis},\n journal = {Molecular
      Cancer Therapeutics},\n title = {Abstract IA21: Combination treatments that
      include PI3K-inhibitors for the treatment of triple-negative breast cancer},\n
      volume = {14},\n year = {2015}\n}\n"}, "authors": [{"authorId": "31554501",
      "name": "G. Wulf"}, {"authorId": "49149990", "name": "Ashish Juvekar"}, {"authorId":
      "88857753", "name": "Costas Lyssiotis"}, {"authorId": "113164867", "name": "Hai
      Hu"}, {"authorId": "2061486079", "name": "K. Baek"}, {"authorId": "3893473",
      "name": "S. Yadegarynia"}, {"authorId": "143905392", "name": "R. Scully"}, {"authorId":
      "2369378", "name": "E. Winer"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6927295", "name":
      "U. Matulonis"}]}, {"paperId": "6a6362bab18ab43adc01735f4e46288144accc7a", "externalIds":
      {"MAG": "2978623456", "DOI": "10.2210/pdb3x09/pdb", "CorpusId": 210527306},
      "corpusId": 210527306, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/6a6362bab18ab43adc01735f4e46288144accc7a",
      "title": "Crystal structure of PIP4KIIBETA F205L complex with AMP", "abstract":
      null, "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-10-14",
      "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Takeuchi2015CrystalSO,\n
      author = {K. Takeuchi and Y. Lo and Kazutaka Sumita and M. Senda and Jumpei
      Terakawa and A. Dimitoris and J. Locasale and Mika Sasaki and H. Yoshino and
      Y. Zhang and E. Kahoud and T. Takano and T. Yokota and B. Emerling and J. Asara
      and T. Ishida and I. Shimada and T. Daikoku and L. Cantley and T. Senda and
      A. Sasaki},\n title = {Crystal structure of PIP4KIIBETA F205L complex with AMP},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "2775065", "name": "K. Takeuchi"},
      {"authorId": "121709354", "name": "Y. Lo"}, {"authorId": "49715313", "name":
      "Kazutaka Sumita"}, {"authorId": "5638813", "name": "M. Senda"}, {"authorId":
      "49515406", "name": "Jumpei Terakawa"}, {"authorId": "1485705386", "name": "A.
      Dimitoris"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "152671464",
      "name": "Mika Sasaki"}, {"authorId": "6824343", "name": "H. Yoshino"}, {"authorId":
      "49891201", "name": "Y. Zhang"}, {"authorId": "4049626", "name": "E. Kahoud"},
      {"authorId": "91895026", "name": "T. Takano"}, {"authorId": "10207871", "name":
      "T. Yokota"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "1394348007",
      "name": "J. Asara"}, {"authorId": "47983250", "name": "T. Ishida"}, {"authorId":
      "144714771", "name": "I. Shimada"}, {"authorId": "145457715", "name": "T. Daikoku"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "50162552", "name":
      "T. Senda"}, {"authorId": "47742211", "name": "A. Sasaki"}]}, {"paperId": "7007ac13c0b4ed5f7440f665580185b6acfc51bb",
      "externalIds": {"MAG": "2291598966", "DOI": "10.1007/978-4-431-55651-0_1", "CorpusId":
      87929585}, "corpusId": 87929585, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/7007ac13c0b4ed5f7440f665580185b6acfc51bb",
      "title": "Diverting Glycolysis to Combat Oxidative Stress", "abstract": null,
      "venue": "", "year": 2015, "referenceCount": 133, "citationCount": 133, "influentialCitationCount":
      10, "isOpenAccess": true, "openAccessPdf": {"url": "https://link.springer.com/content/pdf/10.1007%2F978-4-431-55651-0_1.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": {"volume": "", "pages": "3-23", "name":
      ""}, "citationStyles": {"bibtex": "@Inproceedings{Mullarky2015DivertingGT,\n
      author = {Edouard Mullarky and L. Cantley},\n pages = {3-23},\n title = {Diverting
      Glycolysis to Combat Oxidative Stress},\n year = {2015}\n}\n"}, "authors": [{"authorId":
      "6424987", "name": "Edouard Mullarky"}, {"authorId": "1723755", "name": "L.
      Cantley"}]}, {"paperId": "7c1c5b912b1a4f7ae26daa414416dc85476dab16", "externalIds":
      {"MAG": "2493079089", "DOI": "10.1158/1538-7445.AM2015-2636", "CorpusId": 78503266},
      "corpusId": 78503266, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/7c1c5b912b1a4f7ae26daa414416dc85476dab16",
      "title": "Abstract 2636: Myc vs. Akt therapy in RapidCap, a GEM model for metastatic
      prostate cancer", "abstract": "Metastasis is a major driver of mortality and
      morbidity in prostate cancer, the most common cancer type in men and the second
      leading cause of cancer-related deaths in the western world. To recapitulate
      the process in genetically engineered mice, we have developed the RapidCaP system,
      which uses prostate-directed viral infection to trigger focal loss of Pten and
      Trp53. The system provides a powerful platform for identification and validation
      of candidate driver genes and for efficient testing of novel therapeutics. Using
      this approach, we have recently identified Myc as a critical, spontaneously
      activated driver in Pten-negative metastatic prostate cancer. In agreement,
      our previous trials indicated that the Myc-suppressing Brd4 inhibitor JQ1 is
      ineffective towards primary disease, but causes metastatic regression. Mechanistically,
      this specificity correlates with the switch from Akt-driven primary to Myc-driven
      metastatic disease. \nIntriguingly, however, advanced metastases in RapidCaP
      do not express the androgen receptor, in spite of being of epithelial origin
      as shown by the Nkx3.1 prostate marker. As a consequence, metastatic disease
      often shows little to no response to castration therapy and invariably results
      in lethal disease. Therefore, we will discuss how, when and why targeting of
      Myc using JQ1 and the PI 3-Kinase pathway using NVP-BKM120 are best used to
      treat naive or castration-resistant metastatic disease.", "venue": "", "year":
      2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2015-08-01", "journal": {"volume":
      "75", "pages": "2636-2636", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Stahlhut2015Abstract2M,\n author = {Carlos Stahlhut and Kaitlin Watrud
      and A. Ambrico and Hyejin Cho and Lily C. Wang and J. Qi and L. Cantley and
      J. Bradner and L. Trotman},\n journal = {Cancer Research},\n pages = {2636-2636},\n
      title = {Abstract 2636: Myc vs. Akt therapy in RapidCap, a GEM model for metastatic
      prostate cancer},\n volume = {75},\n year = {2015}\n}\n"}, "authors": [{"authorId":
      "47270173", "name": "Carlos Stahlhut"}, {"authorId": "10426666", "name": "Kaitlin
      Watrud"}, {"authorId": "15976560", "name": "A. Ambrico"}, {"authorId": "4485082",
      "name": "Hyejin Cho"}, {"authorId": "2117931332", "name": "Lily C. Wang"}, {"authorId":
      "145752082", "name": "J. Qi"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "3685746", "name": "J. Bradner"}, {"authorId": "4603490", "name":
      "L. Trotman"}]}, {"paperId": "88eaaaffb83dc4c7fba09fc75af7fe9be27383fa", "externalIds":
      {"MAG": "1469597457", "DOI": "10.1158/1538-7445.AM2015-CT232", "CorpusId": 70940740},
      "corpusId": 70940740, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/88eaaaffb83dc4c7fba09fc75af7fe9be27383fa",
      "title": "Abstract CT232: SU2C Phase Ib study of the PI3K-alpha inhibitor BYL719
      (alpelisib) with letrozole in ER+/HER2-metastatic breast cancer", "abstract":
      "Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia,
      PA\n\nBackground: Mutations in PIK3CA, the gene encoding the p110\u03b1 subunit
      of PI3K, have been associated with antiestrogen resistance in ER+ BC. In general,
      antiestrogen-resistant cancers retain ER and responsiveness to estradiol. This
      suggests that treatment of ER+ BC with PI3K inhibitors should also include antiestrogens.\n\nMethods:
      We conducted a phase Ib 3+3 dose escalation trial of letrozole (2.5 mg/day)
      with the PI3K\u03b1 inhibitor BYL719 in post-menopausal patients (pts) with
      ER+/HER2- metastatic breast cancer (MBC) refractory to previous endocrine therapy.
      BYL719 doses ranged from 300-400 mg/daily. Treatment continued until unacceptable
      toxicity or disease progression. Disease was assessed every 2 months. PIK3CA
      mutation status was determined by SNaPshot or targeted next generation sequencing
      (NGS) in all patients\u2019 tumors.\n\nResults: Twenty-six pts were accrued;
      all patients were refractory to endocrine therapies in the metastatic setting,
      18 had prior aromatase inhibitor (AI) therapy in their first or second-line
      MBC treatment. Median age was 53 years (31-72); 76% of pts had bone and 61%
      had visceral metastases; 50% of pts had a somatic PIK3CA hotspot mutation. Toxicities
      are summarized in Table 1. Rash was the dose limiting toxicity* at 350 mg/day.
      Of the 5 pts with a partial response, 3 (60%) had a PI3KCA mutation, 6/9 pts
      (67%) that were on treatment for \u22656 months; 3/6 pts (50%) that were on
      treatment for \u226512 months and 4/6 pts (67%) that are still on study (range
      11 - 19 months) had a PI3KCA mutation.\n\nDiscussion: The combination of letrozole/
      BYL719 is safe and tolerable in pts with AI-refractory ER+/HER2-negative MBC.
      The MTD and recommended dose for phase II trials of BYL719 in combination with
      letrozole was 300 mg/day. Rash and hyperglycemia were observed at this dose,
      suggesting drug-induced inhibition of PI3K. Pts with PIK3CA-mutant tumors appeared
      to derive better clinical benefit, although activity of the combination was
      also seen in patients with PIK3CA-wild type cancers. Additional NGS of >300
      cancer genes and their correlation with clinical response will be updated at
      the meeting. Clinical trial information: [NCT01791478][1].\n\n| Adverse Events
      (% by Grade) |\n|:---------------------------:| --------------- |\n| Toxicity
      | 300 mg (N = 20) | 300 mg (N = 20) | | 350 mg (N = 6) | 350 mg (N = 6) | |\n|
      | % by Grade | % by Grade | % Total | % by Grade | % by Grade | % Total |\n|
      | 2 | 3 | | 2 | 3 | |\n| Hyperglycemia | 18 | 12 | 56 | 20 | 20 | 70 |\n| Diarrhea
      | 12 | 12 | 81 | 10 | | 50 |\n| Fatigue | 25 | | 43 | 30 | | 80 |\n| Rash |
      18 | | 43 | 10 | 20* | 40 |\n| Nausea | | | 62 | 10 | 10 | 60 |\n| Vomiting
      | | | 25 | | | 30 |\n| Anorexia | 6 | | 25 | 10 | | 40 |\n| Dysgeusia | | |
      18 | | | 50 |\n\n\n\n\n\nCitation Format: Ingrid A. Mayer, Vandana Abramson,
      Justin Balko, Melinda Sanders, Dejan Juric, David Solit, Yisheng Li, Lewis Cantley,
      Eric Winer, Carlos Arteaga. SU2C Phase Ib study of the PI3K-alpha inhibitor
      BYL719 (alpelisib) with letrozole in ER+/HER2-metastatic breast cancer. [abstract].
      In: Proceedings of the 106th Annual Meeting of the American Association for
      Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR;
      Cancer Res 2015;75(15 Suppl):Abstract nr CT232. doi:10.1158/1538-7445.AM2015-CT232\n\n
      [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT01791478&atom=%2Fcanres%2F75%2F15_Supplement%2FCT232.atom",
      "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 3, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2015-08-01", "journal": {"volume": "75", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Mayer2015AbstractCS,\n author = {I. Mayer and V. Abramson
      and J. Balko and M. Sanders and D. Juric and D. Solit and Yisheng Li and L.
      Cantley and E. Winer and C. Arteaga},\n journal = {Cancer Research},\n title
      = {Abstract CT232: SU2C Phase Ib study of the PI3K-alpha inhibitor BYL719 (alpelisib)
      with letrozole in ER+/HER2-metastatic breast cancer},\n volume = {75},\n year
      = {2015}\n}\n"}, "authors": [{"authorId": "2346140", "name": "I. Mayer"}, {"authorId":
      "2186029", "name": "V. Abramson"}, {"authorId": "66935619", "name": "J. Balko"},
      {"authorId": "46945931", "name": "M. Sanders"}, {"authorId": "3342243", "name":
      "D. Juric"}, {"authorId": "2344124", "name": "D. Solit"}, {"authorId": "2111151410",
      "name": "Yisheng Li"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2369378", "name": "E. Winer"}, {"authorId": "2057460", "name": "C. Arteaga"}]},
      {"paperId": "8ab27172e2befd2e4e919ae437f12a6fee332917", "externalIds": {"MAG":
      "2172829973", "DOI": "10.1016/j.molcel.2015.10.018", "CorpusId": 35297754, "PubMed":
      "26590711"}, "corpusId": 35297754, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/8ab27172e2befd2e4e919ae437f12a6fee332917",
      "title": "Cancer''s Fuel Choice: New Flavors for a Picky Eater.", "abstract":
      null, "venue": "Molecules and Cells", "year": 2015, "referenceCount": 74, "citationCount":
      115, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1097276515008096/pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "2015-11-19",
      "journal": {"volume": "60 4", "pages": "\n          514-23\n        ", "name":
      "Molecular cell"}, "citationStyles": {"bibtex": "@Article{DeNicola2015CancersFC,\n
      author = {G. DeNicola and L. Cantley},\n booktitle = {Molecules and Cells},\n
      journal = {Molecular cell},\n pages = {\n          514-23\n        },\n title
      = {Cancer''s Fuel Choice: New Flavors for a Picky Eater.},\n volume = {60 4},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "4772111", "name": "G. DeNicola"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "8ca98de4025ffd44d835e52b0be3f097627d8d16",
      "externalIds": {"CorpusId": 244114332}, "corpusId": 244114332, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/8ca98de4025ffd44d835e52b0be3f097627d8d16",
      "title": "-Dependent Activation of the mTORC2 Kinase Complex", "abstract": null,
      "venue": "", "year": 2015, "referenceCount": 54, "citationCount": 3, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Liu2015DependentAO,\n
      author = {Pengda Liu and W. Gan and Y. R. Chin and K. Ogura and Jian-ping Guo
      and Jinfang Zhang and Bin Wang and J. Blenis and L. Cantley and A. Toker and
      Bing Su and Wenyi Wei},\n title = {-Dependent Activation of the mTORC2 Kinase
      Complex},\n year = {2015}\n}\n"}, "authors": [{"authorId": "3420906", "name":
      "Pengda Liu"}, {"authorId": "40383426", "name": "W. Gan"}, {"authorId": "50611901",
      "name": "Y. R. Chin"}, {"authorId": "9924372", "name": "K. Ogura"}, {"authorId":
      "51049890", "name": "Jian-ping Guo"}, {"authorId": "2016457046", "name": "Jinfang
      Zhang"}, {"authorId": "2152593405", "name": "Bin Wang"}, {"authorId": "4037343",
      "name": "J. Blenis"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "145751285", "name": "A. Toker"}, {"authorId": "2072391827", "name": "Bing Su"},
      {"authorId": "144084152", "name": "Wenyi Wei"}]}, {"paperId": "9ded8e1b19e7cb6c4a3a643e3bb8cb75d24f9cf0",
      "externalIds": {"MAG": "1570826410", "DOI": "10.1158/1538-7445.PANCA2014-PR13",
      "CorpusId": 217974924}, "corpusId": 217974924, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/9ded8e1b19e7cb6c4a3a643e3bb8cb75d24f9cf0",
      "title": "Abstract PR13: Pancreatic tumor stem cells resistant to inhibition
      of oncogenic signaling are dependent on mitochondrial function", "abstract":
      "Pancreatic ductal adenocarcinoma (PDAC) continues to have a poor prognosis
      despite extensive characterization of underlying genetic lesions. Although KRAS
      mutation is a signature driver event required for tumor development and maintenance,
      all the attempts made to target oncogene-driven signaling pathways have been
      met with minimal impact on survival and tumors eventually relapse, suggesting
      that ablation of oncogenic pathways fails to eradicate tumor cells. We used
      a genetically engineered mouse model of PDAC in which we could control the expression
      of mutant KRAS in a time- and tissue-specific manner to study the effects of
      ablating oncogenic signaling on PDAC cells. As previously described (Ying et
      al. 2012), this model showed rapid tumor growth when KRAS was expressed, followed
      by robust tumor regression upon oncogene ablation. However a small population
      of tumor cells survive genetic and pharmacological inactivation of KRAS. These
      surviving cells are tumor stem cells able to remain in a quiescent state for
      months before repopulating the original tumor upon reactivation of KRAS signaling.
      In depth transcriptomic and metabolomic analyses revealed surviving cells have
      different metabolic features with respect to the bulk of tumor cells, showing
      a prominent expression of genes governing mitochondrial function, \u03b2-oxidation
      and autophagy, as well as strong reliance on mitochondrial respiration, yet
      these cells also displayed impaired glycolytic capacity. In accord with their
      decreased dependence on glycolysis for cellular energetics and their complete
      absence of glycolytic reserve, these PDAC surviving tumor stem cells show high
      sensitivity to oxidative phosphorylation inhibitors, which prevented tumor recurrence.
      Our integrated analysis paves the way for new therapeutic strategies combining
      KRAS signaling and oxidative phosphorylation inhibition to completely eradicate
      pancreatic ductal adenocarcinoma. This abstract is also presented as Poster
      A87. Citation Format: Andrea Viale, Piergiorgio Pettazzoni, Costas Lyssiotis,
      Haoqiang Ying, Nora Sanchez, Matteo Marchesini, Alessandro Carugo, Tessa Green,
      Sahil Seth, Virginia Giuliani, Timothy Heffernan, Alec Kimmelman, Huamin Wang,
      Jason Fleming, Lewis Cantley, Ronald DePinho, Giulio Draetta. Pancreatic tumor
      stem cells resistant to inhibition of oncogenic signaling are dependent on mitochondrial
      function. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic
      Cancer: Innovations in Research and Treatment; May 18-21, 2014; New Orleans,
      LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13 Suppl):Abstract nr PR13.",
      "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2015-07-01", "journal": {"volume":
      "75", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Viale2015AbstractPP,\n
      author = {A. Viale and P. Pettazzoni and C. Lyssiotis and H. Ying and Nora S.
      Sanchez and M. Marchesini and A. Carugo and T. Green and S. Seth and Virginia
      Giuliani and T. Heffernan and Alec C. Kimmelman and Huamin Wang and J. Fleming
      and L. Cantley and R. DePinho and G. Draetta},\n journal = {Cancer Research},\n
      title = {Abstract PR13: Pancreatic tumor stem cells resistant to inhibition
      of oncogenic signaling are dependent on mitochondrial function},\n volume =
      {75},\n year = {2015}\n}\n"}, "authors": [{"authorId": "49837367", "name": "A.
      Viale"}, {"authorId": "47110079", "name": "P. Pettazzoni"}, {"authorId": "4901222",
      "name": "C. Lyssiotis"}, {"authorId": "33312849", "name": "H. Ying"}, {"authorId":
      "3461293", "name": "Nora S. Sanchez"}, {"authorId": "48455352", "name": "M.
      Marchesini"}, {"authorId": "8457336", "name": "A. Carugo"}, {"authorId": "39319755",
      "name": "T. Green"}, {"authorId": "4288735", "name": "S. Seth"}, {"authorId":
      "8048176", "name": "Virginia Giuliani"}, {"authorId": "3095168", "name": "T.
      Heffernan"}, {"authorId": "4668673", "name": "Alec C. Kimmelman"}, {"authorId":
      "2109007858", "name": "Huamin Wang"}, {"authorId": "144926646", "name": "J.
      Fleming"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5593407",
      "name": "R. DePinho"}, {"authorId": "5336286", "name": "G. Draetta"}]}, {"paperId":
      "9f73e4f72ac1fe913ba591cba8ded2b5285d9ab0", "externalIds": {"MAG": "2565332264",
      "DOI": "10.1158/1538-7445.AM2015-4714", "CorpusId": 79133222}, "corpusId": 79133222,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/9f73e4f72ac1fe913ba591cba8ded2b5285d9ab0",
      "title": "Abstract 4714: Targeting p53 mutant cancers through inhibition of
      the phosphatidylinositol-5-phosphate 4-kinases", "abstract": "The bulk of cellular
      phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2) is generated by the canonical
      pathway in which a 5-kinase converts phosphatidylinositol-4-phosphate (PI-4-P)
      to PI-4,5-P2. However, several years ago we discovered that PI-4, 5-P2 can also
      be generated at intracellular sites by a family of kinases that phosphorylate
      the 4 position of phosphatidylinositol-5-phosphate (PI-5-P), a lipid that was
      not previously known to exist in nature. These enzymes are called the type 2
      phosphatidylinositol-5-phosphate 4-kinases (PI5P4Ks). To date, we have shown
      that a subset of breast cancers express high levels of PI5P4K\u03b1 and/or \u03b2,
      and have provided evidence that these kinases are essential for growth in the
      absence of p53 (Emerling et al., 2013). Furthermore, we showed that PI5P4K\u03b1
      and \u03b2 play critical roles in mediating changes in metabolism in response
      to cellular stress, in particular, stress that occurs in the absence of p53.
      Here, we disclose the discovery of potent and selective inhibitors of PI5P4K
      (Kis in the range of 10 to 200 nM). These novel PI5P4K inhibitors have provided
      us with powerful tools to further investigate the role of the PI5P4K enzymes
      in cancer metabolism. Through pharmacological inhibition of PI5P4K, we now have
      support that PI5P4K provides an alternative pathway to p53 in regard to mediating
      responses to metabolic and oxidative stress, thereby suggesting that the PI5P4K
      enzymes are essential for survival mechanisms when p53 function is lost. Above
      all, these inhibitors may be effective therapies not only for breast cancers
      with genetic aberrations in TP53, but in all cancer types with loss of p53 function.
      Supported by DOD Breast Research Program Breakthrough Award to B.M.E. References
      Emerling BM, Hurov JB, Poulogiannis G, Tsukazawa KS, Wulf G, Bell EL, Shim H,
      Choo-Wing R, Bellinger G, Lamia KA, Rameh LE, Sasaki A, Asara JM, Yuan X, Bullock
      A, Brown V, Signoretti S, and Cantley LC. (2013) Depletion of a Putatively Druggable
      Class of Phosphatidylinositol Kinases Inhibits Growth of p53 Null Tumors. Cell.
      Nov 7; 155 (4): 844-57. Citation Format: Brooke M. Emerling, Zhiwei Yang, Ryan
      Loughran, T.Jonathan Yang, Jared Johnson, Rajan Pragani, Mindy Davis, Min Shen,
      Matthew Boxer, Anton Simeonov, Lewis C. Cantley. Targeting p53 mutant cancers
      through inhibition of the phosphatidylinositol-5-phosphate 4-kinases. [abstract].
      In: Proceedings of the 106th Annual Meeting of the American Association for
      Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR;
      Cancer Res 2015;75(15 Suppl):Abstract nr 4714. doi:10.1158/1538-7445.AM2015-4714",
      "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2015-08-01", "journal": {"volume": "75", "pages": "4714-4714", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Emerling2015Abstract4T,\n
      author = {B. Emerling and Zhiwei Yang and Ryan Loughran and T. Yang and Jared
      L. Johnson and R. Pragani and Mindy I. Davis and M. Shen and M. Boxer and A.
      Simeonov and L. Cantley},\n journal = {Cancer Research},\n pages = {4714-4714},\n
      title = {Abstract 4714: Targeting p53 mutant cancers through inhibition of the
      phosphatidylinositol-5-phosphate 4-kinases},\n volume = {75},\n year = {2015}\n}\n"},
      "authors": [{"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "50109290",
      "name": "Zhiwei Yang"}, {"authorId": "31875049", "name": "Ryan Loughran"}, {"authorId":
      "2219789781", "name": "T. Yang"}, {"authorId": "145916288", "name": "Jared L.
      Johnson"}, {"authorId": "5123505", "name": "R. Pragani"}, {"authorId": "29195749",
      "name": "Mindy I. Davis"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "3275486", "name": "M. Boxer"}, {"authorId": "145183304", "name": "A. Simeonov"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "a0aab62dfd82bd8add29bd9f42341c4dcdd0f92e",
      "externalIds": {"MAG": "1930038475", "DOI": "10.1158/2159-8290.CD-15-0460",
      "CorpusId": 9682393, "PubMed": "26293922"}, "corpusId": 9682393, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/a0aab62dfd82bd8add29bd9f42341c4dcdd0f92e",
      "title": "PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.",
      "abstract": "UNLABELLED\nmTOR serves as a central regulator of cell growth and
      metabolism by forming two distinct complexes, mTORC1 and mTORC2. Although mechanisms
      of mTORC1 activation by growth factors and amino acids have been extensively
      studied, the upstream regulatory mechanisms leading to mTORC2 activation remain
      largely elusive. Here, we report that the pleckstrin homology (PH) domain of
      SIN1, an essential and unique component of mTORC2, interacts with the mTOR kinase
      domain to suppress mTOR activity. More importantly, PtdIns(3,4,5)P3, but not
      other PtdInsPn species, interacts with SIN1-PH to release its inhibition on
      the mTOR kinase domain, thereby triggering mTORC2 activation. Mutating critical
      SIN1 residues that mediate PtdIns(3,4,5)P3 interaction inactivates mTORC2, whereas
      mTORC2 activity is pathologically increased by patient-derived mutations in
      the SIN1-PH domain, promoting cell growth and tumor formation. Together, our
      study unravels a PI3K-dependent mechanism for mTORC2 activation, allowing mTORC2
      to activate AKT in a manner that is regulated temporally and spatially by PtdIns(3,4,5)P3.\n\n\nSIGNIFICANCE\nThe
      SIN1-PH domain interacts with the mTOR kinase domain to suppress mTOR activity,
      and PtdIns(3,4,5)P3 binds the SIN1-PH domain to release its inhibition on the
      mTOR kinase domain, leading to mTORC2 activation. Cancer patient-derived SIN1-PH
      domain mutations gain oncogenicity by loss of suppressing mTOR activity as a
      means to facilitate tumorigenesis.", "venue": "Cancer Discovery", "year": 2015,
      "referenceCount": 55, "citationCount": 301, "influentialCitationCount": 12,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerdiscovery.aacrjournals.org/content/candisc/5/11/1194.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2015-11-01", "journal": {"volume": "5 11", "pages": "\n          1194-209\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Liu2015PtdIns345P3DependentAO,\n
      author = {Pengda Liu and W. Gan and Y. R. Chin and K. Ogura and Jian-ping Guo
      and Jinfang Zhang and Bin Wang and J. Blenis and L. Cantley and A. Toker and
      B. Su and Bing Su and Wenyi Wei},\n booktitle = {Cancer Discovery},\n journal
      = {Cancer discovery},\n pages = {\n          1194-209\n        },\n title =
      {PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.},\n volume
      = {5 11},\n year = {2015}\n}\n"}, "authors": [{"authorId": "3420906", "name":
      "Pengda Liu"}, {"authorId": "40383426", "name": "W. Gan"}, {"authorId": "50611901",
      "name": "Y. R. Chin"}, {"authorId": "9924372", "name": "K. Ogura"}, {"authorId":
      "51049890", "name": "Jian-ping Guo"}, {"authorId": "2016457046", "name": "Jinfang
      Zhang"}, {"authorId": "2152593405", "name": "Bin Wang"}, {"authorId": "4037343",
      "name": "J. Blenis"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "145751285", "name": "A. Toker"}, {"authorId": "48274675", "name": "B. Su"},
      {"authorId": "2054512630", "name": "Bing Su"}, {"authorId": "144084152", "name":
      "Wenyi Wei"}]}, {"paperId": "a4c080fce099ef7b79d45f81d3f94c6937a5acd1", "externalIds":
      {"MAG": "1524553021", "DOI": "10.1158/1538-7445.MEL2014-B09", "CorpusId": 71090082},
      "corpusId": 71090082, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/a4c080fce099ef7b79d45f81d3f94c6937a5acd1",
      "title": "Abstract B09: Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association
      and cell proliferation", "abstract": "BRAF is an oncogenic protein kinase that
      drives cell growth and proliferation through the MEK-ERK signaling pathway.
      BRAF inhibitors have demonstrated antitumor efficacy in melanoma therapy but
      have also been found to be associated with the development of cutaneous squamous
      cell carcinomas (cSCCs) in certain patients. Here, we report that BRAF is phosphorylated
      at Ser729 by AMP-activated protein kinase (AMPK), a critical energy sensor.
      This phosphorylation promotes the association of BRAF with 14-3-3 proteins and
      disrupts its interaction with the KSR1 scaffolding protein, leading to attenuation
      of the MEK-ERK signaling. We also show that phosphorylation of BRAF by AMPK
      impairs keratinocyte cell proliferation and cell-cycle progression. Furthermore,
      AMPK activation attenuates BRAF inhibitor-induced ERK hyperactivation in keratinocytes
      and epidermal hyperplasia in mouse skin. Our findings reveal a mechanism for
      regulating BRAF signaling in response to energy stress and suggest a strategy
      for preventing the development of cSCCs associated with BRAF-targeted therapy.
      Citation Format: Che-Hung Shen, Ping Yuan, Rolando Perez-Lorenzo, Yaqing Zhang,
      Sze Xian Lee, Yang Ou, Li Cai, John M. Asara, Lewis C. Cantley, Bin Zheng. Phosphorylation
      of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation. [abstract].
      In: Proceedings of the AACR Special Conference on Advances in Melanoma: From
      Biology to Therapy; Sep 20-23, 2014; Philadelphia, PA. Philadelphia (PA): AACR;
      Cancer Res 2015;75(14 Suppl):Abstract nr B09.", "venue": "", "year": 2015, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2015-07-15", "journal": {"volume": "75", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Shen2015AbstractBP,\n author
      = {Che-Hung Shen and P. Yuan and R. P\u00e9rez-Lorenzo and Yaqing Zhang and
      S. Lee and Yang Ou and Li Cai and J. Asara and L. Cantley and B. Zheng},\n journal
      = {Cancer Research},\n title = {Abstract B09: Phosphorylation of BRAF by AMPK
      impairs BRAF-KSR1 association and cell proliferation},\n volume = {75},\n year
      = {2015}\n}\n"}, "authors": [{"authorId": "83946576", "name": "Che-Hung Shen"},
      {"authorId": "22261570", "name": "P. Yuan"}, {"authorId": "1398525526", "name":
      "R. P\u00e9rez-Lorenzo"}, {"authorId": "1591129979", "name": "Yaqing Zhang"},
      {"authorId": "2108098779", "name": "S. Lee"}, {"authorId": "2057924812", "name":
      "Yang Ou"}, {"authorId": "2112831690", "name": "Li Cai"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "143918840", "name": "B. Zheng"}]}, {"paperId": "a88118e09f8d4a25ef2fce5ec88bce255a9a6cff",
      "externalIds": {"MAG": "2305691503", "DOI": "10.1158/1538-8514.PI3K14-IA01",
      "CorpusId": 86884832}, "corpusId": 86884832, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/a88118e09f8d4a25ef2fce5ec88bce255a9a6cff",
      "title": "Abstract IA01: Targeting phosphoinositide 3-kinase for cancer therapy",
      "abstract": "Phosphoinositide 3-kinase (PI3K) is a central enzyme in a signaling
      pathway that mediates cellular responses to insulin and other growth factors.
      The signaling pathway involving insulin, PI3K and the downstream components
      of AKT and mTOR is highly conserved from worms and flies to humans and genetic
      analysis of the pathway has revealed a conserved role in regulating glucose
      metabolism and cell growth. Germline mutational events that lead to hyperactivation
      of the PI3K pathway result in hamartoma syndromes and cancers. Sporadic activating
      mutations in PIK3CA, encoding the p110alpha catalytic subunit of PI3K or inactivating
      mutations in PTEN, a phosphoinositide 3-phosphatases that reverses the effects
      of PI3K, are among the most common events in solid tumors. More than thirty
      drugs that target PI3K and other components of this pathway are in clinical
      trials for a variety of cancers. It is likely that PI3K pathway inhibitors will
      need to be combined with other drugs to be broadly effective. We have employed
      genetically engineered mouse models that develop cancers due to mutations in
      genes in the PI3K pathway and are using these models to explore the efficacy
      of PI3K pathway inhibitors as single agents or in combination with other drugs.
      The role of PI3K inhibitors for treating cancers in these mouse models and in
      human trials will be discussed. Citation Format: Lewis C. Cantley. Targeting
      phosphoinositide 3-kinase for cancer therapy. [abstract]. In: Proceedings of
      the AACR Special Conference: Targeting the PI3K-mTOR Network in Cancer; Sep
      14-17, 2014; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Ther 2015;14(7
      Suppl):Abstract nr IA01.", "venue": "", "year": 2015, "referenceCount": 0, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2015-07-01", "journal": {"volume": "14", "name": "Molecular
      Cancer Therapeutics"}, "citationStyles": {"bibtex": "@Article{Cantley2015AbstractIT,\n
      author = {L. Cantley},\n journal = {Molecular Cancer Therapeutics},\n title
      = {Abstract IA01: Targeting phosphoinositide 3-kinase for cancer therapy},\n
      volume = {14},\n year = {2015}\n}\n"}, "authors": [{"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "a89ec81ac3297925fbb420c55d2a86c6c9a0dc00", "externalIds":
      {"MAG": "2563659124", "DOI": "10.1158/1538-7445.AM2015-1081", "CorpusId": 78196675},
      "corpusId": 78196675, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/a89ec81ac3297925fbb420c55d2a86c6c9a0dc00",
      "title": "Abstract 1081: Non-random genomic alterations in BRCA1-related breast
      cancer", "abstract": "BRCA1-related breast cancer is characterized by a high
      degree of genomic instability. However, to which extent this instability is
      a random result of the homologous recombination defect or the selection of the
      tumor phenotype, is unknown. The objective of this study is to investigate the
      genomic aberrations (copy number variation and somatic mutations) of BRCA1-related
      breast cancer, using a mouse model, to identify likely nonrandom aberrations
      and their biological functions. We examined genomic aberrations of three independent
      BRCA1-related tumors from a genetically engineered mouse model, K14-Cre BRCA1f/fp53f/f.
      Tumors had been propagated in Cre-negative littermates and liver tissue of the
      recipient mice from the controls were used as a germline control. Fresh frozen
      tumors and normal samples were used for exome sequencing and RNA-seq using Illumina
      technology. A commonly used workflow, GATK, was used for the sequence alignment,
      preprocessing and calling somatic mutations. VarScan2 was used for calling somatic
      copy number variations. We investigate the prevalence of common aberrations
      among these mouse in human BRCA1-related breast and ovarian cancer from The
      Cancer Genome Atlas (TCGA). We used the BioMart software tool to map mouse genes
      to human genes for the cross species analysis. After identifying common aberrant
      regions and genes across human and mouse we applied enrichment analysis using
      GOSeq, MetaCore and MSigDB software tools to identify the biological functions
      of the genetic alterations observed in BRCA1-related breast cancer across species.
      The analysis of exome sequencing data from BRCA1-related mouse tumors revealed
      surprisingly similar patterns of CNVs and rates of non-synonymous mutations.
      Correspondingly, distinct pattern were identified with regard to CNVs in human
      BRCA1-related breast and ovarian cancer. The cross species analysis of BRCA1-related
      TCGA ovarian and breast cancer tumors and BRCA1-related mouse tumors identified
      commonly aberrant regions that mapped to the long arms of human chromosomes
      1, 8, 17 and 20 in both breast and ovarian cancer. Functionally, the blocks
      of genes that were commonly amplified in BRCA1-related breast or ovarian cancer
      included genes that transduce mitogenic signaling and ligand independent activation
      of estrogen receptors ESR1 and ESR2 as well as genes of the renin-angiotensin
      system. To conclude, copy number aberrations in BRCA1-related breast or ovarian
      cancers are not random and enrich for genes that enforce mitogenic signaling.
      The data support the notion that in addition to loss of cell cycle checkpoint
      control, tumor development requires activation of a mitogenic signaling program
      that could potentially be targeted for treatment. Citation Format: Sheida Nabavi,
      Kristina M. Holton, Ashish Juvekar, Nicholas Wang, Olivier Elemento, Lewis C.
      Cantley, Gerburg M. Wulf. Non-random genomic alterations in BRCA1-related breast
      cancer. [abstract]. In: Proceedings of the 106th Annual Meeting of the American
      Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia
      (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1081. doi:10.1158/1538-7445.AM2015-1081",
      "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2015-08-01", "journal": {"volume":
      "75", "pages": "1081-1081", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Nabavi2015Abstract1N,\n author = {S. Nabavi and K. Holton and Ashish
      Juvekar and Nicholas J. Wang and O. Elemento and L. Cantley and G. Wulf},\n
      journal = {Cancer Research},\n pages = {1081-1081},\n title = {Abstract 1081:
      Non-random genomic alterations in BRCA1-related breast cancer},\n volume = {75},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "145834073", "name": "S. Nabavi"},
      {"authorId": "6803235", "name": "K. Holton"}, {"authorId": "49149990", "name":
      "Ashish Juvekar"}, {"authorId": "1722194", "name": "Nicholas J. Wang"}, {"authorId":
      "150097652", "name": "O. Elemento"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "31554501", "name": "G. Wulf"}]}, {"paperId": "c5962ef8f08c5b974306298f6f1ca0be2e095ff3",
      "externalIds": {"MAG": "2492086421", "DOI": "10.1002/9781118468678.CH32", "CorpusId":
      89396393}, "corpusId": 89396393, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/c5962ef8f08c5b974306298f6f1ca0be2e095ff3",
      "title": "The Phosphatidylinositol 3\u2010Kinase Pathway in Human Malignancies",
      "abstract": null, "venue": "", "year": 2015, "referenceCount": 75, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2015-10-30", "journal": {"volume": "", "pages": "315-324",
      "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Klempner2015TheP3,\n
      author = {S. Klempner and Thanh-Trang T. Vo and A. Myers and L. Cantley},\n
      pages = {315-324},\n title = {The Phosphatidylinositol 3\u2010Kinase Pathway
      in Human Malignancies},\n year = {2015}\n}\n"}, "authors": [{"authorId": "4677205",
      "name": "S. Klempner"}, {"authorId": "122695603", "name": "Thanh-Trang T. Vo"},
      {"authorId": "6324437", "name": "A. Myers"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "ceeee343b160fbdb557978c6ee3e460ebc1421fe", "externalIds":
      {"DOI": "10.1186/s40170-015-0137-1", "CorpusId": 256374683}, "corpusId": 256374683,
      "publicationVenue": {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f", "name": "Cancer
      & Metabolism", "type": "journal", "alternate_names": ["Cancer Metab", "Cancer
      and Metabolism", "Cancer  Metab"], "issn": "2049-3002", "url": "http://www.cancerandmetabolism.com/"},
      "url": "https://www.semanticscholar.org/paper/ceeee343b160fbdb557978c6ee3e460ebc1421fe",
      "title": "Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven
      metabolic catastrophe induced by \u00df-lapachone", "abstract": null, "venue":
      "Cancer & Metabolism", "year": 2015, "referenceCount": 0, "citationCount": 16,
      "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/s40170-015-0137-1",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2015-10-12", "journal": {"volume":
      "3", "name": "Cancer & Metabolism"}, "citationStyles": {"bibtex": "@Article{Chakrabarti2015TargetingGM,\n
      author = {G. Chakrabarti and Zachary R. Moore and Xiuquan Luo and Mariya Ilcheva
      and Aktar Ali and Mahesh S. Padanad and Yunyun Zhou and Yang Xie and S. Burma
      and P. Scaglioni and L. Cantley and R. Deberardinis and Alec C. Kimmelman and
      C. Lyssiotis and D. Boothman},\n booktitle = {Cancer & Metabolism},\n journal
      = {Cancer & Metabolism},\n title = {Targeting glutamine metabolism sensitizes
      pancreatic cancer to PARP-driven metabolic catastrophe induced by \u00df-lapachone},\n
      volume = {3},\n year = {2015}\n}\n"}, "authors": [{"authorId": "35784792", "name":
      "G. Chakrabarti"}, {"authorId": "145442892", "name": "Zachary R. Moore"}, {"authorId":
      "5617652", "name": "Xiuquan Luo"}, {"authorId": "4735589", "name": "Mariya Ilcheva"},
      {"authorId": "13336581", "name": "Aktar Ali"}, {"authorId": "47393233", "name":
      "Mahesh S. Padanad"}, {"authorId": "2118116344", "name": "Yunyun Zhou"}, {"authorId":
      "2116346113", "name": "Yang Xie"}, {"authorId": "4579757", "name": "S. Burma"},
      {"authorId": "3619786", "name": "P. Scaglioni"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "5834413", "name": "R. Deberardinis"}, {"authorId":
      "4668673", "name": "Alec C. Kimmelman"}, {"authorId": "4901222", "name": "C.
      Lyssiotis"}, {"authorId": "6434802", "name": "D. Boothman"}]}, {"paperId": "db252b726957e883502f52fb5b2ada5b743e09d8",
      "externalIds": {"MAG": "2262820072", "DOI": "10.1158/1538-8514.PI3K14-A33",
      "CorpusId": 87639270}, "corpusId": 87639270, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/db252b726957e883502f52fb5b2ada5b743e09d8",
      "title": "Abstract A33: Utilizing insulin the treatment of prostate cancer with
      BKM120 abrogates the therapeutic effect of PI3K pathway inhibition", "abstract":
      "Genetic aberrations in PTEN, the negative regulator of phosphoinositide 3-kinase
      (PI3K) signaling, are common in prostate cancers (PCA) with high Gleason Scores
      and correlate with adverse outcome. Currently, PI3K inhibitors, as single agents
      and in combination, have entered Phase I and II clinical trials for metastatic
      castrate resistant PCA. Alpha-specific and pan-PI3K inhibitors cause hyperglycemia
      as an on-target side effect by blocking insulin-dependent PI3K signaling in
      the liver and muscle and patients develop hyperinsulinemia in response to hyperglycemia,
      and insulin treatment is often needed to manage drug-induced hyperglycemia.
      Using human and murine prostate cancer cell lines, we examined the effect of
      adding insulin to BKM120 treatment on PI3K pathway activation. Using human prostate
      cancer cell lines LNCaP and PC3 which both express insulin receptor (IR) and
      IGF-1 receptor (IGF-1R), we found downregulation of the PI3K pathway by BKM120
      treatment and upregulation of the PI3K pathway by insulin treatment, as assessed
      by AKT phosphorylation. In both cell lines, the PI3K pathway is reactivated
      when insulin is added to BKM120 treatment. Using cells derived from PTEN-/-P53-/-
      murine PCA which express low levels of IR and IGF-1R, we found minimal activation
      of the PI3K pathway with insulin, either alone or in combination with BKM120.
      Conversely, using cells derived from Myc-overexpressing mice which express high
      levels of IR and IGF-1R, we found robust activation of the PI3K pathway with
      insulin treatment. More importantly, while BKM120 abolished PI3K activity in
      the Myc-overexpressing cells, the addition of insulin to BKM120 resulted in
      the reactivation of the PI3K pathway to the level of PI3K pathway activity without
      BKM120 treatment. Together these findings suggest that the use of insulin in
      combination with BKM120 abrogates the therapeutic effect of PI3K inhibition.
      In addition, they indicate that PCAs that have high levels of IR and/or IGF-1
      expression are particularly sensitive to PI3K inhibitors as well as insulin
      reactivation of the PI3K pathway. Citation Format: Lily C. Wang, Sunnie S. Kim,
      David M. Nanus, Lewis C. Cantley. Utilizing insulin the treatment of prostate
      cancer with BKM120 abrogates the therapeutic effect of PI3K pathway inhibition.
      [abstract]. In: Proceedings of the AACR Special Conference: Targeting the PI3K-mTOR
      Network in Cancer; Sep 14-17, 2014; Philadelphia, PA. Philadelphia (PA): AACR;
      Mol Cancer Ther 2015;14(7 Suppl):Abstract nr A33.", "venue": "", "year": 2015,
      "referenceCount": 0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-07-01",
      "journal": {"volume": "14", "name": "Molecular Cancer Therapeutics"}, "citationStyles":
      {"bibtex": "@Article{Wang2015AbstractAU,\n author = {Lily C. Wang and Sunnie
      S Kim and D. Nanus and L. Cantley},\n journal = {Molecular Cancer Therapeutics},\n
      title = {Abstract A33: Utilizing insulin the treatment of prostate cancer with
      BKM120 abrogates the therapeutic effect of PI3K pathway inhibition},\n volume
      = {14},\n year = {2015}\n}\n"}, "authors": [{"authorId": "2117931332", "name":
      "Lily C. Wang"}, {"authorId": "2109648661", "name": "Sunnie S Kim"}, {"authorId":
      "5430838", "name": "D. Nanus"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "dc88d4dde91802c193fb9f9b39ce757150348bfc", "externalIds": {"MAG":
      "1634157550", "DOI": "10.1016/j.cellsig.2015.09.004", "CorpusId": 31757640,
      "PubMed": "26363466"}, "corpusId": 31757640, "publicationVenue": {"id": "9b987329-d573-412b-a782-84a181c184b9",
      "name": "Cellular Signalling", "type": "journal", "alternate_names": ["Cell
      Signal"], "issn": "0898-6568", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/525462/description#description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/08986568"]},
      "url": "https://www.semanticscholar.org/paper/dc88d4dde91802c193fb9f9b39ce757150348bfc",
      "title": "Suppression of Nkx3.2 by phosphatidylinositol-3-kinase signaling regulates
      cartilage development by modulating chondrocyte hypertrophy.", "abstract": null,
      "venue": "Cellular Signalling", "year": 2015, "referenceCount": 72, "citationCount":
      9, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc4847727?pdf=render", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2015-12-01", "journal":
      {"volume": "27 12", "pages": "\n          2389-400\n        ", "name": "Cellular
      signalling"}, "citationStyles": {"bibtex": "@Article{Kim2015SuppressionON,\n
      author = {Jeong-Ah Kim and Suhjean Im and L. Cantley and Dae-Won Kim},\n booktitle
      = {Cellular Signalling},\n journal = {Cellular signalling},\n pages = {\n          2389-400\n        },\n
      title = {Suppression of Nkx3.2 by phosphatidylinositol-3-kinase signaling regulates
      cartilage development by modulating chondrocyte hypertrophy.},\n volume = {27
      12},\n year = {2015}\n}\n"}, "authors": [{"authorId": "2144149588", "name":
      "Jeong-Ah Kim"}, {"authorId": "12348977", "name": "Suhjean Im"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2115948992", "name": "Dae-Won
      Kim"}]}, {"paperId": "e4482bc435864ecc7c5aff92a1b5561a369157cb", "externalIds":
      {"MAG": "2978089074", "DOI": "10.2210/pdb3x05/pdb", "CorpusId": 210513033},
      "corpusId": 210513033, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/e4482bc435864ecc7c5aff92a1b5561a369157cb",
      "title": "Crystal structure of PIP4KIIBETA T201M complex with AMP", "abstract":
      null, "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2015-10-14",
      "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Takeuchi2015CrystalSO,\n
      author = {K. Takeuchi and Y. Lo and Kazutaka Sumita and M. Senda and Jumpei
      Terakawa and A. Dimitoris and J. Locasale and Mika Sasaki and H. Yoshino and
      Y. Zhang and E. Kahoud and T. Takano and T. Yokota and B. Emerling and J. Asara
      and T. Ishida and I. Shimada and T. Daikoku and L. Cantley and T. Senda and
      A. Sasaki},\n title = {Crystal structure of PIP4KIIBETA T201M complex with AMP},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "2775065", "name": "K. Takeuchi"},
      {"authorId": "121709354", "name": "Y. Lo"}, {"authorId": "49715313", "name":
      "Kazutaka Sumita"}, {"authorId": "5638813", "name": "M. Senda"}, {"authorId":
      "49515406", "name": "Jumpei Terakawa"}, {"authorId": "1485705386", "name": "A.
      Dimitoris"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "152671464",
      "name": "Mika Sasaki"}, {"authorId": "6824343", "name": "H. Yoshino"}, {"authorId":
      "49891201", "name": "Y. Zhang"}, {"authorId": "4049626", "name": "E. Kahoud"},
      {"authorId": "91895026", "name": "T. Takano"}, {"authorId": "10207871", "name":
      "T. Yokota"}, {"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "1394348007",
      "name": "J. Asara"}, {"authorId": "47983250", "name": "T. Ishida"}, {"authorId":
      "144714771", "name": "I. Shimada"}, {"authorId": "145457715", "name": "T. Daikoku"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "50162552", "name":
      "T. Senda"}, {"authorId": "47742211", "name": "A. Sasaki"}]}, {"paperId": "eae582038c8e26db2e68560dcfcdaf4a23ae71fd",
      "externalIds": {"MAG": "2567383469", "DOI": "10.1158/1538-7445.AM2015-2650",
      "CorpusId": 78399704}, "corpusId": 78399704, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/eae582038c8e26db2e68560dcfcdaf4a23ae71fd",
      "title": "Abstract 2650: PI 3-Kinase inhibitors enhance the synthetic lethality
      of Parp inhibitors", "abstract": "Introduction: Clinical trials have shown promising
      responses of BRCA-linked breast and ovarian cancers to PARP inhibitor therapy,
      but remissions are often short-lived and incomplete. Frequent loss of INPP4B
      and PTEN leads to activation in the PI3K pathway in TNBC, making the PI3K pathway
      an attractive treatment target. Here we present mechanistic data that explain
      how PI3K- and PARP-inhibition enhance each other. Methods: We examined the effects
      of PI3K-inhibitors BKM120 or BYL719 and PARP-inhibitor Olaparib on the metabolism
      of HCC1937 cells (BRCA1 5382C mutation and homozygous deletion of PTEN and p53)
      measuring lactic acid production, via seahorse analysis, carbon metabolism using
      targeted Mass Spectrometry (LC-MS/MS) and DNA synthesis. PI3K- but not Akt-
      or SGK-inhibition induced a DNA damage response in this BRCA1 mutant cell line
      as well as in a mouse model of BRCA1-related breast cancer (K14-Cre BRCA1f/f
      p53f/f) mouse model. Summary: Metabolic profiling showed that PI3K-inhibition
      decreased flux through glycolysis and specifically through the non-oxidative
      pentose-phosphate pathway, the main source of ribose-5-phosphate required for
      the de novo synthesis of nucleotides in BRCA1-mutant breast cancer cells. Nucleotide
      shortage led to replication stress with the appearance of \u03b3H2AX, increased
      poly-ADP-ribosylation and an acute drop in DNA synthesis in cell cultures as
      well as in vivo. PI3K inhibition led to a reduced and error-prone S-phase due
      to a decrease in nucleotide biosynthesis which could be rescued upon exogenous
      supply of nucleosides. In a mouse model (K14-Cre BRCA1f/fp53f/f induced breast
      cancers) we could confirm that both BKM120 and BYL719 enhanced the efficacy
      of Parp-inhibitor Olaparib (median PFS for Olaparib 50 days, for BKM120 4 days,
      for BYL719 6 days and for both combinations, BKM120+Olaparib and BYL719+Olaparib
      > 120 days). Conclusion: Preceding cell cycle arrest, PI3K-inhibition leads
      to a decrease in DNA synthesis due to decreased Ribose-5-phosphate production
      required for nucleotide synthesis. PI3K-inhibitors lower nucleotide pools, lead
      to impaired DNA damage repair and S-phase progression and further augment the
      synthetic lethality of Parp-inhibitors in BRCA1-related breast cancer. Citation
      Format: Ashish P. Juvekar, Sina Yadegarynia, Hai Hu, Costas A. Lyssiotis, Hui
      Liu, John M. Asara, Ralph Scully, Lewis C. Cantley, Gerburg M. Wulf. PI 3-Kinase
      inhibitors enhance the synthetic lethality of Parp inhibitors. [abstract]. In:
      Proceedings of the 106th Annual Meeting of the American Association for Cancer
      Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer
      Res 2015;75(15 Suppl):Abstract nr 2650. doi:10.1158/1538-7445.AM2015-2650",
      "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2015-08-01", "journal": {"volume": "75", "pages": "2650-2650", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Juvekar2015Abstract2P,\n
      author = {Ashish Juvekar and S. Yadegarynia and Hai Hu and C. Lyssiotis and
      Hui Liu and J. Asara and R. Scully and L. Cantley and G. Wulf},\n journal =
      {Cancer Research},\n pages = {2650-2650},\n title = {Abstract 2650: PI 3-Kinase
      inhibitors enhance the synthetic lethality of Parp inhibitors},\n volume = {75},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "49149990", "name": "Ashish Juvekar"},
      {"authorId": "3893473", "name": "S. Yadegarynia"}, {"authorId": "113164867",
      "name": "Hai Hu"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId":
      "2146671919", "name": "Hui Liu"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "143905392", "name": "R. Scully"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "31554501", "name": "G. Wulf"}]}, {"paperId": "f3f92601ad4094848415f83af0970902347c6aef",
      "externalIds": {"MAG": "2079742730", "DOI": "10.1016/J.JURO.2015.02.1573", "CorpusId":
      72428359}, "corpusId": 72428359, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/f3f92601ad4094848415f83af0970902347c6aef",
      "title": "MP46-10 UTILIZING INSULIN IN THE TREATMENT OF PROSTATE CANCER WITH
      BKM120 ABROGATES THE THERAPEUTIC EFFECT OF PI3K PATHWAY INHIBITION", "abstract":
      null, "venue": "", "year": 2015, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2015-04-01", "journal": {"volume": "193", "name": "The Journal of Urology"},
      "citationStyles": {"bibtex": "@Article{Wang2015MP4610UI,\n author = {Lily C.
      Wang and D. Nanus and L. Cantley},\n journal = {The Journal of Urology},\n title
      = {MP46-10 UTILIZING INSULIN IN THE TREATMENT OF PROSTATE CANCER WITH BKM120
      ABROGATES THE THERAPEUTIC EFFECT OF PI3K PATHWAY INHIBITION},\n volume = {193},\n
      year = {2015}\n}\n"}, "authors": [{"authorId": "2117931332", "name": "Lily C.
      Wang"}, {"authorId": "5430838", "name": "D. Nanus"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "f748f716d661e711f508ad20f7408c6a6b69fcc1",
      "externalIds": {"MAG": "918031449", "DOI": "10.1016/j.bbadis.2015.07.009", "CorpusId":
      23529456, "PubMed": "26170063"}, "corpusId": 23529456, "publicationVenue": {"id":
      "08ee3346-e195-4333-b008-be3a4f9e23cd", "name": "Biochimica et Biophysica Acta",
      "type": "journal", "alternate_names": ["Biochim Biophys Acta"], "issn": "0006-3002",
      "alternate_issns": ["1878-2434"], "url": "https://www.elsevier.com/life-sciences/biochemistry-genetics-and-molecular-biology/journals/bba",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00063002",
      "http://www.elsevier.com/wps/find/journaldescription.cws_home/506062/description#description"]},
      "url": "https://www.semanticscholar.org/paper/f748f716d661e711f508ad20f7408c6a6b69fcc1",
      "title": "Adaptive changes in amino acid metabolism permit normal longevity
      in mice consuming a low-carbohydrate ketogenic diet.", "abstract": null, "venue":
      "Biochimica et Biophysica Acta", "year": 2015, "referenceCount": 44, "citationCount":
      75, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2015-10-01", "journal":
      {"volume": "1852 10 Pt A", "pages": "\n          2056-65\n        ", "name":
      "Biochimica et biophysica acta"}, "citationStyles": {"bibtex": "@Article{Douris2015AdaptiveCI,\n
      author = {N. Douris and T. Melman and Jordan M Pecherer and P. Pissios and J.
      Flier and L. Cantley and J. Locasale and E. Maratos-Flier},\n booktitle = {Biochimica
      et Biophysica Acta},\n journal = {Biochimica et biophysica acta},\n pages =
      {\n          2056-65\n        },\n title = {Adaptive changes in amino acid metabolism
      permit normal longevity in mice consuming a low-carbohydrate ketogenic diet.},\n
      volume = {1852 10 Pt A},\n year = {2015}\n}\n"}, "authors": [{"authorId": "4157845",
      "name": "N. Douris"}, {"authorId": "1853856", "name": "T. Melman"}, {"authorId":
      "14412308", "name": "Jordan M Pecherer"}, {"authorId": "6720534", "name": "P.
      Pissios"}, {"authorId": "3896998", "name": "J. Flier"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId":
      "1398311201", "name": "E. Maratos-Flier"}]}, {"paperId": "fcdb08e1917bbdf40cdb4f290f03bfa5a8ad4f68",
      "externalIds": {"MAG": "20514746", "DOI": "10.1007/978-1-4939-2425-7_4", "CorpusId":
      37697371, "PubMed": "25859943"}, "corpusId": 37697371, "publicationVenue": null,
      "url": "https://www.semanticscholar.org/paper/fcdb08e1917bbdf40cdb4f290f03bfa5a8ad4f68",
      "title": "Computational prediction of protein-protein interactions.", "abstract":
      null, "venue": "Methods in molecular biology", "year": 2015, "referenceCount":
      54, "citationCount": 24, "influentialCitationCount": 3, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc4435844?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Computer Science"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Computer Science",
      "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Computer Science", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Review"], "publicationDate": null, "journal": {"volume": "1278", "pages": "\n          57-75\n        ",
      "name": "Methods in molecular biology"}, "citationStyles": {"bibtex": "@Article{Ehrenberger2015ComputationalPO,\n
      author = {T. Ehrenberger and L. Cantley and M. Yaffe},\n booktitle = {Methods
      in molecular biology},\n journal = {Methods in molecular biology},\n pages =
      {\n          57-75\n        },\n title = {Computational prediction of protein-protein
      interactions.},\n volume = {1278},\n year = {2015}\n}\n"}, "authors": [{"authorId":
      "2402804", "name": "T. Ehrenberger"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "88402408", "name": "M. Yaffe"}]}, {"paperId": "015888ad63bbcc3e642726f98737ff68f027b0fb",
      "externalIds": {"MAG": "2147683295", "DOI": "10.1101/cshperspect.a022913", "CorpusId":
      27016870, "PubMed": "25359498"}, "corpusId": 27016870, "publicationVenue": {"id":
      "9022e356-13cd-4b20-b9c8-b71402126832", "name": "Cold Spring Harbor Perspectives
      in Biology", "type": "journal", "alternate_names": ["Cold Spring Harb Perspect
      Biology"], "issn": "1943-0264", "url": "https://cshperspectives.cshlp.org/",
      "alternate_urls": ["http://cshperspectives.org/"]}, "url": "https://www.semanticscholar.org/paper/015888ad63bbcc3e642726f98737ff68f027b0fb",
      "title": "Signal transduction: From the atomic age to the post-genomic era.",
      "abstract": "We have come a long way in the 55 years since Edmond Fischer and
      the late Edwin Krebs discovered that the activity of glycogen phosphorylase
      is regulated by reversible protein phosphorylation. Many of the fundamental
      molecular mechanisms that operate in biological signaling have since been characterized
      and the vast web of interconnected pathways that make up the cellular signaling
      network has been mapped in considerable detail. Nonetheless, it is important
      to consider how fast this field is still moving and the issues at the current
      boundaries of our understanding. One must also appreciate what experimental
      strategies have allowed us to attain our present level of knowledge. We summarize
      here some key issues (both conceptual and methodological), raise unresolved
      questions, discuss potential pitfalls, and highlight areas in which our understanding
      is still rudimentary. We hope these wide-ranging ruminations will be useful
      to investigators who carry studies of signal transduction forward during the
      rest of the 21st century.", "venue": "Cold Spring Harbor Perspectives in Biology",
      "year": 2014, "referenceCount": 294, "citationCount": 24, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "http://cshperspectives.cshlp.org/content/6/12/a022913.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2014-12-01", "journal": {"volume": "6 12", "pages": "\n          a022913\n        ",
      "name": "Cold Spring Harbor perspectives in biology"}, "citationStyles": {"bibtex":
      "@Article{Thorner2014SignalTF,\n author = {J. Thorner and T. Hunter and L. Cantley
      and Richard Sever},\n booktitle = {Cold Spring Harbor Perspectives in Biology},\n
      journal = {Cold Spring Harbor perspectives in biology},\n pages = {\n          a022913\n        },\n
      title = {Signal transduction: From the atomic age to the post-genomic era.},\n
      volume = {6 12},\n year = {2014}\n}\n"}, "authors": [{"authorId": "145842074",
      "name": "J. Thorner"}, {"authorId": "143683912", "name": "T. Hunter"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "3816999", "name": "Richard Sever"}]},
      {"paperId": "022e4c787744c47a0172d4ebf198196b88bbddcb", "externalIds": {"MAG":
      "2148931486", "DOI": "10.1038/nature13079", "CorpusId": 4446551, "PubMed": "24670654"},
      "corpusId": 4446551, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/022e4c787744c47a0172d4ebf198196b88bbddcb",
      "title": "Cell-cycle-regulated activation of Akt kinase by phosphorylation at
      its carboxyl terminus", "abstract": null, "venue": "Nature", "year": 2014, "referenceCount":
      47, "citationCount": 306, "influentialCitationCount": 14, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc4076493?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2014-03-09", "journal": {"volume": "508", "pages": "541-545",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Liu2014CellcycleregulatedAO,\n
      author = {Pengda Liu and M. Begley and W. Michowski and H. Inuzuka and M. Ginzberg
      and Daming Gao and P. Tsou and W. Gan and A. Papa and B. Kim and L. Wan and
      Amrik J Singh and B. Zhai and Min Yuan and Zhiwei Wang and S. Gygi and T. Lee
      and K. Lu and A. Toker and P. Pandolfi and J. Asara and M. Kirschner and P.
      Sicinski and L. Cantley and Wenyi Wei},\n booktitle = {Nature},\n journal =
      {Nature},\n pages = {541-545},\n title = {Cell-cycle-regulated activation of
      Akt kinase by phosphorylation at its carboxyl terminus},\n volume = {508},\n
      year = {2014}\n}\n"}, "authors": [{"authorId": "3420906", "name": "Pengda Liu"},
      {"authorId": "69874482", "name": "M. Begley"}, {"authorId": "5528225", "name":
      "W. Michowski"}, {"authorId": "4403700", "name": "H. Inuzuka"}, {"authorId":
      "38246030", "name": "M. Ginzberg"}, {"authorId": "7642679", "name": "Daming
      Gao"}, {"authorId": "143971134", "name": "P. Tsou"}, {"authorId": "40383426",
      "name": "W. Gan"}, {"authorId": "5380009", "name": "A. Papa"}, {"authorId":
      "145266603", "name": "B. Kim"}, {"authorId": "49048640", "name": "L. Wan"},
      {"authorId": "2116287366", "name": "Amrik J Singh"}, {"authorId": "1859720",
      "name": "B. Zhai"}, {"authorId": "49059923", "name": "Min Yuan"}, {"authorId":
      "2108288335", "name": "Zhiwei Wang"}, {"authorId": "2665934", "name": "S. Gygi"},
      {"authorId": "145569223", "name": "T. Lee"}, {"authorId": "1715537", "name":
      "K. Lu"}, {"authorId": "145751285", "name": "A. Toker"}, {"authorId": "4499580",
      "name": "P. Pandolfi"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId":
      "40294231", "name": "M. Kirschner"}, {"authorId": "4616798", "name": "P. Sicinski"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144084152", "name":
      "Wenyi Wei"}]}, {"paperId": "105a81b36eae76d87c687a783130b4e8c8ac19fe", "externalIds":
      {"PubMedCentral": "4073074", "MAG": "1996390758", "DOI": "10.1186/1753-6561-6-S3-O2",
      "CorpusId": 8936707}, "corpusId": 8936707, "publicationVenue": {"id": "5b9b6854-d895-439b-9ab4-1e1ed4c26336",
      "name": "BMC Proceedings", "type": "journal", "alternate_names": ["BMC Proc"],
      "issn": "1753-6561", "url": "http://www.biomedcentral.com/bmcproc", "alternate_urls":
      ["http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=587"]},
      "url": "https://www.semanticscholar.org/paper/105a81b36eae76d87c687a783130b4e8c8ac19fe",
      "title": "PI 3-kinase and disease", "abstract": null, "venue": "BMC Proceedings",
      "year": 2014, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/2049-3002-2-S1-O30",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2014-05-28", "journal": {"volume":
      "2", "pages": "O30 - O30", "name": "Cancer & Metabolism"}, "citationStyles":
      {"bibtex": "@Article{Cantley2014PI3A,\n author = {L. Cantley},\n booktitle =
      {BMC Proceedings},\n journal = {Cancer & Metabolism},\n pages = {O30 - O30},\n
      title = {PI 3-kinase and disease},\n volume = {2},\n year = {2014}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "1247bbe2fbf3a552eae01b15d2190a31246133bb",
      "externalIds": {"MAG": "2781816664", "DOI": "10.1016/J.CMET.2014.11.009", "CorpusId":
      90157920}, "corpusId": 90157920, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/1247bbe2fbf3a552eae01b15d2190a31246133bb",
      "title": "Erratum: BRD7 regulates XBP1s'' activity and glucose homeostasis through
      its interaction with the regulatory subunits of pi3k (Cell Metabolism (2014:20:73-84))",
      "abstract": null, "venue": "", "year": 2014, "referenceCount": 0, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1550413114005063/pdf", "status": null}, "fieldsOfStudy":
      ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": {"volume": "20", "name": "Cell Metabolism"}, "citationStyles": {"bibtex":
      "@Article{Park2014ErratumBR,\n author = {S. Park and H. Herrema and Mario Salazar
      and I. \u00c7ak\u0131r and Serkan Cabi and F. Sahin and Y. Chiu and L. Cantley
      and U. Ozcan},\n journal = {Cell Metabolism},\n title = {Erratum: BRD7 regulates
      XBP1s'' activity and glucose homeostasis through its interaction with the regulatory
      subunits of pi3k (Cell Metabolism (2014:20:73-84))},\n volume = {20},\n year
      = {2014}\n}\n"}, "authors": [{"authorId": "48079845", "name": "S. Park"}, {"authorId":
      "5718734", "name": "H. Herrema"}, {"authorId": "2070687289", "name": "Mario
      Salazar"}, {"authorId": "4196414", "name": "I. \u00c7ak\u0131r"}, {"authorId":
      "12159303", "name": "Serkan Cabi"}, {"authorId": "89884476", "name": "F. Sahin"},
      {"authorId": "47591147", "name": "Y. Chiu"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3088608", "name": "U. Ozcan"}]}, {"paperId": "1e85abbd5708093b5beaa3b41542697e138a466f",
      "externalIds": {"MAG": "2072528662", "DOI": "10.1056/NEJMe1400055", "CorpusId":
      205078499, "PubMed": "24620870"}, "corpusId": 205078499, "publicationVenue":
      {"id": "dc31f077-7737-4e33-baa3-bceeff44ec27", "name": "New England Journal
      of Medicine", "type": "journal", "alternate_names": ["n engl J Med", "The New
      England Journal of Medicine", "N Engl J Med"], "issn": "0028-4793", "url": "https://www.nejm.org/",
      "alternate_urls": ["http://www.nejm.org/content/index.asp", "http://www.nejm.org/"]},
      "url": "https://www.semanticscholar.org/paper/1e85abbd5708093b5beaa3b41542697e138a466f",
      "title": "Idelalisib--a PI3K\u03b4 inhibitor for B-cell cancers.", "abstract":
      "The phosphoinositide 3-kinase (PI3K) signal transduction pathway is highly
      active in tumors and drives many of the hallmarks of cancer. Efforts to develop
      PI3K inhibitors for oncology have been complicated by the existence of four
      distinct PI3K catalytic isoforms with partially overlapping functions. In addition,
      diverse resistance mechanisms and on-target toxic effects have been observed
      with many PI3K inhibitors.1,2 In this issue of the Journal, two clinical teams
      report that idelalisib, a selective inhibitor of the delta isoform of PI3K,
      provides impressive efficacy and has an acceptable side-effect profile when
      used to treat patients with certain B-cell cancers.3, .\u00a0.\u00a0.", "venue":
      "New England Journal of Medicine", "year": 2014, "referenceCount": 10, "citationCount":
      76, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://escholarship.org/content/qt6f3592b4/qt6f3592b4.pdf?t=p5xypb", "status":
      null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["LettersAndComments", "Editorial"], "publicationDate":
      "2014-03-12", "journal": {"volume": "370 11", "pages": "\n          1061-2\n        ",
      "name": "The New England journal of medicine"}, "citationStyles": {"bibtex":
      "@Article{Fruman2014IdelalisibaPI,\n author = {D. Fruman and L. Cantley},\n
      booktitle = {New England Journal of Medicine},\n journal = {The New England
      journal of medicine},\n pages = {\n          1061-2\n        },\n title = {Idelalisib--a
      PI3K\u03b4 inhibitor for B-cell cancers.},\n volume = {370 11},\n year = {2014}\n}\n"},
      "authors": [{"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "35c85036360e82c8e5b159b341ed41e2d9e8b5f8",
      "externalIds": {"MAG": "1983001241", "DOI": "10.1016/j.molcel.2014.02.016",
      "CorpusId": 5588516, "PubMed": "24657164"}, "corpusId": 5588516, "publicationVenue":
      {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11", "name": "Molecules and Cells",
      "type": "journal", "alternate_names": ["Molecular Cell", "Mol Cell"], "issn":
      "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"], "url": "https://link.springer.com/journal/10059",
      "alternate_urls": ["http://www.molcells.org/about/sub06.html", "http://www.molecule.org/",
      "http://www.sciencedirect.com/science/journal/10972765", "http://www.cell.com/molecular-cell/"]},
      "url": "https://www.semanticscholar.org/paper/35c85036360e82c8e5b159b341ed41e2d9e8b5f8",
      "title": "BRD7, a tumor suppressor, interacts with p85\u03b1 and regulates PI3K
      activity.", "abstract": null, "venue": "Molecules and Cells", "year": 2014,
      "referenceCount": 39, "citationCount": 74, "influentialCitationCount": 4, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276514001610/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2014-04-10", "journal": {"volume": "54 1", "pages": "\n          193-202\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Chiu2014BRD7AT,\n
      author = {Y. Chiu and Jennifer Y. Lee and L. Cantley},\n booktitle = {Molecules
      and Cells},\n journal = {Molecular cell},\n pages = {\n          193-202\n        },\n
      title = {BRD7, a tumor suppressor, interacts with p85\u03b1 and regulates PI3K
      activity.},\n volume = {54 1},\n year = {2014}\n}\n"}, "authors": [{"authorId":
      "47591147", "name": "Y. Chiu"}, {"authorId": "46663676", "name": "Jennifer Y.
      Lee"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "472c57895e0b6d38e507cc6a4b649c1e5f857060",
      "externalIds": {"MAG": "2181833926", "CorpusId": 97972389}, "corpusId": 97972389,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/472c57895e0b6d38e507cc6a4b649c1e5f857060",
      "title": "Homeostasis Enzyme Bifunctionality in Glucose Switching and Its Circumvention
      by A Fundamental Trade-off in Covalent Computational Biology:", "abstract":
      null, "venue": "", "year": 2014, "referenceCount": 54, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Computer Science", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Gunawardena2014HomeostasisEB,\n author = {J. Gunawardena
      and W. Locasale and U. Alon and L. Cantley and A. Owen and M. V. Heiden and
      D. Croll},\n title = {Homeostasis Enzyme Bifunctionality in Glucose Switching
      and Its Circumvention by A Fundamental Trade-off in Covalent Computational Biology:},\n
      year = {2014}\n}\n"}, "authors": [{"authorId": "2163633", "name": "J. Gunawardena"},
      {"authorId": "93256439", "name": "W. Locasale"}, {"authorId": "8319448", "name":
      "U. Alon"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2055333220",
      "name": "A. Owen"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId":
      "47425181", "name": "D. Croll"}]}, {"paperId": "48159dfcf99386394400e40c96c70bcc9ad24be2",
      "externalIds": {"MAG": "2946612607", "DOI": "10.1158/1538-7445.PANCA2014-B45",
      "CorpusId": 11408042}, "corpusId": 11408042, "publicationVenue": {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f",
      "name": "Cancer & Metabolism", "type": "journal", "alternate_names": ["Cancer
      Metab", "Cancer and Metabolism", "Cancer  Metab"], "issn": "2049-3002", "url":
      "http://www.cancerandmetabolism.com/"}, "url": "https://www.semanticscholar.org/paper/48159dfcf99386394400e40c96c70bcc9ad24be2",
      "title": "Pancreatic cancers depend on a non-canonical glutamine metabolism
      pathway", "abstract": "Cancer cells exhibit metabolic dependencies that distinguish
      them from their normal counterparts. Among these addictions is an increased
      utilization of the amino acid glutamine (Gln) to fuel anabolic processes. Recently,
      we reported the identification of a non-canonical pathway of Gln utilization
      in human pancreatic cancer cells that is required for tumor growth. While most
      cells utilize glutamate dehydrogenase (GLUD1) to convert Gln-derived glutamate
      (Glu) into alpha-ketoglutarate (alpha-KG) in the mitochondria to fuel the tricarboxylic
      acid cycle, pancreatic cancer cells rely on a distinct pathway that integrates
      the mitochondrial and cytosolic aspartate aminotransferases GOT2 and GOT1. By
      generating alpha-KG from Glu (in conjunction with the conversion of oxaloacetate
      into aspartate), GOT2 fuels anaplerosis in place of GLUD1. The Asp created is
      released into the cytosol and acted on by GOT1. This is subsequently used through
      a series of reactions to yield cytosolic NADPH from malic enzyme. Importantly,
      we have demonstrated that pancreatic cancers are strongly dependent on this
      series of reactions to maintain redox homeostasis which enables proliferation.
      Herein, we detail the subcellular compartmentalization and consequences of the
      aforementioned reactions on pancreatic cancer metabolism. We have also investigated
      the essentiality of this pathway in other contexts and find that pancreatic
      cancers have a uniform and unique reliance on this pathway, which may provide
      novel therapeutic approaches to treat these refractory tumors. Citation Format:
      Costas A. Lyssiotis, Jaekyoung Son, Joesph D. Mancias, Haoqiang Ying, Lewis
      C. Cantley, Alec C. Kimmelman. Pancreatic cancers depend on a non-canonical
      glutamine metabolism pathway. [abstract]. In: Proceedings of the AACR Special
      Conference on Pancreatic Cancer: Innovations in Research and Treatment; May
      18-21, 2014; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13
      Suppl):Abstract nr B45.", "venue": "Cancer & Metabolism", "year": 2014, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2014-05-01", "journal": {"volume": "2", "name": "Cancer
      & Metabolism"}, "citationStyles": {"bibtex": "@Article{Lyssiotis2014PancreaticCD,\n
      author = {C. Lyssiotis and J. Son and J. Mancias and H. Ying and Alec C. Kimmelman
      and L. Cantley},\n booktitle = {Cancer & Metabolism},\n journal = {Cancer &
      Metabolism},\n title = {Pancreatic cancers depend on a non-canonical glutamine
      metabolism pathway},\n volume = {2},\n year = {2014}\n}\n"}, "authors": [{"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "38313825", "name": "J. Son"},
      {"authorId": "5810602", "name": "J. Mancias"}, {"authorId": "33312849", "name":
      "H. Ying"}, {"authorId": "4668673", "name": "Alec C. Kimmelman"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "56ad1278219c9b7d2d716e17a9b4ffafd3e4f903",
      "externalIds": {"MAG": "2039815737", "DOI": "10.1016/j.cmet.2014.04.006", "CorpusId":
      206842632, "PubMed": "24836559"}, "corpusId": 206842632, "publicationVenue":
      {"id": "ad36b49e-5c03-4c48-be8d-321a0d17c2f6", "name": "Cell Metabolism", "type":
      "journal", "alternate_names": ["Cell Metab"], "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/15504131",
      "http://www.cellmetabolism.org/"]}, "url": "https://www.semanticscholar.org/paper/56ad1278219c9b7d2d716e17a9b4ffafd3e4f903",
      "title": "BRD7 regulates XBP1s'' activity and glucose homeostasis through its
      interaction with the regulatory subunits of PI3K.", "abstract": null, "venue":
      "Cell Metabolism", "year": 2014, "referenceCount": 55, "citationCount": 56,
      "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1550413114001703/pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2014-07-01", "journal":
      {"volume": "20 1", "pages": "\n          73-84\n        ", "name": "Cell metabolism"},
      "citationStyles": {"bibtex": "@Article{Park2014BRD7RX,\n author = {S. Park and
      H. Herrema and Mario Salazar and I. \u00c7ak\u0131r and Serkan Cabi and Fatma
      Basibuyuk Sahin and Y. Chiu and L. Cantley and U. Ozcan},\n booktitle = {Cell
      Metabolism},\n journal = {Cell metabolism},\n pages = {\n          73-84\n        },\n
      title = {BRD7 regulates XBP1s'' activity and glucose homeostasis through its
      interaction with the regulatory subunits of PI3K.},\n volume = {20 1},\n year
      = {2014}\n}\n"}, "authors": [{"authorId": "48079845", "name": "S. Park"}, {"authorId":
      "5718734", "name": "H. Herrema"}, {"authorId": "2070687289", "name": "Mario
      Salazar"}, {"authorId": "4196414", "name": "I. \u00c7ak\u0131r"}, {"authorId":
      "12159303", "name": "Serkan Cabi"}, {"authorId": "1399526925", "name": "Fatma
      Basibuyuk Sahin"}, {"authorId": "47591147", "name": "Y. Chiu"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "3088608", "name": "U. Ozcan"}]},
      {"paperId": "59932b4fcacfb9cd0b373f9e7e4ffea539bb3cbc", "externalIds": {"DOI":
      "10.1186/2049-3002-2-S1-O30", "CorpusId": 256376194}, "corpusId": 256376194,
      "publicationVenue": {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f", "name": "Cancer
      & Metabolism", "type": "journal", "alternate_names": ["Cancer Metab", "Cancer
      and Metabolism", "Cancer  Metab"], "issn": "2049-3002", "url": "http://www.cancerandmetabolism.com/"},
      "url": "https://www.semanticscholar.org/paper/59932b4fcacfb9cd0b373f9e7e4ffea539bb3cbc",
      "title": "PI 3-kinase and disease", "abstract": null, "venue": "Cancer & Metabolism",
      "year": 2014, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/2049-3002-2-S1-O30",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2014-05-01", "journal": {"volume":
      "2", "name": "Cancer & Metabolism"}, "citationStyles": {"bibtex": "@Article{Cantley2014PI3A,\n
      author = {L. Cantley},\n booktitle = {Cancer & Metabolism},\n journal = {Cancer
      & Metabolism},\n title = {PI 3-kinase and disease},\n volume = {2},\n year =
      {2014}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "6381aa143eacfe03a2d9628d42d509f4f250c5b6", "externalIds": {"PubMedCentral":
      "4073055", "MAG": "1986963380", "DOI": "10.1186/2049-3002-2-S1-P86", "CorpusId":
      71710356}, "corpusId": 71710356, "publicationVenue": {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f",
      "name": "Cancer & Metabolism", "type": "journal", "alternate_names": ["Cancer
      Metab", "Cancer and Metabolism", "Cancer  Metab"], "issn": "2049-3002", "url":
      "http://www.cancerandmetabolism.com/"}, "url": "https://www.semanticscholar.org/paper/6381aa143eacfe03a2d9628d42d509f4f250c5b6",
      "title": "Phosphoinositide 3-Kinase regulates glycolysis through mobilization
      of Aldolase A from the actin cytoskeleton", "abstract": null, "venue": "Cancer
      & Metabolism", "year": 2014, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/2049-3002-2-S1-P86",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2014-05-01", "journal": {"volume": "2", "pages": "P86 -
      P86", "name": "Cancer & Metabolism"}, "citationStyles": {"bibtex": "@Article{Hu2014Phosphoinositide3R,\n
      author = {Hai Hu and Ashish Juvekar and Costas Lyssiotis and J. Albeck and D.
      Tolan and J. Asara and G. Wulf and L. Cantley},\n booktitle = {Cancer & Metabolism},\n
      journal = {Cancer & Metabolism},\n pages = {P86 - P86},\n title = {Phosphoinositide
      3-Kinase regulates glycolysis through mobilization of Aldolase A from the actin
      cytoskeleton},\n volume = {2},\n year = {2014}\n}\n"}, "authors": [{"authorId":
      "113164867", "name": "Hai Hu"}, {"authorId": "49149990", "name": "Ashish Juvekar"},
      {"authorId": "88857753", "name": "Costas Lyssiotis"}, {"authorId": "2791479",
      "name": "J. Albeck"}, {"authorId": "6482179", "name": "D. Tolan"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "31554501", "name": "G. Wulf"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "7b31cd007923278d21894116e2ab886e14420463",
      "externalIds": {"MAG": "2033347288", "DOI": "10.1158/1538-7445.AM2014-2951",
      "CorpusId": 84252448}, "corpusId": 84252448, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/7b31cd007923278d21894116e2ab886e14420463",
      "title": "Abstract 2951: Vitamin C is selectively toxic to cancer cells harboring
      KRAS or BRAF mutations by targeting GAPDH", "abstract": "Although more than
      half of colorectal cancer patients have either KRAS or BRAF mutations, targeted
      therapies for these subgroups of cancer patients are still lacking. Here, we
      report that KRAS or BRAF mutant cells exhibit a significant increase in the
      uptake of oxidized vitamin C, dehydroascorbate (DHA), via the GLUT1 glucose
      transporter. Increased uptake of DHA in the mutant cell lines causes oxidative
      stress as intracellular DHA is immediately reduced back to vitamin C by reduced
      glutathione. Elevated reactive oxygen species inactivate GAPDH and thus divert
      glycolytic flux into the pentose phosphate pathway. Because KRAS or BRAF mutant
      cells are highly dependent on glycolysis, this altered glucose metabolism induced
      by vitamin C ultimately leads to an energy deficit in KRAS or BRAF mutant cells
      and thereby cell death. There are currently a growing number of clinical trials
      in phases I/II examining the effect of high dose vitamin C as a treatment for
      cancers, including colorectal cancers. Our results provide a rationale for the
      pharmacological use of vitamin C as a therapeutic agent to treat colorectal
      cancer patients with oncogenic KRAS or BRAF mutations. Citation Format: Jihye
      Yun, Adam Kavalier, Edouard Mullarky, Kaitlyn Bosch, Jatin Roper, Carlo Rago,
      Jihye Paik, John Asara, Steven Gross, Bert Vogelstein, Nickolas Papadopoulos,
      Lewis Cantley. Vitamin C is selectively toxic to cancer cells harboring KRAS
      or BRAF mutations by targeting GAPDH. [abstract]. In: Proceedings of the 105th
      Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9;
      San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract
      nr 2951. doi:10.1158/1538-7445.AM2014-2951", "venue": "", "year": 2014, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2014-10-01",
      "journal": {"volume": "74", "pages": "2951-2951", "name": "Cancer Research"},
      "citationStyles": {"bibtex": "@Article{Yun2014Abstract2V,\n author = {Jihye
      Yun and A. Kavalier and Edouard Mullarky and Kaitlyn Bosch and J. Roper and
      C. Rago and J. Paik and J. Asara and S. Gross and B. Vogelstein and N. Papadopoulos
      and L. Cantley},\n journal = {Cancer Research},\n pages = {2951-2951},\n title
      = {Abstract 2951: Vitamin C is selectively toxic to cancer cells harboring KRAS
      or BRAF mutations by targeting GAPDH},\n volume = {74},\n year = {2014}\n}\n"},
      "authors": [{"authorId": "40164091", "name": "Jihye Yun"}, {"authorId": "8391227",
      "name": "A. Kavalier"}, {"authorId": "6424987", "name": "Edouard Mullarky"},
      {"authorId": "7881810", "name": "Kaitlyn Bosch"}, {"authorId": "145864068",
      "name": "J. Roper"}, {"authorId": "1907762", "name": "C. Rago"}, {"authorId":
      "5056578", "name": "J. Paik"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "5769141", "name": "S. Gross"}, {"authorId": "1965563", "name":
      "B. Vogelstein"}, {"authorId": "144798543", "name": "N. Papadopoulos"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "7be5527d516c79561eef8378c3db84ddaeedcfd0",
      "externalIds": {"MAG": "2090449329", "DOI": "10.1074/jbc.M113.546515", "CorpusId":
      12600062, "PubMed": "24634222"}, "corpusId": 12600062, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/7be5527d516c79561eef8378c3db84ddaeedcfd0",
      "title": "A Fundamental Trade-off in Covalent Switching and Its Circumvention
      by Enzyme Bifunctionality in Glucose Homeostasis*", "abstract": "Background:
      Covalent modification cycles are widely used as regulatory switches. Results:
      Mathematical analysis reveals, under very general assumptions, an unavoidable
      trade-off between switching efficiency and cell-to-cell coherence. Conclusion:
      Enzyme bifunctionality offers a way to circumvent this trade-off. Significance:
      This may explain the bifunctionality of PFK-2/FBPase-2 in controlling the switch
      between glycolysis and gluconeogenesis in the mammalian liver. Covalent modification
      provides a mechanism for modulating molecular state and regulating physiology.
      A cycle of competing enzymes that add and remove a single modification can act
      as a molecular switch between \u201con\u201d and \u201coff\u201d and has been
      widely studied as a core motif in systems biology. Here, we exploit the recently
      developed \u201clinear framework\u201d for time scale separation to determine
      the general principles of such switches. These methods are not limited to Michaelis-Menten
      assumptions, and our conclusions hold for enzymes whose mechanisms may be arbitrarily
      complicated. We show that switching efficiency improves with increasing irreversibility
      of the enzymes and that the on/off transition occurs when the ratio of enzyme
      levels reaches a value that depends only on the rate constants. Fluctuations
      in enzyme levels, which habitually occur due to cellular heterogeneity, can
      cause flipping back and forth between on and off, leading to incoherent mosaic
      behavior in tissues, that worsens as switching becomes sharper. This trade-off
      can be circumvented if enzyme levels are correlated. In particular, if the competing
      catalytic domains are on the same protein but do not influence each other, the
      resulting bifunctional enzyme can switch sharply while remaining coherent. In
      the mammalian liver, the switch between glycolysis and gluconeogenesis is regulated
      by the bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2).
      We suggest that bifunctionality of PFK-2/FBPase-2 complements the metabolic
      zonation of the liver by ensuring coherent switching in response to insulin
      and glucagon.", "venue": "Journal of Biological Chemistry", "year": 2014, "referenceCount":
      58, "citationCount": 34, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925820387883/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2014-03-14", "journal": {"volume": "289", "pages": "13010
      - 13025", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Dasgupta2014AFT,\n author = {T. Dasgupta and D. Croll and
      J. Owen and M. V. Vander Heiden and J. Locasale and U. Alon and L. Cantley and
      J. Gunawardena},\n booktitle = {Journal of Biological Chemistry},\n journal
      = {The Journal of Biological Chemistry},\n pages = {13010 - 13025},\n title
      = {A Fundamental Trade-off in Covalent Switching and Its Circumvention by Enzyme
      Bifunctionality in Glucose Homeostasis*},\n volume = {289},\n year = {2014}\n}\n"},
      "authors": [{"authorId": "32933502", "name": "T. Dasgupta"}, {"authorId": "47425181",
      "name": "D. Croll"}, {"authorId": "38261902", "name": "J. Owen"}, {"authorId":
      "3804233", "name": "M. V. Vander Heiden"}, {"authorId": "2268976", "name": "J.
      Locasale"}, {"authorId": "8319448", "name": "U. Alon"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2163633", "name": "J. Gunawardena"}]},
      {"paperId": "7e218d5e3469b90fc1f0e4328fdc3bc50d1352c2", "externalIds": {"DOI":
      "10.1186/1741-7007-12-8", "CorpusId": 255830136}, "corpusId": 255830136, "publicationVenue":
      {"id": "1617f5c3-5410-462d-91c9-7aa8ced2d91d", "name": "BMC Biology", "type":
      "journal", "issn": "1741-7007", "url": "http://www.biomedcentral.com/1741-7007/",
      "alternate_urls": ["http://www.biomedcentral.com/bmcbiol/", "http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=215"]},
      "url": "https://www.semanticscholar.org/paper/7e218d5e3469b90fc1f0e4328fdc3bc50d1352c2",
      "title": "Cancer, metabolism, fructose, artificial sweeteners, and going cold
      turkey on sugar", "abstract": null, "venue": "BMC Biology", "year": 2014, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://bmcbiol.biomedcentral.com/counter/pdf/10.1186/1741-7007-12-8",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2014-01-31", "journal": {"volume":
      "12", "name": "BMC Biology"}, "citationStyles": {"bibtex": "@Article{Cantley2014CancerMF,\n
      author = {L. Cantley},\n booktitle = {BMC Biology},\n journal = {BMC Biology},\n
      title = {Cancer, metabolism, fructose, artificial sweeteners, and going cold
      turkey on sugar},\n volume = {12},\n year = {2014}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "a489eaaf35ec9925cb192db96a3669c7ff73df8d",
      "externalIds": {"MAG": "2074492690", "DOI": "10.1158/1538-7445.AM2014-CT338",
      "CorpusId": 72756487}, "corpusId": 72756487, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/a489eaaf35ec9925cb192db96a3669c7ff73df8d",
      "title": "Abstract CT338: Combination of a PI3K- and a PARP-inhibitor to treat
      high-grade serous ovarian or triple-negative breast cancer", "abstract": "Proceedings:
      AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA\n\nClinical trials
      have shown promising responses of BRCA-linked breast and ovarian cancers to
      PARP inhibitor therapy, but remissions are often short-lived and incomplete.
      The PI3K pathway is frequently activated in these malignancies. Recently, we
      reported in vivo synergy of a PI3K- and a PARP-inhibitor in a mouse model of
      BRCA1-related breast cancer. While the PARP-inhibitor olaparib alone attenuated
      tumor growth modestly, a dramatic reduction in tumor growth was observed when
      olaparib was combined with the PI3K-inhibitor BKM120. In BRCA1-mutant HCC1937
      BC cells, PI3K- (but not akt-) inhibition increased indicators of DNA damage,
      such as poly-ADP-ribosylation and \u03b3H2AX, suggesting a critical role of
      PI3K activity for the maintenance of genomic stability. Here, we report on the
      molecular mechanism underlying this synergy, on treatment outcomes in an improved
      mouse model system and the development of an early-phase clinical study. Pre-clinical
      modeling was done in BRCA1-mutant HCC1937 cells and in a mouse model based on
      the syngenic transplantation of tumors derived on the K14-Cre BRCA1f/fp53f/f
      background. Metabolic profiling in vitro and in vivo showed that PI3K-inhibition
      decreased flux through glycolysis and specifically through the non-oxidative
      pentose-phosphate pathway, the main source of ribose-5-phosphate required for
      the de novo synthesis of nucleotides in HCC1937 cells. Within 3 hours and preceding
      cell cycle changes, BKM120 caused a decrease in nucleotide pools that was further
      exacerbated by the addition of olaparib. Nucleotide shortage led to to replication
      stress with the appearance of \u03b3H2AX and increased poly-ADP-ribosylation.
      Tumors with complete loss of BRCA1 and p53 proved particularly vulnerable to
      this treatment strategy. We were able to induce complete and durable remissions
      of murine tumors arising on the K14-Cre BRCA1f/fp53f/f background with a 28-day
      course of BKM120 and Olaparib. These preclinical data have served as the rationale
      for a phase I, multi-center study ([NCT01623349][1]) combining the oral PARP
      inhibitor olaparib with the oral PI3-kinase inhibitor BKM120 in patients with
      recurrent HGSC or recurrent TNBC. The study is being conducted through the Stand
      Up to Cancer (SU2C)''s Targeting PI3-kinase in Women''s Cancers Dream Team.
      It has a 3 + 3 design, escalating if 0/3 or 1/6 participants have a DLT during
      the first cycle of therapy. The study objectives are to determine the recommended
      phase II dose (RP2D) of daily continuous oral olaparib (using the tablet formulation)
      and BKM120, assess toxicities, safety, and preliminary activity of this combination,
      and determine pharmacokinetic profiles of both agents as well as translational
      endpoints. The study serves as an example for the development of a clinical
      trials concept for TNBC and HGSC based on a close collaboration of basic and
      clinical scientists through the SU2C mechanism.\n\nCitation Format: Gerburg
      M. Wulf, Ashish Juvekar, Costas A. Lyssiotis, Hai Hu, Sina Yadegarynia, Hui
      Liu, Baek Kim, Eric Winter, Ralph Scully, John Asara, Lewis C. Cantley, Ursula
      Matulonis. Combination of a PI3K- and a PARP-inhibitor to treat high-grade serous
      ovarian or triple-negative breast cancer. [abstract]. In: Proceedings of the
      105th Annual Meeting of the American Association for Cancer Research; 2014 Apr
      5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract
      nr CT338. doi:10.1158/1538-7445.AM2014-CT338\n\n [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT01623349&atom=%2Fcanres%2F74%2F19_Supplement%2FCT338.atom",
      "venue": "", "year": 2014, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2014-10-01", "journal": {"volume": "74", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Wulf2014AbstractCC,\n author = {G. Wulf and Ashish Juvekar
      and C. Lyssiotis and Hai Hu and S. Yadegarynia and Hui Liu and Baek Kim and
      Eric P Winter and R. Scully and J. Asara and L. Cantley and U. Matulonis},\n
      journal = {Cancer Research},\n title = {Abstract CT338: Combination of a PI3K-
      and a PARP-inhibitor to treat high-grade serous ovarian or triple-negative breast
      cancer},\n volume = {74},\n year = {2014}\n}\n"}, "authors": [{"authorId": "31554501",
      "name": "G. Wulf"}, {"authorId": "49149990", "name": "Ashish Juvekar"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "113164867", "name": "Hai Hu"},
      {"authorId": "3893473", "name": "S. Yadegarynia"}, {"authorId": "2146671919",
      "name": "Hui Liu"}, {"authorId": "2144570709", "name": "Baek Kim"}, {"authorId":
      "2052370549", "name": "Eric P Winter"}, {"authorId": "143905392", "name": "R.
      Scully"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "6927295", "name": "U. Matulonis"}]}, {"paperId":
      "a68bbd0f336c26d04681e948bf2cf98850e15060", "externalIds": {"MAG": "2043603122",
      "DOI": "10.1016/j.cell.2014.12.009", "CorpusId": 54566844, "PubMed": "25525870"},
      "corpusId": 54566844, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/a68bbd0f336c26d04681e948bf2cf98850e15060",
      "title": "Acetate Fuels the Cancer Engine", "abstract": null, "venue": "Cell",
      "year": 2014, "referenceCount": 15, "citationCount": 45, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867415000641/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2014-12-18", "journal": {"volume": "159", "pages": "1492-1494",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Lyssiotis2014AcetateFT,\n
      author = {C. Lyssiotis and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n
      pages = {1492-1494},\n title = {Acetate Fuels the Cancer Engine},\n volume =
      {159},\n year = {2014}\n}\n"}, "authors": [{"authorId": "4901222", "name": "C.
      Lyssiotis"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "b132df46f298d8e45cb2bc30121b7f6b64c86710",
      "externalIds": {"CorpusId": 207786498}, "corpusId": 207786498, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/b132df46f298d8e45cb2bc30121b7f6b64c86710",
      "title": "compound PARP / PI 3 K inhibition Vulnerabilities of PTEN-p 53-deficient
      prostate cancers to", "abstract": null, "venue": "", "year": 2014, "referenceCount":
      22, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Inproceedings{Gonzalez-Billalabeitia2014compoundP,\n author = {E.
      Gonzalez-Billalabeitia and N. Seitzer and S. Song and M. Song and Akash Patnaik
      and Xue-Song Liu and M. Epping and A. Papa and R. Hobbs and Ming Chen and A.
      Lunardi and Christopher Ng and Kaitlyn A. Webster and S. Signoretti and M. Loda
      and J. Asara and C. Nardella and J. Clohessy and L. Cantley and P. Pandolfi},\n
      title = {compound PARP / PI 3 K inhibition Vulnerabilities of PTEN-p 53-deficient
      prostate cancers to},\n year = {2014}\n}\n"}, "authors": [{"authorId": "1398122926",
      "name": "E. Gonzalez-Billalabeitia"}, {"authorId": "3793357", "name": "N. Seitzer"},
      {"authorId": "9673009", "name": "S. Song"}, {"authorId": "2967391", "name":
      "M. Song"}, {"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId":
      "8015447", "name": "Xue-Song Liu"}, {"authorId": "4276612", "name": "M. Epping"},
      {"authorId": "5380009", "name": "A. Papa"}, {"authorId": "4584039", "name":
      "R. Hobbs"}, {"authorId": "48622732", "name": "Ming Chen"}, {"authorId": "5729169",
      "name": "A. Lunardi"}, {"authorId": "6294709", "name": "Christopher Ng"}, {"authorId":
      "4817196", "name": "Kaitlyn A. Webster"}, {"authorId": "7505152", "name": "S.
      Signoretti"}, {"authorId": "6213932", "name": "M. Loda"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "3547827", "name": "C. Nardella"}, {"authorId":
      "4102988", "name": "J. Clohessy"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "4499580", "name": "P. Pandolfi"}]}, {"paperId": "b42ae6209615380e956f59664c07ef312278a511",
      "externalIds": {"MAG": "2318414253", "DOI": "10.1016/S0959-8049(14)50626-0",
      "CorpusId": 75309643}, "corpusId": 75309643, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/b42ae6209615380e956f59664c07ef312278a511",
      "title": "708: A Phase Ib study of BKM120 combined with abiraterone acetate
      for castrate-resistant, metastatic prostate cancer", "abstract": null, "venue":
      "", "year": 2014, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2014-07-01", "journal": {"volume": "50", "name": "European Journal of Cancer"},
      "citationStyles": {"bibtex": "@Article{Patnaik2014708AP,\n author = {Akash Patnaik
      and J. Kung and Jim S. Wu and M. Loda and P. Kantoff and L. Cantley and S. Balk
      and G. Bubley},\n journal = {European Journal of Cancer},\n title = {708: A
      Phase Ib study of BKM120 combined with abiraterone acetate for castrate-resistant,
      metastatic prostate cancer},\n volume = {50},\n year = {2014}\n}\n"}, "authors":
      [{"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId": "35208382",
      "name": "J. Kung"}, {"authorId": "2110420120", "name": "Jim S. Wu"}, {"authorId":
      "6213932", "name": "M. Loda"}, {"authorId": "9933602", "name": "P. Kantoff"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6189162", "name":
      "S. Balk"}, {"authorId": "5854981", "name": "G. Bubley"}]}, {"paperId": "b962f20d916814950d2b094c1a5827f43552ce7c",
      "externalIds": {"MAG": "2549508308", "DOI": "10.1182/BLOOD.V124.21.SCI-43.SCI-43",
      "CorpusId": 89398284}, "corpusId": 89398284, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/b962f20d916814950d2b094c1a5827f43552ce7c",
      "title": "Maintenance of Pluripotent Stem Cells is Influenced by Ser/Thr Metabolism",
      "abstract": "Recent studies have suggested not only that stem cells have different
      metabolic requirements than terminally differentiated cells, but also that metabolic
      intermediates may play a role in the maintenance of stem cells. It has long
      been clear that changes in acetylation and methylation of histones, as well
      as methylation of DNA play critical roles in deciding cell fate. The availability
      of critical intermediates in metabolism, especially S-adenosylmethionine (SAM),
      acetyl-CoA, nicotinamide adenine dinucleotide (NAD) and a-ketoglutarate play
      critical roles in modulating acetylation and methylation of histones and methylation
      of DNA. In the course of evaluating an unusual requirement of threonine (Thr)
      for the growth of murine embryonic stem cells, we found that metabolism of Thr
      to glycine (Gly) and the subsequent use of the methyl group of Gly for converting
      homocysteine to methionine is critical for maintaining high levels of SAM and
      low levels of S-adenosyl-homocysteine. Importantly, depletion of Thr from the
      media resulted in decreased tri-methylation of histone H3 lysine-4 (H3K4me3),
      leading to slowed growth and increased differentiation. Thus, abundance of SAM
      appears to influence H3K4me3, providing a possible mechanism by which modulation
      of a metabolic pathway might influence stem cell fate. Demethylation of histones
      and DNA can also be controlled by metabolic intermediates. Mutated forms of
      isocitrate dehydrogenase 1 (IDH1) and IDH2 that drive acute myeloid leukemia
      (AML) and other cancers, produce an oncometabolite (2-hydrogyglutarate) that
      can compete with the a-ketoglutarate requirement for enzymes involved in hydroxy-methylation
      and subsequent demethylation of DNA and histones. Recent studies indicate that
      2-hydroxyglutarate plays a role in blocking differentiation of cancer cells.
      These and other observations linking intermediates in metabolism to stem cell
      maintenance will be discussed. Disclosures Cantley: Agios Pharmaceuticals: Consultancy,
      Equity Ownership, Membership on an entity9s Board of Directors or advisory committees,
      Patents & Royalties.", "venue": "", "year": 2014, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2014-12-06", "journal": {"volume": "124", "name": "Blood"}, "citationStyles":
      {"bibtex": "@Article{Cantley2014MaintenanceOP,\n author = {L. Cantley},\n journal
      = {Blood},\n title = {Maintenance of Pluripotent Stem Cells is Influenced by
      Ser/Thr Metabolism},\n volume = {124},\n year = {2014}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "bc8011fa978b52b8c651ca7d2921fe814b00b59d",
      "externalIds": {"MAG": "2050593017", "DOI": "10.1158/1538-7445.AM2014-CT418",
      "CorpusId": 71733885}, "corpusId": 71733885, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/bc8011fa978b52b8c651ca7d2921fe814b00b59d",
      "title": "Abstract CT418: A Phase Ib study of BKM120 combined with abiraterone
      acetate for castrate-resistant, metastatic prostate cancer", "abstract": "Introduction:
      There is significant cross-talk between PI3-kinase (PI3K) and androgen receptor
      (AR) signaling pathways, respectively, which are both critical for cell survival
      in castrate-resistant prostate cancer (CRPC). The primary study objective (NCT01741753)
      is to determine the safety profile and maximum tolerated dose (MTD) of BKM120
      (pan-PI3K inhibitor) in combination with abiraterone/prednisone (A/P) in CRPC
      patients. The secondary study objectives are to assess the impact of PTEN status
      on duration of response/time to progression in the expansion cohort, and to
      evaluate the impact of BKM120 on a PI3-kinase activation fingerprint in metastatic
      bone or lymph node tissue samples. An exploratory objective of the study is
      to assess the effect of BKM120 on transcription of a set of AR-regulated genes
      in metastatic bone biopsy samples. Methods: The trial design involves a 14 day
      lead-in phase with BKM120 alone, to assess single-agent toxicity and perform
      correlative studies. A/P is combined with BKM120 at the end of 14 days using
      the standard 3+3 dose-escalation design with 3 dose levels of BKM120 (80 mg,
      100 mg, 120 mg, respectively), and participants are assessed for safety and
      MTD on the combination therapy. To determine pharmacodynamic impact of single
      agent BKM120 on the PI3K activation signature at a metastatic site, a mandatory
      CT-guided bone or lymph node biopsy is performed prior to BKM120 initiation
      and at the end of 2 weeks on BKM120 single-agent therapy. Immunohistochemical
      (IHC) stains for three markers (p-AKT, p-S6 and PTEN) are used to obtain a semi-quantitative
      PI3K activation score, based on the quartile levels of continuous staining scores
      of each marker. Results: The clinical, PSA biochemical responses, immunohistochemical
      and molecular RT-PCR data for three enrolled patients are summarized here. The
      first patient had symptomatic bone pain with limited functional mobility at
      baseline, and was treated with the first BKM120 dose level of 80 mg daily. He
      had a decline in PSA from 156.5 to 129.6 during the lead-in phase with single-agent
      BKM120 treatment with partial symptomatic pain relief. Interestingly, comparison
      of pre- and post-treatment metastatic bone tumor IHC staining on single-agent
      BKM120 showed inhibition of phospho-S6 staining. Upon adding A/P to BKM120 treatment,
      he had a striking decline in his PSA to 23.3 within 1 week, which reached a
      nadir of 9.2 within 4 weeks of combination therapy treatment. This striking
      biochemical improvement corresponded to a marked decline in narcotic pain requirements,
      increased mobility and quality-of-life. However, he developed clinical, biochemical
      and radiographic disease progression after 4 cycles of combination therapy treatment,
      so had to withdraw from study. The second and third patient had a >90% biochemical
      improvement within 4 weeks of combination therapy treatment and remain on study
      to date. To evaluate cross-talk between AR and PI3K signaling in the bone microenvironment,
      RT-PCR analyses on pre- and BKM120-treated bone biopsy samples were performed.
      The results showed that the feedback relationship between PI3K and AR signaling
      are heterogeneous, and dependent on the PTEN status of the tumor. Conclusion:
      The pan-PI3K inhibitor/abiraterone combination is well-tolerated, and demonstrates
      promising anti-tumor activity in CRPC patients. Citation Format: Akash Patnaik,
      Massimo Loda, Justin Kung, Jim Wu, MaryEllen Taplin, Philip Kantoff, Lewis Cantley,
      Steven Balk, Glenn Bubley. A Phase Ib study of BKM120 combined with abiraterone
      acetate for castrate-resistant, metastatic prostate cancer. [abstract]. In:
      Proceedings of the 105th Annual Meeting of the American Association for Cancer
      Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19
      Suppl):Abstract nr CT418. doi:10.1158/1538-7445.AM2014-CT418", "venue": "",
      "year": 2014, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2014-10-01", "journal": {"volume": "74", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Patnaik2014AbstractCA,\n author = {Akash Patnaik and M.
      Loda and J. Kung and Jim S. Wu and M. Taplin and P. Kantoff and L. Cantley and
      S. Balk and G. Bubley},\n journal = {Cancer Research},\n title = {Abstract CT418:
      A Phase Ib study of BKM120 combined with abiraterone acetate for castrate-resistant,
      metastatic prostate cancer},\n volume = {74},\n year = {2014}\n}\n"}, "authors":
      [{"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId": "6213932",
      "name": "M. Loda"}, {"authorId": "35208382", "name": "J. Kung"}, {"authorId":
      "2110420120", "name": "Jim S. Wu"}, {"authorId": "80786834", "name": "M. Taplin"},
      {"authorId": "9933602", "name": "P. Kantoff"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "6189162", "name": "S. Balk"}, {"authorId": "5854981",
      "name": "G. Bubley"}]}, {"paperId": "c1cf8e9b4442b7d4ecabe79cf8ad8f872817485d",
      "externalIds": {"MAG": "2772115384", "DOI": "10.1200/JCO.2014.32.15_SUPPL.2510",
      "CorpusId": 80085275}, "corpusId": 80085275, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/c1cf8e9b4442b7d4ecabe79cf8ad8f872817485d",
      "title": "Phase I study of oral BKM120 and oral olaparib for high-grade serous
      ovarian cancer (HGSC) or triple-negative breast cancer (TNBC).", "abstract":
      "2510 Background: In vivo synergy of the PI3-kinase inhibitor BKM120 and the
      PARP inhibitor olaparib is seen using a mouse model of BRCA1-related breast
      cancer (BrCa) and sporadic TNBC (Juvekar et al and Ibrahim et al, Cancer Discovery
      2012). The PI3kinase pathway is activated in both TNBC and HGSC (www.cancergenome.nih.gov).
      Olaparib is active in HGSC and germlineBRCA mutation (gBRCAm) ovarian cancer
      (OvCa) and gBRCAm BrCa. These data were the rationale for this phase I, multi-center
      study (NCT01623349) combining BKM120 and olaparib in patients (pts) with recurrent
      HGSC or TNBC. Methods: This study has a 3 + 3 design, escalating dose levels
      (DL) if 0/3 or 1/6 pts have a dose limiting toxicity (DLT) during the first
      cycle (1st 28 days). Objectives are to determine the MTD and RP2D of daily oral
      olaparib (tablet formulation) and BKM120, assess toxicities, preliminary activity
      of this combination, and PK profiles of both drugs. Planned translational endpts
      include PI3kinase pathway effects, BRCA1 immunostain...", "venue": "", "year":
      2014, "referenceCount": 0, "citationCount": 35, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2014-05-20", "journal": {"volume": "32", "pages": "2510-2510", "name": "Journal
      of Clinical Oncology"}, "citationStyles": {"bibtex": "@Article{Matulonis2014PhaseIS,\n
      author = {U. Matulonis and G. Wulf and M. Birrer and S. Westin and P. Quy and
      K. Bell-McGuinn and Brian Lasonde and C. Whalen and C. Aghajanian and D. Solit
      and G. Mills and L. Cantley and E. Winer},\n journal = {Journal of Clinical
      Oncology},\n pages = {2510-2510},\n title = {Phase I study of oral BKM120 and
      oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative
      breast cancer (TNBC).},\n volume = {32},\n year = {2014}\n}\n"}, "authors":
      [{"authorId": "6927295", "name": "U. Matulonis"}, {"authorId": "31554501", "name":
      "G. Wulf"}, {"authorId": "2167106", "name": "M. Birrer"}, {"authorId": "2974900",
      "name": "S. Westin"}, {"authorId": "15775381", "name": "P. Quy"}, {"authorId":
      "1397923721", "name": "K. Bell-McGuinn"}, {"authorId": "12796173", "name": "Brian
      Lasonde"}, {"authorId": "122974814", "name": "C. Whalen"}, {"authorId": "6128162",
      "name": "C. Aghajanian"}, {"authorId": "2344124", "name": "D. Solit"}, {"authorId":
      "2241330", "name": "G. Mills"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2369378", "name": "E. Winer"}]}, {"paperId": "c2c818d35ad6db3edb6899306e625a0e8a108d7d",
      "externalIds": {"MAG": "2017746705", "DOI": "10.1016/j.cell.2014.07.048", "CorpusId":
      8724666, "PubMed": "25215489"}, "corpusId": 8724666, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/c2c818d35ad6db3edb6899306e625a0e8a108d7d",
      "title": "Cell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis",
      "abstract": null, "venue": "Cell", "year": 2014, "referenceCount": 57, "citationCount":
      273, "influentialCitationCount": 10, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S0092867414010381/pdf", "status": null},
      "fieldsOfStudy": ["Medicine", "Biology", "Chemistry"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "external"},
      {"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2014-09-01", "journal": {"volume": "158",
      "pages": "1309-1323", "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Wang2014CellStateSpecificMD,\n
      author = {Ying-hua Wang and William J. Israelsen and Dongjun Lee and V. Yu and
      N. T. Jeanson and C. Clish and L. Cantley and M. V. Heiden and D. Scadden},\n
      booktitle = {Cell},\n journal = {Cell},\n pages = {1309-1323},\n title = {Cell-State-Specific
      Metabolic Dependency in Hematopoiesis and Leukemogenesis},\n volume = {158},\n
      year = {2014}\n}\n"}, "authors": [{"authorId": "47906491", "name": "Ying-hua
      Wang"}, {"authorId": "5553029", "name": "William J. Israelsen"}, {"authorId":
      "47381858", "name": "Dongjun Lee"}, {"authorId": "34345448", "name": "V. Yu"},
      {"authorId": "5100030", "name": "N. T. Jeanson"}, {"authorId": "3633091", "name":
      "C. Clish"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "5002337", "name": "D. Scadden"}]}, {"paperId":
      "ca84197b3fbc7593676217cfd93cc6617e4aa6d0", "externalIds": {"MAG": "2060607801",
      "DOI": "10.1016/j.cell.2013.11.049", "CorpusId": 18517653, "PubMed": "24529379"},
      "corpusId": 18517653, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/ca84197b3fbc7593676217cfd93cc6617e4aa6d0",
      "title": "Spatial Control of the TSC Complex Integrates Insulin and Nutrient
      Regulation of mTORC1 at the Lysosome", "abstract": null, "venue": "Cell", "year":
      2014, "referenceCount": 54, "citationCount": 667, "influentialCitationCount":
      56, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867414000129/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2014-02-13", "journal": {"volume": "156", "pages": "771-785",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Menon2014SpatialCO,\n
      author = {Suchithra Menon and Christian C. Dibble and G. Talbott and G. Hoxhaj
      and Alexander J. Valvezan and Hidenori Takahashi and L. Cantley and B. Manning},\n
      booktitle = {Cell},\n journal = {Cell},\n pages = {771-785},\n title = {Spatial
      Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1
      at the Lysosome},\n volume = {156},\n year = {2014}\n}\n"}, "authors": [{"authorId":
      "49029161", "name": "Suchithra Menon"}, {"authorId": "7449887", "name": "Christian
      C. Dibble"}, {"authorId": "46679535", "name": "G. Talbott"}, {"authorId": "2367206",
      "name": "G. Hoxhaj"}, {"authorId": "6044723", "name": "Alexander J. Valvezan"},
      {"authorId": "2115843581", "name": "Hidenori Takahashi"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2339651", "name": "B. Manning"}]}, {"paperId":
      "cd0d6917325bf9d09e15dd5cda895d675703870a", "externalIds": {"MAG": "2170908060",
      "DOI": "10.1200/JCO.2013.54.0518", "CorpusId": 24709027, "PubMed": "24663045"},
      "corpusId": 24709027, "publicationVenue": {"id": "a5913268-3957-484f-b41f-347b0ba23338",
      "name": "Journal of Clinical Oncology", "type": "journal", "alternate_names":
      ["J Clin Oncol"], "issn": "0732-183X", "url": "https://ascopubs.org/loi/jco",
      "alternate_urls": ["http://www.jco.org/", "http://jco.ascopubs.org/"]}, "url":
      "https://www.semanticscholar.org/paper/cd0d6917325bf9d09e15dd5cda895d675703870a",
      "title": "Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase
      inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal
      growth factor receptor 2-negative metastatic breast cancer.", "abstract": "PURPOSE\nBuparlisib,
      an oral reversible inhibitor of all class I phosphoinositide-3-kinases, has
      shown antitumoral activity against estrogen receptor (ER)-positive breast cancer
      cell lines and xenografts, alone and with endocrine therapy. This phase Ib study
      evaluated buparlisib plus letrozole''s safety, tolerability, and preliminary
      activity in patients with metastatic ER-positive breast cancer refractory to
      endocrine therapy.\n\n\nPATIENTS AND METHODS\nPatients received letrozole and
      buparlisib in two different administration schedules. Outcomes were assessed
      by standard solid-tumor phase I methods. [(18)F]fluorodeoxyglucose-positron
      emission tomography/computed tomography ([(18)F]FDG-PET/CT) scans were done
      at baseline and 2 weeks after treatment initiation. Tumor blocks were collected
      for phosphoinositide-3-kinase pathway mutation analysis.\n\n\nRESULTS\nFifty-one
      patients were allocated sequentially to continuous or intermittent (five on/two
      off days) buparlisib administration on an every-4-week schedule. Buparlisib''s
      maximum-tolerated dose (MTD) was 100 mg/d. Common drug-related adverse events
      included \u2264 grade 2 hyperglycemia, nausea, fatigue, transaminitis, and mood
      disorders. The clinical benefit rate (lack of progression \u2265 6 months) among
      all patients treated at the MTD was 31%, including two objective responses in
      the continuous dose arm. Of seven patients remaining on treatment \u2265 12
      months, three had tumors with PIK3CA hot-spot mutation. Patients exhibiting
      metabolic disease progression by [(18)F]FDG-PET/CT scan at 2 weeks progressed
      rapidly on therapy.\n\n\nCONCLUSION\nThe letrozole and buparlisib combination
      was safe, with reversible toxicities regardless of schedule administration.
      Clinical activity was observed independent of PIK3CA mutation status. No metabolic
      response by [(18)F]FDG-PET/CT scan at 2 weeks was associated with rapid disease
      progression. Phase III trials of buparlisib and endocrine therapy in patients
      with ER-positive breast cancer are ongoing.", "venue": "Journal of Clinical
      Oncology", "year": 2014, "referenceCount": 33, "citationCount": 159, "influentialCitationCount":
      5, "isOpenAccess": true, "openAccessPdf": {"url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.54.0518?role=tab",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Study", "JournalArticle", "ClinicalTrial"], "publicationDate":
      "2014-04-20", "journal": {"volume": "32 12", "pages": "\n          1202-9\n        ",
      "name": "Journal of clinical oncology : official journal of the American Society
      of Clinical Oncology"}, "citationStyles": {"bibtex": "@Article{Mayer2014StandUT,\n
      author = {I. Mayer and V. Abramson and S. Isakoff and A. Forero and J. Balko
      and M. Kuba and M. Sanders and J. Yap and A. D. Van den Abbeele and Yisheng
      Li and L. Cantley and E. Winer and C. Arteaga},\n booktitle = {Journal of Clinical
      Oncology},\n journal = {Journal of clinical oncology : official journal of the
      American Society of Clinical Oncology},\n pages = {\n          1202-9\n        },\n
      title = {Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase
      inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal
      growth factor receptor 2-negative metastatic breast cancer.},\n volume = {32
      12},\n year = {2014}\n}\n"}, "authors": [{"authorId": "2346140", "name": "I.
      Mayer"}, {"authorId": "2186029", "name": "V. Abramson"}, {"authorId": "4327978",
      "name": "S. Isakoff"}, {"authorId": "144854481", "name": "A. Forero"}, {"authorId":
      "66935619", "name": "J. Balko"}, {"authorId": "40266307", "name": "M. Kuba"},
      {"authorId": "46945931", "name": "M. Sanders"}, {"authorId": "34773169", "name":
      "J. Yap"}, {"authorId": "6566244", "name": "A. D. Van den Abbeele"}, {"authorId":
      "2111151410", "name": "Yisheng Li"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2369378", "name": "E. Winer"}, {"authorId": "2057460", "name":
      "C. Arteaga"}]}, {"paperId": "ce33c563f50f42ab8154bf76fe6e53a2b954549a", "externalIds":
      {"MAG": "2033319963", "PubMedCentral": "4073077", "DOI": "10.1186/2049-3002-2-S1-P44",
      "CorpusId": 84257486}, "corpusId": 84257486, "publicationVenue": {"id": "787ea3c5-4d66-450c-b13d-9f7934429b7f",
      "name": "Cancer & Metabolism", "type": "journal", "alternate_names": ["Cancer
      Metab", "Cancer and Metabolism", "Cancer  Metab"], "issn": "2049-3002", "url":
      "http://www.cancerandmetabolism.com/"}, "url": "https://www.semanticscholar.org/paper/ce33c563f50f42ab8154bf76fe6e53a2b954549a",
      "title": "Pancreatic cancers depend on a non-canonical glutamine metabolism
      pathway", "abstract": null, "venue": "Cancer & Metabolism", "year": 2014, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://cancerandmetabolism.biomedcentral.com/counter/pdf/10.1186/2049-3002-2-S1-P44",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2014-05-28", "journal": {"volume": "2", "pages": "P44 -
      P44", "name": "Cancer & Metabolism"}, "citationStyles": {"bibtex": "@Article{Lyssiotis2014PancreaticCD,\n
      author = {C. Lyssiotis and J. Son and J. Mancias and H. Ying and Alec C. Kimmelman
      and L. Cantley},\n booktitle = {Cancer & Metabolism},\n journal = {Cancer &
      Metabolism},\n pages = {P44 - P44},\n title = {Pancreatic cancers depend on
      a non-canonical glutamine metabolism pathway},\n volume = {2},\n year = {2014}\n}\n"},
      "authors": [{"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "38313825",
      "name": "J. Son"}, {"authorId": "5810602", "name": "J. Mancias"}, {"authorId":
      "33312849", "name": "H. Ying"}, {"authorId": "4668673", "name": "Alec C. Kimmelman"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "d59ac67aacc4f9eeb8d12ae9f08ad30076a94355",
      "externalIds": {"MAG": "2169228223", "DOI": "10.1158/2159-8290.CD-13-0230",
      "CorpusId": 9173254, "PubMed": "24866151"}, "corpusId": 9173254, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/d59ac67aacc4f9eeb8d12ae9f08ad30076a94355",
      "title": "Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound
      PARP-PI3K inhibition.", "abstract": "UNLABELLED\nProstate cancer is the most
      prevalent cancer in males, and treatment options are limited for advanced forms
      of the disease. Loss of the PTEN and TP53 tumor suppressor genes is commonly
      observed in prostate cancer, whereas their compound loss is often observed in
      advanced prostate cancer. Here, we show that PARP inhibition triggers a p53-dependent
      cellular senescence in a PTEN-deficient setting in the prostate. Surprisingly,
      we also find that PARP-induced cellular senescence is morphed into an apoptotic
      response upon compound loss of PTEN and p53. We further show that superactivation
      of the prosurvival PI3K-AKT signaling pathway limits the efficacy of a PARP
      single-agent treatment, and that PARP and PI3K inhibitors effectively synergize
      to suppress tumorigenesis in human prostate cancer cell lines and in a Pten/Trp53-deficient
      mouse model of advanced prostate cancer. Our findings, therefore, identify a
      combinatorial treatment with PARP and PI3K inhibitors as an effective option
      for PTEN-deficient prostate cancer.\n\n\nSIGNIFICANCE\nThe paucity of therapeutic
      options in advanced prostate cancer displays an urgent need for the preclinical
      assessment of novel therapeutic strategies. We identified differential therapeutic
      vulnerabilities that emerge upon the loss of both PTEN and p53, and observed
      that combined inhibition of PARP and PI3K provides increased efficacy in hormone-insensitive
      advanced prostate cancer.", "venue": "Cancer Discovery", "year": 2014, "referenceCount":
      27, "citationCount": 79, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://cancerdiscovery.aacrjournals.org/content/candisc/4/8/896.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2014-05-27", "journal": {"volume": "4 8", "pages": "\n          896-904\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Gonzalez-Billalabeitia2014VulnerabilitiesOP,\n
      author = {E. Gonzalez-Billalabeitia and N. Seitzer and S. Song and M. Song and
      Akash Patnaik and Xue-Song Liu and M. Epping and A. Papa and R. Hobbs and Ming
      Chen and A. Lunardi and Christopher Ng and Kaitlyn A. Webster and S. Signoretti
      and M. Loda and J. Asara and C. Nardella and J. Clohessy and L. Cantley and
      P. Pandolfi},\n booktitle = {Cancer Discovery},\n journal = {Cancer discovery},\n
      pages = {\n          896-904\n        },\n title = {Vulnerabilities of PTEN-TP53-deficient
      prostate cancers to compound PARP-PI3K inhibition.},\n volume = {4 8},\n year
      = {2014}\n}\n"}, "authors": [{"authorId": "1398122926", "name": "E. Gonzalez-Billalabeitia"},
      {"authorId": "3793357", "name": "N. Seitzer"}, {"authorId": "9673009", "name":
      "S. Song"}, {"authorId": "2967391", "name": "M. Song"}, {"authorId": "40501341",
      "name": "Akash Patnaik"}, {"authorId": "8015447", "name": "Xue-Song Liu"}, {"authorId":
      "4276612", "name": "M. Epping"}, {"authorId": "5380009", "name": "A. Papa"},
      {"authorId": "4584039", "name": "R. Hobbs"}, {"authorId": "48622732", "name":
      "Ming Chen"}, {"authorId": "5729169", "name": "A. Lunardi"}, {"authorId": "6294709",
      "name": "Christopher Ng"}, {"authorId": "4817196", "name": "Kaitlyn A. Webster"},
      {"authorId": "7505152", "name": "S. Signoretti"}, {"authorId": "6213932", "name":
      "M. Loda"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "3547827",
      "name": "C. Nardella"}, {"authorId": "4102988", "name": "J. Clohessy"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4499580", "name": "P. Pandolfi"}]},
      {"paperId": "d70fa8dfca0f230336c5fe00857ca539f3b0fd12", "externalIds": {"MAG":
      "2072276834", "DOI": "10.1093/NEUONC/NOU242.33", "CorpusId": 85200684}, "corpusId":
      85200684, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/d70fa8dfca0f230336c5fe00857ca539f3b0fd12",
      "title": "CS-33 * DISCOVERY OF A p53-INDEPENDENT SUPPRESSOR OF SENESCENCE OF
      GLIOBLASTOMA MULTIFORME", "abstract": "Glioblastoma multiforme (GBM) is the
      most malignant brain tumor and resistant to cell senescence. Through proteomic
      screening we have identified a novel type of kinase, tentatively named, SSK1
      (Super Signaling Kinase-1) that could connect cellular metabolism to cell growth.
      Depletion of SSK1 induced cellular senescence and diminished GBM cell growth
      in vitro and in a xenograft tumor model. The senescence caused by SSK1 depletion
      was accompanied by the induction of p21WAF1/CIP1, a critical inducer of cell
      senescence. Importantly, p21WAF1/CIP1 induction was independent of p53, reactive
      oxygen species (ROS) status, and DNA damage response pathways. Critically, the
      kinase activity of SSK1 is indispensable for GBM to suppress the induction of
      p21WAF1/CIP1 and escape senescence. Through chemical library screening, we identified
      a small molecule, which inhibited SSK1 activity in vitro and in vivo. Treatment
      of SSK1 inhibitor increased p21WAF1/CIP1 and triggered GBM senescence. Our data
      reveal a novel p21WAF1/CIP1 regulatory pathway mediated by SSK1, which is essential
      for GBM to suppress senescence, and suggest a novel therapy for their treatment,
      pharmacologically targeting SSK1.", "venue": "", "year": 2014, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2014-11-01", "journal": {"volume": "16", "name": "Neuro-oncology"},
      "citationStyles": {"bibtex": "@Article{Sumita2014CS33D,\n author = {Kazutaka
      Sumita and Mindy I. Davis and R. Pragani and Jumpei Terakawa and T. Daikoku
      and Nazanin K. Majd and M. Shen and Zhuyin Li and Xin Hu and L. Cantley and
      M. Boxer and A. Simeonov and A. Sasaki},\n journal = {Neuro-oncology},\n title
      = {CS-33 * DISCOVERY OF A p53-INDEPENDENT SUPPRESSOR OF SENESCENCE OF GLIOBLASTOMA
      MULTIFORME},\n volume = {16},\n year = {2014}\n}\n"}, "authors": [{"authorId":
      "49715313", "name": "Kazutaka Sumita"}, {"authorId": "29195749", "name": "Mindy
      I. Davis"}, {"authorId": "5123505", "name": "R. Pragani"}, {"authorId": "49515406",
      "name": "Jumpei Terakawa"}, {"authorId": "145457715", "name": "T. Daikoku"},
      {"authorId": "48742800", "name": "Nazanin K. Majd"}, {"authorId": "145829790",
      "name": "M. Shen"}, {"authorId": "4837727", "name": "Zhuyin Li"}, {"authorId":
      "51374815", "name": "Xin Hu"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "3275486", "name": "M. Boxer"}, {"authorId": "145183304", "name":
      "A. Simeonov"}, {"authorId": "47742211", "name": "A. Sasaki"}]}, {"paperId":
      "ec897b66db68cd288dc4f249a2daa08fc8f03257", "externalIds": {"MAG": "1999143583",
      "DOI": "10.1158/1538-7445.AM2014-NG05", "CorpusId": 84732150}, "corpusId": 84732150,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/ec897b66db68cd288dc4f249a2daa08fc8f03257",
      "title": "Abstract NG05: Depletion of a putatively druggable class of phosphatidylinositol
      kinases inhibits growth of p53 null tumors", "abstract": null, "venue": "",
      "year": 2014, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2014-10-01", "journal": {"volume":
      "74", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Emerling2014AbstractND,\n
      author = {B. Emerling and J. Hurov and G. Poulogiannis and R. Choo-Wing and
      G. Wulf and Hyeseok Shim and K. Lamia and L. Rameh and Xin Yuan and A. Bullock
      and G. DeNicola and Jiaxi Song and S. Signoretti and L. Cantley},\n journal
      = {Cancer Research},\n title = {Abstract NG05: Depletion of a putatively druggable
      class of phosphatidylinositol kinases inhibits growth of p53 null tumors},\n
      volume = {74},\n year = {2014}\n}\n"}, "authors": [{"authorId": "5542751", "name":
      "B. Emerling"}, {"authorId": "50139635", "name": "J. Hurov"}, {"authorId": "4612853",
      "name": "G. Poulogiannis"}, {"authorId": "1401641678", "name": "R. Choo-Wing"},
      {"authorId": "31554501", "name": "G. Wulf"}, {"authorId": "13574443", "name":
      "Hyeseok Shim"}, {"authorId": "5493258", "name": "K. Lamia"}, {"authorId": "4109960",
      "name": "L. Rameh"}, {"authorId": "48732236", "name": "Xin Yuan"}, {"authorId":
      "4440909", "name": "A. Bullock"}, {"authorId": "4772111", "name": "G. DeNicola"},
      {"authorId": "5112147", "name": "Jiaxi Song"}, {"authorId": "7505152", "name":
      "S. Signoretti"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "01b72f8364dec64206f8807292d931aea286300b", "externalIds": {"MAG": "2033228549",
      "DOI": "10.1016/j.cell.2013.04.023", "CorpusId": 7029480, "PubMed": "23663782"},
      "corpusId": 7029480, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/01b72f8364dec64206f8807292d931aea286300b",
      "title": "The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation
      by Repressing SIRT4", "abstract": null, "venue": "Cell", "year": 2013, "referenceCount":
      61, "citationCount": 502, "influentialCitationCount": 33, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0092867413004650/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-05-09", "journal": {"volume": "153", "pages": "840-854",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Csibi2013TheMP,\n author
      = {A. Csibi and S. Fendt and Chenggang Li and G. Poulogiannis and A. Y. Choo
      and Douglas J. Chapski and S. Jeong and J. Dempsey and A. Parkhitko and Tasha
      A Morrison and E. Henske and M. Haigis and L. Cantley and G. Stephanopoulos
      and Jane J. Yu and J. Blenis},\n booktitle = {Cell},\n journal = {Cell},\n pages
      = {840-854},\n title = {The mTORC1 Pathway Stimulates Glutamine Metabolism and
      Cell Proliferation by Repressing SIRT4},\n volume = {153},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "6688912", "name": "A. Csibi"}, {"authorId": "46775302",
      "name": "S. Fendt"}, {"authorId": "49672566", "name": "Chenggang Li"}, {"authorId":
      "4612853", "name": "G. Poulogiannis"}, {"authorId": "32210637", "name": "A.
      Y. Choo"}, {"authorId": "2267037785", "name": "Douglas J. Chapski"}, {"authorId":
      "2112433", "name": "S. Jeong"}, {"authorId": "3765048", "name": "J. Dempsey"},
      {"authorId": "3744617", "name": "A. Parkhitko"}, {"authorId": "4644464", "name":
      "Tasha A Morrison"}, {"authorId": "4397360", "name": "E. Henske"}, {"authorId":
      "6212141", "name": "M. Haigis"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "1813278", "name": "G. Stephanopoulos"}, {"authorId": "79481462",
      "name": "Jane J. Yu"}, {"authorId": "4037343", "name": "J. Blenis"}]}, {"paperId":
      "08557ebb6996dd01db41a758a2f0f8344b90ef16", "externalIds": {"MAG": "2435209661",
      "CorpusId": 194485798}, "corpusId": 194485798, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/08557ebb6996dd01db41a758a2f0f8344b90ef16",
      "title": "Figure 3, [A) SDS-PAGE run under non-reducing...].", "abstract": null,
      "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Mathematics"],
      "s2FieldsOfStudy": [{"category": "Mathematics", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2013-05-08", "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Brimacombe2013Figure3,\n
      author = {K. Brimacombe and D. Anastasiou and B. Hong and W. Tempel and S. Dimov
      and H. Veith and D. Auld and M. V. Heiden and Craig J. Thomas and Hee-won Park
      and M. Shen and L. Cantley and M. Boxer},\n title = {Figure 3, [A) SDS-PAGE
      run under non-reducing...].},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "2435894", "name": "K. Brimacombe"}, {"authorId": "46996935", "name": "D. Anastasiou"},
      {"authorId": "6351971", "name": "B. Hong"}, {"authorId": "5566934", "name":
      "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"}, {"authorId": "1799343",
      "name": "H. Veith"}, {"authorId": "2607088", "name": "D. Auld"}, {"authorId":
      "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632", "name": "Craig
      J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"}, {"authorId": "145829790",
      "name": "M. Shen"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3275486", "name": "M. Boxer"}]}, {"paperId": "0cea8b880c97b38529f4f24a0745d023ff1176df",
      "externalIds": {"MAG": "1980478078", "DOI": "10.1038/502181a", "CorpusId": 4388649,
      "PubMed": "24108049"}, "corpusId": 4388649, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/0cea8b880c97b38529f4f24a0745d023ff1176df",
      "title": "Metabolic syndrome: F stands for fructose and fat", "abstract": null,
      "venue": "Nature", "year": 2013, "referenceCount": 12, "citationCount": 57,
      "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Chemistry", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["LettersAndComments", "News"],
      "publicationDate": "2013-10-09", "journal": {"volume": "502", "pages": "181-182",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Lyssiotis2013MetabolicSF,\n
      author = {C. Lyssiotis and L. Cantley},\n booktitle = {Nature},\n journal =
      {Nature},\n pages = {181-182},\n title = {Metabolic syndrome: F stands for fructose
      and fat},\n volume = {502},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "0ea33159c583666298a6e6c8f0081844714cc2ed", "externalIds": {"MAG":
      "2030057907", "DOI": "10.1016/j.cell.2013.09.057", "CorpusId": 17031371, "PubMed":
      "24209622"}, "corpusId": 17031371, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/0ea33159c583666298a6e6c8f0081844714cc2ed",
      "title": "Depletion of a Putatively Druggable Class of Phosphatidylinositol
      Kinases Inhibits Growth of p53-Null Tumors", "abstract": null, "venue": "Cell",
      "year": 2013, "referenceCount": 37, "citationCount": 154, "influentialCitationCount":
      5, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867413012336/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-11-07", "journal": {"volume": "155", "pages": "844-857",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Emerling2013DepletionOA,\n
      author = {B. Emerling and J. Hurov and G. Poulogiannis and Kazumi S. Tsukazawa
      and R. Choo-Wing and G. Wulf and Eric L. Bell and Hyeseok Shim and K. Lamia
      and L. Rameh and G. Bellinger and A. Sasaki and J. Asara and Xin Yuan and A.
      Bullock and G. DeNicola and Jiaxi Song and Victoria Brown and S. Signoretti
      and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n pages = {844-857},\n
      title = {Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases
      Inhibits Growth of p53-Null Tumors},\n volume = {155},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "50139635",
      "name": "J. Hurov"}, {"authorId": "4612853", "name": "G. Poulogiannis"}, {"authorId":
      "8254104", "name": "Kazumi S. Tsukazawa"}, {"authorId": "1401641678", "name":
      "R. Choo-Wing"}, {"authorId": "31554501", "name": "G. Wulf"}, {"authorId": "49200178",
      "name": "Eric L. Bell"}, {"authorId": "13574443", "name": "Hyeseok Shim"}, {"authorId":
      "5493258", "name": "K. Lamia"}, {"authorId": "4109960", "name": "L. Rameh"},
      {"authorId": "5679020", "name": "G. Bellinger"}, {"authorId": "47742211", "name":
      "A. Sasaki"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "48732236",
      "name": "Xin Yuan"}, {"authorId": "4440909", "name": "A. Bullock"}, {"authorId":
      "4772111", "name": "G. DeNicola"}, {"authorId": "5112147", "name": "Jiaxi Song"},
      {"authorId": "49917633", "name": "Victoria Brown"}, {"authorId": "7505152",
      "name": "S. Signoretti"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "121d939e8f5f894cd9e2550e175b5afbec6978ed", "externalIds": {"MAG": "2116716449",
      "DOI": "10.1158/2159-8290.CD-13-0015", "CorpusId": 7660190, "PubMed": "23715154"},
      "corpusId": 7660190, "publicationVenue": {"id": "de16002a-77c3-4d03-9348-5a1813238e0b",
      "name": "Cancer Discovery", "type": "journal", "alternate_names": ["Cancer Discov"],
      "issn": "2159-8274", "url": "https://cancerdiscovery.aacrjournals.org/"}, "url":
      "https://www.semanticscholar.org/paper/121d939e8f5f894cd9e2550e175b5afbec6978ed",
      "title": "Metabolic and functional genomic studies identify deoxythymidylate
      kinase as a target in LKB1-mutant lung cancer.", "abstract": "The LKB1/STK11
      tumor suppressor encodes a serine/threonine kinase, which coordinates cell growth,
      polarity, motility, and metabolism. In non-small cell lung carcinoma, LKB1 is
      somatically inactivated in 25% to 30% of cases, often concurrently with activating
      KRAS mutations. Here, we used an integrative approach to define novel therapeutic
      targets in KRAS-driven LKB1-mutant lung cancers. High-throughput RNA interference
      screens in lung cancer cell lines from genetically engineered mouse models driven
      by activated KRAS with or without coincident Lkb1 deletion led to the identification
      of Dtymk, encoding deoxythymidylate kinase (DTYMK), which catalyzes dTTP biosynthesis,
      as synthetically lethal with Lkb1 deficiency in mouse and human lung cancer
      lines. Global metabolite profiling showed that Lkb1-null cells had a striking
      decrease in multiple nucleotide metabolites as compared with the Lkb1-wild-type
      cells. Thus, LKB1-mutant lung cancers have deficits in nucleotide metabolism
      that confer hypersensitivity to DTYMK inhibition, suggesting that DTYMK is a
      potential therapeutic target in this aggressive subset of tumors.", "venue":
      "Cancer Discovery", "year": 2013, "referenceCount": 39, "citationCount": 113,
      "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://cancerdiscovery.aacrjournals.org/content/candisc/3/8/870.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-08-01", "journal": {"volume": "3 8", "pages": "\n          870-9\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Liu2013MetabolicAF,\n
      author = {Yan Liu and K. Marks and G. Cowley and J. Carretero and Qingsong Liu
      and T. J. Nieland and Chunxiao Xu and Travis J. Cohoon and P. Gao and Yong Zhang
      and Zhao Chen and Abigail Altabef and J. Tchaicha and Xiaoxu Wang and Sung E.
      Choe and E. Driggers and Jianming Zhang and Sean T. Bailey and N. Sharpless
      and D. Hayes and N. Patel and P. Janne and N. Bardeesy and J. Engelman and B.
      Manning and R. Shaw and J. Asara and R. Scully and Alec C. Kimmelman and L.
      Byers and D. Gibbons and I. Wistuba and J. Heymach and D. Kwiatkowski and William
      Y. Kim and A. Kung and N. Gray and D. Root and L. Cantley and Kwok-kin Wong},\n
      booktitle = {Cancer Discovery},\n journal = {Cancer discovery},\n pages = {\n          870-9\n        },\n
      title = {Metabolic and functional genomic studies identify deoxythymidylate
      kinase as a target in LKB1-mutant lung cancer.},\n volume = {3 8},\n year =
      {2013}\n}\n"}, "authors": [{"authorId": "1700568", "name": "Yan Liu"}, {"authorId":
      "145638995", "name": "K. Marks"}, {"authorId": "40516027", "name": "G. Cowley"},
      {"authorId": "39474995", "name": "J. Carretero"}, {"authorId": "1933095", "name":
      "Qingsong Liu"}, {"authorId": "3790196", "name": "T. J. Nieland"}, {"authorId":
      "46747874", "name": "Chunxiao Xu"}, {"authorId": "9926063", "name": "Travis
      J. Cohoon"}, {"authorId": "144579867", "name": "P. Gao"}, {"authorId": "2144288313",
      "name": "Yong Zhang"}, {"authorId": "1491946371", "name": "Zhao Chen"}, {"authorId":
      "6594506", "name": "Abigail Altabef"}, {"authorId": "4557419", "name": "J. Tchaicha"},
      {"authorId": "48631933", "name": "Xiaoxu Wang"}, {"authorId": "48918385", "name":
      "Sung E. Choe"}, {"authorId": "4691854", "name": "E. Driggers"}, {"authorId":
      "47294251", "name": "Jianming Zhang"}, {"authorId": "12828558", "name": "Sean
      T. Bailey"}, {"authorId": "3525978", "name": "N. Sharpless"}, {"authorId": "143731085",
      "name": "D. Hayes"}, {"authorId": "3083071", "name": "N. Patel"}, {"authorId":
      "4147848", "name": "P. Janne"}, {"authorId": "5974412", "name": "N. Bardeesy"},
      {"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "2339651", "name":
      "B. Manning"}, {"authorId": "4426388", "name": "R. Shaw"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "143905392", "name": "R. Scully"}, {"authorId":
      "4668673", "name": "Alec C. Kimmelman"}, {"authorId": "1939017", "name": "L.
      Byers"}, {"authorId": "2196489", "name": "D. Gibbons"}, {"authorId": "46528860",
      "name": "I. Wistuba"}, {"authorId": "2192944576", "name": "J. Heymach"}, {"authorId":
      "2942901", "name": "D. Kwiatkowski"}, {"authorId": "46392220", "name": "William
      Y. Kim"}, {"authorId": "145326814", "name": "A. Kung"}, {"authorId": "3977406",
      "name": "N. Gray"}, {"authorId": "3198018", "name": "D. Root"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "32596484", "name": "Kwok-kin
      Wong"}]}, {"paperId": "23a08b9311d1a88ffb1b4651772f255b0e043a6d", "externalIds":
      {"CorpusId": 13060080}, "corpusId": 13060080, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/23a08b9311d1a88ffb1b4651772f255b0e043a6d",
      "title": "FoxO 3 coordinates metabolic pathways to maintain redox balance in
      neural stem cells", "abstract": "-Ref#1 finds interesting data in the study,
      is however concerned that it is entirely based on foldchanges. With the current
      description of methods, s/he finds it difficult to judge the overall significance
      of the data. (As an aside, cropping of blots would need to be verified by provision
      of original source data). Lastly, the NAC-feeding experiments indicate functional
      relevance, though they seem not to offer direct proof for the actual molecular-mechanistic
      underpinnings with regard to glucose/glutamine metabolism.", "venue": "", "year":
      2013, "referenceCount": 0, "citationCount": 16, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Yeo2013FoxO3C,\n
      author = {Hyeonju Yeo and C. Lyssiotis and Yuqing Zhang and H. Ying and J. Asara
      and L. Cantley and J. Paik},\n title = {FoxO 3 coordinates metabolic pathways
      to maintain redox balance in neural stem cells},\n year = {2013}\n}\n"}, "authors":
      [{"authorId": "4250474", "name": "Hyeonju Yeo"}, {"authorId": "4901222", "name":
      "C. Lyssiotis"}, {"authorId": "2108446203", "name": "Yuqing Zhang"}, {"authorId":
      "33312849", "name": "H. Ying"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5056578", "name":
      "J. Paik"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '302837'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:39 GMT
      Via:
      - 1.1 f28e802e600102d0339fa542ab6a0426.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - 09Ui_Gv-NL-oxjE3AmiEfM8Med-zmDMCWaj4YihkukkhPs6ILK3NeA==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0x2EXUvHcEo4w=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '302837'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:39 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - 2bb9dbb8-d755-4c92-98ad-e334a2939c48
    http_version: HTTP/1.1
    status_code: 200
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=300&limit=100
  response:
    content: '{"offset": 300, "next": 400, "data": [{"paperId": "25f6ccedaeb88e88dc7f17c5f47c939b160bf533",
      "externalIds": {"MAG": "2104167441", "DOI": "10.1158/2159-8290.CD-13-0063",
      "CorpusId": 15737239, "PubMed": "24265156"}, "corpusId": 15737239, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/25f6ccedaeb88e88dc7f17c5f47c939b160bf533",
      "title": "What a tangled web we weave: emerging resistance mechanisms to inhibition
      of the phosphoinositide 3-kinase pathway.", "abstract": "UNLABELLED\nThe phosphoinositide
      3-kinase (PI3K) pathway is one of the most frequently mutated pathways in cancer,
      and is actively being pursued as a therapeutic target. Despite the importance
      of the PI3K pathway in cancer, durable responses to PI3K pathway-targeted therapies
      are uncommon with monotherapy. Several in vitro and xenograft models have elucidated
      compensatory signaling and genomic changes which may limit the therapeutic effectiveness
      of PI3K inhibitors in the clinic. Future clinical trials with prospective evaluation
      of tumor signaling and genomic changes are likely to identify novel resistance
      mechanisms as well as subsets of patients who may derive maximal benefit from
      PI3K pathway inhibitors.\n\n\nSIGNIFICANCE\nThere are multiple ongoing clinical
      trials targeting the PI3K pathway members in several malignancies. This review
      summarizes the known mechanisms of resistance to targeting the PI3K pathway.
      Understanding of resistance mechanisms will help to inform more rational clinical
      trial design to optimize the clinical impact of targeting the PI3K pathway in
      cancer.", "venue": "Cancer Discovery", "year": 2013, "referenceCount": 113,
      "citationCount": 139, "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://cancerdiscovery.aacrjournals.org/content/candisc/3/12/1345.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "2013-12-01", "journal": {"volume":
      "3 12", "pages": "\n          1345-54\n        ", "name": "Cancer discovery"},
      "citationStyles": {"bibtex": "@Article{Klempner2013WhatAT,\n author = {S. Klempner
      and A. Myers and L. Cantley},\n booktitle = {Cancer Discovery},\n journal =
      {Cancer discovery},\n pages = {\n          1345-54\n        },\n title = {What
      a tangled web we weave: emerging resistance mechanisms to inhibition of the
      phosphoinositide 3-kinase pathway.},\n volume = {3 12},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "4677205", "name": "S. Klempner"}, {"authorId": "6324437",
      "name": "A. Myers"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "2f1b3fa0b9ec8ba031a7269af5c488640bffe474", "externalIds": {"MAG": "2101967659",
      "DOI": "10.1242/dev.091777", "CorpusId": 8271162, "PubMed": "23715547"}, "corpusId":
      8271162, "publicationVenue": {"id": "179847ef-8e79-48e2-99ee-769211d3e729",
      "name": "Development", "type": "journal", "issn": "0950-1991", "alternate_issns":
      ["0212-2448"], "url": "https://dev.biologists.org/", "alternate_urls": ["http://dev.biologists.org/",
      "http://journals.ecs.soton.ac.uk/journals/dev.html"]}, "url": "https://www.semanticscholar.org/paper/2f1b3fa0b9ec8ba031a7269af5c488640bffe474",
      "title": "Stem cell metabolism in tissue development and aging", "abstract":
      "Recent advances in metabolomics and computational analysis have deepened our
      appreciation for the role of specific metabolic pathways in dictating cell fate.
      Once thought to be a mere consequence of the state of a cell, metabolism is
      now known to play a pivotal role in dictating whether a cell proliferates, differentiates
      or remains quiescent. Here, we review recent studies of metabolism in stem cells
      that have revealed a shift in the balance between glycolysis, mitochondrial
      oxidative phosphorylation and oxidative stress during the maturation of adult
      stem cells, and during the reprogramming of somatic cells to pluripotency. These
      insights promise to inform strategies for the directed differentiation of stem
      cells and to offer the potential for novel metabolic or pharmacological therapies
      to enhance regeneration and the treatment of degenerative disease.", "venue":
      "Development", "year": 2013, "referenceCount": 131, "citationCount": 504, "influentialCitationCount":
      34, "isOpenAccess": true, "openAccessPdf": {"url": "https://dev.biologists.org/content/develop/140/12/2535.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2013-06-15", "journal": {"volume": "140", "pages": "2535
      - 2547", "name": "Development"}, "citationStyles": {"bibtex": "@Article{Shyh\u2010Chang2013StemCM,\n
      author = {Ng Shyh\u2010Chang and G. Daley and L. Cantley},\n booktitle = {Development},\n
      journal = {Development},\n pages = {2535 - 2547},\n title = {Stem cell metabolism
      in tissue development and aging},\n volume = {140},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "1397529716", "name": "Ng Shyh\u2010Chang"}, {"authorId":
      "2028224", "name": "G. Daley"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "390c6da813a7542e9e1b8c1d0fb200b720bf928a", "externalIds": {"MAG":
      "1986653575", "DOI": "10.1074/jbc.M112.441469", "CorpusId": 205328922, "PubMed":
      "23640882"}, "corpusId": 205328922, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/390c6da813a7542e9e1b8c1d0fb200b720bf928a",
      "title": "Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine
      Phosphorylation*", "abstract": "Background: Tyrosine phosphorylation of PKM2
      inhibits its activity; however, the phosphatase(s) that regulates PKM2 phosphorylation
      remains unidentified. Results: PKM2 is a novel PTP1B substrate and PKM2 Tyr-105
      and Tyr-148 are key sites that mediate the interaction. Conclusion: PTP1B regulates
      PKM2 tyrosine phosphorylation and activity in adipocytes. Significance: These
      findings provide new insights into the regulation of adipose PKM2 activity.
      Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of glucose
      homeostasis and adiposity and is a drug target for the treatment of obesity
      and diabetes. Here we identify pyruvate kinase M2 (PKM2) as a novel PTP1B substrate
      in adipocytes. PTP1B deficiency leads to increased PKM2 total tyrosine and Tyr105
      phosphorylation in cultured adipocytes and in vivo. Substrate trapping and mutagenesis
      studies identify PKM2 Tyr-105 and Tyr-148 as key sites that mediate PTP1B-PKM2
      interaction. In addition, in vitro analyses illustrate a direct effect of Tyr-105
      phosphorylation on PKM2 activity in adipocytes. Importantly, PTP1B pharmacological
      inhibition increased PKM2 Tyr-105 phosphorylation and decreased PKM2 activity.
      Moreover, PKM2 Tyr-105 phosphorylation is regulated nutritionally, decreasing
      in adipose tissue depots after high-fat feeding. Further, decreased PKM2 Tyr-105
      phosphorylation correlates with the development of glucose intolerance and insulin
      resistance in rodents, non-human primates, and humans. Together, these findings
      identify PKM2 as a novel substrate of PTP1B and provide new insights into the
      regulation of adipose PKM2 activity.", "venue": "Journal of Biological Chemistry",
      "year": 2013, "referenceCount": 66, "citationCount": 50, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925820458788/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-05-02", "journal": {"volume": "288", "pages": "17360
      - 17371", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Bettaieb2013ProteinTP,\n author = {Ahmed Bettaieb and Jesse
      L Bakke and N. Nagata and Kosuke Matsuo and Yannan Xi and Siming Liu and Daniel
      Aboubechara and R. Melhem and K. Stanhope and B. Cummings and James Graham and
      A. Bremer and Shu-yuan Zhang and C. Lyssiotis and Zhon-Yin Zhang and L. Cantley
      and P. Havel and F. Haj},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of Biological Chemistry},\n pages = {17360 - 17371},\n
      title = {Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine
      Phosphorylation*},\n volume = {288},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "5956178", "name": "Ahmed Bettaieb"}, {"authorId": "50186862", "name": "Jesse
      L Bakke"}, {"authorId": "3957054", "name": "N. Nagata"}, {"authorId": "5647080",
      "name": "Kosuke Matsuo"}, {"authorId": "4692463", "name": "Yannan Xi"}, {"authorId":
      "50152449", "name": "Siming Liu"}, {"authorId": "12055558", "name": "Daniel
      Aboubechara"}, {"authorId": "4659311", "name": "R. Melhem"}, {"authorId": "6126451",
      "name": "K. Stanhope"}, {"authorId": "35012289", "name": "B. Cummings"}, {"authorId":
      "2074475036", "name": "James Graham"}, {"authorId": "34973043", "name": "A.
      Bremer"}, {"authorId": "12212212", "name": "Shu-yuan Zhang"}, {"authorId": "4901222",
      "name": "C. Lyssiotis"}, {"authorId": "29856927", "name": "Zhon-Yin Zhang"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144769314", "name":
      "P. Havel"}, {"authorId": "5546228", "name": "F. Haj"}]}, {"paperId": "4244c0546096c3751b83e0551600df4b80d57619",
      "externalIds": {"DOI": "10.4161/sgtp.26270", "CorpusId": 30148509, "PubMed":
      "24030601"}, "corpusId": 30148509, "publicationVenue": {"id": "3205b34d-949b-4d82-acd2-3ff08406c282",
      "name": "Small GTPases", "type": "journal", "alternate_names": ["Small Gtpases"],
      "issn": "2154-1248", "url": "http://www.landesbioscience.com/journals/smallgtpases/",
      "alternate_urls": ["http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ksgt20",
      "http://www.tandfonline.com/loi/ksgt20", "http://www.tandfonline.com/action/journalInformation?journalCode=ksgt20&show=aimsScope",
      "http://www.tandfonline.com/KSGT"]}, "url": "https://www.semanticscholar.org/paper/4244c0546096c3751b83e0551600df4b80d57619",
      "title": "Site-specific monoubiquitination activates Ras by impeding GTPase-activating
      protein function", "abstract": "KRas has recently been shown to be activated
      by monoubiquitination (mUb). Similar to oncogenic mutations, mUb of Ras at position
      147 activates Ras by causing a defect in GTPase activating protein (GAP) function.
      To characterize the mechanism by which mUb impairs GAP-mediated downregulation
      of Ras, we made various modifications at position 147 of Ras and examined the
      impact on Ras sensitivity to GAP function. Whereas small modifications (iodoacetamide
      and glutathione) at position 147 of Ras do not affect GAP-mediated hydrolysis,
      ligation of Ras to UbG76C (native linker), UbX77C (one residue longer), and
      PDZ2 (with a native ubiquitin linker) was defective in GAP-mediated GTP hydrolysis.
      However, restoration of GAP activity was observed for Ras modified with the
      PDZ2 domain containing a shorter and stiffer linker region than ubiquitin. Therefore,
      the properties of the linker region dictate whether modification affects GAP-mediated
      hydrolysis, and our data indicate that the GAP defect requires a minimum linker
      length of 7 to 8 residues.", "venue": "Small GTPases", "year": 2013, "referenceCount":
      70, "citationCount": 8, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.tandfonline.com/doi/pdf/10.4161/sgtp.26270?needAccess=true",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-07-01", "journal": {"volume": "4", "pages": "186 -
      192 - 52", "name": "Small GTPases"}, "citationStyles": {"bibtex": "@Article{Baker2013SitespecificMA,\n
      author = {R. Baker and Steven M. Lewis and A. Sasaki and Emily M. Wilkerson
      and J. Locasale and L. Cantley and B. Kuhlman and H. Dohlman and S. Campbell},\n
      booktitle = {Small GTPases},\n journal = {Small GTPases},\n pages = {186 - 192
      - 52},\n title = {Site-specific monoubiquitination activates Ras by impeding
      GTPase-activating protein function},\n volume = {4},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "145564214", "name": "R. Baker"}, {"authorId": "7268742",
      "name": "Steven M. Lewis"}, {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId":
      "5527411", "name": "Emily M. Wilkerson"}, {"authorId": "2268976", "name": "J.
      Locasale"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144226889",
      "name": "B. Kuhlman"}, {"authorId": "1710306", "name": "H. Dohlman"}, {"authorId":
      "46713144", "name": "S. Campbell"}]}, {"paperId": "44b72d6c188ee8d3a88c59bb85e55ca849bef638",
      "externalIds": {"PubMedCentral": "3656466", "MAG": "2014988241", "DOI": "10.1038/nature12040",
      "CorpusId": 3831884, "PubMed": "23535601"}, "corpusId": 3831884, "publicationVenue":
      {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/44b72d6c188ee8d3a88c59bb85e55ca849bef638",
      "title": "Glutamine supports pancreatic cancer growth through a Kras-regulated
      metabolic pathway", "abstract": null, "venue": "Nature", "year": 2013, "referenceCount":
      31, "citationCount": 1536, "influentialCitationCount": 85, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3656466?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-03-01", "journal": {"volume": "496", "pages": "101
      - 105", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Son2013GlutamineSP,\n
      author = {J. Son and C. Lyssiotis and H. Ying and Xiaoxu Wang and S. Hua and
      M. Ligorio and R. Perera and C. Ferrone and Edouard Mullarky and Ng Shyh\u2010Chang
      and Ya''an Kang and J. Fleming and N. Bardeesy and J. Asara and M. Haigis and
      R. DePinho and L. Cantley and Alec C. Kimmelman},\n booktitle = {Nature},\n
      journal = {Nature},\n pages = {101 - 105},\n title = {Glutamine supports pancreatic
      cancer growth through a Kras-regulated metabolic pathway},\n volume = {496},\n
      year = {2013}\n}\n"}, "authors": [{"authorId": "38313825", "name": "J. Son"},
      {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "33312849", "name":
      "H. Ying"}, {"authorId": "48631933", "name": "Xiaoxu Wang"}, {"authorId": "50767858",
      "name": "S. Hua"}, {"authorId": "4968898", "name": "M. Ligorio"}, {"authorId":
      "3557245", "name": "R. Perera"}, {"authorId": "3817898", "name": "C. Ferrone"},
      {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId": "1397529716",
      "name": "Ng Shyh\u2010Chang"}, {"authorId": "78102197", "name": "Ya''an Kang"},
      {"authorId": "144926646", "name": "J. Fleming"}, {"authorId": "5974412", "name":
      "N. Bardeesy"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "6212141",
      "name": "M. Haigis"}, {"authorId": "5593407", "name": "R. DePinho"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4668673", "name": "Alec C. Kimmelman"}]},
      {"paperId": "490453132c3f76159170f38e69a0dadb12988468", "externalIds": {"MAG":
      "2038733728", "DOI": "10.1016/j.molcel.2013.08.044", "CorpusId": 28476909, "PubMed":
      "24095280"}, "corpusId": 28476909, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/490453132c3f76159170f38e69a0dadb12988468",
      "title": "Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and
      cell proliferation.", "abstract": null, "venue": "Molecules and Cells", "year":
      2013, "referenceCount": 48, "citationCount": 119, "influentialCitationCount":
      9, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276513006448/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-10-24", "journal": {"volume": "52 2", "pages": "\n          161-72\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Shen2013PhosphorylationOB,\n
      author = {Che-Hung Shen and P. Yuan and R. P\u00e9rez-Lorenzo and Yaqing Zhang
      and S. Lee and Yang Ou and J. Asara and L. Cantley and B. Zheng},\n booktitle
      = {Molecules and Cells},\n journal = {Molecular cell},\n pages = {\n          161-72\n        },\n
      title = {Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell
      proliferation.},\n volume = {52 2},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "83946576", "name": "Che-Hung Shen"}, {"authorId": "22261570", "name": "P. Yuan"},
      {"authorId": "1398525526", "name": "R. P\u00e9rez-Lorenzo"}, {"authorId": "1591129979",
      "name": "Yaqing Zhang"}, {"authorId": "2108098779", "name": "S. Lee"}, {"authorId":
      "2057924812", "name": "Yang Ou"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "143918840", "name":
      "B. Zheng"}]}, {"paperId": "4b9812d5a8d963251bfe8ad7cc6a8432672220c2", "externalIds":
      {"MAG": "1976203358", "DOI": "10.1158/1538-7445.FBCR13-IA22", "CorpusId": 83848030},
      "corpusId": 83848030, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/4b9812d5a8d963251bfe8ad7cc6a8432672220c2",
      "title": "Abstract IA22: PI3K and cancer metabolism", "abstract": "Phosphoinositide
      3-Kinase (PI3K) is a central enzyme in a signaling pathway that mediates cellular
      responses to growth factors. The signaling pathway downstream of PI3K is highly
      conserved from worms and flies to humans and genetic analysis of the pathway
      has revealed a conserved role in regulating glucose metabolism and cell growth.
      Mutational events that lead to hyperactivation of the PI3K pathway result in
      hamartoma syndromes and cancers. Activating mutations in PIK3CA, encoding the
      p110alpha catalytic subunit of PI3K or inactivating mutations in PTEN, a phosphoinositide
      3-phosphatases that reverses the effects of PI3K, are among the most common
      events in solid tumors. Drugs that target PI3K are in clinical trials for a
      variety of cancers. It is likely that PI3K pathway inhibitors will need to be
      combined with other drugs to be broadly effective. We have employed genetically
      engineered mouse models that develop cancers due to mutations in genes in the
      PI3K pathway and are using these models to explore the efficacy of PI3K pathway
      inhibitors as single agents or in combination with other drugs. The role of
      PI3K inhibitors for treating cancers in these mouse models and in human trials
      will be discussed. Citation Format: Lewis C. Cantley. PI3K and cancer metabolism.
      [abstract]. In: Proceedings of the Third AACR International Conference on Frontiers
      in Basic Cancer Research; Sep 18-22, 2013; National Harbor, MD. Philadelphia
      (PA): AACR; Cancer Res 2013;73(19 Suppl):Abstract nr IA22.", "venue": "", "year":
      2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2013-10-01", "journal": {"volume":
      "73", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Cantley2013AbstractIP,\n
      author = {L. Cantley},\n journal = {Cancer Research},\n title = {Abstract IA22:
      PI3K and cancer metabolism},\n volume = {73},\n year = {2013}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "4ba92ec158a39ddfe3a3c487674180ffdb2e325d",
      "externalIds": {"MAG": "1480960095", "DOI": "10.1002/stem.1423", "CorpusId":
      11687941, "PubMed": "23666760"}, "corpusId": 11687941, "publicationVenue": {"id":
      "80635f01-c97a-4607-92eb-64f936e3cb72", "name": "Stem Cells", "type": "journal",
      "alternate_names": ["Stem Cell", "Stem cell"], "issn": "0250-6793", "alternate_issns":
      ["2571-7294", "1945-4570", "1066-5099"], "url": "http://onlinelibrary.wiley.com/journal/10.1002/(issn)1549-4918",
      "alternate_urls": ["http://sciencepub.net/stem/", "http://stemcells.alphamedpress.org/",
      "https://onlinelibrary.wiley.com/journal/15494918"]}, "url": "https://www.semanticscholar.org/paper/4ba92ec158a39ddfe3a3c487674180ffdb2e325d",
      "title": "Fetal Deficiency of Lin28 Programs Life\u2010Long Aberrations in Growth
      and Glucose Metabolism", "abstract": "LIN28A/B are RNA binding proteins implicated
      by genetic association studies in human growth and glucose metabolism. Mice
      with ectopic over\u2010expression of Lin28a have shown related phenotypes. Here,
      we describe the first comprehensive analysis of the physiologic consequences
      of Lin28a and Lin28b deficiency in knockout (KO) mice. Lin28a/b\u2010deficiency
      led to dwarfism starting at different ages, and compound gene deletions showed
      a cumulative dosage effect on organismal growth. Conditional gene deletion at
      specific developmental stages revealed that fetal but neither neonatal nor adult
      deficiency resulted in growth defects and aberrations in glucose metabolism.
      Tissue\u2010specific KO mice implicated skeletal muscle\u2010deficiency in the
      abnormal programming of adult growth and metabolism. The effects of Lin28b KO
      could be rescued by Tsc1 haplo\u2010insufficiency in skeletal muscles. Our data
      implicate fetal expression of Lin28a/b in the regulation of life\u2010long effects
      on metabolism and growth, and demonstrate that fetal Lin28b acts at least in
      part via mTORC1 signaling. STEM Cells 2013;31:1563\u20131573", "venue": "Stem
      Cells", "year": 2013, "referenceCount": 40, "citationCount": 116, "influentialCitationCount":
      7, "isOpenAccess": true, "openAccessPdf": {"url": "https://academic.oup.com/stmcls/article-pdf/31/8/1563/41980047/stmcls_31_8_1563.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-08-01", "journal": {"volume": "31", "name": "STEM CELLS"},
      "citationStyles": {"bibtex": "@Article{Shinoda2013FetalDO,\n author = {Gen Shinoda
      and Ng Shyh\u2010Chang and T. D. Soysa and Hao Zhu and Marc T. Seligson and
      Samar P. Shah and Nora Abo-Sido and A. Yabuuchi and J. Hagan and R. Gregory
      and J. Asara and L. Cantley and E. Moss and G. Daley},\n booktitle = {Stem Cells},\n
      journal = {STEM CELLS},\n title = {Fetal Deficiency of Lin28 Programs Life\u2010Long
      Aberrations in Growth and Glucose Metabolism},\n volume = {31},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "4293162", "name": "Gen Shinoda"}, {"authorId": "1397529716",
      "name": "Ng Shyh\u2010Chang"}, {"authorId": "8534995", "name": "T. D. Soysa"},
      {"authorId": "1705585", "name": "Hao Zhu"}, {"authorId": "4531070", "name":
      "Marc T. Seligson"}, {"authorId": "3935506", "name": "Samar P. Shah"}, {"authorId":
      "1431203868", "name": "Nora Abo-Sido"}, {"authorId": "48326334", "name": "A.
      Yabuuchi"}, {"authorId": "2814984", "name": "J. Hagan"}, {"authorId": "50193322",
      "name": "R. Gregory"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4642292", "name": "E. Moss"},
      {"authorId": "2028224", "name": "G. Daley"}]}, {"paperId": "4caa68d9e48032b072072dc498edea710a0ed6f8",
      "externalIds": {"MAG": "2463178538", "CorpusId": 88736381}, "corpusId": 88736381,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/4caa68d9e48032b072072dc498edea710a0ed6f8",
      "title": "Figure 4, Purified recombinant PKM2 was treated with either A) DMSO
      or B) 1 \u03bcM ML285 followed by H2O2 for 30 minutes, diluted 100-fold and
      PK activity was assayed", "abstract": null, "venue": "", "year": 2013, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Chemistry", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2013-05-08",
      "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Brimacombe2013Figure4P,\n
      author = {K. Brimacombe and D. Anastasiou and B. Hong and W. Tempel and S. Dimov
      and H. Veith and D. Auld and M. V. Heiden and Craig J. Thomas and Hee-won Park
      and M. Shen and L. Cantley and M. Boxer},\n title = {Figure 4, Purified recombinant
      PKM2 was treated with either A) DMSO or B) 1 \u03bcM ML285 followed by H2O2
      for 30 minutes, diluted 100-fold and PK activity was assayed},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "6351971", "name": "B. Hong"}, {"authorId":
      "5566934", "name": "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"},
      {"authorId": "1799343", "name": "H. Veith"}, {"authorId": "2607088", "name":
      "D. Auld"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632",
      "name": "Craig J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3275486", "name": "M. Boxer"}]}, {"paperId": "4e31b31649cf2547655581f8a9facfc6afdb5703",
      "externalIds": {"MAG": "1975215468", "DOI": "10.1016/j.cell.2013.09.025", "CorpusId":
      14504385, "PubMed": "24120138"}, "corpusId": 14504385, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/4e31b31649cf2547655581f8a9facfc6afdb5703",
      "title": "PKM2 Isoform-Specific Deletion Reveals a Differential Requirement
      for Pyruvate Kinase in Tumor Cells", "abstract": null, "venue": "Cell", "year":
      2013, "referenceCount": 62, "citationCount": 443, "influentialCitationCount":
      16, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867413011628/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2013-10-01", "journal":
      {"volume": "155", "pages": "397-409", "name": "Cell"}, "citationStyles": {"bibtex":
      "@Article{Israelsen2013PKM2ID,\n author = {William J. Israelsen and T. Dayton
      and S. Davidson and B. Fiske and Aaron M. Hosios and G. Bellinger and J. Li
      and Yimin Yu and M. Sasaki and J. Horner and Laura N. Burga and Jianxin Xie
      and M. Jurczak and R. DePinho and C. Clish and T. Jacks and R. Kibbey and G.
      Wulf and D. D. Vizio and G. Mills and L. Cantley and M. V. Heiden},\n booktitle
      = {Cell},\n journal = {Cell},\n pages = {397-409},\n title = {PKM2 Isoform-Specific
      Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells},\n
      volume = {155},\n year = {2013}\n}\n"}, "authors": [{"authorId": "5553029",
      "name": "William J. Israelsen"}, {"authorId": "40576003", "name": "T. Dayton"},
      {"authorId": "34711277", "name": "S. Davidson"}, {"authorId": "8143199", "name":
      "B. Fiske"}, {"authorId": "5246254", "name": "Aaron M. Hosios"}, {"authorId":
      "5679020", "name": "G. Bellinger"}, {"authorId": "1684133", "name": "J. Li"},
      {"authorId": "2119040612", "name": "Yimin Yu"}, {"authorId": "2113969237", "name":
      "M. Sasaki"}, {"authorId": "40006904", "name": "J. Horner"}, {"authorId": "48793812",
      "name": "Laura N. Burga"}, {"authorId": "143740055", "name": "Jianxin Xie"},
      {"authorId": "34688689", "name": "M. Jurczak"}, {"authorId": "5593407", "name":
      "R. DePinho"}, {"authorId": "3633091", "name": "C. Clish"}, {"authorId": "3196398",
      "name": "T. Jacks"}, {"authorId": "5304639", "name": "R. Kibbey"}, {"authorId":
      "31554501", "name": "G. Wulf"}, {"authorId": "143753942", "name": "D. D. Vizio"},
      {"authorId": "2241330", "name": "G. Mills"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "35413264", "name": "M. V. Heiden"}]}, {"paperId":
      "52b3d03716946f615947f2f6b5190d9e37aaa689", "externalIds": {"MAG": "2474673362",
      "CorpusId": 184097184}, "corpusId": 184097184, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/52b3d03716946f615947f2f6b5190d9e37aaa689",
      "title": "Figure 5, [A) ML285 shows a dose-response...].", "abstract": null,
      "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Mathematics"],
      "s2FieldsOfStudy": [{"category": "Mathematics", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2013-05-08", "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex":
      "@Inproceedings{Brimacombe2013Figure5,\n author = {K. Brimacombe and D. Anastasiou
      and B. Hong and W. Tempel and S. Dimov and H. Veith and D. Auld and M. V. Heiden
      and Craig J. Thomas and Hee-won Park and M. Shen and L. Cantley and M. Boxer},\n
      title = {Figure 5, [A) ML285 shows a dose-response...].},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "6351971", "name": "B. Hong"}, {"authorId":
      "5566934", "name": "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"},
      {"authorId": "1799343", "name": "H. Veith"}, {"authorId": "2607088", "name":
      "D. Auld"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632",
      "name": "Craig J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3275486", "name": "M. Boxer"}]}, {"paperId": "566c23aacfd9e4dea5475f5c69bba67368eef165",
      "externalIds": {"MAG": "2461999919", "CorpusId": 89186503}, "corpusId": 89186503,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/566c23aacfd9e4dea5475f5c69bba67368eef165",
      "title": "Figure 8, [A) Intracellular ROS levels measured...].", "abstract":
      null, "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2013-05-08", "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex":
      "@Inproceedings{Brimacombe2013Figure8,\n author = {K. Brimacombe and D. Anastasiou
      and B. Hong and W. Tempel and S. Dimov and H. Veith and D. Auld and M. V. Heiden
      and Craig J. Thomas and Hee-won Park and M. Shen and L. Cantley and M. Boxer},\n
      title = {Figure 8, [A) Intracellular ROS levels measured...].},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "6351971", "name": "B. Hong"}, {"authorId":
      "5566934", "name": "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"},
      {"authorId": "1799343", "name": "H. Veith"}, {"authorId": "2607088", "name":
      "D. Auld"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632",
      "name": "Craig J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3275486", "name": "M. Boxer"}]}, {"paperId": "5f119735ec5878e6bd483b8944f6e416cbafa1e0",
      "externalIds": {"MAG": "2489732030", "CorpusId": 100351651}, "corpusId": 100351651,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/5f119735ec5878e6bd483b8944f6e416cbafa1e0",
      "title": "Figure 7, [A) [1-14C]glucose flux through PPP...].", "abstract": null,
      "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2013-05-08", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Brimacombe2013Figure7,\n
      author = {K. Brimacombe and D. Anastasiou and B. Hong and W. Tempel and S. Dimov
      and H. Veith and D. Auld and M. V. Heiden and Craig J. Thomas and Hee-won Park
      and M. Shen and L. Cantley and M. Boxer},\n title = {Figure 7, [A) [1-14C]glucose
      flux through PPP...].},\n year = {2013}\n}\n"}, "authors": [{"authorId": "2435894",
      "name": "K. Brimacombe"}, {"authorId": "46996935", "name": "D. Anastasiou"},
      {"authorId": "6351971", "name": "B. Hong"}, {"authorId": "5566934", "name":
      "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"}, {"authorId": "1799343",
      "name": "H. Veith"}, {"authorId": "2607088", "name": "D. Auld"}, {"authorId":
      "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632", "name": "Craig
      J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"}, {"authorId": "145829790",
      "name": "M. Shen"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3275486", "name": "M. Boxer"}]}, {"paperId": "67c00ce4d2e48ee6fddb2fafafbb50a3c5f0bdd7",
      "externalIds": {"MAG": "2967664220", "DOI": "10.1200/JCO.2013.31.15_SUPPL.5521",
      "CorpusId": 201980568}, "corpusId": 201980568, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/67c00ce4d2e48ee6fddb2fafafbb50a3c5f0bdd7",
      "title": "PTEN loss as a context-dependent determinant of patient outcomes in
      obese and non-obese endometrioid endometrial cancer patients.", "abstract":
      "5521 Background: Aberrations in the PI3K pathway, the central relay pathway
      of insulin signals, occur in the majority of endometrioid endometrial cancers.
      We explored the prognostic utility of PIK3...", "venue": "", "year": 2013, "referenceCount":
      0, "citationCount": 2, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2013-05-20", "journal": {"volume":
      "31", "pages": "5521-5521", "name": "Journal of Clinical Oncology"}, "citationStyles":
      {"bibtex": "@Article{Ju2013PTENLA,\n author = {Z. Ju and S. Westin and R. Broaddus
      and Jie Li and N. Pal and K. Lu and R. Coleman and S. Klempner and L. Cantley
      and G. Mills and A. Myers},\n journal = {Journal of Clinical Oncology},\n pages
      = {5521-5521},\n title = {PTEN loss as a context-dependent determinant of patient
      outcomes in obese and non-obese endometrioid endometrial cancer patients.},\n
      volume = {31},\n year = {2013}\n}\n"}, "authors": [{"authorId": "152983291",
      "name": "Z. Ju"}, {"authorId": "2974900", "name": "S. Westin"}, {"authorId":
      "6416382", "name": "R. Broaddus"}, {"authorId": "2149869719", "name": "Jie Li"},
      {"authorId": "35508831", "name": "N. Pal"}, {"authorId": "2246960153", "name":
      "K. Lu"}, {"authorId": "3124983", "name": "R. Coleman"}, {"authorId": "4677205",
      "name": "S. Klempner"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2241330", "name": "G. Mills"}, {"authorId": "6324437", "name": "A. Myers"}]},
      {"paperId": "6d97c83fb5028df949a618c2c3cb269d97cdc7fc", "externalIds": {"MAG":
      "2152951302", "DOI": "10.1016/j.cell.2013.09.059", "CorpusId": 18616833, "PubMed":
      "24209617"}, "corpusId": 18616833, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/6d97c83fb5028df949a618c2c3cb269d97cdc7fc",
      "title": "Lin28 Enhances Tissue Repair by Reprogramming Cellular Metabolism",
      "abstract": null, "venue": "Cell", "year": 2013, "referenceCount": 74, "citationCount":
      304, "influentialCitationCount": 18, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S0092867413012786/pdf", "status": null},
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2013-11-07", "journal":
      {"volume": "155", "pages": "778-792", "name": "Cell"}, "citationStyles": {"bibtex":
      "@Article{Shyh\u2010Chang2013Lin28ET,\n author = {Ng Shyh\u2010Chang and Hao
      Zhu and T. D. Soysa and Gen Shinoda and Marc T. Seligson and Kaloyan M Tsanov
      and Liem H. Nguyen and J. Asara and L. Cantley and L. Cantley and G. Daley},\n
      booktitle = {Cell},\n journal = {Cell},\n pages = {778-792},\n title = {Lin28
      Enhances Tissue Repair by Reprogramming Cellular Metabolism},\n volume = {155},\n
      year = {2013}\n}\n"}, "authors": [{"authorId": "1397529716", "name": "Ng Shyh\u2010Chang"},
      {"authorId": "1705585", "name": "Hao Zhu"}, {"authorId": "8534995", "name":
      "T. D. Soysa"}, {"authorId": "4293162", "name": "Gen Shinoda"}, {"authorId":
      "4531070", "name": "Marc T. Seligson"}, {"authorId": "7684299", "name": "Kaloyan
      M Tsanov"}, {"authorId": "3747859", "name": "Liem H. Nguyen"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2028224", "name":
      "G. Daley"}]}, {"paperId": "706d1252316288db46ed1f0322c1c76519f15a98", "externalIds":
      {"MAG": "2518362649", "DOI": "10.1182/BLOOD.V122.21.793.793", "CorpusId": 89162777},
      "corpusId": 89162777, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/706d1252316288db46ed1f0322c1c76519f15a98",
      "title": "Differential Dependence On Aerobic Glycolysis In Normal and Malignant
      Hematopoietic Stem and Progenitor Cells To Sustain Daughter Cell Production",
      "abstract": "How glucose is metabolized can influence cell function, but whether
      differences in glucose metabolism reflect, or dictate, cell state is not clear
      and is of particular interest given the association of cancer with aerobic glycolysis.
      Studies on cancer cell lines have indicated that increased glucose uptake with
      lactate production regardless of oxygen concentration, a phenomenon also known
      as the Warburg effect, is promoted in part by expression of the M2 isoform of
      pyruvate kinase (PKM2) and the muscle form of lactate dehydrogenase A (LDHA).
      Normal somatic cells thought to also preferentially use glycolytic metabolism
      are tissue stem cells, particularly the self-renewing hematopoietic stem cells
      (HSC) resident in the hypoxic microenvironment of the bone marrow. It remains
      to be defined, however whether proliferating hematopoietic progenitor cells
      rely on aerobic glycolysis and whether malignant and normal hematopoietic cells
      are dependent on the same metabolic regulation. We observed that PKM2 and LDHA
      are the predominant isoforms expressed by all BM hematopoietic cells. To further
      understand the role of glycolytic metabolism in hematopoiesis and hematological
      malignancy, we utilized a mouse strain that allows conditional deletion of the
      PKM2 specific exon 10. Deletion of PKM2 in hematopoetic cells leads to expression
      of PKM1, accompanied with partial inhibition of lactate production and decreased
      glycolytic intermediates in the hematopoietic stem/progenitor cell (HSPC) population.
      Loss of PKM2 compromises the long-term repopulation capacity of HSPCs as revealed
      by serial transplantation assay. Interestingly, the repopulating defects resulting
      from PKM2 depletion appear to involve progenitors, perhaps due to inadequate
      biomass generation necessary for robust cell proliferation. To confirm that
      the effect of PKM2 deletion on HSPC function is due to metabolic changes rather
      than other putative PKM2 functions, we engineered a mouse strain that allowed
      conditional knockout of LDHA to more potently impair aerobic glycolysis. LDHA
      deletion completely inhibited lactate production, enhanced ROS levels in hematopoietic
      cells and impaired long-term BM repopulating activity. In contrast to PKM2 deletion
      that affects progenitor but not stem cells, LDHA depletion impacts both stem
      cell maintenance and progenitor cell proliferation. Deletion of either PKM2
      or LDHA markedly suppressed leukemia initiation by either putative stem cell
      (BCR-ABL) or progenitor (MLL-AF9) transforming alleles. Therefore, modulating
      aeroblic glycolysis has effects on normal hematopoietic cells that depend upon
      cell state and negatively impacts leukemic growth regardless of cell state.
      The differential sensitivity of normal and malignant cells to modulation of
      aerobic glycolysis suggests a potential therapeutic opportunity for leukemia
      intervention. Disclosures: No relevant conflicts of interest to declare.", "venue":
      "", "year": 2013, "referenceCount": 0, "citationCount": 3, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2013-11-15", "journal": {"volume":
      "122", "pages": "793-793", "name": "Blood"}, "citationStyles": {"bibtex": "@Article{Wang2013DifferentialDO,\n
      author = {Ying-hua Wang and William J. Israelsen and Dongjun Lee and V. Yu and
      N. T. Jeanson and C. Clish and L. Cantley and M. V. Heiden and D. Scadden},\n
      journal = {Blood},\n pages = {793-793},\n title = {Differential Dependence On
      Aerobic Glycolysis In Normal and Malignant Hematopoietic Stem and Progenitor
      Cells To Sustain Daughter Cell Production},\n volume = {122},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "47906491", "name": "Ying-hua Wang"}, {"authorId":
      "5553029", "name": "William J. Israelsen"}, {"authorId": "47381858", "name":
      "Dongjun Lee"}, {"authorId": "34345448", "name": "V. Yu"}, {"authorId": "5100030",
      "name": "N. T. Jeanson"}, {"authorId": "3633091", "name": "C. Clish"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "35413264", "name": "M. V. Heiden"},
      {"authorId": "5002337", "name": "D. Scadden"}]}, {"paperId": "8255336c9ed629fca92835b1ea89e4c396089b7c",
      "externalIds": {"MAG": "2335585954", "DOI": "10.1158/1538-7445.AM2013-4265",
      "CorpusId": 75158058}, "corpusId": 75158058, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/8255336c9ed629fca92835b1ea89e4c396089b7c",
      "title": "Abstract 4265: Derivation and characterization of endometrial cancer
      cells resistant to phosphatidylinositol-3-kinase (PI3K) pathway inhibitors.",
      "abstract": "Endometrial cancer remains the most common gynecologic malignancy
      in the United States with an estimated 43,000 cases annually. Limited options
      exist for patients with recurrent endometrial cancer after tumor progression
      following platinum/taxane combinations, and newer therapies are needed. Endometrial
      cancers have among the highest rates of oncogenic aberrations in the phosphatidylinositol-3-kinase
      (PI3K) pathway with frequencies approaching 75%, and clinical trials targeting
      components on the PI3K pathway are ongoing. Despite the clinical observation
      that many responses to PI3K inhibitors are short lived an understanding of the
      molecular mechanisms of resistance is lacking. We have derived endometrial cancer
      cell lines resistant to a panel of PI3K/AKT/mTOR inhibitors in clinical development
      in an effort to understand molecular mechanisms and signaling changes underlying
      resistance to PI3K-targeted therapy. All lines have previously undergone mutational
      analysis of the PI3K and RAS-ERK pathways. Representative compounds inhibiting
      each node in the canonical class I PI3K signaling cascade have been chosen.
      These agents have been synthesized base on the published structures and include
      a pan-p110 inhibitor, an allosteric AKT inhibitor, a dual p110-mTOR, and a MEK
      inhibitor. Using parallel high-throughput intracellular phospho-kinase and phospho-receptor
      tyrosine kinase (RTK) arrays for screening we have identified candidate common
      resistance mechanisms to inhibition of signaling nodes in the PI3K pathway.
      The phospho-screening approach has highlighted the interplay between PI3K/AKT/mTOR
      signaling and the Ras/Raf/MEK/ERK pathways in the development of resistance.
      We have begun to validate ERK upregulation as an activated escape pathway in
      patient samples from an AKT inhibitor clinical trial. Conserved resistance profiles
      may ultimately be used to define a subset of endometrial cancer patients unlikely
      to respond to PI3K/Akt/mTOR inhibitors and may inform more rational early phase
      combination strategies. Citation Format: Samuel J. Klempner, Andrea P. Myers,
      Jane Li, Gordon Mills, Lewis C. Cantley. Derivation and characterization of
      endometrial cancer cells resistant to phosphatidylinositol-3-kinase (PI3K) pathway
      inhibitors. [abstract]. In: Proceedings of the 104th Annual Meeting of the American
      Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia
      (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4265. doi:10.1158/1538-7445.AM2013-4265",
      "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2013-04-15", "journal": {"volume": "73", "pages": "4265-4265", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Klempner2013Abstract4D,\n
      author = {S. Klempner and A. Myers and Jane Li and G. Mills and L. Cantley},\n
      journal = {Cancer Research},\n pages = {4265-4265},\n title = {Abstract 4265:
      Derivation and characterization of endometrial cancer cells resistant to phosphatidylinositol-3-kinase
      (PI3K) pathway inhibitors.},\n volume = {73},\n year = {2013}\n}\n"}, "authors":
      [{"authorId": "4677205", "name": "S. Klempner"}, {"authorId": "6324437", "name":
      "A. Myers"}, {"authorId": "2108996618", "name": "Jane Li"}, {"authorId": "2241330",
      "name": "G. Mills"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "8f539806f7b279e93e7f415f1ac7b9d4c4e855f4", "externalIds": {"MAG": "2604158347",
      "DOI": "10.1200/JCO.2013.31.15_SUPPL.5524", "CorpusId": 79293091}, "corpusId":
      79293091, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/8f539806f7b279e93e7f415f1ac7b9d4c4e855f4",
      "title": "Phase II, two-stage, two-arm, PIK3CA mutation stratified trial of
      MK-2206 in recurrent endometrial cancer (EC).", "abstract": "5524 Background:
      EC has high rates of PI3K pathway alteration including PTEN mutation (50%) or
      IHC loss (>50%), PIK3CA mutation (25-40%) and PIK3R1 (20%) mutation. MK-2206
      is an allosteric inhibitor of AKT, an effector kinase of PI3K signals. We hypothesized
      that pts whose tumors harbored PIK3CA mutations would be more likely to benefit
      from MK-2206 than those without PIK3CA mutation. Methods: Pts had recurrent
      or advanced EC; all histologies except MMMT were eligible. Up to 2 prior chemo
      lines were permitted; excluding prior treatment with PI3K/MTOR inhibitors. The
      first 19 pts were treated with MK-2206 200mg QW; due to initial skin toxicity
      rates, the starting dose was amended to 135mg QW. Co-primary endpoints were
      objective response and 6 mo PFS. The first 37 pts were stratified retrospectively.
      PIK3CA MT included R88Q, K111N, E110K, E418K, C420R, E453K, E542K/V,E545K, Q546R,
      H701P, M1043V, H1047R/L/Y changes. Independent Simon 2-stage tests were planned
      within PIK3CA MT and WT stratum: for MT, n1=15 a...", "venue": "", "year": 2013,
      "referenceCount": 0, "citationCount": 24, "influentialCitationCount": 1, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2013-05-20",
      "journal": {"volume": "31", "pages": "5524-5524", "name": "Journal of Clinical
      Oncology"}, "citationStyles": {"bibtex": "@Article{Myers2013PhaseIT,\n author
      = {A. Myers and R. Broaddus and V. Makker and P. Konstantinopoulos and R. Drapkin
      and N. Horowitz and Joyce F. Liu and P. Hummelen and F. Meric-Bernstam and M.
      Birrer and L. Doyle and R. Coleman and C. Aghajanian and G. Mills and L. Cantley
      and U. Matulonis and S. Westin},\n journal = {Journal of Clinical Oncology},\n
      pages = {5524-5524},\n title = {Phase II, two-stage, two-arm, PIK3CA mutation
      stratified trial of MK-2206 in recurrent endometrial cancer (EC).},\n volume
      = {31},\n year = {2013}\n}\n"}, "authors": [{"authorId": "6324437", "name":
      "A. Myers"}, {"authorId": "6416382", "name": "R. Broaddus"}, {"authorId": "3553012",
      "name": "V. Makker"}, {"authorId": "49610180", "name": "P. Konstantinopoulos"},
      {"authorId": "5340828", "name": "R. Drapkin"}, {"authorId": "8523393", "name":
      "N. Horowitz"}, {"authorId": "2108419806", "name": "Joyce F. Liu"}, {"authorId":
      "8315735", "name": "P. Hummelen"}, {"authorId": "1397965147", "name": "F. Meric-Bernstam"},
      {"authorId": "2167106", "name": "M. Birrer"}, {"authorId": "39667616", "name":
      "L. Doyle"}, {"authorId": "3124983", "name": "R. Coleman"}, {"authorId": "6128162",
      "name": "C. Aghajanian"}, {"authorId": "2241330", "name": "G. Mills"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "6927295", "name": "U. Matulonis"},
      {"authorId": "2974900", "name": "S. Westin"}]}, {"paperId": "9501773dd47ecb9babe3c1827139a9912c4b980d",
      "externalIds": {"MAG": "1586805947", "DOI": "10.1158/0008-5472.CAN-13-0080",
      "CorpusId": 749004, "PubMed": "23687346"}, "corpusId": 749004, "publicationVenue":
      {"id": "b0bd78b2-6591-460e-af71-196409b62e2c", "name": "Cancer Research", "type":
      "journal", "alternate_names": ["Cancer Res"], "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/",
      "alternate_urls": ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/9501773dd47ecb9babe3c1827139a9912c4b980d",
      "title": "Metformin decreases glucose oxidation and increases the dependency
      of prostate cancer cells on reductive glutamine metabolism.", "abstract": "Metformin
      inhibits cancer cell proliferation, and epidemiology studies suggest an association
      with increased survival in patients with cancer taking metformin; however, the
      mechanism by which metformin improves cancer outcomes remains controversial.
      To explore how metformin might directly affect cancer cells, we analyzed how
      metformin altered the metabolism of prostate cancer cells and tumors. We found
      that metformin decreased glucose oxidation and increased dependency on reductive
      glutamine metabolism in both cancer cell lines and in a mouse model of prostate
      cancer. Inhibition of glutamine anaplerosis in the presence of metformin further
      attenuated proliferation, whereas increasing glutamine metabolism rescued the
      proliferative defect induced by metformin. These data suggest that interfering
      with glutamine may synergize with metformin to improve outcomes in patients
      with prostate cancer.", "venue": "Cancer Research", "year": 2013, "referenceCount":
      56, "citationCount": 198, "influentialCitationCount": 6, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://cancerres.aacrjournals.org/content/canres/73/14/4429.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Chemistry", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2013-05-01", "journal":
      {"volume": "73 14", "pages": "\n          4429-38\n        ", "name": "Cancer
      research"}, "citationStyles": {"bibtex": "@Article{Fendt2013MetforminDG,\n author
      = {S. Fendt and Eric L. Bell and M. Keibler and S. Davidson and G. Wirth and
      B. Fiske and J. Mayers and M. Schwab and G. Bellinger and A. Csibi and Akash
      Patnaik and M. Blouin and L. Cantley and L. Guarente and J. Blenis and M. Pollak
      and A. Olumi and M. V. Vander Heiden and G. Stephanopoulos},\n booktitle = {Cancer
      Research},\n journal = {Cancer research},\n pages = {\n          4429-38\n        },\n
      title = {Metformin decreases glucose oxidation and increases the dependency
      of prostate cancer cells on reductive glutamine metabolism.},\n volume = {73
      14},\n year = {2013}\n}\n"}, "authors": [{"authorId": "46775302", "name": "S.
      Fendt"}, {"authorId": "49200178", "name": "Eric L. Bell"}, {"authorId": "4181119",
      "name": "M. Keibler"}, {"authorId": "34711277", "name": "S. Davidson"}, {"authorId":
      "3495178", "name": "G. Wirth"}, {"authorId": "8143199", "name": "B. Fiske"},
      {"authorId": "34534173", "name": "J. Mayers"}, {"authorId": "145780106", "name":
      "M. Schwab"}, {"authorId": "5679020", "name": "G. Bellinger"}, {"authorId":
      "6688912", "name": "A. Csibi"}, {"authorId": "40501341", "name": "Akash Patnaik"},
      {"authorId": "101487845", "name": "M. Blouin"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "4148406", "name": "L. Guarente"}, {"authorId":
      "4037343", "name": "J. Blenis"}, {"authorId": "78091495", "name": "M. Pollak"},
      {"authorId": "4680166", "name": "A. Olumi"}, {"authorId": "3804233", "name":
      "M. V. Vander Heiden"}, {"authorId": "1813278", "name": "G. Stephanopoulos"}]},
      {"paperId": "97c4153b36f88514088843ecf246fbe88f520443", "externalIds": {"MAG":
      "2027530165", "DOI": "10.1038/nature12317", "CorpusId": 4427426}, "corpusId":
      4427426, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/97c4153b36f88514088843ecf246fbe88f520443",
      "title": "Corrigendum: Glutamine supports pancreatic cancer growth through a
      KRAS-regulated metabolic pathway", "abstract": null, "venue": "Nature", "year":
      2013, "referenceCount": 1, "citationCount": 15, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/nature12317.pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2013-06-12", "journal": {"volume": "499", "pages": "504-504",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Son2013CorrigendumGS,\n
      author = {J. Son and C. Lyssiotis and H. Ying and Xiaoxu Wang and S. Hua and
      M. Ligorio and R. Perera and C. Ferrone and Edouard Mullarky and Ng Shyh\u2010Chang
      and Ya''an Kang and J. Fleming and N. Bardeesy and J. Asara and M. Haigis and
      R. DePinho and L. Cantley and Alec C. Kimmelman},\n booktitle = {Nature},\n
      journal = {Nature},\n pages = {504-504},\n title = {Corrigendum: Glutamine supports
      pancreatic cancer growth through a KRAS-regulated metabolic pathway},\n volume
      = {499},\n year = {2013}\n}\n"}, "authors": [{"authorId": "38313825", "name":
      "J. Son"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "33312849",
      "name": "H. Ying"}, {"authorId": "48631933", "name": "Xiaoxu Wang"}, {"authorId":
      "50767858", "name": "S. Hua"}, {"authorId": "4968898", "name": "M. Ligorio"},
      {"authorId": "3557245", "name": "R. Perera"}, {"authorId": "3817898", "name":
      "C. Ferrone"}, {"authorId": "6424987", "name": "Edouard Mullarky"}, {"authorId":
      "1397529716", "name": "Ng Shyh\u2010Chang"}, {"authorId": "78102197", "name":
      "Ya''an Kang"}, {"authorId": "144926646", "name": "J. Fleming"}, {"authorId":
      "5974412", "name": "N. Bardeesy"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "6212141", "name": "M. Haigis"}, {"authorId": "5593407", "name":
      "R. DePinho"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4668673",
      "name": "Alec C. Kimmelman"}]}, {"paperId": "9a6b71939a602201df39769e169a6c0d67f3226f",
      "externalIds": {"MAG": "2108516575", "DOI": "10.1038/nm.3175", "CorpusId": 3029955,
      "PubMed": "23584089"}, "corpusId": 3029955, "publicationVenue": {"id": "9e995b6d-f30b-4ab4-a13b-3dc2cc992f47",
      "name": "Nature Network Boston", "type": "journal", "alternate_names": ["Nat
      Netw Boston", "Nat Med", "Nature Medicine"], "issn": "1744-7933", "alternate_issns":
      ["1078-8956"], "url": "https://www.nature.com/nature/articles?code=archive_news",
      "alternate_urls": ["http://www.nature.com/news", "http://www.nature.com/nm/",
      "http://www.nature.com/nm/index.html"]}, "url": "https://www.semanticscholar.org/paper/9a6b71939a602201df39769e169a6c0d67f3226f",
      "title": "A colorectal cancer classification system that associates cellular
      phenotype and responses to therapy", "abstract": null, "venue": "Nature Network
      Boston", "year": 2013, "referenceCount": 38, "citationCount": 871, "influentialCitationCount":
      36, "isOpenAccess": true, "openAccessPdf": {"url": "https://escholarship.org/content/qt4fd3z55h/qt4fd3z55h.pdf?t=rsdxhf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-04-14", "journal": {"volume": "19", "pages": "619-625",
      "name": "Nature Medicine"}, "citationStyles": {"bibtex": "@Article{Sadanandam2013ACC,\n
      author = {A. Sadanandam and C. Lyssiotis and K. Homicsko and E. Collisson and
      W. J. Gibb and S. Wullschleger and L. Ostos and William A. Lannon and C. Grotzinger
      and M. Rio and B. Lhermitte and A. Olshen and B. Wiedenmann and L. Cantley and
      J. Gray and D. Hanahan},\n booktitle = {Nature Network Boston},\n journal =
      {Nature Medicine},\n pages = {619-625},\n title = {A colorectal cancer classification
      system that associates cellular phenotype and responses to therapy},\n volume
      = {19},\n year = {2013}\n}\n"}, "authors": [{"authorId": "49973308", "name":
      "A. Sadanandam"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId":
      "145819509", "name": "K. Homicsko"}, {"authorId": "20991761", "name": "E. Collisson"},
      {"authorId": "47487491", "name": "W. J. Gibb"}, {"authorId": "38356613", "name":
      "S. Wullschleger"}, {"authorId": "3495449", "name": "L. Ostos"}, {"authorId":
      "4425076", "name": "William A. Lannon"}, {"authorId": "3770955", "name": "C.
      Grotzinger"}, {"authorId": "36628429", "name": "M. Rio"}, {"authorId": "3757419",
      "name": "B. Lhermitte"}, {"authorId": "2923001", "name": "A. Olshen"}, {"authorId":
      "4406446", "name": "B. Wiedenmann"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2259837582", "name": "J. Gray"}, {"authorId": "6883889", "name":
      "D. Hanahan"}]}, {"paperId": "9b04e9c9a086f25693ebbf5b4ae487198d2c39ae", "externalIds":
      {"MAG": "2473337304", "CorpusId": 88594529}, "corpusId": 88594529, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/9b04e9c9a086f25693ebbf5b4ae487198d2c39ae",
      "title": "Figure 6, ML285-bound crystal structure of human pyruvate kinase M2
      (PDB code: 3GR4)", "abstract": null, "venue": "", "year": 2013, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Chemistry", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2013-05-08", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Brimacombe2013Figure6M,\n author = {K. Brimacombe
      and D. Anastasiou and B. Hong and W. Tempel and S. Dimov and H. Veith and D.
      Auld and M. V. Heiden and Craig J. Thomas and Hee-won Park and M. Shen and L.
      Cantley and M. Boxer},\n title = {Figure 6, ML285-bound crystal structure of
      human pyruvate kinase M2 (PDB code: 3GR4)},\n year = {2013}\n}\n"}, "authors":
      [{"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "6351971", "name": "B. Hong"}, {"authorId":
      "5566934", "name": "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"},
      {"authorId": "1799343", "name": "H. Veith"}, {"authorId": "2607088", "name":
      "D. Auld"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632",
      "name": "Craig J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3275486", "name": "M. Boxer"}]}, {"paperId": "9ca3c60e4f1b3cfe804d13452eb4bb17b04ed2f1",
      "externalIds": {"MAG": "2003997444", "PubMedCentral": "3737294", "DOI": "10.4161/cc.25307",
      "CorpusId": 9104182, "PubMed": "23759579"}, "corpusId": 9104182, "publicationVenue":
      {"id": "1bce1796-d800-4a09-91e5-d3e3ed025037", "name": "Cell Cycle", "type":
      "journal", "issn": "1551-4005", "url": "http://www.landesbioscience.com/journals/cc/",
      "alternate_urls": ["http://www.tandfonline.com/loi/kccy20"]}, "url": "https://www.semanticscholar.org/paper/9ca3c60e4f1b3cfe804d13452eb4bb17b04ed2f1",
      "title": "Pancreatic cancers rely on a novel glutamine metabolism pathway to
      maintain redox balance", "abstract": "In order for a cell to dupli-cate, it
      must double its genome, protein content and lipid mass. This process requires
      energy in the form of ATP and NADPH. However, unlike ATP, the amount of NADPH
      required for biosyn-thesis is much greater than that needed for homeostasis,
      which makes the genera-tion of NADPH rate limiting for cellular proliferation.
      NADPH is used for both macromolecular biosynthesis (e.g., lipids and deoxynucleotide
      triphosphates) and the maintenance of a reduced intracellular environment.",
      "venue": "Cell Cycle", "year": 2013, "referenceCount": 12, "citationCount":
      75, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.tandfonline.com/doi/pdf/10.4161/cc.25307?needAccess=true", "status":
      null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["Editorial"], "publicationDate":
      "2013-06-10", "journal": {"volume": "12", "pages": "1987 - 1988", "name": "Cell
      Cycle"}, "citationStyles": {"bibtex": "@Article{Lyssiotis2013PancreaticCR,\n
      author = {C. Lyssiotis and J. Son and L. Cantley and Alec C. Kimmelman},\n booktitle
      = {Cell Cycle},\n journal = {Cell Cycle},\n pages = {1987 - 1988},\n title =
      {Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain
      redox balance},\n volume = {12},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "38313825", "name": "J. Son"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4668673", "name":
      "Alec C. Kimmelman"}]}, {"paperId": "9ec45094433c316627a794899609c5ea23924c68",
      "externalIds": {"MAG": "2056633943", "DOI": "10.1038/nrc3483", "CorpusId": 42960121,
      "PubMed": "23446547"}, "corpusId": 42960121, "publicationVenue": {"id": "db36cc4c-07df-41a8-9169-9ace7e520923",
      "name": "Nature Reviews. Cancer", "type": "journal", "alternate_names": ["Nature
      Reviews Cancer", "Nat Rev Cancer"], "issn": "1474-175X", "url": "https://www.nature.com/nrc/",
      "alternate_urls": ["http://www.nature.com/nrc/index.html"]}, "url": "https://www.semanticscholar.org/paper/9ec45094433c316627a794899609c5ea23924c68",
      "title": "Cancer metabolism: fatty acid oxidation in the limelight", "abstract":
      null, "venue": "Nature Reviews. Cancer", "year": 2013, "referenceCount": 49,
      "citationCount": 924, "influentialCitationCount": 52, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3766957?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review"], "publicationDate":
      "2013-02-28", "journal": {"volume": "13", "pages": "227-232", "name": "Nature
      Reviews Cancer"}, "citationStyles": {"bibtex": "@Article{Carracedo2013CancerMF,\n
      author = {A. Carracedo and L. Cantley and P. Pandolfi},\n booktitle = {Nature
      Reviews. Cancer},\n journal = {Nature Reviews Cancer},\n pages = {227-232},\n
      title = {Cancer metabolism: fatty acid oxidation in the limelight},\n volume
      = {13},\n year = {2013}\n}\n"}, "authors": [{"authorId": "6988610", "name":
      "A. Carracedo"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4499580", "name": "P. Pandolfi"}]}, {"paperId": "a38bbd62da8f6c20e8dd61cc57855bc2c64827a0",
      "externalIds": {"MAG": "1977846137", "DOI": "10.1016/j.cell.2013.06.026", "CorpusId":
      3012263, "PubMed": "23830207"}, "corpusId": 3012263, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/a38bbd62da8f6c20e8dd61cc57855bc2c64827a0",
      "title": "MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis
      via TET-Family-Dependent Chromatin Remodeling", "abstract": null, "venue": "Cell",
      "year": 2013, "referenceCount": 81, "citationCount": 435, "influentialCitationCount":
      17, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867413007654/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-07-18", "journal": {"volume": "154", "pages": "311-324",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Song2013MicroRNAAntagonismRB,\n
      author = {S. Song and L. Poliseno and M. Song and U. Ala and Kaitlyn A. Webster
      and Christopher Ng and Gary Beringer and Nicolai J. Brikbak and Xin Yuan and
      L. Cantley and A. Richardson and P. Pandolfi},\n booktitle = {Cell},\n journal
      = {Cell},\n pages = {311-324},\n title = {MicroRNA-Antagonism Regulates Breast
      Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling},\n
      volume = {154},\n year = {2013}\n}\n"}, "authors": [{"authorId": "9673009",
      "name": "S. Song"}, {"authorId": "6739662", "name": "L. Poliseno"}, {"authorId":
      "2967391", "name": "M. Song"}, {"authorId": "2901501", "name": "U. Ala"}, {"authorId":
      "4817196", "name": "Kaitlyn A. Webster"}, {"authorId": "6294709", "name": "Christopher
      Ng"}, {"authorId": "48084982", "name": "Gary Beringer"}, {"authorId": "7593991",
      "name": "Nicolai J. Brikbak"}, {"authorId": "48732236", "name": "Xin Yuan"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "145960454", "name":
      "A. Richardson"}, {"authorId": "4499580", "name": "P. Pandolfi"}]}, {"paperId":
      "a8699a6f8c73acfcd0ce50c95c2ac0e5c53fea3f", "externalIds": {"MAG": "2004768888",
      "DOI": "10.1016/j.molcel.2012.10.003", "CorpusId": 40564326, "PubMed": "23142078"},
      "corpusId": 40564326, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/a8699a6f8c73acfcd0ce50c95c2ac0e5c53fea3f",
      "title": "Metabolic stress controls mTORC1 lysosomal localization and dimerization
      by regulating the TTT-RUVBL1/2 complex.", "abstract": null, "venue": "Molecules
      and Cells", "year": 2013, "referenceCount": 44, "citationCount": 184, "influentialCitationCount":
      13, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276512008556/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-01-10", "journal": {"volume": "49 1", "pages": "\n          172-85\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Kim2013MetabolicSC,\n
      author = {Sang Gyun Kim and G. Hoffman and G. Poulogiannis and G. Buel and Y.
      Jang and Ki-Won Lee and Bo-Yeon Kim and R. Erikson and L. Cantley and A. Y.
      Choo and J. Blenis},\n booktitle = {Molecules and Cells},\n journal = {Molecular
      cell},\n pages = {\n          172-85\n        },\n title = {Metabolic stress
      controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2
      complex.},\n volume = {49 1},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "46876889", "name": "Sang Gyun Kim"}, {"authorId": "34846304", "name": "G. Hoffman"},
      {"authorId": "4612853", "name": "G. Poulogiannis"}, {"authorId": "8191429",
      "name": "G. Buel"}, {"authorId": "6603165", "name": "Y. Jang"}, {"authorId":
      "120343663", "name": "Ki-Won Lee"}, {"authorId": "122904929", "name": "Bo-Yeon
      Kim"}, {"authorId": "6286526", "name": "R. Erikson"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "32210637", "name": "A. Y. Choo"}, {"authorId":
      "4037343", "name": "J. Blenis"}]}, {"paperId": "ac3f02f8915a3060710dfacddef49cd04aaa58a6",
      "externalIds": {"MAG": "2230106041", "PubMedCentral": "3681899", "DOI": "10.1038/nbt.2530",
      "CorpusId": 5596677, "PubMed": "23604282"}, "corpusId": 5596677, "publicationVenue":
      {"id": "458166b3-de17-4bf3-bbbb-e53782de2f0f", "name": "Nature Biotechnology",
      "type": "journal", "alternate_names": ["Nat Biotechnol"], "issn": "1087-0156",
      "url": "http://www.nature.com/nbt/", "alternate_urls": ["http://www.nature.com/nbt"]},
      "url": "https://www.semanticscholar.org/paper/ac3f02f8915a3060710dfacddef49cd04aaa58a6",
      "title": "Heterogeneity of tumor-induced gene expression changes in the human
      metabolic network", "abstract": null, "venue": "Nature Biotechnology", "year":
      2013, "referenceCount": 101, "citationCount": 351, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/nbt.2530.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-04-01", "journal": {"volume": "31", "pages": "522 -
      529", "name": "Nature biotechnology"}, "citationStyles": {"bibtex": "@Article{Hu2013HeterogeneityOT,\n
      author = {Jie Hu and J. Locasale and J. Bielas and J. O\u2019Sullivan and K.
      Sheahan and L. Cantley and M. V. Vander Heiden and Dennis Vitkup},\n booktitle
      = {Nature Biotechnology},\n journal = {Nature biotechnology},\n pages = {522
      - 529},\n title = {Heterogeneity of tumor-induced gene expression changes in
      the human metabolic network},\n volume = {31},\n year = {2013}\n}\n"}, "authors":
      [{"authorId": "2112348570", "name": "Jie Hu"}, {"authorId": "2268976", "name":
      "J. Locasale"}, {"authorId": "6261511", "name": "J. Bielas"}, {"authorId": "1395754331",
      "name": "J. O\u2019Sullivan"}, {"authorId": "5833598", "name": "K. Sheahan"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "3804233", "name":
      "M. V. Vander Heiden"}, {"authorId": "2482068", "name": "Dennis Vitkup"}]},
      {"paperId": "adcf5a6db1587a5b59458f4a3e2fea40bc2050c0", "externalIds": {"MAG":
      "2287011628", "DOI": "10.1017/CBO9781139046947.019", "CorpusId": 87836834},
      "corpusId": 87836834, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/adcf5a6db1587a5b59458f4a3e2fea40bc2050c0",
      "title": "Molecular Oncology: PI3K", "abstract": null, "venue": "", "year":
      2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": {"volume": "",
      "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Courtney2013MolecularOP,\n
      author = {K. Courtney and L. Cantley},\n title = {Molecular Oncology: PI3K},\n
      year = {2013}\n}\n"}, "authors": [{"authorId": "13782167", "name": "K. Courtney"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "b04099c383dd23ad783575454d0cbd1772d37b8c",
      "externalIds": {"MAG": "2160689051", "DOI": "10.1158/1078-0432.CCR-13-2570",
      "CorpusId": 416252, "PubMed": "24166909"}, "corpusId": 416252, "publicationVenue":
      {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0", "name": "Clinical Cancer Research",
      "type": "journal", "alternate_names": ["Clin Cancer Res"], "issn": "1078-0432",
      "url": "https://clincancerres.aacrjournals.org/", "alternate_urls": ["http://clincancerres.aacrjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/b04099c383dd23ad783575454d0cbd1772d37b8c",
      "title": "Targeting Metabolic Scavenging in Pancreatic Cancer", "abstract":
      "Pancreatic tumor metabolism is rewired to facilitate survival and growth in
      a nutrient-depleted environment. This leads to a unique dependence on metabolic
      recycling and scavenging pathways, including NAD salvage. Targeting this pathway
      in pancreatic cancer disrupts metabolic homeostasis and impairs tumor growth.
      Clin Cancer Res; 20(1); 6\u20138. \u00a92013 AACR.", "venue": "Clinical Cancer
      Research", "year": 2013, "referenceCount": 12, "citationCount": 8, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://clincancerres.aacrjournals.org/content/clincanres/20/1/6.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["LettersAndComments",
      "JournalArticle"], "publicationDate": "2013-10-28", "journal": {"volume": "20",
      "pages": "6 - 8", "name": "Clinical Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Lyssiotis2013TargetingMS,\n author = {C. Lyssiotis and L. Cantley},\n
      booktitle = {Clinical Cancer Research},\n journal = {Clinical Cancer Research},\n
      pages = {6 - 8},\n title = {Targeting Metabolic Scavenging in Pancreatic Cancer},\n
      volume = {20},\n year = {2013}\n}\n"}, "authors": [{"authorId": "4901222", "name":
      "C. Lyssiotis"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "b4d4419ca3548e0b605db76e9a91a4b8d5a9740b", "externalIds": {"MAG": "2946633963",
      "DOI": "10.1158/1538-7445.FBCR13-C60", "CorpusId": 83941491}, "corpusId": 83941491,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/b4d4419ca3548e0b605db76e9a91a4b8d5a9740b",
      "title": "Abstract C60: Vitamin C inhibits the survival and growth of colorectal
      cancer cells with KRAS or BRAF mutations", "abstract": "Although more than half
      of colorectal cancer patients have either KRAS or BRAF mutations, targeted therapies
      for these subgroups of cancer patients are lacking. We previously showed that
      isogenic human colorectal cancer cell (CRC) lines harboring a KRAS or BRAF mutation
      up-regulate the expression of glucose transporter 1 (GLUT1), and increase glucose
      uptake and glycolysis. In this study, we go on to show that KRAS or BRAF mutant
      cells exhibit a significant increase in the uptake of vitamin C, mainly in its
      oxidized form, dehydroascorbic acid (DHA), relative to their wild-type counterparts
      through GLUT1. Notably, CRCs did not uptake vitamin C in its reduced form, possibly
      due to the fact that its known transporters, sodium vitamin C cotransporters
      (SVCTs) were generally not present in CRCs. Deletion of GLUT1 in mutant cells,
      overexpression of GLUT1 in wild-type cells and competition assays between glucose
      and DHA confirmed that GLUT1 is both necessary and sufficient for the uptake
      of vitamin C in CRCs. Both mutant and wild-type cells were able to grow in low
      glucose (1-2 mM) at a similar rate. In the same condition, we found vitamin
      C to be selectively toxic to KRAS and BRAF mutant cells, causing them to undergo
      apoptosis. In contrast, in high glucose levels (>10 mM), a similar concentration
      of vitamin C had no effect on the survival and growth of mutant cells. In addition,
      vitamin C significantly inhibited the growth of cancer cells with KRAS or BRAF
      mutations in vivo xenografts models. To find the mechanism by which vitamin
      C induces cell death in KRAS or BRAF mutant cells, we performed targeted metabolomics
      using LC/MS. Both unlabeled total metabolite analysis and flux analysis with
      C13-Glucose isotope strongly suggested that vitamin C re-routes glucose usage
      from aerobic glycolysis and non-oxidative pentose phosphate pathway (PPP) to
      the oxidative PPP to compensate for the lower levels of NADPH which was rapidly
      consumed to reduce GSSH to GSH. Having taken up exclusively DHA, the oxidized
      state of vitamin C, the mutant cells immediately use GSH to reduce Vitamin C,
      resulting in the accumulation of GSSH. Shunting glucose to the oxidative PPP
      reduces aerobic glycolysis, lowering ATP levels, and decreases glucose anabolism,
      disfavoring the synthesis of nucleic acids, lipid and amino acids, all needed
      for the survival and growth of mutant cells. Surprisingly the level of reactive
      oxidative stress (ROS) was largely unchanged following vitamin C treatment possibly
      because increased levels of vitamin C served as an anti-oxidant in mutant cells.
      There are currently more than three clinical trials phase I/II examining the
      effect of high dose vitamin C via intravenous administration in patients against
      lymphoma or solid cancers including CRCs. Our findings will provide proof of
      concept that KRAS or BRAF mutations in CRC can be predictive biomarkers for
      vitamin C therapy. Citation Format: Jihye Yun, Adam Kavalier, Jatin Roper, Steve
      Gross, Carlo Rago, Nickolas Papadopoulos, Bert Vogelstein, Lewis Cantley. Vitamin
      C inhibits the survival and growth of colorectal cancer cells with KRAS or BRAF
      mutations. [abstract]. In: Proceedings of the Third AACR International Conference
      on Frontiers in Basic Cancer Research; Sep 18-22, 2013; National Harbor, MD.
      Philadelphia (PA): AACR; Cancer Res 2013;73(19 Suppl):Abstract nr C60.", "venue":
      "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2013-10-01", "journal": {"volume": "73", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Yun2013AbstractCV,\n author
      = {Jihye Yun and A. Kavalier and J. Roper and S. Gross and C. Rago and N. Papadopoulos
      and B. Vogelstein and L. Cantley},\n journal = {Cancer Research},\n title =
      {Abstract C60: Vitamin C inhibits the survival and growth of colorectal cancer
      cells with KRAS or BRAF mutations},\n volume = {73},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "40164091", "name": "Jihye Yun"}, {"authorId": "8391227",
      "name": "A. Kavalier"}, {"authorId": "145864068", "name": "J. Roper"}, {"authorId":
      "5769141", "name": "S. Gross"}, {"authorId": "1907762", "name": "C. Rago"},
      {"authorId": "144798543", "name": "N. Papadopoulos"}, {"authorId": "1965563",
      "name": "B. Vogelstein"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "b592c88fb95851c920810c0cb00b3a497eab2d4a", "externalIds": {"MAG": "1966414227",
      "DOI": "10.1126/scisignal.2003936", "CorpusId": 206671943, "PubMed": "23716717"},
      "corpusId": 206671943, "publicationVenue": {"id": "c0efe552-8a0a-41a7-8ce2-340fb0dbfe6f",
      "name": "Science Signaling", "type": "journal", "alternate_names": ["Sci Signal"],
      "issn": "1945-0877", "url": "https://www.sciencemag.org/", "alternate_urls":
      ["https://stke.sciencemag.org/about/", "https://stke.sciencemag.org/"]}, "url":
      "https://www.semanticscholar.org/paper/b592c88fb95851c920810c0cb00b3a497eab2d4a",
      "title": "Tyrosine Kinase BMX Phosphorylates Phosphotyrosine-Primed Motif Mediating
      the Activation of Multiple Receptor Tyrosine Kinases", "abstract": "The tyrosine
      kinase BMX targets primed tyrosines in other tyrosine kinases for full activation.
      Primed for Activation Various tyrosine kinases have dual tyrosine motifs in
      their kinase domains. Phosphorylation of the first is necessary for activity,
      but full activation requires phosphorylation of the second. Chen et al. showed
      that in vitro BMX (bone marrow tyrosine kinase gene on chromosome X) has a preference
      for these primed \u201cpYY\u201d motifs, only phosphorylating the second tyrosine
      if the first is already phosphorylated. Loss of BMX activity reduced FAK (focal
      adhesion kinase) activity and insulin receptor signaling, suggesting that BMX
      may enhance signaling by various tyrosine kinases that contain the pYY motif.
      These findings reveal a previously uncharacterized property of BMX that may
      be involved in the regulation of multiple tyrosine kinase pathways. The nonreceptor
      tyrosine kinase BMX (bone marrow tyrosine kinase gene on chromosome X) is abundant
      in various cell types and activated downstream of phosphatidylinositol-3 kinase
      (PI3K) and the kinase Src, but its substrates are unknown. Positional scanning
      peptide library screening revealed a marked preference for a priming phosphorylated
      tyrosine (pY) in the \u22121 position, indicating that BMX substrates may include
      multiple tyrosine kinases that are fully activated by pYpY sites in the kinase
      domain. BMX phosphorylated focal adhesion kinase (FAK) at Tyr577 subsequent
      to its Src-mediated phosphorylation at Tyr576. Loss of BMX by RNA interference
      or by genetic deletion in mouse embryonic fibroblasts (MEFs) markedly impaired
      FAK activity. Phosphorylation of the insulin receptor in the kinase domain at
      Tyr1189 and Tyr1190, as well as Tyr1185, and downstream phosphorylation of the
      kinase AKT at Thr308 were similarly impaired by BMX deficiency. However, insulin-induced
      phosphorylation of AKT at Ser473 was not impaired in Bmx knockout MEFs or liver
      tissue from Bmx knockout mice, which also showed increased insulin-stimulated
      glucose uptake, possibly because of decreased abundance of the phosphatase PHLPP
      (PH domain leucine-rich repeat protein phosphatase). Thus, by identifying the
      pYpY motif as a substrate for BMX, our findings suggest that BMX functions as
      a central regulator among multiple signaling pathways mediated by tyrosine kinases.",
      "venue": "Science Signaling", "year": 2013, "referenceCount": 67, "citationCount":
      21, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc3735445?pdf=render", "status": null}, "fieldsOfStudy":
      ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2013-05-28", "journal": {"volume": "6", "pages": "ra40 - ra40", "name": "Science
      Signaling"}, "citationStyles": {"bibtex": "@Article{Chen2013TyrosineKB,\n author
      = {Sen Chen and Xinnong Jiang and C. Gewinner and J. Asara and Nicholas I. Simon
      and Changmeng Cai and L. Cantley and S. Balk},\n booktitle = {Science Signaling},\n
      journal = {Science Signaling},\n pages = {ra40 - ra40},\n title = {Tyrosine
      Kinase BMX Phosphorylates Phosphotyrosine-Primed Motif Mediating the Activation
      of Multiple Receptor Tyrosine Kinases},\n volume = {6},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "3571199", "name": "Sen Chen"}, {"authorId": "2177467180",
      "name": "Xinnong Jiang"}, {"authorId": "7739224", "name": "C. Gewinner"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "38106639", "name": "Nicholas I.
      Simon"}, {"authorId": "143967294", "name": "Changmeng Cai"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "6189162", "name": "S. Balk"}]}, {"paperId":
      "b6276ce7143ecbbe846af012cc9beb206157a1b9", "externalIds": {"MAG": "2074790072",
      "DOI": "10.1073/pnas.1305286110", "CorpusId": 25414810, "PubMed": "23589871"},
      "corpusId": 25414810, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/b6276ce7143ecbbe846af012cc9beb206157a1b9",
      "title": "Phosphoinositides and membrane curvature switch the mode of actin
      polymerization via selective recruitment of toca-1 and Snx9", "abstract": "The
      membrane\u2013cytosol interface is the major locus of control of actin polymerization.
      At this interface, phosphoinositides act as second messengers to recruit membrane-binding
      proteins. We show that curved membranes, but not flat ones, can use phosphatidylinositol
      3-phosphate [PI(3)P] along with phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2]
      to stimulate actin polymerization. In this case, actin polymerization requires
      the small GTPase cell cycle division 42 (Cdc42), the nucleation-promoting factor
      neural Wiskott\u2013Aldrich syndrome protein (N-WASP) and the actin nucleator
      the actin-related protein (Arp) 2/3 complex. In liposomes containing PI(4,5)P2
      as the sole phosphoinositide, actin polymerization requires transducer of Cdc42
      activation-1 (toca-1). In the presence of phosphatidylinositol 3-phosphate,
      polymerization is both more efficient and independent of toca-1. Under these
      conditions, sorting nexin 9 (Snx9) can be implicated as a specific adaptor that
      replaces toca-1 to mobilize neural Wiskott\u2013Aldrich syndrome protein and
      the Arp2/3 complex. This switch in phosphoinositide and adaptor specificity
      for actin polymerization from membranes has implications for how different types
      of actin structures are generated at precise times and locations in the cell.",
      "venue": "Proceedings of the National Academy of Sciences of the United States
      of America", "year": 2013, "referenceCount": 28, "citationCount": 56, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/110/18/7193.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2013-04-15", "journal": {"volume": "110",
      "pages": "7193 - 7198", "name": "Proceedings of the National Academy of Sciences"},
      "citationStyles": {"bibtex": "@Article{Gallop2013PhosphoinositidesAM,\n author
      = {J. Gallop and A. Walrant and L. Cantley and M. Kirschner},\n booktitle =
      {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences},\n pages = {7193
      - 7198},\n title = {Phosphoinositides and membrane curvature switch the mode
      of actin polymerization via selective recruitment of toca-1 and Snx9},\n volume
      = {110},\n year = {2013}\n}\n"}, "authors": [{"authorId": "40618124", "name":
      "J. Gallop"}, {"authorId": "5927133", "name": "A. Walrant"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "40294231", "name": "M. Kirschner"}]}, {"paperId":
      "c2210b2adaca30c2c12ae946a3c7ccf326698750", "externalIds": {"PubMedCentral":
      "3542272", "MAG": "2134189462", "DOI": "10.1371/journal.pone.0054127", "CorpusId":
      6235017, "PubMed": "23326584"}, "corpusId": 6235017, "publicationVenue": {"id":
      "0aed7a40-85f3-4c66-9e1b-c1556c57001b", "name": "PLoS ONE", "type": "journal",
      "alternate_names": ["Plo ONE", "PLOS ONE", "PLO ONE"], "issn": "1932-6203",
      "url": "https://journals.plos.org/plosone/", "alternate_urls": ["http://www.plosone.org/"]},
      "url": "https://www.semanticscholar.org/paper/c2210b2adaca30c2c12ae946a3c7ccf326698750",
      "title": "A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate
      4-Kinase with a Novel, Rapid Substrate Preparation", "abstract": "Phosphoinositide
      kinases regulate diverse cellular functions and are important targets for therapeutic
      development for diseases, such as diabetes and cancer. Preparation of the lipid
      substrate is crucial for the development of a robust and miniaturizable lipid
      kinase assay. Enzymatic assays for phosphoinositide kinases often use lipid
      substrates prepared from lyophilized lipid preparations by sonication, which
      result in variability in the liposome size from preparation to preparation.
      Herein, we report a homogeneous 1536-well luciferase-coupled bioluminescence
      assay for PI5P4K\u03b1. The substrate preparation is novel and allows the rapid
      production of a DMSO-containing substrate solution without the need for lengthy
      liposome preparation protocols, thus enabling the scale-up of this traditionally
      difficult type of assay. The Z\u2019-factor value was greater than 0.7 for the
      PI5P4K\u03b1 assay, indicating its suitability for high-throughput screening
      applications. Tyrphostin AG-82 had been identified as an inhibitor of PI5P4K\u03b1
      by assessing the degree of phospho transfer of \u03b3-32P-ATP to PI5P; its inhibitory
      activity against PI5P4K\u03b1 was confirmed in the present miniaturized assay.
      From a pilot screen of a library of bioactive compounds, another tyrphostin,
      I-OMe tyrphostin AG-538 (I-OMe-AG-538), was identified as an ATP-competitive
      inhibitor of PI5P4K\u03b1 with an IC50 of 1 \u00b5M, affirming the suitability
      of the assay for inhibitor discovery campaigns. This homogeneous assay may apply
      to other lipid kinases and should help in the identification of leads for this
      class of enzymes by enabling high-throughput screening efforts.", "venue": "PLoS
      ONE", "year": 2013, "referenceCount": 45, "citationCount": 47, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": {"url": "https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054127&type=printable",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2013-01-10", "journal":
      {"volume": "8", "name": "PLoS ONE"}, "citationStyles": {"bibtex": "@Article{Davis2013AHH,\n
      author = {Mindy I. Davis and A. Sasaki and M. Shen and B. Emerling and Natasha
      Thorne and Sam Michael and R. Pragani and M. Boxer and Kazutaka Sumita and K.
      Takeuchi and D. Auld and Zhuyin Li and L. Cantley and A. Simeonov},\n booktitle
      = {PLoS ONE},\n journal = {PLoS ONE},\n title = {A Homogeneous, High-Throughput
      Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate
      Preparation},\n volume = {8},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "29195749", "name": "Mindy I. Davis"}, {"authorId": "47742211", "name": "A.
      Sasaki"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "5542751",
      "name": "B. Emerling"}, {"authorId": "29274858", "name": "Natasha Thorne"},
      {"authorId": "88898503", "name": "Sam Michael"}, {"authorId": "5123505", "name":
      "R. Pragani"}, {"authorId": "3275486", "name": "M. Boxer"}, {"authorId": "49715313",
      "name": "Kazutaka Sumita"}, {"authorId": "2775065", "name": "K. Takeuchi"},
      {"authorId": "2607088", "name": "D. Auld"}, {"authorId": "4837727", "name":
      "Zhuyin Li"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "145183304",
      "name": "A. Simeonov"}]}, {"paperId": "c58404c7676f2a2bfc1891eb5a301c10eb11e3fc",
      "externalIds": {"MAG": "2056077438", "DOI": "10.1126/science.1226603", "CorpusId":
      31810174, "PubMed": "23118012"}, "corpusId": 31810174, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/c58404c7676f2a2bfc1891eb5a301c10eb11e3fc",
      "title": "Influence of Threonine Metabolism on S-Adenosylmethionine and Histone
      Methylation", "abstract": "SAM, Histones, and Stem Cells Mouse embryonic stem
      cells require threonine for growth and express large amounts of the enzyme that
      catalyzes the first step in threonine metabolism. To find out what is so important
      about threonine in these cells, Shyh-Change et al. (p. 222, published online
      1 November; see the Perspective by Sassone-Corsi) monitored changes in metabolism
      by mass spectrometry in induced pluripotent stem cells. Threonine was required
      to maintain cellular concentrations of S-adenosylmethionine (SAM), a substrate
      used for protein methylation. Restriction of threonine inhibited methylation
      of histones, which is characteristic of chromatin in embryonic stem cells. Thus,
      altered metabolism of threonine and methionine in stem cells may be linked to
      epigenetic changes that influence genetic reprogramming and decisions of stem
      cells to proliferate or differentiate. Unusual threonine metabolism in mouse
      stem cells influences genetic reprogramming via altered histone methylation.
      [Also see Perspective by Sassone-Corsi] Threonine is the only amino acid critically
      required for the pluripotency of mouse embryonic stem cells (mESCs), but the
      detailed mechanism remains unclear. We found that threonine and S-adenosylmethionine
      (SAM) metabolism are coupled in pluripotent stem cells, resulting in regulation
      of histone methylation. Isotope labeling of mESCs revealed that threonine provides
      a substantial fraction of both the cellular glycine and the acetyl\u2013coenzyme
      A (CoA) needed for SAM synthesis. Depletion of threonine from the culture medium
      or threonine dehydrogenase (Tdh) from mESCs decreased accumulation of SAM and
      decreased trimethylation of histone H3 lysine 4 (H3K4me3), leading to slowed
      growth and increased differentiation. Thus, abundance of SAM appears to influence
      H3K4me3, providing a possible mechanism by which modulation of a metabolic pathway
      might influence stem cell fate.", "venue": "Science", "year": 2013, "referenceCount":
      24, "citationCount": 519, "influentialCitationCount": 31, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.science.org/cms/asset/e3be432e-2fbd-49c7-9c1b-568387c291d9/pap.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-01-11", "journal": {"volume": "339", "pages": "222
      - 226", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Shyh\u2010Chang2013InfluenceOT,\n
      author = {Ng Shyh\u2010Chang and J. Locasale and C. Lyssiotis and Yuxiang Zheng
      and Ren Yi Teo and Sutheera Ratanasirintrawoot and Jin Zhang and T. Onder and
      J. Unternaehrer and Hao Zhu and J. Asara and G. Daley and L. Cantley},\n booktitle
      = {Science},\n journal = {Science},\n pages = {222 - 226},\n title = {Influence
      of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation},\n
      volume = {339},\n year = {2013}\n}\n"}, "authors": [{"authorId": "1397529716",
      "name": "Ng Shyh\u2010Chang"}, {"authorId": "2268976", "name": "J. Locasale"},
      {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "1723564", "name":
      "Yuxiang Zheng"}, {"authorId": "50651504", "name": "Ren Yi Teo"}, {"authorId":
      "5878690", "name": "Sutheera Ratanasirintrawoot"}, {"authorId": "2117170793",
      "name": "Jin Zhang"}, {"authorId": "5073178", "name": "T. Onder"}, {"authorId":
      "38764542", "name": "J. Unternaehrer"}, {"authorId": "2115313565", "name": "Hao
      Zhu"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "2028224",
      "name": "G. Daley"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "d6e11f49978c4ae02ac94fad7d8e172812c1ffb5", "externalIds": {"DOI": "10.1096/fasebj.27.1_supplement.1046.3",
      "CorpusId": 249766417}, "corpusId": 249766417, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/d6e11f49978c4ae02ac94fad7d8e172812c1ffb5",
      "title": "Ras Activity Regulation by Monoubiquitination", "abstract": "Ras proteins
      are critical regulators of cellular growth. The population of activated, GTP\u2010bound
      Ras in normal cells is controlled by protein regulators. Oncogenic mutations
      promote activation by populating the active state of Ras, most frequently by
      impairing the action of proteins that downregulate its activity. Recently, a
      novel mechanism of Ras activation was identified, in which modification by ubiquitination
      was found to populate Ras in its active GTP\u2010bound state, enhance interactions
      with downstream effectors and promote Ras\u2010mediated tumorigenesis. These
      findings represent a paradigm shift in our understanding of the role monoubiquitination
      may play in protein regulation. By conducting NMR, modeling, biochemical and
      biological studies, we find that monoubiquitination of Ras at position 147 has
      little effect on intrinsic guanine nucleotide binding or hydrolysis, but impairs
      the ability of GTPase activating proteins to downregulate Ras activity, accounting
      for the accumulation of Ras\u2010GTP in cells. These findings reveal that a
      post\u2010translational modification can disrupt protein interactions that normally
      constrain cellular signaling and transformation.", "venue": "", "year": 2013,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2013-04-01", "journal": {"volume": "27", "name": "The FASEB Journal"}, "citationStyles":
      {"bibtex": "@Article{Campbell2013RasAR,\n author = {S. Campbell and R. Baker
      and Steven M. Lewis and A. Sasaki and Emily M. Wilkerson and J. Locasale and
      L. Cantley and B. Kuhlman and H. Dohlman},\n journal = {The FASEB Journal},\n
      title = {Ras Activity Regulation by Monoubiquitination},\n volume = {27},\n
      year = {2013}\n}\n"}, "authors": [{"authorId": "46713144", "name": "S. Campbell"},
      {"authorId": "145564214", "name": "R. Baker"}, {"authorId": "7268742", "name":
      "Steven M. Lewis"}, {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId":
      "5527411", "name": "Emily M. Wilkerson"}, {"authorId": "2268976", "name": "J.
      Locasale"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144226889",
      "name": "B. Kuhlman"}, {"authorId": "1710306", "name": "H. Dohlman"}]}, {"paperId":
      "dc41a0f23842d7cffc7494912ed6724d82a683ae", "externalIds": {"MAG": "1975075263",
      "DOI": "10.1158/1538-7445.AM2013-4588", "CorpusId": 58742110}, "corpusId": 58742110,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/dc41a0f23842d7cffc7494912ed6724d82a683ae",
      "title": "Abstract 4588: Identification of CDCP1 as a HIF-2\u03b1 target gene
      involved in the regulation of cancer cell migration and metastasis.", "abstract":
      "CUB domain-containing protein 1 (CDCP1) is a transmembrane protein that is
      highly expressed in stem cells and frequently overexpressed and tyrosine phosphorylated
      in cancer. CDCP1 promotes cancer cell metastasis. However, the mechanisms that
      regulate CDCP1 are not well defined. Studies from our laboratory revealed a
      biochemical pathway by which CDCP1 participates in the activation of Src-family
      kinase (SFK) members and the coupling of SFK-activation to the phosphorylation
      and regulation of protein kinase C-delta (PKC-\u03b4). Here we show that hypoxia
      induces CDCP1 expression and tyrosine phosphorylation in a HIF-2\u03b1, but
      not HIF-1\u03b1, dependent fashion. shRNA knockdown of CDCP1 impairs cancer
      cell migration under hypoxic conditions, while overexpression of HIF-2\u03b1
      promotes the growth of tumor xenografts in association with enhanced CDCP1 expression
      and tyrosine phosphorylation, as well as, significantly promotes lung metastases
      in NOD/SCID mice. To investigate the relationship between HIF-2\u03b1 and CDCP1
      expression, we performed a correlation analysis in the largest up-to-date collection
      (Sanger Cell Line Project) of cancer cell line microarray data (n=732). We found
      a dramatic concordance in the expression of HIF-2\u03b1 and CDCP1 (Pearson9s
      correlation, P Supported by NIH grant 5R01GM056203-15 to L.C.C and Dana Farber/Harvard
      Cancer Center Career Development Award to B.M.E. Citation Format: Brooke M.
      Emerling, Cyril Benes, Eric Bell, George Poulogiannis, Kevin Courtney, Hui Lui,
      Rayman Choo-Wing, Gary Bellinger, Stephen Soltoff, Lewis Cantley. Identification
      of CDCP1 as a HIF-2\u03b1 target gene involved in the regulation of cancer cell
      migration and metastasis. [abstract]. In: Proceedings of the 104th Annual Meeting
      of the American Association for Cancer Research; 2013 Apr 6-10; Washington,
      DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4588. doi:10.1158/1538-7445.AM2013-4588",
      "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2013-04-15", "journal": {"volume":
      "73", "pages": "4588-4588", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Emerling2013Abstract4I,\n author = {B. Emerling and C. Benes and Eric
      L. Bell and G. Poulogiannis and K. Courtney and H. Lui and R. Choo-Wing and
      G. Bellinger and S. Soltoff and L. Cantley},\n journal = {Cancer Research},\n
      pages = {4588-4588},\n title = {Abstract 4588: Identification of CDCP1 as a
      HIF-2\u03b1 target gene involved in the regulation of cancer cell migration
      and metastasis.},\n volume = {73},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "5542751", "name": "B. Emerling"}, {"authorId": "1714039", "name": "C. Benes"},
      {"authorId": "49200178", "name": "Eric L. Bell"}, {"authorId": "4612853", "name":
      "G. Poulogiannis"}, {"authorId": "13782167", "name": "K. Courtney"}, {"authorId":
      "47028670", "name": "H. Lui"}, {"authorId": "1401641678", "name": "R. Choo-Wing"},
      {"authorId": "5679020", "name": "G. Bellinger"}, {"authorId": "4324390", "name":
      "S. Soltoff"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "df9a0a200e678d9c31d9c9ffc18916ed0b6cb21b", "externalIds": {"MAG": "2059380603",
      "DOI": "10.1038/emboj.2013.186", "CorpusId": 7791738, "PubMed": "24013118"},
      "corpusId": 7791738, "publicationVenue": {"id": "b89f0ede-6fa8-4dd2-a8a7-f54695a00323",
      "name": "EMBO Journal", "type": "journal", "alternate_names": ["The EMBO Journal",
      "EMBO J"], "issn": "0261-4189", "url": "http://embojournal.npgjournals.com/",
      "alternate_urls": ["http://emboj.embopress.org/"]}, "url": "https://www.semanticscholar.org/paper/df9a0a200e678d9c31d9c9ffc18916ed0b6cb21b",
      "title": "FoxO3 coordinates metabolic pathways to maintain redox balance in
      neural stem cells", "abstract": null, "venue": "EMBO Journal", "year": 2013,
      "referenceCount": 59, "citationCount": 121, "influentialCitationCount": 5, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3791369?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-10-02", "journal": {"volume": "32", "name": "The EMBO
      Journal"}, "citationStyles": {"bibtex": "@Article{Yeo2013FoxO3CM,\n author =
      {Hyeonju Yeo and C. Lyssiotis and Yuqing Zhang and H. Ying and J. Asara and
      L. Cantley and J. Paik},\n booktitle = {EMBO Journal},\n journal = {The EMBO
      Journal},\n title = {FoxO3 coordinates metabolic pathways to maintain redox
      balance in neural stem cells},\n volume = {32},\n year = {2013}\n}\n"}, "authors":
      [{"authorId": "4250474", "name": "Hyeonju Yeo"}, {"authorId": "4901222", "name":
      "C. Lyssiotis"}, {"authorId": "2108446203", "name": "Yuqing Zhang"}, {"authorId":
      "33312849", "name": "H. Ying"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5056578", "name":
      "J. Paik"}]}, {"paperId": "dffe20ab2c4e73bae7598baa2c68d8a70444d3b6", "externalIds":
      {"PubMedCentral": "3909335", "MAG": "2056078734", "DOI": "10.1186/1741-7007-12-8",
      "CorpusId": 33254184, "PubMed": "24484968"}, "corpusId": 33254184, "publicationVenue":
      {"id": "1617f5c3-5410-462d-91c9-7aa8ced2d91d", "name": "BMC Biology", "type":
      "journal", "issn": "1741-7007", "url": "http://www.biomedcentral.com/1741-7007/",
      "alternate_urls": ["http://www.biomedcentral.com/bmcbiol/", "http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=215"]},
      "url": "https://www.semanticscholar.org/paper/dffe20ab2c4e73bae7598baa2c68d8a70444d3b6",
      "title": "Cancer, metabolism, fructose, artificial sweeteners, and going cold
      turkey on sugar", "abstract": null, "venue": "BMC Biology", "year": 2013, "referenceCount":
      7, "citationCount": 14, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://bmcbiol.biomedcentral.com/counter/pdf/10.1186/1741-7007-12-8",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2013-01-31", "journal": {"volume":
      "12", "pages": "8 - 8", "name": "BMC Biology"}, "citationStyles": {"bibtex":
      "@Article{Cantley2013CancerMF,\n author = {L. Cantley},\n booktitle = {BMC Biology},\n
      journal = {BMC Biology},\n pages = {8 - 8},\n title = {Cancer, metabolism, fructose,
      artificial sweeteners, and going cold turkey on sugar},\n volume = {12},\n year
      = {2013}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "e0c356adeecdf5655e7bfb0266a33bc8dfea8835", "externalIds": {"MAG":
      "2101774229", "DOI": "10.1073/pnas.1317577110", "CorpusId": 24903326, "PubMed":
      "24145418"}, "corpusId": 24903326, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/e0c356adeecdf5655e7bfb0266a33bc8dfea8835",
      "title": "Phenformin enhances the therapeutic benefit of BRAFV600E inhibition
      in melanoma", "abstract": "Significance Inhibitors of BRAF protein kinase, such
      as Vemurafenib and Dabrafenib, have shown remarkable antitumor activity in patients
      with BRAF mutant melanoma. However, most of the patients developed drug resistance
      during the course of treatment, leading to resumed tumor growth. This drug resistance
      challenge underscores the need to improve on current BRAF-targeted therapy.
      In this study, we have shown that phenformin, a biguanide used for treating
      type 2 diabetes, enhances the antitumor activities of BRAF inhibitors in both
      cultured melanoma cells and a genetically engineered BRAFV600E-driven mouse
      model of melanoma. Our preclinical findings suggest that combining phenformin
      with a BRAF inhibitor may be a more effective treatment than a single-agent
      BRAF inhibitor for treating patients with melanoma whose tumor harbor BRAF mutations.
      Biguanides, such as the diabetes therapeutics metformin and phenformin, have
      demonstrated antitumor activity both in vitro and in vivo. The energy-sensing
      AMP-activated protein kinase (AMPK) is known to be a major cellular target of
      biguanides. Based on our discovery of cross-talk between the AMPK and v-Raf
      murine sarcoma viral oncogene homolog B1 (BRAF) signaling pathways, we investigated
      the antitumor effects of combining phenformin with a BRAF inhibitor PLX4720
      on the proliferation of BRAF-mutated melanoma cells in vitro and on BRAF-driven
      tumor growth in vivo. Cotreatment of BRAF-mutated melanoma cell lines with phenformin
      and PLX4720 resulted in synergistic inhibition of cell viability, compared with
      the effects of the single agent alone. Moreover, treatment with phenformin significantly
      delayed the development of resistance to PLX4720 in cultured melanoma cells.
      Biochemical analyses showed that phenformin and PLX4720 exerted cooperative
      effects on inhibiting mTOR signaling and inducing apoptosis. Noticeably, phenformin
      selectively targeted subpopulations of cells expressing JARID1B, a marker for
      slow cycling melanoma cells, whereas PLX4720 selectively targeted JARID1B-negative
      cells. Finally, in contrast to their use as single agents, the combination of
      phenformin and PLX4720 induced tumor regression in both nude mice bearing melanoma
      xenografts and in a genetically engineered BRAFV600E/PTENnull-driven mouse model
      of melanoma. These results strongly suggest that significant therapeutic advantage
      may be achieved by combining AMPK activators such as phenformin with BRAF inhbitors
      for the treatment of melanoma.", "venue": "Proceedings of the National Academy
      of Sciences of the United States of America", "year": 2013, "referenceCount":
      30, "citationCount": 203, "influentialCitationCount": 5, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/110/45/18226.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2013-10-21", "journal": {"volume": "110",
      "pages": "18226 - 18231", "name": "Proceedings of the National Academy of Sciences"},
      "citationStyles": {"bibtex": "@Article{Yuan2013PhenforminET,\n author = {P.
      Yuan and Koichi Ito and R. P\u00e9rez-Lorenzo and Christina A. Del Guzzo and
      Jung Hyun Lee and Che-Hung Shen and M. Bosenberg and M. McMahon and L. Cantley
      and B. Zheng},\n booktitle = {Proceedings of the National Academy of Sciences
      of the United States of America},\n journal = {Proceedings of the National Academy
      of Sciences},\n pages = {18226 - 18231},\n title = {Phenformin enhances the
      therapeutic benefit of BRAFV600E inhibition in melanoma},\n volume = {110},\n
      year = {2013}\n}\n"}, "authors": [{"authorId": "23576567", "name": "P. Yuan"},
      {"authorId": "2111361747", "name": "Koichi Ito"}, {"authorId": "1398525526",
      "name": "R. P\u00e9rez-Lorenzo"}, {"authorId": "1521983646", "name": "Christina
      A. Del Guzzo"}, {"authorId": "2141765417", "name": "Jung Hyun Lee"}, {"authorId":
      "83946576", "name": "Che-Hung Shen"}, {"authorId": "4177474", "name": "M. Bosenberg"},
      {"authorId": "144508121", "name": "M. McMahon"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "143918840", "name": "B. Zheng"}]}, {"paperId":
      "e3731c2c2496d8a2d364ca8952db4489bf9d10bd", "externalIds": {"MAG": "2466818859",
      "CorpusId": 88979582}, "corpusId": 88979582, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/e3731c2c2496d8a2d364ca8952db4489bf9d10bd",
      "title": "Figure 2, [A) Hypoxia and exogenous oxidants...].", "abstract": null,
      "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2013-05-08", "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex":
      "@Inproceedings{Brimacombe2013Figure2,\n author = {K. Brimacombe and D. Anastasiou
      and B. Hong and W. Tempel and S. Dimov and H. Veith and D. Auld and M. V. Heiden
      and Craig J. Thomas and Hee-won Park and M. Shen and L. Cantley and M. Boxer},\n
      title = {Figure 2, [A) Hypoxia and exogenous oxidants...].},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "6351971", "name": "B. Hong"}, {"authorId":
      "5566934", "name": "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"},
      {"authorId": "1799343", "name": "H. Veith"}, {"authorId": "2607088", "name":
      "D. Auld"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632",
      "name": "Craig J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3275486", "name": "M. Boxer"}]}, {"paperId": "ebd6e44bfea315072c0f6b7399186e20968fe4c1",
      "externalIds": {"MAG": "256459495", "CorpusId": 83344047}, "corpusId": 83344047,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/ebd6e44bfea315072c0f6b7399186e20968fe4c1",
      "title": "ML285 affects reactive oxygen species\u2019 inhibition of pyruvate
      kinase M2", "abstract": null, "venue": "", "year": 2013, "referenceCount": 0,
      "citationCount": 11, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2013-05-08", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Brimacombe2013ML285AR,\n
      author = {K. Brimacombe and D. Anastasiou and B. Hong and W. Tempel and S. Dimov
      and H. Veith and D. Auld and M. V. Heiden and Craig J. Thomas and Hee-won Park
      and M. Shen and L. Cantley and M. Boxer},\n title = {ML285 affects reactive
      oxygen species\u2019 inhibition of pyruvate kinase M2},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "6351971", "name": "B. Hong"}, {"authorId":
      "5566934", "name": "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"},
      {"authorId": "1799343", "name": "H. Veith"}, {"authorId": "2607088", "name":
      "D. Auld"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632",
      "name": "Craig J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3275486", "name": "M. Boxer"}]}, {"paperId": "ef0a73612aff3f9f580a06ec5607d14cec462f3b",
      "externalIds": {"MAG": "2399983558", "CorpusId": 99302190}, "corpusId": 99302190,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/ef0a73612aff3f9f580a06ec5607d14cec462f3b",
      "title": "Figure 1, Previously reported PKM2 activator ML probes", "abstract":
      null, "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2013-05-08", "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex":
      "@Inproceedings{Brimacombe2013Figure1P,\n author = {K. Brimacombe and D. Anastasiou
      and B. Hong and W. Tempel and S. Dimov and H. Veith and D. Auld and M. V. Heiden
      and Craig J. Thomas and Hee-won Park and M. Shen and L. Cantley and M. Boxer},\n
      title = {Figure 1, Previously reported PKM2 activator ML probes},\n year = {2013}\n}\n"},
      "authors": [{"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "6351971", "name": "B. Hong"}, {"authorId":
      "5566934", "name": "W. Tempel"}, {"authorId": "33892021", "name": "S. Dimov"},
      {"authorId": "1799343", "name": "H. Veith"}, {"authorId": "2607088", "name":
      "D. Auld"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "2148769632",
      "name": "Craig J. Thomas"}, {"authorId": "2790262", "name": "Hee-won Park"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3275486", "name": "M. Boxer"}]}, {"paperId": "ef15ca796d4265a9dcff47d3bed7d5f4a67359cc",
      "externalIds": {"MAG": "2151419509", "PubMedCentral": "3787876", "DOI": "10.1038/ng.2650",
      "CorpusId": 7036669, "PubMed": "23727860"}, "corpusId": 7036669, "publicationVenue":
      {"id": "bb27e645-e57c-42c3-bcbc-c7b443c58209", "name": "Nature Genetics", "type":
      "journal", "alternate_names": ["Nat Genet"], "issn": "1061-4036", "url": "http://www.nature.com/ng/",
      "alternate_urls": ["http://www.nature.com/ng/index.html"]}, "url": "https://www.semanticscholar.org/paper/ef15ca796d4265a9dcff47d3bed7d5f4a67359cc",
      "title": "A co-clinical approach identifies mechanisms and potential therapies
      for androgen deprivation resistance in prostate cancer", "abstract": null, "venue":
      "Nature Genetics", "year": 2013, "referenceCount": 56, "citationCount": 138,
      "influentialCitationCount": 16, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc3787876?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2013-05-21", "journal":
      {"volume": "45", "pages": "747 - 755", "name": "Nature genetics"}, "citationStyles":
      {"bibtex": "@Article{Lunardi2013ACA,\n author = {A. Lunardi and U. Ala and M.
      Epping and L. Salmena and J. Clohessy and Kaitlyn A. Webster and Guocan Wang
      and R. Mazzucchelli and M. Bianconi and E. Stack and R. Lis and Akash Patnaik
      and L. Cantley and G. Bubley and C. Cordon-Cardo and W. Gerald and R. Montironi
      and S. Signoretti and M. Loda and C. Nardella and P. Pandolfi},\n booktitle
      = {Nature Genetics},\n journal = {Nature genetics},\n pages = {747 - 755},\n
      title = {A co-clinical approach identifies mechanisms and potential therapies
      for androgen deprivation resistance in prostate cancer},\n volume = {45},\n
      year = {2013}\n}\n"}, "authors": [{"authorId": "5729169", "name": "A. Lunardi"},
      {"authorId": "2901501", "name": "U. Ala"}, {"authorId": "4276612", "name": "M.
      Epping"}, {"authorId": "6316033", "name": "L. Salmena"}, {"authorId": "4102988",
      "name": "J. Clohessy"}, {"authorId": "4817196", "name": "Kaitlyn A. Webster"},
      {"authorId": "47227159", "name": "Guocan Wang"}, {"authorId": "3778026", "name":
      "R. Mazzucchelli"}, {"authorId": "144862941", "name": "M. Bianconi"}, {"authorId":
      "5592639", "name": "E. Stack"}, {"authorId": "50267670", "name": "R. Lis"},
      {"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "5854981", "name": "G. Bubley"}, {"authorId": "13870598",
      "name": "C. Cordon-Cardo"}, {"authorId": "3950794", "name": "W. Gerald"}, {"authorId":
      "145421680", "name": "R. Montironi"}, {"authorId": "7505152", "name": "S. Signoretti"},
      {"authorId": "6213932", "name": "M. Loda"}, {"authorId": "3547827", "name":
      "C. Nardella"}, {"authorId": "4499580", "name": "P. Pandolfi"}]}, {"paperId":
      "f00a6d08a329a4c52b7d96f28a13ce8bfda374f2", "externalIds": {"MAG": "2095088245",
      "DOI": "10.1158/0008-5472.SABCS13-OT1-4-02", "CorpusId": 73181944}, "corpusId":
      73181944, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/f00a6d08a329a4c52b7d96f28a13ce8bfda374f2",
      "title": "Abstract OT1-4-02: Phase I study of the combination of BKM120 and
      olaparib for the treatment of high grade serous ovarian cancer (HGSC) and triple
      negative breast cancer (TNBC)", "abstract": "Background: In vivo synergy of
      the PI3-kinase inhibitor BKM120 with the PARP inhibitor olaparib has been observed
      using a mouse model of BRCA1-related breast cancer and sporadic TNBC (Juvekar
      et al and Ibrahim et al, Cancer Discovery 2012). In addition, olaparib has single
      agent activity in both HGSC and BRCA-associated breast cancer. The PI3kinase
      pathway is activated in both TNBC and HGSC (www.cancergenome.nih.gov). These
      preclinical and clinical data have served as the rationale for this phase I,
      multi-center study (NCT01623349) combining the oral PARP inhibitor olaparib
      with the oral PI3-kinase inhibitor BKM120 in patients with recurrent HGSC or
      recurrent TNBC. This study is being conducted through the Stand Up to Cancer
      (SU2C)9s Targeting PI3-kinase in Women9s Cancers Dream Team. Study Design: This
      study has a 3 + 3 design, escalating if 0/3 or 1/6 participants have a dose
      limiting toxicity (DLT) during the first cycle of therapy (first 28 days). The
      study objectives are to determine the recommended phase II dose (RP2D) of daily
      continuous oral olaparib (using the tablet formulation) and BKM120, assess toxicities,
      safety, and preliminary activity of this combination, and determine pharmacokinetic
      profiles of both agents. In addition, there are several translational endpoints
      including elucidation of downstream signaling effects of the PI3-kinase pathway,
      examination of BRCA1 immunostaining, and assessment of BRCA1 promoter hypermethylation
      and somatic mutations in BRCA1 and BRCA2 using archived formalin fixed paraffin
      embedded (FFPE) tissue. Serial IL-8 and circulating DNA levels are also being
      monitored as well. Eligibility includes a diagnosis of recurrent TNBC or HGSC,
      PS 0 or 1, measurable or evaluable cancer, and normal lab values and organ function.
      Prior PARP inhibitor exposure is allowed. In addition, breast cancer or ovarian
      cancer patients with any histologic subtype are eligible if they have a known
      germline BRCA1 or BRCA2 mutation. At the RP2D, 10 pts each with a diagnosis
      of TNBC or HGSC will be enrolled to further determine safety and efficacy profiles
      in addition to more thoroughly studying translational endpoints. As of June
      7, 2013, 16 patients have been enrolled into this study with a planned accrual
      of approximately 50 patients which may change based on number of dose levels
      tested during dose escalation. In addition, an amendment is pending that will
      add a second cohort studying the combination of olaparib and BYL719 based on
      robust pre-clinical activity observed in murine models which will increase our
      total accrual. Once this new cohort is open, both arms will enroll simultaneously.
      For further information, contact Ursula Matulonis at: umatulonis@partners.org.
      Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr OT1-4-02.",
      "venue": "", "year": 2013, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2013-12-15", "journal": {"volume": "73", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Matulonis2013AbstractOP,\n author = {U. Matulonis and G.
      Wulf and L. Cantley and G. Mills and Brian Lasonde and T. Atkinson and C. Whalen
      and S. Isakoff and S. Westin and K. Bell-McGuinn and E. Winer},\n journal =
      {Cancer Research},\n title = {Abstract OT1-4-02: Phase I study of the combination
      of BKM120 and olaparib for the treatment of high grade serous ovarian cancer
      (HGSC) and triple negative breast cancer (TNBC)},\n volume = {73},\n year =
      {2013}\n}\n"}, "authors": [{"authorId": "6927295", "name": "U. Matulonis"},
      {"authorId": "31554501", "name": "G. Wulf"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2241330", "name": "G. Mills"}, {"authorId": "12796173",
      "name": "Brian Lasonde"}, {"authorId": "40371034", "name": "T. Atkinson"}, {"authorId":
      "122974814", "name": "C. Whalen"}, {"authorId": "4327978", "name": "S. Isakoff"},
      {"authorId": "2974900", "name": "S. Westin"}, {"authorId": "1397923721", "name":
      "K. Bell-McGuinn"}, {"authorId": "2369378", "name": "E. Winer"}]}, {"paperId":
      "f303d8aeead0055ee1ca14a8147e4caab66d1857", "externalIds": {"MAG": "2004170579",
      "DOI": "10.1016/j.molcel.2013.01.035", "CorpusId": 206986841, "PubMed": "23453806"},
      "corpusId": 206986841, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/f303d8aeead0055ee1ca14a8147e4caab66d1857",
      "title": "AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced
      glucose uptake via GLUT1.", "abstract": null, "venue": "Molecules and Cells",
      "year": 2013, "referenceCount": 50, "citationCount": 508, "influentialCitationCount":
      35, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276513000993/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2013-03-28", "journal": {"volume": "49 6", "pages": "\n          1167-75\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Wu2013AMPKdependentDO,\n
      author = {N. Wu and B. Zheng and A. Shaywitz and Y. Dagon and Christine M Tower
      and G. Bellinger and Che-Hung Shen and Jennifer Wen and J. Asara and T. McGraw
      and B. Kahn and L. Cantley},\n booktitle = {Molecules and Cells},\n journal
      = {Molecular cell},\n pages = {\n          1167-75\n        },\n title = {AMPK-dependent
      degradation of TXNIP upon energy stress leads to enhanced glucose uptake via
      GLUT1.},\n volume = {49 6},\n year = {2013}\n}\n"}, "authors": [{"authorId":
      "145650836", "name": "N. Wu"}, {"authorId": "143918840", "name": "B. Zheng"},
      {"authorId": "4635185", "name": "A. Shaywitz"}, {"authorId": "3734143", "name":
      "Y. Dagon"}, {"authorId": "40500196", "name": "Christine M Tower"}, {"authorId":
      "5679020", "name": "G. Bellinger"}, {"authorId": "83946576", "name": "Che-Hung
      Shen"}, {"authorId": "50976006", "name": "Jennifer Wen"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "32665208", "name": "T. McGraw"}, {"authorId":
      "1997179", "name": "B. Kahn"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "feb70ba005051b17138728accca3fd6d4e7854fc", "externalIds": {"MAG":
      "2030991075", "DOI": "10.1073/pnas.1222435110", "CorpusId": 25668816, "PubMed":
      "23378636"}, "corpusId": 25668816, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/feb70ba005051b17138728accca3fd6d4e7854fc",
      "title": "Identification of CDCP1 as a hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1)
      target gene that is associated with survival in clear cell renal cell carcinoma
      patients", "abstract": "CUB domain-containing protein 1 (CDCP1) is a transmembrane
      protein that is highly expressed in stem cells and frequently overexpressed
      and tyrosine-phosphorylated in cancer. CDCP1 promotes cancer cell metastasis.
      However, the mechanisms that regulate CDCP1 are not well-defined. Here we show
      that hypoxia induces CDCP1 expression and tyrosine phosphorylation in hypoxia-inducible
      factor (HIF)-2\u03b1\u2013, but not HIF-1\u03b1\u2013, dependent fashion. shRNA
      knockdown of CDCP1 impairs cancer cell migration under hypoxic conditions, whereas
      overexpression of HIF-2\u03b1 promotes the growth of tumor xenografts in association
      with enhanced CDCP1 expression and tyrosine phosphorylation. Immunohistochemistry
      analysis of tissue microarray samples from tumors of patients with clear cell
      renal cell carcinoma shows that increased CDCP1 expression correlates with decreased
      overall survival. Together, these data support a critical role for CDCP1 as
      a unique HIF-2\u03b1 target gene involved in the regulation of cancer metastasis,
      and suggest that CDCP1 is a biomarker and potential therapeutic target for metastatic
      cancers.", "venue": "Proceedings of the National Academy of Sciences of the
      United States of America", "year": 2013, "referenceCount": 36, "citationCount":
      61, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.pnas.org/content/pnas/110/9/3483.full.pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2013-02-01", "journal": {"volume": "110", "pages": "3483 - 3488", "name": "Proceedings
      of the National Academy of Sciences"}, "citationStyles": {"bibtex": "@Article{Emerling2013IdentificationOC,\n
      author = {B. Emerling and C. Benes and G. Poulogiannis and Eric L. Bell and
      K. Courtney and Hui Liu and R. Choo-Wing and G. Bellinger and Kazumi S. Tsukazawa
      and Victoria Brown and S. Signoretti and S. Soltoff and L. Cantley},\n booktitle
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences},\n pages = {3483
      - 3488},\n title = {Identification of CDCP1 as a hypoxia-inducible factor 2\u03b1
      (HIF-2\u03b1) target gene that is associated with survival in clear cell renal
      cell carcinoma patients},\n volume = {110},\n year = {2013}\n}\n"}, "authors":
      [{"authorId": "5542751", "name": "B. Emerling"}, {"authorId": "1714039", "name":
      "C. Benes"}, {"authorId": "4612853", "name": "G. Poulogiannis"}, {"authorId":
      "49200178", "name": "Eric L. Bell"}, {"authorId": "13782167", "name": "K. Courtney"},
      {"authorId": "2146671919", "name": "Hui Liu"}, {"authorId": "1401641678", "name":
      "R. Choo-Wing"}, {"authorId": "5679020", "name": "G. Bellinger"}, {"authorId":
      "8254104", "name": "Kazumi S. Tsukazawa"}, {"authorId": "49917633", "name":
      "Victoria Brown"}, {"authorId": "7505152", "name": "S. Signoretti"}, {"authorId":
      "4324390", "name": "S. Soltoff"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "081b0699d0407441e4452f7c9067db73ad8867fd", "externalIds": {"DOI":
      "10.1038/ncb2629", "CorpusId": 256726614}, "corpusId": 256726614, "publicationVenue":
      {"id": "7d182b83-7d8d-43fb-9fd6-ae67fbafab20", "name": "Nature Cell Biology",
      "type": "journal", "alternate_names": ["Nat Cell Biology"], "issn": "1465-7392",
      "url": "http://www.nature.com/naturecellbiology", "alternate_urls": ["https://www.nature.com/ncb/"]},
      "url": "https://www.semanticscholar.org/paper/081b0699d0407441e4452f7c9067db73ad8867fd",
      "title": "ERK1/2-dependent phosphorylation and nuclear translocation of PKM2
      promotes the Warburg effect", "abstract": null, "venue": "Nature Cell Biology",
      "year": 2012, "referenceCount": 27, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3511602?pdf=render",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-11-25", "journal": {"volume":
      "14", "pages": "1295 - 1304", "name": "Nature Cell Biology"}, "citationStyles":
      {"bibtex": "@Article{Yang2012ERK12dependentPA,\n author = {Weiwei Yang and Yanhua
      Zheng and Yan Xia and Haitao Ji and Xiaomin Chen and F. Guo and C. Lyssiotis
      and K. Aldape and L. Cantley and Zhimin Lu},\n booktitle = {Nature Cell Biology},\n
      journal = {Nature Cell Biology},\n pages = {1295 - 1304},\n title = {ERK1/2-dependent
      phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect},\n
      volume = {14},\n year = {2012}\n}\n"}, "authors": [{"authorId": "143956168",
      "name": "Weiwei Yang"}, {"authorId": "3169180", "name": "Yanhua Zheng"}, {"authorId":
      "143733371", "name": "Yan Xia"}, {"authorId": "2579875", "name": "Haitao Ji"},
      {"authorId": "48283607", "name": "Xiaomin Chen"}, {"authorId": "152831013",
      "name": "F. Guo"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId":
      "50138848", "name": "K. Aldape"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5467266", "name": "Zhimin Lu"}]}, {"paperId": "0b5af00901a54df3f6fb38987ba9d0d537c41350",
      "externalIds": {"MAG": "2073112065", "PubMedCentral": "3395034", "DOI": "10.1186/1753-6561-6-S3-O2",
      "CorpusId": 85358556}, "corpusId": 85358556, "publicationVenue": {"id": "5b9b6854-d895-439b-9ab4-1e1ed4c26336",
      "name": "BMC Proceedings", "type": "journal", "alternate_names": ["BMC Proc"],
      "issn": "1753-6561", "url": "http://www.biomedcentral.com/bmcproc", "alternate_urls":
      ["http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=587"]},
      "url": "https://www.semanticscholar.org/paper/0b5af00901a54df3f6fb38987ba9d0d537c41350",
      "title": "PI 3-kinase and disease", "abstract": null, "venue": "BMC Proceedings",
      "year": 2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://bmcproc.biomedcentral.com/track/pdf/10.1186/1753-6561-6-S3-O2",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-06-01", "journal": {"volume":
      "6", "pages": "O2 - O2", "name": "BMC Proceedings"}, "citationStyles": {"bibtex":
      "@Article{Cantley2012PI3A,\n author = {L. Cantley},\n booktitle = {BMC Proceedings},\n
      journal = {BMC Proceedings},\n pages = {O2 - O2},\n title = {PI 3-kinase and
      disease},\n volume = {6},\n year = {2012}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "150e78f416798147a8a164b104be10c5a196046f",
      "externalIds": {"MAG": "2595755469", "DOI": "10.1038/NCHEMBIO1212-1008B", "CorpusId":
      90537327}, "corpusId": 90537327, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/150e78f416798147a8a164b104be10c5a196046f",
      "title": "Erratum: Pyruvate kinase M2 activators promote tetramer formation
      and suppress tumorigenesis (Nature Chemical Biology (2012) 8 (839-847))", "abstract":
      null, "venue": "", "year": 2012, "referenceCount": 1, "citationCount": 11, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/nchembio1212-1008b.pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-12-01", "journal": {"volume":
      "8", "name": "Nature Chemical Biology"}, "citationStyles": {"bibtex": "@Article{Anastasiou2012ErratumPK,\n
      author = {D. Anastasiou and Yimin Yu and William J. Israelsen and Jian-Kang
      Jiang and M. Boxer and B. Hong and W. Tempel and S. Dimov and M. Shen and Abhishek
      K. Jha and Hua Yang and Katherine R. Mattaini and Christian M. Metallo and B.
      Fiske and K. Courtney and S. Malstrom and Tahsin M. Khan and C. Kung and A.
      P. Skoumbourdis and H. Veith and Noel Southall and M. Walsh and K. Brimacombe
      and W. Leister and S. Lunt and Zachary R. Johnson and K. Yen and K. Kunii and
      S. Davidson and H. Christofk and C. Austin and James Inglese and M. H. Harris
      and J. Asara and G. Stephanopoulos and F. Salituro and Shengfang Jin and L.
      Dang and D. Auld and Hee-won Park and L. Cantley and Craig J. Thomas and M.
      V. Heiden},\n journal = {Nature Chemical Biology},\n title = {Erratum: Pyruvate
      kinase M2 activators promote tetramer formation and suppress tumorigenesis (Nature
      Chemical Biology (2012) 8 (839-847))},\n volume = {8},\n year = {2012}\n}\n"},
      "authors": [{"authorId": "46996935", "name": "D. Anastasiou"}, {"authorId":
      "1924735", "name": "Yimin Yu"}, {"authorId": "5553029", "name": "William J.
      Israelsen"}, {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId":
      "3275486", "name": "M. Boxer"}, {"authorId": "6351971", "name": "B. Hong"},
      {"authorId": "5566934", "name": "W. Tempel"}, {"authorId": "33892021", "name":
      "S. Dimov"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "38884428",
      "name": "Abhishek K. Jha"}, {"authorId": "47912756", "name": "Hua Yang"}, {"authorId":
      "6160202", "name": "Katherine R. Mattaini"}, {"authorId": "2281284", "name":
      "Christian M. Metallo"}, {"authorId": "8143199", "name": "B. Fiske"}, {"authorId":
      "13782167", "name": "K. Courtney"}, {"authorId": "3870192", "name": "S. Malstrom"},
      {"authorId": "47670281", "name": "Tahsin M. Khan"}, {"authorId": "7636232",
      "name": "C. Kung"}, {"authorId": "5914392", "name": "A. P. Skoumbourdis"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "49134285", "name": "Noel Southall"},
      {"authorId": "1699620778", "name": "M. Walsh"}, {"authorId": "2435894", "name":
      "K. Brimacombe"}, {"authorId": "3802281", "name": "W. Leister"}, {"authorId":
      "39089704", "name": "S. Lunt"}, {"authorId": "51164649", "name": "Zachary R.
      Johnson"}, {"authorId": "4886372", "name": "K. Yen"}, {"authorId": "8330889",
      "name": "K. Kunii"}, {"authorId": "34711277", "name": "S. Davidson"}, {"authorId":
      "4164415", "name": "H. Christofk"}, {"authorId": "4066869", "name": "C. Austin"},
      {"authorId": "3155966", "name": "James Inglese"}, {"authorId": "2087058005",
      "name": "M. H. Harris"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId":
      "1813278", "name": "G. Stephanopoulos"}, {"authorId": "5908187", "name": "F.
      Salituro"}, {"authorId": "5210229", "name": "Shengfang Jin"}, {"authorId": "38799894",
      "name": "L. Dang"}, {"authorId": "2607088", "name": "D. Auld"}, {"authorId":
      "2790262", "name": "Hee-won Park"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}]}, {"paperId": "18e214b3035e1ee89cd5c618366fbff1cecbcc2b",
      "externalIds": {"CorpusId": 39822363}, "corpusId": 39822363, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/18e214b3035e1ee89cd5c618366fbff1cecbcc2b",
      "title": "Cellular Control Mechanisms that Regulate Pyruvate Kinase M 2 Activity
      and Promote Cancer Growth", "abstract": "Costas A. Lyssiotis, Dimitrios Anastasiou,
      Jason W. Locasale, Matthew G. Vander Heiden, Heather R. Christofk, Lewis C.
      Cantley* Division of Signal Transduction, Beth Israel Deacon ess Medical Center,
      Harvard Medical School, Boston, MA 02115, USA. Department of Systems Biology,
      Harvard Medical Scho ol, Boston, MA 02115, USA. Koch Institute for Integrative
      Cancer Research, Dep artment of Biology, Massachusetts Institute of Tech nology,
      Cambridge, MA 02139, USA. Department of Medical Oncology, Dana Farber Cancer
      Institute, Harvard Medical School, Boston, MA 02115 , USA Institute for Molecular
      Medicine, Department of Mol ecular and Medical Pharmacology, David Geffen Schoo
      l of Medicine at UCLA, Los Angeles, CA 90095, USA.", "venue": "", "year": 2012,
      "referenceCount": 33, "citationCount": 7, "influentialCitationCount": 1, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Inproceedings{Lyssiotis2012CellularCM,\n author = {C. Lyssiotis
      and D. Anastasiou and J. Locasale and M. V. Heiden and H. Christofk and L. Cantley},\n
      title = {Cellular Control Mechanisms that Regulate Pyruvate Kinase M 2 Activity
      and Promote Cancer Growth},\n year = {2012}\n}\n"}, "authors": [{"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "46996935", "name": "D. Anastasiou"},
      {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "35413264", "name":
      "M. V. Heiden"}, {"authorId": "4164415", "name": "H. Christofk"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "1a6677e1835c937e52e4676851cb301878c62ea3",
      "externalIds": {"CorpusId": 207761373}, "corpusId": 207761373, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/1a6677e1835c937e52e4676851cb301878c62ea3",
      "title": "Therapeutic Effects of Metformin The Kinase LKB 1 Mediates Glucose
      Homeostasis in Liver and", "abstract": "clicking here. colleagues, clients,
      or customers by , you can order high-quality copies for your If you wish to
      distribute this article to others here. following the guidelines can be obtained
      by Permission to republish or repurpose articles or portions of articles ):  October
      4, 2012  www.sciencemag.org (this information is current as of The following
      resources related to this article are available online at", "venue": "", "year":
      2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Shaw2012TherapeuticEO,\n
      author = {R. Shaw and K. Lamia and Debbie S. Vasquez and S. Koo and N. Bardeesy
      and R. DePinho and M. Montminy and L. Cantley},\n title = {Therapeutic Effects
      of Metformin The Kinase LKB 1 Mediates Glucose Homeostasis in Liver and},\n
      year = {2012}\n}\n"}, "authors": [{"authorId": "4426388", "name": "R. Shaw"},
      {"authorId": "5493258", "name": "K. Lamia"}, {"authorId": "49440900", "name":
      "Debbie S. Vasquez"}, {"authorId": "1885308", "name": "S. Koo"}, {"authorId":
      "5974412", "name": "N. Bardeesy"}, {"authorId": "5593407", "name": "R. DePinho"},
      {"authorId": "4892627", "name": "M. Montminy"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "1bf286996662a9e981621fdb5ab692ff480ce80f", "externalIds":
      {"PubMedCentral": "3498106", "MAG": "2100647690", "DOI": "10.1371/journal.pone.0049466",
      "CorpusId": 10830274, "PubMed": "23166678"}, "corpusId": 10830274, "publicationVenue":
      {"id": "0aed7a40-85f3-4c66-9e1b-c1556c57001b", "name": "PLoS ONE", "type": "journal",
      "alternate_names": ["Plo ONE", "PLOS ONE", "PLO ONE"], "issn": "1932-6203",
      "url": "https://journals.plos.org/plosone/", "alternate_urls": ["http://www.plosone.org/"]},
      "url": "https://www.semanticscholar.org/paper/1bf286996662a9e981621fdb5ab692ff480ce80f",
      "title": "Somatic Mutations of PIK3R1 Promote Gliomagenesis", "abstract": "The
      phosphoinositide 3-kinase (PI3K) pathway is targeted for frequent alteration
      in glioblastoma (GBM) and is one of the core GBM pathways defined by The Cancer
      Genome Atlas. Somatic mutations of PIK3R1 are observed in multiple tumor types,
      but the tumorigenic activity of these mutations has not been demonstrated in
      GBM. We show here that somatic mutations in the iSH2 domain of PIK3R1 act as
      oncogenic driver events. Specifically, introduction of a subset of the mutations
      identified in human GBM, in the nSH2 and iSH2 domains, increases signaling through
      the PI3K pathway and promotes tumorigenesis of primary normal human astrocytes
      in an orthotopic xenograft model. Furthermore, we show that cells that are dependent
      on mutant P85\u03b1-mediated PI3K signaling exhibit increased sensitivity to
      a small molecule inhibitor of AKT. Together, these results suggest that GBM
      patients whose tumors carry mutant PIK3R1 alleles may benefit from treatment
      with inhibitors of AKT.", "venue": "PLoS ONE", "year": 2012, "referenceCount":
      22, "citationCount": 52, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0049466&type=printable",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-11-14", "journal": {"volume": "7", "name": "PLoS ONE"},
      "citationStyles": {"bibtex": "@Article{Quayle2012SomaticMO,\n author = {S. Quayle
      and Jennifer Y. Lee and L. W. Cheung and L. Ding and R. Wiedemeyer and Robert
      W. Dewan and Emmet Huang-Hobbs and Zhuang Li and R. Wilson and K. Ligon and
      G. Mills and L. Cantley and L. Chin},\n booktitle = {PLoS ONE},\n journal =
      {PLoS ONE},\n title = {Somatic Mutations of PIK3R1 Promote Gliomagenesis},\n
      volume = {7},\n year = {2012}\n}\n"}, "authors": [{"authorId": "3696841", "name":
      "S. Quayle"}, {"authorId": "46663676", "name": "Jennifer Y. Lee"}, {"authorId":
      "50005741", "name": "L. W. Cheung"}, {"authorId": "49594724", "name": "L. Ding"},
      {"authorId": "5970725", "name": "R. Wiedemeyer"}, {"authorId": "31662497", "name":
      "Robert W. Dewan"}, {"authorId": "1422124289", "name": "Emmet Huang-Hobbs"},
      {"authorId": "2230038725", "name": "Zhuang Li"}, {"authorId": "2234783788",
      "name": "R. Wilson"}, {"authorId": "5627829", "name": "K. Ligon"}, {"authorId":
      "2241330", "name": "G. Mills"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "144750835", "name": "L. Chin"}]}, {"paperId": "297a3affd56803e3d31f6291c08377563f805e25",
      "externalIds": {"MAG": "2077672383", "DOI": "10.1158/0008-5472.SABCS12-MS1-1",
      "CorpusId": 85286105}, "corpusId": 85286105, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/297a3affd56803e3d31f6291c08377563f805e25",
      "title": "Abstract MS1-1: Targeting PI3K", "abstract": "Phosphoinositide 3-Kinase
      (PI3K) is a central enzyme in a signaling pathway that mediates cellular responses
      to growth factors. The signaling pathway downstream of PI3K is highly conserved
      from worms and flies to humans and genetic analysis of the pathway has revealed
      a conserved role in regulating glucose metabolism and cell growth. Mutational
      events that lead to hyperactivation of the PI3K pathway result in hamartoma
      syndromes and cancers. Activating mutations in PIK3CA, encoding the p110alpha
      catalytic subunit of PI3K (PIK3CA) or inactivating mutations in PTEN, a phosphoinositide
      3-phosphatases that reverses the effects of PI3K, are among the most common
      events in solid tumors, especially breast cancers. Drugs that target PI3K are
      in clinical trials for a variety of cancers. It is likely that PI3K pathway
      inhibitors will need to be combined with other drugs to be broadly effective.
      We have employed genetically engineered mouse models that develop cancers due
      to mutations in genes in the PI3K pathway and are using these models to explore
      the efficacy of PI3K pathway inhibitors as single agents or in combination with
      other drugs. We are also interrogating the role of PI3K in the growth and survival
      of Brca1/p53 mutant breast cancers. The role of PI3K inhibitors for treating
      cancers in these mouse models and in human trials will be discussed. Citation
      Information: Cancer Res 2012;72(24 Suppl):Abstract nr MS1-1.", "venue": "",
      "year": 2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-12-15", "journal": {"volume":
      "72", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Cantley2012AbstractMT,\n
      author = {L. Cantley and C. Lewis},\n journal = {Cancer Research},\n title =
      {Abstract MS1-1: Targeting PI3K},\n volume = {72},\n year = {2012}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2082997325", "name":
      "C. Lewis"}]}, {"paperId": "2b1f8062ba70eb0c2c4bec6338f229cc28f5da51", "externalIds":
      {"MAG": "2188400376", "CorpusId": 85632674}, "corpusId": 85632674, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/2b1f8062ba70eb0c2c4bec6338f229cc28f5da51",
      "title": "Phosphoinositide 3- Kinase and disease", "abstract": null, "venue":
      "", "year": 2012, "referenceCount": 2, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": {"volume": "",
      "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Cantley2012Phosphoinositide3K,\n
      author = {L. Cantley and W. Castle},\n title = {Phosphoinositide 3- Kinase and
      disease},\n year = {2012}\n}\n"}, "authors": [{"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "10583217", "name": "W. Castle"}]}, {"paperId":
      "2f5737f36095df9ffaadc652600799474e96f1d0", "externalIds": {"MAG": "2106284801",
      "DOI": "10.1074/mcp.M111.014688", "CorpusId": 8570874, "PubMed": "22240505"},
      "corpusId": 8570874, "publicationVenue": {"id": "f13c562f-8530-4cef-a857-00c4f2d8403d",
      "name": "Molecular & Cellular Proteomics", "type": "journal", "alternate_names":
      ["Mol  Cell Proteom"], "issn": "1535-9476", "url": "https://www.mcponline.org/",
      "alternate_urls": ["http://www.mcponline.org/"]}, "url": "https://www.semanticscholar.org/paper/2f5737f36095df9ffaadc652600799474e96f1d0",
      "title": "Metabolomics of Human Cerebrospinal Fluid Identifies Signatures of
      Malignant Glioma*", "abstract": "Cerebrospinal fluid is routinely collected
      for the diagnosis and monitoring of patients with neurological malignancies.
      However, little is known as to how its constituents may change in a patient
      when presented with a malignant glioma. Here, we used a targeted mass-spectrometry
      based metabolomics platform using selected reaction monitoring with positive/negative
      switching and profiled the relative levels of over 124 polar metabolites present
      in patient cerebrospinal fluid. We analyzed the metabolic profiles from 10 patients
      presenting malignant gliomas and seven control patients that did not present
      malignancy to test whether a small sample size could provide statistically significant
      signatures. We carried out multiple unbiased forms of classification using a
      series of unsupervised techniques and identified metabolic signatures that distinguish
      malignant glioma patients from the control patients. One subtype identified
      contained metabolites enriched in citric acid cycle components. Newly diagnosed
      patients segregated into a different subtype and exhibited low levels of metabolites
      involved in tryptophan metabolism, which may indicate the absence of an inflammatory
      signature. Together our results provide the first global assessment of the polar
      metabolic composition in cerebrospinal fluid that accompanies malignancy, and
      demonstrate that data obtained from high throughput mass spectrometry technology
      may have suitable predictive capabilities for the identification of biomarkers
      and classification of neurological diseases.", "venue": "Molecular & Cellular
      Proteomics", "year": 2012, "referenceCount": 55, "citationCount": 94, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.mcponline.org/content/mcprot/11/6/M111.014688.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-01-12", "journal": {"volume": "11", "name": "Molecular
      & Cellular Proteomics"}, "citationStyles": {"bibtex": "@Article{Locasale2012MetabolomicsOH,\n
      author = {J. Locasale and T. Melman and Susan Song and Xuemei Yang and K. Swanson
      and L. Cantley and E. Wong and J. Asara},\n booktitle = {Molecular & Cellular
      Proteomics},\n journal = {Molecular & Cellular Proteomics},\n title = {Metabolomics
      of Human Cerebrospinal Fluid Identifies Signatures of Malignant Glioma*},\n
      volume = {11},\n year = {2012}\n}\n"}, "authors": [{"authorId": "2268976", "name":
      "J. Locasale"}, {"authorId": "1853856", "name": "T. Melman"}, {"authorId": "2110553093",
      "name": "Susan Song"}, {"authorId": "48520140", "name": "Xuemei Yang"}, {"authorId":
      "6784962", "name": "K. Swanson"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "1913037", "name": "E. Wong"}, {"authorId": "3028470", "name":
      "J. Asara"}]}, {"paperId": "3bae8c5d4830756599569f6ced4969d6cf924053", "externalIds":
      {"PubMedCentral": "3374201", "MAG": "2063288919", "DOI": "10.1186/1753-6561-6-S3-O15",
      "CorpusId": 19806776}, "corpusId": 19806776, "publicationVenue": {"id": "5b9b6854-d895-439b-9ab4-1e1ed4c26336",
      "name": "BMC Proceedings", "type": "journal", "alternate_names": ["BMC Proc"],
      "issn": "1753-6561", "url": "http://www.biomedcentral.com/bmcproc", "alternate_urls":
      ["http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=587"]},
      "url": "https://www.semanticscholar.org/paper/3bae8c5d4830756599569f6ced4969d6cf924053",
      "title": "Amplification of phosphoglycerate dehydrogenase diverts glycolytic
      flux and contributes to oncogenesis", "abstract": null, "venue": "BMC Proceedings",
      "year": 2012, "referenceCount": 10, "citationCount": 969, "influentialCitationCount":
      28, "isOpenAccess": true, "openAccessPdf": {"url": "https://bmcproc.biomedcentral.com/track/pdf/10.1186/1753-6561-6-S3-O15",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2012-06-01", "journal": {"volume": "6", "pages": "O15 -
      O15", "name": "BMC Proceedings"}, "citationStyles": {"bibtex": "@Article{Locasale2012AmplificationOP,\n
      author = {J. Locasale and A. Grassian and R. Beroukhim and M. Meyerson and G.
      Wagner and J. Asara and J. Brugge and M. V. Vander Heiden and L. Cantley},\n
      booktitle = {BMC Proceedings},\n journal = {BMC Proceedings},\n pages = {O15
      - O15},\n title = {Amplification of phosphoglycerate dehydrogenase diverts glycolytic
      flux and contributes to oncogenesis},\n volume = {6},\n year = {2012}\n}\n"},
      "authors": [{"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "3785750",
      "name": "A. Grassian"}, {"authorId": "2318365", "name": "R. Beroukhim"}, {"authorId":
      "145046418", "name": "M. Meyerson"}, {"authorId": "145241228", "name": "G. Wagner"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "3471778", "name":
      "J. Brugge"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "40719c61f30e12c81cf447b08d1e7bfd8913ad34",
      "externalIds": {"MAG": "2915325753", "DOI": "10.1158/1078-0432.CCR-12-2891",
      "CorpusId": 42522937, "PubMed": "22977188"}, "corpusId": 42522937, "publicationVenue":
      {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0", "name": "Clinical Cancer Research",
      "type": "journal", "alternate_names": ["Clin Cancer Res"], "issn": "1078-0432",
      "url": "https://clincancerres.aacrjournals.org/", "alternate_urls": ["http://clincancerres.aacrjournals.org/"]},
      "url": "https://www.semanticscholar.org/paper/40719c61f30e12c81cf447b08d1e7bfd8913ad34",
      "title": "AACR Cancer Progress Report 2012", "abstract": null, "venue": "Clinical
      Cancer Research", "year": 2012, "referenceCount": 162, "citationCount": 30,
      "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://clincancerres.aacrjournals.org/content/clincanres/18/21_Supplement/S1.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2012-11-01", "journal":
      {"volume": "18", "pages": "S1 - S100", "name": "Clinical Cancer Research"},
      "citationStyles": {"bibtex": "@Article{Cantley2012AACRCP,\n author = {L. Cantley
      and W. Dalton and R. Dubois and O. Finn and P. Futreal and T. Golub and W. Hait
      and G. Lozano and J. Maris and W. Nelson and C. Sawyers and S. Schreiber and
      M. Spitz and P. Steeg},\n booktitle = {Clinical Cancer Research},\n journal
      = {Clinical Cancer Research},\n pages = {S1 - S100},\n title = {AACR Cancer
      Progress Report 2012},\n volume = {18},\n year = {2012}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "6230610", "name": "W. Dalton"},
      {"authorId": "4135978", "name": "R. Dubois"}, {"authorId": "3897572", "name":
      "O. Finn"}, {"authorId": "153020660", "name": "P. Futreal"}, {"authorId": "2900051",
      "name": "T. Golub"}, {"authorId": "5559905", "name": "W. Hait"}, {"authorId":
      "144996908", "name": "G. Lozano"}, {"authorId": "2427647", "name": "J. Maris"},
      {"authorId": "81233537", "name": "W. Nelson"}, {"authorId": "4165356", "name":
      "C. Sawyers"}, {"authorId": "2610390", "name": "S. Schreiber"}, {"authorId":
      "3059932", "name": "M. Spitz"}, {"authorId": "6985830", "name": "P. Steeg"}]},
      {"paperId": "4c4b0282f39b3f1211974e0e9cc65f8dbc84c369", "externalIds": {"MAG":
      "1986186950", "DOI": "10.1002/jcp.22895", "CorpusId": 20585236, "PubMed": "21688263"},
      "corpusId": 20585236, "publicationVenue": {"id": "cdf4bb1c-e624-482e-8289-da2009c4c31a",
      "name": "Journal of Cellular Physiology", "type": "journal", "alternate_names":
      ["J Cell Physiol"], "issn": "0021-9541", "url": "http://eu.wiley.com/WileyCDA/WileyTitle/productCd-JCP.html",
      "alternate_urls": ["http://www3.interscience.wiley.com/cgi-bin/jhome/109898032",
      "http://onlinelibrary.wiley.com/journal/10.1002/%28issn%291097-4652", "http://onlinelibrary.wiley.com/journal/10.1002/(issn)1097-4652",
      "https://onlinelibrary.wiley.com/journal/10974652", "http://www3.interscience.wiley.com/cgi-bin/jhome/31010"]},
      "url": "https://www.semanticscholar.org/paper/4c4b0282f39b3f1211974e0e9cc65f8dbc84c369",
      "title": "Inhibition of lung cancer growth: ATP citrate lyase knockdown and
      statin treatment leads to dual blockade of mitogen\u2010activated protein Kinase
      (MAPK) and Phosphatidylinositol\u20103\u2010kinase (PI3K)/AKT pathways", "abstract":
      "ATP citrate lyase (ACL) catalyzes the conversion of cytosolic citrate to acetyl\u2010CoA
      and oxaloacetate. A definitive role for ACL in tumorigenesis has emerged from
      ACL RNAi and chemical inhibitor studies, showing that ACL inhibition limits
      tumor cell proliferation and survival and induces differentiation in vitro.
      In vivo, it reduces tumor growth leading to a cytostatic effect and induces
      differentiation. However, the underlying molecular mechanisms are poorly understood
      and agents that could enhance the efficacy of ACL inhibition have not been identified.
      Our studies focus on non\u2010small cell lung cancer (NSCLC) lines, which show
      phosphatidylinositol 3\u2010kinase (PI3K)/AKT activation secondary to a mutation
      in the K\u2010Ras gene or the EGFR gene. Here we show that ACL knockdown promotes
      apoptosis and differentiation, leading to the inhibition of tumor growth in
      vivo. Moreover, in contrast to most studies, which elucidate how activation/suppression
      of signaling pathways can modify metabolism, we show that inhibition of a metabolic
      pathway \u201creverse signals\u201d and attenuates PI3K/AKT signaling. Additionally,
      we find that statins, inhibitors of 3\u2010hydroxy\u20103\u2010methylglutaryl
      coenzyme A (HMG\u2010CoA) reductase, which act downstream of ACL in the cholesterol
      synthesis pathway, dramatically enhance the anti\u2010tumor effects of ACL inhibition,
      even regressing established tumors. With statin treatment, both PI3K/AKT and
      the MAPK pathways are affected. Moreover, this combined treatment is able to
      reduce the growth of EGF receptor resistant tumor cell types. Given the essential
      role of lipid synthesis in numerous cancers, this work may impact therapy in
      a broad range of tumors. J. Cell. Physiol. 227: 1709\u20131720, 2012. \u00a9
      2011 Wiley Periodicals, Inc.", "venue": "Journal of Cellular Physiology", "year":
      2012, "referenceCount": 63, "citationCount": 141, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3407542?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2012-04-01", "journal": {"volume": "227",
      "name": "Journal of Cellular Physiology"}, "citationStyles": {"bibtex": "@Article{Hanai2012InhibitionOL,\n
      author = {J. Hanai and N. Doro and A. Sasaki and Susumu S. Kobayashi and L.
      Cantley and P. Seth and V. Sukhatme},\n booktitle = {Journal of Cellular Physiology},\n
      journal = {Journal of Cellular Physiology},\n title = {Inhibition of lung cancer
      growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade
      of mitogen\u2010activated protein Kinase (MAPK) and Phosphatidylinositol\u20103\u2010kinase
      (PI3K)/AKT pathways},\n volume = {227},\n year = {2012}\n}\n"}, "authors": [{"authorId":
      "4394032", "name": "J. Hanai"}, {"authorId": "4596169", "name": "N. Doro"},
      {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId": "2109836647", "name":
      "Susumu S. Kobayashi"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "143667851", "name": "P. Seth"}, {"authorId": "3658233", "name": "V. Sukhatme"}]},
      {"paperId": "52652858006f5dd5120b9dc50eafd52697a8c723", "externalIds": {"MAG":
      "2093644658", "DOI": "10.1016/j.cmet.2012.05.010", "CorpusId": 206839490, "PubMed":
      "22727014"}, "corpusId": 206839490, "publicationVenue": {"id": "ad36b49e-5c03-4c48-be8d-321a0d17c2f6",
      "name": "Cell Metabolism", "type": "journal", "alternate_names": ["Cell Metab"],
      "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/15504131", "http://www.cellmetabolism.org/"]},
      "url": "https://www.semanticscholar.org/paper/52652858006f5dd5120b9dc50eafd52697a8c723",
      "title": "p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin''s
      effect on food intake.", "abstract": null, "venue": "Cell Metabolism", "year":
      2012, "referenceCount": 40, "citationCount": 240, "influentialCitationCount":
      15, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1550413112002331/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-07-03", "journal": {"volume": "16 1", "pages": "\n          104-12\n        ",
      "name": "Cell metabolism"}, "citationStyles": {"bibtex": "@Article{Dagon2012p70S6KP,\n
      author = {Y. Dagon and E. Hur and B. Zheng and Kerry Wellenstein and L. Cantley
      and B. Kahn},\n booktitle = {Cell Metabolism},\n journal = {Cell metabolism},\n
      pages = {\n          104-12\n        },\n title = {p70S6 kinase phosphorylates
      AMPK on serine 491 to mediate leptin''s effect on food intake.},\n volume =
      {16 1},\n year = {2012}\n}\n"}, "authors": [{"authorId": "3734143", "name":
      "Y. Dagon"}, {"authorId": "4874129", "name": "E. Hur"}, {"authorId": "143918840",
      "name": "B. Zheng"}, {"authorId": "4673484", "name": "Kerry Wellenstein"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "1997179", "name": "B. Kahn"}]},
      {"paperId": "597475f86bbe11151cac521cf1a6c46a745db69b", "externalIds": {"MAG":
      "2277249887", "CorpusId": 87310081}, "corpusId": 87310081, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/597475f86bbe11151cac521cf1a6c46a745db69b",
      "title": "Pyruvate kinase M2 deficiency promotes a brown fat-like program in
      white adipocytes", "abstract": null, "venue": "", "year": 2012, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Bettaieb2012PyruvateKM,\n author = {Ahmed Bettaieb
      and Jesse L Bakke and N. Nagata and A. Tomilov and C. Lyssiotis and J. Asara
      and G. Cortopassi and L. Cantley and F. Haj},\n title = {Pyruvate kinase M2
      deficiency promotes a brown fat-like program in white adipocytes},\n year =
      {2012}\n}\n"}, "authors": [{"authorId": "5956178", "name": "Ahmed Bettaieb"},
      {"authorId": "50186862", "name": "Jesse L Bakke"}, {"authorId": "3957054", "name":
      "N. Nagata"}, {"authorId": "35252324", "name": "A. Tomilov"}, {"authorId": "4901222",
      "name": "C. Lyssiotis"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId":
      "3560122", "name": "G. Cortopassi"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5546228", "name": "F. Haj"}]}, {"paperId": "5b132427312e64747dfc4fcb7b10d9535069626d",
      "externalIds": {"MAG": "2105685115", "DOI": "10.1016/j.cell.2012.02.030", "CorpusId":
      14246515, "PubMed": "22401813"}, "corpusId": 14246515, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/5b132427312e64747dfc4fcb7b10d9535069626d",
      "title": "Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State",
      "abstract": null, "venue": "Cell", "year": 2012, "referenceCount": 86, "citationCount":
      352, "influentialCitationCount": 9, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S0092867412002309/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2012-03-30", "journal":
      {"volume": "149", "pages": "49-62", "name": "Cell"}, "citationStyles": {"bibtex":
      "@Article{Garcia-Cao2012SystemicEO,\n author = {I. Garcia-Cao and M. Song and
      R. Hobbs and Gaelle Laurent and C. Giorgi and V. D. Boer and D. Anastasiou and
      Keisuke Ito and A. Sasaki and L. Rameh and A. Carracedo and M. V. Heiden and
      L. Cantley and P. Pinton and M. Haigis and P. Pandolfi},\n booktitle = {Cell},\n
      journal = {Cell},\n pages = {49-62},\n title = {Systemic Elevation of PTEN Induces
      a Tumor-Suppressive Metabolic State},\n volume = {149},\n year = {2012}\n}\n"},
      "authors": [{"authorId": "1402741417", "name": "I. Garcia-Cao"}, {"authorId":
      "2967391", "name": "M. Song"}, {"authorId": "4584039", "name": "R. Hobbs"},
      {"authorId": "3543087", "name": "Gaelle Laurent"}, {"authorId": "3571606", "name":
      "C. Giorgi"}, {"authorId": "40052947", "name": "V. D. Boer"}, {"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "143651419", "name": "Keisuke Ito"},
      {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId": "4109960", "name":
      "L. Rameh"}, {"authorId": "6988610", "name": "A. Carracedo"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3936492", "name": "P. Pinton"}, {"authorId": "6212141", "name": "M. Haigis"},
      {"authorId": "4499580", "name": "P. Pandolfi"}]}, {"paperId": "5b1d2d3d01e2fa53506a9e048d1874acf5f5c3ce",
      "externalIds": {"MAG": "2157066764", "DOI": "10.1016/j.chembiol.2012.07.021",
      "CorpusId": 10040118, "PubMed": "22999886"}, "corpusId": 10040118, "publicationVenue":
      {"id": "0c73784e-4058-48ce-b429-740c11d6f005", "name": "Chemistry and Biology",
      "type": "journal", "alternate_names": ["Chemistry & Biology", "Chem  Biology",
      "Chem Biology"], "issn": "1074-5521", "alternate_issns": ["1879-1301"], "url":
      "http://www.chembiol.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/10745521",
      "https://www.journals.elsevier.com/chemistry-and-biology"]}, "url": "https://www.semanticscholar.org/paper/5b1d2d3d01e2fa53506a9e048d1874acf5f5c3ce",
      "title": "Small molecule activation of PKM2 in cancer cells induces serine auxotrophy.",
      "abstract": null, "venue": "Chemistry and Biology", "year": 2012, "referenceCount":
      46, "citationCount": 158, "influentialCitationCount": 5, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Chemistry", "Biology"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Chemistry", "source": "external"}, {"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2012-09-01", "journal": {"volume": "19 9", "pages": "\n          1187-98\n        ",
      "name": "Chemistry & biology"}, "citationStyles": {"bibtex": "@Article{Kung2012SmallMA,\n
      author = {C. Kung and J. Hixon and S. Choe and K. Marks and S. Gross and Erin
      Murphy and B. Delabarre and Giovanni Cianchetta and Shalini Sethumadhavan and
      Xiling Wang and Shunqi Yan and Yi Gao and Cheng Fang and Wentao Wei and F. Jiang
      and Shaohui Wang and K. Qian and J. Saunders and E. Driggers and H. Woo and
      K. Kunii and Stuart Murray and Hua Yang and K. Yen and Wei Liu and L. Cantley
      and M. V. Vander Heiden and Shinsan M. Su and Shengfang Jin and F. Salituro
      and L. Dang},\n booktitle = {Chemistry and Biology},\n journal = {Chemistry
      & biology},\n pages = {\n          1187-98\n        },\n title = {Small molecule
      activation of PKM2 in cancer cells induces serine auxotrophy.},\n volume = {19
      9},\n year = {2012}\n}\n"}, "authors": [{"authorId": "7636232", "name": "C.
      Kung"}, {"authorId": "39459677", "name": "J. Hixon"}, {"authorId": "47406687",
      "name": "S. Choe"}, {"authorId": "145638995", "name": "K. Marks"}, {"authorId":
      "144707828", "name": "S. Gross"}, {"authorId": "2056227217", "name": "Erin Murphy"},
      {"authorId": "49437145", "name": "B. Delabarre"}, {"authorId": "3662288", "name":
      "Giovanni Cianchetta"}, {"authorId": "5222482", "name": "Shalini Sethumadhavan"},
      {"authorId": "2144657971", "name": "Xiling Wang"}, {"authorId": "34156476",
      "name": "Shunqi Yan"}, {"authorId": "2118543810", "name": "Yi Gao"}, {"authorId":
      "144655992", "name": "Cheng Fang"}, {"authorId": "50770525", "name": "Wentao
      Wei"}, {"authorId": "2069982648", "name": "F. Jiang"}, {"authorId": "2145317633",
      "name": "Shaohui Wang"}, {"authorId": "4136146", "name": "K. Qian"}, {"authorId":
      "144512128", "name": "J. Saunders"}, {"authorId": "4691854", "name": "E. Driggers"},
      {"authorId": "40582612", "name": "H. Woo"}, {"authorId": "8330889", "name":
      "K. Kunii"}, {"authorId": "39549437", "name": "Stuart Murray"}, {"authorId":
      "11325796", "name": "Hua Yang"}, {"authorId": "4886372", "name": "K. Yen"},
      {"authorId": "1722649", "name": "Wei Liu"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"}, {"authorId":
      "4297092", "name": "Shinsan M. Su"}, {"authorId": "5210229", "name": "Shengfang
      Jin"}, {"authorId": "5908187", "name": "F. Salituro"}, {"authorId": "38799894",
      "name": "L. Dang"}]}, {"paperId": "5bae21d441b729d1c4b9f9a2137ba8c5d747b1b3",
      "externalIds": {"MAG": "2014040910", "DOI": "10.1158/1538-7445.PANCA2012-IA14",
      "CorpusId": 84282341}, "corpusId": 84282341, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/5bae21d441b729d1c4b9f9a2137ba8c5d747b1b3",
      "title": "Abstract IA14: Autophagy, metabolism, and pancreatic cancer.", "abstract":
      "Pancreatic cancers have an intense resistance to currently available therapeutics
      which results in a dismal 5-year survival rate. This resistance points toward
      altered cell survival and metabolic pathways. In this regard we have previously
      shown that pancreatic cancers have elevated basal autophagy, which is required
      for their continued growth. Importantly, inhibition of autophagy pharmacologically
      or by RNAi approaches leads to decreased oxidative phosphorylation, a drop in
      ATP production, and ultimately growth inhibition. These findings have implicated
      autophagy as a key component of pancreatic cancer metabolism and have motivated
      the opening of multiple clinical trials assessing the efficacy of hydroxychloroquine
      as an autophagy inhibitor in pancreatic cancer. Additional work from our group
      has demonstrated that oncogenic Kras promotes a systematic rewiring of pancreatic
      cancer metabolism allowing glucose and glutamine to be utilized in a variety
      of biosynthetic pathways. Importantly, several of these metabolic pathways are
      critical for tumor growth and therefore represent potential therapeutic targets.
      These and other aspects of pancreatic cancer metabolism will be discussed.\n\nCitation
      Format: Jaekyoung Son, Costas A. Lyssiotis, Shenghong Yang, Haoqiang Ying, Xiaoxu
      Wang, Lewis C. Cantley, Alec C. Kimmelman. Autophagy, metabolism, and pancreatic
      cancer. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic
      Cancer: Progress and Challenges; Jun 18-21, 2012; Lake Tahoe, NV. Philadelphia
      (PA): AACR; Cancer Res 2012;72(12 Suppl):Abstract nr IA14.", "venue": "", "year":
      2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-07-15", "journal": {"volume":
      "72", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Son2012AbstractIA,\n
      author = {J. Son and C. Lyssiotis and Shenghong Yang and H. Ying and Xiaoxu
      Wang and L. Cantley and Alec C. Kimmelman},\n journal = {Cancer Research},\n
      title = {Abstract IA14: Autophagy, metabolism, and pancreatic cancer.},\n volume
      = {72},\n year = {2012}\n}\n"}, "authors": [{"authorId": "38313825", "name":
      "J. Son"}, {"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "50591635",
      "name": "Shenghong Yang"}, {"authorId": "33312849", "name": "H. Ying"}, {"authorId":
      "48631933", "name": "Xiaoxu Wang"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "4668673", "name": "Alec C. Kimmelman"}]}, {"paperId": "5bec7aef76f7550061a5440b5a306ad5d505c112",
      "externalIds": {"MAG": "2044098634", "DOI": "10.1038/cr.2012.5", "CorpusId":
      10626336, "PubMed": "22212478"}, "corpusId": 10626336, "publicationVenue": {"id":
      "45c77f4e-d4c0-4df3-99dd-119b0d2adb78", "name": "Cell Research", "type": "journal",
      "alternate_names": ["Cell Res"], "issn": "1001-0602", "url": "http://www.cell-research.com/",
      "alternate_urls": ["http://www.cell-research.com/index.asp", "http://www.nature.com/cr/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/5bec7aef76f7550061a5440b5a306ad5d505c112",
      "title": "Breathless cancer cells get fat on glutamine", "abstract": null, "venue":
      "Cell Research", "year": 2012, "referenceCount": 14, "citationCount": 61, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/cr20125.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-01-03", "journal": {"volume": "22", "pages": "443-446",
      "name": "Cell Research"}, "citationStyles": {"bibtex": "@Article{Anastasiou2012BreathlessCC,\n
      author = {D. Anastasiou and L. Cantley},\n booktitle = {Cell Research},\n journal
      = {Cell Research},\n pages = {443-446},\n title = {Breathless cancer cells get
      fat on glutamine},\n volume = {22},\n year = {2012}\n}\n"}, "authors": [{"authorId":
      "46996935", "name": "D. Anastasiou"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "61830267754adefd87a2c3f3cd7f518f1e2bb524", "externalIds": {"MAG":
      "1969836970", "PubMedCentral": "3511602", "DOI": "10.1038/ncb2629", "CorpusId":
      11331744, "PubMed": "23178880"}, "corpusId": 11331744, "publicationVenue": {"id":
      "7d182b83-7d8d-43fb-9fd6-ae67fbafab20", "name": "Nature Cell Biology", "type":
      "journal", "alternate_names": ["Nat Cell Biology"], "issn": "1465-7392", "url":
      "http://www.nature.com/naturecellbiology", "alternate_urls": ["https://www.nature.com/ncb/"]},
      "url": "https://www.semanticscholar.org/paper/61830267754adefd87a2c3f3cd7f518f1e2bb524",
      "title": "ERK1/2-dependent phosphorylation and nuclear translocation of PKM2
      promotes the Warburg effect", "abstract": null, "venue": "Nature Cell Biology",
      "year": 2012, "referenceCount": 30, "citationCount": 674, "influentialCitationCount":
      43, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/ncb2677.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-11-05", "journal": {"volume": "14", "pages": "1295
      - 1304", "name": "Nature cell biology"}, "citationStyles": {"bibtex": "@Article{Yang2012ERK12dependentPA,\n
      author = {Weiwei Yang and Yanhua Zheng and Yan Xia and Haitao Ji and Xiaomin
      Chen and F. Guo and C. Lyssiotis and K. Aldape and L. Cantley and Zhimin Lu},\n
      booktitle = {Nature Cell Biology},\n journal = {Nature cell biology},\n pages
      = {1295 - 1304},\n title = {ERK1/2-dependent phosphorylation and nuclear translocation
      of PKM2 promotes the Warburg effect},\n volume = {14},\n year = {2012}\n}\n"},
      "authors": [{"authorId": "143956168", "name": "Weiwei Yang"}, {"authorId": "3169180",
      "name": "Yanhua Zheng"}, {"authorId": "143733371", "name": "Yan Xia"}, {"authorId":
      "2579875", "name": "Haitao Ji"}, {"authorId": "48283607", "name": "Xiaomin Chen"},
      {"authorId": "152831013", "name": "F. Guo"}, {"authorId": "4901222", "name":
      "C. Lyssiotis"}, {"authorId": "50138848", "name": "K. Aldape"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5467266", "name": "Zhimin Lu"}]},
      {"paperId": "666ac0e156154b467ae2dbc15398d107f1c73786", "externalIds": {"PubMedCentral":
      "3255319", "MAG": "2144535296", "DOI": "10.3410/B4-2", "CorpusId": 15640245,
      "PubMed": "22242042"}, "corpusId": 15640245, "publicationVenue": {"id": "98d0f85f-e67d-4612-99a0-ab577ada6952",
      "name": "F1000 Biology Reports", "alternate_names": ["F1000 Biology Rep"], "issn":
      "1757-594X", "url": "https://f1000.com/prime/reports/browse", "alternate_urls":
      ["http://www.f1000biology.com/reports"]}, "url": "https://www.semanticscholar.org/paper/666ac0e156154b467ae2dbc15398d107f1c73786",
      "title": "Decoding key nodes in the metabolism of cancer cells: sugar & spice
      and all things nice", "abstract": "In the past 5 years, a convergence of studies
      has resulted in a broad appreciation in the cancer research community that reprogramming
      of cellular metabolism may be more central to cancer than appreciated in the
      past 30 years. The re-emergence of cancer metabolism stems in part from discoveries
      that a number of common oncogenes and tumor suppressor genes more directly control
      cell metabolism than previously thought. In addition, a number of what would
      previously have been called \u201ccard-carrying\u201d metabolic enzymes have
      been identified as human tumor suppressors or oncogenes, causally mutated in
      a variety of human cancers. This growing appreciation of the role of altered
      cell metabolism has led to further investigation into the rate-limiting proteins
      involved in different aspects of the unique metabolism of tumor cells. Targeting
      cancer metabolism with drugs requires a therapeutic window in which tumor cells,
      compared to normal tissues, have a greater dependence on specific metabolic
      enzymes. Themes that have emerged in the past decade of developing oncogene-targeted
      cancer therapeutics suggest that tumors with distinct oncogenic lesions are
      likely to require drugs that target distinct metabolic pathways. Ultimately,
      the hope is that detailed knowledge of oncogene and tumor suppressor gene functions
      and their effects on metabolism will lead to drug combinations that will be
      far more effective in treating cancers.", "venue": "F1000 Biology Reports",
      "year": 2012, "referenceCount": 38, "citationCount": 31, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2012-01-03", "journal": {"volume": "4",
      "name": "F1000 Biology Reports"}, "citationStyles": {"bibtex": "@Article{Shaw2012DecodingKN,\n
      author = {R. Shaw and L. Cantley},\n booktitle = {F1000 Biology Reports},\n
      journal = {F1000 Biology Reports},\n title = {Decoding key nodes in the metabolism
      of cancer cells: sugar & spice and all things nice},\n volume = {4},\n year
      = {2012}\n}\n"}, "authors": [{"authorId": "4426388", "name": "R. Shaw"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "69c60c9edc44b999870d3bfe7c18fd34dc835973",
      "externalIds": {"MAG": "2044216772", "DOI": "10.1016/j.cell.2012.11.020", "CorpusId":
      691118, "PubMed": "23217699"}, "corpusId": 691118, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/69c60c9edc44b999870d3bfe7c18fd34dc835973",
      "title": "SIRT6 Puts Cancer Metabolism in the Driver\u2019s Seat", "abstract":
      null, "venue": "Cell", "year": 2012, "referenceCount": 16, "citationCount":
      26, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S0092867412014055/pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle", "LettersAndComments"], "publicationDate":
      "2012-12-07", "journal": {"volume": "151", "pages": "1155-1156", "name": "Cell"},
      "citationStyles": {"bibtex": "@Article{Lyssiotis2012SIRT6PC,\n author = {C.
      Lyssiotis and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n pages
      = {1155-1156},\n title = {SIRT6 Puts Cancer Metabolism in the Driver\u2019s
      Seat},\n volume = {151},\n year = {2012}\n}\n"}, "authors": [{"authorId": "4901222",
      "name": "C. Lyssiotis"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "6c972bad36661b430cf345e70b4601769815c17f", "externalIds": {"MAG": "2077776680",
      "DOI": "10.1158/1538-7445.AM2012-LB-365", "CorpusId": 72871432}, "corpusId":
      72871432, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/6c972bad36661b430cf345e70b4601769815c17f",
      "title": "Abstract LB-365: Effective use of PI3K/MTOR and MEK inhibitors prior
      to hormone ablative therapy in PTEN-loss driven murine prostate cancer", "abstract":
      "Proceedings: AACR 103rd Annual Meeting 2012\u2010\u2010 Mar 31\u2010Apr 4,
      2012; Chicago, IL\n\nThe PTEN and p53 tumor suppressors are the most commonly
      altered genes in human cancer, including prostate cancer (PCa). Loss of PTEN
      is associated with increased Gleason score and clinical recurrence, and the
      majority of human metastatic PCas have PTEN loss via multiple mechanisms. Mice
      with prostate-specific homozygous deletion of PTEN develop invasive PCa albeit
      with prolonged latency of 6-8 months. Combined PTEN/p53 inactivation in mouse
      prostate elicits invasive cancer by 9 weeks of age and invariable lethality
      by 6 months of age. Since PTEN loss results in PI3K/mTOR pathway activation,
      we evaluated the impact of GSK458 (PI3K/mTOR inhibitor) and GSK418 (PI3K beta/delta
      isoform-specific inhibitor), singly and in combination with GSK212 (MEK inhibitor),
      in uncastrated, prostate-specific PTEN/p53 double knockout mice (4-6 months)
      and PTEN mice (11-14 months), respectively, harboring advanced PCa. The drugs
      were administered by daily oral gavage for 3 weeks with serial 18FDG-PET/MRI
      imaging at baseline, 2 days, 1 week, 2 weeks and 3 weeks post-treatment respectively.
      GSK458 treatment of PTEN/p53 and PTEN mice results in reduction in FDG-PET uptake
      as early as 24 h post-treatment, with 40% tumor shrinkage by 1 week post-treatment,
      but rapid regrowth of 18FDG-avid tumor by 2-3 weeks post-treatment. This acquired
      resistance was found to be mediated in part through upregulation of multiple
      receptor tyrosine kinases. In contrast, PTEN/p53 and PTEN mice did not respond
      to GSK418, by either FDG-PET or MRI analysis. We observed increased pERK/total
      ERK ratio by Western blot analysis and increased p-ERK staining by immunohistochemistry
      in GSK458 and GSK418-treated PTEN/53 mice, respectively. Treatment of PTEN/p53
      and PTEN mice with GSK212 resulted in an approx. 40% reduction in tumor volume
      over 3 weeks. Treatment of PTEN/p53 mice with a combination of GSK458 plus GSK212
      resulted in approx. 60% reduction of tumor volume at 3 week post-treatment.
      Strikingly, treatment of prostate-specific PTEN only mice with GSK458 plus GSK212
      combination resulted in a >90% tumor regression at 3 weeks post-treatment. These
      results demonstrate the potential utlitity of PI3K/MEK-directed combination
      therapies in the neoadjuvant setting for locally advanced disease or hormone-sensitive
      phase in metastatic disease, thus delaying the need for hormone ablative therapy
      and its associated morbidity in advanced PCa. The data underscore the value
      of genetically engineered mouse models to co-clinically evaluate biomarkers
      of response and resistance to targeted therapies, and elucidate mechanisms of
      acquired resistance early in clinical development. The design of \u201cpersonalized\u201d
      combination therapies to overcome resistance to PI3K/MEK-directed therapies
      in the hormone-naive and castration-resistant contexts are currently underway
      in multiple GEMMs and Phase Ib co-clinical trials in advanced PCa.\n\nCitation
      Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd
      Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr
      4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract
      nr LB-365. doi:1538-7445.AM2012-LB-365", "venue": "", "year": 2012, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-04-15", "journal": {"volume":
      "72", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Patnaik2012AbstractLE,\n
      author = {Akash Patnaik and K. Courtney and K. Robichaud and G. Bellinger and
      C. Nardella and S. Signoretti and R. Wooster and P. Pandolfi and L. Cantley},\n
      journal = {Cancer Research},\n title = {Abstract LB-365: Effective use of PI3K/MTOR
      and MEK inhibitors prior to hormone ablative therapy in PTEN-loss driven murine
      prostate cancer},\n volume = {72},\n year = {2012}\n}\n"}, "authors": [{"authorId":
      "40501341", "name": "Akash Patnaik"}, {"authorId": "13782167", "name": "K. Courtney"},
      {"authorId": "40638403", "name": "K. Robichaud"}, {"authorId": "5679020", "name":
      "G. Bellinger"}, {"authorId": "3547827", "name": "C. Nardella"}, {"authorId":
      "7505152", "name": "S. Signoretti"}, {"authorId": "46825918", "name": "R. Wooster"},
      {"authorId": "4499580", "name": "P. Pandolfi"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "70550699ba9c5f4a62ab0e5c454cdaf99bf4b6c3", "externalIds":
      {"MAG": "2102759054", "DOI": "10.1158/2159-8290.CD-11-0327", "CorpusId": 37975989,
      "PubMed": "22585178"}, "corpusId": 37975989, "publicationVenue": {"id": "de16002a-77c3-4d03-9348-5a1813238e0b",
      "name": "Cancer Discovery", "type": "journal", "alternate_names": ["Cancer Discov"],
      "issn": "2159-8274", "url": "https://cancerdiscovery.aacrjournals.org/"}, "url":
      "https://www.semanticscholar.org/paper/70550699ba9c5f4a62ab0e5c454cdaf99bf4b6c3",
      "title": "Cancer Discovery at one year: the editors'' interim analysis.", "abstract":
      "Our interim analysis is strikingly positive as Cancer Discovery enters into
      its second year, and we hope the journal will become an increasingly indispensable
      resource to both basic and clinical cancer researchers.\n\n![Figure][1] \n\nAs
      Cancer Discovery approaches its first anniversary, we would like to share with
      you our initial assessment of the life and health of this young journal of the
      American Association for Cancer Research (AACR). If we were to analyze the journal
      in a similar fashion as would be done with a clinical trial for a new and exciting
      compound, we would call this a prespecified interim analysis, also known as
      an \u201cearly look.\u201d Early looks are by nature tricky. If the findings
      are positive but do not cross a given boundary, they could simply be false-positive.
      However, if they are negative to begin with, this does not mean that the study
      results will be negative after more prolonged follow-up.\n\nFirst, let us look
      at the Methods of the journal. The concept behind Cancer Discovery was, and
      is, to be a \u2026\n\n [1]: pending:yes", "venue": "Cancer Discovery", "year":
      2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": ["Editorial"], "publicationDate": null,
      "journal": {"volume": "2 1", "pages": "\n          vi\n        ", "name": "Cancer
      discovery"}, "citationStyles": {"bibtex": "@Article{Cantley2012CancerDA,\n author
      = {L. Cantley and J. Baselga},\n booktitle = {Cancer Discovery},\n journal =
      {Cancer discovery},\n pages = {\n          vi\n        },\n title = {Cancer
      Discovery at one year: the editors'' interim analysis.},\n volume = {2 1},\n
      year = {2012}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "144806171", "name": "J. Baselga"}]}, {"paperId": "73fdd0d7ac12e636d4f82e1a090e73b3c6c53466",
      "externalIds": {"PubMedCentral": "3711671", "MAG": "2125836344", "DOI": "10.1038/nchembio.1060",
      "CorpusId": 1641001, "PubMed": "22922757"}, "corpusId": 1641001, "publicationVenue":
      {"id": "7758f686-2a47-473d-835c-6784e70a0aac", "name": "Nature Chemical Biology",
      "type": "journal", "alternate_names": ["Nat Chem Biology"], "issn": "1552-4450",
      "url": "https://www.nature.com/nchembio/", "alternate_urls": ["http://www.nature.com/nchembio/index.html"]},
      "url": "https://www.semanticscholar.org/paper/73fdd0d7ac12e636d4f82e1a090e73b3c6c53466",
      "title": "Pyruvate kinase M2 activators promote tetramer formation and suppress
      tumorigenesis", "abstract": null, "venue": "Nature Chemical Biology", "year":
      2012, "referenceCount": 61, "citationCount": 644, "influentialCitationCount":
      33, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/nchembio1212-1008b.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-09-07", "journal": {"volume": "8", "pages": "839 -
      847", "name": "Nature chemical biology"}, "citationStyles": {"bibtex": "@Article{Anastasiou2012PyruvateKM,\n
      author = {D. Anastasiou and Yimin Yu and William J. Israelsen and Jian-Kang
      Jiang and M. Boxer and B. Hong and W. Tempel and S. Dimov and M. Shen and Abhishek
      K. Jha and Hua Yang and Katherine R. Mattaini and Christian M. Metallo and B.
      Fiske and K. Courtney and S. Malstrom and Tahsin M. Khan and C. Kung and A.
      P. Skoumbourdis and H. Veith and Noel Southall and M. Walsh and K. Brimacombe
      and W. Leister and S. Lunt and Zachary R. Johnson and K. Yen and K. Kunii and
      S. Davidson and H. Christofk and C. Austin and James Inglese and M. H. Harris
      and J. Asara and G. Stephanopoulos and F. Salituro and Shengfang Jin and L.
      Dang and D. Auld and Hee-won Park and L. Cantley and Craig J. Thomas and M.
      V. Vander Heiden},\n booktitle = {Nature Chemical Biology},\n journal = {Nature
      chemical biology},\n pages = {839 - 847},\n title = {Pyruvate kinase M2 activators
      promote tetramer formation and suppress tumorigenesis},\n volume = {8},\n year
      = {2012}\n}\n"}, "authors": [{"authorId": "46996935", "name": "D. Anastasiou"},
      {"authorId": "1924735", "name": "Yimin Yu"}, {"authorId": "5553029", "name":
      "William J. Israelsen"}, {"authorId": "4084746", "name": "Jian-Kang Jiang"},
      {"authorId": "3275486", "name": "M. Boxer"}, {"authorId": "6351971", "name":
      "B. Hong"}, {"authorId": "5566934", "name": "W. Tempel"}, {"authorId": "33892021",
      "name": "S. Dimov"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "38884428", "name": "Abhishek K. Jha"}, {"authorId": "47912756", "name": "Hua
      Yang"}, {"authorId": "6160202", "name": "Katherine R. Mattaini"}, {"authorId":
      "2281284", "name": "Christian M. Metallo"}, {"authorId": "8143199", "name":
      "B. Fiske"}, {"authorId": "13782167", "name": "K. Courtney"}, {"authorId": "3870192",
      "name": "S. Malstrom"}, {"authorId": "47670281", "name": "Tahsin M. Khan"},
      {"authorId": "7636232", "name": "C. Kung"}, {"authorId": "5914392", "name":
      "A. P. Skoumbourdis"}, {"authorId": "1799343", "name": "H. Veith"}, {"authorId":
      "49134285", "name": "Noel Southall"}, {"authorId": "1699620778", "name": "M.
      Walsh"}, {"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId": "3802281",
      "name": "W. Leister"}, {"authorId": "39089704", "name": "S. Lunt"}, {"authorId":
      "51164649", "name": "Zachary R. Johnson"}, {"authorId": "4886372", "name": "K.
      Yen"}, {"authorId": "8330889", "name": "K. Kunii"}, {"authorId": "34711277",
      "name": "S. Davidson"}, {"authorId": "4164415", "name": "H. Christofk"}, {"authorId":
      "4066869", "name": "C. Austin"}, {"authorId": "3155966", "name": "James Inglese"},
      {"authorId": "2087058005", "name": "M. H. Harris"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "1813278", "name": "G. Stephanopoulos"}, {"authorId":
      "5908187", "name": "F. Salituro"}, {"authorId": "5210229", "name": "Shengfang
      Jin"}, {"authorId": "38799894", "name": "L. Dang"}, {"authorId": "2607088",
      "name": "D. Auld"}, {"authorId": "2790262", "name": "Hee-won Park"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2148769632", "name": "Craig
      J. Thomas"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"}]}, {"paperId":
      "787ea424b3f71b4642cb445dbf50347431c988e4", "externalIds": {"MAG": "2941638450",
      "CorpusId": 5166233}, "corpusId": 5166233, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/787ea424b3f71b4642cb445dbf50347431c988e4",
      "title": "Anastasiou Contributes to Cellular Antioxidant Responses Inhibition
      of Pyruvate Kinase M 2 by Reactive Oxygen Species", "abstract": "clicking here.
      colleagues, clients, or customers by , you can order high-quality copies for
      your If you wish to distribute this article to others here. following the guidelines
      can be obtained by Permission to republish or repurpose articles or portions
      of articles ): October 5, 2012 www.sciencemag.org (this information is current
      as of The following resources related to this article are available online at",
      "venue": "", "year": 2012, "referenceCount": 25, "citationCount": 8, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": {"volume": "",
      "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Anastasiou2012AnastasiouCT,\n
      author = {D. Anastasiou and G. Poulogiannis and J. Asara and M. Boxer and Jian-Kang
      Jiang and M. Shen and G. Bellinger and A. Sasaki and J. Locasale and D. Auld
      and C. Thomas and M. V. Heiden and L. Cantley},\n title = {Anastasiou Contributes
      to Cellular Antioxidant Responses Inhibition of Pyruvate Kinase M 2 by Reactive
      Oxygen Species},\n year = {2012}\n}\n"}, "authors": [{"authorId": "46996935",
      "name": "D. Anastasiou"}, {"authorId": "4612853", "name": "G. Poulogiannis"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "3275486", "name":
      "M. Boxer"}, {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId":
      "145829790", "name": "M. Shen"}, {"authorId": "5679020", "name": "G. Bellinger"},
      {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId": "2268976", "name":
      "J. Locasale"}, {"authorId": "2607088", "name": "D. Auld"}, {"authorId": "2149108162",
      "name": "C. Thomas"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "79bc07989e16c7b180f40211aa48c8f4fe317cf2",
      "externalIds": {"MAG": "1971439437", "DOI": "10.1093/ANNONC/MDS366", "CorpusId":
      70477380}, "corpusId": 70477380, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/79bc07989e16c7b180f40211aa48c8f4fe317cf2",
      "title": "PI 3\u2014kinase and cancer metabolism", "abstract": "ABSTRACT Phosphoinositide
      3-kinase (PI 3-Kinase) generates phosphatidylinositol-3,4,5-trisphosphate (PIP3)
      at the plasma membrane in response to stimulation of cells with growth factors
      and hormones. This lipid recruits certain signal transduction proteins to the
      membrane, initializing cellular signaling cascades that control glucose uptake,
      cell metabolism, protein synthesis and cell growth. A central mediator of PI
      3-Kinase signaling is the protein-Ser/Thr kinase, AKT. Over the past six years
      signaling networks downstream of AKT have been elucidated that regulate protein
      synthesis and glucose metabolism, in part via activation of mTOR. Importantly,
      we have found that while growth factor receptors enhance glucose uptake and
      glucose metabolism, they decrease the activity of pyruvate kinase, the last
      step in the pathway. Our studies indicate that the inhibition of pyruvate kinase
      allows cells to divert intermediates in glycolysis into pathways for synthesis
      of DNA, RNA, proteins and lipids that are needed for cell growth. Disclosure
      Dr. Cantley is a founder and member of the BOD of Agios Pharmaceuticals, a company
      that targets metabolic enzymes for treating cancer. Dr. Cantley consults for
      Novartis and GSK, companies developing drugs that target PI3K.", "venue": "",
      "year": 2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-09-01", "journal": {"volume":
      "23", "name": "Annals of Oncology"}, "citationStyles": {"bibtex": "@Article{Cantley2012PI3A,\n
      author = {L. Cantley},\n journal = {Annals of Oncology},\n title = {PI 3\u2014kinase
      and cancer metabolism},\n volume = {23},\n year = {2012}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "7a2160312ce89614d09c94de20d857464bcfaaa7",
      "externalIds": {"MAG": "2120806256", "DOI": "10.1158/2159-8290.CD-11-0336",
      "CorpusId": 9389722, "PubMed": "22915751"}, "corpusId": 9389722, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/7a2160312ce89614d09c94de20d857464bcfaaa7",
      "title": "Combining a PI3K inhibitor with a PARP inhibitor provides an effective
      therapy for BRCA1-related breast cancer.", "abstract": "UNLABELLED\nThere is
      a need to improve treatments for metastatic breast cancer. Here, we show the
      activation of the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein
      kinase (MAPK) pathways in a MMTV-CreBrca1(f/f)Trp53(+/-) mouse model of breast
      cancer. When treated with the pan-class IA PI3K inhibitor NVP-BKM120, tumor
      doubling was delayed from 5 to 26 days. NVP-BKM120 reduced AKT phosphorylation,
      tumor cell proliferation, and angiogenesis. Resistant tumors maintained suppression
      of AKT phosphorylation but exhibited activation of the MAPK pathway at the \"pushing
      margin.\" Surprisingly, PI3K inhibition increased indicators of DNA damage,
      poly-ADP-ribosylation (PAR), and \u03b3-H2AX, but decreased Rad51 focus formation,
      suggesting a critical role of PI3K activity for Rad51 recruitment. The PARP
      inhibitor olaparib alone attenuated tumor growth modestly; however, the combination
      of NVP-BKM120 and olaparib delayed tumor doubling to more than 70 days in the
      mouse model and more than 50 days in xenotransplants from human BRCA1-related
      tumors, suggesting that combined PI3K and PARP inhibition might be an effective
      treatment of BRCA1-related tumors.\n\n\nSIGNIFICANCE\nCurrent treatment options
      for triple-negative breast cancer are limited to chemotherapeutic regimens that
      have considerable toxicity and are not curative. We report here that the combination
      of a PI3K inhibitor with a PARP inhibitor provides in vivo synergy for treatment
      of an endogenous mouse model for BRCA1-related breast cancers, making this a
      candidate combination to be tested in human clinical trials.", "venue": "Cancer
      Discovery", "year": 2012, "referenceCount": 53, "citationCount": 390, "influentialCitationCount":
      10, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerdiscovery.aacrjournals.org/content/candisc/2/11/1048.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2012-11-01", "journal": {"volume": "2
      11", "pages": "\n          1048-63\n        ", "name": "Cancer discovery"},
      "citationStyles": {"bibtex": "@Article{Juvekar2012CombiningAP,\n author = {Ashish
      Juvekar and Laura N. Burga and Hai Hu and E. Lunsford and Y. Ibrahim and J.
      Balma\u00f1a and Anbazhagan Rajendran and A. Papa and Katherine Spencer and
      C. Lyssiotis and C. Nardella and P. Pandolfi and J. Baselga and R. Scully and
      J. Asara and L. Cantley and G. Wulf},\n booktitle = {Cancer Discovery},\n journal
      = {Cancer discovery},\n pages = {\n          1048-63\n        },\n title = {Combining
      a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related
      breast cancer.},\n volume = {2 11},\n year = {2012}\n}\n"}, "authors": [{"authorId":
      "49149990", "name": "Ashish Juvekar"}, {"authorId": "48793812", "name": "Laura
      N. Burga"}, {"authorId": "2108652866", "name": "Hai Hu"}, {"authorId": "3772950",
      "name": "E. Lunsford"}, {"authorId": "2822826", "name": "Y. Ibrahim"}, {"authorId":
      "4568053", "name": "J. Balma\u00f1a"}, {"authorId": "5146712", "name": "Anbazhagan
      Rajendran"}, {"authorId": "5380009", "name": "A. Papa"}, {"authorId": "2060529577",
      "name": "Katherine Spencer"}, {"authorId": "4901222", "name": "C. Lyssiotis"},
      {"authorId": "3547827", "name": "C. Nardella"}, {"authorId": "4499580", "name":
      "P. Pandolfi"}, {"authorId": "144806171", "name": "J. Baselga"}, {"authorId":
      "143905392", "name": "R. Scully"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "31554501", "name":
      "G. Wulf"}]}, {"paperId": "82851aec21dab1cf1a444bcfa4bed5b88eeba0f6", "externalIds":
      {"MAG": "2328336876", "DOI": "10.1158/1538-7445.AM2012-LB-161", "CorpusId":
      75837891}, "corpusId": 75837891, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/82851aec21dab1cf1a444bcfa4bed5b88eeba0f6",
      "title": "Abstract LB-161: Metformin increases lipolytic metabolism and PEDF
      expression in prostate cancer cells", "abstract": "Obesity increases the risk
      of prostate cancer (PCa) progression; however, the mechanism remains unclear.
      Obesity results in metabolic dysfunction, including increases in circulating
      and tissue lipid levels. A common sequela of obesity is Type II diabetes, and
      some studies suggest that PCa patients on the antidiabetic drug, metformin,
      have a reduced PCa risk. The antitumor mechanism of metformin is largely unknown.
      Metformin exerts its antidiabetic function via AMPK activation-dependent inhibition
      of hepatic gluconeogenesis, with secondary decrease in serum insulin/IGF-1 levels
      that may represent an indirect mechanism for its proposed antitumor effects.
      Previous studies have shown that metformin directly inhibits PCa cell proliferation
      and cyclin D1 expression in vitro. Expression of pigment epithelium-derived
      factor (PEDF), a potent angiogenesis inhibitor, is decreased in PCa tissues,
      and PEDF inhibits PCa cell proliferation. Interestingly, PEDF knockout mice
      have defects in lipid metabolism and develop prostate hyperplasia, so we hypothesized
      that metformin9s antitumor mechanism could be mediated, in part, through regulation
      of PEDF expression and lipolytic metabolism. To simulate obesity-induced cellular
      triglyceride (TG) accumulation, we treated cells with oleic acid (OA, 1.0 mM)
      \u00b1 PEDF (10 nM) or metformin (5 mM). Proliferation (cell count or MTT assay)
      and lipid content (TG isolation) were quantified, and lipid and protein were
      assessed by lipid staining and immunocytochemistry or Western blot, respectively.
      In androgen-insensitive PCa cells (PC-3 and DU145), OA treatment promoted TG
      accumulation, cyclin D1 expression and proliferation, with increased expression
      of lipid droplet-associated proteins, adipose triglyceride lipase (ATGL) and
      CGI-58, and conversely suppressed PEDF expression. Furthermore, PEDF treatment
      decreased basal TG levels (32.89 \u00b1 1.0 control vs. 17.3 \u00b1 0.6 in PEDF;
      P Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of
      the 103rd Annual Meeting of the American Association for Cancer Research; 2012
      Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract
      nr LB-161. doi:1538-7445.AM2012-LB-161", "venue": "", "year": 2012, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2012-04-15", "journal": {"volume": "72", "name": "Cancer
      Research"}, "citationStyles": {"bibtex": "@Article{Patnaik2012AbstractLM,\n
      author = {Akash Patnaik and Susan M. Wcislak and L. Cantley and J. Doll},\n
      journal = {Cancer Research},\n title = {Abstract LB-161: Metformin increases
      lipolytic metabolism and PEDF expression in prostate cancer cells},\n volume
      = {72},\n year = {2012}\n}\n"}, "authors": [{"authorId": "40501341", "name":
      "Akash Patnaik"}, {"authorId": "14331821", "name": "Susan M. Wcislak"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5369007", "name": "J. Doll"}]},
      {"paperId": "8c8926d0a6362ce565dba210fbb47c91d17b0102", "externalIds": {"MAG":
      "1998709192", "DOI": "10.1016/j.molcel.2012.01.010", "CorpusId": 22323222, "PubMed":
      "22342344"}, "corpusId": 22323222, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/8c8926d0a6362ce565dba210fbb47c91d17b0102",
      "title": "p85\u03b1 SH2 domain phosphorylation by IKK promotes feedback inhibition
      of PI3K and Akt in response to cellular starvation.", "abstract": null, "venue":
      "Molecules and Cells", "year": 2012, "referenceCount": 39, "citationCount":
      69, "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1097276512000524/pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2012-03-30", "journal": {"volume": "45 6", "pages": "\n          719-30\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Comb2012p85\u03b1SD,\n
      author = {William C. Comb and Jessica E. Hutti and P. Cogswell and L. Cantley
      and A. Baldwin},\n booktitle = {Molecules and Cells},\n journal = {Molecular
      cell},\n pages = {\n          719-30\n        },\n title = {p85\u03b1 SH2 domain
      phosphorylation by IKK promotes feedback inhibition of PI3K and Akt in response
      to cellular starvation.},\n volume = {45 6},\n year = {2012}\n}\n"}, "authors":
      [{"authorId": "4037235", "name": "William C. Comb"}, {"authorId": "6742227",
      "name": "Jessica E. Hutti"}, {"authorId": "6606210", "name": "P. Cogswell"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2157007", "name":
      "A. Baldwin"}]}, {"paperId": "906ec648aab69f9f823e672efcffd7f06ca3f361", "externalIds":
      {"MAG": "2102188028", "DOI": "10.1093/jmcb/mjr030", "CorpusId": 11591143, "PubMed":
      "22044881"}, "corpusId": 11591143, "publicationVenue": {"id": "f5508b8f-47ff-42d2-9d7e-6296f3bb46a2",
      "name": "Journal of Molecular Cell Biology", "type": "journal", "alternate_names":
      ["J Mol Cell Biology"], "issn": "1759-4685", "alternate_issns": ["1673-520X"]},
      "url": "https://www.semanticscholar.org/paper/906ec648aab69f9f823e672efcffd7f06ca3f361",
      "title": "Exon-centric regulation of pyruvate kinase M alternative splicing
      via mutually exclusive exons.", "abstract": "Alternative splicing of the pyruvate
      kinase M gene (PK-M) can generate the M2 isoform and promote aerobic glycolysis
      and tumor growth. However, the cancer-specific alternative splicing regulation
      of PK-M is not completely understood. Here, we demonstrate that PK-M is regulated
      by reciprocal effects on the mutually exclusive exons 9 and 10, such that exon
      9 is repressed and exon 10 is activated in cancer cells. Strikingly, exonic,
      rather than intronic, cis-elements are key determinants of PK-M splicing isoform
      ratios. Using a systematic sub-exonic duplication approach, we identify a potent
      exonic splicing enhancer in exon 10, which differs from its homologous counterpart
      in exon 9 by only two nucleotides. We identify SRSF3 as one of the cognate factors,
      and show that this serine/arginine-rich protein activates exon 10 and mediates
      changes in glucose metabolism. These findings provide mechanistic insights into
      the complex regulation of alternative splicing of a key regulator of the Warburg
      effect, and also have implications for other genes with a similar pattern of
      alternative splicing.", "venue": "Journal of Molecular Cell Biology", "year":
      2012, "referenceCount": 27, "citationCount": 92, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3493165?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-04-01", "journal": {"volume": "4 2", "pages": "\n          79-87\n        ",
      "name": "Journal of molecular cell biology"}, "citationStyles": {"bibtex": "@Article{Wang2012ExoncentricRO,\n
      author = {Zhenxun Wang and D. Chatterjee and H. Y. Jeon and Martin Akerman and
      M. V. Vander Heiden and L. Cantley and A. Krainer},\n booktitle = {Journal of
      Molecular Cell Biology},\n journal = {Journal of molecular cell biology},\n
      pages = {\n          79-87\n        },\n title = {Exon-centric regulation of
      pyruvate kinase M alternative splicing via mutually exclusive exons.},\n volume
      = {4 2},\n year = {2012}\n}\n"}, "authors": [{"authorId": "47196879", "name":
      "Zhenxun Wang"}, {"authorId": "145584048", "name": "D. Chatterjee"}, {"authorId":
      "6967263", "name": "H. Y. Jeon"}, {"authorId": "38765885", "name": "Martin Akerman"},
      {"authorId": "3804233", "name": "M. V. Vander Heiden"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2742032", "name": "A. Krainer"}]}, {"paperId":
      "a598fd46cac498bdf89799c2391c8b9b68bf89d1", "externalIds": {"MAG": "2714245023",
      "CorpusId": 79885471}, "corpusId": 79885471, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/a598fd46cac498bdf89799c2391c8b9b68bf89d1",
      "title": "Loss of the tumour suppressor inositol polyphosphate 4-phosphatase
      type II in ovarian cancer-implications for therapy", "abstract": null, "venue":
      "", "year": 2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": {"volume": "",
      "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Ip2012LossOT,\n author
      = {L. Ip and F. Cia-Viciano and Spanswick and G. Pouigiannis and L. Cantley
      and J. Hartley and D. Hochhauser and C. Gewinner},\n title = {Loss of the tumour
      suppressor inositol polyphosphate 4-phosphatase type II in ovarian cancer-implications
      for therapy},\n year = {2012}\n}\n"}, "authors": [{"authorId": "5824068", "name":
      "L. Ip"}, {"authorId": "1434829101", "name": "F. Cia-Viciano"}, {"authorId":
      "80401680", "name": "Spanswick"}, {"authorId": "81917811", "name": "G. Pouigiannis"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1888139", "name":
      "J. Hartley"}, {"authorId": "50728992", "name": "D. Hochhauser"}, {"authorId":
      "7739224", "name": "C. Gewinner"}]}, {"paperId": "b28d47924bf6efab87ec65695afc5bf499e69ca3",
      "externalIds": {"CorpusId": 207872577}, "corpusId": 207872577, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/b28d47924bf6efab87ec65695afc5bf499e69ca3",
      "title": "B . canadensis Campanian Hadrosaur Biomolecular Characterization and
      Protein Sequences of the", "abstract": "clicking here. colleagues, clients,
      or customers by , you can order high-quality copies for your If you wish to
      distribute this article to others here. following the guidelines can be obtained
      by Permission to republish or repurpose articles or portions of articles ):  May
      15, 2012  www.sciencemag.org (this information is current as of The following
      resources related to this article are available online at", "venue": "", "year":
      2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Materials
      Science", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Schweitzer2012BC,\n
      author = {M. Schweitzer and Wenxia Zheng and C. Organ and R. Avci and Z. Suo
      and Lisa M. Freimark and Valerie S. LeBleu and M. Duncan and M. V. Heiden and
      J. Neveu and William Arbuthnot Sir Lane and J. Cottrell and J. Horner and L.
      Cantley and R. Kalluri and J. Asara},\n title = {B . canadensis Campanian Hadrosaur
      Biomolecular Characterization and Protein Sequences of the},\n year = {2012}\n}\n"},
      "authors": [{"authorId": "5618773", "name": "M. Schweitzer"}, {"authorId": "7494304",
      "name": "Wenxia Zheng"}, {"authorId": "143615392", "name": "C. Organ"}, {"authorId":
      "2988211", "name": "R. Avci"}, {"authorId": "8048771", "name": "Z. Suo"}, {"authorId":
      "4333053", "name": "Lisa M. Freimark"}, {"authorId": "5457987", "name": "Valerie
      S. LeBleu"}, {"authorId": "3418360", "name": "M. Duncan"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "40029126", "name": "J. Neveu"}, {"authorId":
      "145588117", "name": "William Arbuthnot Sir Lane"}, {"authorId": "48894637",
      "name": "J. Cottrell"}, {"authorId": "1701498", "name": "J. Horner"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5090009", "name": "R. Kalluri"},
      {"authorId": "3028470", "name": "J. Asara"}]}, {"paperId": "b39764fdceff4b8ed1a6efebc621d6c963f0f479",
      "externalIds": {"MAG": "2172034799", "PubMedCentral": "3537887", "DOI": "10.1038/nsmb.2430",
      "CorpusId": 9161210, "PubMed": "23178454"}, "corpusId": 9161210, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/b39764fdceff4b8ed1a6efebc621d6c963f0f479",
      "title": "Site\u2013Specific Monoubiquitination Activates Ras by Impeding GTPase
      Activating Protein Function", "abstract": null, "venue": "Nature Structural
      &Molecular Biology", "year": 2012, "referenceCount": 66, "citationCount": 98,
      "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc3537887?pdf=render", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-10-10", "journal": {"volume": "20", "pages": "46 -
      52", "name": "Nature structural & molecular biology"}, "citationStyles": {"bibtex":
      "@Article{Baker2012SiteSpecificMA,\n author = {R. Baker and Steven M. Lewis
      and A. Sasaki and Emily M. Wilkerson and J. Locasale and L. Cantley and B. Kuhlman
      and H. Dohlman and S. Campbell},\n booktitle = {Nature Structural &Molecular
      Biology},\n journal = {Nature structural & molecular biology},\n pages = {46
      - 52},\n title = {Site\u2013Specific Monoubiquitination Activates Ras by Impeding
      GTPase Activating Protein Function},\n volume = {20},\n year = {2012}\n}\n"},
      "authors": [{"authorId": "145564214", "name": "R. Baker"}, {"authorId": "7268742",
      "name": "Steven M. Lewis"}, {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId":
      "5527411", "name": "Emily M. Wilkerson"}, {"authorId": "2268976", "name": "J.
      Locasale"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144226889",
      "name": "B. Kuhlman"}, {"authorId": "1710306", "name": "H. Dohlman"}, {"authorId":
      "46713144", "name": "S. Campbell"}]}, {"paperId": "b42affde6cdb6766aa690f5ae50e81e0f06fffbe",
      "externalIds": {"MAG": "2318294786", "DOI": "10.1158/1538-7445.PANCA2012-A51",
      "CorpusId": 88291245}, "corpusId": 88291245, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/b42affde6cdb6766aa690f5ae50e81e0f06fffbe",
      "title": "Abstract A51: Oncogenic Kras is required for pancreatic tumor maintenance
      through the regulation of anabolic glucose metabolism.", "abstract": "Tumor
      maintenance relies on continued activity of driver oncogenes, although their
      rate-limiting role is highly context-dependent. Oncogenic Kras mutation is the
      signature event in pancreatic ductal adenocarcinoma (PDAC), serving a critical
      role in tumor initiation. Here, an inducible KrasG12D-driven PDAC mouse model
      establishes that advanced PDAC remain strictly dependent on KrasG12D expression.
      Transcriptome and metabolomic analysis indicate that KrasG12D serves a vital
      role in controlling tumor metabolism through stimulation of glucose uptake and
      channeling of glucose intermediates into the hexosamine biosynthesis and pentose
      phosphate pathways (PPP). These studies also reveal that oncogenic Kras promotes
      ribose biogenesis. Unlike canonical models, we demonstrate that KrasG12D drives
      glycolysis intermediates into the non-oxidative PPP, thereby decoupling ribose
      biogenesis from NADP/NADPH-mediated redox control. Together, this work provides
      in vivo mechanistic insights into how oncogenic Kras promotes metabolic reprogramming
      in native tumors and illuminates potential metabolic targets that can be exploited
      for therapeutic benefit in PDAC. Citation Format: Costas Lyssiotis, Haoqiang
      Ying, Alec Kimmelman, Ronald DePinho, Lewis Cantley. Oncogenic Kras is required
      for pancreatic tumor maintenance through the regulation of anabolic glucose
      metabolism. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic
      Cancer: Progress and Challenges; Jun 18-21, 2012; Lake Tahoe, NV. Philadelphia
      (PA): AACR; Cancer Res 2012;72(12 Suppl):Abstract nr A51.", "venue": "", "year":
      2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-07-15", "journal": {"volume":
      "72", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Lyssiotis2012AbstractAO,\n
      author = {C. Lyssiotis and H. Ying and Alec C. Kimmelman and R. DePinho and
      L. Cantley},\n journal = {Cancer Research},\n title = {Abstract A51: Oncogenic
      Kras is required for pancreatic tumor maintenance through the regulation of
      anabolic glucose metabolism.},\n volume = {72},\n year = {2012}\n}\n"}, "authors":
      [{"authorId": "4901222", "name": "C. Lyssiotis"}, {"authorId": "33312849", "name":
      "H. Ying"}, {"authorId": "4668673", "name": "Alec C. Kimmelman"}, {"authorId":
      "5593407", "name": "R. DePinho"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "ba2759db57fad26a4515e84b28006e9e519f3f96", "externalIds": {"CorpusId":
      251233195}, "corpusId": 251233195, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/ba2759db57fad26a4515e84b28006e9e519f3f96",
      "title": "I (cid:1) B Kinase (cid:2) Phosphorylation of TRAF4 Downregulates
      Innate Immune Signaling", "abstract": "Despite their homology, I (cid:1) B kinase
      (cid:2) (IKK (cid:2) ) and IKK (cid:3) have divergent roles in NF- (cid:1) B
      signaling. IKK (cid:3) strongly activates NF- (cid:1) B while IKK (cid:2) can
      downregulate NF- (cid:1) B under certain circumstances. Given this, identifying
      independent substrates for these kinases could help delineate their divergent
      roles. Peptide substrate array technology followed by bioinformatic screening
      identi\ufb01ed TRAF4 as a substrate for IKK (cid:2) . Like IKK (cid:2) , TRAF4
      is atypical within its family because it is the only TRAF family member to negatively
      regulate innate immune signaling. IKK (cid:2) \u2019s phosphorylation of serine-426
      on TRAF4 was required for this negative regulation. Binding to the Crohn\u2019s
      disease susceptibility protein, NOD2, is required for TRAF4 phosphorylation
      and subsequent inhibition of NOD2 signaling. Structurally, serine-426 resides
      within an exaggerated (cid:3) -bulge in TRAF4 that is not present in the other
      TRAF proteins, and phosphorylation of this site provides a structural basis
      for the atypical function of TRAF4 and its atypical role in NOD2", "venue":
      "", "year": 2012, "referenceCount": 53, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Marinis2012IB,\n
      author = {Jill M. Marinis and Jessica E. Hutti and C. Homer and B. Cobb and
      L. Cantley and C. McDonald and Derek W. Abbotta},\n title = {I (cid:1) B Kinase
      (cid:2) Phosphorylation of TRAF4 Downregulates Innate Immune Signaling},\n year
      = {2012}\n}\n"}, "authors": [{"authorId": "5203393", "name": "Jill M. Marinis"},
      {"authorId": "6742227", "name": "Jessica E. Hutti"}, {"authorId": "6842553",
      "name": "C. Homer"}, {"authorId": "2047419", "name": "B. Cobb"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "145258453", "name": "C. McDonald"},
      {"authorId": "70453966", "name": "Derek W. Abbotta"}]}, {"paperId": "bc32c53da1bfe292d251d3e61e10d0db947b8833",
      "externalIds": {"CorpusId": 13910125}, "corpusId": 13910125, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/bc32c53da1bfe292d251d3e61e10d0db947b8833",
      "title": "Somatic Mutations of PIK 3 R 1 Promote Gliomagenesis", "abstract":
      "The phosphoinositide 3-kinase (PI3K) pathway is targeted for frequent alteration
      in glioblastoma (GBM) and is one of the core GBM pathways defined by The Cancer
      Genome Atlas. Somatic mutations of PIK3R1 are observed in multiple tumor types,
      but the tumorigenic activity of these mutations has not been demonstrated in
      GBM. We show here that somatic mutations in the iSH2 domain of PIK3R1 act as
      oncogenic driver events. Specifically, introduction of a subset of the mutations
      identified in human GBM, in the nSH2 and iSH2 domains, increases signaling through
      the PI3K pathway and promotes tumorigenesis of primary normal human astrocytes
      in an orthotopic xenograft model. Furthermore, we show that cells that are dependent
      on mutant P85a-mediated PI3K signaling exhibit increased sensitivity to a small
      molecule inhibitor of AKT. Together, these results suggest that GBM patients
      whose tumors carry mutant PIK3R1 alleles may benefit from treatment with inhibitors
      of AKT. Citation: Quayle SN, Lee JY, Cheung LWT, Ding L, Wiedemeyer R, et al.
      (2012) Somatic Mutations of PIK3R1 Promote Gliomagenesis. PLoS ONE 7(11): e49466.
      doi:10.1371/journal.pone.0049466 Editor: Maria G. Castro, University of Michigan
      School of Medicine, United States of America Received July 20, 2012; Accepted
      October 9, 2012; Published November 14, 2012 Copyright: 2012 Quayle et al. This
      is an open-access article distributed under the terms of the Creative Commons
      Attribution License, which permits unrestricted use, distribution, and reproduction
      in any medium, provided the original author and source are credited. Funding:
      This work was supported by a fellowship from the Canadian Institutes of Health
      (to SNQ), grants from the Sontag Foundation and the Goldhirsh Foundation (to
      KLL), a grant from the Ben and Catherine Ivy Foundation (to LC), and National
      Institutes of Health grants U01CA141508, U24CA143845, and RC2CA148268 (to LC),
      PO1CA095616 (to KLL and LC), and U01CA168394 (to GBM and LC). The funders had
      no role in study design, data collection and analysis, decision to publish,
      or preparation of the manuscript. Competing Interests: The authors have declared
      that no competing interests exist. * E-mail: lchin@mdanderson.org \u00a4 Current
      address: Department of Genomic Medicine and Institute for Applied Cancer Science,
      The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United
      States of America", "venue": "", "year": 2012, "referenceCount": 22, "citationCount":
      3, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": null, "citationStyles": {"bibtex":
      "@Inproceedings{Quayle2012SomaticMO,\n author = {S. Quayle and Jennifer Y. Lee
      and L. W. Cheung and L. Ding and R. Wiedemeyer and Robert W. Dewan and Emmet
      Huang-Hobbs and L. Zhuang and R. Wilson and K. Ligon and G. Mills and L. Cantley
      and L. Chin},\n title = {Somatic Mutations of PIK 3 R 1 Promote Gliomagenesis},\n
      year = {2012}\n}\n"}, "authors": [{"authorId": "3696841", "name": "S. Quayle"},
      {"authorId": "46663676", "name": "Jennifer Y. Lee"}, {"authorId": "50005741",
      "name": "L. W. Cheung"}, {"authorId": "49594724", "name": "L. Ding"}, {"authorId":
      "5970725", "name": "R. Wiedemeyer"}, {"authorId": "31662497", "name": "Robert
      W. Dewan"}, {"authorId": "1422124289", "name": "Emmet Huang-Hobbs"}, {"authorId":
      "117378315", "name": "L. Zhuang"}, {"authorId": "2234783788", "name": "R. Wilson"},
      {"authorId": "5627829", "name": "K. Ligon"}, {"authorId": "2241330", "name":
      "G. Mills"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144750835",
      "name": "L. Chin"}]}, {"paperId": "c1a923c787ca22f145e4c4db78373185a4416eb3",
      "externalIds": {"MAG": "2067636697", "DOI": "10.1126/science.1223140", "CorpusId":
      206541851, "PubMed": "22605741"}, "corpusId": 206541851, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/c1a923c787ca22f145e4c4db78373185a4416eb3",
      "title": "Ancient Sensor for Ancient Drug", "abstract": "A common drug has an
      unexpected effect on a metabolic enzyme that stimulates fat utilization. Salicylate,
      a compound found in willow tree bark, is the active breakdown product of aspirin,
      and has been used for medicinal purposes since ancient times. However, the molecular
      mechanism underlying the beneficial effects of salicylate has been unclear.
      On page 918 of this issue, Hawley et al. (1) show that salicylate activates
      the cellular metabolic regulator adenosine monophosphate (AMP)\u2013activated
      protein kinase (AMPK), which stimulates fat utilization in mice.", "venue":
      "Science", "year": 2012, "referenceCount": 14, "citationCount": 18, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": ["LettersAndComments", "JournalArticle"],
      "publicationDate": "2012-05-18", "journal": {"volume": "336", "pages": "813
      - 814", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Shaw2012AncientSF,\n
      author = {R. Shaw and L. Cantley},\n booktitle = {Science},\n journal = {Science},\n
      pages = {813 - 814},\n title = {Ancient Sensor for Ancient Drug},\n volume =
      {336},\n year = {2012}\n}\n"}, "authors": [{"authorId": "4426388", "name": "R.
      Shaw"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "cd8c573f52f641dd51ebb850be093667ef3b64a7",
      "externalIds": {"MAG": "2208451982", "DOI": "10.1007/978-1-4614-0598-6_13",
      "CorpusId": 86035311}, "corpusId": 86035311, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/cd8c573f52f641dd51ebb850be093667ef3b64a7",
      "title": "Cancer Cell Metabolism", "abstract": null, "venue": "", "year": 2012,
      "referenceCount": 80, "citationCount": 257, "influentialCitationCount": 9, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": {"volume": "", "pages": "245-261",
      "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Patnaik2012CancerCM,\n
      author = {Akash Patnaik and J. Locasale and L. Cantley},\n pages = {245-261},\n
      title = {Cancer Cell Metabolism},\n year = {2012}\n}\n"}, "authors": [{"authorId":
      "40501341", "name": "Akash Patnaik"}, {"authorId": "2268976", "name": "J. Locasale"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "d40354854dd5c47f83de55b9b3f6aff7b0c27700",
      "externalIds": {"PubMedCentral": "3408500", "MAG": "2147592527", "DOI": "10.1371/journal.pone.0041494",
      "CorpusId": 5973641, "PubMed": "22859992"}, "corpusId": 5973641, "publicationVenue":
      {"id": "0aed7a40-85f3-4c66-9e1b-c1556c57001b", "name": "PLoS ONE", "type": "journal",
      "alternate_names": ["Plo ONE", "PLOS ONE", "PLO ONE"], "issn": "1932-6203",
      "url": "https://journals.plos.org/plosone/", "alternate_urls": ["http://www.plosone.org/"]},
      "url": "https://www.semanticscholar.org/paper/d40354854dd5c47f83de55b9b3f6aff7b0c27700",
      "title": "Development of a High-Throughput Assay for Identifying Inhibitors
      of TBK1 and IKK\u03b5", "abstract": "IKK\u03b5 and TBK1 are noncanonical IKK
      family members which regulate inflammatory signaling pathways and also play
      important roles in oncogenesis. However, few inhibitors of these kinases have
      been identified. While the substrate specificity of IKK\u03b5 has recently been
      described, the substrate specificity of TBK1 is unknown, hindering the development
      of high-throughput screening technologies for inhibitor identification. Here,
      we describe the optimal substrate phosphorylation motif for TBK1, and show that
      it is identical to the phosphorylation motif previously described for IKK\u03b5.
      This information enabled the design of an optimal TBK1/IKK\u03b5 substrate peptide
      amenable to high-throughput screening and we assayed a 6,006 compound library
      that included 4,727 kinase-focused compounds to discover in vitro inhibitors
      of TBK1 and IKK\u03b5. 227 compounds in this library inhibited TBK1 at a concentration
      of 10 \u00b5M, while 57 compounds inhibited IKK\u03b5. Together, these data
      describe a new high-throughput screening assay which will facilitate the discovery
      of small molecule TBK1/IKK\u03b5 inhibitors possessing therapeutic potential
      for both inflammatory diseases and cancer.", "venue": "PLoS ONE", "year": 2012,
      "referenceCount": 41, "citationCount": 34, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0041494&type=printable",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-07-30", "journal": {"volume": "7", "name": "PLoS ONE"},
      "citationStyles": {"bibtex": "@Article{Hutti2012DevelopmentOA,\n author = {Jessica
      E. Hutti and Melissa A. Porter and Adam W. Cheely and L. Cantley and Xiaodong
      Wang and D. Kireev and A. Baldwin and W. Janzen},\n booktitle = {PLoS ONE},\n
      journal = {PLoS ONE},\n title = {Development of a High-Throughput Assay for
      Identifying Inhibitors of TBK1 and IKK\u03b5},\n volume = {7},\n year = {2012}\n}\n"},
      "authors": [{"authorId": "6742227", "name": "Jessica E. Hutti"}, {"authorId":
      "22153825", "name": "Melissa A. Porter"}, {"authorId": "4108773", "name": "Adam
      W. Cheely"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2108428054",
      "name": "Xiaodong Wang"}, {"authorId": "32133533", "name": "D. Kireev"}, {"authorId":
      "2157007", "name": "A. Baldwin"}, {"authorId": "5202479", "name": "W. Janzen"}]},
      {"paperId": "d4df8adf1c918774f11f8268cbb182e00f5e901d", "externalIds": {"MAG":
      "2146708267", "DOI": "10.1016/j.nut.2012.07.004", "CorpusId": 5565559, "PubMed":
      "22925542"}, "corpusId": 5565559, "publicationVenue": {"id": "efda22ae-07c9-475b-8193-699753a01eb0",
      "name": "Nutrition (Burbank, Los Angeles County, Calif.)", "type": "journal",
      "alternate_names": ["Nutrition", "Nutr (burbank los angel Cty Calif"], "issn":
      "0899-9007", "url": "https://www.journals.elsevier.com/nutrition", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/08999007", "http://www.nutritionjrnl.com/"]},
      "url": "https://www.semanticscholar.org/paper/d4df8adf1c918774f11f8268cbb182e00f5e901d",
      "title": "Sugar free, cancer free?", "abstract": null, "venue": "Nutrition (Burbank,
      Los Angeles County, Calif.)", "year": 2012, "referenceCount": 6, "citationCount":
      6, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc3746332?pdf=render", "status": null}, "fieldsOfStudy":
      ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["LettersAndComments",
      "Editorial"], "publicationDate": "2012-10-01", "journal": {"volume": "28 10",
      "pages": "\n          1036\n        ", "name": "Nutrition"}, "citationStyles":
      {"bibtex": "@Article{Myers2012SugarFC,\n author = {A. Myers and L. Cantley},\n
      booktitle = {Nutrition (Burbank, Los Angeles County, Calif.)},\n journal = {Nutrition},\n
      pages = {\n          1036\n        },\n title = {Sugar free, cancer free?},\n
      volume = {28 10},\n year = {2012}\n}\n"}, "authors": [{"authorId": "6324437",
      "name": "A. Myers"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "dd72a5e83d3cc7e607c99c3cb5062da509b81ae2", "externalIds": {"MAG": "2332477414",
      "DOI": "10.1158/1940-6207.PREV-12-OP-03", "CorpusId": 87715942}, "corpusId":
      87715942, "publicationVenue": {"id": "30248bd8-0140-4a2a-b2f7-d817cf173fdd",
      "name": "Cancer Prevention Research", "type": "journal", "alternate_names":
      ["Cancer Prev Res"], "issn": "1940-6215", "url": "https://cancerpreventionresearch.aacrjournals.org/"},
      "url": "https://www.semanticscholar.org/paper/dd72a5e83d3cc7e607c99c3cb5062da509b81ae2",
      "title": "Abstract OP-03: PI 3-Kinase, AMPK, and Cancer", "abstract": "Phosphoinositide
      3-kinase (PI3K) is a central enzyme in a signaling pathway that mediates cellular
      responses to growth factors. This enzyme phosphorylates the 3 position of phosphatidylinositol-4,5-bisphosphate
      to produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) at the plasma membrane.
      A number of signaling proteins, including the Ser/Thr protein kinases, AKT and
      PDK1, contain pleckstrin homology domains that bind specifically to PIP3. Thus,
      the generation of PIP3 at the plasma membrane in response to activation of PI3K
      by insulin and by growth factors results in the initiation of downstream Ser/Thr
      phosphorylation cascades that control a variety of cellular responses. The signaling
      pathway downstream of PI3K is highly conserved from worms and flies to humans
      and genetic analysis of the pathway has revealed a conserved role in regulating
      glucose metabolism and cell growth. Based on deletion of genes encoding the
      catalytic or regulatory subunits of PI3K in the mouse, PI3K mediates insulin
      dependent regulation of glucose metabolism, and defects in activation of this
      pathway result in insulin resistance. Studies over the past decade have revealed
      considerable cross-talk between the PI3K signaling pathway and AMP activated
      protein kinase (AMPK). These enzymes have opposing effects in regard to activating
      mTOR signaling, but have complimentary effects in stimulating glucose uptake.
      These two enzymes also play complex roles in cancers. Activating mutations in
      PIK3CA, encoding the p110alpha catalytic subunit of PI3K or inactivating mutations
      in PTEN, a phosphoinositide 3-phosphatases that reverses the effects of PI3K,
      are among the most common events in solid tumors. Loss of function mutations
      in LKB1, a protein kinase that phosphorylates and activates AMPK, can also drive
      cancers. We have generated mouse models in which a mutated form of the PIK3CA
      gene is expressed in a tissue specific and reversibly inducible manner. These
      mice develop cancers that are dependent on continuous expression of the mutant
      PIK3CA gene. The PIK3CA driven tumors are FDG-PET positive and turning off PI
      3-Kinase with PI3K inhibitors that are in human clinical trials results in an
      acute decline in FDG-PET signal that precedes tumor shrinkage. These results
      suggest that the ability of PI3K to stimulate high rates of glucose uptake and
      metabolism may be critical for the survival of PIK3CA mutant tumors. In contrast,
      drugs that activate AMPK may be useful in preventing cancers. Activation of
      AMPK in tumor cells using drugs, such as metformin or phenformin can suppress
      tumor cell growth in a cell-autonomous manner. In addition, metformin and phenformin,
      through actions in the liver, can lower serum glucose and insulin levels and
      thereby indirectly suppress tumor cell growth that is dependent on insulin and
      glucose. The role of PI3K inhibitors and AMPK activators for preventing or treating
      cancers in mouse models and in human trials will be discussed. Citation Format:
      Lewis C. Cantley. PI 3-Kinase, AMPK, and Cancer. [abstract]. In: Proceedings
      of the Eleventh Annual AACR International Conference on Frontiers in Cancer
      Prevention Research; 2012 Oct 16-19; Anaheim, CA. Philadelphia (PA): AACR; Cancer
      Prev Res 2012;5(11 Suppl):Abstract nr OP-03.", "venue": "Cancer Prevention Research",
      "year": 2012, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2012-11-01", "journal": {"volume":
      "5", "pages": "OP-03 - OP-03", "name": "Cancer Prevention Research"}, "citationStyles":
      {"bibtex": "@Article{Cantley2012AbstractOP,\n author = {L. Cantley},\n booktitle
      = {Cancer Prevention Research},\n journal = {Cancer Prevention Research},\n
      pages = {OP-03 - OP-03},\n title = {Abstract OP-03: PI 3-Kinase, AMPK, and Cancer},\n
      volume = {5},\n year = {2012}\n}\n"}, "authors": [{"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "e0d8fbf2841972cf2f605591226e7d3004c6b185", "externalIds":
      {"MAG": "2163993295", "DOI": "10.1128/MCB.00106-12", "CorpusId": 36778340, "PubMed":
      "22547678"}, "corpusId": 36778340, "publicationVenue": {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b",
      "name": "Molecular and Cellular Biology", "type": "journal", "alternate_names":
      ["Mol Cell Biology"], "issn": "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls":
      ["http://mcb.asm.org/"]}, "url": "https://www.semanticscholar.org/paper/e0d8fbf2841972cf2f605591226e7d3004c6b185",
      "title": "I\u03baB Kinase \u03b1 Phosphorylation of TRAF4 Downregulates Innate
      Immune Signaling", "abstract": "ABSTRACT Despite their homology, I\u03baB kinase
      \u03b1 (IKK\u03b1) and IKK\u03b2 have divergent roles in NF-\u03baB signaling.
      IKK\u03b2 strongly activates NF-\u03baB while IKK\u03b1 can downregulate NF-\u03baB
      under certain circumstances. Given this, identifying independent substrates
      for these kinases could help delineate their divergent roles. Peptide substrate
      array technology followed by bioinformatic screening identified TRAF4 as a substrate
      for IKK\u03b1. Like IKK\u03b1, TRAF4 is atypical within its family because it
      is the only TRAF family member to negatively regulate innate immune signaling.
      IKK\u03b1''s phosphorylation of serine-426 on TRAF4 was required for this negative
      regulation. Binding to the Crohn''s disease susceptibility protein, NOD2, is
      required for TRAF4 phosphorylation and subsequent inhibition of NOD2 signaling.
      Structurally, serine-426 resides within an exaggerated \u03b2-bulge in TRAF4
      that is not present in the other TRAF proteins, and phosphorylation of this
      site provides a structural basis for the atypical function of TRAF4 and its
      atypical role in NOD2 signaling.", "venue": "Molecular and Cellular Biology",
      "year": 2012, "referenceCount": 56, "citationCount": 26, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://mcb.asm.org/content/mcb/32/13/2479.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2012-04-30", "journal": {"volume": "32", "pages": "2479
      - 2489", "name": "Molecular and Cellular Biology"}, "citationStyles": {"bibtex":
      "@Article{Marinis2012I\u03baBK\u0391,\n author = {Jill M. Marinis and Jessica
      E. Hutti and C. Homer and B. Cobb and L. Cantley and C. McDonald and Derek W.
      Abbott},\n booktitle = {Molecular and Cellular Biology},\n journal = {Molecular
      and Cellular Biology},\n pages = {2479 - 2489},\n title = {I\u03baB Kinase \u03b1
      Phosphorylation of TRAF4 Downregulates Innate Immune Signaling},\n volume =
      {32},\n year = {2012}\n}\n"}, "authors": [{"authorId": "5203393", "name": "Jill
      M. Marinis"}, {"authorId": "6742227", "name": "Jessica E. Hutti"}, {"authorId":
      "6842553", "name": "C. Homer"}, {"authorId": "2047419", "name": "B. Cobb"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "145258453", "name":
      "C. McDonald"}, {"authorId": "145759174", "name": "Derek W. Abbott"}]}, {"paperId":
      "fabaac3360085ef8aa1880b3085b4ee49a6799b7", "externalIds": {"MAG": "2119489521",
      "DOI": "10.1161/CIRCULATIONAHA.112.115592", "CorpusId": 25448659, "PubMed":
      "23019294"}, "corpusId": 25448659, "publicationVenue": {"id": "0d67273f-71c8-43f4-a642-9c384870ccb2",
      "name": "Circulation", "type": "journal", "issn": "0009-7322", "url": "http://gateway.ovid.com/ovidweb.cgi?AN=00002060-000000000-00000&D=ovft&MODE=ovid&NEWS=N&PAGE=toc&T=JS",
      "alternate_urls": ["http://circ.ahajournals.org/"]}, "url": "https://www.semanticscholar.org/paper/fabaac3360085ef8aa1880b3085b4ee49a6799b7",
      "title": "Pathological Role of Serum- and Glucocorticoid-Regulated Kinase 1
      in Adverse Ventricular Remodeling", "abstract": "Background\u2014 Heart failure
      is a growing cause of morbidity and mortality. Cardiac phosphatidylinositol
      3-kinase signaling promotes cardiomyocyte survival and function, but it is paradoxically
      activated in heart failure, suggesting that chronic activation of this pathway
      may become maladaptive. Here, we investigated the downstream phosphatidylinositol
      3-kinase effector, serum- and glucocorticoid-regulated kinase-1 (SGK1), in heart
      failure and its complications. Methods and Results\u2014 We found that cardiac
      SGK1 is activated in human and murine heart failure. We investigated the role
      of SGK1 in the heart by using cardiac-specific expression of constitutively
      active or dominant-negative SGK1. Cardiac-specific activation of SGK1 in mice
      increased mortality, cardiac dysfunction, and ventricular arrhythmias. The proarrhythmic
      effects of SGK1 were linked to biochemical and functional changes in the cardiac
      sodium channel and could be reversed by treatment with ranolazine, a blocker
      of the late sodium current. Conversely, cardiac-specific inhibition of SGK1
      protected mice after hemodynamic stress from fibrosis, heart failure, and sodium
      channel alterations. Conclusions\u2014 SGK1 appears both necessary and sufficient
      for key features of adverse ventricular remodeling and may provide a novel therapeutic
      target in cardiac disease.", "venue": "Circulation", "year": 2012, "referenceCount":
      46, "citationCount": 98, "influentialCitationCount": 7, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.112.115592",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2012-10-30", "journal":
      {"volume": "126", "pages": "2208\u20132219", "name": "Circulation"}, "citationStyles":
      {"bibtex": "@Article{Das2012PathologicalRO,\n author = {Saumya Das and T. Aiba
      and M. Rosenberg and Katherine Hessler and C. Xiao and P. Quintero and Filomena
      Ottaviano and Ashley C. Knight and E. Graham and P. Bostr\u00f6m and M. Morissette
      and F. Del Monte and M. Begley and L. Cantley and P. Ellinor and G. Tomaselli
      and A. Rosenzweig},\n booktitle = {Circulation},\n journal = {Circulation},\n
      pages = {2208\u20132219},\n title = {Pathological Role of Serum- and Glucocorticoid-Regulated
      Kinase 1 in Adverse Ventricular Remodeling},\n volume = {126},\n year = {2012}\n}\n"},
      "authors": [{"authorId": "2116117659", "name": "Saumya Das"}, {"authorId": "6342525",
      "name": "T. Aiba"}, {"authorId": "38355094", "name": "M. Rosenberg"}, {"authorId":
      "10718959", "name": "Katherine Hessler"}, {"authorId": "47343594", "name": "C.
      Xiao"}, {"authorId": "1781556", "name": "P. Quintero"}, {"authorId": "6513631",
      "name": "Filomena Ottaviano"}, {"authorId": "47830085", "name": "Ashley C. Knight"},
      {"authorId": "40193551", "name": "E. Graham"}, {"authorId": "47428213", "name":
      "P. Bostr\u00f6m"}, {"authorId": "40419316", "name": "M. Morissette"}, {"authorId":
      "6020889", "name": "F. Del Monte"}, {"authorId": "69874482", "name": "M. Begley"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4504266", "name":
      "P. Ellinor"}, {"authorId": "2338824", "name": "G. Tomaselli"}, {"authorId":
      "144061154", "name": "A. Rosenzweig"}]}, {"paperId": "04bb3743d466fe1cf9bb82d9efcb35802603ff0a",
      "externalIds": {"MAG": "2087974103", "DOI": "10.1126/science.1201678", "CorpusId":
      28294963, "PubMed": "21436401"}, "corpusId": 28294963, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/04bb3743d466fe1cf9bb82d9efcb35802603ff0a",
      "title": "AMP-Activated Protein Kinase Regulates Neuronal Polarization by Interfering
      with PI 3-Kinase Localization", "abstract": "A bioenergy-sensing pathway determines
      axon initiation and growth in neurons. Axon-dendrite polarization is crucial
      for neural network wiring and information processing in the brain. Polarization
      begins with the transformation of a single neurite into an axon and its subsequent
      rapid extension, which requires coordination of cellular energy status to allow
      for transport of building materials to support axon growth. We found that activation
      of the energy-sensing adenosine 5\u2032-monophosphate (AMP)\u2013activated protein
      kinase (AMPK) pathway suppressed axon initiation and neuronal polarization.
      Phosphorylation of the kinesin light chain of the Kif5 motor protein by AMPK
      disrupted the association of the motor with phosphatidylinositol 3-kinase (PI3K),
      preventing PI3K targeting to the axonal tip and inhibiting polarization and
      axon growth.", "venue": "Science", "year": 2011, "referenceCount": 32, "citationCount":
      76, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc3325765?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2011-04-08", "journal": {"volume": "332", "pages": "247 - 251", "name": "Science"},
      "citationStyles": {"bibtex": "@Article{Amato2011AMPActivatedPK,\n author = {S.
      Amato and Xiuxin Liu and B. Zheng and L. Cantley and P. Rakic and H. Man},\n
      booktitle = {Science},\n journal = {Science},\n pages = {247 - 251},\n title
      = {AMP-Activated Protein Kinase Regulates Neuronal Polarization by Interfering
      with PI 3-Kinase Localization},\n volume = {332},\n year = {2011}\n}\n"}, "authors":
      [{"authorId": "144098874", "name": "S. Amato"}, {"authorId": "120280954", "name":
      "Xiuxin Liu"}, {"authorId": "29089092", "name": "B. Zheng"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "144100263", "name": "P. Rakic"}, {"authorId":
      "80648567", "name": "H. Man"}]}, {"paperId": "07cf76182e2c4109cb7d912a699c7731f600b0e6",
      "externalIds": {"MAG": "2067314418", "DOI": "10.1021/pr200578n", "CorpusId":
      41114447, "PubMed": "21774532"}, "corpusId": 41114447, "publicationVenue": {"id":
      "c7bbca07-9604-48a6-85d8-512fa663722e", "name": "Journal of Proteome Research",
      "type": "journal", "alternate_names": ["J Proteome Res"], "issn": "1535-3893",
      "url": "https://pubs.acs.org/journal/jprobs", "alternate_urls": ["http://pubs.acs.org/journals/jprobs/",
      "http://pubs.acs.org/journals/jprobs/index.html", "http://pubs.acs.org/journal/jprobs"]},
      "url": "https://www.semanticscholar.org/paper/07cf76182e2c4109cb7d912a699c7731f600b0e6",
      "title": "Proteomic screening method for phosphopeptide motif binding proteins
      using peptide libraries.", "abstract": "Phosphopeptide binding domains mediate
      the directed and localized assembly of protein complexes essential to intracellular
      kinase signaling. To identify phosphopeptide binding proteins, we developed
      a proteomic screening method using immobilized partially degenerate phosphopeptide
      mixtures combined with SILAC and microcapillary LC-MS/MS. The method was used
      to identify proteins that specifically bound to phosphorylated peptide library
      affinity matrices, including pTyr, and the motifs pSer/pThr-Pro, pSer/pThr-X-X-X-pSer/pThr,
      pSer/pThr-Glu/Asp, or pSer/pThr-pSer/pThr in degenerate sequence contexts. Heavy
      and light SILAC lysates were applied to columns containing these phosphorylated
      and nonphosphorylated (control) peptide libraries respectively, and bound proteins
      were eluted, combined, digested, and analyzed by LC-MS/MS using a hybrid quadrupole-TOF
      mass spectrometer. Heavy/light peptide ion ratios were calculated, and peptides
      that yielded ratios greater than \u223c3:1 were considered as being from potential
      phosphopeptide binding proteins since this ratio represents the lowest ratio
      from a known positive control. Many of those identified were known phosphopeptide-binding
      proteins, including the SH2 domain containing p85 subunit of PI3K bound to pTyr,
      14-3-3 bound to pSer/pThr-Asp/Glu, polo-box domain containing PLK1 and Pin1
      bound to pSer/pThr-Pro, and pyruvate kinase M2 binding to pTyr. Approximately
      half of the hits identified by the peptide library screens were novel. Protein
      domain enrichment analysis revealed that most pTyr hits contain SH2 domains,
      as expected, and to a lesser extent SH3, C1, STAT, Tyr phosphatase, Pkinase,
      C2, and PH domains; however, pSer/pThr motifs did not reveal enriched domains
      across hits.", "venue": "Journal of Proteome Research", "year": 2011, "referenceCount":
      36, "citationCount": 16, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3174226?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-09-02", "journal": {"volume": "10 9", "pages": "\n          4158-64\n        ",
      "name": "Journal of proteome research"}, "citationStyles": {"bibtex": "@Article{Christofk2011ProteomicSM,\n
      author = {H. Christofk and Ning Wu and L. Cantley and J. Asara},\n booktitle
      = {Journal of Proteome Research},\n journal = {Journal of proteome research},\n
      pages = {\n          4158-64\n        },\n title = {Proteomic screening method
      for phosphopeptide motif binding proteins using peptide libraries.},\n volume
      = {10 9},\n year = {2011}\n}\n"}, "authors": [{"authorId": "4164415", "name":
      "H. Christofk"}, {"authorId": "2068343858", "name": "Ning Wu"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "3028470", "name": "J. Asara"}]},
      {"paperId": "0a9f908f710d40676d7dfc1a5389b32e667f2669", "externalIds": {"MAG":
      "3019994392", "DOI": "10.3410/f.13411026.14782149", "CorpusId": 223780016},
      "corpusId": 223780016, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/0a9f908f710d40676d7dfc1a5389b32e667f2669",
      "title": "Faculty Opinions recommendation of Genetic and functional studies
      implicate HIF1\u03b1 as a 14q kidney cancer suppressor gene.", "abstract": null,
      "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://f1000.com/download/13411026",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2011-12-19", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Cantley2011FacultyOR,\n author = {L. Cantley},\n
      title = {Faculty Opinions recommendation of Genetic and functional studies implicate
      HIF1\u03b1 as a 14q kidney cancer suppressor gene.},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "0aa3c77c491fad79b984a1cda6565b9df1ae9089",
      "externalIds": {"MAG": "2110393953", "DOI": "10.1158/0008-5472.CAN-11-0445",
      "CorpusId": 4970323, "PubMed": "21775521"}, "corpusId": 4970323, "publicationVenue":
      {"id": "b0bd78b2-6591-460e-af71-196409b62e2c", "name": "Cancer Research", "type":
      "journal", "alternate_names": ["Cancer Res"], "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/",
      "alternate_urls": ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/0aa3c77c491fad79b984a1cda6565b9df1ae9089",
      "title": "Using tandem mass spectrometry in targeted mode to identify activators
      of class IA PI3K in cancer.", "abstract": "Phosphatiditylinositide-3-kinase
      (PI3K) is activated in some cancers by direct mutation, but it is activated
      more commonly in cancer by mutation of upstream acting receptor tyrosine kinases
      (TK). At present, there is no systematic method to determine which TK signaling
      cascades activate PI3K in certain cancers, despite the likely utility of such
      information to help guide selection of tyrosine kinase inhibitor (TKI) drug
      strategies for personalized therapy. Here, we present a quantitative liquid
      chromatography tandem mass spectrometry approach that identifies upstream activators
      of PI3K both in vitro and in vivo. Using non-small cell lung carcinoma to illustrate
      this approach, we show a correct identification of the mechanism of PI3K activation
      in several models, thereby identifying the most appropriate TKI to downregulate
      PI3K signaling. This approach also determined the molecular mechanisms and adaptors
      required for PI3K activation following inhibition of the mTOR kinase TORC1.
      We further validated the approach in breast cancer cells with mutational activation
      of PIK3CA, where tandem mass spectrometry detected and quantitatively measured
      the abundance of a helical domain mutant (E545K) of PIK3CA connected to PI3K
      activation. Overall, our findings establish a mass spectrometric approach to
      identify functional interactions that govern PI3K regulation in cancer cells.
      Using this technique to define the pathways that activate PI3K signaling in
      a given tumor could help inform clinical decision making by helping guide personalized
      therapeutic strategies for different patients.", "venue": "Cancer Research",
      "year": 2011, "referenceCount": 54, "citationCount": 16, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cancerres/article-pdf/71/18/5965/2656984/5965.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-09-15", "journal": {"volume": "71 18", "pages": "\n          5965-75\n        ",
      "name": "Cancer research"}, "citationStyles": {"bibtex": "@Article{Yang2011UsingTM,\n
      author = {Xuemei Yang and Alexa B. Turke and J. Qi and Youngchul Song and B.
      Rexer and T. Miller and P. J\u00e4nne and C. Arteaga and L. Cantley and J. Engelman
      and J. Asara},\n booktitle = {Cancer Research},\n journal = {Cancer research},\n
      pages = {\n          5965-75\n        },\n title = {Using tandem mass spectrometry
      in targeted mode to identify activators of class IA PI3K in cancer.},\n volume
      = {71 18},\n year = {2011}\n}\n"}, "authors": [{"authorId": "48520140", "name":
      "Xuemei Yang"}, {"authorId": "4039016", "name": "Alexa B. Turke"}, {"authorId":
      "46315599", "name": "J. Qi"}, {"authorId": "4846062", "name": "Youngchul Song"},
      {"authorId": "5162072", "name": "B. Rexer"}, {"authorId": "34988079", "name":
      "T. Miller"}, {"authorId": "5984202", "name": "P. J\u00e4nne"}, {"authorId":
      "2057460", "name": "C. Arteaga"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "3028470", "name":
      "J. Asara"}]}, {"paperId": "1ce5b5efac31327266d7872bf110b7a02d35068e", "externalIds":
      {"CorpusId": 207767691}, "corpusId": 207767691, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/1ce5b5efac31327266d7872bf110b7a02d35068e",
      "title": "Yonghao Yu Substrate That Negatively Regulates Insulin Signaling Phosphoproteomic
      Analysis Identifies Grb 10 as an mTORC 1", "abstract": "clicking here. colleagues,
      clients, or customers by , you can order high-quality copies for your If you
      wish to distribute this article to others here. following the guidelines can
      be obtained by Permission to republish or repurpose articles or portions of
      articles ): June 12, 2011 www.sciencemag.org (this infomation is current as
      of The following resources related to this article are available online at",
      "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Yu2011YonghaoYS,\n
      author = {Yonghao Yu and Sang-Oh Yoon and G. Poulogiannis and Qian Yang and
      X. Ma and J. Ville\u0301n and Neil Kubica and G. Hoffman and L. Cantley and
      S. Gygi},\n title = {Yonghao Yu Substrate That Negatively Regulates Insulin
      Signaling Phosphoproteomic Analysis Identifies Grb 10 as an mTORC 1},\n year
      = {2011}\n}\n"}, "authors": [{"authorId": "40508577", "name": "Yonghao Yu"},
      {"authorId": "6168327", "name": "Sang-Oh Yoon"}, {"authorId": "4612853", "name":
      "G. Poulogiannis"}, {"authorId": "144785850", "name": "Qian Yang"}, {"authorId":
      "50088305", "name": "X. Ma"}, {"authorId": "1705488", "name": "J. Ville\u0301n"},
      {"authorId": "8429203", "name": "Neil Kubica"}, {"authorId": "34846304", "name":
      "G. Hoffman"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2665934",
      "name": "S. Gygi"}]}, {"paperId": "2318a667d943d83bd38192d5f611f91209beaa74",
      "externalIds": {"MAG": "2123316972", "DOI": "10.1158/2159-8274.CD-10-0022",
      "CorpusId": 26399965, "PubMed": "22140652"}, "corpusId": 26399965, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/2318a667d943d83bd38192d5f611f91209beaa74",
      "title": "Characterization of KRAS rearrangements in metastatic prostate cancer.",
      "abstract": "UNLABELLED\nUsing an integrative genomics approach called amplification
      breakpoint ranking and assembly analysis, we nominated KRAS as a gene fusion
      with the ubiquitin-conjugating enzyme UBE2L3 in the DU145 cell line, originally
      derived from prostate cancer metastasis to the brain. Interestingly, analysis
      of tissues revealed that 2 of 62 metastatic prostate cancers harbored aberrations
      at the KRAS locus. In DU145 cells, UBE2L3-KRAS produces a fusion protein, a
      specific knockdown of which attenuates cell invasion and xenograft growth. Ectopic
      expression of the UBE2L3-KRAS fusion protein exhibits transforming activity
      in NIH 3T3 fibroblasts and RWPE prostate epithelial cells in vitro and in vivo.
      In NIH 3T3 cells, UBE2L3-KRAS attenuates MEK/ERK signaling, commonly engaged
      by oncogenic mutant KRAS, and instead signals via AKT and p38 mitogen-activated
      protein kinase (MAPK) pathways. This is the first report of a gene fusion involving
      the Ras family, suggesting that this aberration may drive metastatic progression
      in a rare subset of prostate cancers.\n\n\nSIGNIFICANCE\nThis is the first description
      of an oncogenic gene fusion of KRAS, one of the most studied proto-oncogenes.
      KRAS rearrangement may represent the driving mutation in a rare subset of metastatic
      prostate cancers, emphasizing the importance of RAS-RAF-MAPK signaling in this
      disease.", "venue": "Cancer Discovery", "year": 2011, "referenceCount": 24,
      "citationCount": 99, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://aacrjournals.org/cancerdiscovery/article-pdf/1/1/35/1803217/35.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-06-01", "journal": {"volume": "1 1", "pages": "\n          35-43\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Wang2011CharacterizationOK,\n
      author = {Xiao-Song Wang and Sunita Shankar and S. Dhanasekaran and Bushra Ateeq
      and A. Sasaki and Xiaojun Jing and Daniel H. Robinson and Q. Cao and John R.
      Prensner and Anastasia K. Yocum and Rui Wang and Daniel F. Fries and B. Han
      and I. Asangani and Xuhong Cao and Yong Li and G. Omenn and D. Pflueger and
      A. Gopalan and V. Reuter and E. Kahoud and L. Cantley and M. Rubin and N. Palanisamy
      and S. Varambally and A. Chinnaiyan},\n booktitle = {Cancer Discovery},\n journal
      = {Cancer discovery},\n pages = {\n          35-43\n        },\n title = {Characterization
      of KRAS rearrangements in metastatic prostate cancer.},\n volume = {1 1},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "48631932", "name": "Xiao-Song
      Wang"}, {"authorId": "39560950", "name": "Sunita Shankar"}, {"authorId": "3113892",
      "name": "S. Dhanasekaran"}, {"authorId": "3913657", "name": "Bushra Ateeq"},
      {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId": "49737962", "name":
      "Xiaojun Jing"}, {"authorId": "48706636", "name": "Daniel H. Robinson"}, {"authorId":
      "144457382", "name": "Q. Cao"}, {"authorId": "5608756", "name": "John R. Prensner"},
      {"authorId": "4221039", "name": "Anastasia K. Yocum"}, {"authorId": "2037452760",
      "name": "Rui Wang"}, {"authorId": "145571865", "name": "Daniel F. Fries"}, {"authorId":
      "144202024", "name": "B. Han"}, {"authorId": "6382794", "name": "I. Asangani"},
      {"authorId": "2259620692", "name": "Xuhong Cao"}, {"authorId": "2154403330",
      "name": "Yong Li"}, {"authorId": "2716422", "name": "G. Omenn"}, {"authorId":
      "5715823", "name": "D. Pflueger"}, {"authorId": "4059774", "name": "A. Gopalan"},
      {"authorId": "30582790", "name": "V. Reuter"}, {"authorId": "4049626", "name":
      "E. Kahoud"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144014266",
      "name": "M. Rubin"}, {"authorId": "145158003", "name": "N. Palanisamy"}, {"authorId":
      "6088770", "name": "S. Varambally"}, {"authorId": "2186786", "name": "A. Chinnaiyan"}]},
      {"paperId": "246c0c64a06578efbcf0b93ea31d4608139aa728", "externalIds": {"CorpusId":
      10781664}, "corpusId": 10781664, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/246c0c64a06578efbcf0b93ea31d4608139aa728",
      "title": "Integrated Systems and Technologies Using Tandem Mass Spectrometry
      in Targeted Mode to Identify Activators of Class IA PI 3 K in Cancer", "abstract":
      "Phosphatiditylinositide-3-kinase (PI3K) is activated in some cancers by direct
      mutation, but it is activated more commonly in cancer by mutation of upstream
      acting receptor tyrosine kinases (TK). At present, there is no systematic method
      to determine which TK signaling cascades activate PI3K in certain cancers, despite
      the likely utility of such information to help guide selectionof tyrosine kinase
      inhibitor (TKI) drug strategies for personalized therapy. Here, we present a
      quantitative liquid chromatography tandem mass spectrometry approach that identifies
      upstream activators of PI3K both in vitro and in vivo. Using non\u2013small
      cell lung carcinoma to illustrate this approach, we show a correct identification
      of the mechanism of PI3K activation in several models, thereby identifying the
      most appropriate TKI to downregulate PI3K signaling. This approach also determined
      the molecular mechanisms and adaptors required for PI3K activation following
      inhibition of the mTOR kinase TORC1. We further validated the approach in breast
      cancer cells with mutational activation of PIK3CA, where tandem mass spectrometry
      detected and quantitatively measured the abundance of a helical domain mutant
      (E545K) of PIK3CA connected to PI3K activation. Overall, our findings establish
      amass spectrometric approach to identify functional interactions that govern
      PI3K regulation in cancer cells. Using this technique to define the pathways
      that activate PI3K signaling in a given tumor could help inform clinical decision
      making by helping guide personalized therapeutic strategies for different patients.
      Cancer Res; 71(18); 5965\u201375. 2011 AACR.", "venue": "", "year": 2011, "referenceCount":
      51, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Inproceedings{Yang2011IntegratedSA,\n author = {Xuemei Yang and
      Alexa B. Turke and J. Qi and Youngchul Song and B. Rexer and T. Miller and J.
      PasiA. and Anne and C. Arteaga and L. Cantley and J. Engelman and J. Asara},\n
      title = {Integrated Systems and Technologies Using Tandem Mass Spectrometry
      in Targeted Mode to Identify Activators of Class IA PI 3 K in Cancer},\n year
      = {2011}\n}\n"}, "authors": [{"authorId": "48520140", "name": "Xuemei Yang"},
      {"authorId": "4039016", "name": "Alexa B. Turke"}, {"authorId": "46315599",
      "name": "J. Qi"}, {"authorId": "4846062", "name": "Youngchul Song"}, {"authorId":
      "5162072", "name": "B. Rexer"}, {"authorId": "34988079", "name": "T. Miller"},
      {"authorId": "81090960", "name": "J. PasiA."}, {"authorId": "2067373625", "name":
      "Anne"}, {"authorId": "2057460", "name": "C. Arteaga"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "6828387", "name": "J. Engelman"}, {"authorId":
      "3028470", "name": "J. Asara"}]}, {"paperId": "25c52aa0b060b367f88974e987d36e91a0838d78",
      "externalIds": {"MAG": "2156791826", "DOI": "10.1016/j.cell.2011.06.050", "CorpusId":
      13893849, "PubMed": "21854985"}, "corpusId": 13893849, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/25c52aa0b060b367f88974e987d36e91a0838d78",
      "title": "Metabolic Regulation of Protein N-Alpha-Acetylation by Bcl-xL Promotes
      Cell Survival", "abstract": null, "venue": "Cell", "year": 2011, "referenceCount":
      48, "citationCount": 208, "influentialCitationCount": 8, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0092867411007665/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2011-08-01", "journal":
      {"volume": "146", "pages": "607-620", "name": "Cell"}, "citationStyles": {"bibtex":
      "@Article{Yi2011MetabolicRO,\n author = {C. Yi and Heling Pan and J. Seebacher
      and I. Jang and S. Hyberts and G. Heffron and M. V. Heiden and Renliang Yang
      and Fupeng Li and J. Locasale and H. Sharfi and B. Zhai and R. Rodr\u00edguez-Mias
      and H. Luithardt and L. Cantley and G. Daley and J. Asara and S. Gygi and G.
      Wagner and Chuan-fa Liu and Junying Yuan},\n booktitle = {Cell},\n journal =
      {Cell},\n pages = {607-620},\n title = {Metabolic Regulation of Protein N-Alpha-Acetylation
      by Bcl-xL Promotes Cell Survival},\n volume = {146},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "2906327", "name": "C. Yi"}, {"authorId": "4811754",
      "name": "Heling Pan"}, {"authorId": "49911202", "name": "J. Seebacher"}, {"authorId":
      "4629932", "name": "I. Jang"}, {"authorId": "1891857", "name": "S. Hyberts"},
      {"authorId": "6886706", "name": "G. Heffron"}, {"authorId": "35413264", "name":
      "M. V. Heiden"}, {"authorId": "8092839", "name": "Renliang Yang"}, {"authorId":
      "49515730", "name": "Fupeng Li"}, {"authorId": "2268976", "name": "J. Locasale"},
      {"authorId": "4536882", "name": "H. Sharfi"}, {"authorId": "1859720", "name":
      "B. Zhai"}, {"authorId": "1398695904", "name": "R. Rodr\u00edguez-Mias"}, {"authorId":
      "5619108", "name": "H. Luithardt"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2028224", "name": "G. Daley"}, {"authorId": "3028470", "name":
      "J. Asara"}, {"authorId": "2665934", "name": "S. Gygi"}, {"authorId": "145241228",
      "name": "G. Wagner"}, {"authorId": "11157072", "name": "Chuan-fa Liu"}, {"authorId":
      "40146895", "name": "Junying Yuan"}]}, {"paperId": "3141ba16b8c5e721203a093cb2ea31360f584fb5",
      "externalIds": {"MAG": "2167264978", "DOI": "10.1158/2159-8290.CD-11-0039",
      "CorpusId": 27275016, "PubMed": "21984976"}, "corpusId": 27275016, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/3141ba16b8c5e721203a093cb2ea31360f584fb5",
      "title": "High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer
      elucidates a novel mechanism for regulation of PTEN protein stability.", "abstract":
      "We demonstrate that phosphatidylinositol 3-kinase (PI3K) pathway aberrations
      occur in >80% of endometrioid endometrial cancers, with coordinate mutations
      of multiple PI3K pathway members being more common than predicted by chance.
      PIK3R1 (p85\u03b1) mutations occur at a higher rate in endometrial cancer than
      in any other tumor lineage, and PIK3R2 (p85\u03b2), not previously demonstrated
      to be a cancer gene, is also frequently mutated. The dominant activation event
      in the PI3K pathway appears to be PTEN protein loss. However, in tumors with
      retained PTEN protein, PI3K pathway mutations phenocopy PTEN loss, resulting
      in pathway activation. KRAS mutations are common in endometrioid tumors activating
      independent events from PI3K pathway aberrations. Multiple PIK3R1 and PIK3R2
      mutations demonstrate gain of function, including disruption of a novel mechanism
      of pathway regulation wherein p85\u03b1 dimers bind and stabilize PTEN. Taken
      together, the PI3K pathway represents a critical driver of endometrial cancer
      pathogenesis and a novel therapeutic target.", "venue": "Cancer Discovery",
      "year": 2011, "referenceCount": 61, "citationCount": 429, "influentialCitationCount":
      22, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cancerdiscovery/article-pdf/1/2/170/3040420/170.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-07-01", "journal": {"volume": "1 2", "pages": "\n          170-85\n        ",
      "name": "Cancer discovery"}, "citationStyles": {"bibtex": "@Article{Cheung2011HighFO,\n
      author = {L. W. Cheung and B. Hennessy and Jie Li and Shuangxing Yu and A. Myers
      and B. Djordjevic and Yiling Lu and K. Stemke\u2010Hale and Mary D. Dyer and
      Fan Zhang and Z. Ju and L. Cantley and S. Scherer and Han Liang and K. Lu and
      R. Broaddus and G. Mills},\n booktitle = {Cancer Discovery},\n journal = {Cancer
      discovery},\n pages = {\n          170-85\n        },\n title = {High frequency
      of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism
      for regulation of PTEN protein stability.},\n volume = {1 2},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "50005741", "name": "L. W. Cheung"}, {"authorId": "2030236",
      "name": "B. Hennessy"}, {"authorId": "2149869719", "name": "Jie Li"}, {"authorId":
      "5875584", "name": "Shuangxing Yu"}, {"authorId": "6324437", "name": "A. Myers"},
      {"authorId": "120452446", "name": "B. Djordjevic"}, {"authorId": "144004727",
      "name": "Yiling Lu"}, {"authorId": "1399421060", "name": "K. Stemke\u2010Hale"},
      {"authorId": "32111150", "name": "Mary D. Dyer"}, {"authorId": "2153304992",
      "name": "Fan Zhang"}, {"authorId": "152983291", "name": "Z. Ju"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "6757042", "name": "S. Scherer"},
      {"authorId": "67149842", "name": "Han Liang"}, {"authorId": "2246960153", "name":
      "K. Lu"}, {"authorId": "6416382", "name": "R. Broaddus"}, {"authorId": "2241330",
      "name": "G. Mills"}]}, {"paperId": "320d7c4c80330560c8268088c72203bc20190def",
      "externalIds": {"CorpusId": 55834815}, "corpusId": 55834815, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/320d7c4c80330560c8268088c72203bc20190def",
      "title": "The PI3K regulatory subunit p85\u03b1 can exert tumor suppressor properties
      through negative regulation of growth factor signalling", "abstract": "PI3K
      plays a critical role in tumorigenesis and the PI3K p85 regulatory subunit exerts
      both positive and negative effects on signaling. Expression of Pik3r1, the gene
      encoding p85, is decreased in human prostate, lung, ovarian, bladder and liver
      cancers consistent with the possibility that p85 has tumor suppressor properties.
      We tested this hypothesis by studying mice with a liver-specific deletion of
      the Pik3r1 gene. These mice exhibited enhanced insulin and growth factor signaling
      and progressive changes in hepatic pathology, leading to the development of
      aggressive hepatocellular carcinomas with pulmonary metastases. Liver tumors
      that arose exhibited a markedly elevated level of phosphatidylinositol-3,4,5-trisphosphate
      (PIP3), along with Akt activation and and decreased PTEN expression, at both
      the mRNA and protein levels. Together, these results substantiate the concept
      that the p85 subunit of PI3K has a tumor suppressive role in the liver and possibly
      other tissues.", "venue": "", "year": 2011, "referenceCount": 49, "citationCount":
      3, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": null, "citationStyles": {"bibtex":
      "@Inproceedings{Taniguchi2011ThePR,\n author = {C. Taniguchi and J. Winnay and
      Tatsuya Kondo and R. Bronson and A. Guimaraes and J. Alem\u00e1n and Ji Luo
      and G. Stephanopoulos and Ralph and Weissleder and L. Cantley and C. Kahn},\n
      title = {The PI3K regulatory subunit p85\u03b1 can exert tumor suppressor properties
      through negative regulation of growth factor signalling},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "48311527", "name": "C. Taniguchi"}, {"authorId": "3687146",
      "name": "J. Winnay"}, {"authorId": "16114256", "name": "Tatsuya Kondo"}, {"authorId":
      "40803408", "name": "R. Bronson"}, {"authorId": "145030722", "name": "A. Guimaraes"},
      {"authorId": "47567005", "name": "J. Alem\u00e1n"}, {"authorId": "145954100",
      "name": "Ji Luo"}, {"authorId": "1813278", "name": "G. Stephanopoulos"}, {"authorId":
      "91376400", "name": "Ralph"}, {"authorId": "30005093", "name": "Weissleder"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144391716", "name":
      "C. Kahn"}]}, {"paperId": "33c6b78a39b9d30bbb2dfec8bc03ab5b9f783e66", "externalIds":
      {"MAG": "2118390564", "DOI": "10.1158/2159-8274.CD-11-0049", "CorpusId": 34620184,
      "PubMed": "22586302"}, "corpusId": 34620184, "publicationVenue": {"id": "de16002a-77c3-4d03-9348-5a1813238e0b",
      "name": "Cancer Discovery", "type": "journal", "alternate_names": ["Cancer Discov"],
      "issn": "2159-8274", "url": "https://cancerdiscovery.aacrjournals.org/"}, "url":
      "https://www.semanticscholar.org/paper/33c6b78a39b9d30bbb2dfec8bc03ab5b9f783e66",
      "title": "The era of cancer discovery.", "abstract": "Realization of the need
      for a forum that would bring basic and translational scientists and clinical
      trials specialists together inspired the launch of Cancer Discovery .\n\nA growing
      optimism that cancer research and treatment are entering a new era is taking
      hold. Since the late 1950s, when the first real cancer cures were achieved with
      combination therapies, progress in treating cancers has been painfully slow,
      and with a few notable exceptions, breakthroughs came from empirical observations
      in the clinic rather than from detailed understanding of the disease. We did
      not understand why certain therapies were successful in some subsets of cancers
      and failures in others. Most cancer drugs were being developed on the basis
      of their ability to kill cancer cells grown on plastic or in nude mice, with
      no real understanding of the mechanism of drug action. It is therefore not surprising
      that the majority of these investigational drugs ultimately failed when tested
      in large and expensive randomized trials, and those that did succeed typically
      extended lives by only a few months. In 1996, the 25th anniversary of the declaration
      of war on cancer, it was difficult to point to a single breakthrough in treatment
      that emerged from the tens of billions of dollars that had been spent on basic
      and clinical research.\n\nNevertheless, we learned a lot during those first
      25 years. We discovered that cancer was, for the most part, caused by mutations
      in genes (oncogenes) that control cell proliferation, cell growth, cell survival,
      and cell differentiation. Importantly, we discovered that the types of cancers
      that had been historically defined based on tissue of origin and classical techniques
      of pathology could be further divided into dozens of subtypes when analyzed
      at the molecular level. This knowledge began to explain why 2 patients with
      the same disease diagnosis \u2026", "venue": "Cancer Discovery", "year": 2011,
      "referenceCount": 0, "citationCount": 14, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://cancerdiscovery.aacrjournals.org/content/1/1/1.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["Editorial"], "publicationDate": "2011-06-01", "journal": {"volume": "1 1",
      "pages": "\n          1\n        ", "name": "Cancer discovery"}, "citationStyles":
      {"bibtex": "@Article{Cantley2011TheEO,\n author = {L. Cantley and J. Baselga},\n
      booktitle = {Cancer Discovery},\n journal = {Cancer discovery},\n pages = {\n          1\n        },\n
      title = {The era of cancer discovery.},\n volume = {1 1},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144806171",
      "name": "J. Baselga"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '292552'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:41 GMT
      Via:
      - 1.1 b32b674425bc91de1120f0cc3dff96dc.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - RZr5TBYvjWq16qyUi6YENzns2q5AH-Hk1913Et_LD1cdIlVOTM552Q==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0yLGk_PHcEVqA=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '292552'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:41 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - 4b1fa134-bcf7-4c90-9b0d-667835d4debb
    http_version: HTTP/1.1
    status_code: 200
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=400&limit=100
  response:
    content: '{"offset": 400, "next": 500, "data": [{"paperId": "36c1bdaaa9b1ab8156e47ee3cc3f1a5bda2832ee",
      "externalIds": {"MAG": "2135107959", "DOI": "10.1073/pnas.1107747108", "CorpusId":
      10121505, "PubMed": "21825134"}, "corpusId": 10121505, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/36c1bdaaa9b1ab8156e47ee3cc3f1a5bda2832ee",
      "title": "Inhibition of PI3K binding to activators by serine phosphorylation
      of PI3K regulatory subunit p85\u03b1 Src homology-2 domains", "abstract": "Class
      IA PI3Ks are activated by growth factor receptors and generate lipid second
      messengers that mediate downstream responses including cell growth, cell migration,
      and cell survival. The p85 regulatory subunit of PI3K contains Src homology-2
      (SH2) domains that mediate binding to tyrosine-phosphorylated receptors or adaptor
      proteins to facilitate localization and activation of PI3K at the plasma membrane.
      We report here that persistent activation of PKC family members by phorbol ester
      stimulation in cells leads to phosphorylation of two serine residues at analogous
      sites on both SH2 domains of p85\u03b1 (S361 and S652). The modified serine
      residues are located in the phospho-tyrosine binding pockets of the two SH2
      domains, and in the crystal structures the phosphate moieties are predicted
      to occupy the same space as the phosphate moieties of bound phospho-tyrosine
      peptides. Consistent with this prediction, phosphorylation at these serine residues
      or mutation to aspartate inhibits binding of p85\u03b1 to tyrosine-phosphorylated
      peptides. We provide evidence that protein kinase D, which is phosphorylated
      and activated by PKCs, mediates phosphorylation of S652 in the C-terminal SH2
      domain. These results reveal cross talk between PKC signaling and PI3K signaling
      that impairs PI3K pathway activation under conditions of persistent PKC (and
      protein kinase D) activity.", "venue": "Proceedings of the National Academy
      of Sciences of the United States of America", "year": 2011, "referenceCount":
      33, "citationCount": 77, "influentialCitationCount": 5, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/108/34/14157.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-08-08", "journal": {"volume": "108", "pages": "14157
      - 14162", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Lee2011InhibitionOP,\n author = {Jennifer Y. Lee and Y.
      Chiu and J. Asara and L. Cantley},\n booktitle = {Proceedings of the National
      Academy of Sciences of the United States of America},\n journal = {Proceedings
      of the National Academy of Sciences},\n pages = {14157 - 14162},\n title = {Inhibition
      of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit
      p85\u03b1 Src homology-2 domains},\n volume = {108},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "46663676", "name": "Jennifer Y. Lee"}, {"authorId":
      "47591147", "name": "Y. Chiu"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "41ba6b3fecec61f9a8b047cbe2bf0bf11c804341",
      "externalIds": {"MAG": "2011554530", "DOI": "10.1016/j.cub.2010.12.047", "CorpusId":
      17171239, "PubMed": "21256021"}, "corpusId": 17171239, "publicationVenue": {"id":
      "9469269e-53d7-4955-b1a5-17a75bee7634", "name": "Current Biology", "type": "journal",
      "alternate_names": ["Curr Biology"], "issn": "0960-9822", "url": "http://www.current-biology.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/09609822"]},
      "url": "https://www.semanticscholar.org/paper/41ba6b3fecec61f9a8b047cbe2bf0bf11c804341",
      "title": "Cell-to-Cell Variability in PI3K Protein Level Regulates PI3K-AKT
      Pathway Activity in Cell Populations", "abstract": null, "venue": "Current Biology",
      "year": 2011, "referenceCount": 41, "citationCount": 101, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S096098221001715X/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2011-02-08", "journal": {"volume": "21",
      "pages": "173-183", "name": "Current Biology"}, "citationStyles": {"bibtex":
      "@Article{Yuan2011CelltoCellVI,\n author = {T. Yuan and G. Wulf and Laura N.
      Burga and L. Cantley},\n booktitle = {Current Biology},\n journal = {Current
      Biology},\n pages = {173-183},\n title = {Cell-to-Cell Variability in PI3K Protein
      Level Regulates PI3K-AKT Pathway Activity in Cell Populations},\n volume = {21},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "40062987", "name": "T. Yuan"},
      {"authorId": "31554501", "name": "G. Wulf"}, {"authorId": "48793812", "name":
      "Laura N. Burga"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "4a3b6f39f42c720cf78b9d8cb03cb3d17b2b5714", "externalIds": {"MAG": "2810507926",
      "DOI": "10.3410/F.13411025.14782148", "CorpusId": 81829129}, "corpusId": 81829129,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/4a3b6f39f42c720cf78b9d8cb03cb3d17b2b5714",
      "title": "Faculty Opinions recommendation of HIF-1 mediates the Warburg effect
      in clear cell renal carcinoma.", "abstract": null, "venue": "", "year": 2011,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2011-12-19", "journal": {"volume": "", "name": ""},
      "citationStyles": {"bibtex": "@Inproceedings{Cantley2011FacultyOR,\n author
      = {L. Cantley},\n title = {Faculty Opinions recommendation of HIF-1 mediates
      the Warburg effect in clear cell renal carcinoma.},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "5bd292075da0ce7f5a51a26ffb11310ed0cc79fc",
      "externalIds": {"MAG": "2138383559", "DOI": "10.1126/scisignal.2001518", "CorpusId":
      13827655, "PubMed": "21386094"}, "corpusId": 13827655, "publicationVenue": {"id":
      "c0efe552-8a0a-41a7-8ce2-340fb0dbfe6f", "name": "Science Signaling", "type":
      "journal", "alternate_names": ["Sci Signal"], "issn": "1945-0877", "url": "https://www.sciencemag.org/",
      "alternate_urls": ["https://stke.sciencemag.org/about/", "https://stke.sciencemag.org/"]},
      "url": "https://www.semanticscholar.org/paper/5bd292075da0ce7f5a51a26ffb11310ed0cc79fc",
      "title": "Ubiquitination of K-Ras Enhances Activation and Facilitates Binding
      to Select Downstream Effectors", "abstract": "Cancers in which K-Ras activation
      drives tumor growth could be targeted by treatments blocking K-Ras ubiquitination.
      Ubiquitination for Activity Mutational activation of the guanosine triphosphatase
      (GTPase) Ras occurs frequently in various cancers. Although the three mammalian
      isoforms\u2014N-Ras, H-Ras, and K-Ras\u2014couple to the same set of downstream
      signaling pathways, mutations in each isoform are associated with different
      types of cancers. In contrast to previous work showing that ubiquitination of
      N-Ras and H-Ras restricts their activity, Sasaki et al. found that monoubiquitination
      of Lys147 in K-Ras increased its activity and its ability to bind to downstream
      effector proteins. Cells expressing the oncogenic G12V mutant of Ras form tumors
      when injected into mice; however, cells expressing G12V Ras with an additional
      mutation abolishing ubiquitination of Lys147 formed smaller tumors in mice.
      Thus, cancers in which K-Ras activation drives tumor growth and survival could
      be targeted by treatments blocking K-Ras ubiquitination. The accompanying Perspective
      by Pfleger provides context on the distinct effects of ubiquitination on the
      abundance, activity, and access to effectors of different Ras isoforms. The
      guanosine triphosphate (GTP)\u2013loaded form of the guanosine triphosphatase
      (GTPase) Ras initiates multiple signaling pathways by binding to various effectors,
      such as the kinase Raf and phosphatidylinositol 3-kinase (PI3K). Ras activity
      is increased by guanine nucleotide exchange factors that stimulate guanosine
      diphosphate release and GTP loading and is inhibited by GTPase-activating proteins
      that stimulate GTP hydrolysis. KRAS is the most frequently mutated RAS gene
      in cancer. Here, we report that monoubiquitination of lysine-147 in the guanine
      nucleotide\u2013binding motif of wild-type K-Ras could lead to enhanced GTP
      loading. Furthermore, ubiquitination increased the binding of the oncogenic
      Gly12Val mutant of K-Ras to the downstream effectors PI3K and Raf. Thus, monoubiquitination
      could enhance GTP loading on K-Ras and increase its affinity for specific downstream
      effectors, providing a previously unidentified mechanism for Ras activation.",
      "venue": "Science Signaling", "year": 2011, "referenceCount": 36, "citationCount":
      166, "influentialCitationCount": 12, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc3437993?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2011-03-08", "journal":
      {"volume": "4", "pages": "ra13 - ra13", "name": "Science Signaling"}, "citationStyles":
      {"bibtex": "@Article{Sasaki2011UbiquitinationOK,\n author = {A. Sasaki and A.
      Carracedo and J. Locasale and D. Anastasiou and K. Takeuchi and E. Kahoud and
      Sasson Haviv and J. Asara and P. Pandolfi and L. Cantley},\n booktitle = {Science
      Signaling},\n journal = {Science Signaling},\n pages = {ra13 - ra13},\n title
      = {Ubiquitination of K-Ras Enhances Activation and Facilitates Binding to Select
      Downstream Effectors},\n volume = {4},\n year = {2011}\n}\n"}, "authors": [{"authorId":
      "47742211", "name": "A. Sasaki"}, {"authorId": "6988610", "name": "A. Carracedo"},
      {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "46996935", "name":
      "D. Anastasiou"}, {"authorId": "2775065", "name": "K. Takeuchi"}, {"authorId":
      "4049626", "name": "E. Kahoud"}, {"authorId": "13971664", "name": "Sasson Haviv"},
      {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "4499580", "name":
      "P. Pandolfi"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "5e664f9c1ccd6e484bc5881ff5fd3a77e65ea040", "externalIds": {"MAG": "2517306124",
      "CorpusId": 184894453}, "corpusId": 184894453, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/5e664f9c1ccd6e484bc5881ff5fd3a77e65ea040",
      "title": "Table 5, SAR of selected tetrahydroquinoline-sulfonamides", "abstract":
      null, "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2011-03-03", "journal": null,
      "citationStyles": {"bibtex": "@Inproceedings{Boxer2011Table5S,\n author = {M.
      Boxer and Jian-Kang Jiang and M. V. Heiden and M. Shen and H. Veith and L. Cantley
      and Craig J. Thomas},\n title = {Table 5, SAR of selected tetrahydroquinoline-sulfonamides},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "3275486", "name": "M. Boxer"},
      {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}]}, {"paperId": "60366e4b5a285d162ac697b0412664b542625635",
      "externalIds": {"MAG": "2094399892", "DOI": "10.1126/science.1199484", "CorpusId":
      30224632, "PubMed": "21659605"}, "corpusId": 30224632, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/60366e4b5a285d162ac697b0412664b542625635",
      "title": "Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate
      That Negatively Regulates Insulin Signaling", "abstract": "A search for substrates
      of a growth-promoting kinase revealed a regulatory feedback loop involved in
      tumor suppression. The evolutionarily conserved serine-threonine kinase mammalian
      target of rapamycin (mTOR) plays a critical role in regulating many pathophysiological
      processes. Functional characterization of the mTOR signaling pathways, however,
      has been hampered by the paucity of known substrates. We used large-scale quantitative
      phosphoproteomics experiments to define the signaling networks downstream of
      mTORC1 and mTORC2. Characterization of one mTORC1 substrate, the growth factor
      receptor\u2013bound protein 10 (Grb10), showed that mTORC1-mediated phosphorylation
      stabilized Grb10, leading to feedback inhibition of the phosphatidylinositol
      3-kinase (PI3K) and extracellular signal\u2013regulated, mitogen-activated protein
      kinase (ERK-MAPK) pathways. Grb10 expression is frequently down-regulated in
      various cancers, and loss of Grb10 and loss of the well-established tumor suppressor
      phosphatase PTEN appear to be mutually exclusive events, suggesting that Grb10
      might be a tumor suppressor regulated by mTORC1.", "venue": "Science", "year":
      2011, "referenceCount": 17, "citationCount": 756, "influentialCitationCount":
      39, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3195509?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-06-10", "journal": {"volume": "332", "pages": "1322
      - 1326", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Yu2011PhosphoproteomicAI,\n
      author = {Yonghao Yu and Sang-Oh Yoon and G. Poulogiannis and Qian Yang and
      X. Ma and J. Ville\u0301n and Neil Kubica and G. Hoffman and L. Cantley and
      S. Gygi and J. Blenis},\n booktitle = {Science},\n journal = {Science},\n pages
      = {1322 - 1326},\n title = {Phosphoproteomic Analysis Identifies Grb10 as an
      mTORC1 Substrate That Negatively Regulates Insulin Signaling},\n volume = {332},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "40508577", "name": "Yonghao
      Yu"}, {"authorId": "6168327", "name": "Sang-Oh Yoon"}, {"authorId": "4612853",
      "name": "G. Poulogiannis"}, {"authorId": "144785850", "name": "Qian Yang"},
      {"authorId": "50088305", "name": "X. Ma"}, {"authorId": "1705488", "name": "J.
      Ville\u0301n"}, {"authorId": "8429203", "name": "Neil Kubica"}, {"authorId":
      "34846304", "name": "G. Hoffman"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2665934", "name": "S. Gygi"}, {"authorId": "4037343", "name":
      "J. Blenis"}]}, {"paperId": "6525943ff6dcba1547fa65929b1b3f002c86e310", "externalIds":
      {"MAG": "2339444939", "DOI": "10.1158/1538-7445.AM2011-LB-247", "CorpusId":
      87778108}, "corpusId": 87778108, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/6525943ff6dcba1547fa65929b1b3f002c86e310",
      "title": "Mutation and functional analysis of PIK3CA and PIK3R1 in endometrial
      cancer", "abstract": "The phosphatidylinositol 3 kinase (PI3K) pathway is the
      most frequently activated pathway across multiple tumor lineages and this is
      a potential therapeutic target. As a critical step to accelerate therapeutic
      development in endometrial cancer, we performed a comprehensive analysis of
      mutation and function of PI3K pathway members in a set of 243 highly characterized
      endometrial tumors. Whole gene resequencing revealed the highest frequencies
      of mutation in the PI3K pathway of any tumor lineage including PTEN (44%), PIK3CA
      (40%; encoding the p110\u03b1 catalytic subunit of PI3K) and PIK3R1 (20%; encoding
      the p85a regulatory subunit). Indeed, when complete protein loss is considered,
      almost 80% of endometrioid endometrial cancers demonstrate an aberration in
      the PI3K pathway. Remarkably, mutations in the PI3K pathway were not mutually
      exclusive and indeed co-existence of PIK3CA or PIK3R1 mutation with heterozygous
      PTEN mutation occurred at frequencies higher than predicted by the frequency
      of each lesion alone. High-throughput reverse-phase protein array suggested
      that the dominant signaling effects occurred with PTEN protein loss and that
      PIK3CA or PIK3R1 mutation functionally mimic PTEN protein loss as indicated
      by protein markers including phosphorylated Akt and stathmin. Thus it appears
      likely that co-mutations in the PI3K pathway are selected to compensate haploinsufficiency
      of PTEN due to PTEN heterozygous mutation. To determine the functional consequences
      of mutations in PIK3R1, we demonstrated that several somatic PIK3R1 mutations
      tested conferred cytokine-independent growth on interleukin-3-dependent Ba/F3
      cells and induced Akt phosphorylation in endometrial cancer cell lines indicating
      that they were gain of function mutations likely acting as oncogenes. Strikingly
      two of the gain of function mutations (E160* and R348*) lacked the ability to
      bind to the p110 catalytic subunit and E160* failed to bind to both p110 and
      PTEN. We demonstrate that E160* disrupts a novel mechanism of pathway regulation
      wherein p85 binds and stabilizes PTEN. Together, the data indicate that the
      PI3K pathway is targeted in the vast majority of endometrioid endometrial cancers
      representing a novel opportunity for implementation of targeted therapy. Citation
      Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd
      Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6;
      Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr
      LB-247. doi:10.1158/1538-7445.AM2011-LB-247", "venue": "", "year": 2011, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2011-04-15", "journal": {"volume":
      "71", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Cheung2011MutationAF,\n
      author = {L. W. Cheung and B. Hennessy and Jie Li and Shuangxing Yu and A. Myers
      and B. Djordjevic and Yiling Lu and K. Stemke\u2010Hale and Fan Zhang and Z.
      Ju and L. Cantley and S. Scherer and Han Liang and K. Lu and Broaddus R. Russell
      and G. Mills},\n journal = {Cancer Research},\n title = {Mutation and functional
      analysis of PIK3CA and PIK3R1 in endometrial cancer},\n volume = {71},\n year
      = {2011}\n}\n"}, "authors": [{"authorId": "50005741", "name": "L. W. Cheung"},
      {"authorId": "2030236", "name": "B. Hennessy"}, {"authorId": "2149869719", "name":
      "Jie Li"}, {"authorId": "5875584", "name": "Shuangxing Yu"}, {"authorId": "6324437",
      "name": "A. Myers"}, {"authorId": "120452446", "name": "B. Djordjevic"}, {"authorId":
      "144004727", "name": "Yiling Lu"}, {"authorId": "1399421060", "name": "K. Stemke\u2010Hale"},
      {"authorId": "2153304992", "name": "Fan Zhang"}, {"authorId": "152983291", "name":
      "Z. Ju"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6757042",
      "name": "S. Scherer"}, {"authorId": "67149842", "name": "Han Liang"}, {"authorId":
      "2246960153", "name": "K. Lu"}, {"authorId": "152788293", "name": "Broaddus
      R. Russell"}, {"authorId": "2241330", "name": "G. Mills"}]}, {"paperId": "67ea0e4011c6558644aa076882f0b89b5fdd5325",
      "externalIds": {"MAG": "2004329237", "DOI": "10.1158/2159-8290.CD-11-0061",
      "CorpusId": 8952786, "PubMed": "22116793"}, "corpusId": 8952786, "publicationVenue":
      {"id": "de16002a-77c3-4d03-9348-5a1813238e0b", "name": "Cancer Discovery", "type":
      "journal", "alternate_names": ["Cancer Discov"], "issn": "2159-8274", "url":
      "https://cancerdiscovery.aacrjournals.org/"}, "url": "https://www.semanticscholar.org/paper/67ea0e4011c6558644aa076882f0b89b5fdd5325",
      "title": "The APL paradigm and the \"co-clinical trial\" project.", "abstract":
      "Tremendous advances in technologies have allowed the attainment of powerful
      insights into the molecular and genetic determinants that drive human cancers.
      However, this acquired knowledge has been translated into effective therapeutics
      very slowly, in part due to difficulty in predicting which drug or drug combination
      is likely to be effective in the complex mutational background of human cancers.
      To address this difficulty we have proposed and initiated the \"co-clinical
      trial\" project, in which we exploit mouse models that faithfully replicate
      the variety of mutational events observed in human cancers, to conduct preclinical
      trials that parallel ongoing human phase I/II clinical trials. Here, we focus
      on concepts relevant to the application of this novel paradigm and the essential
      components required for its implementation to ultimately achieve the rational
      and rapid development of new therapeutic treatments.", "venue": "Cancer Discovery",
      "year": 2011, "referenceCount": 29, "citationCount": 125, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cancerdiscovery/article-pdf/1/2/108/1712038/108.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": "2011-07-01", "journal": {"volume": "1
      2", "pages": "\n          108-16\n        ", "name": "Cancer discovery"}, "citationStyles":
      {"bibtex": "@Article{Nardella2011TheAP,\n author = {C. Nardella and A. Lunardi
      and Akash Patnaik and L. Cantley and P. Pandolfi},\n booktitle = {Cancer Discovery},\n
      journal = {Cancer discovery},\n pages = {\n          108-16\n        },\n title
      = {The APL paradigm and the \"co-clinical trial\" project.},\n volume = {1 2},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "3547827", "name": "C. Nardella"},
      {"authorId": "5729169", "name": "A. Lunardi"}, {"authorId": "40501341", "name":
      "Akash Patnaik"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4499580", "name": "P. Pandolfi"}]}, {"paperId": "6b2ffc9cbee8d421836061642643d9f1ccc676ff",
      "externalIds": {"MAG": "2116201681", "DOI": "10.1101/sqb.2012.76.010900", "CorpusId":
      27702757, "PubMed": "22262476"}, "corpusId": 27702757, "publicationVenue": {"id":
      "e24353f5-13a9-4d82-8e33-329cd22634a0", "name": "Cold Spring Harbor Symposia
      on Quantitative Biology", "type": "journal", "alternate_names": ["Cold Spring
      Harb Symp Quant Biology"], "issn": "0091-7451", "url": "https://www.cshlpress.com/",
      "alternate_urls": ["http://symposium.cshlp.org/content/by/year", "http://symposium.cshlp.org/",
      "http://symposium.cshlp.org/site/misc/index_archive.xhtml"]}, "url": "https://www.semanticscholar.org/paper/6b2ffc9cbee8d421836061642643d9f1ccc676ff",
      "title": "Metabolic pathway alterations that support cell proliferation.", "abstract":
      "Proliferating cells adapt metabolism to support the conversion of available
      nutrients into biomass. How cell metabolism is regulated to balance the production
      of ATP, metabolite building blocks, and reducing equivalents remains uncertain.
      Proliferative metabolism often involves an increased rate of glycolysis. A key
      regulated step in glycolysis is catalyzed by pyruvate kinase to convert phosphoenolpyruvate
      (PEP) to pyruvate. Surprisingly, there is strong selection for expression of
      the less active M2 isoform of pyruvate kinase (PKM2) in tumors and other proliferative
      tissues. Cell growth signals further decrease PKM2 activity, and cells with
      less active PKM2 use another pathway with separate regulatory properties to
      convert PEP to pyruvate. One consequence of using this alternative pathway is
      an accumulation of 3-phosphoglycerate (3PG) that leads to the diversion of 3PG
      into the serine biosynthesis pathway. In fact, in some cancers a substantial
      portion of the total glucose flux is directed toward serine synthesis, and genetic
      evidence suggests that glucose flux into this pathway can promote cell transformation.
      Environmental conditions can also influence the pathways that cells use to generate
      biomass with the source of carbon for lipid synthesis changing based on oxygen
      availability. Together, these findings argue that distinct metabolic phenotypes
      exist among proliferating cells, and both genetic and environmental factors
      influence how metabolism is regulated to support cell growth.", "venue": "Cold
      Spring Harbor Symposia on Quantitative Biology", "year": 2011, "referenceCount":
      43, "citationCount": 275, "influentialCitationCount": 8, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://symposium.cshlp.org/content/76/325.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": null, "journal": {"volume": "76", "pages": "\n          325-34\n        ",
      "name": "Cold Spring Harbor symposia on quantitative biology"}, "citationStyles":
      {"bibtex": "@Article{Heiden2011MetabolicPA,\n author = {M. V. Heiden and S.
      Lunt and T. Dayton and B. Fiske and William J. Israelsen and Katherine R. Mattaini
      and Natalie I. Vokes and G. Stephanopoulos and L. Cantley and Christian M. Metallo
      and J. Locasale},\n booktitle = {Cold Spring Harbor Symposia on Quantitative
      Biology},\n journal = {Cold Spring Harbor symposia on quantitative biology},\n
      pages = {\n          325-34\n        },\n title = {Metabolic pathway alterations
      that support cell proliferation.},\n volume = {76},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "39089704",
      "name": "S. Lunt"}, {"authorId": "40576003", "name": "T. Dayton"}, {"authorId":
      "8143199", "name": "B. Fiske"}, {"authorId": "5553029", "name": "William J.
      Israelsen"}, {"authorId": "6160202", "name": "Katherine R. Mattaini"}, {"authorId":
      "2223606600", "name": "Natalie I. Vokes"}, {"authorId": "1813278", "name": "G.
      Stephanopoulos"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2281284", "name": "Christian M. Metallo"}, {"authorId": "2268976", "name":
      "J. Locasale"}]}, {"paperId": "6cebb7a72591c4fee0d5a2b330c0701ee423e566", "externalIds":
      {"MAG": "2009762318", "DOI": "10.4161/cc.10.22.18224", "CorpusId": 21098011,
      "PubMed": "22064516"}, "corpusId": 21098011, "publicationVenue": {"id": "1bce1796-d800-4a09-91e5-d3e3ed025037",
      "name": "Cell Cycle", "type": "journal", "issn": "1551-4005", "url": "http://www.landesbioscience.com/journals/cc/",
      "alternate_urls": ["http://www.tandfonline.com/loi/kccy20"]}, "url": "https://www.semanticscholar.org/paper/6cebb7a72591c4fee0d5a2b330c0701ee423e566",
      "title": "Genetic selection for enhanced serine metabolism in cancer development",
      "abstract": "Comment on: Locasale JW, et al. Nat Genet 2011; 43:869-74.", "venue":
      "Cell Cycle", "year": 2011, "referenceCount": 0, "citationCount": 36, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.tandfonline.com/doi/pdf/10.4161/cc.10.22.18224?needAccess=true",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Editorial"], "publicationDate":
      "2011-11-15", "journal": {"volume": "10", "pages": "3812 - 3813", "name": "Cell
      Cycle"}, "citationStyles": {"bibtex": "@Article{Locasale2011GeneticSF,\n author
      = {J. Locasale and L. Cantley},\n booktitle = {Cell Cycle},\n journal = {Cell
      Cycle},\n pages = {3812 - 3813},\n title = {Genetic selection for enhanced serine
      metabolism in cancer development},\n volume = {10},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "73e6f70f34d6ca5ba1a984bac26d02efc53138dd",
      "externalIds": {"MAG": "1978696643", "DOI": "10.1016/j.bmcl.2011.08.114", "CorpusId":
      13780824, "PubMed": "21958545"}, "corpusId": 13780824, "publicationVenue": {"id":
      "56cde9e1-007e-4232-b5ea-ac20f55c39e8", "name": "Bioorganic & Medicinal Chemistry
      Letters", "type": "journal", "alternate_names": ["Bioorganic  Med Chem Lett"],
      "issn": "0960-894X", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/0960894X",
      "https://www.journals.elsevier.com/bioorganic-and-medicinal-chemistry"]}, "url":
      "https://www.semanticscholar.org/paper/73e6f70f34d6ca5ba1a984bac26d02efc53138dd",
      "title": "2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators
      of the tumor cell specific M2 isoform of pyruvate kinase.", "abstract": null,
      "venue": "Bioorganic & Medicinal Chemistry Letters", "year": 2011, "referenceCount":
      17, "citationCount": 58, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3224553?pdf=render",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Chemistry",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2011-09-01", "journal":
      {"volume": "21 21", "pages": "\n          6322-7\n        ", "name": "Bioorganic
      & medicinal chemistry letters"}, "citationStyles": {"bibtex": "@Article{Walsh20112OxoNaryl1234tetrahydroquinoline6sulfonamidesAA,\n
      author = {M. Walsh and K. Brimacombe and H. Veith and James M. Bougie and T.
      Daniel and W. Leister and L. Cantley and William J. Israelsen and M. V. Vander
      Heiden and M. Shen and D. Auld and Craig J. Thomas and M. Boxer},\n booktitle
      = {Bioorganic & Medicinal Chemistry Letters},\n journal = {Bioorganic & medicinal
      chemistry letters},\n pages = {\n          6322-7\n        },\n title = {2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides
      as activators of the tumor cell specific M2 isoform of pyruvate kinase.},\n
      volume = {21 21},\n year = {2011}\n}\n"}, "authors": [{"authorId": "1699620778",
      "name": "M. Walsh"}, {"authorId": "2435894", "name": "K. Brimacombe"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "15778492", "name": "James M. Bougie"},
      {"authorId": "144782742", "name": "T. Daniel"}, {"authorId": "3802281", "name":
      "W. Leister"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5553029",
      "name": "William J. Israelsen"}, {"authorId": "3804233", "name": "M. V. Vander
      Heiden"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "2607088",
      "name": "D. Auld"}, {"authorId": "2148769632", "name": "Craig J. Thomas"}, {"authorId":
      "3275486", "name": "M. Boxer"}]}, {"paperId": "78d79be1f873972ad393761c85edd2997dd5c12d",
      "externalIds": {"MAG": "2050966347", "DOI": "10.1158/1538-7445.AM2011-2808",
      "CorpusId": 84891159}, "corpusId": 84891159, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/78d79be1f873972ad393761c85edd2997dd5c12d",
      "title": "Abstract 2808: Characterization of KRAS rearrangements in metastatic
      prostate cancer", "abstract": "Proceedings: AACR 102nd Annual Meeting 2011\u2010\u2010
      Apr 2\u20106, 2011; Orlando, FL\n\nIn this study, we employed a novel integrative
      genomic-based approach to explore driving gene fusions contributing to the progression
      of advanced prostate cancer. This method, called amplification breakpoint ranking
      and assembly (ABRA), leverages the in vivo amplification and breakpoint analysis
      in cancer cells to assemble novel gene fusions and predict their tumorigenicity.
      Using ABRA, we nominated KRAS as a gene fusion with the ubiquitin-conjugating
      enzyme UBE2L3 in the DU145 cell line- which was originally derived from a metastatic
      prostate cancer to the brain. Interestingly, analysis of tissues revealed that
      2 out of 62 metastatic prostate cancers harbored aberrations at the KRAS locus.
      In DU145 cells, UBE2L3-KRAS produces a chimerical protein which is readily ubiquitinated
      and relative instable, whereas specific knock-down of the fusion attenuates
      cell invasion and xenograft growth. Further, ectopic expression of the UBE2L3-KRAS
      fusion protein in NIH 3T3 fibroblasts and RWPE prostate epithelial cells exhibits
      substantial transforming activity in vitro and in vivo. In NIH 3T3 cells, UBE2L3-KRAS
      attenuates the MEK/ERK pathway, which is commonly engaged by oncogenic mutant
      KRAS. Instead, it enriches Ras proteins in late endosome, and diverts signaling
      to the AKT and p38 MAPK pathways. While a number of oncogenic activating point
      mutations of KRAS have been identified, this is the first description of a mutant
      chimeric version of KRAS that is oncogenic and thus may represent a new class
      of cancer-related alteration. This study also suggests that this aberration
      may drive metastatic progression in a subset of prostate cancers, which may
      be targeted by anti-KRAS therapies.\n\nCitation Format: {Authors}. {Abstract
      title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American
      Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA):
      AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2808. doi:10.1158/1538-7445.AM2011-2808",
      "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2011-04-15", "journal": {"volume":
      "71", "pages": "2808-2808", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Wang2011Abstract2C,\n author = {Xiaosong Wang and Sunita Shankar and
      S. Dhanasekaran and Bushra Ateeq and A. Sasaki and Xiaojun Jing and Daniel H.
      Robinson and Q. Cao and A. Gopalan and V. Reuter and L. Cantley and M. Rubin
      and N. Palanisamy and S. Varambally and A. Chinnaiyan},\n journal = {Cancer
      Research},\n pages = {2808-2808},\n title = {Abstract 2808: Characterization
      of KRAS rearrangements in metastatic prostate cancer},\n volume = {71},\n year
      = {2011}\n}\n"}, "authors": [{"authorId": "2107975065", "name": "Xiaosong Wang"},
      {"authorId": "39560950", "name": "Sunita Shankar"}, {"authorId": "3113892",
      "name": "S. Dhanasekaran"}, {"authorId": "3913657", "name": "Bushra Ateeq"},
      {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId": "49737962", "name":
      "Xiaojun Jing"}, {"authorId": "48706636", "name": "Daniel H. Robinson"}, {"authorId":
      "144457382", "name": "Q. Cao"}, {"authorId": "4059774", "name": "A. Gopalan"},
      {"authorId": "30582790", "name": "V. Reuter"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "144014266", "name": "M. Rubin"}, {"authorId": "145158003",
      "name": "N. Palanisamy"}, {"authorId": "6088770", "name": "S. Varambally"},
      {"authorId": "2186786", "name": "A. Chinnaiyan"}]}, {"paperId": "7f05984e35474cfe410cce91b3aa540de3468dac",
      "externalIds": {"MAG": "2313737236", "DOI": "10.1158/1538-7445.AM2011-956",
      "CorpusId": 88287914}, "corpusId": 88287914, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/7f05984e35474cfe410cce91b3aa540de3468dac",
      "title": "Abstract 956: Receptor tyrosine kinases, not KRAS, activate PI3K in
      KRAS mutant colorectal cancers", "abstract": "Proceedings: AACR 102nd Annual
      Meeting 2011\u2010\u2010 Apr 2\u20106, 2011; Orlando, FL\n\nIntroduction: Therapies
      inhibiting receptor tyrosine kinases (RTKs) are effective when they lead to
      simultaneous downregulation of phosphoinositide 3-kinase (PI3K)-AKT and mitogen-activated
      protein kinase (MEK)-ERK signaling. Although cetuximab has demonstrated activity
      in KRAS wildtype cancers, it remains unknown if RTK inhibition alone can suppress
      one or both of these pathways in colorectal cancers, especially in cancers with
      KRAS mutations.\n\nExperimental Procedures and Results: Colorectal cancer cells
      were treated with gefitinib (1 \u03bcM) or Cetuximab (10 \u03bcg/mL) to compare
      the consequences of EGFR inhibition on downstream signaling events between KRAS
      wt (n=6) and mt (n=8) cell lines. In KRAS wt cancers, either cetuximab or gefitinib
      led to loss of ERK phosphorylation, but had only a modest effect on PI3K signaling.
      However, in most KRAS mutant cancers, EGFR inhibition minimally impacted ERK
      signaling and had neglible effects on PI3K signaling. To determine if KRAS constitutively
      activates ERK and PI3K signaling in KRAS mutant colorectal cancers, we utilized
      shRNA in eight KRAS mutant cancer cell lines and abruptly turned off KRAS expression
      in an vivo transgenic model. In all models, the phosphorylation of ERK was markedly
      decreased by KRAS knockdown, but this was not associated with downregulation
      of PI3K signaling. To determine how PI3K was activated in KRAS mutant cancers,
      we immunoprecipitated the p85 regulatory subunit and identified that IRS proteins
      co-precipitated with PI3K in KRAS mutant cancer. These complexes were disrupted
      by an IGF-IR inhibitor, NVP-AEW541, but not by gefitinib, and accordingly, NVP-AEW541
      led to loss of AKT phosphorylation. Of the eight KRAS mutant cell lines, we
      found p85/IRS-1 or p85/IRS-2 complexes in 7 cell lines. We also observed that
      a monoclonal anti-IGF-IR antibody R1507 (18 mg/kg twice a week) downregulated
      PI3K signaling in SW837 xenografts in vivo. Biochemical assessment of patient
      specimens with KRAS mutations also suggested that PI3K was regulated primarily
      by IGF-IR. Importantly, by combining RTK inhibitors with MEK inhibitors in KRAS
      mutant cancers, both the PI3K and ERK pathways were concomitantly downregulated
      leading to marked growth suppression and robust apoptosis. Furthermore, combining
      R1507 (18 mg/kg twice a week) with a MEK inhibitor (AZD6244 25 mg/kg twice daily)
      induced marked tumor regressions of a KRAS mutant colorectal cancer in vivo.\n\nConclusions:
      In this study, we provide evidence that KRAS does not drive PI3K signaling in
      KRAS mutant cancers, and demonstrate that specific RTK inhibition potently suppresses
      PI3K signaling in vitro and in vivo. These findings provide a framework for
      utilizing RTK inhibitors in the treatment of KRAS mutant colorectal cancers.\n\nCitation
      Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd
      Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6;
      Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr
      956. doi:10.1158/1538-7445.AM2011-956", "venue": "", "year": 2011, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2011-04-15", "journal": {"volume": "71", "pages": "956-956",
      "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Ebi2011Abstract9R,\n
      author = {H. Ebi and R. Corcoran and Anurag Singh and Zhao Chen and Youngchul
      Song and E. Lifshits and D. Ryan and J. Meyerhardt and C. Benes and J. Settleman
      and L. Cantley and Kwok-kin Wong and J. Engelman},\n journal = {Cancer Research},\n
      pages = {956-956},\n title = {Abstract 956: Receptor tyrosine kinases, not KRAS,
      activate PI3K in KRAS mutant colorectal cancers},\n volume = {71},\n year =
      {2011}\n}\n"}, "authors": [{"authorId": "1899940", "name": "H. Ebi"}, {"authorId":
      "5956914", "name": "R. Corcoran"}, {"authorId": "153342143", "name": "Anurag
      Singh"}, {"authorId": "1491946371", "name": "Zhao Chen"}, {"authorId": "4846062",
      "name": "Youngchul Song"}, {"authorId": "144609942", "name": "E. Lifshits"},
      {"authorId": "2946715", "name": "D. Ryan"}, {"authorId": "3859322", "name":
      "J. Meyerhardt"}, {"authorId": "1714039", "name": "C. Benes"}, {"authorId":
      "88647391", "name": "J. Settleman"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "32596484", "name": "Kwok-kin Wong"}, {"authorId": "6828387", "name":
      "J. Engelman"}]}, {"paperId": "8155405e5acfca1dcc0b724eee83f0f9430de772", "externalIds":
      {"MAG": "2312620101", "DOI": "10.1158/1538-7445.AM2011-5121", "CorpusId": 74776458},
      "corpusId": 74776458, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/8155405e5acfca1dcc0b724eee83f0f9430de772",
      "title": "Abstract 5121: A targeted approach to identify activators of class
      IA phosphoinositide-3-kinase in cancers using tandem mass spectrometry", "abstract":
      "A majority of human cancers exhibit aberrant activation of the phosphoinositide
      3-Kinase (PI3K) pathway. In many cases this activation is due to mutations or
      amplifications in upstream activators of PI3K resulting in activation by direct
      binding of phosphotyrosine proteins (e.g., receptor tyrosine kinases (RTK) or
      adaptors such as IRS-1/2 or Gab1/2) to the p85 regulatory subunit of PI3K. To
      date, experiments to identify the mechanisms of PI3K activation in cancer have
      remained difficult and cumbersome. Since inhibitors of many of these RTKs are
      either already approved or in clinical trials, identification of the major upstream
      activators of PI3K in a given tumor could suggest the appropriate therapeutic
      intervention. Here we present a quantitative mass spectrometry approach (targeted
      ion MS/MS \u2013 TIMM) for identifying the upstream activators of PI3K in cancer
      cell lines grown on plastic as well as in tumor Xenografts. Importantly, we
      show that in a series of non small cell lung carcinoma cell lines, it is possible
      to predict the appropriate drug for treating the cells based on the upstream
      activator of PI3K as revealed by TIMM. Specifically, we identified how PI3K
      is activated in MET amplified, EGFR and EML4-ALK driven non-small cell lung
      cancers (NSCLCs) both in vitro and in vivo, and were successful in identifying
      the optimal RTK inhibitor treatment for the H1703 NSCLC cell line. Additionally,
      this technology revealed that TORC1 inhibition leads to activation of PI3K via
      IRS-2, not IRS-1 in KRAS mutant cell lines. Citation Format: {Authors}. {Abstract
      title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American
      Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA):
      AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 5121. doi:10.1158/1538-7445.AM2011-5121",
      "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2011-04-15", "journal": {"volume":
      "71", "pages": "5121-5121", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Asara2011Abstract5A,\n author = {J. Asara and L. Cantley and J. Engelman},\n
      journal = {Cancer Research},\n pages = {5121-5121},\n title = {Abstract 5121:
      A targeted approach to identify activators of class IA phosphoinositide-3-kinase
      in cancers using tandem mass spectrometry},\n volume = {71},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "3028470", "name": "J. Asara"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "6828387", "name": "J. Engelman"}]}, {"paperId":
      "82307456412752c3701d7a4adc378a6662bceded", "externalIds": {"MAG": "2508329323",
      "CorpusId": 99932392}, "corpusId": 99932392, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/82307456412752c3701d7a4adc378a6662bceded",
      "title": "Figure 2, PBS Buffer Stability of NCGC00185916/CID-44543605", "abstract":
      null, "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2011-03-03", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Boxer2011Figure2P,\n author = {M. Boxer and Jian-Kang
      Jiang and M. V. Heiden and M. Shen and H. Veith and L. Cantley and Craig J.
      Thomas},\n title = {Figure 2, PBS Buffer Stability of NCGC00185916/CID-44543605},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "3275486", "name": "M. Boxer"},
      {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}]}, {"paperId": "8233f48bd51990b9b6545798e2c793ec03e7925d",
      "externalIds": {"MAG": "3018915888", "DOI": "10.3410/f.13411030.14782154", "CorpusId":
      223711066}, "corpusId": 223711066, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/8233f48bd51990b9b6545798e2c793ec03e7925d",
      "title": "Faculty Opinions recommendation of Acetylation targets the M2 isoform
      of pyruvate kinase for degradation through chaperone-mediated autophagy and
      promotes tumor growth.", "abstract": null, "venue": "", "year": 2011, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2011-12-19", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Cantley2011FacultyOR,\n author = {L. Cantley},\n
      title = {Faculty Opinions recommendation of Acetylation targets the M2 isoform
      of pyruvate kinase for degradation through chaperone-mediated autophagy and
      promotes tumor growth.},\n year = {2011}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "83516a169e8c70276efc7be9b262b53fb731a74f",
      "externalIds": {"MAG": "2322629870", "DOI": "10.1158/1538-7445.AM2011-LB-255",
      "CorpusId": 86892367}, "corpusId": 86892367, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/83516a169e8c70276efc7be9b262b53fb731a74f",
      "title": "Abstract LB-255: A mass spectrometry platform to quantitatively profile
      cancer cell metabolism from cells, tumors, and fixed tissue", "abstract": "The
      metabolic requirements of cancer and proliferating cells are different from
      that of normal differential tissue and may have diverse applications in the
      treatment of cancers. However, many of the molecular mechanisms that reorganize
      metabolism to support cell proliferation are unknown. To study cancer cell metabolism,
      we implemented a mass spectrometry based platform to quantitatively profile
      endogenous metabolites from proliferating cell lines, tumor tissues and formalin
      fixed paraffin embedded (FFPE) tissue. Cell lines are derived from several cancers
      including lung, multiple myeloma, prostate, and gliobastoma (GBM). In some cases,
      these were compared to a drosophila reference cell line. Patients were also
      profiled for disease classification from their cerebrospinal fluid (CSF). We
      also were successful in extracting polar metabolites from FFPE tissue more than
      five years old stored at room temperature. For FFPE tissue samples, we show
      that we can observe differences in disease states involving PI3K-TSC-TOR pathway
      and we compared different extraction methods for acquiring metabolomics data
      from FFPE blocks. We show that we can cluster GBM versus normal patients from
      analyzing their CSF. We target more than 255 unique metabolites using selected
      reaction monitoring (SRM) based analyses with an AB/Sciex 5500 QTRAP mass spectrometer
      coupled to a Shimadzu UFLC using normal phase chromatography. For a single 18
      min run, our platform allows for unprecedented sensitivity, quantitation and
      coverage of metabolites that comprise of diverse metabolic pathways from as
      little as a single 6 cm tissue culture dish of cells or approximately 2\u20133
      million cells from tissue samples. We find that amide XBridge columns (Waters)
      at 275 uL/min perform well in both negative and positive ion switching mode
      and that the sampling rate of the instrument is sufficiently fast (cycle time
      of 1.6 sec with 3 msec dwell times) to effectively capture up to 300 metabolite
      targets without scheduled SRM runs. Peak areas of metabolites are integrated
      using MultiQuant 1.1 software (Applied Biosystems). Peak areas from triplicate
      runs are hierarchically clustered and statistical analyses are applied to generate
      P values for metabolite changes over different biological conditions. We also
      probed metabolic flux in pathways by targeting a set of 13C glucose labeled
      metabolites. In addition, we have also analyzed a model cell line after stimulation
      with Insulin and EGF to examine if growth factor induced metabolic changes are
      evolutionarily conserved. Using metabolic inhibitors, such as Iodoacetic acid,
      KCN, etc., we have been able to characterize the consequences of inhibiting
      glycolysis and oxidative phosphorylation, respectively. Finally, we considered
      kinase inhibitors and measured their effects on metabolism in proliferating
      cancer cell lines. Citation Format: {Authors}. {Abstract title} [abstract].
      In: Proceedings of the 102nd Annual Meeting of the American Association for
      Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer
      Res 2011;71(8 Suppl):Abstract nr LB-255. doi:10.1158/1538-7445.AM2011-LB-255",
      "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2011-04-15", "journal": {"volume":
      "71", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Yang2011AbstractLA,\n
      author = {Xuemei Yang and J. Locasale and R. Rahal and S. Breitkopf and M. VanderHeiden
      and D. Spentzos and Chin-Lee Wu and N. Perrimon and L. Cantley and E. Wong and
      J. Asara},\n journal = {Cancer Research},\n title = {Abstract LB-255: A mass
      spectrometry platform to quantitatively profile cancer cell metabolism from
      cells, tumors, and fixed tissue},\n volume = {71},\n year = {2011}\n}\n"}, "authors":
      [{"authorId": "48520140", "name": "Xuemei Yang"}, {"authorId": "2268976", "name":
      "J. Locasale"}, {"authorId": "49680398", "name": "R. Rahal"}, {"authorId": "3739417",
      "name": "S. Breitkopf"}, {"authorId": "89152193", "name": "M. VanderHeiden"},
      {"authorId": "8663787", "name": "D. Spentzos"}, {"authorId": "48251343", "name":
      "Chin-Lee Wu"}, {"authorId": "2001255", "name": "N. Perrimon"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "1913037", "name": "E. Wong"},
      {"authorId": "3028470", "name": "J. Asara"}]}, {"paperId": "8792f0b5d29918c5704d8fc26aed8926afad15ac",
      "externalIds": {"MAG": "2512427951", "CorpusId": 100519416}, "corpusId": 100519416,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/8792f0b5d29918c5704d8fc26aed8926afad15ac",
      "title": "Table 4, SAR of selected thieno[3,2-b]pyrrole[3,2-d]pyridazinones",
      "abstract": null, "venue": "", "year": 2011, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Chemistry", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2011-03-03", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Boxer2011Table4S,\n author = {M. Boxer and Jian-Kang
      Jiang and M. V. Heiden and M. Shen and H. Veith and L. Cantley and Craig J.
      Thomas},\n title = {Table 4, SAR of selected thieno[3,2-b]pyrrole[3,2-d]pyridazinones},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "3275486", "name": "M. Boxer"},
      {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}]}, {"paperId": "9773d7e86ac78e68c34d086a4dd228a8bbeb843d",
      "externalIds": {"MAG": "2507977278", "CorpusId": 100232622}, "corpusId": 100232622,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/9773d7e86ac78e68c34d086a4dd228a8bbeb843d",
      "title": "Figure 3, PBS Buffer Stability of NCGC00186527/CID-44246498", "abstract":
      null, "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Materials
      Science", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2011-03-03", "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Boxer2011Figure3P,\n
      author = {M. Boxer and Jian-Kang Jiang and M. V. Heiden and M. Shen and H. Veith
      and L. Cantley and Craig J. Thomas},\n title = {Figure 3, PBS Buffer Stability
      of NCGC00186527/CID-44246498},\n year = {2011}\n}\n"}, "authors": [{"authorId":
      "3275486", "name": "M. Boxer"}, {"authorId": "4084746", "name": "Jian-Kang Jiang"},
      {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "145829790",
      "name": "M. Shen"}, {"authorId": "1799343", "name": "H. Veith"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2148769632", "name": "Craig
      J. Thomas"}]}, {"paperId": "9905df45a72f23d3db52911bce92a7a9d5710f08", "externalIds":
      {"MAG": "2125669886", "PubMedCentral": "3352081", "DOI": "10.1098/rsob.110012",
      "CorpusId": 215534261, "PubMed": "22645651"}, "corpusId": 215534261, "publicationVenue":
      {"id": "5c640382-d1f2-4258-80f5-11f02570f2fc", "name": "Open Biology", "type":
      "journal", "issn": "2046-2441", "url": "https://royalsocietypublishing.org/journal/rsob",
      "alternate_urls": ["http://rsob.royalsocietypublishing.org/"]}, "url": "https://www.semanticscholar.org/paper/9905df45a72f23d3db52911bce92a7a9d5710f08",
      "title": "Discovery of catalytically active orthologues of the Parkinson''s
      disease kinase PINK1: analysis of substrate specificity and impact of mutations",
      "abstract": "Missense mutations of the phosphatase and tensin homolog (PTEN)-induced
      kinase 1 (PINK1) gene cause autosomal-recessive Parkinson''s disease. To date,
      little is known about the intrinsic catalytic properties of PINK1 since the
      human enzyme displays such low kinase activity in vitro. We have discovered
      that, in contrast to mammalian PINK1, insect orthologues of PINK1 we have investigated\u2014namely
      Drosophila melanogaster (dPINK1), Tribolium castaneum (TcPINK1) and Pediculus
      humanus corporis (PhcPINK1)\u2014are active as judged by their ability to phosphorylate
      the generic substrate myelin basic protein. We have exploited the most active
      orthologue, TcPINK1, to assess its substrate specificity and elaborated a peptide
      substrate (PINKtide, KKWIpYRRSPRRR) that can be employed to quantify PINK1 kinase
      activity. Analysis of PINKtide variants reveal that PINK1 phosphorylates serine
      or threonine, but not tyrosine, and we show that PINK1 exhibits a preference
      for a proline at the +1 position relative to the phosphorylation site. We have
      also, for the first time, been able to investigate the effect of Parkinson''s
      disease-associated PINK1 missense mutations, and found that nearly all those
      located within the kinase domain, as well as the C-terminal non-catalytic region,
      markedly suppress kinase activity. This emphasizes the crucial importance of
      PINK1 kinase activity in preventing the development of Parkinson''s disease.
      Our findings will aid future studies aimed at understanding how the activity
      of PINK1 is regulated and the identification of physiological substrates.",
      "venue": "Open Biology", "year": 2011, "referenceCount": 25, "citationCount":
      101, "influentialCitationCount": 8, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-11-01", "journal": {"volume": "1", "name": "Open biology"},
      "citationStyles": {"bibtex": "@Article{Woodroof2011DiscoveryOC,\n author = {Helen
      I. Woodroof and J. Pogson and M. Begley and L. Cantley and M. De\u00e1k and
      D. Campbell and D. V. van Aalten and Alexander J. Whitworth and D. Alessi and
      M. Muqit},\n booktitle = {Open Biology},\n journal = {Open biology},\n title
      = {Discovery of catalytically active orthologues of the Parkinson''s disease
      kinase PINK1: analysis of substrate specificity and impact of mutations},\n
      volume = {1},\n year = {2011}\n}\n"}, "authors": [{"authorId": "6827525", "name":
      "Helen I. Woodroof"}, {"authorId": "4742185", "name": "J. Pogson"}, {"authorId":
      "69874482", "name": "M. Begley"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "4206645", "name": "M. De\u00e1k"}, {"authorId": "144004440", "name":
      "D. Campbell"}, {"authorId": "143949689", "name": "D. V. van Aalten"}, {"authorId":
      "6049024", "name": "Alexander J. Whitworth"}, {"authorId": "3475566", "name":
      "D. Alessi"}, {"authorId": "50684409", "name": "M. Muqit"}]}, {"paperId": "9a1aec82181e0ea356cb11496a61482c3dcddd62",
      "externalIds": {"MAG": "2232391401", "DOI": "10.1007/978-1-4419-9911-5_9", "CorpusId":
      85976444}, "corpusId": 85976444, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/9a1aec82181e0ea356cb11496a61482c3dcddd62",
      "title": "AMP-Activated Protein Kinase and Cancer Cell Metabolism", "abstract":
      null, "venue": "", "year": 2011, "referenceCount": 111, "citationCount": 0,
      "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "pages": "193-211", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Zheng2011AMPActivatedPK,\n author = {B. Zheng and
      L. Cantley},\n pages = {193-211},\n title = {AMP-Activated Protein Kinase and
      Cancer Cell Metabolism},\n year = {2011}\n}\n"}, "authors": [{"authorId": "143918840",
      "name": "B. Zheng"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "a34b686a799b9559d53d1a618c403d71801a1e90", "externalIds": {"MAG": "2465085905",
      "CorpusId": 183596868}, "corpusId": 183596868, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/a34b686a799b9559d53d1a618c403d71801a1e90",
      "title": "[Table, Probe Chemical Characterization].", "abstract": null, "venue":
      "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2011-03-03", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Boxer2011TablePC,\n author = {M. Boxer and Jian-Kang
      Jiang and M. V. Heiden and M. Shen and H. Veith and L. Cantley and Craig J.
      Thomas},\n title = {[Table, Probe Chemical Characterization].},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "3275486", "name": "M. Boxer"}, {"authorId": "4084746",
      "name": "Jian-Kang Jiang"}, {"authorId": "35413264", "name": "M. V. Heiden"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "1799343", "name":
      "H. Veith"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2148769632",
      "name": "Craig J. Thomas"}]}, {"paperId": "ab63932f66167b1a720fd39193283bace5f82e68",
      "externalIds": {"CorpusId": 54725771}, "corpusId": 54725771, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/ab63932f66167b1a720fd39193283bace5f82e68",
      "title": "Quantitative Phosphoproteomic Analysis Identifies the Adaptor Protein
      Grb 10 as an mTORC 1 Substrate that Negatively Regulates Insulin Signaling",
      "abstract": "The evolutionarily conserved Ser-Thr kinase mTOR plays a critical
      role in regulating many pathophysiological processes. Functional characterization
      of the mTOR signaling pathways, however, has been hampered by the paucity of
      known substrates. We used large-scale quantitative phospho-proteomics experiments
      to define the signaling networks downstream of mTORC1 and mTORC2. Characterization
      of one mTORC1 substrate, the growth factor receptor-bound protein 10 (Grb10),
      showed that mTORC1-mediated phosphorylation stabilized Grb10, leading to feedback
      inhibition of the phosphatidylinositol-3-kinase (PI3K) and extracellular signal-regulated,
      mitogen-activated protein kinase (ERK-MAPK) pathways. Grb10 expression is frequently
      downregulated in various cancers, and loss of Grb10 and loss of the well-established
      tumor suppressor phosphatase PTEN appear to be mutually exclusive events, suggesting
      that Grb10 might be a tumor suppressor regulated by mTORC1. The evolutionarily
      conserved Ser-Thr protein kinase mTOR functions as the core catalytic component
      of two structurally and functionally distinct signaling complexes. mTOR complex
      1 (mTORC1) regulates protein translation, autophagy and cell growth whereas
      mTOR complex 2 (mTORC2) regulates the actin cytoskeleton and cell survival (1\u20133).
      mTORC1 and mTORC2 respond to upstream inputs such as growth factors, energetic
      status, and amino acid levels (3) but relatively few downstream targets of mTOR
      have been identified. Misregulated mTOR activity is a common feature of most
      cancers (1) but clinical trials evaluating the mTORC1 selective inhibitor rapamycin
      as an anti-cancer agent have met with limited success (2). Rapamycin resistance
      has emerged as a major challenge to its clinical use (4), and is caused in part
      by feedback loops that activate the PI3K and ERK-MAPK signaling pathways in
      rapamycin treated cells through poorly understood mechanisms (5, 6). Identifying
      substrates of mTORC1 and mTORC2 will be important for understanding how mTOR
      signals downstream, and for defining components of feedback loops involved in
      rapamycin resistance. *To whom correspondence should be addressed. Steven_gygi@hms.harvard.edu
      (S.P.G); john_blenis@hms.harvard.edu (J. B.). 4Current address, Department of
      Cancer and Cell Biology, University of Cincinnati, College of Medicine, Cincinnati,
      OH, 45267 5Current address, Department of Research Oncology Diagnostics, Genentech
      Inc., 1 DNA Way, South San Francisco, CA, 94080 6Current address, Department
      of Genome Sciences, University of Washington, Seattle, WA, 98195 7Current address,
      Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research,
      Cambridge, MA, 02139 NIH Public Access", "venue": "", "year": 2011, "referenceCount":
      0, "citationCount": 15, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Inproceedings{Yu2011QuantitativePA,\n author = {Yonghao Yu and
      Sang-Oh Yoon and G. Poulogiannis and Qian Yang and X. Ma and J. Ville\u0301n
      and Neil Kubica and G. Hoffman and L. Cantley and S. Gygi and J. Blenis},\n
      title = {Quantitative Phosphoproteomic Analysis Identifies the Adaptor Protein
      Grb 10 as an mTORC 1 Substrate that Negatively Regulates Insulin Signaling},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "40508577", "name": "Yonghao
      Yu"}, {"authorId": "6168327", "name": "Sang-Oh Yoon"}, {"authorId": "4612853",
      "name": "G. Poulogiannis"}, {"authorId": "144785850", "name": "Qian Yang"},
      {"authorId": "50088305", "name": "X. Ma"}, {"authorId": "1705488", "name": "J.
      Ville\u0301n"}, {"authorId": "8429203", "name": "Neil Kubica"}, {"authorId":
      "34846304", "name": "G. Hoffman"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2665934", "name": "S. Gygi"}, {"authorId": "4037343", "name":
      "J. Blenis"}]}, {"paperId": "b0d2b1baac5a531e06ff01b1e1fec78a91b40548", "externalIds":
      {"MAG": "2141240740", "DOI": "10.1038/emboj.2011.436", "CorpusId": 734426, "PubMed":
      "22166995"}, "corpusId": 734426, "publicationVenue": {"id": "b89f0ede-6fa8-4dd2-a8a7-f54695a00323",
      "name": "EMBO Journal", "type": "journal", "alternate_names": ["The EMBO Journal",
      "EMBO J"], "issn": "0261-4189", "url": "http://embojournal.npgjournals.com/",
      "alternate_urls": ["http://emboj.embopress.org/"]}, "url": "https://www.semanticscholar.org/paper/b0d2b1baac5a531e06ff01b1e1fec78a91b40548",
      "title": "Human pluripotent stem cells decouple respiration from energy production",
      "abstract": null, "venue": "EMBO Journal", "year": 2011, "referenceCount": 10,
      "citationCount": 38, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc3242981?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["LettersAndComments", "JournalArticle"], "publicationDate":
      "2011-12-14", "journal": {"volume": "30", "name": "The EMBO Journal"}, "citationStyles":
      {"bibtex": "@Article{Shyh\u2010Chang2011HumanPS,\n author = {Ng Shyh\u2010Chang
      and Yuxiang Zheng and J. Locasale and L. Cantley},\n booktitle = {EMBO Journal},\n
      journal = {The EMBO Journal},\n title = {Human pluripotent stem cells decouple
      respiration from energy production},\n volume = {30},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "1397529716", "name": "Ng Shyh\u2010Chang"}, {"authorId":
      "1723564", "name": "Yuxiang Zheng"}, {"authorId": "2268976", "name": "J. Locasale"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "b4d12b89c8a3e23260c43349a843b736395ab1d7",
      "externalIds": {"MAG": "2507756443", "CorpusId": 184627428}, "corpusId": 184627428,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/b4d12b89c8a3e23260c43349a843b736395ab1d7",
      "title": "Table 1, Final optimized 1536-well assay protocol", "abstract": null,
      "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Computer
      Science"], "s2FieldsOfStudy": [{"category": "Computer Science", "source": "external"},
      {"category": "Engineering", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2011-03-03", "journal": {"volume": "", "name": ""},
      "citationStyles": {"bibtex": "@Inproceedings{Boxer2011Table1F,\n author = {M.
      Boxer and Jian-Kang Jiang and M. V. Heiden and M. Shen and H. Veith and L. Cantley
      and Craig J. Thomas},\n title = {Table 1, Final optimized 1536-well assay protocol},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "3275486", "name": "M. Boxer"},
      {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}]}, {"paperId": "b4ede71842e893cfa6ea1e4a9b8a4a359159779b",
      "externalIds": {"MAG": "2038578974", "DOI": "10.1016/j.cmet.2011.03.006", "CorpusId":
      206837719, "PubMed": "21459332"}, "corpusId": 206837719, "publicationVenue":
      {"id": "ad36b49e-5c03-4c48-be8d-321a0d17c2f6", "name": "Cell Metabolism", "type":
      "journal", "alternate_names": ["Cell Metab"], "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/15504131",
      "http://www.cellmetabolism.org/"]}, "url": "https://www.semanticscholar.org/paper/b4ede71842e893cfa6ea1e4a9b8a4a359159779b",
      "title": "A fluorescent reporter of AMPK activity and cellular energy stress.",
      "abstract": null, "venue": "Cell Metabolism", "year": 2011, "referenceCount":
      39, "citationCount": 136, "influentialCitationCount": 7, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S1550413111000933/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2011-04-06", "journal":
      {"volume": "13 4", "pages": "\n          476-486\n        ", "name": "Cell metabolism"},
      "citationStyles": {"bibtex": "@Article{Tsou2011AFR,\n author = {P. Tsou and
      B. Zheng and Chia-Hsien Hsu and A. Sasaki and L. Cantley},\n booktitle = {Cell
      Metabolism},\n journal = {Cell metabolism},\n pages = {\n          476-486\n        },\n
      title = {A fluorescent reporter of AMPK activity and cellular energy stress.},\n
      volume = {13 4},\n year = {2011}\n}\n"}, "authors": [{"authorId": "143971134",
      "name": "P. Tsou"}, {"authorId": "143918840", "name": "B. Zheng"}, {"authorId":
      "5027028", "name": "Chia-Hsien Hsu"}, {"authorId": "47742211", "name": "A. Sasaki"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "bafaba286dd649d81592ab9cd40e677a1e1d4796",
      "externalIds": {"MAG": "2122481965", "DOI": "10.1016/j.molcel.2011.08.030",
      "CorpusId": 6847269, "PubMed": "22017875"}, "corpusId": 6847269, "publicationVenue":
      {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11", "name": "Molecules and Cells",
      "type": "journal", "alternate_names": ["Molecular Cell", "Mol Cell"], "issn":
      "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"], "url": "https://link.springer.com/journal/10059",
      "alternate_urls": ["http://www.molcells.org/about/sub06.html", "http://www.molecule.org/",
      "http://www.sciencedirect.com/science/journal/10972765", "http://www.cell.com/molecular-cell/"]},
      "url": "https://www.semanticscholar.org/paper/bafaba286dd649d81592ab9cd40e677a1e1d4796",
      "title": "mTOR drives its own activation via SCF(\u03b2TrCP)-dependent degradation
      of the mTOR inhibitor DEPTOR.", "abstract": null, "venue": "Molecules and Cells",
      "year": 2011, "referenceCount": 39, "citationCount": 231, "influentialCitationCount":
      9, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276511007222/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-10-21", "journal": {"volume": "44 2", "pages": "\n          290-303\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Gao2011mTORDI,\n
      author = {Daming Gao and H. Inuzuka and Meng-Kwang\u00a0Marcus Tan and H. Fukushima
      and J. Locasale and Pengda Liu and L. Wan and B. Zhai and Y. R. Chin and S.
      Shaik and C. Lyssiotis and S. Gygi and A. Toker and L. Cantley and J. Asara
      and J. Harper and Wenyi Wei},\n booktitle = {Molecules and Cells},\n journal
      = {Molecular cell},\n pages = {\n          290-303\n        },\n title = {mTOR
      drives its own activation via SCF(\u03b2TrCP)-dependent degradation of the mTOR
      inhibitor DEPTOR.},\n volume = {44 2},\n year = {2011}\n}\n"}, "authors": [{"authorId":
      "7642679", "name": "Daming Gao"}, {"authorId": "4403700", "name": "H. Inuzuka"},
      {"authorId": "2231985437", "name": "Meng-Kwang\u00a0Marcus Tan"}, {"authorId":
      "50274365", "name": "H. Fukushima"}, {"authorId": "2268976", "name": "J. Locasale"},
      {"authorId": "3420906", "name": "Pengda Liu"}, {"authorId": "49048640", "name":
      "L. Wan"}, {"authorId": "1859720", "name": "B. Zhai"}, {"authorId": "50611901",
      "name": "Y. R. Chin"}, {"authorId": "39696512", "name": "S. Shaik"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "2665934", "name": "S. Gygi"},
      {"authorId": "145751285", "name": "A. Toker"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "143851342",
      "name": "J. Harper"}, {"authorId": "144084152", "name": "Wenyi Wei"}]}, {"paperId":
      "c242b3e7618c27f4c0c89cc9db39523328bf1fdb", "externalIds": {"MAG": "2515220964",
      "CorpusId": 113594604}, "corpusId": 113594604, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/c242b3e7618c27f4c0c89cc9db39523328bf1fdb",
      "title": "Figure 8, Critical Workflow to Lead to in vivo studies of HPykM2 activators",
      "abstract": null, "venue": "", "year": 2011, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Engineering"], "s2FieldsOfStudy": [{"category": "Engineering",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2011-03-03", "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex":
      "@Inproceedings{Boxer2011Figure8C,\n author = {M. Boxer and Jian-Kang Jiang
      and M. V. Heiden and M. Shen and H. Veith and L. Cantley and Craig J. Thomas},\n
      title = {Figure 8, Critical Workflow to Lead to in vivo studies of HPykM2 activators},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "3275486", "name": "M. Boxer"},
      {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}]}, {"paperId": "c6840388ee0d73d08f80dcf00b38cc41d95fe281",
      "externalIds": {"CorpusId": 17137963}, "corpusId": 17137963, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/c6840388ee0d73d08f80dcf00b38cc41d95fe281",
      "title": "Using Departments of Pathology And", "abstract": "intRoDuction To
      understand the characteristic features of driving gene fusions in cancer, we
      previously carried out a large-scale integrative analysis of cancer genomic
      datasets matched with gene rearrangement data (1). As part of this analysis,
      we observed that in many instances a small subset of tumors or cancer cell lines
      harboring an oncogenic gene fusion displays characteristic amplification at
      the site of genomic rearrangement (refs. 2\u20136; Supplementary Fig. S1A and
      B). Such amplifications usually affect a portion of the fusion gene and are
      generally considered secondary genetic lesions associated with disease progression,
      drug resistance, and poor prognosis (2, 4\u20138). In contrast, high-level copy
      number changes that result in the marked overexpression of oncogenes usually
      encompass the target genes at the center of overlapping amplifications across
      a panel of tumor samples. Thus, a \u201cpartially\u201d amplified cancer gene
      may suggest that this gene participates ReseARcH BRieF JUNE 2011 CANCER DISCOVERY
      | 35 doi: 10.1158/2159-8274.CD-10-0022 \u00a92011 American Association for Cancer
      Research. Cancer Research. on April 20, 2017. \u00a9 2011 American Association
      for cancerdiscovery.aacrjournals.org Downloaded from Published OnlineFirst April
      3, 2011; DOI: 10.1158/2159-8274.CD-10-0022", "venue": "", "year": 2011, "referenceCount":
      29, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Wang2011UsingDO,\n
      author = {Xiao-Song Wang and Sunita Shankar and S. Dhanasekaran and Bushra Ateeq
      and A. Sasaki and Xiaojun Jing and Daniel H. Robinson and Q. Cao and John R.
      Prensner and Anastasia K. Yocum and Rui Wang and Daniel F. Fries and B. Han
      and I. Asangani and Xuhong Cao and Yong Li and G. Omenn and D. Pflueger and
      A. Gopalan and V. Reuter and E. Kahoud and L. Cantley and M. Rubin and N. Palanisamy
      and S. Varambally and A. Chinnaiyan},\n title = {Using Departments of Pathology
      And},\n year = {2011}\n}\n"}, "authors": [{"authorId": "48631932", "name": "Xiao-Song
      Wang"}, {"authorId": "39560950", "name": "Sunita Shankar"}, {"authorId": "3113892",
      "name": "S. Dhanasekaran"}, {"authorId": "3913657", "name": "Bushra Ateeq"},
      {"authorId": "47742211", "name": "A. Sasaki"}, {"authorId": "49737962", "name":
      "Xiaojun Jing"}, {"authorId": "48706636", "name": "Daniel H. Robinson"}, {"authorId":
      "144457382", "name": "Q. Cao"}, {"authorId": "5608756", "name": "John R. Prensner"},
      {"authorId": "4221039", "name": "Anastasia K. Yocum"}, {"authorId": "2037452760",
      "name": "Rui Wang"}, {"authorId": "145571865", "name": "Daniel F. Fries"}, {"authorId":
      "144202024", "name": "B. Han"}, {"authorId": "6382794", "name": "I. Asangani"},
      {"authorId": "2259620692", "name": "Xuhong Cao"}, {"authorId": "2154403330",
      "name": "Yong Li"}, {"authorId": "2716422", "name": "G. Omenn"}, {"authorId":
      "5715823", "name": "D. Pflueger"}, {"authorId": "4059774", "name": "A. Gopalan"},
      {"authorId": "30582790", "name": "V. Reuter"}, {"authorId": "4049626", "name":
      "E. Kahoud"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144014266",
      "name": "M. Rubin"}, {"authorId": "145158003", "name": "N. Palanisamy"}, {"authorId":
      "6088770", "name": "S. Varambally"}, {"authorId": "2186786", "name": "A. Chinnaiyan"}]},
      {"paperId": "d12781afde75f3aa3083c3653d5d469b2df86294", "externalIds": {"MAG":
      "2164405838", "DOI": "10.1042/BJ20110276", "CorpusId": 12583063, "PubMed": "21548880"},
      "corpusId": 12583063, "publicationVenue": {"id": "64838252-a209-4424-a778-3b86b4a83c48",
      "name": "Biochemical Journal", "type": "journal", "alternate_names": ["Biochem
      J"], "issn": "0264-6021", "alternate_issns": ["0006-2936"], "url": "http://www.biochemj.org/"},
      "url": "https://www.semanticscholar.org/paper/d12781afde75f3aa3083c3653d5d469b2df86294",
      "title": "TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing
      mutations on expression, activity, localization and development.", "abstract":
      "Mutations that truncate the C-terminal non-catalytic moiety of TTBK2 (tau tubulin
      kinase 2) cause the inherited, autosomal dominant, SCA11 (spinocerebellar ataxia
      type\u00a011) movement disorder. In the present study we first assess the substrate
      specificity of TTBK2 and demonstrate that it has an unusual preference for a
      phosphotyrosine residue at the +2 position relative to the phosphorylation site.
      We elaborate a peptide substrate (TTBKtide, RRKDLHDDEEDEAMSIYpA) that can be
      employed to quantify TTBK2 kinase activity. Through modelling and mutagenesis
      we identify a putative phosphate-priming groove within the TTBK2 kinase domain.
      We demonstrate that SCA11 truncating mutations promote TTBK2 protein expression,
      suppress kinase activity and lead to enhanced nuclear localization. We generate
      an SCA11-mutation-carrying knockin mouse and show that this leads to inhibition
      of endogenous TTBK2 protein kinase activity. Finally, we find that, in homozygosity,
      the SCA11 mutation causes embryonic lethality at embryonic day 10. These findings
      provide the first insights into some of the intrinsic properties of TTBK2 and
      reveal how SCA11-causing mutations affect protein expression, catalytic activity,
      localization and development. We hope that these findings will be helpful for
      future investigation of the regulation and function of TTBK2 and its role in
      SCA11.", "venue": "Biochemical Journal", "year": 2011, "referenceCount": 24,
      "citationCount": 52, "influentialCitationCount": 6, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc3739326?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2011-07-01", "journal":
      {"volume": "437 1", "pages": "\n          157-67\n        ", "name": "The Biochemical
      journal"}, "citationStyles": {"bibtex": "@Article{Bouskila2011TTBK2KS,\n author
      = {M. Bouskila and Noor Esoof and L. Gay and Emily Fang and M. De\u00e1k and
      M. Begley and L. Cantley and A. Prescott and K. Storey and D. Alessi},\n booktitle
      = {Biochemical Journal},\n journal = {The Biochemical journal},\n pages = {\n          157-67\n        },\n
      title = {TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing
      mutations on expression, activity, localization and development.},\n volume
      = {437 1},\n year = {2011}\n}\n"}, "authors": [{"authorId": "6572211", "name":
      "M. Bouskila"}, {"authorId": "6809445", "name": "Noor Esoof"}, {"authorId":
      "5740524", "name": "L. Gay"}, {"authorId": "48043585", "name": "Emily Fang"},
      {"authorId": "4206645", "name": "M. De\u00e1k"}, {"authorId": "69874482", "name":
      "M. Begley"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2646124",
      "name": "A. Prescott"}, {"authorId": "3917018", "name": "K. Storey"}, {"authorId":
      "3475566", "name": "D. Alessi"}]}, {"paperId": "d17743cae27a10fc1a84da92bff397fcf461fa72",
      "externalIds": {"MAG": "2516911901", "CorpusId": 185106799}, "corpusId": 185106799,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/d17743cae27a10fc1a84da92bff397fcf461fa72",
      "title": "Table 3, SAR of selected N,N-bisarylsulfonamides", "abstract": null,
      "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Mathematics"],
      "s2FieldsOfStudy": [{"category": "Mathematics", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2011-03-03", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Boxer2011Table3S,\n
      author = {M. Boxer and Jian-Kang Jiang and M. V. Heiden and M. Shen and H. Veith
      and L. Cantley and Craig J. Thomas},\n title = {Table 3, SAR of selected N,N-bisarylsulfonamides},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "3275486", "name": "M. Boxer"},
      {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}]}, {"paperId": "d5e6a178c9d12a042bbba7fd5bb45029da7541db",
      "externalIds": {"MAG": "1916946492", "DOI": "10.1111/j.1755-148X.2011.00919.x",
      "CorpusId": 42241825, "PubMed": "21981974"}, "corpusId": 42241825, "publicationVenue":
      {"id": "d4fab1a0-4b1b-43b8-a2e5-4d2a5d0dc3d6", "name": "Pigment Cell & Melanoma
      Research", "type": "journal", "alternate_names": ["Pigment Cell  Melanoma Res"],
      "issn": "1755-1471", "url": "http://www.pigment.org/"}, "url": "https://www.semanticscholar.org/paper/d5e6a178c9d12a042bbba7fd5bb45029da7541db",
      "title": "PHGDH amplification and altered glucose metabolism in human melanoma",
      "abstract": "The metabolic requirements of cancer cells differ from that of
      their normal counterparts. To support their proliferation, cancer cells switch
      to a fermentative metabolism that is thought to support biomass production.
      Instances where metabolic enzymes promote tumorigenesis remain rare. However,
      an enzyme involved in the de novo synthesis of serine, 3\u2010phosphoglycerate
      dehydrogenase (PHGDH), was recently identified as a putative oncogene. The potential
      mechanisms by which PHGDH promotes cancer are discussed.", "venue": "Pigment
      Cell & Melanoma Research", "year": 2011, "referenceCount": 32, "citationCount":
      119, "influentialCitationCount": 4, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2011-12-01", "journal": {"volume": "24", "name": "Pigment
      Cell & Melanoma Research"}, "citationStyles": {"bibtex": "@Article{Mullarky2011PHGDHAA,\n
      author = {Edouard Mullarky and Katherine R. Mattaini and M. V. Vander Heiden
      and L. Cantley and J. Locasale},\n booktitle = {Pigment Cell & Melanoma Research},\n
      journal = {Pigment Cell & Melanoma Research},\n title = {PHGDH amplification
      and altered glucose metabolism in human melanoma},\n volume = {24},\n year =
      {2011}\n}\n"}, "authors": [{"authorId": "6424987", "name": "Edouard Mullarky"},
      {"authorId": "6160202", "name": "Katherine R. Mattaini"}, {"authorId": "3804233",
      "name": "M. V. Vander Heiden"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2268976", "name": "J. Locasale"}]}, {"paperId": "d5e87e8391ac4798e14e9c6138610d18fc6a37e6",
      "externalIds": {"MAG": "2511153834", "CorpusId": 99510790}, "corpusId": 99510790,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/d5e87e8391ac4798e14e9c6138610d18fc6a37e6",
      "title": "Figure 4, PBS Buffer Stability of NCGC00185939/CID-4547230", "abstract":
      null, "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Materials
      Science"], "s2FieldsOfStudy": [{"category": "Materials Science", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2011-03-03", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Boxer2011Figure4P,\n author = {M. Boxer and Jian-Kang
      Jiang and M. V. Heiden and M. Shen and H. Veith and L. Cantley and Craig J.
      Thomas},\n title = {Figure 4, PBS Buffer Stability of NCGC00185939/CID-4547230},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "3275486", "name": "M. Boxer"},
      {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "145829790", "name": "M. Shen"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2148769632", "name": "Craig J. Thomas"}]}, {"paperId": "d9758f49728d9173fb1417c58decd4baaf7c065a",
      "externalIds": {"MAG": "2028974980", "DOI": "10.1016/j.cmet.2011.07.014", "CorpusId":
      5150796, "PubMed": "21982705"}, "corpusId": 5150796, "publicationVenue": {"id":
      "ad36b49e-5c03-4c48-be8d-321a0d17c2f6", "name": "Cell Metabolism", "type": "journal",
      "alternate_names": ["Cell Metab"], "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/15504131",
      "http://www.cellmetabolism.org/"]}, "url": "https://www.semanticscholar.org/paper/d9758f49728d9173fb1417c58decd4baaf7c065a",
      "title": "Metabolic flux and the regulation of mammalian cell growth.", "abstract":
      null, "venue": "Cell Metabolism", "year": 2011, "referenceCount": 67, "citationCount":
      384, "influentialCitationCount": 12, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S1550413111003457/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "2011-10-05",
      "journal": {"volume": "14 4", "pages": "\n          443-51\n        ", "name":
      "Cell metabolism"}, "citationStyles": {"bibtex": "@Article{Locasale2011MetabolicFA,\n
      author = {J. Locasale and L. Cantley},\n booktitle = {Cell Metabolism},\n journal
      = {Cell metabolism},\n pages = {\n          443-51\n        },\n title = {Metabolic
      flux and the regulation of mammalian cell growth.},\n volume = {14 4},\n year
      = {2011}\n}\n"}, "authors": [{"authorId": "2268976", "name": "J. Locasale"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "e45b7d8040426d10d5d0afb970e29398aca9fe4e",
      "externalIds": {"MAG": "2059019158", "DOI": "10.1016/j.molcel.2011.03.017",
      "CorpusId": 5171934, "PubMed": "21474067"}, "corpusId": 5171934, "publicationVenue":
      {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11", "name": "Molecules and Cells",
      "type": "journal", "alternate_names": ["Molecular Cell", "Mol Cell"], "issn":
      "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"], "url": "https://link.springer.com/journal/10059",
      "alternate_urls": ["http://www.molcells.org/about/sub06.html", "http://www.molecule.org/",
      "http://www.sciencedirect.com/science/journal/10972765", "http://www.cell.com/molecular-cell/"]},
      "url": "https://www.semanticscholar.org/paper/e45b7d8040426d10d5d0afb970e29398aca9fe4e",
      "title": "Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular
      size.", "abstract": null, "venue": "Molecules and Cells", "year": 2011, "referenceCount":
      49, "citationCount": 251, "influentialCitationCount": 14, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S1097276511002176/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-04-08", "journal": {"volume": "42 1", "pages": "\n          50-61\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Saci2011Rac1RT,\n
      author = {A. Saci and L. Cantley and C. Carpenter},\n booktitle = {Molecules
      and Cells},\n journal = {Molecular cell},\n pages = {\n          50-61\n        },\n
      title = {Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular
      size.},\n volume = {42 1},\n year = {2011}\n}\n"}, "authors": [{"authorId":
      "50149612", "name": "A. Saci"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2972505", "name": "C. Carpenter"}]}, {"paperId": "e58f4de259573ec03beef312bf66b4238221b599",
      "externalIds": {"MAG": "2320941668", "DOI": "10.1158/1538-7445.AM2011-LB-418",
      "CorpusId": 58321411}, "corpusId": 58321411, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/e58f4de259573ec03beef312bf66b4238221b599",
      "title": "Abstract LB-418: Targeting the PI3K/mTOR pathway in genetically engineered
      mouse models of prostate cancer", "abstract": "The PTEN and p53 tumor suppressors
      are among the most commonly inactivated or mutated genes in human cancer, including
      prostate cancer. Loss of PTEN is associated with increased pathologic Gleason
      score and risk of clinical recurrence, and 20-60% of human metastatic prostate
      cancers have loss of heterozygosity at the PTEN locus, resulting in hyperactivation
      of the PI3K/mTOR pathway. Mice with germline heterozygosity for PTEN have been
      shown to develop prostate intraepithelial neoplasia (PIN) at a high rate (>60%)
      and mice with prostate specific homozygous deletion of PTEN develop invasive
      prostate cancer, albeit with prolonged latency of approx. 6 months. Combined
      inactivation of PTEN and p53 in mouse prostate elicits invasive cancer by 9
      weeks of age and invariable lethality by 7 months of age. There are several
      PI3K pathway-directed therapies currently in Phase I clinical trials, but the
      underlying tumor genetic signature of patients most likely to respond to these
      therapies is largely unknown. To understand the significance of targeting the
      PI3K/mTOR pathway in advanced prostate cancer driven by PTEN +/\u2212 p53 loss,
      we evaluated the impact of GSK458 (a dual PI3K/mTOR inhibitor) in prostate-specific
      PTEN/p53 double knockout mice and prostate-specific PTEN-knockout mice. The
      mice were imaged by synchronized 18 FDG-PET and T2-weighted MRI, respectively,
      for baseline tumor metabolic and volumetric assessment prior to drug administration.
      GSK458 was administered at 3 mg/kg by daily oral gavage for 3 weeks with serial
      18 FDG-PET and T2-weighted MRI imaging at 2 days, 1 week, 2 weeks and 3 weeks
      after initiation of treatment, followed by sacrifice, prostate harvest and standard
      hisopathologic and immunohistochemical staining. GSK458 treatment of PTEN/p53-deficient
      and PTEN-deficient mice results in target inhibition, based on pharmacodynamic
      assessment by 18 FDG-PET uptake. MRI and histopathologic analysis demonstrate
      that there is a significant reduction, but not complete regression of tumor
      burden in both intraepithelial and poorly differentiated atypical components
      within stroma and partial stromal collapse following 3 weeks of GSK458 treatment.
      These data highlight the feasibility of monitoring dual pharmacodynamics/antitumor
      effects of PI3K-directed therapies using 18 FDG-PET/MRI imaging and underscore
      the utility of genetically engineered mouse models to predict response to targeted
      therapies in genetically stratified human clinical trials. The evaluation of
      PI3K-isoform specific inhibitors and the design of rational combinations to
      overcome de novo and acquired resistance mechanisms to PI3K-directed therapies
      are currently being explored in multiple genetically engineered mouse model
      systems. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings
      of the 102nd Annual Meeting of the American Association for Cancer Research;
      2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract
      nr LB-418. doi:10.1158/1538-7445.AM2011-LB-418", "venue": "", "year": 2011,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Engineering", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2011-04-15", "journal": {"volume": "71", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Patnaik2011AbstractLT,\n author = {Akash Patnaik and K.
      Courtney and G. Bellinger and E. Lunsford and K. Robichaud and A. Grant and
      R. Lenkinski and I. Pedrosa and S. Signoretti and R. Wooster and L. Cantley},\n
      journal = {Cancer Research},\n title = {Abstract LB-418: Targeting the PI3K/mTOR
      pathway in genetically engineered mouse models of prostate cancer},\n volume
      = {71},\n year = {2011}\n}\n"}, "authors": [{"authorId": "40501341", "name":
      "Akash Patnaik"}, {"authorId": "13782167", "name": "K. Courtney"}, {"authorId":
      "5679020", "name": "G. Bellinger"}, {"authorId": "3772950", "name": "E. Lunsford"},
      {"authorId": "40638403", "name": "K. Robichaud"}, {"authorId": "33624537", "name":
      "A. Grant"}, {"authorId": "2177723", "name": "R. Lenkinski"}, {"authorId": "3135556",
      "name": "I. Pedrosa"}, {"authorId": "7505152", "name": "S. Signoretti"}, {"authorId":
      "46825918", "name": "R. Wooster"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "ed22246af3a264953ab2e9e6912256fa0a4a240a", "externalIds": {"MAG":
      "2063082413", "DOI": "10.1158/1538-7445.AM2011-SY34-01", "CorpusId": 84854706},
      "corpusId": 84854706, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/ed22246af3a264953ab2e9e6912256fa0a4a240a",
      "title": "Abstract SY34-01: Biomarkers for predicting response to PI3K inhibitors",
      "abstract": "Proceedings: AACR 102nd Annual Meeting 2011\u2010\u2010 Apr 2\u20106,
      2011; Orlando, FL\n\nPhosphoinositide 3-kinase (PI 3-kinase) is a central enzyme
      in a signaling pathway that mediates cellular responses to growth factors. The
      pathway is highly conserved from worms and flies to humans and genetic analysis
      of the pathway has revealed a conserved role in regulating glucose metabolism,
      cell growth and organism longevity. Based on deletion of genes encoding the
      catalytic or regulatory subunits of PI 3-kinase in the mouse, PI 3-kinase mediates
      insulin-dependent regulation of glucose metabolism, and defects in activation
      of this pathway result in insulin resistance and type 2 diabetes. In contrast,
      mutational events that lead to hyperactivation of PI 3-kinase result in cancers.
      Activating mutations in PIK3CA, encoding the p110alpha catalytic subunit of
      PI 3-kinase or inactivating mutations in PTEN, a phosphoinositide 3-phosphatases
      that reverses the effects of PI 3-kinase, are among the most common events in
      solid tumors. We, and others have generated mouse models in which a mutated
      form of the PIK3CA gene is expressed in a tissue-specific and reversibly inducible
      manner. These mice develop cancers that are dependent on continuous expression
      of the mutant PIK3CA gene. The PIK3CA driven tumors are FDG-PET positive and
      turning off PI 3-kinase with drugs results in an acute decline in FDG-PET signal
      that precedes tumor shrinkage. These results suggest that the ability of PI
      3-kinase to stimulate high rates of glucose uptake and metabolism may be critical
      for the survival of PIK3CA mutant tumors.\n\nCitation Format: {Authors}. {Abstract
      title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American
      Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA):
      AACR; Cancer Res 2011;71(8 Suppl):Abstract nr SY34-01. doi:10.1158/1538-7445.AM2011-SY34-01",
      "venue": "", "year": 2011, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2011-04-15", "journal": {"volume":
      "71", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Cantley2011AbstractSB,\n
      author = {L. Cantley},\n journal = {Cancer Research},\n title = {Abstract SY34-01:
      Biomarkers for predicting response to PI3K inhibitors},\n volume = {71},\n year
      = {2011}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "f23d5737db9aeb1a1abd5ca4531eed7ffe2925d3", "externalIds": {"MAG":
      "2030733555", "DOI": "10.1172/JCI57909", "CorpusId": 4969082, "PubMed": "21985784"},
      "corpusId": 4969082, "publicationVenue": {"id": "8c9a9e1b-acf2-4274-8d73-6ea0ecd11fd1",
      "name": "Journal of Clinical Investigation", "type": "journal", "alternate_names":
      ["J Clin Investig"], "issn": "0021-9738", "url": "https://www.jci.org/", "alternate_urls":
      ["http://www.jci.org/", "https://www.jci.org/archive", "http://www.jci.org/impact"]},
      "url": "https://www.semanticscholar.org/paper/f23d5737db9aeb1a1abd5ca4531eed7ffe2925d3",
      "title": "Receptor tyrosine kinases exert dominant control over PI3K signaling
      in human KRAS mutant colorectal cancers.", "abstract": "Therapies inhibiting
      receptor tyrosine kinases (RTKs) are effective against some human cancers when
      they lead to simultaneous downregulation of PI3K/AKT and MEK/ERK signaling.
      However, mutant KRAS has the capacity to directly activate ERK and PI3K signaling,
      and this is thought to underlie the resistance of KRAS mutant cancers to RTK
      inhibitors. Here, we have elucidated the molecular regulation of both the PI3K/AKT
      and MEK/ERK signaling pathways in KRAS mutant colorectal cancer cells and identified
      combination therapies that lead to robust cancer cell apoptosis. KRAS knockdown
      using shRNA suppressed ERK signaling in all of the human KRAS mutant colorectal
      cancer cell lines examined. However, no decrease, and actually a modest increase,
      in AKT phosphorylation was often seen. By performing PI3K immunoprecipitations,
      we determined that RTKs, often IGF-IR, regulated PI3K signaling in the KRAS
      mutant cell lines. This conclusion was also supported by the observation that
      specific RTK inhibition led to marked suppression of PI3K signaling and biochemical
      assessment of patient specimens. Interestingly, combination of RTK and MEK inhibitors
      led to concomitant inhibition of PI3K and MEK signaling, marked growth suppression,
      and robust apoptosis of human KRAS mutant colorectal cancer cell lines in vitro
      and upon xenografting in mice. These findings provide a framework for utilizing
      RTK inhibitors in the treatment of KRAS mutant colorectal cancers.", "venue":
      "Journal of Clinical Investigation", "year": 2011, "referenceCount": 57, "citationCount":
      200, "influentialCitationCount": 18, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.jci.org/articles/view/57909/files/pdf", "status": null},
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2011-11-01", "journal":
      {"volume": "121 11", "pages": "\n          4311-21\n        ", "name": "The
      Journal of clinical investigation"}, "citationStyles": {"bibtex": "@Article{Ebi2011ReceptorTK,\n
      author = {H. Ebi and R. Corcoran and Anurag Singh and Zhao Chen and Youngchul
      Song and E. Lifshits and D. Ryan and J. Meyerhardt and C. Benes and J. Settleman
      and Kwok-kin Wong and L. Cantley and J. Engelman},\n booktitle = {Journal of
      Clinical Investigation},\n journal = {The Journal of clinical investigation},\n
      pages = {\n          4311-21\n        },\n title = {Receptor tyrosine kinases
      exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.},\n
      volume = {121 11},\n year = {2011}\n}\n"}, "authors": [{"authorId": "1899940",
      "name": "H. Ebi"}, {"authorId": "5956914", "name": "R. Corcoran"}, {"authorId":
      "153342143", "name": "Anurag Singh"}, {"authorId": "1491946371", "name": "Zhao
      Chen"}, {"authorId": "4846062", "name": "Youngchul Song"}, {"authorId": "144609942",
      "name": "E. Lifshits"}, {"authorId": "2946715", "name": "D. Ryan"}, {"authorId":
      "3859322", "name": "J. Meyerhardt"}, {"authorId": "1714039", "name": "C. Benes"},
      {"authorId": "88647391", "name": "J. Settleman"}, {"authorId": "32596484", "name":
      "Kwok-kin Wong"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "6828387", "name": "J. Engelman"}]}, {"paperId": "f48a646988ffee21399639bef5d12b7ef86d529a",
      "externalIds": {"MAG": "1506178278", "DOI": "10.1016/j.molcel.2011.11.005",
      "CorpusId": 17520689, "PubMed": "22137581"}, "corpusId": 17520689, "publicationVenue":
      {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11", "name": "Molecules and Cells",
      "type": "journal", "alternate_names": ["Molecular Cell", "Mol Cell"], "issn":
      "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"], "url": "https://link.springer.com/journal/10059",
      "alternate_urls": ["http://www.molcells.org/about/sub06.html", "http://www.molecule.org/",
      "http://www.sciencedirect.com/science/journal/10972765", "http://www.cell.com/molecular-cell/"]},
      "url": "https://www.semanticscholar.org/paper/f48a646988ffee21399639bef5d12b7ef86d529a",
      "title": "Chemical genetic screen for AMPK\u03b12 substrates uncovers a network
      of proteins involved in mitosis.", "abstract": null, "venue": "Molecules and
      Cells", "year": 2011, "referenceCount": 75, "citationCount": 233, "influentialCitationCount":
      16, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276511008550/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2011-12-01", "journal": {"volume": "44 6", "pages": "\n          878-92\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Banko2011ChemicalGS,\n
      author = {M. Banko and J. Allen and Bethany E. Schaffer and E. Wilker and P.
      Tsou and Jamie L. White and J. Ville\u0301n and Beatrice T. Wang and Sara R
      Kim and K. Sakamoto and S. Gygi and L. Cantley and M. Yaffe and K. Shokat and
      A. Brunet},\n booktitle = {Molecules and Cells},\n journal = {Molecular cell},\n
      pages = {\n          878-92\n        },\n title = {Chemical genetic screen for
      AMPK\u03b12 substrates uncovers a network of proteins involved in mitosis.},\n
      volume = {44 6},\n year = {2011}\n}\n"}, "authors": [{"authorId": "3534122",
      "name": "M. Banko"}, {"authorId": "3996589", "name": "J. Allen"}, {"authorId":
      "31358846", "name": "Bethany E. Schaffer"}, {"authorId": "50693404", "name":
      "E. Wilker"}, {"authorId": "143971134", "name": "P. Tsou"}, {"authorId": "144206424",
      "name": "Jamie L. White"}, {"authorId": "1705488", "name": "J. Ville\u0301n"},
      {"authorId": "2109253161", "name": "Beatrice T. Wang"}, {"authorId": "1508120753",
      "name": "Sara R Kim"}, {"authorId": "152590916", "name": "K. Sakamoto"}, {"authorId":
      "2665934", "name": "S. Gygi"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "88402408", "name": "M. Yaffe"}, {"authorId": "143818078", "name":
      "K. Shokat"}, {"authorId": "47295224", "name": "A. Brunet"}]}, {"paperId": "f774644cf805bc0c4add320c02178d7c28368a49",
      "externalIds": {"MAG": "1573141912", "DOI": "10.1126/science.1211485", "CorpusId":
      29899342, "PubMed": "22052977"}, "corpusId": 29899342, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/f774644cf805bc0c4add320c02178d7c28368a49",
      "title": "Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes
      to Cellular Antioxidant Responses", "abstract": "The glycolytic metabolism of
      cancers differs from normal tissues, allowing tumor cells to survive under oxidative
      stress. Control of intracellular reactive oxygen species (ROS) concentrations
      is critical for cancer cell survival. We show that, in human lung cancer cells,
      acute increases in intracellular concentrations of ROS caused inhibition of
      the glycolytic enzyme pyruvate kinase M2 (PKM2) through oxidation of Cys358.
      This inhibition of PKM2 is required to divert glucose flux into the pentose
      phosphate pathway and thereby generate sufficient reducing potential for detoxification
      of ROS. Lung cancer cells in which endogenous PKM2 was replaced with the Cys358
      to Ser358 oxidation-resistant mutant exhibited increased sensitivity to oxidative
      stress and impaired tumor formation in a xenograft model. Besides promoting
      metabolic changes required for proliferation, the regulatory properties of PKM2
      may confer an additional advantage to cancer cells by allowing them to withstand
      oxidative stress.", "venue": "Science", "year": 2011, "referenceCount": 33,
      "citationCount": 1019, "influentialCitationCount": 55, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://www.science.org/cms/asset/82474f4e-007f-43d9-845c-3db47f447586/pap.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Chemistry", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2011-11-01", "journal":
      {"volume": "334", "pages": "1278 - 1283", "name": "Science"}, "citationStyles":
      {"bibtex": "@Article{Anastasiou2011InhibitionOP,\n author = {D. Anastasiou and
      G. Poulogiannis and J. Asara and M. Boxer and Jian-Kang Jiang and M. Shen and
      G. Bellinger and A. Sasaki and J. Locasale and D. Auld and Craig J. Thomas and
      M. V. Vander Heiden and L. Cantley},\n booktitle = {Science},\n journal = {Science},\n
      pages = {1278 - 1283},\n title = {Inhibition of Pyruvate Kinase M2 by Reactive
      Oxygen Species Contributes to Cellular Antioxidant Responses},\n volume = {334},\n
      year = {2011}\n}\n"}, "authors": [{"authorId": "46996935", "name": "D. Anastasiou"},
      {"authorId": "4612853", "name": "G. Poulogiannis"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "3275486", "name": "M. Boxer"}, {"authorId":
      "4084746", "name": "Jian-Kang Jiang"}, {"authorId": "145829790", "name": "M.
      Shen"}, {"authorId": "5679020", "name": "G. Bellinger"}, {"authorId": "47742211",
      "name": "A. Sasaki"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId":
      "2607088", "name": "D. Auld"}, {"authorId": "2148769632", "name": "Craig J.
      Thomas"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "fb13058dbf5f65a98669bc2ff96f7012b44ec1a2",
      "externalIds": {"MAG": "2902408540", "DOI": "10.3410/f.1383974.14782147", "CorpusId":
      92672560}, "corpusId": 92672560, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/fb13058dbf5f65a98669bc2ff96f7012b44ec1a2",
      "title": "Faculty of 1000 evaluation for Q''s next: the diverse functions of
      glutamine in metabolism, cell biology and cancer.", "abstract": null, "venue":
      "", "year": 2011, "referenceCount": 0, "citationCount": 30, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://f1000.com/download/1383974",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2011-12-19", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Cantley2011FacultyO1,\n author = {L. Cantley},\n
      title = {Faculty of 1000 evaluation for Q''s next: the diverse functions of
      glutamine in metabolism, cell biology and cancer.},\n year = {2011}\n}\n"},
      "authors": [{"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "06a531252a14f358a36fc664b45e454306489b62",
      "externalIds": {"MAG": "2238925984", "DOI": "10.7490/F1000RESEARCH.413.1", "CorpusId":
      83230986}, "corpusId": 83230986, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/06a531252a14f358a36fc664b45e454306489b62",
      "title": "A Mass Spectrometry Platform to Quantitatively Profile Cancer Cell
      Metabolism from Cell Lines to Tissues.", "abstract": "RP-60 \n \nThe metabolic
      requirements of cancer and proliferating cells are different from that of normal
      differential tissue (the Warburg effect) and may have diverse applications in
      the treatment of cancers and other neoplastic diseases. However, many of the
      molecular mechanisms that conspire to reorganize metabolism to support cell
      proliferation are unknown. To study the mechanisms of cancer cell metabolism,
      we have implemented a mass spectrometry based platform to robustly quantitatively
      profile endogenous metabolites from proliferating cell lines and tumor tissues
      to extensively study cancer cell metabolism. Cell lines are derived from several
      cancers including lung, multiple myeloma and prostate, as well as from a fast
      proliferating Drosophila cell line. In addition, endogenous and Xenograft tumor
      tissue from tumors such as prostate are profiled before and after drug treatments.
      We routinely target nearly 250 metabolites using multiple reaction monitoring
      (MRM) based analyses with an AB/Sciex 5500 QTRAP mass spectrometer coupled to
      a Shimadzu UFLC using normal phase Hydrophilic interaction chromatography (HILIC)
      at pH=9.0 with positive/negative switching within the same experimental 25 minute
      LC/MS/MS run. For a single experiment, our platform allows for unprecedented
      sensitivity, quantitation and coverage of metabolites that comprise of diverse
      metabolic pathways from as little as a single 6 cm tissue culture dish of cells
      or approximately 3 million cells from tissue samples. We find that 2.00mm id
      x 10cm Luna NH2 HILIC columns (Phenomenex) at 250uL/min perform well in both
      negative and positive ion mode and that the sampling rate of the instrument
      is sufficiently fast to effectively capture up to 300 metabolite targets within
      approximately a 20-25 minute gradient without the need for scheduled MRM runs
      resulting in a cycle time of approximately 2 seconds with 5ms dwell times. Peak
      areas of metabolites are integrated post run using MultiQuant 1.1 software (Applied
      Biosystems). Peak areas from triplicate runs are then clustered using hierarchical
      clustering and statistical analyses are applied in order to generate P values
      for metabolite changes over different cellular conditions. We have also carried
      out preliminary studies to probe flux in pathways by targeting a set of 13C
      labeled metabolites from experiments where 13C labeled glucose is added to cells.
      Using this platform, we have observed the metabolic effects of growth factor
      signaling by analyzing metabolites from serum-starved versus serum-fed cells
      derived from several cancers. We have also analyzed the metabolism of a Drosophila
      model cell line after stimulation with Insulin and EGF (Spitz) to examine if
      growth factor induced metabolic changes are evolutionarily conserved. Using
      metabolic inhibitors, such as Iodoacetic acid and KCN, we have also been able
      to characterize the consequences of inhibiting glycolysis and oxidative phosphorylation,
      respectively. Finally, we considered a dual-pan PI3K/mTOR catalytic site inhibitor
      and measured its effects on metabolism in a proliferating breast epithelial
      cell line. In addition, we have profiled cerebral spinal fluid (CSF) from gliobastoma
      (GBM) patients and noticed several metabolioc profiles that are unique to GBM
      patients with mutated genes.", "venue": "", "year": 2010, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2010-08-13",
      "journal": {"volume": "21", "name": "Journal of biomolecular techniques"}, "citationStyles":
      {"bibtex": "@Article{Yang2010AMS,\n author = {Xuemei Yang and R. Rahal and J.
      Locasale and S. Song and L. Cantley and E. Wong and N. Perrimon and M. V. Heiden
      and J. Asara},\n journal = {Journal of biomolecular techniques},\n title = {A
      Mass Spectrometry Platform to Quantitatively Profile Cancer Cell Metabolism
      from Cell Lines to Tissues.},\n volume = {21},\n year = {2010}\n}\n"}, "authors":
      [{"authorId": "48520140", "name": "Xuemei Yang"}, {"authorId": "49680398", "name":
      "R. Rahal"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "2107567131",
      "name": "S. Song"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "1913037", "name": "E. Wong"}, {"authorId": "2001255", "name": "N. Perrimon"},
      {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId": "3028470", "name":
      "J. Asara"}]}, {"paperId": "07eff9fae82bc5c49df806d09333971fdc7db6ad", "externalIds":
      {"MAG": "2112313590", "DOI": "10.1128/MCB.01105-09", "CorpusId": 35649091, "PubMed":
      "20086096"}, "corpusId": 35649091, "publicationVenue": {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b",
      "name": "Molecular and Cellular Biology", "type": "journal", "alternate_names":
      ["Mol Cell Biology"], "issn": "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls":
      ["http://mcb.asm.org/"]}, "url": "https://www.semanticscholar.org/paper/07eff9fae82bc5c49df806d09333971fdc7db6ad",
      "title": "Characterization of PXK as a Protein Involved in Epidermal Growth
      Factor Receptor Trafficking", "abstract": "ABSTRACT The phox homology (PX) domain
      is a phosphoinositide-binding module that typically binds phosphatidylinositol
      3-phosphate. Out of 47 mammalian proteins containing PX domains, more than 30
      are denoted sorting nexins and several of these have been implicated in internalization
      of cell surface proteins to the endosome, where phosphatidylinositol-3-phosphate
      is concentrated. Here we investigated a multimodular protein termed PXK, composed
      of a PX domain, a protein kinase-like domain, and a WASP homology 2 domain.
      We show that the PX domain of PXK localizes this protein to the endosomal membrane
      via binding to phosphatidylinositol 3-phosphate. PXK expression in COS7 cells
      accelerated the ligand-induced internalization and degradation of epidermal
      growth factor receptors by a mechanism requiring phosphatidylinositol 3-phosphate
      binding but not involving the WASP homology 2 domain. Conversely, depletion
      of PXK using RNA interference decreased the rate of epidermal growth factor
      receptor internalization and degradation. Ubiquitination of epidermal growth
      factor receptor by the ligand stimulation was enhanced in PXK-expressing cells.
      These results indicate that PXK plays a critical role in epidermal growth factor
      receptor trafficking through modulating ligand-induced ubiquitination of the
      receptor.", "venue": "Molecular and Cellular Biology", "year": 2010, "referenceCount":
      77, "citationCount": 28, "influentialCitationCount": 3, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2838084?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2010-01-19", "journal": {"volume": "30",
      "pages": "1689 - 1702", "name": "Molecular and Cellular Biology"}, "citationStyles":
      {"bibtex": "@Article{Takeuchi2010CharacterizationOP,\n author = {H. Takeuchi
      and T. Takeuchi and Jing Gao and L. Cantley and M. Hirata},\n booktitle = {Molecular
      and Cellular Biology},\n journal = {Molecular and Cellular Biology},\n pages
      = {1689 - 1702},\n title = {Characterization of PXK as a Protein Involved in
      Epidermal Growth Factor Receptor Trafficking},\n volume = {30},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "46914940", "name": "H. Takeuchi"}, {"authorId": "2115094818",
      "name": "T. Takeuchi"}, {"authorId": "2115556384", "name": "Jing Gao"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "144519906", "name": "M. Hirata"}]},
      {"paperId": "0c385479fb72a13e819d76ef724eb50c05553a1a", "externalIds": {"MAG":
      "2038424997", "DOI": "10.1042/BJ20090380", "CorpusId": 36558141, "PubMed": "19857203"},
      "corpusId": 36558141, "publicationVenue": {"id": "64838252-a209-4424-a778-3b86b4a83c48",
      "name": "Biochemical Journal", "type": "journal", "alternate_names": ["Biochem
      J"], "issn": "0264-6021", "alternate_issns": ["0006-2936"], "url": "http://www.biochemj.org/"},
      "url": "https://www.semanticscholar.org/paper/0c385479fb72a13e819d76ef724eb50c05553a1a",
      "title": "Development of an intracellularly acting inhibitory peptide selective
      for PKN.", "abstract": "PKNs form a subfamily of the AGC serine/threonine protein
      kinases, and have a catalytic domain homologous with that of PKC (protein kinase
      C) in the C-terminal region and three characteristic ACC (antiparallel coiled-coil)
      domain repeats in the N-terminal region. The preferred peptide phosphorylation
      motif for PKNs determined by a combinatorial peptide library method was highly
      similar to that of PKCs within a 10-amino-acid stretch. Previously reported
      PKN inhibitory compounds also inhibit PKCs to a similar extent, and no PKN selective
      inhibitors have been commercially available. We have identified a 15-amino-acid
      peptide inhibitor of PKNs based on amino acids 485-499 of the C-terminal region
      of the C2-like domain of PKN1. This peptide, designated as PRL, selectively
      inhibits the kinase activity of all isoforms of PKN (Ki=0.7 muM) towards a peptide
      substrate, as well as autophosphorylation activity of PKN in vitro, in contrast
      with PKC. Reversible conjugation by a disulfide bond of a carrier peptide bearing
      a penetration accelerating sequence to PRL, facilitated the cellular uptake
      of this peptide and significantly inhibited phosphorylation of tau by PKN1 at
      the PKN1-specific phosphorylation site in vivo. This peptide may serve as a
      valuable tool for investigating PKN activation and PKN-mediated responses.",
      "venue": "Biochemical Journal", "year": 2010, "referenceCount": 62, "citationCount":
      20, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc3755880?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Chemistry",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2010-01-15", "journal":
      {"volume": "425 2", "pages": "\n          445-53\n        ", "name": "The Biochemical
      journal"}, "citationStyles": {"bibtex": "@Article{Shiga2010DevelopmentOA,\n
      author = {Kazuhiro Shiga and Kentaro Takayama and S. Futaki and Jessica E. Hutti
      and L. Cantley and K. Ueki and Y. Ono and H. Mukai},\n booktitle = {Biochemical
      Journal},\n journal = {The Biochemical journal},\n pages = {\n          445-53\n        },\n
      title = {Development of an intracellularly acting inhibitory peptide selective
      for PKN.},\n volume = {425 2},\n year = {2010}\n}\n"}, "authors": [{"authorId":
      "2074613771", "name": "Kazuhiro Shiga"}, {"authorId": "8210553", "name": "Kentaro
      Takayama"}, {"authorId": "3953054", "name": "S. Futaki"}, {"authorId": "6742227",
      "name": "Jessica E. Hutti"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "32288616", "name": "K. Ueki"}, {"authorId": "47167461", "name":
      "Y. Ono"}, {"authorId": "2463839", "name": "H. Mukai"}]}, {"paperId": "114d8e66a557f837bc8a25847410adb6c4f27f7b",
      "externalIds": {"MAG": "2071759747", "DOI": "10.1158/1538-7445.AM10-34", "CorpusId":
      85201222}, "corpusId": 85201222, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/114d8e66a557f837bc8a25847410adb6c4f27f7b",
      "title": "Abstract 34: Oncogenic tyrosine kinases phosphorylate and inhibit
      PKM2 to provide a metabolic advantage to tumor growth", "abstract": "Proceedings:
      AACR 101st Annual Meeting 2010\u2010\u2010 Apr 17\u201021, 2010; Washington,
      DC\n\nCancer cells show increased aerobic glycolysis and enhanced lactate production
      compared to healthy cells, a phenomenon known as the Warburg effect. Cell surface
      growth factor receptors, which often carry tyrosine kinase activities in their
      cytoplasmic domains, are overexpressed in many human cancers and are believed
      to play a key role in determining cell metabolism. Thus, we explored the hypothesis
      that tyrosine kinase signaling, which is commonly increased in tumors, regulates
      the Warburg effect and contributes to tumorigenesis and maintenance of the tumor.\n\nWe
      performed phospho-proteomics studies and found that oncogenic forms of fibroblast
      growth factor (FGF) receptor type 1 (FGFR1) inhibit the pyruvate kinase M2 isoform
      (PKM2) in cancer cells. Pyruvate kinase is a rate-limiting enzyme during glycolysis
      and catalyzes the production of pyruvate and ATP from phosphoenolpyruvate (PEP)
      and ADP. Recent studies demonstrated that the enzymatic activity of the pyruvate
      kinase M2 isoform (PKM2) is inhibited by phosphotyrosine binding; moreover,
      these researchers found that PKM2 is crucial for aerobic glycolysis and provides
      a growth advantage to tumors. However, it remains unclear which tyrosine kinase
      pathways are physiologically responsible for this inhibition of PKM2 activity
      and which protein factors undergo tyrosine phosphorylation, allowing them to
      bind to and thereby inhibit PKM2. We found that PKM2 is itself tyrosine phosphorylated
      in cancer cells and such a physiological modification of PKM2 promotes the switch
      to aerobic glycolysis from oxidative phosphorylation. FGFR1 directly phosphorylates
      PKM2 at tyrosine residue 105 (Y105). This inhibits the formation of active,
      tetrameric PKM2 by disrupting binding of the PKM2 cofactor fructose-1,6-bisphosphate
      (FBP). Moreover, we found that phosphorylation of PKM2 Y105 is common in human
      cancers. Immunoblotting revealed that PKM2 is phosphorylated at Y105 in diverse
      human breast cancer, lung cancer, prostate cancer and leukemia cell lines. Oncogenic
      tyrosien kianses including BCR-ABL, FLT3-ITD and JAK2 also directly phosphorylate
      PKM2 Y105 in in vitro kinase assays using purified proteins. Furthermore, the
      presence of a PKM2 mutant in which phenylalanine is substituted for Y105 (Y105F)
      in cancer cells leads to decreased cell proliferation under hypoxic conditions,
      increased oxidative phosphorylation with reduced lactate production, and reduced
      tumor growth in xenografts in nude mice.\n\nOur findings suggest that tyrosine
      phosphorylation regulates PKM2 to provide a metabolic advantage to tumor cells,
      thereby promoting tumor growth. This may represent a common, short-term molecular
      mechanism underlying the Warburg effect in both leukemias and solid tumors,
      in addition to the chronic changes believed to be regulated by transcription
      factors, including hypoxia inducible factor 1 and Myc.\n\nCitation Format: {Authors}.
      {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of
      the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC.
      Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 34.", "venue":
      "", "year": 2010, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2010-04-15", "journal": {"volume":
      "70", "pages": "34-34", "name": "Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Hitosugi2010Abstract3O,\n author = {T. Hitosugi and Sumin Kang and
      M. V. Heiden and Tae-Wook Chung and S. Lonial and Xu Wang and G. Chen and Jianxin
      Xie and T. Gu and R. Polakiewicz and J. Roesel and T. Boggon and F. Khuri and
      D. Gilliland and L. Cantley and J. Kaufman and J. Chen},\n journal = {Cancer
      Research},\n pages = {34-34},\n title = {Abstract 34: Oncogenic tyrosine kinases
      phosphorylate and inhibit PKM2 to provide a metabolic advantage to tumor growth},\n
      volume = {70},\n year = {2010}\n}\n"}, "authors": [{"authorId": "5648825", "name":
      "T. Hitosugi"}, {"authorId": "6357969", "name": "Sumin Kang"}, {"authorId":
      "35413264", "name": "M. V. Heiden"}, {"authorId": "2151016785", "name": "Tae-Wook
      Chung"}, {"authorId": "4891579", "name": "S. Lonial"}, {"authorId": "2108598823",
      "name": "Xu Wang"}, {"authorId": "32401310", "name": "G. Chen"}, {"authorId":
      "143740055", "name": "Jianxin Xie"}, {"authorId": "40075084", "name": "T. Gu"},
      {"authorId": "4032764", "name": "R. Polakiewicz"}, {"authorId": "6151924", "name":
      "J. Roesel"}, {"authorId": "3907849", "name": "T. Boggon"}, {"authorId": "5531063",
      "name": "F. Khuri"}, {"authorId": "2246160", "name": "D. Gilliland"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5224106", "name": "J. Kaufman"},
      {"authorId": "5152140", "name": "J. Chen"}]}, {"paperId": "13c26c21b7feeff49d9420445da524d35e8f54d6",
      "externalIds": {"MAG": "2257121093", "CorpusId": 88164633}, "corpusId": 88164633,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/13c26c21b7feeff49d9420445da524d35e8f54d6",
      "title": "Role of the PI 3-kinase signaling pathway in cell regulation and human
      disease", "abstract": null, "venue": "", "year": 2010, "referenceCount": 0,
      "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2010-11-30", "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Cantley2010RoleOT,\n
      author = {L. Cantley},\n title = {Role of the PI 3-kinase signaling pathway
      in cell regulation and human disease},\n year = {2010}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "1ef31d2cc1117e28d103a02e9026b095e3d51e7e",
      "externalIds": {"MAG": "1557882277", "DOI": "10.1158/0008-5472.CAN-09-3399",
      "CorpusId": 23377345, "PubMed": "20530665"}, "corpusId": 23377345, "publicationVenue":
      {"id": "b0bd78b2-6591-460e-af71-196409b62e2c", "name": "Cancer Research", "type":
      "journal", "alternate_names": ["Cancer Res"], "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/",
      "alternate_urls": ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/1ef31d2cc1117e28d103a02e9026b095e3d51e7e",
      "title": "The phosphoinositide 3-kinase regulatory subunit p85alpha can exert
      tumor suppressor properties through negative regulation of growth factor signaling.",
      "abstract": "Phosphoinositide 3-kinase (PI3K) plays a critical role in tumorigenesis,
      and the PI3K p85 regulatory subunit exerts both positive and negative effects
      on signaling. Expression of Pik3r1, the gene encoding p85, is decreased in human
      prostate, lung, ovarian, bladder, and liver cancers, consistent with the possibility
      that p85 has tumor suppressor properties. We tested this hypothesis by studying
      mice with a liver-specific deletion of the Pik3r1 gene. These mice exhibited
      enhanced insulin and growth factor signaling and progressive changes in hepatic
      pathology, leading to the development of aggressive hepatocellular carcinomas
      with pulmonary metastases. Liver tumors that arose exhibited markedly elevated
      levels of phosphatidylinositol (3,4,5)-trisphosphate, along with Akt activation
      and decreased PTEN expression, at both the mRNA and protein levels. Together,
      these results substantiate the concept that the p85 subunit of PI3K has a tumor-suppressive
      role in the liver and possibly other tissues.", "venue": "Cancer Research",
      "year": 2010, "referenceCount": 53, "citationCount": 122, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/cancerres/article-pdf/70/13/5305/2638055/5305.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2010-06-01", "journal": {"volume": "70 13", "pages": "\n          5305-15\n        ",
      "name": "Cancer research"}, "citationStyles": {"bibtex": "@Article{Taniguchi2010TheP3,\n
      author = {C. Taniguchi and J. Winnay and Tatsuya Kondo and R. Bronson and A.
      Guimaraes and J. Alem\u00e1n and Ji Luo and G. Stephanopoulos and R. Weissleder
      and L. Cantley and C. Kahn},\n booktitle = {Cancer Research},\n journal = {Cancer
      research},\n pages = {\n          5305-15\n        },\n title = {The phosphoinositide
      3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through
      negative regulation of growth factor signaling.},\n volume = {70 13},\n year
      = {2010}\n}\n"}, "authors": [{"authorId": "48311527", "name": "C. Taniguchi"},
      {"authorId": "3687146", "name": "J. Winnay"}, {"authorId": "16114256", "name":
      "Tatsuya Kondo"}, {"authorId": "40803408", "name": "R. Bronson"}, {"authorId":
      "2057465705", "name": "A. Guimaraes"}, {"authorId": "47567005", "name": "J.
      Alem\u00e1n"}, {"authorId": "145954100", "name": "Ji Luo"}, {"authorId": "1813278",
      "name": "G. Stephanopoulos"}, {"authorId": "3127756", "name": "R. Weissleder"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144391716", "name":
      "C. Kahn"}]}, {"paperId": "2439e559caaf2918cf435879a72b69dfd5867ea0", "externalIds":
      {"MAG": "1988097276", "DOI": "10.4161/CC.9.21.13925", "CorpusId": 19530489,
      "PubMed": "21045562"}, "corpusId": 19530489, "publicationVenue": {"id": "1bce1796-d800-4a09-91e5-d3e3ed025037",
      "name": "Cell Cycle", "type": "journal", "issn": "1551-4005", "url": "http://www.landesbioscience.com/journals/cc/",
      "alternate_urls": ["http://www.tandfonline.com/loi/kccy20"]}, "url": "https://www.semanticscholar.org/paper/2439e559caaf2918cf435879a72b69dfd5867ea0",
      "title": "Rewiring of glycolysis in cancer cell metabolism", "abstract": "Comment
      on: Vander Heiden MG, et al. Science 2010; 329:1492-9.", "venue": "Cell Cycle",
      "year": 2010, "referenceCount": 0, "citationCount": 30, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.tandfonline.com/doi/pdf/10.4161/cc.9.21.13925?needAccess=true",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["Editorial"], "publicationDate": "2010-11-01", "journal": {"volume": "9", "pages":
      "4253 - 4253", "name": "Cell Cycle"}, "citationStyles": {"bibtex": "@Article{Locasale2010RewiringOG,\n
      author = {J. Locasale and M. V. Vander Heiden and L. Cantley},\n booktitle =
      {Cell Cycle},\n journal = {Cell Cycle},\n pages = {4253 - 4253},\n title = {Rewiring
      of glycolysis in cancer cell metabolism},\n volume = {9},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "3804233",
      "name": "M. V. Vander Heiden"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "34bc4d15e1b1f97e8ccbf8bb2fd20407f06c202e", "externalIds": {"MAG":
      "2780984082", "DOI": "10.1038/nature09132", "CorpusId": 4414182, "PubMed": "20559394"},
      "corpusId": 4414182, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/34bc4d15e1b1f97e8ccbf8bb2fd20407f06c202e",
      "title": "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate", "abstract":
      null, "venue": "Nature", "year": 2010, "referenceCount": 26, "citationCount":
      3482, "influentialCitationCount": 204, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://www.nature.com/articles/nature09132.pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": null, "journal":
      {"volume": "465", "pages": "966-966", "name": "Nature"}, "citationStyles": {"bibtex":
      "@Article{Dang2010CancerassociatedIM,\n author = {L. Dang and D. White and S.
      Gross and Bryson D. Bennett and M. Bittinger and E. Driggers and V. Fantin and
      H. G. Jang and Shengfang Jin and M. Keenan and K. Marks and R. Prins and P.
      Ward and K. Yen and L. Liau and J. Rabinowitz and L. Cantley and C. Thompson
      and M. V. Heiden and Shinsan M. Su},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {966-966},\n title = {Cancer-associated IDH1 mutations produce 2-hydroxyglutarate},\n
      volume = {465},\n year = {2010}\n}\n"}, "authors": [{"authorId": "38799894",
      "name": "L. Dang"}, {"authorId": "143657476", "name": "D. White"}, {"authorId":
      "144707828", "name": "S. Gross"}, {"authorId": "36199097", "name": "Bryson D.
      Bennett"}, {"authorId": "3564730", "name": "M. Bittinger"}, {"authorId": "4691854",
      "name": "E. Driggers"}, {"authorId": "4936699", "name": "V. Fantin"}, {"authorId":
      "5240350", "name": "H. G. Jang"}, {"authorId": "5210229", "name": "Shengfang
      Jin"}, {"authorId": "46624965", "name": "M. Keenan"}, {"authorId": "145638995",
      "name": "K. Marks"}, {"authorId": "2148693", "name": "R. Prins"}, {"authorId":
      "35327932", "name": "P. Ward"}, {"authorId": "4886372", "name": "K. Yen"}, {"authorId":
      "5557307", "name": "L. Liau"}, {"authorId": "35264286", "name": "J. Rabinowitz"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2242436905", "name":
      "C. Thompson"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId":
      "4297092", "name": "Shinsan M. Su"}]}, {"paperId": "393e3ea5c41b8d2d88cf0178687a3b6edbfb468b",
      "externalIds": {"MAG": "2110134310", "DOI": "10.1126/scitranslmed.3001251",
      "CorpusId": 206676697, "PubMed": "20826838"}, "corpusId": 206676697, "publicationVenue":
      {"id": "1cd4baea-5ccc-4522-9dbf-0566f39d3b37", "name": "Science Translational
      Medicine", "type": "journal", "alternate_names": ["Sci Transl Med"], "issn":
      "1946-6234", "url": "https://stm.sciencemag.org/", "alternate_urls": ["https://stm.sciencemag.org/site/misc/about.xhtml"]},
      "url": "https://www.semanticscholar.org/paper/393e3ea5c41b8d2d88cf0178687a3b6edbfb468b",
      "title": "Targeting a Common Collaborator in Cancer Development", "abstract":
      "A small-molecule inhibitor of phosphatidylinositol 3-kinase enhances the cytotoxic
      effects of the common chemotherapeutic agent doxorubicin in breast and ovarian
      cancer cell lines. In this issue of Science Translational Medicine, Wallin et
      al. have identified a subset of breast and ovarian cancer cell lines that show
      synergistic response to the combination of doxorubicin and GDC-0941, a class
      IA phosphatidylinositol 3-kinase (PI3K) inhibitor. Here, we discuss the potential
      implications of these data on the clinical development of PI3K pathway inhibitors
      as cancer therapeutics.", "venue": "Science Translational Medicine", "year":
      2010, "referenceCount": 31, "citationCount": 32, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3425950?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle", "LettersAndComments"], "publicationDate":
      "2010-09-08", "journal": {"volume": "2", "pages": "48ps45 - 48ps45", "name":
      "Science Translational Medicine"}, "citationStyles": {"bibtex": "@Article{Myers2010TargetingAC,\n
      author = {A. Myers and L. Cantley},\n booktitle = {Science Translational Medicine},\n
      journal = {Science Translational Medicine},\n pages = {48ps45 - 48ps45},\n title
      = {Targeting a Common Collaborator in Cancer Development},\n volume = {2},\n
      year = {2010}\n}\n"}, "authors": [{"authorId": "6324437", "name": "A. Myers"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "3c4c747325b8eee2f4d587842951431dbc8f4fd4",
      "externalIds": {"CorpusId": 9137319}, "corpusId": 9137319, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/3c4c747325b8eee2f4d587842951431dbc8f4fd4",
      "title": "Pr R moprevention Meets Glucose Control", "abstract": "wnloade report
      by Memmott et al. (beginning on page 1066 in this issue of the journal) assessing
      the efficacy antidiabetes drug metformin in a mouse model of lung carcinogenesis
      suggests protective effects via ossible avenues: Decreased circulating insulin
      and insulin-like growth factor levels and energy stress g to inhibition of mammalian
      target of rapamycin signaling. These potential mechanisms are disleadin cussed
      in this perspective, as are their implications for cancer prevention and therapy.
      Cancer Prev Res; 3(9); 1049\u201352. \u00a92010 AACR.", "venue": "", "year":
      2010, "referenceCount": 46, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Engelman2010PrRM,\n
      author = {Y. Engelman and L. Cantley},\n title = {Pr R moprevention Meets Glucose
      Control},\n year = {2010}\n}\n"}, "authors": [{"authorId": "103572289", "name":
      "Y. Engelman"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "406beec9864c052113713ba06b5025054940802f", "externalIds": {"MAG": "2146042394",
      "DOI": "10.1158/1940-6207.CAPR-10-0178", "CorpusId": 43822428, "PubMed": "20810671"},
      "corpusId": 43822428, "publicationVenue": {"id": "30248bd8-0140-4a2a-b2f7-d817cf173fdd",
      "name": "Cancer Prevention Research", "type": "journal", "alternate_names":
      ["Cancer Prev Res"], "issn": "1940-6215", "url": "https://cancerpreventionresearch.aacrjournals.org/"},
      "url": "https://www.semanticscholar.org/paper/406beec9864c052113713ba06b5025054940802f",
      "title": "Chemoprevention Meets Glucose Control", "abstract": "The report by
      Memmott et al. (beginning on page 1066 in this issue of the journal) assessing
      the efficacy of the antidiabetes drug metformin in a mouse model of lung carcinogenesis
      suggests protective effects via two possible avenues: Decreased circulating
      insulin and insulin-like growth factor levels and energy stress leading to inhibition
      of mammalian target of rapamycin signaling. These potential mechanisms are discussed
      in this perspective, as are their implications for cancer prevention and therapy.
      Cancer Prev Res; 3(9); 1049\u201352. \u00a92010 AACR.", "venue": "Cancer Prevention
      Research", "year": 2010, "referenceCount": 31, "citationCount": 60, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "LettersAndComments"], "publicationDate": "2010-09-01", "journal": {"volume":
      "3", "pages": "1049 - 1052", "name": "Cancer Prevention Research"}, "citationStyles":
      {"bibtex": "@Article{Engelman2010ChemopreventionMG,\n author = {J. Engelman
      and L. Cantley},\n booktitle = {Cancer Prevention Research},\n journal = {Cancer
      Prevention Research},\n pages = {1049 - 1052},\n title = {Chemoprevention Meets
      Glucose Control},\n volume = {3},\n year = {2010}\n}\n"}, "authors": [{"authorId":
      "6828387", "name": "J. Engelman"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "43178192d84b1bcce32dadb8059a11124fe02f2b", "externalIds": {"MAG":
      "2054668653", "DOI": "10.1016/S1359-6349(10)71748-1", "CorpusId": 72809559},
      "corpusId": 72809559, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/43178192d84b1bcce32dadb8059a11124fe02f2b",
      "title": "43 Targeting PI3K: where are we?", "abstract": null, "venue": "",
      "year": 2010, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2010-11-01", "journal": {"volume":
      "8", "pages": "23", "name": "Ejc Supplements"}, "citationStyles": {"bibtex":
      "@Article{Cantley201043TP,\n author = {L. Cantley},\n journal = {Ejc Supplements},\n
      pages = {23},\n title = {43 Targeting PI3K: where are we?},\n volume = {8},\n
      year = {2010}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "45e4cd831750e7f8024683090632782817d76874", "externalIds": {"MAG":
      "2017496419", "DOI": "10.1016/j.bmcl.2010.04.015", "CorpusId": 13777093, "PubMed":
      "20451379"}, "corpusId": 13777093, "publicationVenue": {"id": "56cde9e1-007e-4232-b5ea-ac20f55c39e8",
      "name": "Bioorganic & Medicinal Chemistry Letters", "type": "journal", "alternate_names":
      ["Bioorganic  Med Chem Lett"], "issn": "0960-894X", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/0960894X",
      "https://www.journals.elsevier.com/bioorganic-and-medicinal-chemistry"]}, "url":
      "https://www.semanticscholar.org/paper/45e4cd831750e7f8024683090632782817d76874",
      "title": "Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators
      of the tumor cell specific M2 isoform of pyruvate kinase.", "abstract": null,
      "venue": "Bioorganic & Medicinal Chemistry Letters", "year": 2010, "referenceCount":
      35, "citationCount": 114, "influentialCitationCount": 4, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2874658?pdf=render",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2010-06-01", "journal": {"volume": "20 11", "pages": "\n          3387-93\n        ",
      "name": "Bioorganic & medicinal chemistry letters"}, "citationStyles": {"bibtex":
      "@Article{Jiang2010EvaluationOT,\n author = {Jian-Kang Jiang and M. Boxer and
      M. V. Vander Heiden and M. Shen and A. P. Skoumbourdis and Noel Southall and
      H. Veith and W. Leister and C. Austin and H. Park and James Inglese and L. Cantley
      and D. Auld and Craig J. Thomas},\n booktitle = {Bioorganic & Medicinal Chemistry
      Letters},\n journal = {Bioorganic & medicinal chemistry letters},\n pages =
      {\n          3387-93\n        },\n title = {Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones
      as activators of the tumor cell specific M2 isoform of pyruvate kinase.},\n
      volume = {20 11},\n year = {2010}\n}\n"}, "authors": [{"authorId": "4084746",
      "name": "Jian-Kang Jiang"}, {"authorId": "3275486", "name": "M. Boxer"}, {"authorId":
      "3804233", "name": "M. V. Vander Heiden"}, {"authorId": "145829790", "name":
      "M. Shen"}, {"authorId": "5914392", "name": "A. P. Skoumbourdis"}, {"authorId":
      "49134285", "name": "Noel Southall"}, {"authorId": "1799343", "name": "H. Veith"},
      {"authorId": "3802281", "name": "W. Leister"}, {"authorId": "4066869", "name":
      "C. Austin"}, {"authorId": "2117003935", "name": "H. Park"}, {"authorId": "3155966",
      "name": "James Inglese"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2607088", "name": "D. Auld"}, {"authorId": "2148769632", "name": "Craig J.
      Thomas"}]}, {"paperId": "496d78960822abfab3138b17da56ead8db445e82", "externalIds":
      {"MAG": "2054339272", "DOI": "10.1158/1538-7445.AM10-33", "CorpusId": 85048723},
      "corpusId": 85048723, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/496d78960822abfab3138b17da56ead8db445e82",
      "title": "Abstract 33: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate",
      "abstract": "Proceedings: AACR 101st Annual Meeting 2010\u2010\u2010 Apr 17\u201021,
      2010; Washington, DC\n\nMutations in the enzyme isocitrate dehydrogenase 1 (IDH1)
      are a common feature of most gliomas and secondary glioblastomas, as well as
      approx 10% acute myeloid leukemias. This event results in loss of the enzyme''s
      ability to catalyze conversion of isocitrate to \u03b1 -ketoglutarate. However,
      these mutations are all heterozygous and occur at a single amino acid residue
      of the IDH1 active site consistent with an enzymatic gain of function rather
      than a simple loss of function. To test this hypothesis we characterized mutant
      IDH1 (IDH1m) biochemically. We have shown that cancer-associated IDH1 mutations
      result in a new ability of the enzyme to catalyze the NADPH-dependent reduction
      of \u03b1-ketoglutarate to R(-)-2-hydroxyglutarate (2-HG). Patients with an
      inherited, neurometabolic disorders called 2-hydroxyglutaric aciduria exhibit
      an accumulation of 2-HG in their CNS, and an increased risk of developing malignant
      brain tumors. Similarly, in human malignant gliomas harboring IDH1 mutations,
      we find elevated levels of 2-HG. Altogether our data demonstrate that the IDH1
      mutations result in production of 2-HG, and suggest that the excess 2HG which
      accumulates in vivo contributes to the formation and malignant progression of
      gliomas.\n\nCitation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings
      of the 101st Annual Meeting of the American Association for Cancer Research;
      2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8
      Suppl):Abstract nr 33.", "venue": "", "year": 2010, "referenceCount": 0, "citationCount":
      3, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2010-04-15", "journal": {"volume": "70", "pages":
      "33-33", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Fantin2010Abstract3C,\n
      author = {V. Fantin and L. Dang and D. White and S. Gross and M. Bittinger and
      E. Driggers and H. G. Jang and Shengfang Jin and M. Keenan and K. Marks and
      K. Yen and P. Ward and R. Prins and L. Liau and Bryson D. Bennett and J. Rabinowitz
      and L. Cantley and C. Thompson and M. V. Heiden and Shinsan M. Su},\n journal
      = {Cancer Research},\n pages = {33-33},\n title = {Abstract 33: Cancer-associated
      IDH1 mutations produce 2-hydroxyglutarate},\n volume = {70},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "4936699", "name": "V. Fantin"}, {"authorId": "38799894",
      "name": "L. Dang"}, {"authorId": "143657476", "name": "D. White"}, {"authorId":
      "144707828", "name": "S. Gross"}, {"authorId": "3564730", "name": "M. Bittinger"},
      {"authorId": "4691854", "name": "E. Driggers"}, {"authorId": "5240350", "name":
      "H. G. Jang"}, {"authorId": "5210229", "name": "Shengfang Jin"}, {"authorId":
      "46624965", "name": "M. Keenan"}, {"authorId": "145638995", "name": "K. Marks"},
      {"authorId": "4886372", "name": "K. Yen"}, {"authorId": "35327932", "name":
      "P. Ward"}, {"authorId": "2148693", "name": "R. Prins"}, {"authorId": "5557307",
      "name": "L. Liau"}, {"authorId": "36199097", "name": "Bryson D. Bennett"}, {"authorId":
      "35264286", "name": "J. Rabinowitz"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2242436905", "name": "C. Thompson"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "4297092", "name": "Shinsan M. Su"}]},
      {"paperId": "4ab10117cbe2875f5f0515d32f82e228f95a10c5", "externalIds": {"MAG":
      "2152445360", "DOI": "10.1073/pnas.0914845107", "CorpusId": 24685399, "PubMed":
      "20133837"}, "corpusId": 24685399, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/4ab10117cbe2875f5f0515d32f82e228f95a10c5",
      "title": "The alternative splicing repressors hnRNP A1/A2 and PTB influence
      pyruvate kinase isoform expression and cell metabolism", "abstract": "Cancer
      cells preferentially metabolize glucose by aerobic glycolysis, characterized
      by increased lactate production. This distinctive metabolism involves expression
      of the embryonic M2 isozyme of pyruvate kinase, in contrast to the M1 isozyme
      normally expressed in differentiated cells, and it confers a proliferative advantage
      to tumor cells. The M1 and M2 pyruvate-kinase isozymes are expressed from a
      single gene through alternative splicing of a pair of mutually exclusive exons.
      We measured the expression of M1 and M2 mRNA and protein isoforms in mouse tissues,
      tumor cell lines, and during terminal differentiation of muscle cells, and show
      that alternative splicing regulation is sufficient to account for the levels
      of expressed protein isoforms. We further show that the M1-specific exon is
      actively repressed in cancer-cell lines\u2014although some M1 mRNA is expressed
      in cell lines derived from brain tumors\u2014and demonstrate that the related
      splicing repressors hnRNP A1 and A2, as well as the polypyrimidine-tract-binding
      protein PTB, contribute to this control. Downregulation of these splicing repressors
      in cancer-cell lines using shRNAs rescues M1 isoform expression and decreases
      the extent of lactate production. These findings extend the links between alternative
      splicing and cancer, and begin to define some of the factors responsible for
      the switch to aerobic glycolysis.", "venue": "Proceedings of the National Academy
      of Sciences of the United States of America", "year": 2010, "referenceCount":
      30, "citationCount": 386, "influentialCitationCount": 23, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2838216?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2010-01-19", "journal": {"volume": "107", "pages": "1894
      - 1899", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Clower2010TheAS,\n author = {C. V. Clower and D. Chatterjee
      and Zhenxun Wang and L. Cantley and M. V. Vander Heiden and A. Krainer},\n booktitle
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences},\n pages = {1894
      - 1899},\n title = {The alternative splicing repressors hnRNP A1/A2 and PTB
      influence pyruvate kinase isoform expression and cell metabolism},\n volume
      = {107},\n year = {2010}\n}\n"}, "authors": [{"authorId": "14815404", "name":
      "C. V. Clower"}, {"authorId": "145584048", "name": "D. Chatterjee"}, {"authorId":
      "47196879", "name": "Zhenxun Wang"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "3804233", "name": "M. V. Vander Heiden"}, {"authorId": "2742032",
      "name": "A. Krainer"}]}, {"paperId": "4f4e7cd92193b67dba2639f3f92de95a3288b67b",
      "externalIds": {"MAG": "1965341570", "DOI": "10.1021/jm901577g", "CorpusId":
      13795326, "PubMed": "20017496"}, "corpusId": 13795326, "publicationVenue": {"id":
      "4cce60a8-2106-4240-bece-fb6488df6bd1", "name": "Journal of Medicinal Chemistry",
      "type": "journal", "alternate_names": ["J Med Chem"], "issn": "0022-2623", "url":
      "https://pubs.acs.org/journal/jmcmar", "alternate_urls": ["http://pubs.acs.org/journal/jmcmar",
      "http://pubs.acs.org/journals/jmcmar/index.html"]}, "url": "https://www.semanticscholar.org/paper/4f4e7cd92193b67dba2639f3f92de95a3288b67b",
      "title": "Evaluation of substituted N,N''-diarylsulfonamides as activators of
      the tumor cell specific M2 isoform of pyruvate kinase.", "abstract": "The metabolism
      of cancer cells is altered to support rapid proliferation. Pharmacological activators
      of a tumor cell specific pyruvate kinase isozyme (PKM2) may be an approach for
      altering the classic Warburg effect characteristic of aberrant metabolism in
      cancer cells yielding a novel antiproliferation strategy. In this manuscript,
      we detail the discovery of a series of substituted N,N''-diarylsulfonamides
      as activators of PKM2. The synthesis of numerous analogues and the evaluation
      of structure-activity relationships are presented as well as assessments of
      mechanism and selectivity. Several agents are found that have good potencies
      and appropriate solubility for use as chemical probes of PKM2 including 55 (AC(50)
      = 43 nM, maximum response = 84%; solubility = 7.3 microg/mL), 56 (AC(50) = 99
      nM, maximum response = 84%; solubility = 5.7 microg/mL), and 58 (AC(50) = 38
      nM, maximum response = 82%; solubility = 51.2 microg/mL). The small molecules
      described here represent first-in-class activators of PKM2.", "venue": "Journal
      of Medicinal Chemistry", "year": 2010, "referenceCount": 26, "citationCount":
      147, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc2818804?pdf=render", "status": null}, "fieldsOfStudy":
      ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Chemistry",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle", "Study"], "publicationDate": "2010-02-11",
      "journal": {"volume": "53 3", "pages": "\n          1048-55\n        ", "name":
      "Journal of medicinal chemistry"}, "citationStyles": {"bibtex": "@Article{Boxer2010EvaluationOS,\n
      author = {M. Boxer and Jian-Kang Jiang and M. V. Vander Heiden and M. Shen and
      A. P. Skoumbourdis and Noel Southall and H. Veith and W. Leister and C. Austin
      and H. Park and James Inglese and L. Cantley and D. Auld and Craig J. Thomas},\n
      booktitle = {Journal of Medicinal Chemistry},\n journal = {Journal of medicinal
      chemistry},\n pages = {\n          1048-55\n        },\n title = {Evaluation
      of substituted N,N''-diarylsulfonamides as activators of the tumor cell specific
      M2 isoform of pyruvate kinase.},\n volume = {53 3},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "3275486", "name": "M. Boxer"}, {"authorId": "4084746",
      "name": "Jian-Kang Jiang"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"},
      {"authorId": "145829790", "name": "M. Shen"}, {"authorId": "5914392", "name":
      "A. P. Skoumbourdis"}, {"authorId": "49134285", "name": "Noel Southall"}, {"authorId":
      "1799343", "name": "H. Veith"}, {"authorId": "3802281", "name": "W. Leister"},
      {"authorId": "4066869", "name": "C. Austin"}, {"authorId": "2117003935", "name":
      "H. Park"}, {"authorId": "3155966", "name": "James Inglese"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2607088", "name": "D. Auld"}, {"authorId":
      "2148769632", "name": "Craig J. Thomas"}]}, {"paperId": "5cb4f3ce25d6eae9b1aacb9073c4946e02e7b855",
      "externalIds": {"MAG": "2082410084", "DOI": "10.1016/j.bcp.2009.12.003", "CorpusId":
      45020461, "PubMed": "20005212"}, "corpusId": 45020461, "publicationVenue": {"id":
      "c2ed7282-3d57-4734-ac70-51f9bffc1368", "name": "Biochemical Pharmacology",
      "type": "journal", "alternate_names": ["Biochem Pharmacol"], "issn": "0006-2952",
      "alternate_issns": ["1356-1839"], "url": "http://www.elsevier.com/locate/issn/00062952",
      "alternate_urls": ["http://www.elsevier.com/wps/find/journaldescription.cws_home/525454/description",
      "http://www.sciencedirect.com/science/journal/00062952"]}, "url": "https://www.semanticscholar.org/paper/5cb4f3ce25d6eae9b1aacb9073c4946e02e7b855",
      "title": "Identification of small molecule inhibitors of pyruvate kinase M2.",
      "abstract": null, "venue": "Biochemical Pharmacology", "year": 2010, "referenceCount":
      23, "citationCount": 231, "influentialCitationCount": 12, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2823991?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2010-04-15", "journal": {"volume": "79 8", "pages": "\n          1118-24\n        ",
      "name": "Biochemical pharmacology"}, "citationStyles": {"bibtex": "@Article{Heiden2010IdentificationOS,\n
      author = {M. V. Vander Heiden and H. Christofk and Eli R. Schuman and Alexander
      O. Subtelny and H. Sharfi and E. Harlow and Jun Xian and L. Cantley},\n booktitle
      = {Biochemical Pharmacology},\n journal = {Biochemical pharmacology},\n pages
      = {\n          1118-24\n        },\n title = {Identification of small molecule
      inhibitors of pyruvate kinase M2.},\n volume = {79 8},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "3804233", "name": "M. V. Vander Heiden"}, {"authorId":
      "4164415", "name": "H. Christofk"}, {"authorId": "37745571", "name": "Eli R.
      Schuman"}, {"authorId": "6866092", "name": "Alexander O. Subtelny"}, {"authorId":
      "4536882", "name": "H. Sharfi"}, {"authorId": "143686358", "name": "E. Harlow"},
      {"authorId": "13566176", "name": "Jun Xian"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "6cb36fabb309de3a9d4466c32a149780ea2276db", "externalIds":
      {"MAG": "988130218", "CorpusId": 82777837}, "corpusId": 82777837, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/6cb36fabb309de3a9d4466c32a149780ea2276db",
      "title": "PTEN PATHWAYS & TARGETS", "abstract": null, "venue": "", "year": 2010,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2010-03-01", "journal": {"volume": "", "name": ""},
      "citationStyles": {"bibtex": "@Inproceedings{Baker2010PTENP,\n author = {S.
      Baker and L. Cantley and P. Pandolfi and R. Parsons},\n title = {PTEN PATHWAYS
      & TARGETS},\n year = {2010}\n}\n"}, "authors": [{"authorId": "46748541", "name":
      "S. Baker"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4499580",
      "name": "P. Pandolfi"}, {"authorId": "47689907", "name": "R. Parsons"}]}, {"paperId":
      "70878a703e97b15bc8a5afa8008a1048fce77c9c", "externalIds": {"MAG": "2052771249",
      "DOI": "10.1126/scisignal.2000998", "CorpusId": 39057842, "PubMed": "20736484"},
      "corpusId": 39057842, "publicationVenue": {"id": "c0efe552-8a0a-41a7-8ce2-340fb0dbfe6f",
      "name": "Science Signaling", "type": "journal", "alternate_names": ["Sci Signal"],
      "issn": "1945-0877", "url": "https://www.sciencemag.org/", "alternate_urls":
      ["https://stke.sciencemag.org/about/", "https://stke.sciencemag.org/"]}, "url":
      "https://www.semanticscholar.org/paper/70878a703e97b15bc8a5afa8008a1048fce77c9c",
      "title": "Akt\u2013RSK\u2013S6 Kinase Signaling Networks Activated by Oncogenic
      Receptor Tyrosine Kinases", "abstract": "A phosphoproteomic analysis of signaling
      pathways downstream of oncogenic receptor tyrosine kinases identified potential
      therapeutic targets. Breaking a Deadly Addiction Most carcinomas are driven
      by aberrant signaling from receptor tyrosine kinases (RTKs) and, indeed, may
      become so dependent on these signals that they rely on them for survival. The
      enormous complexity of the downstream pathways, however, and the sheer numbers
      of potential targets, have made determining the substrates that mediate this
      \u201concogene addiction\u201d a daunting task. Moritz et al. developed a phosphoproteomic
      approach to identify targets of three core signaling pathways\u2014all of which
      involve activation of AGC family kinases\u2014downstream of oncogenic RTKs.
      They identified more than 300 phosphorylation targets of these signaling pathways,
      including a set of proteins downstream of three different oncogenic RTKs [c-Met,
      epidermal growth factor receptor (EGFR), and platelet-derived growth factor
      receptor \u03b1 (PDGFR\u03b1)]. Moreover, they identified six targets of RTK
      signaling whose knockdown affected cell viability. A detailed analysis of one
      of these proteins\u2014the chaperone SGTA\u2014revealed a role for it in stabilization
      of PDGFR\u03b1 and survival of cancer cells addicted to PDGFR\u03b1 signaling.
      Receptor tyrosine kinases (RTKs) activate pathways mediated by serine-threonine
      kinases, such as the PI3K (phosphatidylinositol 3-kinase)\u2013Akt pathway,
      the Ras\u2013MAPK (mitogen-activated protein kinase)\u2013RSK (ribosomal S6
      kinase) pathway, and the mTOR (mammalian target of rapamycin)\u2013p70 S6 pathway,
      that control important aspects of cell growth, proliferation, and survival.
      The Akt, RSK, and p70 S6 family of protein kinases transmits signals by phosphorylating
      substrates on an RxRxxS/T motif (R, arginine; S, serine; T, threonine; and x,
      any amino acid). We developed a large-scale proteomic approach to identify more
      than 300 substrates of this kinase family in cancer cell lines driven by the
      c-Met, epidermal growth factor receptor (EGFR), or platelet-derived growth factor
      receptor \u03b1 (PDGFR\u03b1) RTKs. We identified a subset of proteins with
      RxRxxS/T sites for which phosphorylation was decreased by RTK inhibitors (RTKIs),
      as well as by inhibitors of the PI3K, mTOR, and MAPK pathways, and we determined
      the effects of small interfering RNA directed against these substrates on cell
      viability. Phosphorylation of the protein chaperone SGTA (small glutamine-rich
      tetratricopeptide repeat\u2013containing protein \u03b1) at serine-305 was essential
      for PDGFR\u03b1 stabilization and cell survival in PDGFR\u03b1-dependent cancer
      cells. Our approach provides a new view of RTK and Akt\u2013RSK\u2013S6 kinase
      signaling, revealing previously unidentified Akt\u2013RSK\u2013S6 kinase substrates
      that merit further consideration as targets for combination therapy with RTKIs.",
      "venue": "Science Signaling", "year": 2010, "referenceCount": 37, "citationCount":
      305, "influentialCitationCount": 19, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc3137639?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2010-08-24", "journal":
      {"volume": "3", "pages": "ra64 - ra64", "name": "Science Signaling"}, "citationStyles":
      {"bibtex": "@Article{Moritz2010AktRSKS6KS,\n author = {A. Moritz and Y. Li and
      A. Guo and J. Ville\u0301n and Yi Wang and Joan Macneill and J. Kornhauser and
      K. Sprott and Jing Zhou and A. Possemato and J. Ren and P. Hornbeck and L. Cantley
      and S. Gygi and J. Rush and M. Comb},\n booktitle = {Science Signaling},\n journal
      = {Science Signaling},\n pages = {ra64 - ra64},\n title = {Akt\u2013RSK\u2013S6
      Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine Kinases},\n
      volume = {3},\n year = {2010}\n}\n"}, "authors": [{"authorId": "47890210", "name":
      "A. Moritz"}, {"authorId": "47002721", "name": "Y. Li"}, {"authorId": "49688792",
      "name": "A. Guo"}, {"authorId": "1705488", "name": "J. Ville\u0301n"}, {"authorId":
      "2154459653", "name": "Yi Wang"}, {"authorId": "4804575", "name": "Joan Macneill"},
      {"authorId": "2269300", "name": "J. Kornhauser"}, {"authorId": "46975075", "name":
      "K. Sprott"}, {"authorId": "2145786143", "name": "Jing Zhou"}, {"authorId":
      "6536164", "name": "A. Possemato"}, {"authorId": "48116069", "name": "J. Ren"},
      {"authorId": "46627576", "name": "P. Hornbeck"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2665934", "name": "S. Gygi"}, {"authorId": "1762119",
      "name": "J. Rush"}, {"authorId": "1756003", "name": "M. Comb"}]}, {"paperId":
      "70e3782c102c70490ac8038dff212d0ac87dea85", "externalIds": {"MAG": "100733775",
      "CorpusId": 68110415}, "corpusId": 68110415, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/70e3782c102c70490ac8038dff212d0ac87dea85",
      "title": "Abstract 12839: Cardiac-Specific Deletion of RhoA Results in the Development
      of Cardiac Hypertrophy via Effects on the Erk/MAPK and PI3K/Akt pathways", "abstract":
      "Increased cardiac hypertrophy in response to pathological stimuli can, over
      time, become decompensatory, leading to dilated cardiomyopathy (DCM) and heart
      failure. Though several hypertrophic signa...", "venue": "", "year": 2010, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2010-11-23", "journal": {"volume": "122", "name": "Circulation"},
      "citationStyles": {"bibtex": "@Article{Guha2010Abstract1C,\n author = {Prajna
      Guha and A. Couvillon and T. M. Marin and K. Keith and Nina Mann and S. Choudhury
      and P. Kang and A. Rosenzweig and Christopher L. Carpenter and L. Cantley and
      M. Kontaridis},\n journal = {Circulation},\n title = {Abstract 12839: Cardiac-Specific
      Deletion of RhoA Results in the Development of Cardiac Hypertrophy via Effects
      on the Erk/MAPK and PI3K/Akt pathways},\n volume = {122},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "40013703", "name": "Prajna Guha"}, {"authorId": "4328102",
      "name": "A. Couvillon"}, {"authorId": "39988752", "name": "T. M. Marin"}, {"authorId":
      "50403088", "name": "K. Keith"}, {"authorId": "50285364", "name": "Nina Mann"},
      {"authorId": "39514826", "name": "S. Choudhury"}, {"authorId": "2302010", "name":
      "P. Kang"}, {"authorId": "144061154", "name": "A. Rosenzweig"}, {"authorId":
      "2064407011", "name": "Christopher L. Carpenter"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "5806645", "name": "M. Kontaridis"}]}, {"paperId":
      "791df30a33cd20a9875134af59c138ca4d1e6561", "externalIds": {"MAG": "2071727216",
      "DOI": "10.1016/S1359-6349(10)71731-6", "CorpusId": 72912698}, "corpusId": 72912698,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/791df30a33cd20a9875134af59c138ca4d1e6561",
      "title": "27A Targeting the PI3K/mTOR pathway in genetically engineered mouse
      models of advanced prostate cancer", "abstract": null, "venue": "", "year":
      2010, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2010-11-01", "journal": {"volume":
      "8", "pages": "18-19", "name": "Ejc Supplements"}, "citationStyles": {"bibtex":
      "@Article{Patnaik201027ATT,\n author = {Akash Patnaik and K. Courtney and S.
      Signoretti and M. Loda and A. Grant and I. Pedrosa and E. Lunsford and J. Frangioni
      and P. Pandolfi and L. Cantley},\n journal = {Ejc Supplements},\n pages = {18-19},\n
      title = {27A Targeting the PI3K/mTOR pathway in genetically engineered mouse
      models of advanced prostate cancer},\n volume = {8},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId":
      "13782167", "name": "K. Courtney"}, {"authorId": "7505152", "name": "S. Signoretti"},
      {"authorId": "6213932", "name": "M. Loda"}, {"authorId": "33624537", "name":
      "A. Grant"}, {"authorId": "3135556", "name": "I. Pedrosa"}, {"authorId": "3772950",
      "name": "E. Lunsford"}, {"authorId": "1788876", "name": "J. Frangioni"}, {"authorId":
      "4499580", "name": "P. Pandolfi"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "7ad1bd3392c5f940ff6cf943c3470cbd3400b5ad", "externalIds": {"MAG":
      "1596236557", "DOI": "10.1126/science.1188015", "CorpusId": 7314606, "PubMed":
      "20847263"}, "corpusId": 7314606, "publicationVenue": {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad",
      "name": "Science", "type": "journal", "issn": "0193-4511", "alternate_issns":
      ["0036-8075"], "url": "https://www.jstor.org/journal/science", "alternate_urls":
      ["https://www.sciencemag.org/", "http://www.sciencemag.org/", "http://www.jstor.org/journals/00368075.html",
      "http://www.sciencemag.org/archive/"]}, "url": "https://www.semanticscholar.org/paper/7ad1bd3392c5f940ff6cf943c3470cbd3400b5ad",
      "title": "Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating
      Cells", "abstract": "Glucose Metabolism Revisited Cancer cells are revved up
      to reproduce rapidly and typically consume glucose rapidly by glycolysis. Why
      then do cancer cells express an isoform of a rate-limiting enzyme in glycolysis,
      pyruvate kinase M2, which has decreased activity? Vander Heiden et al. (p. 1492)
      propose that consequent accumulation of phosphoenolpyruvate, with the help of
      an enzymatic activity that remains to be characterized, can lead to phosphate
      transfer to phosphoglycerate mutase, another glycolytic enzyme, providing the
      cell with a different way to make pyruvate. This may allow cancer cells to produce
      pyruvate without generating excess adenosine triphosphate, which can act through
      feedback to inhibit glycolyis. Characterization of cancer cell metabolism provides
      evidence for a previously uncharacterized metabolic pathway. Proliferating cells,
      including cancer cells, require altered metabolism to efficiently incorporate
      nutrients such as glucose into biomass. The M2 isoform of pyruvate kinase (PKM2)
      promotes the metabolism of glucose by aerobic glycolysis and contributes to
      anabolic metabolism. Paradoxically, decreased pyruvate kinase enzyme activity
      accompanies the expression of PKM2 in rapidly dividing cancer cells and tissues.
      We demonstrate that phosphoenolpyruvate (PEP), the substrate for pyruvate kinase
      in cells, can act as a phosphate donor in mammalian cells because PEP participates
      in the phosphorylation of the glycolytic enzyme phosphoglycerate mutase (PGAM1)
      in PKM2-expressing cells. We used mass spectrometry to show that the phosphate
      from PEP is transferred to the catalytic histidine (His11) on human PGAM1. This
      reaction occurred at physiological concentrations of PEP and produced pyruvate
      in the absence of PKM2 activity. The presence of histidine-phosphorylated PGAM1
      correlated with the expression of PKM2 in cancer cell lines and tumor tissues.
      Thus, decreased pyruvate kinase activity in PKM2-expressing cells allows PEP-dependent
      histidine phosphorylation of PGAM1 and may provide an alternate glycolytic pathway
      that decouples adenosine triphosphate production from PEP-mediated phosphotransfer,
      allowing for the high rate of glycolysis to support the anabolic metabolism
      observed in many proliferating cells.", "venue": "Science", "year": 2010, "referenceCount":
      61, "citationCount": 618, "influentialCitationCount": 23, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3030121?pdf=render",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2010-09-01", "journal":
      {"volume": "329", "pages": "1492 - 1499", "name": "Science"}, "citationStyles":
      {"bibtex": "@Article{Heiden2010EvidenceFA,\n author = {M. V. Vander Heiden and
      J. Locasale and K. Swanson and H. Sharfi and G. Heffron and D. Amador-Noguez
      and H. Christofk and G. Wagner and J. Rabinowitz and J. Asara and L. Cantley},\n
      booktitle = {Science},\n journal = {Science},\n pages = {1492 - 1499},\n title
      = {Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells},\n
      volume = {329},\n year = {2010}\n}\n"}, "authors": [{"authorId": "3804233",
      "name": "M. V. Vander Heiden"}, {"authorId": "2268976", "name": "J. Locasale"},
      {"authorId": "6784962", "name": "K. Swanson"}, {"authorId": "4536882", "name":
      "H. Sharfi"}, {"authorId": "6886706", "name": "G. Heffron"}, {"authorId": "1397671921",
      "name": "D. Amador-Noguez"}, {"authorId": "4164415", "name": "H. Christofk"},
      {"authorId": "145241228", "name": "G. Wagner"}, {"authorId": "35264286", "name":
      "J. Rabinowitz"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "808b4eba03bbf952999adaabfff110dfcd4da0e7",
      "externalIds": {"MAG": "2148420701", "PubMedCentral": "2892450", "DOI": "10.1186/1741-7007-8-88",
      "CorpusId": 11874960, "PubMed": "20598111"}, "corpusId": 11874960, "publicationVenue":
      {"id": "1617f5c3-5410-462d-91c9-7aa8ced2d91d", "name": "BMC Biology", "type":
      "journal", "issn": "1741-7007", "url": "http://www.biomedcentral.com/1741-7007/",
      "alternate_urls": ["http://www.biomedcentral.com/bmcbiol/", "http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=215"]},
      "url": "https://www.semanticscholar.org/paper/808b4eba03bbf952999adaabfff110dfcd4da0e7",
      "title": "Altered metabolism in cancer", "abstract": null, "venue": "BMC Biology",
      "year": 2010, "referenceCount": 15, "citationCount": 156, "influentialCitationCount":
      12, "isOpenAccess": true, "openAccessPdf": {"url": "https://bmcbiol.biomedcentral.com/counter/pdf/10.1186/1741-7007-8-88",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2010-06-25", "journal": {"volume": "8", "pages": "88 - 88",
      "name": "BMC Biology"}, "citationStyles": {"bibtex": "@Article{Locasale2010AlteredMI,\n
      author = {J. Locasale and L. Cantley},\n booktitle = {BMC Biology},\n journal
      = {BMC Biology},\n pages = {88 - 88},\n title = {Altered metabolism in cancer},\n
      volume = {8},\n year = {2010}\n}\n"}, "authors": [{"authorId": "2268976", "name":
      "J. Locasale"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "82ae500805536ee0f9e7cfb62e39ee0c0f8b8183", "externalIds": {"MAG": "1996926758",
      "DOI": "10.1073/pnas.1009941107", "CorpusId": 24844395, "PubMed": "20696900"},
      "corpusId": 24844395, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/82ae500805536ee0f9e7cfb62e39ee0c0f8b8183",
      "title": "PARK2 deletions occur frequently in sporadic colorectal cancer and
      accelerate adenoma development in Apc mutant mice", "abstract": "In 100 primary
      colorectal carcinomas, we demonstrate by array comparative genomic hybridization
      (aCGH) that 33% show DNA copy number (DCN) loss involving PARK2, the gene encoding
      PARKIN, the E3 ubiquitin ligase whose deficiency is responsible for a form of
      autosomal recessive juvenile parkinsonism. PARK2 is located on chromosome 6
      (at 6q25\u201327), a chromosome with one of the lowest overall frequencies of
      DNA copy number alterations recorded in colorectal cancers. The PARK2 deletions
      are mostly focal (31% \u223c0.5 Mb on average), heterozygous, and show maximum
      incidence in exons 3 and 4. As PARK2 lies within FRA6E, a large common fragile
      site, it has been argued that the observed DCN losses in PARK2 in cancer may
      represent merely the result of enforced replication of locally vulnerable DNA.
      However, we show that deficiency in expression of PARK2 is significantly associated
      with adenomatous polyposis coli (APC) deficiency in human colorectal cancer.
      Evidence of some PARK2 mutations and promoter hypermethylation is described.
      PARK2 overexpression inhibits cell proliferation in vitro. Moreover, interbreeding
      of Park2 heterozygous knockout mice with ApcMin mice resulted in a dramatic
      acceleration of intestinal adenoma development and increased polyp multiplicity.
      We conclude that PARK2 is a tumor suppressor gene whose haploinsufficiency cooperates
      with mutant APC in colorectal carcinogenesis.", "venue": "Proceedings of the
      National Academy of Sciences of the United States of America", "year": 2010,
      "referenceCount": 49, "citationCount": 211, "influentialCitationCount": 11,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/107/34/15145.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2010-08-09", "journal": {"volume": "107", "pages": "15145
      - 15150", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Poulogiannis2010PARK2DO,\n author = {G. Poulogiannis and
      R. McIntyre and M. Dimitriadi and J. Apps and Catherine H. Wilson and K. Ichimura
      and F. Luo and L. Cantley and A. Wyllie and D. Adams and M. Arends},\n booktitle
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences},\n pages = {15145
      - 15150},\n title = {PARK2 deletions occur frequently in sporadic colorectal
      cancer and accelerate adenoma development in Apc mutant mice},\n volume = {107},\n
      year = {2010}\n}\n"}, "authors": [{"authorId": "4612853", "name": "G. Poulogiannis"},
      {"authorId": "1852968", "name": "R. McIntyre"}, {"authorId": "49235150", "name":
      "M. Dimitriadi"}, {"authorId": "6683881", "name": "J. Apps"}, {"authorId": "2841675",
      "name": "Catherine H. Wilson"}, {"authorId": "4040402", "name": "K. Ichimura"},
      {"authorId": "48784567", "name": "F. Luo"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2184292", "name": "A. Wyllie"}, {"authorId": "145669576",
      "name": "D. Adams"}, {"authorId": "118353344", "name": "M. Arends"}]}, {"paperId":
      "8851d6e9d18610713205e84c3cfb972d21ee8f72", "externalIds": {"MAG": "2915168871",
      "CorpusId": 89179986}, "corpusId": 89179986, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/8851d6e9d18610713205e84c3cfb972d21ee8f72",
      "title": "Figure 1, Pyruvate kinase-luciferase coupled assay", "abstract": null,
      "venue": "", "year": 2010, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2010-08-06", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Boxer2010Figure1P,\n
      author = {M. Boxer and Jian-Kang Jiang and M. V. Heiden and M. Shen and H. Veith
      and L. Cantley and Craig J. Thomas},\n title = {Figure 1, Pyruvate kinase-luciferase
      coupled assay},\n year = {2010}\n}\n"}, "authors": [{"authorId": "3275486",
      "name": "M. Boxer"}, {"authorId": "4084746", "name": "Jian-Kang Jiang"}, {"authorId":
      "35413264", "name": "M. V. Heiden"}, {"authorId": "145829790", "name": "M. Shen"},
      {"authorId": "1799343", "name": "H. Veith"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2148769632", "name": "Craig J. Thomas"}]}, {"paperId":
      "8beadf78462bacf28941a8fb82511c5941df27aa", "externalIds": {"MAG": "2166848534",
      "DOI": "10.1073/pnas.1005642107", "CorpusId": 205248976, "PubMed": "20534477"},
      "corpusId": 205248976, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/8beadf78462bacf28941a8fb82511c5941df27aa",
      "title": "A constitutively activated form of the p110\u03b2 isoform of PI3-kinase
      induces prostatic intraepithelial neoplasia in mice", "abstract": "Recent work
      has shown that ablation of p110\u03b2, but not p110\u03b1, markedly impairs
      tumorigenesis driven by loss of phosphatase and tensin homolog (PTEN) in the
      mouse prostate. Other laboratories have reported complementary data in human
      prostate tumor lines, suggesting that p110\u03b2 activation is necessary for
      tumorigenesis driven by PTEN loss. Given the multiple functions of PTEN, we
      wondered if p110\u03b2 activation also is sufficient for tumorigenesis. Here,
      we report that transgenic expression of a constitutively activated p110\u03b2
      allele in the prostate drives prostate intraepithelial neoplasia formation.
      The resulting lesions are similar to, but are clearly distinct from, the ones
      arising from PTEN loss or Akt activation. Array analyses of transcription in
      multiple murine prostate tumor models featuring PI3K/AKT pathway activation
      allowed construction of a pathway signature that may be useful in predicting
      the prognosis of human prostate tumors.", "venue": "Proceedings of the National
      Academy of Sciences of the United States of America", "year": 2010, "referenceCount":
      56, "citationCount": 57, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2890726?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "2010-06-01", "journal": {"volume": "107", "pages":
      "11002 - 11007", "name": "Proceedings of the National Academy of Sciences"},
      "citationStyles": {"bibtex": "@Article{Lee2010ACA,\n author = {Sang Hyun Lee
      and G. Poulogiannis and Saumyadipta Pyne and S. Jia and L. Zou and S. Signoretti
      and M. Loda and L. Cantley and T. Roberts},\n booktitle = {Proceedings of the
      National Academy of Sciences of the United States of America},\n journal = {Proceedings
      of the National Academy of Sciences},\n pages = {11002 - 11007},\n title = {A
      constitutively activated form of the p110\u03b2 isoform of PI3-kinase induces
      prostatic intraepithelial neoplasia in mice},\n volume = {107},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "2152572449", "name": "Sang Hyun Lee"}, {"authorId":
      "4612853", "name": "G. Poulogiannis"}, {"authorId": "2411964", "name": "Saumyadipta
      Pyne"}, {"authorId": "48143584", "name": "S. Jia"}, {"authorId": "2599871",
      "name": "L. Zou"}, {"authorId": "7505152", "name": "S. Signoretti"}, {"authorId":
      "6213932", "name": "M. Loda"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "6665338", "name": "T. Roberts"}]}, {"paperId": "91fde10af79259e572c71b10f4b3ea2de0012e38",
      "externalIds": {"MAG": "2167699749", "DOI": "10.1158/1538-7445.AM10-LB-188",
      "CorpusId": 74544484}, "corpusId": 74544484, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/91fde10af79259e572c71b10f4b3ea2de0012e38",
      "title": "Abstract LB-188: Positive regulation of the Ras oncogene by ubiquitination",
      "abstract": "Proceedings: AACR 101st Annual Meeting 2010\u2010\u2010 Apr 17\u201021,
      2010; Washington, DC\n\nDiscussion \n\nCitation Format: {Authors}. {Abstract
      title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American
      Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia
      (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr LB-188.", "venue": "", "year":
      2010, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2010-04-15", "journal": {"volume": "70", "name": "Cancer Research"}, "citationStyles":
      {"bibtex": "@Article{Sasaki2010AbstractLP,\n author = {A. Sasaki and L. Cantley},\n
      journal = {Cancer Research},\n title = {Abstract LB-188: Positive regulation
      of the Ras oncogene by ubiquitination},\n volume = {70},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "47742211", "name": "A. Sasaki"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "9e88c75f809f013914433cc83f73cf44f3d8a3cb",
      "externalIds": {"MAG": "2077223675", "DOI": "10.1016/j.gde.2009.11.002", "CorpusId":
      205003010, "PubMed": "20006486"}, "corpusId": 205003010, "publicationVenue":
      {"id": "c828ed19-475e-4afd-ab62-1eac0a2dae95", "name": "Current Opinion in Genetics
      and Development", "type": "journal", "alternate_names": ["Current Opinion in
      Genetics & Development", "Curr Opin Genet Dev", "Curr Opin Genet  Dev"], "issn":
      "0959-437X", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/601302/description#description",
      "alternate_urls": ["https://www.sciencedirect.com/journal/current-opinion-in-genetics-and-development",
      "http://www.sciencedirect.com/science/journal/0959437X"]}, "url": "https://www.semanticscholar.org/paper/9e88c75f809f013914433cc83f73cf44f3d8a3cb",
      "title": "Targeting the PI3K signaling pathway in cancer.", "abstract": null,
      "venue": "Current Opinion in Genetics and Development", "year": 2010, "referenceCount":
      32, "citationCount": 556, "influentialCitationCount": 13, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2822054?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2010-02-01", "journal": {"volume": "20 1", "pages": "\n          87-90\n        ",
      "name": "Current opinion in genetics & development"}, "citationStyles": {"bibtex":
      "@Article{Wong2010TargetingTP,\n author = {Kwok-kin Wong and J. Engelman and
      L. Cantley},\n booktitle = {Current Opinion in Genetics and Development},\n
      journal = {Current opinion in genetics & development},\n pages = {\n          87-90\n        },\n
      title = {Targeting the PI3K signaling pathway in cancer.},\n volume = {20 1},\n
      year = {2010}\n}\n"}, "authors": [{"authorId": "32596484", "name": "Kwok-kin
      Wong"}, {"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "ac219e4a263eac45831bbc0cb7d5eb0740f554be",
      "externalIds": {"MAG": "2091903353", "DOI": "10.1016/j.molcel.2010.05.007",
      "CorpusId": 23547764, "PubMed": "20513425"}, "corpusId": 23547764, "publicationVenue":
      {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11", "name": "Molecules and Cells",
      "type": "journal", "alternate_names": ["Molecular Cell", "Mol Cell"], "issn":
      "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"], "url": "https://link.springer.com/journal/10059",
      "alternate_urls": ["http://www.molcells.org/about/sub06.html", "http://www.molecule.org/",
      "http://www.sciencedirect.com/science/journal/10972765", "http://www.cell.com/molecular-cell/"]},
      "url": "https://www.semanticscholar.org/paper/ac219e4a263eac45831bbc0cb7d5eb0740f554be",
      "title": "Glucose addiction of TSC null cells is caused by failed mTORC1-dependent
      balancing of metabolic demand with supply.", "abstract": null, "venue": "Molecules
      and Cells", "year": 2010, "referenceCount": 35, "citationCount": 260, "influentialCitationCount":
      9, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276510003692/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2010-05-28", "journal": {"volume": "38 4", "pages": "\n          487-99\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Choo2010GlucoseAO,\n
      author = {A. Y. Choo and Sang Gyun Kim and M. V. Vander Heiden and S. J. Mahoney
      and Hieu S. Vu and Sang-Oh Yoon and L. Cantley and J. Blenis},\n booktitle =
      {Molecules and Cells},\n journal = {Molecular cell},\n pages = {\n          487-99\n        },\n
      title = {Glucose addiction of TSC null cells is caused by failed mTORC1-dependent
      balancing of metabolic demand with supply.},\n volume = {38 4},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "32210637", "name": "A. Y. Choo"}, {"authorId": "46876889",
      "name": "Sang Gyun Kim"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"},
      {"authorId": "48247811", "name": "S. J. Mahoney"}, {"authorId": "46470616",
      "name": "Hieu S. Vu"}, {"authorId": "6168327", "name": "Sang-Oh Yoon"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4037343", "name": "J. Blenis"}]},
      {"paperId": "d5b1fb5b851050629034b90521a7346bd6acc610", "externalIds": {"MAG":
      "1985599023", "DOI": "10.1016/j.cmet.2010.11.005", "CorpusId": 27643634, "PubMed":
      "21109194"}, "corpusId": 27643634, "publicationVenue": {"id": "ad36b49e-5c03-4c48-be8d-321a0d17c2f6",
      "name": "Cell Metabolism", "type": "journal", "alternate_names": ["Cell Metab"],
      "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/15504131", "http://www.cellmetabolism.org/"]},
      "url": "https://www.semanticscholar.org/paper/d5b1fb5b851050629034b90521a7346bd6acc610",
      "title": "Class IA phosphatidylinositol 3-kinase in pancreatic \u03b2 cells
      controls insulin secretion by multiple mechanisms.", "abstract": null, "venue":
      "Cell Metabolism", "year": 2010, "referenceCount": 62, "citationCount": 99,
      "influentialCitationCount": 7, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1550413110003979/pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2010-12-01", "journal":
      {"volume": "12 6", "pages": "\n          619-32\n        ", "name": "Cell metabolism"},
      "citationStyles": {"bibtex": "@Article{Kaneko2010ClassIP,\n author = {Kazuma
      Kaneko and K. Ueki and N. Takahashi and Shinji Hashimoto and M. Okamoto and
      M. Awazawa and Yukiko Okazaki and M. Ohsugi and K. Inabe and T. Umehara and
      Masashi Yoshida and M. Kakei and T. Kitamura and Ji Luo and R. Kulkarni and
      C. Kahn and H. Kasai and L. Cantley and T. Kadowaki},\n booktitle = {Cell Metabolism},\n
      journal = {Cell metabolism},\n pages = {\n          619-32\n        },\n title
      = {Class IA phosphatidylinositol 3-kinase in pancreatic \u03b2 cells controls
      insulin secretion by multiple mechanisms.},\n volume = {12 6},\n year = {2010}\n}\n"},
      "authors": [{"authorId": "2061403809", "name": "Kazuma Kaneko"}, {"authorId":
      "5177377", "name": "K. Ueki"}, {"authorId": "47893508", "name": "N. Takahashi"},
      {"authorId": "123302527", "name": "Shinji Hashimoto"}, {"authorId": "123075443",
      "name": "M. Okamoto"}, {"authorId": "4292978", "name": "M. Awazawa"}, {"authorId":
      "40289171", "name": "Yukiko Okazaki"}, {"authorId": "35179845", "name": "M.
      Ohsugi"}, {"authorId": "6805315", "name": "K. Inabe"}, {"authorId": "37289333",
      "name": "T. Umehara"}, {"authorId": "145329883", "name": "Masashi Yoshida"},
      {"authorId": "4801935", "name": "M. Kakei"}, {"authorId": "32660808", "name":
      "T. Kitamura"}, {"authorId": "145954100", "name": "Ji Luo"}, {"authorId": "144242661",
      "name": "R. Kulkarni"}, {"authorId": "144391716", "name": "C. Kahn"}, {"authorId":
      "32414353", "name": "H. Kasai"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "34587810", "name": "T. Kadowaki"}]}, {"paperId": "e3bea883d3a051fbde6a4c2f3b430622036ed965",
      "externalIds": {"CorpusId": 35625091}, "corpusId": 35625091, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/e3bea883d3a051fbde6a4c2f3b430622036ed965",
      "title": "Cancer evention esearch pective rspective on Memmott et al . , p .
      1066 Pr R moprevention Meets Glucose Control", "abstract": "Downlo report by
      Memmott et al. (beginning on page 1066 in this issue of the journal) assessing
      the efficacy antidiabetes drug metformin in a mouse model of lung carcinogenesis
      suggests protective effects via ossible avenues: Decreased circulating insulin
      and insulin-like growth factor levels and energy stress g to inhibition of mammalian
      target of rapamycin signaling. These potential mechanisms are disleadin cussed
      in this perspective, as are their implications for cancer prevention and therapy.
      Cancer Prev Res; 3(9); 1049\u201352. \u00a92010 AACR.", "venue": "", "year":
      2010, "referenceCount": 25, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Engelman2010CancerEE,\n
      author = {Y. Engelman and L. Cantley},\n title = {Cancer evention esearch pective
      rspective on Memmott et al . , p . 1066 Pr R moprevention Meets Glucose Control},\n
      year = {2010}\n}\n"}, "authors": [{"authorId": "103572289", "name": "Y. Engelman"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "e8c7c243658808e72432469b164067d5855fd123",
      "externalIds": {"MAG": "2556333180", "DOI": "10.1182/BLOOD.V116.21.3142.3142",
      "CorpusId": 89600254}, "corpusId": 89600254, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/e8c7c243658808e72432469b164067d5855fd123",
      "title": "Leukemogenic Tyrosine Kinases Inhibit PKM2 to Promote the Warburg
      Effect and Tumor Growth", "abstract": "Abstract 3142 The Warburg effect describes
      a pro-oncogenic metabolic switch in which cancer cells, including leukemia cells,
      take up more glucose than normal tissue, yet use less glucose for oxidative
      phosphorylation and favor glycolysis even in the presence of oxygen (aerobic
      glycolysis). However, the molecular mechanisms underlying the Warburg effect
      remain unclear. Growth factor (GF) receptors are believed to play a key role
      in programming cancer cell metabolism. These GF receptors are expressed in many
      hematopoietic malignancies as constitutively activated tyrosine kinase mutants.
      Thus, we examinined whether tyrosine kinase signaling \u2014 commonly upregulated
      in hematopoietic malignancies \u2014 regulates the Warburg effect to contribute
      to leukemogenesis and disease progression. We performed phospho-proteomics studies
      and found that pyruvate kinase M2 isoform (PKM2), which is a rate-limiting enzyme
      of glycolysis, is tyrosine phosphorylated in leukemia cells expressing FGFR1
      fusion tyrosine kinases, which are associated with 8p11 leukemia/lymphoma syndrome.
      We also found that 8p11 leukemogenic FGFR1 directly phosphorylates and inhibits
      PKM2. Recent seminal studies from Dr. Lew Cantley9s group demonstrated that
      the enzymatic activity of PKM2 is inhibited by phosphotyrosine binding; PKM2
      expression is important for aerobic glycolysis and provides a growth advantage
      to tumors. However, it remains unclear which dedicated tyrosine kinase pathways
      are physiologically responsible for this regulation and whether PKM2 itself
      is tyrosine phosphorylated to achieve inhibition of PKM2 in cancer cells. Here
      we report that FGFR1 inhibits PKM2 by direct phosphorylation at Y105. This consequently
      inhibits the formation of tetrameric, active PKM2 by disrupting cofactor fructose-1,6-bisphosphate
      (FBP) binding in a putative \u201cinter-molecule manner\u201d, where one molecule
      in an active PKM2 tetramer, when phosphorylated, may function as an inhibitory
      binding partner to the other sister molecules. In addition, phosphorylation
      of PKM2 at Y105 is common in many human leukemia cell lines expressing oncogenic
      tyrosine kinases such as BCR-ABL, FLT3-ITD, and JAK2V617F. Furthermore, expression
      of the PKM2 Y105F mutant in cancer cells following RNAi-mediated knockdown of
      endogenous PKM2 leads to decreased cell proliferation under hypoxia, increased
      oxidative phosphorylation with reduced lactate production, and reduced tumor
      growth in xenograft nude mice. Our findings suggest that tyrosine phosphorylation
      regulates PKM2 to program cancer cell metabolism and promote tumor growth. This
      may represent a common, acute molecular mechanism to regulate the Warburg effect,
      in addition to the chronic changes that are believed to be regulated by hypoxia
      inducible factor 1 and Myc. Disclosures: No relevant conflicts of interest to
      declare.", "venue": "", "year": 2010, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2010-11-19", "journal": {"volume": "116", "pages": "3142-3142", "name": "Blood"},
      "citationStyles": {"bibtex": "@Article{Hitosugi2010LeukemogenicTK,\n author
      = {T. Hitosugi and Sumin Kang and M. V. Heiden and T. Chung and Shannon E Elf
      and Katherine Lythgoe and Shaozhong Dong and S. Lonial and Xu Wang and G. Chen
      and Jianxin Xie and T. Gu and R. Polakiewicz and J. Roesel and T. Boggon and
      F. Khuri and D. Gilliland and L. Cantley and J. Kaufman and J. Chen},\n journal
      = {Blood},\n pages = {3142-3142},\n title = {Leukemogenic Tyrosine Kinases Inhibit
      PKM2 to Promote the Warburg Effect and Tumor Growth},\n volume = {116},\n year
      = {2010}\n}\n"}, "authors": [{"authorId": "5648825", "name": "T. Hitosugi"},
      {"authorId": "6357969", "name": "Sumin Kang"}, {"authorId": "35413264", "name":
      "M. V. Heiden"}, {"authorId": "3712752", "name": "T. Chung"}, {"authorId": "46955429",
      "name": "Shannon E Elf"}, {"authorId": "13728283", "name": "Katherine Lythgoe"},
      {"authorId": "6137304", "name": "Shaozhong Dong"}, {"authorId": "4891579", "name":
      "S. Lonial"}, {"authorId": "2108598823", "name": "Xu Wang"}, {"authorId": "32401310",
      "name": "G. Chen"}, {"authorId": "143740055", "name": "Jianxin Xie"}, {"authorId":
      "40075084", "name": "T. Gu"}, {"authorId": "4032764", "name": "R. Polakiewicz"},
      {"authorId": "6151924", "name": "J. Roesel"}, {"authorId": "3907849", "name":
      "T. Boggon"}, {"authorId": "5531063", "name": "F. Khuri"}, {"authorId": "2246160",
      "name": "D. Gilliland"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "5224106", "name": "J. Kaufman"}, {"authorId": "5152140", "name": "J. Chen"}]},
      {"paperId": "ea552254f1f0d220bc05c7f2f8296486345607ea", "externalIds": {"MAG":
      "1983839663", "PubMedCentral": "2866327", "DOI": "10.1371/journal.pone.0010504",
      "CorpusId": 3872863, "PubMed": "20498699"}, "corpusId": 3872863, "publicationVenue":
      {"id": "0aed7a40-85f3-4c66-9e1b-c1556c57001b", "name": "PLoS ONE", "type": "journal",
      "alternate_names": ["Plo ONE", "PLOS ONE", "PLO ONE"], "issn": "1932-6203",
      "url": "https://journals.plos.org/plosone/", "alternate_urls": ["http://www.plosone.org/"]},
      "url": "https://www.semanticscholar.org/paper/ea552254f1f0d220bc05c7f2f8296486345607ea",
      "title": "Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism
      and Activity of Insulin", "abstract": "Background Insulin is a vital peptide
      hormone that is a central regulator of glucose homeostasis, and impairments
      in insulin signaling cause diabetes mellitus. In principle, it should be possible
      to enhance the activity of insulin by inhibiting its catabolism, which is mediated
      primarily by insulin-degrading enzyme (IDE), a structurally and evolutionarily
      distinctive zinc-metalloprotease. Despite interest in pharmacological inhibition
      of IDE as an attractive anti-diabetic approach dating to the 1950s, potent and
      selective inhibitors of IDE have not yet emerged. Methodology/Principal Findings
      We used a rational design approach based on analysis of combinatorial peptide
      mixtures and focused compound libraries to develop novel peptide hydroxamic
      acid inhibitors of IDE. The resulting compounds are \u223c106 times more potent
      than existing inhibitors, non-toxic, and surprisingly selective for IDE vis-\u00e0-vis
      conventional zinc-metalloproteases. Crystallographic analysis of an IDE-inhibitor
      complex reveals a novel mode of inhibition based on stabilization of IDE''s
      \u201cclosed,\u201d inactive conformation. We show further that pharmacological
      inhibition of IDE potentiates insulin signaling by a mechanism involving reduced
      catabolism of internalized insulin. Conclusions/Significance The inhibitors
      we describe are the first to potently and selectively inhibit IDE or indeed
      any member of this atypical zinc-metalloprotease superfamily. The distinctive
      structure of IDE''s active site, and the mode of action of our inhibitors, suggests
      that it may be possible to develop inhibitors that cross-react minimally with
      conventional zinc-metalloproteases. Significantly, our results reveal that insulin
      signaling is normally regulated by IDE activity not only extracellularly but
      also within cells, supporting the longstanding view that IDE inhibitors could
      hold therapeutic value for the treatment of diabetes.", "venue": "PLoS ONE",
      "year": 2010, "referenceCount": 54, "citationCount": 97, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0010504&type=printable",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2010-05-07", "journal": {"volume": "5", "name": "PLoS ONE"},
      "citationStyles": {"bibtex": "@Article{Leissring2010DesignedIO,\n author = {M.
      Leissring and E. Malito and Sabrine H\u00e9douin and L. Reinstatler and Tomoko
      Sahara and S. Abdul-Hay and Shakeel Choudhry and Ghulam M. Maharvi and A. Fauq
      and M. Huzarska and Philip S. May and Sungwoong Choi and Todd Logan and B. Turk
      and L. Cantley and M. Manolopoulou and Wei-Jen Tang and R. Stein and G. Cuny
      and D. Selkoe},\n booktitle = {PLoS ONE},\n journal = {PLoS ONE},\n title =
      {Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and
      Activity of Insulin},\n volume = {5},\n year = {2010}\n}\n"}, "authors": [{"authorId":
      "6667807", "name": "M. Leissring"}, {"authorId": "46377688", "name": "E. Malito"},
      {"authorId": "6044838", "name": "Sabrine H\u00e9douin"}, {"authorId": "4111437",
      "name": "L. Reinstatler"}, {"authorId": "48713460", "name": "Tomoko Sahara"},
      {"authorId": "1395003715", "name": "S. Abdul-Hay"}, {"authorId": "35359166",
      "name": "Shakeel Choudhry"}, {"authorId": "92904229", "name": "Ghulam M. Maharvi"},
      {"authorId": "4218139", "name": "A. Fauq"}, {"authorId": "49088275", "name":
      "M. Huzarska"}, {"authorId": "2070635457", "name": "Philip S. May"}, {"authorId":
      "98570863", "name": "Sungwoong Choi"}, {"authorId": "36589908", "name": "Todd
      Logan"}, {"authorId": "25581223", "name": "B. Turk"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "34905390", "name": "M. Manolopoulou"},
      {"authorId": "1766067", "name": "Wei-Jen Tang"}, {"authorId": "113262814", "name":
      "R. Stein"}, {"authorId": "35117700", "name": "G. Cuny"}, {"authorId": "4190578",
      "name": "D. Selkoe"}]}, {"paperId": "f51f52bc076e2d0080c598fc90f2a2290c9066c2",
      "externalIds": {"MAG": "2013276658", "DOI": "10.1016/S1359-6349(10)71865-6",
      "CorpusId": 71188166}, "corpusId": 71188166, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/f51f52bc076e2d0080c598fc90f2a2290c9066c2",
      "title": "160 Cancer-associated IDH1 and IDH2 mutations: therapeutic opportunities",
      "abstract": null, "venue": "", "year": 2010, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2010-11-01", "journal": {"volume":
      "8", "pages": "56", "name": "Ejc Supplements"}, "citationStyles": {"bibtex":
      "@Article{Jin2010160CI,\n author = {Shengfang Jin and L. Dang and S. Gross and
      E. Driggers and K. Yen and M. Bittinger and C. Thompson and L. Cantley and Michael
      Su and V. Fantin},\n journal = {Ejc Supplements},\n pages = {56},\n title =
      {160 Cancer-associated IDH1 and IDH2 mutations: therapeutic opportunities},\n
      volume = {8},\n year = {2010}\n}\n"}, "authors": [{"authorId": "5210229", "name":
      "Shengfang Jin"}, {"authorId": "38799894", "name": "L. Dang"}, {"authorId":
      "144707828", "name": "S. Gross"}, {"authorId": "4691854", "name": "E. Driggers"},
      {"authorId": "4886372", "name": "K. Yen"}, {"authorId": "3564730", "name": "M.
      Bittinger"}, {"authorId": "2242436905", "name": "C. Thompson"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "39135065", "name": "Michael
      Su"}, {"authorId": "4936699", "name": "V. Fantin"}]}, {"paperId": "0d8f82ac6ac15f16debac0a968e66e9455942a94",
      "externalIds": {"MAG": "2097259163", "DOI": "10.1126/science.1160809", "CorpusId":
      4598043, "PubMed": "19460998"}, "corpusId": 4598043, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/0d8f82ac6ac15f16debac0a968e66e9455942a94",
      "title": "Understanding the Warburg Effect: The Metabolic Requirements of Cell
      Proliferation", "abstract": "Fuel Economy for Growing Cells Sophisticated 21st-century
      analyses of the signaling pathways that control cell growth have led researchers
      back to the seminal work of Otto Warburg, who discovered in the 1920s that tumor
      cells generate their energy in an unusual way\u2014by switching from mitochondrial
      respiration to glycolysis. The advantage conferred by this metabolic switch
      is puzzling because mitochondrial respiration is a more efficient way to produce
      ATP. Vander Heiden et al. (p. 1029) review arguments that rapidly growing cells
      have critical metabolic requirements that extend beyond ATP and that a better
      understanding of these requirements may shed new light on the \u201cWarburg
      effect\u201d and ultimately lead to new therapies for cancer. In contrast to
      normal differentiated cells, which rely primarily on mitochondrial oxidative
      phosphorylation to generate the energy needed for cellular processes, most cancer
      cells instead rely on aerobic glycolysis, a phenomenon termed \u201cthe Warburg
      effect.\u201d Aerobic glycolysis is an inefficient way to generate adenosine
      5\u2032-triphosphate (ATP), however, and the advantage it confers to cancer
      cells has been unclear. Here we propose that the metabolism of cancer cells,
      and indeed all proliferating cells, is adapted to facilitate the uptake and
      incorporation of nutrients into the biomass (e.g., nucleotides, amino acids,
      and lipids) needed to produce a new cell. Supporting this idea are recent studies
      showing that (i) several signaling pathways implicated in cell proliferation
      also regulate metabolic pathways that incorporate nutrients into biomass; and
      that (ii) certain cancer-associated mutations enable cancer cells to acquire
      and metabolize nutrients in a manner conducive to proliferation rather than
      efficient ATP production. A better understanding of the mechanistic links between
      cellular metabolism and growth control may ultimately lead to better treatments
      for human cancer.", "venue": "Science", "year": 2009, "referenceCount": 52,
      "citationCount": 12658, "influentialCitationCount": 415, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2849637?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2009-05-22", "journal": {"volume": "324", "pages": "1029
      - 1033", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Heiden2009UnderstandingTW,\n
      author = {M. V. Vander Heiden and L. Cantley and C. Thompson},\n booktitle =
      {Science},\n journal = {Science},\n pages = {1029 - 1033},\n title = {Understanding
      the Warburg Effect: The Metabolic Requirements of Cell Proliferation},\n volume
      = {324},\n year = {2009}\n}\n"}, "authors": [{"authorId": "3804233", "name":
      "M. V. Vander Heiden"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2242436905", "name": "C. Thompson"}]}, {"paperId": "1104cfc1f233d9208b1b1177499b56cb8996e982",
      "externalIds": {"CorpusId": 17179248}, "corpusId": 17179248, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/1104cfc1f233d9208b1b1177499b56cb8996e982",
      "title": "Stefan Wuchty , of Knowledge The Increasing Dominance of Teams in
      Production", "abstract": "http://www.sciencemag.org/cgi/content/full/316/5827/1036
      version of this article at: including high-resolution figures, can be found
      in the online Updated information and services, http://www.sciencemag.org/cgi/content/full/1136099/DC1
      can be found at: Supporting Online Material found at: can be related to this
      article A list of selected additional articles on the Science Web sites http://www.sciencemag.org/cgi/content/full/316/5827/1036#related-content
      http://www.sciencemag.org/cgi/content/full/316/5827/1036#otherarticles , 3 of
      which can be accessed for free: cites 14 articles This article 45 article(s)
      on the ISI Web of Science. cited by This article has been http://www.sciencemag.org/cgi/content/full/316/5827/1036#otherarticles
      10 articles hosted by HighWire Press; see: cited by This article has been http://www.sciencemag.org/cgi/collection/sociology
      Sociology : subject collections This article appears in the following", "venue":
      "", "year": 2009, "referenceCount": 29, "citationCount": 50, "influentialCitationCount":
      4, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Business", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Zejnullahu2009StefanW,\n
      author = {K. Zejnullahu and T. Mitsudomi and Youngchul Song and Courtney Hyland
      and Joon-Oh Park and N. Lindeman and Christopher-Michael Gale and Xiaojun Zhao
      and J. Christensen and T. Kosaka and A. Holmes and A. M. Rogers and F. Cappuzzo
      and T. Mok and Charles Lee and Bruce E. Johnson and L. Cantley},\n title = {Stefan
      Wuchty , of Knowledge The Increasing Dominance of Teams in Production},\n year
      = {2009}\n}\n"}, "authors": [{"authorId": "5610750", "name": "K. Zejnullahu"},
      {"authorId": "4441512", "name": "T. Mitsudomi"}, {"authorId": "121610638", "name":
      "Youngchul Song"}, {"authorId": "40053421", "name": "Courtney Hyland"}, {"authorId":
      "48490520", "name": "Joon-Oh Park"}, {"authorId": "3734755", "name": "N. Lindeman"},
      {"authorId": "77094637", "name": "Christopher-Michael Gale"}, {"authorId": "2111027786",
      "name": "Xiaojun Zhao"}, {"authorId": "2054179920", "name": "J. Christensen"},
      {"authorId": "2638484", "name": "T. Kosaka"}, {"authorId": "48115918", "name":
      "A. Holmes"}, {"authorId": "2056849769", "name": "A. M. Rogers"}, {"authorId":
      "3740336", "name": "F. Cappuzzo"}, {"authorId": "17750315", "name": "T. Mok"},
      {"authorId": "2118593740", "name": "Charles Lee"}, {"authorId": "2111408112",
      "name": "Bruce E. Johnson"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "12567efdc6f85b862b3523fc9ece405950cc3b3c", "externalIds": {"MAG":
      "2100260504", "DOI": "10.1126/scisignal.2000431", "CorpusId": 7194806, "PubMed":
      "19920251"}, "corpusId": 7194806, "publicationVenue": {"id": "c0efe552-8a0a-41a7-8ce2-340fb0dbfe6f",
      "name": "Science Signaling", "type": "journal", "alternate_names": ["Sci Signal"],
      "issn": "1945-0877", "url": "https://www.sciencemag.org/", "alternate_urls":
      ["https://stke.sciencemag.org/about/", "https://stke.sciencemag.org/"]}, "url":
      "https://www.semanticscholar.org/paper/12567efdc6f85b862b3523fc9ece405950cc3b3c",
      "title": "Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect
      and Tumor Growth", "abstract": "Tyrosine phosphorylation of pyruvate kinase
      M2 gives tumor cells a metabolic advantage. A Malignant Metabolic Switch Cancer
      cells show aberrant metabolism, consuming more glucose than do healthy cells
      and producing lactate even in the presence of abundant oxygen, rather than shifting
      to oxidative phosphorylation. This phenomenon is called the Warburg effect,
      after Otto Warburg, who described it many years ago. Building on recent research
      implicating inhibition of the M2 isoform of the glycolytic enzyme pyruvate kinase
      (PKM2) by phosphotyrosine binding as critical to the Warburg effect\u2014and
      tumorigenesis\u2014Hitosugi et al. explored the role of signaling from oncogenic
      forms of the fibroblast growth factor receptor type 1 (FGFR1) in mediating this
      metabolic switch. They found that FGFR1, a receptor tyrosine kinase, phosphorylated
      a tyrosine residue (Y105) on PKM2 itself. Further analysis revealed that this
      tyrosine residue was commonly phosphorylated in human cancers and that a mutant
      form of PKM2 lacking this tyrosine residue inhibited both \u201cWarburg metabolism\u201d
      and tumor growth. They thus propose that phosphorylation of PKM2 by oncogenic
      tyrosine kinases provides the very phosphotyrosine that binds to and inhibits
      PKM2 to induce the Warburg effect and promote tumor growth. The Warburg effect
      describes a pro-oncogenic metabolism switch such that cancer cells take up more
      glucose than normal tissue and favor incomplete oxidation of glucose even in
      the presence of oxygen. To better understand how tyrosine kinase signaling,
      which is commonly increased in tumors, regulates the Warburg effect, we performed
      phosphoproteomic studies. We found that oncogenic forms of fibroblast growth
      factor receptor type 1 inhibit the pyruvate kinase M2 (PKM2) isoform by direct
      phosphorylation of PKM2 tyrosine residue 105 (Y105). This inhibits the formation
      of active, tetrameric PKM2 by disrupting binding of the PKM2 cofactor fructose-1,6-bisphosphate.
      Furthermore, we found that phosphorylation of PKM2 Y105 is common in human cancers.
      The presence of a PKM2 mutant in which phenylalanine is substituted for Y105
      (Y105F) in cancer cells leads to decreased cell proliferation under hypoxic
      conditions, increased oxidative phosphorylation with reduced lactate production,
      and reduced tumor growth in xenografts in nude mice. Our findings suggest that
      tyrosine phosphorylation regulates PKM2 to provide a metabolic advantage to
      tumor cells, thereby promoting tumor growth.", "venue": "Science Signaling",
      "year": 2009, "referenceCount": 26, "citationCount": 693, "influentialCitationCount":
      45, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2812789?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2009-11-17", "journal": {"volume": "2", "pages": "ra73 -
      ra73", "name": "Science Signaling"}, "citationStyles": {"bibtex": "@Article{Hitosugi2009TyrosinePI,\n
      author = {T. Hitosugi and Sumin Kang and M. V. Vander Heiden and Tae-Wook Chung
      and Shannon E Elf and Katherine Lythgoe and Shaozhong Dong and S. Lonial and
      Xu Wang and G. Chen and Jianxin Xie and T. Gu and R. Polakiewicz and J. Roesel
      and T. Boggon and F. Khuri and D. Gilliland and L. Cantley and J. Kaufman and
      Jing Chen},\n booktitle = {Science Signaling},\n journal = {Science Signaling},\n
      pages = {ra73 - ra73},\n title = {Tyrosine Phosphorylation Inhibits PKM2 to
      Promote the Warburg Effect and Tumor Growth},\n volume = {2},\n year = {2009}\n}\n"},
      "authors": [{"authorId": "5648825", "name": "T. Hitosugi"}, {"authorId": "6357969",
      "name": "Sumin Kang"}, {"authorId": "3804233", "name": "M. V. Vander Heiden"},
      {"authorId": "2151016785", "name": "Tae-Wook Chung"}, {"authorId": "46955429",
      "name": "Shannon E Elf"}, {"authorId": "13728283", "name": "Katherine Lythgoe"},
      {"authorId": "6137304", "name": "Shaozhong Dong"}, {"authorId": "4891579", "name":
      "S. Lonial"}, {"authorId": "2108598823", "name": "Xu Wang"}, {"authorId": "32401310",
      "name": "G. Chen"}, {"authorId": "143740055", "name": "Jianxin Xie"}, {"authorId":
      "40075084", "name": "T. Gu"}, {"authorId": "4032764", "name": "R. Polakiewicz"},
      {"authorId": "6151924", "name": "J. Roesel"}, {"authorId": "3907849", "name":
      "T. Boggon"}, {"authorId": "5531063", "name": "F. Khuri"}, {"authorId": "2246160",
      "name": "D. Gilliland"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "5224106", "name": "J. Kaufman"}, {"authorId": "40337424", "name": "Jing Chen"}]},
      {"paperId": "141c09067d0d54897476a5a8dc0b2365ca4d4c4b", "externalIds": {"MAG":
      "2108746644", "DOI": "10.1158/1535-7163.MCT-08-1012", "CorpusId": 6528350, "PubMed":
      "19509266"}, "corpusId": 6528350, "publicationVenue": {"id": "05590b5e-de5a-404d-bec3-bfe1e9d96382",
      "name": "Molecular Cancer Therapeutics", "type": "journal", "alternate_names":
      ["Mol Cancer Ther"], "issn": "1535-7163", "url": "https://mct.aacrjournals.org/"},
      "url": "https://www.semanticscholar.org/paper/141c09067d0d54897476a5a8dc0b2365ca4d4c4b",
      "title": "The antiproliferative cytostatic effects of a self-activating viridin
      prodrug", "abstract": "Although viridins like wortmannin (Wm) have long been
      examined as anticancer agents, their ability to self-activate has only recently
      been recognized. Here, we describe the cytostatic effects of a self-activating
      viridin (SAV), which is an inactive, polymeric prodrug. SAV self-activates to
      generate a bioactive, fluorescent viridin NBD-Wm with a half-time of 9.2 hours.
      With cultured A549 cells, 10 \u03bcmol/L SAV caused growth arrest without inducing
      apoptosis or cell death, a cytostatic action markedly different from other chemotherapeutic
      agents (vinblastine, camptothecin, and paclitaxel). In vivo, a SAV dosing of
      1 mg/kg once in 48 hours (i.p.) resulted in growth arrest of an A549 tumor xenograft,
      with growth resuming when dosing ceased. With a peak serum concentration of
      SAV of 2.36 \u03bcmol/L (at 2 hours post i.p. injection), the concentration
      of bioactive NBD-Wm was 41 nmol/L based on the partial inhibition of neutrophil
      respiratory burst. Therefore, SAV was present as an inactive prodrug in serum
      (peak = 2.36 \u03bcmol/L), which generated low concentrations of active viridin
      (41 nmol/L). SAV is a prodrug, the slow release and cytostatic activities of
      which suggest that it might be useful as a component of metronomic-based chemotherapeutic
      strategies. [Mol Cancer Ther 2009;8(6):1666\u201375]", "venue": "Molecular Cancer
      Therapeutics", "year": 2009, "referenceCount": 30, "citationCount": 16, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://aacrjournals.org/mct/article-pdf/8/6/1666/1884036/1666.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2009-06-01", "journal": {"volume": "8", "pages": "1666 -
      1675", "name": "Molecular Cancer Therapeutics"}, "citationStyles": {"bibtex":
      "@Article{Smith2009TheAC,\n author = {Adam Smith and Joseph T. Blois and Hushan
      Yuan and E. Aikawa and C. Ellson and Jose-Luiz Figueiredo and R. Weissleder
      and Rainer H. Kohler and M. Yaffe and L. Cantley and L. Josephson},\n booktitle
      = {Molecular Cancer Therapeutics},\n journal = {Molecular Cancer Therapeutics},\n
      pages = {1666 - 1675},\n title = {The antiproliferative cytostatic effects of
      a self-activating viridin prodrug},\n volume = {8},\n year = {2009}\n}\n"},
      "authors": [{"authorId": "2109352731", "name": "Adam Smith"}, {"authorId": "37048404",
      "name": "Joseph T. Blois"}, {"authorId": "6230104", "name": "Hushan Yuan"},
      {"authorId": "3280645", "name": "E. Aikawa"}, {"authorId": "3579696", "name":
      "C. Ellson"}, {"authorId": "46728536", "name": "Jose-Luiz Figueiredo"}, {"authorId":
      "3127756", "name": "R. Weissleder"}, {"authorId": "3517894", "name": "Rainer
      H. Kohler"}, {"authorId": "88402408", "name": "M. Yaffe"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "5095505", "name": "L. Josephson"}]}, {"paperId":
      "15c67b38867283667bcffc4fb9ddab096fc99679", "externalIds": {"MAG": "2165002727",
      "DOI": "10.1016/j.molcel.2008.12.026", "CorpusId": 35835179, "PubMed": "19187764"},
      "corpusId": 35835179, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/15c67b38867283667bcffc4fb9ddab096fc99679",
      "title": "Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to
      promote melanoma cell proliferation.", "abstract": null, "venue": "Molecules
      and Cells", "year": 2009, "referenceCount": 62, "citationCount": 357, "influentialCitationCount":
      25, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276509000021/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2009-01-30", "journal": {"volume": "33 2", "pages": "\n          237-47\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Zheng2009OncogenicBN,\n
      author = {B. Zheng and Joseph H. Jeong and J. Asara and Yuan Yuan and S. Granter
      and L. Chin and L. Cantley},\n booktitle = {Molecules and Cells},\n journal
      = {Molecular cell},\n pages = {\n          237-47\n        },\n title = {Oncogenic
      B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell
      proliferation.},\n volume = {33 2},\n year = {2009}\n}\n"}, "authors": [{"authorId":
      "143918840", "name": "B. Zheng"}, {"authorId": "46973400", "name": "Joseph H.
      Jeong"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "48009853",
      "name": "Yuan Yuan"}, {"authorId": "6318792", "name": "S. Granter"}, {"authorId":
      "144750835", "name": "L. Chin"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "2b793875fa5210f8c09f434be555e9c0350e600a", "externalIds": {"MAG":
      "2103414735", "DOI": "10.1200/JCO.2008.18.6544", "CorpusId": 37687233, "PubMed":
      "19237633"}, "corpusId": 37687233, "publicationVenue": {"id": "a5913268-3957-484f-b41f-347b0ba23338",
      "name": "Journal of Clinical Oncology", "type": "journal", "alternate_names":
      ["J Clin Oncol"], "issn": "0732-183X", "url": "https://ascopubs.org/loi/jco",
      "alternate_urls": ["http://www.jco.org/", "http://jco.ascopubs.org/"]}, "url":
      "https://www.semanticscholar.org/paper/2b793875fa5210f8c09f434be555e9c0350e600a",
      "title": "PIK3CA mutation is associated with poor prognosis among patients with
      curatively resected colon cancer.", "abstract": "PURPOSE\nPIK3CA mutation and
      subsequent activation of the AKT pathway play an important role in colorectal
      carcinogenesis. However, little is known about the prognostic role of PIK3CA
      mutation in colon cancer.\n\n\nPATIENTS AND METHODS\nUsing 450 resectable colon
      cancers (stage I to III) in two independent prospective cohorts, we detected
      PIK3CA mutation in 82 tumors (18%) by pyrosequencing. Cox proportional hazards
      models were used to calculate hazard ratios (HRs) of colon cancer-specific and
      overall mortalities, adjusted for patient characteristics and tumoral molecular
      features, including the CpG island methylation phenotype, microsatellite instability
      (MSI), LINE-1 hypomethylation, and p53, CIMP, KRAS and BRAF mutation.\n\n\nRESULTS\nCompared
      with patients with PIK3CA wild-type tumors, those with PIK3CA-mutated tumors
      experienced an increase in colon cancer-specific mortality according to univariate
      analysis (HR = 1.64; 95% CI, 0.95 to 2.86), which persisted after adjusting
      for other known or potential risk factors for cancer recurrence (including MSI;
      multivariate HR = 2.23; 95% CI, 1.21 to 4.11). The effect of PIK3CA mutation
      on cancer survival seemed to differ according to KRAS mutational status. Among
      patients with KRAS wild-type tumors, the presence of PIK3CA mutation was associated
      with a significant increase in colon cancer-specific mortality (HR = 3.80; 95%
      CI, 1.56 to 9.27). In contrast, PIK3CA mutation conferred no significant effect
      on mortality among patients with KRAS-mutated tumors (HR = 1.25; 95% CI, 0.52
      to 2.96).\n\n\nCONCLUSION\nAmong patients who undergo a curative resection of
      colon cancer, PIK3CA mutation is associated with shorter cancer-specific survival.
      The adverse effect of PIK3CA mutation may be potentially limited to patients
      with KRAS wild-type tumors.", "venue": "Journal of Clinical Oncology", "year":
      2009, "referenceCount": 45, "citationCount": 328, "influentialCitationCount":
      18, "isOpenAccess": true, "openAccessPdf": {"url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.18.6544?role=tab",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2009-03-20", "journal":
      {"volume": "27 9", "pages": "\n          1477-84\n        ", "name": "Journal
      of clinical oncology : official journal of the American Society of Clinical
      Oncology"}, "citationStyles": {"bibtex": "@Article{Ogino2009PIK3CAMI,\n author
      = {S. Ogino and K. Nosho and G. Kirkner and K. Shima and N. Irahara and Shoko
      Kure and A. Chan and J. Engelman and P. Kraft and L. Cantley and E. Giovannucci
      and C. Fuchs},\n booktitle = {Journal of Clinical Oncology},\n journal = {Journal
      of clinical oncology : official journal of the American Society of Clinical
      Oncology},\n pages = {\n          1477-84\n        },\n title = {PIK3CA mutation
      is associated with poor prognosis among patients with curatively resected colon
      cancer.},\n volume = {27 9},\n year = {2009}\n}\n"}, "authors": [{"authorId":
      "3513211", "name": "S. Ogino"}, {"authorId": "5913727", "name": "K. Nosho"},
      {"authorId": "5726687", "name": "G. Kirkner"}, {"authorId": "1921948", "name":
      "K. Shima"}, {"authorId": "5888152", "name": "N. Irahara"}, {"authorId": "21523224",
      "name": "Shoko Kure"}, {"authorId": "2168928633", "name": "A. Chan"}, {"authorId":
      "6828387", "name": "J. Engelman"}, {"authorId": "143832374", "name": "P. Kraft"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144786791", "name":
      "E. Giovannucci"}, {"authorId": "1710084", "name": "C. Fuchs"}]}, {"paperId":
      "32b1eaf84a1a3784fcddce31326be24410915f91", "externalIds": {"MAG": "2154350109",
      "DOI": "10.1158/1078-0432.CCR-09-2305", "CorpusId": 14250276, "PubMed": "19903790"},
      "corpusId": 14250276, "publicationVenue": {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0",
      "name": "Clinical Cancer Research", "type": "journal", "alternate_names": ["Clin
      Cancer Res"], "issn": "1078-0432", "url": "https://clincancerres.aacrjournals.org/",
      "alternate_urls": ["http://clincancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/32b1eaf84a1a3784fcddce31326be24410915f91",
      "title": "Getting Knit-PI3Ky: PIK3CA Mutation Status to Direct Multimodality
      Therapy?", "abstract": "There is high morbidity associated with local recurrence
      of rectal cancer. However, the adjuvant therapies given to prevent such recurrences
      also have significant side effects and associated risks. The ability to select
      patients with the highest risk of recurrence and greatest therapeutic response
      will improve rectal cancer care. (Clin Cancer Res 2009;15(22):674850)", "venue":
      "Clinical Cancer Research", "year": 2009, "referenceCount": 13, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://aacrjournals.org/clincancerres/article-pdf/15/22/6748/1985082/6748.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2009-11-10", "journal":
      {"volume": "15", "pages": "6748 - 6750", "name": "Clinical Cancer Research"},
      "citationStyles": {"bibtex": "@Article{Myers2009GettingKP,\n author = {A. Myers
      and J. Meyerhardt and L. Cantley},\n booktitle = {Clinical Cancer Research},\n
      journal = {Clinical Cancer Research},\n pages = {6748 - 6750},\n title = {Getting
      Knit-PI3Ky: PIK3CA Mutation Status to Direct Multimodality Therapy?},\n volume
      = {15},\n year = {2009}\n}\n"}, "authors": [{"authorId": "6324437", "name":
      "A. Myers"}, {"authorId": "3859322", "name": "J. Meyerhardt"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "4b03f59f6b553a36324d4849dacb00deb2900f6d",
      "externalIds": {"MAG": "2753561643", "DOI": "10.1073/PNAS.0905401106", "CorpusId":
      59191106}, "corpusId": 59191106, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/4b03f59f6b553a36324d4849dacb00deb2900f6d",
      "title": "Sj\u00f6gren''s syndrome-like disease in mice with T cells lacking
      class 1A phosphoinositide-3-kinase (Proceedings of the National Academy of Sciences
      of the United States of America (2009) 103, 45, (16882-16887) 10.1073/pnas.
      0607984103)", "abstract": null, "venue": "", "year": 2009, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2009-06-30", "journal": {"volume": "106", "name": "Proceedings
      of the National Academy of Sciences of the United States of America"}, "citationStyles":
      {"bibtex": "@Article{Oak2009Sj\u00f6grensSD,\n author = {J. Oak and J. Deane
      and M. Kharas and Ji Luo and T. Lane and L. Cantley and D. Fruman},\n journal
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      title = {Sj\u00f6gren''s syndrome-like disease in mice with T cells lacking
      class 1A phosphoinositide-3-kinase (Proceedings of the National Academy of Sciences
      of the United States of America (2009) 103, 45, (16882-16887) 10.1073/pnas.
      0607984103)},\n volume = {106},\n year = {2009}\n}\n"}, "authors": [{"authorId":
      "39001132", "name": "J. Oak"}, {"authorId": "33653557", "name": "J. Deane"},
      {"authorId": "152500082", "name": "M. Kharas"}, {"authorId": "145954100", "name":
      "Ji Luo"}, {"authorId": "2385578", "name": "T. Lane"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "6241317", "name": "D. Fruman"}]}, {"paperId":
      "593a97c57c763a51d1dd1ba8b6eb3109637ef860", "externalIds": {"MAG": "2415206665",
      "DOI": "10.1016/j.cub.2009.06.010", "CorpusId": 19060385, "PubMed": "19655422"},
      "corpusId": 19060385, "publicationVenue": {"id": "9469269e-53d7-4955-b1a5-17a75bee7634",
      "name": "Current Biology", "type": "journal", "alternate_names": ["Curr Biology"],
      "issn": "0960-9822", "url": "http://www.current-biology.com/", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/09609822"]}, "url": "https://www.semanticscholar.org/paper/593a97c57c763a51d1dd1ba8b6eb3109637ef860",
      "title": "Lewis C. Cantley", "abstract": null, "venue": "Current Biology", "year":
      2009, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0960982209012469/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Environmental Science", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2009-07-28", "journal": {"volume":
      "19", "pages": "R540-R541", "name": "Current Biology"}, "citationStyles": {"bibtex":
      "@Article{Cantley2009LewisCC,\n author = {L. Cantley},\n booktitle = {Current
      Biology},\n journal = {Current Biology},\n pages = {R540-R541},\n title = {Lewis
      C. Cantley},\n volume = {19},\n year = {2009}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "7ecfc763ee0c96cd424e39a088b6e31325ae7141",
      "externalIds": {"MAG": "2080679736", "DOI": "10.1042/BJ20091035", "CorpusId":
      24699068, "PubMed": "19740074"}, "corpusId": 24699068, "publicationVenue": {"id":
      "64838252-a209-4424-a778-3b86b4a83c48", "name": "Biochemical Journal", "type":
      "journal", "alternate_names": ["Biochem J"], "issn": "0264-6021", "alternate_issns":
      ["0006-2936"], "url": "http://www.biochemj.org/"}, "url": "https://www.semanticscholar.org/paper/7ecfc763ee0c96cd424e39a088b6e31325ae7141",
      "title": "Substrate specificity and inhibitors of LRRK2, a protein kinase mutated
      in Parkinson''s disease.", "abstract": "The LRRK2 (leucine-rich repeat protein
      kinase-2) is mutated in a significant number of Parkinson''s disease patients,
      but little is known about its regulation and function. A common mutation changing
      Gly2019 to serine enhances catalytic activity, suggesting that small-molecule
      inhibitors might have utility in treating Parkinson''s disease. We employed
      various approaches to explore the substrate-specificity requirements of LRRK2
      and elaborated a peptide substrate termed Nictide, that had 20-fold lower Km
      and nearly 2-fold higher Vmax than the widely deployed LRRKtide substrate. We
      demonstrate that LRRK2 has marked preference for phosphorylating threonine over
      serine. We also observed that several ROCK (Rho kinase) inhibitors such as Y-27632
      and H-1152, suppressed LRRK2 with similar potency to which they inhibited ROCK2.
      In contrast, GSK429286A, a selective ROCK inhibitor, did not significantly inhibit
      LRRK2. We also identified a mutant LRRK2[A2016T] that was normally active, but
      resistant to H-1152 and Y-27632, as well as sunitinib, a structurally unrelated
      multikinase inhibitor that, in contrast with other compounds, suppresses LRRK2,
      but not ROCK. We have also developed the first sensitive antibody that enables
      measurement of endogenous LRRK2 protein levels and kinase activity as well as
      shRNA (short hairpin RNA) methods to reduce LRRK2 expression. Finally, we describe
      a pharmacological approach to validate whether substrates are phosphorylated
      by LRRK2 and use this to provide evidence that LRRK2 may not be rate-limiting
      for the phosphorylation of the proposed substrate moesin. The findings of the
      present study will aid with the investigation of LRRK2.", "venue": "Biochemical
      Journal", "year": 2009, "referenceCount": 43, "citationCount": 199, "influentialCitationCount":
      17, "isOpenAccess": true, "openAccessPdf": {"url": "https://hal.archives-ouvertes.fr/hal-00479223/file/PEER_stage2_10.1042%252FBJ20091035.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2009-11-15", "journal": {"volume": "424 1", "pages": "\n          47-60\n        ",
      "name": "The Biochemical journal"}, "citationStyles": {"bibtex": "@Article{Nichols2009SubstrateSA,\n
      author = {R. Nichols and Nicolas Dzamko and Jessica E. Hutti and Jessica E.
      Hutti and L. Cantley and L. Cantley and M. De\u00e1k and Jennifer M. Moran and
      P. Bamborough and A. Reith and D. Alessi},\n booktitle = {Biochemical Journal},\n
      journal = {The Biochemical journal},\n pages = {\n          47-60\n        },\n
      title = {Substrate specificity and inhibitors of LRRK2, a protein kinase mutated
      in Parkinson''s disease.},\n volume = {424 1},\n year = {2009}\n}\n"}, "authors":
      [{"authorId": "36960808", "name": "R. Nichols"}, {"authorId": "46728221", "name":
      "Nicolas Dzamko"}, {"authorId": "6742227", "name": "Jessica E. Hutti"}, {"authorId":
      "6742227", "name": "Jessica E. Hutti"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4206645",
      "name": "M. De\u00e1k"}, {"authorId": "46717397", "name": "Jennifer M. Moran"},
      {"authorId": "8064952", "name": "P. Bamborough"}, {"authorId": "46487022", "name":
      "A. Reith"}, {"authorId": "3475566", "name": "D. Alessi"}]}, {"paperId": "8e6de6f779093fa07c510d81b00224b836c9f97f",
      "externalIds": {"MAG": "2016899606", "DOI": "10.1016/j.molcel.2009.04.031",
      "CorpusId": 23156747, "PubMed": "19481526"}, "corpusId": 23156747, "publicationVenue":
      {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11", "name": "Molecules and Cells",
      "type": "journal", "alternate_names": ["Molecular Cell", "Mol Cell"], "issn":
      "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"], "url": "https://link.springer.com/journal/10059",
      "alternate_urls": ["http://www.molcells.org/about/sub06.html", "http://www.molecule.org/",
      "http://www.sciencedirect.com/science/journal/10972765", "http://www.cell.com/molecular-cell/"]},
      "url": "https://www.semanticscholar.org/paper/8e6de6f779093fa07c510d81b00224b836c9f97f",
      "title": "Phosphorylation of the tumor suppressor CYLD by the breast cancer
      oncogene IKKepsilon promotes cell transformation.", "abstract": null, "venue":
      "Molecules and Cells", "year": 2009, "referenceCount": 41, "citationCount":
      239, "influentialCitationCount": 14, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S109727650900313X/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2009-05-14", "journal":
      {"volume": "34 4", "pages": "\n          461-72\n        ", "name": "Molecular
      cell"}, "citationStyles": {"bibtex": "@Article{Hutti2009PhosphorylationOT,\n
      author = {Jessica E. Hutti and R. Shen and Derek W. Abbott and A. Zhou and K.
      Sprott and J. Asara and W. Hahn and L. Cantley},\n booktitle = {Molecules and
      Cells},\n journal = {Molecular cell},\n pages = {\n          461-72\n        },\n
      title = {Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene
      IKKepsilon promotes cell transformation.},\n volume = {34 4},\n year = {2009}\n}\n"},
      "authors": [{"authorId": "6742227", "name": "Jessica E. Hutti"}, {"authorId":
      "5642912", "name": "R. Shen"}, {"authorId": "145759174", "name": "Derek W. Abbott"},
      {"authorId": "5858765", "name": "A. Zhou"}, {"authorId": "46975075", "name":
      "K. Sprott"}, {"authorId": "3028470", "name": "J. Asara"}, {"authorId": "1890553",
      "name": "W. Hahn"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "94e5fd34373defb83b52bd8f5b47a59780d73504", "externalIds": {"MAG": "1977952379",
      "DOI": "10.1021/bc900176a", "CorpusId": 23079243, "PubMed": "19883074"}, "corpusId":
      23079243, "publicationVenue": {"id": "727c9075-57df-4276-83b3-a90e2722f883",
      "name": "Bioconjugate chemistry", "type": "journal", "alternate_names": ["Bioconjugate
      Chem", "Bioconjugate chem", "Bioconjugate Chemistry"], "issn": "1043-1802",
      "url": "https://pubs.acs.org/journal/bcches", "alternate_urls": ["http://pubs.acs.org/journals/bcches/index.html",
      "http://pubs.acs.org/journal/bcches"]}, "url": "https://www.semanticscholar.org/paper/94e5fd34373defb83b52bd8f5b47a59780d73504",
      "title": "A wortmannin-cetuximab as a double drug.", "abstract": "Double drugs
      are obtained when two pharmacologically active entities are covalently joined
      to improve potency. We conjugated the viridin Wm with a self-activating linkage
      to cetuximab and demonstrated the retention of immunoreactivity by the conjugate.
      Though cetuximab lacked a growth inhibitory activity against A549 cells, the
      Wm-cetuximab conjugate had an antiproliferative IC(50) of 155 nM in vitro. The
      chemistry of attaching a self-releasing Wm to clinically approved antibodies
      is general and, in selected instances, may yield antibody-based double drugs
      with improved efficacy.", "venue": "Bioconjugate chemistry", "year": 2009, "referenceCount":
      28, "citationCount": 8, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://dash.harvard.edu/bitstream/1/41384272/1/14537%20aam%20nihms-387058.pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2009-11-02", "journal": {"volume": "20 11", "pages": "\n          2185-9\n        ",
      "name": "Bioconjugate chemistry"}, "citationStyles": {"bibtex": "@Article{Smith2009AWA,\n
      author = {R. Smith and Hushan Yuan and R. Weissleder and L. Cantley and L. Josephson},\n
      booktitle = {Bioconjugate chemistry},\n journal = {Bioconjugate chemistry},\n
      pages = {\n          2185-9\n        },\n title = {A wortmannin-cetuximab as
      a double drug.},\n volume = {20 11},\n year = {2009}\n}\n"}, "authors": [{"authorId":
      "2256101553", "name": "R. Smith"}, {"authorId": "6230104", "name": "Hushan Yuan"},
      {"authorId": "3127756", "name": "R. Weissleder"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "5095505", "name": "L. Josephson"}]}, {"paperId":
      "9fc366d0304be3fa2236f8fb210f5ea8f809160a", "externalIds": {"MAG": "2062388859",
      "DOI": "10.1016/J.BONE.2009.01.127", "CorpusId": 85157501}, "corpusId": 85157501,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/9fc366d0304be3fa2236f8fb210f5ea8f809160a",
      "title": "Class IA phosphatidylinositol 3-kinases are indispensable for osteoclast
      function by regulating cytoskeletal organization and cell death", "abstract":
      null, "venue": "", "year": 2009, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2009-05-01", "journal": {"volume":
      "44", "name": "Bone"}, "citationStyles": {"bibtex": "@Article{Nakamura2009ClassIP,\n
      author = {Masaki Nakamura and Hironari Masuda and M. Iwasawa and Y. Nagase and
      Toshikazu Nakamura and S. Kato and K. Ueki and Ji Luo and L. Cantley and Kozo
      Nakamura and Sakae Tanaka},\n journal = {Bone},\n title = {Class IA phosphatidylinositol
      3-kinases are indispensable for osteoclast function by regulating cytoskeletal
      organization and cell death},\n volume = {44},\n year = {2009}\n}\n"}, "authors":
      [{"authorId": "2108944170", "name": "Masaki Nakamura"}, {"authorId": "5169247",
      "name": "Hironari Masuda"}, {"authorId": "40651060", "name": "M. Iwasawa"},
      {"authorId": "145429399", "name": "Y. Nagase"}, {"authorId": "2110184214", "name":
      "Toshikazu Nakamura"}, {"authorId": "2568535", "name": "S. Kato"}, {"authorId":
      "5177377", "name": "K. Ueki"}, {"authorId": "145954100", "name": "Ji Luo"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "28278589", "name":
      "Kozo Nakamura"}, {"authorId": "144638767", "name": "Sakae Tanaka"}]}, {"paperId":
      "a5d7657201d83a62dfcff93bd25e44b550c19973", "externalIds": {"MAG": "2166472612",
      "DOI": "10.1126/science.1165069", "CorpusId": 5358680, "PubMed": "19407199"},
      "corpusId": 5358680, "publicationVenue": {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad",
      "name": "Science", "type": "journal", "issn": "0193-4511", "alternate_issns":
      ["0036-8075"], "url": "https://www.jstor.org/journal/science", "alternate_urls":
      ["https://www.sciencemag.org/", "http://www.sciencemag.org/", "http://www.jstor.org/journals/00368075.html",
      "http://www.sciencemag.org/archive/"]}, "url": "https://www.semanticscholar.org/paper/a5d7657201d83a62dfcff93bd25e44b550c19973",
      "title": "Biomolecular Characterization and Protein Sequences of the Campanian
      Hadrosaur B. canadensis", "abstract": "The Birds and the Dinosaurs The extent
      to which primary tissues are preserved in ancient fossils remains controversial.
      Schweitzer et al. (p. 626; see the news story by Service) describe well-preserved
      tissues and primary collagen sequences from the femur of an 80-million-year-old
      hadrosaur. The fossil preserved structures resembling primary bone tissues and
      vessels. Both extracts and tissue pieces were analyzed in multiple laboratories
      by mass spectrometry, which revealed ancient collagen sequences that support
      a close relation between birds and dinosaurs. Analysis of well-preserved tissues
      from an 80-million-year-old hadrosaur supports the dinosaur-bird relationship.
      Molecular preservation in non-avian dinosaurs is controversial. We present multiple
      lines of evidence that endogenous proteinaceous material is preserved in bone
      fragments and soft tissues from an 80-million-year-old Campanian hadrosaur,
      Brachylophosaurus canadensis [Museum of the Rockies (MOR) 2598]. Microstructural
      and immunological data are consistent with preservation of multiple bone matrix
      and vessel proteins, and phylogenetic analyses of Brachylophosaurus collagen
      sequenced by mass spectrometry robustly support the bird-dinosaur clade, consistent
      with an endogenous source for these collagen peptides. These data complement
      earlier results from Tyrannosaurus rex (MOR 1125) and confirm that molecular
      preservation in Cretaceous dinosaurs is not a unique event.", "venue": "Science",
      "year": 2009, "referenceCount": 26, "citationCount": 216, "influentialCitationCount":
      7, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2009-05-01", "journal": {"volume": "324", "pages": "626 - 631", "name": "Science"},
      "citationStyles": {"bibtex": "@Article{Schweitzer2009BiomolecularCA,\n author
      = {M. Schweitzer and Wenxia Zheng and C. Organ and R. Avci and Z. Suo and Lisa
      M. Freimark and Valerie S. LeBleu and M. Duncan and M. V. Vander Heiden and
      J. Neveu and William S. Lane and J. Cottrell and J. Horner and L. Cantley and
      R. Kalluri and J. Asara},\n booktitle = {Science},\n journal = {Science},\n
      pages = {626 - 631},\n title = {Biomolecular Characterization and Protein Sequences
      of the Campanian Hadrosaur B. canadensis},\n volume = {324},\n year = {2009}\n}\n"},
      "authors": [{"authorId": "5618773", "name": "M. Schweitzer"}, {"authorId": "7494304",
      "name": "Wenxia Zheng"}, {"authorId": "143615392", "name": "C. Organ"}, {"authorId":
      "2988211", "name": "R. Avci"}, {"authorId": "8048771", "name": "Z. Suo"}, {"authorId":
      "4333053", "name": "Lisa M. Freimark"}, {"authorId": "5457987", "name": "Valerie
      S. LeBleu"}, {"authorId": "1441583847", "name": "M. Duncan"}, {"authorId": "3804233",
      "name": "M. V. Vander Heiden"}, {"authorId": "1400084319", "name": "J. Neveu"},
      {"authorId": "1400084865", "name": "William S. Lane"}, {"authorId": "48894637",
      "name": "J. Cottrell"}, {"authorId": "1701498", "name": "J. Horner"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5090009", "name": "R. Kalluri"},
      {"authorId": "3028470", "name": "J. Asara"}]}, {"paperId": "af2dee0a2e3460fd1504377da271d63874d759e0",
      "externalIds": {"MAG": "2030357707", "DOI": "10.1038/nbt1009-916", "CorpusId":
      28569221, "PubMed": "19816448"}, "corpusId": 28569221, "publicationVenue": {"id":
      "458166b3-de17-4bf3-bbbb-e53782de2f0f", "name": "Nature Biotechnology", "type":
      "journal", "alternate_names": ["Nat Biotechnol"], "issn": "1087-0156", "url":
      "http://www.nature.com/nbt/", "alternate_urls": ["http://www.nature.com/nbt"]},
      "url": "https://www.semanticscholar.org/paper/af2dee0a2e3460fd1504377da271d63874d759e0",
      "title": "Cancer''s insatiable appetite", "abstract": null, "venue": "Nature
      Biotechnology", "year": 2009, "referenceCount": 15, "citationCount": 46, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc3744822?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["News"], "publicationDate":
      "2009-10-01", "journal": {"volume": "27", "pages": "916-917", "name": "Nature
      Biotechnology"}, "citationStyles": {"bibtex": "@Article{Locasale2009CancersIA,\n
      author = {J. Locasale and L. Cantley and M. V. Heiden},\n booktitle = {Nature
      Biotechnology},\n journal = {Nature Biotechnology},\n pages = {916-917},\n title
      = {Cancer''s insatiable appetite},\n volume = {27},\n year = {2009}\n}\n"},
      "authors": [{"authorId": "2268976", "name": "J. Locasale"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "35413264", "name": "M. V. Heiden"}]}, {"paperId":
      "b9fe6d51c45464cd999dd9bf01e85133f38d0c44", "externalIds": {"CorpusId": 30217707},
      "corpusId": 30217707, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/b9fe6d51c45464cd999dd9bf01e85133f38d0c44",
      "title": "Substrate specificity and inhibitors of LRRK 2 , a protein kinase
      mutated in Parkinson \u2019 s disease", "abstract": "R. Jeremy NICHOLS*1, Nicolas
      DZAMKO*, Jessica E. HUTTI\u2020\u2021, Lewis C. CANTLEY\u2020\u2021, Maria DEAK*,
      Jennifer MORAN\u00a7, Paul BAMBOROUGH\u2016, Alastair D. REITH\u00b6 and Dario
      R. ALESSI*1 *MRC Protein Phosphorylation Unit, College of Life Sciences, University
      of Dundee, Dow Street, Dundee DD1 5EH, Scotland, U.K., \u2020Department of Systems
      Biology, Harvard Medical School, Boston, MA 02115, U.S.A., \u2021Division of
      Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02215,
      U.S.A., \u00a7Division of Signal Transduction Therapy Unit, College of Life
      Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland, U.K.,
      \u2016Molecular Discovery Research, GlaxoSmithKline Pharmaceuticals R&D, Medicines
      Research Centre, Gunnels Wood Road, Stevenage, Herts. SG1 2NY, U.K., and \u00b6Neurosciences
      Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals R&D,
      New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, U.K.", "venue":
      "", "year": 2009, "referenceCount": 41, "citationCount": 19, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Nichols2009SubstrateSA,\n
      author = {R. Nichols and Nicolas Dzamko and Jessica E. Hutti and L. Cantley
      and M. De\u00e1k and Jennifer M. Moran and P. Bamborough and A. Reith and D.
      Alessi},\n title = {Substrate specificity and inhibitors of LRRK 2 , a protein
      kinase mutated in Parkinson \u2019 s disease},\n year = {2009}\n}\n"}, "authors":
      [{"authorId": "36960808", "name": "R. Nichols"}, {"authorId": "46728221", "name":
      "Nicolas Dzamko"}, {"authorId": "6742227", "name": "Jessica E. Hutti"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4206645", "name": "M. De\u00e1k"},
      {"authorId": "46717397", "name": "Jennifer M. Moran"}, {"authorId": "8064952",
      "name": "P. Bamborough"}, {"authorId": "46487022", "name": "A. Reith"}, {"authorId":
      "3475566", "name": "D. Alessi"}]}, {"paperId": "c51823907e3cd5f6194907f9bc71d4c17299ea4b",
      "externalIds": {"MAG": "2325532503", "DOI": "10.1158/0008-5472.FBCR09-IA-2",
      "CorpusId": 75206763}, "corpusId": 75206763, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/c51823907e3cd5f6194907f9bc71d4c17299ea4b",
      "title": "Abstract IA-2: PI3\u2010Kinase and cancer metabolism", "abstract":
      null, "venue": "", "year": 2009, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2009-12-01", "journal": {"volume":
      "69", "name": "Cancer Research"}, "citationStyles": {"bibtex": "@Article{Cantley2009AbstractIP,\n
      author = {L. Cantley},\n journal = {Cancer Research},\n title = {Abstract IA-2:
      PI3\u2010Kinase and cancer metabolism},\n volume = {69},\n year = {2009}\n}\n"},
      "authors": [{"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "c5718d066904b280538c92596cab6c5ccca30d27",
      "externalIds": {"MAG": "2012116166", "DOI": "10.1016/j.ccr.2009.06.006", "CorpusId":
      206536589, "PubMed": "19647222"}, "corpusId": 206536589, "publicationVenue":
      {"id": "11e469cb-37ad-487e-b0ab-d26e82037c22", "name": "Cancer Cell", "type":
      "journal", "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/c5718d066904b280538c92596cab6c5ccca30d27",
      "title": "Evidence that inositol polyphosphate 4-phosphatase type II is a tumor
      suppressor that inhibits PI3K signaling.", "abstract": null, "venue": "Cancer
      Cell", "year": 2009, "referenceCount": 49, "citationCount": 452, "influentialCitationCount":
      42, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1535610809001809/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2009-08-04", "journal": {"volume": "16 2", "pages": "\n          115-25\n        ",
      "name": "Cancer cell"}, "citationStyles": {"bibtex": "@Article{Gewinner2009EvidenceTI,\n
      author = {C. Gewinner and Z. Wang and A. Richardson and J. Teruya-Feldstein
      and D. Etemadmoghadam and D. Bowtell and J. Barretina and William M. Lin and
      L. Rameh and L. Salmena and P. Pandolfi and L. Cantley},\n booktitle = {Cancer
      Cell},\n journal = {Cancer cell},\n pages = {\n          115-25\n        },\n
      title = {Evidence that inositol polyphosphate 4-phosphatase type II is a tumor
      suppressor that inhibits PI3K signaling.},\n volume = {16 2},\n year = {2009}\n}\n"},
      "authors": [{"authorId": "7739224", "name": "C. Gewinner"}, {"authorId": "2108217710",
      "name": "Z. Wang"}, {"authorId": "145960454", "name": "A. Richardson"}, {"authorId":
      "1396943744", "name": "J. Teruya-Feldstein"}, {"authorId": "4654839", "name":
      "D. Etemadmoghadam"}, {"authorId": "2693074", "name": "D. Bowtell"}, {"authorId":
      "49632549", "name": "J. Barretina"}, {"authorId": "2221690611", "name": "William
      M. Lin"}, {"authorId": "4109960", "name": "L. Rameh"}, {"authorId": "6316033",
      "name": "L. Salmena"}, {"authorId": "4499580", "name": "P. Pandolfi"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "cdc7344063a4c8088a42b0b1023c961f553db60d",
      "externalIds": {"MAG": "2168858265", "DOI": "10.1210/en.2009-0454", "CorpusId":
      1532541, "PubMed": "19819947"}, "corpusId": 1532541, "publicationVenue": {"id":
      "c9a5576c-9a45-4071-ac6f-efa4d4d5b200", "name": "Endocrinology", "type": "journal",
      "issn": "2510-1935", "alternate_issns": ["0013-7227"], "url": "http://endo.endojournals.org/"},
      "url": "https://www.semanticscholar.org/paper/cdc7344063a4c8088a42b0b1023c961f553db60d",
      "title": "Phosphatidyl inositol 3-kinase signaling in hypothalamic proopiomelanocortin
      neurons contributes to the regulation of glucose homeostasis.", "abstract":
      "Recent studies demonstrated a role for hypothalamic insulin and leptin action
      in the regulation of glucose homeostasis. This regulation involves proopiomelanocortin
      (POMC) neurons because suppression of phosphatidyl inositol 3-kinase (PI3K)
      signaling in these neurons blunts the acute effects of insulin and leptin on
      POMC neuronal activity. In the current study, we investigated whether disruption
      of PI3K signaling in POMC neurons alters normal glucose homeostasis using mouse
      models designed to both increase and decrease PI3K-mediated signaling in these
      neurons. We found that deleting p85alpha alone induced resistance to diet-induced
      obesity. In contrast, deletion of the p110alpha catalytic subunit of PI3K led
      to increased weight gain and adipose tissue along with reduced energy expenditure.
      Independent of these effects, increased PI3K activity in POMC neurons improved
      insulin sensitivity, whereas decreased PI3K signaling resulted in impaired glucose
      regulation. These studies show that activity of the PI3K pathway in POMC neurons
      is involved in not only normal energy regulation but also glucose homeostasis.",
      "venue": "Endocrinology", "year": 2009, "referenceCount": 70, "citationCount":
      82, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://academic.oup.com/endo/article-pdf/150/11/4874/8998896/endo4874.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2009-11-01", "journal": {"volume": "150 11", "pages": "\n          4874-82\n        ",
      "name": "Endocrinology"}, "citationStyles": {"bibtex": "@Article{Hill2009PhosphatidylI3,\n
      author = {Jennifer W. Hill and Yong Xu and F. Preitner and M. Fukuda and You-Ree
      Cho and Ji Luo and N. Balthasar and R. Coppari and L. Cantley and B. Kahn and
      Jean J. Zhao and J. Elmquist},\n booktitle = {Endocrinology},\n journal = {Endocrinology},\n
      pages = {\n          4874-82\n        },\n title = {Phosphatidyl inositol 3-kinase
      signaling in hypothalamic proopiomelanocortin neurons contributes to the regulation
      of glucose homeostasis.},\n volume = {150 11},\n year = {2009}\n}\n"}, "authors":
      [{"authorId": "2111068085", "name": "Jennifer W. Hill"}, {"authorId": "2247345764",
      "name": "Yong Xu"}, {"authorId": "3725193", "name": "F. Preitner"}, {"authorId":
      "153230305", "name": "M. Fukuda"}, {"authorId": "90176312", "name": "You-Ree
      Cho"}, {"authorId": "2247448227", "name": "Ji Luo"}, {"authorId": "5201594",
      "name": "N. Balthasar"}, {"authorId": "5582429", "name": "R. Coppari"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "1997179", "name": "B. Kahn"},
      {"authorId": "50985038", "name": "Jean J. Zhao"}, {"authorId": "5905630", "name":
      "J. Elmquist"}]}, {"paperId": "e0756852ed9fee5b05d0eb6dbd00272fd43cb987", "externalIds":
      {"MAG": "1994961642", "DOI": "10.1002/dvdy.22078", "CorpusId": 26322702, "PubMed":
      "19705443"}, "corpusId": 26322702, "publicationVenue": {"id": "a4cd271c-e78f-486f-bf3c-c0c28f2cb575",
      "name": "Developmental Dynamics", "type": "journal", "alternate_names": ["Dev
      Dyn"], "issn": "1058-8388", "url": "http://www3.interscience.wiley.com/cgi-bin/jhome/109873231",
      "alternate_urls": ["http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0177",
      "http://www3.interscience.wiley.com/cgi-bin/jhome/38417", "https://onlinelibrary.wiley.com/journal/10970177"]},
      "url": "https://www.semanticscholar.org/paper/e0756852ed9fee5b05d0eb6dbd00272fd43cb987",
      "title": "Organ\u2010specific lymphangiectasia, arrested lymphatic sprouting,
      and maturation defects resulting from gene\u2010targeting of the PI3K regulatory
      isoforms p85\u03b1, p55\u03b1, and p50\u03b1", "abstract": "The phosphoinositide
      3\u2010kinase (PI3K) family has multiple vascular functions, but the specific
      regulatory isoform supporting lymphangiogenesis remains unidentified. Here,
      we report that deletion of the Pik3r1 gene, encoding the regulatory subunits
      p85\u03b1, p55\u03b1, and p50\u03b1 impairs lymphatic sprouting and maturation,
      and causes abnormal lymphatic morphology, without major impact on blood vessels.
      Pik3r1 deletion had the most severe consequences among gut and diaphragm lymphatics,
      which share the retroperitoneal anlage, initially suggesting that the Pik3r1
      role in this vasculature is anlage\u2010dependent. However, whereas lymphatic
      sprouting toward the diaphragm was arrested, lymphatics invaded the gut, where
      remodeling and valve formation were impaired. Thus, cell\u2010origin fails to
      explain the phenotype. Only the gut showed lymphangiectasia, lymphatic up\u2010regulation
      of the transforming growth factor\u2010\u03b2 co\u2010receptor endoglin, and
      reduced levels of mature vascular endothelial growth factor\u2010C protein.
      Our data suggest that Pik3r1 isoforms are required for distinct steps of embryonic
      lymphangiogenesis in different organ microenvironments, whereas they are largely
      dispensable for hemangiogenesis. Developmental Dynamics 238:2670\u20132679,
      2009. \u00a9 2009 Wiley\u2010Liss, Inc.", "venue": "Developmental Dynamics",
      "year": 2009, "referenceCount": 57, "citationCount": 46, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dvdy.22078",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2009-10-01", "journal": {"volume": "238", "name": "Developmental
      Dynamics"}, "citationStyles": {"bibtex": "@Article{Mouta-Bellum2009OrganspecificLA,\n
      author = {Carla Mouta-Bellum and A. Kirov and Laura Miceli-Libby and Maura Mancini
      and T. Petrova and L. Liaw and I. Prudovsky and P. Thorpe and N. Miura and L.
      Cantley and K. Alitalo and D. Fruman and C. Vary},\n booktitle = {Developmental
      Dynamics},\n journal = {Developmental Dynamics},\n title = {Organ\u2010specific
      lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting
      from gene\u2010targeting of the PI3K regulatory isoforms p85\u03b1, p55\u03b1,
      and p50\u03b1},\n volume = {238},\n year = {2009}\n}\n"}, "authors": [{"authorId":
      "1403487625", "name": "Carla Mouta-Bellum"}, {"authorId": "145286026", "name":
      "A. Kirov"}, {"authorId": "1422447285", "name": "Laura Miceli-Libby"}, {"authorId":
      "32714495", "name": "Maura Mancini"}, {"authorId": "2066574927", "name": "T.
      Petrova"}, {"authorId": "145241025", "name": "L. Liaw"}, {"authorId": "6057816",
      "name": "I. Prudovsky"}, {"authorId": "13545505", "name": "P. Thorpe"}, {"authorId":
      "48246980", "name": "N. Miura"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "4943908", "name": "K. Alitalo"}, {"authorId": "6241317", "name":
      "D. Fruman"}, {"authorId": "2800536", "name": "C. Vary"}]}, {"paperId": "f87313ac5400130b1c3e99cd8209835901dfdd69",
      "externalIds": {"MAG": "2169903226", "DOI": "10.1016/j.cell.2008.11.044", "CorpusId":
      18141193, "PubMed": "19203585"}, "corpusId": 18141193, "publicationVenue": {"id":
      "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal", "alternate_names":
      ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"], "url":
      "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/f87313ac5400130b1c3e99cd8209835901dfdd69",
      "title": "Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy",
      "abstract": null, "venue": "Cell", "year": 2009, "referenceCount": 59, "citationCount":
      1558, "influentialCitationCount": 90, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S0092867408015195/pdf", "status": null},
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2009-02-06", "journal":
      {"volume": "136", "pages": "521-534", "name": "Cell"}, "citationStyles": {"bibtex":
      "@Article{Nicklin2009BidirectionalTO,\n author = {P. Nicklin and Phil Bergman
      and Bailin Zhang and E. Triantafellow and Henry Wang and B. Nyfeler and Haidi
      Yang and M. Hild and C. Kung and Christopher J. Wilson and V. Myer and J. MacKeigan
      and Jeffrey A. Porter and Y. Karen Wang and L. Cantley and P. Finan and Leon
      O. Murphy},\n booktitle = {Cell},\n journal = {Cell},\n pages = {521-534},\n
      title = {Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy},\n
      volume = {136},\n year = {2009}\n}\n"}, "authors": [{"authorId": "2443785",
      "name": "P. Nicklin"}, {"authorId": "153877611", "name": "Phil Bergman"}, {"authorId":
      "48335317", "name": "Bailin Zhang"}, {"authorId": "5726884", "name": "E. Triantafellow"},
      {"authorId": "2155263853", "name": "Henry Wang"}, {"authorId": "5476944", "name":
      "B. Nyfeler"}, {"authorId": "2118696793", "name": "Haidi Yang"}, {"authorId":
      "3721603", "name": "M. Hild"}, {"authorId": "7636232", "name": "C. Kung"}, {"authorId":
      "145013770", "name": "Christopher J. Wilson"}, {"authorId": "4436761", "name":
      "V. Myer"}, {"authorId": "3706796", "name": "J. MacKeigan"}, {"authorId": "46558196",
      "name": "Jeffrey A. Porter"}, {"authorId": "2157159627", "name": "Y. Karen Wang"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144774406", "name":
      "P. Finan"}, {"authorId": "2561067", "name": "Leon O. Murphy"}]}, {"paperId":
      "1026830b7bd949578f06ef2a22e349920bbaf54f", "externalIds": {"MAG": "2157983986",
      "DOI": "10.1172/JCI34739", "CorpusId": 36856227, "PubMed": "18725988"}, "corpusId":
      36856227, "publicationVenue": {"id": "8c9a9e1b-acf2-4274-8d73-6ea0ecd11fd1",
      "name": "Journal of Clinical Investigation", "type": "journal", "alternate_names":
      ["J Clin Investig"], "issn": "0021-9738", "url": "https://www.jci.org/", "alternate_urls":
      ["http://www.jci.org/", "https://www.jci.org/archive", "http://www.jci.org/impact"]},
      "url": "https://www.semanticscholar.org/paper/1026830b7bd949578f06ef2a22e349920bbaf54f",
      "title": "Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent
      feedback loop in human cancer.", "abstract": "Numerous studies have established
      a causal link between aberrant mammalian target of rapamycin (mTOR) activation
      and tumorigenesis, indicating that mTOR inhibition may have therapeutic potential.
      In this study, we show that rapamycin and its analogs activate the MAPK pathway
      in human cancer, in what represents a novel mTORC1-MAPK feedback loop. We found
      that tumor samples from patients with biopsy-accessible solid tumors of advanced
      disease treated with RAD001, a rapamycin derivative, showed an administration
      schedule-dependent increase in activation of the MAPK pathway. RAD001 treatment
      also led to MAPK activation in a mouse model of prostate cancer. We further
      show that rapamycin-induced MAPK activation occurs in both normal cells and
      cancer cells lines and that this feedback loop depends on an S6K-PI3K-Ras pathway.
      Significantly, pharmacological inhibition of the MAPK pathway enhanced the antitumoral
      effect of mTORC1 inhibition by rapamycin in cancer cells in vitro and in a xenograft
      mouse model. Taken together, our findings identify MAPK activation as a consequence
      of mTORC1 inhibition and underscore the potential of a combined therapeutic
      approach with mTORC1 and MAPK inhibitors, currently employed as single agents
      in the clinic, for the treatment of human cancers.", "venue": "Journal of Clinical
      Investigation", "year": 2008, "referenceCount": 44, "citationCount": 1424, "influentialCitationCount":
      68, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jci.org/articles/view/34739/files/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2008-09-02", "journal": {"volume": "118 9", "pages": "\n          3065-74\n        ",
      "name": "The Journal of clinical investigation"}, "citationStyles": {"bibtex":
      "@Article{Carracedo2008InhibitionOM,\n author = {A. Carracedo and Li Ma and
      J. Teruya-Feldstein and F. Rojo and L. Salmena and A. Alimonti and Ainara Egia
      and A. Sasaki and G. Thomas and S. Kozma and A. Papa and C. Nardella and L.
      Cantley and J. Baselga and P. Pandolfi},\n booktitle = {Journal of Clinical
      Investigation},\n journal = {The Journal of clinical investigation},\n pages
      = {\n          3065-74\n        },\n title = {Inhibition of mTORC1 leads to
      MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.},\n
      volume = {118 9},\n year = {2008}\n}\n"}, "authors": [{"authorId": "6988610",
      "name": "A. Carracedo"}, {"authorId": "2109875821", "name": "Li Ma"}, {"authorId":
      "1396943744", "name": "J. Teruya-Feldstein"}, {"authorId": "33614121", "name":
      "F. Rojo"}, {"authorId": "6316033", "name": "L. Salmena"}, {"authorId": "34946126",
      "name": "A. Alimonti"}, {"authorId": "5135778", "name": "Ainara Egia"}, {"authorId":
      "47742211", "name": "A. Sasaki"}, {"authorId": "144125778", "name": "G. Thomas"},
      {"authorId": "6542324", "name": "S. Kozma"}, {"authorId": "5380009", "name":
      "A. Papa"}, {"authorId": "3547827", "name": "C. Nardella"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "144806171", "name": "J. Baselga"}, {"authorId":
      "4499580", "name": "P. Pandolfi"}]}, {"paperId": "14edeb5badfec455ef912d96dc7fd14bed170c40",
      "externalIds": {"MAG": "2164959077", "CorpusId": 85845312}, "corpusId": 85845312,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/14edeb5badfec455ef912d96dc7fd14bed170c40",
      "title": "Pyruvate kinase M2 is a phosphotyrosine", "abstract": null, "venue":
      "", "year": 2008, "referenceCount": 14, "citationCount": 4, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Christofk2008PyruvateKM,\n author = {H. Christofk
      and M. V. Heiden and Ning Wu and J. Asara and L. Cantley},\n title = {Pyruvate
      kinase M2 is a phosphotyrosine},\n year = {2008}\n}\n"}, "authors": [{"authorId":
      "4164415", "name": "H. Christofk"}, {"authorId": "35413264", "name": "M. V.
      Heiden"}, {"authorId": "2068343858", "name": "Ning Wu"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "4864d3cbb670dfb271441da22fc76a964ca17371", "externalIds": {"MAG": "2929737142",
      "CorpusId": 132138683}, "corpusId": 132138683, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/4864d3cbb670dfb271441da22fc76a964ca17371",
      "title": "Activateurs de la pyruvate kinase m2 et proc\u00e9d\u00e9 de traitement
      d''une maladie", "abstract": "La presente invention concerne des procedes, des
      compositions, et des kits pour l''utilisation d''activateurs de la PKM2 pour
      le traitement, la prevention, ou l''amelioration de maladies associees a la
      fonction de la PKM2, comprenant par exemple le cancer, le diabete, l''atherosclerose,
      la restenose, l''obesite, les troubles autoimmuns, et les troubles proliferatifs.",
      "venue": "", "year": 2008, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}], "publicationTypes":
      null, "publicationDate": "2008-08-18", "journal": null, "citationStyles": {"bibtex":
      "@Inproceedings{Cantley2008ActivateursDL,\n author = {L. Cantley and M. V. Heiden
      and H. Christofk},\n title = {Activateurs de la pyruvate kinase m2 et proc\u00e9d\u00e9
      de traitement d''une maladie},\n year = {2008}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "35413264", "name": "M. V. Heiden"},
      {"authorId": "4164415", "name": "H. Christofk"}]}, {"paperId": "524fde341fed330eab2b1c34f44967c29cb47e4f",
      "externalIds": {"MAG": "2069493334", "DOI": "10.1021/jm800374f", "CorpusId":
      31457919, "PubMed": "18630894"}, "corpusId": 31457919, "publicationVenue": {"id":
      "4cce60a8-2106-4240-bece-fb6488df6bd1", "name": "Journal of Medicinal Chemistry",
      "type": "journal", "alternate_names": ["J Med Chem"], "issn": "0022-2623", "url":
      "https://pubs.acs.org/journal/jmcmar", "alternate_urls": ["http://pubs.acs.org/journal/jmcmar",
      "http://pubs.acs.org/journals/jmcmar/index.html"]}, "url": "https://www.semanticscholar.org/paper/524fde341fed330eab2b1c34f44967c29cb47e4f",
      "title": "Slow self-activation enhances the potency of viridin prodrugs.", "abstract":
      "When the viridin wortmannin (Wm) is modified by reaction with certain nucleophiles
      at the C20 position, the compounds obtained exhibit an improved antiproliferative
      activity even though a covalent reaction between C20 and a lysine in the active
      site of PI3 kinase is essential to Wm''s ability to inhibit this enzyme. Here
      we show that this improved potency results from an intramolecular attack by
      the C6 hydroxyl group that slowly converts these inactive prodrugs to the active
      species Wm over the 48 h duration of the antiproliferative assay. Our results
      provide a guide for selecting Wm-like compounds to maximize kinase inhibition
      with the variety of protocols used to assess the role of PI3 kinase in biological
      systems, or for achieving optimal therapeutic effects in vivo . In addition,
      the slow self-activation of WmC20 derivatives provides a mechanism that can
      be exploited to obtain kinase inhibitors endowed with physical and pharmacokinetic
      properties far different from man-made kinase inhibitors because they do not
      bind to kinase active sites.", "venue": "Journal of Medicinal Chemistry", "year":
      2008, "referenceCount": 44, "citationCount": 12, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2663427?pdf=render",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2008-08-14", "journal": {"volume": "51 15", "pages": "\n          4699-707\n        ",
      "name": "Journal of medicinal chemistry"}, "citationStyles": {"bibtex": "@Article{Blois2008SlowSE,\n
      author = {Joseph T. Blois and Hushan Yuan and Adam Smith and M. Pacold and R.
      Weissleder and L. Cantley and L. Josephson},\n booktitle = {Journal of Medicinal
      Chemistry},\n journal = {Journal of medicinal chemistry},\n pages = {\n          4699-707\n        },\n
      title = {Slow self-activation enhances the potency of viridin prodrugs.},\n
      volume = {51 15},\n year = {2008}\n}\n"}, "authors": [{"authorId": "37048404",
      "name": "Joseph T. Blois"}, {"authorId": "6230104", "name": "Hushan Yuan"},
      {"authorId": "2109352731", "name": "Adam Smith"}, {"authorId": "5141475", "name":
      "M. Pacold"}, {"authorId": "3127756", "name": "R. Weissleder"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5095505", "name": "L. Josephson"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '285828'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:43 GMT
      Via:
      - 1.1 2f93d8be63d2d7d0447e8c12c41dd942.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - v5qeRIOIpha3LeCaINWKSeT0Q8k29XJ9Ax0oZRfrTQhLKYptwQS6fQ==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0ygEupPHcEbJg=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '285828'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:43 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - 6e6d1643-f016-45e8-a9c1-99ada4fa05e8
    http_version: HTTP/1.1
    status_code: 200
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=500&limit=100
  response:
    content: '{"offset": 500, "next": 600, "data": [{"paperId": "5a612171768a46cf6e97878c507c78401b773fcd",
      "externalIds": {"MAG": "2512525477", "DOI": "10.1126/science.1157829", "CorpusId":
      14077852, "PubMed": "17431180"}, "corpusId": 14077852, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/5a612171768a46cf6e97878c507c78401b773fcd",
      "title": "Response to Comment on \"Protein Sequences from Mastodon and Tyrannosaurus
      rex Revealed by Mass Spectrometry\"", "abstract": "Endogenous peptide sequences
      extracted from a 68-million-year-old Tyrannosaurus rex fossil bone and obtained
      by mass spectrometry have been shown to be statistically significant based on
      protein database searches using two different search engines and similarity
      comparisons to authentic tandem mass spectrometry spectra. Specifically, we
      have validated the sequence GVVGLP(OH)GQR.", "venue": "Science", "year": 2008,
      "referenceCount": 43, "citationCount": 38, "influentialCitationCount": 5, "isOpenAccess":
      true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2008-08-22", "journal": {"volume": "321", "pages": "1040
      - 1040", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Asara2008ResponseTC,\n
      author = {J. Asara and M. Schweitzer and L. Cantley and J. Cottrell},\n booktitle
      = {Science},\n journal = {Science},\n pages = {1040 - 1040},\n title = {Response
      to Comment on \"Protein Sequences from Mastodon and Tyrannosaurus rex Revealed
      by Mass Spectrometry\"},\n volume = {321},\n year = {2008}\n}\n"}, "authors":
      [{"authorId": "3028470", "name": "J. Asara"}, {"authorId": "5618773", "name":
      "M. Schweitzer"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "48894637", "name": "J. Cottrell"}]}, {"paperId": "5dadeeb7b1f02d8103a0d2263e39225c50e0c29f",
      "externalIds": {"MAG": "2147246316", "DOI": "10.1002/pmic.200700426", "CorpusId":
      33178155, "PubMed": "18324724"}, "corpusId": 33178155, "publicationVenue": {"id":
      "2c469df0-fa01-4dee-8f25-0d87a6fc4ef1", "name": "Proteomics", "type": "journal",
      "issn": "1615-9853", "url": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1615-9861",
      "alternate_urls": ["https://onlinelibrary.wiley.com/journal/16159861", "http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%291615-9861",
      "http://www.wiley-vch.de/publish/en/journals/alphabeticIndex/2120"]}, "url":
      "https://www.semanticscholar.org/paper/5dadeeb7b1f02d8103a0d2263e39225c50e0c29f",
      "title": "A label\u2010free quantification method by MS/MS TIC compared to SILAC
      and spectral counting in a proteomics screen", "abstract": "In order to assess
      the biological function of proteins and their modifications for understanding
      signaling mechanisms within cells as well as specific biomarkers to disease,
      it is important that quantitative information be obtained under different experimental
      conditions. Stable isotope labeling is a powerful method for accurately determining
      changes in the levels of proteins and PTMs; however, isotope labeling experiments
      suffer from limited dynamic range resulting in signal change ratios of less
      than \u223c20:1 using most commercial mass spectrometers. Label\u2010free approaches
      to relative quantification in proteomics such as spectral counting have gained
      popularity since no additional chemistries are needed. Here, we show a label\u2010free
      method for relative quantification based on the TIC from peptide MS/MS spectra
      collected from data\u2010dependent runs can be used effectively as a quantitative
      measure and expands the dynamic range over isotope labeling experiments allowing
      for abundance differences up to \u223c60:1 in a screen for proteins that bind
      to phosphotyrosine residues.", "venue": "Proteomics", "year": 2008, "referenceCount":
      23, "citationCount": 217, "influentialCitationCount": 7, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pmic.200700426",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "2008-03-01", "journal": {"volume": "8", "name":
      "PROTEOMICS"}, "citationStyles": {"bibtex": "@Article{Asara2008ALQ,\n author
      = {J. Asara and H. Christofk and Lisa M. Freimark and L. Cantley},\n booktitle
      = {Proteomics},\n journal = {PROTEOMICS},\n title = {A label\u2010free quantification
      method by MS/MS TIC compared to SILAC and spectral counting in a proteomics
      screen},\n volume = {8},\n year = {2008}\n}\n"}, "authors": [{"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "4164415", "name": "H. Christofk"}, {"authorId":
      "4333053", "name": "Lisa M. Freimark"}, {"authorId": "1723755", "name": "L.
      Cantley"}]}, {"paperId": "68258db00627c0a1a2bc7398583dcabdc9d47abd", "externalIds":
      {"MAG": "2071836703", "DOI": "10.1021/BC7002204", "CorpusId": 34703802, "PubMed":
      "17988080"}, "corpusId": 34703802, "publicationVenue": {"id": "727c9075-57df-4276-83b3-a90e2722f883",
      "name": "Bioconjugate chemistry", "type": "journal", "alternate_names": ["Bioconjugate
      Chem", "Bioconjugate chem", "Bioconjugate Chemistry"], "issn": "1043-1802",
      "url": "https://pubs.acs.org/journal/bcches", "alternate_urls": ["http://pubs.acs.org/journals/bcches/index.html",
      "http://pubs.acs.org/journal/bcches"]}, "url": "https://www.semanticscholar.org/paper/68258db00627c0a1a2bc7398583dcabdc9d47abd",
      "title": "Fate of a bioactive fluorescent wortmannin derivative in cells.",
      "abstract": "Here, we report on NBD-Wm, a fluorescent wortmannin (Wm) probe
      that maintains the bioactivity of Wm as an inhibitor of PI3 kinase and as an
      antiproliferative agent. The attachment of the NBD fluorochrome permits NBD-Wm
      in cells to be monitored by NBD fluorescence-based methods such as FACS or fluorescence
      microscopy or with an anti-NBD antibody. The fluorescence of NBD-Wm treated
      cells reached a peak at 1.5 h and then decreased because of the extrusion of
      a fluorescent compound into the culture media. Cells accumulated NBD-Wm to levels
      about 30-fold higher than those in the media. NBD-Wm modified five major proteins,
      with the modification of the catalytic subunit of PI3 kinase being a minor band.
      The bioactivity of NBD-Wm, coupled with a variety of techniques available for
      determining its disposition, suggest that NBD-Wm can be a useful tool in understanding
      the mechanism of action of viridins.", "venue": "Bioconjugate chemistry", "year":
      2008, "referenceCount": 0, "citationCount": 14, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": null, "journal": {"volume": "19 1", "pages": "\n          130-7\n        ",
      "name": "Bioconjugate chemistry"}, "citationStyles": {"bibtex": "@Article{Barnes2008FateOA,\n
      author = {Katie R Barnes and Joseph T. Blois and Adam Smith and Hushan Yuan
      and F. Reynolds and R. Weissleder and L. Cantley and L. Josephson},\n booktitle
      = {Bioconjugate chemistry},\n journal = {Bioconjugate chemistry},\n pages =
      {\n          130-7\n        },\n title = {Fate of a bioactive fluorescent wortmannin
      derivative in cells.},\n volume = {19 1},\n year = {2008}\n}\n"}, "authors":
      [{"authorId": "40284134", "name": "Katie R Barnes"}, {"authorId": "37048404",
      "name": "Joseph T. Blois"}, {"authorId": "2109352731", "name": "Adam Smith"},
      {"authorId": "6230104", "name": "Hushan Yuan"}, {"authorId": "144649277", "name":
      "F. Reynolds"}, {"authorId": "3127756", "name": "R. Weissleder"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5095505", "name": "L. Josephson"}]},
      {"paperId": "7569b72221055030f3398c2326deaa13fd2201e1", "externalIds": {"MAG":
      "2015207840", "DOI": "10.1038/nature06734", "CorpusId": 16111842, "PubMed":
      "18337823"}, "corpusId": 16111842, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/7569b72221055030f3398c2326deaa13fd2201e1",
      "title": "The M2 splice isoform of pyruvate kinase is important for cancer metabolism
      and tumour growth", "abstract": null, "venue": "Nature", "year": 2008, "referenceCount":
      21, "citationCount": 2569, "influentialCitationCount": 100, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2008-03-13", "journal": {"volume": "452", "pages": "230-233",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Christofk2008TheMS,\n
      author = {H. Christofk and M. V. Heiden and M. Harris and A. Ramanathan and
      R. Gerszten and Ru Wei and M. Fleming and S. Schreiber and L. Cantley},\n booktitle
      = {Nature},\n journal = {Nature},\n pages = {230-233},\n title = {The M2 splice
      isoform of pyruvate kinase is important for cancer metabolism and tumour growth},\n
      volume = {452},\n year = {2008}\n}\n"}, "authors": [{"authorId": "4164415",
      "name": "H. Christofk"}, {"authorId": "35413264", "name": "M. V. Heiden"}, {"authorId":
      "4027329", "name": "M. Harris"}, {"authorId": "46431693", "name": "A. Ramanathan"},
      {"authorId": "1864575", "name": "R. Gerszten"}, {"authorId": "2143698038", "name":
      "Ru Wei"}, {"authorId": "2199934", "name": "M. Fleming"}, {"authorId": "2610390",
      "name": "S. Schreiber"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "7d18c2ffc32dc3aebb154d81d7610efdd3af0292", "externalIds": {"MAG": "156118465",
      "DOI": "10.1096/fasebj.22.1_supplement.263.3", "CorpusId": 82271172}, "corpusId":
      82271172, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/7d18c2ffc32dc3aebb154d81d7610efdd3af0292",
      "title": "Growth and survival signaling by lipid kinases", "abstract": "The
      phosphoinositide 3\u2010kinase (PI3K) pathway plays a critical role in cell
      growth regulation. PI3K generates the lipid, phosphatidylinositol\u20103,4,5\u2010trisphosphate
      (PIP3), that acts as a membrane bound second messenger to activate AKT/PKB family
      protein Ser/Thr kinases as well Tec family protein\u2010Tyr kinases. PIP3 also
      regulates proteins that control Arf, Rac and Ras family GTP\u2010binding proteins.
      This lipid is elevated in cancers, either due to loss of PTEN, the phosphatases
      that degrades it, or due to constitutive PI3K activity because of activating
      mutations in PIK3CA or an upstream activator of PI3K. The ultimate consequence
      of activating PI3K is to generate changes in signaling networks and gene expression
      patterns that promote cell growth, cell survival and cell movement. In order
      to elucidate the role of the PI3K pathway in normal cell growth and in cancer,
      we have generated mice in which genes for PI3K are deleted or activated in specific
      tissues. In addition, we have investigated the biochemical mechanisms by which
      PI3K becomes activated in human cancers. Our progress in these areas will be
      summarized.", "venue": "", "year": 2008, "referenceCount": 0, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2008-03-01", "journal": {"volume": "22", "name": "The FASEB Journal"}, "citationStyles":
      {"bibtex": "@Article{Cantley2008GrowthAS,\n author = {L. Cantley},\n journal
      = {The FASEB Journal},\n title = {Growth and survival signaling by lipid kinases},\n
      volume = {22},\n year = {2008}\n}\n"}, "authors": [{"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "81f42c1dd1db0aeb2cc900799022c8453f126f7e", "externalIds":
      {"CorpusId": 57499592}, "corpusId": 57499592, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/81f42c1dd1db0aeb2cc900799022c8453f126f7e",
      "title": "Methods for treating cancer resistant to ErbB therapeutics", "abstract":
      null, "venue": "", "year": 2008, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}], "publicationTypes":
      null, "publicationDate": null, "journal": null, "citationStyles": {"bibtex":
      "@Inproceedings{Janne2008MethodsFT,\n author = {Pasi Antero Janne and Jeffrey
      A. Engelman and Lewis C. Cantley},\n title = {Methods for treating cancer resistant
      to ErbB therapeutics},\n year = {2008}\n}\n"}, "authors": [{"authorId": "4147848",
      "name": "Pasi Antero Janne"}, {"authorId": "6828387", "name": "Jeffrey A. Engelman"},
      {"authorId": "1723755", "name": "Lewis C. Cantley"}]}, {"paperId": "9e49004ea26397410420c71008c57f3c98c94a9a",
      "externalIds": {"MAG": "2044823943", "DOI": "10.1016/j.cmet.2008.08.011", "CorpusId":
      31103050, "PubMed": "18762017"}, "corpusId": 31103050, "publicationVenue": {"id":
      "ad36b49e-5c03-4c48-be8d-321a0d17c2f6", "name": "Cell Metabolism", "type": "journal",
      "alternate_names": ["Cell Metab"], "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/15504131",
      "http://www.cellmetabolism.org/"]}, "url": "https://www.semanticscholar.org/paper/9e49004ea26397410420c71008c57f3c98c94a9a",
      "title": "PI3K enters beta-testing.", "abstract": null, "venue": "Cell Metabolism",
      "year": 2008, "referenceCount": 12, "citationCount": 11, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1550413108002520/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2008-09-03", "journal": {"volume": "8 3", "pages": "\n          179-81\n        ",
      "name": "Cell metabolism"}, "citationStyles": {"bibtex": "@Article{Shaywitz2008PI3KEB,\n
      author = {A. Shaywitz and K. Courtney and Akash Patnaik and L. Cantley},\n booktitle
      = {Cell Metabolism},\n journal = {Cell metabolism},\n pages = {\n          179-81\n        },\n
      title = {PI3K enters beta-testing.},\n volume = {8 3},\n year = {2008}\n}\n"},
      "authors": [{"authorId": "4635185", "name": "A. Shaywitz"}, {"authorId": "13782167",
      "name": "K. Courtney"}, {"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "a2f90cbb3dd682c3ef2d38bfc880f4562a0ea8fe",
      "externalIds": {"MAG": "2001999652", "PubMedCentral": "2683415", "DOI": "10.1038/nm.1890",
      "CorpusId": 4961038, "PubMed": "19029981"}, "corpusId": 4961038, "publicationVenue":
      {"id": "9e995b6d-f30b-4ab4-a13b-3dc2cc992f47", "name": "Nature Network Boston",
      "type": "journal", "alternate_names": ["Nat Netw Boston", "Nat Med", "Nature
      Medicine"], "issn": "1744-7933", "alternate_issns": ["1078-8956"], "url": "https://www.nature.com/nature/articles?code=archive_news",
      "alternate_urls": ["http://www.nature.com/news", "http://www.nature.com/nm/",
      "http://www.nature.com/nm/index.html"]}, "url": "https://www.semanticscholar.org/paper/a2f90cbb3dd682c3ef2d38bfc880f4562a0ea8fe",
      "title": "Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D
      and PIK3CA H1047R Murine Lung Cancers", "abstract": null, "venue": "Nature Network
      Boston", "year": 2008, "referenceCount": 23, "citationCount": 1303, "influentialCitationCount":
      45, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2683415?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2008-11-30", "journal": {"volume": "14", "pages": "1351
      - 1356", "name": "Nature medicine"}, "citationStyles": {"bibtex": "@Article{Engelman2008EffectiveUO,\n
      author = {J. Engelman and Liang Chen and X. Tan and K. Crosby and A. Guimaraes
      and Rabi Upadhyay and Michel Maira and K. McNamara and Samanthi A. Perera and
      Youngchul Song and L. Chirieac and R. Kaur and Angela Lightbown and Jessica
      Simendinger and Timothy Q Li and R. Padera and C. Garc\u00eda-echeverr\u00eda
      and R. Weissleder and U. Mahmood and L. Cantley and Kwok-kin Wong},\n booktitle
      = {Nature Network Boston},\n journal = {Nature medicine},\n pages = {1351 -
      1356},\n title = {Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras
      G12D and PIK3CA H1047R Murine Lung Cancers},\n volume = {14},\n year = {2008}\n}\n"},
      "authors": [{"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "49330091",
      "name": "Liang Chen"}, {"authorId": "46880153", "name": "X. Tan"}, {"authorId":
      "50144013", "name": "K. Crosby"}, {"authorId": "145030722", "name": "A. Guimaraes"},
      {"authorId": "122354247", "name": "Rabi Upadhyay"}, {"authorId": "40159145",
      "name": "Michel Maira"}, {"authorId": "6605449", "name": "K. McNamara"}, {"authorId":
      "116397043", "name": "Samanthi A. Perera"}, {"authorId": "4846062", "name":
      "Youngchul Song"}, {"authorId": "6510669", "name": "L. Chirieac"}, {"authorId":
      "2274302", "name": "R. Kaur"}, {"authorId": "5006113", "name": "Angela Lightbown"},
      {"authorId": "2028975460", "name": "Jessica Simendinger"}, {"authorId": "2109887600",
      "name": "Timothy Q Li"}, {"authorId": "144315421", "name": "R. Padera"}, {"authorId":
      "1401237414", "name": "C. Garc\u00eda-echeverr\u00eda"}, {"authorId": "3127756",
      "name": "R. Weissleder"}, {"authorId": "2531456", "name": "U. Mahmood"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "32596484", "name": "Kwok-kin
      Wong"}]}, {"paperId": "a345de7c29c2552d519741dc949da6fd4c2c399e", "externalIds":
      {"MAG": "2936425830", "CorpusId": 145854304}, "corpusId": 145854304, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/a345de7c29c2552d519741dc949da6fd4c2c399e",
      "title": "Methods of treating resistant cancer therapeutic agents ERBB", "abstract":
      "A therapeutic agent anti-ErbB and an anti-MET therapeutic agent for use in
      treating a cancer in a subject that has developed resistance to treatment with
      anti-ErbB therapeutic agent, wherein the subject has an amplification of the
      MET gene wherein the anti-ErbB therapeutic agent is gefitinib, erlotinib, lapatinib,
      PF00299804, CI-1033, EKB-569, BIBW2992, ZD6474, AV-412 or HKI-272, and wherein
      the anti-MET therapeutic agent is PHA-665752, SU11274, SU5416, PF-02341066,
      XL-880 or MGCD265.", "venue": "", "year": 2008, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2008-04-11", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Janne2008MethodsOT,\n
      author = {P. Janne and J. Engelman and L. Cantley},\n title = {Methods of treating
      resistant cancer therapeutic agents ERBB},\n year = {2008}\n}\n"}, "authors":
      [{"authorId": "4147848", "name": "P. Janne"}, {"authorId": "6828387", "name":
      "J. Engelman"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "ab43a7089bdc207e4b3ce3524beec97bac7ec1ea", "externalIds": {"MAG": "2923765412",
      "CorpusId": 109101823}, "corpusId": 109101823, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/ab43a7089bdc207e4b3ce3524beec97bac7ec1ea",
      "title": "Methods of treating cancer resistant to ErbB doctor mites", "abstract":
      null, "venue": "", "year": 2008, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2008-04-11", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Janne2008MethodsOT,\n
      author = {P. Janne and L. Cantley and J. Engelman},\n title = {Methods of treating
      cancer resistant to ErbB doctor mites},\n year = {2008}\n}\n"}, "authors": [{"authorId":
      "4147848", "name": "P. Janne"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "6828387", "name": "J. Engelman"}]}, {"paperId": "c8e1d999171f446434bef4b2ab03cb4e59e8546d",
      "externalIds": {"MAG": "1995444593", "DOI": "10.1038/nature06667", "CorpusId":
      4346405, "PubMed": "18337815"}, "corpusId": 4346405, "publicationVenue": {"id":
      "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/c8e1d999171f446434bef4b2ab03cb4e59e8546d",
      "title": "Pyruvate kinase M2 is a phosphotyrosine-binding protein", "abstract":
      null, "venue": "Nature", "year": 2008, "referenceCount": 20, "citationCount":
      954, "influentialCitationCount": 40, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2008-03-13", "journal": {"volume": "452", "pages": "181-186", "name": "Nature"},
      "citationStyles": {"bibtex": "@Article{Christofk2008PyruvateKM,\n author = {H.
      Christofk and M. V. Heiden and Ning Wu and J. Asara and L. Cantley},\n booktitle
      = {Nature},\n journal = {Nature},\n pages = {181-186},\n title = {Pyruvate kinase
      M2 is a phosphotyrosine-binding protein},\n volume = {452},\n year = {2008}\n}\n"},
      "authors": [{"authorId": "4164415", "name": "H. Christofk"}, {"authorId": "35413264",
      "name": "M. V. Heiden"}, {"authorId": "2068343858", "name": "Ning Wu"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "d02d36830d9140811a5b814d4dd28754ac2d45a1", "externalIds": {"MAG":
      "2146414563", "DOI": "10.1038/onc.2008.245", "CorpusId": 27772494, "PubMed":
      "18794884"}, "corpusId": 27772494, "publicationVenue": {"id": "55bed249-d30f-456b-9d2c-a51dc149cb7a",
      "name": "Oncogene", "type": "journal", "issn": "0950-9232", "url": "http://www.nature.com/onc/",
      "alternate_urls": ["http://www.nature.com/onc", "http://www.naturesj.com/onc/index.html"]},
      "url": "https://www.semanticscholar.org/paper/d02d36830d9140811a5b814d4dd28754ac2d45a1",
      "title": "PI3K pathway alterations in cancer: variations on a theme", "abstract":
      null, "venue": "Oncogene", "year": 2008, "referenceCount": 85, "citationCount":
      1795, "influentialCitationCount": 79, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc3398461?pdf=render", "status": null},
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "2008-09-18",
      "journal": {"volume": "27", "pages": "5497-5510", "name": "Oncogene"}, "citationStyles":
      {"bibtex": "@Article{Yuan2008PI3KPA,\n author = {TL Yuan and L. Cantley},\n
      booktitle = {Oncogene},\n journal = {Oncogene},\n pages = {5497-5510},\n title
      = {PI3K pathway alterations in cancer: variations on a theme},\n volume = {27},\n
      year = {2008}\n}\n"}, "authors": [{"authorId": "2227936168", "name": "TL Yuan"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "e40f2444e9d18a0baf706ad43edc60b91909928e",
      "externalIds": {"MAG": "2019962211", "DOI": "10.1073/pnas.0804123105", "CorpusId":
      8189132, "PubMed": "18621722"}, "corpusId": 8189132, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/e40f2444e9d18a0baf706ad43edc60b91909928e",
      "title": "Class 1A PI3K regulates vessel integrity during development and tumorigenesis",
      "abstract": "PI3K is important in the regulation of growth, proliferation, and
      survival of tumor cells. We show that class 1A PI3K is also critical in the
      tumor microenvironment by regulating the integrity of the tumor vasculature.
      Using Tie2Cre-mediated deletion of the PI3K regulatory subunits (p85\u03b1,
      p55\u03b1, p50\u03b1, and p85\u03b2), we generated mice with endothelial cell-specific
      loss of class 1A PI3K. Complete loss of all subunits caused acute embryonic
      lethality at E11.5 due to hemorrhaging, whereas retention of a single p85\u03b1
      allele yielded viable mice that survived to adulthood. These heterozygous mice
      exhibited no vascular defects until challenged with a pathological insult, such
      as tumor cells or high levels of VEGF. Under these pathological conditions,
      heterozygous mice exhibited localized vascular abnormalities, including vessel
      leakage and the inability to maintain large vessels, which caused a deceleration
      of tumorigenesis. Furthermore, we show that a PI3K inhibitor can mimic the effects
      of class 1A PI3K loss, which suggests that targeting class 1A PI3K may be a
      promising therapy for blocking tumor angiogenesis.", "venue": "Proceedings of
      the National Academy of Sciences of the United States of America", "year": 2008,
      "referenceCount": 38, "citationCount": 102, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://www.pnas.org/doi/pdf/10.1073/pnas.0804123105",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2008-07-15", "journal": {"volume": "105", "pages": "9739
      - 9744", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Yuan2008Class1P,\n author = {T. Yuan and H. Choi and A.
      Matsui and C. Benes and E. Lifshits and Ji Luo and J. Frangioni and L. Cantley},\n
      booktitle = {Proceedings of the National Academy of Sciences of the United States
      of America},\n journal = {Proceedings of the National Academy of Sciences},\n
      pages = {9739 - 9744},\n title = {Class 1A PI3K regulates vessel integrity during
      development and tumorigenesis},\n volume = {105},\n year = {2008}\n}\n"}, "authors":
      [{"authorId": "40062987", "name": "T. Yuan"}, {"authorId": "23597680", "name":
      "H. Choi"}, {"authorId": "8528956", "name": "A. Matsui"}, {"authorId": "1714039",
      "name": "C. Benes"}, {"authorId": "144609942", "name": "E. Lifshits"}, {"authorId":
      "145954100", "name": "Ji Luo"}, {"authorId": "1788876", "name": "J. Frangioni"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "f064561b94c7355c7ee52e5c668032972cfb73e2",
      "externalIds": {"MAG": "2098623033", "DOI": "10.1172/JCI32964", "CorpusId":
      1269658, "PubMed": "18382766"}, "corpusId": 1269658, "publicationVenue": {"id":
      "8c9a9e1b-acf2-4274-8d73-6ea0ecd11fd1", "name": "Journal of Clinical Investigation",
      "type": "journal", "alternate_names": ["J Clin Investig"], "issn": "0021-9738",
      "url": "https://www.jci.org/", "alternate_urls": ["http://www.jci.org/", "https://www.jci.org/archive",
      "http://www.jci.org/impact"]}, "url": "https://www.semanticscholar.org/paper/f064561b94c7355c7ee52e5c668032972cfb73e2",
      "title": "Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin
      neurons in mice.", "abstract": "Normal food intake and body weight homeostasis
      require the direct action of leptin on hypothalamic proopiomelanocortin (POMC)
      neurons. It has been proposed that leptin action requires PI3K activity. We
      therefore assessed the contribution of PI3K signaling to leptin''s effects on
      POMC neurons and organismal energy balance. Leptin caused a rapid depolarization
      of POMC neurons and an increase in action potential frequency in patch-clamp
      recordings of hypothalamic slices. Pharmacologic inhibition of PI3K prevented
      this depolarization and increased POMC firing rate, indicating a PI3K-dependent
      mechanism of leptin action. Mice with genetically disrupted PI3K signaling in
      POMC cells failed to undergo POMC depolarization or increased firing frequency
      in response to leptin. Insulin''s ability to hyperpolarize POMC neurons was
      also abolished in these mice. Moreover, targeted disruption of PI3K blunted
      the suppression of feeding elicited by central leptin administration. Despite
      these differences, mice with impaired PI3K signaling in POMC neurons exhibited
      normal long-term body weight regulation. Collectively, these results suggest
      that PI3K signaling in POMC neurons is essential for leptin-induced activation
      and insulin-induced inhibition of POMC cells and for the acute suppression of
      food intake elicited by leptin, but is not a major contributor to the regulation
      of long-term organismal energy homeostasis.", "venue": "Journal of Clinical
      Investigation", "year": 2008, "referenceCount": 68, "citationCount": 346, "influentialCitationCount":
      21, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jci.org/articles/view/32964/files/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2008-05-01", "journal": {"volume": "118 5", "pages": "\n          1796-805\n        ",
      "name": "The Journal of clinical investigation"}, "citationStyles": {"bibtex":
      "@Article{Hill2008AcuteEO,\n author = {Jennifer W. Hill and K. Williams and
      C. Ye and Ji Luo and N. Balthasar and R. Coppari and M. Cowley and L. Cantley
      and B. Lowell and J. Elmquist},\n booktitle = {Journal of Clinical Investigation},\n
      journal = {The Journal of clinical investigation},\n pages = {\n          1796-805\n        },\n
      title = {Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin
      neurons in mice.},\n volume = {118 5},\n year = {2008}\n}\n"}, "authors": [{"authorId":
      "2111068085", "name": "Jennifer W. Hill"}, {"authorId": "2242372162", "name":
      "K. Williams"}, {"authorId": "2064450337", "name": "C. Ye"}, {"authorId": "145954100",
      "name": "Ji Luo"}, {"authorId": "5201594", "name": "N. Balthasar"}, {"authorId":
      "5582429", "name": "R. Coppari"}, {"authorId": "145855817", "name": "M. Cowley"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5942236", "name":
      "B. Lowell"}, {"authorId": "5905630", "name": "J. Elmquist"}]}, {"paperId":
      "fc393db3315181e8a10087354b4a808fb2884b46", "externalIds": {"MAG": "2111491167",
      "DOI": "10.1016/j.ccr.2008.04.008", "CorpusId": 26918420, "PubMed": "18455118"},
      "corpusId": 26918420, "publicationVenue": {"id": "11e469cb-37ad-487e-b0ab-d26e82037c22",
      "name": "Cancer Cell", "type": "journal", "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/fc393db3315181e8a10087354b4a808fb2884b46",
      "title": "A sweet new role for EGFR in cancer.", "abstract": null, "venue":
      "Cancer Cell", "year": 2008, "referenceCount": 13, "citationCount": 43, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1535610808001256/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["LettersAndComments",
      "JournalArticle"], "publicationDate": "2008-05-06", "journal": {"volume": "13
      5", "pages": "\n          375-6\n        ", "name": "Cancer cell"}, "citationStyles":
      {"bibtex": "@Article{Engelman2008ASN,\n author = {J. Engelman and L. Cantley},\n
      booktitle = {Cancer Cell},\n journal = {Cancer cell},\n pages = {\n          375-6\n        },\n
      title = {A sweet new role for EGFR in cancer.},\n volume = {13 5},\n year =
      {2008}\n}\n"}, "authors": [{"authorId": "6828387", "name": "J. Engelman"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "09a4f384aa5e65ce85ee0b610f30c85a838b256e",
      "externalIds": {"CorpusId": 88509816}, "corpusId": 88509816, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/09a4f384aa5e65ce85ee0b610f30c85a838b256e",
      "title": "OBSERVATION AKT 1 Overexpression in Endothelial Cells Leads to the
      Development of Cutaneous Vascular Malformations In Vivo", "abstract": "Background:
      Vascular malformations are clinical disorders in which endothelial cells fail
      to remodel and/or undergo programmed cell death, leading to abnormal persistence
      of blood vessels. The abnormal persistence of vessels makes therapy difficult
      because these lesions are resistant to interventions that are effective against
      hemangiomas. Akt1 is a serine-threonine protein kinase, which is a key mediator
      of resistance to programmed cell death. Our objective was to determine whether
      sustained activation of Akt1 could lead to vascular malformation in mice.",
      "venue": "", "year": 2007, "referenceCount": 16, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Perry2007OBSERVATIONA1,\n
      author = {B. Perry and J. Banyard and E. R. McLaughlin and R. Watnick and Allie
      M. Sohn and D. Brindley and T. Obata and L. Cantley and C. Cohen and J. Arbiser},\n
      title = {OBSERVATION AKT 1 Overexpression in Endothelial Cells Leads to the
      Development of Cutaneous Vascular Malformations In Vivo},\n year = {2007}\n}\n"},
      "authors": [{"authorId": "3020797", "name": "B. Perry"}, {"authorId": "5275632",
      "name": "J. Banyard"}, {"authorId": "40057331", "name": "E. R. McLaughlin"},
      {"authorId": "5456170", "name": "R. Watnick"}, {"authorId": "35549806", "name":
      "Allie M. Sohn"}, {"authorId": "3631923", "name": "D. Brindley"}, {"authorId":
      "3091430", "name": "T. Obata"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "27260993", "name": "C. Cohen"}, {"authorId": "5860236", "name":
      "J. Arbiser"}]}, {"paperId": "13940bb03727bbf79aef2c143fe9bfb4e6787d0a", "externalIds":
      {"MAG": "2085927367", "DOI": "10.1001/ARCHDERM.143.4.504", "CorpusId": 17388466,
      "PubMed": "17438183"}, "corpusId": 17388466, "publicationVenue": {"id": "686b1216-1c8e-48fa-ac90-53c43abc85de",
      "name": "Archives of Dermatology", "type": "journal", "alternate_names": ["Arch
      Dermatol", "A M A Archives of Dermatology", "M Arch Dermatol"], "issn": "0003-987X",
      "alternate_issns": ["0096-5359"], "url": "http://archderm.ama-assn.org/contents-by-date.0.dtl"},
      "url": "https://www.semanticscholar.org/paper/13940bb03727bbf79aef2c143fe9bfb4e6787d0a",
      "title": "AKT1 overexpression in endothelial cells leads to the development
      of cutaneous vascular malformations in vivo.", "abstract": "BACKGROUND\nVascular
      malformations are clinical disorders in which endothelial cells fail to remodel
      and/or undergo programmed cell death, leading to abnormal persistence of blood
      vessels. The abnormal persistence of vessels makes therapy difficult because
      these lesions are resistant to interventions that are effective against hemangiomas.
      Akt1 is a serine-threonine protein kinase, which is a key mediator of resistance
      to programmed cell death. Our objective was to determine whether sustained activation
      of Akt1 could lead to vascular malformation in mice.\n\n\nOBSERVATIONS\nWe examined
      the effect of constitutive activation of Akt1 in murine endothelial cells (MS1
      cells). Overexpression of active AKT1 in MS1 cells led to the development of
      vascular malformations, characterized by wide endothelial lumens and minimal
      investment of smooth muscle surrounding the vessels. The histologic features
      of these vascular malformations is distinct from ras-transformed MS1 cells (angiosarcoma)
      and suggest that differing signal abnormalities give rise to human vascular
      malformations vs malignant vascular tumors.\n\n\nCONCLUSIONS\nInhibition of
      Akt signaling may be useful in the treatment of vascular malformations. Examination
      of problematic hemangiomas and vascular malformations for the presence of activated
      Akt or downstream targets of Akt, such as mammalian target of rapamycin (mTOR),
      may predict response to treatment with Akt inhibitors or rapamycin. This study
      provides a potential rationale for the systemic and topical use of these inhibitors
      for vascular malformations and hemangiomas.", "venue": "Archives of Dermatology",
      "year": 2007, "referenceCount": 17, "citationCount": 56, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2007-04-01", "journal":
      {"volume": "143 4", "pages": "\n          504-6\n        ", "name": "Archives
      of dermatology"}, "citationStyles": {"bibtex": "@Article{Perry2007AKT1OI,\n
      author = {B. Perry and J. Banyard and E. R. McLaughlin and R. Watnick and Allie
      M. Sohn and D. Brindley and T. Obata and L. Cantley and C. Cohen and J. Arbiser},\n
      booktitle = {Archives of Dermatology},\n journal = {Archives of dermatology},\n
      pages = {\n          504-6\n        },\n title = {AKT1 overexpression in endothelial
      cells leads to the development of cutaneous vascular malformations in vivo.},\n
      volume = {143 4},\n year = {2007}\n}\n"}, "authors": [{"authorId": "3020797",
      "name": "B. Perry"}, {"authorId": "5275632", "name": "J. Banyard"}, {"authorId":
      "40057331", "name": "E. R. McLaughlin"}, {"authorId": "5456170", "name": "R.
      Watnick"}, {"authorId": "35549806", "name": "Allie M. Sohn"}, {"authorId": "3631923",
      "name": "D. Brindley"}, {"authorId": "3091430", "name": "T. Obata"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "27260993", "name": "C. Cohen"},
      {"authorId": "5860236", "name": "J. Arbiser"}]}, {"paperId": "1e771985795efbdaf71e3cf7e9df5b616f9afe4d",
      "externalIds": {"MAG": "2520856817", "DOI": "10.1097/01.JTO.0000283263.45841.E0",
      "CorpusId": 79424089}, "corpusId": 79424089, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/1e771985795efbdaf71e3cf7e9df5b616f9afe4d",
      "title": "D2-07: Mechanisms of activating PI3K signaling in lung cancers that
      become resistant EGFR tyrosine kinase inhibitors", "abstract": null, "venue":
      "", "year": 2007, "referenceCount": 0, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jto.org/article/S1556086415339794/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2007-08-01", "journal": {"volume":
      "2", "name": "Journal of Thoracic Oncology"}, "citationStyles": {"bibtex": "@Article{Engelman2007D207MO,\n
      author = {J. Engelman and K. Zejnullahu and T. Mitsudomi and Courtney Hyland
      and Joon-Oh Park and N. Lindeman and Christopher-Michael Gale and Xiaojun Zhao
      and J. Christensen and Rogers M. Rogers and F. Cappuzzo and T. Mok and Charles
      Lee and J. E. Bruce and L. Cantley and P. J\u00e4nne},\n journal = {Journal
      of Thoracic Oncology},\n title = {D2-07: Mechanisms of activating PI3K signaling
      in lung cancers that become resistant EGFR tyrosine kinase inhibitors},\n volume
      = {2},\n year = {2007}\n}\n"}, "authors": [{"authorId": "6828387", "name": "J.
      Engelman"}, {"authorId": "5610750", "name": "K. Zejnullahu"}, {"authorId": "4441512",
      "name": "T. Mitsudomi"}, {"authorId": "40053421", "name": "Courtney Hyland"},
      {"authorId": "48490520", "name": "Joon-Oh Park"}, {"authorId": "3734755", "name":
      "N. Lindeman"}, {"authorId": "77094637", "name": "Christopher-Michael Gale"},
      {"authorId": "2111027786", "name": "Xiaojun Zhao"}, {"authorId": "2054179920",
      "name": "J. Christensen"}, {"authorId": "78976333", "name": "Rogers M. Rogers"},
      {"authorId": "3740336", "name": "F. Cappuzzo"}, {"authorId": "17750315", "name":
      "T. Mok"}, {"authorId": "2118593740", "name": "Charles Lee"}, {"authorId": "50138468",
      "name": "J. E. Bruce"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "5984202", "name": "P. J\u00e4nne"}]}, {"paperId": "1fea77a0309a94b75aaa07426c493f1ae088086a",
      "externalIds": {"MAG": "2158668670", "DOI": "10.1128/MCB.01101-07", "CorpusId":
      85675592}, "corpusId": 85675592, "publicationVenue": {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b",
      "name": "Molecular and Cellular Biology", "type": "journal", "alternate_names":
      ["Mol Cell Biology"], "issn": "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls":
      ["http://mcb.asm.org/"]}, "url": "https://www.semanticscholar.org/paper/1fea77a0309a94b75aaa07426c493f1ae088086a",
      "title": "I\u03baB Kinase \u03b2 Phosphorylates the K63 Deubiquitinase A20 To
      Cause Feedback Inhibition of the NF-\u03baB Pathway", "abstract": "ABSTRACT
      Misregulation of NF-\u03baB signaling leads to infectious, inflammatory, or
      autoimmune disorders. I\u03baB kinase \u03b2 (IKK\u03b2) is an essential activator
      of NF-\u03baB and is known to phosphorylate the NF-\u03baB inhibitor, I\u03baB\u03b1,
      allowing it to undergo ubiquitin-mediated proteasomal degradation. However,
      beyond I\u03baB\u03b1, few additional IKK\u03b2 substrates have been identified.
      Here we utilize a peptide library and bioinformatic approach to predict likely
      substrates of IKK\u03b2. This approach predicted Ser381 of the K63 deubiquitinase
      A20 as a likely site of IKK\u03b2 phosphorylation. While A20 is a known negative
      regulator of innate immune signaling pathways, the mechanisms regulating the
      activity of A20 are poorly understood. We show that IKK\u03b2 phosphorylates
      A20 in vitro and in vivo at serine 381, and we further show that this phosphorylation
      event increases the ability of A20 to inhibit the NF-\u03baB signaling pathway.
      Phosphorylation of A20 by IKK\u03b2 thus represents part of a novel feedback
      loop that regulates the duration of NF-\u03baB signaling following activation
      of innate immune signaling pathways.", "venue": "Molecular and Cellular Biology",
      "year": 2007, "referenceCount": 41, "citationCount": 139, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2169042?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2007-08-20", "journal": {"volume": "27", "pages": "7451
      - 7461", "name": "Molecular and Cellular Biology"}, "citationStyles": {"bibtex":
      "@Article{Hutti2007I\u03baBK\u0392,\n author = {Jessica E. Hutti and B. Turk
      and J. Asara and A. Ma and L. Cantley and Derek W. Abbott},\n booktitle = {Molecular
      and Cellular Biology},\n journal = {Molecular and Cellular Biology},\n pages
      = {7451 - 7461},\n title = {I\u03baB Kinase \u03b2 Phosphorylates the K63 Deubiquitinase
      A20 To Cause Feedback Inhibition of the NF-\u03baB Pathway},\n volume = {27},\n
      year = {2007}\n}\n"}, "authors": [{"authorId": "6742227", "name": "Jessica E.
      Hutti"}, {"authorId": "25581223", "name": "B. Turk"}, {"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "145400524", "name": "A. Ma"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "145759174", "name": "Derek W.
      Abbott"}]}, {"paperId": "220eb59e8fc484cc4a378113396635541edbf35d", "externalIds":
      {"MAG": "2927172772", "CorpusId": 208370767}, "corpusId": 208370767, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/220eb59e8fc484cc4a378113396635541edbf35d",
      "title": "Pyruvate kinase inhibitors and disease treatment methods", "abstract":
      "A compound selected from ** Formula ** and salts thereof, for use in the treatment
      of cancer, in which the cancer is selected from cancers of the breast, prostate,
      lung, bronchial, colon, rectal, kidney, renal, skin, pelvic, pancreatic, oral,
      ovary, head, neck, thyroid, parathyroid, stomach, gastrointestinal, intestine
      (for example, thin and thick), brain, esophagus, liver, gallbladder, pleura,
      intrahepatic bile ducts, cervix , testicular, ureter, anal, larynx, pharynx,
      bone, articular, vulvar, eye and urinary bladder, non-Hodgkin lymphoma, Hodgkin
      lymphoma, melanomas, carcinomas, basal cell carcinomas, neuroblastomas, multiple
      myelomas, chronic lymphocytic leukemia, soft tissue cancers (eg, heart), gastrointestinal
      stromal tumors, chronic myeloid leukemias, malignant mesotheliomas, retinoblastomas
      and soft tissue sarcomas.", "venue": "", "year": 2007, "referenceCount": 0,
      "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2007-08-06", "journal": null,
      "citationStyles": {"bibtex": "@Inproceedings{Cantley2007PyruvateKI,\n author
      = {L. Cantley and M. V. Heiden and H. Christofk},\n title = {Pyruvate kinase
      inhibitors and disease treatment methods},\n year = {2007}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "35413264", "name":
      "M. V. Heiden"}, {"authorId": "4164415", "name": "H. Christofk"}]}, {"paperId":
      "240d0db8a1294a73ba68ded45c3963eccd838df9", "externalIds": {"MAG": "2013185671",
      "DOI": "10.1016/J.CHEMBIOL.2007.02.007", "CorpusId": 27730009, "PubMed": "17379147"},
      "corpusId": 27730009, "publicationVenue": {"id": "0c73784e-4058-48ce-b429-740c11d6f005",
      "name": "Chemistry and Biology", "type": "journal", "alternate_names": ["Chemistry
      & Biology", "Chem  Biology", "Chem Biology"], "issn": "1074-5521", "alternate_issns":
      ["1879-1301"], "url": "http://www.chembiol.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/10745521",
      "https://www.journals.elsevier.com/chemistry-and-biology"]}, "url": "https://www.semanticscholar.org/paper/240d0db8a1294a73ba68ded45c3963eccd838df9",
      "title": "Covalent reactions of wortmannin under physiological conditions.",
      "abstract": null, "venue": "Chemistry and Biology", "year": 2007, "referenceCount":
      29, "citationCount": 30, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2007-03-01", "journal": {"volume": "14 3", "pages": "\n          321-8\n        ",
      "name": "Chemistry & biology"}, "citationStyles": {"bibtex": "@Article{Yuan2007CovalentRO,\n
      author = {Hushan Yuan and Katie R Barnes and R. Weissleder and L. Cantley and
      L. Josephson},\n booktitle = {Chemistry and Biology},\n journal = {Chemistry
      & biology},\n pages = {\n          321-8\n        },\n title = {Covalent reactions
      of wortmannin under physiological conditions.},\n volume = {14 3},\n year =
      {2007}\n}\n"}, "authors": [{"authorId": "6230104", "name": "Hushan Yuan"}, {"authorId":
      "40284134", "name": "Katie R Barnes"}, {"authorId": "3127756", "name": "R. Weissleder"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5095505", "name":
      "L. Josephson"}]}, {"paperId": "2aa428e82908c5ce039df2fa36afb0c5e3d478bb", "externalIds":
      {"MAG": "278996039", "DOI": "10.1182/BLOOD-2006-07-038620", "CorpusId": 3156314,
      "PubMed": "17164340"}, "corpusId": 3156314, "publicationVenue": {"id": "9b6db04a-2990-4cf9-a14c-01d47636ee53",
      "name": "Blood", "type": "journal", "issn": "0006-4971", "url": "http://www.bloodjournal.org/"},
      "url": "https://www.semanticscholar.org/paper/2aa428e82908c5ce039df2fa36afb0c5e3d478bb",
      "title": "T-cell function is partially maintained in the absence of class IA
      phosphoinositide 3-kinase signaling.", "abstract": "The class IA subgroup of
      phosphoinositide 3-kinase (PI3K) is activated downstream of antigen receptors,
      costimulatory molecules, and cytokine receptors on lymphocytes. Targeted deletion
      of individual genes for class IA regulatory subunits severely impairs the development
      and function of B cells but not T cells. Here we analyze conditional mutant
      mice in which thymocytes and T cells lack the major class IA regulatory subunits
      p85alpha, p55alpha, p50alpha, and p85beta. These cells exhibit nearly complete
      loss of PI3K signaling downstream of the T-cell receptor (TCR) and CD28. Nevertheless,
      T-cell development is largely unperturbed, and peripheral T cells show only
      partial impairments in proliferation and cytokine production in vitro. Both
      genetic and pharmacologic experiments suggest that class IA PI3K signaling plays
      a limited role in T-cell proliferation driven by TCR/CD28 clustering. In vivo,
      class IA-deficient T cells provide reduced help to B cells but show normal ability
      to mediate antiviral immunity. Together these findings provide definitive evidence
      that class IA PI3K regulatory subunits are essential for a subset of T-cell
      functions while challenging the notion that this signaling mechanism is a critical
      mediator of costimulatory signals downstream of CD28.", "venue": "Blood", "year":
      2007, "referenceCount": 70, "citationCount": 61, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://ashpublications.org/blood/article-pdf/109/7/2894/1289739/zh800707002894.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2007-04-01", "journal": {"volume": "109 7", "pages": "\n          2894-902\n        ",
      "name": "Blood"}, "citationStyles": {"bibtex": "@Article{Deane2007TcellFI,\n
      author = {J. Deane and M. Kharas and J. Oak and Linda N. Stiles and Ji Luo and
      T. Moore and H. Ji and C. Rommel and L. Cantley and T. Lane and D. Fruman},\n
      booktitle = {Blood},\n journal = {Blood},\n pages = {\n          2894-902\n        },\n
      title = {T-cell function is partially maintained in the absence of class IA
      phosphoinositide 3-kinase signaling.},\n volume = {109 7},\n year = {2007}\n}\n"},
      "authors": [{"authorId": "33653557", "name": "J. Deane"}, {"authorId": "152500082",
      "name": "M. Kharas"}, {"authorId": "39001132", "name": "J. Oak"}, {"authorId":
      "40480164", "name": "Linda N. Stiles"}, {"authorId": "145954100", "name": "Ji
      Luo"}, {"authorId": "34820441", "name": "T. Moore"}, {"authorId": "143969328",
      "name": "H. Ji"}, {"authorId": "2892041", "name": "C. Rommel"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2385578", "name": "T. Lane"},
      {"authorId": "6241317", "name": "D. Fruman"}]}, {"paperId": "2b970026aa91c43f5c37872358feb01425004e48",
      "externalIds": {"MAG": "2064230121", "DOI": "10.1126/SCIENCE.1137614", "CorpusId":
      85299309}, "corpusId": 85299309, "publicationVenue": {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad",
      "name": "Science", "type": "journal", "issn": "0193-4511", "alternate_issns":
      ["0036-8075"], "url": "https://www.jstor.org/journal/science", "alternate_urls":
      ["https://www.sciencemag.org/", "http://www.sciencemag.org/", "http://www.jstor.org/journals/00368075.html",
      "http://www.sciencemag.org/archive/"]}, "url": "https://www.semanticscholar.org/paper/2b970026aa91c43f5c37872358feb01425004e48",
      "title": "Protein Sequences from Mastodon and Tyrannosaurus Rex Revealed by
      Mass Spectrometry", "abstract": "Fossilized bones from extinct taxa harbor the
      potential for obtaining protein or DNA sequences that could reveal evolutionary
      links to extant species. We used mass spectrometry to obtain protein sequences
      from bones of a 160,000- to 600,000-year-old extinct mastodon (Mammut americanum)
      and a 68-million-year-old dinosaur (Tyrannosaurus rex). The presence of T. rex
      sequences indicates that their peptide bonds were remarkably stable. Mass spectrometry
      can thus be used to determine unique sequences from ancient organisms from peptide
      fragmentation patterns, a valuable tool to study the evolution and adaptation
      of ancient taxa from which genomic sequences are unlikely to be obtained.",
      "venue": "Science", "year": 2007, "referenceCount": 24, "citationCount": 263,
      "influentialCitationCount": 9, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Environmental Science", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2007-04-13", "journal": {"volume": "316", "pages": "280
      - 285", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Asara2007ProteinSF,\n
      author = {J. Asara and M. Schweitzer and Lisa M. Freimark and M. Phillips and
      L. Cantley},\n booktitle = {Science},\n journal = {Science},\n pages = {280
      - 285},\n title = {Protein Sequences from Mastodon and Tyrannosaurus Rex Revealed
      by Mass Spectrometry},\n volume = {316},\n year = {2007}\n}\n"}, "authors":
      [{"authorId": "3028470", "name": "J. Asara"}, {"authorId": "5618773", "name":
      "M. Schweitzer"}, {"authorId": "4333053", "name": "Lisa M. Freimark"}, {"authorId":
      "13194369", "name": "M. Phillips"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "3386f902e4c9f0c6662884a94ce757b8d945a0a8", "externalIds": {"CorpusId":
      44657962, "PubMed": "17626872"}, "corpusId": 44657962, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/3386f902e4c9f0c6662884a94ce757b8d945a0a8",
      "title": "Biochemistry. PI3K charges ahead.", "abstract": null, "venue": "Science",
      "year": 2007, "referenceCount": 0, "citationCount": 10, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle", "LettersAndComments"], "publicationDate":
      null, "journal": {"volume": "317 5835", "pages": "\n          206-7\n        ",
      "name": "Science"}, "citationStyles": {"bibtex": "@Article{Lee2007BiochemistryPC,\n
      author = {Jennifer Y. Lee and J. Engelman and L. Cantley},\n booktitle = {Science},\n
      journal = {Science},\n pages = {\n          206-7\n        },\n title = {Biochemistry.
      PI3K charges ahead.},\n volume = {317 5835},\n year = {2007}\n}\n"}, "authors":
      [{"authorId": "46663676", "name": "Jennifer Y. Lee"}, {"authorId": "6828387",
      "name": "J. Engelman"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "398483c0f72d1766f871ca97d5fae789a8998229", "externalIds": {"MAG": "1984621921",
      "DOI": "10.1016/j.cell.2007.06.009", "CorpusId": 9466184, "PubMed": "17604717"},
      "corpusId": 9466184, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/398483c0f72d1766f871ca97d5fae789a8998229",
      "title": "AKT/PKB Signaling: Navigating Downstream", "abstract": null, "venue":
      "Cell", "year": 2007, "referenceCount": 119, "citationCount": 5688, "influentialCitationCount":
      262, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867407007751/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2007-06-29", "journal": {"volume": "129", "pages": "1261-1274",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Manning2007AKTPKBSN,\n
      author = {B. Manning and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n
      pages = {1261-1274},\n title = {AKT/PKB Signaling: Navigating Downstream},\n
      volume = {129},\n year = {2007}\n}\n"}, "authors": [{"authorId": "2339651",
      "name": "B. Manning"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "4766c77e1a38110c5d7c1499c2a91c732ea9a448", "externalIds": {"MAG": "2094309012",
      "DOI": "10.1016/J.MOLCEL.2007.02.012", "CorpusId": 30670572, "PubMed": "17349956"},
      "corpusId": 30670572, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/4766c77e1a38110c5d7c1499c2a91c732ea9a448",
      "title": "Evolution of Ime2 phosphorylation sites on Cdk1 substrates provides
      a mechanism to limit the effects of the phosphatase Cdc14 in meiosis.", "abstract":
      null, "venue": "Molecules and Cells", "year": 2007, "referenceCount": 54, "citationCount":
      81, "influentialCitationCount": 9, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1097276507001128/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2007-03-09", "journal": {"volume": "25 5", "pages": "\n          689-702\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Holt2007EvolutionOI,\n
      author = {L. Holt and Jessica E. Hutti and L. Cantley and D. Morgan},\n booktitle
      = {Molecules and Cells},\n journal = {Molecular cell},\n pages = {\n          689-702\n        },\n
      title = {Evolution of Ime2 phosphorylation sites on Cdk1 substrates provides
      a mechanism to limit the effects of the phosphatase Cdc14 in meiosis.},\n volume
      = {25 5},\n year = {2007}\n}\n"}, "authors": [{"authorId": "4344976", "name":
      "L. Holt"}, {"authorId": "6742227", "name": "Jessica E. Hutti"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "35719273", "name": "D. Morgan"}]},
      {"paperId": "503f28ba57b0c711e8146f7bc72f73a8105b0d11", "externalIds": {"MAG":
      "2113561514", "DOI": "10.1128/MCB.00079-07", "CorpusId": 35281735}, "corpusId":
      35281735, "publicationVenue": {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b",
      "name": "Molecular and Cellular Biology", "type": "journal", "alternate_names":
      ["Mol Cell Biology"], "issn": "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls":
      ["http://mcb.asm.org/"]}, "url": "https://www.semanticscholar.org/paper/503f28ba57b0c711e8146f7bc72f73a8105b0d11",
      "title": "The p85\u03b1 Regulatory Subunit of Phosphoinositide 3-Kinase Potentiates
      c-Jun N-Terminal Kinase-Mediated Insulin Resistance", "abstract": "ABSTRACT
      Insulin resistance is a defining feature of type 2 diabetes and the metabolic
      syndrome. While the molecular mechanisms of insulin resistance are multiple,
      recent evidence suggests that attenuation of insulin signaling by c-Jun N-terminal
      kinase (JNK) may be a central part of the pathobiology of insulin resistance.
      Here we demonstrate that the p85\u03b1 regulatory subunit of phosphoinositide
      3-kinase (PI3K), a key mediator of insulin''s metabolic actions, is also required
      for the activation of JNK in states of insulin resistance, including high-fat
      diet-induced obesity and JNK1 overexpression. The requirement of the p85\u03b1
      regulatory subunit for JNK occurs independently of its role as a component of
      the PI3K heterodimer and occurs only in response to specific stimuli, namely,
      insulin and tunicamycin, a chemical that induces endoplasmic reticulum stress.
      We further show that insulin and p85 activate JNK by via cdc42 and MKK4. The
      activation of this cdc42/JNK pathway requires both an intact N terminus and
      functional SH2 domains within the C terminus of the p85\u03b1 regulatory subunit.
      Thus, p85\u03b1 plays a dual role in regulating insulin sensitivity and may
      mediate cross talk between the PI3K and stress kinase pathways.", "venue": "Molecular
      and Cellular Biology", "year": 2007, "referenceCount": 53, "citationCount":
      72, "influentialCitationCount": 6, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc1899914?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2007-02-05", "journal": {"volume": "27", "pages": "2830
      - 2840", "name": "Molecular and Cellular Biology"}, "citationStyles": {"bibtex":
      "@Article{Taniguchi2007ThePR,\n author = {C. Taniguchi and J. Alem\u00e1n and
      K. Ueki and Ji Luo and T. Asano and H. Kaneto and G. Stephanopoulos and L. Cantley
      and C. Kahn},\n booktitle = {Molecular and Cellular Biology},\n journal = {Molecular
      and Cellular Biology},\n pages = {2830 - 2840},\n title = {The p85\u03b1 Regulatory
      Subunit of Phosphoinositide 3-Kinase Potentiates c-Jun N-Terminal Kinase-Mediated
      Insulin Resistance},\n volume = {27},\n year = {2007}\n}\n"}, "authors": [{"authorId":
      "48311527", "name": "C. Taniguchi"}, {"authorId": "47567005", "name": "J. Alem\u00e1n"},
      {"authorId": "5177377", "name": "K. Ueki"}, {"authorId": "145954100", "name":
      "Ji Luo"}, {"authorId": "1928077", "name": "T. Asano"}, {"authorId": "4628208",
      "name": "H. Kaneto"}, {"authorId": "1813278", "name": "G. Stephanopoulos"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144391716", "name":
      "C. Kahn"}]}, {"paperId": "658b36eb92235e85cacf11738c1f64d8cc5fccc9", "externalIds":
      {"MAG": "2059839442", "DOI": "10.1073/pnas.0702663104", "CorpusId": 19447508,
      "PubMed": "17483449"}, "corpusId": 19447508, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/658b36eb92235e85cacf11738c1f64d8cc5fccc9",
      "title": "Deletion of the phosphoinositide 3-kinase p110\u03b3 gene attenuates
      murine atherosclerosis", "abstract": "Inflammatory cell activation by chemokines
      requires intracellular signaling through phosphoinositide 3-kinase (PI3-kinase)
      and the PI3-kinase-dependent protein serine/threonine kinase Akt. Atherosclerosis
      is a chronic inflammatory process driven by oxidatively modified (atherogenic)
      lipoproteins, chemokines, and other agonists that activate PI3-kinase. Here
      we show that macrophage PI3-kinase/Akt is activated by oxidized low-density
      lipoprotein, inflammatory chemokines, and angiotensin II. This activation is
      markedly reduced or absent in macrophages lacking p110\u03b3, the catalytic
      subunit of class Ib PI3-kinase. We further demonstrate activation of macrophage/foam
      cell PI3-kinase/Akt in atherosclerotic plaques from apolipoprotein E (apoE)-null
      mice, which manifest an aggressive form of atherosclerosis, whereas activation
      of PI3-kinase/Akt was undetectable in lesions from apoE-null mice lacking p110\u03b3
      despite the presence of class Ia PI3-kinase. Moreover, plaques were significantly
      smaller in apoE\u2212/\u2212p110\u03b3\u2212/\u2212 mice than in apoE\u2212/\u2212p110\u03b3+/+
      or apoE\u2212/\u2212p110\u03b3+/\u2212mice at all ages studied. In marked contrast
      to the embryonic lethality seen in mice lacking class Ia PI3-kinase, germ-line
      deletion of p110\u03b3 results in mice that exhibit normal viability, longevity,
      and fertility, with relatively well tolerated defects in innate immune and inflammatory
      responses that may play a role in diseases such as atherosclerosis and multiple
      sclerosis. Our results not only shed mechanistic light on inflammatory signaling
      during atherogenesis, but further identify p110\u03b3 as a possible target for
      pharmacological intervention in the primary and secondary prevention of human
      atherosclerotic cardiovascular disease.", "venue": "Proceedings of the National
      Academy of Sciences of the United States of America", "year": 2007, "referenceCount":
      38, "citationCount": 109, "influentialCitationCount": 5, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc1864909?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2007-05-08", "journal": {"volume": "104", "pages": "8077
      - 8082", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Chang2007DeletionOT,\n author = {James D. Chang and G.
      Sukhova and P. Libby and Eugenia Schvartz and A. Lichtenstein and S. Field and
      Caitlin Kennedy and Swetha Madhavarapu and Ji Luo and Dianqing Wu and L. Cantley},\n
      booktitle = {Proceedings of the National Academy of Sciences of the United States
      of America},\n journal = {Proceedings of the National Academy of Sciences},\n
      pages = {8077 - 8082},\n title = {Deletion of the phosphoinositide 3-kinase
      p110\u03b3 gene attenuates murine atherosclerosis},\n volume = {104},\n year
      = {2007}\n}\n"}, "authors": [{"authorId": "2116093125", "name": "James D. Chang"},
      {"authorId": "4552671", "name": "G. Sukhova"}, {"authorId": "145096401", "name":
      "P. Libby"}, {"authorId": "21192775", "name": "Eugenia Schvartz"}, {"authorId":
      "4704909", "name": "A. Lichtenstein"}, {"authorId": "123039768", "name": "S.
      Field"}, {"authorId": "144705393", "name": "Caitlin Kennedy"}, {"authorId":
      "4302322", "name": "Swetha Madhavarapu"}, {"authorId": "145954100", "name":
      "Ji Luo"}, {"authorId": "49709514", "name": "Dianqing Wu"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "65f5f4e3f5d0d854a404732f4163572033ca47a4",
      "externalIds": {"MAG": "2069548854", "DOI": "10.1126/SCIENCE.317.5843.1324",
      "CorpusId": 42564943, "PubMed": "17823333"}, "corpusId": 42564943, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/65f5f4e3f5d0d854a404732f4163572033ca47a4",
      "title": "Interpreting Sequences from Mastodon and T. rex", "abstract": "J.
      Asara et al. reported that collagen proteins from well-preserved ancient fossil
      bones from a 160,000- to 600,000-year-old mastodon and a 68-million-year-old
      T. rex can be extracted and sequenced (\u201cProtein sequences from mastodon
      and Tyrannosaurus rex revealed by mass spectrometry,\u201d 13 April,", "venue":
      "Science", "year": 2007, "referenceCount": 7, "citationCount": 42, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Geology", "source": "s2-fos-model"}], "publicationTypes":
      ["LettersAndComments"], "publicationDate": "2007-09-07", "journal": {"volume":
      "317", "pages": "1324 - 1325", "name": "Science"}, "citationStyles": {"bibtex":
      "@Article{Asara2007InterpretingSF,\n author = {J. Asara and J. Garavelli and
      D. Slatter and M. Schweitzer and Lisa M. Freimark and M. Phillips and L. Cantley},\n
      booktitle = {Science},\n journal = {Science},\n pages = {1324 - 1325},\n title
      = {Interpreting Sequences from Mastodon and T. rex},\n volume = {317},\n year
      = {2007}\n}\n"}, "authors": [{"authorId": "3028470", "name": "J. Asara"}, {"authorId":
      "2000634", "name": "J. Garavelli"}, {"authorId": "32424032", "name": "D. Slatter"},
      {"authorId": "5618773", "name": "M. Schweitzer"}, {"authorId": "4333053", "name":
      "Lisa M. Freimark"}, {"authorId": "13194369", "name": "M. Phillips"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "79577f98f4e49d1e77e6c85fc9a0b8f139e62aa8",
      "externalIds": {"MAG": "2116494541", "DOI": "10.1128/MCB.00270-07", "CorpusId":
      36865089, "PubMed": "17562858"}, "corpusId": 36865089, "publicationVenue": {"id":
      "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular and Cellular Biology",
      "type": "journal", "alternate_names": ["Mol Cell Biology"], "issn": "0270-7306",
      "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]}, "url":
      "https://www.semanticscholar.org/paper/79577f98f4e49d1e77e6c85fc9a0b8f139e62aa8",
      "title": "Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by
      K63-Linked Polyubiquitin Chains", "abstract": "ABSTRACT K63 polyubiquitin chains
      spatially and temporally link innate immune signaling effectors such that cytokine
      release can be coordinated. Crohn''s disease is a prototypical inflammatory
      disorder in which this process may be faulty as the major Crohn''s disease-associated
      protein, NOD2 (nucleotide oligomerization domain 2), regulates the formation
      of K63-linked polyubiquitin chains on the I kappa kinase (IKK) scaffolding protein,
      NEMO (NF-\u03baB essential modifier). In this work, we study these K63-linked
      ubiquitin networks to begin to understand the biochemical basis for the signaling
      cross talk between extracellular pathogen Toll-like receptors (TLRs) and intracellular
      pathogen NOD receptors. This work shows that TLR signaling requires the same
      ubiquitination event on NEMO to properly signal through NF-\u03baB. This ubiquitination
      is partially accomplished through the E3 ubiquitin ligase TRAF6. TRAF6 is activated
      by NOD2, and this activation is lost with a major Crohn''s disease-associated
      NOD2 allele, L1007insC. We further show that TRAF6 and NOD2/RIP2 share the same
      biochemical machinery (transforming growth factor \u03b2-activated kinase 1
      [TAK1]/TAB/Ubc13) to activate NF-\u03baB, allowing TLR signaling and NOD2 signaling
      to synergistically augment cytokine release. These findings suggest a biochemical
      mechanism for the faulty cytokine balance seen in Crohn''s disease.", "venue":
      "Molecular and Cellular Biology", "year": 2007, "referenceCount": 48, "citationCount":
      183, "influentialCitationCount": 10, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc1952158?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2007-06-11", "journal":
      {"volume": "27", "pages": "6012 - 6025", "name": "Molecular and Cellular Biology"},
      "citationStyles": {"bibtex": "@Article{Abbott2007CoordinatedRO,\n author = {Derek
      W. Abbott and Yibin Yang and Jessica E. Hutti and Swetha Madhavarapu and M.
      Kelliher and L. Cantley},\n booktitle = {Molecular and Cellular Biology},\n
      journal = {Molecular and Cellular Biology},\n pages = {6012 - 6025},\n title
      = {Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by K63-Linked
      Polyubiquitin Chains},\n volume = {27},\n year = {2007}\n}\n"}, "authors": [{"authorId":
      "145759174", "name": "Derek W. Abbott"}, {"authorId": "2140143157", "name":
      "Yibin Yang"}, {"authorId": "6742227", "name": "Jessica E. Hutti"}, {"authorId":
      "4302322", "name": "Swetha Madhavarapu"}, {"authorId": "5739575", "name": "M.
      Kelliher"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "99e5b842aec9d42221a7b315f168a92d7bd58413",
      "externalIds": {"MAG": "1998971866", "DOI": "10.1126/science.1141478", "CorpusId":
      23254145, "PubMed": "17463250"}, "corpusId": 23254145, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/99e5b842aec9d42221a7b315f168a92d7bd58413",
      "title": "MET Amplification Leads to Gefitinib Resistance in Lung Cancer by
      Activating ERBB3 Signaling", "abstract": "The epidermal growth factor receptor
      (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for
      lung cancers with EGFR activating mutations, but these tumors invariably develop
      drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line
      that developed resistance to gefitinib as a result of focal amplification of
      the MET proto-oncogene. inhibition of MET signaling in these cells restored
      their sensitivity to gefitinib. MET amplification was detected in 4 of 18 (22%)
      lung cancer specimens that had developed resistance to gefitinib or erlotinib.
      We find that amplification of MET causes gefitinib resistance by driving ERBB3
      (HER3)\u2013dependent activation of PI3K, a pathway thought to be specific to
      EGFR/ERBB family receptors. Thus, we propose that MET amplification may promote
      drug resistance in other ERBB-driven cancers as well.", "venue": "Science",
      "year": 2007, "referenceCount": 24, "citationCount": 4088, "influentialCitationCount":
      256, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.science.org/cms/asset/714da696-0aa4-4371-8018-08b492cd98b9/pap.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2007-05-18", "journal": {"volume": "316",
      "pages": "1039 - 1043", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Engelman2007METAL,\n
      author = {J. Engelman and K. Zejnullahu and T. Mitsudomi and Youngchul Song
      and Courtney Hyland and Joon-Oh Park and N. Lindeman and Christopher-Michael
      Gale and Xiaojun Zhao and J. Christensen and T. Kosaka and A. Holmes and A.
      Rogers and F. Cappuzzo and T. Mok and Charles Lee and B. Johnson and L. Cantley
      and P. J\u00e4nne},\n booktitle = {Science},\n journal = {Science},\n pages
      = {1039 - 1043},\n title = {MET Amplification Leads to Gefitinib Resistance
      in Lung Cancer by Activating ERBB3 Signaling},\n volume = {316},\n year = {2007}\n}\n"},
      "authors": [{"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "5610750",
      "name": "K. Zejnullahu"}, {"authorId": "4441512", "name": "T. Mitsudomi"}, {"authorId":
      "4846062", "name": "Youngchul Song"}, {"authorId": "40053421", "name": "Courtney
      Hyland"}, {"authorId": "48490520", "name": "Joon-Oh Park"}, {"authorId": "3734755",
      "name": "N. Lindeman"}, {"authorId": "77094637", "name": "Christopher-Michael
      Gale"}, {"authorId": "2111027786", "name": "Xiaojun Zhao"}, {"authorId": "2054179920",
      "name": "J. Christensen"}, {"authorId": "2638484", "name": "T. Kosaka"}, {"authorId":
      "48115918", "name": "A. Holmes"}, {"authorId": "35112344", "name": "A. Rogers"},
      {"authorId": "3740336", "name": "F. Cappuzzo"}, {"authorId": "17750315", "name":
      "T. Mok"}, {"authorId": "2118593740", "name": "Charles Lee"}, {"authorId": "115060139",
      "name": "B. Johnson"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "5984202", "name": "P. J\u00e4nne"}]}, {"paperId": "a616a4f6914c98ef7f423d4837fdba97d37345dd",
      "externalIds": {"MAG": "1972115026", "DOI": "10.1016/S1359-6349(07)70219-7",
      "CorpusId": 59087857}, "corpusId": 59087857, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/a616a4f6914c98ef7f423d4837fdba97d37345dd",
      "title": "105 INVITED The role of PI3K in cancer", "abstract": null, "venue":
      "", "year": 2007, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2007-09-01", "journal": {"volume": "5", "pages": "29", "name": "Ejc Supplements"},
      "citationStyles": {"bibtex": "@Article{Cantley2007105IT,\n author = {L. Cantley},\n
      journal = {Ejc Supplements},\n pages = {29},\n title = {105 INVITED The role
      of PI3K in cancer},\n volume = {5},\n year = {2007}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "ad434f51de7468232a71d46398f1a0c10e0c84d5",
      "externalIds": {"CorpusId": 30706377, "PubMed": "17709380"}, "corpusId": 30706377,
      "publicationVenue": {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular
      and Cellular Biology", "type": "journal", "alternate_names": ["Mol Cell Biology"],
      "issn": "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]},
      "url": "https://www.semanticscholar.org/paper/ad434f51de7468232a71d46398f1a0c10e0c84d5",
      "title": "IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause
      feedback inhibition of the NF-kappaB pathway.", "abstract": "Misregulation of
      NF-kappaB signaling leads to infectious, inflammatory, or autoimmune disorders.
      IkappaB kinase beta (IKKbeta) is an essential activator of NF-kappaB and is
      known to phosphorylate the NF-kappaB inhibitor, IkappaBalpha, allowing it to
      undergo ubiquitin-mediated proteasomal degradation. However, beyond IkappaBalpha,
      few additional IKKbeta substrates have been identified. Here we utilize a peptide
      library and bioinformatic approach to predict likely substrates of IKKbeta.
      This approach predicted Ser381 of the K63 deubiquitinase A20 as a likely site
      of IKKbeta phosphorylation. While A20 is a known negative regulator of innate
      immune signaling pathways, the mechanisms regulating the activity of A20 are
      poorly understood. We show that IKKbeta phosphorylates A20 in vitro and in vivo
      at serine 381, and we further show that this phosphorylation event increases
      the ability of A20 to inhibit the NF-kappaB signaling pathway. Phosphorylation
      of A20 by IKKbeta thus represents part of a novel feedback loop that regulates
      the duration of NF-kappaB signaling following activation of innate immune signaling
      pathways.", "venue": "Molecular and Cellular Biology", "year": 2007, "referenceCount":
      0, "citationCount": 75, "influentialCitationCount": 4, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": null, "journal": {"volume": "27 21", "pages": "\n          7451-61\n        ",
      "name": "Molecular and cellular biology"}, "citationStyles": {"bibtex": "@Article{Hutti2007IkappaBKB,\n
      author = {Jessica E. Hutti and B. Turk and J. Asara and A. Ma and L. Cantley
      and Derek W. Abbott},\n booktitle = {Molecular and Cellular Biology},\n journal
      = {Molecular and cellular biology},\n pages = {\n          7451-61\n        },\n
      title = {IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause
      feedback inhibition of the NF-kappaB pathway.},\n volume = {27 21},\n year =
      {2007}\n}\n"}, "authors": [{"authorId": "6742227", "name": "Jessica E. Hutti"},
      {"authorId": "25581223", "name": "B. Turk"}, {"authorId": "3028470", "name":
      "J. Asara"}, {"authorId": "145400524", "name": "A. Ma"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "145759174", "name": "Derek W. Abbott"}]},
      {"paperId": "b6245f81d43ac9ccb0c8593eff19e8cadece8701", "externalIds": {"MAG":
      "2049713190", "DOI": "10.1073/pnas.0610157104", "CorpusId": 20223560, "PubMed":
      "17204563"}, "corpusId": 20223560, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/b6245f81d43ac9ccb0c8593eff19e8cadece8701",
      "title": "Regulation of epithelial tight junction assembly and disassembly by
      AMP-activated protein kinase", "abstract": "AMP-activated protein kinase (AMPK)
      is a serine/threonine protein kinase that plays an important role in maintaining
      cellular energy balance. The activity of AMPK is modulated both by the cellular
      AMP-to-ATP ratio and by upstream kinases. Recently, AMPK was shown to be phosphorylated
      and activated by LKB1, a protein kinase that plays a conserved role in epithelial
      polarity regulation in mammals and Drosophila. Here, we investigate the involvement
      of AMPK in the regulation of epithelial tight junction assembly and cell polarization
      in MDCK cells. We show that the level of AMPK phosphorylation increases during
      calcium-induced tight junction assembly and cell polarization and that this
      increase depends on the kinase activity of LKB1. Expression of a kinase-dead
      mutant of AMPK inhibits tight junction assembly as indicated by measurement
      of transepithelial resistance and analysis of ZO-1 localization to the tight
      junction after calcium switch. Conversely, 5-aminoimidizole-4-carboxamide riboside,
      an activator of AMPK, promotes transepithelial resistance development and tight
      junction assembly upon calcium switch. Furthermore, 5-aminoimidizole-4-carboxamide
      riboside partially protects the tight junctions from disassembly induced by
      calcium depletion. These results support an important role of AMPK in the regulation
      of epithelial tight junction assembly and disassembly and suggest an intriguing
      link between cellular energy status and tight junction function.", "venue":
      "Proceedings of the National Academy of Sciences of the United States of America",
      "year": 2007, "referenceCount": 32, "citationCount": 265, "influentialCitationCount":
      11, "isOpenAccess": true, "openAccessPdf": {"url": "https://dash.harvard.edu/bitstream/1/41543070/1/90110%20zpq819.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2007-01-16", "journal": {"volume": "104", "pages": "819
      - 822", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Zheng2007RegulationOE,\n author = {B. Zheng and L. Cantley},\n
      booktitle = {Proceedings of the National Academy of Sciences of the United States
      of America},\n journal = {Proceedings of the National Academy of Sciences},\n
      pages = {819 - 822},\n title = {Regulation of epithelial tight junction assembly
      and disassembly by AMP-activated protein kinase},\n volume = {104},\n year =
      {2007}\n}\n"}, "authors": [{"authorId": "143918840", "name": "B. Zheng"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "c65d1001e0e4bfa0816487259cdeabbbe52ecdb3",
      "externalIds": {"CorpusId": 34475514}, "corpusId": 34475514, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/c65d1001e0e4bfa0816487259cdeabbbe52ecdb3",
      "title": "Deletion of the phosphoinositide 3-kinase p 110 { gamma } gene attenuates
      murine", "abstract": "www.pnas.org/cgi/content/full/104/19/8077#otherarticles
      This article has been cited by other articles: E-mail Alerts . click here at
      the top right corner of the article or Receive free email alerts when new articles
      cite this article sign up in the box Rights & Permissions www.pnas.org/misc/rightperm.shtml
      To reproduce this article in part (figures, tables) or in entirety, see: Reprints
      www.pnas.org/misc/reprints.shtml To order reprints, see:", "venue": "", "year":
      2007, "referenceCount": 0, "citationCount": 5, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Chang2007DeletionOT,\n
      author = {James D. Chang and G. Sukhova and P. Libby and Eugenia Schvartz and
      A. Lichtenstein and S. Field and Caitlin Kennedy and Swetha Madhavarapu and
      Ji Luo and Dianqing Wu and L. Cantley},\n title = {Deletion of the phosphoinositide
      3-kinase p 110 { gamma } gene attenuates murine},\n year = {2007}\n}\n"}, "authors":
      [{"authorId": "2116093125", "name": "James D. Chang"}, {"authorId": "4552671",
      "name": "G. Sukhova"}, {"authorId": "145096401", "name": "P. Libby"}, {"authorId":
      "21192775", "name": "Eugenia Schvartz"}, {"authorId": "4704909", "name": "A.
      Lichtenstein"}, {"authorId": "123039768", "name": "S. Field"}, {"authorId":
      "144705393", "name": "Caitlin Kennedy"}, {"authorId": "4302322", "name": "Swetha
      Madhavarapu"}, {"authorId": "145954100", "name": "Ji Luo"}, {"authorId": "49709514",
      "name": "Dianqing Wu"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "d102c6d3eee445e6dd1dd9a67dcfb4bb81ac32fb", "externalIds": {"MAG": "1996894913",
      "DOI": "10.1073/pnas.0701179104", "CorpusId": 28914577, "PubMed": "17372192"},
      "corpusId": 28914577, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/d102c6d3eee445e6dd1dd9a67dcfb4bb81ac32fb",
      "title": "Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic
      rate, decreased adiposity, and insulin hypersensitivity in vivo", "abstract":
      "Obesity is a major factor central to the development of insulin resistance
      and type 2 diabetes. The identification and characterization of genes involved
      in regulation of adiposity, insulin sensitivity, and glucose uptake are key
      to the design and development of new drug therapies for this disease. In this
      study, we show that the polarity kinase Par-1b/MARK2 is required for regulating
      glucose metabolism in vivo. Mice null for Par-1b were lean, insulin hypersensitive,
      resistant to high-fat diet-induced weight gain, and hypermetabolic. 18F-FDG
      microPET and hyperinsulinemic\u2013euglycemic clamp analyses demonstrated increased
      glucose uptake into white and brown adipose tissue, but not into skeletal muscle
      of Par-1b null mice relative to wild-type controls. Taken together, these data
      indicate that Par-1b is a regulator of glucose metabolism and adiposity in the
      whole animal and may be a valuable drug target for the treatment of both type
      2 diabetes and obesity.", "venue": "Proceedings of the National Academy of Sciences
      of the United States of America", "year": 2007, "referenceCount": 61, "citationCount":
      86, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc1838456?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2007-03-27", "journal":
      {"volume": "104", "pages": "5680 - 5685", "name": "Proceedings of the National
      Academy of Sciences"}, "citationStyles": {"bibtex": "@Article{Hurov2007LossOT,\n
      author = {J. Hurov and Mei Huang and L. White and J. Lennerz and C. Choi and
      You-Ree Cho and Hyo-Jeong Kim and Julie L. Prior and D. Piwnica-Worms and L.
      Cantley and Jason K. Kim and G. Shulman and H. Piwnica-Worms},\n booktitle =
      {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences},\n pages = {5680
      - 5685},\n title = {Loss of the Par-1b/MARK2 polarity kinase leads to increased
      metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo},\n
      volume = {104},\n year = {2007}\n}\n"}, "authors": [{"authorId": "50139635",
      "name": "J. Hurov"}, {"authorId": "2112586271", "name": "Mei Huang"}, {"authorId":
      "113240482", "name": "L. White"}, {"authorId": "6254704", "name": "J. Lennerz"},
      {"authorId": "2150789377", "name": "C. Choi"}, {"authorId": "90176312", "name":
      "You-Ree Cho"}, {"authorId": "2109648507", "name": "Hyo-Jeong Kim"}, {"authorId":
      "2255860", "name": "Julie L. Prior"}, {"authorId": "1421123275", "name": "D.
      Piwnica-Worms"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "1992964472", "name": "Jason K. Kim"}, {"authorId": "1856502", "name": "G. Shulman"},
      {"authorId": "1400810799", "name": "H. Piwnica-Worms"}]}, {"paperId": "d491c5c39f591a1354b45e02b42381be0bfffb47",
      "externalIds": {"MAG": "1766269169", "DOI": "10.1126/SCIENCE.1146073", "CorpusId":
      84007363}, "corpusId": 84007363, "publicationVenue": {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad",
      "name": "Science", "type": "journal", "issn": "0193-4511", "alternate_issns":
      ["0036-8075"], "url": "https://www.jstor.org/journal/science", "alternate_urls":
      ["https://www.sciencemag.org/", "http://www.sciencemag.org/", "http://www.jstor.org/journals/00368075.html",
      "http://www.sciencemag.org/archive/"]}, "url": "https://www.semanticscholar.org/paper/d491c5c39f591a1354b45e02b42381be0bfffb47",
      "title": "PI3K Charges Ahead", "abstract": "Structural information about an
      enzyme implicated in numerous cancers provides insights into to how certain
      mutations promote cancer cell growth and survival.", "venue": "Science", "year":
      2007, "referenceCount": 8, "citationCount": 37, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2007-07-13", "journal": {"volume":
      "317", "pages": "206 - 207", "name": "Science"}, "citationStyles": {"bibtex":
      "@Article{Lee2007PI3KCA,\n author = {Jennifer Y. Lee and J. Engelman and L.
      Cantley},\n booktitle = {Science},\n journal = {Science},\n pages = {206 - 207},\n
      title = {PI3K Charges Ahead},\n volume = {317},\n year = {2007}\n}\n"}, "authors":
      [{"authorId": "46663676", "name": "Jennifer Y. Lee"}, {"authorId": "6828387",
      "name": "J. Engelman"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "34ec109c1f2d6271e870a10f4242c56ffd5a456b", "externalIds": {"MAG": "2041600623",
      "DOI": "10.1038/nprot.2006.57", "CorpusId": 12433784, "PubMed": "17406259"},
      "corpusId": 12433784, "publicationVenue": {"id": "705a5f2b-aaf1-41fb-bc28-be78040b4587",
      "name": "Nature Protocols", "type": "journal", "alternate_names": ["Nat Protoc"],
      "issn": "1750-2799", "url": "https://www.nature.com/nprot/", "alternate_urls":
      ["http://www.nature.com/nprot/index.html"]}, "url": "https://www.semanticscholar.org/paper/34ec109c1f2d6271e870a10f4242c56ffd5a456b",
      "title": "Determining protein kinase substrate specificity by parallel solution-phase
      assay of large numbers of peptide substrates", "abstract": null, "venue": "Nature
      Protocols", "year": 2006, "referenceCount": 7, "citationCount": 72, "influentialCitationCount":
      4, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": null, "journal": {"volume": "1", "pages":
      "375-379", "name": "Nature Protocols"}, "citationStyles": {"bibtex": "@Article{Turk2006DeterminingPK,\n
      author = {B. Turk and Jessica E. Hutti and L. Cantley},\n booktitle = {Nature
      Protocols},\n journal = {Nature Protocols},\n pages = {375-379},\n title = {Determining
      protein kinase substrate specificity by parallel solution-phase assay of large
      numbers of peptide substrates},\n volume = {1},\n year = {2006}\n}\n"}, "authors":
      [{"authorId": "25581223", "name": "B. Turk"}, {"authorId": "6742227", "name":
      "Jessica E. Hutti"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "36c79ddf639ff9a134b9512087375275de6266e4", "externalIds": {"MAG": "2128368215",
      "DOI": "10.1038/sj.emboj.7601001", "CorpusId": 41698564, "PubMed": "16482216"},
      "corpusId": 41698564, "publicationVenue": {"id": "b89f0ede-6fa8-4dd2-a8a7-f54695a00323",
      "name": "EMBO Journal", "type": "journal", "alternate_names": ["The EMBO Journal",
      "EMBO J"], "issn": "0261-4189", "url": "http://embojournal.npgjournals.com/",
      "alternate_urls": ["http://emboj.embopress.org/"]}, "url": "https://www.semanticscholar.org/paper/36c79ddf639ff9a134b9512087375275de6266e4",
      "title": "PtdIns(5)P activates the host cell PI3\u2010kinase/Akt pathway during
      Shigella flexneri infection", "abstract": null, "venue": "EMBO Journal", "year":
      2006, "referenceCount": 52, "citationCount": 215, "influentialCitationCount":
      16, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc1409730?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2006-03-08", "journal": {"volume": "25", "name": "The EMBO
      Journal"}, "citationStyles": {"bibtex": "@Article{Pendaries2006PtdIns5PAT,\n
      author = {C. Pendaries and H. Tronch\u00e8re and L. Arbibe and J. Mounier and
      O. Gozani and L. Cantley and M. J. Fry and F. Gaits\u2010Iacovoni and P. Sansonetti
      and B. Payrastre},\n booktitle = {EMBO Journal},\n journal = {The EMBO Journal},\n
      title = {PtdIns(5)P activates the host cell PI3\u2010kinase/Akt pathway during
      Shigella flexneri infection},\n volume = {25},\n year = {2006}\n}\n"}, "authors":
      [{"authorId": "3397215", "name": "C. Pendaries"}, {"authorId": "4511306", "name":
      "H. Tronch\u00e8re"}, {"authorId": "3757633", "name": "L. Arbibe"}, {"authorId":
      "2228870", "name": "J. Mounier"}, {"authorId": "6896988", "name": "O. Gozani"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "30565077", "name":
      "M. J. Fry"}, {"authorId": "1398654140", "name": "F. Gaits\u2010Iacovoni"},
      {"authorId": "10187502", "name": "P. Sansonetti"}, {"authorId": "3933495", "name":
      "B. Payrastre"}]}, {"paperId": "407c5a50c877726a242a00c162e97955b57e7537", "externalIds":
      {"MAG": "2117780766", "DOI": "10.1158/1078-0432.CCR-06-0795", "CorpusId": 33401812,
      "PubMed": "16857813"}, "corpusId": 33401812, "publicationVenue": {"id": "a360cd20-21d0-42cf-a0af-2f14e10514f0",
      "name": "Clinical Cancer Research", "type": "journal", "alternate_names": ["Clin
      Cancer Res"], "issn": "1078-0432", "url": "https://clincancerres.aacrjournals.org/",
      "alternate_urls": ["http://clincancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/407c5a50c877726a242a00c162e97955b57e7537",
      "title": "The Role of the ErbB Family Members in Non\u2013Small Cell Lung Cancers
      Sensitive to Epidermal Growth Factor Receptor Kinase Inhibitors", "abstract":
      "Inhibitors targeting the epidermal growth factor receptor (EGFR) are effective
      in a subset of non\u2013small cell lung cancers. Such cancers often harbor EGFR
      mutations and/or amplification. These cancers require EGFR activity for the
      maintenance of critical intracellular survival and growth signaling pathways.
      Evidence is now accruing that EGFR works in concert with other ErbB family members,
      particularly HER2 and ErbB3, to activate these signaling pathways in lung cancers.
      These findings have important implications regarding the biology of these cancers
      and may lead to improved methods for identifying tumors that are responsive
      to EGFR kinase inhibitors and alternative therapies to treat cancers driven
      by ErbB signaling.", "venue": "Clinical Cancer Research", "year": 2006, "referenceCount":
      41, "citationCount": 92, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://aacrjournals.org/clincancerres/article-pdf/12/14/4372s/1965213/4372s.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2006-07-15", "journal": {"volume": "12", "pages": "4372s
      - 4376s", "name": "Clinical Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Engelman2006TheRO,\n author = {J. Engelman and L. Cantley},\n booktitle
      = {Clinical Cancer Research},\n journal = {Clinical Cancer Research},\n pages
      = {4372s - 4376s},\n title = {The Role of the ErbB Family Members in Non\u2013Small
      Cell Lung Cancers Sensitive to Epidermal Growth Factor Receptor Kinase Inhibitors},\n
      volume = {12},\n year = {2006}\n}\n"}, "authors": [{"authorId": "6828387", "name":
      "J. Engelman"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "43c9a351dd30d14912e840777e1115f4a7ef1a23", "externalIds": {"MAG": "2060968396",
      "DOI": "10.1016/J.CMET.2006.04.005", "CorpusId": 24541977, "PubMed": "16679292"},
      "corpusId": 24541977, "publicationVenue": {"id": "ad36b49e-5c03-4c48-be8d-321a0d17c2f6",
      "name": "Cell Metabolism", "type": "journal", "alternate_names": ["Cell Metab"],
      "issn": "1550-4131", "url": "https://www.cell.com/cell-metabolism/home", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/15504131", "http://www.cellmetabolism.org/"]},
      "url": "https://www.semanticscholar.org/paper/43c9a351dd30d14912e840777e1115f4a7ef1a23",
      "title": "Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide
      3-kinase via Akt and PKClambda/zeta.", "abstract": null, "venue": "Cell Metabolism",
      "year": 2006, "referenceCount": 33, "citationCount": 277, "influentialCitationCount":
      8, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1550413106001240/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2006-05-01", "journal": {"volume": "3 5", "pages": "\n          343-53\n        ",
      "name": "Cell metabolism"}, "citationStyles": {"bibtex": "@Article{Taniguchi2006DivergentRO,\n
      author = {C. Taniguchi and Tatsuya Kondo and M. Sajan and Ji Luo and R. Bronson
      and T. Asano and R. Farese and L. Cantley and C. Kahn},\n booktitle = {Cell
      Metabolism},\n journal = {Cell metabolism},\n pages = {\n          343-53\n        },\n
      title = {Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide
      3-kinase via Akt and PKClambda/zeta.},\n volume = {3 5},\n year = {2006}\n}\n"},
      "authors": [{"authorId": "48311527", "name": "C. Taniguchi"}, {"authorId": "16114256",
      "name": "Tatsuya Kondo"}, {"authorId": "3511388", "name": "M. Sajan"}, {"authorId":
      "145954100", "name": "Ji Luo"}, {"authorId": "40803408", "name": "R. Bronson"},
      {"authorId": "1928077", "name": "T. Asano"}, {"authorId": "1601207486", "name":
      "R. Farese"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144391716",
      "name": "C. Kahn"}]}, {"paperId": "4e054f477b96fe08f1efefe79aff0adc1d9171bd",
      "externalIds": {"MAG": "2063578317", "DOI": "10.1073/pnas.0607984103", "CorpusId":
      6113188, "PubMed": "17071741"}, "corpusId": 6113188, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/4e054f477b96fe08f1efefe79aff0adc1d9171bd",
      "title": "Sj\u00f6gren''s syndrome-like disease in mice with T cells lacking
      class 1A phosphoinositide-3-kinase", "abstract": "Sj\u00f6gren''s syndrome (SS)
      is an autoimmune disease that is characterized by infiltration of exocrine tissues,
      resulting in xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes).
      Here, we show that mice with T cell-specific loss of class IA phosphoinositide
      3-kinase function develop organ-specific autoimmunity that resembles the human
      disease SS. Most mutant mice aged 3\u20138 months develop corneal opacity and
      eye lesions due to irritation and constant scratching. These mice display cardinal
      signs of primary SS such as marked lymphocytic infiltration of the lacrimal
      glands, antinuclear antibodies in the serum, and elevated titer of anti-SS-A
      antibody, in the absence of kidney pathology. Immunofluorescence studies show
      the presence of numerous CD4+ T cells with a smaller number of CD8+ T cells
      and B cells in the lacrimal glands. CD4+ T cells from these mice exhibit aberrant
      differentiation in vitro. These results indicate that aberrant T cells with
      impaired class IA phosphoinositide 3-kinase signaling can lead to organ-specific
      autoimmunity. In addition, the mouse model described here represents a tool
      to study the pathogenesis and treatment of SS.", "venue": "Proceedings of the
      National Academy of Sciences of the United States of America", "year": 2006,
      "referenceCount": 42, "citationCount": 69, "influentialCitationCount": 2, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.pnas.org/content/103/45/16882.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2006-11-07", "journal": {"volume": "103", "pages": "16882
      - 16887", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Oak2006Sj\u00f6grensSD,\n author = {J. Oak and J. Deane
      and M. Kharas and Ji Luo and T. Lane and L. Cantley and D. Fruman},\n booktitle
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences},\n pages = {16882
      - 16887},\n title = {Sj\u00f6gren''s syndrome-like disease in mice with T cells
      lacking class 1A phosphoinositide-3-kinase},\n volume = {103},\n year = {2006}\n}\n"},
      "authors": [{"authorId": "39001132", "name": "J. Oak"}, {"authorId": "33653557",
      "name": "J. Deane"}, {"authorId": "152500082", "name": "M. Kharas"}, {"authorId":
      "145954100", "name": "Ji Luo"}, {"authorId": "2385578", "name": "T. Lane"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6241317", "name":
      "D. Fruman"}]}, {"paperId": "62d195f01a47755743553ce3c8309551e1dca518", "externalIds":
      {"MAG": "2008201842", "DOI": "10.1021/PR050334T", "CorpusId": 25498622, "PubMed":
      "16396506"}, "corpusId": 25498622, "publicationVenue": {"id": "c7bbca07-9604-48a6-85d8-512fa663722e",
      "name": "Journal of Proteome Research", "type": "journal", "alternate_names":
      ["J Proteome Res"], "issn": "1535-3893", "url": "https://pubs.acs.org/journal/jprobs",
      "alternate_urls": ["http://pubs.acs.org/journals/jprobs/", "http://pubs.acs.org/journals/jprobs/index.html",
      "http://pubs.acs.org/journal/jprobs"]}, "url": "https://www.semanticscholar.org/paper/62d195f01a47755743553ce3c8309551e1dca518",
      "title": "In-Gel Stable-Isotope Labeling (ISIL): a strategy for mass spectrometry-based
      relative quantification.", "abstract": "Most proteomics approaches for relative
      quantification of protein expression use a combination of stable-isotope labeling
      and mass spectrometry. Traditionally, researchers have used difference gel electrophoresis
      (DIGE) from stained 1D and 2D gels for relative quantification. While differences
      in protein staining intensity can often be visualized, abundant proteins can
      obscure less abundant proteins, and quantification of post-translational modifications
      is difficult. A method is presented for quantifying changes in the abundance
      of a specific protein or changes in specific modifications of a protein using
      In-gel Stable-Isotope Labeling (ISIL). Proteins extracted from any source (tissue,
      cell line, immunoprecipitate, etc.), treated under two experimental conditions,
      are resolved in separate lanes by gel electrophoresis. The regions of interest
      (visualized by staining) are reacted separately with light versus heavy isotope-labeled
      reagents, and the gel slices are then mixed and digested with proteases. The
      resulting peptides are then analyzed by LC-MS to determine relative abundance
      of light/heavy isotope pairs and analyzed by LC-MS/MS for identification of
      sequence and modifications. The strategy compares well with other relative quantification
      strategies, and in silico calculations reveal its effectiveness as a global
      relative quantification strategy. An advantage of ISIL is that visualization
      of gel differences can be used as a first quantification step followed by accurate
      and sensitive protein level stable-isotope labeling and mass spectrometry-based
      relative quantification.", "venue": "Journal of Proteome Research", "year":
      2006, "referenceCount": 14, "citationCount": 32, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": null, "journal": {"volume": "5 1", "pages":
      "\n          155-63\n        ", "name": "Journal of proteome research"}, "citationStyles":
      {"bibtex": "@Article{Asara2006InGelSL,\n author = {J. Asara and Xiang Zhang
      and B. Zheng and Heather H Christofk and Ning Wu and L. Cantley},\n booktitle
      = {Journal of Proteome Research},\n journal = {Journal of proteome research},\n
      pages = {\n          155-63\n        },\n title = {In-Gel Stable-Isotope Labeling
      (ISIL): a strategy for mass spectrometry-based relative quantification.},\n
      volume = {5 1},\n year = {2006}\n}\n"}, "authors": [{"authorId": "3028470",
      "name": "J. Asara"}, {"authorId": "47958479", "name": "Xiang Zhang"}, {"authorId":
      "143918840", "name": "B. Zheng"}, {"authorId": "12474335", "name": "Heather
      H Christofk"}, {"authorId": "2068343858", "name": "Ning Wu"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "657b9110e5bf0f844d72de6ed0043af3bc9070a7",
      "externalIds": {"MAG": "2144323242", "DOI": "10.1038/nature04869", "CorpusId":
      4423556, "PubMed": "16724053"}, "corpusId": 4423556, "publicationVenue": {"id":
      "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/657b9110e5bf0f844d72de6ed0043af3bc9070a7",
      "title": "Ras, PI(3)K and mTOR signalling controls tumour cell growth", "abstract":
      null, "venue": "Nature", "year": 2006, "referenceCount": 88, "citationCount":
      2040, "influentialCitationCount": 72, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2006-05-25", "journal": {"volume": "441", "pages": "424-430",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Shaw2006RasPA,\n author
      = {R. Shaw and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {424-430},\n title = {Ras, PI(3)K and mTOR signalling controls tumour
      cell growth},\n volume = {441},\n year = {2006}\n}\n"}, "authors": [{"authorId":
      "4426388", "name": "R. Shaw"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "790cf5a1dcff8ea5e52429d08a1475ba00f18f56", "externalIds": {"MAG":
      "2075342501", "DOI": "10.1073/pnas.0604628103", "CorpusId": 45226883, "PubMed":
      "16880400"}, "corpusId": 45226883, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/790cf5a1dcff8ea5e52429d08a1475ba00f18f56",
      "title": "Phosphoinositide 3-kinase regulatory subunit p85\u03b1 suppresses
      insulin action via positive regulation of PTEN", "abstract": "The phosphoinositide
      3-kinase (PI3K) pathway is central to the metabolic actions of insulin on liver.
      Here, we show that mice with a liver-specific deletion of the p85\u03b1 regulatory
      subunit of PI3K (L-Pik3r1KO) exhibit a paradoxical improvement of hepatic and
      peripheral insulin sensitivity. Although PI3K enzymatic activity is diminished
      in L-Pik3r1KO livers because of a reduced level of regulatory and catalytic
      subunits of PI3K, insulin-stimulated Akt activity is actually increased. This
      increased Akt activity correlates with increased phosphatidylinositol (3,4,5)-trisphosphate
      levels which are due, at least in part, to diminished activity of the (3,4,5)-trisphosphate
      phosphatase PTEN. Thus, the regulatory subunit p85\u03b1 is a critical modulator
      of insulin sensitivity in vivo not only because of its effects on PI3K activation,
      but also as a regulator of PTEN activity.", "venue": "Proceedings of the National
      Academy of Sciences of the United States of America", "year": 2006, "referenceCount":
      31, "citationCount": 156, "influentialCitationCount": 5, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc1524929?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2006-08-08", "journal": {"volume": "103", "pages": "12093
      - 12097", "name": "Proceedings of the National Academy of Sciences"}, "citationStyles":
      {"bibtex": "@Article{Taniguchi2006Phosphoinositide3R,\n author = {C. Taniguchi
      and T. Tran and Tatsuya Kondo and Ji Luo and K. Ueki and L. Cantley and C. Kahn},\n
      booktitle = {Proceedings of the National Academy of Sciences of the United States
      of America},\n journal = {Proceedings of the National Academy of Sciences},\n
      pages = {12093 - 12097},\n title = {Phosphoinositide 3-kinase regulatory subunit
      p85\u03b1 suppresses insulin action via positive regulation of PTEN},\n volume
      = {103},\n year = {2006}\n}\n"}, "authors": [{"authorId": "48311527", "name":
      "C. Taniguchi"}, {"authorId": "3500862", "name": "T. Tran"}, {"authorId": "16114256",
      "name": "Tatsuya Kondo"}, {"authorId": "145954100", "name": "Ji Luo"}, {"authorId":
      "5177377", "name": "K. Ueki"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "144391716", "name": "C. Kahn"}]}, {"paperId": "79314bb75bcb4dc30abe0daba154b391ae5dbf0f",
      "externalIds": {"PubMedCentral": "1334198", "MAG": "2106507395", "DOI": "10.1371/journal.pbio.0040038",
      "CorpusId": 4844154, "PubMed": "16417406"}, "corpusId": 4844154, "publicationVenue":
      {"id": "83ff973b-8a0e-4e00-a06a-2cfd9e222de9", "name": "PLoS Biology", "type":
      "journal", "alternate_names": ["Plo Biology", "PLOS Biology", "PLO Biology"],
      "issn": "1544-9173", "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=212",
      "alternate_urls": ["http://www.plosbiology.org/", "https://journals.plos.org/plosbiology/"]},
      "url": "https://www.semanticscholar.org/paper/79314bb75bcb4dc30abe0daba154b391ae5dbf0f",
      "title": "Hem-1 Complexes Are Essential for Rac Activation, Actin Polymerization,
      and Myosin Regulation during Neutrophil Chemotaxis", "abstract": "Migrating
      cells need to make different actin assemblies at the cell''s leading and trailing
      edges and to maintain physical separation of signals for these assemblies. This
      asymmetric control of activities represents one important form of cell polarity.
      There are significant gaps in our understanding of the components involved in
      generating and maintaining polarity during chemotaxis. Here we characterize
      a family of complexes (which we term leading edge complexes), scaffolded by
      hematopoietic protein 1 (Hem-1), that organize the neutrophil''s leading edge.
      The Wiskott-Aldrich syndrome protein family Verprolin-homologous protein (WAVE)2
      complex, which mediates activation of actin polymerization by Rac, is only one
      member of this family. A subset of these leading edge complexes are biochemically
      separable from the WAVE2 complex and contain a diverse set of potential polarity-regulating
      proteins. RNA interference\u2013mediated knockdown of Hem-1\u2013containing
      complexes in neutrophil-like cells: (a) dramatically impairs attractant-induced
      actin polymerization, polarity, and chemotaxis; (b) substantially weakens Rac
      activation and phosphatidylinositol-(3,4,5)-tris-phosphate production, disrupting
      the (phosphatidylinositol-(3,4,5)-tris-phosphate)/Rac/F-actin\u2013mediated
      feedback circuit that organizes the leading edge; and (c) prevents exclusion
      of activated myosin from the leading edge, perhaps by misregulating leading
      edge complexes that contain inhibitors of the Rho-actomyosin pathway. Taken
      together, these observations show that versatile Hem-1\u2013containing complexes
      coordinate diverse regulatory signals at the leading edge of polarized neutrophils,
      including but not confined to those involving WAVE2-dependent actin polymerization.",
      "venue": "PLoS Biology", "year": 2006, "referenceCount": 89, "citationCount":
      178, "influentialCitationCount": 12, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.0040038&type=printable",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2006-01-24", "journal": {"volume": "4", "name": "PLoS Biology"},
      "citationStyles": {"bibtex": "@Article{Weiner2006Hem1CA,\n author = {O. Weiner
      and Maike C Rentel and A. Ott and G. Brown and Mark P. Jedrychowski and M. Yaffe
      and S. Gygi and L. Cantley and H. Bourne and M. Kirschner},\n booktitle = {PLoS
      Biology},\n journal = {PLoS Biology},\n title = {Hem-1 Complexes Are Essential
      for Rac Activation, Actin Polymerization, and Myosin Regulation during Neutrophil
      Chemotaxis},\n volume = {4},\n year = {2006}\n}\n"}, "authors": [{"authorId":
      "3528639", "name": "O. Weiner"}, {"authorId": "6306375", "name": "Maike C Rentel"},
      {"authorId": "2069916342", "name": "A. Ott"}, {"authorId": "2219979", "name":
      "G. Brown"}, {"authorId": "6432355", "name": "Mark P. Jedrychowski"}, {"authorId":
      "88402408", "name": "M. Yaffe"}, {"authorId": "2665934", "name": "S. Gygi"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2324026", "name":
      "H. Bourne"}, {"authorId": "40294231", "name": "M. Kirschner"}]}, {"paperId":
      "7f76e9cde19b22ad1a25856f78f24c30dc6c6801", "externalIds": {"MAG": "2068244265",
      "DOI": "10.1172/JCI28656", "CorpusId": 23034765, "PubMed": "16906227"}, "corpusId":
      23034765, "publicationVenue": {"id": "8c9a9e1b-acf2-4274-8d73-6ea0ecd11fd1",
      "name": "Journal of Clinical Investigation", "type": "journal", "alternate_names":
      ["J Clin Investig"], "issn": "0021-9738", "url": "https://www.jci.org/", "alternate_urls":
      ["http://www.jci.org/", "https://www.jci.org/archive", "http://www.jci.org/impact"]},
      "url": "https://www.semanticscholar.org/paper/7f76e9cde19b22ad1a25856f78f24c30dc6c6801",
      "title": "Allelic dilution obscures detection of a biologically significant
      resistance mutation in EGFR-amplified lung cancer.", "abstract": "EGFR is frequently
      mutated and amplified in lung adenocarcinomas sensitive to EGFR inhibitors gefitinib
      and erlotinib. A secondary mutation, T790M, has been associated with acquired
      resistance but has not been shown to be sufficient to render EGFR mutant/amplified
      lung cancers resistant to EGFR inhibitors. We created a model for studying acquired
      resistance to gefitinib by prolonged exposure of a gefitinib-sensitive lung
      carcinoma cell line (H3255; EGFR mutated and amplified) to gefitinib in vitro.
      The resulting resistant cell line acquired a T790M mutation in a small fraction
      of the amplified alleles that was undetected by direct sequencing and identified
      only by a highly sensitive HPLC-based technique. In gefitinib-sensitive lung
      cancer cells with EGFR mutations and amplifications, exogenous introduction
      of EGFR T790M effectively conferred resistance to gefitinib and continued ErbB-3/PI3K/Akt
      signaling when in cis to an activating mutation. Moreover, continued activation
      of PI3K signaling by the PIK3CA oncogenic mutant, p110alpha E545K, was sufficient
      to abrogate gefitinib-induced apoptosis. These findings suggest that allelic
      dilution of biologically significant resistance mutations may go undetected
      by direct sequencing in cancers with amplified oncogenes and that restoration
      of PI3K activation via either a T790M mutation or other mechanisms can provide
      resistance to gefitinib.", "venue": "Journal of Clinical Investigation", "year":
      2006, "referenceCount": 55, "citationCount": 458, "influentialCitationCount":
      24, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jci.org/articles/view/28656/files/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2006-10-02", "journal": {"volume": "116
      10", "pages": "\n          2695-706\n        ", "name": "The Journal of clinical
      investigation"}, "citationStyles": {"bibtex": "@Article{Engelman2006AllelicDO,\n
      author = {J. Engelman and T. Mukohara and K. Zejnullahu and E. Lifshits and
      A. Borras and Christopher-Michael Gale and G. Naumov and B. Yeap and E. Jarrell
      and J. Sun and Sean I Tracy and Xiaojun Zhao and J. Heymach and B. Johnson and
      L. Cantley and P. J\u00e4nne},\n booktitle = {Journal of Clinical Investigation},\n
      journal = {The Journal of clinical investigation},\n pages = {\n          2695-706\n        },\n
      title = {Allelic dilution obscures detection of a biologically significant resistance
      mutation in EGFR-amplified lung cancer.},\n volume = {116 10},\n year = {2006}\n}\n"},
      "authors": [{"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "4944777",
      "name": "T. Mukohara"}, {"authorId": "5610750", "name": "K. Zejnullahu"}, {"authorId":
      "144609942", "name": "E. Lifshits"}, {"authorId": "39319608", "name": "A. Borras"},
      {"authorId": "77094637", "name": "Christopher-Michael Gale"}, {"authorId": "3808694",
      "name": "G. Naumov"}, {"authorId": "2127357", "name": "B. Yeap"}, {"authorId":
      "7844726", "name": "E. Jarrell"}, {"authorId": "2110677231", "name": "J. Sun"},
      {"authorId": "35925520", "name": "Sean I Tracy"}, {"authorId": "2111027786",
      "name": "Xiaojun Zhao"}, {"authorId": "2192944576", "name": "J. Heymach"}, {"authorId":
      "115060139", "name": "B. Johnson"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5984202", "name": "P. J\u00e4nne"}]}, {"paperId": "9153cf9b582d9d3c686ae014fb8130a20d94a898",
      "externalIds": {"MAG": "2009886463", "DOI": "10.1038/nrg1879", "CorpusId": 19832477,
      "PubMed": "16847462"}, "corpusId": 19832477, "publicationVenue": {"id": "f44976b5-2cb9-402a-bc59-6a174239987b",
      "name": "Nature reviews genetics", "type": "journal", "alternate_names": ["Nature
      Reviews Genetics", "Nat rev genet", "Nat Rev Genet"], "issn": "1471-0056", "url":
      "https://www.nature.com/nrg/", "alternate_urls": ["http://www.nature.com/nrg/index.html"]},
      "url": "https://www.semanticscholar.org/paper/9153cf9b582d9d3c686ae014fb8130a20d94a898",
      "title": "The evolution of phosphatidylinositol 3-kinases as regulators of growth
      and metabolism", "abstract": null, "venue": "Nature reviews genetics", "year":
      2006, "referenceCount": 171, "citationCount": 3037, "influentialCitationCount":
      160, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "2006-08-01", "journal": {"volume":
      "7", "pages": "606-619", "name": "Nature Reviews Genetics"}, "citationStyles":
      {"bibtex": "@Article{Engelman2006TheEO,\n author = {J. Engelman and Ji Luo and
      L. Cantley},\n booktitle = {Nature reviews genetics},\n journal = {Nature Reviews
      Genetics},\n pages = {606-619},\n title = {The evolution of phosphatidylinositol
      3-kinases as regulators of growth and metabolism},\n volume = {7},\n year =
      {2006}\n}\n"}, "authors": [{"authorId": "6828387", "name": "J. Engelman"}, {"authorId":
      "145954100", "name": "Ji Luo"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "ca3bf8fab2360c5efd323a6ce9441f280886d55a", "externalIds": {"MAG":
      "2103919441", "DOI": "10.1021/BI052252O", "CorpusId": 5695487, "PubMed": "16548514"},
      "corpusId": 5695487, "publicationVenue": {"id": "ae7a3201-e479-4666-8a93-3d35d6bf7cd1",
      "name": "Biochemistry", "type": "journal", "issn": "0006-2960", "alternate_issns":
      ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw", "alternate_urls":
      ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/ca3bf8fab2360c5efd323a6ce9441f280886d55a",
      "title": "MMP-20 is predominately a tooth-specific enzyme with a deep catalytic
      pocket that hydrolyzes type V collagen.", "abstract": "Matrix metalloproteinase-20
      (MMP-20, enamelysin) has a highly restricted pattern of expression. In healthy
      tissues, MMP-20 is observed in the enamel organ and pulp organ of developing
      teeth and is present only as an activated enzyme. To identify other tissues
      that may express MMP-20, we performed a systematic mouse tissue expression screen.
      Among the non-tooth tissues assayed, MMP-20 transcripts were identified only
      in minute quantities within the large intestine. The murine Mmp20 promoter was
      cloned, sequenced, and assessed for potential tooth-specific regulatory elements.
      In silico analysis identified four promoter modules that were common to Mmp20
      and at least two of three coregulated predominantly tooth-specific genes that
      encode ameloblastin, amelogenin, and enamelin. We asked if the highly restricted
      MMP-20 expression pattern was associated with a broad substrate specificity
      that might preclude its expression in other tissues. An iterative mixture-based
      random doedecamer peptide library screen with Edman sequencing of MMP-20 cleavage
      products revealed that, among MMPs previously screened, MMP-20 had unique substrate
      preferences. These preferences indicate that MMP-20 has a deep and wide catalytic
      pocket that can accommodate substrates with large aromatic residues in the P1''
      position. On the basis of matrices derived from the peptide library data, we
      identified and then confirmed that type V collagen is an MMP-20 substrate. Since
      type V collagen is not present in dental enamel but is an otherwise widely distributed
      collagen, and since only active MMP-20 has been observed in teeth, our data
      suggest that control of MMP-20 activity is primarily regulated by transcriptional
      means.", "venue": "Biochemistry", "year": 2006, "referenceCount": 65, "citationCount":
      40, "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc2536712?pdf=render", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2006-03-28", "journal":
      {"volume": "45 12", "pages": "\n          3863-74\n        ", "name": "Biochemistry"},
      "citationStyles": {"bibtex": "@Article{Turk2006MMP20IP,\n author = {B. Turk
      and Daniel H Lee and Y. Yamakoshi and A. Klingenhoff and E. Reichenberger and
      J. T. Wright and J. Simmer and Justin Komisarof and L. Cantley and J. D. Bartlett},\n
      booktitle = {Biochemistry},\n journal = {Biochemistry},\n pages = {\n          3863-74\n        },\n
      title = {MMP-20 is predominately a tooth-specific enzyme with a deep catalytic
      pocket that hydrolyzes type V collagen.},\n volume = {45 12},\n year = {2006}\n}\n"},
      "authors": [{"authorId": "25581223", "name": "B. Turk"}, {"authorId": "143876402",
      "name": "Daniel H Lee"}, {"authorId": "3290904", "name": "Y. Yamakoshi"}, {"authorId":
      "2332760", "name": "A. Klingenhoff"}, {"authorId": "1911457", "name": "E. Reichenberger"},
      {"authorId": "1400404078", "name": "J. T. Wright"}, {"authorId": "3110446",
      "name": "J. Simmer"}, {"authorId": "50560564", "name": "Justin Komisarof"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "38065324", "name":
      "J. D. Bartlett"}]}, {"paperId": "cf3da94e66e95c7b055538d46c3e7fccc4f9ae4a",
      "externalIds": {"MAG": "2528261300", "DOI": "10.1182/BLOOD-2005-07-2755", "CorpusId":
      15728726, "PubMed": "16434494"}, "corpusId": 15728726, "publicationVenue": {"id":
      "9b6db04a-2990-4cf9-a14c-01d47636ee53", "name": "Blood", "type": "journal",
      "issn": "0006-4971", "url": "http://www.bloodjournal.org/"}, "url": "https://www.semanticscholar.org/paper/cf3da94e66e95c7b055538d46c3e7fccc4f9ae4a",
      "title": "Characterization of the megakaryocyte demarcation membrane system
      and its role in thrombopoiesis.", "abstract": "To produce blood platelets, megakaryocytes
      elaborate proplatelets, accompanied by expansion of membrane surface area and
      dramatic cytoskeletal rearrangements. The invaginated demarcation membrane system
      (DMS), a hallmark of mature cells, has been proposed as the source of proplatelet
      membranes. By direct visualization of labeled DMS, we demonstrate that this
      is indeed the case. Late in megakaryocyte ontogeny, the DMS gets loaded with
      PI-4,5-P(2), a phospholipid that is confined to plasma membranes in other cells.
      Appearance of PI-4,5-P(2) in the DMS occurs in proximity to PI-5-P-4-kinase
      alpha (PIP4Kalpha), and short hairpin (sh) RNA-mediated loss of PIP4Kalpha impairs
      both DMS development and expansion of megakaryocyte size. Thus, PI-4,5-P(2)
      is a marker and possibly essential component of internal membranes. PI-4,5-P(2)
      is known to promote actin polymerization by activating Rho-like GTPases and
      Wiskott-Aldrich syndrome (WASp) family proteins. Indeed, PI-4,5-P(2) in the
      megakaryocyte DMS associates with filamentous actin. Expression of a dominant-negative
      N-WASp fragment or pharmacologic inhibition of actin polymerization causes similar
      arrests in proplatelet formation, acting at a step beyond expansion of the DMS
      and cell mass. These observations collectively suggest a signaling pathway wherein
      PI-4,5-P(2) might facilitate DMS development and local assembly of actin fibers
      in preparation for platelet biogenesis.", "venue": "Blood", "year": 2006, "referenceCount":
      62, "citationCount": 203, "influentialCitationCount": 11, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2006-05-15", "journal": {"volume": "107 10", "pages": "\n          3868-75\n        ",
      "name": "Blood"}, "citationStyles": {"bibtex": "@Article{Schulze2006CharacterizationOT,\n
      author = {H. Schulze and M. Korpal and J. Hurov and Sang-We Kim and Jinghang
      Zhang and L. Cantley and T. Graf and R. Shivdasani},\n booktitle = {Blood},\n
      journal = {Blood},\n pages = {\n          3868-75\n        },\n title = {Characterization
      of the megakaryocyte demarcation membrane system and its role in thrombopoiesis.},\n
      volume = {107 10},\n year = {2006}\n}\n"}, "authors": [{"authorId": "145453589",
      "name": "H. Schulze"}, {"authorId": "4263913", "name": "M. Korpal"}, {"authorId":
      "50139635", "name": "J. Hurov"}, {"authorId": "2109704632", "name": "Sang-We
      Kim"}, {"authorId": "2108045556", "name": "Jinghang Zhang"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "144437468", "name": "T. Graf"}, {"authorId":
      "2785025", "name": "R. Shivdasani"}]}, {"paperId": "fb8aeddb1c5c3b63de79c08be81becf99dbcd6b3",
      "externalIds": {"MAG": "2081328577", "DOI": "10.1038/nprot.2006.7", "CorpusId":
      13055577, "PubMed": "17406210"}, "corpusId": 13055577, "publicationVenue": {"id":
      "705a5f2b-aaf1-41fb-bc28-be78040b4587", "name": "Nature Protocols", "type":
      "journal", "alternate_names": ["Nat Protoc"], "issn": "1750-2799", "url": "https://www.nature.com/nprot/",
      "alternate_urls": ["http://www.nature.com/nprot/index.html"]}, "url": "https://www.semanticscholar.org/paper/fb8aeddb1c5c3b63de79c08be81becf99dbcd6b3",
      "title": "In-gel stable isotope labeling for relative quantification using mass
      spectrometry", "abstract": null, "venue": "Nature Protocols", "year": 2006,
      "referenceCount": 17, "citationCount": 14, "influentialCitationCount": 1, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": null, "journal": {"volume": "1", "pages": "46-51", "name":
      "Nature Protocols"}, "citationStyles": {"bibtex": "@Article{Asara2006IngelSI,\n
      author = {J. Asara and Xiang Zhang and B. Zheng and Lisa A Maroney and H. Christofk
      and Ning Wu and L. Cantley},\n booktitle = {Nature Protocols},\n journal = {Nature
      Protocols},\n pages = {46-51},\n title = {In-gel stable isotope labeling for
      relative quantification using mass spectrometry},\n volume = {1},\n year = {2006}\n}\n"},
      "authors": [{"authorId": "3028470", "name": "J. Asara"}, {"authorId": "47958479",
      "name": "Xiang Zhang"}, {"authorId": "143918840", "name": "B. Zheng"}, {"authorId":
      "50399376", "name": "Lisa A Maroney"}, {"authorId": "4164415", "name": "H. Christofk"},
      {"authorId": "2068343858", "name": "Ning Wu"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "05e55d3b08a279dcabde2f50576ce5ab5f50b88b", "externalIds":
      {"MAG": "1977443562", "DOI": "10.4161/cc.4.10.2062", "CorpusId": 83542271},
      "corpusId": 83542271, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/05e55d3b08a279dcabde2f50576ce5ab5f50b88b",
      "title": "Then Negative Regulation of Phosphoinositide 3-Kinase Signaling by
      p85 and Its Implication in Cancer", "abstract": "The phosphoinositide 3-kinase
      (PI3K) signaling pathway critically regulates cell growth and cell survival.
      Mutations that lead to aberrant activation of this pathway are frequent events
      in human cancers. Here we discuss some recent studies identifying the mechanisms
      by which p85, the regulatory subunit of PI3K, negatively regulates PI3K signaling.
      While necessary for the stability and membrane recruitment of the p110 catalytic
      subunit of PI3K. p85 represses the basal activity of p110 in the absence of
      growth factor stimulation. In its unbound, free form, p85 sequesters the adaptor
      protein IRS-1 and therefore limits the extent of PI3K signaling downstream of
      the insulin and IGF-1 receptors. These findings lend new insight to how changes
      in p85 gene dosage or mutations in p85 could lead to the hyper-activation of
      PI3K and thus contribute towards tumorigenesis.", "venue": "", "year": 2005,
      "referenceCount": 35, "citationCount": 82, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://www.tandfonline.com/doi/pdf/10.4161/cc.4.10.2062?needAccess=true",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "2005-09-23", "journal": {"volume": "4", "pages": "1309 -
      1312", "name": "Cell Cycle"}, "citationStyles": {"bibtex": "@Article{Luo2005ThenNR,\n
      author = {Ji Luo and L. Cantley},\n journal = {Cell Cycle},\n pages = {1309
      - 1312},\n title = {Then Negative Regulation of Phosphoinositide 3-Kinase Signaling
      by p85 and Its Implication in Cancer},\n volume = {4},\n year = {2005}\n}\n"},
      "authors": [{"authorId": "145954100", "name": "Ji Luo"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "20c3389ac3c7db80188e2d564de14cf9f1b6f035",
      "externalIds": {"MAG": "2123933189", "DOI": "10.1128/MCB.25.21.9491-9502.2005",
      "CorpusId": 33188272, "PubMed": "16227599"}, "corpusId": 33188272, "publicationVenue":
      {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular and Cellular
      Biology", "type": "journal", "alternate_names": ["Mol Cell Biology"], "issn":
      "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]},
      "url": "https://www.semanticscholar.org/paper/20c3389ac3c7db80188e2d564de14cf9f1b6f035",
      "title": "Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological
      Cardiac Hypertrophy", "abstract": "ABSTRACT Class IA phosphoinositide 3-kinases
      (PI3Ks) are activated by growth factor receptors, and they regulate, among other
      processes, cell growth and organ size. Studies using transgenic mice overexpressing
      constitutively active and dominant negative forms of the p110\u03b1 catalytic
      subunit of class IA PI3K have implicated the role of this enzyme in regulating
      heart size and physiological cardiac hypertrophy. To further understand the
      role\u2009of class IA PI3K in controlling heart growth and to circumvent potential
      complications from the overexpression of dominant negative and constitutively
      active proteins, we generated mice with muscle-specific deletion of the p85\u03b1
      regulatory subunit and germ line deletion of the p85\u03b2 regulatory subunit
      of class IA PI3K. Here we show that mice with cardiac deletion of both p85 subunits
      exhibit attenuated Akt signaling in the heart, reduced heart size, and altered
      cardiac gene expression. Furthermore, exercise-induced cardiac hypertrophy is
      also attenuated in the p85 knockout hearts. Despite such defects in postnatal
      developmental growth and physiological hypertrophy, the p85 knockout hearts
      exhibit normal contractility and myocardial histology. Our results therefore
      provide strong genetic evidence that class IA PI3Ks are critical regulators
      for the developmental growth and physiological hypertrophy of the heart.", "venue":
      "Molecular and Cellular Biology", "year": 2005, "referenceCount": 63, "citationCount":
      213, "influentialCitationCount": 5, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc1265829?pdf=render", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2005-11-01", "journal":
      {"volume": "25", "pages": "9491 - 9502", "name": "Molecular and Cellular Biology"},
      "citationStyles": {"bibtex": "@Article{Luo2005ClassIP,\n author = {Ji Luo and
      J. McMullen and Cassandra L. Sobkiw and Li Zhang and A. Dorfman and M. Sherwood
      and M. Logsdon and J. Horner and R. DePinho and S. Izumo and S. Izumo and L.
      Cantley},\n booktitle = {Molecular and Cellular Biology},\n journal = {Molecular
      and Cellular Biology},\n pages = {9491 - 9502},\n title = {Class IA Phosphoinositide
      3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy},\n volume
      = {25},\n year = {2005}\n}\n"}, "authors": [{"authorId": "145954100", "name":
      "Ji Luo"}, {"authorId": "6688807", "name": "J. McMullen"}, {"authorId": "16248879",
      "name": "Cassandra L. Sobkiw"}, {"authorId": "2152828772", "name": "Li Zhang"},
      {"authorId": "47130853", "name": "A. Dorfman"}, {"authorId": "2697164", "name":
      "M. Sherwood"}, {"authorId": "143800250", "name": "M. Logsdon"}, {"authorId":
      "40006904", "name": "J. Horner"}, {"authorId": "5593407", "name": "R. DePinho"},
      {"authorId": "47072554", "name": "S. Izumo"}, {"authorId": "47072554", "name":
      "S. Izumo"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "33fe9b71272dfd845d5c47d2b33cc144bb54bfd4",
      "externalIds": {"CorpusId": 249519062}, "corpusId": 249519062, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/33fe9b71272dfd845d5c47d2b33cc144bb54bfd4",
      "title": "Purification and characterization of human erythrocyte phosphatidylinositol
      4-kinase", "abstract": "Andrea GRAZIANI,*1I Leona E. LING,t Gerda ENDEMANN,T\u00b6
      Chris L. CARPENTER\u00a7 and Lewis C. CANTLEY* *Department of Physiology, Tufts
      University School of Medicine, Boston, MA 021 11, U.S.A., tDana Farber Cancer
      Institute, Boston, MA 02115, U.S.A., tDepartment of Cell Biology, Stanford University
      School of Medicine, Stanford, CA 94305, U.S.A., and \u00a7Hematology-Oncology
      Unit, Massachusetts General Hospital, Boston, MA 02114, U.S.A.", "venue": "",
      "year": 2005, "referenceCount": 1, "citationCount": 2, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Andrea2005PurificationAC,\n
      author = {Andrea and Graziani and Gerda and Endemann and L. Cantley},\n title
      = {Purification and characterization of human erythrocyte phosphatidylinositol
      4-kinase},\n year = {2005}\n}\n"}, "authors": [{"authorId": "2075627490", "name":
      "Andrea"}, {"authorId": "89727637", "name": "Graziani"}, {"authorId": "2084151248",
      "name": "Gerda"}, {"authorId": "2083062036", "name": "Endemann"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "4b6252344eb6005c24b6394815f7bb943294f350",
      "externalIds": {"MAG": "2153518477", "DOI": "10.1016/S0169-5002(05)80475-1",
      "CorpusId": 72975736}, "corpusId": 72975736, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/4b6252344eb6005c24b6394815f7bb943294f350",
      "title": "PD-142 ErbB-3 mediates PI3K activity in gefitinib-sensitive non-smallcell
      lung cancer cell lines", "abstract": null, "venue": "", "year": 2005, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2005-07-01", "journal": {"volume":
      "49", "name": "Lung Cancer"}, "citationStyles": {"bibtex": "@Article{Engelman2005PD142EM,\n
      author = {J. Engelman and P. J\u00e4nne and C. Mermel and J. Pearlberg and T.
      Mukohara and C. Fleet and K. Cichowski and B. Johnson and L. Cantley},\n journal
      = {Lung Cancer},\n title = {PD-142 ErbB-3 mediates PI3K activity in gefitinib-sensitive
      non-smallcell lung cancer cell lines},\n volume = {49},\n year = {2005}\n}\n"},
      "authors": [{"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "5984202",
      "name": "P. J\u00e4nne"}, {"authorId": "145234673", "name": "C. Mermel"}, {"authorId":
      "6927277", "name": "J. Pearlberg"}, {"authorId": "4944777", "name": "T. Mukohara"},
      {"authorId": "39554977", "name": "C. Fleet"}, {"authorId": "6306836", "name":
      "K. Cichowski"}, {"authorId": "115060139", "name": "B. Johnson"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "4cca7d6b25989ff0e8d91199ed73048670936849",
      "externalIds": {"CorpusId": 13581290}, "corpusId": 13581290, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/4cca7d6b25989ff0e8d91199ed73048670936849",
      "title": "Oncogenic in Mammary Epithelial Cells Mutations Are PIK 3 CA Associated
      \u2212 Breast Cancer", "abstract": "Activation of the phosphoinositide 3-kinase
      (PI3K) pathway has been implicated in the pathogenesis of a variety of cancers.
      Recently, mutations in the gene encoding the p110A catalytic subunit of PI3K
      (PIK3CA) have been identified in several human cancers. The mutations primarily
      result in single amino acid substitutions, with >85% of the mutations in either
      exon 9 or 20. Multiple studies have shown that these mutations are observed
      in 18% to 40% of breast cancers. However, the phenotypic effects of these PIK3CA
      mutations have not been examined in breast epithelial cells. Herein, we examine
      the activity of the two most common variants, E545K and H1047R, in the MCF-10A
      immortalized breast epithelial cell line. Both variants display higher PI3K
      activity than wild-type p110A yet remain sensitive to pharmacologic PI3K inhibition.
      In addition, expression of p110A mutants in mammary epithelial cells induces
      multiple phenotypic alterations characteristic of breast tumor cells, including
      anchorage-independent proliferation in soft agar, growth factor\u2013independent
      proliferation, and protection from anoikis. Expression of these mutant p110A
      isoforms also confers increased resistance to paclitaxel and induces abnormal
      mammary acinar morphogenesis in three-dimensional basement membrane cultures.
      Together, these data support the notion that the cancer-associated mutations
      in PIK3CA may significantly contribute to breast cancer pathogenesis and represent
      attractive targets for therapeutic inhibition. (Cancer Res 2005; 65(23): 10992-11000)",
      "venue": "", "year": 2005, "referenceCount": 53, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Isakoff2005OncogenicIM,\n
      author = {S. Isakoff and J. Engelman and H. Irie and Ji Luo and S. Brachmann
      and R. Pearline and L. Cantley and J. Brugge},\n title = {Oncogenic in Mammary
      Epithelial Cells Mutations Are PIK 3 CA Associated \u2212 Breast Cancer},\n
      year = {2005}\n}\n"}, "authors": [{"authorId": "4327978", "name": "S. Isakoff"},
      {"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "49807003", "name":
      "H. Irie"}, {"authorId": "145954100", "name": "Ji Luo"}, {"authorId": "3710358",
      "name": "S. Brachmann"}, {"authorId": "3679091", "name": "R. Pearline"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "3471778", "name": "J. Brugge"}]},
      {"paperId": "52707f333e8c6c5b254cc38561dc39500924e027", "externalIds": {"MAG":
      "2401341245", "CorpusId": 221222794}, "corpusId": 221222794, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/52707f333e8c6c5b254cc38561dc39500924e027",
      "title": "Marine source \u03c9-3 fatty acid, docosahexaenoic acid (DHA), inhibits
      human colorectal cancer growth through multiple mechanisms depending on the
      mutational status of p53 protein", "abstract": "5569 Epidemiological data and
      previous in vivo and in vitro studies in our lab have suggested that diets rich
      in \u03c9-3 polyunsaturated fatty acids (PUFAs) are inversely related to human
      colorectal cancer growth. In addition, those studies revealed that DHA was the
      primary tumor inhibiting \u03c9-3 fatty acid compared to EPA. Using flow cytometry
      and spectrophotometric techniques, proliferation and apoptosis assays were performed
      on two human colorectal cancer cell lines, WiDr and COLO 205, which possess
      mutated and wild type p53 protein respectively, treated with linoleic acid (LA),
      eicosapentaenoic acid (EPA) and DHA in vitro. The study showed that DHA induced
      apoptosis in COLO 205 and only inhibited cell proliferation in WiDr. EPA did
      not induce apoptotic events nor inhibit cell proliferation in both cell lines
      although it inhibited cell growth by 30%. To confirm an involvement of p53 protein
      in the growth inhibition exerted by DHA, a p53 inhibitor, Pifithrin-\u03b1,
      was employed and the growth inhibition of DHA treated COLO 205 but not WiDr
      cells was reversed with the inhibitor treatment. To further elucidate mechanisms
      of the growth inhibition, levels of phospho- shc, JNK and ERK which play major
      roles in the regulation of cell proliferation and apoptosis, were measured in
      the both cell lines. fatty acid treated WiDr cells exhibited lower levels of
      phospho- shc and ERK proteins, but not JNK. In contrast, levels of phospho-JNK
      were lower in DHA treated COLO 205 cells, but phosphorylation levels of other
      two proteins were not altered. We have demonstrated that the growth inhibitory
      effect of DHA is mediated through a p53 pathway when the tumor possesses a wild
      type protein. In the tumor line possessing a mutated p53, DHA caused decrease
      in cell proliferation through an inhibition of the MAPK signaling pathway. EPA
      does not activate the p53 pathway. These different mechanism of actions may
      be the cause for differential potencies between DHA and EPA. In addition, we
      have demonstrated that DHA possesses tumor inhibiting activity in tumors with
      wild type and mutated p53.", "venue": "", "year": 2005, "referenceCount": 0,
      "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Environmental Science",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2005-05-01",
      "journal": {"volume": "65", "pages": "1311-1311", "name": "Cancer Research"},
      "citationStyles": {"bibtex": "@Article{Kharas2005MarineS\u03a9,\n author = {M.
      Kharas and T. Moore and Ji Luo and L. Cantley and D. Fruman},\n journal = {Cancer
      Research},\n pages = {1311-1311},\n title = {Marine source \u03c9-3 fatty acid,
      docosahexaenoic acid (DHA), inhibits human colorectal cancer growth through
      multiple mechanisms depending on the mutational status of p53 protein},\n volume
      = {65},\n year = {2005}\n}\n"}, "authors": [{"authorId": "152500082", "name":
      "M. Kharas"}, {"authorId": "34820441", "name": "T. Moore"}, {"authorId": "145954100",
      "name": "Ji Luo"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "6241317", "name": "D. Fruman"}]}, {"paperId": "5aca15f465d45cdddb35b7e30fbdfbcc0cec26f5",
      "externalIds": {"MAG": "2024406739", "DOI": "10.1007/BF01868774", "CorpusId":
      20664895, "PubMed": "6148424"}, "corpusId": 20664895, "publicationVenue": {"id":
      "41cc63f8-c51d-469c-b169-65dfc2f9e2a6", "name": "Journal of Membrane Biology",
      "type": "journal", "alternate_names": ["The Journal of Membrane Biology", "J
      Membr Biology"], "issn": "0022-2631", "url": "http://www.springer.com/life+sci/biochemistry+and+biophysics/journal/232",
      "alternate_urls": ["https://link.springer.com/journal/232"]}, "url": "https://www.semanticscholar.org/paper/5aca15f465d45cdddb35b7e30fbdfbcc0cec26f5",
      "title": "The plasma membrane (Mg2+)-dependent adenosine triphosphatase from
      the human erythrocyte is not an ion pump", "abstract": null, "venue": "Journal
      of Membrane Biology", "year": 2005, "referenceCount": 47, "citationCount": 2,
      "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": null, "journal": {"volume": "80", "pages": "185-190",
      "name": "The Journal of Membrane Biology"}, "citationStyles": {"bibtex": "@Article{Forgac2005ThePM,\n
      author = {M. Forgac and L. Cantley},\n booktitle = {Journal of Membrane Biology},\n
      journal = {The Journal of Membrane Biology},\n pages = {185-190},\n title =
      {The plasma membrane (Mg2+)-dependent adenosine triphosphatase from the human
      erythrocyte is not an ion pump},\n volume = {80},\n year = {2005}\n}\n"}, "authors":
      [{"authorId": "145289081", "name": "M. Forgac"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "608fbc091b340ae36c36eb4b2bb1ac1a41371679", "externalIds":
      {"MAG": "2324902959", "DOI": "10.1016/S1040-1741(08)70159-3", "CorpusId": 23695860,
      "PubMed": "16106023"}, "corpusId": 23695860, "publicationVenue": {"id": "917421ed-0c48-4dc3-897b-a8caae75761d",
      "name": "Journal of the National Cancer Institute", "type": "journal", "alternate_names":
      ["J National Cancer Inst"], "issn": "0027-8874", "url": "http://jnci.oupjournals.org/",
      "alternate_urls": ["http://jnci.oxfordjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/608fbc091b340ae36c36eb4b2bb1ac1a41371679",
      "title": "Differential effects of gefitinib and cetuximab on non-small-cell
      lung cancers bearing epidermal growth factor receptor mutations.", "abstract":
      null, "venue": "Journal of the National Cancer Institute", "year": 2005, "referenceCount":
      42, "citationCount": 199, "influentialCitationCount": 5, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://jnci.oxfordjournals.org/content/97/16/1185.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": null, "journal":
      {"volume": "97 16", "pages": "\n          1185-94\n        ", "name": "Journal
      of the National Cancer Institute"}, "citationStyles": {"bibtex": "@Article{Mukohara2005DifferentialEO,\n
      author = {T. Mukohara and J. Engelman and N. Hanna and B. Yeap and Susumu S.
      Kobayashi and N. Lindeman and B. Halmos and J. Pearlberg and Z. Tsuchihashi
      and L. Cantley and D. Tenen and B. Johnson and P. J\u00e4nne},\n booktitle =
      {Journal of the National Cancer Institute},\n journal = {Journal of the National
      Cancer Institute},\n pages = {\n          1185-94\n        },\n title = {Differential
      effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal
      growth factor receptor mutations.},\n volume = {97 16},\n year = {2005}\n}\n"},
      "authors": [{"authorId": "4944777", "name": "T. Mukohara"}, {"authorId": "6828387",
      "name": "J. Engelman"}, {"authorId": "35398614", "name": "N. Hanna"}, {"authorId":
      "2127357", "name": "B. Yeap"}, {"authorId": "2109836647", "name": "Susumu S.
      Kobayashi"}, {"authorId": "3734755", "name": "N. Lindeman"}, {"authorId": "3698254",
      "name": "B. Halmos"}, {"authorId": "6927277", "name": "J. Pearlberg"}, {"authorId":
      "46281629", "name": "Z. Tsuchihashi"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5523919", "name": "D. Tenen"}, {"authorId": "115060139", "name":
      "B. Johnson"}, {"authorId": "5984202", "name": "P. J\u00e4nne"}]}, {"paperId":
      "621d225cef47a0dd24af2edeb93c602c7cc6a5b5", "externalIds": {"MAG": "2501352848",
      "DOI": "10.1182/BLOOD.V106.11.732.732", "CorpusId": 89303813}, "corpusId": 89303813,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/621d225cef47a0dd24af2edeb93c602c7cc6a5b5",
      "title": "Phosphatidyl Inositol (4,5)P2 Marks Megakaryocyte Internal Membranes
      and Is Associated with Megakaryocyte Maturation and Platelet Release.", "abstract":
      "To produce blood platelets, the megakaryocyte (MK) cytoplasm elaborates proplatelets,
      accompanied by expansion of membrane surface area and dramatic cytoskeletal
      rearrangements. Invaginated demarcation membranes (DMS) are thought to be the
      source for the proplatelet and platelet membranes, however, they have THUS far
      BEEN INSUFFICIENTLY characterized. We first used a mouse model where the cDNA
      encoding enhanced yellow fluorescence protein (EYFP) with a C-terminally introduced
      myristoyl acceptor site has been introduced into the GPIIb locus. Heterozygous
      knock-in mice reveal yellow fluroescent MKs with an internal staining pattern
      that resembles the reticiulated pattern of the DMS as found in micrographs.
      Proplatelet-forming MKs reveal contiguous membrane connection between the internally
      stained membranes and the outlines of the proplatelet shaft resulting in production
      of fluorescent platelets. We next sought to characterize the internal membranes
      biochemically and retrovirally infected MKs to express the green fluorescence
      protein (EGFP) tagged with the pleckstrin homology domain of phospholipase C\u03b41
      (PLC\u03b41) which binds with high specificity to phosphatidylinositol(4,5)P2
      (PIP2). Young MKs stain the cell periphery as described for most other cell
      types. Mature MKs, however, stain the internal membranes, whereas the plasma
      membrane becomes PIP2-negative as shown by co-staining with CD41. Proplatelet
      membranes emanate from these internal PIP2-positive membranes, proving that
      the DMS is indeed the membrane reservoir during platelet biogenesis. Appearance
      of PI-4,5-P2 in the DMS occurs in proximity to PI-5-P-4-kinase\u03b1 (PI4K\u03b1),
      a protein highly expressed in MKs and platelets, as shown by overexpressing
      EGFP-tagged kinase in primary MKs. In addition, shRNA-mediated loss of PIP4K\u03b1
      or depletion of its presumptive substrate block DMS development and expansion
      of MK size. Thus, PI-4,5-P2 is a marker and essential component of internal
      membranes and is most likely introduced about the non-canonical pathway using
      PI5P as the substrate. PI-4,5-P2 promotes actin polymerization by activating
      small GTPases from the Rac/Rho superfamily as well as Wiskott-Aldrich Syndrome
      (WASp) family proteins. Indeed, PIP2 is associated with filamentous actin when
      MKs are co-stained with phalloidin. Expression of a dominant-negative N-WASp
      C-terminal fragment (CA-domain) that inactivats all WASp/WAVE family members
      leads to Arp3 binding without assembling the complete Arp2/3 complex, thus inhibiting
      actin filament nucleation. F-Actin staining in the infected MKs reveals a pattern
      similar to that of MKs treated with pharmacologic dosage of actin polymerization-antagonists
      like cytochalasin D, which disrupts actin filaments and inhibits proplatelet
      formation when administered early in MK culture. Dominant-negative WASp impairs
      proplatelet elaboration similarly, acting at a step past expansion of the cell
      volume. These observations implicate a signaling pathway wherein PI-4,5-P2 facilitates
      DMS development and suggests a pathway that links a DMS lipid marker with local
      assembly of actin fibers as a requirement for platelet biogenesis.", "venue":
      "", "year": 2005, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2005-11-16", "journal": {"volume":
      "106", "pages": "732-732", "name": "Blood"}, "citationStyles": {"bibtex": "@Article{Schulze2005PhosphatidylI,\n
      author = {H. Schulze and M. Korpal and J. Hurov and Sang-We Kim and Jinghang
      Zhang and L. Cantley and T. Graf and R. Shivdasani},\n journal = {Blood},\n
      pages = {732-732},\n title = {Phosphatidyl Inositol (4,5)P2 Marks Megakaryocyte
      Internal Membranes and Is Associated with Megakaryocyte Maturation and Platelet
      Release.},\n volume = {106},\n year = {2005}\n}\n"}, "authors": [{"authorId":
      "145453589", "name": "H. Schulze"}, {"authorId": "4263913", "name": "M. Korpal"},
      {"authorId": "50139635", "name": "J. Hurov"}, {"authorId": "2109704632", "name":
      "Sang-We Kim"}, {"authorId": "2108045556", "name": "Jinghang Zhang"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "144437468", "name": "T. Graf"},
      {"authorId": "2785025", "name": "R. Shivdasani"}]}, {"paperId": "663e2ca43ad12040f62098e32073013c095d5223",
      "externalIds": {"MAG": "2975564322", "DOI": "10.2210/pdb1yrk/pdb", "CorpusId":
      204105166}, "corpusId": 204105166, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/663e2ca43ad12040f62098e32073013c095d5223",
      "title": "The C2 Domain of PKC is a new Phospho-Tyrosine Binding Domain", "abstract":
      null, "venue": "", "year": 2005, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2005-07-26", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Benes2005TheCD,\n
      author = {C. Benes and Ning Wu and A. Elia and T. Dharia and L. Cantley and
      S. Soltoff},\n title = {The C2 Domain of PKC is a new Phospho-Tyrosine Binding
      Domain},\n year = {2005}\n}\n"}, "authors": [{"authorId": "1714039", "name":
      "C. Benes"}, {"authorId": "2068343858", "name": "Ning Wu"}, {"authorId": "35398419",
      "name": "A. Elia"}, {"authorId": "32165121", "name": "T. Dharia"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4324390", "name": "S. Soltoff"}]},
      {"paperId": "6782f7973a81c1b9f97c84e384038aa6f3deec7e", "externalIds": {"MAG":
      "2133942178", "DOI": "10.1101/GAD.1311105", "CorpusId": 1240553, "PubMed": "15985609"},
      "corpusId": 1240553, "publicationVenue": {"id": "94df828d-8411-48df-8aec-f13101ebb8f4",
      "name": "Genes & Development", "type": "journal", "alternate_names": ["Gene  Dev"],
      "issn": "0890-9369", "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=101",
      "alternate_urls": ["http://www.genesdev.org/", "http://genesdev.cshlp.org/"]},
      "url": "https://www.semanticscholar.org/paper/6782f7973a81c1b9f97c84e384038aa6f3deec7e",
      "title": "The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB:
      substrate identification and regulation of cell shape.", "abstract": "The Mycobacterium
      tuberculosis genome contains 11 serine/threonine kinase genes including two,
      pknA and pknB, that are part of an operon encoding genes involved in cell shape
      control and cell wall synthesis. Here we demonstrate that pknA and pknB are
      predominantly expressed during exponential growth, and that overexpression of
      these kinases slows growth and alters cell morphology. We determined the preferred
      substrate motifs of PknA and PknB, and identified three in vivo substrates of
      these kinases: PknB; Wag31, an ortholog of the cell division protein DivIVA;
      and Rv1422, a conserved protein of unknown function. Expression of different
      alleles of wag31 in vivo alters cell shape, in a manner dependent on the phosphoacceptor
      residue in the protein produced. Partial depletion of pknA or pknB results in
      narrow, elongated cells. These data indicate that signal transduction mediated
      by these kinases is a novel mechanism for the regulation of cell shape in mycobacteria,
      one that may be conserved among gram-positive bacteria.", "venue": "Genes &
      Development", "year": 2005, "referenceCount": 38, "citationCount": 389, "influentialCitationCount":
      37, "isOpenAccess": true, "openAccessPdf": {"url": "http://genesdev.cshlp.org/content/19/14/1692.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2005-07-15", "journal": {"volume": "19 14", "pages": "\n          1692-704\n        ",
      "name": "Genes & development"}, "citationStyles": {"bibtex": "@Article{Kang2005TheMT,\n
      author = {Choong-Min Kang and Derek W. Abbott and S. T. Park and C. Dascher
      and L. Cantley and R. Husson},\n booktitle = {Genes & Development},\n journal
      = {Genes & development},\n pages = {\n          1692-704\n        },\n title
      = {The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate
      identification and regulation of cell shape.},\n volume = {19 14},\n year =
      {2005}\n}\n"}, "authors": [{"authorId": "50717577", "name": "Choong-Min Kang"},
      {"authorId": "145759174", "name": "Derek W. Abbott"}, {"authorId": "30877912",
      "name": "S. T. Park"}, {"authorId": "3748659", "name": "C. Dascher"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "3216305", "name": "R. Husson"}]},
      {"paperId": "6d09951c91bf36006dbac37de3c39a99355960be", "externalIds": {"MAG":
      "2099051331", "DOI": "10.1074/jbc.M506967200", "CorpusId": 37538310, "PubMed":
      "16166093"}, "corpusId": 37538310, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/6d09951c91bf36006dbac37de3c39a99355960be",
      "title": "Increased P85\u03b1 Is a Potent Negative Regulator of Skeletal Muscle
      Insulin Signaling and Induces in Vivo Insulin Resistance Associated with Growth
      Hormone Excess*", "abstract": "Insulin resistance is a cardinal feature of normal
      pregnancy and excess growth hormone (GH) states, but its underlying mechanism
      remains enigmatic. We previously found a significant increase in the p85 regulatory
      subunit of phosphatidylinositol kinase (PI 3-kinase) and striking decrease in
      IRS-1-associated PI 3-kinase activity in the skeletal muscle of transgenic animals
      overexpressing human placental growth hormone. Herein, using transgenic mice
      bearing deletions in p85\u03b1, p85\u03b2, or insulin-like growth factor-1,
      we provide novel evidence suggesting that overexpression of p85\u03b1 is a primary
      mechanism for skeletal muscle insulin resistance in response to GH. We found
      that the excess in total p85 was entirely accounted for by an increase in the
      free p85\u03b1-specific isoform. In mice with a liver-specific deletion in insulin-like
      growth factor-1, excess GH caused insulin resistance and an increase in skeletal
      muscle p85\u03b1, which was completely reversible using a GH-releasing hormone
      antagonist. To understand the role of p85\u03b1 in GH-induced insulin resistance,
      we used mice bearing deletions of the genes coding for p85\u03b1 or p85\u03b2,
      respectively (p85\u03b1 +/\u2013 and p85\u03b2\u2013/\u2013). Wild type and
      p85\u03b2\u2013/\u2013 mice developed in vivo insulin resistance and demonstrated
      overexpression of p85\u03b1 and reduced insulin-stimulated PI 3-kinase activity
      in skeletal muscle in response to GH. In contrast, p85\u03b1+/\u2013mice retained
      global insulin sensitivity and PI 3-kinase activity associated with reduced
      p85\u03b1 expression. These findings demonstrated the importance of increased
      p85\u03b1 in mediating skeletal muscle insulin resistance in response to GH
      and suggested a potential role for reducing p85\u03b1 as a therapeutic strategy
      for enhancing insulin sensitivity in skeletal muscle.", "venue": "Journal of
      Biological Chemistry", "year": 2005, "referenceCount": 19, "citationCount":
      146, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.jbc.org/article/S0021925820592077/pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2005-11-11", "journal":
      {"volume": "280", "pages": "37489 - 37494", "name": "Journal of Biological Chemistry"},
      "citationStyles": {"bibtex": "@Article{Barbour2005IncreasedPI,\n author = {L.
      Barbour and Shaikh Mizanoor Rahman and I. Gurevich and J. Leitner and S. Fischer
      and M. Roper and T. Knotts and Y. Vo and C. McCurdy and S. Yakar and D. Leroith
      and C. Kahn and L. Cantley and J. Friedman and B. Draznin},\n booktitle = {Journal
      of Biological Chemistry},\n journal = {Journal of Biological Chemistry},\n pages
      = {37489 - 37494},\n title = {Increased P85\u03b1 Is a Potent Negative Regulator
      of Skeletal Muscle Insulin Signaling and Induces in Vivo Insulin Resistance
      Associated with Growth Hormone Excess*},\n volume = {280},\n year = {2005}\n}\n"},
      "authors": [{"authorId": "2091878908", "name": "L. Barbour"}, {"authorId": "16357511",
      "name": "Shaikh Mizanoor Rahman"}, {"authorId": "2085695734", "name": "I. Gurevich"},
      {"authorId": "1765665", "name": "J. Leitner"}, {"authorId": "40654003", "name":
      "S. Fischer"}, {"authorId": "47109935", "name": "M. Roper"}, {"authorId": "32789701",
      "name": "T. Knotts"}, {"authorId": "6739808", "name": "Y. Vo"}, {"authorId":
      "3651315", "name": "C. McCurdy"}, {"authorId": "5698844", "name": "S. Yakar"},
      {"authorId": "4504946", "name": "D. Leroith"}, {"authorId": "144391716", "name":
      "C. Kahn"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1796879",
      "name": "J. Friedman"}, {"authorId": "5662727", "name": "B. Draznin"}]}, {"paperId":
      "6d0f2e2803c71b21cd435abb493a5ea97bac4ea9", "externalIds": {"MAG": "2077994677",
      "DOI": "10.1074/jbc.M412065200", "CorpusId": 20738175, "PubMed": "15713674"},
      "corpusId": 20738175, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/6d0f2e2803c71b21cd435abb493a5ea97bac4ea9",
      "title": "DNA Damage-induced Association of ATM with Its Target Proteins Requires
      a Protein Interaction Domain in the N Terminus of ATM*", "abstract": "The ATM
      protein kinase regulates the response of the cell to DNA damage by associating
      with and then phosphorylating proteins involved in cell cycle checkpoints and
      DNA repair. Here, we report on deletion studies designed to identify protein
      domains required for ATM to phosphorylate target proteins and to control cell
      survival following exposure to ionizing radiation. Deletion studies demonstrated
      that amino acids 1\u2013150 of ATM were required for the ATM protein to regulate
      cellular radiosensitivity. Additional deletions and point mutations indicated
      that this domain extended from amino acids 81\u2013106 of ATM, with amino acid
      substitutions located between amino acids 91 and 97 inactivating the functional
      activity of ATM. When ATM with mutations in this region (termed ATM90) was expressed
      in AT cells, it was unable to restore normal radiosensitivity to the cells.
      However, ATM90 retained normal kinase activity and was autophosphorylated on
      serine 1981 following exposure to DNA damage. Furthermore, wild-type ATM displayed
      DNA-damage induced association with p53, brca1, and LKB1 in vivo, whereas ATM90
      failed to form productive complexes with these target proteins either in vivo
      or in vitro. Furthermore, ATM90 did not phosphorylate p53 in vivo and did not
      form nuclear foci in response to ionizing radiation. We propose that amino acids
      91\u201397 of ATM contain a protein interaction domain required for the DNA
      damage-induced association between ATM and its target proteins, including the
      brca1, p53, and LKB1 proteins. Furthermore, this domain of ATM is required for
      ATM to form nuclear foci following exposure to ionizing radiation.", "venue":
      "Journal of Biological Chemistry", "year": 2005, "referenceCount": 36, "citationCount":
      75, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2005-04-15", "journal": {"volume": "280", "pages": "15158
      - 15164", "name": "Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Fernandes2005DNADA,\n author = {N. Fernandes and Yingli Sun and Shujuan
      Chen and Proma Paul and R. Shaw and L. Cantley and B. Price},\n booktitle =
      {Journal of Biological Chemistry},\n journal = {Journal of Biological Chemistry},\n
      pages = {15158 - 15164},\n title = {DNA Damage-induced Association of ATM with
      Its Target Proteins Requires a Protein Interaction Domain in the N Terminus
      of ATM*},\n volume = {280},\n year = {2005}\n}\n"}, "authors": [{"authorId":
      "144613406", "name": "N. Fernandes"}, {"authorId": "2837150", "name": "Yingli
      Sun"}, {"authorId": "2144303098", "name": "Shujuan Chen"}, {"authorId": "2059688003",
      "name": "Proma Paul"}, {"authorId": "4426388", "name": "R. Shaw"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "1732453", "name": "B. Price"}]},
      {"paperId": "719fb04fd061a2478522fe8233b6687052561d54", "externalIds": {"MAG":
      "2001493878", "DOI": "10.1007/BF01871514", "CorpusId": 1207676, "PubMed": "2993627"},
      "corpusId": 1207676, "publicationVenue": {"id": "41cc63f8-c51d-469c-b169-65dfc2f9e2a6",
      "name": "Journal of Membrane Biology", "type": "journal", "alternate_names":
      ["The Journal of Membrane Biology", "J Membr Biology"], "issn": "0022-2631",
      "url": "http://www.springer.com/life+sci/biochemistry+and+biophysics/journal/232",
      "alternate_urls": ["https://link.springer.com/journal/232"]}, "url": "https://www.semanticscholar.org/paper/719fb04fd061a2478522fe8233b6687052561d54",
      "title": "Delta endotoxin inhibits Rb+ uptake, lowers cytoplasmic pH and inhibits
      a K+-ATPase inManduca sexta CHE cells", "abstract": null, "venue": "Journal
      of Membrane Biology", "year": 2005, "referenceCount": 33, "citationCount": 6,
      "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Environmental Science",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      null, "journal": {"volume": "85", "pages": "199-204", "name": "The Journal of
      Membrane Biology"}, "citationStyles": {"bibtex": "@Article{English2005DeltaEI,\n
      author = {L. English and L. Cantley},\n booktitle = {Journal of Membrane Biology},\n
      journal = {The Journal of Membrane Biology},\n pages = {199-204},\n title =
      {Delta endotoxin inhibits Rb+ uptake, lowers cytoplasmic pH and inhibits a K+-ATPase
      inManduca sexta CHE cells},\n volume = {85},\n year = {2005}\n}\n"}, "authors":
      [{"authorId": "34784769", "name": "L. English"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "7513cfcaf72f455da866bbe522ef36b36eba6854", "externalIds":
      {"MAG": "1981682252", "DOI": "10.1128/MCB.25.7.2593-2606.2005", "CorpusId":
      25200624, "PubMed": "15767666"}, "corpusId": 25200624, "publicationVenue": {"id":
      "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular and Cellular Biology",
      "type": "journal", "alternate_names": ["Mol Cell Biology"], "issn": "0270-7306",
      "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]}, "url":
      "https://www.semanticscholar.org/paper/7513cfcaf72f455da866bbe522ef36b36eba6854",
      "title": "Role of Phosphoinositide 3-Kinase Regulatory Isoforms in Development
      and Actin Rearrangement", "abstract": "ABSTRACT Class Ia phosphoinositide 3-kinases
      (PI3Ks) are heterodimers of p110 catalytic and p85 regulatory subunits that
      mediate a variety of cellular responses to growth and differentiation factors.
      Although embryonic development is not impaired in mice lacking all isoforms
      of the p85\u03b1 gene (p85\u03b1\u2212/\u2212 p55\u03b1\u2212/\u2212 p50\u03b1\u2212/\u2212)
      or in mice lacking the p85\u03b2 gene (p85\u03b2\u2212/\u2212) (D. A. Fruman,
      F. Mauvais-Jarvis, D. A. Pollard, C. M. Yballe, D. Brazil, R. T. Bronson, C.
      R. Kahn, and L. C. Cantley, Nat Genet. 26:379-382, 2000; K. Ueki, C. M. Yballe,
      S. M. Brachmann, D. Vicent, J. M. Watt, C. R. Kahn, and L. C. Cantley, Proc.
      Natl. Acad. Sci. USA 99:419-424, 2002), we show here that loss of both genes
      results in lethality at embryonic day 12.5 (E12.5). The phenotypes of these
      embryos, including subepidermal blebs flanking the neural tube at E8 and bleeding
      into the blebs during the turning process, are similar to defects observed in
      platelet-derived growth factor receptor \u03b1 null (PDGFR\u03b1\u2212/\u2212)
      mice (P. Soriano, Development 124:2691-2700, 1997), suggesting that PI3K is
      an essential mediator of PDGFR\u03b1 signaling at this developmental stage.
      p85\u03b1\u2212/\u2212 p55\u03b1+/+ p50\u03b1+/+ p85\u03b2\u2212/\u2212 mice
      had similar but less severe defects, indicating that p85\u03b1 and p85\u03b2
      have a critical and redundant function in development. Mouse embryo fibroblasts
      deficient in all p85\u03b1 and p85\u03b2 gene products (p85\u03b1\u2212/\u2212
      p55\u03b1\u2212/\u2212 p50\u03b1\u2212/\u2212 p85\u03b2\u2212/\u2212) are defective
      in PDGF-induced membrane ruffling. Overexpression of the Rac-specific GDP-GTP
      exchange factor Vav2 or reintroduction of p85\u03b1 or p85\u03b2 rescues the
      membrane ruffling defect. Surprisingly, reintroduction of p50\u03b1 also restored
      PDGF-dependent membrane ruffling. These results indicate that class Ia PI3K
      is critical for PDGF-dependent actin rearrangement but that the SH3 domain and
      the Rho/Rac/Cdc42-interacting domain of p85, which lacks p50\u03b1, are not
      required for this response.", "venue": "Molecular and Cellular Biology", "year":
      2005, "referenceCount": 50, "citationCount": 139, "influentialCitationCount":
      6, "isOpenAccess": true, "openAccessPdf": {"url": "https://mcb.asm.org/content/mcb/25/7/2593.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2005-04-01", "journal": {"volume": "25",
      "pages": "2593 - 2606", "name": "Molecular and Cellular Biology"}, "citationStyles":
      {"bibtex": "@Article{Brachmann2005RoleOP,\n author = {S. Brachmann and C. Yballe
      and M. Innocenti and J. Deane and D. Fruman and Sheila M. Thomas and L. Cantley},\n
      booktitle = {Molecular and Cellular Biology},\n journal = {Molecular and Cellular
      Biology},\n pages = {2593 - 2606},\n title = {Role of Phosphoinositide 3-Kinase
      Regulatory Isoforms in Development and Actin Rearrangement},\n volume = {25},\n
      year = {2005}\n}\n"}, "authors": [{"authorId": "3710358", "name": "S. Brachmann"},
      {"authorId": "7777071", "name": "C. Yballe"}, {"authorId": "47104808", "name":
      "M. Innocenti"}, {"authorId": "33653557", "name": "J. Deane"}, {"authorId":
      "6241317", "name": "D. Fruman"}, {"authorId": "1909079", "name": "Sheila M.
      Thomas"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "7968640fd68df779469975a15661fbf9161b32c3",
      "externalIds": {"MAG": "2168009839", "DOI": "10.1016/J.ADVENZREG.2005.02.010",
      "CorpusId": 2061342, "PubMed": "16199078"}, "corpusId": 2061342, "publicationVenue":
      {"id": "d04a7366-76cb-4b8a-b3ca-35b14bd12c87", "name": "Advances in Enzyme Regulation",
      "type": "journal", "alternate_names": ["Adv Enzym Regul"], "issn": "0065-2571",
      "alternate_issns": ["1873-2437"], "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/427/description#description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00652571"]},
      "url": "https://www.semanticscholar.org/paper/7968640fd68df779469975a15661fbf9161b32c3",
      "title": "Modification of protein sub-nuclear localization by synthetic phosphoinositides:
      evidence for nuclear phosphoinositide signaling mechanisms.", "abstract": null,
      "venue": "Advances in Enzyme Regulation", "year": 2005, "referenceCount": 58,
      "citationCount": 14, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      null, "journal": {"volume": "45", "pages": "\n          171-85\n        ", "name":
      "Advances in enzyme regulation"}, "citationStyles": {"bibtex": "@Article{Gozani2005ModificationOP,\n
      author = {O. Gozani and S. Field and C. G. Ferguson and M. Ewalt and Christian
      Mahlke and L. Cantley and G. Prestwich and Junying Yuan},\n booktitle = {Advances
      in Enzyme Regulation},\n journal = {Advances in enzyme regulation},\n pages
      = {\n          171-85\n        },\n title = {Modification of protein sub-nuclear
      localization by synthetic phosphoinositides: evidence for nuclear phosphoinositide
      signaling mechanisms.},\n volume = {45},\n year = {2005}\n}\n"}, "authors":
      [{"authorId": "6896988", "name": "O. Gozani"}, {"authorId": "123039768", "name":
      "S. Field"}, {"authorId": "143978896", "name": "C. G. Ferguson"}, {"authorId":
      "4434881", "name": "M. Ewalt"}, {"authorId": "8563805", "name": "Christian Mahlke"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2565299", "name":
      "G. Prestwich"}, {"authorId": "40146895", "name": "Junying Yuan"}]}, {"paperId":
      "862073eed118cddbcb5ca696c7320ea3591da4da", "externalIds": {"CorpusId": 36332755,
      "PubMed": "16131837"}, "corpusId": 36332755, "publicationVenue": {"id": "1bce1796-d800-4a09-91e5-d3e3ed025037",
      "name": "Cell Cycle", "type": "journal", "issn": "1551-4005", "url": "http://www.landesbioscience.com/journals/cc/",
      "alternate_urls": ["http://www.tandfonline.com/loi/kccy20"]}, "url": "https://www.semanticscholar.org/paper/862073eed118cddbcb5ca696c7320ea3591da4da",
      "title": "The negative regulation of phosphoinositide 3-kinase signaling by
      p85 and it''s implication in cancer.", "abstract": "The phosphoinositide 3-kinase
      (PI3K) signaling pathway critically regulates cell growth and cell survival.
      Mutations that lead to aberrant activation of this pathway are frequent events
      in human cancers. Here we discuss some recent studies identifying the mechanisms
      by which p85, the regulatory subunit of PI3K, negatively regulates PI3K signaling.
      While necessary for the stability and membrane recruitment of the p110 catalytic
      subunit of PI3K. p85 represses the basal activity of p110 in the absence of
      growth factor stimulation. In its unbound, free form, p85 sequesters the adaptor
      protein IRS-1 and therefore limits the extent of PI3K signaling downstream of
      the insulin and IGF-1 receptors. These findings lend new insight to how changes
      in p85 gene dosage or mutations in p85 could lead to the hyper-activation of
      PI3K and thus contribute towards tumorigenesis.", "venue": "Cell Cycle", "year":
      2005, "referenceCount": 0, "citationCount": 65, "influentialCitationCount":
      2, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": null, "journal":
      {"volume": "4 10", "pages": "\n          1309-12\n        ", "name": "Cell cycle"},
      "citationStyles": {"bibtex": "@Article{Luo2005TheNR,\n author = {Ji Luo and
      L. Cantley},\n booktitle = {Cell Cycle},\n journal = {Cell cycle},\n pages =
      {\n          1309-12\n        },\n title = {The negative regulation of phosphoinositide
      3-kinase signaling by p85 and it''s implication in cancer.},\n volume = {4 10},\n
      year = {2005}\n}\n"}, "authors": [{"authorId": "145954100", "name": "Ji Luo"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "93028da3cd52ebc38cd2778ff6e04e34acad2478",
      "externalIds": {"MAG": "2086524655", "DOI": "10.1101/GAD.1314605", "CorpusId":
      21627960, "PubMed": "16027169"}, "corpusId": 21627960, "publicationVenue": {"id":
      "94df828d-8411-48df-8aec-f13101ebb8f4", "name": "Genes & Development", "type":
      "journal", "alternate_names": ["Gene  Dev"], "issn": "0890-9369", "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=101",
      "alternate_urls": ["http://www.genesdev.org/", "http://genesdev.cshlp.org/"]},
      "url": "https://www.semanticscholar.org/paper/93028da3cd52ebc38cd2778ff6e04e34acad2478",
      "title": "Feedback inhibition of Akt signaling limits the growth of tumors lacking
      Tsc2.", "abstract": "The PTEN and TSC2 tumor suppressors inhibit mammalian target
      of rapamycin (mTOR) signaling and are defective in distinct hamartoma syndromes.
      Using mouse genetics, we find that Pten and Tsc2 act synergistically to suppress
      the severity of a subset of tumors specific to loss of each of these genes.
      Interestingly, we find that the slow-growing tumors specific to Tsc2+/- mice
      exhibit defects in signaling downstream of Akt. However, Pten haploinsufficiency
      restores Akt signaling in these tumors and dramatically enhances their severity.
      This study demonstrates that attenuation of the PI3K-Akt pathway in tumors lacking
      TSC2 contributes to their benign nature.", "venue": "Genes & Development", "year":
      2005, "referenceCount": 39, "citationCount": 260, "influentialCitationCount":
      11, "isOpenAccess": true, "openAccessPdf": {"url": "http://genesdev.cshlp.org/content/19/15/1773.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2005-08-01", "journal": {"volume": "19 15", "pages": "\n          1773-8\n        ",
      "name": "Genes & development"}, "citationStyles": {"bibtex": "@Article{Manning2005FeedbackIO,\n
      author = {B. Manning and M. Logsdon and A. Lipovsky and Derek W. Abbott and
      D. Kwiatkowski and L. Cantley},\n booktitle = {Genes & Development},\n journal
      = {Genes & development},\n pages = {\n          1773-8\n        },\n title =
      {Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.},\n
      volume = {19 15},\n year = {2005}\n}\n"}, "authors": [{"authorId": "2339651",
      "name": "B. Manning"}, {"authorId": "143800250", "name": "M. Logsdon"}, {"authorId":
      "5359676", "name": "A. Lipovsky"}, {"authorId": "145759174", "name": "Derek
      W. Abbott"}, {"authorId": "2942901", "name": "D. Kwiatkowski"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "98b846347cb182403f0a29bf004a93dfcd14194d",
      "externalIds": {"MAG": "2159370679", "DOI": "10.1016/j.cub.2005.06.059", "CorpusId":
      10494885, "PubMed": "16085494"}, "corpusId": 10494885, "publicationVenue": {"id":
      "9469269e-53d7-4955-b1a5-17a75bee7634", "name": "Current Biology", "type": "journal",
      "alternate_names": ["Curr Biology"], "issn": "0960-9822", "url": "http://www.current-biology.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/09609822"]},
      "url": "https://www.semanticscholar.org/paper/98b846347cb182403f0a29bf004a93dfcd14194d",
      "title": "PtdIns(4,5)P2 Functions at the Cleavage Furrow during Cytokinesis",
      "abstract": null, "venue": "Current Biology", "year": 2005, "referenceCount":
      28, "citationCount": 189, "influentialCitationCount": 17, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0960982205007074/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle", "Study"], "publicationDate": "2005-08-09", "journal": {"volume":
      "15", "pages": "1407-1412", "name": "Current Biology"}, "citationStyles": {"bibtex":
      "@Article{Field2005PtdIns45P2FA,\n author = {S. Field and Nikki Madson and M.
      L. Kerr and K. Galbraith and Caitlin Kennedy and Mamta Tahiliani and A. Wilkins
      and L. Cantley},\n booktitle = {Current Biology},\n journal = {Current Biology},\n
      pages = {1407-1412},\n title = {PtdIns(4,5)P2 Functions at the Cleavage Furrow
      during Cytokinesis},\n volume = {15},\n year = {2005}\n}\n"}, "authors": [{"authorId":
      "123039768", "name": "S. Field"}, {"authorId": "6347712", "name": "Nikki Madson"},
      {"authorId": "5196339", "name": "M. L. Kerr"}, {"authorId": "2058329252", "name":
      "K. Galbraith"}, {"authorId": "144705393", "name": "Caitlin Kennedy"}, {"authorId":
      "5749666", "name": "Mamta Tahiliani"}, {"authorId": "3679332", "name": "A. Wilkins"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "a8a68e5fe39a390b06ed54a1adeb9970b25b4545",
      "externalIds": {"MAG": "2043052104", "DOI": "10.1073/PNAS.0503141102", "CorpusId":
      8342266, "PubMed": "15928075"}, "corpusId": 8342266, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/a8a68e5fe39a390b06ed54a1adeb9970b25b4545",
      "title": "Building a human kinase gene repository: bioinformatics, molecular
      cloning, and functional validation.", "abstract": "Kinases catalyze the phosphorylation
      of proteins, lipids, sugars, nucleosides, and other important cellular metabolites
      and play key regulatory roles in all aspects of eukaryotic cell physiology.
      Here, we describe the mining of public databases to collect the sequence information
      of all identified human kinase genes and the cloning of the corresponding ORFs.
      We identified 663 genes, 511 encoding protein kinases, and 152 encoding nonprotein
      kinases. We describe the successful cloning and sequence verification of 270
      of these genes. Subcloning of this gene set in mammalian expression vectors
      and their use in high-throughput cell-based screens allowed the validation of
      the clones at the level of expression and the identification of previously uncharacterized
      modulators of the survivin promoter. Moreover, expressions of the kinase genes
      in bacteria, followed by autophosphorylation assays, identified 21 protein kinases
      that showed autocatalytic activity. The work described here will facilitate
      the functional assaying of this important gene family in phenotypic screens
      and their use in biochemical and structural studies.", "venue": "Proceedings
      of the National Academy of Sciences of the United States of America", "year":
      2005, "referenceCount": 46, "citationCount": 40, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc1149441?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Computer Science", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2005-06-07", "journal": {"volume": "102 23", "pages": "\n          8114-9\n        ",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America"}, "citationStyles": {"bibtex": "@Article{Park2005BuildingAH,\n author
      = {Jaehong Park and Yanhui Hu and T. Murthy and F. Vannberg and Binghua Shen
      and A. Rolfs and Jessica E. Hutti and L. Cantley and J. LaBaer and E. Harlow
      and L. Brizuela},\n booktitle = {Proceedings of the National Academy of Sciences
      of the United States of America},\n journal = {Proceedings of the National Academy
      of Sciences of the United States of America},\n pages = {\n          8114-9\n        },\n
      title = {Building a human kinase gene repository: bioinformatics, molecular
      cloning, and functional validation.},\n volume = {102 23},\n year = {2005}\n}\n"},
      "authors": [{"authorId": "2116811142", "name": "Jaehong Park"}, {"authorId":
      "2228212", "name": "Yanhui Hu"}, {"authorId": "37452956", "name": "T. Murthy"},
      {"authorId": "2729254", "name": "F. Vannberg"}, {"authorId": "144531145", "name":
      "Binghua Shen"}, {"authorId": "35454156", "name": "A. Rolfs"}, {"authorId":
      "6742227", "name": "Jessica E. Hutti"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "2112063", "name": "J. LaBaer"}, {"authorId": "143686358",
      "name": "E. Harlow"}, {"authorId": "144818828", "name": "L. Brizuela"}]}, {"paperId":
      "b3080d83a570d1341899e3cbc6e535ff234e8425", "externalIds": {"MAG": "2159791953",
      "DOI": "10.1073/PNAS.0504378102", "CorpusId": 26909029, "PubMed": "16006513"},
      "corpusId": 26909029, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/b3080d83a570d1341899e3cbc6e535ff234e8425",
      "title": "Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/-
      mice by the p85 regulatory subunits of phosphoinositide 3-kinase.", "abstract":
      "Mice with heterozygous deletion of the PTEN tumor suppressor gene develop a
      range of epithelial neoplasia as well as lymphoid hyperplasia. Previous studies
      suggest that PTEN suppresses tumor formation by acting as a phosphoinositide
      phosphatase to limit signaling by phosphoinositide 3-kinase (PI3K). Here, we
      examined the effect of deleting various regulatory subunits of PI3K (p85alpha
      and p85beta) on epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice.
      Interestingly, we found the loss of one p85alpha allele with or without the
      loss of p85beta led to increased incidence of intestinal polyps. Signaling downstream
      of PI3K was enhanced in the PTEN+/-p85alpha+/-p85beta-/- polyps, as judged by
      an increased fraction of both cells with cytoplasmic staining of the transcription
      factor FKHR and cells with positive staining for the proliferation marker Ki-67.
      In contrast, the incidence of prostate intraepithelial neoplasia was not significantly
      altered in PTEN+/- mice heterozygous for p85alpha or null for p85beta, whereas
      the fraction of proliferating cells in prostate intraepithelial neoplasia was
      reduced in mice lacking p85beta. Finally, there was no significant change in
      T lymphocyte hyperplasia in the PTEN+/- mice with various p85 deletions, although
      anti-CD3-stimulated AKT activation was somewhat reduced in the p85alpha+/- background.
      These results indicate that decreasing the levels of different p85 regulatory
      subunits can result in enhanced PI3K signaling in some tissues and decreased
      PI3K signaling in others, supporting the model that, although p85 proteins are
      essential for class I(A) PI3K signaling, they can function as inhibitors of
      PI3K signaling in some tissues and thus suppress tumor formation.", "venue":
      "Proceedings of the National Academy of Sciences of the United States of America",
      "year": 2005, "referenceCount": 32, "citationCount": 49, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc1174923?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "2005-07-19", "journal": {"volume": "102 29", "pages":
      "\n          10238-43\n        ", "name": "Proceedings of the National Academy
      of Sciences of the United States of America"}, "citationStyles": {"bibtex":
      "@Article{Luo2005ModulationOE,\n author = {Ji Luo and Cassandra L. Sobkiw and
      Nicole M Logsdon and J. Watt and S. Signoretti and F. O''Connell and Eyoung
      Shin and Youn-Soo Shim and L. Pao and B. Neel and R. DePinho and M. Loda and
      L. Cantley},\n booktitle = {Proceedings of the National Academy of Sciences
      of the United States of America},\n journal = {Proceedings of the National Academy
      of Sciences of the United States of America},\n pages = {\n          10238-43\n        },\n
      title = {Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/-
      mice by the p85 regulatory subunits of phosphoinositide 3-kinase.},\n volume
      = {102 29},\n year = {2005}\n}\n"}, "authors": [{"authorId": "145954100", "name":
      "Ji Luo"}, {"authorId": "16248879", "name": "Cassandra L. Sobkiw"}, {"authorId":
      "11269726", "name": "Nicole M Logsdon"}, {"authorId": "40474206", "name": "J.
      Watt"}, {"authorId": "7505152", "name": "S. Signoretti"}, {"authorId": "1398422569",
      "name": "F. O''Connell"}, {"authorId": "40536567", "name": "Eyoung Shin"}, {"authorId":
      "82732598", "name": "Youn-Soo Shim"}, {"authorId": "5471449", "name": "L. Pao"},
      {"authorId": "2291271", "name": "B. Neel"}, {"authorId": "5593407", "name":
      "R. DePinho"}, {"authorId": "6213932", "name": "M. Loda"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "c533dfdd9f821cecb709589ae34b971e2ea3a795",
      "externalIds": {"MAG": "2048818391", "DOI": "10.1016/S0169-5002(05)80141-2",
      "CorpusId": 72318826}, "corpusId": 72318826, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/c533dfdd9f821cecb709589ae34b971e2ea3a795",
      "title": "O-009 Differential effects of gefitinib and cetuximab on EGFR mutant
      non-small cell lung cancers (NSCLC) cell lines", "abstract": null, "venue":
      "", "year": 2005, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "2005-07-01", "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Mukohara2005O009DE,\n
      author = {T. Mukohara and J. Engelman and N. Lindeman and J. Pearlberg and L.
      Cantley and B. Johnson and P. J\u00e4nne},\n title = {O-009 Differential effects
      of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers (NSCLC)
      cell lines},\n year = {2005}\n}\n"}, "authors": [{"authorId": "4944777", "name":
      "T. Mukohara"}, {"authorId": "6828387", "name": "J. Engelman"}, {"authorId":
      "3734755", "name": "N. Lindeman"}, {"authorId": "6927277", "name": "J. Pearlberg"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "115060139", "name":
      "B. Johnson"}, {"authorId": "5984202", "name": "P. J\u00e4nne"}]}, {"paperId":
      "cb2ab298e9b0c358db9700532a8478ba457642ff", "externalIds": {"MAG": "2119863908",
      "DOI": "10.1021/BC049714F", "CorpusId": 1783990, "PubMed": "15898736"}, "corpusId":
      1783990, "publicationVenue": {"id": "727c9075-57df-4276-83b3-a90e2722f883",
      "name": "Bioconjugate chemistry", "type": "journal", "alternate_names": ["Bioconjugate
      Chem", "Bioconjugate chem", "Bioconjugate Chemistry"], "issn": "1043-1802",
      "url": "https://pubs.acs.org/journal/bcches", "alternate_urls": ["http://pubs.acs.org/journals/bcches/index.html",
      "http://pubs.acs.org/journal/bcches"]}, "url": "https://www.semanticscholar.org/paper/cb2ab298e9b0c358db9700532a8478ba457642ff",
      "title": "Synthesis and activity of C11-modified wortmannin probes for PI3 kinase.",
      "abstract": "The key role played by PI3 kinase in cancer, hormone action, and
      a host of other biological functions suggests that specific inhibitors whose
      disposition could be ascertained in vivo would be useful in biological research
      or, potentially, for imaging PI3K in a clinical setting. Wortmannin (Wm, 1)
      is an inhibitor of PI3 kinase with high specificity for this enzyme. We synthesized
      three modified Wm probes, a biotinylated Wm (7a), a 4-hydroxy-3-iodophenylated
      Wm, which was obtained both unlabeled (7b) and labeled with (125)I (8), and
      a fluoresceinated Wm (7c), through modification at C-11, and evaluated their
      inhibitive activity as inhibitors of PI3 kinase. Biotinylated (7a) and 4-hydroxy-3-iodophenylated
      Wm''s (7b) had IC(50)s for PI3K of 6.11 and 11.02 nM, respectively, compared
      to an IC(50) for Wm of 1.63 nM. Fluoresceinated Wm (7c) lost considerably more
      activity than the other derivatives, with an IC(50) of 64.9 nM. The (125)I labeled
      4-hydroxy-3-iodophenylated Wm (8) could be detected after reaction with an immunoprecipitate
      of PI3 kinase. The activity of these reporter Wm''s is discussed in relationship
      to earlier findings on the pharmacological activity of Wm derivatives and the
      ability of inhibitors to fit into the ATP pocket of PI3 kinase.", "venue": "Bioconjugate
      chemistry", "year": 2005, "referenceCount": 19, "citationCount": 17, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2005-04-29", "journal": {"volume": "16
      3", "pages": "\n          669-75\n        ", "name": "Bioconjugate chemistry"},
      "citationStyles": {"bibtex": "@Article{Yuan2005SynthesisAA,\n author = {Hushan
      Yuan and Ji Luo and S. Field and R. Weissleder and L. Cantley and L. Josephson},\n
      booktitle = {Bioconjugate chemistry},\n journal = {Bioconjugate chemistry},\n
      pages = {\n          669-75\n        },\n title = {Synthesis and activity of
      C11-modified wortmannin probes for PI3 kinase.},\n volume = {16 3},\n year =
      {2005}\n}\n"}, "authors": [{"authorId": "6230104", "name": "Hushan Yuan"}, {"authorId":
      "145954100", "name": "Ji Luo"}, {"authorId": "123039768", "name": "S. Field"},
      {"authorId": "3127756", "name": "R. Weissleder"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "5095505", "name": "L. Josephson"}]}, {"paperId":
      "cf92b90535764070c4995b3f9a3d3780c80e2eaf", "externalIds": {"MAG": "2137618229",
      "DOI": "10.1128/MCB.25.5.1596-1607.2005", "CorpusId": 25212900, "PubMed": "15713620"},
      "corpusId": 25212900, "publicationVenue": {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b",
      "name": "Molecular and Cellular Biology", "type": "journal", "alternate_names":
      ["Mol Cell Biology"], "issn": "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls":
      ["http://mcb.asm.org/"]}, "url": "https://www.semanticscholar.org/paper/cf92b90535764070c4995b3f9a3d3780c80e2eaf",
      "title": "Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory
      Subunit Deletion Have Opposite Effects on Insulin Sensitivity in Mice", "abstract":
      "ABSTRACT Studies ex vivo have shown that phosphoinositide 3-kinase (PI3K) activity
      is necessary but not sufficient for insulin-stimulated glucose uptake. Unexpectedly,
      mice lacking either of the PI3K regulatory subunits p85\u03b1 or p85\u03b2 exhibit
      increased insulin sensitivity. The insulin hypersensitivity is particularly
      unexpected in p85\u03b1\u2212/\u2212 p55\u03b1\u2212/\u2212 p50\u03b1\u2212/\u2212
      mice, where a decrease in p110\u03b1 and p110\u03b2 catalytic subunits was observed
      in insulin-sensitive tissues. These results raised the possibility that decreasing
      total PI3K available for stimulation by insulin might circumvent negative feedback
      loops that ultimately shut off insulin-dependent glucose uptake in vivo. Here
      we present results arguing against this explanation. We show that p110\u03b1+/\u2212
      p110\u03b2+/\u2212 mice exhibit mild glucose intolerance and hyperinsulinemia
      in the fasted state. Unexpectedly, p110\u03b1+/\u2212 p110\u03b2+/\u2212 mice
      showed a \u223c50% decrease in p85 expression in liver and muscle. Consistent
      with this in vivo observation, knockdown of p110 by RNA interference in mammalian
      cells resulted in loss of p85 proteins due to decreased protein stability. We
      propose that insulin sensitivity is regulated by a delicate balance between
      p85 and p110 subunits and that p85 subunits mediate a negative role in insulin
      signaling independent of their role as mediators of PI3K activation.", "venue":
      "Molecular and Cellular Biology", "year": 2005, "referenceCount": 50, "citationCount":
      186, "influentialCitationCount": 10, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc549361?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2005-03-01", "journal":
      {"volume": "25", "pages": "1596 - 1607", "name": "Molecular and Cellular Biology"},
      "citationStyles": {"bibtex": "@Article{Brachmann2005Phosphoinositide3C,\n author
      = {S. Brachmann and K. Ueki and J. Engelman and R. Kahn and L. Cantley},\n booktitle
      = {Molecular and Cellular Biology},\n journal = {Molecular and Cellular Biology},\n
      pages = {1596 - 1607},\n title = {Phosphoinositide 3-Kinase Catalytic Subunit
      Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity
      in Mice},\n volume = {25},\n year = {2005}\n}\n"}, "authors": [{"authorId":
      "3710358", "name": "S. Brachmann"}, {"authorId": "5177377", "name": "K. Ueki"},
      {"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "2057941343", "name":
      "R. Kahn"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "db3e6b920cc69825a0b289ec818443012ba49c1a",
      "externalIds": {"MAG": "2093087608", "DOI": "10.1016/j.cell.2005.02.019", "CorpusId":
      1498824}, "corpusId": 1498824, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/db3e6b920cc69825a0b289ec818443012ba49c1a",
      "title": "The C2 Domain of PKC\u03b4 Is a Phosphotyrosine Binding Domain", "abstract":
      null, "venue": "Cell", "year": 2005, "referenceCount": 49, "citationCount":
      215, "influentialCitationCount": 6, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S0092867405001649/pdf", "status": null}, "fieldsOfStudy":
      ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "2005-04-22",
      "journal": {"volume": "121", "pages": "271-280", "name": "Cell"}, "citationStyles":
      {"bibtex": "@Article{Benes2005TheCD,\n author = {C. Benes and Ning Wu and A.
      Elia and T. Dharia and L. Cantley and S. Soltoff},\n booktitle = {Cell},\n journal
      = {Cell},\n pages = {271-280},\n title = {The C2 Domain of PKC\u03b4 Is a Phosphotyrosine
      Binding Domain},\n volume = {121},\n year = {2005}\n}\n"}, "authors": [{"authorId":
      "1714039", "name": "C. Benes"}, {"authorId": "2068343858", "name": "Ning Wu"},
      {"authorId": "35398419", "name": "A. Elia"}, {"authorId": "32165121", "name":
      "T. Dharia"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4324390",
      "name": "S. Soltoff"}]}, {"paperId": "e619703a3dc10b14e35775e1702e48910e73c92b",
      "externalIds": {"MAG": "2042103473", "DOI": "10.1073/PNAS.0409773102", "CorpusId":
      25837815, "PubMed": "15731348"}, "corpusId": 25837815, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/e619703a3dc10b14e35775e1702e48910e73c92b",
      "title": "ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive
      non-small cell lung cancer cell lines.", "abstract": "Therapies that target
      the EGF receptor (EGFR), such as gefitinib (IRESSA), are effective in a subset
      of patients with advanced non-small cell lung cancer (NSCLC). The differences
      in intracellular signaling networks between gefitinib-sensitive and -resistant
      NSCLCs remain poorly understood. In this study, we observe that gefitinib reduces
      phospho-Akt levels only in NSCLC cell lines in which it inhibits growth. To
      elucidate the mechanism underlying this observation, we compared immunoprecipitates
      of phosphoinositide 3-kinase (PI3K) between gefitinib-sensitive and -resistant
      NSCLC cell lines. We observe that PI3K associates with ErbB-3 exclusively in
      gefitinib-sensitive NSCLC cell lines. Gefitinib dissociates this complex, thereby
      linking EGFR inhibition to decreased Akt activity. In contrast, gefitinib-resistant
      cells do not use ErbB-3 to activate the PI3K/Akt pathway. In fact, abundant
      ErbB-3 expression is detected only in gefitinib-sensitive NSCLC cell lines.
      Two gefitinib-sensitive NSCLC cell lines with endogenous distinct activating
      EGFR mutations (L858R and Del747-749), frequently observed in NSCLC patients
      who respond to gefitinib, also use ErbB-3 to couple to PI3K. Down-regulation
      of ErbB-3 by means of short hairpin RNA leads to decreased phospho-Akt levels
      in the gefitinib-sensitive NSCLC cell lines, Calu-3 (WT EGFR) and H3255 (L858R
      EGFR), but has no effect on Akt activation in the gefitinib-resistant cell lines,
      A549 and H522. We conclude that ErbB-3 is used to couple EGFR to the PI3K/Akt
      pathway in gefitinib-sensitive NSCLC cell lines harboring WT and mutant EGFRs.",
      "venue": "Proceedings of the National Academy of Sciences of the United States
      of America", "year": 2005, "referenceCount": 29, "citationCount": 521, "influentialCitationCount":
      21, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc553328?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2005-03-08", "journal": {"volume": "102
      10", "pages": "\n          3788-93\n        ", "name": "Proceedings of the National
      Academy of Sciences of the United States of America"}, "citationStyles": {"bibtex":
      "@Article{Engelman2005ErbB3MP,\n author = {J. Engelman and P. J\u00e4nne and
      C. Mermel and J. Pearlberg and T. Mukohara and C. Fleet and K. Cichowski and
      B. Johnson and L. Cantley},\n booktitle = {Proceedings of the National Academy
      of Sciences of the United States of America},\n journal = {Proceedings of the
      National Academy of Sciences of the United States of America},\n pages = {\n          3788-93\n        },\n
      title = {ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive
      non-small cell lung cancer cell lines.},\n volume = {102 10},\n year = {2005}\n}\n"},
      "authors": [{"authorId": "6828387", "name": "J. Engelman"}, {"authorId": "5984202",
      "name": "P. J\u00e4nne"}, {"authorId": "145234673", "name": "C. Mermel"}, {"authorId":
      "6927277", "name": "J. Pearlberg"}, {"authorId": "4944777", "name": "T. Mukohara"},
      {"authorId": "39554977", "name": "C. Fleet"}, {"authorId": "6306836", "name":
      "K. Cichowski"}, {"authorId": "115060139", "name": "B. Johnson"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "e8dbfd9f625841a52c4e3714b1a577c2b16c94da",
      "externalIds": {"MAG": "2010238890", "DOI": "10.1126/science.1120781", "CorpusId":
      206508115, "PubMed": "16308421"}, "corpusId": 206508115, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/e8dbfd9f625841a52c4e3714b1a577c2b16c94da",
      "title": "The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic
      Effects of Metformin", "abstract": "The Peutz-Jegher syndrome tumor-suppressor
      gene encodes a protein-threonine kinase, LKB1, which phosphorylates and activates
      AMPK [adenosine monophosphate (AMP)\u2013activated protein kinase]. The deletion
      of LKB1 in the liver of adult mice resulted in a nearly complete loss of AMPK
      activity. Loss of LKB1 function resulted in hyperglycemia with increased gluconeogenic
      and lipogenic gene expression. In LKB1-deficient livers, TORC2, a transcriptional
      coactivator of CREB (cAMP response element\u2013binding protein), was dephosphorylated
      and entered the nucleus, driving the expression of peroxisome proliferator-activated
      receptor-\u03b3 coactivator 1\u03b1 (PGC-1\u03b1), which in turn drives gluconeogenesis.
      Adenoviral small hairpin RNA (shRNA) for TORC2 reduced PGC-1\u03b1 expression
      and normalized blood glucose levels in mice with deleted liver LKB1, indicating
      that TORC2 is a critical target of LKB1/AMPK signals in the regulation of gluconeogenesis.
      Finally, we show that metformin, one of the most widely prescribed type 2 diabetes
      therapeutics, requires LKB1 in the liver to lower blood glucose levels.", "venue":
      "Science", "year": 2005, "referenceCount": 49, "citationCount": 1928, "influentialCitationCount":
      123, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.science.org/cms/asset/da3f4ca4-4c5c-4a66-bc4a-ce14af63a43c/pap.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2005-12-09", "journal": {"volume": "310",
      "pages": "1642 - 1646", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Shaw2005TheKL,\n
      author = {R. Shaw and K. Lamia and Debbie S. Vasquez and S. Koo and N. Bardeesy
      and R. DePinho and M. Montminy and L. Cantley},\n booktitle = {Science},\n journal
      = {Science},\n pages = {1642 - 1646},\n title = {The Kinase LKB1 Mediates Glucose
      Homeostasis in Liver and Therapeutic Effects of Metformin},\n volume = {310},\n
      year = {2005}\n}\n"}, "authors": [{"authorId": "4426388", "name": "R. Shaw"},
      {"authorId": "5493258", "name": "K. Lamia"}, {"authorId": "49440900", "name":
      "Debbie S. Vasquez"}, {"authorId": "1885308", "name": "S. Koo"}, {"authorId":
      "5974412", "name": "N. Bardeesy"}, {"authorId": "5593407", "name": "R. DePinho"},
      {"authorId": "4892627", "name": "M. Montminy"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "ecef9a65d07cd8d9a8fed92c28e240ef183d4d8f", "externalIds":
      {"MAG": "2043160859", "DOI": "10.1074/JBC.M504699200", "CorpusId": 2149884,
      "PubMed": "15987685"}, "corpusId": 2149884, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/ecef9a65d07cd8d9a8fed92c28e240ef183d4d8f",
      "title": "Diverse Biochemical Properties of Shp2 Mutants", "abstract": "Mutations
      in the Src homology 2 (SH2)-containing protein-tyrosine phosphatase Shp2 (PTPN11)
      underlie half of the cases of the autosomal dominant genetic disorder Noonan
      syndrome, and somatic Shp2 mutations are found in several hematologic and solid
      malignancies. Earlier studies of small numbers of mutants suggested that disease-associated
      mutations cause constitutive (SH2 binding-independent) activation and that cancer-associated
      mutants are more active than those associated with Noonan syndrome. We have
      characterized a larger panel of Shp2 mutants and find that this \u201cactivity-centric\u201d
      model cannot explain the behaviors of all pathogenic Shp2 mutations. Instead,
      enzymatic, structural, and mathematical modeling analyses show that these mutants
      can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate
      specificity to varying degrees. Furthermore, there is no absolute correlation
      between the mutants'' extents of basal activation and the diseases they induce.
      We propose that activated mutants of Shp2 modulate signaling from specific stimuli
      to a subset of effectors and provide a theoretical framework for understanding
      the complex relationship between Shp2 activation, intracellular signaling, and
      pathology.", "venue": "Journal of Biological Chemistry", "year": 2005, "referenceCount":
      49, "citationCount": 272, "influentialCitationCount": 16, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925820793713/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2005-09-02", "journal": {"volume": "280", "pages": "30984
      - 30993", "name": "Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Keilhack2005DiverseBP,\n author = {H. Keilhack and F. S. David and
      M. McGregor and L. Cantley and B. Neel},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {Journal of Biological Chemistry},\n pages = {30984
      - 30993},\n title = {Diverse Biochemical Properties of Shp2 Mutants},\n volume
      = {280},\n year = {2005}\n}\n"}, "authors": [{"authorId": "6860109", "name":
      "H. Keilhack"}, {"authorId": "47687902", "name": "F. S. David"}, {"authorId":
      "34824608", "name": "M. McGregor"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2291271", "name": "B. Neel"}]}, {"paperId": "ed730103730cfdeda1e50c3b3a209bc61e47be6c",
      "externalIds": {"MAG": "2099019742", "DOI": "10.1158/0008-5472.CAN-05-2612",
      "CorpusId": 6121082, "PubMed": "16322248"}, "corpusId": 6121082, "publicationVenue":
      {"id": "b0bd78b2-6591-460e-af71-196409b62e2c", "name": "Cancer Research", "type":
      "journal", "alternate_names": ["Cancer Res"], "issn": "0008-5472", "url": "https://cancerres.aacrjournals.org/",
      "alternate_urls": ["http://cancerres.aacrjournals.org/"]}, "url": "https://www.semanticscholar.org/paper/ed730103730cfdeda1e50c3b3a209bc61e47be6c",
      "title": "Breast cancer-associated PIK3CA mutations are oncogenic in mammary
      epithelial cells.", "abstract": "Activation of the phosphoinositide 3-kinase
      (PI3K) pathway has been implicated in the pathogenesis of a variety of cancers.
      Recently, mutations in the gene encoding the p110alpha catalytic subunit of
      PI3K (PIK3CA) have been identified in several human cancers. The mutations primarily
      result in single amino acid substitutions, with >85% of the mutations in either
      exon 9 or 20. Multiple studies have shown that these mutations are observed
      in 18% to 40% of breast cancers. However, the phenotypic effects of these PIK3CA
      mutations have not been examined in breast epithelial cells. Herein, we examine
      the activity of the two most common variants, E545K and H1047R, in the MCF-10A
      immortalized breast epithelial cell line. Both variants display higher PI3K
      activity than wild-type p110alpha yet remain sensitive to pharmacologic PI3K
      inhibition. In addition, expression of p110alpha mutants in mammary epithelial
      cells induces multiple phenotypic alterations characteristic of breast tumor
      cells, including anchorage-independent proliferation in soft agar, growth factor-independent
      proliferation, and protection from anoikis. Expression of these mutant p110alpha
      isoforms also confers increased resistance to paclitaxel and induces abnormal
      mammary acinar morphogenesis in three-dimensional basement membrane cultures.
      Together, these data support the notion that the cancer-associated mutations
      in PIK3CA may significantly contribute to breast cancer pathogenesis and represent
      attractive targets for therapeutic inhibition.", "venue": "Cancer Research",
      "year": 2005, "referenceCount": 53, "citationCount": 491, "influentialCitationCount":
      16, "isOpenAccess": true, "openAccessPdf": {"url": "https://cancerres.aacrjournals.org/content/canres/65/23/10992.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2005-12-01", "journal": {"volume": "65 23", "pages": "\n          10992-1000\n        ",
      "name": "Cancer research"}, "citationStyles": {"bibtex": "@Article{Isakoff2005BreastCP,\n
      author = {S. Isakoff and J. Engelman and H. Irie and Ji Luo and S. Brachmann
      and R. Pearline and L. Cantley and J. Brugge},\n booktitle = {Cancer Research},\n
      journal = {Cancer research},\n pages = {\n          10992-1000\n        },\n
      title = {Breast cancer-associated PIK3CA mutations are oncogenic in mammary
      epithelial cells.},\n volume = {65 23},\n year = {2005}\n}\n"}, "authors": [{"authorId":
      "4327978", "name": "S. Isakoff"}, {"authorId": "6828387", "name": "J. Engelman"},
      {"authorId": "49807003", "name": "H. Irie"}, {"authorId": "145954100", "name":
      "Ji Luo"}, {"authorId": "3710358", "name": "S. Brachmann"}, {"authorId": "3679091",
      "name": "R. Pearline"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3471778", "name": "J. Brugge"}]}, {"paperId": "faabc285120865e63fbbf4170473b0775b935466",
      "externalIds": {"CorpusId": 9911809, "PubMed": "15851033"}, "corpusId": 9911809,
      "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell",
      "type": "journal", "alternate_names": ["La Cellule"], "issn": "0092-8674", "alternate_issns":
      ["0008-8757"], "url": "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/faabc285120865e63fbbf4170473b0775b935466",
      "title": "The C2 domain of PKCdelta is a phosphotyrosine binding domain.", "abstract":
      "In eukaryotic cells, the SH2 and PTB domains mediate protein-protein interactions
      by recognizing phosphotyrosine residues on target proteins. Here we make the
      unexpected finding that the C2 domain of PKCdelta directly binds to phosphotyrosine
      peptides in a sequence-specific manner. We provide evidence that this domain
      mediates PKCdelta interaction with a Src binding glycoprotein, CDCP1. The crystal
      structure of the PKCdelta C2 domain in complex with an optimal phosphopeptide
      reveals a new mode of phosphotyrosine binding in which the phosphotyrosine moiety
      forms a ring-stacking interaction with a histidine residue of the C2 domain.
      This is also the first example of a protein Ser/Thr kinase containing a domain
      that binds phosphotyrosine.", "venue": "Cell", "year": 2005, "referenceCount":
      0, "citationCount": 117, "influentialCitationCount": 7, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": null, "journal": {"volume": "121 2", "pages": "\n          271-80\n        ",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Benes2005TheCD,\n author
      = {C. Benes and Ning Wu and A. Elia and T. Dharia and L. Cantley and S. Soltoff},\n
      booktitle = {Cell},\n journal = {Cell},\n pages = {\n          271-80\n        },\n
      title = {The C2 domain of PKCdelta is a phosphotyrosine binding domain.},\n
      volume = {121 2},\n year = {2005}\n}\n"}, "authors": [{"authorId": "1714039",
      "name": "C. Benes"}, {"authorId": "2068343858", "name": "Ning Wu"}, {"authorId":
      "35398419", "name": "A. Elia"}, {"authorId": "32165121", "name": "T. Dharia"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4324390", "name":
      "S. Soltoff"}]}, {"paperId": "04b0c4339e6e58e9360995bf0afc246fee73a57a", "externalIds":
      {"MAG": "2149312498", "DOI": "10.1074/JBC.M309721200", "CorpusId": 26046836,
      "PubMed": "14701839"}, "corpusId": 26046836, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/04b0c4339e6e58e9360995bf0afc246fee73a57a",
      "title": "Identification and Characterization of a Phosphoinositide Phosphate
      Kinase Homolog*", "abstract": "Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)
      plays a central role in regulating the actin cytoskeleton as a substrate for
      phosphoinositide 3-kinase and phospholipase C as well as by binding directly
      to proteins that control the processes of actin monomer sequestration, filament
      severing, capping, nucleation, cross-linking, and bundling (Ma, L., Cantley,
      L. C., Janmey, P. A., and Kirschner, M. W. (1998) J. Cell Biol. 140, 1125\u20131136;
      Hinchliffe, K. (2000) Curr. Biol. 10, R104\u2013R1051). Three related phosphatidylinositol
      4-phosphate 5-kinases (PI(4)P 5-kinases) have been identified in mammalian cells
      (types I\u03b1, I\u03b2, and I\u03b3) and appear to play distinct roles in actin
      remodeling. Here we have identified a fourth member of this family by searching
      the human genome and EST data bases. This new protein, which we have designated
      phosphatidylinositol phosphate kinase homolog (PIPKH), is expressed at relatively
      high levels in brain and testis. Immunoprecipitates of PIPKH expressed in mammalian
      cells contain PI(4)P 5-kinase activity, but this activity is not affected by
      mutations in residues that inactivate other type I PI(4)P 5-kinases. We show
      that the PI(4)P 5-kinase activity in PIPKH immunoprecipitates can be explained
      by the ability of PIPKH to heterodimerize with other type I PI(4)P 5-kinases.
      Transfection of 293t cells with PIPKH resulted in >8-fold increase in total
      phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) without a significant
      net increase in total PI(4,5)P2. When coexpressed with PIPKH, green fluorescent
      protein (GFP) fusion construct of the pleckstrin homology domain from Bruton''s
      tyrosine kinase (GFP-BTK-PH) localized in intracellular vesicular structures,
      suggesting an unusual intracellular site of PI(3,4,5)P3 production. Finally,
      expression of PIPKH induced the reorganization of actin from predominantly stress
      fibers to predominantly foci and comets similar to those observed previously
      in cells infected with the intracellular pathogen Listeria or transfected with
      recombinant PIPKI\u03b1. These results suggest that PIPKH acts as a scaffold
      to localize and regulate type I PI(4)P 5-kinases and the synthesis of PI(3,4,5)P3.",
      "venue": "Journal of Biological Chemistry", "year": 2004, "referenceCount":
      32, "citationCount": 19, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819643838/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2004-03-19", "journal": {"volume": "279", "pages": "11672
      - 11679", "name": "Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Chang2004IdentificationAC,\n author = {James D. Chang and S. Field
      and L. Rameh and C. Carpenter and L. Cantley},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {Journal of Biological Chemistry},\n pages = {11672
      - 11679},\n title = {Identification and Characterization of a Phosphoinositide
      Phosphate Kinase Homolog*},\n volume = {279},\n year = {2004}\n}\n"}, "authors":
      [{"authorId": "2116093125", "name": "James D. Chang"}, {"authorId": "123039768",
      "name": "S. Field"}, {"authorId": "4109960", "name": "L. Rameh"}, {"authorId":
      "2972505", "name": "C. Carpenter"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "31cdff697f23ed127b41226eecd00430839dbca0", "externalIds": {"MAG":
      "2055854788", "DOI": "10.1038/431128a", "CorpusId": 85197250}, "corpusId": 85197250,
      "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature",
      "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls":
      ["http://www.nature.com/nature/", "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/31cdff697f23ed127b41226eecd00430839dbca0",
      "title": "Sizing up a growing field", "abstract": null, "venue": "Nature", "year":
      2004, "referenceCount": 0, "citationCount": 2, "influentialCitationCount": 0,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/431128a.pdf",
      "status": null}, "fieldsOfStudy": ["Environmental Science"], "s2FieldsOfStudy":
      [{"category": "Environmental Science", "source": "external"}, {"category": "Psychology",
      "source": "s2-fos-model"}, {"category": "Education", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2004-09-01", "journal": {"volume":
      "431", "pages": "128-129", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Manning2004SizingUA,\n
      author = {B. Manning and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {128-129},\n title = {Sizing up a growing field},\n volume = {431},\n
      year = {2004}\n}\n"}, "authors": [{"authorId": "2339651", "name": "B. Manning"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "47310b92c485a301788a19efd3b798ac84e8ad3c",
      "externalIds": {"MAG": "1978479807", "DOI": "10.1016/J.YEXCR.2004.03.024", "CorpusId":
      6403470, "PubMed": "15194438"}, "corpusId": 6403470, "publicationVenue": {"id":
      "e4d93d07-bb1f-45a0-bb72-c46ea127fc8c", "name": "Experimental Cell Research",
      "type": "journal", "alternate_names": ["Exp Cell Res"], "issn": "0014-4827",
      "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/622826/description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00144827"]},
      "url": "https://www.semanticscholar.org/paper/47310b92c485a301788a19efd3b798ac84e8ad3c",
      "title": "Differential regulation of the phosphoinositide 3-kinase and MAP kinase
      pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic
      cells.", "abstract": null, "venue": "Experimental Cell Research", "year": 2004,
      "referenceCount": 57, "citationCount": 74, "influentialCitationCount": 4, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "2004-07-01", "journal": {"volume": "297 1", "pages":
      "\n          224-34\n        ", "name": "Experimental cell research"}, "citationStyles":
      {"bibtex": "@Article{Halevy2004DifferentialRO,\n author = {O. Halevy and L.
      Cantley},\n booktitle = {Experimental Cell Research},\n journal = {Experimental
      cell research},\n pages = {\n          224-34\n        },\n title = {Differential
      regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte
      growth factor vs. insulin-like growth factor-I in myogenic cells.},\n volume
      = {297 1},\n year = {2004}\n}\n"}, "authors": [{"authorId": "5224577", "name":
      "O. Halevy"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "4d8d80589eface13e6884a88ea5f78515c2a9f67",
      "externalIds": {"MAG": "2006695188", "DOI": "10.1038/nsmb708", "CorpusId": 39119275,
      "PubMed": "14718924"}, "corpusId": 39119275, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/4d8d80589eface13e6884a88ea5f78515c2a9f67",
      "title": "The structural basis for substrate and inhibitor selectivity of the
      anthrax lethal factor", "abstract": null, "venue": "Nature Structural &Molecular
      Biology", "year": 2004, "referenceCount": 43, "citationCount": 181, "influentialCitationCount":
      10, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": null, "journal": {"volume": "11", "pages":
      "60-66", "name": "Nature Structural &Molecular Biology"}, "citationStyles":
      {"bibtex": "@Article{Turk2004TheSB,\n author = {B. Turk and T. Wong and R. Schwarzenbacher
      and E. Jarrell and S. Leppla and R. Collier and R. Liddington and L. Cantley},\n
      booktitle = {Nature Structural &Molecular Biology},\n journal = {Nature Structural
      &Molecular Biology},\n pages = {60-66},\n title = {The structural basis for
      substrate and inhibitor selectivity of the anthrax lethal factor},\n volume
      = {11},\n year = {2004}\n}\n"}, "authors": [{"authorId": "2080620010", "name":
      "B. Turk"}, {"authorId": "50350421", "name": "T. Wong"}, {"authorId": "4049676",
      "name": "R. Schwarzenbacher"}, {"authorId": "7844726", "name": "E. Jarrell"},
      {"authorId": "145102855", "name": "S. Leppla"}, {"authorId": "2056679116", "name":
      "R. Collier"}, {"authorId": "4427762", "name": "R. Liddington"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "54bbd1b10ccd68093a9fdca8131c7321c5ca6bd9",
      "externalIds": {"MAG": "2059370277", "DOI": "10.1016/J.YMETH.2003.10.003", "CorpusId":
      27365039, "PubMed": "15003602"}, "corpusId": 27365039, "publicationVenue": {"id":
      "054ddb2c-47fb-4de8-acfd-38566bec5015", "name": "Methods", "type": "journal",
      "issn": "1046-2023", "url": "https://www.journals.elsevier.com/methods/", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/10462023"]}, "url": "https://www.semanticscholar.org/paper/54bbd1b10ccd68093a9fdca8131c7321c5ca6bd9",
      "title": "Using peptide libraries to identify optimal cleavage motifs for proteolytic
      enzymes.", "abstract": null, "venue": "Methods", "year": 2004, "referenceCount":
      29, "citationCount": 25, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2004-04-01", "journal": {"volume": "32 4", "pages": "\n          398-405\n        ",
      "name": "Methods"}, "citationStyles": {"bibtex": "@Article{Turk2004UsingPL,\n
      author = {B. Turk and L. Cantley},\n booktitle = {Methods},\n journal = {Methods},\n
      pages = {\n          398-405\n        },\n title = {Using peptide libraries
      to identify optimal cleavage motifs for proteolytic enzymes.},\n volume = {32
      4},\n year = {2004}\n}\n"}, "authors": [{"authorId": "25581223", "name": "B.
      Turk"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "5de40039ce053e4f3318613990173aed85e34417",
      "externalIds": {"MAG": "2085293179", "DOI": "10.1016/S0092-8674(04)00041-8",
      "CorpusId": 17178990, "PubMed": "15055580"}, "corpusId": 17178990, "publicationVenue":
      {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal",
      "alternate_names": ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"],
      "url": "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/5de40039ce053e4f3318613990173aed85e34417",
      "title": "ZIP codes for delivering SH2 domains", "abstract": null, "venue":
      "Cell", "year": 2004, "referenceCount": 20, "citationCount": 26, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle", "LettersAndComments"],
      "publicationDate": "2004-01-23", "journal": {"volume": "116", "pages": "S41-S43",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Songyang2004ZIPCF,\n
      author = {Z. Songyang and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n
      pages = {S41-S43},\n title = {ZIP codes for delivering SH2 domains},\n volume
      = {116},\n year = {2004}\n}\n"}, "authors": [{"authorId": "6731027", "name":
      "Z. Songyang"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "77755f94685bc59b111847c601f64a26ceac6b2b", "externalIds": {"DOI": "10.1038/431128b",
      "CorpusId": 4394539}, "corpusId": 4394539, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/77755f94685bc59b111847c601f64a26ceac6b2b",
      "title": "New and revised textbooks", "abstract": null, "venue": "", "year":
      2004, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Education", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": {"volume": "431", "pages": "128", "name":
      "Nature"}, "citationStyles": {"bibtex": "@Article{Manning2004NewAR,\n author
      = {B. Manning and L. Cantley},\n journal = {Nature},\n pages = {128},\n title
      = {New and revised textbooks},\n volume = {431},\n year = {2004}\n}\n"}, "authors":
      [{"authorId": "2339651", "name": "B. Manning"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "7a8f1e10aa06c50b916669cb6fe96144f6c6db69", "externalIds":
      {"MAG": "2780362317", "CorpusId": 171978686}, "corpusId": 171978686, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/7a8f1e10aa06c50b916669cb6fe96144f6c6db69",
      "title": "Activation directe de la kinase activee par l''amp reposant sur l''utilisation
      de la kinase lkb1, suppresseur de tumeurs", "abstract": "L''invention concerne
      la modulation de l''activite de la kinase-proteine LKB1 ou AMP pour le traitement
      de certains troubles, y compris le diabete et le cancer. L''invention concerne
      egalement la detection d''agents qui modulent l''activite consideree, utiles
      pour le traitement du diabete et du cancer, et elle concerne aussi l''elaboration
      de composes pour le traitement du diabete et du cancer.", "venue": "", "year":
      2004, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}], "publicationTypes":
      null, "publicationDate": "2004-09-09", "journal": null, "citationStyles": {"bibtex":
      "@Inproceedings{Cantley2004ActivationDD,\n author = {L. Cantley and Reuben J.
      Shaw and N. Bardeesy and R. DePinho},\n title = {Activation directe de la kinase
      activee par l''amp reposant sur l''utilisation de la kinase lkb1, suppresseur
      de tumeurs},\n year = {2004}\n}\n"}, "authors": [{"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2060344437", "name": "Reuben J. Shaw"}, {"authorId":
      "5974412", "name": "N. Bardeesy"}, {"authorId": "5593407", "name": "R. DePinho"}]},
      {"paperId": "81c3ec79398ca668a0957687cfb90fb2ada282cc", "externalIds": {"MAG":
      "2474540200", "CorpusId": 10264526, "PubMed": "16970176"}, "corpusId": 10264526,
      "publicationVenue": {"id": "fa938a14-1042-4a8e-92f4-8bca2693dc6d", "name": "The
      Harvey lectures", "type": "journal", "alternate_names": ["Harvey Lect", "Harvey
      lect", "Harvey Lectures"], "issn": "0073-0874"}, "url": "https://www.semanticscholar.org/paper/81c3ec79398ca668a0957687cfb90fb2ada282cc",
      "title": "The role of phosphoinositide 3-kinase in human disease.", "abstract":
      null, "venue": "The Harvey lectures", "year": 2004, "referenceCount": 0, "citationCount":
      23, "influentialCitationCount": 2, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": null, "journal":
      {"volume": "100", "pages": "\n          103-22\n        ", "name": "Harvey lectures"},
      "citationStyles": {"bibtex": "@Article{Cantley2004TheRO,\n author = {L. Cantley},\n
      booktitle = {The Harvey lectures},\n journal = {Harvey lectures},\n pages =
      {\n          103-22\n        },\n title = {The role of phosphoinositide 3-kinase
      in human disease.},\n volume = {100},\n year = {2004}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "936a8cc748f8978c2799d3ea919759912657d5f6",
      "externalIds": {"MAG": "2129777487", "DOI": "10.1073/PNAS.0404720101", "CorpusId":
      10531919, "PubMed": "15302935"}, "corpusId": 10531919, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/936a8cc748f8978c2799d3ea919759912657d5f6",
      "title": "Large-scale characterization of HeLa cell nuclear phosphoproteins.",
      "abstract": "Determining the site of a regulatory phosphorylation event is often
      essential for elucidating specific kinase-substrate relationships, providing
      a handle for understanding essential signaling pathways and ultimately allowing
      insights into numerous disease pathologies. Despite intense research efforts
      to elucidate mechanisms of protein phosphorylation regulation, efficient, large-scale
      identification and characterization of phosphorylation sites remains an unsolved
      problem. In this report we describe an application of existing technology for
      the isolation and identification of phosphorylation sites. By using a strategy
      based on strong cation exchange chromatography, phosphopeptides were enriched
      from the nuclear fraction of HeLa cell lysate. From 967 proteins, 2,002 phosphorylation
      sites were determined by tandem MS. This unprecedented large collection of sites
      permitted a detailed accounting of known and unknown kinase motifs and substrates.",
      "venue": "Proceedings of the National Academy of Sciences of the United States
      of America", "year": 2004, "referenceCount": 49, "citationCount": 1358, "influentialCitationCount":
      79, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2004-08-17", "journal": {"volume": "101
      33", "pages": "\n          12130-5\n        ", "name": "Proceedings of the National
      Academy of Sciences of the United States of America"}, "citationStyles": {"bibtex":
      "@Article{Beausoleil2004LargescaleCO,\n author = {S. Beausoleil and Mark P.
      Jedrychowski and Daniel Schwartz and Joshua E. Elias and J. Ville\u0301n and
      Jiaxu Li and M. Cohn and L. Cantley and S. Gygi},\n booktitle = {Proceedings
      of the National Academy of Sciences of the United States of America},\n journal
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      pages = {\n          12130-5\n        },\n title = {Large-scale characterization
      of HeLa cell nuclear phosphoproteins.},\n volume = {101 33},\n year = {2004}\n}\n"},
      "authors": [{"authorId": "4424720", "name": "S. Beausoleil"}, {"authorId": "6432355",
      "name": "Mark P. Jedrychowski"}, {"authorId": "48917076", "name": "Daniel Schwartz"},
      {"authorId": "34117028", "name": "Joshua E. Elias"}, {"authorId": "1705488",
      "name": "J. Ville\u0301n"}, {"authorId": "47786895", "name": "Jiaxu Li"}, {"authorId":
      "32650867", "name": "M. Cohn"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2665934", "name": "S. Gygi"}]}, {"paperId": "a02c0db49b2a59a7fee0598f0f3ca104dd34467f",
      "externalIds": {"MAG": "2096244860", "DOI": "10.1074/jbc.M405842200", "CorpusId":
      5936098, "PubMed": "15199048"}, "corpusId": 5936098, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/a02c0db49b2a59a7fee0598f0f3ca104dd34467f",
      "title": "A Multi-enzyme Cascade of Hemoglobin Proteolysis in the Intestine
      of Blood-feeding Hookworms*", "abstract": "Blood-feeding pathogens digest hemoglobin
      (Hb) as a source of nutrition, but little is known about this process in multicellular
      parasites. The intestinal brush border membrane of the canine hookworm, Ancylostoma
      caninum, contains aspartic proteases (APR-1), cysteine proteases (CP-2), and
      metalloproteases (MEP-1), the first of which is known to digest Hb. We now show
      that Hb is degraded by a multi-enzyme, synergistic cascade of proteolysis. Recombinant
      APR-1 and CP-2, but not MEP-1, digested native Hb and denatured globin. MEP-1,
      however, did cleave globin fragments that had undergone prior digestion by APR-1
      and CP-2. Proteolytic cleavage sites within the Hb \u03b1 and \u03b2 chains
      were determined for the three enzymes, identifying a total of 131 cleavage sites.
      By scanning synthetic combinatorial peptide libraries with each enzyme, we compared
      the preferred residues cleaved in the libraries with the known cleavage sites
      within Hb. The semi-ordered pathway of Hb digestion described here is surprisingly
      similar to that used by Plasmodium to digest Hb and provides a potential mechanism
      by which these hemoglobinases are efficacious vaccines in animal models of hookworm
      infection.", "venue": "Journal of Biological Chemistry", "year": 2004, "referenceCount":
      59, "citationCount": 161, "influentialCitationCount": 3, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925820731820/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2004-08-20", "journal": {"volume": "279", "pages": "35950
      - 35957", "name": "Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Williamson2004AMC,\n author = {A. Williamson and P. Lecchi and B.
      Turk and Youngchool Choe and P. Hotez and J. McKerrow and L. Cantley and M.
      Sajid and C. Craik and A. Loukas},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {Journal of Biological Chemistry},\n pages = {35950 - 35957},\n title
      = {A Multi-enzyme Cascade of Hemoglobin Proteolysis in the Intestine of Blood-feeding
      Hookworms*},\n volume = {279},\n year = {2004}\n}\n"}, "authors": [{"authorId":
      "34420936", "name": "A. Williamson"}, {"authorId": "4393302", "name": "P. Lecchi"},
      {"authorId": "25581223", "name": "B. Turk"}, {"authorId": "47634131", "name":
      "Youngchool Choe"}, {"authorId": "5943884", "name": "P. Hotez"}, {"authorId":
      "3274892", "name": "J. McKerrow"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "39360449", "name": "M. Sajid"}, {"authorId": "2143214", "name":
      "C. Craik"}, {"authorId": "145322315", "name": "A. Loukas"}]}, {"paperId": "a4c2f30ce709a0e76582e60a4e11c3e00b1de83d",
      "externalIds": {"MAG": "2124099460", "PubMedCentral": "2172303", "DOI": "10.1083/jcb.200404150",
      "CorpusId": 9957390, "PubMed": "15249580"}, "corpusId": 9957390, "publicationVenue":
      {"id": "bf59074e-18fd-4f9a-a1b0-a9bafc16f518", "name": "Journal of Cell Biology",
      "type": "journal", "alternate_names": ["J Cell Biology"], "issn": "0021-9525",
      "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=482",
      "alternate_urls": ["http://www.jstor.org/journals/00219525.html", "https://www.jstor.org/journal/jcellbiology",
      "http://www.jcb.org/"]}, "url": "https://www.semanticscholar.org/paper/a4c2f30ce709a0e76582e60a4e11c3e00b1de83d",
      "title": "A novel phosphatidylinositol(3,4,5)P3 pathway in fission yeast", "abstract":
      "The mammalian tumor suppressor, phosphatase and tensin homologue deleted on
      chromosome 10 (PTEN), inhibits cell growth and survival by dephosphorylating
      phosphatidylinositol-(3,4,5)-trisphosphate (PI[3,4,5]P3). We have found a homologue
      of PTEN in the fission yeast, Schizosaccharomyces pombe (ptn1). This was an
      unexpected finding because yeast (S. pombe and Saccharomyces cerevisiae) lack
      the class I phosphoinositide 3-kinases that generate PI(3,4,5)P3 in higher eukaryotes.
      Indeed, PI(3,4,5)P3 has not been detected in yeast. Surprisingly, upon deletion
      of ptn1 in S. pombe, PI(3,4,5)P3 became detectable at levels comparable to those
      in mammalian cells, indicating that a pathway exists for synthesis of this lipid
      and that the S. pombe ptn1, like mammalian PTEN, suppresses PI(3,4,5)P3 levels.
      By examining various mutants, we show that synthesis of PI(3,4,5)P3 in S. pombe
      requires the class III phosphoinositide 3-kinase, vps34p, and the phosphatidylinositol-4-phosphate
      5-kinase, its3p, but does not require the phosphatidylinositol-3-phosphate 5-kinase,
      fab1p. These studies suggest that a pathway for PI(3,4,5)P3 synthesis downstream
      of a class III phosphoinositide 3-kinase evolved before the appearance of class
      I phosphoinositide 3-kinases.", "venue": "Journal of Cell Biology", "year":
      2004, "referenceCount": 33, "citationCount": 86, "influentialCitationCount":
      7, "isOpenAccess": true, "openAccessPdf": {"url": "http://jcb.rupress.org/content/166/2/205.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2004-07-19", "journal": {"volume": "166",
      "pages": "205 - 211", "name": "The Journal of Cell Biology"}, "citationStyles":
      {"bibtex": "@Article{Mitra2004ANP,\n author = {Prasenjit Mitra and Yingjie Zhang
      and L. Rameh and Maria P Ivshina and D. McCollum and J. Nunnari and G. Hendricks
      and M. L. Kerr and S. Field and L. Cantley and A. Ross},\n booktitle = {Journal
      of Cell Biology},\n journal = {The Journal of Cell Biology},\n pages = {205
      - 211},\n title = {A novel phosphatidylinositol(3,4,5)P3 pathway in fission
      yeast},\n volume = {166},\n year = {2004}\n}\n"}, "authors": [{"authorId": null,
      "name": "Prasenjit Mitra"}, {"authorId": "2108307841", "name": "Yingjie Zhang"},
      {"authorId": "4109960", "name": "L. Rameh"}, {"authorId": "4242861", "name":
      "Maria P Ivshina"}, {"authorId": "144637141", "name": "D. McCollum"}, {"authorId":
      "39444034", "name": "J. Nunnari"}, {"authorId": "40314991", "name": "G. Hendricks"},
      {"authorId": "5196339", "name": "M. L. Kerr"}, {"authorId": "123039768", "name":
      "S. Field"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1715886",
      "name": "A. Ross"}]}, {"paperId": "b260087c48d85b7488519b1f54fb10cdeae2a0e4",
      "externalIds": {"MAG": "1992257057", "DOI": "10.1016/J.CCR.2004.06.007", "CorpusId":
      13646157, "PubMed": "15261145"}, "corpusId": 13646157, "publicationVenue": {"id":
      "11e469cb-37ad-487e-b0ab-d26e82037c22", "name": "Cancer Cell", "type": "journal",
      "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/b260087c48d85b7488519b1f54fb10cdeae2a0e4",
      "title": "The LKB1 tumor suppressor negatively regulates mTOR signaling.", "abstract":
      null, "venue": "Cancer Cell", "year": 2004, "referenceCount": 60, "citationCount":
      1097, "influentialCitationCount": 61, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S1535610804001771/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2004-07-01", "journal":
      {"volume": "6 1", "pages": "\n          91-9\n        ", "name": "Cancer cell"},
      "citationStyles": {"bibtex": "@Article{Shaw2004TheLT,\n author = {R. Shaw and
      N. Bardeesy and B. Manning and L. Lopez and Monica Kosmatka and R. DePinho and
      L. Cantley},\n booktitle = {Cancer Cell},\n journal = {Cancer cell},\n pages
      = {\n          91-9\n        },\n title = {The LKB1 tumor suppressor negatively
      regulates mTOR signaling.},\n volume = {6 1},\n year = {2004}\n}\n"}, "authors":
      [{"authorId": "4426388", "name": "R. Shaw"}, {"authorId": "5974412", "name":
      "N. Bardeesy"}, {"authorId": "2339651", "name": "B. Manning"}, {"authorId":
      "5308858", "name": "L. Lopez"}, {"authorId": "15440166", "name": "Monica Kosmatka"},
      {"authorId": "5593407", "name": "R. DePinho"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "d97c3714ddb39c27ec2aba7acd6dab0dcbffa756", "externalIds":
      {"MAG": "2010161321", "DOI": "10.1038/nmeth708", "CorpusId": 4671684, "PubMed":
      "15782149"}, "corpusId": 4671684, "publicationVenue": {"id": "099483df-e8f2-4bee-805d-8a69f07b6cbf",
      "name": "Nature Methods", "type": "journal", "alternate_names": ["Nat Method"],
      "issn": "1548-7091", "url": "http://www.nature.com/", "alternate_urls": ["http://www.nature.com/nmeth/index.html",
      "https://www.nature.com/nmeth/", "http://www.nature.com/nmeth/authors/index.html#aims"]},
      "url": "https://www.semanticscholar.org/paper/d97c3714ddb39c27ec2aba7acd6dab0dcbffa756",
      "title": "A rapid method for determining protein kinase phosphorylation specificity",
      "abstract": null, "venue": "Nature Methods", "year": 2004, "referenceCount":
      16, "citationCount": 341, "influentialCitationCount": 5, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "2004-10-01", "journal": {"volume": "1", "pages":
      "27-29", "name": "Nature Methods"}, "citationStyles": {"bibtex": "@Article{Hutti2004ARM,\n
      author = {Jessica E. Hutti and E. Jarrell and James D. Chang and Derek W. Abbott
      and P. Storz and A. Toker and L. Cantley and B. Turk},\n booktitle = {Nature
      Methods},\n journal = {Nature Methods},\n pages = {27-29},\n title = {A rapid
      method for determining protein kinase phosphorylation specificity},\n volume
      = {1},\n year = {2004}\n}\n"}, "authors": [{"authorId": "6742227", "name": "Jessica
      E. Hutti"}, {"authorId": "7844726", "name": "E. Jarrell"}, {"authorId": "2116093125",
      "name": "James D. Chang"}, {"authorId": "145759174", "name": "Derek W. Abbott"},
      {"authorId": "4373748", "name": "P. Storz"}, {"authorId": "145751285", "name":
      "A. Toker"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "25581223",
      "name": "B. Turk"}]}, {"paperId": "de22e2c3e1e8759a5cfdaf0100108ff613a1ae66",
      "externalIds": {"MAG": "2399164308", "CorpusId": 36824738, "PubMed": "23573644"},
      "corpusId": 36824738, "publicationVenue": {"id": "66fa3a04-1561-48ac-8933-39a60b63cfad",
      "name": "Drug Discovery Today", "type": "journal", "alternate_names": ["Drug
      Discov Today"], "issn": "1359-6446", "url": "http://www.drugdiscoverytoday.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/13596446"]},
      "url": "https://www.semanticscholar.org/paper/de22e2c3e1e8759a5cfdaf0100108ff613a1ae66",
      "title": "Peptide libraries: at the crossroads of proteomics and bioinformatics.",
      "abstract": "Peptide libraries offer a valuable means for providing functional
      information regarding protein-modifying enzymes and protein interaction domains.
      Library approaches have become increasingly useful as high-throughput strategies
      for the analysis of large numbers of new proteins identified as a result of
      genome-sequencing efforts. Recent developments in the field have produced faster
      methods with broadened applicability. Crucially, new computational and biochemical
      tools have emerged that facilitate identification of interaction partners and
      substrates for proteins on the basis of their peptide selectivity profiles.
      Such combinations of proteomics-scale experimental approaches with bioinformatics
      tools hold great promise for the elucidation of protein interaction networks
      and signal transduction pathways in living cells.", "venue": "Drug Discovery
      Today", "year": 2004, "referenceCount": 0, "citationCount": 6, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Computer Science", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": "2004-01-15", "journal": {"volume": "9
      2 Suppl", "pages": "\n          S47-52\n        ", "name": "Drug discovery today"},
      "citationStyles": {"bibtex": "@Article{Turk2004PeptideLA,\n author = {B. Turk
      and L. Cantley},\n booktitle = {Drug Discovery Today},\n journal = {Drug discovery
      today},\n pages = {\n          S47-52\n        },\n title = {Peptide libraries:
      at the crossroads of proteomics and bioinformatics.},\n volume = {9 2 Suppl},\n
      year = {2004}\n}\n"}, "authors": [{"authorId": "25581223", "name": "B. Turk"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "e2689bb0d08e79457bcb86722b8f9264b6c67115",
      "externalIds": {"MAG": "2045743590", "DOI": "10.1016/j.cub.2004.12.032", "CorpusId":
      14331145, "PubMed": "15620648"}, "corpusId": 14331145, "publicationVenue": {"id":
      "9469269e-53d7-4955-b1a5-17a75bee7634", "name": "Current Biology", "type": "journal",
      "alternate_names": ["Curr Biology"], "issn": "0960-9822", "url": "http://www.current-biology.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/09609822"]},
      "url": "https://www.semanticscholar.org/paper/e2689bb0d08e79457bcb86722b8f9264b6c67115",
      "title": "The Crohn''s Disease Protein, NOD2, Requires RIP2 in Order to Induce
      Ubiquitinylation of a Novel Site on NEMO", "abstract": null, "venue": "Current
      Biology", "year": 2004, "referenceCount": 49, "citationCount": 401, "influentialCitationCount":
      19, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0960982204009881/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "2004-12-29", "journal": {"volume": "14", "pages":
      "2217-2227", "name": "Current Biology"}, "citationStyles": {"bibtex": "@Article{Abbott2004TheCD,\n
      author = {Derek W. Abbott and A. Wilkins and J. Asara and L. Cantley},\n booktitle
      = {Current Biology},\n journal = {Current Biology},\n pages = {2217-2227},\n
      title = {The Crohn''s Disease Protein, NOD2, Requires RIP2 in Order to Induce
      Ubiquitinylation of a Novel Site on NEMO},\n volume = {14},\n year = {2004}\n}\n"},
      "authors": [{"authorId": "145759174", "name": "Derek W. Abbott"}, {"authorId":
      "3679332", "name": "A. Wilkins"}, {"authorId": "3028470", "name": "J. Asara"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "ff47f5c6153e5eddc66deacab2a4d3b83b11ff6f",
      "externalIds": {"MAG": "2120166232", "DOI": "10.1128/MCB.24.11.5080-5087.2004",
      "CorpusId": 21869376, "PubMed": "15143198"}, "corpusId": 21869376, "publicationVenue":
      {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular and Cellular
      Biology", "type": "journal", "alternate_names": ["Mol Cell Biology"], "issn":
      "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]},
      "url": "https://www.semanticscholar.org/paper/ff47f5c6153e5eddc66deacab2a4d3b83b11ff6f",
      "title": "Increased Insulin Sensitivity and Reduced Adiposity in Phosphatidylinositol
      5-Phosphate 4-Kinase \u03b2\u2212/\u2212 Mice", "abstract": "ABSTRACT Phosphorylated
      derivatives of the lipid phosphatidylinositol are known to play critical roles
      in insulin response. Phosphatidylinositol 5-phosphate 4-kinases convert phosphatidylinositol
      5-phosphate to phosphatidylinositol 4,5-bis-phosphate. To understand the physiological
      role of these kinases, we generated mice that do not express phosphatidylinositol
      5-phosphate 4-kinase \u03b2. These mice are hypersensitive to insulin and have
      reduced body weights compared to wild-type littermates. While adult male mice
      lacking phosphatidylinositol 5-phosphate 4-kinase \u03b2 have significantly
      less body fat than wild-type littermates, female mice lacking phosphatidylinositol
      5-phosphate 4-kinase \u03b2 have increased insulin sensitivity in the presence
      of normal adiposity. Furthermore, in vivo insulin-induced activation of the
      protein kinase Akt is enhanced in skeletal muscle and liver from mice lacking
      phosphatidylinositol 5-phosphate 4-kinase \u03b2. These results indicate that
      phosphatidylinositol 5-phosphate 4-kinase \u03b2 plays a role in determining
      insulin sensitivity and adiposity in vivo and suggest that inhibitors of this
      enzyme may be useful in the treatment of type 2 diabetes.", "venue": "Molecular
      and Cellular Biology", "year": 2004, "referenceCount": 37, "citationCount":
      118, "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2004-06-01", "journal":
      {"volume": "24", "pages": "5080 - 5087", "name": "Molecular and Cellular Biology"},
      "citationStyles": {"bibtex": "@Article{Lamia2004IncreasedIS,\n author = {K.
      Lamia and O. Peroni and Young-Bum Kim and L. Rameh and B. Kahn and L. Cantley},\n
      booktitle = {Molecular and Cellular Biology},\n journal = {Molecular and Cellular
      Biology},\n pages = {5080 - 5087},\n title = {Increased Insulin Sensitivity
      and Reduced Adiposity in Phosphatidylinositol 5-Phosphate 4-Kinase \u03b2\u2212/\u2212
      Mice},\n volume = {24},\n year = {2004}\n}\n"}, "authors": [{"authorId": "5493258",
      "name": "K. Lamia"}, {"authorId": "5675837", "name": "O. Peroni"}, {"authorId":
      "1713886", "name": "Young-Bum Kim"}, {"authorId": "4109960", "name": "L. Rameh"},
      {"authorId": "1997179", "name": "B. Kahn"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "02b11866bdc03d7df7ea0efcd1ba7e2b1a5bb674", "externalIds":
      {"MAG": "2036254130", "DOI": "10.1016/J.TIBS.2003.09.003", "CorpusId": 6710251,
      "PubMed": "14607085"}, "corpusId": 6710251, "publicationVenue": {"id": "bb8a9b7a-e5e7-4572-b03d-52d99bb0a3b7",
      "name": "TIBS -Trends in Biochemical Sciences. Regular ed", "type": "journal",
      "alternate_names": ["TIB trends Biochem Sci Regul ed", "Trends Biochem Sci",
      "Trends in Biochemical Sciences"], "issn": "0968-0004", "url": "http://www.sciencedirect.com/science/journal/09680004"},
      "url": "https://www.semanticscholar.org/paper/02b11866bdc03d7df7ea0efcd1ba7e2b1a5bb674",
      "title": "Rheb fills a GAP between TSC and TOR.", "abstract": null, "venue":
      "TIBS -Trends in Biochemical Sciences. Regular ed", "year": 2003, "referenceCount":
      23, "citationCount": 481, "influentialCitationCount": 19, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0968000403002275/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2003-11-01", "journal": {"volume": "28 11", "pages": "\n          573-6\n        ",
      "name": "Trends in biochemical sciences"}, "citationStyles": {"bibtex": "@Article{Manning2003RhebFA,\n
      author = {B. Manning and L. Cantley},\n booktitle = {TIBS -Trends in Biochemical
      Sciences. Regular ed},\n journal = {Trends in biochemical sciences},\n pages
      = {\n          573-6\n        },\n title = {Rheb fills a GAP between TSC and
      TOR.},\n volume = {28 11},\n year = {2003}\n}\n"}, "authors": [{"authorId":
      "2339651", "name": "B. Manning"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "17812e7141ae3cccb8d9293a95791acfc5517357", "externalIds": {"MAG":
      "2056070148", "DOI": "10.1016/S0092-8674(03)00480-X", "CorpusId": 16506650,
      "PubMed": "12859901"}, "corpusId": 16506650, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/17812e7141ae3cccb8d9293a95791acfc5517357",
      "title": "The PHD Finger of the Chromatin-Associated Protein ING2 Functions
      as a Nuclear Phosphoinositide Receptor", "abstract": null, "venue": "Cell",
      "year": 2003, "referenceCount": 68, "citationCount": 493, "influentialCitationCount":
      32, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S009286740300480X/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2003-07-11", "journal": {"volume": "114",
      "pages": "99-111", "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Gozani2003ThePF,\n
      author = {O. Gozani and P. Karuman and David R. Jones and D. Ivanov and J. Cha
      and A. Lugovskoy and Cheryl L. Baird and Hong Zhu and S. Field and S. Lessnick
      and J. Villase\u00f1or and B. Mehrotra and Jian Chen and V. Rao and J. Brugge
      and C. G. Ferguson and B. Payrastre and D. Myszka and L. Cantley and G. Wagner
      and N. Divecha and G. Prestwich and Junying Yuan},\n booktitle = {Cell},\n journal
      = {Cell},\n pages = {99-111},\n title = {The PHD Finger of the Chromatin-Associated
      Protein ING2 Functions as a Nuclear Phosphoinositide Receptor},\n volume = {114},\n
      year = {2003}\n}\n"}, "authors": [{"authorId": "6896988", "name": "O. Gozani"},
      {"authorId": "6519399", "name": "P. Karuman"}, {"authorId": "77190616", "name":
      "David R. Jones"}, {"authorId": "144052482", "name": "D. Ivanov"}, {"authorId":
      "2054440913", "name": "J. Cha"}, {"authorId": "3877350", "name": "A. Lugovskoy"},
      {"authorId": "2072317320", "name": "Cheryl L. Baird"}, {"authorId": "50319426",
      "name": "Hong Zhu"}, {"authorId": "123039768", "name": "S. Field"}, {"authorId":
      "6789492", "name": "S. Lessnick"}, {"authorId": "8059403", "name": "J. Villase\u00f1or"},
      {"authorId": "2080375177", "name": "B. Mehrotra"}, {"authorId": "2118446510",
      "name": "Jian Chen"}, {"authorId": "48149554", "name": "V. Rao"}, {"authorId":
      "3471778", "name": "J. Brugge"}, {"authorId": "143978896", "name": "C. G. Ferguson"},
      {"authorId": "3933495", "name": "B. Payrastre"}, {"authorId": "3342884", "name":
      "D. Myszka"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "145241228",
      "name": "G. Wagner"}, {"authorId": "9277588", "name": "N. Divecha"}, {"authorId":
      "2565299", "name": "G. Prestwich"}, {"authorId": "40146895", "name": "Junying
      Yuan"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '274733'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:45 GMT
      Via:
      - 1.1 f28e802e600102d0339fa542ab6a0426.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - e_H7A6uVyhB9OqRcBTxQuf-Ec-jgBQh2GlKi3QizyWDDFIpcIefwHQ==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0y0FpBvHcEqlw=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '274733'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:45 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - c29214a7-635b-4be3-a986-7dfe22688729
    http_version: HTTP/1.1
    status_code: 200
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=600&limit=100
  response:
    content: '{"offset": 600, "next": 700, "data": [{"paperId": "3913bd1cbab8b412075d594a79910848c38348d6",
      "externalIds": {"MAG": "2109263914", "DOI": "10.1016/S0960-9822(03)00506-2",
      "CorpusId": 6519150, "PubMed": "12906785"}, "corpusId": 6519150, "publicationVenue":
      {"id": "9469269e-53d7-4955-b1a5-17a75bee7634", "name": "Current Biology", "type":
      "journal", "alternate_names": ["Curr Biology"], "issn": "0960-9822", "url":
      "http://www.current-biology.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/09609822"]},
      "url": "https://www.semanticscholar.org/paper/3913bd1cbab8b412075d594a79910848c38348d6",
      "title": "Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control
      mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb",
      "abstract": null, "venue": "Current Biology", "year": 2003, "referenceCount":
      58, "citationCount": 1201, "influentialCitationCount": 67, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S0960982203005062/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "2003-08-05", "journal": {"volume": "13", "pages":
      "1259-1268", "name": "Current Biology"}, "citationStyles": {"bibtex": "@Article{Tee2003TuberousSC,\n
      author = {Andrew R. Tee and B. Manning and Philippe P Roux and L. Cantley and
      J. Blenis},\n booktitle = {Current Biology},\n journal = {Current Biology},\n
      pages = {1259-1268},\n title = {Tuberous Sclerosis Complex Gene Products, Tuberin
      and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein
      Complex toward Rheb},\n volume = {13},\n year = {2003}\n}\n"}, "authors": [{"authorId":
      "2273106160", "name": "Andrew R. Tee"}, {"authorId": "2339651", "name": "B.
      Manning"}, {"authorId": "1718769", "name": "Philippe P Roux"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4037343", "name": "J. Blenis"}]},
      {"paperId": "3e11d5142f925ead05a9d6b7e375bda0b9e2ba4b", "externalIds": {"MAG":
      "2077230170", "DOI": "10.1042/BST0310573", "CorpusId": 10655005, "PubMed": "12773158"},
      "corpusId": 10655005, "publicationVenue": {"id": "9c7806c9-5d45-4670-86ed-e7e052ef142a",
      "name": "Biochemical Society Transactions", "type": "journal", "alternate_names":
      ["Biochem Soc Trans"], "issn": "0300-5127"}, "url": "https://www.semanticscholar.org/paper/3e11d5142f925ead05a9d6b7e375bda0b9e2ba4b",
      "title": "United at last: the tuberous sclerosis complex gene products connect
      the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR)
      signalling.", "abstract": "The molecular interplay between the phosphoinositide
      3-kinase (PI3K) pathway and mammalian target of rapamycin (mTOR) signalling
      in the control of cell growth and proliferation has been the subject of much
      interest and debate amongst cell biologists. A recent escalation of research
      in this area has come from the discovery of the tuberous sclerosis complex gene
      products, tuberin and hamartin, as central regulators of mTOR activation. The
      PI3K effector Akt/protein kinase B has been found to directly phosphorylate
      tuberin and is thereby thought to activate mTOR through inhibition of the tuberin-hamartin
      complex. The many recent studies aimed at defining the molecular nature of this
      revamped PI3K/Akt/mTOR pathway are reviewed here. The collective data discussed
      have laid the groundwork for important new insights into the many cancers caused
      by aberrant PI3K activation and the clinically challenging tuberous sclerosis
      complex disease and have suggested a possible means of treatment for both.",
      "venue": "Biochemical Society Transactions", "year": 2003, "referenceCount":
      0, "citationCount": 221, "influentialCitationCount": 9, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2003-06-01", "journal": {"volume": "31 Pt 3", "pages": "\n          573-8\n        ",
      "name": "Biochemical Society transactions"}, "citationStyles": {"bibtex": "@Article{Manning2003UnitedAL,\n
      author = {B. Manning and L. Cantley},\n booktitle = {Biochemical Society Transactions},\n
      journal = {Biochemical Society transactions},\n pages = {\n          573-8\n        },\n
      title = {United at last: the tuberous sclerosis complex gene products connect
      the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR)
      signalling.},\n volume = {31 Pt 3},\n year = {2003}\n}\n"}, "authors": [{"authorId":
      "2339651", "name": "B. Manning"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "4590e752389488799b6cf91719a026f756a225c3", "externalIds": {"MAG":
      "2755570915", "CorpusId": 102730079}, "corpusId": 102730079, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/4590e752389488799b6cf91719a026f756a225c3",
      "title": "Modulation de la phosphoinositide phosphate kinase de type ii$g(b)",
      "abstract": "L''invention concerne des procedes pour moduler l''activite de
      la phosphoinositide phosphate kinase de type II\u03b2 (PIPKII\u03b2) dans le
      but de traiter des troubles associes a la PIPKII\u03b2. L''invention concerne
      egalement des procedes pour identifier des agents candidats pour le traitement
      de troubles associes a la PIPKII\u03b2.", "venue": "", "year": 2003, "referenceCount":
      1, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}], "publicationTypes": null, "publicationDate":
      "2003-02-03", "journal": {"volume": "", "name": ""}, "citationStyles": {"bibtex":
      "@Inproceedings{Cantley2003ModulationDL,\n author = {L. Cantley and K. Lamia
      and L. Rameh and B. Kahn and O. Peroni},\n title = {Modulation de la phosphoinositide
      phosphate kinase de type ii$g(b)},\n year = {2003}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5493258", "name": "K. Lamia"},
      {"authorId": "4109960", "name": "L. Rameh"}, {"authorId": "1997179", "name":
      "B. Kahn"}, {"authorId": "5675837", "name": "O. Peroni"}]}, {"paperId": "45aab1bbb6ace745f37ed22c04aefd63af66cfe8",
      "externalIds": {"MAG": "2048551141", "DOI": "10.1016/S0092-8674(03)00725-6",
      "CorpusId": 15110841, "PubMed": "14532005"}, "corpusId": 15110841, "publicationVenue":
      {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal",
      "alternate_names": ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"],
      "url": "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/45aab1bbb6ace745f37ed22c04aefd63af66cfe8",
      "title": "The Molecular Basis for Phosphodependent Substrate Targeting and Regulation
      of Plks by the Polo-Box Domain", "abstract": null, "venue": "Cell", "year":
      2003, "referenceCount": 54, "citationCount": 746, "influentialCitationCount":
      60, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867403007256/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2003-10-03", "journal": {"volume": "115", "pages": "83-95",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Elia2003TheMB,\n author
      = {A. Elia and P. Rellos and L. Haire and Jerry W. Chao and Frank J. Ivins and
      K. Hoepker and Duaa H. Mohammad and L. Cantley and S. Smerdon and M. Yaffe},\n
      booktitle = {Cell},\n journal = {Cell},\n pages = {83-95},\n title = {The Molecular
      Basis for Phosphodependent Substrate Targeting and Regulation of Plks by the
      Polo-Box Domain},\n volume = {115},\n year = {2003}\n}\n"}, "authors": [{"authorId":
      "35398419", "name": "A. Elia"}, {"authorId": "5757608", "name": "P. Rellos"},
      {"authorId": "4551084", "name": "L. Haire"}, {"authorId": "2066447044", "name":
      "Jerry W. Chao"}, {"authorId": "4379012", "name": "Frank J. Ivins"}, {"authorId":
      "3953017", "name": "K. Hoepker"}, {"authorId": "40028226", "name": "Duaa H.
      Mohammad"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4189482",
      "name": "S. Smerdon"}, {"authorId": "88402408", "name": "M. Yaffe"}]}, {"paperId":
      "8086754eb7197795d478c7cb0b7dda18ca9e152d", "externalIds": {"CorpusId": 11300729,
      "PubMed": "14504291"}, "corpusId": 11300729, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/8086754eb7197795d478c7cb0b7dda18ca9e152d",
      "title": "Positive and negative roles of p85 alpha and p85 beta regulatory subunits
      of phosphoinositide 3-kinase in insulin signaling.", "abstract": "Class IA phosphoinositide
      (PI) 3-kinase is composed of a p110 catalytic subunit and a p85 regulatory subunit
      and plays a pivotal role in insulin signaling. To explore the physiological
      roles of two major regulatory isoforms, p85 alpha and p85 beta, we have established
      brown adipose cell lines with disruption of the Pik3r1 or Pik3r2 gene. Pik3r1-/-
      (p85 alpha-/-) cells show a 70% reduction of p85 protein and a parallel reduction
      of p110. These cells have a 50% decrease in PI 3-kinase activity and a 30% decrease
      in Akt activity, leading to decreased insulin-induced glucose uptake and anti-apoptosis.
      Pik3r2-/- (p85 beta-/-) cells show a 25% reduction of p85 protein but normal
      levels of p85-p110 and PI 3-kinase activity, supporting the fact that p85 is
      more abundant than p110 in wild type. p85 beta-/- cells, however, exhibit significantly
      increased insulin-induced Akt activation, leading to increased anti-apoptosis.
      Reconstitution experiments suggest that the discrepancy between PI 3-kinase
      activity and Akt activity is at least in part due to the p85-dependent negative
      regulation of downstream signaling of PI 3-kinase. Indeed, both p85 alpha-/-
      cells and p85 beta-/- cells exhibit significantly increased insulin-induced
      glycogen synthase activation. p85 alpha-/- cells show decreased insulin-stimulated
      Jun N-terminal kinase activity, which is restored by expression of p85 alpha,
      p85 beta, or a p85 mutant that does not bind to p110, indicating the existence
      of p85-dependent, but PI 3-kinase-independent, signaling pathway. Furthermore,
      a reduction of p85 beta specifically increases insulin receptor substrate-2
      phosphorylation. Thus, p85 alpha and p85 beta modulate PI 3-kinase-dependent
      signaling by multiple mechanisms and transmit signals independent of PI 3-kinase
      activation.", "venue": "Journal of Biological Chemistry", "year": 2003, "referenceCount":
      0, "citationCount": 89, "influentialCitationCount": 4, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": null, "journal": {"volume": "278 48", "pages": "\n          48453-66\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Ueki2003PositiveAN,\n author = {K. Ueki and D. Fruman and C. Yballe
      and M. Fasshauer and J. Klein and T. Asano and L. Cantley and C. Kahn},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          48453-66\n        },\n title = {Positive
      and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide
      3-kinase in insulin signaling.},\n volume = {278 48},\n year = {2003}\n}\n"},
      "authors": [{"authorId": "5177377", "name": "K. Ueki"}, {"authorId": "6241317",
      "name": "D. Fruman"}, {"authorId": "7777071", "name": "C. Yballe"}, {"authorId":
      "48775825", "name": "M. Fasshauer"}, {"authorId": "50073811", "name": "J. Klein"},
      {"authorId": "1928077", "name": "T. Asano"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "144391716", "name": "C. Kahn"}]}, {"paperId": "80ea372d65d908cbe36badc84c19970ab039129a",
      "externalIds": {"MAG": "2141732393", "DOI": "10.1074/JBC.M308659200", "CorpusId":
      27322516, "PubMed": "14512424"}, "corpusId": 27322516, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/80ea372d65d908cbe36badc84c19970ab039129a",
      "title": "Binding Specificity and Regulation of the Serine Protease and PDZ
      Domains of HtrA2/Omi*", "abstract": "Inhibitor of apoptosis proteins (IAPs)
      prevent apoptosis through direct inhibition of caspases. The serine protease
      HtrA2/Omi has an amino-terminal IAP interaction motif like that found in Reaper,
      which displaces IAPs from caspases, leading to enhanced caspase activity. The
      cell death-promoting properties of HtrA2/Omi are not only exerted through its
      capacity to oppose IAP inhibition of caspases but also through its integral
      serine protease activity. We have used peptide libraries to determine the optimal
      substrate sequence for cleavage by HtrA2 and also the preferred binding sequence
      for its PDZ domain. Using these peptides, we show that the PDZ domain of HtrA2/Omi
      suppresses the proteolytic activity unless it is engaged by a binding partner.
      Subjecting HtrA2/Omi to heat shock treatment also increases its protease activity.
      Unexpectedly, binding of X-linked inhibitor of apoptosis protein (XIAP) to the
      Reaper motif of HtrA2/Omi results in a marked increase in proteolytic activity,
      suggesting a new role for IAPs. When HtrA2/Omi is released from mitochondria
      following an apoptotic stimulus, binding to IAPs may switch their function from
      caspase inhibition to serine protease activation. Thus although IAP overexpression
      can suppress caspase activation, it could have the opposite effect on HtrA2/Omi-dependent
      cell death. This, together with the ability of HtrA2/Omi to degrade IAPs, may
      limit the overall cellular protection that can be provided by these proteins.",
      "venue": "Journal of Biological Chemistry", "year": 2003, "referenceCount":
      22, "citationCount": 121, "influentialCitationCount": 12, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925820757194/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2003-12-05", "journal": {"volume": "278", "pages": "49417
      - 49427", "name": "Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Martins2003BindingSA,\n author = {L. Martins and B. Turk and V. Cowling
      and Annabel Borg and E. Jarrell and L. Cantley and J. Downward},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {Journal of Biological Chemistry},\n
      pages = {49417 - 49427},\n title = {Binding Specificity and Regulation of the
      Serine Protease and PDZ Domains of HtrA2/Omi*},\n volume = {278},\n year = {2003}\n}\n"},
      "authors": [{"authorId": "143931284", "name": "L. Martins"}, {"authorId": "25581223",
      "name": "B. Turk"}, {"authorId": "5042757", "name": "V. Cowling"}, {"authorId":
      "39732969", "name": "Annabel Borg"}, {"authorId": "7844726", "name": "E. Jarrell"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6851395", "name":
      "J. Downward"}]}, {"paperId": "83a5314df92758d2eb55945e6f05f5d0df387ba2", "externalIds":
      {"MAG": "2104640364", "DOI": "10.1242/jcs.00666", "CorpusId": 10295948, "PubMed":
      "12876217"}, "corpusId": 10295948, "publicationVenue": {"id": "398b46b8-6014-4478-b7af-f477167f7bde",
      "name": "Journal of Cell Science", "type": "journal", "alternate_names": ["J
      Cell Sci"], "issn": "0021-9533", "url": "https://jcs.biologists.org/", "alternate_urls":
      ["http://jcs.biologists.org/"]}, "url": "https://www.semanticscholar.org/paper/83a5314df92758d2eb55945e6f05f5d0df387ba2",
      "title": "Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and
      vacuole maturation", "abstract": "Mammalian cell invasion by the protozoan parasite,
      Trypanosoma cruzi, is facilitated by the activation of host cell phosphatidylinositol
      3 (PI 3)-kinases. We demonstrate that the well-characterized Ca2+-regulated
      lysosome-mediated parasite entry pathway is abolished by wortmannin pretreatment.
      In addition, we have characterized a novel route of T. cruzi invasion unexpectedly
      revealed in the course of this study. For over a decade, targeted exocytosis
      of lysosomes at the host cell plasma membrane was considered as the primary
      mechanism for T. cruzi entry into non-professional phagocytic cells. We now
      provide evidence that a significant fraction (50% or greater) of invading T.
      cruzi trypomastigotes exploit an alternate actin-independent entry pathway that
      involves formation of a tightly associated host cell plasma membrane-derived
      vacuole enriched in the lipid products of class I PI 3-kinases, PtdInsP3/PtdIns(3,4)P2.
      Initially devoid of lysosomal markers, the resultant parasite-containing vacuoles
      gradually acquire lysosome associated membrane protein 1 (lamp-1) and fluid
      phase endocytic tracer from the lysosomal compartment. In striking contrast
      to latex bead phagosomes, few T. cruzi vacuoles associate with the early endosomal
      marker, EEA1 and the ''maturation'' process becomes refractory to PI 3-kinase
      inhibition immediately following parasite internalization. Jointly, these data
      provide a new paradigm for T. cruzi invasion of non-professional phagocytic
      cells and reveal a novel vacuole maturation process that appears to bypass the
      requirement for EEA1.", "venue": "Journal of Cell Science", "year": 2003, "referenceCount":
      74, "citationCount": 161, "influentialCitationCount": 13, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2003-09-01", "journal": {"volume": "116", "pages": "3611
      - 3622", "name": "Journal of Cell Science"}, "citationStyles": {"bibtex": "@Article{Woolsey2003NovelP3,\n
      author = {A. Woolsey and Lisa Sunwoo and C. Petersen and S. Brachmann and L.
      Cantley and B. Burleigh},\n booktitle = {Journal of Cell Science},\n journal
      = {Journal of Cell Science},\n pages = {3611 - 3622},\n title = {Novel PI 3-kinase-dependent
      mechanisms of trypanosome invasion and vacuole maturation},\n volume = {116},\n
      year = {2003}\n}\n"}, "authors": [{"authorId": "34644153", "name": "A. Woolsey"},
      {"authorId": "12644017", "name": "Lisa Sunwoo"}, {"authorId": "145385785", "name":
      "C. Petersen"}, {"authorId": "3710358", "name": "S. Brachmann"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5164780", "name": "B. Burleigh"}]},
      {"paperId": "8748a4c4c86885c285d6eac02b54c1325f5b5e6d", "externalIds": {"CorpusId":
      249604594}, "corpusId": 249604594, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/8748a4c4c86885c285d6eac02b54c1325f5b5e6d",
      "title": "Identification and Characterization of a High-Affinity Interaction
      between v-Crk and Tyrosine-Phosphorylated Paxillin in CT 10-Transformed Fibroblasts",
      "abstract": "The genome of avian sarcoma virus CT1O encodes a fusion protein
      in which viral Gag sequences are fused to cellular Crk sequences containing
      primarily Src homology 2 (SH2) and Src homology 3 (SH3) domains. Transformation
      of chicken embryo fibroblasts (CEF) with the Gag-Crk fusion protein results
      in the elevation of tyrosine phosphorylation on specific cellular proteins with
      molecular weights of 130,000, 110,000, and 70,000 (p130, p110, and p70, respectively),
      an event which has been correlated with cell transformation. In this study,
      we have identified the 70-kDa yrosine-phosphorylated protein in CT10-transformed
      CEF (CT10-CEF) as paxillin, a cytoskeletal protein suggested to be important
      for organizing the focal adhesion. Tyrosinephosphorylated paxillin was found
      to be complexed with v-Crk in vivo as evident from coimmunoprecipitation studies.
      Moreover, a bacterially expressed recombinant glutathione S-transferase (GST)-CrkSH2
      fragment bound paxillin in vitro with a subnanomolar affinity, suggesting that
      the SH2 domain of v-Crk is sufficient for binding. Mapping of the sequence specificity
      of a GST-CrkSH2 fusion protein with a partially degenerate phosphopeptide library
      determined a motif consisting ofpYDXP, and in competitive coprecipitation studies,
      an acetylated A(p)YDAPA hexapeptide was able to quantitatively inhibit the binding
      of GST-CrkSH2 to paxillin and p130, suggesting that it meets the minimal structural
      requirements necessary for the interaction of CrkSH2 with physiological targets.
      To investigate the mechanism by which v-Crk elevates the tyrosine phosphorylation
      of paxillin in vivo, we have treated normal CEF and CT10-CEF with sodium vanadate
      to inhibit protein tyrosine phosphatase activity. Although many additional cellular
      proteins became hyperphosphorylated on tyrosine in the vanadate-treated CT10-CEF,
      the GST-CrkSH2 fragment still bound preferentially to the paxillin and 130-kDa
      proteins, suggesting a high degree of specificity in the interaction of CrkSH2
      with these proteins. Paxillin phosphorylation was highly sensitive to vanadate
      treatment in both normal CEF and CT1O-CEF, and the elevation in tyrosine phosphorylation
      resulted in increased binding to GST-CrkSH2. Moreover, binding of full-length
      GST-v-Crk to tyrosine-phosphorylated paxillin in vitro protected paxillin from
      dephosphorylation by cellular protein tyrosine phosphatase activity. These data
      suggest that paxillin is involved in a highly dynamic kinase-phosphatase interplay
      in normal CEF and that v-Crk binding may interrupt this balance to increase
      the steady-state level of tyrosine phosphorylation. By contrast, the 130-kDa
      protein was not tyrosine phosphorylated upon vanadate treatment of normal CEF
      and only weakly affected in the CT10-CEF, suggesting that a different mechanism
      may be involved in its phosphorylation.", "venue": "", "year": 2003, "referenceCount":
      51, "citationCount": 7, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Raymond2003IdentificationAC,\n
      author = {B. Raymond and Birge and J. Fajardo and Charles and Reichman and Z.
      Songyang and L. Cantley and H. Hanafusa},\n title = {Identification and Characterization
      of a High-Affinity Interaction between v-Crk and Tyrosine-Phosphorylated Paxillin
      in CT 10-Transformed Fibroblasts},\n year = {2003}\n}\n"}, "authors": [{"authorId":
      "35085909", "name": "B. Raymond"}, {"authorId": "29963164", "name": "Birge"},
      {"authorId": "143676959", "name": "J. Fajardo"}, {"authorId": "2070859071",
      "name": "Charles"}, {"authorId": "2102743601", "name": "Reichman"}, {"authorId":
      "6731027", "name": "Z. Songyang"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "1973946", "name": "H. Hanafusa"}]}, {"paperId": "8af8f11d66b0ddffa6655cd36d622567add83211",
      "externalIds": {"MAG": "2117263216", "DOI": "10.1016/S1535-6108(03)00248-4",
      "CorpusId": 1101699, "PubMed": "14585353"}, "corpusId": 1101699, "publicationVenue":
      {"id": "11e469cb-37ad-487e-b0ab-d26e82037c22", "name": "Cancer Cell", "type":
      "journal", "issn": "1535-6108", "url": "http://www.sciencedirect.com/science/journal/15356108",
      "alternate_urls": ["http://www.cancercell.org/"]}, "url": "https://www.semanticscholar.org/paper/8af8f11d66b0ddffa6655cd36d622567add83211",
      "title": "Targeting the PI3K-Akt pathway in human cancer: rationale and promise.",
      "abstract": null, "venue": "Cancer Cell", "year": 2003, "referenceCount": 65,
      "citationCount": 1375, "influentialCitationCount": 46, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.cell.com/article/S1535610803002484/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "2003-10-01", "journal": {"volume":
      "4 4", "pages": "\n          257-62\n        ", "name": "Cancer cell"}, "citationStyles":
      {"bibtex": "@Article{Luo2003TargetingTP,\n author = {Ji Luo and B. Manning and
      L. Cantley},\n booktitle = {Cancer Cell},\n journal = {Cancer cell},\n pages
      = {\n          257-62\n        },\n title = {Targeting the PI3K-Akt pathway
      in human cancer: rationale and promise.},\n volume = {4 4},\n year = {2003}\n}\n"},
      "authors": [{"authorId": "145954100", "name": "Ji Luo"}, {"authorId": "2339651",
      "name": "B. Manning"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "970633c231a6829e99e743d74ff874369f5c0a2a", "externalIds": {"MAG": "2019225962",
      "DOI": "10.1016/S1367-5931(02)00004-2", "CorpusId": 20997727, "PubMed": "12547431"},
      "corpusId": 20997727, "publicationVenue": {"id": "20ab0f70-2011-4d23-a963-eb604a78ae7d",
      "name": "Current Opinion in Chemical Biology", "type": "journal", "alternate_names":
      ["Curr Opin Chem Biology"], "issn": "1367-5931", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/601299/description#description",
      "alternate_urls": ["https://www.journals.elsevier.com/current-opinion-in-chemical-biology",
      "http://www.sciencedirect.com/science/journal/13675931"]}, "url": "https://www.semanticscholar.org/paper/970633c231a6829e99e743d74ff874369f5c0a2a",
      "title": "Peptide libraries: at the crossroads of proteomics and bioinformatics.",
      "abstract": null, "venue": "Current Opinion in Chemical Biology", "year": 2003,
      "referenceCount": 50, "citationCount": 38, "influentialCitationCount": 2, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Computer Science", "source":
      "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"], "publicationDate":
      "2003-02-01", "journal": {"volume": "7 1", "pages": "\n          84-90\n        ",
      "name": "Current opinion in chemical biology"}, "citationStyles": {"bibtex":
      "@Article{Turk2003PeptideLA,\n author = {B. Turk and L. Cantley},\n booktitle
      = {Current Opinion in Chemical Biology},\n journal = {Current opinion in chemical
      biology},\n pages = {\n          84-90\n        },\n title = {Peptide libraries:
      at the crossroads of proteomics and bioinformatics.},\n volume = {7 1},\n year
      = {2003}\n}\n"}, "authors": [{"authorId": "25581223", "name": "B. Turk"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "a8aa9d511dd2b19cefa903a2ab23b8ed0b59a7b7",
      "externalIds": {"MAG": "1994652412", "DOI": "10.1126/SCIENCE.1079079", "CorpusId":
      1952408, "PubMed": "12595692"}, "corpusId": 1952408, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/a8aa9d511dd2b19cefa903a2ab23b8ed0b59a7b7",
      "title": "Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to
      Mitotic Substrates", "abstract": "We have developed a proteomic approach for
      identifying phosphopeptide binding domains that modulate kinase-dependent signaling
      pathways. An immobilized library of partially degenerate phosphopeptides biased
      toward a particular protein kinase phosphorylation motif is used to isolate
      phospho-binding domains that bind to proteins phosphorylated by that kinase.
      Applying this approach to cyclin-dependent kinases (Cdks), we identified the
      polo-box domain (PBD) of the mitotic kinase polo-like kinase 1 (Plk1) as a specific
      phosphoserine (pSer) or phosphothreonine (pThr) binding domain and determined
      its optimal binding motif. This motif is present in known Plk1 substrates such
      as Cdc25, and an optimal phosphopeptide containing the motif disrupted PBD-substrate
      binding and localization of the PBD to centrosomes. This finding reveals how
      Plk1 can localize to specific sites within cells in response to Cdk phosphorylation
      at those sites and provides a structural mechanism for targeting the Plk1 kinase
      domain to its substrates.", "venue": "Science", "year": 2003, "referenceCount":
      24, "citationCount": 703, "influentialCitationCount": 81, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2003-02-21", "journal": {"volume": "299", "pages": "1228
      - 1231", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Elia2003ProteomicSF,\n
      author = {A. Elia and L. Cantley and M. Yaffe},\n booktitle = {Science},\n journal
      = {Science},\n pages = {1228 - 1231},\n title = {Proteomic Screen Finds pSer/pThr-Binding
      Domain Localizing Plk1 to Mitotic Substrates},\n volume = {299},\n year = {2003}\n}\n"},
      "authors": [{"authorId": "35398419", "name": "A. Elia"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "88402408", "name": "M. Yaffe"}]}, {"paperId":
      "be69cf71571b3c65fbfb2927c2820cca1ed1d7b7", "externalIds": {"MAG": "2037308821",
      "DOI": "10.1074/JBC.M302094200", "CorpusId": 24820838, "PubMed": "12734182"},
      "corpusId": 24820838, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/be69cf71571b3c65fbfb2927c2820cca1ed1d7b7",
      "title": "Use of RNA Interference-mediated Gene Silencing and Adenoviral Overexpression
      to Elucidate the Roles of AKT/Protein Kinase B Isoforms in Insulin Actions*",
      "abstract": "Insulin plays a central role in the regulation of glucose homeostasis
      in part by stimulating glucose uptake and glycogen synthesis. The serine/threonine
      protein kinase Akt has been proposed to mediate insulin signaling in several
      processes. However, it is unclear whether Akt is involved in insulin-stimulated
      glucose uptake and which isoforms of Akt are responsible for each insulin action.
      We confirmed that expression of a constitutively active Akt, using an adenoviral
      expression vector, promoted translocation of glucose transporter 4 (GLUT4) to
      plasma membrane, 2-deoxyglucose (2-DG) uptake, and glycogen synthesis in both
      Chinese hamster ovary cells and 3T3-L1 adipocytes. Inhibition of Akt either
      by adenoviral expression of a dominant negative Akt or by the introduction of
      synthetic 21-mer short interference RNA against Akt markedly reduced insulin-stimulated
      GLUT4 translocation, 2-DG uptake, and glycogen synthesis. Experiments with isoform-specific
      short interference RNA revealed that Akt2, and Akt1 to a lesser extent, has
      an essential role in insulin-stimulated GLUT4 translocation and 2-DG uptake
      in both cell lines, whereas Akt1 and Akt2 contribute equally to insulin-stimulated
      glycogen synthesis. These data suggest a prerequisite role of Akt in insulin-stimulated
      glucose uptake and distinct functions among Akt isoforms.", "venue": "Journal
      of Biological Chemistry", "year": 2003, "referenceCount": 53, "citationCount":
      214, "influentialCitationCount": 6, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.jbc.org/article/S0021925820845669/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Medicine",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2003-07-25", "journal":
      {"volume": "278", "pages": "28312 - 28323", "name": "Journal of Biological Chemistry"},
      "citationStyles": {"bibtex": "@Article{Katome2003UseOR,\n author = {Takashi
      Katome and T. Obata and R. Matsushima and Norihisa Masuyama and L. Cantley and
      Y. Gotoh and K. Kishi and H. Shiota and Y. Ebina},\n booktitle = {Journal of
      Biological Chemistry},\n journal = {Journal of Biological Chemistry},\n pages
      = {28312 - 28323},\n title = {Use of RNA Interference-mediated Gene Silencing
      and Adenoviral Overexpression to Elucidate the Roles of AKT/Protein Kinase B
      Isoforms in Insulin Actions*},\n volume = {278},\n year = {2003}\n}\n"}, "authors":
      [{"authorId": "6207063", "name": "Takashi Katome"}, {"authorId": "3091430",
      "name": "T. Obata"}, {"authorId": "35453046", "name": "R. Matsushima"}, {"authorId":
      "5026168", "name": "Norihisa Masuyama"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "1955165", "name": "Y. Gotoh"}, {"authorId": "46480734",
      "name": "K. Kishi"}, {"authorId": "3023951", "name": "H. Shiota"}, {"authorId":
      "2081978", "name": "Y. Ebina"}]}, {"paperId": "dd7118898f6b705ba06a870f2ecb5d85388f54bb",
      "externalIds": {"MAG": "1992190316", "DOI": "10.1126/STKE.2122003TR8", "CorpusId":
      83876605}, "corpusId": 83876605, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/dd7118898f6b705ba06a870f2ecb5d85388f54bb",
      "title": "Growth Factors Bind Receptor Tyrosine Kinases to Stimulate Cell Survival,
      Cell Division, Cell Growth, and Cytoskeletal Rearrangement", "abstract": "These
      two animations show some of the molecular events associated with the growth
      factors activation of receptor tyrosine kinases that leads to the stimulation
      of phosphoinositide 3-kinase. In Animation 1, growth factors stimulate cell
      survival and entry into the S phase of the cell cycle. In Animation 2, growth
      factors stimulate the activation of proteins that regulate the cytoskeleton,
      stimulation of protein synthesis, and stimulation of the Tec family of tyrosine
      kinases. Animation 2 also shows how the action of phosphatases, such as PTEN,
      terminates signaling and resets the system to receive a new stimulus. The cellular
      processes illustrated include protein and lipid phosphorylation and dephosphorylation,
      protein degradation, protein translocation, and regulation of gene expression.",
      "venue": "Science''s STKE", "year": 2003, "referenceCount": 0, "citationCount":
      4, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": "2003-12-09", "journal": {"volume": "2003", "pages":
      "tr8 - tr8", "name": "Science''s STKE"}, "citationStyles": {"bibtex": "@Article{Cantley2003GrowthFB,\n
      author = {L. Cantley},\n booktitle = {Science''s STKE},\n journal = {Science''s
      STKE},\n pages = {tr8 - tr8},\n title = {Growth Factors Bind Receptor Tyrosine
      Kinases to Stimulate Cell Survival, Cell Division, Cell Growth, and Cytoskeletal
      Rearrangement},\n volume = {2003},\n year = {2003}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "f48777af4c169b15a53c2c0f81dc04a9dc780a4d",
      "externalIds": {"MAG": "2065989299", "DOI": "10.1073/pnas.1734038100", "CorpusId":
      24521062, "PubMed": "12897244"}, "corpusId": 24521062, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/f48777af4c169b15a53c2c0f81dc04a9dc780a4d",
      "title": "The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme
      controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation",
      "abstract": "Phosphatidylinositol-5-phosphate (PI-5-P) is a newly identified
      phosphoinositide with characteristics of a signaling lipid but no known cellular
      function. PI-5-P levels are controlled by the type II PI-5-P 4-kinases (PIP4K
      IIs), a family of kinases that converts PI-5-P into phosphatidylinositol-4,5-bisphosphate
      (PI-4,5-P2). The PI-5-P pathway is an alternative route for PI-4,5-P2 synthesis
      as the bulk of this lipid is generated by the canonical pathway in which phosphatidylinositol-4-phosphate
      (PI-4-P) is the intermediate. Here we examined the effect of activation of the
      PI-5-P pathway on phosphoinositide 3-kinase (PI3K) signaling by expressing PIP4K
      II\u03b2 in cells that lack this enzyme. Although PIP4K II generates PI-4,5-P2,
      a substrate for PI3K, expression of this enzyme reduced rather than increased
      phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) levels in cells stimulated
      with insulin or cells expressing activated PI3K. This reduction in PI-3,4,5-P3
      levels resulted in decreased activation of the downstream protein kinase, Akt/PKB.
      Consistent with these results, expression of IpgD, a bacterial phosphatase that
      converts PI-4,5-P2 to PI-5-P, resulted in Akt activation, and this effect was
      partially reversed by PIP4K II\u03b2. PIP4K II\u03b2 expression did not impair
      insulin-dependent association of PI3K with insulin receptor substrate 1 (IRS1)
      but abbreviated Akt activation, indicating that PIP4K II regulates PI-3,4,5-P3
      degradation rather than synthesis. These data support a model in which the PI-5-P
      pathway controls insulin signaling that leads to Akt activation by regulating
      a PI-3,4,5-P3 phosphatase.", "venue": "Proceedings of the National Academy of
      Sciences of the United States of America", "year": 2003, "referenceCount": 13,
      "citationCount": 121, "influentialCitationCount": 6, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc187868?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2003-08-01", "journal":
      {"volume": "100", "pages": "9867 - 9872", "name": "Proceedings of the National
      Academy of Sciences of the United States of America"}, "citationStyles": {"bibtex":
      "@Article{Carricaburu2003TheP,\n author = {V. Carricaburu and K. Lamia and Elizabeth
      Lo and Laetitia Favereaux and B. Payrastre and L. Cantley and L. Rameh},\n booktitle
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences of the United States
      of America},\n pages = {9867 - 9872},\n title = {The phosphatidylinositol (PI)-5-phosphate
      4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate
      degradation},\n volume = {100},\n year = {2003}\n}\n"}, "authors": [{"authorId":
      "7238684", "name": "V. Carricaburu"}, {"authorId": "5493258", "name": "K. Lamia"},
      {"authorId": "2061333591", "name": "Elizabeth Lo"}, {"authorId": "14794392",
      "name": "Laetitia Favereaux"}, {"authorId": "3933495", "name": "B. Payrastre"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4109960", "name":
      "L. Rameh"}]}, {"paperId": "fb04e214da3820c1ea8decfcf81735a1a859d7f5", "externalIds":
      {"MAG": "2085037886", "DBLP": "journals/nar/ObenauerCY03", "DOI": "10.1093/nar/gkg584",
      "CorpusId": 6939160, "PubMed": "12824383"}, "corpusId": 6939160, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/fb04e214da3820c1ea8decfcf81735a1a859d7f5",
      "title": "Scansite 2.0: proteome-wide prediction of cell signaling interactions
      using short sequence motifs", "abstract": "Scansite identifies short protein
      sequence motifs that are recognized by modular signaling domains, phosphorylated
      by protein Ser/Thr- or Tyr-kinases or mediate specific interactions with protein
      or phospholipid ligands. Each sequence motif is represented as a position-specific
      scoring matrix (PSSM) based on results from oriented peptide library and phage
      display experiments. Predicted domain-motif interactions from Scansite can be
      sequentially combined, allowing segments of biological pathways to be constructed
      in silico. The current release of Scansite, version 2.0, includes 62 motifs
      characterizing the binding and/or substrate specificities of many families of
      Ser/Thr- or Tyr-kinases, SH2, SH3, PDZ, 14-3-3 and PTB domains, together with
      signature motifs for PtdIns(3,4,5)P(3)-specific PH domains. Scansite 2.0 contains
      significant improvements to its original interface, including a number of new
      generalized user features and significantly enhanced performance. Searches of
      all SWISS-PROT, TrEMBL, Genpept and Ensembl protein database entries are now
      possible with run times reduced by approximately 60% when compared with Scansite
      version 1.0. Scansite 2.0 allows restricted searching of species-specific proteins,
      as well as isoelectric point and molecular weight sorting to facilitate comparison
      of predictions with results from two-dimensional gel electrophoresis experiments.
      Support for user-defined motifs has been increased, allowing easier input of
      user-defined matrices and permitting user-defined motifs to be combined with
      pre-compiled Scansite motifs for dual motif searching. In addition, a new series
      of Sequence Match programs for non-quantitative user-defined motifs has been
      implemented. Scansite is available via the World Wide Web at http://scansite.mit.edu.",
      "venue": "Nucleic Acids Res.", "year": 2003, "referenceCount": 18, "citationCount":
      1652, "influentialCitationCount": 188, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://academic.oup.com/nar/article-pdf/31/13/3635/9487448/gkg584.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Computer Science", "Medicine"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Computer Science", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Computer Science", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2003-07-01", "journal": {"volume": "31 13", "pages": "\n          3635-41\n        ",
      "name": "Nucleic acids research"}, "citationStyles": {"bibtex": "@Article{Obenauer2003Scansite2P,\n
      author = {J. Obenauer and L. Cantley and M. Yaffe},\n booktitle = {Nucleic Acids
      Res.},\n journal = {Nucleic acids research},\n pages = {\n          3635-41\n        },\n
      title = {Scansite 2.0: proteome-wide prediction of cell signaling interactions
      using short sequence motifs},\n volume = {31 13},\n year = {2003}\n}\n"}, "authors":
      [{"authorId": "1750479", "name": "J. Obenauer"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "88402408", "name": "M. Yaffe"}]}, {"paperId": "00a54f15b22dc76350926c43eaf245180e36cd7f",
      "externalIds": {"MAG": "2036618934", "DOI": "10.1038/nature01304", "CorpusId":
      4367083, "PubMed": "12478301"}, "corpusId": 4367083, "publicationVenue": {"id":
      "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/00a54f15b22dc76350926c43eaf245180e36cd7f",
      "title": "Overview of the Alliance for Cellular Signaling", "abstract": null,
      "venue": "Nature", "year": 2002, "referenceCount": 3, "citationCount": 126,
      "influentialCitationCount": 2, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://www.nature.com/articles/nature01304.pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle", "Review"], "publicationDate": "2002-12-12",
      "journal": {"volume": "420", "pages": "703-706", "name": "Nature"}, "citationStyles":
      {"bibtex": "@Article{Simon2002OverviewOT,\n author = {M. Simon and H. Bourne
      and B. A. Harris and Rochelle Long and E. Ross and J. Stull and A. Arkin and
      M. Cobb and J. Cyster and P. Devreotes and J. Ferrell and D. Fruman and M. Berridge
      and L. Cantley and W. Catterall and J. Dixon and R. Lefkowitz and A. Pawson
      and P. Sternberg and R. Sinkovits and Joshua Li and W. Heo and N. O\u2019Rourke
      and Jeffrey S. Forrester and M. L. Gray and T. Meyer and S. Michnick and M.
      Schmidt and M. Toner},\n booktitle = {Nature},\n journal = {Nature},\n pages
      = {703-706},\n title = {Overview of the Alliance for Cellular Signaling},\n
      volume = {420},\n year = {2002}\n}\n"}, "authors": [{"authorId": "4204614",
      "name": "M. Simon"}, {"authorId": "2324026", "name": "H. Bourne"}, {"authorId":
      "48296505", "name": "B. A. Harris"}, {"authorId": "46313934", "name": "Rochelle
      Long"}, {"authorId": "2693015", "name": "E. Ross"}, {"authorId": "3572450",
      "name": "J. Stull"}, {"authorId": "1756978", "name": "A. Arkin"}, {"authorId":
      "2039872", "name": "M. Cobb"}, {"authorId": "36795799", "name": "J. Cyster"},
      {"authorId": "1801962", "name": "P. Devreotes"}, {"authorId": "6407990", "name":
      "J. Ferrell"}, {"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "2258496",
      "name": "M. Berridge"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2184965", "name": "W. Catterall"}, {"authorId": "30894895", "name": "J. Dixon"},
      {"authorId": "6412926", "name": "R. Lefkowitz"}, {"authorId": "30576773", "name":
      "A. Pawson"}, {"authorId": "1808359", "name": "P. Sternberg"}, {"authorId":
      "2940708", "name": "R. Sinkovits"}, {"authorId": "2109044140", "name": "Joshua
      Li"}, {"authorId": "144636585", "name": "W. Heo"}, {"authorId": "1403901937",
      "name": "N. O\u2019Rourke"}, {"authorId": "48165059", "name": "Jeffrey S. Forrester"},
      {"authorId": "2053941089", "name": "M. L. Gray"}, {"authorId": "145284943",
      "name": "T. Meyer"}, {"authorId": "6485491", "name": "S. Michnick"}, {"authorId":
      "144713191", "name": "M. Schmidt"}, {"authorId": "145527638", "name": "M. Toner"}]},
      {"paperId": "143d55f2da249f69ecc5328a411a45447143039b", "externalIds": {"MAG":
      "2014187690", "DOI": "10.1074/jbc.M205071200", "CorpusId": 12879881, "PubMed":
      "12119297"}, "corpusId": 12879881, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/143d55f2da249f69ecc5328a411a45447143039b",
      "title": "Peptide Substrate Specificities and Protein Cleavage Sites of Human
      Endometase/Matrilysin-2/Matrix Metalloproteinase-26*", "abstract": "Human endometase/matrilysin-2/matrix
      metalloproteinase-26 (MMP-26) is a novel epithelial and cancer-specific metalloproteinase.
      Peptide libraries were used to profile the substrate specificity of MMP-26 from
      the P4\u2013P4\u2032 sites. The optimal cleavage motifs for MMP-26 were Lys-Pro-Ile/Leu-Ser(P1)-Leu/Met(P1\u2032)-Ile/Thr-Ser/Ala-Ser.
      The strongest preference was observed at the P1\u2032 and P2 sites where hydrophobic
      residues were favored. Proline was preferred at P3, and Serine was preferred
      at P1. The overall specificity was similar to that of other MMPs with the exception
      that more flexibility was observed at P1, P2\u2032, and P3\u2032. Accordingly,
      synthetic inhibitors of gelatinases and collagenases inhibited MMP-26 with similar
      efficacy. A pair of stereoisomers had only a 40-fold difference inK i app values
      against MMP-26 compared with a 250-fold difference against neutrophil collagenase,
      indicating that MMP-26 is less stereoselective for its inhibitors. MMP-26 autodigested
      itself during the folding process. Two of the major autolytic sites were Leu49\u2013Thr50
      and Ala75\u2013Leu76, which still left the cysteine switch sequence (PHC82GVPD)
      intact. This suggests that Cys82 may not play a role in the latency of the zymogen.
      Interestingly, inhibitor titration studies revealed that only \u223c5% of the
      total MMP-26 molecules was catalytically active, indicating that the thiol groups
      of Cys82 in the active molecules may be dissociated or removed from the active
      site zinc ions. MMP-26 cleaved Phe352\u2013Leu353 and Pro357\u2013Met358 in
      the reactive loop of \u03b11-proteinase inhibitor and His140\u2013Val141 in
      insulin-like growth factor-binding protein-1, probably rendering these substrates
      inactive. Among the fluorescent peptide substrates analyzed, Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2
      displayed the highest specificity constant (30,000/molar second) with MMP-26.
      This report proposes a working model for the future studies of pro-MMP-26 activation,
      the design of inhibitors, and the identification of optimal physiological and
      pathological substrates of MMP-26 in vivo.", "venue": "Journal of Biological
      Chemistry", "year": 2002, "referenceCount": 48, "citationCount": 60, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818367474/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2002-09-20", "journal": {"volume": "277",
      "pages": "35168 - 35175", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Park2002PeptideSS,\n author = {H. Park and B. Turk and
      Ferry E. Gerkema and L. Cantley and Q. Sang},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {35168
      - 35175},\n title = {Peptide Substrate Specificities and Protein Cleavage Sites
      of Human Endometase/Matrilysin-2/Matrix Metalloproteinase-26*},\n volume = {277},\n
      year = {2002}\n}\n"}, "authors": [{"authorId": "40163601", "name": "H. Park"},
      {"authorId": "25581223", "name": "B. Turk"}, {"authorId": "15435278", "name":
      "Ferry E. Gerkema"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "47807700", "name": "Q. Sang"}]}, {"paperId": "18a9f248d48a73edbac1a1a03ff1abaa83406eb9",
      "externalIds": {"MAG": "2078685722", "DOI": "10.1006/SMIM.2001.0337", "CorpusId":
      37044612, "PubMed": "11884226"}, "corpusId": 37044612, "publicationVenue": {"id":
      "1d2c294f-5435-4adc-84d0-cd6903a42990", "name": "Seminars in Immunology", "type":
      "journal", "alternate_names": ["Semin Immunol"], "issn": "1044-5323", "url":
      "http://www.clinicalkey.com.au/dura/browse/journalIssue/10445323", "alternate_urls":
      ["http://www.idealibrary.com/cgi-bin/links/toc/si", "https://www.journals.elsevier.com/seminars-in-immunology/",
      "http://www.clinicalkey.com/dura/browse/journalIssue/10445323", "http://www.sciencedirect.com/science/journal/10445323"]},
      "url": "https://www.semanticscholar.org/paper/18a9f248d48a73edbac1a1a03ff1abaa83406eb9",
      "title": "Phosphoinositide 3-kinase in immunological systems.", "abstract":
      "Phosphoinositide 3-kinases (PI3Ks) are an evolutionarily conserved family of
      signal transducing enzymes. A great variety of stimuli activate PI3K, leading
      to the transient accumulation of its lipid products in cell membranes. These
      lipids serve as second messengers to regulate the location and activity of an
      array of downstream effector molecules. In cells of the mammalian immune system,
      PI3K is activated by receptors for antigen, cytokines, costimulatory molecules,
      immunoglobulins and chemoattractants. Signaling via PI3K regulates immune cell
      proliferation, survival, differentiation, chemotaxis, phagocytosis, degranulation,
      and respiratory burst. Here we review our current understanding of PI3K signaling
      in leukocytes.", "venue": "Seminars in Immunology", "year": 2002, "referenceCount":
      133, "citationCount": 242, "influentialCitationCount": 13, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "2002-02-01", "journal": {"volume": "14 1", "pages": "\n          7-18\n        ",
      "name": "Seminars in immunology"}, "citationStyles": {"bibtex": "@Article{Fruman2002Phosphoinositide3I,\n
      author = {D. Fruman and L. Cantley},\n booktitle = {Seminars in Immunology},\n
      journal = {Seminars in immunology},\n pages = {\n          7-18\n        },\n
      title = {Phosphoinositide 3-kinase in immunological systems.},\n volume = {14
      1},\n year = {2002}\n}\n"}, "authors": [{"authorId": "6241317", "name": "D.
      Fruman"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "4b8206b199b5737c7f78020112555f0ab8a658b7",
      "externalIds": {"MAG": "1967830116", "DOI": "10.1016/S0003-2697(02)00268-3",
      "CorpusId": 21594528, "PubMed": "12419351"}, "corpusId": 21594528, "publicationVenue":
      {"id": "d0046ca9-9064-464a-ab1f-8947412a4f14", "name": "Analytical Biochemistry",
      "type": "journal", "alternate_names": ["Anal Biochem"], "issn": "0003-2697",
      "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/622781/description#description",
      "alternate_urls": ["http://www.journals.elsevier.com/analytical-biochemistry-methods-in-the-biological-sciences/",
      "http://www.sciencedirect.com/science/journal/00032697"]}, "url": "https://www.semanticscholar.org/paper/4b8206b199b5737c7f78020112555f0ab8a658b7",
      "title": "An integrated vector system for cellular studies of phage display-derived
      peptides.", "abstract": null, "venue": "Analytical Biochemistry", "year": 2002,
      "referenceCount": 12, "citationCount": 8, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2002-09-15", "journal": {"volume": "308
      2", "pages": "\n          364-72\n        ", "name": "Analytical biochemistry"},
      "citationStyles": {"bibtex": "@Article{Voss2002AnIV,\n author = {S. Voss and
      A. Degrand and G. Romeo and L. Cantley and J. Frangioni},\n booktitle = {Analytical
      Biochemistry},\n journal = {Analytical biochemistry},\n pages = {\n          364-72\n        },\n
      title = {An integrated vector system for cellular studies of phage display-derived
      peptides.},\n volume = {308 2},\n year = {2002}\n}\n"}, "authors": [{"authorId":
      "2045394", "name": "S. Voss"}, {"authorId": "14477240", "name": "A. Degrand"},
      {"authorId": "1736674926", "name": "G. Romeo"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "1788876", "name": "J. Frangioni"}]}, {"paperId":
      "4f8058d520e7287725c518740facc77f703d356c", "externalIds": {"MAG": "2139270233",
      "DOI": "10.1172/JCI13305", "CorpusId": 29471107, "PubMed": "11781359"}, "corpusId":
      29471107, "publicationVenue": {"id": "8c9a9e1b-acf2-4274-8d73-6ea0ecd11fd1",
      "name": "Journal of Clinical Investigation", "type": "journal", "alternate_names":
      ["J Clin Investig"], "issn": "0021-9738", "url": "https://www.jci.org/", "alternate_urls":
      ["http://www.jci.org/", "https://www.jci.org/archive", "http://www.jci.org/impact"]},
      "url": "https://www.semanticscholar.org/paper/4f8058d520e7287725c518740facc77f703d356c",
      "title": "Reduced expression of the murine p85alpha subunit of phosphoinositide
      3-kinase improves insulin signaling and ameliorates diabetes.", "abstract":
      "A critical component of insulin action is the enzyme phosphoinositide (PI)
      3-kinase. The major regulatory subunits of PI 3-kinase, p85alpha and its splice
      variants, are encoded by the Pik3r1 gene. Heterozygous disruption of Pik3r1
      improves insulin signaling and glucose homeostasis in normal mice and mice made
      insulin-resistant by heterozygous deletion of the Insulin receptor and/or insulin
      receptor substrate-1 (IRS1) genes. Reduced expression of p85 modulates the molecular
      balance between this protein, the p110 catalytic subunit of PI 3-kinase, and
      the IRS proteins. Thus, despite the decrease in p85alpha, PI 3-kinase activation
      is normal, insulin-stimulated Akt activity is increased, and glucose tolerance
      and insulin sensitivity are improved. Furthermore, Pik3r1 heterozygosity protects
      mice with genetic insulin resistance from developing diabetes. These data suggest
      that regulation of p85alpha levels may provide a novel therapeutic target for
      the treatment of type 2 diabetes.", "venue": "Journal of Clinical Investigation",
      "year": 2002, "referenceCount": 41, "citationCount": 254, "influentialCitationCount":
      9, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jci.org/articles/view/13305/files/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": null, "journal": {"volume": "109 1",
      "pages": "\n          141-9\n        ", "name": "The Journal of clinical investigation"},
      "citationStyles": {"bibtex": "@Article{Mauvais-Jarvis2002ReducedEO,\n author
      = {F. Mauvais-Jarvis and K. Ueki and D. Fruman and M. Hirshman and K. Sakamoto
      and L. Goodyear and M. Iannacone and D. Accili and L. Cantley and C. Kahn},\n
      booktitle = {Journal of Clinical Investigation},\n journal = {The Journal of
      clinical investigation},\n pages = {\n          141-9\n        },\n title =
      {Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase
      improves insulin signaling and ameliorates diabetes.},\n volume = {109 1},\n
      year = {2002}\n}\n"}, "authors": [{"authorId": "1396480779", "name": "F. Mauvais-Jarvis"},
      {"authorId": "5177377", "name": "K. Ueki"}, {"authorId": "6241317", "name":
      "D. Fruman"}, {"authorId": "6040440", "name": "M. Hirshman"}, {"authorId": "152590916",
      "name": "K. Sakamoto"}, {"authorId": "5766174", "name": "L. Goodyear"}, {"authorId":
      "47379953", "name": "M. Iannacone"}, {"authorId": "4246425", "name": "D. Accili"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144391716", "name":
      "C. Kahn"}]}, {"paperId": "50ced3e181cb003698fd6e97743e38ec3ac9c74f", "externalIds":
      {"MAG": "2087812126", "DOI": "10.1073/pnas.202476899", "CorpusId": 24561818,
      "PubMed": "12271141"}, "corpusId": 24561818, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/50ced3e181cb003698fd6e97743e38ec3ac9c74f",
      "title": "Tuberous sclerosis complex-1 and -2 gene products function together
      to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling",
      "abstract": "Tuberous sclerosis complex (TSC) is an autosomal dominant genetic
      disorder that occurs upon mutation of either the TSC1 or TSC2 genes, which encode
      the protein products hamartin and tuberin, respectively. Here, we show that
      hamartin and tuberin function together to inhibit mammalian target of rapamycin
      (mTOR)-mediated signaling to eukaryotic initiation factor 4E-binding protein
      1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1). First, coexpression of
      hamartin and tuberin repressed phosphorylation of 4E-BP1, resulting in increased
      association of 4E-BP1 with eIF4E; importantly, a mutant of TSC2 derived from
      TSC patients was defective in repressing phosphorylation of 4E-BP1. Second,
      the activity of S6K1 was repressed by coexpression of hamartin and tuberin,
      but the activity of rapamycin-resistant mutants of S6K1 were not affected, implicating
      mTOR in the TSC-mediated inhibitory effect on S6K1. Third, hamartin and tuberin
      blocked the ability of amino acids to activate S6K1 within nutrient-deprived
      cells, a process that is dependent on mTOR. These findings strongly implicate
      the tuberin-hamartin tumor suppressor complex as an inhibitor of mTOR and suggest
      that the formation of tumors within TSC patients may result from aberrantly
      high levels of mTOR-mediated signaling to downstream targets.", "venue": "Proceedings
      of the National Academy of Sciences of the United States of America", "year":
      2002, "referenceCount": 30, "citationCount": 823, "influentialCitationCount":
      32, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/doi/pdf/10.1073/pnas.202476899",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2002-09-23", "journal": {"volume": "99", "pages": "13571
      - 13576", "name": "Proceedings of the National Academy of Sciences of the United
      States of America"}, "citationStyles": {"bibtex": "@Article{Tee2002TuberousSC,\n
      author = {Andrew R. Tee and D. Fingar and B. Manning and D. Kwiatkowski and
      L. Cantley and J. Blenis},\n booktitle = {Proceedings of the National Academy
      of Sciences of the United States of America},\n journal = {Proceedings of the
      National Academy of Sciences of the United States of America},\n pages = {13571
      - 13576},\n title = {Tuberous sclerosis complex-1 and -2 gene products function
      together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream
      signaling},\n volume = {99},\n year = {2002}\n}\n"}, "authors": [{"authorId":
      "2273106160", "name": "Andrew R. Tee"}, {"authorId": "6713214", "name": "D.
      Fingar"}, {"authorId": "2339651", "name": "B. Manning"}, {"authorId": "2942901",
      "name": "D. Kwiatkowski"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4037343", "name": "J. Blenis"}]}, {"paperId": "687b9c3ac404bb2580d763e2bf634b6f1137960b",
      "externalIds": {"MAG": "2090715627", "DOI": "10.1126/stke.2002.162.pe49", "CorpusId":
      20620012, "PubMed": "12475999"}, "corpusId": 20620012, "publicationVenue": null,
      "url": "https://www.semanticscholar.org/paper/687b9c3ac404bb2580d763e2bf634b6f1137960b",
      "title": "Hitting the Target: Emerging Technologies in the Search for Kinase
      Substrates", "abstract": "Through phosphorylation, protein kinases can alter
      the activity, localization, protein association, and stability of their targets.
      Despite the importance to our understanding of all aspects of cell biology,
      progress toward identifying bona fide substrates of specific protein kinases
      has been slow. Traditionally used techniques to identify true kinase substrates,
      such as genetics, yeast two-hybrid screens, and biochemical purification, are
      often laborious and unreliable. However, several new approaches have recently
      been developed and used successfully to identify genuine in vivo substrates
      of certain protein kinases. These methods include screening for phosphorylation
      of proteins from phage expression libraries, peptide library screens to determine
      optimal motifs favored by specific kinases, the use of phospho-motif antibodies,
      and an approach that uses structurally altered kinases and allele-specific adenosine
      triphosphate analogs and kinase inhibitors. We describe these approaches and
      discuss their utility and inherent caveats.", "venue": "Science''s STKE", "year":
      2002, "referenceCount": 31, "citationCount": 113, "influentialCitationCount":
      3, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "2002-12-10", "journal": {"volume":
      "2002", "pages": "pe49 - pe49", "name": "Science''s STKE"}, "citationStyles":
      {"bibtex": "@Article{Manning2002HittingTT,\n author = {B. Manning and L. Cantley},\n
      booktitle = {Science''s STKE},\n journal = {Science''s STKE},\n pages = {pe49
      - pe49},\n title = {Hitting the Target: Emerging Technologies in the Search
      for Kinase Substrates},\n volume = {2002},\n year = {2002}\n}\n"}, "authors":
      [{"authorId": "2339651", "name": "B. Manning"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "8c23e74cb3f0b27d00b946c82e4f67e90de121c8", "externalIds":
      {"MAG": "2133891056", "DOI": "10.1038/ncb811", "CorpusId": 13038816, "PubMed":
      "12080346"}, "corpusId": 13038816, "publicationVenue": {"id": "7d182b83-7d8d-43fb-9fd6-ae67fbafab20",
      "name": "Nature Cell Biology", "type": "journal", "alternate_names": ["Nat Cell
      Biology"], "issn": "1465-7392", "url": "http://www.nature.com/naturecellbiology",
      "alternate_urls": ["https://www.nature.com/ncb/"]}, "url": "https://www.semanticscholar.org/paper/8c23e74cb3f0b27d00b946c82e4f67e90de121c8",
      "title": "A PtdInsP3- and Rho GTPase-mediated positive feedback loop regulates
      neutrophil polarity", "abstract": null, "venue": "Nature Cell Biology", "year":
      2002, "referenceCount": 29, "citationCount": 542, "influentialCitationCount":
      27, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2823287?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2002-07-01", "journal": {"volume": "4",
      "pages": "509-513", "name": "Nature Cell Biology"}, "citationStyles": {"bibtex":
      "@Article{Weiner2002APA,\n author = {O. Weiner and Paul O. Neilsen and G. Prestwich
      and M. Kirschner and L. Cantley and H. Bourne},\n booktitle = {Nature Cell Biology},\n
      journal = {Nature Cell Biology},\n pages = {509-513},\n title = {A PtdInsP3-
      and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity},\n
      volume = {4},\n year = {2002}\n}\n"}, "authors": [{"authorId": "3528639", "name":
      "O. Weiner"}, {"authorId": "33510096", "name": "Paul O. Neilsen"}, {"authorId":
      "2565299", "name": "G. Prestwich"}, {"authorId": "40294231", "name": "M. Kirschner"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2324026", "name":
      "H. Bourne"}]}, {"paperId": "b9358d3593e10c8af9f433e9502a2c34a0662133", "externalIds":
      {"MAG": "1964659850", "DOI": "10.1073/pnas.052713899", "CorpusId": 40838184,
      "PubMed": "11867762"}, "corpusId": 40838184, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/b9358d3593e10c8af9f433e9502a2c34a0662133",
      "title": "Interferon regulatory factor-3 is an in vivo target of DNA-PK", "abstract":
      "Eukaryotic cells have evolved complex signaling networks to sense environmental
      stress and to repair stress-induced damage. IFN regulatory factor-3 (IRF-3)
      is a transcription factor that plays a central role in the host response to
      viral infection. Although the main activity of IRF-3 characterized to date has
      been its role in the induction of IFN-\u03b1 and -\u03b2 after virus infection,
      recent evidence indicates additional roles for IRF-3 in the response to DNA
      damage and in virus-induced apoptosis. Here we identify IRF-3 as the first in
      vivo target for DNA-dependent protein kinase (DNA-PK). Phosphorylation of IRF-3
      by DNA-PK after virus infection results in its nuclear retention and delayed
      proteolysis. These results expand the known roles of DNA-PK and provide a functional
      link between the cellular machineries that regulate the innate immune response
      and that sense and respond to DNA damage. As such this study contributes to
      a more integrated view of the cellular responses to various cellular stress
      signals.", "venue": "Proceedings of the National Academy of Sciences of the
      United States of America", "year": 2002, "referenceCount": 33, "citationCount":
      126, "influentialCitationCount": 12, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc122431?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2002-02-26", "journal":
      {"volume": "99", "pages": "2818 - 2823", "name": "Proceedings of the National
      Academy of Sciences of the United States of America"}, "citationStyles": {"bibtex":
      "@Article{Karpova2002InterferonRF,\n author = {A. Karpova and M. Trost and J.
      Murray and L. Cantley and P. Howley},\n booktitle = {Proceedings of the National
      Academy of Sciences of the United States of America},\n journal = {Proceedings
      of the National Academy of Sciences of the United States of America},\n pages
      = {2818 - 2823},\n title = {Interferon regulatory factor-3 is an in vivo target
      of DNA-PK},\n volume = {99},\n year = {2002}\n}\n"}, "authors": [{"authorId":
      "36006807", "name": "A. Karpova"}, {"authorId": "152124389", "name": "M. Trost"},
      {"authorId": "145517618", "name": "J. Murray"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3294583", "name": "P. Howley"}]}, {"paperId": "bc94ab46bf47a79eb2ebc93891fbca46658ad866",
      "externalIds": {"MAG": "2070732456", "DOI": "10.1126/SCIENCE.296.5573.1655",
      "CorpusId": 25108977, "PubMed": "12040186"}, "corpusId": 25108977, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/bc94ab46bf47a79eb2ebc93891fbca46658ad866",
      "title": "The phosphoinositide 3-kinase pathway.", "abstract": "Phosphorylated
      lipids are produced at cellular membranes during signaling events and contribute
      to the recruitment and activation of various signaling components. The role
      of phosphoinositide 3-kinase (PI3K), which catalyzes the production of phosphatidylinositol-3,4,5-trisphosphate,
      in cell survival pathways; the regulation of gene expression and cell metabolism;
      and cytoskeletal rearrangements are highlighted. The PI3K pathway is implicated
      in human diseases including diabetes and cancer, and understanding the intricacies
      of this pathway may provide new avenues for therapuetic intervention.", "venue":
      "Science", "year": 2002, "referenceCount": 5, "citationCount": 5539, "influentialCitationCount":
      269, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "2002-05-31", "journal": {"volume":
      "296 5573", "pages": "\n          1655-7\n        ", "name": "Science"}, "citationStyles":
      {"bibtex": "@Article{Cantley2002TheP3,\n author = {L. Cantley},\n booktitle
      = {Science},\n journal = {Science},\n pages = {\n          1655-7\n        },\n
      title = {The phosphoinositide 3-kinase pathway.},\n volume = {296 5573},\n year
      = {2002}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "db091e961df79eba4d8e009a75aa4cb1d69ccc98", "externalIds": {"MAG":
      "2129221351", "DOI": "10.1128/MCB.22.3.965-977.2002", "CorpusId": 33429041,
      "PubMed": "11784871"}, "corpusId": 33429041, "publicationVenue": {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b",
      "name": "Molecular and Cellular Biology", "type": "journal", "alternate_names":
      ["Mol Cell Biology"], "issn": "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls":
      ["http://mcb.asm.org/"]}, "url": "https://www.semanticscholar.org/paper/db091e961df79eba4d8e009a75aa4cb1d69ccc98",
      "title": "Molecular Balance between the Regulatory and Catalytic Subunits of
      Phosphoinositide 3-Kinase Regulates Cell Signaling and Survival", "abstract":
      "ABSTRACT Class Ia phosphoinositide (PI) 3-kinase is a central component in
      growth factor signaling and is comprised of a p110 catalytic subunit and a regulatory
      subunit, the most common family of which is derived from the p85\u03b1 gene
      (Pik3r1). Optimal signaling through the PI 3-kinase pathway depends on a critical
      molecular balance between the regulatory and catalytic subunits. In wild-type
      cells, the p85 subunit is more abundant than p110, leading to competition between
      the p85 monomer and the p85-p110 dimer and ineffective signaling. Heterozygous
      disruption of Pik3r1 results in increased Akt activity and decreased apoptosis
      by insulin-like growth factor 1 (IGF-1) through up-regulated phosphatidylinositol
      (3,4,5)-triphosphate production. Complete depletion of p85\u03b1, on the other
      hand, results in significantly increased apoptosis due to reduced PI 3-kinase-dependent
      signaling. Thus, a reduction in p85\u03b1 represents a novel therapeutic target
      for enhancing IGF-1/insulin signaling, prolongation of cell survival, and protection
      against apoptosis.", "venue": "Molecular and Cellular Biology", "year": 2002,
      "referenceCount": 57, "citationCount": 287, "influentialCitationCount": 14,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://mcb.asm.org/content/mcb/22/3/965.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2002-02-01", "journal": {"volume": "22",
      "pages": "965 - 977", "name": "Molecular and Cellular Biology"}, "citationStyles":
      {"bibtex": "@Article{Ueki2002MolecularBB,\n author = {K. Ueki and D. Fruman
      and D. Fruman and S. Brachmann and S. Brachmann and S. Brachmann and Y. Tseng
      and L. Cantley and L. Cantley and C. Kahn},\n booktitle = {Molecular and Cellular
      Biology},\n journal = {Molecular and Cellular Biology},\n pages = {965 - 977},\n
      title = {Molecular Balance between the Regulatory and Catalytic Subunits of
      Phosphoinositide 3-Kinase Regulates Cell Signaling and Survival},\n volume =
      {22},\n year = {2002}\n}\n"}, "authors": [{"authorId": "5177377", "name": "K.
      Ueki"}, {"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "6241317",
      "name": "D. Fruman"}, {"authorId": "3710358", "name": "S. Brachmann"}, {"authorId":
      "3710358", "name": "S. Brachmann"}, {"authorId": "3710358", "name": "S. Brachmann"},
      {"authorId": "87128090", "name": "Y. Tseng"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "144391716",
      "name": "C. Kahn"}]}, {"paperId": "ed269fcd6d673ea7773d4762d013cd10467f18b6",
      "externalIds": {"MAG": "2252774238", "DOI": "10.1128/MCB.22.8.2799-2809.2002",
      "CorpusId": 21764354, "PubMed": "11909972"}, "corpusId": 21764354, "publicationVenue":
      {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular and Cellular
      Biology", "type": "journal", "alternate_names": ["Mol Cell Biology"], "issn":
      "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]},
      "url": "https://www.semanticscholar.org/paper/ed269fcd6d673ea7773d4762d013cd10467f18b6",
      "title": "Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice", "abstract":
      "ABSTRACT One of the least-understood areas in biology is the determination
      of the size of animals and their organs. In Drosophila, components of the insulin
      receptor phosphoinositide 3-kinase (PI3K) pathway determine body, organ, and
      cell size. Several biochemical studies have suggested that Akt/protein kinase
      B is one of the important downstream targets of PI3K. To examine the role of
      Akt in the regulation of organ size in mammals, we have generated and characterized
      transgenic mice expressing constitutively active Akt (caAkt) or kinase-deficient
      Akt (kdAkt) specifically in the heart. The heart weight of caAkt transgenic
      mice was increased 2.0-fold compared with that of nontransgenic mice. The increase
      in heart size was associated with a comparable increase in myocyte cell size
      in caAkt mice. The kdAkt mutant protein attenuated the constitutively active
      PI3K-induced overgrowth of the heart, and the caAkt mutant protein circumvented
      cardiac growth retardation induced by a kinase-deficient PI3K mutant protein.
      Rapamycin attenuated caAkt-induced overgrowth of the heart, suggesting that
      the mammalian target of rapamycin (mTOR) or effectors of mTOR mediated caAkt-induced
      heart growth. In conclusion, Akt is sufficient to induce a marked increase in
      heart size and is likely to be one of the effectors of the PI3K pathway in mediating
      heart growth.", "venue": "Molecular and Cellular Biology", "year": 2002, "referenceCount":
      83, "citationCount": 531, "influentialCitationCount": 17, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc133704?pdf=render",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2002-04-01", "journal":
      {"volume": "22", "pages": "2799 - 2809", "name": "Molecular and Cellular Biology"},
      "citationStyles": {"bibtex": "@Article{Shioi2002AktProteinKB,\n author = {T.
      Shioi and J. McMullen and P. Kang and P. Douglas and T. Obata and T. Franke
      and L. Cantley and S. Izumo},\n booktitle = {Molecular and Cellular Biology},\n
      journal = {Molecular and Cellular Biology},\n pages = {2799 - 2809},\n title
      = {Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice},\n volume
      = {22},\n year = {2002}\n}\n"}, "authors": [{"authorId": "6946601", "name":
      "T. Shioi"}, {"authorId": "6688807", "name": "J. McMullen"}, {"authorId": "2302010",
      "name": "P. Kang"}, {"authorId": "1995988", "name": "P. Douglas"}, {"authorId":
      "3091430", "name": "T. Obata"}, {"authorId": "50377077", "name": "T. Franke"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "47072554", "name":
      "S. Izumo"}]}, {"paperId": "ee8682f38a69a649d631641f427778581e88bd67", "externalIds":
      {"MAG": "2788515798", "DOI": "10.1016/S1534-5807(02)00150-8", "CorpusId": 27188319,
      "PubMed": "11970891"}, "corpusId": 27188319, "publicationVenue": {"id": "744d2ff9-76f1-4f43-be2a-45775418e1a2",
      "name": "Developmental Cell", "type": "journal", "alternate_names": ["Dev Cell"],
      "issn": "1534-5807", "url": "https://www.cell.com/developmental-cell/home",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/15345807",
      "http://www.developmentalcell.com/"]}, "url": "https://www.semanticscholar.org/paper/ee8682f38a69a649d631641f427778581e88bd67",
      "title": "Lipid research picks up speed on the slopes of Taos.", "abstract":
      null, "venue": "Developmental Cell", "year": 2002, "referenceCount": 12, "citationCount":
      3, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S1534580702001508/pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["Review"],
      "publicationDate": "2002-04-01", "journal": {"volume": "2 4", "pages": "\n          407-10\n        ",
      "name": "Developmental cell"}, "citationStyles": {"bibtex": "@Article{Field2002LipidRP,\n
      author = {S. Field and K. Lamia and L. Rameh and L. Cantley},\n booktitle =
      {Developmental Cell},\n journal = {Developmental cell},\n pages = {\n          407-10\n        },\n
      title = {Lipid research picks up speed on the slopes of Taos.},\n volume = {2
      4},\n year = {2002}\n}\n"}, "authors": [{"authorId": "123039768", "name": "S.
      Field"}, {"authorId": "5493258", "name": "K. Lamia"}, {"authorId": "4109960",
      "name": "L. Rameh"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "f060372cd7c9c05c58b12cfdb817efaa651ebbfe", "externalIds": {"MAG": "2094941511",
      "DOI": "10.1016/S1097-2765(02)00568-3", "CorpusId": 14936921, "PubMed": "12150915"},
      "corpusId": 14936921, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/f060372cd7c9c05c58b12cfdb817efaa651ebbfe",
      "title": "Identification of the tuberous sclerosis complex-2 tumor suppressor
      gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.",
      "abstract": null, "venue": "Molecules and Cells", "year": 2002, "referenceCount":
      77, "citationCount": 1558, "influentialCitationCount": 111, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276502005683/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2002-07-01", "journal": {"volume": "10 1", "pages": "\n          151-62\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Manning2002IdentificationOT,\n
      author = {B. Manning and B. Manning and Andrew R. Tee and M. Logsdon and J.
      Blenis and L. Cantley and L. Cantley},\n booktitle = {Molecules and Cells},\n
      journal = {Molecular cell},\n pages = {\n          151-62\n        },\n title
      = {Identification of the tuberous sclerosis complex-2 tumor suppressor gene
      product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.},\n
      volume = {10 1},\n year = {2002}\n}\n"}, "authors": [{"authorId": "2339651",
      "name": "B. Manning"}, {"authorId": "2339651", "name": "B. Manning"}, {"authorId":
      "2273106160", "name": "Andrew R. Tee"}, {"authorId": "143800250", "name": "M.
      Logsdon"}, {"authorId": "4037343", "name": "J. Blenis"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "05fcaec1bc344b4e2ebfcb0841da85d9d5208f28", "externalIds": {"MAG": "2157917051",
      "DOI": "10.1074/JBC.M011414200", "CorpusId": 25722761, "PubMed": "11278902"},
      "corpusId": 25722761, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/05fcaec1bc344b4e2ebfcb0841da85d9d5208f28",
      "title": "Marked Differences between Metalloproteases Meprin A and B in Substrate
      and Peptide Bond Specificity*", "abstract": "Meprin A and B are highly regulated,
      secreted, and cell-surface metalloendopeptidases that are abundantly expressed
      in the kidney and intestine. Meprin oligomers consist of evolutionarily related
      \u03b1 and/or \u03b2 subunits. The work herein was carried out to identify bioactive
      peptides and proteins that are susceptible to hydrolysis by mouse meprins and
      kinetically characterize the hydrolysis. Gastrin-releasing peptide fragment
      14\u201327 and gastrin 17, regulatory molecules of the gastrointestinal tract,
      were found to be the best peptide substrates for meprin A and B, respectively.
      Peptide libraries and a variety of naturally occurring peptides revealed that
      the meprin \u03b2 subunit has a clear preference for acidic amino acids in the
      P1 and P1\u2032 sites of substrates. The meprin \u03b1 subunit selected for
      small (e.g. serine, alanine) or hydrophobic (e.g. phenylalanine) residues in
      the P1 and P1\u2032 sites, and proline was the most preferred amino acid at
      the P2\u2032 position. Thus, although the meprin \u03b1 and \u03b2 subunits
      share 55% amino acid identity within the protease domain and are normally localized
      at the same tissue cell surfaces, they have very different substrate and peptide
      bond specificities indicating different functions. Homology models of the mouse
      meprin \u03b1 and \u03b2 protease domains, based on the astacin crystal structure,
      revealed active site differences that can account for the marked differences
      in substrate specificity of the two subunits.", "venue": "Journal of Biological
      Chemistry", "year": 2001, "referenceCount": 39, "citationCount": 118, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819344473/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "2001-04-20", "journal": {"volume": "276", "pages":
      "13248 - 13255", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Bertenshaw2001MarkedDB,\n author = {G. Bertenshaw and B.
      Turk and S. Hubbard and G. Matters and J. Bylander and J. Crisman and L. Cantley
      and J. Bond},\n booktitle = {Journal of Biological Chemistry},\n journal = {The
      Journal of Biological Chemistry},\n pages = {13248 - 13255},\n title = {Marked
      Differences between Metalloproteases Meprin A and B in Substrate and Peptide
      Bond Specificity*},\n volume = {276},\n year = {2001}\n}\n"}, "authors": [{"authorId":
      "5838666", "name": "G. Bertenshaw"}, {"authorId": "25581223", "name": "B. Turk"},
      {"authorId": "145830304", "name": "S. Hubbard"}, {"authorId": "6524877", "name":
      "G. Matters"}, {"authorId": "4051561", "name": "J. Bylander"}, {"authorId":
      "34392859", "name": "J. Crisman"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "13210436", "name": "J. Bond"}]}, {"paperId": "27a932e4e03c4cb58c91c305478a9d82368c80f3",
      "externalIds": {"CorpusId": 14591803}, "corpusId": 14591803, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/27a932e4e03c4cb58c91c305478a9d82368c80f3",
      "title": "Downstream Effectors Through the Activation of Distinct Herpes Simplex
      Virus-Induced Cell Death Resistance to Encephalomyocarditis and Phosphatidylinositol
      3-Kinase Confers", "abstract": null, "venue": "", "year": 2001, "referenceCount":
      45, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Inproceedings{Prejean2001DownstreamET,\n author = {C. Prejean and
      T. Sarma and O. Kurnasov and A. Usacheva and B. Hemmings and L. Cantley and
      D. Fruman and L. Morrison and R. Buller and O. Colamonici},\n title = {Downstream
      Effectors Through the Activation of Distinct Herpes Simplex Virus-Induced Cell
      Death Resistance to Encephalomyocarditis and Phosphatidylinositol 3-Kinase Confers},\n
      year = {2001}\n}\n"}, "authors": [{"authorId": "49918065", "name": "C. Prejean"},
      {"authorId": "39939310", "name": "T. Sarma"}, {"authorId": "6048665", "name":
      "O. Kurnasov"}, {"authorId": "8986504", "name": "A. Usacheva"}, {"authorId":
      "2384507", "name": "B. Hemmings"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "31973366", "name":
      "L. Morrison"}, {"authorId": "143637244", "name": "R. Buller"}, {"authorId":
      "6324275", "name": "O. Colamonici"}]}, {"paperId": "40780fbb1e8cccabe504151e7ef73df1326d01b6",
      "externalIds": {"MAG": "2148997157", "DOI": "10.1074/JBC.M100602200", "CorpusId":
      22572629, "PubMed": "11297548"}, "corpusId": 22572629, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/40780fbb1e8cccabe504151e7ef73df1326d01b6",
      "title": "Growth Factor-specific Signaling Pathway Stimulation and Gene Expression
      Mediated by ErbB Receptors* 210", "abstract": "The mechanisms by which receptor
      tyrosine kinases (RTKs) utilize intracellular signaling pathways to direct gene
      expression and cellular response remain unclear. A current question is whether
      different RTKs within a single cell target similar or different sets of genes.
      In this study we have used the ErbB receptor network to explore the relationship
      between RTK activation and gene expression. We profiled growth factor-stimulated
      signaling pathway usage and broad gene expression patterns in two human mammary
      tumor cell lines expressing different complements of ErbB receptors. Although
      the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly
      stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2
      heterodimer preferentially stimulated protein kinase C, and NRG1\u03b2 acting
      through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt. The two growth
      factors regulated partially overlapping yet distinct sets of genes in these
      cells. In MDA-MB-453 cells, NRG1\u03b2 acting through an ErbB2/ErbB3 heterodimer
      stimulated prolonged signaling of all pathways examined relative to NRG2\u03b2
      acting through the same heterodimeric receptor species. Surprisingly, NRG1\u03b2
      and NRG2\u03b2 also regulated partially overlapping but distinct sets of genes
      in these cells. These results demonstrate that the activation of different RTKs,
      or activation of the same RTKs with different ligands, can lead to distinct
      profiles of gene regulation within a single cell type. Our observations also
      suggest that the identity and kinetics of signaling pathway usage by RTKs may
      play a role in the selection of regulated genes.", "venue": "Journal of Biological
      Chemistry", "year": 2001, "referenceCount": 57, "citationCount": 120, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925820785571/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2001-06-22", "journal": {"volume": "276", "pages": "22685
      - 22698", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Sweeney2001GrowthFS,\n author = {C. Sweeney and D. Fambrough
      and C. Huard and A. Diamonti and E. Lander and L. Cantley and K. L. Carraway},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {22685 - 22698},\n title = {Growth Factor-specific Signaling
      Pathway Stimulation and Gene Expression Mediated by ErbB Receptors* 210},\n
      volume = {276},\n year = {2001}\n}\n"}, "authors": [{"authorId": "40187510",
      "name": "C. Sweeney"}, {"authorId": "5271873", "name": "D. Fambrough"}, {"authorId":
      "5899757", "name": "C. Huard"}, {"authorId": "48917515", "name": "A. Diamonti"},
      {"authorId": "9311320", "name": "E. Lander"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "153075552", "name": "K. L. Carraway"}]}, {"paperId":
      "45cc15f59fdf15bdeda88a8cbe53a835671ebfce", "externalIds": {"MAG": "2118469376",
      "DOI": "10.1073/pnas.012581799", "CorpusId": 30402101, "PubMed": "11752399"},
      "corpusId": 30402101, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/45cc15f59fdf15bdeda88a8cbe53a835671ebfce",
      "title": "Increased insulin sensitivity in mice lacking p85\u03b2 subunit of
      phosphoinositide 3-kinase", "abstract": "On the basis of ex vivo studies using
      insulin-responsive cells, activation of a Class IA phosphoinositide 3-kinase
      (PI3K) seems to be required for a wide variety of cellular responses downstream
      of insulin. The Class IA PI3K enzymes are heterodimers of catalytic and regulatory
      subunits. In mammals, insulin-responsive tissues express both the p85\u03b1
      and p85\u03b2 isoforms of the regulatory subunit. Surprisingly, recent studies
      have revealed that disruption of the p85\u03b1 gene in the mouse (p85\u03b1\u2212/\u2212
      mice) results in hypoglycemia with decreased plasma insulin, and the p85\u03b1+/\u2212
      mice exhibit significantly increased insulin sensitivity. These results suggest
      either that p85\u03b1 negatively regulates insulin signaling, or that p85\u03b2,
      which mediates the major fraction of Class IA PI3K signaling in the absence
      of p85\u03b1, is more efficient than p85\u03b1 in mediating insulin responses.
      To address this question, we have generated mice in which the p85\u03b2 gene
      is deleted (p85\u03b2\u2212/\u2212 mice). As with the p85\u03b1\u2212/\u2212
      mice, the p85\u03b2\u2212/\u2212 mice showed hypoinsulinemia, hypoglycemia,
      and improved insulin sensitivity. At the molecular level, PI3K activity associated
      with phosphotyrosine complexes was preserved despite a 20\u201330% reduction
      in the total protein level of the regulatory subunits. Moreover, insulin-induced
      activation of AKT was significantly up-regulated in muscle from the p85\u03b2\u2212/\u2212
      mice. In addition, insulin-dependent tyrosine phosphorylation of insulin receptor
      substrate-2 was enhanced in the p85\u03b2\u2212/\u2212 mice, a phenotype not
      observed in the p85\u03b1\u2212/\u2212 mice. These results indicate that in
      addition to their roles in recruiting the catalytic subunit of PI3K to the insulin
      receptor substrate proteins, both p85\u03b1 and p85\u03b2 play negative roles
      in insulin signaling.", "venue": "Proceedings of the National Academy of Sciences
      of the United States of America", "year": 2001, "referenceCount": 38, "citationCount":
      252, "influentialCitationCount": 10, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc117575?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2001-12-18", "journal":
      {"volume": "99", "pages": "419 - 424", "name": "Proceedings of the National
      Academy of Sciences of the United States of America"}, "citationStyles": {"bibtex":
      "@Article{Ueki2001IncreasedIS,\n author = {K. Ueki and C. Yballe and S. Brachmann
      and D. Vicent and J. Watt and C. Kahn and L. Cantley},\n booktitle = {Proceedings
      of the National Academy of Sciences of the United States of America},\n journal
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      pages = {419 - 424},\n title = {Increased insulin sensitivity in mice lacking
      p85\u03b2 subunit of phosphoinositide 3-kinase},\n volume = {99},\n year = {2001}\n}\n"},
      "authors": [{"authorId": "5177377", "name": "K. Ueki"}, {"authorId": "7777071",
      "name": "C. Yballe"}, {"authorId": "3710358", "name": "S. Brachmann"}, {"authorId":
      "9928532", "name": "D. Vicent"}, {"authorId": "40474206", "name": "J. Watt"},
      {"authorId": "144391716", "name": "C. Kahn"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "7d1a6ed048fc0bb7462b0625ab3e254a2389e0dc", "externalIds":
      {"CorpusId": 252035666}, "corpusId": 252035666, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/7d1a6ed048fc0bb7462b0625ab3e254a2389e0dc",
      "title": "Growth Factor-Specific Signaling Pathway Stimulation and Gene Expression
      Mediated by ErbB Receptors", "abstract": "The mechanisms by which receptor tyrosine
      kinases (RTKs) utilize intracellular signaling pathways to direct gene expression
      and cellular response remain unclear. A current question is whether different
      RTKs within a single cell target similar or different sets of genes. In this
      study we have used the ErbB receptor network to explore the relationship between
      RTK activation and gene expression. We profiled growth factor-stimulated signaling
      pathway usage and broad gene expression patterns in two human mammary tumor
      cell lines expressing different complements of ErbB receptors. While the growth
      factors EGF and NRG1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting
      through an EGF receptor/ErbB2 heterodimer preferentially stimulated PKC, and
      NRG1 \u03b2 acting through an ErbB2/ErbB3 heterodimer preferentially stimulated
      Akt. The two growth factors regulated partially overlapping yet distinct sets
      of genes in these cells. In MDA-MB-453 cells, NRG1 \u03b2 acting through an
      ErbB2/ErbB3 heterodimer stimulated prolonged signaling of all pathways examined
      relative to NRG2 \u03b2 acting through the same heterodimeric receptor species.
      Surprisingly, NRG1 \u03b2 and NRG2 \u03b2 also regulated partially overlapping
      but distinct sets of genes in these cells. These results demonstrate that the
      activation of different RTKs, or activation of the same RTKs with different
      ligands, can lead to distinct profiles of gene regulation within a single cell
      type. Our observations also suggest that the identity and kinetics of signaling
      pathway usage by RTKs may play a role in the selection of regulated genes. lysed
      1 ml 1X sample \u00b5 l lysates phosphorylated anti-pAkt(S473), rabbit anti-pp70(T389,
      T421, S424), rabbit anti-pp90(S381), anti-pPKC(pan), rabbit anti-phospho-c-Myc(T58,
      S62), rabbit anti-phospho-c-Jun(S63, S73), and rabbit anti-pCREB(S133). Filters
      were stripped and re-probed with antibodies to actin (Sigma).", "venue": "",
      "year": 2001, "referenceCount": 0, "citationCount": 18, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Sweeney2001GrowthFS,\n
      author = {C. Sweeney and D. Fambrough and C. Huard and A. Diamonti and S. Eric
      and Lander and L. Cantley and K. Carraway},\n title = {Growth Factor-Specific
      Signaling Pathway Stimulation and Gene Expression Mediated by ErbB Receptors},\n
      year = {2001}\n}\n"}, "authors": [{"authorId": "40187510", "name": "C. Sweeney"},
      {"authorId": "5271873", "name": "D. Fambrough"}, {"authorId": "5899757", "name":
      "C. Huard"}, {"authorId": "48917515", "name": "A. Diamonti"}, {"authorId": "89333493",
      "name": "S. Eric"}, {"authorId": "2094986476", "name": "Lander"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "145331905", "name": "K. Carraway"}]},
      {"paperId": "82e23963895661958ecbb80f43c651a88ebe3d86", "externalIds": {"MAG":
      "2170516740", "DOI": "10.1172/JCI12874", "CorpusId": 33120473, "PubMed": "11696584"},
      "corpusId": 33120473, "publicationVenue": {"id": "8c9a9e1b-acf2-4274-8d73-6ea0ecd11fd1",
      "name": "Journal of Clinical Investigation", "type": "journal", "alternate_names":
      ["J Clin Investig"], "issn": "0021-9738", "url": "https://www.jci.org/", "alternate_urls":
      ["http://www.jci.org/", "https://www.jci.org/archive", "http://www.jci.org/impact"]},
      "url": "https://www.semanticscholar.org/paper/82e23963895661958ecbb80f43c651a88ebe3d86",
      "title": "Phosphatidylinositol 3-kinase-dependent activation of trypsinogen
      modulates the severity of acute pancreatitis.", "abstract": "Intra-acinar cell
      activation of digestive enzyme zymogens including trypsinogen is generally believed
      to be an early and critical event in acute pancreatitis. We have found that
      the phosphatidylinositol 3-kinase inhibitor wortmannin can reduce the intrapancreatic
      activation of trypsinogen that occurs during two dissimilar experimental models
      of rodent acute pancreatitis, secretagogue- and duct injection-induced pancreatitis.
      The severity of both models was also reduced by wortmannin administration. In
      contrast, the NF-kappa B activation that occurs during the early stages of secretagogue-induced
      pancreatitis is not altered by administration of wortmannin. Ex vivo, caerulein-induced
      trypsinogen activation is inhibited by wortmannin and LY294002. However, the
      cytoskeletal changes induced by caerulein were not affected by wortmannin. Concentrations
      of caerulein that induced ex vivo trypsinogen activation do not significantly
      increase phosphatidylinositol-3,4-bisphosphate or phosphatidylinositol 3,4,5-trisphosphate
      levels or induce phosphorylation of Akt/PKB, suggesting that class I phosphatidylinositol
      3-kinases are not involved. The concentration of wortmannin that inhibits trypsinogen
      activation causes a 75% decrease in phosphatidylinositol 3-phosphate, which
      is implicated in vesicle trafficking and fusion. We conclude that a wortmannin-inhibitable
      phosphatidylinositol 3-kinase is necessary for intrapancreatic activation of
      trypsinogen and regulating the severity of acute pancreatitis. Our observations
      suggest that phosphatidylinositol 3-kinase inhibition might be of benefit in
      preventing acute pancreatitis.", "venue": "Journal of Clinical Investigation",
      "year": 2001, "referenceCount": 34, "citationCount": 120, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "2001-11-01", "journal": {"volume": "108 9", "pages": "\n          1387-95\n        ",
      "name": "The Journal of clinical investigation"}, "citationStyles": {"bibtex":
      "@Article{Singh2001Phosphatidylinositol3A,\n author = {V. P. Singh and A. Saluja
      and L. Bhagat and G. V. Acker and A. Song and S. Soltoff and L. Cantley and
      M. Steer and M. Steer},\n booktitle = {Journal of Clinical Investigation},\n
      journal = {The Journal of clinical investigation},\n pages = {\n          1387-95\n        },\n
      title = {Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates
      the severity of acute pancreatitis.},\n volume = {108 9},\n year = {2001}\n}\n"},
      "authors": [{"authorId": "2193044151", "name": "V. P. Singh"}, {"authorId":
      "3243764", "name": "A. Saluja"}, {"authorId": "4197684", "name": "L. Bhagat"},
      {"authorId": "35001075", "name": "G. V. Acker"}, {"authorId": "32459743", "name":
      "A. Song"}, {"authorId": "4324390", "name": "S. Soltoff"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2840737", "name": "M. Steer"}, {"authorId":
      "2840737", "name": "M. Steer"}]}, {"paperId": "95a5e7d238d2f998b983a19a6f3c2ee17034a244",
      "externalIds": {"MAG": "2104467943", "PubMedCentral": "2150784", "DOI": "10.1083/jcb.200107069",
      "CorpusId": 3336237, "PubMed": "11581283"}, "corpusId": 3336237, "publicationVenue":
      {"id": "bf59074e-18fd-4f9a-a1b0-a9bafc16f518", "name": "Journal of Cell Biology",
      "type": "journal", "alternate_names": ["J Cell Biology"], "issn": "0021-9525",
      "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=482",
      "alternate_urls": ["http://www.jstor.org/journals/00219525.html", "https://www.jstor.org/journal/jcellbiology",
      "http://www.jcb.org/"]}, "url": "https://www.semanticscholar.org/paper/95a5e7d238d2f998b983a19a6f3c2ee17034a244",
      "title": "Distinct roles of class I and class III phosphatidylinositol 3-kinases
      in phagosome formation and maturation", "abstract": "Phagosomes acquire their
      microbicidal properties by fusion with lysosomes. Products of phosphatidylinositol
      3-kinase (PI 3-kinase) are required for phagosome formation, but their role
      in maturation is unknown. Using chimeric fluorescent proteins encoding tandem
      FYVE domains, we found that phosphatidylinositol 3-phosphate (PI[3]P) accumulates
      greatly but transiently on the phagosomal membrane. Unlike the 3\u2032-phosphoinositides
      generated by class I PI 3-kinases which are evident in the nascent phagosomal
      cup, PI(3)P is only detectable after the phagosome has sealed. The class III
      PI 3-kinase VPS34 was found to be responsible for PI(3)P synthesis and essential
      for phagolysosome formation. In contrast, selective ablation of class I PI 3-kinase
      revealed that optimal phagocytosis, but not maturation, requires this type of
      enzyme. These results highlight the differential functional role of the two
      families of kinases, and raise the possibility that PI(3)P production by VPS34
      may be targeted during the maturation arrest induced by some intracellular parasites.",
      "venue": "Journal of Cell Biology", "year": 2001, "referenceCount": 26, "citationCount":
      533, "influentialCitationCount": 30, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://rupress.org/jcb/article-pdf/155/1/19/1300581/jcb155119.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2001-10-01", "journal": {"volume": "155",
      "pages": "19 - 26", "name": "The Journal of Cell Biology"}, "citationStyles":
      {"bibtex": "@Article{Vieira2001DistinctRO,\n author = {Ot\u00edlia V. Vieira
      and R. Botelho and L. Rameh and S. Brachmann and T. Matsuo and H. Davidson and
      A. Schreiber and J. Backer and L. Cantley and S. Grinstein},\n booktitle = {Journal
      of Cell Biology},\n journal = {The Journal of Cell Biology},\n pages = {19 -
      26},\n title = {Distinct roles of class I and class III phosphatidylinositol
      3-kinases in phagosome formation and maturation},\n volume = {155},\n year =
      {2001}\n}\n"}, "authors": [{"authorId": "4383992", "name": "Ot\u00edlia V. Vieira"},
      {"authorId": "16066763", "name": "R. Botelho"}, {"authorId": "4109960", "name":
      "L. Rameh"}, {"authorId": "3710358", "name": "S. Brachmann"}, {"authorId": "92795093",
      "name": "T. Matsuo"}, {"authorId": "40343004", "name": "H. Davidson"}, {"authorId":
      "36178153", "name": "A. Schreiber"}, {"authorId": "35244019", "name": "J. Backer"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6104144", "name":
      "S. Grinstein"}]}, {"paperId": "a4bd3fa1f9d47b52800894f2a3cbce8e3e7d0043", "externalIds":
      {"MAG": "2123558789", "DOI": "10.1016/S1097-2765(01)00258-1", "CorpusId": 33675567,
      "PubMed": "11430832"}, "corpusId": 33675567, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/a4bd3fa1f9d47b52800894f2a3cbce8e3e7d0043",
      "title": "The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent
      cell death.", "abstract": null, "venue": "Molecules and Cells", "year": 2001,
      "referenceCount": 36, "citationCount": 338, "influentialCitationCount": 17,
      "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S1097276501002581/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2001-06-01", "journal": {"volume": "7 6", "pages": "\n          1307-19\n        ",
      "name": "Molecular cell"}, "citationStyles": {"bibtex": "@Article{Karuman2001ThePG,\n
      author = {P. Karuman and O. Gozani and R. Odze and X. Zhou and Hong Zhu and
      R. Shaw and T. Brien and Christopher D. Bozzuto and D. Ooi and L. Cantley and
      Junying Yuan},\n booktitle = {Molecules and Cells},\n journal = {Molecular cell},\n
      pages = {\n          1307-19\n        },\n title = {The Peutz-Jegher gene product
      LKB1 is a mediator of p53-dependent cell death.},\n volume = {7 6},\n year =
      {2001}\n}\n"}, "authors": [{"authorId": "6519399", "name": "P. Karuman"}, {"authorId":
      "6896988", "name": "O. Gozani"}, {"authorId": "4798074", "name": "R. Odze"},
      {"authorId": "2229617944", "name": "X. Zhou"}, {"authorId": "2149669709", "name":
      "Hong Zhu"}, {"authorId": "4426388", "name": "R. Shaw"}, {"authorId": "25598868",
      "name": "T. Brien"}, {"authorId": "2229676992", "name": "Christopher D. Bozzuto"},
      {"authorId": "21764505", "name": "D. Ooi"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "40146895", "name": "Junying Yuan"}]}, {"paperId":
      "aa0f9a9da2077c7b3ff472308d68abac5a75733b", "externalIds": {"MAG": "2074058888",
      "DOI": "10.1038/nbt1201-1148", "CorpusId": 485155, "PubMed": "11731784"}, "corpusId":
      485155, "publicationVenue": {"id": "458166b3-de17-4bf3-bbbb-e53782de2f0f", "name":
      "Nature Biotechnology", "type": "journal", "alternate_names": ["Nat Biotechnol"],
      "issn": "1087-0156", "url": "http://www.nature.com/nbt/", "alternate_urls":
      ["http://www.nature.com/nbt"]}, "url": "https://www.semanticscholar.org/paper/aa0f9a9da2077c7b3ff472308d68abac5a75733b",
      "title": "In vivo near-infrared fluorescence imaging of osteoblastic activity",
      "abstract": null, "venue": "Nature Biotechnology", "year": 2001, "referenceCount":
      35, "citationCount": 362, "influentialCitationCount": 3, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Materials Science", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2001-12-01", "journal": {"volume": "19", "pages": "1148-1154",
      "name": "Nature Biotechnology"}, "citationStyles": {"bibtex": "@Article{Zaheer2001InVN,\n
      author = {A. Zaheer and R. Lenkinski and A. Mahmood and Alun G. Jones and L.
      Cantley and J. Frangioni},\n booktitle = {Nature Biotechnology},\n journal =
      {Nature Biotechnology},\n pages = {1148-1154},\n title = {In vivo near-infrared
      fluorescence imaging of osteoblastic activity},\n volume = {19},\n year = {2001}\n}\n"},
      "authors": [{"authorId": "2571809", "name": "A. Zaheer"}, {"authorId": "2177723",
      "name": "R. Lenkinski"}, {"authorId": "39119051", "name": "A. Mahmood"}, {"authorId":
      "3084194", "name": "Alun G. Jones"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "1788876", "name": "J. Frangioni"}]}, {"paperId": "aad734bd4a3d0ce98a4f5ce204b9d9e837fdb64a",
      "externalIds": {"DOI": "10.1126/science.1062796", "CorpusId": 42509408}, "corpusId":
      42509408, "publicationVenue": {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad",
      "name": "Science", "type": "journal", "issn": "0193-4511", "alternate_issns":
      ["0036-8075"], "url": "https://www.jstor.org/journal/science", "alternate_urls":
      ["https://www.sciencemag.org/", "http://www.sciencemag.org/", "http://www.jstor.org/journals/00368075.html",
      "http://www.sciencemag.org/archive/"]}, "url": "https://www.semanticscholar.org/paper/aad734bd4a3d0ce98a4f5ce204b9d9e837fdb64a",
      "title": "Translocating Tubby", "abstract": null, "venue": "Science", "year":
      2001, "referenceCount": 0, "citationCount": 15, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [], "publicationTypes": null, "publicationDate": "2001-06-15", "journal": {"volume":
      "292", "pages": "2019 - 2021", "name": "Science"}, "citationStyles": {"bibtex":
      "@Article{Cantley2001TranslocatingT,\n author = {L. Cantley},\n booktitle =
      {Science},\n journal = {Science},\n pages = {2019 - 2021},\n title = {Translocating
      Tubby},\n volume = {292},\n year = {2001}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "b0e46f5ce2e84cefbcacad5627c811341570443a",
      "externalIds": {"MAG": "1517631297", "DOI": "10.1038/35083070", "CorpusId":
      32649658, "PubMed": "11433300"}, "corpusId": 32649658, "publicationVenue": {"id":
      "7d182b83-7d8d-43fb-9fd6-ae67fbafab20", "name": "Nature Cell Biology", "type":
      "journal", "alternate_names": ["Nat Cell Biology"], "issn": "1465-7392", "url":
      "http://www.nature.com/naturecellbiology", "alternate_urls": ["https://www.nature.com/ncb/"]},
      "url": "https://www.semanticscholar.org/paper/b0e46f5ce2e84cefbcacad5627c811341570443a",
      "title": "The PX domains of p47phox and p40phox bind to lipid products of PI(3)K",
      "abstract": null, "venue": "Nature Cell Biology", "year": 2001, "referenceCount":
      31, "citationCount": 620, "influentialCitationCount": 40, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2001-07-01", "journal": {"volume": "3", "pages": "675-678",
      "name": "Nature Cell Biology"}, "citationStyles": {"bibtex": "@Article{Kanai2001ThePD,\n
      author = {F. Kanai and Hui Liu and S. Field and Hares Akbary and T. Matsuo and
      G. Brown and L. Cantley and M. Yaffe},\n booktitle = {Nature Cell Biology},\n
      journal = {Nature Cell Biology},\n pages = {675-678},\n title = {The PX domains
      of p47phox and p40phox bind to lipid products of PI(3)K},\n volume = {3},\n
      year = {2001}\n}\n"}, "authors": [{"authorId": "36196723", "name": "F. Kanai"},
      {"authorId": "2146672868", "name": "Hui Liu"}, {"authorId": "123039768", "name":
      "S. Field"}, {"authorId": "2084848622", "name": "Hares Akbary"}, {"authorId":
      "92795093", "name": "T. Matsuo"}, {"authorId": "2219979", "name": "G. Brown"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "88402408", "name":
      "M. Yaffe"}]}, {"paperId": "c4f1e5a8fb5ad48b7bbaa08d39b770eb785eebad", "externalIds":
      {"MAG": "1555862556", "DOI": "10.1038/90273", "CorpusId": 13510196, "PubMed":
      "11433279"}, "corpusId": 13510196, "publicationVenue": {"id": "458166b3-de17-4bf3-bbbb-e53782de2f0f",
      "name": "Nature Biotechnology", "type": "journal", "alternate_names": ["Nat
      Biotechnol"], "issn": "1087-0156", "url": "http://www.nature.com/nbt/", "alternate_urls":
      ["http://www.nature.com/nbt"]}, "url": "https://www.semanticscholar.org/paper/c4f1e5a8fb5ad48b7bbaa08d39b770eb785eebad",
      "title": "Determination of protease cleavage site motifs using mixture-based
      oriented peptide libraries", "abstract": null, "venue": "Nature Biotechnology",
      "year": 2001, "referenceCount": 39, "citationCount": 533, "influentialCitationCount":
      25, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2001-07-01", "journal": {"volume": "19",
      "pages": "661-667", "name": "Nature Biotechnology"}, "citationStyles": {"bibtex":
      "@Article{Turk2001DeterminationOP,\n author = {B. Turk and Lisa L. Huang and
      Elizabeth T. Piro and L. Cantley},\n booktitle = {Nature Biotechnology},\n journal
      = {Nature Biotechnology},\n pages = {661-667},\n title = {Determination of protease
      cleavage site motifs using mixture-based oriented peptide libraries},\n volume
      = {19},\n year = {2001}\n}\n"}, "authors": [{"authorId": "25581223", "name":
      "B. Turk"}, {"authorId": "2111011719", "name": "Lisa L. Huang"}, {"authorId":
      "2071966448", "name": "Elizabeth T. Piro"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "ced21c9721e29e64a24edc1977523ddbd39b21e7", "externalIds":
      {"MAG": "1493799579", "DOI": "10.1038/86737", "CorpusId": 22637369, "PubMed":
      "11283593"}, "corpusId": 22637369, "publicationVenue": {"id": "458166b3-de17-4bf3-bbbb-e53782de2f0f",
      "name": "Nature Biotechnology", "type": "journal", "alternate_names": ["Nat
      Biotechnol"], "issn": "1087-0156", "url": "http://www.nature.com/nbt/", "alternate_urls":
      ["http://www.nature.com/nbt"]}, "url": "https://www.semanticscholar.org/paper/ced21c9721e29e64a24edc1977523ddbd39b21e7",
      "title": "A motif-based profile scanning approach for genome-wide prediction
      of signaling pathways", "abstract": null, "venue": "Nature Biotechnology", "year":
      2001, "referenceCount": 32, "citationCount": 549, "influentialCitationCount":
      22, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Computer Science", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2001-04-01", "journal":
      {"volume": "19", "pages": "348-353", "name": "Nature Biotechnology"}, "citationStyles":
      {"bibtex": "@Article{Yaffe2001AMP,\n author = {M. Yaffe and G. Leparc and J.
      Lai and T. Obata and S. Volinia and L. Cantley},\n booktitle = {Nature Biotechnology},\n
      journal = {Nature Biotechnology},\n pages = {348-353},\n title = {A motif-based
      profile scanning approach for genome-wide prediction of signaling pathways},\n
      volume = {19},\n year = {2001}\n}\n"}, "authors": [{"authorId": "88402408",
      "name": "M. Yaffe"}, {"authorId": "39756254", "name": "G. Leparc"}, {"authorId":
      "5000276", "name": "J. Lai"}, {"authorId": "3091430", "name": "T. Obata"}, {"authorId":
      "1906416", "name": "S. Volinia"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "030678b47521ce0566887c331dd02fc2f8e1a88f", "externalIds": {"MAG":
      "1567219202", "DOI": "10.1038/81715", "CorpusId": 8376820, "PubMed": "11062485"},
      "corpusId": 8376820, "publicationVenue": {"id": "bb27e645-e57c-42c3-bcbc-c7b443c58209",
      "name": "Nature Genetics", "type": "journal", "alternate_names": ["Nat Genet"],
      "issn": "1061-4036", "url": "http://www.nature.com/ng/", "alternate_urls": ["http://www.nature.com/ng/index.html"]},
      "url": "https://www.semanticscholar.org/paper/030678b47521ce0566887c331dd02fc2f8e1a88f",
      "title": "Hypoglycaemia, liver necrosis and perinatal death in mice lacking
      all isoforms of phosphoinositide 3-kinase p85\u03b1", "abstract": null, "venue":
      "Nature Genetics", "year": 2000, "referenceCount": 28, "citationCount": 311,
      "influentialCitationCount": 10, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2000-11-01", "journal":
      {"volume": "26", "pages": "379-382", "name": "Nature Genetics"}, "citationStyles":
      {"bibtex": "@Article{Fruman2000HypoglycaemiaLN,\n author = {D. Fruman and F.
      Mauvais-Jarvis and Daniel A. Pollard and C. Yballe and D. Brazil and R. Bronson
      and C. Kahn and L. Cantley},\n booktitle = {Nature Genetics},\n journal = {Nature
      Genetics},\n pages = {379-382},\n title = {Hypoglycaemia, liver necrosis and
      perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85\u03b1},\n
      volume = {26},\n year = {2000}\n}\n"}, "authors": [{"authorId": "6241317", "name":
      "D. Fruman"}, {"authorId": "1396480779", "name": "F. Mauvais-Jarvis"}, {"authorId":
      "3055031", "name": "Daniel A. Pollard"}, {"authorId": "7777071", "name": "C.
      Yballe"}, {"authorId": "5592218", "name": "D. Brazil"}, {"authorId": "40803408",
      "name": "R. Bronson"}, {"authorId": "144391716", "name": "C. Kahn"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "037b7f4432f45323733731eb9b9b86d25ab38d7e",
      "externalIds": {"CorpusId": 1805846, "PubMed": "10681597"}, "corpusId": 1805846,
      "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal
      of Biological Chemistry", "type": "journal", "alternate_names": ["J Biological
      Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/037b7f4432f45323733731eb9b9b86d25ab38d7e",
      "title": "Impaired kit- but not FcepsilonRI-initiated mast cell activation in
      the absence of phosphoinositide 3-kinase p85alpha gene products.", "abstract":
      "The class I(A) phosphoinositide 3-kinases (PI3Ks) consist of a 110-kDa catalytic
      domain and a regulatory subunit encoded by the p85alpha, p85beta, or p55gamma
      genes. We have determined the effects of disrupting the p85alpha gene on the
      responses of mast cells stimulated by the cross-linking of Kit and FcepsilonRI,
      receptors that reflect innate and adaptive responses, respectively. The absence
      of p85alpha gene products partially inhibited Kit ligand/stem cell factor-induced
      secretory granule exocytosis, proliferation, and phosphorylation of the serine/threonine
      kinase Akt. In contrast, p85alpha gene products were not required for FcepsilonRI-initiated
      exocytosis and phosphorylation of Akt. LY294002, which inhibits all classes
      of PI3Ks, strongly suppressed Kit- and FcepsilonRI-induced responses in p85alpha
      -/- mast cells, revealing the contribution of another PI3K family member(s).
      In contrast to B lymphocytes, mast cell proliferation was not dependent on Bruton''s
      tyrosine kinase, a downstream effector of PI3K, revealing a distinct pathway
      of PI3K-dependent proliferation in mast cells. Our findings represent the first
      example of receptor-specific usage of different PI3K family members in a single
      cell type. In addition, because Kit- but not FcepsilonRI-initiated signaling
      is associated with mast cell proliferation, the results provide evidence that
      distinct biologic functions signaled by these two receptors may reflect differential
      usage of PI3Ks.", "venue": "Journal of Biological Chemistry", "year": 2000,
      "referenceCount": 0, "citationCount": 34, "influentialCitationCount": 1, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      null, "journal": {"volume": "275 8", "pages": "\n          6022-9\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Lu-Kuo2000ImpairedKB,\n author = {J. Lu-Kuo and D. Fruman and D. M.
      Joyal and L. Cantley and H. Katz},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of biological chemistry},\n pages = {\n          6022-9\n        },\n
      title = {Impaired kit- but not FcepsilonRI-initiated mast cell activation in
      the absence of phosphoinositide 3-kinase p85alpha gene products.},\n volume
      = {275 8},\n year = {2000}\n}\n"}, "authors": [{"authorId": "1403245024", "name":
      "J. Lu-Kuo"}, {"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "88707799",
      "name": "D. M. Joyal"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3648966", "name": "H. Katz"}]}, {"paperId": "1150af2454a992b78864391dee8e4bd57e766fac",
      "externalIds": {"MAG": "11510632", "DOI": "10.1038/35036447", "CorpusId": 511112,
      "PubMed": "11025682"}, "corpusId": 511112, "publicationVenue": {"id": "7d182b83-7d8d-43fb-9fd6-ae67fbafab20",
      "name": "Nature Cell Biology", "type": "journal", "alternate_names": ["Nat Cell
      Biology"], "issn": "1465-7392", "url": "http://www.nature.com/naturecellbiology",
      "alternate_urls": ["https://www.nature.com/ncb/"]}, "url": "https://www.semanticscholar.org/paper/1150af2454a992b78864391dee8e4bd57e766fac",
      "title": "Phosphoinositide biology \u2013 messages from lipids", "abstract":
      null, "venue": "Nature Cell Biology", "year": 2000, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "2000-10-01", "journal":
      {"volume": "2", "pages": "E190-E190", "name": "Nature Cell Biology"}, "citationStyles":
      {"bibtex": "@Article{Luo2000PhosphoinositideB,\n author = {Ji Luo and L. Cantley},\n
      booktitle = {Nature Cell Biology},\n journal = {Nature Cell Biology},\n pages
      = {E190-E190},\n title = {Phosphoinositide biology \u2013 messages from lipids},\n
      volume = {2},\n year = {2000}\n}\n"}, "authors": [{"authorId": "145954100",
      "name": "Ji Luo"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "18d826bf92792aca513ee4adc120452d781808ce", "externalIds": {"MAG": "2016125507",
      "DOI": "10.1074/JBC.C901015199", "CorpusId": 11445441, "PubMed": "10867024"},
      "corpusId": 11445441, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/18d826bf92792aca513ee4adc120452d781808ce",
      "title": "Ligand Discrimination in Signaling through an ErbB4 Receptor Homodimer*",
      "abstract": "The epidermal growth factor (EGF)-like family of growth factors
      elicits cellular responses by stimulating the dimerization, autophosphorylation,
      and tyrosine kinase activities of the ErbB family of receptor tyrosine kinases.
      Although several different EGF-like ligands are capable of binding to a single
      ErbB family member, it is generally thought that the biological and biochemical
      responses of a single receptor dimer to different ligands are indistinguishable.
      To test whether an ErbB receptor dimer is capable of discriminating among ligands
      we have examined the effect of four EGF-like growth factors on signaling through
      the ErbB4 receptor homodimer in CEM/HER4 cells, a transfected human T cell line
      ectopically expressing ErbB4 in an ErbB-null background. Despite stimulating
      similar levels of gross receptor tyrosine phosphorylation, the EGF-like growth
      factors betacellulin, neuregulin-1\u03b2, neuregulin-2\u03b2, and neuregulin-3
      exhibited different biological potencies in a cellular growth assay. Moreover,
      the different ligands induced different patterns of recruitment of intracellular
      signaling proteins to the activated receptor and induced differential usage
      of intracellular kinase signaling cascades. Finally, two-dimensional phosphopeptide
      mapping of ligand-stimulated ErbB4 revealed that the different growth factors
      induce different patterns of receptor tyrosine phosphorylation. These results
      indicate that ErbB4 activation by growth factors is not generic and suggest
      that individual ErbB receptors can discriminate between different EGF-like ligands
      within the context of a single receptor dimer. More generally, our observations
      significantly modify our understanding of signaling through receptor tyrosine
      kinases and point to a number of possible models for ligand-mediated signal
      diversification.", "venue": "Journal of Biological Chemistry", "year": 2000,
      "referenceCount": 32, "citationCount": 121, "influentialCitationCount": 5, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819800534/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2000-06-30", "journal": {"volume": "275",
      "pages": "19803 - 19807", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Sweeney2000LigandDI,\n author = {C. Sweeney and Cary Lai
      and D. Riese and A. Diamonti and L. Cantley and K. L. Carraway},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {19803 - 19807},\n title = {Ligand Discrimination in Signaling
      through an ErbB4 Receptor Homodimer*},\n volume = {275},\n year = {2000}\n}\n"},
      "authors": [{"authorId": "40187510", "name": "C. Sweeney"}, {"authorId": "2148764882",
      "name": "Cary Lai"}, {"authorId": "3631746", "name": "D. Riese"}, {"authorId":
      "48917515", "name": "A. Diamonti"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "153075552", "name": "K. L. Carraway"}]}, {"paperId": "229f933300200d94e6a5417f89e3dcdeb50fa3ac",
      "externalIds": {"MAG": "2502174291", "DOI": "10.1385/1-59259-218-X:247", "CorpusId":
      88991620}, "corpusId": 88991620, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/229f933300200d94e6a5417f89e3dcdeb50fa3ac",
      "title": "PI3-Kinases: Role in Signal Transduction", "abstract": null, "venue":
      "", "year": 2000, "referenceCount": 0, "citationCount": 3, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2000-04-14", "journal": {"volume":
      "", "pages": "247-266", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Fruman2000PI3KinasesRI,\n
      author = {D. Fruman and L. Cantley},\n pages = {247-266},\n title = {PI3-Kinases:
      Role in Signal Transduction},\n year = {2000}\n}\n"}, "authors": [{"authorId":
      "6241317", "name": "D. Fruman"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "250a856f7beb9278aa7d0fc5dc6dcd4559de3a39", "externalIds": {"MAG":
      "2045201777", "DOI": "10.1074/jbc.M005497200", "CorpusId": 2280830, "PubMed":
      "10945990"}, "corpusId": 2280830, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/250a856f7beb9278aa7d0fc5dc6dcd4559de3a39",
      "title": "Peptide and Protein Library Screening Defines Optimal Substrate Motifs
      for AKT/PKB*", "abstract": "AKT was originally identified as a proto-oncogene
      with a pleckstrin homology and Ser/Thr protein kinase domains. Recent studies
      revealed that AKT regulates a variety of cellular functions including cell survival,
      cell growth, cell differentiation, cell cycle progression, transcription, translation,
      and cellular metabolism. To clarify the substrate specificity of AKT, we have
      used an oriented peptide library approach to determine optimal amino acids at
      positions N-terminal and C-terminal to the site of phosphorylation. The predicted
      optimal peptide substrate (Arg-Lys-Arg-Xaa-Arg-Thr-Tyr-Ser*-Phe-Gly where Ser*
      is the phosphorylation site) has similarities to but is distinct from optimal
      substrates that we previously defined for related basophilic protein kinases
      such as protein kinase A, Ser/Arg-rich kinases, and protein kinase C family
      members. The positions most important for highV max/K m ratio were Arg-3>Arg-5>Arg-7.
      The substrate specificity of AKT was further investigated by screening a \u03bbGEX
      phage HeLa cell cDNA expression library. All of the substrates identified by
      this procedure contained Arg-Xaa-Arg-Xaa-Xaa-(Ser/Thr) motifs and were in close
      agreement with the motif identified by peptide library screening. The results
      of this study should help in prediction of likely AKT substrates from primary
      sequences.", "venue": "Journal of Biological Chemistry", "year": 2000, "referenceCount":
      77, "citationCount": 406, "influentialCitationCount": 19, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925820887171/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2000-11-17", "journal": {"volume": "275", "pages": "36108
      - 36115", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Obata2000PeptideAP,\n author = {T. Obata and M. Yaffe and
      G. Leparc and Elizabeth T. Piro and H. Maegawa and Atsunori Kashiwagi and R.
      Kikkawa and L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of Biological Chemistry},\n pages = {36108 - 36115},\n
      title = {Peptide and Protein Library Screening Defines Optimal Substrate Motifs
      for AKT/PKB*},\n volume = {275},\n year = {2000}\n}\n"}, "authors": [{"authorId":
      "3091430", "name": "T. Obata"}, {"authorId": "88402408", "name": "M. Yaffe"},
      {"authorId": "39756254", "name": "G. Leparc"}, {"authorId": "2071966448", "name":
      "Elizabeth T. Piro"}, {"authorId": "3319953", "name": "H. Maegawa"}, {"authorId":
      "2064884851", "name": "Atsunori Kashiwagi"}, {"authorId": "6808657", "name":
      "R. Kikkawa"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "305b7cbff881b531508563375b6dcb98758504ac", "externalIds": {"MAG": "2063074486",
      "DOI": "10.1074/JBC.275.8.6022", "CorpusId": 85250354}, "corpusId": 85250354,
      "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal
      of Biological Chemistry", "type": "journal", "alternate_names": ["J Biological
      Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/305b7cbff881b531508563375b6dcb98758504ac",
      "title": "Impaired Kit- but Not Fc\u03b5RI-initiated Mast Cell Activation in
      the Absence of Phosphoinositide 3-Kinase p85\u03b1 Gene Products*", "abstract":
      "The class IAphosphoinositide 3-kinases (PI3Ks) consist of a 110-kDa catalytic
      domain and a regulatory subunit encoded by the p85\u03b1, p85\u03b2, or p55\u03b3
      genes. We have determined the effects of disrupting the p85\u03b1 gene on the
      responses of mast cells stimulated by the cross-linking of Kit and Fc\u03b5RI,
      receptors that reflect innate and adaptive responses, respectively. The absence
      of p85\u03b1 gene products partially inhibited Kit ligand/stem cell factor-induced
      secretory granule exocytosis, proliferation, and phosphorylation of the serine/threonine
      kinase Akt. In contrast, p85\u03b1 gene products were not required for Fc\u03b5RI-initiated
      exocytosis and phosphorylation of Akt. LY294002, which inhibits all classes
      of PI3Ks, strongly suppressed Kit- and Fc\u03b5RI-induced responses in p85\u03b1
      \u2212/\u2212 mast cells, revealing the contribution of another PI3K family
      member(s). In contrast to B lymphocytes, mast cell proliferation was not dependent
      on Bruton''s tyrosine kinase, a downstream effector of PI3K, revealing a distinct
      pathway of PI3K-dependent proliferation in mast cells. Our findings represent
      the first example of receptor-specific usage of different PI3K family members
      in a single cell type. In addition, because Kit- but not Fc\u03b5RI-initiated
      signaling is associated with mast cell proliferation, the results provide evidence
      that distinct biologic functions signaled by these two receptors may reflect
      differential usage of PI3Ks.", "venue": "Journal of Biological Chemistry", "year":
      2000, "referenceCount": 77, "citationCount": 84, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818306434/pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "2000-02-25", "journal": {"volume":
      "275", "pages": "6022 - 6029", "name": "The Journal of Biological Chemistry"},
      "citationStyles": {"bibtex": "@Article{Lu-Kuo2000ImpairedKB,\n author = {J.
      Lu-Kuo and D. Fruman and D. M. Joyal and L. Cantley and H. Katz},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {6022 - 6029},\n title = {Impaired Kit- but Not Fc\u03b5RI-initiated
      Mast Cell Activation in the Absence of Phosphoinositide 3-Kinase p85\u03b1 Gene
      Products*},\n volume = {275},\n year = {2000}\n}\n"}, "authors": [{"authorId":
      "1403245024", "name": "J. Lu-Kuo"}, {"authorId": "6241317", "name": "D. Fruman"},
      {"authorId": "88707799", "name": "D. M. Joyal"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3648966", "name": "H. Katz"}]}, {"paperId": "351bb8a44f2b5a46670f652d0326e39a703f7c9c",
      "externalIds": {"MAG": "2159310898", "DOI": "10.1093/emboj/19.24.6778", "CorpusId":
      10566416, "PubMed": "11118213"}, "corpusId": 10566416, "publicationVenue": {"id":
      "b89f0ede-6fa8-4dd2-a8a7-f54695a00323", "name": "EMBO Journal", "type": "journal",
      "alternate_names": ["The EMBO Journal", "EMBO J"], "issn": "0261-4189", "url":
      "http://embojournal.npgjournals.com/", "alternate_urls": ["http://emboj.embopress.org/"]},
      "url": "https://www.semanticscholar.org/paper/351bb8a44f2b5a46670f652d0326e39a703f7c9c",
      "title": "TAZ: a novel transcriptional co\u2010activator regulated by interactions
      with 14\u20103\u20103 and PDZ domain proteins", "abstract": "The highly conserved
      and ubiquitously expressed 14\u20103\u20103 proteins regulate differentiation,
      cell cycle progression and apoptosis by binding intracellular phosphoproteins
      involved in signal transduction. By screening in vitro translated cDNA pools
      for the ability to bind 14\u20103\u20103, we identified a novel transcriptional
      co\u2010activator, TAZ (transcriptional co\u2010activator with PDZ\u2010binding
      motif) as a 14\u20103\u20103\u2010binding molecule. TAZ shares homology with
      Yes\u2010associated protein (YAP), contains a WW domain and functions as a transcriptional
      co\u2010activator by binding to the PPXY motif present on transcription factors.
      14\u20103\u20103 binding requires TAZ phosphorylation on a single serine residue,
      resulting in the inhibition of TAZ transcriptional co\u2010activation through
      14\u20103\u20103\u2010mediated nuclear export. The C\u2010terminus of TAZ contains
      a highly conserved PDZ\u2010binding motif that localizes TAZ into discrete nuclear
      foci and is essential for TAZ\u2010stimulated gene transcription. TAZ uses this
      same motif to bind the PDZ domain\u2010containing protein NHERF\u20102, a molecule
      that tethers plasma membrane ion channels and receptors to cytoskeletal actin.
      TAZ may link events at the plasma membrane and cytoskeleton to nuclear transcription
      in a manner that can be regulated by 14\u20103\u20103.", "venue": "EMBO Journal",
      "year": 2000, "referenceCount": 56, "citationCount": 697, "influentialCitationCount":
      45, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc305881?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2000-12-15", "journal": {"volume": "19",
      "name": "The EMBO Journal"}, "citationStyles": {"bibtex": "@Article{Kanai2000TAZAN,\n
      author = {F. Kanai and P. Marignani and Dilara Sarbassova and Ryohei Yagi and
      R. Hall and M. Donowitz and Akihiko Hisaminato and Tsutomu Fujiwara and Yoshiaki
      Ito and L. Cantley and M. Yaffe},\n booktitle = {EMBO Journal},\n journal =
      {The EMBO Journal},\n title = {TAZ: a novel transcriptional co\u2010activator
      regulated by interactions with 14\u20103\u20103 and PDZ domain proteins},\n
      volume = {19},\n year = {2000}\n}\n"}, "authors": [{"authorId": "36196723",
      "name": "F. Kanai"}, {"authorId": "40278978", "name": "P. Marignani"}, {"authorId":
      "3871851", "name": "Dilara Sarbassova"}, {"authorId": "46728276", "name": "Ryohei
      Yagi"}, {"authorId": "143838334", "name": "R. Hall"}, {"authorId": "5469802",
      "name": "M. Donowitz"}, {"authorId": "13888755", "name": "Akihiko Hisaminato"},
      {"authorId": "152910706", "name": "Tsutomu Fujiwara"}, {"authorId": "2132382",
      "name": "Yoshiaki Ito"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "88402408", "name": "M. Yaffe"}]}, {"paperId": "3f02cf242b8e7e66bdfc6513cdb9f800fbe19584",
      "externalIds": {"MAG": "2031365072", "DOI": "10.1074/jbc.M001002200", "CorpusId":
      42596932, "PubMed": "10801797"}, "corpusId": 42596932, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/3f02cf242b8e7e66bdfc6513cdb9f800fbe19584",
      "title": "Utilization of Oriented Peptide Libraries to Identify Substrate Motifs
      Selected by ATM*", "abstract": "The ataxia telangiectasiamutated (ATM) gene
      encodes a serine/threonine protein kinase that plays a critical role in genomic
      surveillance and development. Here, we use a peptide library approach to define
      thein vitro substrate specificity of ATM kinase activity. The peptide library
      analysis identified an optimal sequence with a central core motif of LSQE that
      is preferentially phosphorylated by ATM. The contributions of the amino acids
      surrounding serine in the LSQE motif were assessed by utilizing specific peptide
      libraries or individual peptide substrates. All amino acids comprising the LSQE
      sequence were critical for maximum peptide substrate suitability for ATM. The
      DNA-dependent proteinkinase (DNA-PK), a Ser/Thr kinase related to ATM and important
      in DNA repair, was compared with ATM in terms of peptide substrate selectivity.
      DNA-PK was found to be unique in its preference of neighboring amino acids to
      the phosphorylated serine. Peptide library analyses defined a preferred amino
      acid motif for ATM that permits clear distinctions between ATM and DNA-PK kinase
      activity. Data base searches using the library-derived ATM sequence identified
      previously characterized substrates of ATM, as well as novel candidate substrate
      targets that may function downstream in ATM-directed signaling pathways.", "venue":
      "Journal of Biological Chemistry", "year": 2000, "referenceCount": 63, "citationCount":
      193, "influentialCitationCount": 11, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.jbc.org/article/S002192581966120X/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2000-07-28", "journal": {"volume": "275", "pages": "22719
      - 22727", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{O''Neill2000UtilizationOO,\n author = {T. O''Neill and
      Alison J. Dwyer and Y. Ziv and D. Chan and S. Lees-Miller and Robert H. Abraham
      and J. Lai and D. Hill and Y. Shiloh and L. Cantley and G. Rathbun},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {22719 - 22727},\n title = {Utilization of Oriented Peptide
      Libraries to Identify Substrate Motifs Selected by ATM*},\n volume = {275},\n
      year = {2000}\n}\n"}, "authors": [{"authorId": "2072861267", "name": "T. O''Neill"},
      {"authorId": "2187573102", "name": "Alison J. Dwyer"}, {"authorId": "48277931",
      "name": "Y. Ziv"}, {"authorId": "153637109", "name": "D. Chan"}, {"authorId":
      "1398713833", "name": "S. Lees-Miller"}, {"authorId": "2187574258", "name":
      "Robert H. Abraham"}, {"authorId": "5000276", "name": "J. Lai"}, {"authorId":
      "50570936", "name": "D. Hill"}, {"authorId": "35164321", "name": "Y. Shiloh"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2508043", "name":
      "G. Rathbun"}]}, {"paperId": "45f118bf141e32361ec9bd40541df12e3dd7bd5a", "externalIds":
      {"MAG": "2897380573", "CorpusId": 186967450}, "corpusId": 186967450, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/45f118bf141e32361ec9bd40541df12e3dd7bd5a",
      "title": "Methodes et reactifs permettant de reguler l''expression genique",
      "abstract": "L''invention concerne une approche generale permettant d''identifier
      des sequences d''activation transcriptionnelle minimales specifiques d''un domaine.
      On a notamment decouvert que les approches utilisant la diversite moleculaire
      peuvent servir a decouvrir des activateurs synthetiques specifiques d''un domaine
      de co-activateur et que l''activation transcriptionnelle peut etre modulee a
      volonte au niveau du recrutement du co-activateur.", "venue": "", "year": 2000,
      "referenceCount": 4, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [],
      "publicationTypes": null, "publicationDate": "2000-08-31", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Frangioni2000MethodesER,\n
      author = {J. Frangioni and L. Cantley and M. Montminy},\n title = {Methodes
      et reactifs permettant de reguler l''expression genique},\n year = {2000}\n}\n"},
      "authors": [{"authorId": "1788876", "name": "J. Frangioni"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4892627", "name": "M. Montminy"}]}, {"paperId":
      "510bba74fd28a7939e9d164841a8fae836ad9928", "externalIds": {"MAG": "1607067835",
      "DOI": "10.1038/80280", "CorpusId": 6829642, "PubMed": "11017047"}, "corpusId":
      6829642, "publicationVenue": {"id": "458166b3-de17-4bf3-bbbb-e53782de2f0f",
      "name": "Nature Biotechnology", "type": "journal", "alternate_names": ["Nat
      Biotechnol"], "issn": "1087-0156", "url": "http://www.nature.com/nbt/", "alternate_urls":
      ["http://www.nature.com/nbt"]}, "url": "https://www.semanticscholar.org/paper/510bba74fd28a7939e9d164841a8fae836ad9928",
      "title": "Minimal activators that bind to the KIX domain of p300/CBP identified
      by phage display screening", "abstract": null, "venue": "Nature Biotechnology",
      "year": 2000, "referenceCount": 30, "citationCount": 43, "influentialCitationCount":
      2, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2000-10-01", "journal": {"volume": "18",
      "pages": "1080-1085", "name": "Nature Biotechnology"}, "citationStyles": {"bibtex":
      "@Article{Frangioni2000MinimalAT,\n author = {J. Frangioni and Leah M. LaRiccia
      and L. Cantley and M. Montminy},\n booktitle = {Nature Biotechnology},\n journal
      = {Nature Biotechnology},\n pages = {1080-1085},\n title = {Minimal activators
      that bind to the KIX domain of p300/CBP identified by phage display screening},\n
      volume = {18},\n year = {2000}\n}\n"}, "authors": [{"authorId": "1788876", "name":
      "J. Frangioni"}, {"authorId": "2104786467", "name": "Leah M. LaRiccia"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4892627", "name": "M. Montminy"}]},
      {"paperId": "69c798e12670d7759eb6c90a156887c9b4414ae2", "externalIds": {"MAG":
      "1980152312", "DOI": "10.1016/S0091-6749(00)90955-2", "CorpusId": 71437176},
      "corpusId": 71437176, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/69c798e12670d7759eb6c90a156887c9b4414ae2",
      "title": "527 Impaird Kit- but not Fc\u03b5RI-mediated mast cell activation
      in the absence of regulatory subunits encoded by the phosphoinositide 3-kinase
      (PI3K) p85\u03b1 gene", "abstract": null, "venue": "", "year": 2000, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Lu-Kuo2000527IK,\n
      author = {J. Lu-Kuo and D. Fruman and L. Cantley and H. Katz},\n title = {527
      Impaird Kit- but not Fc\u03b5RI-mediated mast cell activation in the absence
      of regulatory subunits encoded by the phosphoinositide 3-kinase (PI3K) p85\u03b1
      gene},\n year = {2000}\n}\n"}, "authors": [{"authorId": "1403245024", "name":
      "J. Lu-Kuo"}, {"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "3648966", "name": "H. Katz"}]}, {"paperId":
      "6e29e558df951b9811c08f727893460abfe4762e", "externalIds": {"MAG": "2031874417",
      "DOI": "10.1016/S0960-9822(00)00315-8", "CorpusId": 20209389, "PubMed": "10679324"},
      "corpusId": 20209389, "publicationVenue": {"id": "9469269e-53d7-4955-b1a5-17a75bee7634",
      "name": "Current Biology", "type": "journal", "alternate_names": ["Curr Biology"],
      "issn": "0960-9822", "url": "http://www.current-biology.com/", "alternate_urls":
      ["http://www.sciencedirect.com/science/journal/09609822"]}, "url": "https://www.semanticscholar.org/paper/6e29e558df951b9811c08f727893460abfe4762e",
      "title": "Type I\u03b1 phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent
      actin assembly", "abstract": null, "venue": "Current Biology", "year": 2000,
      "referenceCount": 18, "citationCount": 239, "influentialCitationCount": 9, "isOpenAccess":
      true, "openAccessPdf": {"url": "http://www.cell.com/article/S0960982200003158/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "2000-02-01", "journal": {"volume": "10",
      "pages": "153-156", "name": "Current Biology"}, "citationStyles": {"bibtex":
      "@Article{Tolias2000TypeIP,\n author = {K. Tolias and J. Hartwig and H. Ishihara
      and Y. Shibasaki and L. Cantley and C. Carpenter},\n booktitle = {Current Biology},\n
      journal = {Current Biology},\n pages = {153-156},\n title = {Type I\u03b1 phosphatidylinositol-4-phosphate
      5-kinase mediates Rac-dependent actin assembly},\n volume = {10},\n year = {2000}\n}\n"},
      "authors": [{"authorId": "4661935", "name": "K. Tolias"}, {"authorId": "2999768",
      "name": "J. Hartwig"}, {"authorId": "2805489", "name": "H. Ishihara"}, {"authorId":
      "49569235", "name": "Y. Shibasaki"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2972505", "name": "C. Carpenter"}]}, {"paperId": "718952afde5c86e117085296a6dfc5ebc18c3e03",
      "externalIds": {"MAG": "2067837318", "DOI": "10.1093/emboj/19.11.2537", "CorpusId":
      23456358, "PubMed": "10835352"}, "corpusId": 23456358, "publicationVenue": {"id":
      "b89f0ede-6fa8-4dd2-a8a7-f54695a00323", "name": "EMBO Journal", "type": "journal",
      "alternate_names": ["The EMBO Journal", "EMBO J"], "issn": "0261-4189", "url":
      "http://embojournal.npgjournals.com/", "alternate_urls": ["http://emboj.embopress.org/"]},
      "url": "https://www.semanticscholar.org/paper/718952afde5c86e117085296a6dfc5ebc18c3e03",
      "title": "The conserved phosphoinositide 3\u2010kinase pathway determines heart
      size in mice", "abstract": "Phosphoinositide 3\u2010kinase (PI3K) has been shown
      to regulate cell and organ size in Drosophila, but the role of PI3K in vertebrates
      in vivo is not well understood. To examine the role of PI3K in intact mammalian
      tissue, we have created and characterized transgenic mice expressing constitutively
      active or dominant\u2010negative mutants of PI3K in the heart. Cardiac\u2010
      specific expression of constitutively active PI3K resulted in mice with larger
      hearts, while dominant\u2010negative PI3K resulted in mice with smaller hearts.
      The increase or decrease in heart size was associated with comparable increase
      or decrease in myocyte size. Cardiomyopathic changes, such as myocyte necrosis,
      apoptosis, interstitial fibrosis or contractile dysfunction, were not observed
      in either of the transgenic mice. Thus, the PI3K pathway is necessary and sufficient
      to promote organ growth in mammals.", "venue": "EMBO Journal", "year": 2000,
      "referenceCount": 78, "citationCount": 622, "influentialCitationCount": 31,
      "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc212739?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2000-06-01", "journal": {"volume": "19", "name": "The EMBO
      Journal"}, "citationStyles": {"bibtex": "@Article{Shioi2000TheCP,\n author =
      {T. Shioi and P. Kang and P. Douglas and J. Hampe and C. Yballe and J. Lawitts
      and L. Cantley and S. Izumo},\n booktitle = {EMBO Journal},\n journal = {The
      EMBO Journal},\n title = {The conserved phosphoinositide 3\u2010kinase pathway
      determines heart size in mice},\n volume = {19},\n year = {2000}\n}\n"}, "authors":
      [{"authorId": "6946601", "name": "T. Shioi"}, {"authorId": "2302010", "name":
      "P. Kang"}, {"authorId": "1995988", "name": "P. Douglas"}, {"authorId": "15410490",
      "name": "J. Hampe"}, {"authorId": "7777071", "name": "C. Yballe"}, {"authorId":
      "6704546", "name": "J. Lawitts"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "47072554", "name": "S. Izumo"}]}, {"paperId": "cedfb2fc68646aed19c4250779520e3f5804b576",
      "externalIds": {"MAG": "1591760396", "DOI": "10.1016/S0076-6879(00)28397-3",
      "CorpusId": 41373492, "PubMed": "11075345"}, "corpusId": 41373492, "publicationVenue":
      {"id": "1e7039c8-e30c-4af0-b7d3-f5e05dff5d21", "name": "Methods in Enzymology",
      "type": "journal", "alternate_names": ["Method Enzymol"], "issn": "0076-6879",
      "alternate_issns": ["1557-7988"], "url": "https://www.elsevier.com/books/book-series/methods-in-enzymology",
      "alternate_urls": ["http://www.sciencedirect.com/science/bookseries/00766879"]},
      "url": "https://www.semanticscholar.org/paper/cedfb2fc68646aed19c4250779520e3f5804b576",
      "title": "Mapping specificity determinants for protein-protein association using
      protein fusions and random peptide libraries.", "abstract": null, "venue": "Methods
      in Enzymology", "year": 2000, "referenceCount": 11, "citationCount": 34, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": null, "journal": {"volume": "328", "pages":
      "\n          157-70\n        ", "name": "Methods in enzymology"}, "citationStyles":
      {"bibtex": "@Article{Yaffe2000MappingSD,\n author = {M. Yaffe and L. Cantley},\n
      booktitle = {Methods in Enzymology},\n journal = {Methods in enzymology},\n
      pages = {\n          157-70\n        },\n title = {Mapping specificity determinants
      for protein-protein association using protein fusions and random peptide libraries.},\n
      volume = {328},\n year = {2000}\n}\n"}, "authors": [{"authorId": "88402408",
      "name": "M. Yaffe"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "f21574d4da5878510edd4fad62982f8e452d0bc8", "externalIds": {"MAG": "2043363499",
      "DOI": "10.1074/jbc.275.3.2219", "CorpusId": 46124821, "PubMed": "10636929"},
      "corpusId": 46124821, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/f21574d4da5878510edd4fad62982f8e452d0bc8",
      "title": "Biochemical Interactions Integrating Itk with the T Cell Receptor-initiated
      Signaling Cascade*", "abstract": "Itk, a Tec family tyrosine kinase, acts downstream
      of Lck and phosphatidylinositol 3\u2032-kinase to facilitate T cell receptor
      (TCR)-dependent calcium influxes and increases in extracellular-regulated kinase
      activity. Here we demonstrate interactions between Itk and crucial components
      of TCR-dependent signaling pathways. First, the inositide-binding pocket of
      the Itk pleckstrin homology domain directs the constitutive association of Itk
      with buoyant membranes that are the primary site of TCR activation and are enriched
      in both Lck and LAT. This association is required for the transphosphorylation
      of Itk. Second, the Itk proline-rich region binds to Grb2 and LAT. Third, the
      Itk Src homology (SH3) 3 and SH2 domains interact cooperatively with Syk-phosphorylated
      SLP-76. Notably, SLP-76 contains a predicted binding motif for the Itk SH2 domain
      and binds to full-length Itk in vitro. Finally, we show that kinase-inactive
      Itk can antagonize the SLP-76-dependent activation of NF-AT. The inhibition
      of NF-AT activation depends on the Itk pleckstrin homology domain, proline-rich
      region, and SH2 domain. Together, these observations suggest that multivalent
      interactions recruit Itk to LAT-nucleated signaling complexes and facilitate
      the activation of LAT-associated phospholipase C\u03b31 by Itk.", "venue": "Journal
      of Biological Chemistry", "year": 2000, "referenceCount": 85, "citationCount":
      304, "influentialCitationCount": 23, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.jbc.org/article/S0021925818311621/pdf", "status": null},
      "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Chemistry", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "2000-01-21", "journal": {"volume": "275", "pages": "2219
      - 2230", "name": "The Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Bunnell2000BiochemicalII,\n author = {S. Bunnell and M. Diehn and
      M. Yaffe and P. Findell and L. Cantley and L. Berg},\n booktitle = {Journal
      of Biological Chemistry},\n journal = {The Journal of Biological Chemistry},\n
      pages = {2219 - 2230},\n title = {Biochemical Interactions Integrating Itk with
      the T Cell Receptor-initiated Signaling Cascade*},\n volume = {275},\n year
      = {2000}\n}\n"}, "authors": [{"authorId": "4808985", "name": "S. Bunnell"},
      {"authorId": "1907024", "name": "M. Diehn"}, {"authorId": "88402408", "name":
      "M. Yaffe"}, {"authorId": "6175740", "name": "P. Findell"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "1905806", "name": "L. Berg"}]}, {"paperId":
      "10d1177f4a523a485ea2389f4b737795f54631f0", "externalIds": {"MAG": "2028211858",
      "DOI": "10.1126/SCIENCE.285.5436.2129", "CorpusId": 39529372, "PubMed": "10497131"},
      "corpusId": 39529372, "publicationVenue": {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad",
      "name": "Science", "type": "journal", "issn": "0193-4511", "alternate_issns":
      ["0036-8075"], "url": "https://www.jstor.org/journal/science", "alternate_urls":
      ["https://www.sciencemag.org/", "http://www.sciencemag.org/", "http://www.jstor.org/journals/00368075.html",
      "http://www.sciencemag.org/archive/"]}, "url": "https://www.semanticscholar.org/paper/10d1177f4a523a485ea2389f4b737795f54631f0",
      "title": "Affinity-driven peptide selection of an NFAT inhibitor more selective
      than cyclosporin A.", "abstract": "The flow of information from calcium-mobilizing
      receptors to nuclear factor of activated T cells (NFAT)-dependent genes is critically
      dependent on interaction between the phosphatase calcineurin and the transcription
      factor NFAT. A high-affinity calcineurin-binding peptide was selected from combinatorial
      peptide libraries based on the calcineurin docking motif of NFAT. This peptide
      potently inhibited NFAT activation and NFAT-dependent expression of endogenous
      cytokine genes in T cells, without affecting the expression of other cytokines
      that require calcineurin but not NFAT. Substitution of the optimized peptide
      sequence into the natural calcineurin docking site increased the calcineurin
      responsiveness of NFAT. Compounds that interfere selectively with the calcineurin-NFAT
      interaction without affecting calcineurin phosphatase activity may be useful
      as therapeutic agents that are less toxic than current drugs.", "venue": "Science",
      "year": 1999, "referenceCount": 29, "citationCount": 600, "influentialCitationCount":
      45, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle", "LettersAndComments"], "publicationDate": "1999-09-24", "journal":
      {"volume": "285 5436", "pages": "\n          2129-33\n        ", "name": "Science"},
      "citationStyles": {"bibtex": "@Article{Aramburu1999AffinitydrivenPS,\n author
      = {J. Aramburu and M. Yaffe and C. L\u00f3pez-Rodr\u00edguez and L. Cantley
      and P. Hogan and A. Rao},\n booktitle = {Science},\n journal = {Science},\n
      pages = {\n          2129-33\n        },\n title = {Affinity-driven peptide
      selection of an NFAT inhibitor more selective than cyclosporin A.},\n volume
      = {285 5436},\n year = {1999}\n}\n"}, "authors": [{"authorId": "145087088",
      "name": "J. Aramburu"}, {"authorId": "88402408", "name": "M. Yaffe"}, {"authorId":
      "1401469293", "name": "C. L\u00f3pez-Rodr\u00edguez"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "1965988", "name": "P. Hogan"}, {"authorId":
      "144619116", "name": "A. Rao"}]}, {"paperId": "15c54f58c4cf7556ecec89fe0f9631f64b8e8300",
      "externalIds": {"MAG": "1997712588", "DOI": "10.1016/S1097-2765(00)80206-3",
      "CorpusId": 27032155, "PubMed": "10549287"}, "corpusId": 27032155, "publicationVenue":
      {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11", "name": "Molecules and Cells",
      "type": "journal", "alternate_names": ["Molecular Cell", "Mol Cell"], "issn":
      "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"], "url": "https://link.springer.com/journal/10059",
      "alternate_urls": ["http://www.molcells.org/about/sub06.html", "http://www.molecule.org/",
      "http://www.sciencedirect.com/science/journal/10972765", "http://www.cell.com/molecular-cell/"]},
      "url": "https://www.semanticscholar.org/paper/15c54f58c4cf7556ecec89fe0f9631f64b8e8300",
      "title": "Crystal structures of the XLP protein SAP reveal a class of SH2 domains
      with extended, phosphotyrosine-independent sequence recognition.", "abstract":
      null, "venue": "Molecules and Cells", "year": 1999, "referenceCount": 31, "citationCount":
      259, "influentialCitationCount": 10, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S1097276500802063/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1999-10-01", "journal":
      {"volume": "4 4", "pages": "\n          555-61\n        ", "name": "Molecular
      cell"}, "citationStyles": {"bibtex": "@Article{Poy1999CrystalSO,\n author =
      {F. Poy and M. Yaffe and J. Say\u00f3s and K. Saxena and M. Morra and J. Sumegi
      and L. Cantley and L. Cantley and C. Terhorst and M. Eck},\n booktitle = {Molecules
      and Cells},\n journal = {Molecular cell},\n pages = {\n          555-61\n        },\n
      title = {Crystal structures of the XLP protein SAP reveal a class of SH2 domains
      with extended, phosphotyrosine-independent sequence recognition.},\n volume
      = {4 4},\n year = {1999}\n}\n"}, "authors": [{"authorId": "4096365", "name":
      "F. Poy"}, {"authorId": "88402408", "name": "M. Yaffe"}, {"authorId": "4306050",
      "name": "J. Say\u00f3s"}, {"authorId": "50526125", "name": "K. Saxena"}, {"authorId":
      "4187907", "name": "M. Morra"}, {"authorId": "5921216", "name": "J. Sumegi"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "4658870", "name": "C. Terhorst"}, {"authorId":
      "2026802", "name": "M. Eck"}]}, {"paperId": "1e6e9e1e94938c4235db01a2b7f82554d905da6c",
      "externalIds": {"MAG": "2309312299", "DOI": "10.1042/BST0270624", "CorpusId":
      5921491, "PubMed": "10917654"}, "corpusId": 5921491, "publicationVenue": {"id":
      "9c7806c9-5d45-4670-86ed-e7e052ef142a", "name": "Biochemical Society Transactions",
      "type": "journal", "alternate_names": ["Biochem Soc Trans"], "issn": "0300-5127"},
      "url": "https://www.semanticscholar.org/paper/1e6e9e1e94938c4235db01a2b7f82554d905da6c",
      "title": "Phosphoinositide 3-kinase knockout mice: role of p85alpha in B cell
      development and proliferation.", "abstract": "Cur. Opin. Cell Biol. 10, 504-5
      I 2 49 Barylko, B., Binns, D., Lin, K. M., Atkinson, M. A,, Jameson, D. M.,
      Yin, H. L. and Albanesi, J. P. ( I 998) J. Biol. Chern. 273, 379 1-3797 50 Achiriloaie,
      M., Barylko, B. and Albanesi, J. P. ( I 999) Mol. Cell. Biol. 19, 141Ck1415
      51 Vallis, Y., Wigge, P., Marks, B., Evans, P. R and McMahon, H T. ( 1999) Curr.
      Biol. 9, 257-260 52 Lee, A., Frank, D. W., Marks, M. S. and Lemrnon, M. A. (
      I 999) Cur. Biol. 9, 26 1-264 53 Owen, D. J., Wigge, P., Vallis, Y., Moore,
      J. D. A,, Evans, P. R and McMahon, H. T. ( 1998) EMBO J. 18, 5273-5288", "venue":
      "Biochemical Society Transactions", "year": 1999, "referenceCount": 0, "citationCount":
      40, "influentialCitationCount": 2, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": "1999-08-01", "journal": {"volume": "27
      4", "pages": "\n          624-9\n        ", "name": "Biochemical Society transactions"},
      "citationStyles": {"bibtex": "@Article{Fruman1999Phosphoinositide3K,\n author
      = {D. Fruman and S. Snapper and C. Yballe and F. Alt and L. Cantley},\n booktitle
      = {Biochemical Society Transactions},\n journal = {Biochemical Society transactions},\n
      pages = {\n          624-9\n        },\n title = {Phosphoinositide 3-kinase
      knockout mice: role of p85alpha in B cell development and proliferation.},\n
      volume = {27 4},\n year = {1999}\n}\n"}, "authors": [{"authorId": "6241317",
      "name": "D. Fruman"}, {"authorId": "4818618", "name": "S. Snapper"}, {"authorId":
      "7777071", "name": "C. Yballe"}, {"authorId": "31713146", "name": "F. Alt"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "300e7558e448a3a8c809ce7817996c52a890ea6f",
      "externalIds": {"MAG": "147860631", "DOI": "10.1007/978-3-642-60162-0_33", "CorpusId":
      41588876, "PubMed": "10396065"}, "corpusId": 41588876, "publicationVenue": {"id":
      "35b70977-7c87-4140-8eb7-b63988a12c83", "name": "Current Topics in Microbiology
      and Immunology", "type": "journal", "alternate_names": ["Curr Top Microbiol
      Immunol"], "issn": "0070-217X", "alternate_issns": ["2196-9965"], "url": "https://link.springer.com/bookseries/82"},
      "url": "https://www.semanticscholar.org/paper/300e7558e448a3a8c809ce7817996c52a890ea6f",
      "title": "ATM and lymphoid malignancies; use of oriented peptide libraries to
      identify novel substrates of ATM critical in downstream signaling pathways.",
      "abstract": null, "venue": "Current Topics in Microbiology and Immunology",
      "year": 1999, "referenceCount": 23, "citationCount": 3, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": null, "journal": {"volume":
      "246", "pages": "\n          267-73; discussion 274\n        ", "name": "Current
      topics in microbiology and immunology"}, "citationStyles": {"bibtex": "@Article{Rathbun1999ATMAL,\n
      author = {G. Rathbun and Y. Ziv and J. Lai and D. Hill and R. Abraham and Y.
      Shiloh and L. Cantley},\n booktitle = {Current Topics in Microbiology and Immunology},\n
      journal = {Current topics in microbiology and immunology},\n pages = {\n          267-73;
      discussion 274\n        },\n title = {ATM and lymphoid malignancies; use of
      oriented peptide libraries to identify novel substrates of ATM critical in downstream
      signaling pathways.},\n volume = {246},\n year = {1999}\n}\n"}, "authors": [{"authorId":
      "2508043", "name": "G. Rathbun"}, {"authorId": "48277931", "name": "Y. Ziv"},
      {"authorId": "5000276", "name": "J. Lai"}, {"authorId": "50570936", "name":
      "D. Hill"}, {"authorId": "2097710310", "name": "R. Abraham"}, {"authorId": "144157302",
      "name": "Y. Shiloh"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "3e835ad09141d38dd5a69263dc72f38b805b404b", "externalIds": {"MAG": "1984418041",
      "DOI": "10.1073/PNAS.96.8.4240", "CorpusId": 43439834, "PubMed": "10200246"},
      "corpusId": 43439834, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/3e835ad09141d38dd5a69263dc72f38b805b404b",
      "title": "New insights into tumor suppression: PTEN suppresses tumor formation
      by restraining the phosphoinositide 3-kinase/AKT pathway.", "abstract": "The
      most recently discovered PTEN tumor suppressor gene has been found to be defective
      in a large number of human cancers. In addition, germ-line mutations in PTEN
      result in the dominantly inherited disease Cowden syndrome, which is characterized
      by multiple hamartomas and a high proclivity for developing cancer. A series
      of publications over the past year now suggest a mechanism by which PTEN loss
      of function results in tumors. PTEN appears to negatively control the phosphoinositide
      3-kinase signaling pathway for regulation of cell growth and survival by dephosphorylating
      the 3 position of phosphoinositides.", "venue": "Proceedings of the National
      Academy of Sciences of the United States of America", "year": 1999, "referenceCount":
      76, "citationCount": 2034, "influentialCitationCount": 83, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc33561?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "1999-04-13", "journal": {"volume": "96 8", "pages": "\n          4240-5\n        ",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America"}, "citationStyles": {"bibtex": "@Article{Cantley1999NewII,\n author
      = {L. Cantley and B. Neel},\n booktitle = {Proceedings of the National Academy
      of Sciences of the United States of America},\n journal = {Proceedings of the
      National Academy of Sciences of the United States of America},\n pages = {\n          4240-5\n        },\n
      title = {New insights into tumor suppression: PTEN suppresses tumor formation
      by restraining the phosphoinositide 3-kinase/AKT pathway.},\n volume = {96 8},\n
      year = {1999}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2291271", "name": "B. Neel"}]}, {"paperId": "5afc6eee8fb45b431bdea6b2db5dcd480215932e",
      "externalIds": {"MAG": "2916153727", "DOI": "10.2210/pdb1qjb/pdb", "CorpusId":
      104387460}, "corpusId": 104387460, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/5afc6eee8fb45b431bdea6b2db5dcd480215932e",
      "title": "14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 1)", "abstract": null, "venue":
      "", "year": 1999, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "1999-09-15", "journal": null,
      "citationStyles": {"bibtex": "@Inproceedings{Rittinger19991433ZC,\n author =
      {K. Rittinger and J. Budman and Jian Xu and S. Volinia and L. Cantley and S.
      Smerdon and S. Gamblin and M. Yaffe},\n title = {14-3-3 ZETA/PHOSPHOPEPTIDE
      COMPLEX (MODE 1)},\n year = {1999}\n}\n"}, "authors": [{"authorId": "6239566",
      "name": "K. Rittinger"}, {"authorId": "4299977", "name": "J. Budman"}, {"authorId":
      "2110980007", "name": "Jian Xu"}, {"authorId": "1906416", "name": "S. Volinia"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4189482", "name":
      "S. Smerdon"}, {"authorId": "1958388", "name": "S. Gamblin"}, {"authorId": "88402408",
      "name": "M. Yaffe"}]}, {"paperId": "5d0079e0aa8004a0961e1033ddc9acec65fe11d8",
      "externalIds": {"DOI": "10.1038/46925", "CorpusId": 5374019}, "corpusId": 5374019,
      "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature",
      "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls":
      ["http://www.nature.com/nature/", "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/5d0079e0aa8004a0961e1033ddc9acec65fe11d8",
      "title": "Signal transduction: Grabbing phosphoproteins", "abstract": null,
      "venue": "Nature", "year": 1999, "referenceCount": 0, "citationCount": 72, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.nature.com/articles/46925.pdf",
      "status": null}, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": {"volume": "402", "pages": "30-31", "name": "Nature"}, "citationStyles":
      {"bibtex": "@Article{Yaffe1999SignalTG,\n author = {M. Yaffe and L. Cantley},\n
      booktitle = {Nature},\n journal = {Nature},\n pages = {30-31},\n title = {Signal
      transduction: Grabbing phosphoproteins},\n volume = {402},\n year = {1999}\n}\n"},
      "authors": [{"authorId": "88402408", "name": "M. Yaffe"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "743aaaadb1cded9b403f4eee827844492b4d7ee0",
      "externalIds": {"MAG": "2002127663", "DOI": "10.1074/jbc.274.13.8347", "CorpusId":
      6022170, "PubMed": "10085060"}, "corpusId": 6022170, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/743aaaadb1cded9b403f4eee827844492b4d7ee0",
      "title": "The Role of Phosphoinositide 3-Kinase Lipid Products in Cell Function*",
      "abstract": "Phosphoinositide 3-kinases (PI 3-Ks) are a subfamily of lipid kinases
      that catalyze the addition of a phosphate molecule specifically to the 3-position
      of the inositol ring of phosphoinositides. Phosphatidylinositol (PtdIns), the
      precursor of all phosphoinositides (PI), constitutes less than 10% of the total
      lipid in eukaryotic cell membranes (Fig. 1). Approximately 5% of cellular PI
      is phosphorylated at the 4-position (PtdIns-4-P), and another 5% is phosphorylated
      at both the 4and 5-positions (PtdIns-4,5-P2). However, less than 0.25% of the
      total inositol-containing lipids are phosphorylated at the 3-position, consistent
      with the idea that these lipids exert specific regulatory functions inside the
      cell, as opposed to a structural function. To date, nine members of the PI 3-K
      family have been isolated from mammalian cells. They are grouped, as suggested
      by Domin and Waterfield (1), into three classes according to the molecules that
      they preferentially utilize as substrates. Four different lipid products can
      be generated by the different PI 3-K members: the singly phosphorylated form
      PtdIns-3-P; the doubly phosphorylated forms PtdIns-3,4-P2 and PtdIns-3,5-P2;
      and finally the triply phosphorylated form PtdIns-3,4,5-P3 (Fig. 1). PI 3-K
      was first described as a PI kinase activity associated with the viral oncoproteins,
      v-Src, v-Ros, and polyomavirus middle T. Mutational studies of these oncoproteins
      more than 10 years ago indicated a critical role for the associated PI kinase
      in cell transformation (reviewed by Ref. 2). Recent advances in the field have
      been achieved by the development of new techniques to probe for the direct targets
      of PI 3-K lipid products. The chemical synthesis of short chain fatty acid versions
      of these lipids (3\u20135) has been a crucial step in determining the specificity
      of lipid-binding proteins. Additionally, new cloning strategies have been developed
      to isolate new lipid-binding proteins (6). Here we will review the most recent
      advances in our understanding of the role of PI 3-K in cell function by dissecting
      the contribution of each of its lipid products.", "venue": "Journal of Biological
      Chemistry", "year": 1999, "referenceCount": 91, "citationCount": 1052, "influentialCitationCount":
      46, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819873374/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "1999-03-26", "journal": {"volume":
      "274", "pages": "8347 - 8350", "name": "The Journal of Biological Chemistry"},
      "citationStyles": {"bibtex": "@Article{Rameh1999TheRO,\n author = {L. Rameh
      and L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n journal
      = {The Journal of Biological Chemistry},\n pages = {8347 - 8350},\n title =
      {The Role of Phosphoinositide 3-Kinase Lipid Products in Cell Function*},\n
      volume = {274},\n year = {1999}\n}\n"}, "authors": [{"authorId": "4109960",
      "name": "L. Rameh"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "8de62be269797f581b996518e6792f88390d20f8", "externalIds": {"MAG": "2068921184",
      "DOI": "10.1006/BBRC.1999.1150", "CorpusId": 5619185, "PubMed": "10462494"},
      "corpusId": 5619185, "publicationVenue": {"id": "1a9c698b-7fe4-4444-b391-208b4b2326e2",
      "name": "Biochemical and Biophysical Research Communications - BBRC", "type":
      "journal", "alternate_names": ["Biochem Biophys Res Commun", "Biochemical and
      Biophysical Research Communications", "Biochem Biophys Res Commun  BBRC"], "issn":
      "0006-291X", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description",
      "alternate_urls": ["http://www.idealibrary.com/links/toc/bbrc", "https://www.journals.elsevier.com/biochemical-and-biophysical-research-communications/",
      "http://www.sciencedirect.com/science/journal/0006291X"]}, "url": "https://www.semanticscholar.org/paper/8de62be269797f581b996518e6792f88390d20f8",
      "title": "Mouse phosphoinositide 3-kinase p110alpha gene: cloning, structural
      organization, and localization to chromosome 3 band B.", "abstract": "Phosphoinositide
      3-Kinases (PI3-Kinases) are a family of dual specificity enzymes with a unique
      lipid kinase activity toward the D-3 position of the inositol ring of phosphoinositides
      and a less well characterized serine/threonine protein kinase activity. Class
      IA PI3-Kinases comprise a 110-120 kDa catalytic subunit (usually termed p110)
      and an 85 kDa or 50 to 55 kDa regulatory subunit (often called p85). cDNAs for
      three mammalian Class IA PI3-Kinase catalytic subunits designated p110alpha,
      p110beta, and p110delta have been cloned from several species. A YAC clone for
      the human p110alpha gene has also been cloned and mapped to chromosome 3q26.3.
      However, structural organization for any of the PI3-Kinase p110alpha genes has
      not been reported. Here, we report the cloning, structural organization, and
      chromosomal localization of the mouse PI3-Kinase p110alpha gene. The translated
      portion of the mouse p110alpha gene is encoded by 19 exons that span at least
      24 kb. Dual color fluorescence in situ hybridization (FISH) was performed to
      determine the chromosomal localization of the mouse PI3-Kinase p110alpha gene.
      FISH results and DAPI banding demonstrated localization of the p110alpha gene
      to band B on mouse chromosome 3, a region syntenic with human chromosome 3q26.3.",
      "venue": "Biochemical and Biophysical Research Communications - BBRC", "year":
      1999, "referenceCount": 27, "citationCount": 6, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1999-08-27", "journal": {"volume": "262 2", "pages": "\n          438-42\n        ",
      "name": "Biochemical and biophysical research communications"}, "citationStyles":
      {"bibtex": "@Article{Aksoy1999MouseP3,\n author = {I. Aksoy and M. Ramsey and
      D. Fruman and S. Aksoy and L. Cantley and J. Tucker and T. Roberts},\n booktitle
      = {Biochemical and Biophysical Research Communications - BBRC},\n journal =
      {Biochemical and biophysical research communications},\n pages = {\n          438-42\n        },\n
      title = {Mouse phosphoinositide 3-kinase p110alpha gene: cloning, structural
      organization, and localization to chromosome 3 band B.},\n volume = {262 2},\n
      year = {1999}\n}\n"}, "authors": [{"authorId": "3490135", "name": "I. Aksoy"},
      {"authorId": "4025207", "name": "M. Ramsey"}, {"authorId": "6241317", "name":
      "D. Fruman"}, {"authorId": "48355989", "name": "S. Aksoy"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "33378554", "name": "J. Tucker"}, {"authorId":
      "6665338", "name": "T. Roberts"}]}, {"paperId": "a1110c534e9712312077bff378534bb86f809c9c",
      "externalIds": {"MAG": "1975573101", "DOI": "10.1016/S0092-8674(00)80792-8",
      "CorpusId": 17886164, "PubMed": "10399908"}, "corpusId": 17886164, "publicationVenue":
      {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal",
      "alternate_names": ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"],
      "url": "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/a1110c534e9712312077bff378534bb86f809c9c",
      "title": "Phosphoinositide Binding Domains Embracing 3-Phosphate", "abstract":
      null, "venue": "Cell", "year": 1999, "referenceCount": 33, "citationCount":
      137, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.cell.com/article/S0092867400807928/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "1999-06-25",
      "journal": {"volume": "97", "pages": "817-820", "name": "Cell"}, "citationStyles":
      {"bibtex": "@Article{Fruman1999PhosphoinositideBD,\n author = {D. Fruman and
      L. Rameh and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n pages
      = {817-820},\n title = {Phosphoinositide Binding Domains Embracing 3-Phosphate},\n
      volume = {97},\n year = {1999}\n}\n"}, "authors": [{"authorId": "6241317", "name":
      "D. Fruman"}, {"authorId": "4109960", "name": "L. Rameh"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "a9e6e4528afd7d105cb34011caca7496200b8fe3",
      "externalIds": {"MAG": "2008065206", "DOI": "10.1126/SCIENCE.283.5400.393",
      "CorpusId": 7445833, "PubMed": "9888855"}, "corpusId": 7445833, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/a9e6e4528afd7d105cb34011caca7496200b8fe3",
      "title": "Impaired B cell development and proliferation in absence of phosphoinositide
      3-kinase p85alpha.", "abstract": "Phosphoinositide 3-kinase (PI3K) activation
      has been implicated in many cellular responses, including fibroblast growth,
      transformation, survival, and chemotaxis. Although PI3K is activated by several
      agents that stimulate T and B cells, the role of PI3K in lymphocyte function
      is not clear. The mouse gene encoding the PI3K adapter subunit p85alpha and
      its splice variants p55alpha and p50alpha was disrupted. Most p85alpha-p55alpha-p50alpha-/-
      mice die within days after birth. Lymphocyte development and function was studied
      with the use of the RAG2-deficient blastocyst complementation system. Chimeric
      mice had reduced numbers of peripheral mature B cells and decreased serum immunoglobulin.
      The B cells that developed had diminished proliferative responses to antibody
      to immunoglobulin M, antibody to CD40, and lipopolysaccharide stimulation and
      decreased survival after incubation with interleukin-4. In contrast, T cell
      development and proliferation was normal. This phenotype is similar to defects
      observed in mice lacking the tyrosine kinase Btk.", "venue": "Science", "year":
      1999, "referenceCount": 23, "citationCount": 692, "influentialCitationCount":
      17, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1999-01-15", "journal": {"volume": "283 5400", "pages": "\n          393-7\n        ",
      "name": "Science"}, "citationStyles": {"bibtex": "@Article{Fruman1999ImpairedBC,\n
      author = {D. Fruman and S. Snapper and C. Yballe and L. Davidson and Jonathan
      Yu and F. Alt and L. Cantley},\n booktitle = {Science},\n journal = {Science},\n
      pages = {\n          393-7\n        },\n title = {Impaired B cell development
      and proliferation in absence of phosphoinositide 3-kinase p85alpha.},\n volume
      = {283 5400},\n year = {1999}\n}\n"}, "authors": [{"authorId": "6241317", "name":
      "D. Fruman"}, {"authorId": "4818618", "name": "S. Snapper"}, {"authorId": "7777071",
      "name": "C. Yballe"}, {"authorId": "49326303", "name": "L. Davidson"}, {"authorId":
      "2142549699", "name": "Jonathan Yu"}, {"authorId": "31713146", "name": "F. Alt"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "ae566410e977074dcd0bd185e95d2b519da3e7d8",
      "externalIds": {"MAG": "2005131087", "DOI": "10.1074/jbc.274.11.7489", "CorpusId":
      12756819, "PubMed": "10066815"}, "corpusId": 12756819, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/ae566410e977074dcd0bd185e95d2b519da3e7d8",
      "title": "The SH2 Domain-containing Inositol 5\u2032-Phosphatase (SHIP) Recruits
      the p85 Subunit of Phosphoinositide 3-Kinase during Fc\u03b3RIIb1-mediated Inhibition
      of B Cell Receptor Signaling*", "abstract": "Coligation of Fc\u03b3RIIb1 with
      the B cell receptor (BCR) or Fc\u03b5RI on mast cells inhibits B cell or mast
      cell activation. Activity of the inositol phosphatase SHIP is required for this
      negative signal. In vitro, SHIP catalyzes the conversion of the phosphoinositide
      3-kinase (PI3K) product phosphatidylinositol 3,4,5-trisphosphate (PIP3) into
      phosphatidylinositol 3,4-bisphosphate. Recent data demonstrate that coligation
      of Fc\u03b3RIIb1 with BCR inhibits PIP3-dependent Btk (Bruton\u2019s tyrosine
      kinase) activation and the Btk-dependent generation of inositol trisphosphate
      that regulates sustained calcium influx. In this study, we provide evidence
      that coligation of Fc\u03b3RIIb1 with BCR induces binding of PI3K to SHIP. This
      interaction is mediated by the binding of the SH2 domains of the p85 subunit
      of PI3K to a tyrosine-based motif in the C-terminal region of SHIP. Furthermore,
      the generation of phosphatidylinositol 3,4-bisphosphate was only partially reduced
      during coligation of BCR with Fc\u03b3RIIb1 despite a drastic reduction in PIP3.
      In contrast to the complete inhibition of Tec kinase-dependent calcium signaling,
      activation of the serine/threonine kinase Akt was partially preserved during
      BCR and Fc\u03b3RIIb1 coligation. The association of PI3K with SHIP may serve
      to activate PI3K and to regulate downstream events such as B cell activation-induced
      apoptosis.", "venue": "Journal of Biological Chemistry", "year": 1999, "referenceCount":
      39, "citationCount": 70, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818370261/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1999-03-12", "journal": {"volume": "274", "pages": "7489
      - 7494", "name": "The Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Gupta1999TheSD,\n author = {N. Gupta and A. Scharenberg and D. Fruman
      and L. Cantley and J. Kinet and Eric O Long},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {7489
      - 7494},\n title = {The SH2 Domain-containing Inositol 5\u2032-Phosphatase (SHIP)
      Recruits the p85 Subunit of Phosphoinositide 3-Kinase during Fc\u03b3RIIb1-mediated
      Inhibition of B Cell Receptor Signaling*},\n volume = {274},\n year = {1999}\n}\n"},
      "authors": [{"authorId": "1871947", "name": "N. Gupta"}, {"authorId": "4727704",
      "name": "A. Scharenberg"}, {"authorId": "6241317", "name": "D. Fruman"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "145931354", "name": "J. Kinet"},
      {"authorId": "35267053", "name": "Eric O Long"}]}, {"paperId": "c0b7687500595ce89a8f22d2fa8878f05e8ae09a",
      "externalIds": {"MAG": "2793367634", "DOI": "10.2210/pdb1qja/pdb", "CorpusId":
      103146693}, "corpusId": 103146693, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/c0b7687500595ce89a8f22d2fa8878f05e8ae09a",
      "title": "14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 2)", "abstract": null, "venue":
      "", "year": 1999, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "1999-09-15", "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Rittinger19991433ZC,\n
      author = {K. Rittinger and J. Budman and Jian Xu and S. Volinia and L. Cantley
      and S. Smerdon and S. Gamblin and M. Yaffe},\n title = {14-3-3 ZETA/PHOSPHOPEPTIDE
      COMPLEX (MODE 2)},\n year = {1999}\n}\n"}, "authors": [{"authorId": "6239566",
      "name": "K. Rittinger"}, {"authorId": "4299977", "name": "J. Budman"}, {"authorId":
      "2110980007", "name": "Jian Xu"}, {"authorId": "1906416", "name": "S. Volinia"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "4189482", "name":
      "S. Smerdon"}, {"authorId": "1958388", "name": "S. Gamblin"}, {"authorId": "88402408",
      "name": "M. Yaffe"}]}, {"paperId": "db10b9b7ad6fba1678dd63a72b571eabc152d9ec",
      "externalIds": {"MAG": "1964622351", "DOI": "10.1016/S0009-3084(99)00019-5",
      "CorpusId": 2918480, "PubMed": "10358929"}, "corpusId": 2918480, "publicationVenue":
      {"id": "556509f4-0eb1-4dc2-b738-f76b2812717f", "name": "Chemistry and Physics
      of Lipids", "type": "journal", "alternate_names": ["Chem Phys Lipid"], "issn":
      "0009-3084", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/506036/description#description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00093084",
      "https://www.journals.elsevier.com/chemistry-and-physics-of-lipids"]}, "url":
      "https://www.semanticscholar.org/paper/db10b9b7ad6fba1678dd63a72b571eabc152d9ec",
      "title": "Pathways for phosphoinositide synthesis.", "abstract": null, "venue":
      "Chemistry and Physics of Lipids", "year": 1999, "referenceCount": 59, "citationCount":
      84, "influentialCitationCount": 7, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "1999-04-01", "journal": {"volume": "98 1-2", "pages": "\n          69-77\n        ",
      "name": "Chemistry and physics of lipids"}, "citationStyles": {"bibtex": "@Article{Tolias1999PathwaysFP,\n
      author = {K. Tolias and L. Cantley},\n booktitle = {Chemistry and Physics of
      Lipids},\n journal = {Chemistry and physics of lipids},\n pages = {\n          69-77\n        },\n
      title = {Pathways for phosphoinositide synthesis.},\n volume = {98 1-2},\n year
      = {1999}\n}\n"}, "authors": [{"authorId": "4661935", "name": "K. Tolias"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "e2e9a4dc4a425eec2a8962b5be9a78cbe8c801d3",
      "externalIds": {"MAG": "2976585521", "DOI": "10.2210/pdb14ps/pdb", "CorpusId":
      204112664}, "corpusId": 204112664, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/e2e9a4dc4a425eec2a8962b5be9a78cbe8c801d3",
      "title": "14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX", "abstract": null, "venue": "",
      "year": 1999, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "1999-01-13", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Yaffe19991433ZC,\n
      author = {M. Yaffe and K. Rittinger and S. Volinia and P. Caron and A. Aitken
      and H. Leffers and S. Gamblin and S. Smerdon and L. Cantley},\n title = {14-3-3
      ZETA/PHOSPHOPEPTIDE COMPLEX},\n year = {1999}\n}\n"}, "authors": [{"authorId":
      "88402408", "name": "M. Yaffe"}, {"authorId": "6239566", "name": "K. Rittinger"},
      {"authorId": "1906416", "name": "S. Volinia"}, {"authorId": "46947956", "name":
      "P. Caron"}, {"authorId": "2092260", "name": "A. Aitken"}, {"authorId": "4053866",
      "name": "H. Leffers"}, {"authorId": "1958388", "name": "S. Gamblin"}, {"authorId":
      "4189482", "name": "S. Smerdon"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "ec75d3d76d188a3091f2ade2c873aca1794c544c", "externalIds": {"MAG":
      "1965802234", "DOI": "10.1074/jbc.274.46.32662", "CorpusId": 31837259, "PubMed":
      "10551821"}, "corpusId": 31837259, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/ec75d3d76d188a3091f2ade2c873aca1794c544c",
      "title": "SYK Is Upstream of Phosphoinositide 3-Kinase in B Cell Receptor Signaling*",
      "abstract": "We have recently demonstrated that the D3-phosphoinositide phosphatidylinositol
      3,4,5-trisphosphate (PtdIns-3,4,5-P3) is critical for producing sustained calcium
      signals through its role in promoting the function of TEC family tyrosine kinases
      such as Bruton''s tyrosine kinase. Although PtdIns-3,4,5-P3 can potentially
      be synthesized by any of several types of phosphoinositide 3-kinases (PI3Ks),
      B cell receptor (BCR)-induced PtdIns-3,4,5-P3 production is thought to occur
      primarily through the activation of the class Ia (p85/p110) PI3Ks. This process
      has been proposed to be mediated by an interaction between the Src family kinase
      LYN and the p85 subunit of PI3K and/or through p85 membrane recruitment mediated
      by CBL and/or CD19. However, calcium signaling and other PI3K-dependent signals
      are relatively preserved in a LYN kinase-deficient B lymphocyte cell line, suggesting
      that an alternative pathway for PI3K activation exists. As SYK/ZAP70 kinases
      are upstream from many BCR-initiated signaling events, we directly analyzed
      SYK-dependent accumulation of both PtdIns-3,4,5-P3 and PtdIns-3,4-P2 in B cell
      receptor signaling using both dominant negative and genetic knockout approaches.
      Both methods indicate that SYK is upstream of, and necessary for, a significant
      portion of BCR-induced PtdIns-3,4,5-P3 production. Whereas CD19 does not appear
      to be involved in this SYK-dependent pathway, the SYK substrate CBL is likely
      involved as the dominant negative SYK markedly attenuates CBL tyrosine phosphorylation
      and completely blocks the BCR-dependent association of CBL with p85 PI3K.",
      "venue": "Journal of Biological Chemistry", "year": 1999, "referenceCount":
      59, "citationCount": 189, "influentialCitationCount": 16, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925817465604/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1999-11-12", "journal": {"volume": "274",
      "pages": "32662 - 32666", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Beitz1999SYKIU,\n author = {L. Beitz and D. Fruman and
      T. Kurosaki and L. Cantley and A. Scharenberg},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {32662
      - 32666},\n title = {SYK Is Upstream of Phosphoinositide 3-Kinase in B Cell
      Receptor Signaling*},\n volume = {274},\n year = {1999}\n}\n"}, "authors": [{"authorId":
      "6614940", "name": "L. Beitz"}, {"authorId": "6241317", "name": "D. Fruman"},
      {"authorId": "1860005", "name": "T. Kurosaki"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "4727704", "name": "A. Scharenberg"}]}, {"paperId":
      "f4aadb7f32dc0d83637edcb91092c7c280e229f9", "externalIds": {"MAG": "2077895194",
      "DOI": "10.1016/S1097-2765(00)80363-9", "CorpusId": 925317, "PubMed": "10488331"},
      "corpusId": 925317, "publicationVenue": {"id": "419fc6db-c7c4-4275-80ef-4b89c59bec11",
      "name": "Molecules and Cells", "type": "journal", "alternate_names": ["Molecular
      Cell", "Mol Cell"], "issn": "1016-8478", "alternate_issns": ["0219-1032", "1097-2765"],
      "url": "https://link.springer.com/journal/10059", "alternate_urls": ["http://www.molcells.org/about/sub06.html",
      "http://www.molecule.org/", "http://www.sciencedirect.com/science/journal/10972765",
      "http://www.cell.com/molecular-cell/"]}, "url": "https://www.semanticscholar.org/paper/f4aadb7f32dc0d83637edcb91092c7c280e229f9",
      "title": "Structural analysis of 14-3-3 phosphopeptide complexes identifies
      a dual role for the nuclear export signal of 14-3-3 in ligand binding.", "abstract":
      null, "venue": "Molecules and Cells", "year": 1999, "referenceCount": 80, "citationCount":
      503, "influentialCitationCount": 31, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S1097276500803639/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1999-08-01", "journal":
      {"volume": "4 2", "pages": "\n          153-66\n        ", "name": "Molecular
      cell"}, "citationStyles": {"bibtex": "@Article{Rittinger1999StructuralAO,\n
      author = {K. Rittinger and J. Budman and Jian Xu and S. Volinia and L. Cantley
      and L. Cantley and S. Smerdon and S. Gamblin and M. Yaffe},\n booktitle = {Molecules
      and Cells},\n journal = {Molecular cell},\n pages = {\n          153-66\n        },\n
      title = {Structural analysis of 14-3-3 phosphopeptide complexes identifies a
      dual role for the nuclear export signal of 14-3-3 in ligand binding.},\n volume
      = {4 2},\n year = {1999}\n}\n"}, "authors": [{"authorId": "6239566", "name":
      "K. Rittinger"}, {"authorId": "4299977", "name": "J. Budman"}, {"authorId":
      "2110980007", "name": "Jian Xu"}, {"authorId": "1906416", "name": "S. Volinia"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "4189482", "name": "S. Smerdon"}, {"authorId": "1958388",
      "name": "S. Gamblin"}, {"authorId": "88402408", "name": "M. Yaffe"}]}, {"paperId":
      "f60ed956df1863612236c5df17315236b2153561", "externalIds": {"MAG": "2724572059",
      "DOI": "10.1042/BST027A073C", "CorpusId": 90097503}, "corpusId": 90097503, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/f60ed956df1863612236c5df17315236b2153561",
      "title": "PI 3-KINASE KNOCKOUT MICE: ROLE OF p85\u03b1 IN B CELL DEVELOPMENT
      AND PROLIFERATION", "abstract": null, "venue": "", "year": 1999, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "1999-06-01", "journal": {"volume":
      "27", "name": "Biochemical Society Transactions"}, "citationStyles": {"bibtex":
      "@Article{Fruman1999PI3K,\n author = {D. Fruman and S. Snapper and C. Yballe
      and F. Mauvais-Jarvis and C. Kahn and F. Alt and L. Cantley},\n journal = {Biochemical
      Society Transactions},\n title = {PI 3-KINASE KNOCKOUT MICE: ROLE OF p85\u03b1
      IN B CELL DEVELOPMENT AND PROLIFERATION},\n volume = {27},\n year = {1999}\n}\n"},
      "authors": [{"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "4818618",
      "name": "S. Snapper"}, {"authorId": "7777071", "name": "C. Yballe"}, {"authorId":
      "1396480779", "name": "F. Mauvais-Jarvis"}, {"authorId": "144391716", "name":
      "C. Kahn"}, {"authorId": "31713146", "name": "F. Alt"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "0093753fc77eccd1248d1237709470d5e770eda0",
      "externalIds": {"MAG": "2165742826", "DOI": "10.1093/emboj/17.7.1961", "CorpusId":
      7246866, "PubMed": "9524119"}, "corpusId": 7246866, "publicationVenue": {"id":
      "b89f0ede-6fa8-4dd2-a8a7-f54695a00323", "name": "EMBO Journal", "type": "journal",
      "alternate_names": ["The EMBO Journal", "EMBO J"], "issn": "0261-4189", "url":
      "http://embojournal.npgjournals.com/", "alternate_urls": ["http://emboj.embopress.org/"]},
      "url": "https://www.semanticscholar.org/paper/0093753fc77eccd1248d1237709470d5e770eda0",
      "title": "Phosphatidylinositol\u20103,4,5\u2010trisphosphate (PtdIns\u20103,4,5\u2010P3)/Tec
      kinase\u2010dependent calcium signaling pathway: a target for SHIP\u2010mediated
      inhibitory signals", "abstract": "Tec family non\u2010receptor tyrosine kinases
      have been implicated in signal transduction events initiated by cell surface
      receptors from a broad range of cell types, including an essential role in B\u2010cell
      development. A unique feature of several Tec members among known tyrosine kinases
      is the presence of an N\u2010terminal pleckstrin homology (PH) domain. We directly
      demonstrate that phosphatidylinositol\u20103,4,5\u2010trisphosphate (PtdIns\u20103,4,5\u2010P3)
      interacting with the PH domain acts as an upstream activation signal for Tec
      kinases, resulting in Tec kinase\u2010dependent phospholipase C\u03b3 (PLC\u03b3)
      tyrosine phosphorylation and inositol trisphosphate production. In addition,
      we show that this pathway is blocked when an SH2\u2010containing inositol phosphatase
      (SHIP)\u2010dependent inhibitory receptor is engaged. Together, our results
      suggest a general mechanism whereby PtdIns\u20103,4,5\u2010P3 regulates receptor\u2010dependent
      calcium signals through the function of Tec kinases.", "venue": "EMBO Journal",
      "year": 1998, "referenceCount": 66, "citationCount": 463, "influentialCitationCount":
      19, "isOpenAccess": true, "openAccessPdf": {"url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1093/emboj/17.7.1961",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1998-04-01", "journal": {"volume": "17", "name": "The EMBO
      Journal"}, "citationStyles": {"bibtex": "@Article{Scharenberg1998Phosphatidylinositol345trisphosphateK,\n
      author = {A. Scharenberg and O. El\u2010Hillal and D. Fruman and L. Beitz and
      Zuomei Li and Siqi Lin and I. Gout and L. Cantley and D. Rawlings and J. Kinet},\n
      booktitle = {EMBO Journal},\n journal = {The EMBO Journal},\n title = {Phosphatidylinositol\u20103,4,5\u2010trisphosphate
      (PtdIns\u20103,4,5\u2010P3)/Tec kinase\u2010dependent calcium signaling pathway:
      a target for SHIP\u2010mediated inhibitory signals},\n volume = {17},\n year
      = {1998}\n}\n"}, "authors": [{"authorId": "4727704", "name": "A. Scharenberg"},
      {"authorId": "1422641592", "name": "O. El\u2010Hillal"}, {"authorId": "6241317",
      "name": "D. Fruman"}, {"authorId": "6614940", "name": "L. Beitz"}, {"authorId":
      "121544277", "name": "Zuomei Li"}, {"authorId": "2107932426", "name": "Siqi
      Lin"}, {"authorId": "6814491", "name": "I. Gout"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2156694", "name": "D. Rawlings"}, {"authorId":
      "145931354", "name": "J. Kinet"}]}, {"paperId": "0cb94c7b1866632932aaf193fc60a7d252f372bd",
      "externalIds": {"MAG": "2142055861", "DOI": "10.1128/MCB.18.2.762", "CorpusId":
      36686515, "PubMed": "9447972"}, "corpusId": 36686515, "publicationVenue": {"id":
      "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular and Cellular Biology",
      "type": "journal", "alternate_names": ["Mol Cell Biology"], "issn": "0270-7306",
      "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]}, "url":
      "https://www.semanticscholar.org/paper/0cb94c7b1866632932aaf193fc60a7d252f372bd",
      "title": "Characterization of a Rac1- and RhoGDI-Associated Lipid Kinase Signaling
      Complex", "abstract": "ABSTRACT Rho family GTPases regulate a number of cellular
      processes, including actin cytoskeletal organization, cellular proliferation,
      and NADPH oxidase activation. The mechanisms by which these G proteins mediate
      their effects are unclear, although a number of downstream targets have been
      identified. The interaction of most of these target proteins with Rho GTPases
      is GTP dependent and requires the effector domain. The activation of the NADPH
      oxidase also depends on the C terminus of Rac, but no effector molecules that
      bind to this region have yet been identified. We previously showed that Rac
      interacts with a type I phosphatidylinositol-4-phosphate (PtdInsP) 5-kinase,
      independent of GTP. Here we report the identification of a diacylglycerol kinase
      (DGK) which also associates with both GTP- and GDP-bound Rac1. In vitro binding
      analysis using chimeric proteins, peptides, and a truncation mutant demonstrated
      that the C terminus of Rac is necessary and sufficient for binding to both lipid
      kinases. The Rac-associated PtdInsP 5-kinase and DGK copurify by liquid chromatography,
      suggesting that they bind as a complex to Rac. RhoGDI also associates with this
      lipid kinase complex both in vivo and in vitro, primarily via its interaction
      with Rac. The interaction between Rac and the lipid kinases was enhanced by
      specific phospholipids, indicating a possible mechanism of regulation in vivo.
      Given that the products of the PtdInsP 5-kinase and the DGK have been implicated
      in several Rac-regulated processes, and they bind to the Rac C terminus, these
      lipid kinases may play important roles in Rac activation of the NADPH oxidase,
      actin polymerization, and other signaling pathways.", "venue": "Molecular and
      Cellular Biology", "year": 1998, "referenceCount": 68, "citationCount": 159,
      "influentialCitationCount": 12, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc108787?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1998-02-01", "journal":
      {"volume": "18", "pages": "762 - 770", "name": "Molecular and Cellular Biology"},
      "citationStyles": {"bibtex": "@Article{Tolias1998CharacterizationOA,\n author
      = {K. Tolias and A. Couvillon and L. Cantley and C. Carpenter},\n booktitle
      = {Molecular and Cellular Biology},\n journal = {Molecular and Cellular Biology},\n
      pages = {762 - 770},\n title = {Characterization of a Rac1- and RhoGDI-Associated
      Lipid Kinase Signaling Complex},\n volume = {18},\n year = {1998}\n}\n"}, "authors":
      [{"authorId": "4661935", "name": "K. Tolias"}, {"authorId": "153879281", "name":
      "A. Couvillon"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2972505", "name": "C. Carpenter"}]}, {"paperId": "1ff2b14a88912d051e31273ae0c4fa72c218c8eb",
      "externalIds": {"MAG": "2039185825", "DOI": "10.1074/jbc.273.4.1859", "CorpusId":
      19293669, "PubMed": "9442017"}, "corpusId": 19293669, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/1ff2b14a88912d051e31273ae0c4fa72c218c8eb",
      "title": "Regulation of GRP1-catalyzed ADP Ribosylation Factor Guanine Nucleotide
      Exchange by Phosphatidylinositol 3,4,5-Trisphosphate*", "abstract": "Cellular
      levels of phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) are rapidly
      elevated in response to activation of growth factor receptor tyrosine kinases.
      This polyphosphoinositide binds the pleckstrin homology (PH) domain of GRP1,
      a protein that also contains 200 residues with high sequence similarity to a
      segment of the yeast Sec7 protein that functions as an ADP ribosylation exchange
      factor (ARF) (Klarlund, J., Guilherme, A., Holik, J. J., Virbasius, J. V., Chawla,
      A., and Czech, M. P. (1997)Science 275, 1927\u20131930). Here we show that dioctanoyl
      PtdIns(3,4,5)P3 binds the PH domain of GRP1 with aK d = 0.5 \u03bcm, an affinity
      2 orders of magnitude greater than dioctanoyl-PtdIns(4,5)P2. Further, the Sec7
      domain of GRP1 is found to catalyze guanine nucleotide exchange of ARF1 and
      -5 but not ARF6. Importantly, PtdIns(3,4,5)P3, but not PtdIns(4,5)P2, markedly
      enhances the ARF exchange activity of GRP1 in a reaction mixture containing
      dimyristoylphosphatidylcholine micelles, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic
      acid, and a low concentration of sodium cholate. PtdIns(3,4,5)P3-mediated ARF
      nucleotide exchange through GRP1 is selectively blocked by 100 \u03bcm inositol
      1,3,4,5-tetrakisphosphate, which also binds the PH domain of GRP1. Taken together,
      these data are consistent with the hypothesis that selective recruitment of
      GRP1 to PtdIns(3,4,5)P3 in membranes activates ARF1 and -5, known regulators
      of intracellular membrane trafficking.", "venue": "Journal of Biological Chemistry",
      "year": 1998, "referenceCount": 29, "citationCount": 147, "influentialCitationCount":
      9, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819841303/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1998-01-23", "journal": {"volume": "273", "pages": "1859
      - 1862", "name": "The Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Klarlund1998RegulationOG,\n author = {J. Klarlund and L. Rameh and
      L. Cantley and J. Buxton and J. Holik and Christoper Sakelis and V. Patki and
      S. Corvera and M. Czech},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of Biological Chemistry},\n pages = {1859 - 1862},\n
      title = {Regulation of GRP1-catalyzed ADP Ribosylation Factor Guanine Nucleotide
      Exchange by Phosphatidylinositol 3,4,5-Trisphosphate*},\n volume = {273},\n
      year = {1998}\n}\n"}, "authors": [{"authorId": "3593228", "name": "J. Klarlund"},
      {"authorId": "4109960", "name": "L. Rameh"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "39917771", "name": "J. Buxton"}, {"authorId": "2550047",
      "name": "J. Holik"}, {"authorId": "2196801774", "name": "Christoper Sakelis"},
      {"authorId": "144766253", "name": "V. Patki"}, {"authorId": "3950323", "name":
      "S. Corvera"}, {"authorId": "144307657", "name": "M. Czech"}]}, {"paperId":
      "23d382b18781cc655c17ca510bc01d027e8b1bca", "externalIds": {"MAG": "2051627027",
      "DOI": "10.1006/BBRC.1997.7877", "CorpusId": 84938992}, "corpusId": 84938992,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/23d382b18781cc655c17ca510bc01d027e8b1bca",
      "title": "Extracellular HIV-1 Tat Protein Induces a Rapid and Selective Activation
      of Protein Kinase C (PKC)-\u03b1, -\u03f5, and -\u03b6 Isoforms in PC12 Cells",
      "abstract": "Abstract The addition in culture of extracellular HIV-1 Tat protein
      (0.1-1 nM) to PC12 cells induced a rapid increase of the bulk protein kinase
      C (PKC) catalytic activity. Among various PKC isoforms (\u03b1, \u03b2I, \u03b2II,
      \u03b4, \u03f5, \u03b7, \u03b8, and \u03b6) expressed in PC12 cells, Tat selectively
      stimulated \u03b1, \u03f5, and \u03b6, as judged by activities in immunoprecipitates.
      Activation of these isoforms was suppressed by the tyrosine kinase inhibitor
      genistein. Moreover, PKC-\u03b6 showed the fastest kinetics of activation in
      response to Tat, but PKC-\u03b1 and PKC-\u03f5 showed the highest levels of
      activation. PKC-\u03b1 activation was accompanied by a rise of intracellular
      IP3, while the PI 3-kinase inhibitors wortmannin and LY294002 suppressed PKC-\u03f5
      activation. Taken together, these findings demonstrate that extracellular Tat
      shows a cytokine-like activity in PC12 cells, being able to trigger an intracellular
      signalling cascade which involves PKC-\u03b1, -\u03f5, and -\u03b6.", "venue":
      "", "year": 1998, "referenceCount": 23, "citationCount": 36, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "1998-01-14", "journal": {"volume":
      "242", "pages": "332-337", "name": "Biochemical and Biophysical Research Communications"},
      "citationStyles": {"bibtex": "@Article{Borgatti1998ExtracellularHT,\n author
      = {P. Borgatti and G. Zauli and L. Cantley and S. Capitani},\n journal = {Biochemical
      and Biophysical Research Communications},\n pages = {332-337},\n title = {Extracellular
      HIV-1 Tat Protein Induces a Rapid and Selective Activation of Protein Kinase
      C (PKC)-\u03b1, -\u03f5, and -\u03b6 Isoforms in PC12 Cells},\n volume = {242},\n
      year = {1998}\n}\n"}, "authors": [{"authorId": "5619854", "name": "P. Borgatti"},
      {"authorId": "4754758", "name": "G. Zauli"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3996531", "name": "S. Capitani"}]}, {"paperId":
      "28cf20508330c0596c5fd4292f4ac39d1d81e27f", "externalIds": {"CorpusId": 20682842,
      "PubMed": "10427554"}, "corpusId": 20682842, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/28cf20508330c0596c5fd4292f4ac39d1d81e27f",
      "title": "Phosphatidylinositol 4-kinases. Assays and product analysis.", "abstract":
      null, "venue": "Methods in molecular biology", "year": 1998, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": null, "journal": {"volume": "105", "pages":
      "\n          99-108\n        ", "name": "Methods in molecular biology"}, "citationStyles":
      {"bibtex": "@Article{Meyers1998Phosphatidylinositol4A,\n author = {R. Meyers
      and L. Cantley},\n booktitle = {Methods in molecular biology},\n journal = {Methods
      in molecular biology},\n pages = {\n          99-108\n        },\n title = {Phosphatidylinositol
      4-kinases. Assays and product analysis.},\n volume = {105},\n year = {1998}\n}\n"},
      "authors": [{"authorId": "48408223", "name": "R. Meyers"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "3fa4ad334602f0b8fd9b63cf880facfeec7e2f14",
      "externalIds": {"MAG": "2021124770", "PubMedCentral": "2132704", "DOI": "10.1083/JCB.140.5.1125",
      "CorpusId": 18498085, "PubMed": "9490725"}, "corpusId": 18498085, "publicationVenue":
      {"id": "bf59074e-18fd-4f9a-a1b0-a9bafc16f518", "name": "Journal of Cell Biology",
      "type": "journal", "alternate_names": ["J Cell Biology"], "issn": "0021-9525",
      "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=482",
      "alternate_urls": ["http://www.jstor.org/journals/00219525.html", "https://www.jstor.org/journal/jcellbiology",
      "http://www.jcb.org/"]}, "url": "https://www.semanticscholar.org/paper/3fa4ad334602f0b8fd9b63cf880facfeec7e2f14",
      "title": "Corequirement of Specific Phosphoinositides and Small GTP-binding
      Protein Cdc42 in Inducing Actin Assembly in Xenopus Egg Extracts", "abstract":
      "Both phosphoinositides and small GTP-binding proteins of the Rho family have
      been postulated to regulate actin assembly in cells. We have reconstituted actin
      assembly in response to these signals in Xenopus extracts and examined the relationship
      of these pathways. We have found that GTP\u03b3S stimulates actin assembly in
      the presence of endogenous membrane vesicles in low speed extracts. These membrane
      vesicles are required, but can be replaced by lipid vesicles prepared from purified
      phospholipids containing phosphoinositides. Vesicles containing phosphatidylinositol
      (4,5) bisphosphate or phosphatidylinositol (3,4,5) trisphosphate can induce
      actin assembly even in the absence of GTP\u03b3S. RhoGDI, a guanine-nucleotide
      dissociation inhibitor for the Rho family, inhibits phosphoinositide-induced
      actin assembly, suggesting the involvement of the Rho family small G proteins.
      Using various dominant mutants of these G proteins, we demonstrate the requirement
      of Cdc42 for phosphoinositide-induced actin assembly. Our results suggest that
      phosphoinositides may act to facilitate GTP exchange on Cdc42, as well as to
      anchor Cdc42 and actin nucleation activities. Hence, both phosphoinositides
      and Cdc42 are required to induce actin assembly in this cell-free system.",
      "venue": "Journal of Cell Biology", "year": 1998, "referenceCount": 62, "citationCount":
      200, "influentialCitationCount": 14, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://jcb.rupress.org/content/140/5/1125.full.pdf", "status": null},
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1998-03-09", "journal": {"volume": "140", "pages": "1125
      - 1136", "name": "The Journal of Cell Biology"}, "citationStyles": {"bibtex":
      "@Article{Ma1998CorequirementOS,\n author = {Le Ma and L. Cantley and P. Janmey
      and M. Kirschner},\n booktitle = {Journal of Cell Biology},\n journal = {The
      Journal of Cell Biology},\n pages = {1125 - 1136},\n title = {Corequirement
      of Specific Phosphoinositides and Small GTP-binding Protein Cdc42 in Inducing
      Actin Assembly in Xenopus Egg Extracts},\n volume = {140},\n year = {1998}\n}\n"},
      "authors": [{"authorId": "2252190114", "name": "Le Ma"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2194622", "name": "P. Janmey"}, {"authorId":
      "40294231", "name": "M. Kirschner"}]}, {"paperId": "4342ed49c8c83780769189b0874a8ea97fd0992f",
      "externalIds": {"MAG": "2067232669", "DOI": "10.1074/jbc.273.36.23126", "CorpusId":
      35784628, "PubMed": "9722541"}, "corpusId": 35784628, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/4342ed49c8c83780769189b0874a8ea97fd0992f",
      "title": "Association of Protein Kinase C\u03bc with Type II Phosphatidylinositol
      4-Kinase and Type I Phosphatidylinositol-4-phosphate 5-Kinase*", "abstract":
      "Protein kinase C\u03bc (PKC\u03bc), also named protein kinase D, is an unusual
      member of the PKC family that has a putative transmembrane domain and pleckstrin
      homology domain. This enzyme has a substrate specificity distinct from other
      PKC isoforms (Nishikawa, K., Toker, A., Johannes, F. J., Songyang, Z., and Cantley,
      L. C. (1997) J. Biol. Chem. 272, 952\u2013960), and its mechanism of regulation
      is not yet clear. Here we show that PKC\u03bc forms a complex in vivo with a
      phosphatidylinositol 4-kinase and a phosphatidylinositol-4-phosphate 5-kinase.
      A region of PKC\u03bc between the amino-terminal transmembrane domain and the
      pleckstrin homology domain is shown to be involved in the association with the
      lipid kinases. Interestingly, a kinase-dead point mutant of PKC\u03bc failed
      to associate with either lipid kinase activity, indicating that autophosphorylation
      may be required to expose the lipid kinase interaction domain. Furthermore,
      the subcellular distribution of the PKC\u03bc-associated lipid kinases to the
      particulate fraction depends on the presence of the amino-terminal region of
      PKC\u03bc including the predicted transmembrane region. These results suggest
      a novel model in which the non-catalytic region of PKC\u03bc acts as a scaffold
      for assembly of enzymes involved in phosphoinositide synthesis at specific membrane
      locations.", "venue": "Journal of Biological Chemistry", "year": 1998, "referenceCount":
      38, "citationCount": 93, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1998-09-04", "journal": {"volume": "273", "pages": "23126
      - 23133", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Nishikawa1998AssociationOP,\n author = {K. Nishikawa and
      A. Toker and K. Wong and P. Marignani and F. Johannes and L. Cantley},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {23126 - 23133},\n title = {Association of Protein Kinase
      C\u03bc with Type II Phosphatidylinositol 4-Kinase and Type I Phosphatidylinositol-4-phosphate
      5-Kinase*},\n volume = {273},\n year = {1998}\n}\n"}, "authors": [{"authorId":
      "2060316864", "name": "K. Nishikawa"}, {"authorId": "145751285", "name": "A.
      Toker"}, {"authorId": "2107345046", "name": "K. Wong"}, {"authorId": "40278978",
      "name": "P. Marignani"}, {"authorId": "87883210", "name": "F. Johannes"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "4d75d1d9289e2239e6c12ef7be358f6c881ef6ec",
      "externalIds": {"CorpusId": 43669096, "PubMed": "9726983"}, "corpusId": 43669096,
      "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal
      of Biological Chemistry", "type": "journal", "alternate_names": ["J Biological
      Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/4d75d1d9289e2239e6c12ef7be358f6c881ef6ec",
      "title": "Phosphoinositide 3-kinase regulates phospholipase Cgamma-mediated
      calcium signaling.", "abstract": "It has been demonstrated that the lipid products
      of the phosphoinositide 3-kinase (PI3K) can associate with the Src homology
      2 (SH2) domains of specific signaling molecules and modify their actions. In
      the current experiments, phosphatidylinositol 3,4, 5-trisphosphate (PtdIns-3,4,5-P3)
      was found to bind to the C-terminal SH2 domain of phospholipase Cgamma (PLCgamma)
      with an apparent Kd of 2.4 microM and to displace the C-terminal SH2 domain
      from the activated platelet-derived growth factor receptor (PDGFR). To investigate
      the in vivo relevance of this observation, intracellular inositol trisphosphate
      (IP3) generation and calcium release were examined in HepG2 cells expressing
      a series of PDGFR mutants that activate PLCgamma with or without receptor association
      with PI3K. Coactivation of PLCgamma and PI3K resulted in an approximately 40%
      increase in both intracellular IP3 generation and intracellular calcium release
      as compared with selective activation of PLCgamma. Similarly, the addition of
      wortmannin or LY294002 to cells expressing the wild-type PDGFR inhibited the
      release of intracellular calcium. Thus, generation of PtdIns-3,4,5-P3 by receptor-associated
      PI3K causes an increase in IP3 production and intracellular calcium release,
      potentially via enhanced PtdIns-4, 5-P2 substrate availability due to PtdIns-3,4,5-P3-mediated
      recruitment of PLCgamma to the lipid bilayer.", "venue": "Journal of Biological
      Chemistry", "year": 1998, "referenceCount": 0, "citationCount": 60, "influentialCitationCount":
      4, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": null, "journal":
      {"volume": "273 37", "pages": "\n          23750-7\n        ", "name": "The
      Journal of biological chemistry"}, "citationStyles": {"bibtex": "@Article{Rameh1998Phosphoinositide3R,\n
      author = {L. Rameh and S. Rhee and K. Spokes and A. Kazlauskas and L. Cantley
      and L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n journal
      = {The Journal of biological chemistry},\n pages = {\n          23750-7\n        },\n
      title = {Phosphoinositide 3-kinase regulates phospholipase Cgamma-mediated calcium
      signaling.},\n volume = {273 37},\n year = {1998}\n}\n"}, "authors": [{"authorId":
      "4109960", "name": "L. Rameh"}, {"authorId": "3034828", "name": "S. Rhee"},
      {"authorId": "4375980", "name": "K. Spokes"}, {"authorId": "49161111", "name":
      "A. Kazlauskas"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "5601835", "name": "L. Cantley"}]}, {"paperId": "6ea34b2f81614cf943cf761e5335742ffde60e5b",
      "externalIds": {"PubMedCentral": "2141757", "MAG": "2154153541", "DOI": "10.1083/JCB.140.4.737",
      "CorpusId": 168715, "PubMed": "9472028"}, "corpusId": 168715, "publicationVenue":
      {"id": "bf59074e-18fd-4f9a-a1b0-a9bafc16f518", "name": "Journal of Cell Biology",
      "type": "journal", "alternate_names": ["J Cell Biology"], "issn": "0021-9525",
      "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=482",
      "alternate_urls": ["http://www.jstor.org/journals/00219525.html", "https://www.jstor.org/journal/jcellbiology",
      "http://www.jcb.org/"]}, "url": "https://www.semanticscholar.org/paper/6ea34b2f81614cf943cf761e5335742ffde60e5b",
      "title": "SRPK2: A Differentially Expressed SR Protein-specific Kinase Involved
      in Mediating the Interaction and Localization of Pre-mRNA Splicing Factors in
      Mammalian Cells", "abstract": "Abstract. Reversible phosphorylation plays an
      important role in pre-mRNA splicing in mammalian cells. Two kinases, SR protein-specific
      kinase (SRPK1) and Clk/Sty, have been shown to phosphorylate the SR family of
      splicing factors. We report here the cloning and characterization of SRPK2,
      which is highly related to SRPK1 in sequence, kinase activity, and substrate
      specificity. Random peptide selection for preferred phosphorylation sites revealed
      a stringent preference of SRPK2 for SR dipeptides, and the consensus derived
      may be used to predict potential phosphorylation sites in candidate arginine
      and serine-rich (RS) domain\u2013containing proteins. Phosphorylation of an
      SR protein (ASF/SF2) by either SRPK1 or 2 enhanced its interaction with another
      RS domain\u2013containing protein (U1 70K), and overexpression of either kinase
      induced specific redistribution of splicing factors in the nucleus. These observations
      likely reflect the function of the SRPK family of kinases in spliceosome assembly
      and in mediating the trafficking of splicing factors in mammalian cells. The
      biochemical and functional similarities between SRPK1 and 2, however, are in
      contrast to their differences in expression. SRPK1 is highly expressed in pancreas,
      whereas SRPK2 is highly expressed in brain, although both are coexpressed in
      other human tissues and in many experimental cell lines. Interestingly, SRPK2
      also contains a proline-rich sequence at its NH2 terminus, and a recent study
      showed that this NH2-terminal sequence has the capacity to interact with a WW
      domain protein in vitro. Together, our studies suggest that different SRPK family
      members may be uniquely regulated and targeted, thereby contributing to splicing
      regulation in different tissues, during development, or in response to signaling.",
      "venue": "Journal of Cell Biology", "year": 1998, "referenceCount": 64, "citationCount":
      322, "influentialCitationCount": 22, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://rupress.org/jcb/article-pdf/140/4/737/1275188/16515.pdf", "status":
      null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1998-02-23", "journal": {"volume": "140", "pages": "737
      - 750", "name": "The Journal of Cell Biology"}, "citationStyles": {"bibtex":
      "@Article{Wang1998SRPK2AD,\n author = {Huan-You Wang and Wen-chang Lin and J.
      Dyck and J. Yeakley and Songyang Zhou and L. Cantley and Xiang-Dong Fu},\n booktitle
      = {Journal of Cell Biology},\n journal = {The Journal of Cell Biology},\n pages
      = {737 - 750},\n title = {SRPK2: A Differentially Expressed SR Protein-specific
      Kinase Involved in Mediating the Interaction and Localization of Pre-mRNA Splicing
      Factors in Mammalian Cells},\n volume = {140},\n year = {1998}\n}\n"}, "authors":
      [{"authorId": "2113268866", "name": "Huan-You Wang"}, {"authorId": "34503377",
      "name": "Wen-chang Lin"}, {"authorId": "88013281", "name": "J. Dyck"}, {"authorId":
      "5439166", "name": "J. Yeakley"}, {"authorId": "2111144577", "name": "Songyang
      Zhou"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1683422",
      "name": "Xiang-Dong Fu"}]}, {"paperId": "8403a2e0e7f1b3a42c9fec10862e93b25af91eb3",
      "externalIds": {"MAG": "2417568262", "DOI": "10.1385/0-89603-491-7:99", "CorpusId":
      89544479}, "corpusId": 89544479, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/8403a2e0e7f1b3a42c9fec10862e93b25af91eb3",
      "title": "Phosphatidylinositol 4-Kinases", "abstract": null, "venue": "", "year":
      1998, "referenceCount": 10, "citationCount": 5, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": {"volume": "105",
      "pages": "99-108", "name": "Methods of Molecular Biology"}, "citationStyles":
      {"bibtex": "@Article{Meyers1998Phosphatidylinositol4,\n author = {R. Meyers
      and L. Cantley},\n journal = {Methods of Molecular Biology},\n pages = {99-108},\n
      title = {Phosphatidylinositol 4-Kinases},\n volume = {105},\n year = {1998}\n}\n"},
      "authors": [{"authorId": "48408223", "name": "R. Meyers"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "8f219c96cfe6e51cc6e9f93ab4de7b7afae6a906",
      "externalIds": {"DOI": "10.1146/annurev.biochem.67.1.481", "CorpusId": 684244,
      "PubMed": "9759495"}, "corpusId": 684244, "publicationVenue": {"id": "9e5ab0fc-a36d-4a05-bc89-12dd1cb12e2b",
      "name": "Annual Review of Biochemistry", "type": "journal", "alternate_names":
      ["Annu Rev Biochem"], "issn": "0066-4154", "url": "https://www.annualreviews.org/journal/biochem",
      "alternate_urls": ["http://www.annualreviews.org/journal/biochem", "http://biochem.annualreviews.org/",
      "https://www.annualreviews.org/loi/biochem", "http://intl-biomedical.annualreviews.org/",
      "http://arjournals.annualreviews.org/loi/biochem", "http://arjournals.annualreviews.org/loi/biochem?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/8f219c96cfe6e51cc6e9f93ab4de7b7afae6a906",
      "title": "Phosphoinositide kinases.", "abstract": "Phosphatidylinositol, a component
      of eukaryotic cell membranes, is unique among phospholipids in that its head
      group can be phosphorylated at multiple free hydroxyls. Several phosphorylated
      derivatives of phosphatidylinositol, collectively termed phosphoinositides,
      have been identified in eukaryotic cells from yeast to mammals. Phosphoinositides
      are involved in the regulation of diverse cellular processes, including proliferation,
      survival, cytoskeletal organization, vesicle trafficking, glucose transport,
      and platelet function. The enzymes that phosphorylate phosphatidylinositol and
      its derivatives are termed phosphoinositide kinases. Recent advances have challenged
      previous hypotheses about the substrate selectivity of different phosphoinositide
      kinase families. Here we re-examine the pathways of phosphoinositide synthesis
      and the enzymes involved.", "venue": "Annual Review of Biochemistry", "year":
      1998, "referenceCount": 0, "citationCount": 1163, "influentialCitationCount":
      107, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.annualreviews.org/doi/pdf/10.1146/annurev.biochem.67.1.481",
      "status": null}, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["Review",
      "JournalArticle"], "publicationDate": null, "journal": {"volume": "67", "pages":
      "\n          481-507\n        ", "name": "Annual review of biochemistry"}, "citationStyles":
      {"bibtex": "@Article{Fruman1998PhosphoinositideK,\n author = {D. Fruman and
      R. Meyers and L. Cantley},\n booktitle = {Annual Review of Biochemistry},\n
      journal = {Annual review of biochemistry},\n pages = {\n          481-507\n        },\n
      title = {Phosphoinositide kinases.},\n volume = {67},\n year = {1998}\n}\n"},
      "authors": [{"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "48408223",
      "name": "R. Meyers"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "93f46880bcc8daccce8f38ee95b2b18b366f9335", "externalIds": {"MAG": "2410983068",
      "DOI": "10.1385/0-89603-392-9:87", "CorpusId": 38881761, "PubMed": "9523263"},
      "corpusId": 38881761, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/93f46880bcc8daccce8f38ee95b2b18b366f9335",
      "title": "The use of peptide library for the determination of kinase peptide
      substrates.", "abstract": null, "venue": "Methods in molecular biology", "year":
      1998, "referenceCount": 3, "citationCount": 48, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": null, "journal": {"volume": "87", "pages":
      "\n          87-98\n        ", "name": "Methods in molecular biology"}, "citationStyles":
      {"bibtex": "@Article{Zhou1998TheUO,\n author = {Songyang Zhou and L. Cantley},\n
      booktitle = {Methods in molecular biology},\n journal = {Methods in molecular
      biology},\n pages = {\n          87-98\n        },\n title = {The use of peptide
      library for the determination of kinase peptide substrates.},\n volume = {87},\n
      year = {1998}\n}\n"}, "authors": [{"authorId": "2111144577", "name": "Songyang
      Zhou"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "a67196f0e621a9c575903d80ef7b7004d2219a82",
      "externalIds": {"MAG": "1980980623", "DOI": "10.1074/jbc.273.41.26954", "CorpusId":
      26866924, "PubMed": "9756944"}, "corpusId": 26866924, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/a67196f0e621a9c575903d80ef7b7004d2219a82",
      "title": "Differential Signaling by the Epidermal Growth Factor-like Growth
      Factors Neuregulin-1 and Neuregulin-2*", "abstract": "The neuregulins comprise
      a subfamily of epidermal growth factor (EGF)-like growth factors that elicit
      diverse cellular responses by activating members of the ErbB family of receptor
      tyrosine kinases. Although neuregulin-1 and neuregulin-2 are both binding ligands
      for the ErbB3 and ErbB4 receptors, they exhibit distinct biological activities
      depending on cellular context. In MDA-MB-468 human mammary tumor cells, neuregulin-2\u03b2
      (NRG2\u03b2) inhibits cell growth, whereas neuregulin-1\u03b2 (NRG1\u03b2) does
      not. In these cells, NRG2\u03b2 appears to preferentially act through the EGF
      receptor, stimulating receptor tyrosine phosphorylation and the recruitment
      of phospholipase C-\u03b3, Cbl, SHP2, and Shc to that receptor. NRG1\u03b2 preferentially
      acts through ErbB3 in these cells by stimulating the tyrosine phosphorylation
      and recruitment of phosphatidylinositol 3-kinase and Shc to that receptor. In
      MDA-MB-453 cells, both NRG1\u03b2 and NRG2\u03b2 stimulate the tyrosine phosphorylation
      of the ErbB2 and ErbB3 receptors to similar extents, but only NRG1\u03b2 potently
      stimulates morphological changes consistent with their differentiation. The
      profiles of SH2 domain-containing proteins that are efficiently recruited to
      activated receptors differ for the two factors. These observations indicate
      that despite their overlapping receptor specificity, the neuregulins exhibit
      distinct biological and biochemical properties. Since both of these cell lines
      express only two of the known ErbB receptors, our results imply that EGF-like
      ligands might elicit differential signaling within the context of a single receptor
      heterodimer.", "venue": "Journal of Biological Chemistry", "year": 1998, "referenceCount":
      41, "citationCount": 87, "influentialCitationCount": 1, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1998-10-09", "journal": {"volume": "273",
      "pages": "26954 - 26961", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Crovello1998DifferentialSB,\n author = {C. S. Crovello
      and Cary Lai and L. Cantley and K. Carraway},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {26954
      - 26961},\n title = {Differential Signaling by the Epidermal Growth Factor-like
      Growth Factors Neuregulin-1 and Neuregulin-2*},\n volume = {273},\n year = {1998}\n}\n"},
      "authors": [{"authorId": "5252276", "name": "C. S. Crovello"}, {"authorId":
      "2148764882", "name": "Cary Lai"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "145331905", "name": "K. Carraway"}]}, {"paperId": "ae1e135a963f6f04bdf3575199523d8fc716137a",
      "externalIds": {"MAG": "2072253274", "DOI": "10.1074/jbc.273.29.18040", "CorpusId":
      25563430, "PubMed": "9660759"}, "corpusId": 25563430, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/ae1e135a963f6f04bdf3575199523d8fc716137a",
      "title": "Type I Phosphatidylinositol-4-phosphate 5-Kinases Synthesize the Novel
      Lipids Phosphatidylinositol 3,5-Bisphosphate and Phosphatidylinositol 5-Phosphate*",
      "abstract": "Inositol phospholipids regulate a variety of cellular processes
      including proliferation, survival, vesicular trafficking, and cytoskeletal organization.
      Recently, two novel phosphoinositides, phosphatidylinositol-3,5-bisphosphate
      (PtdIns-3,5-P2) and phosphatidylinositol- 5-phosphate (PtdIns-5-P), have been
      shown to exist in cells. PtdIns-3,5-P2, which is regulated by osmotic stress,
      appears to be synthesized by phosphorylation of PtdIns-3-P at the D-5 position.
      No evidence yet exists for how PtdIns-5-P is produced in cells. Understanding
      the regulation of synthesis of these molecules will be important for identifying
      their function in cellular signaling. To determine the pathway by which PtdIns-3,5-P2
      and Ptd-Ins-5-P might be synthesized, we tested the ability of the recently
      cloned type I PtdIns-4-P 5-kinases (PIP5Ks) \u03b1 and \u03b2 to phosphorylate
      PtdIns-3-P and PtdIns at the D-5 position of the inositol ring. We found that
      the type I PIP5Ks phosphorylate PtdIns-3-P to form PtdIns-3,5-P2. The identity
      of the PtdIns-3,5-P2 product was determined by anion exchange high performance
      liquid chromatography analysis and periodate treatment. PtdIns-3,4-P2 and PtdIns-3,4,5-P3
      were also produced from PtdIns-3-P phosphorylation by both isoforms. When expressed
      in mammalian cells, PIP5K I\u03b1 and PIP5K I\u03b2 differed in their ability
      to synthesize PtdIns-3,5-P2 relative to PtdIns-3,4-P2. We also found that the
      type I PIP5Ks phosphorylate PtdIns to produce PtdIns-5-P and phosphorylate PtdIns-3,4-P2
      to produce PtdIns-3,4,5-P3. Our findings suggest that type I PIP5Ks synthesize
      the novel phospholipids PtdIns-3,5-P2 and PtdIns-5-P. The ability of PIP5Ks
      to produce multiple signaling molecules indicates that they may participate
      in a variety of cellular processes.", "venue": "Journal of Biological Chemistry",
      "year": 1998, "referenceCount": 34, "citationCount": 125, "influentialCitationCount":
      6, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818803945/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1998-07-17", "journal": {"volume": "273", "pages": "18040
      - 18046", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Tolias1998TypeIP,\n author = {K. Tolias and L. Rameh and
      H. Ishihara and Y. Shibasaki and Jian Chen and G. Prestwich and L. Cantley and
      C. Carpenter},\n booktitle = {Journal of Biological Chemistry},\n journal =
      {The Journal of Biological Chemistry},\n pages = {18040 - 18046},\n title =
      {Type I Phosphatidylinositol-4-phosphate 5-Kinases Synthesize the Novel Lipids
      Phosphatidylinositol 3,5-Bisphosphate and Phosphatidylinositol 5-Phosphate*},\n
      volume = {273},\n year = {1998}\n}\n"}, "authors": [{"authorId": "4661935",
      "name": "K. Tolias"}, {"authorId": "4109960", "name": "L. Rameh"}, {"authorId":
      "2805489", "name": "H. Ishihara"}, {"authorId": "49569359", "name": "Y. Shibasaki"},
      {"authorId": "2118446510", "name": "Jian Chen"}, {"authorId": "2565299", "name":
      "G. Prestwich"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "2972505", "name": "C. Carpenter"}]}, {"paperId": "cbead89294f23f0ef546103176f2453d7989fc14",
      "externalIds": {"CorpusId": 37523925, "PubMed": "9446795"}, "corpusId": 37523925,
      "publicationVenue": {"id": "1a9c698b-7fe4-4444-b391-208b4b2326e2", "name": "Biochemical
      and Biophysical Research Communications - BBRC", "type": "journal", "alternate_names":
      ["Biochem Biophys Res Commun", "Biochemical and Biophysical Research Communications",
      "Biochem Biophys Res Commun  BBRC"], "issn": "0006-291X", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description",
      "alternate_urls": ["http://www.idealibrary.com/links/toc/bbrc", "https://www.journals.elsevier.com/biochemical-and-biophysical-research-communications/",
      "http://www.sciencedirect.com/science/journal/0006291X"]}, "url": "https://www.semanticscholar.org/paper/cbead89294f23f0ef546103176f2453d7989fc14",
      "title": "Extracellular HIV-1 Tat protein induces a rapid and selective activation
      of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.",
      "abstract": "The addition in culture of extracellular HIV-1 Tat protein (0.1-1
      nM) to PC12 cells induced a rapid increase of the bulk protein kinase C (PKC)
      catalytic activity. Among various PKC isoforms (alpha, beta I, beta II, delta,
      epsilon, eta, theta, and zeta) expressed in PC12 cells, Tat selectively stimulated
      alpha, epsilon, and zeta, as judged by activities in immunoprecipitates. Activation
      of these isoforms was suppressed by the tyrosine kinase inhibitor genistein.
      Moreover, PKC-zeta showed the fastest kinetics of activation in response to
      Tat, but PKC-alpha and PKC-epsilon showed the highest levels of activation.
      PKC-alpha activation was accompanied by a rise of intracellular IP3, while the
      PI 3-kinase inhibitors wortmannin and LY294002 suppressed PKC-epsilon activation.
      Taken together, these findings demonstrate that extracellular Tat shows a cytokine-like
      activity in PC12 cells, being able to trigger an intracellular signalling cascade
      which involves PKC-alpha, -epsilon, and -zeta.", "venue": "Biochemical and Biophysical
      Research Communications - BBRC", "year": 1998, "referenceCount": 0, "citationCount":
      14, "influentialCitationCount": 2, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": null, "journal": {"volume": "242 2", "pages": "\n          332-7\n        ",
      "name": "Biochemical and biophysical research communications"}, "citationStyles":
      {"bibtex": "@Article{Borgatti1998ExtracellularHT,\n author = {P. Borgatti and
      G. Zauli and L. Cantley and S. Capitani},\n booktitle = {Biochemical and Biophysical
      Research Communications - BBRC},\n journal = {Biochemical and biophysical research
      communications},\n pages = {\n          332-7\n        },\n title = {Extracellular
      HIV-1 Tat protein induces a rapid and selective activation of protein kinase
      C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.},\n volume = {242
      2},\n year = {1998}\n}\n"}, "authors": [{"authorId": "5619854", "name": "P.
      Borgatti"}, {"authorId": "4754758", "name": "G. Zauli"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "3996531", "name": "S. Capitani"}]}, {"paperId":
      "dde5b284129a6a0fbdd5a4e271d0788217db9769", "externalIds": {"MAG": "1988454267",
      "DOI": "10.1038/2283", "CorpusId": 7590464, "PubMed": "9783737"}, "corpusId":
      7590464, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/dde5b284129a6a0fbdd5a4e271d0788217db9769",
      "title": "A flattened face for membranes", "abstract": null, "venue": "Nature
      Structural Biology", "year": 1998, "referenceCount": 8, "citationCount": 6,
      "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["News"], "publicationDate": "1998-10-01", "journal": {"volume":
      "5", "pages": "843-845", "name": "Nature Structural Biology"}, "citationStyles":
      {"bibtex": "@Article{Carpenter1998AFF,\n author = {C. Carpenter and L. Cantley},\n
      booktitle = {Nature Structural Biology},\n journal = {Nature Structural Biology},\n
      pages = {843-845},\n title = {A flattened face for membranes},\n volume = {5},\n
      year = {1998}\n}\n"}, "authors": [{"authorId": "2972505", "name": "C. Carpenter"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "f20c6542f544feb77b003c4d36bd57b8bd725c90",
      "externalIds": {"MAG": "2056358535", "DOI": "10.1074/JBC.273.5.2653", "CorpusId":
      25089405, "PubMed": "9446569"}, "corpusId": 25089405, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/f20c6542f544feb77b003c4d36bd57b8bd725c90",
      "title": "Activation of P2Y2 Receptors by UTP and ATP Stimulates Mitogen-activated
      Kinase Activity through a Pathway That Involves Related Adhesion Focal Tyrosine
      Kinase and Protein Kinase C*", "abstract": "We examined downstream signaling
      events that followed the exposure of PC12 cells to extracellular ATP and UTP,
      and we compared the effects of these P2 receptor agonists with those of growth
      factors and other stimuli. Based on early findings, we focused particular attention
      on the mitogen-activated protein (MAP) kinase pathway. ATP and/or UTP produced
      increases in tyrosine phosphorylation of multiple proteins, including p42 MAP
      (ERK2) kinase, related adhesion focal tyrosine kinase (RAFTK) (PYK2, CAK\u03b2),
      focal adhesion kinase (FAK), Shc, and protein kinase C\u03b4 (PKC\u03b4). MAP
      (ERK2) kinase activity (quantified by substrate phosphorylation) was increased
      by UTP, ATP, phorbol 12-myristate 13-acetate, ionomycin, and growth factors.
      UTP and ATP were equipotent (EC50 \u223c25 \u03bcm) in stimulating MAP kinase
      activity, suggesting that these effects were mediated via the Gi-linked P2Y2
      (P2U) receptor. Consistent with this, the UTP- and ATP-promoted activation of
      MAP kinase was diminished in pertussis toxin-treated cells. Treatment of cells
      with pertussis toxin also reduced both the UTP-dependent increases in intracellular
      calcium ion concentration ([Ca2+] i ) and the tyrosine phosphorylation of RAFTK.
      Similarly, when [Ca2+] i elevation was prevented using BAPTA and EGTA, the activation
      of MAP kinase by UTP and ionomycin was blocked, and the tyrosine phosphorylation
      of RAFTK was reduced. The UTP-promoted increase in MAP kinase activity was partially
      reduced in cells in which PKC was down-regulated, suggesting that both PKC-dependent
      and PKC-independent pathways were involved. PKC\u03b4, which increases MAP kinase
      activity in some systems, became tyrosine-phosphorylated within 15 s of exposure
      of cells to ATP or UTP; but epidermal growth factor, nerve growth factor, and
      insulin had little effect. UTP also promoted the association of Shc with Grb2.
      These results suggest that the P2Y2 receptor-initiated activation of MAP kinase
      was dependent on the elevation of [Ca2+] i , involved the recruitment of Shc
      and Grb2, and was mediated by RAFTK and PKC.", "venue": "Journal of Biological
      Chemistry", "year": 1998, "referenceCount": 45, "citationCount": 183, "influentialCitationCount":
      17, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818949434/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1998-01-30", "journal": {"volume": "273",
      "pages": "2653 - 2660", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Soltoff1998ActivationOP,\n author = {S. Soltoff and H.
      Avraham and S. Avraham and L. Cantley},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {2653
      - 2660},\n title = {Activation of P2Y2 Receptors by UTP and ATP Stimulates Mitogen-activated
      Kinase Activity through a Pathway That Involves Related Adhesion Focal Tyrosine
      Kinase and Protein Kinase C*},\n volume = {273},\n year = {1998}\n}\n"}, "authors":
      [{"authorId": "4324390", "name": "S. Soltoff"}, {"authorId": "2423275", "name":
      "H. Avraham"}, {"authorId": "38846009", "name": "S. Avraham"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "0571ff236bcdfbfd24dd3f7c6c5c4ea793e73e61",
      "externalIds": {"MAG": "2056270776", "DOI": "10.1126/SCIENCE.276.5320.1848",
      "CorpusId": 42804840, "PubMed": "9188528"}, "corpusId": 42804840, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/0571ff236bcdfbfd24dd3f7c6c5c4ea793e73e61",
      "title": "Transformation of chicken cells by the gene encoding the catalytic
      subunit of PI 3-kinase.", "abstract": "The avian sarcoma virus 16 (ASV 16) is
      a retrovirus that induces hemangiosarcomas in chickens. Analysis of the ASV
      16 genome revealed that it encodes an oncogene that is derived from the cellular
      gene for the catalytic subunit of phosphoinositide 3-kinase (PI 3-kinase). The
      gene is referred to as v-p3k, and like its cellular counterpart c-p3k, it is
      a potent transforming gene in cultured chicken embryo fibroblasts (CEFs). The
      products of the viral and cellular p3k genes have PI 3-kinase activity. CEFs
      transformed with either gene showed elevated levels of phosphatidylinositol
      3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate and activation
      of Akt kinase.", "venue": "Science", "year": 1997, "referenceCount": 26, "citationCount":
      422, "influentialCitationCount": 10, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-06-20", "journal": {"volume": "276 5320", "pages":
      "\n          1848-50\n        ", "name": "Science"}, "citationStyles": {"bibtex":
      "@Article{Chang1997TransformationOC,\n author = {H-W Chang and M. Aoki and D.
      Fruman and K. Auger and A. Bellacosa and P. Tsichlis and L. Cantley and T. Roberts
      and P. Vogt},\n booktitle = {Science},\n journal = {Science},\n pages = {\n          1848-50\n        },\n
      title = {Transformation of chicken cells by the gene encoding the catalytic
      subunit of PI 3-kinase.},\n volume = {276 5320},\n year = {1997}\n}\n"}, "authors":
      [{"authorId": "120076311", "name": "H-W Chang"}, {"authorId": "1695107", "name":
      "M. Aoki"}, {"authorId": "6241317", "name": "D. Fruman"}, {"authorId": "6603909",
      "name": "K. Auger"}, {"authorId": "5542241", "name": "A. Bellacosa"}, {"authorId":
      "4535090", "name": "P. Tsichlis"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "6665338", "name": "T. Roberts"}, {"authorId": "3286670", "name":
      "P. Vogt"}]}, {"paperId": "064078adf9ab23e93bbe5c0c086b834e459cc05a", "externalIds":
      {"MAG": "2080115585", "DOI": "10.1074/jbc.272.2.952", "CorpusId": 46342228,
      "PubMed": "8995387"}, "corpusId": 46342228, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/064078adf9ab23e93bbe5c0c086b834e459cc05a",
      "title": "Determination of the Specific Substrate Sequence Motifs of Protein
      Kinase C Isozymes*", "abstract": "Protein kinase C (PKC) family members play
      significant roles in a variety of intracellular signal transduction processes,
      but information about the substrate specificities of each PKC family member
      is quite limited. In this study, we have determined the optimal peptide substrate
      sequence for each of nine human PKC isozymes (\u03b1, \u03b2I, \u03b2II, \u03b3,
      \u03b4, \u03b5, \u03b7, \u03bc, and \u03b6) by using an oriented peptide library.
      All PKC isozymes preferentially phosphorylated peptides with hydrophobic amino
      acids at position +1 carboxyl-terminal of the phosphorylated Ser and basic residues
      at position \u22123. All isozymes, except PKC\u03bc, selected peptides with
      basic amino acids at positions \u22126, \u22124, and \u22122. PKC\u03b1, -\u03b2I,
      -\u03b2II, -\u03b3, and -\u03b7 selected peptides with basic amino acid at positions
      +2, +3, and +4, but PKC\u03b4, -\u03b5, -\u03b6, and -\u03bc preferred peptides
      with hydrophobic amino acid at these positions. At position \u22125, the selectivity
      was quite different among the various isozymes; PKC\u03b1, -\u03b3, and -\u03b4
      selected peptides with Arg at this position while other PKC isozymes selected
      hydrophobic amino acids such as Phe, Leu, or Val. Interestingly, PKC\u03bc showed
      extreme selectivity for peptides with Leu at this position. The predicted optimal
      sequences from position \u22123 to +2 for PKC\u03b1, -\u03b2I, -\u03b2II, -\u03b3,
      -\u03b4, and -\u03b7 were very similar to the endogenous pseudosubstrate sequences
      of these PKC isozymes, indicating that these core regions may be important to
      the binding of corresponding substrate peptides. Synthetic peptides based on
      the predicted optimal sequences for PKC\u03b1, -\u03b2I, -\u03b4, -\u03b6, and
      -\u03bc were prepared and used for the determination of Km and Vmax for these
      isozymes. As judged by Vmax/Km values, these peptides were in general better
      substrates of the corresponding isozymes than those of the other PKC isozymes,
      supporting the idea that individual PKC isozymes have distinct optimal substrates.
      The structural basis for the selectivity of PKC isozymes is discussed based
      on residues predicted to form the catalytic cleft.", "venue": "Journal of Biological
      Chemistry", "year": 1997, "referenceCount": 34, "citationCount": 579, "influentialCitationCount":
      17, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819775589/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1997-01-10", "journal": {"volume": "272", "pages":
      "952 - 960", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Nishikawa1997DeterminationOT,\n author = {K. Nishikawa
      and A. Toker and F. Johannes and Songyang Zhou and L. Cantley},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {952 - 960},\n title = {Determination of the Specific
      Substrate Sequence Motifs of Protein Kinase C Isozymes*},\n volume = {272},\n
      year = {1997}\n}\n"}, "authors": [{"authorId": "2060316864", "name": "K. Nishikawa"},
      {"authorId": "145751285", "name": "A. Toker"}, {"authorId": "87883210", "name":
      "F. Johannes"}, {"authorId": "2111144577", "name": "Songyang Zhou"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "07003144a9d50ece62fe58100386f44f1631c2ac",
      "externalIds": {"MAG": "2132382863", "DOI": "10.1074/jbc.272.35.22059", "CorpusId":
      35887018, "PubMed": "9268346"}, "corpusId": 35887018, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/07003144a9d50ece62fe58100386f44f1631c2ac",
      "title": "A Comparative Analysis of the Phosphoinositide Binding Specificity
      of Pleckstrin Homology Domains*", "abstract": "Pleckstrin homology (PH) and
      phosphotyrosine binding (PTB) domains are structurally related regulatory modules
      that are present in a variety of proteins involved in signal transduction, such
      as kinases, phospholipases, GTP exchange proteins, and adapter proteins. Initially
      these domains were shown to mediate protein-protein interactions, but more recently
      they were also found to bind phosphoinositides. Most studies to date have focused
      on binding of PH domains to phosphatidylinositol (PtdIns)-4-P and PtdIns-4,5-P2
      and have not considered the lipid products of phosphoinositide 3-kinase: PtdIns-3-P,
      PtdIns-3,4-P2, and PtdIns-3,4,5-P3. Here we have compared the phosphoinositide
      specificity of six different PH domains and the Shc PTB domain using all five
      phosphoinositides. We show that the Bruton\u2019s tyrosine kinase PH domain
      binds to PtdIns-3,4,5-P3 with higher affinity than to PtdIns-4,5-P2, PtdIns-3,4-P2
      or inositol 1,3,4,5-tetrakisphosphate (Ins-1,3,4,5-P4). This selectivity is
      decreased by the xid mutation (R28C). Selective binding of PtdIns-3,4,5-P3 over
      PtdIns-4,5-P2 or PtdIns-3,4-P2 was also observed for the amino-terminal PH domain
      of T lymphoma invasion and metastasis protein (Tiam-1), the PH domains of Son-of-sevenless
      (Sos) and, to a lesser extent, the PH domain of the \u03b2-adrenergic receptor
      kinase. The oxysterol binding protein and \u03b2-spectrin PH domains bound PtdIns-3,4,5-P3and
      PtdIns-4,5-P2 with similar affinities. PtdIns-3,4,5-P3 and PtdIns-4,5-P2 also
      bound to the PTB domain of Shc with similar affinities and lipid binding was
      competed with phosphotyrosine (Tyr(P)-containing peptides. These results indicate
      that distinct PH domains select for different phosphoinositides.", "venue":
      "Journal of Biological Chemistry", "year": 1997, "referenceCount": 41, "citationCount":
      487, "influentialCitationCount": 16, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.jbc.org/article/S0021925819656619/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1997-08-29", "journal":
      {"volume": "272", "pages": "22059 - 22066", "name": "The Journal of Biological
      Chemistry"}, "citationStyles": {"bibtex": "@Article{Rameh1997ACA,\n author =
      {L. Rameh and A. Arvidsson and K. Carraway and A. Couvillon and G. Rathbun and
      A. Crompton and B. Vanrenterghem and M. Czech and K. Ravichandran and S. Burakoff
      and Dasheng Wang and Ching-shih Chen and L. Cantley},\n booktitle = {Journal
      of Biological Chemistry},\n journal = {The Journal of Biological Chemistry},\n
      pages = {22059 - 22066},\n title = {A Comparative Analysis of the Phosphoinositide
      Binding Specificity of Pleckstrin Homology Domains*},\n volume = {272},\n year
      = {1997}\n}\n"}, "authors": [{"authorId": "4109960", "name": "L. Rameh"}, {"authorId":
      "92556800", "name": "A. Arvidsson"}, {"authorId": "145331905", "name": "K. Carraway"},
      {"authorId": "153879281", "name": "A. Couvillon"}, {"authorId": "2508043", "name":
      "G. Rathbun"}, {"authorId": "48345856", "name": "A. Crompton"}, {"authorId":
      "5811628", "name": "B. Vanrenterghem"}, {"authorId": "144307657", "name": "M.
      Czech"}, {"authorId": "144044294", "name": "K. Ravichandran"}, {"authorId":
      "2549319", "name": "S. Burakoff"}, {"authorId": "88869660", "name": "Dasheng
      Wang"}, {"authorId": "2145623779", "name": "Ching-shih Chen"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "07e5d5ee463e3f47fc615175f7b1e168ba932dc8",
      "externalIds": {"MAG": "2071075259", "DOI": "10.1016/S0092-8674(00)80487-0",
      "CorpusId": 14107687, "PubMed": "9428519"}, "corpusId": 14107687, "publicationVenue":
      {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal",
      "alternate_names": ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"],
      "url": "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/07e5d5ee463e3f47fc615175f7b1e168ba932dc8",
      "title": "The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity",
      "abstract": null, "venue": "Cell", "year": 1997, "referenceCount": 62, "citationCount":
      1588, "influentialCitationCount": 93, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.cell.com/article/S0092867400804870/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1997-12-26", "journal":
      {"volume": "91", "pages": "961-971", "name": "Cell"}, "citationStyles": {"bibtex":
      "@Article{Yaffe1997TheSB,\n author = {M. Yaffe and K. Rittinger and S. Volinia
      and P. Caron and A. Aitken and H. Leffers and S. Gamblin and S. Smerdon and
      L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n pages = {961-971},\n
      title = {The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity},\n
      volume = {91},\n year = {1997}\n}\n"}, "authors": [{"authorId": "88402408",
      "name": "M. Yaffe"}, {"authorId": "6239566", "name": "K. Rittinger"}, {"authorId":
      "1906416", "name": "S. Volinia"}, {"authorId": "46947956", "name": "P. Caron"},
      {"authorId": "2092260", "name": "A. Aitken"}, {"authorId": "4053866", "name":
      "H. Leffers"}, {"authorId": "1958388", "name": "S. Gamblin"}, {"authorId": "4189482",
      "name": "S. Smerdon"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "16c6bbcd9592b73b95ba0c05713ea70ee284122b", "externalIds": {"MAG": "2082494746",
      "DOI": "10.1093/emboj/16.13.3877", "CorpusId": 14704532, "PubMed": "9233798"},
      "corpusId": 14704532, "publicationVenue": {"id": "b89f0ede-6fa8-4dd2-a8a7-f54695a00323",
      "name": "EMBO Journal", "type": "journal", "alternate_names": ["The EMBO Journal",
      "EMBO J"], "issn": "0261-4189", "url": "http://embojournal.npgjournals.com/",
      "alternate_urls": ["http://emboj.embopress.org/"]}, "url": "https://www.semanticscholar.org/paper/16c6bbcd9592b73b95ba0c05713ea70ee284122b",
      "title": "Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk
      to specific SH2 domain proteins in neuronal cells", "abstract": "Eph\u2010related
      receptor tyrosine kinases have been implicated in the control of axonal navigation
      and fasciculation. To investigate the biochemical mechanisms underlying such
      functions, we have expressed the EphB2 receptor (formerly Nuk/Cek5/Sek3) in
      neuronal NG108\u201015 cells, and have observed the tyrosine phosphorylation
      of multiple cellular proteins upon activation of EphB2 by its ligand, ephrin\u2010B1
      (formerly Elk\u2010L/Lerk2). The activated EphB2 receptor induced the tyrosine
      phosphorylation of a 62\u201364 kDa protein (p62dok), which in turn formed a
      complex with the Ras GTPase\u2010activating protein (RasGAP) and SH2/SH3 domain
      adaptor protein Nck. RasGAP also bound through its SH2 domains to tyrosine\u2010phosphorylated
      EphB2 in vitro, and complexed with activated EphB2 in vivo. We have localized
      an in vitro RasGAP\u2010binding site to conserved tyrosine residues Y604 and
      Y610 in the juxtamembrane region of EphB2, and demonstrated that substitution
      of these amino acids abolishes ephrin\u2010B1\u2010induced signalling events
      in EphB2\u2010expressing NG108\u201015 cells. These tyrosine residues are followed
      by proline at the +3 position, consistent with the binding specificity of RasGAP
      SH2 domains determined using a degenerate phosphopeptide library. These results
      identify an EphB2\u2010activated signalling cascade involving proteins that
      potentially play a role in axonal guidance and control of cytoskeletal architecture.",
      "venue": "EMBO Journal", "year": 1997, "referenceCount": 80, "citationCount":
      285, "influentialCitationCount": 17, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://europepmc.org/articles/pmc1170012?pdf=render", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-07-01", "journal": {"volume": "16", "name": "The EMBO
      Journal"}, "citationStyles": {"bibtex": "@Article{Holland1997JuxtamembraneTR,\n
      author = {S. Holland and N. Gale and G. Gish and R. Roth and Songyang Zhou and
      L. Cantley and M. Henkemeyer and G. Yancopoulos and T. Pawson},\n booktitle
      = {EMBO Journal},\n journal = {The EMBO Journal},\n title = {Juxtamembrane tyrosine
      residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins
      in neuronal cells},\n volume = {16},\n year = {1997}\n}\n"}, "authors": [{"authorId":
      "33801300", "name": "S. Holland"}, {"authorId": "144667047", "name": "N. Gale"},
      {"authorId": "37993016", "name": "G. Gish"}, {"authorId": "50578252", "name":
      "R. Roth"}, {"authorId": "2111144577", "name": "Songyang Zhou"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4157754", "name": "M. Henkemeyer"},
      {"authorId": "3887512", "name": "G. Yancopoulos"}, {"authorId": "50999462",
      "name": "T. Pawson"}]}, {"paperId": "20e8b564070eee34fbfc516733e388a4f371afa1",
      "externalIds": {"MAG": "1508167890", "DOI": "10.1038/36621", "CorpusId": 4403301,
      "PubMed": "9367159"}, "corpusId": 4403301, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/20e8b564070eee34fbfc516733e388a4f371afa1",
      "title": "A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate",
      "abstract": null, "venue": "Nature", "year": 1997, "referenceCount": 17, "citationCount":
      431, "influentialCitationCount": 22, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1997-11-13", "journal": {"volume": "390", "pages": "192-196", "name": "Nature"},
      "citationStyles": {"bibtex": "@Article{Rameh1997ANP,\n author = {L. Rameh and
      K. Tolias and B. Duckworth and L. Cantley},\n booktitle = {Nature},\n journal
      = {Nature},\n pages = {192-196},\n title = {A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate},\n
      volume = {390},\n year = {1997}\n}\n"}, "authors": [{"authorId": "4109960",
      "name": "L. Rameh"}, {"authorId": "4661935", "name": "K. Tolias"}, {"authorId":
      "21162853", "name": "B. Duckworth"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "25cb802bf3009d3184f401b09e076e5145562310", "externalIds": {"MAG":
      "2188025744", "DOI": "10.1074/jbc.272.44.27665", "CorpusId": 8280568, "PubMed":
      "9346906"}, "corpusId": 8280568, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/25cb802bf3009d3184f401b09e076e5145562310",
      "title": "Conditional Inhibition of the Mitogen-activated Protein Kinase Cascade
      by Wortmannin", "abstract": "Phosphoinositide (PI) 3-kinase and the mitogen-activated
      protein (MAP) kinase cascades are activated by many of the same ligands. Several
      groups have reported involvement of PI 3-kinase in the activation of Erk1 and
      Erk2, whereas many other groups have shown that activation of Erk1 and Erk2
      is not sensitive to inhibitors of PI 3-kinase such as wortmannin. Here we show
      that wortmannin inhibition of the MAP kinase pathway is cell type- and ligand-specific.
      Wortmannin blocks platelet-derived growth factor (PDGF)-dependent activation
      of Raf-1 and the MAP kinase cascade in Chinese hamster ovary cells, which have
      few PDGF receptors, but has no significant effect on Erk activation in Swiss
      3T3 cells, which have high levels of PDGF receptors. However, wortmannin blocks
      activation of Erk proteins if Swiss 3T3 cells are stimulated with lower, physiological
      levels of PDGF. These results suggest that PI 3-kinase is in an efficient pathway
      for activation of MAP kinase, but that MAP kinase can be stimulated by a redundant
      pathway when a large number of receptors are activated. We present evidence
      that a protein kinase C family member downstream of phospholipase C\u03b3 is
      involved in the redundant pathway.", "venue": "Journal of Biological Chemistry",
      "year": 1997, "referenceCount": 44, "citationCount": 223, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818803118/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1997-10-31", "journal": {"volume": "272",
      "pages": "27665 - 27670", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Duckworth1997ConditionalIO,\n author = {B. Duckworth and
      L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n journal = {The
      Journal of Biological Chemistry},\n pages = {27665 - 27670},\n title = {Conditional
      Inhibition of the Mitogen-activated Protein Kinase Cascade by Wortmannin},\n
      volume = {272},\n year = {1997}\n}\n"}, "authors": [{"authorId": "21162853",
      "name": "B. Duckworth"}, {"authorId": "1723755", "name": "L. Cantley"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '284140'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:47 GMT
      Via:
      - 1.1 6fe8e2d5db6a80353eb675f61c249810.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - f20R84EZQMOiYmXqaBa0T898OeAfIc4QzpdEXk_23Yyvv3nTbbVgUQ==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0zIFYKPHcEMZQ=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '284140'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:47 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - 3d710040-ae73-42e5-8687-357178df4460
    http_version: HTTP/1.1
    status_code: 200
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=700&limit=100
  response:
    content: '{"offset": 700, "next": 800, "data": [{"paperId": "3933b3e325552959faa40951ee856e6fbf400b4e",
      "externalIds": {"MAG": "2525347699", "CorpusId": 88833992}, "corpusId": 88833992,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/3933b3e325552959faa40951ee856e6fbf400b4e",
      "title": "Minireview Blocks Apoptosis", "abstract": ". In vitro, this lipid
      can beMontreal Neurological Institute producedby thep170/mCpk-typePI3K that
      phosphory-McGill University lates PtdIns-4-P at the D-3 position (Figure 1)
      or by aMontreal, Quebec H3A 2B4 kinase that phosphorylates PtdIns-3-P at the
      D-4 posi-Canada tion (not shown). Thus, the relative levels of PtdIns-3,4-",
      "venue": "", "year": 1997, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["Review"], "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Inproceedings{Franke1997MinireviewBA,\n author = {T. Franke and
      D. Kaplan and L. Cantley},\n title = {Minireview Blocks Apoptosis},\n year =
      {1997}\n}\n"}, "authors": [{"authorId": "50377077", "name": "T. Franke"}, {"authorId":
      "2112191705", "name": "D. Kaplan"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "45c0de36133cc86a5c590ab01c9728100dfd71d5", "externalIds": {"MAG":
      "2011392056", "DOI": "10.1074/jbc.272.10.6465", "CorpusId": 41813897, "PubMed":
      "9045671"}, "corpusId": 41813897, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/45c0de36133cc86a5c590ab01c9728100dfd71d5",
      "title": "The Lipid Products of Phosphoinositide 3-Kinase Increase Cell Motility
      through Protein Kinase C*", "abstract": "Phosphoinositide 3-kinase has been
      implicated as an activator of cell motility in a variety of recent studies,
      yet the role of its lipid product, phosphatidylinositol 1,4,5-trisphosphate
      (PtdIns-3,4,5-P3), has yet to be elucidated. In this study, three independent
      preparations of PtdIns-3,4,5-P3 were found to increase the motility of NIH 3T3
      cells when examined utilizing a microchemotaxis chamber. Dipalmitoyl L-\u03b1-phosphatidyl-D-myo-inositol
      3,4,5-triphosphate (Di-C16-PtdIns-3,4,5-P3) also produced actin reorganization
      and membrane ruffling. Cells pretreated with 12-O-tetradecanoylphorbol-13-acetate
      to cause down-regulation of protein kinase C (PKC) exhibited complete inhibition
      of cell motility induced by Di-C16-PtdIns-3,4,5-P3. These results are consistent
      with previous observations that PtdIns-3,4,5-P3 activates Ca2+-independent PKC
      isoforms in vitro and in vivo and provide the first demonstration of an in vivo
      role for the lipid products of the phosphoinositide 3-kinase. PtdIns-3,4,5-P3
      appears to directly initiate cellular motility via activation of a PKC family
      member.", "venue": "Journal of Biological Chemistry", "year": 1997, "referenceCount":
      42, "citationCount": 139, "influentialCitationCount": 5, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818411659/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-03-07", "journal": {"volume": "272", "pages": "6465
      - 6470", "name": "The Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Derman1997TheLP,\n author = {M. Derman and A. Toker and J. Hartwig
      and K. Spokes and J. Falck and Ching-shih Chen and L. Cantley and L. Cantley},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {6465 - 6470},\n title = {The Lipid Products of Phosphoinositide
      3-Kinase Increase Cell Motility through Protein Kinase C*},\n volume = {272},\n
      year = {1997}\n}\n"}, "authors": [{"authorId": "144476444", "name": "M. Derman"},
      {"authorId": "145751285", "name": "A. Toker"}, {"authorId": "2999768", "name":
      "J. Hartwig"}, {"authorId": "4375980", "name": "K. Spokes"}, {"authorId": "49877841",
      "name": "J. Falck"}, {"authorId": "2145623779", "name": "Ching-shih Chen"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5601835", "name":
      "L. Cantley"}]}, {"paperId": "56d780c0edf47e8c5f3ed24829f14e4995310154", "externalIds":
      {"MAG": "2006232099", "DOI": "10.1073/PNAS.94.14.7204", "CorpusId": 23447408,
      "PubMed": "9207069"}, "corpusId": 23447408, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/56d780c0edf47e8c5f3ed24829f14e4995310154",
      "title": "High-affinity binding of the Drosophila Numb phosphotyrosine-binding
      domain to peptides containing a Gly-Pro-(p)Tyr motif.", "abstract": "The phosphotyrosine-binding
      (PTB) domain is a recently identified protein module that has been characterized
      as binding to phosphopeptides containing an NPXpY motif (X = any amino acid).
      We describe here a novel peptide sequence recognized by the PTB domain from
      Drosophila Numb (dNumb), a protein involved in cell fate determination and asymmetric
      cell division during the development of the Drosophila nervous system. Using
      a Tyr-oriented peptide library to screen for ligands, the dNumb PTB domain was
      found to bind selectively to peptides containing a YIGPYphi motif (phi represents
      a hydrophobic residue). A synthetic peptide containing this sequence bound specifically
      to the isolated dNumb PTB domain in solution with a dissociation constant (Kd)
      of 5.78 +/- 0.74 microM. Interestingly, the affinity of this peptide for the
      dNumb PTB domain was increased (Kd = 1.41 +/- 0.10 microM) when the second tyrosine
      in the sequence was phosphorylated. Amino acid substitution studies of the phosphopeptide
      demonstrated that a core motif of sequence GP(p)Y is required for high-affinity
      binding to the dNumb PTB domain. Nuclear magnetic resonance experiments performed
      on isotopically labeled protein complexed with either Tyr- or pTyr-containing
      peptides suggest that the same set of amino acids in the dNumb PTB domain is
      involved in binding both phosphorylated and nonphosphorylated forms of the peptide.
      The in vitro selectivity of the dNumb PTB domain is therefore markedly different
      from those of the Shc and IRS-1 PTB domains, in that it interacts preferentially
      with a GP(p)Y motif, rather than NPXpY, and does not absolutely require ligand
      phosphorylation for binding. Our results suggest that the PTB domain is a versatile
      protein module, capable of exhibiting varied binding specificities.", "venue":
      "Proceedings of the National Academy of Sciences of the United States of America",
      "year": 1997, "referenceCount": 33, "citationCount": 66, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1997-07-08", "journal": {"volume": "94
      14", "pages": "\n          7204-9\n        ", "name": "Proceedings of the National
      Academy of Sciences of the United States of America"}, "citationStyles": {"bibtex":
      "@Article{Li1997HighaffinityBO,\n author = {S. C. Li and Z. Songyang and S.
      Vincent and C. Zwahlen and S. Wiley and L. Cantley and L. Kay and J. Forman-Kay
      and T. Pawson},\n booktitle = {Proceedings of the National Academy of Sciences
      of the United States of America},\n journal = {Proceedings of the National Academy
      of Sciences of the United States of America},\n pages = {\n          7204-9\n        },\n
      title = {High-affinity binding of the Drosophila Numb phosphotyrosine-binding
      domain to peptides containing a Gly-Pro-(p)Tyr motif.},\n volume = {94 14},\n
      year = {1997}\n}\n"}, "authors": [{"authorId": "3355322", "name": "S. C. Li"},
      {"authorId": "6731027", "name": "Z. Songyang"}, {"authorId": "47486540", "name":
      "S. Vincent"}, {"authorId": "48706514", "name": "C. Zwahlen"}, {"authorId":
      "34735160", "name": "S. Wiley"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "4451948", "name": "L. Kay"}, {"authorId": "1398007359", "name":
      "J. Forman-Kay"}, {"authorId": "50999462", "name": "T. Pawson"}]}, {"paperId":
      "58e5eb18283eeb15eb4c13e0700c82239b5c41fb", "externalIds": {"MAG": "2033801757",
      "DOI": "10.1016/S0092-8674(00)81883-8", "CorpusId": 2574667, "PubMed": "9038334"},
      "corpusId": 2574667, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/58e5eb18283eeb15eb4c13e0700c82239b5c41fb",
      "title": "PI3K: Downstream AKTion Blocks Apoptosis", "abstract": null, "venue":
      "Cell", "year": 1997, "referenceCount": 24, "citationCount": 1765, "influentialCitationCount":
      58, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867400818838/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "1997-02-21", "journal": {"volume": "88", "pages": "435-437",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Franke1997PI3KDA,\n
      author = {T. Franke and D. Kaplan and L. Cantley},\n booktitle = {Cell},\n journal
      = {Cell},\n pages = {435-437},\n title = {PI3K: Downstream AKTion Blocks Apoptosis},\n
      volume = {88},\n year = {1997}\n}\n"}, "authors": [{"authorId": "50377077",
      "name": "T. Franke"}, {"authorId": "32389352", "name": "D. Kaplan"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "76b361e8530cdc8a370fe10fdbc066f270c695a0",
      "externalIds": {"MAG": "1650807611", "DOI": "10.1038/36442", "CorpusId": 4348611,
      "PubMed": "9367147"}, "corpusId": 4348611, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/76b361e8530cdc8a370fe10fdbc066f270c695a0",
      "title": "Apoptosis: A Bad kinase makes good", "abstract": null, "venue": "Nature",
      "year": 1997, "referenceCount": 1, "citationCount": 196, "influentialCitationCount":
      5, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["News"], "publicationDate": "1997-11-13", "journal": {"volume": "390", "pages":
      "116-117", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Franke1997ApoptosisAB,\n
      author = {T. Franke and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n
      pages = {116-117},\n title = {Apoptosis: A Bad kinase makes good},\n volume
      = {390},\n year = {1997}\n}\n"}, "authors": [{"authorId": "50377077", "name":
      "T. Franke"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "7a55b4e72f67f9aef7769436ac09945948be5809",
      "externalIds": {"MAG": "1999922223", "DOI": "10.1074/jbc.272.20.13419", "CorpusId":
      29943100, "PubMed": "9148966"}, "corpusId": 29943100, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/7a55b4e72f67f9aef7769436ac09945948be5809",
      "title": "The SH3 Domain of Amphiphysin Binds the Proline-rich Domain of Dynamin
      at a Single Site That Defines a New SH3 Binding Consensus Sequence*", "abstract":
      "Amphiphysin is an SH3 domain-containing neuronal protein that is highly concentrated
      in nerve terminals where it interacts via its SH3 domain with dynamin I, a GTPase
      implicated in synaptic vesicle endocytosis. We show here that the SH3 domain
      of amphiphysin, but not a mutant SH3 domain, bound with high affinity to a single
      site in the long proline-rich region of human dynamin I, that this site was
      distinct from the binding sites for other SH3 domains, and that the mutation
      of two adjacent amino acids in dynamin I was sufficient to abolish binding.
      The dynamin I sequence critically required for amphiphysin binding (PSRPNR)
      fits in the novel SH3 binding consensus identified for the SH3 domain of amphiphysin
      via a combinatorial peptide library approach: PXRPXR(H)R(H). Our data demonstrate
      that the long proline-rich stretch present in dynamin I contained multiple SH3
      domain binding sites that recognize interacting proteins with high specificity.",
      "venue": "Journal of Biological Chemistry", "year": 1997, "referenceCount":
      38, "citationCount": 244, "influentialCitationCount": 16, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/content/272/20/13419.full.pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-05-16", "journal": {"volume": "272", "pages": "13419
      - 13425", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Grabs1997TheSD,\n author = {D. Grabs and V. Slepnev and
      Songyang Zhou and C. David and M. Lynch and L. Cantley and P. De Camilli},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {13419 - 13425},\n title = {The SH3 Domain of Amphiphysin
      Binds the Proline-rich Domain of Dynamin at a Single Site That Defines a New
      SH3 Binding Consensus Sequence*},\n volume = {272},\n year = {1997}\n}\n"},
      "authors": [{"authorId": "6943642", "name": "D. Grabs"}, {"authorId": "5444300",
      "name": "V. Slepnev"}, {"authorId": "2111144577", "name": "Songyang Zhou"},
      {"authorId": "2053464291", "name": "C. David"}, {"authorId": "2071053200", "name":
      "M. Lynch"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "3318861",
      "name": "P. De Camilli"}]}, {"paperId": "842663edc91d5ce9bfb3ace965a0398c9b1f1622",
      "externalIds": {"MAG": "2140194302", "DOI": "10.1093/emboj/16.9.2240", "CorpusId":
      12817757, "PubMed": "9171339"}, "corpusId": 12817757, "publicationVenue": {"id":
      "b89f0ede-6fa8-4dd2-a8a7-f54695a00323", "name": "EMBO Journal", "type": "journal",
      "alternate_names": ["The EMBO Journal", "EMBO J"], "issn": "0261-4189", "url":
      "http://embojournal.npgjournals.com/", "alternate_urls": ["http://emboj.embopress.org/"]},
      "url": "https://www.semanticscholar.org/paper/842663edc91d5ce9bfb3ace965a0398c9b1f1622",
      "title": "Regulatory interactions in the recognition of endocytic sorting signals
      by AP\u20102 complexes", "abstract": "Many plasma membrane proteins destined
      for endocytosis are concentrated into clathrin\u2010coated pits through the
      recognition of a tyrosine\u2010based motif in their cytosolic domains by an
      adaptor (AP\u20102) complex. The \u03bc2 subunit of isolated AP\u20102 complexes
      binds specifically, but rather weakly, to proteins bearing the tyrosine\u2010based
      signal. We now demonstrate, using peptides with a photoreactive probe, that
      this binding is strengthened significantly when the AP\u20102 complex is present
      in clathrin coats, indicating that there is cooperativity between receptor\u2013AP\u20102
      interactions and coat formation. Phosphoinositides with a phosphate at the D\u20103
      position of the inositol ring, but not other isomers, also increase the affinity
      of the AP\u20102 complex for the tyrosine\u2010based motif. AP\u20102 is the
      first protein known (in any context) to interact with phosphatidylinositol 3\u2010phosphate.
      Our findings indicate that receptor recruitment can be coupled to clathrin coat
      assembly and suggest a mechanism for regulation of membrane traffic by lipid
      products of phosphoinositide 3\u2010kinases.", "venue": "EMBO Journal", "year":
      1997, "referenceCount": 94, "citationCount": 231, "influentialCitationCount":
      7, "isOpenAccess": true, "openAccessPdf": {"url": "http://emboj.embopress.org/content/embojnl/16/9/2240.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-05-01", "journal": {"volume": "16", "name": "The EMBO
      Journal"}, "citationStyles": {"bibtex": "@Article{Rapoport1997RegulatoryII,\n
      author = {Iris Rapoport and M. Miyazaki and W. Boll and B. Duckworth and L.
      Cantley and S. Shoelson and T. Kirchhausen},\n booktitle = {EMBO Journal},\n
      journal = {The EMBO Journal},\n title = {Regulatory interactions in the recognition
      of endocytic sorting signals by AP\u20102 complexes},\n volume = {16},\n year
      = {1997}\n}\n"}, "authors": [{"authorId": "2053078190", "name": "Iris Rapoport"},
      {"authorId": "144610439", "name": "M. Miyazaki"}, {"authorId": "6576021", "name":
      "W. Boll"}, {"authorId": "21162853", "name": "B. Duckworth"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4790900", "name": "S. Shoelson"}, {"authorId":
      "4218577", "name": "T. Kirchhausen"}]}, {"paperId": "8eec8d2813f6955a670e804df4ef0b8cf74ed4a4",
      "externalIds": {"MAG": "1993205500", "DOI": "10.1073/PNAS.94.21.11345", "CorpusId":
      17086418, "PubMed": "9326612"}, "corpusId": 17086418, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/8eec8d2813f6955a670e804df4ef0b8cf74ed4a4",
      "title": "Interleukin 3-dependent survival by the Akt protein kinase.", "abstract":
      "Interleukin 3 (IL-3)-dependent survival of hematopoietic cells is known to
      rely on the activity of multiple signaling pathways, including a pathway leading
      to activation of phosphoinositide 3-kinase (PI 3-kinase), and protein kinase
      Akt is a direct target of PI 3-kinase. We find that Akt kinase activity is rapidly
      induced by the cytokine IL-3, suggesting a role for Akt in PI 3-kinase-dependent
      signaling in hematopoetic cells. Dominant-negative mutants of Akt specifically
      block Akt activation by IL-3 and interfere with IL-3-dependent proliferation.
      Overexpression of Akt or oncogenic v-akt protects 32D cells from apoptosis induced
      by IL-3 withdrawal. Apoptosis after IL-3 withdrawal is accelerated by expression
      of dominant-negative mutants of Akt, indicating that a functional Akt signaling
      pathway is necessary for cell survival mediated by the cytokine IL-3. Thus Akt
      appears to be an important mediator of anti-apoptotic signaling in this system.",
      "venue": "Proceedings of the National Academy of Sciences of the United States
      of America", "year": 1997, "referenceCount": 69, "citationCount": 397, "influentialCitationCount":
      16, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.pnas.org/content/pnas/94/21/11345.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-10-14", "journal": {"volume": "94 21", "pages": "\n          11345-50\n        ",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America"}, "citationStyles": {"bibtex": "@Article{Zhou1997Interleukin3S,\n
      author = {Songyang Zhou and D. Baltimore and L. Cantley and D. Kaplan and T.
      Franke},\n booktitle = {Proceedings of the National Academy of Sciences of the
      United States of America},\n journal = {Proceedings of the National Academy
      of Sciences of the United States of America},\n pages = {\n          11345-50\n        },\n
      title = {Interleukin 3-dependent survival by the Akt protein kinase.},\n volume
      = {94 21},\n year = {1997}\n}\n"}, "authors": [{"authorId": "2111144577", "name":
      "Songyang Zhou"}, {"authorId": "144293138", "name": "D. Baltimore"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2112191705", "name": "D. Kaplan"},
      {"authorId": "50377077", "name": "T. Franke"}]}, {"paperId": "9630b575c263be3b36b99c88768791bb60e2e4ab",
      "externalIds": {"MAG": "2046208810", "DOI": "10.1111/J.1432-1033.1997.T01-1-00433.X",
      "CorpusId": 25708621, "PubMed": "9208935"}, "corpusId": 25708621, "publicationVenue":
      {"id": "9b975127-186d-4b72-b03c-7b63988f3aec", "name": "European Journal of
      Biochemistry", "type": "journal", "alternate_names": ["Eur J Biochem"], "issn":
      "0014-2956", "alternate_issns": ["1432-1033"], "url": "https://onlinelibrary.wiley.com/journal/17424658",
      "alternate_urls": ["http://www.ejbiochem.org/", "http://www.febsjournal.org/"]},
      "url": "https://www.semanticscholar.org/paper/9630b575c263be3b36b99c88768791bb60e2e4ab",
      "title": "Sequence specificity of C-terminal Src kinase (CSK)--a comparison
      with Src-related kinases c-Fgr and Lyn.", "abstract": "An eicosapeptide encompassing
      the C-terminal tail of c-Src (Tyr527) which is conserved in most Src-related
      protein kinases, is phosphorylated by C-terminal Src kinase (CSK) and by the
      two Src-related protein kinases c-Fgr and Lyn, with similar kinetic constants.
      Two related peptides reproducing the C-terminal segments of c-Src mutants defective
      in CSK phosphorylation [MacAuley, A., Okada, M., Nada, S., Nakagawa, H. & Cooper,
      J. A. (1993) Oncogene 8, 117-124] AFLEDSCTGTEPLYQRGENL (mutant number 28) and
      AFLEDNFTGTKPQYHPGENL (mutant number 29), proved a better and a much worse substrates,
      respectively than the wild-type peptide, with either CSK or the two Src kinases.
      By changing individual residues in the best peptide substrate, it was shown
      that the main element responsible for its improved phosphorylation is leucine
      at position -1 (instead of glutamine), while lysine at position -3 (instead
      of glutamate) has a detrimental effect, possibly accounting for the negligible
      phosphorylation of peptide derived from mutant number 29. By contrast to most
      peptide substrates, including the Src C-terminal peptides, which exhibit relatively
      high K(m) values, a polyoma-virus-middle-T-antigen-(mT)-derived peptide with
      tyrosine embedded in a highly hydrophobic sequence (EEEPQFEEIPIYLELLP) exhibits
      with CSK a quite low K(m) value (63 microM). Consistent with this, the optimal
      sequence selected by CSK in an oriented peptide library is XXXIYMFFF. This is
      different from sequences selected by Lyn (DEEIYEELX) and c-Fgr (XEEIYGIFF),
      although they all share a high selection for a hydrophobic residue at n-1. In
      sharp contrast, TPKIIB/p38syk, related to the catalytic domain of p72syk, selects
      acidic residues at nearly all positions, n-1 included. These data support the
      notion that the features determining the specific phosphorylation of the C-terminal
      tyrosine residue of Src do not reside in the primary structure surrounding the
      target tyrosine. They also show that this site does not entirely fulfil the
      optimal consensus sequence recognized by CSK, disclosing the possibility that
      as yet unrecognized CSK targets structurally unrelated to the C-terminal tyrosine
      residue of Src kinases may exist.", "venue": "European Journal of Biochemistry",
      "year": 1997, "referenceCount": 51, "citationCount": 26, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": {"url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1432-1033.1997.t01-1-00433.x",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1997-06-01", "journal": {"volume": "246 2", "pages":
      "\n          433-9\n        ", "name": "European journal of biochemistry"},
      "citationStyles": {"bibtex": "@Article{Ruzzene1997SequenceSO,\n author = {M.
      Ruzzene and Z. Songyang and O. Marin and A. Donella\u2010Deana and A. Brunati
      and B. Guerra and P. Agostinis and L. Cantley and L. Pinna},\n booktitle = {European
      Journal of Biochemistry},\n journal = {European journal of biochemistry},\n
      pages = {\n          433-9\n        },\n title = {Sequence specificity of C-terminal
      Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and Lyn.},\n volume
      = {246 2},\n year = {1997}\n}\n"}, "authors": [{"authorId": "2709754", "name":
      "M. Ruzzene"}, {"authorId": "6731027", "name": "Z. Songyang"}, {"authorId":
      "33761180", "name": "O. Marin"}, {"authorId": "1397947088", "name": "A. Donella\u2010Deana"},
      {"authorId": "6573879", "name": "A. Brunati"}, {"authorId": "145585360", "name":
      "B. Guerra"}, {"authorId": "3971054", "name": "P. Agostinis"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2079990", "name": "L. Pinna"}]},
      {"paperId": "992fb58aa10ba00c6b4bfd80331c9589d4f1f9fd", "externalIds": {"MAG":
      "1568605582", "DOI": "10.1038/42648", "CorpusId": 4347728, "PubMed": "9192891"},
      "corpusId": 4347728, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/992fb58aa10ba00c6b4bfd80331c9589d4f1f9fd",
      "title": "Signalling through the lipid products of phosphoinositide-3-OH kinase",
      "abstract": null, "venue": "Nature", "year": 1997, "referenceCount": 46, "citationCount":
      1383, "influentialCitationCount": 48, "isOpenAccess": true, "openAccessPdf":
      {"url": "https://www.nature.com/articles/42648.pdf", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": "1997-06-12",
      "journal": {"volume": "387", "pages": "673-676", "name": "Nature"}, "citationStyles":
      {"bibtex": "@Article{Toker1997SignallingTT,\n author = {A. Toker and L. Cantley},\n
      booktitle = {Nature},\n journal = {Nature},\n pages = {673-676},\n title = {Signalling
      through the lipid products of phosphoinositide-3-OH kinase},\n volume = {387},\n
      year = {1997}\n}\n"}, "authors": [{"authorId": "145751285", "name": "A. Toker"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "d81b0874f40b7f32378b384f336d701f766a9883",
      "externalIds": {"MAG": "2975658554", "DOI": "10.2210/pdb1pbw/pdb", "CorpusId":
      204136780}, "corpusId": 204136780, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/d81b0874f40b7f32378b384f336d701f766a9883",
      "title": "STRUCTURE OF BCR-HOMOLOGY (BH) DOMAIN", "abstract": null, "venue":
      "", "year": 1997, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "1997-03-12", "journal": {"volume":
      "", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Musacchio1997STRUCTUREOB,\n
      author = {A. Musacchio and L. Cantley and S. Harrison},\n title = {STRUCTURE
      OF BCR-HOMOLOGY (BH) DOMAIN},\n year = {1997}\n}\n"}, "authors": [{"authorId":
      "4370379", "name": "A. Musacchio"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2150243975", "name": "S. Harrison"}]}, {"paperId": "d9170821d47371ce2c5848f8ef544a591b14a634",
      "externalIds": {"MAG": "2126043496", "DOI": "10.1126/SCIENCE.278.5345.1957",
      "CorpusId": 46210419, "PubMed": "9395400"}, "corpusId": 46210419, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/d9170821d47371ce2c5848f8ef544a591b14a634",
      "title": "Sequence-specific and phosphorylation-dependent proline isomerization:
      a potential mitotic regulatory mechanism.", "abstract": "Pin1 is an essential
      and conserved mitotic peptidyl-prolyl isomerase (PPIase) that is distinct from
      members of two other families of conventional PPIases, cyclophilins and FKBPs
      (FK-506 binding proteins). In response to their phosphorylation during mitosis,
      Pin1 binds and regulates members of a highly conserved set of proteins that
      overlaps with antigens recognized by the mitosis-specific monoclonal antibody
      MPM-2. Pin1 is here shown to be a phosphorylation-dependent PPIase that specifically
      recognizes the phosphoserine-proline or phosphothreonine-proline bonds present
      in mitotic phosphoproteins. Both Pin1 and MPM-2 selected similar phosphorylated
      serine-proline-containing peptides, providing the basis for the specific interaction
      between Pin1 and MPM-2 antigens. Pin1 preferentially isomerized proline residues
      preceded by phosphorylated serine or threonine with up to 1300-fold selectivity
      compared with unphosphorylated peptides. Pin1 may thus regulate mitotic progression
      by catalyzing sequence-specific and phosphorylation-dependent proline isomerization.",
      "venue": "Science", "year": 1997, "referenceCount": 27, "citationCount": 782,
      "influentialCitationCount": 26, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1997-12-12", "journal":
      {"volume": "278 5345", "pages": "\n          1957-60\n        ", "name": "Science"},
      "citationStyles": {"bibtex": "@Article{Yaffe1997SequencespecificAP,\n author
      = {M. Yaffe and M. Schutkowski and Minhui Shen and Xiao Zhen Zhou and P. Stukenberg
      and J. Rahfeld and Jian Xu and J. Kuang and M. Kirschner and G. Fischer and
      L. Cantley and K. Lu},\n booktitle = {Science},\n journal = {Science},\n pages
      = {\n          1957-60\n        },\n title = {Sequence-specific and phosphorylation-dependent
      proline isomerization: a potential mitotic regulatory mechanism.},\n volume
      = {278 5345},\n year = {1997}\n}\n"}, "authors": [{"authorId": "88402408", "name":
      "M. Yaffe"}, {"authorId": "6092366", "name": "M. Schutkowski"}, {"authorId":
      "2153277109", "name": "Minhui Shen"}, {"authorId": "1409650665", "name": "Xiao
      Zhen Zhou"}, {"authorId": "5090761", "name": "P. Stukenberg"}, {"authorId":
      "49127913", "name": "J. Rahfeld"}, {"authorId": "2110980007", "name": "Jian
      Xu"}, {"authorId": "145526176", "name": "J. Kuang"}, {"authorId": "40294231",
      "name": "M. Kirschner"}, {"authorId": "1693102", "name": "G. Fischer"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "1715537", "name": "K. Lu"}]},
      {"paperId": "dee1bba8217028c0b88731f1deb621437ceb944e", "externalIds": {"MAG":
      "2078400325", "DOI": "10.1074/jbc.272.52.33140", "CorpusId": 8179761, "PubMed":
      "9407100"}, "corpusId": 8179761, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/dee1bba8217028c0b88731f1deb621437ceb944e",
      "title": "The Cbl Phosphotyrosine-binding Domain Selects a D(N/D)XpY Motif and
      Binds to the Tyr292Negative Regulatory Phosphorylation Site of ZAP-70*", "abstract":
      "The Cbl protooncogene product has emerged as a novel negative regulator of
      receptor and non-receptor tyrosine kinases through currently undefined mechanisms.
      Therefore, determining how Cbl physically interacts with tyrosine kinases is
      of substantial interest. We recently identified a phosphotyrosine binding (PTB)
      domain residing within the N-terminal transforming region of Cbl (Cbl-N), which
      mediated direct binding to ZAP-70 tyrosine kinase. Here, we have screened a
      degenerate phosphopeptide library and show that the Cbl-PTB domain selects a
      D(N/D)XpY motif, reminiscent of but distinct from the NPXpY motif recognized
      by the PTB domains of Shc and IRS-1/2. A phosphopeptide predicted by this motif
      and corresponding to the in vivo negative regulatory phosphorylation site of
      ZAP-70 (Tyr(P)292) specifically inhibited binding of ZAP-70 to Cbl-N. A ZAP-70/Y292F
      mutant failed to bind to Cbl-N, whereas a D290A mutant resulted in a 64% decrease
      in binding, confirming the importance of the Tyr(P) and Y-2 residues in Cbl-PTB
      domain recognition. Finally the ZAP-70/Y292F mutant also failed to associate
      with Cbl-N or full-length Cbl in vivo. These results identify a potential Cbl-PTB
      domain-dependent role for Cbl in the negative regulation of ZAP-70 and predict
      potential Cbl-PTB domain binding sites on other protein tyrosine kinases known
      to interact with Cbl.", "venue": "Journal of Biological Chemistry", "year":
      1997, "referenceCount": 48, "citationCount": 232, "influentialCitationCount":
      9, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818396662/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-12-26", "journal": {"volume": "272", "pages": "33140
      - 33144", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Lupher1997TheCP,\n author = {M. Lupher and Songyang Zhou
      and S. Shoelson and L. Cantley and H. Band},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {33140
      - 33144},\n title = {The Cbl Phosphotyrosine-binding Domain Selects a D(N/D)XpY
      Motif and Binds to the Tyr292Negative Regulatory Phosphorylation Site of ZAP-70*},\n
      volume = {272},\n year = {1997}\n}\n"}, "authors": [{"authorId": "5236504",
      "name": "M. Lupher"}, {"authorId": "2111144577", "name": "Songyang Zhou"}, {"authorId":
      "4790900", "name": "S. Shoelson"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "145119394", "name": "H. Band"}]}, {"paperId": "df7a2e7ecd0deff9114f7b42f82603fded211188",
      "externalIds": {"MAG": "1988594478", "DOI": "10.1126/SCIENCE.275.5296.73", "CorpusId":
      8726366, "PubMed": "8974395"}, "corpusId": 8726366, "publicationVenue": {"id":
      "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/df7a2e7ecd0deff9114f7b42f82603fded211188",
      "title": "Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains",
      "abstract": "The oriented peptide library technique was used to investigate
      the peptide-binding specificities of nine PDZ domains. Each PDZ domain selected
      peptides with hydrophobic residues at the carboxyl terminus. Individual PDZ
      domains selected unique optimal motifs defined primarily by the carboxyl terminal
      three to seven residues of the peptides. One family of PDZ domains, including
      those of the Discs Large protein, selected peptides with the consensus motif
      Glu-(Ser/Thr)-Xxx-(Val/Ile) (where Xxx represents any amino acid) at the carboxyl
      terminus. In contrast, another family of PDZ domains, including those of LIN-2,
      p55, and Tiam-1, selected peptides with hydrophobic or aromatic side chains
      at the carboxyl terminal three residues. On the basis of crystal structures
      of the PSD-95-3 PDZ domain, the specificities observed with the peptide library
      can be rationalized.", "venue": "Science", "year": 1997, "referenceCount": 24,
      "citationCount": 1401, "influentialCitationCount": 63, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1997-01-03", "journal": {"volume": "275",
      "pages": "73 - 77", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Zhou1997RecognitionOU,\n
      author = {Songyang Zhou and A. Fanning and C. Fu and Jian Xu and S. Marfatia
      and A. Chishti and A. Crompton and A. Chan and James M. Anderson and L. Cantley},\n
      booktitle = {Science},\n journal = {Science},\n pages = {73 - 77},\n title =
      {Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains},\n
      volume = {275},\n year = {1997}\n}\n"}, "authors": [{"authorId": "2111144577",
      "name": "Songyang Zhou"}, {"authorId": "39814834", "name": "A. Fanning"}, {"authorId":
      "2084646749", "name": "C. Fu"}, {"authorId": "2110980007", "name": "Jian Xu"},
      {"authorId": "6428784", "name": "S. Marfatia"}, {"authorId": "3739451", "name":
      "A. Chishti"}, {"authorId": "48345856", "name": "A. Crompton"}, {"authorId":
      "144387609", "name": "A. Chan"}, {"authorId": "2110869031", "name": "James M.
      Anderson"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "e0badc8710740a515ed591a871a14d1c30265117",
      "externalIds": {"MAG": "2094068658", "DOI": "10.1126/SCIENCE.275.5300.665",
      "CorpusId": 31186873, "PubMed": "9005852"}, "corpusId": 31186873, "publicationVenue":
      {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad", "name": "Science", "type": "journal",
      "issn": "0193-4511", "alternate_issns": ["0036-8075"], "url": "https://www.jstor.org/journal/science",
      "alternate_urls": ["https://www.sciencemag.org/", "http://www.sciencemag.org/",
      "http://www.jstor.org/journals/00368075.html", "http://www.sciencemag.org/archive/"]},
      "url": "https://www.semanticscholar.org/paper/e0badc8710740a515ed591a871a14d1c30265117",
      "title": "Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate",
      "abstract": "The regulation of the serine-threonine kinase Akt by lipid products
      of phosphoinositide 3-kinase (PI 3-kinase) was investigated. Akt activity was
      found to correlate with the amount of phosphatidylinositol-3,4-bisphosphate
      (PtdIns-3,4-P2) in vivo, and synthetic PtdIns-3,4-P2 activated Akt both in vitro
      and in vivo. Binding of PtdIns-3,4-P2 occurred within the Akt pleckstrin homology
      (PH) domain and facilitated dimerization of Akt. Akt mutated in the PH domain
      was not activated by PI 3-kinase in vivo or by PtdIns-3,4-P2 in vitro, and it
      was impaired in binding to PtdIns-3,4-P2. Examination of the binding to other
      phosphoinositides revealed that they bound to the Akt PH domain with much lower
      affinity than did PtdIns-3,4-P2 and failed to increase Akt activity. Thus, Akt
      is apparently regulated by the direct interaction of PtdIns-3,4-P2 with the
      Akt PH domain.", "venue": "Science", "year": 1997, "referenceCount": 13, "citationCount":
      1561, "influentialCitationCount": 79, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-01-31", "journal": {"volume": "275", "pages": "665
      - 668", "name": "Science"}, "citationStyles": {"bibtex": "@Article{Franke1997DirectRO,\n
      author = {T. Franke and D. Kaplan and L. Cantley and A. Toker},\n booktitle
      = {Science},\n journal = {Science},\n pages = {665 - 668},\n title = {Direct
      Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate},\n
      volume = {275},\n year = {1997}\n}\n"}, "authors": [{"authorId": "50377077",
      "name": "T. Franke"}, {"authorId": "32389352", "name": "D. Kaplan"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "145751285", "name": "A. Toker"}]},
      {"paperId": "eb924acd1f5b93abe75ca33ebc6934f09cf3a1fc", "externalIds": {"MAG":
      "2078411393", "DOI": "10.1074/jbc.272.7.4384", "CorpusId": 33901540, "PubMed":
      "9020160"}, "corpusId": 33901540, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/eb924acd1f5b93abe75ca33ebc6934f09cf3a1fc",
      "title": "Cloning and Characterization of a Wortmannin-sensitive Human Phosphatidylinositol
      4-Kinase*", "abstract": "Phosphatidylinositol (PtdIns) 4-kinases catalyze the
      synthesis of PtdIns-4-P, the immediate precursor of PtdIns-4,5-P2. Here we report
      the cloning of a novel, ubiquitously expressed PtdIns 4-kinase (PI4K\u03b2).
      The 2.4-kilobase pair cDNA encodes a putative translation product of 801 amino
      acids which shows greatest homology to the yeast PIK1 gene. The recombinant
      protein exhibits lipid kinase activity when expressed in Escherichia coli, and
      specific antibodies recognize a 110-kDa PtdIns 4-kinase in cell lysates. The
      biochemical properties of PI4K\u03b2 are characteristic of a type III enzyme.
      Interestingly, both recombinant PI4K\u03b2 and the endogenous protein are inhibited
      by 150 nM wortmannin, suggesting that we have cloned the previously described
      PtdIns 4-kinase that is responsible for regulating the synthesis of agonist-sensitive
      pools of polyphosphoinositides (Nakanishi, S., Catt, J. K., and Balla, T. (1995)
      Proc. Natl. Acad. Sci. U. S. A. 92, 5317-5321).", "venue": "Journal of Biological
      Chemistry", "year": 1997, "referenceCount": 49, "citationCount": 166, "influentialCitationCount":
      6, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819673060/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-02-14", "journal": {"volume": "272", "pages": "4384
      - 4390", "name": "The Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Meyers1997CloningAC,\n author = {R. Meyers and L. Cantley},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {4384 - 4390},\n title = {Cloning and Characterization
      of a Wortmannin-sensitive Human Phosphatidylinositol 4-Kinase*},\n volume =
      {272},\n year = {1997}\n}\n"}, "authors": [{"authorId": "48408223", "name":
      "R. Meyers"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "fb968f8f961b964d00cf434026dcdef0d404e367",
      "externalIds": {"MAG": "1998749044", "DOI": "10.1074/jbc.272.20.13236", "CorpusId":
      23850268, "PubMed": "9148941"}, "corpusId": 23850268, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/fb968f8f961b964d00cf434026dcdef0d404e367",
      "title": "Subcellular Locations of Phosphatidylinositol 4-Kinase Isoforms*",
      "abstract": "Phosphatidylinositol (PtdIns) 4-kinase catalyzes the synthesis
      of PtdIns-4-P, the precursor of an array of lipid second messengers generated
      by additional phosphorylation by PtdIns-4-P 5-kinase and PtdIns 3-kinase. PtdIns
      4-kinase activity is conserved from yeast to higher eukaryotes. Multiple isoforms
      of mammalian PtdIns 4-kinase have been purified, and the activities have been
      detected in almost all subcellular locations. We previously reported the cloning
      and characterization of the first mammalian PtdIns 4-kinase named PI4K\u03b1
      (Wong, K., and Cantley, L. C. (1994) J. Biol. Chem. 269, 28878\u201328884).
      Alternatively spliced forms of PI4K\u03b1 have also been identified from several
      sources including bovine brain (Gehrmann, T., Vereb, G., Schmidt, M., Klix,
      D., Meyer, H. E., Varsanyi, M., and Heilmeyer, L. M., Jr. (1996) Biochim. Biophys.
      Acta 1311, 53\u201363). Recently we isolated a distinct human PtdIns 4-kinase
      gene, named PI4K\u03b2, that encodes an enzyme that is wortmannin sensitive
      (Meyers, R., and Cantley, L. C. (1997) J. Biol. Chem. 272, 4384\u20134390).
      Here we report the locations of these enzymes and provide evidence for other
      yet unidentified isoforms present in specific organelles. PI4K\u03b1 is mostly
      membrane-bound and located at the endoplasmic reticulum; whereas PI4K\u03b2
      is in the cytosol and also present in the Golgi region. Neither of these isoforms
      accounts for the major type II PtdIns 4-kinase activity detected in the lysosomes
      and plasma membrane fraction.", "venue": "Journal of Biological Chemistry",
      "year": 1997, "referenceCount": 31, "citationCount": 181, "influentialCitationCount":
      12, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819569198/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1997-05-16", "journal": {"volume": "272", "pages": "13236
      - 13241", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Wong1997SubcellularLO,\n author = {Karen Wong and R. Meyers
      and L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n journal
      = {The Journal of Biological Chemistry},\n pages = {13236 - 13241},\n title
      = {Subcellular Locations of Phosphatidylinositol 4-Kinase Isoforms*},\n volume
      = {272},\n year = {1997}\n}\n"}, "authors": [{"authorId": "2046941766", "name":
      "Karen Wong"}, {"authorId": "48408223", "name": "R. Meyers"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "1af15d0e649fc28c7353c834a3f775962a6d3206",
      "externalIds": {"MAG": "2168259122", "DOI": "10.1128/MCB.16.11.6486", "CorpusId":
      21452280, "PubMed": "8887677"}, "corpusId": 21452280, "publicationVenue": {"id":
      "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular and Cellular Biology",
      "type": "journal", "alternate_names": ["Mol Cell Biology"], "issn": "0270-7306",
      "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]}, "url":
      "https://www.semanticscholar.org/paper/1af15d0e649fc28c7353c834a3f775962a6d3206",
      "title": "A structural basis for substrate specificities of protein Ser/Thr
      kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase
      kinase, calmodulin-dependent kinase II, CDK5, and Erk1", "abstract": "We have
      developed a method to study the primary sequence specificities of protein kinases
      by using an oriented degenerate peptide library. We report here the substrate
      specificities of eight protein Ser/Thr kinases. All of the kinases studied selected
      distinct optimal substrates. The identified substrate specificities of these
      kinases, together with known crystal structures of protein kinase A, CDK2, Erk2,
      twitchin, and casein kinase I, provide a structural basis for the substrate
      recognition of protein Ser/Thr kinases. In particular, the specific selection
      of amino acids at the +1 and -3 positions to the substrate serine/threonine
      can be rationalized on the basis of sequences of protein kinases. The identification
      of optimal peptide substrates of CDK5, casein kinases I and II, NIMA, calmodulin-dependent
      kinases, Erk1, and phosphorylase kinase makes it possible to predict the potential
      in vivo targets of these kinases.", "venue": "Molecular and Cellular Biology",
      "year": 1996, "referenceCount": 27, "citationCount": 547, "influentialCitationCount":
      17, "isOpenAccess": true, "openAccessPdf": {"url": "https://mcb.asm.org/content/mcb/16/11/6486.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1996-11-01", "journal": {"volume": "16", "pages": "6486
      - 6493", "name": "Molecular and Cellular Biology"}, "citationStyles": {"bibtex":
      "@Article{Zhou1996ASB,\n author = {Songyang Zhou and K. Lu and Young T. Kwon
      and L. Tsai and O. Filhol and C. Cochet and D. Brickey and T. Soderling and
      C. Bartleson and D. Graves and A. Demaggio and M. Hoekstra and J. Blenis and
      T. Hunter and L. Cantley},\n booktitle = {Molecular and Cellular Biology},\n
      journal = {Molecular and Cellular Biology},\n pages = {6486 - 6493},\n title
      = {A structural basis for substrate specificities of protein Ser/Thr kinases:
      primary sequence preference of casein kinases I and II, NIMA, phosphorylase
      kinase, calmodulin-dependent kinase II, CDK5, and Erk1},\n volume = {16},\n
      year = {1996}\n}\n"}, "authors": [{"authorId": "2111144577", "name": "Songyang
      Zhou"}, {"authorId": "1715537", "name": "K. Lu"}, {"authorId": "32583474", "name":
      "Young T. Kwon"}, {"authorId": "2066282492", "name": "L. Tsai"}, {"authorId":
      "6639228", "name": "O. Filhol"}, {"authorId": "3289173", "name": "C. Cochet"},
      {"authorId": "4426396", "name": "D. Brickey"}, {"authorId": "6789866", "name":
      "T. Soderling"}, {"authorId": "40497410", "name": "C. Bartleson"}, {"authorId":
      "2006315", "name": "D. Graves"}, {"authorId": "6941515", "name": "A. Demaggio"},
      {"authorId": "4939757", "name": "M. Hoekstra"}, {"authorId": "4037343", "name":
      "J. Blenis"}, {"authorId": "143683912", "name": "T. Hunter"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "2a4f3da9edaf015dc9d607da7e7acd1df904307c",
      "externalIds": {"MAG": "2131134035", "DOI": "10.1002/j.1460-2075.1996.tb00965.x",
      "CorpusId": 25498292, "PubMed": "8918456"}, "corpusId": 25498292, "publicationVenue":
      {"id": "b89f0ede-6fa8-4dd2-a8a7-f54695a00323", "name": "EMBO Journal", "type":
      "journal", "alternate_names": ["The EMBO Journal", "EMBO J"], "issn": "0261-4189",
      "url": "http://embojournal.npgjournals.com/", "alternate_urls": ["http://emboj.embopress.org/"]},
      "url": "https://www.semanticscholar.org/paper/2a4f3da9edaf015dc9d607da7e7acd1df904307c",
      "title": "Sequence requirements for the recognition of tyrosine\u2010based endocytic
      signals by clathrin AP\u20102 complexes.", "abstract": "We recently determined
      that fusion proteins containing tyrosine\u2010based endocytic signals bind to
      the mu 2 subunit of AP\u20102, the complex that drives clathrin coat formation
      and mediates endocytosis from the plasma membrane. Here we analyze the selectivity
      of peptide recognition by mu 2 and by AP\u20102 using combinatorial selection
      methods and surface plasmon resonance. Both mu 2 and AP\u20102 are shown to
      interact with various sequences of the form tyrosine\u2010polar\u2010polar\u2010hydrophobic
      (Ypp\u00f8) found on receptors that follow the clathrin pathway. The optimal
      sequence for interaction with mu 2 and with AP\u20102 has tyrosine as an anchor
      and prefers arginine at position Y + 2 and leucine at position Y + 3. In contrast,
      no preferred sequence is detected surrounding the Ypp\u00f8 signal, indicating
      that recognition of the Ypp\u00f8 endocytic signal does not require a prefolded
      structure. We conclude that sorting into the endocytic pathway is governed by
      a surprisingly simple interaction between the mu 2 chain and a tyrosine\u2010containing
      tetrapeptide sequence.", "venue": "EMBO Journal", "year": 1996, "referenceCount":
      0, "citationCount": 274, "influentialCitationCount": 8, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/j.1460-2075.1996.tb00965.x",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1996-11-01", "journal": {"volume": "15", "name": "The EMBO
      Journal"}, "citationStyles": {"bibtex": "@Article{Boll1996SequenceRF,\n author
      = {W. Boll and H. Ohno and Songyang Zhou and Iris Rapoport and L. Cantley and
      J. Bonifacino and T. Kirchhausen},\n booktitle = {EMBO Journal},\n journal =
      {The EMBO Journal},\n title = {Sequence requirements for the recognition of
      tyrosine\u2010based endocytic signals by clathrin AP\u20102 complexes.},\n volume
      = {15},\n year = {1996}\n}\n"}, "authors": [{"authorId": "6576021", "name":
      "W. Boll"}, {"authorId": "2065492673", "name": "H. Ohno"}, {"authorId": "2111144577",
      "name": "Songyang Zhou"}, {"authorId": "2053078190", "name": "Iris Rapoport"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5269672", "name":
      "J. Bonifacino"}, {"authorId": "4218577", "name": "T. Kirchhausen"}]}, {"paperId":
      "32f985d4f7f9c89ebaae84251ecbba97cc65de65", "externalIds": {"MAG": "2048926606",
      "DOI": "10.1074/jbc.271.20.11787", "CorpusId": 36378361, "PubMed": "8662772"},
      "corpusId": 36378361, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/32f985d4f7f9c89ebaae84251ecbba97cc65de65",
      "title": "Binding Specificity and Mutational Analysis of the Phosphotyrosine
      Binding Domain of the Brain-specific Adaptor Protein ShcC (*)", "abstract":
      "Shc proteins (hereafter referred to as ShcA) represent major substrates of
      tyrosine phosphorylation by a wide variety of growth factors and cytokines.
      We have recently described a novel ShcA-like protein, ShcC, which like ShcA
      contains an NH-terminal phosphotyrosine binding domain (PTB), a central effector
      region (CH1) and a COOH-terminal Src homology 2 domain (SH2). Both the SH2 and
      PTB domains of ShcC bind a similar profile of proteins as the comparable regions
      of ShcA. In an effort to define the functional differences or similarities between
      ShcA and ShcC, we have further characterized the PTB domain of ShcC. Using a
      degenerate phosphopeptide library screen, we show that the PTB domain of ShcC
      preferentially binds the sequence His-hydrophobic-Asn/hydrophobic-Asn-Pro-Ser/Thr-Tyr(P).
      This sequence is similar to the binding site for the ShcA PTB domain, suggesting
      that these two proteins may have overlapping specificities. In addition, random
      mutagenesis of the ShcC PTB domain has identified several amino acids important
      for PTB function (Gly, Glu, Ala, Gly, and Asp). Mutation of these amino acids
      dramatically reduces the affinity of the ShcC PTB domain for the activated epidermal
      growth factor receptor in vitro.", "venue": "Journal of Biological Chemistry",
      "year": 1996, "referenceCount": 29, "citationCount": 20, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818826217/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1996-05-17", "journal": {"volume": "271", "pages": "11787
      - 11791", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{O\u2019Bryan1996BindingSA,\n author = {J. O\u2019Bryan
      and Carol B. Martin and Z. Songyang and L. Cantley and C. Der},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {11787 - 11791},\n title = {Binding Specificity and Mutational
      Analysis of the Phosphotyrosine Binding Domain of the Brain-specific Adaptor
      Protein ShcC (*)},\n volume = {271},\n year = {1996}\n}\n"}, "authors": [{"authorId":
      "1403224640", "name": "J. O\u2019Bryan"}, {"authorId": "123047982", "name":
      "Carol B. Martin"}, {"authorId": "6731027", "name": "Z. Songyang"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4764611", "name": "C. Der"}]},
      {"paperId": "4b203b72d7396db076229654157934d534be1943", "externalIds": {"MAG":
      "28313440", "DOI": "10.1007/978-1-4899-1361-6_4", "CorpusId": 92579248}, "corpusId":
      92579248, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/4b203b72d7396db076229654157934d534be1943",
      "title": "PI 3-Kinase and Receptor-Linked Signal Transduction", "abstract":
      null, "venue": "", "year": 1996, "referenceCount": 194, "citationCount": 10,
      "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "pages": "125-175", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Duckworth1996PI3A,\n author = {B. Duckworth and L.
      Cantley},\n pages = {125-175},\n title = {PI 3-Kinase and Receptor-Linked Signal
      Transduction},\n year = {1996}\n}\n"}, "authors": [{"authorId": "21162853",
      "name": "B. Duckworth"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "51e176586c3075290705c0aeb61e756607cccd04", "externalIds": {"MAG": "175250784",
      "DOI": "10.1007/978-3-642-61180-3_2", "CorpusId": 82312158}, "corpusId": 82312158,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/51e176586c3075290705c0aeb61e756607cccd04",
      "title": "The Structural Basis for Specificity in Protein-Tyrosine Kinase Signaling",
      "abstract": null, "venue": "", "year": 1996, "referenceCount": 19, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "pages": "5-16", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Cantley1996TheSB,\n author = {L. Cantley and Z. Songyang},\n
      pages = {5-16},\n title = {The Structural Basis for Specificity in Protein-Tyrosine
      Kinase Signaling},\n year = {1996}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "6731027", "name": "Z. Songyang"}]}, {"paperId":
      "5c9060ce2a37eb3dd5d6e15e290e27189bb11908", "externalIds": {"MAG": "2029164510",
      "DOI": "10.1016/0167-4889(95)00176-X", "CorpusId": 32513505, "PubMed": "8603102"},
      "corpusId": 32513505, "publicationVenue": {"id": "08ee3346-e195-4333-b008-be3a4f9e23cd",
      "name": "Biochimica et Biophysica Acta", "type": "journal", "alternate_names":
      ["Biochim Biophys Acta"], "issn": "0006-3002", "alternate_issns": ["1878-2434"],
      "url": "https://www.elsevier.com/life-sciences/biochemistry-genetics-and-molecular-biology/journals/bba",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00063002",
      "http://www.elsevier.com/wps/find/journaldescription.cws_home/506062/description#description"]},
      "url": "https://www.semanticscholar.org/paper/5c9060ce2a37eb3dd5d6e15e290e27189bb11908",
      "title": "Association of phosphatidylinositol 3-kinase, via the SH2 domains
      of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts.",
      "abstract": null, "venue": "Biochimica et Biophysica Acta", "year": 1996, "referenceCount":
      50, "citationCount": 42, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1996-03-27", "journal": {"volume": "1311
      1", "pages": "\n          45-52\n        ", "name": "Biochimica et biophysica
      acta"}, "citationStyles": {"bibtex": "@Article{Bachelot1996AssociationOP,\n
      author = {Christilla Bachelot and Christilla Bachelot and L. Rameh and T. Parsons
      and L. Cantley},\n booktitle = {Biochimica et Biophysica Acta},\n journal =
      {Biochimica et biophysica acta},\n pages = {\n          45-52\n        },\n
      title = {Association of phosphatidylinositol 3-kinase, via the SH2 domains of
      p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts.},\n
      volume = {1311 1},\n year = {1996}\n}\n"}, "authors": [{"authorId": "2122133958",
      "name": "Christilla Bachelot"}, {"authorId": "2122133958", "name": "Christilla
      Bachelot"}, {"authorId": "4109960", "name": "L. Rameh"}, {"authorId": "2061061776",
      "name": "T. Parsons"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "609a94ea2cd6ad7de090ff6c61f87e29b8020e82", "externalIds": {"MAG": "1977891434",
      "DOI": "10.1074/jbc.271.27.15934", "CorpusId": 42671115, "PubMed": "8663233"},
      "corpusId": 42671115, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/609a94ea2cd6ad7de090ff6c61f87e29b8020e82",
      "title": "Specificity of LIM Domain Interactions with Receptor Tyrosine Kinases*",
      "abstract": "LIM domains, Cys-rich motifs containing approximately 50 amino
      acids found in a variety of proteins, are proposed to direct protein\u00b7protein
      interactions. To identify structural targets recognized by LIM domains, we have
      utilized random peptide library selection, the yeast two-hybrid system, and
      glutathione S-transferase fusions. Enigma contains three LIM domains within
      its carboxyl terminus and LIM3 of Enigma specifically recognizes active but
      not mutant endocytic codes of the insulin receptor (InsR) (Wu, R. Y., and Gill,
      G. N. (1994)J. Biol. Chem. 269, 25085-25090). Interaction of two random peptide
      libraries with glutathione S-transferase-LIM3 of Enigma indicated specific binding
      to Gly-Pro-Hyd-Gly-Pro-Hyd-Tyr-Ala corresponding to the major endocytic code
      of InsR. Peptide competition demonstrated that both Pro and Tyr residues were
      required for specific interaction of InsR with Enigma. In contrast to LIM3 of
      Enigma binding to InsR, LIM2 of Enigma associated specifically with the receptor
      tyrosine kinase, Ret. Ret was specific for LIM2 of Enigma and did not bind other
      LIM domains tested. Mutational analysis indicated that the residues responsible
      for binding to Enigma were localized to the carboxyl-terminal 61 amino acids
      of Ret. A peptide corresponding to the carboxyl-terminal 20 amino acids of Ret
      dissociated Enigma and Ret complexes, while a mutant that changed Asn-Lys-Leu-Tyr
      in the peptide to Ala-Lys-Leu-Ala or a peptide corresponding to exon16 of InsR
      failed to disrupt the complexes, indicating the Asn-Lys-Leu-Tyr sequence of
      Ret is essential to the recognition motif for LIM2 of Enigma. We conclude that
      LIM domains of Enigma recognize tyrosine-containing motifs with specificity
      residing in both the LIM domains and in the target structures.", "venue": "Journal
      of Biological Chemistry", "year": 1996, "referenceCount": 42, "citationCount":
      99, "influentialCitationCount": 4, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1996-07-05", "journal":
      {"volume": "271", "pages": "15934 - 15941", "name": "The Journal of Biological
      Chemistry"}, "citationStyles": {"bibtex": "@Article{Wu1996SpecificityOL,\n author
      = {Rui-yun Wu and K. Durick and Songyang Zhou and L. Cantley and S. Taylor and
      G. Gill},\n booktitle = {Journal of Biological Chemistry},\n journal = {The
      Journal of Biological Chemistry},\n pages = {15934 - 15941},\n title = {Specificity
      of LIM Domain Interactions with Receptor Tyrosine Kinases*},\n volume = {271},\n
      year = {1996}\n}\n"}, "authors": [{"authorId": "90528521", "name": "Rui-yun
      Wu"}, {"authorId": "4012671", "name": "K. Durick"}, {"authorId": "2111144577",
      "name": "Songyang Zhou"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "1396694186", "name": "S. Taylor"}, {"authorId": "1977402", "name": "G. Gill"}]},
      {"paperId": "660ac58e4ce0fe53df336fa45f6f8c802a339c98", "externalIds": {"MAG":
      "2006844704", "DOI": "10.1016/0304-419X(96)00018-2", "CorpusId": 12934303, "PubMed":
      "8764841"}, "corpusId": 12934303, "publicationVenue": {"id": "08ee3346-e195-4333-b008-be3a4f9e23cd",
      "name": "Biochimica et Biophysica Acta", "type": "journal", "alternate_names":
      ["Biochim Biophys Acta"], "issn": "0006-3002", "alternate_issns": ["1878-2434"],
      "url": "https://www.elsevier.com/life-sciences/biochemistry-genetics-and-molecular-biology/journals/bba",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00063002",
      "http://www.elsevier.com/wps/find/journaldescription.cws_home/506062/description#description"]},
      "url": "https://www.semanticscholar.org/paper/660ac58e4ce0fe53df336fa45f6f8c802a339c98",
      "title": "Phosphoinositide 3-kinase and the regulation of cell growth.", "abstract":
      null, "venue": "Biochimica et Biophysica Acta", "year": 1996, "referenceCount":
      60, "citationCount": 124, "influentialCitationCount": 9, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "1996-08-08", "journal": {"volume":
      "1288 1", "pages": "\n          M11-6\n        ", "name": "Biochimica et biophysica
      acta"}, "citationStyles": {"bibtex": "@Article{Carpenter1996Phosphoinositide3A,\n
      author = {C. Carpenter and L. Cantley},\n booktitle = {Biochimica et Biophysica
      Acta},\n journal = {Biochimica et biophysica acta},\n pages = {\n          M11-6\n        },\n
      title = {Phosphoinositide 3-kinase and the regulation of cell growth.},\n volume
      = {1288 1},\n year = {1996}\n}\n"}, "authors": [{"authorId": "2972505", "name":
      "C. Carpenter"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "6e8f5fcc6b2a51c964d4a3c796953bd86f95fee9", "externalIds": {"MAG": "2029849554",
      "DOI": "10.1074/JBC.271.1.563", "CorpusId": 37141087, "PubMed": "8550620"},
      "corpusId": 37141087, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/6e8f5fcc6b2a51c964d4a3c796953bd86f95fee9",
      "title": "p120 Is a Cytosolic Adapter Protein That Associates with Phosphoinositide
      3-Kinase in Response to Epidermal Growth Factor in PC12 and Other Cells (*)",
      "abstract": "Although epidermal growth factor (EGF) activates phosphoinositide
      (PI) 3-kinase activity in a number of types of cells or cell lines, in most
      cases that we have investigated the p85 regulatory subunit of PI 3-kinase does
      not appear to bind directly to the EGF receptor. Previously we demonstrated
      that EGF-dependent activation of PI 3-kinase activity in A431 cells is accompanied
      by the binding of p85 to ErbB3, an EGF receptor homologue. However, this mechanism
      did not explain the large activation of PI 3-kinase activity that was found
      in PC12 and A549 cells, which possess little or no ErbB3. Here we provide evidence
      that the p120 proto-oncoprotein is an intracellular adapter protein that associates
      with PI 3-kinase and thus is involved in the EGF-dependent activation of this
      enzyme in these two cell lines. Using an anti-p120 antibody, we immunoprecipitated
      the EGF receptor from PC12 cells and PI 3-kinase activity from PC12 and A549
      cells in an EGF-dependent fashion. Treatment of PC12 cells with nerve growth
      factor or insulin stimulated large increases in PI 3-kinase activity that was
      immunoprecipitated using anti-Tyr(P) antibody but not using anti-p120 antibody.
      In EGF-treated PC12 cells, the tyrosine phosphorylation of p120 displayed similar
      kinetics to the activation of PI 3-kinase as measured by both in vivo lipid
      production and lipid kinase assays conducted using anti-p120 and anti-Tyr(P)
      immunoprecipitates. The use of glutathione S-transferase fusion proteins of
      various domains of p85 demonstrated that p120 associated with both the SH2 and
      SH3 domains of p85. p120 was also present in A431 cells and offers an additional
      pathway by which EGF can activate PI 3-kinase in these cells.", "venue": "Journal
      of Biological Chemistry", "year": 1996, "referenceCount": 25, "citationCount":
      155, "influentialCitationCount": 6, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.jbc.org/article/S0021925818953780/pdf", "status": null}, "fieldsOfStudy":
      ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1996-01-05", "journal": {"volume": "271", "pages": "563 - 567", "name": "The
      Journal of Biological Chemistry"}, "citationStyles": {"bibtex": "@Article{Soltoff1996p120IA,\n
      author = {S. Soltoff and L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of Biological Chemistry},\n pages = {563 - 567},\n title
      = {p120 Is a Cytosolic Adapter Protein That Associates with Phosphoinositide
      3-Kinase in Response to Epidermal Growth Factor in PC12 and Other Cells (*)},\n
      volume = {271},\n year = {1996}\n}\n"}, "authors": [{"authorId": "4324390",
      "name": "S. Soltoff"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "9ab201a03716fc9886a650e6c03cf71d6492345f", "externalIds": {"MAG": "1985782864",
      "DOI": "10.1074/jbc.271.46.29271", "CorpusId": 31687634, "PubMed": "8910587"},
      "corpusId": 31687634, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/9ab201a03716fc9886a650e6c03cf71d6492345f",
      "title": "The Inositol 5\u2032-Phosphatase SHIP Binds to Immunoreceptor Signaling
      Motifs and Responds to High Affinity IgE Receptor Aggregation*", "abstract":
      "Immunoreceptors such as the high affinity IgE receptor, Fc\u03b5RI, and T-cell
      receptor-associated proteins share a common motif, the immunoreceptor tyrosine-based
      activation motif (ITAM). We used the yeast tribrid system to identify downstream
      effectors of the phosphorylated Fc\u03b5RI ITAM-containing subunits \u03b2 and
      \u03b3. One novel cDNA was isolated that encodes a protein that is phosphorylated
      on tyrosine, contains a Src-homology 2 (SH2) domain, inositolpolyphosphate 5-phosphatase
      activity, three NXXY motifs, several proline-rich regions, and is called SHIP.
      Mutation of the conserved tyrosine or leucine residues within the Fc\u03b5RI
      \u03b2 or \u03b3 ITAMs eliminates SHIP binding and indicates that the SHIP-ITAM
      interaction is specific. SHIP also binds to ITAMs from the CD3 complex and T
      cell receptor \u03b6 chain in vitro. SHIP protein possesses both phosphatidylinositol-3,4,5-trisphosphate
      5\u2032-phosphatase and inositol-1,3,4,5-tetrakisphosphate 5\u2032-phosphatase
      activity. Phosphorylation of SHIP by a protein-tyrosine kinase, Lck, results
      in a reduction in enzyme activity. Fc\u03b5RI activation induces the association
      of several tyrosine phosphoproteins with SHIP. SHIP is constitutively tyrosine-phosphorylated
      and associated with Shc and Grb2. These data suggest that SHIP may serve as
      a multifunctional linker protein in receptor activation.", "venue": "Journal
      of Biological Chemistry", "year": 1996, "referenceCount": 46, "citationCount":
      198, "influentialCitationCount": 10, "isOpenAccess": true, "openAccessPdf":
      {"url": "http://www.jbc.org/article/S0021925818350622/pdf", "status": null},
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1996-11-15", "journal":
      {"volume": "271", "pages": "29271 - 29278", "name": "The Journal of Biological
      Chemistry"}, "citationStyles": {"bibtex": "@Article{Osborne1996TheI5,\n author
      = {M. Osborne and Georg Zenner and M. Lubinus and Xiaoling Zhang and Songyang
      Zhou and L. Cantley and P. Majerus and P. Burn and J. Kochan},\n booktitle =
      {Journal of Biological Chemistry},\n journal = {The Journal of Biological Chemistry},\n
      pages = {29271 - 29278},\n title = {The Inositol 5\u2032-Phosphatase SHIP Binds
      to Immunoreceptor Signaling Motifs and Responds to High Affinity IgE Receptor
      Aggregation*},\n volume = {271},\n year = {1996}\n}\n"}, "authors": [{"authorId":
      "48234741", "name": "M. Osborne"}, {"authorId": "6208795", "name": "Georg Zenner"},
      {"authorId": "16342565", "name": "M. Lubinus"}, {"authorId": "2118044546", "name":
      "Xiaoling Zhang"}, {"authorId": "2242492756", "name": "Songyang Zhou"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2676378", "name": "P. Majerus"},
      {"authorId": "145340757", "name": "P. Burn"}, {"authorId": "7659975", "name":
      "J. Kochan"}]}, {"paperId": "9b67ff313f2759f8cf79a512cf15c3c0dbcde336", "externalIds":
      {"MAG": "2132366506", "DOI": "10.1016/S0092-8674(00)81814-0", "CorpusId": 3010436,
      "PubMed": "8980225"}, "corpusId": 3010436, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/9b67ff313f2759f8cf79a512cf15c3c0dbcde336",
      "title": "Vascular Dysmorphogenesis Caused by an Activating Mutation in the
      Receptor Tyrosine Kinase TIE2", "abstract": null, "venue": "Cell", "year": 1996,
      "referenceCount": 68, "citationCount": 764, "influentialCitationCount": 20,
      "isOpenAccess": true, "openAccessPdf": {"url": "http://www.cell.com/article/S0092867400818140/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1996-12-27", "journal": {"volume": "87", "pages": "1181-1190",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Vikkula1996VascularDC,\n
      author = {M. Vikkula and L. Boon and Kermit L.Carraway and Jennifer T. Calvert
      and A. Diamonti and Boyan C. Goumnerov and K. Pasyk and D. Marchuk and M. Warman
      and L. Cantley and J. Mulliken and B. Olsen},\n booktitle = {Cell},\n journal
      = {Cell},\n pages = {1181-1190},\n title = {Vascular Dysmorphogenesis Caused
      by an Activating Mutation in the Receptor Tyrosine Kinase TIE2},\n volume =
      {87},\n year = {1996}\n}\n"}, "authors": [{"authorId": "3640552", "name": "M.
      Vikkula"}, {"authorId": "6863639", "name": "L. Boon"}, {"authorId": "1438822712",
      "name": "Kermit L.Carraway"}, {"authorId": "48532116", "name": "Jennifer T.
      Calvert"}, {"authorId": "48917515", "name": "A. Diamonti"}, {"authorId": "4268821",
      "name": "Boyan C. Goumnerov"}, {"authorId": "4034486", "name": "K. Pasyk"},
      {"authorId": "6555638", "name": "D. Marchuk"}, {"authorId": "3999657", "name":
      "M. Warman"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "3892628",
      "name": "J. Mulliken"}, {"authorId": "1818556", "name": "B. Olsen"}]}, {"paperId":
      "9ea425d0943a7cc39526698fdb2795ace1d9863c", "externalIds": {"MAG": "2000790515",
      "DOI": "10.1006/GENO.1996.0527", "CorpusId": 84731266}, "corpusId": 84731266,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/9ea425d0943a7cc39526698fdb2795ace1d9863c",
      "title": "Structural Organization and Alternative Splicing of the Murine Phosphoinositide
      3-Kinase p85\u03b1 Gene", "abstract": "Phosphoinositide 3-kinase is a lipid
      and protein kinase composed of a 110-kDa catalytic subunit and an 85-kDa (p85)
      or 55-kDa (p55) regulatory subunit. In mammals, at least two genes encode catalytic
      subunits, and at least three genes encode regulatory subunits. Here we report
      the cloning and structural analysis of the mouse p85 alpha gene. The translated
      portion of mouse p85 alpha is encoded by 15 exons that span at least 40 kb.
      We have cloned an alternatively spliced form of p85 alpha from both mouse and
      rat cDNA libraries. This splice variant encodes a unique 5''-untranslated region,
      start codon, and 6-amino-acid aminoterminus followed by the carboxyterminal
      418 amino acids of p85 alpha. A corresponding exon is present within the p85
      alpha genomic locus. In vitro transcription and translation of the splice variant
      cDNA generate a protein of approximately 45 kDa that is reactive with an anti-p85
      alpha antiserum. Northern blot analysis of mouse tissues reveals differential
      expression of full-length and alternatively spliced p85 alpha, with the splice
      variant most abundant in the liver.", "venue": "", "year": 1996, "referenceCount":
      0, "citationCount": 105, "influentialCitationCount": 1, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "1996-10-01", "journal": {"volume":
      "37", "pages": "113-121", "name": "Genomics"}, "citationStyles": {"bibtex":
      "@Article{Fruman1996StructuralOA,\n author = {D. Fruman and L. Cantley and C.
      Carpenter},\n journal = {Genomics},\n pages = {113-121},\n title = {Structural
      Organization and Alternative Splicing of the Murine Phosphoinositide 3-Kinase
      p85\u03b1 Gene},\n volume = {37},\n year = {1996}\n}\n"}, "authors": [{"authorId":
      "6241317", "name": "D. Fruman"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2972505", "name": "C. Carpenter"}]}, {"paperId": "b7b1b863403ea98759a6a5262c3574a8144c49f2",
      "externalIds": {"CorpusId": 40022962, "PubMed": "8921377"}, "corpusId": 40022962,
      "publicationVenue": {"id": "85914651-dd2f-4b80-84eb-9e87943a555b", "name": "Genomics",
      "type": "journal", "issn": "0888-7543", "url": "https://www.journals.elsevier.com/genomics",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/08887543",
      "http://www.idealibrary.com/links/toc/geno", "http://www.journals.elsevier.com/genomics"]},
      "url": "https://www.semanticscholar.org/paper/b7b1b863403ea98759a6a5262c3574a8144c49f2",
      "title": "Structural organization and alternative splicing of the murine phosphoinositide
      3-kinase p85 alpha gene.", "abstract": "Phosphoinositide 3-kinase is a lipid
      and protein kinase composed of a 110-kDa catalytic subunit and an 85-kDa (p85)
      or 55-kDa (p55) regulatory subunit. In mammals, at least two genes encode catalytic
      subunits, and at least three genes encode regulatory subunits. Here we report
      the cloning and structural analysis of the mouse p85 alpha gene. The translated
      portion of mouse p85 alpha is encoded by 15 exons that span at least 40 kb.
      We have cloned an alternatively spliced form of p85 alpha from both mouse and
      rat cDNA libraries. This splice variant encodes a unique 5''-untranslated region,
      start codon, and 6-amino-acid aminoterminus followed by the carboxyterminal
      418 amino acids of p85 alpha. A corresponding exon is present within the p85
      alpha genomic locus. In vitro transcription and translation of the splice variant
      cDNA generate a protein of approximately 45 kDa that is reactive with an anti-p85
      alpha antiserum. Northern blot analysis of mouse tissues reveals differential
      expression of full-length and alternatively spliced p85 alpha, with the splice
      variant most abundant in the liver.", "venue": "Genomics", "year": 1996, "referenceCount":
      0, "citationCount": 37, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": null, "journal":
      {"volume": "37 1", "pages": "\n          113-21\n        ", "name": "Genomics"},
      "citationStyles": {"bibtex": "@Article{Fruman1996StructuralOA,\n author = {D.
      Fruman and L. Cantley and C. Carpenter},\n booktitle = {Genomics},\n journal
      = {Genomics},\n pages = {\n          113-21\n        },\n title = {Structural
      organization and alternative splicing of the murine phosphoinositide 3-kinase
      p85 alpha gene.},\n volume = {37 1},\n year = {1996}\n}\n"}, "authors": [{"authorId":
      "6241317", "name": "D. Fruman"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2972505", "name": "C. Carpenter"}]}, {"paperId": "c457f5f005f88d0209fd9850e38bc94cbdcd57df",
      "externalIds": {"DOI": "10.1016/s0955-0674(96)80060-3", "CorpusId": 42258451,
      "PubMed": "8791418"}, "corpusId": 42258451, "publicationVenue": {"id": "bda8ed3e-063e-43a6-ba9e-f4357d8a3e66",
      "name": "Current Opinion in Cell Biology", "type": "journal", "alternate_names":
      ["Curr Opin Cell Biology"], "issn": "0955-0674", "url": "http://journals.elsevier.com/09550674/current-opinion-in-cell-biology/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/09550674"]},
      "url": "https://www.semanticscholar.org/paper/c457f5f005f88d0209fd9850e38bc94cbdcd57df",
      "title": "Phosphoinositide kinases.", "abstract": null, "venue": "Current Opinion
      in Cell Biology", "year": 1996, "referenceCount": 0, "citationCount": 10, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": null, "journal": {"volume": "8 2", "pages": "\n          153-8\n        ",
      "name": "Current opinion in cell biology"}, "citationStyles": {"bibtex": "@Article{Carpenter1996PhosphoinositideK,\n
      author = {C. Carpenter and L. Cantley},\n booktitle = {Current Opinion in Cell
      Biology},\n journal = {Current opinion in cell biology},\n pages = {\n          153-8\n        },\n
      title = {Phosphoinositide kinases.},\n volume = {8 2},\n year = {1996}\n}\n"},
      "authors": [{"authorId": "2972505", "name": "C. Carpenter"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "ca3d7470be7af31b15c900d32045ab53bae70e75",
      "externalIds": {"MAG": "2054805783", "DOI": "10.1074/jbc.271.51.32986", "CorpusId":
      35660758, "PubMed": "8955143"}, "corpusId": 35660758, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/ca3d7470be7af31b15c900d32045ab53bae70e75",
      "title": "D3 Phosphoinositides and Outside-in integrin Signaling by Glycoprotein
      IIb-IIIa Mediate Platelet Actin Assembly and Filopodial Extension Induced by
      Phorbol 12-Myristate 13-Acetate*", "abstract": "Phorbol 12-myristate 13-acetate
      (PMA) uncaps a small number of the fast-growing (barbed) ends of actin filaments,
      thereby eliciting slow actin assembly and extension of filopodia in human blood
      platelets. These reactions, which also occur in response to immunologic perturbation
      of the integrin glycoprotein (GP) IIb-IIIa, are sensitive to the phosphoinositide
      3-kinase inhibitor wortmannin. Platelets deficient in GPIIb-IIIa integrins or
      with GPIIb-IIIa function inhibited by calcium chelation or the peptide RGDS
      have diminished PMA responsiveness. The effects of PMA contrast with thrombin
      receptor stimulation by \u22655 \u03bcM thrombin receptor-activating peptide
      (TRAP), which causes rapid and massive wortmannin-insensitive actin assembly
      and lamellar and filopodial extension. However, we show here that wortmannin
      can inhibit filopod formation if the thrombin receptor is ligated using suboptimal
      doses (<1 \u03bcM) of TRAP. Phosphatidylinositol 3,4-bisphosphate inhibits actin
      filament severing and capping by human gelsolin in vitro. The findings implicate
      D3 polyphosphoinositides and integrin signaling in PMA-mediated platelet stimulation
      and implicate D3 containing phosphoinositides generated in response to protein
      kinase C activation and GPIIb-IIIa signaling as late-acting intermediates leading
      to filopodial actin assembly.", "venue": "Journal of Biological Chemistry",
      "year": 1996, "referenceCount": 49, "citationCount": 132, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925819788085/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1996-12-20", "journal": {"volume": "271",
      "pages": "32986 - 32993", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Hartwig1996D3PA,\n author = {J. Hartwig and Sophia Kung
      and T. Kovacsovics and P. Janmey and L. Cantley and T. Stossel and A. Toker},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of Biological
      Chemistry},\n pages = {32986 - 32993},\n title = {D3 Phosphoinositides and Outside-in
      integrin Signaling by Glycoprotein IIb-IIIa Mediate Platelet Actin Assembly
      and Filopodial Extension Induced by Phorbol 12-Myristate 13-Acetate*},\n volume
      = {271},\n year = {1996}\n}\n"}, "authors": [{"authorId": "2999768", "name":
      "J. Hartwig"}, {"authorId": "2120653511", "name": "Sophia Kung"}, {"authorId":
      "46327570", "name": "T. Kovacsovics"}, {"authorId": "2194622", "name": "P. Janmey"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5661139", "name":
      "T. Stossel"}, {"authorId": "145751285", "name": "A. Toker"}]}, {"paperId":
      "d82b268bfd494a0a391f72e8886250ad95dbb611", "externalIds": {"MAG": "2054792404",
      "DOI": "10.1073/PNAS.93.25.14373", "CorpusId": 35192014, "PubMed": "8962058"},
      "corpusId": 35192014, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/d82b268bfd494a0a391f72e8886250ad95dbb611",
      "title": "Crystal structure of the breakpoint cluster region-homology domain
      from phosphoinositide 3-kinase p85 alpha subunit.", "abstract": "Proteins such
      as the product of the break-point cluster region, chimaerin, and the Src homology
      3-binding protein 3BP1, are GTPase activating proteins (GAPs) for members of
      the Rho subfamily of small GTP-binding proteins (G proteins or GTPases). A 200-residue
      region, named the breakpoint cluster region-homology (BH) domain, is responsible
      for the GAP activity. We describe here the crystal structure of the BH domain
      from the p85 subunit of phosphatidylinositol 3-kinase at 2.0 A resolution. The
      domain is composed of seven helices, having a previously unobserved arrangement.
      A core of four helices contains most residues that are conserved in the BH family.
      Their packing suggests the location of a G-protein binding site. This structure
      of a GAP-like domain for small GTP-binding proteins provides a framework for
      analyzing the function of this class of molecules.", "venue": "Proceedings of
      the National Academy of Sciences of the United States of America", "year": 1996,
      "referenceCount": 35, "citationCount": 113, "influentialCitationCount": 6, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc26139?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1996-12-10", "journal": {"volume": "93 25", "pages": "\n          14373-8\n        ",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America"}, "citationStyles": {"bibtex": "@Article{Musacchio1996CrystalSO,\n
      author = {A. Musacchio and L. Cantley and S. Harrison},\n booktitle = {Proceedings
      of the National Academy of Sciences of the United States of America},\n journal
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      pages = {\n          14373-8\n        },\n title = {Crystal structure of the
      breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85
      alpha subunit.},\n volume = {93 25},\n year = {1996}\n}\n"}, "authors": [{"authorId":
      "4370379", "name": "A. Musacchio"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2150243975", "name": "S. Harrison"}]}, {"paperId": "e43083320ee529615d58520229c32870a19cac7c",
      "externalIds": {"MAG": "2100426048", "DOI": "10.1073/PNAS.93.7.2729", "CorpusId":
      39845223, "PubMed": "8610109"}, "corpusId": 39845223, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/e43083320ee529615d58520229c32870a19cac7c",
      "title": "A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding
      domains is related to Shc and is specifically expressed in the brain.", "abstract":
      "The Shc adaptor protein, hereafter referred to as ShcA, possesses two distinct
      phosphotyrosine-recognition modules, a C-terminal Src homology 2 (SH2) domain
      and an N-terminal phosphotyrosine-binding (PTB) domain, and is itself phosphorylated
      on tyrosine in response to many extracellular signals. Phosphorylation of human
      ShcA at Tyr-317 within its central (CH1) region induces binding to the Grb2
      SH2 domain and is thereby implicated in activation of the Ras pathway. Two shc-related
      genes (shcB and shcC) have been identified in the mouse. shcB is closely related
      to human SCK, while shcC has not yet been found in other organisms. The ShcC
      protein is predicted to have a C-terminal SH2 domain, a CH1 region with a putative
      Grb2-binding site, and an N-terminal PTB domain. The ShcC and ShcB SH2 domains
      bind phosphotyrosine-containing peptides and receptors with a specificity related
      to, but distinct from, that of the ShcA SH2 domain. The ShcC PTB domain specifically
      associates in vitro with the autophosphorylated receptors for nerve growth factor
      and epidermal growth factor. These results indicate that ShcC has functional
      SH2 and PTB; domains. In contrast to shcA, which is widely expressed, shcC RNA
      and proteins are predominantly expressed in the adult brain. These results suggest
      that ShcC may mediate signaling from tyrosine kinases in the nervous system,
      such as receptors for neurotrophins.", "venue": "Proceedings of the National
      Academy of Sciences of the United States of America", "year": 1996, "referenceCount":
      32, "citationCount": 104, "influentialCitationCount": 3, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc39699?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle", "Study"], "publicationDate": "1996-04-02", "journal": {"volume":
      "93 7", "pages": "\n          2729-34\n        ", "name": "Proceedings of the
      National Academy of Sciences of the United States of America"}, "citationStyles":
      {"bibtex": "@Article{O\u2019Bryan1996AMA,\n author = {J. O\u2019Bryan and Songyang
      Zhou and L. Cantley and C. Der and T. Pawson},\n booktitle = {Proceedings of
      the National Academy of Sciences of the United States of America},\n journal
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      pages = {\n          2729-34\n        },\n title = {A mammalian adaptor protein
      with conserved Src homology 2 and phosphotyrosine-binding domains is related
      to Shc and is specifically expressed in the brain.},\n volume = {93 7},\n year
      = {1996}\n}\n"}, "authors": [{"authorId": "1403224640", "name": "J. O\u2019Bryan"},
      {"authorId": "2111144577", "name": "Songyang Zhou"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4764611", "name": "C. Der"}, {"authorId":
      "50999462", "name": "T. Pawson"}]}, {"paperId": "fc8d01ca34e728d8143b26fbd29682277db3d14d",
      "externalIds": {"MAG": "2072499270", "DOI": "10.1074/jbc.271.40.24880", "CorpusId":
      24714762, "PubMed": "8798764"}, "corpusId": 24714762, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/fc8d01ca34e728d8143b26fbd29682277db3d14d",
      "title": "Regulation of the Lck SH2 Domain by Tyrosine Phosphorylation*", "abstract":
      "Src homology 2 (SH2) domains bind to phosphotyrosine (Tyr(P)) residues in specific
      sequence contexts in other proteins and thereby mediate tyrosine phosphorylationdependent
      protein-protein interactions. The SH2 domain of the Src family kinase Lck is
      phosphorylated at tyrosine 192 in T cells upon T cell antigen receptor triggering.
      We have studied the consequences of this phosphorylation on the properties of
      the SH2 domain and on the function of Lck in T cell activation. We report that
      phosphorylation at Tyr192 reduced the capacity of the isolated SH2 domain to
      bind a high affinity peptide ligand and Tyr(P)-containing cellular proteins.
      This effect was mimicked by mutation of Tyr192 to an acidic residue. In intact
      T cells, where Lck participates in T cell antigen receptor signal transduction
      in an SH2 domain-dependent manner, phosphorylation of Tyr192 correlated with
      reduced downstream signaling. Our results indicate that tyrosine phosphorylation
      of the SH2 domain of Lck terminates its high affinity binding to ligands, thereby
      negatively regulating its participation in T cell antigen receptor signaling.
      This represents a novel mechanism for the regulation of the function of SH2
      domains.", "venue": "Journal of Biological Chemistry", "year": 1996, "referenceCount":
      33, "citationCount": 80, "influentialCitationCount": 4, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818400889/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1996-10-04", "journal": {"volume": "271",
      "pages": "24880 - 24884", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Couture1996RegulationOT,\n author = {C. Couture and Songyang
      Zhou and T. Jascur and Scott M. Williams and P. Tailor and L. Cantley and T.
      Mustelin},\n booktitle = {Journal of Biological Chemistry},\n journal = {The
      Journal of Biological Chemistry},\n pages = {24880 - 24884},\n title = {Regulation
      of the Lck SH2 Domain by Tyrosine Phosphorylation*},\n volume = {271},\n year
      = {1996}\n}\n"}, "authors": [{"authorId": "47751552", "name": "C. Couture"},
      {"authorId": "2111144577", "name": "Songyang Zhou"}, {"authorId": "5844467",
      "name": "T. Jascur"}, {"authorId": "10028783", "name": "Scott M. Williams"},
      {"authorId": "38501602", "name": "P. Tailor"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "5389022", "name": "T. Mustelin"}]}, {"paperId":
      "07bd79d241abd67df644cdb500f07b4c88ecfbb0", "externalIds": {"MAG": "1982304503",
      "DOI": "10.1016/0092-8674(95)90525-1", "CorpusId": 15869636, "PubMed": "7774006"},
      "corpusId": 15869636, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/07bd79d241abd67df644cdb500f07b4c88ecfbb0",
      "title": "Signal transduction and membrane traffic: The PITP/phosphoinositide
      connection", "abstract": null, "venue": "Cell", "year": 1995, "referenceCount":
      30, "citationCount": 261, "influentialCitationCount": 6, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "1995-06-02", "journal": {"volume": "81", "pages": "659-662",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Liscovitch1995SignalTA,\n
      author = {M. Liscovitch and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n
      pages = {659-662},\n title = {Signal transduction and membrane traffic: The
      PITP/phosphoinositide connection},\n volume = {81},\n year = {1995}\n}\n"},
      "authors": [{"authorId": "6319769", "name": "M. Liscovitch"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "145d73a65f6f7c6cd162c8fd8cd2972c85f9841f",
      "externalIds": {"MAG": "1966748170", "DOI": "10.1016/0167-4838(95)00016-N",
      "CorpusId": 8987446, "PubMed": "7748894"}, "corpusId": 8987446, "publicationVenue":
      {"id": "08ee3346-e195-4333-b008-be3a4f9e23cd", "name": "Biochimica et Biophysica
      Acta", "type": "journal", "alternate_names": ["Biochim Biophys Acta"], "issn":
      "0006-3002", "alternate_issns": ["1878-2434"], "url": "https://www.elsevier.com/life-sciences/biochemistry-genetics-and-molecular-biology/journals/bba",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00063002",
      "http://www.elsevier.com/wps/find/journaldescription.cws_home/506062/description#description"]},
      "url": "https://www.semanticscholar.org/paper/145d73a65f6f7c6cd162c8fd8cd2972c85f9841f",
      "title": "Type 2 phosphatidylinositol 4-kinase is recruited to CD4 in response
      to CD4 cross-linking.", "abstract": null, "venue": "Biochimica et Biophysica
      Acta", "year": 1995, "referenceCount": 52, "citationCount": 14, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1995-04-27", "journal": {"volume": "1248
      2", "pages": "\n          129-34\n        ", "name": "Biochimica et biophysica
      acta"}, "citationStyles": {"bibtex": "@Article{Pertile1995Type2P,\n author =
      {P. Pertile and L. Cantley},\n booktitle = {Biochimica et Biophysica Acta},\n
      journal = {Biochimica et biophysica acta},\n pages = {\n          129-34\n        },\n
      title = {Type 2 phosphatidylinositol 4-kinase is recruited to CD4 in response
      to CD4 cross-linking.},\n volume = {1248 2},\n year = {1995}\n}\n"}, "authors":
      [{"authorId": "1960212", "name": "P. Pertile"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "1987fb488beb02b4b52639c7013f4768e27d45b4", "externalIds":
      {"MAG": "2053139373", "DOI": "10.1021/JM00021A017", "CorpusId": 40161417, "PubMed":
      "7473555"}, "corpusId": 40161417, "publicationVenue": {"id": "4cce60a8-2106-4240-bece-fb6488df6bd1",
      "name": "Journal of Medicinal Chemistry", "type": "journal", "alternate_names":
      ["J Med Chem"], "issn": "0022-2623", "url": "https://pubs.acs.org/journal/jmcmar",
      "alternate_urls": ["http://pubs.acs.org/journal/jmcmar", "http://pubs.acs.org/journals/jmcmar/index.html"]},
      "url": "https://www.semanticscholar.org/paper/1987fb488beb02b4b52639c7013f4768e27d45b4",
      "title": "Identification of efficient pentapeptide substrates for the tyrosine
      kinase pp60c-src.", "abstract": "The development of inhibitors of protein tyrosine
      kinases (PTKs) is a promising approach to obtaining new therapeutic agents for
      a variety of diseases, particularly cancer. However, the discovery of peptide-based
      inhibitors has been hindered by the lack of small peptide substrate sequences
      (i.e. five residues or less) with which a variety of inhibitor designs could
      be readily evaluated by replacing the Tyr with natural and unnatural amino acids.
      These prototypical small peptide inhibitors could then form the basis for designing
      analogous conformationally constrained, peptide-mimetic or non-peptide inhibitors
      with improved therapeutic potential. In this study we have identified the best
      known small peptide substrate for the PTK pp60c-src, which is the parent of
      the src family of nonreceptor PTKs. This pentapeptide substrate, Ac-Ile-Tyr-Gly-Glu-Phe-NH2,
      has a Km of 368 microM and Vmax of 1.02 mumol/min/mg when tested utilizing the
      assay methodology of Budde et al. (Anal. Biochem. 1992, 200, 347-351) after
      a series of modifications were made to more closely simulate the conditions
      inside a typical mammalian cell. This substrate was designed from information
      obtained by Songyang et al. (Nature 1995, 373, 536-539) with a 2.5 billion member
      combinatorial library of peptide substrates for pp60c-src. A second pentapeptide
      substrate, Ac-Glu-Asp-Ala-Ile-Tyr-NH2, with a weaker binding affinity (Km =
      880 microM) but improved Vmax (1.86 mumol/min/mg), was also identified. This
      peptide was designed from the pp60c-src autophosphorylation sequence and information
      obtained by Songyang et al. (Ibid.) and Till et al. (J. Biol. Chem. 1994, 269,
      7423-7428) with combinatorial libraries of peptide substrates. These new substrates
      provide sufficient binding affinities and rates of phosphorylation to be utilized
      for evaluating the relative effectiveness of various reversible and mechanism-based
      irreversible inhibitor designs for pp60c-src while appended to easily prepared
      small peptides.", "venue": "Journal of Medicinal Chemistry", "year": 1995, "referenceCount":
      0, "citationCount": 22, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1995-10-13", "journal": {"volume": "38 21", "pages":
      "\n          4276-83\n        ", "name": "Journal of medicinal chemistry"},
      "citationStyles": {"bibtex": "@Article{Nair1995IdentificationOE,\n author =
      {S. Nair and M. Kim and S. D. Warren and S. Choi and Z. Songyang and L. Cantley
      and D. Hangauer},\n booktitle = {Journal of Medicinal Chemistry},\n journal
      = {Journal of medicinal chemistry},\n pages = {\n          4276-83\n        },\n
      title = {Identification of efficient pentapeptide substrates for the tyrosine
      kinase pp60c-src.},\n volume = {38 21},\n year = {1995}\n}\n"}, "authors": [{"authorId":
      "152126173", "name": "S. Nair"}, {"authorId": "2107617132", "name": "M. Kim"},
      {"authorId": "40408634", "name": "S. D. Warren"}, {"authorId": "32145924", "name":
      "S. Choi"}, {"authorId": "6731027", "name": "Z. Songyang"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4549140", "name": "D. Hangauer"}]}, {"paperId":
      "28b551e0356f678a41dc3d00b14910e262c43424", "externalIds": {"MAG": "2100869656",
      "DOI": "10.1016/0092-8674(95)90351-8", "CorpusId": 16866005, "PubMed": "7889566"},
      "corpusId": 16866005, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/28b551e0356f678a41dc3d00b14910e262c43424",
      "title": "Specific recruitment of SH-PTP1 to the erythropoietin receptor causes
      inactivation of JAK2 and termination of proliferative signals", "abstract":
      null, "venue": "Cell", "year": 1995, "referenceCount": 48, "citationCount":
      974, "influentialCitationCount": 30, "isOpenAccess": true, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Medicine", "source": "s2-fos-model"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1995-03-10", "journal": {"volume": "80", "pages": "729-738", "name": "Cell"},
      "citationStyles": {"bibtex": "@Article{Klingm\u00fcller1995SpecificRO,\n author
      = {U. Klingm\u00fcller and U. Lorenz and L. Cantley and B. Neel and H. Lodish},\n
      booktitle = {Cell},\n journal = {Cell},\n pages = {729-738},\n title = {Specific
      recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of
      JAK2 and termination of proliferative signals},\n volume = {80},\n year = {1995}\n}\n"},
      "authors": [{"authorId": "1906951", "name": "U. Klingm\u00fcller"}, {"authorId":
      "40622792", "name": "U. Lorenz"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2291271", "name": "B. Neel"}, {"authorId": "7757698", "name":
      "H. Lodish"}]}, {"paperId": "2a77db9d8590c0a83b3f0bcd1c05fbcc4aa26936", "externalIds":
      {"MAG": "2115666887", "CorpusId": 21760382, "PubMed": "7620084"}, "corpusId":
      21760382, "publicationVenue": {"id": "f034b560-0c02-434d-93bc-8cd645d76640",
      "name": "Journal of the American Society of Nephrology", "type": "journal",
      "alternate_names": ["J Am Soc Nephrol", "Journal of The American Society of
      Nephrology"], "issn": "1046-6673", "url": "https://jasn.asnjournals.org/", "alternate_urls":
      ["http://www.jasn.org/"]}, "url": "https://www.semanticscholar.org/paper/2a77db9d8590c0a83b3f0bcd1c05fbcc4aa26936",
      "title": "Signal transduction by the hepatocyte growth factor receptor, c-met.
      Activation of the phosphatidylinositol 3-kinase.", "abstract": "Signal transduction
      by tyrosine kinase growth factor receptors involves the activation of multiple
      intracellular signaling pathways. In many cases, this occurs via direct binding
      of a downstream signaling protein to the phosphorylated receptor via src-homology
      2 domains on the signaling protein. In this review of the hepatocyte growth
      factor receptor c-met, the ability of the amino acid sequence of the receptor
      to dictate which signaling proteins are activated is described, with particular
      emphasis on association with the phosphatidylinositol 3-kinase. Recent developments
      that provide new understanding of the mechanisms of downstream signal transduction
      by the phosphatidylinositol 3-kinase are discussed, including how these might
      be involved in the mitogenic, motogenic, and tubulogenic effects of hepatocyte
      growth factor on renal epithelial cells.", "venue": "Journal of the American
      Society of Nephrology", "year": 1995, "referenceCount": 93, "citationCount":
      39, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "Editorial"],
      "publicationDate": "1995-05-01", "journal": {"volume": "5 11", "pages": "\n          1872-81\n        ",
      "name": "Journal of the American Society of Nephrology : JASN"}, "citationStyles":
      {"bibtex": "@Article{Cantley1995SignalTB,\n author = {L. Cantley and L. Cantley},\n
      booktitle = {Journal of the American Society of Nephrology},\n journal = {Journal
      of the American Society of Nephrology : JASN},\n pages = {\n          1872-81\n        },\n
      title = {Signal transduction by the hepatocyte growth factor receptor, c-met.
      Activation of the phosphatidylinositol 3-kinase.},\n volume = {5 11},\n year
      = {1995}\n}\n"}, "authors": [{"authorId": "5601835", "name": "L. Cantley"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "2ca38cf48247d33e3f4367bbf687fc8cfd2d6efd",
      "externalIds": {"MAG": "2026907934", "DOI": "10.1038/373536A0", "CorpusId":
      1105841, "PubMed": "7845468"}, "corpusId": 1105841, "publicationVenue": {"id":
      "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/2ca38cf48247d33e3f4367bbf687fc8cfd2d6efd",
      "title": "Catalytic specificity of protein-tyrosine kinases is critical for
      selective signalling", "abstract": null, "venue": "Nature", "year": 1995, "referenceCount":
      23, "citationCount": 912, "influentialCitationCount": 34, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1995-02-09", "journal": {"volume": "373", "pages": "536-539",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Zhou1995CatalyticSO,\n
      author = {Songyang Zhou and K. Carraway and M. Eck and S. Harrison and R. Feldman
      and M. Mohammadi and J. Schlessinger and S. Hubbard and Darrin P. Smith and
      C. Eng and M. J. Lorenzo and B. Ponder and B. Mayer and L. Cantley},\n booktitle
      = {Nature},\n journal = {Nature},\n pages = {536-539},\n title = {Catalytic
      specificity of protein-tyrosine kinases is critical for selective signalling},\n
      volume = {373},\n year = {1995}\n}\n"}, "authors": [{"authorId": "2111144577",
      "name": "Songyang Zhou"}, {"authorId": "145331905", "name": "K. Carraway"},
      {"authorId": "2026802", "name": "M. Eck"}, {"authorId": "2150243975", "name":
      "S. Harrison"}, {"authorId": "48725230", "name": "R. Feldman"}, {"authorId":
      "143902042", "name": "M. Mohammadi"}, {"authorId": "4607078", "name": "J. Schlessinger"},
      {"authorId": "34863469", "name": "S. Hubbard"}, {"authorId": "1949522380", "name":
      "Darrin P. Smith"}, {"authorId": "144966010", "name": "C. Eng"}, {"authorId":
      "50398854", "name": "M. J. Lorenzo"}, {"authorId": "153509268", "name": "B.
      Ponder"}, {"authorId": "32634768", "name": "B. Mayer"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "2d251c6d67c3ec75f99023c8bd202bc202483202",
      "externalIds": {"MAG": "62744173", "CorpusId": 33790614, "PubMed": "7537362"},
      "corpusId": 33790614, "publicationVenue": {"id": "55bed249-d30f-456b-9d2c-a51dc149cb7a",
      "name": "Oncogene", "type": "journal", "issn": "0950-9232", "url": "http://www.nature.com/onc/",
      "alternate_urls": ["http://www.nature.com/onc", "http://www.naturesj.com/onc/index.html"]},
      "url": "https://www.semanticscholar.org/paper/2d251c6d67c3ec75f99023c8bd202bc202483202",
      "title": "Molecular interactions of the Src homology 2 domain protein Shb with
      phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain
      proteins.", "abstract": "The molecular interactions of the Src homology 2 (SH2)
      domain and the N-terminal proline-rich sequence motifs (pro-1 to pro-5) of the
      SH2 protein Shb with other components were presently characterised. Using a
      degenerate phosphopeptide library the preferred binding site for the Shb SH2
      domain was determined to pTyr-Thr/Val/Ile-X-Leu at positions +1 to +3 relative
      the phosphotyrosine residue. Experiments with competing peptides and platelet-derived
      growth factor (PDGF) beta-receptor mutants with Y to F substitutions in autophosphorylation
      sites revealed multiple binding sites for the Shb SH2 domain in the receptor.
      The Shb SH2 domain also binds to in vitro phosphorylated fibroblast growth factor
      receptor-1 (FGFR-1) mainly through position Y776. The receptor experiments suggest
      that other residues besides the +1 to +3 positions may also be of significance
      for Shb binding. The pro-4/pro-5 motif of Shb binds in vitro particularly well
      to the Src, p85 alpha PI3-kinase and Eps8 SH3 domains expressed as GST fusion
      proteins. However, the GST-SH3 domain fusion proteins tested bind in vitro to
      peptides corresponding to the pro-1 to pro-5 motifs of Shb with low affinity
      and selectivity, suggesting that sequences outside the core proline motif may
      also be important for Shb-SH3 domain interactions. In vivo association between
      Shb-SH3 domain proteins v-Src and Eps8 was detected by coimmunoprecipitation.
      PDGF treatment did not affect the association between Eps8 and Shb. The data
      suggest that Shb is an adaptor protein linking SH3 domain proteins to tyrosine
      kinases or other tyrosine phosphorylated proteins.", "venue": "Oncogene", "year":
      1995, "referenceCount": 0, "citationCount": 71, "influentialCitationCount":
      7, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1995-04-20", "journal": {"volume": "10
      8", "pages": "\n          1475-83\n        ", "name": "Oncogene"}, "citationStyles":
      {"bibtex": "@Article{Karlsson1995MolecularIO,\n author = {T. Karlsson and Z.
      Songyang and E. Landgren and C. Lavergne and P. P. Di Fiore and M. Anafi and
      T. Pawson and L. Cantley and L. Claesson-Welsh and M. Welsh},\n booktitle =
      {Oncogene},\n journal = {Oncogene},\n pages = {\n          1475-83\n        },\n
      title = {Molecular interactions of the Src homology 2 domain protein Shb with
      phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain
      proteins.},\n volume = {10 8},\n year = {1995}\n}\n"}, "authors": [{"authorId":
      "145168992", "name": "T. Karlsson"}, {"authorId": "6731027", "name": "Z. Songyang"},
      {"authorId": "5057913", "name": "E. Landgren"}, {"authorId": "117249643", "name":
      "C. Lavergne"}, {"authorId": "6724547", "name": "P. P. Di Fiore"}, {"authorId":
      "4175143", "name": "M. Anafi"}, {"authorId": "50999462", "name": "T. Pawson"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "1398055038", "name":
      "L. Claesson-Welsh"}, {"authorId": "145515062", "name": "M. Welsh"}]}, {"paperId":
      "305930c1039f12f1fae2ba1381b2e16abc9ea576", "externalIds": {"MAG": "2001138501",
      "DOI": "10.1074/JBC.270.49.29525", "CorpusId": 44991100, "PubMed": "7493994"},
      "corpusId": 44991100, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/305930c1039f12f1fae2ba1381b2e16abc9ea576",
      "title": "Phosphorylation of the Platelet p47 Phosphoprotein Is Mediated by
      the Lipid Products of Phosphoinositide 3-Kinase (*)", "abstract": "Platelet
      stimulation by thrombin or the thrombin receptor activating peptide (TRAP) results
      in the activation of phosphoinositide 3-kinase and the production of the novel
      polyphosphoinositides phosphatidylinositol 3,4-bisphosphate (PtdIns-3,4-P2)
      and phosphatidylinositol 3,4,5-trisphosphate (PtdIns-3,4,5-P3). We have shown
      previously that these lipids activate calcium-independent protein kinase C (PKC)
      isoforms in vitro (Toker, A., Meyer, M., Reddy, K. K., Falck, J. R., Aneja,
      R., Aneja, S., Parra, A., Burns, D. J., Ballas, L. M. and Cantley, L. C.(1994)
      J. Biol. Chem. 269, 32358-32367). Activation of platelet PKC in response to
      TRAP is detected by the phosphorylation of the major PKC substrate in platelets,
      the p47 phosphoprotein, also known as pleckstrin. Here we provide evidence for
      two phases of pleckstrin phosphorylation in response to TRAP. A rapid phase
      of pleckstrin phosphorylation (<1 min) precedes the peak of PtdIns-3,4-P2 production
      and is unaffected by concentrations of wortmannin (10-100 nM) that block production
      of this lipid. However prolonged phosphorylation of pleckstrin (>2 min) is inhibited
      by wortmannin concentrations that block PtdIns-3,4-P2 production. Phorbol ester-mediated
      pleckstrin phosphorylation was not affected by wortmannin and wortmannin had
      no effect on purified platelet PKC activity. Phosphorylation of pleckstrin could
      be induced using permeabilized platelets supplied with exogenous -P[ATP] and
      synthetic dipalmitoyl PtdIns-3,4,5-P3 and dipalmitoyl PtdIns-3,4-P2 micelles,
      but not with dipalmitoyl phosphatidylinositol 3-phosphate or phosphatidylinositol
      4,5-bisphosphate. These results suggest two modes of stimulating pleckstrin
      phosphorylation: a rapid activation of PKC (via diacylglycerol and calcium)
      followed by a slower activation of calcium-independent PKCs via PtdIns-3,4-P2.",
      "venue": "Journal of Biological Chemistry", "year": 1995, "referenceCount":
      47, "citationCount": 72, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818877778/pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1995-12-08", "journal": {"volume": "270", "pages": "29525
      - 29531", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Toker1995PhosphorylationOT,\n author = {A. Toker and Christilla
      Bachelot and Ching-shih Chen and J. Falck and J. Hartwig and L. Cantley and
      T. Kovacsovics},\n booktitle = {Journal of Biological Chemistry},\n journal
      = {The Journal of Biological Chemistry},\n pages = {29525 - 29531},\n title
      = {Phosphorylation of the Platelet p47 Phosphoprotein Is Mediated by the Lipid
      Products of Phosphoinositide 3-Kinase (*)},\n volume = {270},\n year = {1995}\n}\n"},
      "authors": [{"authorId": "145751285", "name": "A. Toker"}, {"authorId": "2122133958",
      "name": "Christilla Bachelot"}, {"authorId": "2145623779", "name": "Ching-shih
      Chen"}, {"authorId": "49877841", "name": "J. Falck"}, {"authorId": "2999768",
      "name": "J. Hartwig"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "46327570", "name": "T. Kovacsovics"}]}, {"paperId": "3d8292916e5f3c40c09231441c1187995e6fad23",
      "externalIds": {"MAG": "1965703662", "DOI": "10.1074/jbc.270.43.25985", "CorpusId":
      83961524}, "corpusId": 83961524, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/3d8292916e5f3c40c09231441c1187995e6fad23",
      "title": "Phosphoinositide 3-Kinase Binds Constitutively to \u03b1/\u03b2-Tubulin
      and Binds to \u03b3-Tubulin in Response to Insulin (*)", "abstract": "Recently
      we reported the localization of phosphoinositide 3-kinase (PI 3-kinase) by immunofluorescence
      to microtubule bundles and the centrosome (Kapeller, R., Chakrabarti, R., Cantley,
      L., Fay, F., and Corvera, S.(1993) Mol. Cell. Biol. 13, 6052-6063). [Abstract]
      In complementary experiments we used the recombinant p85 subunit of PI 3-kinase
      to identify proteins that associate with phosphoinositide 3-kinase and found
      that phosphoinositide 3-kinase associates with \u03b1/\u03b2-tubulin. The association
      occurs in vivo but was not significantly affected by growth factor stimulation.
      We localized the region of p85 that interacts with \u03b1/\u03b2-tubulin to
      the inter-SH2 domain. These results support the immunofluorescence data and
      show that p85 directly associates with \u03b1/\u03b2-tubulin. We then determined
      whether phosphoinositide 3-kinase associates with \u03b1/\u03b2-tubulin. We
      found a dramatic growth factor-dependent association of phosphoinositide 3-kinase
      with \u03b1/\u03b2-tubulin. Phosphoinositide 3-kinase associates with \u03b1/\u03b2-tubulin
      in response to insulin and, to a lesser extent, in response to platelet-derived
      growth factor. Neither epidermal growth factor nor nerve growth factor treatment
      of cells results in association of phosphoinositide 3-kinase and \u03b1/\u03b2-tubulin.
      Phosphoinositide 3-kinase is also immunoprecipitated with antibodies to pericentrin
      in response to insulin, indicating that phosphoinositide 3-kinase is recruited
      to the centrosome. Neither phosphoinositide 3-kinase activity, nor intact microtubules
      are necessary for the association. Treatment of cells with 0.5 M NaCl dissociates
      \u03b1/\u03b2-tubulin from the centrosome and disrupts the association of phosphoinositide
      3-kinase with pericentrin, but not \u03b1/\u03b2-tubulin. Recombinant p85 binds
      to \u03b1/\u03b2-tubulin from both insulin stimulated and quiescent cells. These
      results suggest that the association of phosphoinositide 3-kinase with \u03b1/\u03b2-tubulin
      is direct. These data suggest that phosphoinositide 3-kinase may be involved
      in regulating microtubule responses to insulin and platelet-derived growth factor.",
      "venue": "Journal of Biological Chemistry", "year": 1995, "referenceCount":
      1, "citationCount": 103, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818924233/pdf",
      "status": null}, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": "1995-10-27", "journal": {"volume":
      "270", "pages": "25985 - 25991", "name": "The Journal of Biological Chemistry"},
      "citationStyles": {"bibtex": "@Article{Kapeller1995Phosphoinositide3B,\n author
      = {R. Kapeller and A. Toker and L. Cantley and C. Carpenter},\n booktitle =
      {Journal of Biological Chemistry},\n journal = {The Journal of Biological Chemistry},\n
      pages = {25985 - 25991},\n title = {Phosphoinositide 3-Kinase Binds Constitutively
      to \u03b1/\u03b2-Tubulin and Binds to \u03b3-Tubulin in Response to Insulin
      (*)},\n volume = {270},\n year = {1995}\n}\n"}, "authors": [{"authorId": "2028875",
      "name": "R. Kapeller"}, {"authorId": "145751285", "name": "A. Toker"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "2972505", "name": "C. Carpenter"}]},
      {"paperId": "6cbc7246784eb582f5f978a2978cf9aa4151e42e", "externalIds": {"MAG":
      "2117811396", "DOI": "10.1074/JBC.270.19.11358", "CorpusId": 37391498, "PubMed":
      "7744773"}, "corpusId": 37391498, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/6cbc7246784eb582f5f978a2978cf9aa4151e42e",
      "title": "Phosphoinositide 3-kinase inhibition spares actin assembly in activating
      platelets but reverses platelet aggregation", "abstract": "Platelet stimulation
      by thrombin leads to the activation of phosphoinositide 3-kinase (PI 3K) and
      to the production of the D3 phosphoinositides, phosphatidylinositol 3,4-bisphosphate
      (PdtIns-3,4P2) and 3,4,5-trisphosphate (PdtIns-3,4,5-P3). Because changes in
      the levels of these phosphoinositides correlate with the kinetics of actin assembly,
      they have been proposed to mediate actin assembly, causing cell shape changes.
      Wortmannin and LY294002, two unrelated inhibitors of PI 3-K, were used to investigate
      the role of PI 3-K in platelet actin assembly and aggregation. Both PI 3-K inhibitors
      abrogated the production of PdtIns-3,4-P2 and PdtIns-3,4,5-P3 in thrombin receptor-
      activating peptide (TRAP)-stimulated cells. However, neither wortmannin nor
      LY294002 altered the kinetics of actin assembly or the exposure of nucleation
      sites in TRAP-stimulated cells. In contrast, PI 3-K inhibitors showed a specific
      inhibitory pattern of cell aggregation, characterized by a primary phase of
      aggregation followed by progressive disaggregation. Flow cytometry analysis
      with the PAC1 monoclonal antibody or with FITC-labeled fibrinogen indicated
      that wortmannin inhibited the maintenance of the platelet integrin GPIIb-IIIa
      in its active state. Wortmannin also inhibited, in a dose-dependent manner,
      platelet aggregation induced by the binding of the monoclonal antibodies P256
      and LIBS-6 to GPIIb-IIIa. LIBS Fab-induced aggregation also led to the production
      of PdtIns-3,4-P2. Platelet secretion, as evidenced by the release of preloaded
      14C-5-hydroxy-tryptamine secretion or P-selectin up-regulation, was not affected
      by PI 3-K inhibition. These results demonstrate that the generation of D3 phosphoinositides
      is not required for actin assembly in TRAP-activated platelets. However, PI
      3-K stimulation is necessary for prolonged GPIIb- IIIa activation and irreversible
      platelet aggregation. PI 3-K stimulation downstream of GPIIb-IIIa engagement
      may provide positive feedback required to sustain active GPIIb-IIIa.", "venue":
      "Journal of Biological Chemistry", "year": 1995, "referenceCount": 0, "citationCount":
      222, "influentialCitationCount": 5, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://www.jbc.org/article/S0021925817502082/pdf", "status": null}, "fieldsOfStudy":
      ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1995-05-01", "journal":
      {"volume": "270", "pages": "11358 - 11366", "name": "The Journal of Biological
      Chemistry"}, "citationStyles": {"bibtex": "@Article{Kovacsovics1995Phosphoinositide3I,\n
      author = {Tibor Kovacsovics and C. Bachelot and A. Toker and Cj Vlahos and B.
      Duckworth and L. Cantley and J. Hartwig},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {11358
      - 11366},\n title = {Phosphoinositide 3-kinase inhibition spares actin assembly
      in activating platelets but reverses platelet aggregation},\n volume = {270},\n
      year = {1995}\n}\n"}, "authors": [{"authorId": "2229636728", "name": "Tibor
      Kovacsovics"}, {"authorId": "13478754", "name": "C. Bachelot"}, {"authorId":
      "145751285", "name": "A. Toker"}, {"authorId": "2121710626", "name": "Cj Vlahos"},
      {"authorId": "21162853", "name": "B. Duckworth"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "2999768", "name": "J. Hartwig"}]}, {"paperId":
      "7ac3a5a9c57138ead45fd881561a80327fef99cd", "externalIds": {"MAG": "1983672881",
      "DOI": "10.1074/jbc.270.44.26029", "CorpusId": 31746462, "PubMed": "7592796"},
      "corpusId": 31746462, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/7ac3a5a9c57138ead45fd881561a80327fef99cd",
      "title": "A Single Point Mutation Switches the Specificity of Group III Src
      Homology (SH) 2 Domains to That of Group I SH2 Domains (*)", "abstract": "Src
      homology 2 (SH2) domains recognize phosphotyrosine-containing sequences, and
      thereby mediate the association of specific signaling proteins in response to
      tyrosine phosphorylation (Pawson, T., and Schlessinger, J.(1993) Curr. Biol.
      3, 434-442). We have shown that specific binding of SH2 domains to tyrosine-phosphorylated
      sites is determined by sequences adjacent to the phosphotyrosine. Based on the
      phosphopeptide specificity and crystal structures, SH2 domains were classified
      into four different groups (Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish,
      G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider,
      R. J., Neel, B. G., R. B. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen,
      B., and Cantley, L. C.(1993) Cell 72, 767-778). The [Medline] \u03b2D5 residues
      of SH2 domains were predicted to be critical in distinguishing these groups
      (Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser,
      W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J., Neel, B. G.,
      R. B. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley,
      L. C.(1993) Cell 72, 767-778; Eck, M. J., Shoelson, S. E., and Harrison, S.
      C.(1993) Nature 362, 87-91). We report here that replacing the aliphatic residues
      at the \u03b2D5 positions of two Group III SH2 domains (phosphoinositide 3-kinase
      N-terminal SH2 domain and phospholipase C- C-terminal SH2 domain) with Tyr (as
      found in Group I SH2 domains) results in a switch in phosphopeptide selectivity,
      consistent with the specificities of Group I SH2 domains. These results establish
      the importance of the \u03b2D5 residue in determining specificities of SH2 domains.",
      "venue": "Journal of Biological Chemistry", "year": 1995, "referenceCount":
      14, "citationCount": 81, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818924348/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1995-11-03", "journal": {"volume": "270", "pages":
      "26029 - 26032", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Zhou1995ASP,\n author = {Songyang Zhou and G. Gish and
      G. Mbamalu and T. Pawson and L. Cantley},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of Biological Chemistry},\n pages = {26029
      - 26032},\n title = {A Single Point Mutation Switches the Specificity of Group
      III Src Homology (SH) 2 Domains to That of Group I SH2 Domains (*)},\n volume
      = {270},\n year = {1995}\n}\n"}, "authors": [{"authorId": "2242492756", "name":
      "Songyang Zhou"}, {"authorId": "37993016", "name": "G. Gish"}, {"authorId":
      "4867984", "name": "G. Mbamalu"}, {"authorId": "50999462", "name": "T. Pawson"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "9a9f41b1733ea8cebdf98d76e56fed61b8223d1b",
      "externalIds": {"MAG": "2060538012", "DOI": "10.1074/JBC.270.30.17656", "CorpusId":
      25210483, "PubMed": "7629060"}, "corpusId": 25210483, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/9a9f41b1733ea8cebdf98d76e56fed61b8223d1b",
      "title": "Rho Family GTPases Bind to Phosphoinositide Kinases (*)", "abstract":
      "Rho family GTPases appear to play an important role in the regulation of the
      actin cytoskeleton, but the mechanism of regulation is unknown. Since phosphoinositide
      3-kinase and phosphatidylinositol 4,5-bisphosphate have also been implicated
      in actin reorganization, we investigated the possibility that Rho family members
      interact with phosphoinositide kinases. We found that both GTP- and GDP-bound
      Rac1 associate with phosphatidylinositol-4-phosphate 5-kinase in vitro and in
      vivo. Phosphoinositide 3-kinase also bound to Rac1 and Cdc42Hs, and these interactions
      were GTP-dependent. Stimulation of Swiss 3T3 cells with platelet-derived growth
      factor induced the association of PI 3-kinase with Rac in immunoprecipitates.
      PI 3-kinase activity was also detected in Cdc42 immunoprecipitates from COS7
      cells. These results suggest that phosphoinositide kinases are involved in Rho
      family signal transduction pathways and raise the possibility that the effects
      of Rho family members on the actin cytoskeleton are mediated in part by phosphoinositide
      kinases.", "venue": "Journal of Biological Chemistry", "year": 1995, "referenceCount":
      25, "citationCount": 498, "influentialCitationCount": 22, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925817479919/pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1995-07-28", "journal": {"volume": "270",
      "pages": "17656 - 17659", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Tolias1995RhoFG,\n author = {K. Tolias and L. Cantley and
      C. Carpenter},\n booktitle = {Journal of Biological Chemistry},\n journal =
      {The Journal of Biological Chemistry},\n pages = {17656 - 17659},\n title =
      {Rho Family GTPases Bind to Phosphoinositide Kinases (*)},\n volume = {270},\n
      year = {1995}\n}\n"}, "authors": [{"authorId": "4661935", "name": "K. Tolias"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2972505", "name":
      "C. Carpenter"}]}, {"paperId": "aff5fb19faec26ae778184ee6cd42b9f44839183", "externalIds":
      {"MAG": "2075339282", "DOI": "10.1016/0092-8674(95)90195-7", "CorpusId": 2380964,
      "PubMed": "8521499"}, "corpusId": 2380964, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/aff5fb19faec26ae778184ee6cd42b9f44839183",
      "title": "Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates
      PI 3-kinase association with tyrosine-phosphorylated proteins", "abstract":
      null, "venue": "Cell", "year": 1995, "referenceCount": 58, "citationCount":
      309, "influentialCitationCount": 8, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1995-12-01", "journal":
      {"volume": "83", "pages": "821-830", "name": "Cell"}, "citationStyles": {"bibtex":
      "@Article{Rameh1995PhosphatidylinositolI,\n author = {L. Rameh and Ching-shih
      Chen and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n pages = {821-830},\n
      title = {Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates
      PI 3-kinase association with tyrosine-phosphorylated proteins},\n volume = {83},\n
      year = {1995}\n}\n"}, "authors": [{"authorId": "4109960", "name": "L. Rameh"},
      {"authorId": "2145623779", "name": "Ching-shih Chen"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "c9304f5eebf62399a137f0ea9ff2e1954cddb0ab",
      "externalIds": {"MAG": "2040716393", "DOI": "10.1016/1043-6618(95)86360-5",
      "CorpusId": 84416505}, "corpusId": 84416505, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/c9304f5eebf62399a137f0ea9ff2e1954cddb0ab",
      "title": "Lessons in signal transduction from a DNA tumor virus", "abstract":
      null, "venue": "", "year": 1995, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Inproceedings{Schaffhausen1995LessonsIS,\n author = {B. Schaffhausen
      and M. Yoakim and Karen P. Mullane and O. Gj\u00f8rup and L. Cantley and T.
      Roberts and K. S. Campbell and W. Su and D. Pallas},\n title = {Lessons in signal
      transduction from a DNA tumor virus},\n year = {1995}\n}\n"}, "authors": [{"authorId":
      "4362128", "name": "B. Schaffhausen"}, {"authorId": "8945145", "name": "M. Yoakim"},
      {"authorId": "39702934", "name": "Karen P. Mullane"}, {"authorId": "1438568861",
      "name": "O. Gj\u00f8rup"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "6665338", "name": "T. Roberts"}, {"authorId": "143744228", "name": "K. S. Campbell"},
      {"authorId": "144344948", "name": "W. Su"}, {"authorId": "5515098", "name":
      "D. Pallas"}]}, {"paperId": "d6c86ce9bcd9651dc16a0821b687ebdfce847f6e", "externalIds":
      {"MAG": "2917280912", "CorpusId": 86788444}, "corpusId": 86788444, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/d6c86ce9bcd9651dc16a0821b687ebdfce847f6e",
      "title": "The lipid products of phosphatidylinositol 3-kinase mediate chemotaxis
      via protein kinase C", "abstract": null, "venue": "", "year": 1995, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "1995-06-23",
      "journal": {"volume": "6", "pages": "789", "name": "Journal of The American
      Society of Nephrology"}, "citationStyles": {"bibtex": "@Article{Derman1995TheLP,\n
      author = {M. Derman and A. Toker and L. Cantley and L. Cantley},\n journal =
      {Journal of The American Society of Nephrology},\n pages = {789},\n title =
      {The lipid products of phosphatidylinositol 3-kinase mediate chemotaxis via
      protein kinase C},\n volume = {6},\n year = {1995}\n}\n"}, "authors": [{"authorId":
      "144476444", "name": "M. Derman"}, {"authorId": "145751285", "name": "A. Toker"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5601835", "name":
      "L. Cantley"}]}, {"paperId": "ef0a3f03e2588d7be3f08529a213f7d0dcf52001", "externalIds":
      {"MAG": "1981552687", "DOI": "10.1074/JBC.270.25.14863", "CorpusId": 42064743,
      "PubMed": "7541030"}, "corpusId": 42064743, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/ef0a3f03e2588d7be3f08529a213f7d0dcf52001",
      "title": "The Phosphotyrosine Interaction Domain of SHC Recognizes Tyrosine-phosphorylated
      NPXY Motif (*)", "abstract": "Reversible assembly of intracellular signaling
      complexes is, in some cases, mediated by direct binding of a Src homology 2
      (SH2) domain of one protein to a phosphotyrosine moiety of another protein (Cantley,
      L. C., Auger, K. R., Carpenter, C. L., Duckworth, B., Graziani, A., Kapeller,
      R., and Soltoff, S.(1991) Cell 64, 281-302). Using a degenerate phosphotyrosine-containing
      peptide library, we showed that individual SH2 domains recognize phosphotyrosine
      in a specific sequence context to provide fidelity in signaling (Songyang, Z.,
      Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F.,
      Roberts, T., Ratnofsky, S., Lechleider, R. J., Neel, B. G., Birge, R. B., Fajardo,
      J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley, L. C.(1993)
      Cell 72, 767-778). Recently a second type of phosphotyrosine interaction domain
      (PID) or phosphotyrosine-binding domain (PTB) was discovered in the amino terminus
      of the SHC proto-oncoprotein (Kavanaugh, W. M., and Williams, L.(1994) Science
      266, 1862-1865; Blaikie, P., Immanuel, D., Wu, J., Li, N., Yajnik, V., and Margolis,
      B.(1994) J. Biol. Chem. 269, 32031-32034). Here we demonstrate, using a phosphotyrosine
      peptide library, that the SHC PID domain preferentially binds to the sequence
      Asn-Pro-Xaa-phosphotyrosine. This motif is in agreement with sequences at sites
      implicated in in vivo SHC binding. These results indicate that while SH2 domains
      predominantly interact with specific residues carboxyl-terminal of phosphotyrosine,
      the PID domain has high specificity for residues amino-terminal of phosphotyrosine.",
      "venue": "Journal of Biological Chemistry", "year": 1995, "referenceCount":
      25, "citationCount": 168, "influentialCitationCount": 2, "isOpenAccess": true,
      "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818904758/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1995-06-23", "journal": {"volume": "270", "pages":
      "14863 - 14866", "name": "The Journal of Biological Chemistry"}, "citationStyles":
      {"bibtex": "@Article{Zhou1995ThePI,\n author = {Songyang Zhou and B. Margolis
      and M. Chaudhuri and S. Shoelson and L. Cantley},\n booktitle = {Journal of
      Biological Chemistry},\n journal = {The Journal of Biological Chemistry},\n
      pages = {14863 - 14866},\n title = {The Phosphotyrosine Interaction Domain of
      SHC Recognizes Tyrosine-phosphorylated NPXY Motif (*)},\n volume = {270},\n
      year = {1995}\n}\n"}, "authors": [{"authorId": "2242492756", "name": "Songyang
      Zhou"}, {"authorId": "2075552899", "name": "B. Margolis"}, {"authorId": "2073353181",
      "name": "M. Chaudhuri"}, {"authorId": "4790900", "name": "S. Shoelson"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "efabeb657bb3df1f9012940f7bae1aa4d9080cae",
      "externalIds": {"MAG": "1999405592", "DOI": "10.1074/JBC.270.10.5130", "CorpusId":
      6374320, "PubMed": "7890622"}, "corpusId": 6374320, "publicationVenue": {"id":
      "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological Chemistry",
      "type": "journal", "alternate_names": ["J Biological Chem"], "issn": "0021-9258",
      "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729", "alternate_urls":
      ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/efabeb657bb3df1f9012940f7bae1aa4d9080cae",
      "title": "Phosphatidylinositol 4,5-Bisphosphate Synthesis Is Required for Activation
      of Phospholipase D in U937 Cells (*)", "abstract": "Phospholipase D (PLD) has
      been implicated in signal transduction and membrane traffic. We have previously
      shown that phosphatidylinositol 4,5-bisphosphate (PtdIns-4,5-P2) stimulates
      in vitro partially purified brain membrane PLD activity, defining a novel function
      of PtdIns-4,5-P2 as a PLD cofactor. In the present study we extend these observations
      to permeabilized U937 cells. In these cells, the activation of PLD by guanosine
      5\u2032-3-O-(thio)triphosphate (GTP\u03b3S) is greatly potentiated by MgATP.
      We have utilized this experimental system to test the hypothesis that MgATP
      potentiates PLD activation by G proteins because it is required for PtdIns-4,5-P2
      synthesis by phosphoinositide kinases. As expected, MgATP was absolutely required
      for maintaining elevated phosphatidylinositol 4-phosphate (PtdIns-4-P) and PtdIns-4,5-P2
      levels in the permeabilized cells. In the presence of MgATP, GTP\u03b3S further
      elevated the levels of the phosphoinositides. The importance of PtdIns-4,5-P2
      for PLD activation was examined by utilizing a specific inhibitory antibody
      directed against phosphatidylinositol 4-kinase (PtdIns 4-kinase), the enzyme
      responsible for the first step in the synthesis of PtdIns-4,5-P2. Anti-PtdIns
      4-kinase completely inhibited PtdIns 4-kinase activity in vitro and reduced
      by 75-80% PtdIns-4-P and PtdIns-4,5-P2 levels in the permeabilized cells. In
      parallel, the anti-PtdIns 4-kinase fully inhibited the activation of PLD by
      GTP\u03b3S and caused a 60% inhibition of PLD activation by the phorbol ester
      12-O-tetradecanoylphorbol-13-acetate, indicating that elevated PtdIns-4,5-P2
      levels are required for PLD activation. This conclusion is supported by the
      fact that neomycin, a high affinity ligand of PtdIns-4,5-P2, also blocked PLD
      activation. Furthermore, the activity of PLD in U937 cell lysate was stimulated
      by PtdIns-4,5-P2 in a dose-dependent manner. The current results indicate that
      PtdIns-4,5-P2 synthesis is required for PLD activation in permeabilized U937
      cells and strongly support the proposed function of PtdIns-4,5-P2 as a cofactor
      for PLD. In addition, the results further establish PtdIns-4,5-P2 as a key component
      in the generation of second messengers via multiple pathways including phosphoinositidephospholipase
      C, phosphoinositide 3-kinase and PLD.", "venue": "Journal of Biological Chemistry",
      "year": 1995, "referenceCount": 60, "citationCount": 104, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": {"url": "http://www.jbc.org/article/S0021925818947277/pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1995-03-10", "journal": {"volume": "270", "pages": "5130
      - 5135", "name": "The Journal of Biological Chemistry"}, "citationStyles": {"bibtex":
      "@Article{Pertile1995Phosphatidylinositol4S,\n author = {P. Pertile and M. Liscovitch
      and V. Chalifa and L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of Biological Chemistry},\n pages = {5130 - 5135},\n
      title = {Phosphatidylinositol 4,5-Bisphosphate Synthesis Is Required for Activation
      of Phospholipase D in U937 Cells (*)},\n volume = {270},\n year = {1995}\n}\n"},
      "authors": [{"authorId": "1960212", "name": "P. Pertile"}, {"authorId": "6319769",
      "name": "M. Liscovitch"}, {"authorId": "7626687", "name": "V. Chalifa"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "fc124a811d0f33a6f1a21bae79b3b6b33f9f6c4b",
      "externalIds": {"CorpusId": 39020971, "PubMed": "7592789"}, "corpusId": 39020971,
      "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal
      of Biological Chemistry", "type": "journal", "alternate_names": ["J Biological
      Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/fc124a811d0f33a6f1a21bae79b3b6b33f9f6c4b",
      "title": "Phosphoinositide 3-kinase binds constitutively to alpha/beta-tubulin
      and binds to gamma-tubulin in response to insulin.", "abstract": "Recently we
      reported the localization of phosphoinositide 3-kinase (PI 3-kinase) by immunofluorescence
      to microtubule bundles and the centrosome (Kapeller, R., Chakrabarti, R., Cantley,
      L., Fay, F., and Corvera, S. (1993) Mol. Cell. Biol. 13, 6052-6063). In complementary
      experiments we used the recombinant p85 subunit of PI 3-kinase to identify proteins
      that associate with phosphoinositide 3-kinase and found that phosphoinositide
      3-kinase associates with alpha/beta-tubulin. The association occurs in vivo
      but was not significantly affected by growth factor stimulation. We localized
      the region of p85 that interacts with alpha/beta-tubulin to the inter-SH2 domain.
      These results support the immunofluorescence data and show that p85 directly
      associates with alpha/beta-tubulin. We then determined whether phosphoinositide
      3-kinase associates with gamma-tubulin. We found a dramatic growth factor-dependent
      association of phosphoinositide 3-kinase with gamma-tubulin. Phosphoinositide
      3-kinase associates with gamma-tubulin in response to insulin and, to a lesser
      extent, in response to platelet-derived growth factor. Neither epidermal growth
      factor nor nerve growth factor treatment of cells results in association of
      phosphoinositide 3-kinase and gamma-tubulin. Phosphoinositide 3-kinase is also
      immunoprecipitated with antibodies to pericentrin in response to insulin, indicating
      that phosphoinositide 3-kinase is recruited to the centrosome. Neither phosphoinositide
      3-kinase activity, nor intact microtubules are necessary for the association.
      Treatment of cells with 0.5 M NaCl dissociates gamma-tubulin from the centrosome
      and disrupts the association of phosphoinositide 3-kinase with pericentrin,
      but not gamma-tubulin. Recombinant p85 binds to gamma-tubulin from both insulin
      stimulated and quiescent cells. These results suggest that the association of
      phosphoinositide 3-kinase with gamma-tubulin is direct. These data suggest that
      phosphoinositide 3-kinase may be involved in regulating microtubule responses
      to insulin and platelet-derived growth factor.", "venue": "Journal of Biological
      Chemistry", "year": 1995, "referenceCount": 0, "citationCount": 42, "influentialCitationCount":
      3, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": null, "journal": {"volume": "270 43", "pages":
      "\n          25985-91\n        ", "name": "The Journal of biological chemistry"},
      "citationStyles": {"bibtex": "@Article{Kapeller1995Phosphoinositide3B,\n author
      = {R. Kapeller and A. Toker and L. Cantley and C. Carpenter},\n booktitle =
      {Journal of Biological Chemistry},\n journal = {The Journal of biological chemistry},\n
      pages = {\n          25985-91\n        },\n title = {Phosphoinositide 3-kinase
      binds constitutively to alpha/beta-tubulin and binds to gamma-tubulin in response
      to insulin.},\n volume = {270 43},\n year = {1995}\n}\n"}, "authors": [{"authorId":
      "2028875", "name": "R. Kapeller"}, {"authorId": "145751285", "name": "A. Toker"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2972505", "name":
      "C. Carpenter"}]}, {"paperId": "1805a0c296c4ca2bbb6e82c96a79ba18d1672272", "externalIds":
      {"MAG": "1488828742", "DOI": "10.1016/s0021-9258(17)36789-3", "CorpusId": 19998792,
      "PubMed": "8188716"}, "corpusId": 19998792, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/1805a0c296c4ca2bbb6e82c96a79ba18d1672272",
      "title": "The erbB3 gene product is a receptor for heregulin.", "abstract":
      null, "venue": "Journal of Biological Chemistry", "year": 1994, "referenceCount":
      0, "citationCount": 352, "influentialCitationCount": 13, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1994-05-13", "journal": {"volume": "269 19", "pages": "\n          14303-6\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Carraway1994TheEG,\n author = {K. L. Carraway and M. Sliwkowski and
      R. Akita and J. Platko and P. M. Guy and A. Nuijens and A. Diamonti and R. Vandlen
      and L. Cantley and R. Cerione},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of biological chemistry},\n pages = {\n          14303-6\n        },\n
      title = {The erbB3 gene product is a receptor for heregulin.},\n volume = {269
      19},\n year = {1994}\n}\n"}, "authors": [{"authorId": "153075552", "name": "K.
      L. Carraway"}, {"authorId": "152442893", "name": "M. Sliwkowski"}, {"authorId":
      "5465680", "name": "R. Akita"}, {"authorId": "4977593", "name": "J. Platko"},
      {"authorId": "47873744", "name": "P. M. Guy"}, {"authorId": "2173324444", "name":
      "A. Nuijens"}, {"authorId": "48917515", "name": "A. Diamonti"}, {"authorId":
      "2102354104", "name": "R. Vandlen"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "4142168", "name": "R. Cerione"}]}, {"paperId": "25e8f1904e4f8b6daa0b912ef121d2f6573eb9cc",
      "externalIds": {"MAG": "1999450178", "DOI": "10.1016/S0960-9822(00)00221-9",
      "CorpusId": 7507217, "PubMed": "7874496"}, "corpusId": 7507217, "publicationVenue":
      {"id": "9469269e-53d7-4955-b1a5-17a75bee7634", "name": "Current Biology", "type":
      "journal", "alternate_names": ["Curr Biology"], "issn": "0960-9822", "url":
      "http://www.current-biology.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/09609822"]},
      "url": "https://www.semanticscholar.org/paper/25e8f1904e4f8b6daa0b912ef121d2f6573eb9cc",
      "title": "Use of an oriented peptide library to determine the optimal substrates
      of protein kinases", "abstract": null, "venue": "Current Biology", "year": 1994,
      "referenceCount": 28, "citationCount": 631, "influentialCitationCount": 20,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1994-11-01", "journal": {"volume": "4",
      "pages": "973-982", "name": "Current Biology"}, "citationStyles": {"bibtex":
      "@Article{Zhou1994UseOA,\n author = {Songyang Zhou and S. Blechner and N. Hoagland
      and M. Hoekstra and H. Piwnica-Worms and L. Cantley},\n booktitle = {Current
      Biology},\n journal = {Current Biology},\n pages = {973-982},\n title = {Use
      of an oriented peptide library to determine the optimal substrates of protein
      kinases},\n volume = {4},\n year = {1994}\n}\n"}, "authors": [{"authorId": "2111144577",
      "name": "Songyang Zhou"}, {"authorId": "7926608", "name": "S. Blechner"}, {"authorId":
      "6607412", "name": "N. Hoagland"}, {"authorId": "4939757", "name": "M. Hoekstra"},
      {"authorId": "1400810799", "name": "H. Piwnica-Worms"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "3459757224680a407174df97d4daa63c83bc10af",
      "externalIds": {"MAG": "1981108516", "DOI": "10.1016/0092-8674(94)90564-9",
      "CorpusId": 39726384, "PubMed": "8033211"}, "corpusId": 39726384, "publicationVenue":
      {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal",
      "alternate_names": ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"],
      "url": "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/3459757224680a407174df97d4daa63c83bc10af",
      "title": "A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization
      in growth signaling", "abstract": null, "venue": "Cell", "year": 1994, "referenceCount":
      19, "citationCount": 638, "influentialCitationCount": 17, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "1994-07-15", "journal": {"volume": "78", "pages": "5-8",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Carraway1994ANA,\n author
      = {K. Carraway and L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n
      pages = {5-8},\n title = {A neu acquaintance for ErbB3 and ErbB4: A role for
      receptor heterodimerization in growth signaling},\n volume = {78},\n year =
      {1994}\n}\n"}, "authors": [{"authorId": "145331905", "name": "K. Carraway"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "6886cf242da4640818da5e32fc99eae43f67e7b6",
      "externalIds": {"MAG": "2156475226", "DOI": "10.1002/bies.950160810", "CorpusId":
      39196874, "PubMed": "8086005"}, "corpusId": 39196874, "publicationVenue": {"id":
      "d0f8ce9f-9934-4c7b-aad8-7b2bfcf812c1", "name": "Bioessays", "type": "journal",
      "alternate_names": ["BioEssays"], "issn": "0265-9247", "url": "http://www.bioessays-journal.com/",
      "alternate_urls": ["http://www3.interscience.wiley.com/cgi-bin/jtoc/34201/",
      "http://www3.interscience.wiley.com/cgi-bin/jhome/109911273", "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-1878",
      "https://onlinelibrary.wiley.com/journal/15211878"]}, "url": "https://www.semanticscholar.org/paper/6886cf242da4640818da5e32fc99eae43f67e7b6",
      "title": "Phosphatidylinositol 3\u2010kinase", "abstract": "Currently, a central
      question in biology is how signals from the cell surface modulate intracellular
      processes. In recent years phosphoinositides have been shown to play a key role
      in signal transduction. Two phosphoinositide pathways have been characterized,
      to date. In the canonical phosphoinositide turnover pathway, activation of phosphatidylinositol\u2010specific
      phospholipase C results in the hydrolysis of phosphatidylinositol 4,5\u2010bisphospate
      and the generation of two second messengers, inositol 1,4,5\u2010trisphosphate
      and diacylglycerol. The 3\u2010phosphoinositide pathway involves protein\u2010tyrosine
      kinase\u2010mediated recruitment and activation of phosphatidylinositol 3\u2010kinase,
      resulting in the production of phosphatidylinositol 3,4\u2010bisphosphate and
      phosphatidylinositol 3,4,5\u2010trisphosphate. The 3\u2010phosphoinositides
      are not substrates of any known phospholipase C, are not components of the canonical
      phosphoinositide turnover pathway, and may themselves act as intracellular mediators.
      The 3\u2010phosphoinositide pathway has been implicated in growth factor\u2010dependent
      mitogenesis, membrane ruffling and glucose uptake. Furthermore the homology
      of the yeast vps34 with the mammalian phosphatidylinositol 3\u2010kinase has
      suggested a role for this pathway in vesicular trafficking.", "venue": "Bioessays",
      "year": 1994, "referenceCount": 96, "citationCount": 772, "influentialCitationCount":
      24, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "1994-08-01", "journal": {"volume":
      "16", "name": "BioEssays"}, "citationStyles": {"bibtex": "@Article{Kapeller1994Phosphatidylinositol3,\n
      author = {R. Kapeller and L. Cantley},\n booktitle = {Bioessays},\n journal
      = {BioEssays},\n title = {Phosphatidylinositol 3\u2010kinase},\n volume = {16},\n
      year = {1994}\n}\n"}, "authors": [{"authorId": "2028875", "name": "R. Kapeller"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "6ce9fb2dfb1334b47cd8abc0157f251240ef34c7",
      "externalIds": {"MAG": "2015366690", "PubMedCentral": "2191364", "DOI": "10.1084/JEM.179.2.551",
      "CorpusId": 15400516, "PubMed": "8294866"}, "corpusId": 15400516, "publicationVenue":
      {"id": "7d071626-1aa2-4dad-a259-bcccedccf44d", "name": "Journal of Experimental
      Medicine", "type": "journal", "alternate_names": ["J Exp Med"], "issn": "0022-1007",
      "url": "http://www.jem.org/"}, "url": "https://www.semanticscholar.org/paper/6ce9fb2dfb1334b47cd8abc0157f251240ef34c7",
      "title": "Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-
      ligand interaction", "abstract": "Induced activation of protein tyrosine kinase(s)
      is a central event in signal transduction mediated via the low affinity receptor
      for IgG (Fc gamma RIIIA, CD16) in natural killer (NK) cells. Tyrosine phosphorylation
      may affect the function of several protein directly, or indirectly by inducing
      their association with other tyrosine phosphorylated proteins. Here, we report
      that Fc gamma RIII stimulation induces activation of phosphatidylinositol (PI)-3
      kinase in NK cells. Phosphotyrosine immunoprecipitates from Fc gamma RIII-stimulated
      NK cells contain PI-kinase activity and PI-3 kinase can be directly precipitated
      from them. Conversely, a series of tyrosine-phosphorylated proteins is coprecipitated
      with PI-3 kinase from the stimulated, but not from control cells. Analogous
      results obtained using Jurkat T cells expressing transfected Fc gamma RIIIA
      alpha ligand binding chain in association with gamma 2 or zeta 2 homodimers
      indicate that both complexes transduce this effect, although the Fc gamma RIIIA-zeta
      2 complexes do so with greater efficiency. Accumulation of phosphoinositide
      D3 phosphorylated products in stimulated cells confirms PI-3 kinase activation,
      indicating the participation of this enzyme in Fc gamma RIIIA-mediated signal
      transduction.", "venue": "Journal of Experimental Medicine", "year": 1994, "referenceCount":
      47, "citationCount": 89, "influentialCitationCount": 5, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://rupress.org/jem/article-pdf/179/2/551/1395347/551.pdf",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1994-02-01", "journal": {"volume": "179",
      "pages": "551 - 558", "name": "The Journal of Experimental Medicine"}, "citationStyles":
      {"bibtex": "@Article{Kanakaraj1994Phosphatidylinositol3KA,\n author = {P. Kanakaraj
      and B. Duckworth and L. Azzoni and Malek Kamoun and L. Cantley and B. Perussia},\n
      booktitle = {Journal of Experimental Medicine},\n journal = {The Journal of
      Experimental Medicine},\n pages = {551 - 558},\n title = {Phosphatidylinositol-3
      kinase activation induced upon Fc gamma RIIIA- ligand interaction},\n volume
      = {179},\n year = {1994}\n}\n"}, "authors": [{"authorId": "152590000", "name":
      "P. Kanakaraj"}, {"authorId": "21162853", "name": "B. Duckworth"}, {"authorId":
      "1706855", "name": "L. Azzoni"}, {"authorId": "2235058665", "name": "Malek Kamoun"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5893025", "name":
      "B. Perussia"}]}, {"paperId": "6f6e6b2617c168e176c74f3635fa940cfad7b1fa", "externalIds":
      {"MAG": "2154060541", "DOI": "10.1073/PNAS.91.7.2834", "CorpusId": 25831434,
      "PubMed": "8146197"}, "corpusId": 25831434, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/6f6e6b2617c168e176c74f3635fa940cfad7b1fa",
      "title": "T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol
      3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.", "abstract": "The T-cell
      antigen CD28 provides a costimulatory signal that is required for T-cell proliferation.
      T-cell receptor zeta/CD3 engagement without CD28 ligation leads to a state of
      nonresponsiveness/anergy, thereby implicating CD28 in the control of peripheral
      tolerance to foreign antigens or tumors. A key unresolved question has concerned
      the mechanism by which CD28 generates intracellular signals. Phosphatidylinositol
      3-kinase (PI 3-kinase) is a lipid kinase with Src-homology 2 (SH2) domain(s)
      that binds to the platelet-derived growth factor receptor (PDGF-R), an interaction
      that is essential for signaling by growth factor. In this study, we demonstrate
      that CD28 binds to PI 3-kinase by means of a Y(P)MXM motif within its cytoplasmic
      tail. CD28-associated PI 3-kinase was detected by lipid kinase and HPLC analysis
      as well as by reconstitution experiments with baculoviral-expressed p85 subunit
      of PI 3-kinase. CD28 bound directly to the p85 subunit without the need for
      the associated p110 subunit. Site-directed mutagenesis and peptide competition
      analysis using Y(P)-MXM-containing peptides showed that PI 3-kinase bound to
      a Y(P)MXM motif within the CD28 cytoplasmic tail (residues 191-194). Mutation
      of the Y191 within the motif resulted in a complete loss of binding, while mutation
      of M194 caused partial loss of binding. Binding analysis showed that the CD28
      Y(P)-MXM motif bound to the p85 C- and N-terminal SH2 domains with an affinity
      comparable to that observed for PDGF-R and insulin receptor substrate 1. In
      terms of signaling, CD28 ligation induced a dramatic increase in the recruitment
      and association of PI 3-kinase with the receptor. CD28 is likely to use PI 3-kinase
      as the second signal leading to T-cell proliferation, an event with implications
      for anergy and peripheral T-cell tolerance.", "venue": "Proceedings of the National
      Academy of Sciences of the United States of America", "year": 1994, "referenceCount":
      3, "citationCount": 297, "influentialCitationCount": 7, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc43465?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1994-03-29", "journal": {"volume": "91
      7", "pages": "\n          2834-8\n        ", "name": "Proceedings of the National
      Academy of Sciences of the United States of America"}, "citationStyles": {"bibtex":
      "@Article{Prasad1994TcellAC,\n author = {K. Prasad and Yun-Cai Cai and M. Raab
      and B. Duckworth and L. Cantley and S. Shoelson and C. Rudd},\n booktitle =
      {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences of the United States
      of America},\n pages = {\n          2834-8\n        },\n title = {T-cell antigen
      CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic
      Tyr(P)-Met-Xaa-Met motif.},\n volume = {91 7},\n year = {1994}\n}\n"}, "authors":
      [{"authorId": "49084493", "name": "K. Prasad"}, {"authorId": "2116361811", "name":
      "Yun-Cai Cai"}, {"authorId": "3982584", "name": "M. Raab"}, {"authorId": "21162853",
      "name": "B. Duckworth"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4790900", "name": "S. Shoelson"}, {"authorId": "3745275", "name": "C. Rudd"}]},
      {"paperId": "a07d06eba97b523bed133639b044d10cbd956272", "externalIds": {"MAG":
      "2108246579", "DOI": "10.1128/mcb.14.6.3550-3558.1994", "CorpusId": 41728331,
      "PubMed": "7515147"}, "corpusId": 41728331, "publicationVenue": {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b",
      "name": "Molecular and Cellular Biology", "type": "journal", "alternate_names":
      ["Mol Cell Biology"], "issn": "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls":
      ["http://mcb.asm.org/"]}, "url": "https://www.semanticscholar.org/paper/a07d06eba97b523bed133639b044d10cbd956272",
      "title": "ErbB3 is involved in activation of phosphatidylinositol 3-kinase by
      epidermal growth factor", "abstract": "Conflicting results concerning the ability
      of the epidermal growth factor (EGF) receptor to associate with and/or activate
      phosphatidylinositol (PtdIns) 3-kinase have been published. Despite the ability
      of EGF to stimulate the production of PtdIns 3-kinase products and to cause
      the appearance of PtdIns 3-kinase activity in antiphosphotyrosine immunoprecipitates
      in several cell lines, we did not detect EGF-stimulated PtdIns 3-kinase activity
      in anti-EGF receptor immunoprecipitates. This result is consistent with the
      lack of a phosphorylated Tyr-X-X-Met motif, the p85 Src homology 2 (SH2) domain
      recognition sequence, in this receptor sequence. The EGF receptor homolog, ErbB2
      protein, also lacks this motif. However, the ErbB3 protein has seven repeats
      of the Tyr-X-X-Met motif in the carboxy-terminal unique domain. Here we show
      that in A431 cells, which express both the EGF receptor and ErbB3, PtdIns 3-kinase
      coprecipitates with the ErbB3 protein (p180erbB3) in response to EGF. p180erbB3
      is also shown to be tyrosine phosphorylated in response to EGF. In contrast,
      a different mechanism for the activation of PtdIns 3-kinase in response to EGF
      occurs in certain cells (PC12 and A549 cells). Thus, we show for the first time
      that ErbB3 can mediate EGF responses in cells expressing both ErbB3 and the
      EGF receptor.", "venue": "Molecular and Cellular Biology", "year": 1994, "referenceCount":
      47, "citationCount": 558, "influentialCitationCount": 35, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://europepmc.org/articles/pmc358722?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1994-06-01", "journal": {"volume": "14",
      "pages": "3550 - 3558", "name": "Molecular and Cellular Biology"}, "citationStyles":
      {"bibtex": "@Article{Soltoff1994ErbB3II,\n author = {S. Soltoff and K. L. Carraway
      and S. Prigent and W. Gullick and L. Cantley},\n booktitle = {Molecular and
      Cellular Biology},\n journal = {Molecular and Cellular Biology},\n pages = {3550
      - 3558},\n title = {ErbB3 is involved in activation of phosphatidylinositol
      3-kinase by epidermal growth factor},\n volume = {14},\n year = {1994}\n}\n"},
      "authors": [{"authorId": "4324390", "name": "S. Soltoff"}, {"authorId": "153075552",
      "name": "K. L. Carraway"}, {"authorId": "14615148", "name": "S. Prigent"}, {"authorId":
      "2071010729", "name": "W. Gullick"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "acd3a27973c7d0258f7674048f6dcf947d37aa51", "externalIds": {"MAG":
      "2082839106", "DOI": "10.1242/jcs.1994.Supplement_18.18", "CorpusId": 20160734,
      "PubMed": "7533766"}, "corpusId": 20160734, "publicationVenue": {"id": "398b46b8-6014-4478-b7af-f477167f7bde",
      "name": "Journal of Cell Science", "type": "journal", "alternate_names": ["J
      Cell Sci"], "issn": "0021-9533", "url": "https://jcs.biologists.org/", "alternate_urls":
      ["http://jcs.biologists.org/"]}, "url": "https://www.semanticscholar.org/paper/acd3a27973c7d0258f7674048f6dcf947d37aa51",
      "title": "Specificity in recognition of phosphopeptides by src-homology 2 domains",
      "abstract": "SUMMARY SH2 domains and SH3 domains, found in a number of protein-tyrosine
      kinases and substrates of protein-tyrosine kinases, provide specificity in downstream
      signaling. Both of these domains bind to relatively short linear sequences of
      peptides to provide specific interactions between proteins. The SH2 domains
      directly bind to phosphotyrosine residues of proteins in a specific sequence
      context. We have devised a phosphopeptide library technique that allows us to
      rapidly determine the sequence specificity of individual SH2 domains on the
      basis of amino acids selected at position +1,+2 and +3 C-terminal of the phosphotyrosine.
      The optimal motif for 22 distinct SH2 domains has been determined and used to
      predict likely sites of in vivo interaction. A second phosphopeptide library
      was devised in which the amino acids N-terminal of the phosphotyrosine were
      also varied. The residues N-terminal of phosphotyrosine had little influence
      on binding to the N-SH2 domain of the 85 kDa subunit of phosphoinositide 3-kinase.
      These results indicate that for this SH2 domain, specificity is determined by
      sequences carboxy-terminal of the phosphotyrosine moiety. Knowledge of the specificity
      of SH2 domains allows predictions about likely downstream targets on the basis
      of primary sequence of proteins. Some of these predictions will be discussed.",
      "venue": "Journal of Cell Science", "year": 1994, "referenceCount": 36, "citationCount":
      63, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": {"url":
      "http://jcs.biologists.org/content/joces/1994/Supplement_18/121.full.pdf", "status":
      null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1994-01-01", "journal": {"volume": "1994", "pages": "121 - 126", "name": "Journal
      of Cell Science"}, "citationStyles": {"bibtex": "@Article{Cantley1994SpecificityIR,\n
      author = {L. Cantley and Songyang Zhou},\n booktitle = {Journal of Cell Science},\n
      journal = {Journal of Cell Science},\n pages = {121 - 126},\n title = {Specificity
      in recognition of phosphopeptides by src-homology 2 domains},\n volume = {1994},\n
      year = {1994}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2111144577", "name": "Songyang Zhou"}]}, {"paperId": "ace6bf58ba218fdb0fc63e3121a9ce79916cadcd",
      "externalIds": {"MAG": "2021938232", "DOI": "10.1038/369502A0", "CorpusId":
      22767669, "PubMed": "7515480"}, "corpusId": 22767669, "publicationVenue": {"id":
      "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/ace6bf58ba218fdb0fc63e3121a9ce79916cadcd",
      "title": "SH2 domain specificity and activity modified by a single residue",
      "abstract": null, "venue": "Nature", "year": 1994, "referenceCount": 31, "citationCount":
      190, "influentialCitationCount": 4, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://tspace.library.utoronto.ca/bitstream/1807/9433/3/Bidirectional%20signalling%20through%20the%20EPH.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1994-06-09", "journal": {"volume": "369", "pages": "502-505",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Mareng\u00e8re1994SH2DS,\n
      author = {L. Mareng\u00e8re and L. Mareng\u00e8re and Songyang Zhou and G. Gish
      and M. Schaller and J. Parsons and M. Stern and L. Cantley and Tony Pawson and
      Tony Pawson},\n booktitle = {Nature},\n journal = {Nature},\n pages = {502-505},\n
      title = {SH2 domain specificity and activity modified by a single residue},\n
      volume = {369},\n year = {1994}\n}\n"}, "authors": [{"authorId": "4055899",
      "name": "L. Mareng\u00e8re"}, {"authorId": "4055899", "name": "L. Mareng\u00e8re"},
      {"authorId": "2111144577", "name": "Songyang Zhou"}, {"authorId": "37993016",
      "name": "G. Gish"}, {"authorId": "2955823", "name": "M. Schaller"}, {"authorId":
      "4756296", "name": "J. Parsons"}, {"authorId": "47189623", "name": "M. Stern"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2255574775", "name":
      "Tony Pawson"}, {"authorId": "2255574775", "name": "Tony Pawson"}]}, {"paperId":
      "b82b31d5a6f71b2b97b3c7d7675c50df95e047cd", "externalIds": {"DOI": "10.1128/mcb.14.9.6372-6385.1994",
      "CorpusId": 11180518}, "corpusId": 11180518, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/b82b31d5a6f71b2b97b3c7d7675c50df95e047cd",
      "title": "Physical and functional interactions between SH2 and SH3 domains of
      the Src family protein tyrosine kinase p59fyn", "abstract": "The Src family
      protein tyrosine kinases participate in signalling through cell surface receptors
      that lack intrinsic tyrosine kinase domains. All nine members of this family
      possess adjacent Src homology (SH2 and SH3) domains, both of which are essential
      for repression of the enzymatic activity. The repression is mediated by binding
      between the SH2 domain and a C-terminal phosphotyrosine, and the SH3 domain
      is required for this interaction. However, the biochemical basis of functional
      SH2-SH3 interaction is unclear. Here, we demonstrate that when the SH2 and SH3
      domains of p59fyn (Fyn) were present as adjacent domains in a single protein,
      binding of phosphotyrosyl peptides and proteins to the SH2 domain was enhanced,
      whereas binding of a subset of cellular polypeptide ligands to the SH3 domain
      was decreased. An interdomain communication was further revealed by occupancy
      with domain-specific peptide ligands: occupancy of the SH3 domain with a proline-rich
      peptide enhanced phosphotyrosine binding to the linked SH2 domain, and occupancy
      of the SH2 domain with phosphotyrosyl peptides enhanced binding of certain SH3-specific
      cellular polypeptides. Second, we demonstrate a direct binding between purified
      SH2 and SH3 domains of Fyn and Lck Src family kinases. Heterologous binding
      between SH2 and SH3 domains of closely related members of the Src family, namely,
      Fyn, Lck, and Src, was also observed. In contrast, Grb2, Crk, Abl, p85 phosphatidylinositol
      3-kinase, and GTPase-activating protein SH2 domains showed lower or no binding
      to Fyn or Lck SH3 domains. SH2-SH3 binding did not require an intact phosphotyrosine
      binding pocket on the SH2 domain; however, perturbations of the SH2 domain induced
      by specific high-affinity phosphotyrosyl peptide binding abrogated binding of
      the SH3 domain. SH3-SH2 binding was observed in the presence of proline-rich
      peptides or when a point mutation (W119K) was introduced in the putative ligand-binding
      pouch of the Fyn SH3 domain, although these treatments completely abolished
      the binding to p85 phosphatidylinositol 3-kinase and other SH3-specific polypeptides.
      These biochemical SH2-SH3 interactions suggest novel mechanisms of regulating
      the enzymatic activity of Src kinases and their interactions with other proteins.",
      "venue": "", "year": 1994, "referenceCount": 80, "citationCount": 60, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": "1994-09-01",
      "journal": {"volume": "14", "pages": "6372 - 6385", "name": "Molecular and Cellular
      Biology"}, "citationStyles": {"bibtex": "@Article{Panchamoorthy1994PhysicalAF,\n
      author = {G. Panchamoorthy and T. Fukazawa and L. Stolz and G. Payne and K.
      Reedquist and S. Shoelson and Z. Songyang and L. Cantley and C. Walsh and H.
      Band},\n journal = {Molecular and Cellular Biology},\n pages = {6372 - 6385},\n
      title = {Physical and functional interactions between SH2 and SH3 domains of
      the Src family protein tyrosine kinase p59fyn},\n volume = {14},\n year = {1994}\n}\n"},
      "authors": [{"authorId": "50086870", "name": "G. Panchamoorthy"}, {"authorId":
      "152932875", "name": "T. Fukazawa"}, {"authorId": "37494394", "name": "L. Stolz"},
      {"authorId": "98763489", "name": "G. Payne"}, {"authorId": "4061084", "name":
      "K. Reedquist"}, {"authorId": "4790900", "name": "S. Shoelson"}, {"authorId":
      "6731027", "name": "Z. Songyang"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "1929648539", "name": "C. Walsh"}, {"authorId": "145119394", "name":
      "H. Band"}]}, {"paperId": "d3f100a9bc1170e5609f4a4a42d8ebc0b2b06865", "externalIds":
      {"MAG": "59209658", "CorpusId": 25413597, "PubMed": "8063770"}, "corpusId":
      25413597, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/d3f100a9bc1170e5609f4a4a42d8ebc0b2b06865",
      "title": "Novel function of phosphatidylinositol 4,5-bisphosphate as a cofactor
      for brain membrane phospholipase D.", "abstract": "The activation of phospholipase
      D (PLD) is a receptor-mediated event that has been implicated in signal transduction
      and membrane traffic in eukaryotic cells. Little is known about the biochemical
      and molecular properties of signal-activated PLDs, and none has been isolated.
      Here we report that phosphatidylinositol 4,5-bisphosphate (PIP2) potently stimulates
      brain membrane PLD activity in vitro in a highly specific manner. PIP2 increases
      10-fold the maximal activity of a partially purified PLD with an EC50 of < 0.5
      mol %. Other acidic phospholipids, including phosphatidylinositol 4-phosphate,
      phosphatidylinositol, phosphatidylserine, and phosphatidic acid, are completely
      or nearly ineffective. Neomycin, a high affinity ligand of PIP2, inhibits membrane-bound
      PLD but has no effect on the activity of a detergent-solubilized or partially
      purified enzyme. The addition of PIP2 restores the sensitivity of partially
      purified PLD to neomycin inhibition, indicating that neomycin blocks membrane
      PLD activity by binding to endogenous PIP2. These results define a novel function
      of PIP2 as a cofactor for brain membrane PLD and suggest that PIP2 synthesis
      and hydrolysis could be important determinants in regulating PLD action in signal
      transduction and membrane transport.", "venue": "Journal of Biological Chemistry",
      "year": 1994, "referenceCount": 2, "citationCount": 269, "influentialCitationCount":
      9, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Chemistry"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Chemistry", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1994-08-26", "journal": {"volume": "269 34", "pages":
      "\n          21403-6\n        ", "name": "The Journal of biological chemistry"},
      "citationStyles": {"bibtex": "@Article{Liscovitch1994NovelFO,\n author = {M.
      Liscovitch and V. Chalifa and P. Pertile and C. S. Chen and L. Cantley},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          21403-6\n        },\n title = {Novel function
      of phosphatidylinositol 4,5-bisphosphate as a cofactor for brain membrane phospholipase
      D.},\n volume = {269 34},\n year = {1994}\n}\n"}, "authors": [{"authorId": "6319769",
      "name": "M. Liscovitch"}, {"authorId": "7626687", "name": "V. Chalifa"}, {"authorId":
      "1960212", "name": "P. Pertile"}, {"authorId": "49751345", "name": "C. S. Chen"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "23ab2836a31a3f5b4bda1b19a2ed65c5d84c5dff",
      "externalIds": {"MAG": "2066040740", "DOI": "10.1016/0006-2952(93)90455-6",
      "CorpusId": 19952952, "PubMed": "7684222"}, "corpusId": 19952952, "publicationVenue":
      {"id": "c2ed7282-3d57-4734-ac70-51f9bffc1368", "name": "Biochemical Pharmacology",
      "type": "journal", "alternate_names": ["Biochem Pharmacol"], "issn": "0006-2952",
      "alternate_issns": ["1356-1839"], "url": "http://www.elsevier.com/locate/issn/00062952",
      "alternate_urls": ["http://www.elsevier.com/wps/find/journaldescription.cws_home/525454/description",
      "http://www.sciencedirect.com/science/journal/00062952"]}, "url": "https://www.semanticscholar.org/paper/23ab2836a31a3f5b4bda1b19a2ed65c5d84c5dff",
      "title": "Blockade of ATP binding site of P2 purinoceptors in rat parotid acinar
      cells by isothiocyanate compounds.", "abstract": null, "venue": "Biochemical
      Pharmacology", "year": 1993, "referenceCount": 20, "citationCount": 49, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1993-05-05", "journal": {"volume": "45
      9", "pages": "\n          1936-40\n        ", "name": "Biochemical pharmacology"},
      "citationStyles": {"bibtex": "@Article{Soltoff1993BlockadeOA,\n author = {S.
      Soltoff and M. McMillian and B. Talamo and L. Cantley},\n booktitle = {Biochemical
      Pharmacology},\n journal = {Biochemical pharmacology},\n pages = {\n          1936-40\n        },\n
      title = {Blockade of ATP binding site of P2 purinoceptors in rat parotid acinar
      cells by isothiocyanate compounds.},\n volume = {45 9},\n year = {1993}\n}\n"},
      "authors": [{"authorId": "4324390", "name": "S. Soltoff"}, {"authorId": "144664118",
      "name": "M. McMillian"}, {"authorId": "3683975", "name": "B. Talamo"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "23f63abb380b90ea875c104eb3fbb0a7db11fde6",
      "externalIds": {"MAG": "2164682544", "DOI": "10.1016/0092-8674(93)90404-E",
      "CorpusId": 731207, "PubMed": "7680959"}, "corpusId": 731207, "publicationVenue":
      {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal",
      "alternate_names": ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"],
      "url": "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/23f63abb380b90ea875c104eb3fbb0a7db11fde6",
      "title": "SH2 domains recognize specific phosphopeptide sequences", "abstract":
      null, "venue": "Cell", "year": 1993, "referenceCount": 50, "citationCount":
      2596, "influentialCitationCount": 44, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1993-03-12", "journal": {"volume": "72", "pages": "767-778", "name": "Cell"},
      "citationStyles": {"bibtex": "@Article{Zhou1993SH2DR,\n author = {Songyang Zhou
      and S. Shoelson and M. Chaudhuri and G. Gish and T. Pawson and W. Haser and
      Fred King and T. Roberts and S. Ratnofsky and R. Lechleider and B. Neel and
      R. Birge and J. Fajardo and M. Chou and H. Hanafusa and B. Schaffhausen and
      L. Cantley},\n booktitle = {Cell},\n journal = {Cell},\n pages = {767-778},\n
      title = {SH2 domains recognize specific phosphopeptide sequences},\n volume
      = {72},\n year = {1993}\n}\n"}, "authors": [{"authorId": "2111144577", "name":
      "Songyang Zhou"}, {"authorId": "4790900", "name": "S. Shoelson"}, {"authorId":
      "2073353181", "name": "M. Chaudhuri"}, {"authorId": "37993016", "name": "G.
      Gish"}, {"authorId": "50999462", "name": "T. Pawson"}, {"authorId": "4104149",
      "name": "W. Haser"}, {"authorId": "2115046366", "name": "Fred King"}, {"authorId":
      "2053044498", "name": "T. Roberts"}, {"authorId": "5982171", "name": "S. Ratnofsky"},
      {"authorId": "4551861", "name": "R. Lechleider"}, {"authorId": "2291271", "name":
      "B. Neel"}, {"authorId": "3752444", "name": "R. Birge"}, {"authorId": "143676959",
      "name": "J. Fajardo"}, {"authorId": "15675591", "name": "M. Chou"}, {"authorId":
      "1973946", "name": "H. Hanafusa"}, {"authorId": "4362128", "name": "B. Schaffhausen"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "4cc1af566110f6cf0563cc6b25b20e22fcf29201",
      "externalIds": {"MAG": "2118110409", "DOI": "10.1098/RSTB.1993.0132", "CorpusId":
      19832710, "PubMed": "7904344"}, "corpusId": 19832710, "publicationVenue": {"id":
      "6de51a3e-86d6-4b08-92f5-a2a4a3a1c47b", "name": "Philosophical transactions
      of the Royal Society of London. Series B, Biological sciences", "alternate_names":
      ["Philos trans R Soc Lond Ser B Biological sci"], "issn": "0080-4622", "alternate_issns":
      ["2054-0280"], "url": "http://www.jstor.org/action/showPublication?journalCode=philtranroyasoc2"},
      "url": "https://www.semanticscholar.org/paper/4cc1af566110f6cf0563cc6b25b20e22fcf29201",
      "title": "Regulation of CD4-p56lck-associated phosphatidylinositol 3-kinase
      (PI 3-kinase) and phosphatidylinositol 4-kinase (PI 4-kinase).", "abstract":
      "CD4 serves as a receptor for MHC class II antigens and as a receptor for the
      human immunodeficiency virus (HIV-1) viral coat protein gp120. It is coupled
      to the protein-tyrosine kinase p56lck, an interaction necessary for an optimal
      response of certain T cells to antigen. Although anti-CD4 crosslinking may increase
      lck activity, the effects of HIV-1 gp120 have been controversial. Activated
      protein-tyrosine kinases are known to associate with certain intracellular proteins
      possessing src-homology regions (SH-2 domains) such as phosphatidylinositol
      3-kinase (PI 3-kinase). In this paper, we demonstrate that the CD4:p56lck complex
      associates with significant amounts of phosphatidylinositol (PI) kinase activity.
      High pressure liquid chromatographic (HPLC) analysis of the reaction products
      demonstrated the presence of phosphatidylinositol 3-phosphate (PI 3-P) and phosphatidylinositol
      4-phosphate (PI 4-P), thus indicating that PI 3 and PI 4 kinases associate with
      CD4-p56lck. The p85 subunit of PI 3-kinase was also detected in anti-CD4 immunoprecipitates
      by immunoblotting with anti-p85 antiserum. Significantly, p56lck binding to
      CD4 appears to be necessary for the detection of lipid kinase activity associated
      with p56lck. Also, anti-HIV gp120 and anti-CD4 crosslinking induced a 10-15-fold
      increase in levels of both PI 3- and PI 4-kinase activity in anti-CD4 precipitates.
      Stimulation of CD4-p56lck-linked PI kinases by crosslinked HIV-1 gp120 may play
      a role in HIV-1-induced immune defects.", "venue": "Philosophical transactions
      of the Royal Society of London. Series B, Biological sciences", "year": 1993,
      "referenceCount": 27, "citationCount": 7, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1993-10-29", "journal": {"volume": "342 1299", "pages":
      "\n          35-42\n        ", "name": "Philosophical transactions of the Royal
      Society of London. Series B, Biological sciences"}, "citationStyles": {"bibtex":
      "@Article{Prasad1993RegulationOC,\n author = {K. Prasad and R. Kapeller and
      O. Janssen and J. Duke-Cohan and H. Repke and L. Cantley and C. Rudd},\n booktitle
      = {Philosophical transactions of the Royal Society of London. Series B, Biological
      sciences},\n journal = {Philosophical transactions of the Royal Society of London.
      Series B, Biological sciences},\n pages = {\n          35-42\n        },\n title
      = {Regulation of CD4-p56lck-associated phosphatidylinositol 3-kinase (PI 3-kinase)
      and phosphatidylinositol 4-kinase (PI 4-kinase).},\n volume = {342 1299},\n
      year = {1993}\n}\n"}, "authors": [{"authorId": "49084493", "name": "K. Prasad"},
      {"authorId": "2028875", "name": "R. Kapeller"}, {"authorId": "2694949", "name":
      "O. Janssen"}, {"authorId": "1400208976", "name": "J. Duke-Cohan"}, {"authorId":
      "5014538", "name": "H. Repke"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "3745275", "name": "C. Rudd"}]}, {"paperId": "66b77a160b27aac1295bca2889e37801f678e38e",
      "externalIds": {"MAG": "2092677752", "DOI": "10.1111/j.1476-5381.1993.tb12825.x",
      "CorpusId": 24479493, "PubMed": "8448596"}, "corpusId": 24479493, "publicationVenue":
      {"id": "72dc4a68-546a-4211-947e-a9ef859d12ad", "name": "British Journal of Pharmacology",
      "type": "journal", "alternate_names": ["Br J Pharmacol"], "issn": "0007-1188",
      "url": "http://www.nature.com/bjp/index.html", "alternate_urls": ["http://www.brjpharmacol.org/",
      "https://onlinelibrary.wiley.com/journal/14765381", "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=282",
      "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues"]}, "url":
      "https://www.semanticscholar.org/paper/66b77a160b27aac1295bca2889e37801f678e38e",
      "title": "Two distinct cytosolic calcium responses to extracellular ATP in rat
      parotid acinar cells", "abstract": "1 Increasing concentrations of ATP (0.5
      \u03bcm\u2010300 \u03bcm) produced a biphasic increase in intracellular calcium
      concentration [Ca]i in rat parotid acinar cells, reflecting two distinct Cai
      responses to extracellular ATP. 2 In the absence of Mg2+ (with 3 mm CaCl2 in
      the buffer solution), the more sensitive response was maximal at 3\u20135 \u03bcm
      and was not further increased by 30 \u03bcm ATP. This response to ATP was not
      well maintained and was blocked by ADP (0.5 mm). A second, much larger increase
      in Cai was observed on addition of 300 \u03bcm ATP. This larger effect, which
      we have described previously, appears to be mediated by ATP4\u2013, and was
      selectively reversed by 4,4\u2032\u2010di\u2010isothiocyanato\u2010dihydrostilbene\u20102,2\u2032\u2010disulphonate
      as well as by high concentrations of \u03b1,\u03b2\u2010methylene ATP. 3 Among
      ATP analogues, only the putative P2Z agonist, 3\u2032\u20100\u2010(4\u2010benzoyl)benzoyl\u2010ATP
      distinguished between the two responses. This analogue was at least 10 fold
      more potent than ATP in stimulating the ATP4\u2013\u2010response, but did not
      evoke the more sensitive response. The agonist potency series for both responses
      to ATP was identical for other analogues examined (ATP>ATP\u2010\u03b3S = 2\u2010methylthio
      ATP (a P2y\u2010selective agonist) 72>ADP, ITP and \u03b1,\u03b2\u2010methylene
      ATP (a P2X\u2010selective agonist)). 4 Although the effect of ATP4\u2013 could
      best be characterized as a P2Z\u2010type purinoceptor response, this effect
      was strongly and selectively blocked by reactive blue 2, a putative P2y\u2010purinoceptor
      antagonist. Reactive blue 2 may bind to and block P2Z purinoceptors since [\u03b332P]\u2010ATP
      binding to parotid cells was inhibited by this compound. 5 In contrast to the
      response to ATP4\u2013, the more sensitive response to ATP was potentiated by
      reactive blue 2 and was less affected by increases in external Mg2+ and Ca2+.
      6 Parasympathetic denervation selectively increased the more sensitive response,
      suggesting that it may be physiologically regulated.", "venue": "British Journal
      of Pharmacology", "year": 1993, "referenceCount": 45, "citationCount": 61, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1993.tb12825.x",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1993-02-01", "journal": {"volume": "108", "name":
      "British Journal of Pharmacology"}, "citationStyles": {"bibtex": "@Article{McMillian1993TwoDC,\n
      author = {M. McMillian and S. Soltoff and L. Cantley and R. Rudel and B. Talamo},\n
      booktitle = {British Journal of Pharmacology},\n journal = {British Journal
      of Pharmacology},\n title = {Two distinct cytosolic calcium responses to extracellular
      ATP in rat parotid acinar cells},\n volume = {108},\n year = {1993}\n}\n"},
      "authors": [{"authorId": "144664118", "name": "M. McMillian"}, {"authorId":
      "4324390", "name": "S. Soltoff"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "2378702", "name": "R. Rudel"}, {"authorId": "3683975", "name":
      "B. Talamo"}]}, {"paperId": "96e9ac3cbd6ee7e467ae6e775f65685dab63a555", "externalIds":
      {"MAG": "112200190", "DOI": "10.1007/978-3-642-78247-3_20", "CorpusId": 91547247},
      "corpusId": 91547247, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/96e9ac3cbd6ee7e467ae6e775f65685dab63a555",
      "title": "Role of Phosphatidylinositol 3-Kinase in Growth Factor and Oncogene
      Signaling", "abstract": null, "venue": "", "year": 1993, "referenceCount": 35,
      "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "pages": "149-165", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Cantley1993RoleOP,\n author = {L. Cantley},\n pages
      = {149-165},\n title = {Role of Phosphatidylinositol 3-Kinase in Growth Factor
      and Oncogene Signaling},\n year = {1993}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "b3bc181e9fa491ccdc293374a6ac381961f37a02",
      "externalIds": {"MAG": "1537485228", "DOI": "10.1016/s0021-9258(18)53589-4",
      "CorpusId": 9178517, "PubMed": "8382694"}, "corpusId": 9178517, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/b3bc181e9fa491ccdc293374a6ac381961f37a02",
      "title": "A murine genomic DNA fragment amplifies ouabain-induced Na,K-ATPase
      alpha/beta-subunit mRNA up-regulation and confers ouabain resistance.", "abstract":
      null, "venue": "Journal of Biological Chemistry", "year": 1993, "referenceCount":
      0, "citationCount": 4, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1993-02-25", "journal": {"volume": "268 6", "pages": "\n          4126-33\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Zhou1993AMG,\n author = {X. M. Zhou and M. J. Cunha and J. Epstein
      and R. Levenson and L. Cantley and L. Cantley},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of biological chemistry},\n pages = {\n          4126-33\n        },\n
      title = {A murine genomic DNA fragment amplifies ouabain-induced Na,K-ATPase
      alpha/beta-subunit mRNA up-regulation and confers ouabain resistance.},\n volume
      = {268 6},\n year = {1993}\n}\n"}, "authors": [{"authorId": "48666973", "name":
      "X. M. Zhou"}, {"authorId": "2056117768", "name": "M. J. Cunha"}, {"authorId":
      "48381149", "name": "J. Epstein"}, {"authorId": "144579743", "name": "R. Levenson"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5601835", "name":
      "L. Cantley"}]}, {"paperId": "b5fba79e88954c8057574e8257a7dc92301cbe48", "externalIds":
      {"MAG": "226520676", "DOI": "10.1002/j.1460-2075.1993.tb05929.x", "CorpusId":
      29371814, "PubMed": "8392933"}, "corpusId": 29371814, "publicationVenue": {"id":
      "b89f0ede-6fa8-4dd2-a8a7-f54695a00323", "name": "EMBO Journal", "type": "journal",
      "alternate_names": ["The EMBO Journal", "EMBO J"], "issn": "0261-4189", "url":
      "http://embojournal.npgjournals.com/", "alternate_urls": ["http://emboj.embopress.org/"]},
      "url": "https://www.semanticscholar.org/paper/b5fba79e88954c8057574e8257a7dc92301cbe48",
      "title": "Granulocyte macrophage\u2010colony stimulating factor stimulates both
      association and activation of phosphoinositide 3OH\u2010kinase and src\u2010related
      tyrosine kinase(s) in human myeloid derived cells.", "abstract": "The signalling
      pathways used by the GM\u2010CSF receptor are currently unknown. Here we show
      that in human myeloid derived cells GM\u2010CSF can stimulate; (i) the accumulation
      of PtdIns(3,4,5)P3; (ii) increases in p53/p56lyn and p62c\u2010yes directed
      protein tyrosine kinase activities in anti\u2010lyn and anti\u2010c\u2010yes
      antibody directed immunoprecipitates, respectively and; (iii) increases in phosphoinositide
      3OH\u2010kinase activity in antiphosphotyrosine, anti\u2010p53/p56lyn and anti\u2010p62c\u2010yes
      antibody directed immunoprecipitates. These results suggest that GM\u2010CSF
      can stimulate formation of protein tyrosine kinase co\u2010ordinated signalling
      complexes, that contain p53/p56lyn, p62c\u2010yes and an activated PtdInsP2
      directed phosphoinositide 3OH\u2010kinase, which can drive the accumulation
      of the putative second\u2010messenger PtdIns(3,4,5)P3.", "venue": "EMBO Journal",
      "year": 1993, "referenceCount": 0, "citationCount": 199, "influentialCitationCount":
      4, "isOpenAccess": true, "openAccessPdf": {"url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/j.1460-2075.1993.tb05929.x",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1993-07-01", "journal": {"volume": "12", "name": "The EMBO
      Journal"}, "citationStyles": {"bibtex": "@Article{Corey1993GranulocyteMS,\n
      author = {S. Corey and A. Eguinoa and K. Puyana-Theall and Bolen Jb and L. Cantley
      and F. Mollinedo and Jackson Tr and Hawkins Pt and Stephens Lr},\n booktitle
      = {EMBO Journal},\n journal = {The EMBO Journal},\n title = {Granulocyte macrophage\u2010colony
      stimulating factor stimulates both association and activation of phosphoinositide
      3OH\u2010kinase and src\u2010related tyrosine kinase(s) in human myeloid derived
      cells.},\n volume = {12},\n year = {1993}\n}\n"}, "authors": [{"authorId": "3718221",
      "name": "S. Corey"}, {"authorId": "6757707", "name": "A. Eguinoa"}, {"authorId":
      "1436343879", "name": "K. Puyana-Theall"}, {"authorId": "2224750796", "name":
      "Bolen Jb"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "3345125",
      "name": "F. Mollinedo"}, {"authorId": "2224746779", "name": "Jackson Tr"}, {"authorId":
      "2224747921", "name": "Hawkins Pt"}, {"authorId": "80978403", "name": "Stephens
      Lr"}]}, {"paperId": "d12468292ebd04c5fe35580632c7d027b1e2282f", "externalIds":
      {"MAG": "2230463915", "DOI": "10.1016/B978-0-12-185285-6.50004-X", "CorpusId":
      180661452}, "corpusId": 180661452, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/d12468292ebd04c5fe35580632c7d027b1e2282f",
      "title": "Contributors to Volume 18", "abstract": null, "venue": "", "year":
      1993, "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0,
      "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["History"],
      "s2FieldsOfStudy": [{"category": "History", "source": "external"}], "publicationTypes":
      null, "publicationDate": null, "journal": {"volume": "18", "name": "Methods
      in Neurosciences"}, "citationStyles": {"bibtex": "@Article{Anthes1993ContributorsTV,\n
      author = {J. Anthes and E. S. Bardes and R. Bell and M. Billah and J. Bloomenthal
      and R. Borchardt and U. Brodbeck and L. Cantley and V. Chalifa and R. A. Challiss
      and E. Claro and M. Danin and J. F. Dixon and J. Eichberg and C. Erneux and
      J. Fain and David Frith and A. Ghalayini and Akio Yamakawa},\n journal = {Methods
      in Neurosciences},\n title = {Contributors to Volume 18},\n volume = {18},\n
      year = {1993}\n}\n"}, "authors": [{"authorId": "3862153", "name": "J. Anthes"},
      {"authorId": "4892620", "name": "E. S. Bardes"}, {"authorId": "145671938", "name":
      "R. Bell"}, {"authorId": "47217081", "name": "M. Billah"}, {"authorId": "87501526",
      "name": "J. Bloomenthal"}, {"authorId": "8002063", "name": "R. Borchardt"},
      {"authorId": "3624038", "name": "U. Brodbeck"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "7626687", "name": "V. Chalifa"}, {"authorId": "2095803270",
      "name": "R. A. Challiss"}, {"authorId": "6623565", "name": "E. Claro"}, {"authorId":
      "6239175", "name": "M. Danin"}, {"authorId": "2034026833", "name": "J. F. Dixon"},
      {"authorId": "2362462", "name": "J. Eichberg"}, {"authorId": "4851890", "name":
      "C. Erneux"}, {"authorId": "5565994", "name": "J. Fain"}, {"authorId": "2875568",
      "name": "David Frith"}, {"authorId": "87387818", "name": "A. Ghalayini"}, {"authorId":
      "2056755217", "name": "Akio Yamakawa"}]}, {"paperId": "d76fe36c4f18641cccfacd9e6e47166cece7e0fe",
      "externalIds": {"MAG": "2099661341", "DOI": "10.1016/s0021-9258(18)98375-4",
      "CorpusId": 28533702, "PubMed": "7683653"}, "corpusId": 28533702, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/d76fe36c4f18641cccfacd9e6e47166cece7e0fe",
      "title": "Phosphoinositide 3-kinase is activated by phosphopeptides that bind
      to the SH2 domains of the 85-kDa subunit.", "abstract": null, "venue": "Journal
      of Biological Chemistry", "year": 1993, "referenceCount": 2, "citationCount":
      367, "influentialCitationCount": 10, "isOpenAccess": true, "openAccessPdf":
      null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1993-05-05", "journal": {"volume": "268 13", "pages": "\n          9478-83\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Carpenter1993Phosphoinositide3I,\n author = {C. Carpenter and K. Auger
      and Manas Chanudhuri and M. Yoakim and B. Schaffhausen and S. Shoelson and L.
      Cantley},\n booktitle = {Journal of Biological Chemistry},\n journal = {The
      Journal of biological chemistry},\n pages = {\n          9478-83\n        },\n
      title = {Phosphoinositide 3-kinase is activated by phosphopeptides that bind
      to the SH2 domains of the 85-kDa subunit.},\n volume = {268 13},\n year = {1993}\n}\n"},
      "authors": [{"authorId": "2972505", "name": "C. Carpenter"}, {"authorId": "6603909",
      "name": "K. Auger"}, {"authorId": "2232140164", "name": "Manas Chanudhuri"},
      {"authorId": "8945145", "name": "M. Yoakim"}, {"authorId": "4362128", "name":
      "B. Schaffhausen"}, {"authorId": "4790900", "name": "S. Shoelson"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "f50f7dd9de1beb834afbba500b015d2d986951b1",
      "externalIds": {"MAG": "2746189979", "DOI": "10.1016/B978-0-12-185285-6.50018-X",
      "CorpusId": 90330609}, "corpusId": 90330609, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/f50f7dd9de1beb834afbba500b015d2d986951b1",
      "title": "[12] - Phosphatidylinositol 3-Kinase", "abstract": null, "venue":
      "", "year": 1993, "referenceCount": 15, "citationCount": 3, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"],
      "s2FieldsOfStudy": [{"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "18", "name": "Methods in Neurosciences"}, "citationStyles":
      {"bibtex": "@Article{Soltoff199312P,\n author = {S. Soltoff and D. Kaplan and
      L. Cantley},\n journal = {Methods in Neurosciences},\n title = {[12] - Phosphatidylinositol
      3-Kinase},\n volume = {18},\n year = {1993}\n}\n"}, "authors": [{"authorId":
      "4324390", "name": "S. Soltoff"}, {"authorId": "2112191705", "name": "D. Kaplan"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "4fd524fb1e296516a35d1db366f8a441841765f2",
      "externalIds": {"MAG": "1510919372", "DOI": "10.1016/s0021-9258(18)41950-3",
      "CorpusId": 21163314, "PubMed": "1380963"}, "corpusId": 21163314, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/4fd524fb1e296516a35d1db366f8a441841765f2",
      "title": "Nerve growth factor promotes the activation of phosphatidylinositol
      3-kinase and its association with the trk tyrosine kinase.", "abstract": null,
      "venue": "Journal of Biological Chemistry", "year": 1992, "referenceCount":
      2, "citationCount": 229, "influentialCitationCount": 6, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1992-08-25", "journal": {"volume": "267 24", "pages": "\n          17472-7\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Soltoff1992NerveGF,\n author = {S. Soltoff and S. Rabin and L. Cantley
      and D. Kaplan},\n booktitle = {Journal of Biological Chemistry},\n journal =
      {The Journal of biological chemistry},\n pages = {\n          17472-7\n        },\n
      title = {Nerve growth factor promotes the activation of phosphatidylinositol
      3-kinase and its association with the trk tyrosine kinase.},\n volume = {267
      24},\n year = {1992}\n}\n"}, "authors": [{"authorId": "4324390", "name": "S.
      Soltoff"}, {"authorId": "144521093", "name": "S. Rabin"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "32389352", "name": "D. Kaplan"}]}, {"paperId":
      "ab4903ec94fab162c3af60a5eccfb42c72512397", "externalIds": {"MAG": "1995503266",
      "DOI": "10.1101/SQB.1992.057.01.010", "CorpusId": 44794812, "PubMed": "1339706"},
      "corpusId": 44794812, "publicationVenue": {"id": "e24353f5-13a9-4d82-8e33-329cd22634a0",
      "name": "Cold Spring Harbor Symposia on Quantitative Biology", "type": "journal",
      "alternate_names": ["Cold Spring Harb Symp Quant Biology"], "issn": "0091-7451",
      "url": "https://www.cshlpress.com/", "alternate_urls": ["http://symposium.cshlp.org/content/by/year",
      "http://symposium.cshlp.org/", "http://symposium.cshlp.org/site/misc/index_archive.xhtml"]},
      "url": "https://www.semanticscholar.org/paper/ab4903ec94fab162c3af60a5eccfb42c72512397",
      "title": "Phosphatidylinositol-3 kinase and growth regulation.", "abstract":
      null, "venue": "Cold Spring Harbor Symposia on Quantitative Biology", "year":
      1992, "referenceCount": 0, "citationCount": 23, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"], "publicationDate":
      null, "journal": {"volume": "57", "pages": "\n          75-80\n        ", "name":
      "Cold Spring Harbor symposia on quantitative biology"}, "citationStyles": {"bibtex":
      "@Article{Soltoff1992Phosphatidylinositol3KA,\n author = {S. Soltoff and C.
      Carpenter and K. Auger and R. Kapeller and B. Schaffhausen and L. Cantley},\n
      booktitle = {Cold Spring Harbor Symposia on Quantitative Biology},\n journal
      = {Cold Spring Harbor symposia on quantitative biology},\n pages = {\n          75-80\n        },\n
      title = {Phosphatidylinositol-3 kinase and growth regulation.},\n volume = {57},\n
      year = {1992}\n}\n"}, "authors": [{"authorId": "4324390", "name": "S. Soltoff"},
      {"authorId": "2972505", "name": "C. Carpenter"}, {"authorId": "6603909", "name":
      "K. Auger"}, {"authorId": "2028875", "name": "R. Kapeller"}, {"authorId": "4362128",
      "name": "B. Schaffhausen"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "dc2a65a49dba5ef71f34ab196d06173f85e595fc", "externalIds": {"MAG":
      "1636397264", "DOI": "10.1016/S0021-9258(18)41922-9", "CorpusId": 28992858,
      "PubMed": "1324928"}, "corpusId": 28992858, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/dc2a65a49dba5ef71f34ab196d06173f85e595fc",
      "title": "Ouabain-resistant transfectants of the murine ouabain resistance gene
      contain mutations in the alpha-subunit of the Na,K-ATPase.", "abstract": null,
      "venue": "Journal of Biological Chemistry", "year": 1992, "referenceCount":
      0, "citationCount": 16, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle", "Study"], "publicationDate": "1992-08-25", "journal": {"volume":
      "267 24", "pages": "\n          17271-8\n        ", "name": "The Journal of
      biological chemistry"}, "citationStyles": {"bibtex": "@Article{Cantley1992OuabainresistantTO,\n
      author = {L. Cantley and X. M. Zhou and M. J. Cunha and J. Epstein and L. Cantley},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          17271-8\n        },\n title = {Ouabain-resistant
      transfectants of the murine ouabain resistance gene contain mutations in the
      alpha-subunit of the Na,K-ATPase.},\n volume = {267 24},\n year = {1992}\n}\n"},
      "authors": [{"authorId": "5601835", "name": "L. Cantley"}, {"authorId": "48666973",
      "name": "X. M. Zhou"}, {"authorId": "2056117768", "name": "M. J. Cunha"}, {"authorId":
      "48381149", "name": "J. Epstein"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "dde614da0efd54672d584a131a275d905ed65514", "externalIds": {"MAG":
      "1583451712", "DOI": "10.1128/jvi.66.3.1702-1708.1992", "CorpusId": 25071119,
      "PubMed": "1371171"}, "corpusId": 25071119, "publicationVenue": {"id": "dd4e1ddc-2cf4-4384-9544-cc9a88639c1e",
      "name": "Journal of Virology", "type": "journal", "alternate_names": ["J Virol"],
      "issn": "0022-538X", "url": "https://jvi.asm.org/", "alternate_urls": ["http://jvi.asm.org/"]},
      "url": "https://www.semanticscholar.org/paper/dde614da0efd54672d584a131a275d905ed65514",
      "title": "Transformation-defective mutants of polyomavirus middle T antigen
      associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to
      maintain wild-type levels of PI 3-kinase products in intact cells", "abstract":
      "Middle T antigen (MT) of polyomavirus causes transformation by associating
      with a number of cellular proteins. The association with and activation of two
      such proteins, phosphatidylinositol 3-kinase (PI 3-kinase) and pp60c-src, appears
      to be necessary for transformation by MT. The tyrosine kinase activity of MT-associated
      pp60c-src is significantly increased when assayed in vitro, and levels of phosphotyrosine-containing
      proteins are elevated in vivo. Similarly, levels of the PI 3-kinase products
      phosphatidylinositol-3,4-bisphosphate [PI(3,4)P2] and phosphatiylinositol-3,4,5-trisphosphate
      [PI(3,4,5)P3] are constitutively elevated in MT-transformed cells. However,
      the formation of a complete MT/cellular protein complex and the activation of
      tyrosine kinase are not sufficient to cause transformation, since the transformation-defective
      mutants 248m and dl1015 associate with all wild-type MT-associated proteins,
      including PI 3-kinase and pp60c-src, and neither mutant appears to be defective
      in MT-associated tyrosine kinase activity. Studies presented here compared (i)
      the amount of PI 3-kinase activity associated with the MT complex and (ii) levels
      of [3H]inositol incorporation into PI 3-kinase products in cells expressing
      mutant or wild-type MT. The results show that dl1015 is defective in both assays,
      whereas 248m is defective only for incorporation of [3H]inositol into PI(3,4,5)P2
      and PI(3,4)P3. These findings identify a biochemical defect in the 248m mutant
      and corroborate previous results correlating transformation and elevated levels
      of PI 3-kinase products in vivo. In addition, they indicate that PI 3-kinase
      product levels are affected by factors other than simply the amount of PI 3-kinase
      activity associated with the MT complex.", "venue": "Journal of Virology", "year":
      1992, "referenceCount": 38, "citationCount": 61, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://jvi.asm.org/content/jvi/66/3/1702.full.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1992-03-01", "journal": {"volume": "66",
      "pages": "1702 - 1708", "name": "Journal of Virology"}, "citationStyles": {"bibtex":
      "@Article{Ling1992TransformationdefectiveMO,\n author = {L. Ling and B. Druker
      and L. Cantley and T. Roberts},\n booktitle = {Journal of Virology},\n journal
      = {Journal of Virology},\n pages = {1702 - 1708},\n title = {Transformation-defective
      mutants of polyomavirus middle T antigen associate with phosphatidylinositol
      3-kinase (PI 3-kinase) but are unable to maintain wild-type levels of PI 3-kinase
      products in intact cells},\n volume = {66},\n year = {1992}\n}\n"}, "authors":
      [{"authorId": "50678030", "name": "L. Ling"}, {"authorId": "144082761", "name":
      "B. Druker"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6665338",
      "name": "T. Roberts"}]}, {"paperId": "e8d899326c33bee7d4e0ec59850f377a4860a152",
      "externalIds": {"MAG": "2489175956", "DOI": "10.1016/B978-0-12-150403-8.50010-5",
      "CorpusId": 88887564}, "corpusId": 88887564, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/e8d899326c33bee7d4e0ec59850f377a4860a152",
      "title": "Phosphatidylinositol 3-kinase: A Novel Signal Transduction Pathway?",
      "abstract": null, "venue": "", "year": 1992, "referenceCount": 69, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": {"volume": "", "pages": "175-194",
      "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Auger1992Phosphatidylinositol3A,\n
      author = {K. Auger and L. Cantley},\n pages = {175-194},\n title = {Phosphatidylinositol
      3-kinase: A Novel Signal Transduction Pathway?},\n year = {1992}\n}\n"}, "authors":
      [{"authorId": "6603909", "name": "K. Auger"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "f3c3b7116399fd5c74c2000f34e929b605a28f38", "externalIds":
      {"MAG": "1523963819", "DOI": "10.1016/s0021-9258(18)42781-0", "CorpusId": 22931330,
      "PubMed": "1372000"}, "corpusId": 22931330, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/f3c3b7116399fd5c74c2000f34e929b605a28f38",
      "title": "Polyoma virus middle T antigen-pp60c-src complex associates with purified
      phosphatidylinositol 3-kinase in vitro.", "abstract": null, "venue": "Journal
      of Biological Chemistry", "year": 1992, "referenceCount": 0, "citationCount":
      56, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1992-03-15", "journal": {"volume": "267 8", "pages":
      "\n          5408-15\n        ", "name": "The Journal of biological chemistry"},
      "citationStyles": {"bibtex": "@Article{Auger1992PolyomaVM,\n author = {K. Auger
      and C. Carpenter and S. Shoelson and H. Piwnica-Worms and L. Cantley},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          5408-15\n        },\n title = {Polyoma virus
      middle T antigen-pp60c-src complex associates with purified phosphatidylinositol
      3-kinase in vitro.},\n volume = {267 8},\n year = {1992}\n}\n"}, "authors":
      [{"authorId": "6603909", "name": "K. Auger"}, {"authorId": "2972505", "name":
      "C. Carpenter"}, {"authorId": "4790900", "name": "S. Shoelson"}, {"authorId":
      "1400810799", "name": "H. Piwnica-Worms"}, {"authorId": "1723755", "name": "L.
      Cantley"}]}, {"paperId": "57879f64de3c2012755817e78ee4fb45aaa43d38", "externalIds":
      {"MAG": "2416916901", "CorpusId": 39692600, "PubMed": "1654970"}, "corpusId":
      39692600, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/57879f64de3c2012755817e78ee4fb45aaa43d38",
      "title": "Novel polyphosphoinositides in cell growth and activation.", "abstract":
      "The \"conventional\" polyphosphoinositide pathway is important for the transmission
      and amplification of signals across the cell membrane. Ligand-induced activation
      of phospholipase C results in the hydrolysis of phosphatidylinositol 4,5-bisphosphate
      to produce the well-characterized second messengers, inositol 1,4,5-trisphosphate
      and diacylglycerol. Recently, three novel polyphosphoinositides have been implicated
      as important signaling molecules for cell proliferation and activation. These
      lipids are phosphorylated in the D-3 position of the inositol ring and appear
      to represent branch points from the conventional polyphosphoinositide pathway.",
      "venue": "Cancer cells", "year": 1991, "referenceCount": 0, "citationCount":
      54, "influentialCitationCount": 1, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "1991-07-01", "journal": {"volume": "3 7", "pages": "\n          263-70\n        ",
      "name": "Cancer cells"}, "citationStyles": {"bibtex": "@Article{Auger1991NovelPI,\n
      author = {K. Auger and L. Cantley},\n booktitle = {Cancer cells},\n journal
      = {Cancer cells},\n pages = {\n          263-70\n        },\n title = {Novel
      polyphosphoinositides in cell growth and activation.},\n volume = {3 7},\n year
      = {1991}\n}\n"}, "authors": [{"authorId": "6603909", "name": "K. Auger"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "673c3b345ddecddcfb1fbee37573235ae330f91d",
      "externalIds": {"MAG": "2402463253", "DOI": "10.1042/BJ2730063", "CorpusId":
      21859781, "PubMed": "1846531"}, "corpusId": 21859781, "publicationVenue": {"id":
      "64838252-a209-4424-a778-3b86b4a83c48", "name": "Biochemical Journal", "type":
      "journal", "alternate_names": ["Biochem J"], "issn": "0264-6021", "alternate_issns":
      ["0006-2936"], "url": "http://www.biochemj.org/"}, "url": "https://www.semanticscholar.org/paper/673c3b345ddecddcfb1fbee37573235ae330f91d",
      "title": "A monoclonal antibody distinguishes two types of phosphatidylinositol
      4-kinase.", "abstract": "A monoclonal antibody has been developed against the
      type II PtdIns 4-kinase from bovine brain. This antibody, 4C5G, causes greater
      than 90% inhibition of the type II PtdIns 4-kinase from bovine brain, rat brain
      and human erythrocytes. However, it fails to inhibit type III PtdIns 4-kinase
      from bovine brain or PtdIns 3-kinase from rat liver. These results suggest that
      type II and type III PtdIns 4-kinases are distinct gene products, and that 4C5G
      will be useful in studying the function of the type II PtdIns 4-kinase.", "venue":
      "Biochemical Journal", "year": 1991, "referenceCount": 0, "citationCount": 44,
      "influentialCitationCount": 3, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc1149879?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": null, "journal":
      {"volume": "273(Pt 1)", "pages": "\n          63-6\n        ", "name": "The
      Biochemical journal"}, "citationStyles": {"bibtex": "@Article{Endemann1991AMA,\n
      author = {G. Endemann and A. Graziani and L. Cantley},\n booktitle = {Biochemical
      Journal},\n journal = {The Biochemical journal},\n pages = {\n          63-6\n        },\n
      title = {A monoclonal antibody distinguishes two types of phosphatidylinositol
      4-kinase.},\n volume = {273(Pt 1)},\n year = {1991}\n}\n"}, "authors": [{"authorId":
      "10330714", "name": "G. Endemann"}, {"authorId": "144157656", "name": "A. Graziani"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "6a61c204d7bfb6d6afd0abec49c344f468f65fee",
      "externalIds": {"MAG": "1915712652", "DOI": "10.1128/mcb.11.2.1107-1113.1991",
      "CorpusId": 26203872, "PubMed": "1846663"}, "corpusId": 26203872, "publicationVenue":
      {"id": "7b32fa10-02cb-49a7-a303-15aa60030b9b", "name": "Molecular and Cellular
      Biology", "type": "journal", "alternate_names": ["Mol Cell Biology"], "issn":
      "0270-7306", "url": "https://mcb.asm.org/", "alternate_urls": ["http://mcb.asm.org/"]},
      "url": "https://www.semanticscholar.org/paper/6a61c204d7bfb6d6afd0abec49c344f468f65fee",
      "title": "Activation of phosphatidylinositol 3-kinase in cells expressing abl
      oncogene variants", "abstract": "A phosphoinositide kinase specific for the
      D-3 position of the inositol ring, phosphatidylinositol (PI) 3-kinase, associates
      with activated receptors for platelet-derived growth factor, insulin, and colony-stimulating
      factor 1, with products of the oncogenes src, fms, yes, crk, and with polyomavirus
      middle T antigen. Efficient fibroblast transformation by proteins of the abl
      and src oncogene families requires activation of their protein-tyrosine kinase
      activity and membrane association via an amino-terminal myristoylation. We have
      demonstrated that the PI 3-kinase directly associates with autophosphorylated,
      activated protein-tyrosine kinase variants of the abl protein. In vivo, this
      association leads to accumulation of the highly phosphorylated products of PI
      3-kinase, PI-3,4-bisphosphate and PI-3,4,5-trisphosphate, only in myristoylated,
      transforming abl protein variants. Myristoylation thus appears to be required
      to recruit PI 3-kinase activity to the plasma membrane for in vivo activation
      and correlates with the mitogenicity of the abl protein variants.", "venue":
      "Molecular and Cellular Biology", "year": 1991, "referenceCount": 43, "citationCount":
      197, "influentialCitationCount": 7, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://authors.library.caltech.edu/30211/1/VARmcb91.pdf", "status": null},
      "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy": [{"category": "Medicine",
      "source": "external"}, {"category": "Biology", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1991-02-01", "journal": {"volume": "11", "pages": "1107
      - 1113", "name": "Molecular and Cellular Biology"}, "citationStyles": {"bibtex":
      "@Article{Varticovski1991ActivationOP,\n author = {L. Varticovski and G. Daley
      and Peter K. Jackson and D. Baltimore and L. Cantley},\n booktitle = {Molecular
      and Cellular Biology},\n journal = {Molecular and Cellular Biology},\n pages
      = {1107 - 1113},\n title = {Activation of phosphatidylinositol 3-kinase in cells
      expressing abl oncogene variants},\n volume = {11},\n year = {1991}\n}\n"},
      "authors": [{"authorId": "10119277", "name": "L. Varticovski"}, {"authorId":
      "2028224", "name": "G. Daley"}, {"authorId": "143791010", "name": "Peter K.
      Jackson"}, {"authorId": "144293138", "name": "D. Baltimore"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "984e255eda45d9904e6b42789cd523b1c626b39d",
      "externalIds": {"MAG": "2022163051", "DOI": "10.1210/MEND-5-6-769", "CorpusId":
      2437375, "PubMed": "1656240"}, "corpusId": 2437375, "publicationVenue": {"id":
      "828763fb-d162-432e-929f-4841dc01a887", "name": "Molecular Endocrinology", "type":
      "journal", "alternate_names": ["Mol Endocrinol"], "issn": "0888-8809", "url":
      "http://mend.endojournals.org/"}, "url": "https://www.semanticscholar.org/paper/984e255eda45d9904e6b42789cd523b1c626b39d",
      "title": "Mutations in the juxtamembrane region of the insulin receptor impair
      activation of phosphatidylinositol 3-kinase by insulin.", "abstract": "CHO/IRF960/T962
      cells express a mutant human insulin receptor in which Tyr960 and Ser962 in
      the juxtamembrane region of the receptor''s beta-subunit are replaced by Phe
      and Thr, respectively. The mutant insulin receptor undergoes autophosphorylation
      normally in response to insulin; however, insulin fails to stimulate thymidine
      incorporation into DNA, glycogen synthesis, and tyrosyl phosphorylation of an
      endogenous substrate pp185 in these cells. Another putative substrate of the
      insulin receptor tyrosine kinase is phosphatidylinositol 3-kinase (Ptdlns 3-kinase).
      We have previously shown that Ptdlns 3-kinase activity in Chinese hamster ovary
      cells expressing the wild-type human insulin receptor (CHO/IR) increases in
      both antiphosphotyrosine [anti-Tyr(P)] immunoprecipitates and intact cells in
      response to insulin. In the present study a new technique (detection of the
      85-kDa subunit of Ptdlns 3-kinase using [32P]phosphorylated polyoma virus middle
      T-antigen as probe) is used to monitor the Ptdlns 3-kinase protein. The 85-kDa
      subunit of Ptdlns 3-kinase is precipitated by anti-Tyr(P) antibodies from insulin-stimulated
      CHO/IR cells, but markedly less protein is precipitated from CHO/IRF960/T962
      cells. The amount of Ptdlns 3-kinase activity in the immunoprecipitates was
      also reduced in the CHO/IRF960/T962 cells compared to CHO/IR cells. In intact
      CHO/IRF960/T962 cells, insulin failed to stimulate phosphate incorporation into
      one of the products of activated Ptdlns 3-kinase, phosphatidylinositol-3,4-bisphosphate
      [Ptdlns(3,4)P2], whereas it caused a 12-fold increase in CHO/IR cells. In contrast,
      phosphate incorporation into another product, phosphatidylinositol trisphosphate
      [PtdlnsP3], was only partially depressed in the CHO/IRF960/T962 cells.(ABSTRACT
      TRUNCATED AT 250 WORDS)", "venue": "Molecular Endocrinology", "year": 1991,
      "referenceCount": 30, "citationCount": 35, "influentialCitationCount": 0, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://academic.oup.com/mend/article-pdf/5/6/769/9078708/mend0769.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1991-06-01", "journal": {"volume": "5 6", "pages":
      "\n          769-77\n        ", "name": "Molecular endocrinology"}, "citationStyles":
      {"bibtex": "@Article{Kapeller1991MutationsIT,\n author = {R. Kapeller and Kim
      S. Chen and M. Yoakim and B. Schaffhausen and J. Backer and M. White and L.
      Cantley and N. B. Ruderman},\n booktitle = {Molecular Endocrinology},\n journal
      = {Molecular endocrinology},\n pages = {\n          769-77\n        },\n title
      = {Mutations in the juxtamembrane region of the insulin receptor impair activation
      of phosphatidylinositol 3-kinase by insulin.},\n volume = {5 6},\n year = {1991}\n}\n"},
      "authors": [{"authorId": "2028875", "name": "R. Kapeller"}, {"authorId": "2110591012",
      "name": "Kim S. Chen"}, {"authorId": "8945145", "name": "M. Yoakim"}, {"authorId":
      "4362128", "name": "B. Schaffhausen"}, {"authorId": "35244019", "name": "J.
      Backer"}, {"authorId": "2343034", "name": "M. White"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "2231141703", "name": "N. B. Ruderman"}]},
      {"paperId": "a2df94baba49e0676f6bedb5531fcfa140ed7599", "externalIds": {"MAG":
      "2005529016", "DOI": "10.1016/0092-8674(91)90639-G", "CorpusId": 10422282, "PubMed":
      "1846320"}, "corpusId": 10422282, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/a2df94baba49e0676f6bedb5531fcfa140ed7599",
      "title": "Oncogenes and signal transduction", "abstract": null, "venue": "Cell",
      "year": 1991, "referenceCount": 219, "citationCount": 2472, "influentialCitationCount":
      51, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle", "Study"], "publicationDate": "1991-01-25", "journal":
      {"volume": "64", "pages": "281-302", "name": "Cell"}, "citationStyles": {"bibtex":
      "@Article{Cantley1991OncogenesAS,\n author = {L. Cantley and K. Auger and C.
      Carpenter and B. Duckworth and A. Graziani and R. Kapeller and S. Soltoff},\n
      booktitle = {Cell},\n journal = {Cell},\n pages = {281-302},\n title = {Oncogenes
      and signal transduction},\n volume = {64},\n year = {1991}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6603909", "name":
      "K. Auger"}, {"authorId": "2972505", "name": "C. Carpenter"}, {"authorId": "21162853",
      "name": "B. Duckworth"}, {"authorId": "144157656", "name": "A. Graziani"}, {"authorId":
      "2028875", "name": "R. Kapeller"}, {"authorId": "4324390", "name": "S. Soltoff"}]},
      {"paperId": "dcc5d603c6ea216c148ed717982cbef2954599da", "externalIds": {"MAG":
      "91266548", "DOI": "10.1016/0076-6879(91)98010-4", "CorpusId": 29005038, "PubMed":
      "1649958"}, "corpusId": 29005038, "publicationVenue": {"id": "1e7039c8-e30c-4af0-b7d3-f5e05dff5d21",
      "name": "Methods in Enzymology", "type": "journal", "alternate_names": ["Method
      Enzymol"], "issn": "0076-6879", "alternate_issns": ["1557-7988"], "url": "https://www.elsevier.com/books/book-series/methods-in-enzymology",
      "alternate_urls": ["http://www.sciencedirect.com/science/bookseries/00766879"]},
      "url": "https://www.semanticscholar.org/paper/dcc5d603c6ea216c148ed717982cbef2954599da",
      "title": "Identification and quantification of polyphosphoinositides produced
      in response to platelet-derived growth factor stimulation.", "abstract": null,
      "venue": "Methods in Enzymology", "year": 1991, "referenceCount": 21, "citationCount":
      140, "influentialCitationCount": 7, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      null, "journal": {"volume": "198", "pages": "\n          78-87\n        ", "name":
      "Methods in enzymology"}, "citationStyles": {"bibtex": "@Article{Serunian1991IdentificationAQ,\n
      author = {L. Serunian and K. Auger and L. Cantley},\n booktitle = {Methods in
      Enzymology},\n journal = {Methods in enzymology},\n pages = {\n          78-87\n        },\n
      title = {Identification and quantification of polyphosphoinositides produced
      in response to platelet-derived growth factor stimulation.},\n volume = {198},\n
      year = {1991}\n}\n"}, "authors": [{"authorId": "5260667", "name": "L. Serunian"},
      {"authorId": "6603909", "name": "K. Auger"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "1b2744489cb1873f4cf96fe9a82081635ccbc8ab", "externalIds":
      {"MAG": "2092045274", "DOI": "10.1073/PNAS.87.4.1411", "CorpusId": 34520561,
      "PubMed": "2154747"}, "corpusId": 34520561, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/1b2744489cb1873f4cf96fe9a82081635ccbc8ab",
      "title": "Activation of phosphatidylinositol 3-kinase by insulin.", "abstract":
      "Insulin action appears to require the protein-tyrosine kinase domain of the
      beta subunit of the insulin receptor. Despite this, the identities and biochemical
      functions of the cellular targets of this tyrosine kinase are unknown. A phosphatidylinositol
      3-kinase (PI 3-kinase) that phosphorylates the D-3 position of the inositol
      ring associates with several protein-tyrosine kinases. Here we report that PI
      3-kinase activity is immunoprecipitated from insulin-stimulated CHO cells by
      antiphosphotyrosine and anti-insulin receptor antibodies. Insulin as low as
      0.3 nM increased immunoprecipitable PI 3-kinase activity within 1 min. Increases
      in activity were much greater in CHO cells expressing the human insulin receptor
      (100,000 receptors per cell) than in control CHO cells (2000 receptors per cell).
      During insulin stimulation, various lipid products of the PI 3-kinase either
      appeared or increased in quantity in intact cells, suggesting that the appearance
      of immunoprecipitable PI 3-kinase reflects an increase in its activity in vivo.
      These results indicate that insulin at physiological concentrations regulates
      the PI 3-kinase and suggest that this regulation involves a physical association
      between the insulin receptor and the PI 3-kinase and tyrosyl phosphorylation.",
      "venue": "Proceedings of the National Academy of Sciences of the United States
      of America", "year": 1990, "referenceCount": 5, "citationCount": 444, "influentialCitationCount":
      10, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc53485?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1990-02-01", "journal": {"volume": "87",
      "pages": "1411 - 1415", "name": "Proceedings of the National Academy of Sciences
      of the United States of America"}, "citationStyles": {"bibtex": "@Article{Ruderman1990ActivationOP,\n
      author = {N. Ruderman and R. Kapeller and M. White and L. Cantley},\n booktitle
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences of the United States
      of America},\n pages = {1411 - 1415},\n title = {Activation of phosphatidylinositol
      3-kinase by insulin.},\n volume = {87},\n year = {1990}\n}\n"}, "authors": [{"authorId":
      "3978573", "name": "N. Ruderman"}, {"authorId": "2028875", "name": "R. Kapeller"},
      {"authorId": "2343034", "name": "M. White"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "3a38cc52e2fbf9f5767e3983fa2443d69f07d5f7", "externalIds":
      {"MAG": "2185282572", "CorpusId": 97883248}, "corpusId": 97883248, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/3a38cc52e2fbf9f5767e3983fa2443d69f07d5f7",
      "title": "Comparison with the Muscarinic Agonist Carbachol", "abstract": "The
      effects of extracellular ATP on ion fluxes and the intracellular free Ca 2\u00a7
      concentration ((Ca~+)i) were examined using a suspension of rat parotid acinar
      cells and were contrasted with the effects of the muscarinic agonist carba-
      chol. Although ATP and carbachol both rapidly increased (Ca2+) i about threefold
      above the resting level (200-250 nM), the effect of ATP was due primarily to
      an influx of Ca ~+ across the plasma membrane, while the initial response to
      carbachol was due to a release of Ca ~\u00a7 from intracellular stores. Within
      10 s, ATP (1 mM) and carbachol (20 #M) reduced the cellular C1- content by 39-50%
      and cell vol- ume by 15-25%. Both stimuli reduced the cytosolic K + content
      by 57-65%, but there were marked differences in the rate and pattern of net
      K \u00a7 movement as well as the effects of K + channel inhibitors on the effluxes
      initiated by the two stimuli. The maximum rate of the ATP-stimulated K \u00a7
      efflux (~2,200 nmol K+/mg protein per min) was about two-thirds that of the
      carbachol-initiated efflux rate, and was reduced by ~30% (vs. 60% for the carbachol-stimulated
      K + efflux) by TEA (tetra- ethylammonium), an inhibitor of the large conductance
      (BK) K \u00a7 channel. Charyb- dotoxin, another K \u00a7 channel blocker, was
      markedly more effective than TEA on the effects of both agonists, and reduced
      the rate of K \u00a7 effiux initiated by both ATP and carbachol by ~80%. The
      removal of extracellular Ca ~\u00a7 reduced the ATP- and the carbachol-stimulated
      rates of K + efflux by 55 and 17%, respectively. The rate of K + effiux initiated
      by either agonist was reduced by 78-95% in cells that were loaded with BAPTA
      to slow the elevation of (Ca2+)i. These results indicated that ATP and carbachol
      stimulated the effiux of K + through multiple types of K \u00a7 permeable channels,
      and demonstrated that the relative proportion of efflux", "venue": "", "year":
      1990, "referenceCount": 47, "citationCount": 6, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Soltoff1990ComparisonWT,\n author = {S. Soltoff and
      M. McMillian and E. Cragoe and L. Cantley and B. Talamo},\n title = {Comparison
      with the Muscarinic Agonist Carbachol},\n year = {1990}\n}\n"}, "authors": [{"authorId":
      "4324390", "name": "S. Soltoff"}, {"authorId": "144664118", "name": "M. McMillian"},
      {"authorId": "5783113", "name": "E. Cragoe"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3683975", "name": "B. Talamo"}]}, {"paperId": "3fdd62cb9174c24c737e7ba46e72491588c54336",
      "externalIds": {"MAG": "2171783790", "PubMedCentral": "2216318", "DOI": "10.1085/JGP.95.2.319",
      "CorpusId": 13505799, "PubMed": "1689766"}, "corpusId": 13505799, "publicationVenue":
      {"id": "eb5b7fda-8fd6-48a1-bfed-2aac4b99cbee", "name": "The Journal of General
      Physiology", "type": "journal", "alternate_names": ["J Gen Physiol"], "issn":
      "0022-1295", "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=484",
      "alternate_urls": ["http://jgp.rupress.org/"]}, "url": "https://www.semanticscholar.org/paper/3fdd62cb9174c24c737e7ba46e72491588c54336",
      "title": "Effects of extracellular ATP on ion transport systems and [Ca2+]i
      in rat parotid acinar cells. Comparison with the muscarinic agonist carbachol",
      "abstract": "The effects of extracellular ATP on ion fluxes and the intracellular
      free Ca2+ concentration ([Ca2+]i) were examined using a suspension of rat parotid
      acinar cells and were contrasted with the effects of the muscarinic agonist
      carbachol. Although ATP and carbachol both rapidly increased [Ca2+]i about threefold
      above the resting level (200-250 nM), the effect of ATP was due primarily to
      an influx of Ca2+ across the plasma membrane, while the initial response to
      carbachol was due to a release of Ca2+ from intracellular stores. Within 10
      s, ATP (1 mM) and carbachol (20 microM) reduced the cellular Cl- content by
      39-50% and cell volume by 15-25%. Both stimuli reduced the cytosolic K+ content
      by 57-65%, but there were marked differences in the rate and pattern of net
      K+ movement as well as the effects of K+ channel inhibitors on the effluxes
      initiated by the two stimuli. The maximum rate of the ATP- stimulated K+ efflux
      (approximately 2,200 nmol K+/mg protein per min) was about two-thirds that of
      the carbachol-initiated efflux rate, and was reduced by approximately 30% (vs.
      60% for the carbachol-stimulated K+ efflux) by TEA (tetraethylammonium), an
      inhibitor of the large conductance (BK) K+ channel. Charybdotoxin, another K+
      channel blocker, was markedly more effective than TEA on the effects of both
      agonists, and reduced the rate of K+ efflux initiated by both ATP and carbachol
      by approximately 80%. The removal of extracellular Ca2+ reduced the ATP- and
      the carbachol-stimulated rates of K+ efflux by 55 and 17%, respectively. The
      rate of K+ efflux initiated by either agonist was reduced by 78-95% in cells
      that were loaded with BAPTA to slow the elevation of [Ca2+]i. These results
      indicated that ATP and carbachol stimulated the efflux of K+ through multiple
      types of K(+)-permeable channels, and demonstrated that the relative proportion
      of efflux through the different pathways was different for the two stimuli.
      ATP and carbachol also stimulated the rapid entry of Na+ into the parotid cell,
      and elevated the intracellular Na+ content to 4.4 and 2.6 times the normal level,
      respectively. The rate of Na+ entry through Na(+)- K(+)-2Cl- cotransport and
      Na(+)-H+ exchange was similar whether stimulated by ATP, carbachol, or ionomycin,
      and uptake through these two carrier-mediated transporters accounted for 50%
      of the ATP-promoted Na+ influx. The remainder may be due to a nonselective cation
      channel and an ATP-gated cation channel that is also permeable to Ca2+.(ABSTRACT
      TRUNCATED AT 400 WORDS)", "venue": "The Journal of General Physiology", "year":
      1990, "referenceCount": 61, "citationCount": 80, "influentialCitationCount":
      3, "isOpenAccess": true, "openAccessPdf": {"url": "https://rupress.org/jgp/article-pdf/95/2/319/1249408/319.pdf",
      "status": null}, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle",
      "Study"], "publicationDate": "1990-02-01", "journal": {"volume": "95", "pages":
      "319 - 346", "name": "The Journal of General Physiology"}, "citationStyles":
      {"bibtex": "@Article{Soltoff1990EffectsOE,\n author = {S. Soltoff and M. McMillian
      and E. Cragoe and L. Cantley and B. Talamo},\n booktitle = {The Journal of General
      Physiology},\n journal = {The Journal of General Physiology},\n pages = {319
      - 346},\n title = {Effects of extracellular ATP on ion transport systems and
      [Ca2+]i in rat parotid acinar cells. Comparison with the muscarinic agonist
      carbachol},\n volume = {95},\n year = {1990}\n}\n"}, "authors": [{"authorId":
      "4324390", "name": "S. Soltoff"}, {"authorId": "144664118", "name": "M. McMillian"},
      {"authorId": "5783113", "name": "E. Cragoe"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "3683975", "name": "B. Talamo"}]}, {"paperId": "4a945a71468432a8c691957d6518b571bb436e5f",
      "externalIds": {"MAG": "2915750128", "CorpusId": 104472401}, "corpusId": 104472401,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/4a945a71468432a8c691957d6518b571bb436e5f",
      "title": "Phosphatidylinositol 3 kinase is activated by insulin", "abstract":
      null, "venue": "", "year": 1990, "referenceCount": 0, "citationCount": 4, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "1990-08-16", "journal": null, "citationStyles": {"bibtex": "@Inproceedings{Kapeller1990Phosphatidylinositol3K,\n
      author = {R. Kapeller and N. Ruderman and M. White and L. Cantley},\n title
      = {Phosphatidylinositol 3 kinase is activated by insulin},\n year = {1990}\n}\n"},
      "authors": [{"authorId": "2028875", "name": "R. Kapeller"}, {"authorId": "3978573",
      "name": "N. Ruderman"}, {"authorId": "2343034", "name": "M. White"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "4abf293420ac6fabe46bc886619bfdccfa99b60c",
      "externalIds": {"MAG": "2021855501", "DOI": "10.1016/0955-2863(90)90054-O",
      "CorpusId": 25103037, "PubMed": "15539189"}, "corpusId": 25103037, "publicationVenue":
      {"id": "cff0222c-6e21-445c-881c-3c9da8b7c947", "name": "Journal of Nutritional
      Biochemistry", "type": "journal", "alternate_names": ["J Nutr Biochem"], "issn":
      "0955-2863", "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/525013/description#description",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/09552863",
      "http://www.journals.elsevier.com/the-journal-of-nutritional-biochemistry/",
      "https://www.journals.elsevier.com/the-journal-of-nutritional-biochemistry/"]},
      "url": "https://www.semanticscholar.org/paper/4abf293420ac6fabe46bc886619bfdccfa99b60c",
      "title": "1,25(OH)2D3 increases calcium and phosphatidylinositol metabolism
      in differentiating cultured human keratinocytes.", "abstract": null, "venue":
      "Journal of Nutritional Biochemistry", "year": 1990, "referenceCount": 23, "citationCount":
      52, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Environmental Science", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1990-02-01", "journal": {"volume": "1 2", "pages": "\n          81-7\n        ",
      "name": "The Journal of nutritional biochemistry"}, "citationStyles": {"bibtex":
      "@Article{MacLaughlin1990125OH2D3IC,\n author = {J. MacLaughlin and L. Cantley
      and M. Holick},\n booktitle = {Journal of Nutritional Biochemistry},\n journal
      = {The Journal of nutritional biochemistry},\n pages = {\n          81-7\n        },\n
      title = {1,25(OH)2D3 increases calcium and phosphatidylinositol metabolism in
      differentiating cultured human keratinocytes.},\n volume = {1 2},\n year = {1990}\n}\n"},
      "authors": [{"authorId": "144606947", "name": "J. MacLaughlin"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4873870", "name": "M. Holick"}]},
      {"paperId": "7dd7d4d8ea9f4ae216a0411393fac1a960fe2a98", "externalIds": {"MAG":
      "2066874852", "DOI": "10.1111/j.1749-6632.1990.tb37663.x", "CorpusId": 36146594,
      "PubMed": "1705402"}, "corpusId": 36146594, "publicationVenue": {"id": "fa1f0815-0811-4291-b4fc-8230a6c9bf5b",
      "name": "Annals of the New York Academy of Sciences", "type": "journal", "alternate_names":
      ["Ann n y Acad Sci"], "issn": "0077-8923", "url": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1749-6632",
      "alternate_urls": ["http://www.annalsnyas.org/", "http://www.nyas.org/publications/annals/default.aspx",
      "https://onlinelibrary.wiley.com/journal/17496632"]}, "url": "https://www.semanticscholar.org/paper/7dd7d4d8ea9f4ae216a0411393fac1a960fe2a98",
      "title": "Elevation of [Ca2+]i and the Activation of Ion Channels and Fluxes
      by Extracellular ATP and Phospholipase C\u2010Linked Agonists in Rat Parotid
      Acinar Cells", "abstract": "Extracellular ATP initiates a variety of changes
      in the parotid acinar cell. The initial effect appears to be the entry of Ca2+
      (and perhaps Na+), and a series of ion transport events result from the subsequent
      elevation of [Ca2+]i. Agonists of phospholipase C-linked receptors elevate [Ca2+]i
      by a different pathway, involving the generation of inositol polyphosphate compounds,
      but share in the subsequent initiation of the ion transport events. Although
      the maintenance of the physiological changes may depend on specific inositol
      polyphosphate intermediates, the critical initiating factor is the elevation
      of [Ca2+]i. Fluid secretion by the parotid gland is triggered by the action
      of neurotransmitters, which alter the membrane permeability of the acinar cell.
      The similarities between the two receptor-mediated activation pathways suggests
      that ATP may act as a neurotransmitter and play a role in the control of fluid
      secretion. Basing our analysis on the purinoceptor characteristics outlined
      by Gordon, we suggest that the parotid receptor belongs to the P2Z class, which
      is highly sensitive to ATP4-. Basing his analysis on the earlier report by Gallacher
      of the effects of ATP on mouse parotid cells, Gordon placed the parotid purinoceptor
      in a different P2 subclass (P2Y). However, our findings of an increased potency
      of ATP in the absence of Mg2+, as well as the potency order of different nucleotides,
      indicate that the P2Z class is a more appropriate category.", "venue": "Annals
      of the New York Academy of Sciences", "year": 1990, "referenceCount": 34, "citationCount":
      42, "influentialCitationCount": 3, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "1990-12-01", "journal": {"volume": "603", "name": "Annals
      of the New York Academy of Sciences"}, "citationStyles": {"bibtex": "@Article{Soltoff1990ElevationO,\n
      author = {S. Soltoff and M. McMillian and J. Lechleiter and L. Cantley and B.
      Talamo},\n booktitle = {Annals of the New York Academy of Sciences},\n journal
      = {Annals of the New York Academy of Sciences},\n title = {Elevation of [Ca2+]i
      and the Activation of Ion Channels and Fluxes by Extracellular ATP and Phospholipase
      C\u2010Linked Agonists in Rat Parotid Acinar Cells},\n volume = {603},\n year
      = {1990}\n}\n"}, "authors": [{"authorId": "4324390", "name": "S. Soltoff"},
      {"authorId": "144664118", "name": "M. McMillian"}, {"authorId": "144776879",
      "name": "J. Lechleiter"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3683975", "name": "B. Talamo"}]}, {"paperId": "aa8f12da64f41d14a9519e92c549bceb06680fe9",
      "externalIds": {"MAG": "2014852355", "DOI": "10.1111/j.1749-6632.1990.tb37700.x",
      "CorpusId": 84482224}, "corpusId": 84482224, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/aa8f12da64f41d14a9519e92c549bceb06680fe9",
      "title": "ATP Produces Two Cai Responses in Rat Parotid Cells", "abstract":
      "Extracellular ATP increased intracellular calcium (Ca,) in a biphasic manner
      in Fura2-loaded rat parotid acinar cells, with a small effect apparent between
      0.1 and 10 p M ATP and a much larger effect observed between 50 and 300 p M
      ATP (in the absence of Mg\u2019+ with 1 mM Ca\u2019 \u2019 present). This latter
      effect, which we previously described,\u2019 appears to be mediated by a P,,-purinergic
      receptor; blockade by high Mg\u2019 \u2019 or Ca2 \u2019 suggests that ATP4
      is the actual agonist, and the selective P,z agonist 3\u2019-0-(4benzoyl)benz.oyl-ATP
      (Bz-ATP) was about 30-fold more potent and 3-fold more efficacious than ATP
      (these differences being due, at least in part, to covalent activation by Bz-ATP).
      In contrast, the more sensitive ATP response was only slightly diminished by
      elevated Mg2 \u2019 or Ca\u2019 \u2019( 10 mM) in the buffer (this difference
      probably being due to increased degradation of ATP and/or production of ADP,
      which blocked the ATP response). Bz-ATP was ineffective as an agonist on the
      more sensitive response to ATP, but other P,-purinergic agonists showed a similar
      potency series for both ATP responses in parotid cells: ATP > ATP-y-S 2 2I-MeS-ATP
      > > ITP and AMPCPP. Thus, the more sensitive response, though not mediated through
      a P22 receptor, is more similar to this response than to P2,or P,,-purinergic
      responses. 4,4\u2018-Diisothiocyano-2,2\u2019-stilbene disulfonate (DIDS) and
      reactive blue 2 (Cibacron blue) blocked the large ATP4 effect on Ca, and also
      inhibited [\u2018*P]ATP binding to parotid cells under conditions (phosphate-buffered
      saline with no added Mg\u201d or Ca2+) selective for ATP4. Reactive blue 2 pretreatment
      blocked irreversible effects of DIDS and Bz-ATP, presumably by blocking the
      P2, receptor and protecting it from covalent inactivation or activation, respectively.
      In contrast to Ca, responses to ATP4 , the more sensitive response to ATP was
      slightly potentiated by both DIDS and reactive blue 2 (this difference probably
      being due to inhibition of ATPases). Both P,-receptors on parotid cells may
      open Ca\u2019 \u2019 -permeable channels, since both responses are largely dependent
      on extracellular calcium and are quenched by extracellular Mn2 \u2019 , in contrast
      to muscarinic agonists and substance P. A weak effect of ATP on phosphatidylinositol
      turnover and Ca, mobilization was due to ATP4 , since this effect required high
      concentrations of ATP, was mimicked by Bz-ATP, and was blocked by DIDS and MgZ
      \u2019 . The more sensitive ATP response may be physiologically important, since
      parasympathetic denervation produced a 3-fold increase in the maximal Ca, response
      to 3 p M ATP, with no change in the ATP4 response or in maximal carbachol or
      substance P responses.", "venue": "", "year": 1990, "referenceCount": 1, "citationCount":
      3, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "1990-12-01", "journal": {"volume": "603", "name": "Annals of the New York Academy
      of Sciences"}, "citationStyles": {"bibtex": "@Article{McMillian1990ATPPT,\n
      author = {M. McMillian and S. Soltoff and L. Cantley and B. Talamo},\n journal
      = {Annals of the New York Academy of Sciences},\n title = {ATP Produces Two
      Cai Responses in Rat Parotid Cells},\n volume = {603},\n year = {1990}\n}\n"},
      "authors": [{"authorId": "144664118", "name": "M. McMillian"}, {"authorId":
      "4324390", "name": "S. Soltoff"}, {"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "3683975", "name": "B. Talamo"}]}, {"paperId": "b2838fdd768aa383ce1f7e345c8dc8826ac8f7ad",
      "externalIds": {"MAG": "1545503281", "DOI": "10.1016/S0021-9258(17)45429-9",
      "CorpusId": 20077714, "PubMed": "2174051"}, "corpusId": 20077714, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/b2838fdd768aa383ce1f7e345c8dc8826ac8f7ad",
      "title": "Purification and characterization of phosphoinositide 3-kinase from
      rat liver.", "abstract": null, "venue": "Journal of Biological Chemistry", "year":
      1990, "referenceCount": 34, "citationCount": 532, "influentialCitationCount":
      11, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1990-11-15", "journal": {"volume": "265 32", "pages": "\n          19704-11\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Carpenter1990PurificationAC,\n author = {C. Carpenter and B. Duckworth
      and K. Auger and B. D. Cohen and B. Schaffhausen and L. Cantley},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          19704-11\n        },\n title = {Purification
      and characterization of phosphoinositide 3-kinase from rat liver.},\n volume
      = {265 32},\n year = {1990}\n}\n"}, "authors": [{"authorId": "2972505", "name":
      "C. Carpenter"}, {"authorId": "21162853", "name": "B. Duckworth"}, {"authorId":
      "6603909", "name": "K. Auger"}, {"authorId": "47828784", "name": "B. D. Cohen"},
      {"authorId": "4362128", "name": "B. Schaffhausen"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "d7021ed3b8cb53a59fca98463dc80d948e864a7a",
      "externalIds": {"MAG": "1617300304", "DOI": "10.1111/J.1749-6632.1990.TB37699.X",
      "CorpusId": 83965272}, "corpusId": 83965272, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/d7021ed3b8cb53a59fca98463dc80d948e864a7a",
      "title": "Extracellular ATP Gates a Ca2+\u2010Permeable Nonselective Cation
      Channel in Rat Parotid Acinar Cells", "abstract": "We investigated the effect
      of ATP4on 4sCa2+ entry into rat parotid acinar cells. The maximum ATP-stimulated
      influx rate (6 nmol/mg/min, with a of 150 pM) was about 20 times the basal rate.
      3''-0-( 4-Benzoy1)benzoyl-ATP ( Bz-ATP) was 30 times more potent and nearly
      twice as effective as ATP in stimulating Ca2+ influx. Other analogues were much
      less effective than ATP. The order of effectiveness of nucleotide analogues
      on 45Ca2+ entry was Bz-ATP > ATP > ATP-y-S > 2-methylthio-ATP > a$-methylene
      ATP, ADP. The potency and effectiveness of ATP were increased 2-3-fold in the
      absence of extracellular Na2+, which may compete with Ca2+ for entry through
      an ATP-gated Na+and Ca*+-permeable channel. 4,4''Diisothiocyano-2,2''-stilbene
      disulfonate (DIDS), which has two -NCS groups, at 100 pM completely blocked
      the ATP-stimulated influx (EC,,, = 40 pM). 4-Acetamino4''-isothiocyanostilbene-2,2''-disulfonate
      (SITs), which has one -NCS group, was about 50% as potent as DIDS. 4,4''-Dinitrostilbene-2,2''-disulfonate
      (DNDS), which lacks -NCS groups, at 1 mM was ineffective, as was K+SCN-. Reactive
      blue 2 (Cibacron Blue), a nonstilbene compound, also blocked 45Ca2+ entry (EC,,
      = 50 FM). The effect of DIDS was irreversible, but the effect of reactive blue
      2 was reversible by washing the cells. Reactive blue 2, added before DIDS, blocked
      the irreversible effect of DIDS. Our conclusions are as follows: 1) ATP activates
      a nonselective cation channel. 2) Stilbene compounds with -NCS groups covalently
      block the binding of ATP to its receptor. 3 ) Reactive blue 2 binds noncovalently
      to prevent DIDS and ATP binding.", "venue": "", "year": 1990, "referenceCount":
      0, "citationCount": 2, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "1990-12-01", "journal": {"volume": "603", "name": "Annals
      of the New York Academy of Sciences"}, "citationStyles": {"bibtex": "@Article{Soltoff1990ExtracellularAG,\n
      author = {S. Soltoff and M. McMillian and B. Talamo and L. Cantley},\n journal
      = {Annals of the New York Academy of Sciences},\n title = {Extracellular ATP
      Gates a Ca2+\u2010Permeable Nonselective Cation Channel in Rat Parotid Acinar
      Cells},\n volume = {603},\n year = {1990}\n}\n"}, "authors": [{"authorId": "4324390",
      "name": "S. Soltoff"}, {"authorId": "144664118", "name": "M. McMillian"}, {"authorId":
      "3683975", "name": "B. Talamo"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "ecc6ad0cd6f5143b26a6388d6b0e2d2d2c6f526f", "externalIds": {"DOI":
      "10.1021/bi00503a001", "CorpusId": 35406982, "PubMed": "2176895"}, "corpusId":
      35406982, "publicationVenue": {"id": "ae7a3201-e479-4666-8a93-3d35d6bf7cd1",
      "name": "Biochemistry", "type": "journal", "issn": "0006-2960", "alternate_issns":
      ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw", "alternate_urls":
      ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/ecc6ad0cd6f5143b26a6388d6b0e2d2d2c6f526f",
      "title": "Phosphoinositide kinases.", "abstract": null, "venue": "Biochemistry",
      "year": 1990, "referenceCount": 0, "citationCount": 85, "influentialCitationCount":
      7, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine"],
      "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": null, "journal":
      {"volume": "29 51", "pages": "\n          11147-56\n        ", "name": "Biochemistry"},
      "citationStyles": {"bibtex": "@Article{Carpenter1990PhosphoinositideK,\n author
      = {C. Carpenter and L. Cantley},\n booktitle = {Biochemistry},\n journal = {Biochemistry},\n
      pages = {\n          11147-56\n        },\n title = {Phosphoinositide kinases.},\n
      volume = {29 51},\n year = {1990}\n}\n"}, "authors": [{"authorId": "2972505",
      "name": "C. Carpenter"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "ed04a19ea30e280224800323560c7f435fd3a8ce", "externalIds": {"MAG": "2917446036",
      "CorpusId": 104420985}, "corpusId": 104420985, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/ed04a19ea30e280224800323560c7f435fd3a8ce",
      "title": "Phosphatidylinositol pathways in growth and transformation", "abstract":
      null, "venue": "", "year": 1990, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "1990-02-15", "journal": {"volume": "", "pages": "246", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Cantley1990PhosphatidylinositolPI,\n author = {L.
      Cantley and L. Serunian and K. Auger and L. Varticovski and R. Kapeller and
      C. Carpenter and B. Drucker and N. Ruderman and M. White},\n pages = {246},\n
      title = {Phosphatidylinositol pathways in growth and transformation},\n year
      = {1990}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5260667", "name": "L. Serunian"}, {"authorId": "6603909", "name":
      "K. Auger"}, {"authorId": "10119277", "name": "L. Varticovski"}, {"authorId":
      "2028875", "name": "R. Kapeller"}, {"authorId": "2972505", "name": "C. Carpenter"},
      {"authorId": "2056828167", "name": "B. Drucker"}, {"authorId": "3978573", "name":
      "N. Ruderman"}, {"authorId": "2343034", "name": "M. White"}]}, {"paperId": "f2db7bcf4b61271d8264c8580726e6ae9dfe6141",
      "externalIds": {"MAG": "1595741577", "DOI": "10.1016/s0021-9258(18)45672-4",
      "CorpusId": 24034131, "PubMed": "2176203"}, "corpusId": 24034131, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/f2db7bcf4b61271d8264c8580726e6ae9dfe6141",
      "title": "A novel pathway for the formation of phosphatidylinositol 3,4-bisphosphate.
      Phosphorylation of phosphatidylinositol 3-monophosphate by phosphatidylinositol-3-monophosphate
      4-kinase.", "abstract": null, "venue": "Journal of Biological Chemistry", "year":
      1990, "referenceCount": 0, "citationCount": 41, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Chemistry"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Chemistry", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1990-12-25", "journal": {"volume": "265
      36", "pages": "\n          22086-9\n        ", "name": "The Journal of biological
      chemistry"}, "citationStyles": {"bibtex": "@Article{Yamamoto1990ANP,\n author
      = {K. Yamamoto and A. Graziani and C. Carpenter and L. Cantley and E. Lapetina},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          22086-9\n        },\n title = {A novel pathway
      for the formation of phosphatidylinositol 3,4-bisphosphate. Phosphorylation
      of phosphatidylinositol 3-monophosphate by phosphatidylinositol-3-monophosphate
      4-kinase.},\n volume = {265 36},\n year = {1990}\n}\n"}, "authors": [{"authorId":
      "2107575636", "name": "K. Yamamoto"}, {"authorId": "144157656", "name": "A.
      Graziani"}, {"authorId": "2972505", "name": "C. Carpenter"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "7004693", "name": "E. Lapetina"}]}, {"paperId":
      "fe00566546f2876557cd00b0ac501bd3990ca98e", "externalIds": {"MAG": "1789958833",
      "DOI": "10.1128/jvi.64.10.4718-4725.1990", "CorpusId": 33672361, "PubMed": "2168961"},
      "corpusId": 33672361, "publicationVenue": {"id": "dd4e1ddc-2cf4-4384-9544-cc9a88639c1e",
      "name": "Journal of Virology", "type": "journal", "alternate_names": ["J Virol"],
      "issn": "0022-538X", "url": "https://jvi.asm.org/", "alternate_urls": ["http://jvi.asm.org/"]},
      "url": "https://www.semanticscholar.org/paper/fe00566546f2876557cd00b0ac501bd3990ca98e",
      "title": "Production of novel polyphosphoinositides in vivo is linked to cell
      transformation by polyomavirus middle T antigen", "abstract": "Phosphatidylinositol
      3-kinase associates with the polyomavirus middle T antigen (PyMTAg)-pp60c-src
      complex in polyomavirus-transformed cells. Here we show that anti-PyMTAg immunoprecipitates
      from PyMTAg-transformed NIH 3T3 cells have lipid kinase activities that phosphorylate
      phosphatidylinositol, phosphatidylinositol-4-bisphosphate, and phosphatidylinositol-4,5-bisphosphate
      at the D-3 position of the inositol ring to produce three new polyphosphoinositides:
      phosphatidylinositol-3-phosphate (PI-3-P), phosphatidylinositol-3,4-bisphosphate
      (PI-3,4-P2), and phosphatidylinositol trisphosphate (PIP3), respectively. PI-3-P
      was detected in intact parental and PyMTAg-transformed NIH 3T3 fibroblasts at
      both low and high cell densities. However, parental NIH 3T3 fibroblasts produced
      no detectable PI-3,4-P2 or PIP3 at high density. In contrast, growing, subconfluent
      cells and wild-type PyMTAg-transformed cells at high density had greatly enhanced
      incorporation of [3H]-inositol into these highly phosphorylated lipids. Cells
      transfected with a transformation-defective mutant of PyMTAg had undetectable
      levels of PI-3,4-P2 and PIP3 at high density. Thus, the synthesis of novel polyphosphoinositides
      by lipid kinase activity associated with PyMTAg correlates with cell growth
      and transformation.", "venue": "Journal of Virology", "year": 1990, "referenceCount":
      31, "citationCount": 78, "influentialCitationCount": 1, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://jvi.asm.org/content/jvi/64/10/4718.full.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1990-10-01", "journal": {"volume": "64",
      "pages": "4718 - 4725", "name": "Journal of Virology"}, "citationStyles": {"bibtex":
      "@Article{Serunian1990ProductionON,\n author = {L. Serunian and K. Auger and
      T. Roberts and L. Cantley},\n booktitle = {Journal of Virology},\n journal =
      {Journal of Virology},\n pages = {4718 - 4725},\n title = {Production of novel
      polyphosphoinositides in vivo is linked to cell transformation by polyomavirus
      middle T antigen},\n volume = {64},\n year = {1990}\n}\n"}, "authors": [{"authorId":
      "5260667", "name": "L. Serunian"}, {"authorId": "6603909", "name": "K. Auger"},
      {"authorId": "6665338", "name": "T. Roberts"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "4e9acf3c918479f1ac0585c4cc237e46fc212d0d", "externalIds":
      {"MAG": "1975642651", "DOI": "10.1016/0092-8674(89)90182-7", "CorpusId": 22154860,
      "PubMed": "2467744"}, "corpusId": 22154860, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/4e9acf3c918479f1ac0585c4cc237e46fc212d0d",
      "title": "PDGF-dependent tyrosine phosphorylation stimulates production of novel
      polyphosphoinositides in intact cells", "abstract": null, "venue": "Cell", "year":
      1989, "referenceCount": 33, "citationCount": 800, "influentialCitationCount":
      19, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1989-04-07", "journal": {"volume": "57",
      "pages": "167-175", "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Auger1989PDGFdependentTP,\n
      author = {K. Auger and L. Serunian and S. Soltoff and P. Libby and L. Cantley},\n
      booktitle = {Cell},\n journal = {Cell},\n pages = {167-175},\n title = {PDGF-dependent
      tyrosine phosphorylation stimulates production of novel polyphosphoinositides
      in intact cells},\n volume = {57},\n year = {1989}\n}\n"}, "authors": [{"authorId":
      "6603909", "name": "K. Auger"}, {"authorId": "5260667", "name": "L. Serunian"},
      {"authorId": "4324390", "name": "S. Soltoff"}, {"authorId": "145096401", "name":
      "P. Libby"}, {"authorId": "1723755", "name": "L. Cantley"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '283957'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:49 GMT
      Via:
      - 1.1 feb2cae68b8552b88ccb4488144416be.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - 1_k2sRQcpLrnF23gi9aixgY-WV92IoiRHBurEKKZEhg8S2ndhTceVQ==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0zeE4KvHcEbJg=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '283957'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:49 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - eb61d149-d098-4bdd-89e5-3a5fb29a1547
    http_version: HTTP/1.1
    status_code: 200
- request:
    body: ''
    headers:
      accept:
      - '*/*'
      accept-encoding:
      - gzip, deflate
      connection:
      - keep-alive
      host:
      - api.semanticscholar.org
      user-agent:
      - python-httpx/0.25.2
    method: GET
    uri: https://api.semanticscholar.org/graph/v1/author/1723755/papers?fields=abstract,authors,citationCount,citationStyles,corpusId,externalIds,fieldsOfStudy,influentialCitationCount,isOpenAccess,journal,openAccessPdf,paperId,publicationDate,publicationTypes,publicationVenue,referenceCount,s2FieldsOfStudy,title,url,venue,year&offset=800&limit=100
  response:
    content: '{"offset": 800, "data": [{"paperId": "833c06d33753a4c676bad7474647f714e00e12cb",
      "externalIds": {"PubMedCentral": "2216206", "MAG": "2118044213", "DOI": "10.1085/JGP.93.2.285",
      "CorpusId": 475047, "PubMed": "2467962"}, "corpusId": 475047, "publicationVenue":
      {"id": "eb5b7fda-8fd6-48a1-bfed-2aac4b99cbee", "name": "The Journal of General
      Physiology", "type": "journal", "alternate_names": ["J Gen Physiol"], "issn":
      "0022-1295", "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=484",
      "alternate_urls": ["http://jgp.rupress.org/"]}, "url": "https://www.semanticscholar.org/paper/833c06d33753a4c676bad7474647f714e00e12cb",
      "title": "Effects of muscarinic, alpha-adrenergic, and substance P agonists
      and ionomycin on ion transport mechanisms in the rat parotid acinar cell. The
      dependence of ion transport on intracellular calcium", "abstract": "The relationship
      between receptor-mediated increases in the intracellular free calcium concentration
      [( Ca]i) and the stimulation of ion fluxes involved in fluid secretion was examined
      in the rat parotid acinar cell. Agonist-induced increases in [Ca]i caused the
      rapid net loss of up to 50-60% of the total content of intracellular chloride
      (Cli) and potassium (Ki), which is consistent with the activation of calcium-sensitive
      chloride and potassium channels. These ion movements were accompanied by a 25%
      reduction in the intracellular volume. The relative magnitudes of the losses
      of Ki and the net potassium fluxes promoted by carbachol (a muscarinic agonist),
      phenylephrine (an alpha-adrenergic agonist), and substance P were very similar
      to their characteristic effects on elevating [Ca]i. Carbachol stimulated the
      loss of Ki through multiple efflux pathways, including the large-conductance
      Ca-activated K channel. Carbachol and substance P increased the levels of intracellular
      sodium (Nai) to more than 2.5 times the normal level by stimulating the net
      uptake of sodium through multiple pathways; Na-K-2Cl cotransport accounted for
      greater than 50% of the influx, and approximately 20% was via Na-H exchange,
      which led to a net alkalinization of the cells. Ionomycin stimulated similar
      fluxes through these two pathways, but also promoted sodium influx through an
      additional pathway which was nearly equivalent in magnitude to the combined
      uptake through the other two pathways. The carbachol- induced increase in Nai
      and decrease in Ki stimulated the activity of the sodium pump, measured by the
      ouabain-sensitive rate of oxygen consumption, to nearly maximal levels. In the
      absence of extracellular calcium or in cells loaded with the calcium chelator
      BAPTA (bis[o- aminophenoxy]ethane-N,N,N'',N''-tetraacetic acid) the magnitudes
      of agonist- or ionomycin-stimulated ion fluxes were greatly reduced. The parotid
      cells displayed a marked desensitization to substance P; within 10 min the elevation
      of [Ca]i and alterations in Ki, Nai, and cell volume spontaneously returned
      to near baseline levels. In addition to quantitating the activation of various
      ion flux pathways in the rat parotid acinar cell, these results demonstrate
      that the activation of ion transport systems responsible for fluid secretion
      in this tissue is closely linked to the elevation of [Ca]i.", "venue": "The
      Journal of General Physiology", "year": 1989, "referenceCount": 65, "citationCount":
      82, "influentialCitationCount": 5, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://rupress.org/jgp/article-pdf/93/2/285/1249135/285.pdf", "status": null},
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1989-02-01", "journal": {"volume": "93", "pages": "285 - 319", "name": "The
      Journal of General Physiology"}, "citationStyles": {"bibtex": "@Article{Soltoff1989EffectsOM,\n
      author = {S. Soltoff and M. McMillian and L. Cantley and E. Cragoe and B. Talamo},\n
      booktitle = {The Journal of General Physiology},\n journal = {The Journal of
      General Physiology},\n pages = {285 - 319},\n title = {Effects of muscarinic,
      alpha-adrenergic, and substance P agonists and ionomycin on ion transport mechanisms
      in the rat parotid acinar cell. The dependence of ion transport on intracellular
      calcium},\n volume = {93},\n year = {1989}\n}\n"}, "authors": [{"authorId":
      "4324390", "name": "S. Soltoff"}, {"authorId": "144664118", "name": "M. McMillian"},
      {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5783113", "name":
      "E. Cragoe"}, {"authorId": "3683975", "name": "B. Talamo"}]}, {"paperId": "9a311dc0a3d841e86a1bee1c8ae905deaedb34e5",
      "externalIds": {"MAG": "2005536723", "DOI": "10.1038/342699A0", "CorpusId":
      4358862, "PubMed": "2556641"}, "corpusId": 4358862, "publicationVenue": {"id":
      "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/9a311dc0a3d841e86a1bee1c8ae905deaedb34e5",
      "title": "The colony stimulating factor-1 receptor associates with and activates
      phosphatidylinositol-3 kinase", "abstract": null, "venue": "Nature", "year":
      1989, "referenceCount": 22, "citationCount": 242, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1989-12-07", "journal": {"volume": "342",
      "pages": "699-702", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Varticovski1989TheCS,\n
      author = {L. Varticovski and B. Druker and D. Morrison and L. Cantley and Thomas
      M. Roberts},\n booktitle = {Nature},\n journal = {Nature},\n pages = {699-702},\n
      title = {The colony stimulating factor-1 receptor associates with and activates
      phosphatidylinositol-3 kinase},\n volume = {342},\n year = {1989}\n}\n"}, "authors":
      [{"authorId": "10119277", "name": "L. Varticovski"}, {"authorId": "122361032",
      "name": "B. Druker"}, {"authorId": "31828216", "name": "D. Morrison"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "48074942", "name": "Thomas M.
      Roberts"}]}, {"paperId": "d1a62b401c71f5790a08f31c2dea535b9914b527", "externalIds":
      {"MAG": "2106495708", "DOI": "10.1016/0304-419X(89)90005-X", "CorpusId": 34196580,
      "PubMed": "2537660"}, "corpusId": 34196580, "publicationVenue": {"id": "08ee3346-e195-4333-b008-be3a4f9e23cd",
      "name": "Biochimica et Biophysica Acta", "type": "journal", "alternate_names":
      ["Biochim Biophys Acta"], "issn": "0006-3002", "alternate_issns": ["1878-2434"],
      "url": "https://www.elsevier.com/life-sciences/biochemistry-genetics-and-molecular-biology/journals/bba",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00063002",
      "http://www.elsevier.com/wps/find/journaldescription.cws_home/506062/description#description"]},
      "url": "https://www.semanticscholar.org/paper/d1a62b401c71f5790a08f31c2dea535b9914b527",
      "title": "Phosphoinositide metabolism and the control of cell proliferation.",
      "abstract": null, "venue": "Biochimica et Biophysica Acta", "year": 1989, "referenceCount":
      125, "citationCount": 140, "influentialCitationCount": 2, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": "1989-02-01", "journal": {"volume":
      "948 3", "pages": "\n          327-44\n        ", "name": "Biochimica et biophysica
      acta"}, "citationStyles": {"bibtex": "@Article{Whitman1989PhosphoinositideMA,\n
      author = {M. Whitman and L. Cantley},\n booktitle = {Biochimica et Biophysica
      Acta},\n journal = {Biochimica et biophysica acta},\n pages = {\n          327-44\n        },\n
      title = {Phosphoinositide metabolism and the control of cell proliferation.},\n
      volume = {948 3},\n year = {1989}\n}\n"}, "authors": [{"authorId": "32113608",
      "name": "M. Whitman"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "30bbb2b5fadd900c508bfe05722ca55649f6e389", "externalIds": {"MAG": "2340979889",
      "DOI": "10.1152/AJPCELL.1988.255.4.C531", "CorpusId": 45736808, "PubMed": "3177626"},
      "corpusId": 45736808, "publicationVenue": {"id": "998813ea-da72-494a-90fc-783751929f3c",
      "name": "American Journal of Physiology", "type": "journal", "alternate_names":
      ["Am J Physiol"], "issn": "0002-9513", "alternate_issns": ["2163-5773"], "url":
      "http://search.epnet.com/direct.asp?db=aph&jid=AHY", "alternate_urls": ["http://www.physiology.org/",
      "http://www.physiology.org/journal/ajplegacy", "https://www.physiology.org/journal/ajpcell",
      "http://ajpcon.physiology.org/", "https://www.biodiversitylibrary.org/bibliography/38917"]},
      "url": "https://www.semanticscholar.org/paper/30bbb2b5fadd900c508bfe05722ca55649f6e389",
      "title": "Cell cycle dependence of inositol phosphate levels in neuroblastoma
      cells.", "abstract": "To investigate the timing of inositol lipid turnover in
      relation to the cell cycle, inositol phosphates and lipids were measured in
      neuroblastoma (Neuro-2A) cells that were prelabeled with [3H]inositol and synchronized
      by a mitotic shakeoff technique. Distinct early and late phases of inositol
      phosphate production were identified. The early peak occurs between the 2nd
      and 4th hour after mitosis near the G1/S transition. A later peak occurs around
      the peak of S phase (DNA synthesis) at 7-8 h after mitosis. These findings suggest
      that activation of phosphatidylinositol turnover generates signals that play
      a role in cell cycle progression.", "venue": "American Journal of Physiology",
      "year": 1988, "referenceCount": 26, "citationCount": 5, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1988-10-01", "journal": {"volume": "255 4 Pt 1", "pages": "\n          C531-5\n        ",
      "name": "The American journal of physiology"}, "citationStyles": {"bibtex":
      "@Article{Fleischman1988CellCD,\n author = {L. Fleischman and L. Cantley},\n
      booktitle = {American Journal of Physiology},\n journal = {The American journal
      of physiology},\n pages = {\n          C531-5\n        },\n title = {Cell cycle
      dependence of inositol phosphate levels in neuroblastoma cells.},\n volume =
      {255 4 Pt 1},\n year = {1988}\n}\n"}, "authors": [{"authorId": "4459392", "name":
      "L. Fleischman"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "420e719f6076d2aae02650579b06ee4b49e9ec90", "externalIds": {"MAG": "2039744950",
      "DOI": "10.1146/annurev.physiol.50.1.205", "CorpusId": 84417138}, "corpusId":
      84417138, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/420e719f6076d2aae02650579b06ee4b49e9ec90",
      "title": "Cell and molecular physiology. Modulation of membrane transport systems",
      "abstract": null, "venue": "", "year": 1988, "referenceCount": 0, "citationCount":
      0, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": null, "citationStyles": {"bibtex":
      "@Inproceedings{Hoffman1988CellAM,\n author = {J. Hoffman and S. Soltoff and
      L. Cantley and P. Weer and D. Gadsby and R. Rakowski and H. Kaback and A. Carruthers
      and D. Melchior and T. Tsong and R. Astumian and D. Yingst},\n title = {Cell
      and molecular physiology. Modulation of membrane transport systems},\n year
      = {1988}\n}\n"}, "authors": [{"authorId": "4742485", "name": "J. Hoffman"},
      {"authorId": "4324390", "name": "S. Soltoff"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "5839611", "name": "P. Weer"}, {"authorId": "5028893",
      "name": "D. Gadsby"}, {"authorId": "144647718", "name": "R. Rakowski"}, {"authorId":
      "144999726", "name": "H. Kaback"}, {"authorId": "7612148", "name": "A. Carruthers"},
      {"authorId": "4377194", "name": "D. Melchior"}, {"authorId": "3234098", "name":
      "T. Tsong"}, {"authorId": "2450724", "name": "R. Astumian"}, {"authorId": "3929882",
      "name": "D. Yingst"}]}, {"paperId": "568951378ddfba2d59712a23383ab16a46b978c6",
      "externalIds": {"MAG": "1591713964", "DOI": "10.1016/s0021-9258(19)35398-0",
      "CorpusId": 25676403, "PubMed": "2826456"}, "corpusId": 25676403, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/568951378ddfba2d59712a23383ab16a46b978c6",
      "title": "CV-1 cell recipients of the mouse ouabain resistance gene express
      a ouabain-insensitive Na,K-ATPase after growth in cardioactive steroids.", "abstract":
      null, "venue": "Journal of Biological Chemistry", "year": 1988, "referenceCount":
      0, "citationCount": 5, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1988-01-15", "journal": {"volume": "263 2", "pages": "\n          624-32\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Schulz1988CV1CR,\n author = {J. Schulz and L. Cantley},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          624-32\n        },\n title = {CV-1 cell recipients
      of the mouse ouabain resistance gene express a ouabain-insensitive Na,K-ATPase
      after growth in cardioactive steroids.},\n volume = {263 2},\n year = {1988}\n}\n"},
      "authors": [{"authorId": "152355108", "name": "J. Schulz"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "6b5de5123efd8a796ed2c870754af8ace3fcb262",
      "externalIds": {"DOI": "10.1007/BF02919091", "CorpusId": 198225131}, "corpusId":
      198225131, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/6b5de5123efd8a796ed2c870754af8ace3fcb262",
      "title": "From meetings", "abstract": null, "venue": "", "year": 1988, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Mathematics", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "18", "pages": "330-373", "name": "Ricerca in clinica
      e in laboratorio"}, "citationStyles": {"bibtex": "@Article{Arias1988FromM,\n
      author = {I. Arias and A. J\u00e9z\u00e9quel and P. Berg and A. Gatta and P.
      Angeli and B. Galanti and G. Gaeta and C. Gallo and G. Giusti and C. Pourcel
      and A. Zignego and C. Br\u00e9chot and L. Cantley and M. Rizzetto and R. Mazzanti
      and S. Moscarella and P. Gentilini and G. Buzzelli and C. Smorlesi and P. Dattolo
      and G. Focardi and G. Laffi and E. Meacci and F. Marra and T. Reynolds and V.
      Arroyo and G. T. Haupert and A. Gerbes and L. Varticovski and N. Villari and
      S. Bartoletti and M. Strazzabosco and M. Muraca and M. Venuti and A. Varotto
      and R. Iemmolo and A. Fragasso and D. Passera and L. Okolics\u00e0nyi and L.
      Capocaccia and F. Ariosto and M. Merli and O. Riggio and A. Romiti and L. Pagliaro
      and G. D\u2019Amico and M. Traina and L. Montalbano and G. Gatto and R. Pisa
      and S. Maisano and F. Politi and P. Colletti and F. Tin\u00e9 and L. Barbara
      and R. Corinaldesi and R. Giorgio and V. Stanghellini and L. Scuro and I. Vantini
      and G. Dobrilla and S. Amplatz and R. Naccarato and F. Mario and A. Blasi and
      A. Mangiameli and G. Bianchi porro and M. Petrillo and M. Forg\u00e1c and M.
      Donowitz and R. Rood and J. Wesolek and E. Emmer and M. Cohen and J. McCullen
      and R. Braithwaite and G. Sharp and H. Murer and H. D. Ward and M. Pereira},\n
      journal = {Ricerca in clinica e in laboratorio},\n pages = {330-373},\n title
      = {From meetings},\n volume = {18},\n year = {1988}\n}\n"}, "authors": [{"authorId":
      "5933076", "name": "I. Arias"}, {"authorId": "118265567", "name": "A. J\u00e9z\u00e9quel"},
      {"authorId": "2060736759", "name": "P. Berg"}, {"authorId": "2805899", "name":
      "A. Gatta"}, {"authorId": "118664996", "name": "P. Angeli"}, {"authorId": "5047464",
      "name": "B. Galanti"}, {"authorId": "144936110", "name": "G. Gaeta"}, {"authorId":
      "120787627", "name": "C. Gallo"}, {"authorId": "145318321", "name": "G. Giusti"},
      {"authorId": "2081288527", "name": "C. Pourcel"}, {"authorId": "4550486", "name":
      "A. Zignego"}, {"authorId": "2051645", "name": "C. Br\u00e9chot"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5616087", "name": "M. Rizzetto"},
      {"authorId": "4329279", "name": "R. Mazzanti"}, {"authorId": "3810221", "name":
      "S. Moscarella"}, {"authorId": "3356672", "name": "P. Gentilini"}, {"authorId":
      "11428061", "name": "G. Buzzelli"}, {"authorId": "14011613", "name": "C. Smorlesi"},
      {"authorId": "34576755", "name": "P. Dattolo"}, {"authorId": "13756706", "name":
      "G. Focardi"}, {"authorId": "4132949", "name": "G. Laffi"}, {"authorId": "35153679",
      "name": "E. Meacci"}, {"authorId": "3338065", "name": "F. Marra"}, {"authorId":
      "2055821366", "name": "T. Reynolds"}, {"authorId": "2071055800", "name": "V.
      Arroyo"}, {"authorId": "6466373", "name": "G. T. Haupert"}, {"authorId": "6140128",
      "name": "A. Gerbes"}, {"authorId": "10119277", "name": "L. Varticovski"}, {"authorId":
      "3245818", "name": "N. Villari"}, {"authorId": "48627488", "name": "S. Bartoletti"},
      {"authorId": "6759392", "name": "M. Strazzabosco"}, {"authorId": "5439418",
      "name": "M. Muraca"}, {"authorId": "102183061", "name": "M. Venuti"}, {"authorId":
      "80536931", "name": "A. Varotto"}, {"authorId": "4823916", "name": "R. Iemmolo"},
      {"authorId": "79710689", "name": "A. Fragasso"}, {"authorId": "15885247", "name":
      "D. Passera"}, {"authorId": "11481605", "name": "L. Okolics\u00e0nyi"}, {"authorId":
      "6673479", "name": "L. Capocaccia"}, {"authorId": "15244710", "name": "F. Ariosto"},
      {"authorId": "143882801", "name": "M. Merli"}, {"authorId": "5827445", "name":
      "O. Riggio"}, {"authorId": "144872574", "name": "A. Romiti"}, {"authorId": "6012728",
      "name": "L. Pagliaro"}, {"authorId": "1393649265", "name": "G. D\u2019Amico"},
      {"authorId": "4372293", "name": "M. Traina"}, {"authorId": "5907570", "name":
      "L. Montalbano"}, {"authorId": "3319034", "name": "G. Gatto"}, {"authorId":
      "4194472", "name": "R. Pisa"}, {"authorId": "7204493", "name": "S. Maisano"},
      {"authorId": "4960432", "name": "F. Politi"}, {"authorId": "2878630", "name":
      "P. Colletti"}, {"authorId": "5813229", "name": "F. Tin\u00e9"}, {"authorId":
      "143653588", "name": "L. Barbara"}, {"authorId": "4689162", "name": "R. Corinaldesi"},
      {"authorId": "3666705", "name": "R. Giorgio"}, {"authorId": "3764545", "name":
      "V. Stanghellini"}, {"authorId": "7495889", "name": "L. Scuro"}, {"authorId":
      "6063806", "name": "I. Vantini"}, {"authorId": "7407346", "name": "G. Dobrilla"},
      {"authorId": "10331365", "name": "S. Amplatz"}, {"authorId": "5052234", "name":
      "R. Naccarato"}, {"authorId": "83442733", "name": "F. Mario"}, {"authorId":
      "145503196", "name": "A. Blasi"}, {"authorId": "5269597", "name": "A. Mangiameli"},
      {"authorId": "47442841", "name": "G. Bianchi porro"}, {"authorId": "2237164",
      "name": "M. Petrillo"}, {"authorId": "66110219", "name": "M. Forg\u00e1c"},
      {"authorId": "5469802", "name": "M. Donowitz"}, {"authorId": "49027465", "name":
      "R. Rood"}, {"authorId": "32150266", "name": "J. Wesolek"}, {"authorId": "14115329",
      "name": "E. Emmer"}, {"authorId": "143827072", "name": "M. Cohen"}, {"authorId":
      "50308731", "name": "J. McCullen"}, {"authorId": "145235879", "name": "R. Braithwaite"},
      {"authorId": "35359539", "name": "G. Sharp"}, {"authorId": "4082230", "name":
      "H. Murer"}, {"authorId": "77333781", "name": "H. D. Ward"}, {"authorId": "2140477333",
      "name": "M. Pereira"}]}, {"paperId": "7a7ad425fc39d1f8f200b547c00b2fed98523261",
      "externalIds": {"MAG": "2153534403", "DOI": "10.1146/ANNUREV.PH.50.030188.001231",
      "CorpusId": 26846658, "PubMed": "2454071"}, "corpusId": 26846658, "publicationVenue":
      {"id": "eedc6e61-e846-485a-a273-0cc8bb06d7d3", "name": "Annual Review of Physiology",
      "type": "journal", "alternate_names": ["Annu Rev Physiol"], "issn": "0066-4278",
      "url": "https://www.annualreviews.org/journal/physiol", "alternate_urls": ["https://www.annualreviews.org/loi/physiol",
      "http://physiol.annualreviews.org/", "http://arjournals.annualreviews.org/loi/physiol"]},
      "url": "https://www.semanticscholar.org/paper/7a7ad425fc39d1f8f200b547c00b2fed98523261",
      "title": "Mitogens and ion fluxes.", "abstract": "The response of growth-arrested
      cells to a variety of growth factors and pharmacological mitogens involves a
      cascade of biochemical and ionic changes that occur within minutes and are believed
      to play critical roles in the initiation of cell proliferation. In general,
      investigations of these phenomena have used proliferating cells in culture that
      can be made to reversibly enter the nonproliferative Go/Gt state, usually by
      the withdrawal of serum. The bio\u00ad chemical changes observed within the
      first few minutes of the addition of growth factors and mitogens include protein
      phosphorylation, an increased turnover of inositol lipids, and increased transcription
      of several proto\u00ad oncogenes. The ionic alterations include rapid increases
      in the cytosolic free calcium concentration ([Ca2+l) from intracellular calcium
      stores andlor ,via influx through channels in the plasma membrane and the stimulation
      of the plasma membrane Na+ -H+ exchanger, which promotes an increase in sodium
      influx and cytoplasmic alkalinization. The relationship between these early
      changes and the increase in DNA synthesis that occurs many hours later is a
      key question in the understanding of mitogenesis. This article focuses on the
      alterations in ion fluxes that have been observed in response to mitogens in
      a variety of cells. In addition, the association of biochemical events with
      ion fluxes and the association of these eady events with the subsequent initiation
      of DNA synthesis are discussed. Important considerations that arc addressed
      are whether there are multiple pathways by which different mitogens induce proliferation
      and whether a single mitogen can induce proliferation by multi\u00ad ple pathways.",
      "venue": "Annual Review of Physiology", "year": 1988, "referenceCount": 51,
      "citationCount": 97, "influentialCitationCount": 1, "isOpenAccess": false, "openAccessPdf":
      null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": null, "journal": {"volume": "50", "pages": "\n          207-23\n        ",
      "name": "Annual review of physiology"}, "citationStyles": {"bibtex": "@Article{Soltoff1988MitogensAI,\n
      author = {S. Soltoff and L. Cantley},\n booktitle = {Annual Review of Physiology},\n
      journal = {Annual review of physiology},\n pages = {\n          207-23\n        },\n
      title = {Mitogens and ion fluxes.},\n volume = {50},\n year = {1988}\n}\n"},
      "authors": [{"authorId": "4324390", "name": "S. Soltoff"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "831cd0bf50765d0cf08d236f62df8b6548f76d80",
      "externalIds": {"MAG": "2485622678", "DOI": "10.1515/9783110846713.340", "CorpusId":
      102455003}, "corpusId": 102455003, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/831cd0bf50765d0cf08d236f62df8b6548f76d80",
      "title": "INCREASE IN [Ca2+]i IN CULTURED HUMAN KERATINOCYTES BY 1,25(OH)2D3
      IS CALCIUM DEPENDENT AND COINCIDES WITH AN INCREASE IN PHOSPHATIDYLINOSITOL
      METABOLISM.", "abstract": null, "venue": "", "year": 1988, "referenceCount":
      1, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": "1988-01-31", "journal": {"volume": "", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{MacLaughlin1988INCREASEI,\n author = {J. MacLaughlin
      and L. Cantley and M. Holick},\n title = {INCREASE IN [Ca2+]i IN CULTURED HUMAN
      KERATINOCYTES BY 1,25(OH)2D3 IS CALCIUM DEPENDENT AND COINCIDES WITH AN INCREASE
      IN PHOSPHATIDYLINOSITOL METABOLISM.},\n year = {1988}\n}\n"}, "authors": [{"authorId":
      "145531353", "name": "J. MacLaughlin"}, {"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "4873870", "name": "M. Holick"}]}, {"paperId": "9c23ce7db2c9ba311c9e584892c951cfcf78c025",
      "externalIds": {"MAG": "2017499074", "DOI": "10.1038/332644A0", "CorpusId":
      4326568, "PubMed": "2833705"}, "corpusId": 4326568, "publicationVenue": {"id":
      "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a", "name": "Nature", "type": "journal",
      "issn": "0028-0836", "url": "https://www.nature.com/", "alternate_urls": ["http://www.nature.com/nature/",
      "https://www.nature.com/nature/", "http://www.nature.com/nature/archive/index.html"]},
      "url": "https://www.semanticscholar.org/paper/9c23ce7db2c9ba311c9e584892c951cfcf78c025",
      "title": "Type I phosphatidylinositol kinase makes a novel inositol phospholipid,
      phosphatidylinositol-3-phosphate", "abstract": null, "venue": "Nature", "year":
      1988, "referenceCount": 15, "citationCount": 933, "influentialCitationCount":
      32, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle", "Study"], "publicationDate": "1988-04-14", "journal": {"volume":
      "332", "pages": "644-646", "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Whitman1988TypeIP,\n
      author = {M. Whitman and M. Whitman and C. Downes and M. Keeler and T. Keller
      and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n pages = {644-646},\n
      title = {Type I phosphatidylinositol kinase makes a novel inositol phospholipid,
      phosphatidylinositol-3-phosphate},\n volume = {332},\n year = {1988}\n}\n"},
      "authors": [{"authorId": "32113608", "name": "M. Whitman"}, {"authorId": "32113608",
      "name": "M. Whitman"}, {"authorId": "144639842", "name": "C. Downes"}, {"authorId":
      "40332617", "name": "M. Keeler"}, {"authorId": "47254988", "name": "T. Keller"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "dce25b42f36ae7528fd335f286e9dab1eb73ddcd",
      "externalIds": {"MAG": "2026101018", "DOI": "10.1111/j.1749-6632.1988.tb22357.x",
      "CorpusId": 20394909, "PubMed": "2854424"}, "corpusId": 20394909, "publicationVenue":
      {"id": "fa1f0815-0811-4291-b4fc-8230a6c9bf5b", "name": "Annals of the New York
      Academy of Sciences", "type": "journal", "alternate_names": ["Ann n y Acad Sci"],
      "issn": "0077-8923", "url": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1749-6632",
      "alternate_urls": ["http://www.annalsnyas.org/", "http://www.nyas.org/publications/annals/default.aspx",
      "https://onlinelibrary.wiley.com/journal/17496632"]}, "url": "https://www.semanticscholar.org/paper/dce25b42f36ae7528fd335f286e9dab1eb73ddcd",
      "title": "Growth Factor and Oncogene Influences on Cell Growth Regulation",
      "abstract": "Efforts to understand the mechanisms that control cell growth have,
      in a variety of scientific fields, stimulated research in which different cell
      types and proliferative agents such as retroviruses and mitogens are used. Progress
      in unraveling the complexities of growth regulation has been facilitated by
      studies of growth factor receptor structure, viral oncogenes, and their cellular
      homologues called protooncogenes. Moreover, the realization that cell transformation
      involves the same biochemical processes that regulate nontransformed cell growth,
      but with loss of the normal restraints, has provided new insights into the mechanisms
      of cell proliferation. Recent biochemical and molecular information about growth
      factors and their receptors has shed light on their relationships to both normal
      and abnormal cell growth. Several peptide growth factor receptors have now been
      purified and, with a few notable exceptions, constitute a family of homologous
      proteins with growth-factorstimulated tyrosine kinase activities. These tryosine
      kinases undergo autophosphorylation, which appears to be critical for their
      regulation; other physiologically relevant targets of these tyrosine kinases
      have not yet been determined. Furthermore, the peptide growth factor receptors
      that have been purified are structurally very distinct from the hormone receptors
      whose signals are known to be transduced by GTP-binding proteins. In spite of
      the structural similarities among growth factor receptors, the primary responses
      to different growth factors are quite distinct. For example, whereas a t least
      some of the primary responses to platelet-derived growth factor (PDGF) and bombesin
      are due to elevation of second messengers produced from turnover of products
      in the phosphatidylinositol (PI) pathway, many other growth factors do not appear
      to involve the classical PI pathway. Recent evidence that insulin stimulates
      the production of a novel second messenger derived from glycosylated PI raises
      the interesting possibility that other growth factors may act through other
      novel second-messenger molecules derived from PI. A link between elevation of
      second messengers and the growth response is based primarily on activators of
      protein kinase C that affect cell proliferation. However, this activation only
      partially explains growth responses to some factors and is irrelevant to growth
      responses to other factors. Like certain growth factor receptors, may oncoproteins
      are enzymes with proteintyrosine kinase activity toward as yet unidentified
      target molecules which, in turn, convey a growth signal to the cell nucleus.
      In contrast, a distinct subset of oncoproteins target directly to the nucleus,
      where at least some are thought to act as specific", "venue": "Annals of the
      New York Academy of Sciences", "year": 1988, "referenceCount": 45, "citationCount":
      5, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": "1988-12-01", "journal": {"volume": "551", "name": "Annals
      of the New York Academy of Sciences"}, "citationStyles": {"bibtex": "@Article{Serunian1988GrowthFA,\n
      author = {L. Serunian and L. Cantley},\n booktitle = {Annals of the New York
      Academy of Sciences},\n journal = {Annals of the New York Academy of Sciences},\n
      title = {Growth Factor and Oncogene Influences on Cell Growth Regulation},\n
      volume = {551},\n year = {1988}\n}\n"}, "authors": [{"authorId": "5260667",
      "name": "L. Serunian"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "33f573f8e3b629702c0e2135226aea851582e317", "externalIds": {"MAG": "123919963",
      "CorpusId": 30001443, "PubMed": "2835058"}, "corpusId": 30001443, "publicationVenue":
      {"id": "e441f16f-e93a-44b5-8dfb-e035124977e2", "name": "Anti-Cancer Drug Design",
      "type": "journal", "alternate_names": ["Anti-cancer Drug Design", "Anti-cancer
      Drug Des"], "issn": "0266-9536"}, "url": "https://www.semanticscholar.org/paper/33f573f8e3b629702c0e2135226aea851582e317",
      "title": "The role of lipid-derived second messengers in cell growth and transformation.",
      "abstract": "Recent information on the structure of growth factor receptors
      and oncogenes has advanced our understanding of the biochemical mechanism of
      growth control. Several peptide growth factor receptors have now been purified
      and, with a few notable exceptions, they fall into a family of homologous proteins
      with growth factor-stimulated protein-tyrosine kinase (PTK) activity. Mutations
      in the genes encoding for both the growth factors and the growth factor receptors
      of this family have been shown to cause cell transformation. Thus, PTKs have
      been implicated both in normal growth control and in cell transformation. The
      critical targets for these PTKs have not been determined. Several but not all
      growth factors stimulate production of the phosphatidylinositol (PI)-derived
      second messengers, diacylglycerol and inositol-1,4,5-trisphosphate. By purifying
      and characterizing the enzymes involved in PI turnover we are attempting to
      determine how this system is regulated by growth factors and oncogene products.
      We have found that fibroblasts contain two distinct PI kinases, and that one
      of these enzymes can be precipitated with antibodies against phosphotyrosine
      only after addition of platelet-derived growth factor. The relevance of the
      PI turnover pathway in propagation of growth signals is discussed.", "venue":
      "Anti-Cancer Drug Design", "year": 1987, "referenceCount": 0, "citationCount":
      2, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1987-10-01", "journal": {"volume": "2 2", "pages": "\n          129-38\n        ",
      "name": "Anti-cancer drug design"}, "citationStyles": {"bibtex": "@Article{Cantley1987TheRO,\n
      author = {L. Cantley and L. Fleischman and M. Whitman},\n booktitle = {Anti-Cancer
      Drug Design},\n journal = {Anti-cancer drug design},\n pages = {\n          129-38\n        },\n
      title = {The role of lipid-derived second messengers in cell growth and transformation.},\n
      volume = {2 2},\n year = {1987}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "4459392", "name": "L. Fleischman"}, {"authorId":
      "32113608", "name": "M. Whitman"}]}, {"paperId": "6b9937082a77dc23aeef7c79f23262ba569ce5de",
      "externalIds": {"MAG": "2029201128", "DOI": "10.1021/BI00376A037", "CorpusId":
      29272153, "PubMed": "3548823"}, "corpusId": 29272153, "publicationVenue": {"id":
      "ae7a3201-e479-4666-8a93-3d35d6bf7cd1", "name": "Biochemistry", "type": "journal",
      "issn": "0006-2960", "alternate_issns": ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw",
      "alternate_urls": ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/6b9937082a77dc23aeef7c79f23262ba569ce5de",
      "title": "Kinetic analysis of guanosine 5''-O-(3-thiotriphosphate) effects on
      phosphatidylinositol turnover in NRK cell homogenates.", "abstract": "Addition
      of the guanine nucleotide analogue guanosine 5''-O-(3-thiotriphosphate) (GTP
      gamma S) to [3H]inositol-labeled NRK cell homogenates resulted in rapid breakdown
      of cellular polyphosphoinositides. GTP gamma S stimulated phospholipase C, resulting
      in a more than 4-fold increase in the hydrolysis rates of phosphatidylinositol
      4-phosphate (PIP) and phosphatidylinositol 4,5-bis(phosphate) (PIP2). No significant
      effect of GTP gamma S on direct phosphatidylinositol (PI) hydrolysis was detected.
      There was an increase in water-soluble inositols, with inositol tris(phosphate)
      (IP3) levels increasing at least 10 times over the decrease seen in PIP2, indicating
      that PIP kinase activity was also accelerated following GTP gamma S addition.
      Inositol 1,4,5-tris(phosphate) peaked rapidly after GTP gamma S addition (less
      than 2 min) while inositol 1,3,4-tris-(phosphate) was produced more slowly and
      leveled off after approximately 10 min. The differential equations describing
      conversion between intermediates in the PI turnover pathway were solved and
      fitted to data obtained from both [3H]inositol and [32P]phosphate fluxes by
      nonlinear least-squares analysis. GTP gamma S effects on the pseudo-first-order
      rate constants for the lipase, kinase, and phosphatase steps were determined
      from the analysis. From these measurements it can be estimated that, in the
      presence of GTP gamma S and calcium buffered to 130 nM, hydrolysis of PIP2 accounts
      for at least 10 times as much diacylglycerol as direct PI breakdown despite
      the 100-fold excess of PI over PIP2. From the kinetic model it is predicted
      that small changes in the activities of PI and PIP kinases can have large but
      different effects on the level of IP3 and diacylglycerol following GTP gamma
      S addition. These results argue that regulation of PI and PIP kinases may be
      important for determining both cellular IP3 and diacylglycerol levels.", "venue":
      "Biochemistry", "year": 1987, "referenceCount": 40, "citationCount": 21, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1987-01-27", "journal": {"volume": "26
      2", "pages": "\n          612-22\n        ", "name": "Biochemistry"}, "citationStyles":
      {"bibtex": "@Article{Chahwala1987KineticAO,\n author = {S. Chahwala and L. Fleischman
      and L. Cantley},\n booktitle = {Biochemistry},\n journal = {Biochemistry},\n
      pages = {\n          612-22\n        },\n title = {Kinetic analysis of guanosine
      5''-O-(3-thiotriphosphate) effects on phosphatidylinositol turnover in NRK cell
      homogenates.},\n volume = {26 2},\n year = {1987}\n}\n"}, "authors": [{"authorId":
      "8044764", "name": "S. Chahwala"}, {"authorId": "4459392", "name": "L. Fleischman"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "7ec9910fa2854b9c9f0915a51f4d981ce77fd659",
      "externalIds": {"MAG": "2149452654", "DOI": "10.1161/01.HYP.10.5_PT_2.I93",
      "CorpusId": 27854076, "PubMed": "2824373"}, "corpusId": 27854076, "publicationVenue":
      {"id": "066fa0b1-bbd7-4e12-a6ad-cafd76ba0811", "name": "HYPERTENSION", "type":
      "journal", "alternate_names": ["Hypertension"], "issn": "2224-1485", "alternate_issns":
      ["0194-911X"], "url": "http://hypertension.zaslavsky.com.ua/", "alternate_urls":
      ["http://hyper.ahajournals.org/", "http://ovidsp.ovid.com/ovidweb.cgi?AN=00004268-000000000-00000&CSC=Y&D=yrovft&NEWS=n&PAGE=toc&T=JS"]},
      "url": "https://www.semanticscholar.org/paper/7ec9910fa2854b9c9f0915a51f4d981ce77fd659",
      "title": "Membrane biochemistry of the ouabain-resistant potassium transport
      system.", "abstract": "A 6.5-kilobase fragment of genomic DNA from mutant mouse
      cells under ouabain selection pressure conferred ouabain resistance when transfected
      into ouabain-sensitive CV1 green monkey fibroblasts. Ouabain resistance was
      induced in the presence of 10 microM ouabain. Amiloride (500 microM) completely
      blocked ouabain-insensitive 86Rb+ uptake into these cells. Plasma membranes
      from these cells demonstrated little sodium-dependent adenosine triphosphatase
      (ATPase) activity but had potassium-dependent and ouabain-resistant p-nitrophenylphosphatase
      activity. Like Na+,K+-ATPase this activity was vanadate- and sodium-inhibitable.
      Also, like the Na+,K+-ATPase, sodium inhibition of the p-nitrophenylphosphatase
      was reversed by 10 microM adenosine 5''-triphosphate.", "venue": "HYPERTENSION",
      "year": 1987, "referenceCount": 8, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.10.5_Pt_2.I93",
      "status": null}, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1987-11-01", "journal": {"volume": "10 5 Pt 2", "pages":
      "\n          I93-4\n        ", "name": "Hypertension"}, "citationStyles": {"bibtex":
      "@Article{English1987MembraneBO,\n author = {L. English and B. White and L.
      Cantley},\n booktitle = {HYPERTENSION},\n journal = {Hypertension},\n pages
      = {\n          I93-4\n        },\n title = {Membrane biochemistry of the ouabain-resistant
      potassium transport system.},\n volume = {10 5 Pt 2},\n year = {1987}\n}\n"},
      "authors": [{"authorId": "34784769", "name": "L. English"}, {"authorId": "33469167",
      "name": "B. White"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "a1d1b7a4adc579f3aeb7b2c7c18da65ec28c0c12", "externalIds": {"MAG": "2260076009",
      "DOI": "10.1042/BJ2470165", "CorpusId": 20432411, "PubMed": "2825654"}, "corpusId":
      20432411, "publicationVenue": {"id": "64838252-a209-4424-a778-3b86b4a83c48",
      "name": "Biochemical Journal", "type": "journal", "alternate_names": ["Biochem
      J"], "issn": "0264-6021", "alternate_issns": ["0006-2936"], "url": "http://www.biochemj.org/"},
      "url": "https://www.semanticscholar.org/paper/a1d1b7a4adc579f3aeb7b2c7c18da65ec28c0c12",
      "title": "Evidence for two distinct phosphatidylinositol kinases in fibroblasts.
      Implications for cellular regulation.", "abstract": "Phosphatidylinositol (PtdIns)
      kinase activities from non-transformed and polyoma-middle-T-transformed murine
      fibroblasts were examined. Both normal and transformed 3T3 fibroblasts have
      two PtdIns kinases, which can be separated by anion-exchange chromatography.
      One of these activities (Type I) has a Km for ATP of 10 microM, is resistant
      to inhibition by adenosine, AMP or ADP, and is inhibited by non-ionic detergents.
      The other activity (Type II) has a somewhat higher Km for ATP (35 microM) and
      is inhibited competitively by ADP, AMP and adenosine at concentrations suggesting
      regulation of this activity by the energy charge of the cell. The Type II PtdIns
      kinase is activated by non-ionic detergents. We have previously reported the
      specific association of a PtdIns kinase activity with polyoma-middle-T immunoprecipitates
      [Whitman, Kaplan, Schaffhausen, Cantley & Roberts (1985) Nature (London) 315,
      239-242; Kaplan, Whitman, Schaffhausen, Raptis, Garcea, Pallas, Roberts & Cantley
      (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 3624-3628]. Comparison of the immunoprecipitated
      PtdIns kinase with the activities identified by ion-exchange chromatography
      indicates that it is the Type I enzyme which specifically associates with the
      middle-T/pp60c-src complex. This PtdIns kinase activity is separable from both
      middle T and pp60c-src. Type I PtdIns kinase also associates with pp60v-src
      immunoprecipitates from Rous-sarcoma-virus-transformed cells. Furthermore, this
      PtdIns kinase appears to co-precipitate with partially purified platelet derived
      growth factor (PDGF) receptor. The amount of this activity found in anti-phosphotyrosine
      immunoprecipitates or in wheat-germ-lectin-agarose precipitates is increased
      50-fold by stimulation of quiescent Balb/C 3T3 fibroblasts with PDGF. These
      results suggest that the Type I PtdIns kinase is regulated by agents which affect
      cell growth and transformation, whereas the Type II PtdIns kinase may be regulated
      by the local [ATP]/[ADP] ratio.", "venue": "Biochemical Journal", "year": 1987,
      "referenceCount": 2, "citationCount": 202, "influentialCitationCount": 2, "isOpenAccess":
      true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc1148384?pdf=render",
      "status": null}, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1987-10-01", "journal": {"volume": "247
      1", "pages": "\n          165-74\n        ", "name": "The Biochemical journal"},
      "citationStyles": {"bibtex": "@Article{Whitman1987EvidenceFT,\n author = {M.
      Whitman and D. Kaplan and T. Roberts and L. Cantley},\n booktitle = {Biochemical
      Journal},\n journal = {The Biochemical journal},\n pages = {\n          165-74\n        },\n
      title = {Evidence for two distinct phosphatidylinositol kinases in fibroblasts.
      Implications for cellular regulation.},\n volume = {247 1},\n year = {1987}\n}\n"},
      "authors": [{"authorId": "32113608", "name": "M. Whitman"}, {"authorId": "2251300618",
      "name": "D. Kaplan"}, {"authorId": "6665338", "name": "T. Roberts"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "020866d124a5e04cda4d33112890966d4a59d0ae",
      "externalIds": {"MAG": "1506627435", "CorpusId": 45199369, "PubMed": "3003059"},
      "corpusId": 45199369, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/020866d124a5e04cda4d33112890966d4a59d0ae",
      "title": "Delta endotoxin is a potent inhibitor of the (Na,K)-ATPase.", "abstract":
      "A 68-kDa protein, delta endotoxin, produced by Bacillus thuringiensis ssp.
      Kurstaki inhibits ion transport, (Na,K)-ATPase, and K+-p-nitrophenylphosphatase
      activity catalyzed by the Na+ pump. The Ki for inhibition of the K+-p-nitrophenylphosphatase
      activity of purified dog kidney (Na,K)-ATPase was approximately 0.37 microM.
      Delta endotoxin had a similar Ki for inhibition of (Na,K)-ATPase activity when
      assayed at low Na+ concentration (10 mM) but the inhibition was reversed when
      high concentrations of Na+ (100 mM NaCl) were added to the assay. Phosphorylation
      of the active site aspartyl residue with 32PO3-4 was also blocked by delta endotoxin.
      Ouabain-sensitive 86Rb+ uptake into intact human red blood cells was not inhibited
      by externally added toxin; however, strophanthidin-inhibitable 22Na+ uptake
      into inside-out vesicles from red blood cells was completely blocked by delta
      endotoxin (Ki = 0.73 microM). These data suggest that delta endotoxin must enter
      the cell before it can inhibit the Na+ pump.", "venue": "Journal of Biological
      Chemistry", "year": 1986, "referenceCount": 4, "citationCount": 38, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Medicine", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1986-01-25", "journal": {"volume": "261 3", "pages": "\n          1170-3\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{English1986DeltaEI,\n author = {L. English and L. Cantley},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          1170-3\n        },\n title = {Delta endotoxin
      is a potent inhibitor of the (Na,K)-ATPase.},\n volume = {261 3},\n year = {1986}\n}\n"},
      "authors": [{"authorId": "34784769", "name": "L. English"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "0eea62e1f266f8b86ac52ade7ee3ceb70e9f62d2",
      "externalIds": {"MAG": "2136900732", "DOI": "10.1146/ANNUREV.BI.55.070186.002455",
      "CorpusId": 36746866, "PubMed": "3527050"}, "corpusId": 36746866, "publicationVenue":
      {"id": "9e5ab0fc-a36d-4a05-bc89-12dd1cb12e2b", "name": "Annual Review of Biochemistry",
      "type": "journal", "alternate_names": ["Annu Rev Biochem"], "issn": "0066-4154",
      "url": "https://www.annualreviews.org/journal/biochem", "alternate_urls": ["http://www.annualreviews.org/journal/biochem",
      "http://biochem.annualreviews.org/", "https://www.annualreviews.org/loi/biochem",
      "http://intl-biomedical.annualreviews.org/", "http://arjournals.annualreviews.org/loi/biochem",
      "http://arjournals.annualreviews.org/loi/biochem?cookieSet=1"]}, "url": "https://www.semanticscholar.org/paper/0eea62e1f266f8b86ac52ade7ee3ceb70e9f62d2",
      "title": "Structural aspects of the red cell anion exchange protein.", "abstract":
      "PERSPECTIVES AND SUMMARy 512 STRUCTURE OF THE BAND 3 PROTEIN 513 Proteolytic
      Cleavage Sites 513 Sequence ... , . . . . . . . . . . . . . . . . . . . . .
      . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .
      . . . . . . . . . . . . . . . . . .. . . . . . . . . . 514 Chemical Modifications
      517 Topology oj Membrane Domain 519 Topology oJ Cytoplasmic Domain 523 POSTTRANSLATIONAL
      MODIFICATIONS 523 Glycosylation . . . . . . . . . . . . . . . . . . . . . .
      . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
      . . . . . . . . . . . . . . . . . . . . . . . . . . 523 Phosphorylation .. ........
      524 Methylation ....... . . ....... . .. . ....... . . , 524 BIOSYNTHESIS AND
      ASSEMBLy 524", "venue": "Annual Review of Biochemistry", "year": 1986, "referenceCount":
      0, "citationCount": 123, "influentialCitationCount": 3, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": null, "journal": {"volume": "55", "pages": "\n          511-38\n        ",
      "name": "Annual review of biochemistry"}, "citationStyles": {"bibtex": "@Article{Jay1986StructuralAO,\n
      author = {D. Jay and L. Cantley},\n booktitle = {Annual Review of Biochemistry},\n
      journal = {Annual review of biochemistry},\n pages = {\n          511-38\n        },\n
      title = {Structural aspects of the red cell anion exchange protein.},\n volume
      = {55},\n year = {1986}\n}\n"}, "authors": [{"authorId": "4860515", "name":
      "D. Jay"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "1933bbfb32fa01db38664c8ae31531cda4db257d",
      "externalIds": {"MAG": "2034431401", "DOI": "10.1111/j.1749-6632.1986.tb54426.x",
      "CorpusId": 84367254}, "corpusId": 84367254, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/1933bbfb32fa01db38664c8ae31531cda4db257d",
      "title": "Oncogenes and Phosphatidylinositol Turnover a", "abstract": "Products
      of phosphatidylinositol turnover have recently been implicated as regulators
      of cell growth and differentiation. Transformation of cells in culture by infection
      with certain viruses (Rous sarcoma virus, Kirsten sarcoma virus, and polyoma
      virus) or by transfection with the oncogenes carried by these viruses affect
      the steady-state level of intermediates in the PI turnover pathway. In addition,
      immunoprecipitates of the transforming gene products of Rous sarcoma virus and
      polyoma virus contain activities of certain enzymes in the PI turnover pathway.
      We have previously reported that polyoma middle T immunoprecipitates can catalyze
      phosphorylation of PI to phosphatidylinositol-4-phosphate (PIP). This activity
      is not intrinsic to middle T or c-src but is due to a cellular enzyme that specifically
      associates with this complex. The PI kinase is found in immunoprecipitates of
      the middle T protein from polyoma viruses that are capable of cell transformation
      but does not associate with mutants of middle T defective in transformation
      suggesting that this association may be important for transformation.", "venue":
      "", "year": 1986, "referenceCount": 26, "citationCount": 7, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "1986-12-01", "journal": {"volume": "488", "name": "Annals of the New York Academy
      of Sciences"}, "citationStyles": {"bibtex": "@Article{Cantley1986OncogenesAP,\n
      author = {L. Cantley and M. Whitman and S. Chahwala and L. Fleischman and D.
      Kaplan and B. Schaffhausen and T. Roberts},\n journal = {Annals of the New York
      Academy of Sciences},\n title = {Oncogenes and Phosphatidylinositol Turnover
      a},\n volume = {488},\n year = {1986}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "79989587", "name": "M. Whitman"}, {"authorId":
      "8044764", "name": "S. Chahwala"}, {"authorId": "4459392", "name": "L. Fleischman"},
      {"authorId": "32389352", "name": "D. Kaplan"}, {"authorId": "4362128", "name":
      "B. Schaffhausen"}, {"authorId": "6665338", "name": "T. Roberts"}]}, {"paperId":
      "28b1a45babdcf7676c1fc78bef49e163888d0912", "externalIds": {"MAG": "2467678472",
      "CorpusId": 29918419, "PubMed": "3019785"}, "corpusId": 29918419, "publicationVenue":
      {"id": "c9cbc673-d571-425e-ad6e-edb23bb759e9", "name": "Federation proceedings",
      "alternate_names": ["Fed proc"], "issn": "0014-9446"}, "url": "https://www.semanticscholar.org/paper/28b1a45babdcf7676c1fc78bef49e163888d0912",
      "title": "Phosphoinositide kinase activity and transformation.", "abstract":
      "We have used the DNA tumor virus polyoma as a model system to examine whether
      the phosphatidylinositol (PI) turnover pathway is a critical target for transforming
      gene products. Polyoma-infected cells show elevated levels of polyphosphoinositides
      and polyphosphoinositols, and a PI kinase activity is associated with middle
      T antigen, a transforming gene product of polyoma virus. In anti-T immunoprecipitates
      from polyoma-infected or -transformed cells, comparisons of wild-type and polyoma
      mutants defective for transformation show a strong correlation between middle
      T-associated PI kinase activity and transforming ability. Middle T has previously
      been found to associate at the plasma membrane with pp60 c-src and to activate
      it as a tyrosine kinase. c-src itself does not appear to phosphorylate PI; however,
      the middle T/pp60 c-src tyrosine kinase activity may be important for activation
      of PI kinase. Ammonium orthovanadate, a tyrosine phosphatase inhibitor, elevates
      the middle T/pp60 c-src-associated PI kinase activity. We propose that middle
      T/pp60 c-src activates a PI kinase and modulates PI turnover in vivo by tyrosine
      phosphorylation.", "venue": "Federation proceedings", "year": 1986, "referenceCount":
      0, "citationCount": 3, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1986-10-01", "journal": {"volume": "45
      11", "pages": "\n          2647-52\n        ", "name": "Federation proceedings"},
      "citationStyles": {"bibtex": "@Article{Whitman1986PhosphoinositideKA,\n author
      = {M. Whitman and D. Kaplan and L. Cantley and T. Roberts and B. Schaffhausen},\n
      booktitle = {Federation proceedings},\n journal = {Federation proceedings},\n
      pages = {\n          2647-52\n        },\n title = {Phosphoinositide kinase
      activity and transformation.},\n volume = {45 11},\n year = {1986}\n}\n"}, "authors":
      [{"authorId": "32113608", "name": "M. Whitman"}, {"authorId": "32389352", "name":
      "D. Kaplan"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "6665338",
      "name": "T. Roberts"}, {"authorId": "4362128", "name": "B. Schaffhausen"}]},
      {"paperId": "3daeb661d851e4d7bc4ffd92e125a48ccd485e64", "externalIds": {"MAG":
      "1408723449", "DOI": "10.1016/S0070-2161(08)60733-9", "CorpusId": 82727337},
      "corpusId": 82727337, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/3daeb661d851e4d7bc4ffd92e125a48ccd485e64",
      "title": "Chapter 11 B Lymphocyte Differentiation: Role of Phosphoinositides,
      C Kinase, and Na+-H+ Exchange", "abstract": null, "venue": "", "year": 1986,
      "referenceCount": 23, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": null, "publicationDate": null, "journal":
      {"volume": "26", "pages": "193-199", "name": "Current topics in membranes and
      transport"}, "citationStyles": {"bibtex": "@Article{Rosoff1986Chapter1B,\n author
      = {P. Rosoff and L. Cantley},\n journal = {Current topics in membranes and transport},\n
      pages = {193-199},\n title = {Chapter 11 B Lymphocyte Differentiation: Role
      of Phosphoinositides, C Kinase, and Na+-H+ Exchange},\n volume = {26},\n year
      = {1986}\n}\n"}, "authors": [{"authorId": "4078651", "name": "P. Rosoff"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "4e448176d72cf9f227c28af699be535e61c1cb94",
      "externalIds": {"MAG": "1979715535", "DOI": "10.1016/0167-4889(86)90048-0",
      "CorpusId": 33545013, "PubMed": "3013320"}, "corpusId": 33545013, "publicationVenue":
      {"id": "08ee3346-e195-4333-b008-be3a4f9e23cd", "name": "Biochimica et Biophysica
      Acta", "type": "journal", "alternate_names": ["Biochim Biophys Acta"], "issn":
      "0006-3002", "alternate_issns": ["1878-2434"], "url": "https://www.elsevier.com/life-sciences/biochemistry-genetics-and-molecular-biology/journals/bba",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00063002",
      "http://www.elsevier.com/wps/find/journaldescription.cws_home/506062/description#description"]},
      "url": "https://www.semanticscholar.org/paper/4e448176d72cf9f227c28af699be535e61c1cb94",
      "title": "Protein kinase C of human erythrocytes phosphorylates bands 4.1 and
      4.9.", "abstract": null, "venue": "Biochimica et Biophysica Acta", "year": 1986,
      "referenceCount": 33, "citationCount": 21, "influentialCitationCount": 1, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1986-07-11", "journal": {"volume": "887
      2", "pages": "\n          142-9\n        ", "name": "Biochimica et biophysica
      acta"}, "citationStyles": {"bibtex": "@Article{Faquin1986ProteinKC,\n author
      = {W. Faquin and S. Chahwala and L. Cantley and D. Branton},\n booktitle = {Biochimica
      et Biophysica Acta},\n journal = {Biochimica et biophysica acta},\n pages =
      {\n          142-9\n        },\n title = {Protein kinase C of human erythrocytes
      phosphorylates bands 4.1 and 4.9.},\n volume = {887 2},\n year = {1986}\n}\n"},
      "authors": [{"authorId": "5052888", "name": "W. Faquin"}, {"authorId": "8044764",
      "name": "S. Chahwala"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "6913699", "name": "D. Branton"}]}, {"paperId": "50655e6df66bdbb388459e8c52b64949466af1f0",
      "externalIds": {"MAG": "2396781587", "CorpusId": 24113374, "PubMed": "2827283"},
      "corpusId": 24113374, "publicationVenue": {"id": "8dd9c381-1194-487b-b007-8aa1dfe260f4",
      "name": "Symposium on Fundamental Cancer Research", "alternate_names": ["Symp
      Fundam Cancer Res"], "issn": "0190-1214"}, "url": "https://www.semanticscholar.org/paper/50655e6df66bdbb388459e8c52b64949466af1f0",
      "title": "Phosphatidylinositol kinases and cell transformation.", "abstract":
      "Products of phosphatidylinositol (PI) turnover have recently been implicated
      as regulators of cell growth and differentiation. Transformation of cells in
      culture by infection with certain viruses (Rous sarcoma virus, Kirsten sarcoma
      virus, and polyoma virus) or by transfection with the oncogenes carried by these
      viruses affect the steady-state level of intermediates in the PI turnover pathway.
      In addition, immunoprecipitates of the transforming gene products of Rous sarcoma
      virus and polyoma virus contain activities of certain enzymes in the PI turnover
      pathway. We have previously reported that polyoma middle T immunoprecipitates
      can catalyze phosphorylation of PI to phosphatidylinositol-4-phosphate (PIP).
      This activity is not intrinsic to middle T or pp60c-src but is due to a cellular
      enzyme that specifically associates with the middle T/pp60c-src complex. The
      PI kinase is found in immunoprecipitates of the middle t protein from polyoma
      viruses that are capable of cell transformation but does not associate with
      mutants of middle t defective in transformation, suggesting that this association
      may be important for transformation. Two PI kinases from fibroblasts (type I
      and type II) that are separable by anion exchange chromatography have been partially
      purified and characterized. These enzymes differ in their Km for ATP as well
      as their Ki for adenosine and ADP. Only the type I PI kinase specifically associates
      with the transformation-competent mutants of middle T.", "venue": "Symposium
      on Fundamental Cancer Research", "year": 1986, "referenceCount": 0, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": ["Review", "JournalArticle"],
      "publicationDate": null, "journal": {"volume": "39", "pages": "\n          165-72\n        ",
      "name": "Symposium on Fundamental Cancer Research"}, "citationStyles": {"bibtex":
      "@Article{Cantley1986PhosphatidylinositolKA,\n author = {L. Cantley and M. Whitman
      and D. Kaplan and S. Chahwala and L. Fleischman and G. Endemann and B. Schaffhausen
      and T. Roberts},\n booktitle = {Symposium on Fundamental Cancer Research},\n
      journal = {Symposium on Fundamental Cancer Research},\n pages = {\n          165-72\n        },\n
      title = {Phosphatidylinositol kinases and cell transformation.},\n volume =
      {39},\n year = {1986}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "32113608", "name": "M. Whitman"}, {"authorId": "32389352",
      "name": "D. Kaplan"}, {"authorId": "8044764", "name": "S. Chahwala"}, {"authorId":
      "4459392", "name": "L. Fleischman"}, {"authorId": "10330714", "name": "G. Endemann"},
      {"authorId": "4362128", "name": "B. Schaffhausen"}, {"authorId": "6665338",
      "name": "T. Roberts"}]}, {"paperId": "870784461424be9a388da21961018326ced401f1",
      "externalIds": {"DOI": "10.1111/j.1749-6632.1986.tb46580.x", "CorpusId": 25171573,
      "PubMed": "2437850"}, "corpusId": 25171573, "publicationVenue": {"id": "fa1f0815-0811-4291-b4fc-8230a6c9bf5b",
      "name": "Annals of the New York Academy of Sciences", "type": "journal", "alternate_names":
      ["Ann n y Acad Sci"], "issn": "0077-8923", "url": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1749-6632",
      "alternate_urls": ["http://www.annalsnyas.org/", "http://www.nyas.org/publications/annals/default.aspx",
      "https://onlinelibrary.wiley.com/journal/17496632"]}, "url": "https://www.semanticscholar.org/paper/870784461424be9a388da21961018326ced401f1",
      "title": "Oncogenes and phosphatidylinositol turnover.", "abstract": "Products
      of phosphatidylinositol turnover have recently been implicated as regulators
      of cell growth and differentiation. Transformation of cells in culture by infection
      with certain viruses (Rous sarcoma virus, Kirsten sarcoma virus, and polyoma
      virus) or by transfection with the oncogenes carried by these viruses affect
      the steady-state level of intermediates in the PI turnover pathway. In addition,
      immunoprecipitates of the transforming gene products of Rous sarcoma virus and
      polyoma virus contain activities of certain enzymes in the PI turnover pathway.
      We have previously reported that polyoma middle T immunoprecipitates can catalyze
      phosphorylation of PI to phosphatidylinositol-4-phosphate (PIP). This activity
      is not intrinsic to middle T or c-src but is due to a cellular enzyme that specifically
      associates with this complex. The PI kinase is found in immunoprecipitates of
      the middle T protein from polyoma viruses that are capable of cell transformation
      but does not associate with mutants of middle T defective in transformation
      suggesting that this association may be important for transformation.", "venue":
      "Annals of the New York Academy of Sciences", "year": 1986, "referenceCount":
      0, "citationCount": 6, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["Review", "JournalArticle"], "publicationDate": null, "journal":
      {"volume": "488", "pages": "\n          481-90\n        ", "name": "Annals of
      the New York Academy of Sciences"}, "citationStyles": {"bibtex": "@Article{Cantley1986OncogenesAP,\n
      author = {L. Cantley and M. Whitman and S. Chahwala and L. Fleischman and D.
      Kaplan and B. Schaffhausen and T. Roberts},\n booktitle = {Annals of the New
      York Academy of Sciences},\n journal = {Annals of the New York Academy of Sciences},\n
      pages = {\n          481-90\n        },\n title = {Oncogenes and phosphatidylinositol
      turnover.},\n volume = {488},\n year = {1986}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "32113608", "name": "M. Whitman"},
      {"authorId": "8044764", "name": "S. Chahwala"}, {"authorId": "4459392", "name":
      "L. Fleischman"}, {"authorId": "32389352", "name": "D. Kaplan"}, {"authorId":
      "4362128", "name": "B. Schaffhausen"}, {"authorId": "6665338", "name": "T. Roberts"}]},
      {"paperId": "b3e5245b9784a5fbff52a1570469ab75f8bdbdd3", "externalIds": {"MAG":
      "2036744157", "DOI": "10.1126/SCIENCE.3001936", "CorpusId": 44327583, "PubMed":
      "3001936"}, "corpusId": 44327583, "publicationVenue": {"id": "f59506a8-d8bb-4101-b3d4-c4ac3ed03dad",
      "name": "Science", "type": "journal", "issn": "0193-4511", "alternate_issns":
      ["0036-8075"], "url": "https://www.jstor.org/journal/science", "alternate_urls":
      ["https://www.sciencemag.org/", "http://www.sciencemag.org/", "http://www.jstor.org/journals/00368075.html",
      "http://www.sciencemag.org/archive/"]}, "url": "https://www.semanticscholar.org/paper/b3e5245b9784a5fbff52a1570469ab75f8bdbdd3",
      "title": "ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate
      and catabolites.", "abstract": "Steady-state cellular levels of phosphatidylinositol-4,5-bisphosphate
      (PIP2), 1,2-diacylglycerol (DAG), and inositol phosphates have been measured
      in two different fibroblast cell lines (NIH 3T3 and NRK cells) before and after
      transformation with three different ras genes. At high cell density the ratio
      of DAG to PIP2 was 2.5- to 3-fold higher in the ras-transformed cells than in
      their untransformed counterparts. The sum of the water-soluble breakdown products
      of the polyphosphoinositides, inositol-1,4-bisphosphate and inositol-1,4,5-trisphosphate,
      was also elevated in ras-transformed NRK cells compared with nontransformed
      NRK cells. These findings suggest that the ras (p21) protein may act by affecting
      these levels, possibly as a regulatory element in the PIP2 breakdown pathway.",
      "venue": "Science", "year": 1986, "referenceCount": 53, "citationCount": 367,
      "influentialCitationCount": 3, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1986-01-24", "journal": {"volume": "231 4736", "pages":
      "\n          407-10\n        ", "name": "Science"}, "citationStyles": {"bibtex":
      "@Article{Fleischman1986rastransformedCA,\n author = {L. Fleischman and S. Chahwala
      and L. Cantley},\n booktitle = {Science},\n journal = {Science},\n pages = {\n          407-10\n        },\n
      title = {ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate
      and catabolites.},\n volume = {231 4736},\n year = {1986}\n}\n"}, "authors":
      [{"authorId": "4459392", "name": "L. Fleischman"}, {"authorId": "8044764", "name":
      "S. Chahwala"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "d9e6538d636f195d4bb8b6c4942f2fe7bce9d10a", "externalIds": {"MAG": "57097630",
      "DOI": "10.1007/978-1-4684-5062-0_12", "CorpusId": 81108690}, "corpusId": 81108690,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/d9e6538d636f195d4bb8b6c4942f2fe7bce9d10a",
      "title": "Comparison of the Na+ Pump and the Ouabain-Resistant K+ Transport
      System with Other Metal Ion Transport ATPases", "abstract": null, "venue": "",
      "year": 1986, "referenceCount": 32, "citationCount": 1, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": {"volume": "", "pages": "249-259", "name":
      ""}, "citationStyles": {"bibtex": "@Inproceedings{English1986ComparisonOT,\n
      author = {L. English and B. White and L. Cantley},\n pages = {249-259},\n title
      = {Comparison of the Na+ Pump and the Ouabain-Resistant K+ Transport System
      with Other Metal Ion Transport ATPases},\n year = {1986}\n}\n"}, "authors":
      [{"authorId": "34784769", "name": "L. English"}, {"authorId": "33469167", "name":
      "B. White"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "ddf80e3bda0cd0f5fa91378bf34f02b26f42228b",
      "externalIds": {"MAG": "2065447875", "DOI": "10.1073/PNAS.83.11.3624", "CorpusId":
      40508765, "PubMed": "2424008"}, "corpusId": 40508765, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/ddf80e3bda0cd0f5fa91378bf34f02b26f42228b",
      "title": "Phosphatidylinositol metabolism and polyoma-mediated transformation.",
      "abstract": "The effect of polyoma middle-sized tumor antigen (MTAg) on phosphatidylinositol
      metabolism has been characterized in vivo and in vitro using polyoma-transformed
      and polyoma-infected cells. Cells infected with transformation-competent polyoma
      virus exhibit increased levels of inositol phospholipids and the second messenger
      inositol trisphosphate. MTAg or pp60c-src immunoprecipitates from MTAg-transformed
      cells contain an activity that phosphorylates phosphatidylinositol and phosphatidylinositol
      4-phosphate. This activity is induced in parallel with MTAg when the MTAg synthesis
      is regulated by hormonal or heavy metal inducers. Immunoprecipitates from one
      class of polyoma mutants defective in transformation have a reduced level of
      associated phosphatidylinositol kinase activity in vitro yet are capable of
      tyrosine phosphorylation on exogenous protein substrates at rates comparable
      to wild-type virus. Thus, for these mutants, phosphatidylinositol kinase activity
      is more tightly correlated with transformation than is protein kinase activity.
      These results suggest that alterations in phosphatidylinositol metabolism by
      MTAg play a role in transformation by polyoma virus.", "venue": "Proceedings
      of the National Academy of Sciences of the United States of America", "year":
      1986, "referenceCount": 0, "citationCount": 170, "influentialCitationCount":
      6, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1986-06-01", "journal": {"volume": "83 11", "pages": "\n          3624-8\n        ",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America"}, "citationStyles": {"bibtex": "@Article{Kaplan1986PhosphatidylinositolMA,\n
      author = {D. Kaplan and M. Whitman and B. Schaffhausen and L. Raptis and R.
      Garcea and D. Pallas and T. Roberts and L. Cantley},\n booktitle = {Proceedings
      of the National Academy of Sciences of the United States of America},\n journal
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      pages = {\n          3624-8\n        },\n title = {Phosphatidylinositol metabolism
      and polyoma-mediated transformation.},\n volume = {83 11},\n year = {1986}\n}\n"},
      "authors": [{"authorId": "32389352", "name": "D. Kaplan"}, {"authorId": "32113608",
      "name": "M. Whitman"}, {"authorId": "4362128", "name": "B. Schaffhausen"}, {"authorId":
      "77741236", "name": "L. Raptis"}, {"authorId": "5539122", "name": "R. Garcea"},
      {"authorId": "5515098", "name": "D. Pallas"}, {"authorId": "6665338", "name":
      "T. Roberts"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "093ac1569ef5833ababe3e30fb198ef2a48706c9", "externalIds": {"MAG": "2090940799",
      "DOI": "10.1038/315239A0", "CorpusId": 4337999, "PubMed": "2987699"}, "corpusId":
      4337999, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/093ac1569ef5833ababe3e30fb198ef2a48706c9",
      "title": "Association of phosphatidylinositol kinase activity with polyoma middle-T
      competent for transformation", "abstract": null, "venue": "Nature", "year":
      1985, "referenceCount": 27, "citationCount": 699, "influentialCitationCount":
      13, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1985-05-16", "journal": {"volume": "315", "pages": "239-242", "name": "Nature"},
      "citationStyles": {"bibtex": "@Article{Whitman1985AssociationOP,\n author =
      {M. Whitman and D. Kaplan and B. Schaffhausen and L. Cantley and T. Roberts},\n
      booktitle = {Nature},\n journal = {Nature},\n pages = {239-242},\n title = {Association
      of phosphatidylinositol kinase activity with polyoma middle-T competent for
      transformation},\n volume = {315},\n year = {1985}\n}\n"}, "authors": [{"authorId":
      "32113608", "name": "M. Whitman"}, {"authorId": "32389352", "name": "D. Kaplan"},
      {"authorId": "4362128", "name": "B. Schaffhausen"}, {"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "6665338", "name": "T. Roberts"}]}, {"paperId":
      "42d5440c808ed4397b5f66d61bdbfd03bbeb4eb9", "externalIds": {"MAG": "1507900720",
      "CorpusId": 31043389, "PubMed": "2981832"}, "corpusId": 31043389, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/42d5440c808ed4397b5f66d61bdbfd03bbeb4eb9",
      "title": "Expression of an ouabain resistance gene in transfected cells. Ouabain
      treatment induces a K+-transport system.", "abstract": "We have investigated
      the expression of a cloned mouse gene which confers ouabain resistance to African
      green monkey kidney (CV1) cells. CV1 cells carrying the transfected ouabain
      resistance (ouaR) gene express an ouabain-inducible K+-transport system. This
      K+-transport system is not a normal (Na,K)-ATPase since plasma membranes prepared
      from the transfected cells have significantly reduced Na+-stimulated ATPase
      activity. RNA sequences homologous to the transfected gene are observed in abundance
      only following exposure of transfectants to ouabain. The small size of the message
      induced (1.2 kilobases) also argues that the gene does not code for the alpha-subunit
      of the (Na,K)-ATPase. Ouabain-treated transfected cells maintain an internal
      [K+] of 113 mM; a level close to the 139 mM of control cells. However, ouabain-treated
      transfectants exhibit an internal [Na+] of 61 mM, which is 3-6 times the level
      in untreated cells (11-21 mM). These results suggest: ouabain resistance can
      be conferred by a gene which codes for an ouabain-inducible K+-transport system;
      induction of this transport system by ouabain is due to increased levels of
      mRNA coded for by the ouabain resistance gene; and the ouabain resistance gene
      does not encode for the alpha-subunit of the (Na,K)-ATPase.", "venue": "Journal
      of Biological Chemistry", "year": 1985, "referenceCount": 0, "citationCount":
      21, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology",
      "source": "external"}, {"category": "Medicine", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1985-01-25", "journal": {"volume": "260 2", "pages": "\n          1114-9\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{English1985ExpressionOA,\n author = {L. English and J. Epstein and
      L. Cantley and D. Housman and R. Levenson},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of biological chemistry},\n pages = {\n          1114-9\n        },\n
      title = {Expression of an ouabain resistance gene in transfected cells. Ouabain
      treatment induces a K+-transport system.},\n volume = {260 2},\n year = {1985}\n}\n"},
      "authors": [{"authorId": "34784769", "name": "L. English"}, {"authorId": "48381149",
      "name": "J. Epstein"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "10127476", "name": "D. Housman"}, {"authorId": "144579743", "name": "R. Levenson"}]},
      {"paperId": "8aed6016a5f08f28a308166e557b2d32bdfb11a7", "externalIds": {"MAG":
      "2412355881", "CorpusId": 11472520, "PubMed": "2996016"}, "corpusId": 11472520,
      "publicationVenue": {"id": "736e8a50-08e5-4fdf-a56c-1288eae28f3c", "name": "Progress
      in clinical and biological research", "type": "journal", "alternate_names":
      ["Progress in Clinical and Biological Research", "Prog Clin Biological Res",
      "Prog clin biological res"], "issn": "0361-7742"}, "url": "https://www.semanticscholar.org/paper/8aed6016a5f08f28a308166e557b2d32bdfb11a7",
      "title": "The role of ion fluxes in hematopoietic cell differentiation.", "abstract":
      null, "venue": "Progress in clinical and biological research", "year": 1985,
      "referenceCount": 0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": null, "journal": {"volume": "184", "pages": "\n          331-9\n        ",
      "name": "Progress in clinical and biological research"}, "citationStyles": {"bibtex":
      "@Article{Rosoff1985TheRO,\n author = {P. Rosoff and L. Cantley},\n booktitle
      = {Progress in clinical and biological research},\n journal = {Progress in clinical
      and biological research},\n pages = {\n          331-9\n        },\n title =
      {The role of ion fluxes in hematopoietic cell differentiation.},\n volume =
      {184},\n year = {1985}\n}\n"}, "authors": [{"authorId": "4078651", "name": "P.
      Rosoff"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "9656af04e36107ac2516b775151125166d9c3b85",
      "externalIds": {"MAG": "1603620343", "DOI": "10.1016/s0021-9258(17)38683-0",
      "CorpusId": 6202775, "PubMed": "2997191"}, "corpusId": 6202775, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/9656af04e36107ac2516b775151125166d9c3b85",
      "title": "Stimulation of the T3-T cell receptor-associated Ca2+ influx enhances
      the activity of the Na+/H+ exchanger in a leukemic human T cell line.", "abstract":
      null, "venue": "Journal of Biological Chemistry", "year": 1985, "referenceCount":
      2, "citationCount": 66, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1985-11-15", "journal": {"volume": "260 26", "pages": "\n          14053-9\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Rosoff1985StimulationOT,\n author = {P. Rosoff and L. Cantley},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          14053-9\n        },\n title = {Stimulation
      of the T3-T cell receptor-associated Ca2+ influx enhances the activity of the
      Na+/H+ exchanger in a leukemic human T cell line.},\n volume = {260 26},\n year
      = {1985}\n}\n"}, "authors": [{"authorId": "4078651", "name": "P. Rosoff"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "a4821cc4667211847f23810a3f7dafdc368027ed",
      "externalIds": {"MAG": "1509406829", "DOI": "10.1016/s0021-9258(17)39354-7",
      "CorpusId": 36602004, "PubMed": "3874870"}, "corpusId": 36602004, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/a4821cc4667211847f23810a3f7dafdc368027ed",
      "title": "Lipopolysaccharide and phorbol esters induce differentiation but have
      opposite effects on phosphatidylinositol turnover and Ca2+ mobilization in 70Z/3
      pre-B lymphocytes.", "abstract": null, "venue": "Journal of Biological Chemistry",
      "year": 1985, "referenceCount": 0, "citationCount": 107, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1985-08-05", "journal": {"volume": "260 16", "pages": "\n          9209-15\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Rosoff1985LipopolysaccharideAP,\n author = {P. Rosoff and L. Cantley},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          9209-15\n        },\n title = {Lipopolysaccharide
      and phorbol esters induce differentiation but have opposite effects on phosphatidylinositol
      turnover and Ca2+ mobilization in 70Z/3 pre-B lymphocytes.},\n volume = {260
      16},\n year = {1985}\n}\n"}, "authors": [{"authorId": "4078651", "name": "P.
      Rosoff"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "c25f85524acff9fe905be75c28da2979d78cc5b2",
      "externalIds": {"MAG": "106263185", "CorpusId": 39958523, "PubMed": "2984780"},
      "corpusId": 39958523, "publicationVenue": {"id": "15ff847f-6fb7-4298-88a5-9604bbd7baec",
      "name": "Society of General Physiologists series", "type": "journal", "alternate_names":
      ["Soc Gen Physiol ser"], "issn": "0094-7733"}, "url": "https://www.semanticscholar.org/paper/c25f85524acff9fe905be75c28da2979d78cc5b2",
      "title": "Ion fluxes and differentiation in transformed cell lines.", "abstract":
      null, "venue": "Society of General Physiologists series", "year": 1985, "referenceCount":
      0, "citationCount": 8, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["Review", "JournalArticle"], "publicationDate": null, "journal": {"volume":
      "39", "pages": "\n          193-204\n        ", "name": "Society of General
      Physiologists series"}, "citationStyles": {"bibtex": "@Article{Rosoff1985IonFA,\n
      author = {P. Rosoff and L. Cantley},\n booktitle = {Society of General Physiologists
      series},\n journal = {Society of General Physiologists series},\n pages = {\n          193-204\n        },\n
      title = {Ion fluxes and differentiation in transformed cell lines.},\n volume
      = {39},\n year = {1985}\n}\n"}, "authors": [{"authorId": "4078651", "name":
      "P. Rosoff"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "df8e7cf49fc5eeb55b7286cf4aeecc1f3a35466c",
      "externalIds": {"MAG": "2243707934", "DOI": "10.1007/978-1-4613-2377-8_20",
      "CorpusId": 101149200}, "corpusId": 101149200, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/df8e7cf49fc5eeb55b7286cf4aeecc1f3a35466c",
      "title": "Na+ and Ca2+ Fluxes and Differentiation of Transformed Cells", "abstract":
      null, "venue": "", "year": 1985, "referenceCount": 20, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "pages": "173-178", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Cantley1985NaAC,\n author = {L. Cantley and P. Rosoff
      and R. Levenson and I. Macara and L. Yeh and L. Ling and L. English},\n pages
      = {173-178},\n title = {Na+ and Ca2+ Fluxes and Differentiation of Transformed
      Cells},\n year = {1985}\n}\n"}, "authors": [{"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "4078651", "name": "P. Rosoff"}, {"authorId": "144579743",
      "name": "R. Levenson"}, {"authorId": "5583964", "name": "I. Macara"}, {"authorId":
      "34912412", "name": "L. Yeh"}, {"authorId": "50678030", "name": "L. Ling"},
      {"authorId": "34784769", "name": "L. English"}]}, {"paperId": "f74e8f673b4b1f9ed804f34af9b5b2ee96c4ab2b",
      "externalIds": {"MAG": "2054320393", "DOI": "10.1016/0092-8674(85)90206-5",
      "CorpusId": 38617826, "PubMed": "2578888"}, "corpusId": 38617826, "publicationVenue":
      {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b", "name": "Cell", "type": "journal",
      "alternate_names": ["La Cellule"], "issn": "0092-8674", "alternate_issns": ["0008-8757"],
      "url": "https://www.cell.com/", "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/f74e8f673b4b1f9ed804f34af9b5b2ee96c4ab2b",
      "title": "Stimulation of the T3-T cell receptor complex induces a membrane-potential-sensitive
      calcium influx", "abstract": null, "venue": "Cell", "year": 1985, "referenceCount":
      57, "citationCount": 234, "influentialCitationCount": 2, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Biology"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1985-03-01", "journal": {"volume": "40", "pages": "583-590",
      "name": "Cell"}, "citationStyles": {"bibtex": "@Article{Oettgen1985StimulationOT,\n
      author = {H. Oettgen and C. Terhorst and L. Cantley and P. Rosoff},\n booktitle
      = {Cell},\n journal = {Cell},\n pages = {583-590},\n title = {Stimulation of
      the T3-T cell receptor complex induces a membrane-potential-sensitive calcium
      influx},\n volume = {40},\n year = {1985}\n}\n"}, "authors": [{"authorId": "12579610",
      "name": "H. Oettgen"}, {"authorId": "4658870", "name": "C. Terhorst"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "4078651", "name": "P. Rosoff"}]},
      {"paperId": "4917b16b5e37b0538c3efbad7bf0458523e11235", "externalIds": {"MAG":
      "183187594", "DOI": "10.1152/AJPRENAL.1984.247.6.F919", "CorpusId": 32623618,
      "PubMed": "6095682"}, "corpusId": 32623618, "publicationVenue": {"id": "998813ea-da72-494a-90fc-783751929f3c",
      "name": "American Journal of Physiology", "type": "journal", "alternate_names":
      ["Am J Physiol"], "issn": "0002-9513", "alternate_issns": ["2163-5773"], "url":
      "http://search.epnet.com/direct.asp?db=aph&jid=AHY", "alternate_urls": ["http://www.physiology.org/",
      "http://www.physiology.org/journal/ajplegacy", "https://www.physiology.org/journal/ajpcell",
      "http://ajpcon.physiology.org/", "https://www.biodiversitylibrary.org/bibliography/38917"]},
      "url": "https://www.semanticscholar.org/paper/4917b16b5e37b0538c3efbad7bf0458523e11235",
      "title": "Hypothalamic sodium-transport inhibitor is a high-affinity reversible
      inhibitor of Na+-K+-ATPase.", "abstract": "Bovine hypothalamus contains a stable,
      low molecular weight substance with ouabain-like properties. To further study
      its mechanism of action and potential physiological importance we examined its
      effects on purified Na+-K+-ATPase in a kinetic coupled-enzyme assay. Under optimal
      conditions up to 95% of Na+-K+-ATPase activity could be inhibited by the factor.
      Mg2+ is required for maximal inhibitory activity, but ligand requirements for
      optimal activity are otherwise distinct from those of both ouabain and vanadate.
      Inhibition is reversed by high concentrations of sodium chloride plus EDTA.
      Kinetic analysis yielded a Ki = 1.4 nM. The hypothalamic factor is a high-affinity
      reversible inhibitor of Na+-K+-ATPase, being at least as potent as the cardiac
      glycoside ouabain and may be a circulating inhibitor of sodium transport, which
      appears to be associated with experimental volume-expanded hypertension and
      human essential hypertension.", "venue": "American Journal of Physiology", "year":
      1984, "referenceCount": 0, "citationCount": 53, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1984-12-01", "journal": {"volume": "247
      6 Pt 2", "pages": "\n          F919-24\n        ", "name": "The American journal
      of physiology"}, "citationStyles": {"bibtex": "@Article{Haupert1984HypothalamicSI,\n
      author = {G. T. Haupert and C. Carilli and L. Cantley},\n booktitle = {American
      Journal of Physiology},\n journal = {The American journal of physiology},\n
      pages = {\n          F919-24\n        },\n title = {Hypothalamic sodium-transport
      inhibitor is a high-affinity reversible inhibitor of Na+-K+-ATPase.},\n volume
      = {247 6 Pt 2},\n year = {1984}\n}\n"}, "authors": [{"authorId": "6466373",
      "name": "G. T. Haupert"}, {"authorId": "2060790666", "name": "C. Carilli"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "68e6babe5546eb91d99134e348e1afc7ec292e1e",
      "externalIds": {"MAG": "1971333358", "DOI": "10.1073/PNAS.81.7.2117", "CorpusId":
      22275277, "PubMed": "6326105"}, "corpusId": 22275277, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/68e6babe5546eb91d99134e348e1afc7ec292e1e",
      "title": "Evidence that the Rous sarcoma virus transforming gene product phosphorylates
      phosphatidylinositol and diacylglycerol.", "abstract": "The ability of purified
      Rous sarcoma virus transforming gene product, pp60v-src, to phosphorylate phosphatidylinositol
      and diacylglycerol was investigated. Phosphatidylinositol was phosphorylated
      to form both mono- and diphosphorylated derivatives. 1,2-Diacylglycerol was
      phosphorylated to form phosphatidic acid. These activities showed the same thermolability
      and the same sensitivity to inhibitors as shown by the casein kinase activity
      of pp60v-src. In addition, when serum-starved chicken embryo fibroblasts transformed
      by a virus mutant temperature-sensitive for transformation were shifted from
      the nonpermissive to permissive temperature, an increase of 50-100% in the labeling
      of phosphatidylinositol 4-phosphate, phosphatidylinositol 4,5-bisphosphate,
      and phosphatidic acid was observed, as compared to uninfected cells.", "venue":
      "Proceedings of the National Academy of Sciences of the United States of America",
      "year": 1984, "referenceCount": 1, "citationCount": 364, "influentialCitationCount":
      5, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc345448?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1984-04-01", "journal": {"volume": "81 7", "pages": "\n          2117-21\n        ",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America"}, "citationStyles": {"bibtex": "@Article{Sugimoto1984EvidenceTT,\n
      author = {Y. Sugimoto and M. Whitman and L. Cantley and R. Erikson},\n booktitle
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      journal = {Proceedings of the National Academy of Sciences of the United States
      of America},\n pages = {\n          2117-21\n        },\n title = {Evidence
      that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol
      and diacylglycerol.},\n volume = {81 7},\n year = {1984}\n}\n"}, "authors":
      [{"authorId": "2052521806", "name": "Y. Sugimoto"}, {"authorId": "39063562",
      "name": "M. Whitman"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "6286526", "name": "R. Erikson"}]}, {"paperId": "8110a2ca685475b976654d14d4a0ca50321add66",
      "externalIds": {"MAG": "1585242164", "DOI": "10.1016/s0021-9258(17)39836-8",
      "CorpusId": 7721367, "PubMed": "6144681"}, "corpusId": 7721367, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/8110a2ca685475b976654d14d4a0ca50321add66",
      "title": "Phorbol esters induce differentiation in a pre-B-lymphocyte cell line
      by enhancing Na+/H+ exchange.", "abstract": null, "venue": "Journal of Biological
      Chemistry", "year": 1984, "referenceCount": 1, "citationCount": 148, "influentialCitationCount":
      1, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Chemistry"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Chemistry", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1984-06-10", "journal": {"volume": "259 11", "pages": "\n          7056-60\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Rosoff1984PhorbolEI,\n author = {P. Rosoff and L. Stein and L. Cantley},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          7056-60\n        },\n title = {Phorbol esters
      induce differentiation in a pre-B-lymphocyte cell line by enhancing Na+/H+ exchange.},\n
      volume = {259 11},\n year = {1984}\n}\n"}, "authors": [{"authorId": "4078651",
      "name": "P. Rosoff"}, {"authorId": "87374149", "name": "L. Stein"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "be525f6f4cb36e8dcb6c58b2e4da2d88b3200a63",
      "externalIds": {"MAG": "1580187066", "DOI": "10.1016/s0021-9258(17)39699-0",
      "CorpusId": 44937037, "PubMed": "6145711"}, "corpusId": 44937037, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/be525f6f4cb36e8dcb6c58b2e4da2d88b3200a63",
      "title": "Characterization of the ATP-dependent proton pump of clathrin-coated
      vesicles.", "abstract": null, "venue": "Journal of Biological Chemistry", "year":
      1984, "referenceCount": 0, "citationCount": 41, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1984-07-10", "journal": {"volume": "259
      13", "pages": "\n          8101-5\n        ", "name": "The Journal of biological
      chemistry"}, "citationStyles": {"bibtex": "@Article{Forgac1984CharacterizationOT,\n
      author = {M. Forgac and L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of biological chemistry},\n pages = {\n          8101-5\n        },\n
      title = {Characterization of the ATP-dependent proton pump of clathrin-coated
      vesicles.},\n volume = {259 13},\n year = {1984}\n}\n"}, "authors": [{"authorId":
      "145289081", "name": "M. Forgac"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "d7638f17c6bcf162c56a6a1d4670c48399989a05", "externalIds": {"MAG":
      "1574702655", "CorpusId": 25502233, "PubMed": "6594338"}, "corpusId": 25502233,
      "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal
      of Biological Chemistry", "type": "journal", "alternate_names": ["J Biological
      Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/d7638f17c6bcf162c56a6a1d4670c48399989a05",
      "title": "Extracellular ATP induces ion fluxes and inhibits growth of Friend
      erythroleukemia cells.", "abstract": "Extracellular ATP (1 mM) inhibited the
      growth of Friend virus-infected murine erythroleukemia cells (MEL cells) but
      had no effect on dimethyl sulfoxide-induced differentiation. ATP (1 mM) also
      caused changes in the permeability of MEL cells to ions. There was an increased
      influx of 45Ca2+ from a basal level of 5 pmol/min to 18 pmol/min/10(6) cells
      to achieve a 2-fold increase in steady-state Ca2+ as measured at isotopic equilibration.
      Ca2+ influx was blocked by diisothiocyanostilbene disulfonate (DIDS), an inhibitor
      of anion transport. ATP also stimulated Cl- uptake, and this flux was inhibited
      by DIDS. The ratio of ATP stimulated Cl- to Ca2+ uptake was 1.6:1. K+ and Na+
      influx were also stimulated by ATP, but phosphate uptake was inhibited; the
      Na+ influx dissipated the Na+ gradient and thus inhibited nutrient uptake. ATP-stimulated
      K+ influx was ouabain inhibitable; however, the total cellular K+ decreased
      due to an ATP-stimulated ouabain-resistant K+ efflux. Na+ influx and Ca2+ influx
      occurred by separate independent routes, since Na+ influx was not inhibited
      by DIDS. The effects observed were specific for ATP *K1/2 MgATP = 0.7 mM) since
      AMP, GTP, adenosine, and the slowly hydrolyzable ATP analogue adenyl-5''-yl
      imidodiphosphate were without effect. The major ionic changes in the cell were
      a decrease in K+ and increase in Na+; cytoplasmic pH and free Ca2+ did not change
      appreciably. These ATP-induced changes in ion flux are considered to be responsible
      for growth inhibition.", "venue": "Journal of Biological Chemistry", "year":
      1984, "referenceCount": 2, "citationCount": 71, "influentialCitationCount":
      3, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1984-11-25", "journal": {"volume": "259
      22", "pages": "\n          13717-22\n        ", "name": "The Journal of biological
      chemistry"}, "citationStyles": {"bibtex": "@Article{Chahwala1984ExtracellularAI,\n
      author = {S. Chahwala and L. Cantley},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of biological chemistry},\n pages = {\n          13717-22\n        },\n
      title = {Extracellular ATP induces ion fluxes and inhibits growth of Friend
      erythroleukemia cells.},\n volume = {259 22},\n year = {1984}\n}\n"}, "authors":
      [{"authorId": "8044764", "name": "S. Chahwala"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "e2ff03903fb47314482c2603f926f7cd5265f63d", "externalIds":
      {"MAG": "2090761406", "DOI": "10.1002/jcp.1041210115", "CorpusId": 22010992,
      "PubMed": "6480706"}, "corpusId": 22010992, "publicationVenue": {"id": "cdf4bb1c-e624-482e-8289-da2009c4c31a",
      "name": "Journal of Cellular Physiology", "type": "journal", "alternate_names":
      ["J Cell Physiol"], "issn": "0021-9541", "url": "http://eu.wiley.com/WileyCDA/WileyTitle/productCd-JCP.html",
      "alternate_urls": ["http://www3.interscience.wiley.com/cgi-bin/jhome/109898032",
      "http://onlinelibrary.wiley.com/journal/10.1002/%28issn%291097-4652", "http://onlinelibrary.wiley.com/journal/10.1002/(issn)1097-4652",
      "https://onlinelibrary.wiley.com/journal/10974652", "http://www3.interscience.wiley.com/cgi-bin/jhome/31010"]},
      "url": "https://www.semanticscholar.org/paper/e2ff03903fb47314482c2603f926f7cd5265f63d",
      "title": "Characterization of monovalent ion transport systems in an insect
      cell line (Manduca sexta embryonic cell line che)", "abstract": "The monovalent
      ion transport systems of an immortalized insect cell line (CHE) have been investigated.
      These cells are unusual in that unlike most vertebrate cells, their normal extracellular
      environment consists of high potassium and low sodium concentrations. CHE cells
      maintained high intracellular [K+] through both a furosemide\u2010inhibitable
      and a vanadate\u2010inhibitable transport system. Intracellular exchangeable
      [Na+] was slightly lower than the extracellular [Na+] and was maintained at
      this level through a vanadate\u2010sensitive transport system. Na+ uptake was
      also inhibited by furosemide: however, the stoichiometry of furosemide\u2010sensitive
      Na+ uptake when compared with furosemide\u2010sensitive K+ uptake indicated
      that these cations are not cotransported. 4,4\u2032\u2010Diisothiocyano\u20102,2\u2032\u2010disulfonic
      acid stilbene (DIDS) inhibited Na+, K+, and Cl\u2212 uptake. Vanadate and furosemide
      decreased cytoplasmimic pH, while cytoplasmic pH increased in the presence of
      DIDS. A model is presented explaining how Na+, K+, Cl\u2212, H+ and HCO3 \u2212
      fluxes are regulated in these cells.", "venue": "Journal of Cellular Physiology",
      "year": 1984, "referenceCount": 36, "citationCount": 19, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1984-10-01", "journal": {"volume": "121", "name": "Journal of Cellular Physiology"},
      "citationStyles": {"bibtex": "@Article{English1984CharacterizationOM,\n author
      = {L. English and L. Cantley},\n booktitle = {Journal of Cellular Physiology},\n
      journal = {Journal of Cellular Physiology},\n title = {Characterization of monovalent
      ion transport systems in an insect cell line (Manduca sexta embryonic cell line
      che)},\n volume = {121},\n year = {1984}\n}\n"}, "authors": [{"authorId": "34784769",
      "name": "L. English"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "1ca4e503c84fc64ffb789f5033ea4e049538e89a", "externalIds": {"MAG": "1185978304",
      "DOI": "10.1016/S0070-2161(08)60564-X", "CorpusId": 82338418}, "corpusId": 82338418,
      "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/1ca4e503c84fc64ffb789f5033ea4e049538e89a",
      "title": "The Active Site Structure of Na,K-ATPase: Location of a Specific Fluorescein
      Isothiocyanate-Reactive Site", "abstract": null, "venue": "", "year": 1983,
      "referenceCount": 4, "citationCount": 3, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Chemistry",
      "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": {"volume": "19",
      "pages": "149-151", "name": "Current topics in membranes and transport"}, "citationStyles":
      {"bibtex": "@Article{Carilli1983TheAS,\n author = {C. Carilli and R. Farley
      and L. Cantley},\n journal = {Current topics in membranes and transport},\n
      pages = {149-151},\n title = {The Active Site Structure of Na,K-ATPase: Location
      of a Specific Fluorescein Isothiocyanate-Reactive Site},\n volume = {19},\n
      year = {1983}\n}\n"}, "authors": [{"authorId": "2060790666", "name": "C. Carilli"},
      {"authorId": "2284479", "name": "R. Farley"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "3198c7f92cd7bc3b6d6099d5cefed911304cd82c", "externalIds":
      {"MAG": "2197834256", "DOI": "10.1016/S0070-2161(08)60637-1", "CorpusId": 86259996},
      "corpusId": 86259996, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/3198c7f92cd7bc3b6d6099d5cefed911304cd82c",
      "title": "Role of Na+ andCa2+ Fluxes in Terminal Differentiation of Murine Erythroleukemia
      Cells", "abstract": null, "venue": "", "year": 1983, "referenceCount": 8, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": {"volume": "19", "pages": "797-802",
      "name": "Current topics in membranes and transport"}, "citationStyles": {"bibtex":
      "@Article{Macara1983RoleON,\n author = {I. Macara and R. Smith and L. Cantley},\n
      journal = {Current topics in membranes and transport},\n pages = {797-802},\n
      title = {Role of Na+ andCa2+ Fluxes in Terminal Differentiation of Murine Erythroleukemia
      Cells},\n volume = {19},\n year = {1983}\n}\n"}, "authors": [{"authorId": "5583964",
      "name": "I. Macara"}, {"authorId": "2253624854", "name": "R. Smith"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "3d2a4cafcf11e90cd15f2bfd445543044a1e174a",
      "externalIds": {"MAG": "2053803291", "DOI": "10.1073/PNAS.80.24.7547", "CorpusId":
      38391710, "PubMed": "6608724"}, "corpusId": 38391710, "publicationVenue": {"id":
      "bb95bf2e-8383-4748-bf9d-d6906d091085", "name": "Proceedings of the National
      Academy of Sciences of the United States of America", "type": "journal", "alternate_names":
      ["PNAS", "PNAS online", "Proceedings of the National Academy of Sciences of
      the United States of America.", "Proc National Acad Sci", "Proceedings of the
      National Academy of Sciences", "Proc National Acad Sci u s Am"], "issn": "0027-8424",
      "alternate_issns": ["1091-6490"], "url": "https://www.jstor.org/journal/procnatiacadscie",
      "alternate_urls": ["http://www.pnas.org/", "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html",
      "www.pnas.org/"]}, "url": "https://www.semanticscholar.org/paper/3d2a4cafcf11e90cd15f2bfd445543044a1e174a",
      "title": "Increasing the intracellular Na+ concentration induces differentiation
      in a pre-B lymphocyte cell line.", "abstract": "The ability of lipopolysaccharide
      (LPS), a polyclonal B-cell mitogen, to induce differentiation in the pre-B cell
      tumor line 70Z/3 can be mimicked by drugs that increase the intracellular Na+
      concentration. Pharmacologically increasing the cellular Na+ content with monensin,
      a sodium ionophore, or ouabain, a specific inhibitor of Na+, K+-ATPase, induces
      surface IgM expression in these cells. We have shown that LPS stimulates uptake
      of Na+ through an amiloride-sensitive pathway. These results show that the essential
      action of LPS to induce surface IgM expression is activation of a Na+ uptake
      system.", "venue": "Proceedings of the National Academy of Sciences of the United
      States of America", "year": 1983, "referenceCount": 1, "citationCount": 56,
      "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc389989?pdf=render", "status": null}, "fieldsOfStudy":
      ["Biology", "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1983-12-01", "journal":
      {"volume": "80 24", "pages": "\n          7547-50\n        ", "name": "Proceedings
      of the National Academy of Sciences of the United States of America"}, "citationStyles":
      {"bibtex": "@Article{Rosoff1983IncreasingTI,\n author = {P. Rosoff and L. Cantley},\n
      booktitle = {Proceedings of the National Academy of Sciences of the United States
      of America},\n journal = {Proceedings of the National Academy of Sciences of
      the United States of America},\n pages = {\n          7547-50\n        },\n
      title = {Increasing the intracellular Na+ concentration induces differentiation
      in a pre-B lymphocyte cell line.},\n volume = {80 24},\n year = {1983}\n}\n"},
      "authors": [{"authorId": "4078651", "name": "P. Rosoff"}, {"authorId": "1723755",
      "name": "L. Cantley"}]}, {"paperId": "4946a3ab3de02737180767f925ea67f8f67e17ec",
      "externalIds": {"MAG": "1501557066", "DOI": "10.1016/s0021-9258(18)33056-4",
      "CorpusId": 33811079, "PubMed": "6185490"}, "corpusId": 33811079, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/4946a3ab3de02737180767f925ea67f8f67e17ec",
      "title": "Evidence that inhibitors of anion exchange induce a transmembrane
      conformational change in band 3.", "abstract": null, "venue": "Journal of Biological
      Chemistry", "year": 1983, "referenceCount": 1, "citationCount": 46, "influentialCitationCount":
      2, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1983-02-10", "journal": {"volume": "258
      3", "pages": "\n          1785-92\n        ", "name": "The Journal of biological
      chemistry"}, "citationStyles": {"bibtex": "@Article{Macara1983EvidenceTI,\n
      author = {I. Macara and S. Kuo and L. Cantley},\n booktitle = {Journal of Biological
      Chemistry},\n journal = {The Journal of biological chemistry},\n pages = {\n          1785-92\n        },\n
      title = {Evidence that inhibitors of anion exchange induce a transmembrane conformational
      change in band 3.},\n volume = {258 3},\n year = {1983}\n}\n"}, "authors": [{"authorId":
      "5583964", "name": "I. Macara"}, {"authorId": "2056251182", "name": "S. Kuo"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "5691bd00477717f05133d8a56a678be2ab1ab39d",
      "externalIds": {"PubMedCentral": "2112600", "MAG": "2083822287", "DOI": "10.1083/JCB.97.4.1299",
      "CorpusId": 84974704, "PubMed": "6311842"}, "corpusId": 84974704, "publicationVenue":
      {"id": "bf59074e-18fd-4f9a-a1b0-a9bafc16f518", "name": "Journal of Cell Biology",
      "type": "journal", "alternate_names": ["J Cell Biology"], "issn": "0021-9525",
      "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=482",
      "alternate_urls": ["http://www.jstor.org/journals/00219525.html", "https://www.jstor.org/journal/jcellbiology",
      "http://www.jcb.org/"]}, "url": "https://www.semanticscholar.org/paper/5691bd00477717f05133d8a56a678be2ab1ab39d",
      "title": "Vanadium stimulates the (Na+,K+) pump in friend erythroleukemia cells
      and blocks erythropoiesis", "abstract": "Friend murine erythroleukemia cells
      underwent apparently normal erythropoiesis when treated with dimethyl sulfoxide.
      One of the earliest events associated with this induction was a decrease in
      ouabain sensitive 86Rb+ uptake, an assay of the plasma membrane Na,K(ATPase).
      Ammonium vanadate (10 microM) blocked differentiation of these cells without
      affecting cell viability. Vanadium was taken up by Friend cells and prevented
      the dimethyl sulfoxide-induced decrease in ouabain sensitive 86Rb+ uptake. Vanadate
      reactivated 86Rb+ transport previously inhibited by dimethyl sulfoxide treatment
      but had no affect on 86Rb+ transport in untreated cells. These results suggest
      an essential role for the (Na,K)ATPase in cell differentiation.", "venue": "Journal
      of Cell Biology", "year": 1983, "referenceCount": 19, "citationCount": 31, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": {"url": "https://europepmc.org/articles/pmc2112600?pdf=render",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Medicine", "source": "s2-fos-model"}, {"category":
      "Biology", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1983-10-01", "journal": {"volume": "97", "pages": "1299
      - 1302", "name": "The Journal of Cell Biology"}, "citationStyles": {"bibtex":
      "@Article{English1983VanadiumST,\n author = {L. English and I. Macara and L.
      Cantley},\n booktitle = {Journal of Cell Biology},\n journal = {The Journal
      of Cell Biology},\n pages = {1299 - 1302},\n title = {Vanadium stimulates the
      (Na+,K+) pump in friend erythroleukemia cells and blocks erythropoiesis},\n
      volume = {97},\n year = {1983}\n}\n"}, "authors": [{"authorId": "34784769",
      "name": "L. English"}, {"authorId": "5583964", "name": "I. Macara"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "715270708d9fedd8049b38d956ee4e91790bfd85",
      "externalIds": {"MAG": "2497890084", "DOI": "10.1007/978-1-4684-4511-4_2", "CorpusId":
      100424663}, "corpusId": 100424663, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/715270708d9fedd8049b38d956ee4e91790bfd85",
      "title": "The Structure and Function of Band 3", "abstract": null, "venue":
      "", "year": 1983, "referenceCount": 121, "citationCount": 34, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Physics", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      null, "journal": {"volume": "", "pages": "41-87", "name": ""}, "citationStyles":
      {"bibtex": "@Inproceedings{Macara1983TheSA,\n author = {I. Macara and L. Cantley},\n
      pages = {41-87},\n title = {The Structure and Function of Band 3},\n year =
      {1983}\n}\n"}, "authors": [{"authorId": "5583964", "name": "I. Macara"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "76ff34d7bd418aa1b010f62e1eff13158d72c818",
      "externalIds": {"MAG": "1890087866", "DOI": "10.1016/S0070-2161(08)60582-1",
      "CorpusId": 83862727}, "corpusId": 83862727, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/76ff34d7bd418aa1b010f62e1eff13158d72c818",
      "title": "Conformational Changes of Na,K-ATPase Necessary for Transport", "abstract":
      null, "venue": "", "year": 1983, "referenceCount": 11, "citationCount": 14,
      "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry"], "s2FieldsOfStudy": [{"category": "Chemistry",
      "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": {"volume": "19", "pages": "315-322",
      "name": "Current topics in membranes and transport"}, "citationStyles": {"bibtex":
      "@Article{Cantley1983ConformationalCO,\n author = {L. Cantley and C. Carilli
      and Roderick L. Smith and D. Perlman},\n journal = {Current topics in membranes
      and transport},\n pages = {315-322},\n title = {Conformational Changes of Na,K-ATPase
      Necessary for Transport},\n volume = {19},\n year = {1983}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "2060790666", "name":
      "C. Carilli"}, {"authorId": "2108905883", "name": "Roderick L. Smith"}, {"authorId":
      "49822428", "name": "D. Perlman"}]}, {"paperId": "bbb60de51755ffe10991a3d69d227bdfbb20f1a7",
      "externalIds": {"MAG": "232897932", "DOI": "10.1016/B978-0-444-80540-9.50013-3",
      "CorpusId": 83186045}, "corpusId": 83186045, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/bbb60de51755ffe10991a3d69d227bdfbb20f1a7",
      "title": "CHARACTERIZATION OF A PLASMA MEMBRANE KINASE WHICH SPECIFICALLY PHOSPHORYLATES
      THE (NA,K)PUMP", "abstract": null, "venue": "", "year": 1983, "referenceCount":
      11, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Biology"], "s2FieldsOfStudy": [{"category":
      "Biology", "source": "external"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": {"volume": "",
      "pages": "73-79", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Cantley1983CHARACTERIZATIONOA,\n
      author = {L. Cantley and L. Yeh and L. Ling and J. Schulz and L. English},\n
      pages = {73-79},\n title = {CHARACTERIZATION OF A PLASMA MEMBRANE KINASE WHICH
      SPECIFICALLY PHOSPHORYLATES THE (NA,K)PUMP},\n year = {1983}\n}\n"}, "authors":
      [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "34912412", "name":
      "L. Yeh"}, {"authorId": "50678030", "name": "L. Ling"}, {"authorId": "152355108",
      "name": "J. Schulz"}, {"authorId": "34784769", "name": "L. English"}]}, {"paperId":
      "24c615f319e6c9c131d1f9bb5b749ea8d69adf16", "externalIds": {"MAG": "2059911212",
      "DOI": "10.1016/0092-8674(82)90064-2", "CorpusId": 36543606, "PubMed": "6807553"},
      "corpusId": 36543606, "publicationVenue": {"id": "e4782337-db2d-4ab2-8eda-a71d1c60709b",
      "name": "Cell", "type": "journal", "alternate_names": ["La Cellule"], "issn":
      "0092-8674", "alternate_issns": ["0008-8757"], "url": "https://www.cell.com/",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00928674",
      "http://www.cell.com/", "https://www.sciencedirect.com/journal/cell", "https://www.biodiversitylibrary.org/bibliography/7344"]},
      "url": "https://www.semanticscholar.org/paper/24c615f319e6c9c131d1f9bb5b749ea8d69adf16",
      "title": "Role of mitochondrial membrane potential in the regulation of murine
      erythroleukemia cell differentiation", "abstract": null, "venue": "Cell", "year":
      1982, "referenceCount": 21, "citationCount": 74, "influentialCitationCount":
      2, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Biology"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Biology", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1982-04-01", "journal": {"volume": "28", "pages": "855-863", "name": "Cell"},
      "citationStyles": {"bibtex": "@Article{Levenson1982RoleOM,\n author = {R. Levenson
      and I. Macara and Roderick L. Smith and L. Cantley and D. Housman},\n booktitle
      = {Cell},\n journal = {Cell},\n pages = {855-863},\n title = {Role of mitochondrial
      membrane potential in the regulation of murine erythroleukemia cell differentiation},\n
      volume = {28},\n year = {1982}\n}\n"}, "authors": [{"authorId": "144579743",
      "name": "R. Levenson"}, {"authorId": "5583964", "name": "I. Macara"}, {"authorId":
      "2108905883", "name": "Roderick L. Smith"}, {"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "10127476", "name": "D. Housman"}]}, {"paperId":
      "5384587f623d397dcc3892038184c7c0b8ac4333", "externalIds": {"MAG": "1645602382",
      "DOI": "10.1016/s0021-9258(19)68263-3", "CorpusId": 26044835, "PubMed": "7054181"},
      "corpusId": 26044835, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/5384587f623d397dcc3892038184c7c0b8ac4333",
      "title": "Evidence that a Na+/Ca2+ antiport system regulates murine erythroleukemia
      cell differentiation.", "abstract": null, "venue": "Journal of Biological Chemistry",
      "year": 1982, "referenceCount": 0, "citationCount": 144, "influentialCitationCount":
      0, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Biology",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Biology", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1982-01-25", "journal": {"volume": "257 2", "pages": "\n          773-80\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Smith1982EvidenceTA,\n author = {R. Smith and I. Macara and R. Levenson
      and D. Housman and L. Cantley},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of biological chemistry},\n pages = {\n          773-80\n        },\n
      title = {Evidence that a Na+/Ca2+ antiport system regulates murine erythroleukemia
      cell differentiation.},\n volume = {257 2},\n year = {1982}\n}\n"}, "authors":
      [{"authorId": "2256101546", "name": "R. Smith"}, {"authorId": "5583964", "name":
      "I. Macara"}, {"authorId": "144579743", "name": "R. Levenson"}, {"authorId":
      "10127476", "name": "D. Housman"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "c7a27fc21d8639e0feb4ce48e7e44ad21bcf6261", "externalIds": {"MAG":
      "1564076413", "CorpusId": 33714376, "PubMed": "6279607"}, "corpusId": 33714376,
      "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal
      of Biological Chemistry", "type": "journal", "alternate_names": ["J Biological
      Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/c7a27fc21d8639e0feb4ce48e7e44ad21bcf6261",
      "title": "The active site structure of Na+- and K+-stimulated ATPase. Location
      of a specific fluorescein isothiocyanate reactive site.", "abstract": "Fluorescein
      5''-isothiocyanate (FITC) has been shown to specifically inactivate the Na+-
      and K+-stimulated adenosine triphosphatase ((Na,K)-ATPase) at low concentrations
      (Karlish, S. J. D. (1979) Na+,K+ATPase Structure and Kinetics 115-128). The
      site of modification of purified dog kidney (Na,K)-ATPase by FITC has been investigated
      by enzymatic cleavage and fluorescence resonance energy transfer. The binding
      of FITC, which occurs at a stoichiometry of approximately one site per ATP binding
      site, causes an ATP-protectable inactivation of ATPase activity suggesting that
      it is reacting at the ATP hydrolysis site. The FITC reaction site apparently
      is located near the center of the COOH-terminal 77,000-dalton peptide fragment
      obtained by chymotryptic cleavage of the alpha subunit. Addition of ouabain
      to the native enzyme in the presence of chymotrypsin enhances cleavage at this
      site and releases the fluorescein moiety from the membrane. It is further shown
      that the distance from the FITC reaction site to the ouabain binding site, as
      judged by fluorescence resonance energy transfer from anthroyl ouabain to FITC,
      is approximately 74 A. These results demonstrate that ouabain inhibits the (Na,K)-ATPase
      by causing a protein conformational change which extends an unusually large
      distance across the membrane.", "venue": "Journal of Biological Chemistry",
      "year": 1982, "referenceCount": 1, "citationCount": 92, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1982-05-25", "journal": {"volume": "257
      10", "pages": "\n          5601-6\n        ", "name": "The Journal of biological
      chemistry"}, "citationStyles": {"bibtex": "@Article{Carilli1982TheAS,\n author
      = {C. Carilli and R. Farley and D. Perlman and L. Cantley},\n booktitle = {Journal
      of Biological Chemistry},\n journal = {The Journal of biological chemistry},\n
      pages = {\n          5601-6\n        },\n title = {The active site structure
      of Na+- and K+-stimulated ATPase. Location of a specific fluorescein isothiocyanate
      reactive site.},\n volume = {257 10},\n year = {1982}\n}\n"}, "authors": [{"authorId":
      "2060790666", "name": "C. Carilli"}, {"authorId": "2284479", "name": "R. Farley"},
      {"authorId": "49822428", "name": "D. Perlman"}, {"authorId": "1723755", "name":
      "L. Cantley"}]}, {"paperId": "7b0a02bd653b60e7b2960a568a2041011551a5d2", "externalIds":
      {"MAG": "36684287", "DOI": "10.1016/B978-0-12-152511-8.50012-8", "CorpusId":
      81930800}, "corpusId": 81930800, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/7b0a02bd653b60e7b2960a568a2041011551a5d2",
      "title": "Structure and Mechanism of the (Na,K)-ATPase", "abstract": null, "venue":
      "", "year": 1981, "referenceCount": 148, "citationCount": 270, "influentialCitationCount":
      2, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": ["Review"], "publicationDate": null, "journal": {"volume":
      "11", "pages": "201-237", "name": ""}, "citationStyles": {"bibtex": "@Inproceedings{Cantley1981StructureAM,\n
      author = {L. Cantley},\n pages = {201-237},\n title = {Structure and Mechanism
      of the (Na,K)-ATPase},\n volume = {11},\n year = {1981}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "9162b6ab998e995be916bb28ac8e70a67bb379bf",
      "externalIds": {"MAG": "2021341443", "DOI": "10.1021/BI00523A009", "CorpusId":
      19370125, "PubMed": "7295699"}, "corpusId": 19370125, "publicationVenue": {"id":
      "ae7a3201-e479-4666-8a93-3d35d6bf7cd1", "name": "Biochemistry", "type": "journal",
      "issn": "0006-2960", "alternate_issns": ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw",
      "alternate_urls": ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/9162b6ab998e995be916bb28ac8e70a67bb379bf",
      "title": "Mechanism of anion exchange across the red cell membrane by band 3:
      interactions between stilbenedisulfonate and NAP-taurine binding sites.", "abstract":
      "Anion exchange across the erythrocyte membrane can be inhibited competitively
      by stilbenedisulfonates, which bind to the external transport of the band 3
      protein, and noncompetitively by external NAP-taurine [2-[N-(4-azido-2-nitrophenyl)amino]ethanesulfonate],
      which it has been suggested binds to a \"modifier site\" [Knauf, P. A., Ship.
      S., Breur, W., MCCulloch, L., & Rothstein, A. (1978) J. Gen. Physiol. 72, 604-630].
      The binding of the two types of inhibitor of erythrocyte membranes is shown
      in the present study to be competitive, indicating that binding to the same
      subunit of band 3 is mutually exclusive. Covalent labeling of red cells with
      a stilbenedisulfonate [4-benzamido-4''-isothiocyano-stilbene-2,2''-disulfonate
      (BIDS)] to 80% saturation had no detectable effect upon the Ki for inhibition
      of [32P]phosphate influx by NAP-taurine, indicating that when bound to adjacent
      subunits in the band 3 dimer, the two types of inhibitor do not interact. In
      addition to the external NAP-taurine site, a second high-affinity NAP-taurine
      site (Kd = 15 microM) was detected on the cytoplasmic side of red cell membranes.
      This site is less than 51 A from the disulfonic stilbene binding site, as judged
      by fluorescence resonance energy transfer from BIDS to NAP-taurine. Binding
      at this site is not affected by covalent attachment of BIDS, and no clear role
      for this site in transport could be determined. On the basis of these studies
      we present a model indicating that disulfonic stilbenes bind to a site which
      overlaps both the anion transport site and the modifier site on a band 3 monomer
      and suggests that the modifier site may be part of a transporting gate.", "venue":
      "Biochemistry", "year": 1981, "referenceCount": 16, "citationCount": 45, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1981-09-29", "journal": {"volume": "20 20", "pages": "\n          5695-701\n        ",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Macara1981MechanismOA,\n
      author = {I. Macara and L. Cantley},\n booktitle = {Biochemistry},\n journal
      = {Biochemistry},\n pages = {\n          5695-701\n        },\n title = {Mechanism
      of anion exchange across the red cell membrane by band 3: interactions between
      stilbenedisulfonate and NAP-taurine binding sites.},\n volume = {20 20},\n year
      = {1981}\n}\n"}, "authors": [{"authorId": "5583964", "name": "I. Macara"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "d4487da1249d636d01e2b45ddebe82561f69665a",
      "externalIds": {"PubMedCentral": "2111862", "MAG": "1968550320", "DOI": "10.1083/JCB.90.2.542",
      "CorpusId": 18168731, "PubMed": "6793600"}, "corpusId": 18168731, "publicationVenue":
      {"id": "bf59074e-18fd-4f9a-a1b0-a9bafc16f518", "name": "Journal of Cell Biology",
      "type": "journal", "alternate_names": ["J Cell Biology"], "issn": "0021-9525",
      "url": "http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=482",
      "alternate_urls": ["http://www.jstor.org/journals/00219525.html", "https://www.jstor.org/journal/jcellbiology",
      "http://www.jcb.org/"]}, "url": "https://www.semanticscholar.org/paper/d4487da1249d636d01e2b45ddebe82561f69665a",
      "title": "Calcium regulates the commitment of murine erythroleukemia cells to
      terminal erythroid differentiation", "abstract": "An alteration in the rate
      of calcium transport appears to be the rate- limiting event for the commitment
      of murine erythroleukemia (MEL) cells to initiate a program of terminal erythroid
      differentiation. The dimethyl sulfoxide (DMSO)-induced commitment of MEL cells
      to erythroid differentiation can be inhibited by treatment of cells with the
      calcium- chelating agent EGTA. Upon removal of EGTA, cells initiate commitment
      without the 12-h lag normally observed after treatment with DMSO alone. Treatment
      of cells with DMSO in the presence of calcium ionophore A23187 causes cells
      to initiate commitment from time zero with no lag. These results suggest that
      the lag is the time required for DMSO to alter the calcium transport properties
      of the cell.", "venue": "Journal of Cell Biology", "year": 1981, "referenceCount":
      12, "citationCount": 73, "influentialCitationCount": 0, "isOpenAccess": true,
      "openAccessPdf": {"url": "https://rupress.org/jcb/article-pdf/90/2/542/1266884/542.pdf",
      "status": null}, "fieldsOfStudy": ["Biology", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Biology", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1981-08-01", "journal": {"volume": "90",
      "pages": "542 - 544", "name": "The Journal of Cell Biology"}, "citationStyles":
      {"bibtex": "@Article{Bridges1981CalciumRT,\n author = {K. Bridges and R. Levenson
      and D. Housman and L. Cantley},\n booktitle = {Journal of Cell Biology},\n journal
      = {The Journal of Cell Biology},\n pages = {542 - 544},\n title = {Calcium regulates
      the commitment of murine erythroleukemia cells to terminal erythroid differentiation},\n
      volume = {90},\n year = {1981}\n}\n"}, "authors": [{"authorId": "145912522",
      "name": "K. Bridges"}, {"authorId": "144579743", "name": "R. Levenson"}, {"authorId":
      "10127476", "name": "D. Housman"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "ed56f186df239bbff63f62a57e00123c91ad1610", "externalIds": {"MAG":
      "2048328629", "DOI": "10.1021/BI00521A001", "CorpusId": 1688960, "PubMed": "7295667"},
      "corpusId": 1688960, "publicationVenue": {"id": "ae7a3201-e479-4666-8a93-3d35d6bf7cd1",
      "name": "Biochemistry", "type": "journal", "issn": "0006-2960", "alternate_issns":
      ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw", "alternate_urls":
      ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/ed56f186df239bbff63f62a57e00123c91ad1610",
      "title": "Interactions between transport inhibitors at the anion binding sites
      of the band 3 dimer.", "abstract": "Evidence is presented that the binding of
      aromatic disulfonates to the external transport sites of the red cell anion-exchange
      protein (band 3) can exhibit negative cooperativity. Fluorescence resonance
      energy transfer has been used to compare the affinities of an aromatic disulfonate
      4,4''-bis-(4-nitro-2,1,3-benzoxadiazolyl)dihydrostilbene-2,2''-disulfonate[H2(NBD)2DS]
      for \"empty\" band 3 dimers (in which neither external transport site is occupied)
      and for \"half-filled\" dimers (in which one site per dimer is occupied by a
      covalently attached fluorescent stilbenedisulfonate). H2(NBD)2DS apparently
      binds to the external anion transport site since it is a potent inhibitor of
      [35S]sulfate influx into red cells (Ki = 20-50 nM), binds reversibly to approximately
      one site per band 3 monomer (1.6 X 10(6) sites/cell), and is displaced by covalent
      labeling with a disulfonic stilbene. The affinity of H2(NBD)2DS for membranes
      in which 80% of the transport sites are occupied by covalently attached 4-benzamido-4''-isothiocyanostilbene-2,2''-disulfonate
      (BIDS) was approximately 1 order of magnitude lower than that for unmodified
      membranes. However, when a similar proportion of the transport sites on red
      cells was blocked by reaction with BIDS, [35S]sulfate was taken up with a lower
      Vmax but with a Km identical with that observed for unmodified cells, suggesting
      that no subunit interactions are necessary for transport. Therefore, in order
      to test whether the observed negative cooperativity of aromatic disulfonate
      binding could be ascribed simply to steric hindrance, the distance between transport
      sites was measured by fluorescence resonance energy transfer. H2(NBD)2DS and
      eosin maleimide were used as acceptors, with BIDS as donor. Transfer efficiencies
      were determined by donor fluorescence quenching, by acceptor fluorescence enhancement,
      and from donor lifetime changes. Uncertainties in the distance were estimated
      from measured depolarization factors. The donor-acceptor distance was found
      to be only 28-52 A. Since the probes are large molecules, they could therefore
      be very close together, and the observed negative cooperativity might be explained
      by overlapping sites. The results suggest that the subunits of a band 3 dimer
      transport anions independently but that access to the transport sites may be
      provided by a cavity between the subunits.", "venue": "Biochemistry", "year":
      1981, "referenceCount": 20, "citationCount": 53, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1981-09-01", "journal": {"volume": "20 18", "pages": "\n          5095-105\n        ",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Macara1981InteractionsBT,\n
      author = {I. Macara and L. Cantley},\n booktitle = {Biochemistry},\n journal
      = {Biochemistry},\n pages = {\n          5095-105\n        },\n title = {Interactions
      between transport inhibitors at the anion binding sites of the band 3 dimer.},\n
      volume = {20 18},\n year = {1981}\n}\n"}, "authors": [{"authorId": "5583964",
      "name": "I. Macara"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "71cb4e8042446a747af14345c888677b882166b3", "externalIds": {"MAG": "2070295305",
      "DOI": "10.1073/PNAS.77.10.5948", "CorpusId": 25967675, "PubMed": "6934526"},
      "corpusId": 25967675, "publicationVenue": {"id": "bb95bf2e-8383-4748-bf9d-d6906d091085",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America", "type": "journal", "alternate_names": ["PNAS", "PNAS online", "Proceedings
      of the National Academy of Sciences of the United States of America.", "Proc
      National Acad Sci", "Proceedings of the National Academy of Sciences", "Proc
      National Acad Sci u s Am"], "issn": "0027-8424", "alternate_issns": ["1091-6490"],
      "url": "https://www.jstor.org/journal/procnatiacadscie", "alternate_urls": ["http://www.pnas.org/",
      "https://www.pnas.org/", "http://www.jstor.org/journals/00278424.html", "www.pnas.org/"]},
      "url": "https://www.semanticscholar.org/paper/71cb4e8042446a747af14345c888677b882166b3",
      "title": "Amiloride inhibits murine erythroleukemia cell differentiation: evidence
      for a Ca2+ requirement for commitment.", "abstract": "The effect of amiloride
      (an inhibitor of passive Na+ transport in many tissues) on the differentiation
      of murine erythroleukemia cells was investigated. Amiloride completely blocked
      the dimethyl sulfoxide (Me2SO)-induced erythroid differentiation of cells at
      a concentration (10 microgram/ml) that did not affect cell proliferation. Amiloride
      also prevented the decrease in cell volume normally observed afte a 20-hr exposure
      to Me2SO. The ratio of total cell Na+ to total cell water was essentially the
      same for control cells, Me2SO-treated cells, and cells treated with Me2SO plus
      amiloride. However, cells treated for 24 hr with Me2SO had a rate of Ca2+ uptake
      that was twice that of untreated cells and a similarly higher Ca2+ content.
      Addition of amiloride plus Me2SO prevented both the increase in Ca2+ uptake
      rate and the increase in Ca2+ content. Cells grown in the presence of Me2SO
      plus amiloride initiated differentiation immediately after removal of amiloride
      or addition of the Ca2+ ionophore A23187 (1 microgram/ml). Addition of sufficient
      ethylene glycol bis(beta-aminoethyl ether)-N,N,N'',N''-tetraacetic acid to reduce
      free extracellular Ca2+ to submicromolar levels prevented Me2SO-induced differentiation
      while only slightly affecting cell proliferation. These results suggest that
      an increase in in the Ca2+ level is an essential step in Me2SO induction, that
      amiloride either directly or indirectly inhibits this process, and that Me2SO
      has an early effect on cells that is necessary for differentiation and is not
      mimicked by A23187.", "venue": "Proceedings of the National Academy of Sciences
      of the United States of America", "year": 1980, "referenceCount": 0, "citationCount":
      92, "influentialCitationCount": 0, "isOpenAccess": true, "openAccessPdf": {"url":
      "https://europepmc.org/articles/pmc350189?pdf=render", "status": null}, "fieldsOfStudy":
      ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source":
      "external"}, {"category": "Medicine", "source": "external"}, {"category": "Biology",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1980-10-01", "journal": {"volume": "77 10", "pages": "\n          5948-52\n        ",
      "name": "Proceedings of the National Academy of Sciences of the United States
      of America"}, "citationStyles": {"bibtex": "@Article{Levenson1980AmilorideIM,\n
      author = {R. Levenson and D. Housman and L. Cantley},\n booktitle = {Proceedings
      of the National Academy of Sciences of the United States of America},\n journal
      = {Proceedings of the National Academy of Sciences of the United States of America},\n
      pages = {\n          5948-52\n        },\n title = {Amiloride inhibits murine
      erythroleukemia cell differentiation: evidence for a Ca2+ requirement for commitment.},\n
      volume = {77 10},\n year = {1980}\n}\n"}, "authors": [{"authorId": "144579743",
      "name": "R. Levenson"}, {"authorId": "10127476", "name": "D. Housman"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "7c09c8649f040bbc281ecdce37ac8d9b9f3f09d2",
      "externalIds": {"MAG": "2092308816", "DOI": "10.1016/0304-4165(80)90268-8",
      "CorpusId": 28159214, "PubMed": "6245716"}, "corpusId": 28159214, "publicationVenue":
      {"id": "08ee3346-e195-4333-b008-be3a4f9e23cd", "name": "Biochimica et Biophysica
      Acta", "type": "journal", "alternate_names": ["Biochim Biophys Acta"], "issn":
      "0006-3002", "alternate_issns": ["1878-2434"], "url": "https://www.elsevier.com/life-sciences/biochemistry-genetics-and-molecular-biology/journals/bba",
      "alternate_urls": ["http://www.sciencedirect.com/science/journal/00063002",
      "http://www.elsevier.com/wps/find/journaldescription.cws_home/506062/description#description"]},
      "url": "https://www.semanticscholar.org/paper/7c09c8649f040bbc281ecdce37ac8d9b9f3f09d2",
      "title": "Glutathione reduces cytoplasmic vanadate. Mechanism and physiological
      implications.", "abstract": null, "venue": "Biochimica et Biophysica Acta",
      "year": 1980, "referenceCount": 29, "citationCount": 234, "influentialCitationCount":
      5, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1980-04-17", "journal": {"volume": "629 1", "pages": "\n          95-106\n        ",
      "name": "Biochimica et biophysica acta"}, "citationStyles": {"bibtex": "@Article{Macara1980GlutathioneRC,\n
      author = {I. Macara and K. Kustin and L. Cantley},\n booktitle = {Biochimica
      et Biophysica Acta},\n journal = {Biochimica et biophysica acta},\n pages =
      {\n          95-106\n        },\n title = {Glutathione reduces cytoplasmic vanadate.
      Mechanism and physiological implications.},\n volume = {629 1},\n year = {1980}\n}\n"},
      "authors": [{"authorId": "5583964", "name": "I. Macara"}, {"authorId": "6237815",
      "name": "K. Kustin"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "7febd16c83d434aeed405d5bc8be94af173610a4", "externalIds": {"MAG": "1480907586",
      "DOI": "10.1016/s0021-9258(18)43471-0", "CorpusId": 21175170, "PubMed": "6253455"},
      "corpusId": 21175170, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/7febd16c83d434aeed405d5bc8be94af173610a4",
      "title": "A study of the vanadate-trapped state of the (Na,K)-ATPase. Evidence
      against interacting nucleotide site models.", "abstract": null, "venue": "Journal
      of Biological Chemistry", "year": 1980, "referenceCount": 1, "citationCount":
      89, "influentialCitationCount": 1, "isOpenAccess": true, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Chemistry", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1980-10-25", "journal": {"volume": "255 20", "pages": "\n          9852-9\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Smith1980ASO,\n author = {R. Smith and K. Zinn and L. Cantley},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          9852-9\n        },\n title = {A study of
      the vanadate-trapped state of the (Na,K)-ATPase. Evidence against interacting
      nucleotide site models.},\n volume = {255 20},\n year = {1980}\n}\n"}, "authors":
      [{"authorId": "2256101546", "name": "R. Smith"}, {"authorId": "2073410407",
      "name": "K. Zinn"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "46a04a9aa293d297cdf93b7c3a96797b30e27525", "externalIds": {"MAG": "2094264339",
      "DOI": "10.1021/BI00588A008", "CorpusId": 38082120, "PubMed": "497152"}, "corpusId":
      38082120, "publicationVenue": {"id": "ae7a3201-e479-4666-8a93-3d35d6bf7cd1",
      "name": "Biochemistry", "type": "journal", "issn": "0006-2960", "alternate_issns":
      ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw", "alternate_urls":
      ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/46a04a9aa293d297cdf93b7c3a96797b30e27525",
      "title": "Location of the stilbenedisulfonate binding site of the human erythrocyte
      anion-exchange system by resonance energy transfer.", "abstract": "The stilbenedisulfonate
      inhibitory site of the human erythrocyte anion-exchange system has been characterized
      by using serveral fluorescent stilbenedisulfonates. The covalent inhibitor 4-benzamido-4''-isothiocyanostilbene-2,2''-disulfonate
      (BIDS) reacts specifically with the band 3 protein of the plasma membrane when
      added to intact erythrocytes, and the reversible inhibitors 4,4''-dibenzamidostilbene-2,2''-disulfonate
      (DBDS) and 4-benzamido-4''-aminostilbene-2,2''-disulfonate (BADS) show a fluorescence
      enhancement upon binding to the inhibitory site on erythrocyte ghosts. The fluorescence
      properties of all three bound probes indicate a rigid, hydrophobic site with
      nearby tryptophan residues. The Triton X-100 solublized and purified band 3
      protein has similar affinities for DBDS, BADS, and 4,4''-dinitrostilbene-2,2''-disulfonate
      (DNDS) to those observed on intact erythrocytes and erythrocyte ghosts, showing
      that the anion binding site is not perturbed by the solubilization procedure.
      The distance between the stilbenedisulfonate binding site and a group of cysteine
      residues on the 40 000-dalton amino-terminal cytoplasmic domain of band 3 was
      measured by the fluorescence resonance energy transfer technique. Four different
      fluorescent sulfhydryl reagents were used as either energy transfer donors or
      energy transfer acceptors in combination with the stilbenedisulfonates (BIDS,
      DBDS, BADS, and DNDS). Efficiencies of transfer were measured by sensitized
      emisssion, donor quenching, and donor lifetime changes. Although these sites
      are approachable from opposite sides of the membrane by impermeant reagents,
      they are separated by only 34--42 A, indicating that the anion binding site
      is located in a protein cleft which extends some distance into the membrane.",
      "venue": "Biochemistry", "year": 1979, "referenceCount": 0, "citationCount":
      93, "influentialCitationCount": 1, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy": [{"category":
      "Chemistry", "source": "external"}, {"category": "Medicine", "source": "external"},
      {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1979-10-16", "journal": {"volume": "18 21", "pages": "\n          4505-16\n        ",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Rao1979LocationOT,\n
      author = {A. Rao and P. Martin and R. Reithmeier and L. Cantley},\n booktitle
      = {Biochemistry},\n journal = {Biochemistry},\n pages = {\n          4505-16\n        },\n
      title = {Location of the stilbenedisulfonate binding site of the human erythrocyte
      anion-exchange system by resonance energy transfer.},\n volume = {18 21},\n
      year = {1979}\n}\n"}, "authors": [{"authorId": "2113654796", "name": "A. Rao"},
      {"authorId": "2107715199", "name": "P. Martin"}, {"authorId": "3310395", "name":
      "R. Reithmeier"}, {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId":
      "8d1a31924429e4045ce8ef4417db41788aa52c55", "externalIds": {"MAG": "1980265359",
      "DOI": "10.1038/282520A0", "CorpusId": 4306035, "PubMed": "503233"}, "corpusId":
      4306035, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/8d1a31924429e4045ce8ef4417db41788aa52c55",
      "title": "Human erythrocyte anion exchange site characterised using a fluorescent
      probe", "abstract": null, "venue": "Nature", "year": 1979, "referenceCount":
      4, "citationCount": 34, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}],
      "publicationTypes": ["JournalArticle"], "publicationDate": "1979-11-29", "journal":
      {"volume": "282", "pages": "520-522", "name": "Nature"}, "citationStyles": {"bibtex":
      "@Article{Dix1979HumanEA,\n author = {J. Dix and A. Verkman and A. K. Solomon
      and L. Cantley},\n booktitle = {Nature},\n journal = {Nature},\n pages = {520-522},\n
      title = {Human erythrocyte anion exchange site characterised using a fluorescent
      probe},\n volume = {282},\n year = {1979}\n}\n"}, "authors": [{"authorId": "6156118",
      "name": "J. Dix"}, {"authorId": "4265624", "name": "A. Verkman"}, {"authorId":
      "4595664", "name": "A. K. Solomon"}, {"authorId": "1723755", "name": "L. Cantley"}]},
      {"paperId": "9d3256dd8e7e75a9d8de4457630ae7ee8dddce49", "externalIds": {"MAG":
      "1528985492", "DOI": "10.1016/s0021-9258(17)37721-9", "CorpusId": 32153077,
      "PubMed": "217870"}, "corpusId": 32153077, "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f",
      "name": "Journal of Biological Chemistry", "type": "journal", "alternate_names":
      ["J Biological Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/9d3256dd8e7e75a9d8de4457630ae7ee8dddce49",
      "title": "The fate of cytoplasmic vanadium. Implications on (NA,K)-ATPase inhibition.",
      "abstract": null, "venue": "Journal of Biological Chemistry", "year": 1979,
      "referenceCount": 0, "citationCount": 244, "influentialCitationCount": 1, "isOpenAccess":
      true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1979-03-25", "journal": {"volume": "254 6", "pages": "\n          1781-4\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Cantley1979TheFO,\n author = {L. Cantley and P. Aisen},\n booktitle
      = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          1781-4\n        },\n title = {The fate of
      cytoplasmic vanadium. Implications on (NA,K)-ATPase inhibition.},\n volume =
      {254 6},\n year = {1979}\n}\n"}, "authors": [{"authorId": "1723755", "name":
      "L. Cantley"}, {"authorId": "145150128", "name": "P. Aisen"}]}, {"paperId":
      "334f40046bdc39bcffc3a345de1fb83e2e145cd9", "externalIds": {"MAG": "2033463478",
      "DOI": "10.1038/272552A0", "CorpusId": 4253398, "PubMed": "211419"}, "corpusId":
      4253398, "publicationVenue": {"id": "6c24a0a0-b07d-4d7b-a19b-fd09a3ed453a",
      "name": "Nature", "type": "journal", "issn": "0028-0836", "url": "https://www.nature.com/",
      "alternate_urls": ["http://www.nature.com/nature/", "https://www.nature.com/nature/",
      "http://www.nature.com/nature/archive/index.html"]}, "url": "https://www.semanticscholar.org/paper/334f40046bdc39bcffc3a345de1fb83e2e145cd9",
      "title": "Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic
      side", "abstract": null, "venue": "Nature", "year": 1978, "referenceCount":
      14, "citationCount": 352, "influentialCitationCount": 9, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Chemistry", "source": "s2-fos-model"}, {"category":
      "Medicine", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1978-04-06", "journal": {"volume": "272", "pages": "552-554",
      "name": "Nature"}, "citationStyles": {"bibtex": "@Article{Cantley1978VanadateIT,\n
      author = {L. Cantley and M. Resh and G. Guidotti},\n booktitle = {Nature},\n
      journal = {Nature},\n pages = {552-554},\n title = {Vanadate inhibits the red
      cell (Na+, K+) ATPase from the cytoplasmic side},\n volume = {272},\n year =
      {1978}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "3397888", "name": "M. Resh"}, {"authorId": "2219731", "name": "G. Guidotti"}]},
      {"paperId": "6ab4b81575435abd775ca99bdf20923451991723", "externalIds": {"MAG":
      "2051820316", "DOI": "10.1021/JA00484A053", "CorpusId": 85222955}, "corpusId":
      85222955, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/6ab4b81575435abd775ca99bdf20923451991723",
      "title": "Norepinephrine complexes and reduced vanadium(V) to reverse vanadate
      inhibition of the (sodium, potassium ion)-dependent ATPase", "abstract": null,
      "venue": "", "year": 1978, "referenceCount": 0, "citationCount": 80, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry"],
      "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate":
      "1978-08-01", "journal": {"volume": "100", "pages": "5210-5212", "name": "Journal
      of the American Chemical Society"}, "citationStyles": {"bibtex": "@Article{Cantley1978NorepinephrineCA,\n
      author = {L. Cantley and J. Ferguson and K. Kustin},\n journal = {Journal of
      the American Chemical Society},\n pages = {5210-5212},\n title = {Norepinephrine
      complexes and reduced vanadium(V) to reverse vanadate inhibition of the (sodium,
      potassium ion)-dependent ATPase},\n volume = {100},\n year = {1978}\n}\n"},
      "authors": [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "143945662",
      "name": "J. Ferguson"}, {"authorId": "6237815", "name": "K. Kustin"}]}, {"paperId":
      "b4aa3804656faa15b4e890c790c3bb280b369665", "externalIds": {"MAG": "2025657863",
      "DOI": "10.1021/BI00596A006", "CorpusId": 20399818, "PubMed": "145873"}, "corpusId":
      20399818, "publicationVenue": {"id": "ae7a3201-e479-4666-8a93-3d35d6bf7cd1",
      "name": "Biochemistry", "type": "journal", "issn": "0006-2960", "alternate_issns":
      ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw", "alternate_urls":
      ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/b4aa3804656faa15b4e890c790c3bb280b369665",
      "title": "Reaction of (Na-K)ATPase with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole:
      evidence for an essential tyrosine at the active site.", "abstract": "The reaction
      of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole [NBD-Cl] with purified eel electrophax
      Na+ and K+ stimulated adenosine triphosphatase [(Na-K)ATPase] has been monitored
      by changes in the (Na-K)ATPase activity, the K+ stimulated p-nitrophenyl phosphatase
      [PNPase] activity, and the protein ultraviolet absorption spectrum. The NBD-Cl
      reacts with two tyrosine residues per mol of enzyme (approximately 6-7 nmol/mg
      of protein), as judged by changes in protein absorption spectra and incorporation
      of [14C]NBD-Cl. The modified tyrosine groups are located on the Mr = 95 000
      polypeptide chain and react at different rates. Only one tyrosine modification
      is necessary for complete inhibition of (Na-K)ATPase activity, although both
      must be modified for complete inhibition of PNPase activity. Reversal of these
      modifications by 2-mercaptoethanol restores 65% of both activities. Na+ increases
      the rate of tyrosine modification, K+ decreases the rate, and ATP affords the
      more reactive tyrosine group complete protection. NBD-Cl modification of approximately
      6-7 nmol of tyrosine groups/mg of protein results in a large decrease in ATP
      affinity as judged by equilibrium binding. These results are compared with similar
      results obtained from NBD-Cl modification of the coupling factors of oxidative
      phosphorylation and photophosphorylation. A model is presented suggesting an
      asymmetric arrangement of two 95 000 polypeptide chains with a single tyrosine
      residue at the ATP site.", "venue": "Biochemistry", "year": 1978, "referenceCount":
      46, "citationCount": 64, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1978-02-07", "journal": {"volume": "17 3", "pages": "\n          418-25\n        ",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Cantley1978ReactionO,\n
      author = {L. Cantley and J. Gelles and L. Josephson},\n booktitle = {Biochemistry},\n
      journal = {Biochemistry},\n pages = {\n          418-25\n        },\n title
      = {Reaction of (Na-K)ATPase with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: evidence
      for an essential tyrosine at the active site.},\n volume = {17 3},\n year =
      {1978}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "4616517", "name": "J. Gelles"}, {"authorId": "5095505", "name": "L. Josephson"}]},
      {"paperId": "fc2e434d53c2fcf193dd89519c278e5a676bcfc0", "externalIds": {"MAG":
      "2309189149", "CorpusId": 41917525, "PubMed": "212422"}, "corpusId": 41917525,
      "publicationVenue": {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal
      of Biological Chemistry", "type": "journal", "alternate_names": ["J Biological
      Chem"], "issn": "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/fc2e434d53c2fcf193dd89519c278e5a676bcfc0",
      "title": "A characterization of vanadate interactions with the (Na,K)-ATPase.
      Mechanistic and regulatory implications.", "abstract": "The interaction of vanadium
      in the +5 oxidation state (vanadate) with purified dog kidney Na+ and K+-stim-
      ulated adenosine trlphosphatase [(Na,K)-ATPase] has been studied using equilibrium
      binding, steady state kinetics, and measurements of relaxation kinetics. Van-
      adate binds to one high affinity site (Kl = 4 no) and one low afinity site (Kz
      = 0.5", "venue": "Journal of Biological Chemistry", "year": 1978, "referenceCount":
      2, "citationCount": 449, "influentialCitationCount": 6, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy":
      [{"category": "Medicine", "source": "external"}, {"category": "Chemistry", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1978-10-25", "journal": {"volume": "253 20", "pages": "\n          7361-8\n        ",
      "name": "The Journal of biological chemistry"}, "citationStyles": {"bibtex":
      "@Article{Cantley1978ACO,\n author = {L. Cantley and L. Cantley and L. Josephson},\n
      booktitle = {Journal of Biological Chemistry},\n journal = {The Journal of biological
      chemistry},\n pages = {\n          7361-8\n        },\n title = {A characterization
      of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory
      implications.},\n volume = {253 20},\n year = {1978}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5601835", "name": "L. Cantley"},
      {"authorId": "5095505", "name": "L. Josephson"}]}, {"paperId": "94a9c6dd32da30388c035b8ffa3e362adcf81a13",
      "externalIds": {"MAG": "2071273962", "DOI": "10.1021/BI00640A006", "CorpusId":
      12403766, "PubMed": "143955"}, "corpusId": 12403766, "publicationVenue": {"id":
      "ae7a3201-e479-4666-8a93-3d35d6bf7cd1", "name": "Biochemistry", "type": "journal",
      "issn": "0006-2960", "alternate_issns": ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw",
      "alternate_urls": ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/94a9c6dd32da30388c035b8ffa3e362adcf81a13",
      "title": "Isolation of a potent (Na-K)ATPase inhibitor from striated muscle.",
      "abstract": null, "venue": "Biochemistry", "year": 1977, "referenceCount": 16,
      "citationCount": 223, "influentialCitationCount": 2, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1977-10-18", "journal": {"volume": "16 21", "pages": "\n          4572-8\n        ",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Josephson1977IsolationOA,\n
      author = {L. Josephson and L. Cantley},\n booktitle = {Biochemistry},\n journal
      = {Biochemistry},\n pages = {\n          4572-8\n        },\n title = {Isolation
      of a potent (Na-K)ATPase inhibitor from striated muscle.},\n volume = {16 21},\n
      year = {1977}\n}\n"}, "authors": [{"authorId": "5095505", "name": "L. Josephson"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "c07c1345f4b920f35507ddeb521e30a9f119e58f",
      "externalIds": {"MAG": "1520021552", "DOI": "10.1016/s0021-9258(17)40978-1",
      "CorpusId": 44622950, "PubMed": "144127"}, "corpusId": 44622950, "publicationVenue":
      {"id": "099a2ecc-54f9-42d3-9ea0-0189027aa04f", "name": "Journal of Biological
      Chemistry", "type": "journal", "alternate_names": ["J Biological Chem"], "issn":
      "0021-9258", "url": "http://ejournals.ebsco.com/direct.asp?JournalID=101729",
      "alternate_urls": ["https://www.jbc.org/", "http://www.jbc.org/"]}, "url": "https://www.semanticscholar.org/paper/c07c1345f4b920f35507ddeb521e30a9f119e58f",
      "title": "Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived
      from muscle.", "abstract": null, "venue": "Journal of Biological Chemistry",
      "year": 1977, "referenceCount": 0, "citationCount": 761, "influentialCitationCount":
      14, "isOpenAccess": true, "openAccessPdf": null, "fieldsOfStudy": ["Medicine",
      "Chemistry"], "s2FieldsOfStudy": [{"category": "Medicine", "source": "external"},
      {"category": "Chemistry", "source": "external"}, {"category": "Chemistry", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1977-11-10", "journal": {"volume": "252
      21", "pages": "\n          7421-3\n        ", "name": "The Journal of biological
      chemistry"}, "citationStyles": {"bibtex": "@Article{Cantley1977VanadateIA,\n
      author = {L. Cantley and L. Josephson and R. Warner and M. Yanagisawa and C.
      Lechene and G. Guidotti},\n booktitle = {Journal of Biological Chemistry},\n
      journal = {The Journal of biological chemistry},\n pages = {\n          7421-3\n        },\n
      title = {Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from
      muscle.},\n volume = {252 21},\n year = {1977}\n}\n"}, "authors": [{"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5095505", "name": "L. Josephson"},
      {"authorId": "50212668", "name": "R. Warner"}, {"authorId": "2285635", "name":
      "M. Yanagisawa"}, {"authorId": "4383026", "name": "C. Lechene"}, {"authorId":
      "2219731", "name": "G. Guidotti"}]}, {"paperId": "1933b03efcc743de8ffcfac014a539327914a3f8",
      "externalIds": {"MAG": "2035636114", "DOI": "10.1021/BI00646A001", "CorpusId":
      32111571, "PubMed": "1247500"}, "corpusId": 32111571, "publicationVenue": {"id":
      "ae7a3201-e479-4666-8a93-3d35d6bf7cd1", "name": "Biochemistry", "type": "journal",
      "issn": "0006-2960", "alternate_issns": ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw",
      "alternate_urls": ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/1933b03efcc743de8ffcfac014a539327914a3f8",
      "title": "Investigation of quercetin binding sites on chloroplast coupling factor
      1.", "abstract": "The quercetin binding sites on spinach chloroplast coupling
      factor 1 (CF1) have been investigated using direct and competitive binding,
      stopped-flow, temperature-jump, and fluorescence resonance energy transfer measurements.
      It was found that 8-anilino-1-naphthalensulfonic acid (ANS) competes with quercetin
      binding at two sites on the solubilized enzyme which are distinct from the two
      tight nucleotide binding sites and the 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole
      (NBD-Cl) reactive site. The bimolecular association of quercetin with CF1 is
      too fast to measure directly and is followed by two slower conformational changes.
      The distances from the tight nucleotide sites to the quercetin-ANS sites were
      estimated as 40-48 A by fluorescence resonance energy transfer using 1,N6-ethenoadenosine
      diphosphate and 1,N6-ethenoadenylyl imidodiphosphate as donors and quercetin
      as the acceptor. The distance from the quercetin-ANS site to the NBD-C1 reactive
      site was found to be about 30 A using ANS as a donor and NBD-C1 reacted with
      a tyrosine group on CF1 as the energy acceptor. A model is proposed for the
      relative location of these sites on CF1.", "venue": "Biochemistry", "year":
      1976, "referenceCount": 21, "citationCount": 57, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1976-01-13", "journal": {"volume": "15
      1", "pages": "\n          1-8\n        ", "name": "Biochemistry"}, "citationStyles":
      {"bibtex": "@Article{Cantley1976InvestigationOQ,\n author = {L. Cantley and
      G. Hammes},\n booktitle = {Biochemistry},\n journal = {Biochemistry},\n pages
      = {\n          1-8\n        },\n title = {Investigation of quercetin binding
      sites on chloroplast coupling factor 1.},\n volume = {15 1},\n year = {1976}\n}\n"},
      "authors": [{"authorId": "1723755", "name": "L. Cantley"}, {"authorId": "5738308",
      "name": "G. Hammes"}]}, {"paperId": "8658daf8f8dab887596f8a62f5a2be942e6d7d28",
      "externalIds": {"MAG": "2035688421", "DOI": "10.1021/BI00646A002", "CorpusId":
      1211586, "PubMed": "129152"}, "corpusId": 1211586, "publicationVenue": {"id":
      "ae7a3201-e479-4666-8a93-3d35d6bf7cd1", "name": "Biochemistry", "type": "journal",
      "issn": "0006-2960", "alternate_issns": ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw",
      "alternate_urls": ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/8658daf8f8dab887596f8a62f5a2be942e6d7d28",
      "title": "Characterization of sulfhydryl groups on chloroplast coupling factor
      1 exposed by heat activation.", "abstract": "Two sulfhydryl groups in the gamma
      subunit of solubilized chloroplast coupling factor 1 (CF1) are exposed by heat
      activating the enzyme. These two groups have been selectively labeled with [3H]-N-ethylmaleimide,
      N-[p-(2-benzoxazolyl)phenyl]maleimide (NBPM), and N-(4-dimethylamino-3,5-dinitrophenyl)maleimide
      (DDPM). Modifying these groups did not appreciably effect Ca2+-ATPase activity,
      the ability of the enzyme to bind quercetin and 1,N6-ethenoadenosine diphosphate
      (epsilonADP), or the ability of the enzyme to react with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole
      (NBD-C1). Fluorescence resonance energy transfer was used to measure the distance
      from the sulfhydryl groups on the gamma subunit to the quercetin sites, the
      NBD-C1 reactive sites, and the tight nucleotide sites on CF1 using the donor-acceptor
      pairs NBPM-quercetin, NBPM-NBD, and epsilonADP-DDPM, respectively. The distance
      from the sulfhydryl groups to the quercetin sites was found to be less than
      30 A, the distance to the NBD-C1 reactive was 34-41 A, and the distance to the
      tight nucleotide sites as greater than 40 A. A three-dimensional symmetrical
      model is proposed for the relative positions of sites on CF1.", "venue": "Biochemistry",
      "year": 1976, "referenceCount": 27, "citationCount": 30, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1976-01-13", "journal": {"volume": "15
      1", "pages": "\n          9-14\n        ", "name": "Biochemistry"}, "citationStyles":
      {"bibtex": "@Article{Cantley1976CharacterizationOS,\n author = {L. Cantley and
      G. Hammes},\n booktitle = {Biochemistry},\n journal = {Biochemistry},\n pages
      = {\n          9-14\n        },\n title = {Characterization of sulfhydryl groups
      on chloroplast coupling factor 1 exposed by heat activation.},\n volume = {15
      1},\n year = {1976}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "5738308", "name": "G. Hammes"}]}, {"paperId": "988933ac97cd043955512a566ce3b19a0c8aa3e9",
      "externalIds": {"MAG": "1967263378", "DOI": "10.1021/BI00669A013", "CorpusId":
      33424448, "PubMed": "136980"}, "corpusId": 33424448, "publicationVenue": {"id":
      "ae7a3201-e479-4666-8a93-3d35d6bf7cd1", "name": "Biochemistry", "type": "journal",
      "issn": "0006-2960", "alternate_issns": ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw",
      "alternate_urls": ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/988933ac97cd043955512a566ce3b19a0c8aa3e9",
      "title": "A slow interconversion between active and inactive states of the (Na-K)ATPase.",
      "abstract": "We have examined slow changes in the rate of ATP hydrolysis for
      purified dog kidney Na+ and K+ stimulated adenosine triphosphatase [(Na-K)ATPase]
      at various concentrations of free Mg2+, Mg-ATP, K+, and Na+. The effect of these
      ligands on the rate of ATP hydrolysis is explained by a rapid binding step determining
      the initial rate of turnover followed by a slow conformational change. Inactivation
      of enzyme stored in the presence of ethylenediaminetetraacetic acid occurs upon
      adding free Mg2+, Mg-ATP, and K+; reactivation may be achieved if the concentration
      of these ligands is reduced. Because of the slow conformational change, the
      affinities for ligands affecting inactivation are time dependent. A model is
      presented to explain the effects of free Mg2+ and Ma-ATP on (Na-K)ATPase activity.",
      "venue": "Biochemistry", "year": 1976, "referenceCount": 26, "citationCount":
      26, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": ["Medicine", "Chemistry"], "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "external"}, {"category": "Chemistry", "source": "external"},
      {"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1976-11-30", "journal": {"volume": "15 24", "pages": "\n          5280-7\n        ",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Cantley1976ASI,\n
      author = {L. Cantley and L. Josephson},\n booktitle = {Biochemistry},\n journal
      = {Biochemistry},\n pages = {\n          5280-7\n        },\n title = {A slow
      interconversion between active and inactive states of the (Na-K)ATPase.},\n
      volume = {15 24},\n year = {1976}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "5095505", "name": "L. Josephson"}]}, {"paperId":
      "a42ba50dfd6939496fc0d25e5c3c3accf057c814", "externalIds": {"MAG": "2080861877",
      "DOI": "10.1021/BI00684A027", "CorpusId": 36277958, "PubMed": "1148187"}, "corpusId":
      36277958, "publicationVenue": {"id": "ae7a3201-e479-4666-8a93-3d35d6bf7cd1",
      "name": "Biochemistry", "type": "journal", "issn": "0006-2960", "alternate_issns":
      ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw", "alternate_urls":
      ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/a42ba50dfd6939496fc0d25e5c3c3accf057c814",
      "title": "Characterization of nucleotide binding sites on chloroplast coupling
      factor 1.", "abstract": "A study of the equilibrium binding of ADP, 1,N6-ethenoadenosine
      diphosphate, adenylyl imidodiphosphate, and 1,N6-ethenoadenylyl imidodiphosphate
      to solubilized spinach chloroplast coupling factor 1 (CF1) has been carried
      out. All four nucleotides were found to bind to two apparently identical \"tight\"
      sites, with characteristic dissociation contants generally less than 10 muM.
      The binding to these \"tight\" sites is similar in the presence of Mg2+ and
      Ca2+, is stronger in 0.1 M NaC1 than in 20 mM Tris-C1, and is only slightly
      altered by heat activation. The slow rate of association of ADP and 1,N6-ethenoadenosine
      diphosphate at these sites rules out the possibility that they are catalytic
      sites for ATPase activity on the solubilized enzyme. A third tight site for
      adenylyl imidodiphosphate was found on the heat-activated enzyme. The dissociation
      constant for this interaction (7.6 muM) is similar to the adenylyl imidodiphosphate
      competitive inhibition constant for ATPase activity (4 muM). ADP, which inhibits
      ATPase activity but is not a strong competitive inhibitor, binds only weakly
      at a third site (dissociation constant greater than 70 muM). One mole of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole
      reacted per mole of CF1 prevents ADP and adenylyl imidodiphosphate binding at
      the \"catalytic\" site and abolishes the ATPase activity. A model is proposed
      in which the \"tight\" nucleotide binding sites act as allosteric conformational
      switches for the ATPase activity of solubilizedCF1.", "venue": "Biochemistry",
      "year": 1975, "referenceCount": 23, "citationCount": 93, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}], "publicationTypes": ["JournalArticle"], "publicationDate":
      "1975-07-01", "journal": {"volume": "14 13", "pages": "\n          2968-75\n        ",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Cantley1975CharacterizationON,\n
      author = {L. Cantley and G. Hammes},\n booktitle = {Biochemistry},\n journal
      = {Biochemistry},\n pages = {\n          2968-75\n        },\n title = {Characterization
      of nucleotide binding sites on chloroplast coupling factor 1.},\n volume = {14
      13},\n year = {1975}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L.
      Cantley"}, {"authorId": "5738308", "name": "G. Hammes"}]}, {"paperId": "bbfdb526852c4c10aabe021b41cc3e2739458ff4",
      "externalIds": {"MAG": "2031413887", "DOI": "10.1021/BI00684A028", "CorpusId":
      31588230, "PubMed": "1148188"}, "corpusId": 31588230, "publicationVenue": {"id":
      "ae7a3201-e479-4666-8a93-3d35d6bf7cd1", "name": "Biochemistry", "type": "journal",
      "issn": "0006-2960", "alternate_issns": ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw",
      "alternate_urls": ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/bbfdb526852c4c10aabe021b41cc3e2739458ff4",
      "title": "Fluorescence energy transfer between ligand binding sites on chloroplast
      coupling factor 1.", "abstract": "The method of fluorescence energy transfer
      is used to measure the distance from the tight nucleotide binding sites to the
      7-chloro-4-nitrobenzo-2-oxa-1,3-diazole reactive sites on solubilized spinach
      chloroplast coupling factor 1 (CF1). The fluorescent adenine nucleotide analogs
      1,N-6-ethenoadenosine diphosphate and 1,N-6-ethenoadenylyl imidodiphosphate
      were used as donors and 4-nitrobenzo-2-oxa-1,3-diazole bound to a tyrosine group
      and to an amino group were used as acceptors of energy transfer. Using three
      different donor-acceptor pairs, the distance measured varied from 38 to 43 A
      assuming both donor sites are equidistant from the acceptor site. A model is
      proposed for the location of the tight nucleotide binding sites and the active
      site on the alpha and beta subunits of CF1.", "venue": "Biochemistry", "year":
      1975, "referenceCount": 16, "citationCount": 67, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry",
      "Medicine"], "s2FieldsOfStudy": [{"category": "Chemistry", "source": "external"},
      {"category": "Medicine", "source": "external"}, {"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}], "publicationTypes":
      ["JournalArticle"], "publicationDate": "1975-07-01", "journal": {"volume": "14
      13", "pages": "\n          2976-81\n        ", "name": "Biochemistry"}, "citationStyles":
      {"bibtex": "@Article{Cantley1975FluorescenceET,\n author = {L. Cantley and G.
      Hammes},\n booktitle = {Biochemistry},\n journal = {Biochemistry},\n pages =
      {\n          2976-81\n        },\n title = {Fluorescence energy transfer between
      ligand binding sites on chloroplast coupling factor 1.},\n volume = {14 13},\n
      year = {1975}\n}\n"}, "authors": [{"authorId": "1723755", "name": "L. Cantley"},
      {"authorId": "5738308", "name": "G. Hammes"}]}, {"paperId": "8dacd1423377b87714687115f8287fb8555c1923",
      "externalIds": {"MAG": "2068021516", "DOI": "10.1021/BI00748A014", "CorpusId":
      30213623, "PubMed": "4271561"}, "corpusId": 30213623, "publicationVenue": {"id":
      "ae7a3201-e479-4666-8a93-3d35d6bf7cd1", "name": "Biochemistry", "type": "journal",
      "issn": "0006-2960", "alternate_issns": ["2632-0983"], "url": "https://pubs.acs.org/journal/bichaw",
      "alternate_urls": ["http://pubs.acs.org/journal/bichaw", "https://mts.intechopen.com/series/biochemistry",
      "http://pubs.acs.org/journals/bichaw/index.html", "http://pubs.acs.org/journal/bichaw?cookieSet=1"]},
      "url": "https://www.semanticscholar.org/paper/8dacd1423377b87714687115f8287fb8555c1923",
      "title": "Activation of beef heart mitochondrial adenosine triphosphatase by
      2,4-dinitrophenol.", "abstract": null, "venue": "Biochemistry", "year": 1973,
      "referenceCount": 15, "citationCount": 56, "influentialCitationCount": 0, "isOpenAccess":
      false, "openAccessPdf": null, "fieldsOfStudy": ["Chemistry", "Medicine"], "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "external"}, {"category": "Medicine", "source":
      "external"}, {"category": "Biology", "source": "s2-fos-model"}, {"category":
      "Chemistry", "source": "s2-fos-model"}], "publicationTypes": ["JournalArticle"],
      "publicationDate": "1973-11-20", "journal": {"volume": "12 24", "pages": "\n          4900-4\n        ",
      "name": "Biochemistry"}, "citationStyles": {"bibtex": "@Article{Cantley1973ActivationOB,\n
      author = {L. Cantley and G. Hammes},\n booktitle = {Biochemistry},\n journal
      = {Biochemistry},\n pages = {\n          4900-4\n        },\n title = {Activation
      of beef heart mitochondrial adenosine triphosphatase by 2,4-dinitrophenol.},\n
      volume = {12 24},\n year = {1973}\n}\n"}, "authors": [{"authorId": "1723755",
      "name": "L. Cantley"}, {"authorId": "5738308", "name": "G. Hammes"}]}, {"paperId":
      "370d9a009edf4cedd253c4e46dc82d541280e135", "externalIds": {"CorpusId": 16821735},
      "corpusId": 16821735, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/370d9a009edf4cedd253c4e46dc82d541280e135",
      "title": "The Phosphoinositide 3-kinase Regulatory Subunit P85 Can Exert Tumor
      Suppressor Properties through Negative Regulation of Growth Factor Signaling
      Publisher American Association for Cancer Research Accessed Terms of Use Detailed
      Terms the Pi3k Regulatory Subunit P85\u03b1 Can Exert Tumor Suppressor Proper",
      "abstract": "The MIT Faculty has made this article openly available. Please
      share how this access benefits you. Your story matters. Abstract PI3K plays
      a critical role in tumorigenesis and the PI3K p85 regulatory subunit exerts
      both positive and negative effects on signaling. Expression of Pik3r1, the gene
      encoding p85, is decreased in human prostate, lung, ovarian, bladder and liver
      cancers consistent with the possibility that p85 has tumor suppressor properties.
      We tested this hypothesis by studying mice with a liver-specific deletion of
      the Pik3r1 gene. These mice exhibited enhanced insulin and growth factor signaling
      and progressive changes in hepatic pathology, leading to the development of
      aggressive hepatocellular carcinomas with pulmonary metastases. Liver tumors
      that arose exhibited a markedly elevated level of phosphatidylinositol-3,4,5-trisphosphate
      (PIP3), along with Akt activation and and decreased PTEN expression, at both
      the mRNA and protein levels. Together, these results substantiate the concept
      that the p85 subunit of PI3K has a tumor suppressive role in the liver and possibly
      other tissues.", "venue": "", "year": null, "referenceCount": 46, "citationCount":
      1, "influentialCitationCount": 0, "isOpenAccess": false, "openAccessPdf": null,
      "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category": "Biology", "source":
      "s2-fos-model"}, {"category": "Medicine", "source": "s2-fos-model"}], "publicationTypes":
      null, "publicationDate": null, "journal": null, "citationStyles": {"bibtex":
      "@Misc{None,\n author = {Citation Taniguchi and J. Winnay and T. Kondo and R.
      T. Bronson and A. Guimaraes and J. O. Aleman and J. Luo and Cullen M. Taniguchi
      and J. Winnay and T. Kondo and R. T. Bronson and A. Guimaraes and J. O. Aleman
      and Ji Luo and G. Stephanopoulos and R. Weissleder and L. Cantley and C. Kahn
      and Ronald Kahn and Joslin},\n title = {The Phosphoinositide 3-kinase Regulatory
      Subunit P85 Can Exert Tumor Suppressor Properties through Negative Regulation
      of Growth Factor Signaling Publisher American Association for Cancer Research
      Accessed Terms of Use Detailed Terms the Pi3k Regulatory Subunit P85\u03b1 Can
      Exert Tumor Suppressor Proper}\n}\n"}, "authors": [{"authorId": "2253564652",
      "name": "Citation Taniguchi"}, {"authorId": "3687146", "name": "J. Winnay"},
      {"authorId": "2253641982", "name": "T. Kondo"}, {"authorId": "2244849748", "name":
      "R. T. Bronson"}, {"authorId": "2057465705", "name": "A. Guimaraes"}, {"authorId":
      "2247548886", "name": "J. O. Aleman"}, {"authorId": "2253914425", "name": "J.
      Luo"}, {"authorId": "2240776654", "name": "Cullen M. Taniguchi"}, {"authorId":
      "3687146", "name": "J. Winnay"}, {"authorId": "2253641982", "name": "T. Kondo"},
      {"authorId": "2244849748", "name": "R. T. Bronson"}, {"authorId": "2057465705",
      "name": "A. Guimaraes"}, {"authorId": "2247548886", "name": "J. O. Aleman"},
      {"authorId": "2247448227", "name": "Ji Luo"}, {"authorId": "1813278", "name":
      "G. Stephanopoulos"}, {"authorId": "3127756", "name": "R. Weissleder"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "144391716", "name": "C. Kahn"},
      {"authorId": "2250868285", "name": "Ronald Kahn"}, {"authorId": "2254003153",
      "name": "Joslin"}]}, {"paperId": "50e70f931b25f06d0d2085529580c973aede55b8",
      "externalIds": {"CorpusId": 207793454}, "corpusId": 207793454, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/50e70f931b25f06d0d2085529580c973aede55b8",
      "title": "Cell Metabolism Previews PI 3 K Enters Beta-Testing", "abstract":
      "Adam J. Shaywitz,1,2 Kevin D. Courtney,1,3 Akash Patnaik,1,4 and Lewis C. Cantley1,5,*
      1Division of Signal Transduction 2Division of Endocrinology Beth Israel Deaconess
      Medical Center, Boston, MA 02215, USA 3Department of Medical Oncology, Dana-Farber
      Cancer Institute, Boston, MA 02115, USA 4Division of Hematology/Oncology, Beth
      Israel Deaconess Medical Center, Boston, MA 02215, USA 5Department of Systems
      Biology, Harvard Medical School, Boston, MA 02115, USA *Correspondence: lewis_cantley@hms.harvard.edu
      DOI 10.1016/j.cmet.2008.08.011", "venue": "", "year": null, "referenceCount":
      0, "citationCount": 0, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Medicine", "source": "s2-fos-model"}, {"category": "Biology", "source": "s2-fos-model"}],
      "publicationTypes": ["Review"], "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Misc{None,\n author = {A. Shaywitz and K. Courtney and Akash Patnaik
      and L. Cantley},\n title = {Cell Metabolism Previews PI 3 K Enters Beta-Testing}\n}\n"},
      "authors": [{"authorId": "4635185", "name": "A. Shaywitz"}, {"authorId": "13782167",
      "name": "K. Courtney"}, {"authorId": "40501341", "name": "Akash Patnaik"}, {"authorId":
      "1723755", "name": "L. Cantley"}]}, {"paperId": "86e16b2299ef230a67506a9a93d0310a972d7763",
      "externalIds": {"CorpusId": 5698342}, "corpusId": 5698342, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/86e16b2299ef230a67506a9a93d0310a972d7763",
      "title": "Methionine-Labeled Proteins in CHO / IR Cells", "abstract": null,
      "venue": "", "year": null, "referenceCount": 0, "citationCount": 0, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}, {"category": "Chemistry",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Misc{None,\n author = {N. Ruderman
      and R. Kapeller and Morris F. Whites and L. Cantley},\n title = {Methionine-Labeled
      Proteins in CHO / IR Cells}\n}\n"}, "authors": [{"authorId": "3978573", "name":
      "N. Ruderman"}, {"authorId": "2028875", "name": "R. Kapeller"}, {"authorId":
      "2104916910", "name": "Morris F. Whites"}, {"authorId": "1723755", "name": "L.
      Cantley"}]}, {"paperId": "cfab756f944676f58c653d205bcf932f10fa0020", "externalIds":
      {"CorpusId": 22941542}, "corpusId": 22941542, "publicationVenue": null, "url":
      "https://www.semanticscholar.org/paper/cfab756f944676f58c653d205bcf932f10fa0020",
      "title": "Synthesis and Activity of C 11-Modified Wortmannin Probes for PI 3
      Kinase", "abstract": "The key role played by PI3 kinase in cancer, hormone action,
      and a host of other biological functions suggests that specific inhibitors whose
      disposition could be ascertained in vivo would be useful in biological research
      or, potentially, for imaging PI3K in a clinical setting. Wortmannin (Wm, 1)
      is an inhibitor of PI3 kinase with high specificity for this enzyme. We synthesized
      three modified Wm probes, a biotinylated Wm (7a), a 4-hydroxy-3-iodophenylated
      Wm, which was obtained both unlabeled (7b) and labeled with 125I (8), and a
      fluoresceinated Wm (7c), through modification at C-11, and evaluated their inhibitive
      activity as inhibitors of PI3 kinase. Biotinylated (7a) and 4-hydroxy-3-iodophenylated
      Wm\u2019s (7b) had IC50s for PI3K of 6.11 and 11.02 nM, respectively, compared
      to an IC50 for Wm of 1.63 nM. Fluoresceinated Wm (7c) lost considerably more
      activity than the other derivatives, with an IC50 of 64.9 nM. The 125I labeled
      4-hydroxy-3-iodophenylated Wm (8) could be detected after reaction with an immunoprecipitate
      of PI3 kinase. The activity of these reporter Wm\u2019s is discussed in relationship
      to earlier findings on the pharmacological activity of Wm derivatives and the
      ability of inhibitors to fit into the ATP pocket of PI3 kinase.", "venue": "",
      "year": null, "referenceCount": 23, "citationCount": 2, "influentialCitationCount":
      0, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Chemistry", "source": "s2-fos-model"}, {"category": "Medicine",
      "source": "s2-fos-model"}], "publicationTypes": null, "publicationDate": null,
      "journal": null, "citationStyles": {"bibtex": "@Misc{None,\n author = {Hushan
      Yuan and Ji Luo and S. Field and R. Weissleder and L. Cantley and L. Josephson},\n
      title = {Synthesis and Activity of C 11-Modified Wortmannin Probes for PI 3
      Kinase}\n}\n"}, "authors": [{"authorId": "6230104", "name": "Hushan Yuan"},
      {"authorId": "145954100", "name": "Ji Luo"}, {"authorId": "123039768", "name":
      "S. Field"}, {"authorId": "3127756", "name": "R. Weissleder"}, {"authorId":
      "1723755", "name": "L. Cantley"}, {"authorId": "5095505", "name": "L. Josephson"}]},
      {"paperId": "d01c021f3f20c64e03e049f42e520b2921b04c78", "externalIds": {"CorpusId":
      207769406}, "corpusId": 207769406, "publicationVenue": null, "url": "https://www.semanticscholar.org/paper/d01c021f3f20c64e03e049f42e520b2921b04c78",
      "title": "Histone Methylation-Adenosylmethionine and S Influence of Threonine
      Metabolism on", "abstract": null, "venue": "", "year": null, "referenceCount":
      0, "citationCount": 1, "influentialCitationCount": 0, "isOpenAccess": false,
      "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy": [{"category":
      "Biology", "source": "s2-fos-model"}, {"category": "Chemistry", "source": "s2-fos-model"}],
      "publicationTypes": null, "publicationDate": null, "journal": null, "citationStyles":
      {"bibtex": "@Misc{None,\n author = {Ng Shyh\u2010Chang and J. Locasale and C.
      Lyssiotis and Yuxiang Zheng and Ren Yi Teo and Sutheera Ratanasirintrawoot and
      Jin Zhang and T. Onder and J. Unternaehrer and Hao Zhu and J. Asara and G. Daley
      and L. Cantley},\n title = {Histone Methylation-Adenosylmethionine and S Influence
      of Threonine Metabolism on}\n}\n"}, "authors": [{"authorId": "1397529716", "name":
      "Ng Shyh\u2010Chang"}, {"authorId": "2268976", "name": "J. Locasale"}, {"authorId":
      "4901222", "name": "C. Lyssiotis"}, {"authorId": "1723564", "name": "Yuxiang
      Zheng"}, {"authorId": "50651504", "name": "Ren Yi Teo"}, {"authorId": "5878690",
      "name": "Sutheera Ratanasirintrawoot"}, {"authorId": "2117170793", "name": "Jin
      Zhang"}, {"authorId": "5073178", "name": "T. Onder"}, {"authorId": "38764542",
      "name": "J. Unternaehrer"}, {"authorId": "1410084451", "name": "Hao Zhu"}, {"authorId":
      "3028470", "name": "J. Asara"}, {"authorId": "2028224", "name": "G. Daley"},
      {"authorId": "1723755", "name": "L. Cantley"}]}, {"paperId": "d3ba40f9be03277b52740056c787ecda4ca42f2c",
      "externalIds": {"CorpusId": 13613107}, "corpusId": 13613107, "publicationVenue":
      null, "url": "https://www.semanticscholar.org/paper/d3ba40f9be03277b52740056c787ecda4ca42f2c",
      "title": "Evolution of Ime 2 Phosphorylation Sites on Cdk 1 Substrates Provides
      a Mechanism to Limit the Effects of the Phosphatase Cdc 14 in Meiosis", "abstract":
      "Progression through meiosis in yeast is governed by the cyclin-dependent kinase
      Cdk1, in concert with a related kinase called Ime2. It remains unclear how these
      kinases collaborate to meet the unique demands of meiotic progression. We demonstrate
      that Ime2 and Cdk1 phosphorylate an overlapping substrate set and that the two
      kinases overlap functionally as inhibitors of the ubiquitin ligase APC and replication
      origin licensing. Surprisingly, Ime2 phosphorylates Cdk1 substrates at distinct
      phosphorylation sites that are highly resistant to dephosphorylation by the
      phosphatase Cdc14. We propose that Ime2-dependent phosphorylation of a subset
      of cell-cycle proteins limits the effects of Cdc14 in meiosis.", "venue": "",
      "year": null, "referenceCount": 56, "citationCount": 9, "influentialCitationCount":
      1, "isOpenAccess": false, "openAccessPdf": null, "fieldsOfStudy": null, "s2FieldsOfStudy":
      [{"category": "Biology", "source": "s2-fos-model"}], "publicationTypes": null,
      "publicationDate": null, "journal": null, "citationStyles": {"bibtex": "@Misc{None,\n
      author = {L. Holt and Jessica E. Hutti and L. Cantley and D. Morgan},\n title
      = {Evolution of Ime 2 Phosphorylation Sites on Cdk 1 Substrates Provides a Mechanism
      to Limit the Effects of the Phosphatase Cdc 14 in Meiosis}\n}\n"}, "authors":
      [{"authorId": "4344976", "name": "L. Holt"}, {"authorId": "6742227", "name":
      "Jessica E. Hutti"}, {"authorId": "1723755", "name": "L. Cantley"}, {"authorId":
      "35719273", "name": "D. Morgan"}]}]}

      '
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - keep-alive
      Content-Length:
      - '198579'
      Content-Type:
      - application/json
      Date:
      - Wed, 27 Dec 2023 21:46:51 GMT
      Via:
      - 1.1 8364ca155003e291b521198d3285c5d6.cloudfront.net (CloudFront)
      X-Amz-Cf-Id:
      - IMaXsUvDeaYInY5Edbc9F3OGxo31tDao_vDSOAR47QanoyIXCJGbgA==
      X-Amz-Cf-Pop:
      - GRU3-P4
      X-Cache:
      - Miss from cloudfront
      x-amz-apigw-id:
      - Qn0zzEL-PHcEcSw=
      x-amzn-Remapped-Connection:
      - keep-alive
      x-amzn-Remapped-Content-Length:
      - '198579'
      x-amzn-Remapped-Date:
      - Wed, 27 Dec 2023 21:46:51 GMT
      x-amzn-Remapped-Server:
      - gunicorn
      x-amzn-RequestId:
      - d080ec46-ad4b-4833-8b0b-5e0ec602ef9f
    http_version: HTTP/1.1
    status_code: 200
version: 1
